<SEC-DOCUMENT>0000950123-20-002894.txt : 20200511
<SEC-HEADER>0000950123-20-002894.hdr.sgml : 20200511
<ACCEPTANCE-DATETIME>20200313215834
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-20-002894
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		52
FILED AS OF DATE:		20200316
<PUBLIC-REL-DATE>20200511
DATE AS OF CHANGE:		20200313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLIANT THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001746473
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474272481
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-02641
		FILM NUMBER:		20715111

	BUSINESS ADDRESS:	
		STREET 1:		260 LITTLEFIELD AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-481-6770

	MAIL ADDRESS:	
		STREET 1:		260 LITTLEFIELD AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>DRS/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As confidentially submitted to the Securities and Exchange Commission on March 13,
2020, as Amendment No. 3 to the Confidential Submission dated May&nbsp;10, 2019. </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>This draft registration statement has not been
filed publicly with the Securities and Exchange Commission and all information contained herein remains confidential. </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </B></P> <P STYLE="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-1</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>PLIANT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>2834</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">47-4272481</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>260 Littlefield Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, CA 94080 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">481-6770</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code and telephone number, including area code, of Registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Bernard Coulie, M.D., Ph.D. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>260 Littlefield Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, CA 94080 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">481-6770</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sam Zucker</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Deepa M. Rich</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>James
Xu</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin Procter LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>601 Marshall Street</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Redwood
City, CA 94063</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">752-3100</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Keith Cummings</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Chief Financial Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>260 Littlefield Avenue</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, CA 94080</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">481-6770</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Kristin VanderPas</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sean Clayton</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>David
Peinsipp</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Charles S. Kim</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>101 California
Street 5th Floor</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>San Francisco, CA 94111</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(415) <FONT STYLE="white-space:nowrap">693-2000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this registration
statement. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933 check the following box.&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT
STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148;
and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE>  <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF
REGISTRATION FEE </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of Each Class&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities to be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering Price(1)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registration&nbsp;Fee(2)</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Common Stock, par value $0.0001 per share</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Includes the offering price of any additional shares that the underwriters have the option to
purchase. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price. </TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the Registration
Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#de1a1e"><B>The information in this preliminary prospectus is not complete and may be changed. We may not
sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in
any state or other jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#de1a1e"><B>SUBJECT TO COMPLETION,
DATED&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PRELIMINARY PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g20r95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is the initial public offering of our common stock. We are selling
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock. Prior to this offering there has been no public market for our shares. We currently expect the initial public offering price to
be between $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted the underwriters an option to purchase up to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares of common stock. The underwriters can exercise this option at any time within 30&nbsp;days after the date of this prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to list our common stock on The Nasdaq Global Market under the symbol &#147;PLRX.&#148; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our common stock involves risks. See &#147;<A HREF="#toc729258_3">Risk Factors</A>&#148; beginning on page&nbsp;12. </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Act of 2012 and, as such, we have elected to comply
with certain reduced reporting requirements for this prospectus and may elect to do so in future filings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Offering Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting Discounts and
Commissions<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds to Pliant Therapeutics, Inc. (before expenses)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See &#147;Underwriting&#148; for additional information regarding total underwriter compensation. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters expect to deliver the shares of common stock to purchasers on or
about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 through book-entry facilities of The Depository Trust Company. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Joint Book-Running Managers </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:16pt">
<TD VALIGN="top"><B>Citigroup</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Cowen&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Piper Sandler</B></TD></TR>
</TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Lead Manager </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Needham&nbsp;&amp; Company </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_2">The Offering</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_4">Cautionary Note Regarding Forward-looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_999">Market and Industry Data and Forecasts </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_6">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_7">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_8">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_9">Selected Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_10">Management&#146;s Discussion and Analysis of Financial Condition and Results
 of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_11">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_12">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_13">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_13a">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_14">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_15">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_16">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_17">Shares Eligible for Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_18">Material U.S. Federal Income Tax Considerations to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_19">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_20">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_21">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_22">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_23">Index to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the underwriters have not authorized anyone to provide any information other than that contained
in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
you. We and the underwriters are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the
front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For investors outside of the United States: We have not, and the underwriters have not, done anything that would permit this offering or
possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside of the United States. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should
consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our financial statements and the related notes included elsewhere in this prospectus. You should also
consider, among other things, the matters described in the sections entitled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; Unless otherwise stated, all references
to &#147;us,&#148; &#147;our,&#148; &#147;Pliant,&#148; &#147;we,&#148; the &#147;Company&#148; and similar designations refer to Pliant Therapeutics, Inc. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Overview </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a
clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set of proprietary tools designed to discover and <FONT
STYLE="white-space:nowrap">de-risk</FONT> product candidates quickly and efficiently. Our wholly-owned lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule dual selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. We
have completed a Phase&nbsp;1a SAD/MAD trial and a Phase&nbsp;1b proof-of-mechanism trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and are currently enrolling two Phase&nbsp;2a trials in IPF. We also plan to submit an
investigational new drug application, or IND, for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of PSC in the first half of 2020, and plan to initiate a Phase&nbsp;2a PSC trial as soon as possible thereafter. Our second product
candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 for the treatment of liver fibrosis associated with NASH, which we have partnered with
Novartis. <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is currently undergoing a Phase&nbsp;1 trial with top-line data expected in the second half of 2020. In addition to our clinical programs, we currently have preclinical integrin-based
programs in lead-optimization stage targeting oncology and muscular dystrophies. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fibrosis Background </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis refers to excessive scarring, often resulting from aberrant tissue repair processes. Fibrosis occurs when normal tissue repair
pathways become dysregulated, causing excessive collagen deposition in the affected organs and ultimately impairing their physiological function. Fibrosis occurs in many organ systems throughout the body including the lungs, liver, kidneys,
gastrointestinal tract, skin and muscles. While the exact pathologies for diseases in these organs vary, the development of fibrosis involves many common cell types and biochemical pathways including the transforming growth factor beta, or <FONT
STYLE="white-space:nowrap">TGF-&szlig;,</FONT> signaling pathway. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> and Integrins in Fibrosis
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling is the central pathway by which fibrosis occurs. <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> is a signaling molecule that is secreted by cells as an inactive complex and stored in the extra-cellular matrix. In healthy tissue, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> is transiently
activated in response to tissue injury, resulting in collagen production and, ultimately, healing of the tissue. In fibrosis, however, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> becomes continuously activated, leading to excess collagen
production, sometimes even in the absence of the initial tissue injury, which leads to thickening and stiffening of tissues. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There
have been a number of prior approaches to treating fibrosis through <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> inhibition, including through antibodies to <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> and its receptor. However,
systemic blockade of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling has shown significant toxicity due to effects on <FONT STYLE="white-space:nowrap">TGF-&szlig;&#146;s</FONT> normal physiologic functions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> can be activated by a class of cell surface proteins known as integrins. In certain
fibrotic diseases such as IPF and PSC, the integrins <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, which are normally expressed at very low levels, have been
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shown to be upregulated and to cause the continuous activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We believe that, by inhibiting fibrosis-specific <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activators such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, it may be possible to block abnormal
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in fibrotic tissues without affecting <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling in healthy tissues. Historically, integrin drug development has been hampered by the
difficulty of developing integrin inhibitors that are both selective for specific integrins and bioavailable. We believe our pipeline of bioavailable, highly selective integrin inhibitors has the potential to address these challenges. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Pipeline </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g06c08.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We plan to submit an IND for PLN-74809 for the treatment of PSC in the first half of 2020 incorporating the data from the completed Phase 1a/1b healthy volunteer trials and plan to initiate a Phase&nbsp;2a clinical
trial for PSC thereafter. </TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and PSC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead wholly-owned product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule, dual-selective inhibitor
of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 that we are advancing in IPF and PSC. IPF is the most common and severe form of progressive pulmonary fibrosis, affecting
approximately 140,000 patients in the United States. The average life expectancy for patients with confirmed IPF is between three and five years. There are currently two U.S. Food and Drug Administration, or FDA, approved therapies for IPF. Both
have shown modest slowing of disease progression. However, both therapies have raised significant safety and tolerability concerns. PSC is a progressive liver disorder affecting approximately 30,000 to 45,000 patients in the United States. Patients
have a median survival of 10 to 12&nbsp;years without intervention and carry high lifetime risk of developing gastrointestinal malignancies. There are currently no <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapies for PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While expressed at very low levels in normal tissues, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are upregulated in the pulmonary tissues of IPF patients, and in the liver tissues of PSC patients. They both serve as activators of <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> leading to
increased collagen production and fibrosis in these tissues. By blocking <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, we believe <FONT STYLE="white-space:nowrap">PLN-74809</FONT> may slow and potentially halt the progression of fibrosis in these patient populations.
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> has been granted orphan drug designation by the FDA for both IPF and PSC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
completed a Phase 1a single ascending dose, or SAD, multiple ascending dose, or MAD, and food effect clinical trial involving 85 healthy volunteers in which <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was shown to be orally bioavailable and
generally well tolerated with a half-life that may support once-daily dosing. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also completed a Phase 1b proof-of-mechanism trial in healthy volunteers
evaluating PLN-74809&#146;s ability to inhibit TGF-&szlig; activation as measured through pSMAD2/3 activation levels. pSMADs act as signaling molecules directly downstream from the TGF-&szlig; receptor, and therefore pSMAD2/3 activation is used as a
reliable biomarker for TGF-&szlig; activation. In the Phase 1b trial, PLN-74809 was shown to inhibit TGF-&szlig; activation by up to 70% in alveolar macrophages collected from healthy volunteers, in a dose- and exposure-dependent manner.
Additionally, PLN-74809 was well tolerated with only mild adverse events and no drug-related adverse events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently enrolling
two Phase 2a trials of PLN-74809 in IPF. In the first of these trials, we plan to enroll IPF patients and utilize a positron emission tomography, or PET, ligand to measure av&szlig;6 target engagement by PLN-74809 in the lungs post-treatment. The
second trial is a 12-week double blind placebo-controlled trial enrolling IPF patients across up to four cohorts consisting of up to three doses of PLN-74809 and one placebo and will evaluate safety, tolerability and pharmacokinetics, or PK. We also
plan to employ exploratory efficacy endpoints including Quantitative Lung Fibrosis imaging analysis, biomarkers and pulmonary function. We plan to submit an IND for PLN-74809 in PSC in the first half of 2020 and initiate a Phase 2a trial as soon as
possible thereafter. This trial is expected to be a 12-week double blind placebo-controlled trial enrolling PSC patients across up to four cohorts consisting of up to three doses of PLN-74809 and one placebo and will evaluate safety, tolerability
and PK. We also plan to employ exploratory efficacy endpoints including biomarkers and evaluation of liver-stiffness. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PLN-1474 in F3/F4 Liver
Fibrosis Associated with NASH </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second clinical-stage product candidate, PLN-1474, is a small-molecule, selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 in development for treatment of stage F3/F4 liver fibrosis associated with nonalcoholic steatohepatitis, or NASH. NASH is a more severe form of non-alcoholic fatty liver disease, or NAFLD. In October
2019, we entered into a license and collaboration agreement with Novartis Institutes for Biomedical Research, Inc., or Novartis, in which Novartis licensed global rights to PLN-1474. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NASH is highly prevalent, affecting approximately 16.5&nbsp;million adults in the United States, including approximately 3.3&nbsp;million with
stage F3/F4 fibrosis. The stage of fibrosis is the strongest predictor of liver-related morbidity and all-cause mortality in NASH. Patients with F3 and F4 fibrosis carry liver-related mortality risk that is 17 times and 42 times greater,
respectively, than NASH patients without fibrosis. Therefore, we believe that treating F3/F4 liver fibrosis will have an impact on liver-related morbidity and all-cause mortality in NASH. There are currently no approved therapies for NASH and the
candidates in development to date have shown only modest antifibrotic effects in published clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our collaboration
with Novartis, Novartis will reimburse us for all development activities associated with the PLN-1474 Phase 1 trials and will be responsible for all development and commercialization activities following Phase 1 trials. Novartis will also pay us
tiered royalties, on a product-by-product basis based on annual net sales of products, at percentages ranging from high-single digits to low-double digits of the applicable licensed products and mid-single digits to high-single digits for the
applicable research products. In addition to PLN-1474, during the research term, Novartis will also collaborate with us on up to three separate research programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 serves as an activator of TGF-&szlig; and its expression has been shown to be
upregulated in activated hepatic stellate cells and correlated with severity of liver fibrosis. By inhibiting <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, we believe PLN-1474 could have a potent direct antifibrotic effect in advanced
liver fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have shown through our assays of live human fibrotic liver tissue that PLN-1474 is able to decrease the expression of
pro-fibrotic genes such as <I>COL1A1</I>, the gene associated with the production of the most abundant </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
type of collagen produced in fibrosis. We have also shown in multiple animal models of NASH that PLN-1474 has a potent anti-fibrotic effect. We are currently conducting a Phase 1a trial of
PLN-1474 in healthy volunteers with data expected in the second half of 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our clinical programs, we are developing two
additional preclinical integrin-based programs. The first of these is our oncology program. As TGF-&szlig; biology has been elucidated, it has become increasingly understood in the scientific literature that TGF-&szlig; plays an important
anti-inflammatory role in the tumor micro-environment, preventing T-cell infiltration and inhibiting release of various cytokines. This mechanism is becoming increasingly recognized as a potential cause of the resistance to checkpoint inhibitors
such as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> therapies seen in many tumors. We are targeting the TGF-&szlig; activating integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8, which is
upregulated in certain tumors with the goal of sensitizing tumors to checkpoint inhibitors. This program has generated positive data in preclinical tumor models and is currently in the lead-optimization phase of development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second preclinical program is an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor being developed for
treatment of muscular dystrophies, including Duchenne Muscular Dystrophy. The target integrin is upregulated on muscle cells across multiple muscular dystrophy indications, acting as a substitute for dystrophin and helping to anchor muscle cells to
the extracellular matrix. The program utilizes an allosteric agonistic antibody to activate the target in order to augment the naturally occurring compensatory mechanism. Because the antibody is not mutation specific, it could potentially be
effective as a single therapy or in combination with other treatment modalities across multiple muscular dystrophy indications. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Approach and Capabilities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach to drug development in fibrosis combines our deep knowledge of the biology of fibrosis with various cellular, tissue, and <I>in
vivo</I> assays developed in house to uncover pathways and potential targets. We have developed and utilized a quantitative fibrosis target expression atlas to identify and validate novel fibrosis targets. We have built a library of over 7,000
integrin inhibitors that we test against these identified targets to select potential candidates. In addition to our integrin library, we have a non-integrin based library of over 70,000 compounds that we also screen against non-integrin targets. We
evaluate potential candidates in a series of integrin selectivity assays, cell-based assays, precision cut tissue slices and animal models prior to advancing our product candidates into development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A key component of our de-risking strategy is our live fibrotic human tissue program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We obtain live fibrotic human tissue post-transplant through partnerships with research hospitals and organ tissue networks and utilize
proprietary protocols to maintain viability of these tissues for multiple days. We test our product candidates in this live tissue and measure multiple markers of antifibrotic activity, effectively bridging the gap between animal models and clinical
proof-of-concept. We believe data from these live fibrotic human tissue experiments will increase our confidence that the tested product candidates will show anti-fibrotic effects in patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once in the clinic, we continue to <FONT STYLE="white-space:nowrap">de-risk</FONT> our programs by designing clinical trials that allow us to
show proof-of-mechanism in advance of clinical efficacy data. We utilize pharmacodynamic biomarkers and advanced imaging techniques, including positron emission tomography, or PET, to evaluate target engagement of our product candidates over
relatively short time periods and observe whether the product candidate is having its anticipated effect. We believe these collective capabilities uniquely allow us to (i)&nbsp;efficiently identify targets, (ii)&nbsp;optimize the potency and
selectivity of candidates and <FONT STYLE="white-space:nowrap">(iii)&nbsp;de-risk</FONT> product candidates in advance of clinical proof-of-concept. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant was founded in 2015 by world-renowned researchers Dean Sheppard, Rik Derynck,
Bill DeGrado and Hal Chapman from the University of California, San Francisco who bring broad experience in fibrosis biology and small-molecule chemistry among other related disciplines. In addition, we have built an executive team with highly
relevant experience in drug discovery and clinical development. To date, Pliant has raised over $220&nbsp;million from investors including, Third Rock Ventures, Cowen Healthcare Investments, Eventide Asset Management, Novartis, Redmile Group,
Farallon Capital Management, Cormorant Asset Management, Surveyor Capital (a Citadel company), Logos Capital Schroder Adveq Management, Menlo Ventures, <FONT STYLE="white-space:nowrap">S-Cubed</FONT> Capital and Agent Capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Strategy </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is
to become a world-leading fibrosis company, developing and commercializing disease-modifying therapies across a spectrum of fibrotic diseases. To achieve this, we are focused on the following key strategies: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Rapidly advance <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and PSC through clinical development and
commercialization. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Rapidly advance our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> through Phase 1
for subsequent trials in NASH associated liver fibrosis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Selectively evaluate additional partnerships in indications and geographies where we believe partners can add
commercial and/or development capabilities. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Explore opportunities for our pipeline assets in additional fibrotic indications. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Leverage our industry leading tools and capabilities to advance our mission of becoming a leading fibrosis
company. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Associated with Our Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more
fully in the section entitled &#147;Risk Factors.&#148; These risks include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have a limited operating history, which may make it difficult to evaluate our prospects and likelihood of
success. </P></TD></TR></TABLE>   <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our business is highly dependent on the success of our lead product candidate,
<FONT STYLE="white-space:nowrap">PLN-74809,</FONT> as well as any other product candidates that we advance into the clinic. All of our product candidates will require significant additional preclinical and clinical development before we may be able
to seek regulatory approval for and launch a product commercially. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Clinical development involves a lengthy, complex and expensive process, with an uncertain outcome.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the
development and commercialization of PLN-74809 or any other product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could
be delayed or otherwise adversely affected. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We face substantial competition, which may result in others discovering, developing or commercializing products
before or more successfully than us. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pandemics such as the COVID-19 coronavirus could have an adverse impact on our developmental programs and our
financial condition. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to
develop current product candidates or identify and develop new product candidates will be impaired, could result in loss of markets or market share and could make us less competitive. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our success depends in part on our ability to protect our intellectual property. It is difficult and costly to
protect our proprietary rights and technology, and we may not be able to ensure their protection. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate History and Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated under the laws of the State of Delaware in June 2015. Our principal executive office is located at 260 Littlefield
Avenue, South San Francisco, California 94080, and our telephone number is (650) <FONT STYLE="white-space:nowrap">481-6770.</FONT> Our website address is https://pliantrx.com. We do not incorporate the information on or accessible through our
website into this prospectus, and you should not consider any information on, or that can be accessed through, our website as part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use various trademarks and trade names in our business, including without limitation our corporate name and logo. All other trademarks or
trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks and trade names in this prospectus may be referred to without the
<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and <I><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></I> symbols, but such references should not be construed as any indicator that their respective owners will not assert, to
the fullest extent under applicable law, their rights thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Implications of Being an Emerging Growth Company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We qualify as an &#147;emerging growth company,&#148; or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or
the JOBS Act. As an EGC, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">being permitted to present only two years of audited financial statements in this prospectus and only two years
of related &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in our periodic reports and registration statements, including this prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act of 2002, as amended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements, and
registration statements, including in this prospectus; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may take advantage of these exemptions for up to
five years from the date of effectiveness of this registration statement or such earlier time that we are no longer an EGC. We will cease to be an EGC on the date that is the earliest of (i)&nbsp;the last day of the fiscal year in which we have
total annual gross revenues of $1.07&nbsp;billion or more; (ii)&nbsp;the last day of our fiscal year following the fifth anniversary of the date of the completion of this offering; (iii)&nbsp;the date on which we have issued more than
$1.0&nbsp;billion in nonconvertible debt during the previous three years; or (iv)&nbsp;the last day of the fiscal year in which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission, or SEC, which
means the market value of our common stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June 30th. We may choose to take advantage of some but not all of these exemptions. We have
taken advantage of reduced reporting requirements in this prospectus. Accordingly, the information contained herein may be different from the </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information you receive from other public companies in which you hold stock. In addition, the JOBS Act provides that an EGC can take advantage of an extended transition period for complying with
new or revised accounting standards. This provision allows an EGC to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to use this extended transition period for
complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an EGC or (ii) affirmatively and irrevocably opt out of the extended
transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_2"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Option to purchase additional shares </P></TD>
<TD>We have granted the underwriters an option to purchase up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us. The underwriters can exercise this option at any time within 30 days
from the date of this prospectus. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after this offering </P></TD>
<TD><BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares (or&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters exercise their option to purchase additional shares in
full). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate that we will receive net proceeds from the sale of our common stock in this offering of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million
if the underwriters exercise in full their option to purchase additional shares, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the price range set forth on the cover
page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We intend to use the net proceeds from this offering to fund the clinical development of our lead product candidate, <FONT
STYLE="white-space:nowrap">PLN-74809,</FONT> the ongoing clinical trial development of our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> the preclinical development of our early-stage programs in oncology and muscular
dystrophy, and for business development activities, working capital and other general corporate purposes. See the section entitled &#147;Use of Proceeds&#148; for additional information. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should read carefully the section entitled &#147;Risk Factors&#148; and other information included in this prospectus for a discussion of factors that you should consider before deciding to invest in our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Proposed Nasdaq Global Market symbol </P></TD>
<TD>&#147;PLRX&#148; </TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding after this offering is based on
147,221,857&nbsp;shares of common stock (including our redeemable convertible preferred stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) outstanding as of December 31, 2019, and excludes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">28,527,313 shares of common stock issuable upon the conversion of our Series C redeemable convertible preferred
stock issued in February 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,593,137 shares of our common stock issuable upon the exercise of options outstanding as of December&nbsp;31,
2019, under the 2015 Equity Incentive Plan, or the 2015 Plan, at a weighted-average exercise price of $0.45 per share, or pursuant to rights to purchase restricted stock at a weighted-average purchase price of $0.01 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,054,837 shares of our common stock reserved for future issuance under the 2015 Plan as of December&nbsp;31,
2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock reserved for
future issuance under our 2020 Stock Option and Incentive Plan, or the 2020 Plan, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part; and </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock reserved for
future issuance under our 2020 Employee Stock Purchase Plan, or the 2020 ESPP, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, this prospectus reflects and assumes the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT>
reverse stock split of our common stock to be effected on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into an
aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock immediately prior to the completion of this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the outstanding options or purchase rights described above; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their option to purchase up to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of our common stock in this offering; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing and effectiveness of our amended and restated certificate of incorporation and the adoption of our
amended and restated bylaws, which will occur immediately prior the completion of this offering. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise
indicated, the number of shares of common stock outstanding includes &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unvested restricted shares of common stock subject to repurchase as of December 31, 2019. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Summary Financial Data </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present summary financial data for our business. We have derived the summary statements of operations data for the years
ended December&nbsp;31, 2018 and 2019 from our audited financial statements included elsewhere in this prospectus. We have derived the summary balance sheet data as of December 31, 2019, from our audited financial statements included elsewhere in
this prospectus. Our historical results are not necessarily indicative of the results that may be expected in the future and our operating results for the year ended December 31, 2019 are not necessarily indicative of the actual or expected results
for any other interim periods or any future period. You should read this data together with our financial statements and related notes appearing elsewhere in this prospectus and the information in the sections entitled &#147;Selected Financial
Data&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(In thousands, except share and per share amounts)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended December 31, </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders, basic and diluted<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used in computing net loss per share attributable to common stockholders,
basic and diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,608,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders, basic and diluted<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing pro forma net loss per share attributable to
common stockholders, basic and diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See Notes 2 and 16 to our financial statements included elsewhere in the prospectus for an explanation of the calculations of our basic and diluted net loss per share, pro forma net loss per share and the
weighted-average number of shares used in the computation of the per share amounts. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December 31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B><br><B>As<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(2)(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheets Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">102,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">) &nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma column in the balance sheet data table above gives effect to (i) our issuance and sale in February 2020 of an additional 28,527,313 shares of Series C redeemable convertible preferred stock for gross
proceeds of $52.2 million; (ii) the automatic conversion of all outstanding shares of our redeemable convertible preferred stock as of December 31, 2019 into an aggregate of 131,861,966&nbsp;shares of our common stock immediately prior to the
completion of this offering as if such conversion had occurred on December 31, 2019; and (iii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation, which will occur immediately prior to the completion of this
offering. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma as adjusted column in the balance sheet data table above gives effect to (i)&nbsp;the pro forma adjustments set forth in footnote (1)&nbsp;above; and (ii)&nbsp;the issuance and sale of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the price
range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. See our financial statements and related notes appearing elsewhere in this prospectus for details regarding our current assets and current
liabilities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the price range set forth on the cover page of this
prospectus, would increase or decrease, as applicable, the amount of each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated
offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase or decrease of 1.0&nbsp;million shares in the number of shares we are offering would increase or decrease, as applicable, the
amount of each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, based on the assumed initial public offering
price per share, the midpoint of the price range as set forth on the cover page of this prospectus, remains the same. The pro forma as adjusted information is illustrative only, and we will adjust this information based on the actual initial public
offering price and other terms of this offering determined at pricing. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_3"></A>RISK FACTORS</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other
information in this prospectus, including our financial statements and related notes appearing elsewhere in this prospectus and in the section entitled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations,&#148; before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. In such an event,
the market price of our common stock could decline and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Position and Need for Additional Capital </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have incurred significant net losses since inception and we expect to continue to incur significant net losses for the foreseeable
future. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred significant net losses in each reporting period since our inception and have financed our operations
principally through equity financing.&nbsp;We continue to incur significant research and development and other expenses related to our ongoing operations. For the years ended December&nbsp;31, 2018 and 2019, we reported a net loss of $30.3 million
and $0.6&nbsp;million, respectively. As of December&nbsp;31, 2019, we had an accumulated deficit of $76.3&nbsp;million. We have devoted substantially all of our resources and efforts to research and development and we expect that it will be several
years, if ever, before we generate revenue from product sales. Even if we receive marketing approval for and commercialize one or more of our product candidates, we expect that we will continue to incur substantial research and development and other
expenses in order to develop and market additional potential product candidates. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to continue to incur significant losses
for the foreseeable future, and we anticipate that our expenses will increase substantially if, and as, we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance the development of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> and our
second product candidate, PLN 1474, and our other product candidates through clinical development, and, if successful, later-stage clinical trials; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discover and develop new product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance our preclinical development programs into clinical development; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approvals for any product candidates that successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commercialize <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> our other product candidates and any future
product candidates, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increase the amount of research and development activities to identify and develop product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire additional clinical development, quality control, scientific and management personnel;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand our operational, financial and management systems and increase personnel, including personnel to support
our clinical development and manufacturing efforts and our operations as a public company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a sales, marketing, medical affairs and distribution infrastructure to commercialize any products for
which we may obtain marketing approval and intend to commercialize on our own or jointly with third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain, expand and protect our intellectual property portfolio; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">invest in or <FONT STYLE="white-space:nowrap">in-license</FONT> other technologies or product candidates.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To become and remain profitable, we must develop and eventually commercialize products with significant market
potential. This will require us to be successful in a range of challenging activities, including completing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preclinical studies and clinical trials, obtaining marketing approval for product candidates, manufacturing, marketing and selling products for which we may obtain marketing approval and
satisfying any post-marketing requirements. We may never succeed in any or all of these activities and, even if we do, we may never generate revenue that is significant enough to achieve profitability. If we do achieve profitability, we may not be
able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development
efforts, expand our business or continue our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if this offering is successful, we will require substantial
additional capital to finance our operations. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce and/or eliminate one or more of our research and drug development programs, future
commercialization efforts or other operations. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Developing biopharmaceutical products, including conducting preclinical studies
and clinical trials, is a very time-consuming, expensive and uncertain process that takes years to complete. Our operations have consumed substantial amounts of cash since inception. We expect our expenses to increase in connection with our ongoing
activities, particularly as we conduct our planned clinical trials of <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> continue research and development to initiate additional clinical trials of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and
any future product candidates that we may develop, seek regulatory approvals for our product candidates and to launch and commercialize any products for which we receive regulatory approval. Following this offering, we also expect to incur
additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in order to maintain our continuing operations. If we are unable to raise capital when needed or on acceptable terms,
we may be forced to delay, reduce or eliminate one or more of our research and drug development programs or future commercialization efforts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, we had approximately $102.8&nbsp;million in cash, cash equivalents and short-term investments. Based on our current
operating plan, we believe that the net proceeds from this offering, together with existing cash, cash equivalents and short-term investments, will be sufficient to fund our operating expenses and capital expenditure requirements through
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. However, our future capital requirements and the period for which our existing resources will support our operations may vary
significantly from what we expect, and we will in any event require additional capital in order to complete clinical development of any of our current programs. Our monthly spending levels will vary based on new and ongoing development and corporate
activities. Because the length of time and activities associated with development of our product candidates is highly uncertain, we are unable to estimate the actual funds we will require for development, marketing and commercialization activities.
Our future funding requirements, both near and long-term, will depend on many factors, including, but not limited to: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, progress, timing, costs and results of preclinical studies and clinical trials for our product
candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the clinical development plans we establish for these product candidates;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and characteristics of product candidates that we develop;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome, timing and cost of meeting regulatory requirements established by the U.S. Food and Drug
Administration, or FDA, and other comparable foreign regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we are able to enter into collaboration agreements and the terms of any such
agreements;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property
rights;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of defending intellectual property disputes, including patent infringement actions brought by third
parties against us or our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of competing technological and market developments;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost and timing of completion of commercial-scale outsourced manufacturing activities;
and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of establishing sales, marketing and distribution capabilities for any product candidates for which we
may receive regulatory approval in regions where we choose to commercialize our products on our own. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have any
committed external source of funds or other support for our development efforts and we cannot be certain that additional funding will be available on acceptable terms, or at all. Until we can generate sufficient revenue to finance our cash
requirements, which we may never do, we expect to finance our future cash needs through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing or
distribution arrangements. If we raise additional funds through public or private equity offerings, the terms of these securities may include liquidation or other preferences that adversely the rights of our common stockholders. Further, to the
extent that we raise additional capital through the sale of common stock or securities convertible or exchangeable into common stock, your ownership interest will be diluted. In addition, any debt financing may subject us to fixed payment
obligations and covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional capital through marketing and distribution
arrangements or other collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish certain valuable intellectual property or other rights to our product candidates, technologies, future revenue streams
or research programs or grant licenses on terms that may not be favorable to us. We also may be required to seek collaborators for any of our product candidates at an earlier stage than otherwise would be desirable or relinquish our rights to
product candidates or technologies that we otherwise would seek to develop or commercialize ourselves. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or
discontinue the development or commercialization of one or more of our product candidates or one or more of our other research and development initiatives. Any of the above events could significantly harm our business, prospects, financial condition
and results of operations and cause the price of our common stock to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The amount of our future losses is uncertain and our
quarterly operating results may fluctuate significantly or may fall below the expectations of investors or securities analysts, each of which may cause our stock price to fluctuate or decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our quarterly and annual operating results may fluctuate significantly in the future due to a variety of factors, many of which are outside of
our control and may be difficult to predict, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and success or failure of clinical trials for our product candidates or competing product candidates,
or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully recruit and retain subjects for clinical trials, and any delays caused by
difficulties in such efforts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain marketing approval for our product candidates, and the timing and scope of any such
approvals we may receive; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and cost of, and level of investment in, research and development activities relating to our product
candidates, which may change from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of manufacturing our product candidates, which may vary depending on the quantity of production and the
terms of our agreements with manufacturers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract, hire and retain qualified personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenditures that we will or may incur to develop additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of demand for our product candidates should they receive approval, which may vary significantly;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk/benefit profile, cost and reimbursement policies with respect to our product candidates, if approved,
and existing and potential future therapeutics that compete with our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the changing and volatile U.S. and global economic environments; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future accounting pronouncements or changes in our accounting policies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results.
As a result, comparing our operating results on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;period-to-period&nbsp;basis</FONT></FONT> may not be meaningful. This variability and unpredictability could also result in our
failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the
forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated guidance
we may provide. </P>   <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Research and Development and the Biopharmaceutical Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have a limited operating history, which may make it difficult to evaluate our prospects and likelihood of success. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company with a limited operating history. We were incorporated in 2015, have no products approved for
commercial sale and have not generated any revenue. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio and performing research and
development of our product candidates and our technology related to transforming growth factor beta, or <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> signaling and integrin biology, medicinal chemistry, translational screening technologies,
and clinical insights to discover and develop novel therapies for the treatment of fibrosis. Our approach to the discovery and development of product candidates is unproven, and we do not know whether we will be able to develop any products of
commercial value.&nbsp;In addition, our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is in early clinical development for the treatment of IPF and preclinical development for the treatment of PSC, and our second product
candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is in early clinical development. Both programs will require substantial additional development and clinical research time and resources before we would be able to apply for or receive
regulatory approvals and begin generating revenue from product sales. We have not yet demonstrated the ability to progress any product candidate through clinical trials. We are still in preclinical and early clinical development and may be unable to
obtain regulatory approval, manufacture a commercial scale product, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. Investment in biopharmaceutical
product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain
regulatory approval and become commercially viable. In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors and risks frequently
experienced by early-stage biopharmaceutical companies in rapidly evolving fields. Consequently, we have no meaningful history of operations upon which to evaluate our business, and predictions about our future success or viability may not be as
accurate as they could be if we had a longer operating history or a history of successfully developing and commercializing drug products. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our business is highly dependent on the success of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> as
well as <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and any other product candidates that we advance into the clinic. All of our product candidates will require significant additional preclinical and clinical development before we may be able
to seek regulatory approval for and launch a product commercially. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have no products that are approved for
commercial sale and may never be able to develop marketable products. We are very early in our development efforts and have only one product candidate, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">PLN-74809,</FONT> in early clinical development. Because <FONT STYLE="white-space:nowrap">PLN-74809</FONT> is our lead product candidate, if <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> encounters safety or efficacy problems, development delays, regulatory issues or other problems, our development plans and business would be significantly harmed. We have completed a Phase 1a SAD/MAD trial
and a Phase 1b proof-of-mechanism trial of PLN-74809 in IPF and are currently enrolling two Phase 2a trials in IPF. We also plan to submit an IND for PLN-74809 for the treatment of primary sclerosing cholangitis, or PSC, in the first half of 2020,
and plan to initiate a Phase 2a PSC trial thereafter. We are also developing <FONT STYLE="white-space:nowrap">PLN-1474</FONT> for liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, and are currently evaluating PLN-1474 in Phase 1a
SAD/MAD testing. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before we can generate any revenue from sales of our lead product candidate,
<FONT STYLE="white-space:nowrap">PLN-74809,</FONT> or any of our other product candidates, we must undergo additional preclinical and clinical development, regulatory review and approval in one or more jurisdictions. In addition, if one or more of
our product candidates are approved, we must ensure access to sufficient commercial manufacturing capacity and conduct significant marketing efforts in connection with any commercial launch. These efforts will require substantial investment, and we
may not have the financial resources to continue development of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience setbacks that could delay or
prevent regulatory approval of, or our ability to commercialize, our product candidates, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negative or inconclusive results from our preclinical studies or clinical trials or the clinical trials of others
for product candidates similar to ours, leading to a decision or requirement to conduct additional preclinical testing or clinical trials or abandon a program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product-related side effects experienced by subjects in our clinical trials or by individuals using drugs or
therapeutics similar to our product candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in submitting INDs or comparable foreign applications or delays or failure in obtaining the necessary
approvals from regulators to commence a clinical trial, or a suspension or termination of a clinical trial once commenced; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conditions imposed by the FDA or comparable foreign authorities regarding the scope or design of our clinical
trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in enrolling subjects in clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high <FONT STYLE="white-space:nowrap">drop-out</FONT> rates of subjects from clinical trials;&nbsp;inadequate
supply or quality of product candidates or other materials necessary for the conduct of our clinical trials;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">greater than anticipated clinical trial costs;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability to compete with other therapies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">poor efficacy of our product candidates during clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unfavorable FDA or other regulatory agency inspection and review of a clinical trial site;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure of our third-party contractors or investigators to comply with regulatory requirements or otherwise meet
their contractual obligations in a timely manner, or at all;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays related to the impact of the spread of COVID-19 on the FDA&#146;s ability to continue its normal
operations; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays and changes in regulatory requirements, policy and guidelines, including the imposition of additional
regulatory oversight around clinical testing generally or with respect to our technology in particular; or</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">varying interpretations of data by the FDA and similar foreign regulatory agencies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission
process, potential threats to our intellectual property rights and our manufacturing, marketing, distribution and sales efforts or that of any future collaborator. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our approach to drug discovery and development in the area of fibrotic diseases, with
an initial focus on tissue-specific integrin modulation and <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling inhibition, is unproven and may not result in marketable products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach is designed to discover and develop targeted treatments for fibrosis with an initial focus on the antagonism of tissue-specific <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling through the inhibition of integrins known to mediate the release of activated <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> in fibrotic tissue. However, although multiple studies are
currently underway, to date, this mechanism has not been definitively proven to successfully treat fibrosis. Targeting integrins to treat fibrosis is a novel approach in a rapidly developing field, and there can be no assurance that we will not
experience currently unknown problems or delays in developing our product candidates, that such problems or delays will not result in unanticipated costs, or that any such development problems can be solved. We have only tested our lead product
candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> in healthy volunteers. Therefore, we may ultimately discover that our approach and any product candidates resulting therefrom do not possess properties required for therapeutic
effectiveness. As a result, we may never succeed in developing a marketable product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, while we have developed an extensive
panel of cell assays and precision cut tissue assays and have utilized animal models to uncover biological pathways, understood gene expression changes and optimized the potency and selectivity of our potential product candidates, there can be no
assurance that our technology will yield their intended benefits. While we believe our assays represent a differentiator in our approach to drug development, our approach has not yet been clinically proven to yield results. Our practice of
evaluating our product candidates in live human fibrotic tissue samples before advancing them into the clinic is intended to serve as a bridge between animal models and clinical proof-of-concept. However, there can be no assurance that positive
results observed from preclinical animal testing and human fibrotic tissue models will be replicated when a program is advanced into clinical development. In addition, our practice of utilizing live human fibrotic tissue as part of our development
efforts may become more widespread in the future, and this approach may be adopted and replicated by others, including our competitors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Studies involving human tissue samples may also be subject to institutional and government human subject privacy policies that may vary by
territory. We or our partners who provide us with human tissue samples, or conduct tissue and/or animal studies on our behalf, may be found to be in violation of one or more of these regulations or policies and may be subject to closure, censure or
other penalties. In some cases, these penalties could materially impact the performance, availability, or validity of studies conducted by us on our behalf. Even in the absence of violations resulting in penalties, regulatory and other authorities
may refuse to authorize the conduct or to accept the results of studies for regulatory or ethical reasons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical development
involves a lengthy, complex and expensive process, with an uncertain outcome. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To obtain the requisite regulatory approvals to
commercialize any product candidates, we must demonstrate through extensive preclinical studies and clinical trials that our product candidates are safe and effective in humans. Clinical testing is expensive and can take many years to complete, and
its outcome is inherently uncertain. In particular, the general approach for FDA approval of a new drug is dispositive data from two well-controlled, Phase&nbsp;3 clinical trials of the relevant drug in the relevant patient population. Phase&nbsp;3
clinical trials typically involve hundreds of patients, have significant costs and take years to complete. A product candidate can fail at any stage of testing, even after observing promising signals of activity in earlier preclinical studies or
clinical trials. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. In addition, initial success in clinical trials may not be indicative of
results obtained when such trials are completed. There is typically an extremely high rate of attrition from the failure of product candidates proceeding through clinical trials. Product candidates in later stages of clinical trials may fail to show
the desired safety and efficacy profile despite having progressed through preclinical studies and initial clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to
lack of efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that commence clinical trials are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
never approved as products and there can be no assurance that any of our future clinical trials will ultimately be successful or support further clinical development of <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> or any of our other product candidates. Product candidates that appear promising in the early phases of development may fail to reach the market for several reasons, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preclinical studies or clinical trials may show the product candidates to be less effective than expected
(e.g.,&nbsp;a clinical trial could fail to meet its primary endpoint(s)) or to have unacceptable side effects or toxicities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to establish clinical endpoints that applicable regulatory authorities would consider clinically
meaningful; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to receive the necessary regulatory approvals;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturing costs, formulation issues, pricing or reimbursement issues, or other factors that make a product
candidate uneconomical; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proprietary rights of others and their competing products and technologies that may prevent one of our
product candidates from being commercialized. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, differences in trial design between early-stage clinical
trials and later-stage clinical trials make it difficult to extrapolate the results of earlier clinical trials to later clinical trials. Moreover, clinical data are often susceptible to varying interpretations and analyses, and many companies that
have believed their product candidates performed satisfactorily in clinical trials have nonetheless failed to obtain marketing approval of their products. Additionally, some of our trials may be open-label studies, where both the patient and
investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. Most typically, open-label clinical trials test only the investigational product candidate and sometimes do so
at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. In addition, open-label
clinical trials may be subject to an &#147;investigator bias&#148; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the
treated group more favorably given this knowledge. Therefore, it is possible that positive results observed in open-label trials will not be replicated in later placebo-controlled trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the standards that the FDA and comparable foreign regulatory authorities use when regulating us require judgment and can change,
which makes it difficult to predict with certainty how they will be applied. Any analysis we perform of data from preclinical and clinical activities is subject to confirmation and interpretation by regulatory authorities, which could delay, limit
or prevent regulatory approval. We may also encounter unexpected delays or increased costs due to new government regulations. Examples of such regulations include future legislation or administrative action, or changes in FDA policy during the
period of product development and FDA regulatory review. It is impossible to predict whether legislative changes will be enacted, or whether FDA or foreign regulations, guidance or interpretations will be changed, or what the impact of such changes,
if any, may be. The FDA may also require a panel of experts, referred to as an Advisory Committee, to deliberate on the adequacy of the safety and efficacy data to support approval. The opinion of the Advisory Committee, although not binding, may
have a significant impact on our ability to obtain approval of any product candidates that we develop. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we seek to conduct clinical
trials in foreign countries or pursue marketing approvals in foreign jurisdictions, we must comply with numerous foreign regulatory requirements governing, among other things, the conduct of clinical trials, manufacturing and marketing
authorization, pricing and third-party reimbursement. The foreign regulatory approval process varies among countries and may include all of the risks associated with FDA approval described above as well as risks attributable to the satisfaction of
local regulations in foreign jurisdictions. Moreover, the time required to obtain approval may differ from that required to obtain FDA approval. Approval by the FDA does not ensure approval by regulatory authorities outside the United States and
vice versa. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Successful completion of clinical trials is a prerequisite to submitting a marketing
application to the FDA and similar marketing applications to comparable foreign regulatory authorities, for each product candidate and, consequently, the ultimate approval and commercial marketing of any product candidates. We may experience
negative or inconclusive results, which may result in our deciding, or our being required by regulators, to conduct additional clinical studies or trials or abandon some or all of our product development programs, which could have a material adverse
effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the
development and commercialization of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may
experience delays in initiating or completing clinical trials. We also may experience numerous unforeseen events during, or as a result of, any future clinical trials that could delay or prevent our ability to receive marketing approval or
commercialize <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidates, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulators or institutional review boards, or IRBs, or ethics committees may not authorize us or our
investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or other comparable regulatory authorities may disagree with our clinical trial design, including with
respect to dosing levels administered in our planned clinical trials, which may delay or prevent us from initiating our clinical trials with our originally intended trial design;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may experience delays in reaching, or fail to reach, agreement on acceptable terms with prospective trial
sites and prospective contract research organizations, or CROs, which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of subjects required for clinical trials of any product candidates may be larger than we anticipate or
subjects may drop out of these clinical trials or fail to return for post-treatment <FONT STYLE="white-space:nowrap">follow-up</FONT> at a higher rate than we anticipate;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations
to us in a timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may elect to, or regulators, IRBs, Data Safety Monitoring Boards, or DSMBs, or ethics committees may require
that we or our investigators, suspend or terminate clinical research or trials for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health
risks;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not have the financial resources available to begin and complete the planned trials, or the cost of
clinical trials of any product candidates may be greater than we anticipate;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our
product candidates may be insufficient or inadequate to initiate or complete a given clinical trial; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or other comparable foreign regulatory authorities may require us to submit additional data such as
long-term toxicology studies, or impose other requirements before permitting us to initiate a clinical trial. </P></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
product development costs will increase if we experience delays in clinical testing or in obtaining marketing approvals. We do not know whether any of our clinical trials will begin as planned, will need to be restructured or will be completed on
schedule, or at all. If we do not achieve our product development goals in the time frames we announce and expect, the approval and commercialization of our product candidates may be delayed or prevented entirely. Significant clinical trial delays
also could shorten any periods during which we may have the exclusive right to commercialize our product candidates and may allow our competitors to bring products to market before we do, potentially impairing our ability to successfully
commercialize our product candidates and harming our business and results of operations. Any delays in our clinical development programs may harm our business, financial condition and results of operations significantly. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our ongoing and future clinical trials may reveal significant adverse events or
unexpected drug-drug interactions not seen in our preclinical studies and may result in a safety profile that could delay or prevent regulatory approval or market acceptance of any of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We completed our Phase 1a clinical trial of our lead product candidate <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in healthy volunteers,
and, with the exception of a number of reported minor adverse events, the product candidate was observed to be generally well-tolerated across all doses in 71 trial participants. However, if significant adverse events or other side effects are
observed in any of our ongoing or future clinical trials, we may have difficulty recruiting patients to our clinical trials, patients may drop out of our trials, or we may be required to abandon the trials or our development efforts altogether. In
addition, in our planned Phase 2a clinical trials, we expect to evaluate <FONT STYLE="white-space:nowrap">PLN-74809</FONT> administered with approved IPF agents. As a result, we may encounter unexpected drug-drug interactions in our planned trials,
and may be required to further test these candidates, including in drug-drug interaction studies, which may be expensive, time-consuming and result in delays to our programs. Some potential therapeutics developed in the biopharmaceutical industry
that initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the product candidate from obtaining or maintaining
marketing approval, undesirable side effects may inhibit market acceptance of the approved product due to its tolerability versus other therapies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or
otherwise adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience difficulties in patient enrollment in our clinical trials for a variety of
reasons. The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the trial until its conclusion. The enrollment of patients
depends on many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient eligibility and exclusion criteria defined in the protocol;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the patient population required for analysis of the trial&#146;s primary endpoints and the process
for identifying patients;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the willingness or availability of patients to participate in our trials (including due to the recent outbreak of
the respiratory illness caused by a coronavirus strain known as COVID-19, or the COVID-19 coronavirus); </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proximity of patients to trial sites;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the design of the trial;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to recruit clinical trial investigators with the appropriate competencies and
experience;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinicians&#146; and patients&#146; perceptions as to the potential advantages and risks of the product candidate
being studied in relation to other available therapies, including any new products that may be approved for the indications we are investigating;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of competing commercially available therapies and other competing drug candidates&#146; clinical
trials;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain patient informed consents; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that patients enrolled in clinical trials will drop out of the trials before completion.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, we are initially developing <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of IPF and
PSC, each of which is an orphan indication. In the United States, IPF is estimated to affect approximately 140,000 patients, while PSC is estimated to affect approximately 30,000 to 45,000 patients. As a result, we may encounter difficulties
enrolling subjects in our clinical trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> due, in part, to the small size of these patient populations. In addition, our clinical trials will compete with other clinical trials for product
candidates that are in the same therapeutic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
areas as our product candidates, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead
opt to enroll in a trial being conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use,
which will reduce the number of patients who are available for our clinical trials in such clinical trial site. Certain of our planned clinical trials may also involve invasive procedures such as bronchoscopy and broncho-alveolar lavage, or BAL,
procedure, which may lead some patients to drop out of trials to avoid these follow-up procedures. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, timely enrollment in
clinical trials is reliant on clinical trial sites which may be adversely affected by global health matters, including, among other things, pandemics. For example, our clinical trial sites may be located in regions currently being affected by the
COVID-19 coronavirus. Some factors from the COVID-19 coronavirus outbreak that we believe may adversely affect enrollment in our trials include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the diversion of healthcare resources away from the conduct of clinical trial matters to focus on pandemic
concerns, including the attention of infectious disease physicians serving as our clinical trial investigators, hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">given that our clinical trials target respiratory indications, patients who would otherwise be candidates for
enrollment in our clinical trials, may become infected with the COVID-19 coronavirus, which may kill some patients and render others too ill to participate, limiting the available pool of participants for our trials. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on travel that interrupt key trial activities, such as clinical trial site initiations and
monitoring; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption in global shipping affecting the transport of clinical trial materials, such as investigational drug
product and comparator drugs used in our trials; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee furlough days that delay necessary interactions with local regulators, ethics committees and other
important agencies and contractors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These and other factors arising from the COVID-19 coronavirus could worsen in
countries that are already afflicted with the virus or could continue to spread to additional countries, each of which may further adversely impact our clinical trials. The global outbreak of the COVID-19 coronavirus continues to evolve and the
conduct of our trials may continue to be adversely affected, despite efforts to mitigate this impact. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The design or execution
of our ongoing and future clinical trials may not support marketing approval. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The design or execution of a clinical trial can
determine whether its results will support marketing approval, and flaws in the design or execution of a clinical trial may not become apparent until the clinical trial is well advanced. We are currently enrolling two Phase 2a trials of PLN-74809 in
IPF. In the first of these trials, we plan to enroll IPF patients and utilize a positron emission tomography, or PET, ligand to measure av&szlig;6 target engagement by PLN-74809 in the lungs post-treatment. The second trial is a 12-week double blind
placebo-controlled trial enrolling IPF patients across up to four cohorts consisting of up to three doses of PLN-74809 and one placebo and will evaluate safety, tolerability and pharmacokinetics, or PK. It is possible that we may need to amend our
clinical trial, which would require us to resubmit our clinical trial protocols to IRBs for reexamination, and may impact the costs, timing or successful completion of such clinical trial. In addition, we may desire to test <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> at doses exceeding those evaluated in the Phase&nbsp;1a trial, and may not be able to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, in some instances, there can be significant variability in safety or efficacy results between different trials with the same
product candidate due to numerous factors, including differences in trial protocols, size and type of the patient populations, variable adherence to the dosing regimen or other protocol requirements and the rate of dropout among clinical trial
participants. We do not know whether any clinical trials we conduct will demonstrate consistent or adequate efficacy and safety to obtain marketing approval to market our product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the FDA and comparable foreign regulatory authorities have substantial discretion
in the approval process and in determining when or whether marketing approval will be obtained for any of our product candidates. Our product candidates may not be approved even if they achieve their primary endpoints in future Phase&nbsp;3 clinical
trials or registrational trials. The FDA or comparable foreign regulatory authorities may disagree with our trial designs and our interpretation of data from preclinical studies or clinical trials. In addition, any of these regulatory authorities
may change requirements for the approval of a product candidate even after reviewing and providing comments or advice on a protocol for a pivotal Phase&nbsp;3 or registrational clinical trial. In addition, any of these regulatory authorities may
also approve a product candidate for fewer or more limited indications than we request or may grant approval contingent on the performance of costly post-marketing clinical trials. The FDA or comparable foreign regulatory authorities may not approve
the labeling claims that we believe would be necessary or desirable for the successful commercialization of our product candidates, if approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delays in patient enrollment may result in increased costs or may affect the timing or outcome of our future clinical trials, which could
prevent completion of these trials and adversely affect our ability to advance the development of our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Although
we have received US orphan drug designation for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for IPF and PSC indications, we may be unable to obtain and maintain orphan drug designation for our other product candidates and, even if we obtain
such designation, we may not be able to realize the benefits of such designation, including potential marketing exclusivity of our product candidates, if approved. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regulatory authorities in some jurisdictions, including the United States and other major markets, may designate drugs intended to treat
conditions or diseases affecting relatively small patient populations as orphan drugs. Under the Orphan Drug Act of 1983, the FDA may designate a product candidate as an orphan drug if it is intended to treat a rare disease or condition, which is
generally defined as having a patient population of fewer than 200,000 individuals in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug
will be recovered from sales in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we have received U.S. orphan drug designation for <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> for IPF and PSC indications, the designation of any of our product candidates as an orphan drug does not mean that any regulatory agency will accelerate regulatory review of, or ultimately approve, that
product candidate, nor does it limit the ability of any regulatory agency to grant orphan drug designation to product candidates of other companies that treat the same indications as our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, if a product candidate with an orphan drug designation receives the first marketing approval for the indication for which it has
such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or foreign regulatory authorities from approving another marketing application for a product that constitutes the same drug treating the same
indication for that marketing exclusivity period, except in limited circumstances. The applicable period is seven years in the United States. Orphan drug exclusivity may be revoked if any regulatory agency determines that the request for designation
was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of patients with the rare disease or condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we obtain orphan drug exclusivity for a product candidate, that exclusivity may not effectively protect the product candidate from
competition because different drugs can be approved for the same condition in the United States. Even after an orphan drug is approved, the FDA may subsequently approve another drug for the same condition if the FDA concludes that the latter drug is
not the same drug or is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in methods of product candidate manufacturing or formulation may result in
additional costs or delay. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As product candidates progress through preclinical to late stage clinical trials to marketing approval
and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize yield, manufacturing batch size, minimize costs and achieve
consistent quality and results. Such changes carry the risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or
other future clinical trials conducted with the altered materials. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay
approval of our product candidates and jeopardize our ability to commercialize our product candidates and generate revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
there are risks associated with large scale manufacturing for clinical trials or commercial scale including, among others, cost overruns, potential problems with <FONT STYLE="white-space:nowrap">process&nbsp;scale-up,&nbsp;process</FONT>
reproducibility, stability issues, compliance with good manufacturing practices, lot consistency and timely availability of raw materials. Even if we obtain marketing approval for any of our product candidates, there is no assurance that our
manufacturers will be able to manufacture the approved product to specifications acceptable to the FDA or other comparable foreign regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential commercial
launch of the product or to meet potential future demand. If our manufacturers are unable to produce sufficient quantities for clinical trials or for commercialization, our development and commercialization efforts would be impaired, which would
have an adverse effect on our business, financial condition, results of operations and growth prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful
in our efforts to identify or discover additional product candidates in the future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research programs may initially show
promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for a number of reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to design such product candidates with the pharmacological properties that we desire or attractive
pharmacokinetics; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential product candidates may, on further study, be shown to have harmful side effects or other
characteristics that indicate that they are unlikely to be medicines that will receive marketing approval and achieve market acceptance. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research programs to identify new product candidates require substantial technical, financial and human resources. If we are unable to
identify suitable compounds for preclinical and clinical development, we will not be able to obtain product revenue in future periods, which likely would result in significant harm to our financial position and adversely impact our stock price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Due to our limited resources and access to capital, we must make decisions on the allocation of resources to certain programs and
product candidates; these decisions may prove to be wrong and may adversely affect our business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have limited financial and
human resources and intend to initially focus on research programs and product candidates for a limited set of indications. As a result, we may forgo or delay pursuit of opportunities with other product candidates or for other indications that later
prove to have greater commercial potential or a greater likelihood of success. In addition, we seek to accelerate our development timelines, including by initiating certain clinical trials of our product candidates before earlier-stage studies have
been completed. This approach may cause us to commit significant resources to prepare for and conduct later-stage trials for one or more product candidates that subsequently fail earlier-stage clinical testing. Therefore, our resource allocation
decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities, or expend resources on product candidates that are not viable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that we will ever be able to identify additional therapeutic
opportunities for our product candidates or to develop suitable potential product candidates through internal research programs, which could materially adversely affect our future growth and prospects. We may focus our efforts and resources on
potential product candidates or other potential programs that ultimately prove to be unsuccessful. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If product liability lawsuits
are brought against us, we may incur substantial financial or other liabilities and may be required to limit commercialization of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face an inherent risk of product liability as a result of testing <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and any of our other
product candidates in clinical trials, and will face an even greater risk if we commercialize any products. For example, we may be sued if our product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during
clinical trials, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a
breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of
our product candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability to bring a product candidate to the market;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decreased demand for our products;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injury to our reputation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">withdrawal of clinical trial participants and inability to continue clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiation of investigations by regulators; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, injunctions or criminal penalties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs to defend the related litigation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of management&#146;s time and our resources;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial monetary awards to trial participants;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product recalls, withdrawals or labeling, marketing or promotional restrictions;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of revenue;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exhaustion of any available insurance and our capital resources;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to commercialize any product candidate, if approved; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decline in our share price. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our inability to obtain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims
could prevent or inhibit the commercialization of products we develop. We need to obtain additional insurance for clinical trials as <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and PLN-1474 continue clinical development and as additional
product candidates enter the clinic. However, we may be unable to obtain, or may obtain on unfavorable terms, clinical trial insurance in amounts adequate to cover any liabilities from any of our clinical trials. Our insurance policies may also have
various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our
insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or
adequate should any claim arise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We face substantial competition, which may result in others discovering, developing or
commercializing products before or more successfully than us. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The development and commercialization of new drug products is highly
competitive. We may face competition with respect to any product candidates that we seek to develop or commercialize in the future from major biopharmaceutical companies, specialty biopharmaceutical companies, and biotechnology companies worldwide.
Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development,
manufacturing, and commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are a number of large biopharmaceutical and biotechnology companies that are currently
pursuing the development of products for the treatment of fibrosis. Companies that we are aware of that are targeting the treatment of various fibrosis indications through inhibiting various parts of the TGF-&szlig; pathway include large companies
with significant financial resources such as Biogen, Inc., AbbVie Inc., Gilead Sciences, Inc., Indalo Therapeutics, Inc., FibroGen, Inc., Galapagos NV, Bristol Myers Squibb Co., and Novartis AG. However, we know of no other companies currently in
clinical development with an orally bioavailable small-molecule, selective integrin inhibitor. For additional information regarding our competition, see &#147;Business&#151;Competition.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of our current or potential competitors, either alone or with their strategic partners, have significantly greater financial resources
and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mergers and acquisitions in the biopharmaceutical and biotechnology industries may result in even more resources being concentrated among a
smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in
recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our
commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, more convenient, or less expensive than any products that we may develop. Furthermore, products currently
approved for other indications could be discovered to be effective treatments of fibrosis as well, which could give such products significant regulatory and market timing advantages over <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or other
product candidates that we may identify. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours and may do, which could result in our competitors establishing a strong
market position before we are able to enter the market. Additionally, products or technologies developed by our competitors may render our potential product candidates uneconomical or obsolete and we may not be successful in marketing any product
candidates we may develop against competitors. The availability of competitive products could limit the demand, and the price we are able to charge, for any products that we may develop and commercialize. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Marketing, Reimbursement, Healthcare Regulations and Ongoing Regulatory Compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if a product candidate we develop receives marketing approval, it may fail to achieve the degree of market acceptance by physicians,
patients, third-party payors and others in the medical community necessary for commercial success. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidate we develop receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors, such as Medicare and
Medicaid programs and managed care organizations, and others in the medical community. In addition, the availability of coverage by third-party payors may be affected by existing and future health care reform measures designed to reduce the cost of
health care. If the product candidates we develop do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of market acceptance of any product candidate, if approved for commercial sale,
will depend on a number of factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">efficacy and potential advantages compared to alternative treatments;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to offer our products, if approved, for sale at competitive prices;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">convenience and ease of administration compared to alternative treatments;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these
therapies;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the recommendations with respect to our product candidates in guidelines published by various scientific
organizations applicable to us and our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strength of marketing and distribution support;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to obtain sufficient third-party coverage and adequate reimbursement; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prevalence and severity of any side effects. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If government and other third-party payors do not provide coverage and adequate reimbursement levels for any products we commercialize, market
acceptance and commercial success would be reduced. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Coverage and reimbursement may be limited or unavailable in certain market
segments for our product candidates, if approved, which could make it difficult for us to sell any product candidates profitably. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant uncertainty exists as to the coverage and reimbursement status of any products for which we may obtain regulatory approval. In the
U.S., sales of any products for which we may receive regulatory marketing approval will depend, in part, on the availability of coverage and reimbursement from third-party payors. Third-party payors include government authorities such as Medicare,
Medicaid, TRICARE, and the Veterans Administration, managed care providers, private health insurers, and other organizations. Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or
part of the costs associated with their treatment. Coverage and adequate reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. Patients are unlikely to use
our product candidates unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost. We cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from,
our product candidates or assure that coverage and reimbursement will be available for any product that we may develop. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government
authorities and other third-party payors decide which drugs and treatments they will cover and the amount of reimbursement. Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#146;s
determination that use of a product is: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a covered benefit under its health plan;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safe, effective and medically necessary;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appropriate for the specific patient;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cost-effective; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">neither experimental nor investigational. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, no uniform policy of coverage and reimbursement for products exists among third-party payors. As a result, obtaining
coverage and reimbursement approval of a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the
use of our products on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">payor-by-payor</FONT></FONT> basis, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with no assurance that coverage and adequate reimbursement will be obtained. Even if we obtain coverage for a given product, the resulting reimbursement payment rates might not be adequate for us
to achieve or sustain profitability or may require <FONT STYLE="white-space:nowrap">co-payments</FONT> that patients find unacceptably high. Additionally, third-party payors may not cover, or provide adequate reimbursement for, long-term <FONT
STYLE="white-space:nowrap">follow-up</FONT> evaluations required following the use of product candidates, once approved. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for
our product candidates, if approved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Medicare Prescription Drug, Improvement, and Modernization Act of 2003, also called the Medicare
Modernization Act, or the MMA, established the Medicare Part D program to provide a voluntary prescription drug and biologic benefit to Medicare beneficiaries. Under Part D, Medicare beneficiaries may enroll in prescription drug plans offered by
private entities that provide coverage of outpatient prescription drugs and biologics. Unlike Medicare Parts A and B, Part D coverage is not standardized. Part D prescription drug plan sponsors are not required to pay for all covered Part D drugs
and biologics, and each drug plan can develop its own formulary that identifies which drugs and biologics it will cover, and at what tier or level. However, Part D prescription drug formularies must include products within each therapeutic category
and class of covered Part D drugs, though not necessarily all the drugs and biologics in each category or class. Any formulary used by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic committee. Government
payment for some of the costs of prescription drugs and biologics may increase demand for products for which we obtain marketing approval. Any negotiated prices for any of our products covered by a Part D prescription drug plan will likely be lower
than the prices we might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any
reduction in payment that results from the MMA may result in a similar reduction in payments from <FONT STYLE="white-space:nowrap">non-governmental</FONT> payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a drug or biologic product to receive federal reimbursement under the Medicaid or Medicare Part B programs or to be sold directly to U.S.
government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the average manufacturer price, or AMP, and
Medicaid rebate amounts reported by the manufacturer. As of 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the ACA, expanded the types of entities
eligible to receive discounted 340B pricing, although under the current state of the law these newly eligible entities (with the exception of children&#146;s hospitals) will not be eligible to receive discounted 340B pricing on orphan drugs. As 340B
drug pricing is determined based on AMP and Medicaid rebate data, the revisions to the Medicaid rebate formula and AMP definition described above could cause the required 340B discount to increase. Further, on December&nbsp;27, 2018, the District
Court for the District of Columbia invalidated a reimbursement formula change instituted by the Centers for Medicare &amp; Medicaid Services, or CMS, under the 340B program. For the 2019 and 2018 fiscal years, CMS altered the reimbursement formula.
The court ruled this change was not an &#147;adjustment&#148; that was within the Secretary&#146;s discretion to make but was instead a fundamental change in the reimbursement calculation, and such a dramatic change was beyond the scope of the
Secretary&#146;s authority. On May 6, 2019, the district court reiterated that the rate reduction exceeded the Secretary&#146;s authority and declared that the rate reduction for 2019 also exceeded the Secretary&#146;s authority and remanded the
issue to HHS to devise an appropriate remedy. On July 10, 2019, the district court entered its final judgment and CMS has filed an appeal and a decision by the Court of Appeals for the D.C. Circuit is pending. However, subsequently, hospitals have
filed a complaint in the U.S. District Court for D.C. to enjoin the reimbursement cuts for 2020. It is unclear how such litigation could affect covered hospitals who might purchase our products in the future, and affect the rates we may charge such
facilities for our approved products. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes to these current laws and state and federal healthcare reform measures that may be
adopted in the future may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any product candidates for which we may obtain regulatory approval or the frequency with which any
such product candidate is prescribed or used. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, increasing efforts by governmental and third-party payors in the United States
and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates.
There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and
state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government
program reimbursement methodologies for drugs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 10, 2019, the Centers for Medicare and Medicaid Services announced a new pricing
transparency rule, which was set to take effect on July 9, 2019. The rule would have required direct-to-consumer television advertisements for prescription drugs and biological products for which reimbursement is available, directly or indirectly,
through or under Medicare or Medicaid to include the list price of that product, except for a prescription drug or biological product that has a list price of less than $35 per month for a 30-day supply or typical course of treatment. The final rule
was vacated by the D.C. District Court prior to taking effect. Several states have adopted price transparency requirements and those as well as any future federal price transparency requirements that may be implemented in the future could have a
negative effect on our business. Additionally, we expect to experience pricing pressures in connection with the sale of any future approved product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance
organizations, cost containment initiatives and additional legislative changes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the federal level, the Trump administration&#146;s
budget for fiscal year 2020 contains further drug price control measures that could be enacted during the 2020 legislative session or in other future sessions, including, for example, measures to permit Medicare Part D plans to negotiate the price
of certain drugs under Medicare Part B, to allow some states to negotiate drug prices under Medicaid, and to eliminate cost sharing for generic drugs for low-income patients. Congress and the Trump administration have each indicated that it will
continue to seek new legislative and/or administrative measures to control drug costs. Recently, the Trump administration released a &#147;Blueprint&#148; to lower drug prices and reduce out of pocket costs of drugs that contains additional
proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by
consumers. The U.S. Department of Health and Human Services, or HHS, has already started the process of soliciting feedback on some of these measures and, at the same time, is immediately implementing others under its existing authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control biopharmaceutical and
biologic product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from
other countries and bulk purchasing. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if we obtain FDA approval of any of our product candidates, we may never obtain
approval or commercialize such products outside of the United States, which would limit our ability to realize their full market potential. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to market any products outside of the United States, we must establish and comply with numerous and varying regulatory requirements of
other countries regarding safety and efficacy. Clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not mean that regulatory approval will be obtained
in any other country. Approval procedures vary among countries and can involve additional product testing and validation and additional administrative review periods. Seeking foreign regulatory approvals could result in significant delays,
difficulties and costs for us and may require additional preclinical studies or clinical trials which would be costly and time consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of
our products in those countries. Satisfying these and other regulatory requirements is costly, time consuming, uncertain and subject to unanticipated delays. In addition, our failure to obtain regulatory approval in any country
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may delay or have negative effects on the process for regulatory approval in other countries. We do not have any product candidates approved for sale in any jurisdiction, including international
markets, and we do not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, our ability to realize the
full market potential of our products will be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We currently have no marketing and sales organization and have no experience
as a company in commercializing products, and we may have to invest significant resources to develop these capabilities. If we are unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell
our products, we may not be able to generate product revenue. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no internal sales, marketing or distribution capabilities,
nor have we commercialized a product. If any of our product candidates ultimately receives regulatory approval, we expect to establish a marketing and sales organization with technical expertise and supporting distribution capabilities to
commercialize each such product in major markets, which will be expensive and time consuming. We have no prior experience as a company in the marketing, sale and distribution of pharmaceutical products and there are significant risks involved in
building and managing a sales organization, including our ability to hire, retain and incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel and effectively manage a
geographically dispersed sales and marketing team. Any failure or delay in the development of our internal sales, marketing and distribution capabilities would adversely impact the commercialization of these products. We may also choose to
collaborate with third parties that have direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force and distribution systems. We may not be able to enter
into collaborations or hire consultants or external service providers to assist us in sales, marketing and distribution functions on acceptable financial terms, or at all. In addition, our product revenues and our profitability, if any, may be lower
if we rely on third parties for these functions than if we were to market, sell and distribute any products that we develop ourselves. We likely will have little control over such third parties, and any of them may fail to devote the necessary
resources and attention to sell and market our products effectively. If we are not successful in commercializing our products, either on our own or through arrangements with one or more third parties, we may not be able to generate any future
product revenue and we would incur significant additional losses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our relationships with healthcare providers and physicians and
third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits
and future earnings. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians and third-party payors in the United States and elsewhere play a primary
role in the recommendation and prescription of biopharmaceutical products. Arrangements with third-party payors and customers can expose biopharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations,
including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act, which may constrain the business or financial arrangements and relationships through which such companies sell, market and distribute
biopharmaceutical products. In particular, the research of our product candidates, as well as the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to
extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain
customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials. The applicable federal, state and
foreign healthcare laws and regulations laws that may affect our ability to operate include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting,
receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of
any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity can be found guilty of violating the statute without actual
knowledge of the statute or specific intent to violate it. In addition, a claim submitted for payment to any federal health care program that includes items or services that were made as a result of a violation of the federal Anti-Kickback Statute
constitutes a false or fraudulent claim for purposes of the federal False Claims Act, or FCA. The Anti-Kickback Statute has been interpreted to apply to arrangements between biopharmaceutical manufacturers on the one hand and prescribers,
purchasers, and formulary managers, among others, on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil and criminal false claims laws including the FCA, and civil monetary penalty laws, including
the FCA, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, false, fictious or fraudulent claims for payment to, or approval by Medicare, Medicaid, or other federal healthcare programs;
knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim or an obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and
improperly avoiding or decreasing or concealing an obligation to pay money to the federal government. A claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim
under the FCA. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims. The FCA also permits a private
individual acting as a &#147;whistleblower&#148; to bring <I>qui tam</I> actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional
federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the
money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g.,&nbsp;public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a
material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can
be found guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, which impose, among other things, requirements relating to the privacy, security and transmission of individually identifiable health information on certain covered healthcare providers, health plans,
and healthcare clearinghouses, known as covered entities, as well as their respective &#147;business associates,&#148; those independent contractors or agents of covered entities that perform services for covered entities that involve the creation,
use, receipt, maintenance or disclosure of individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and
gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which
require some manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program (with certain exceptions) to report annually to CMS information
related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their
immediate family members. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Effective January 1, 2022, these reporting obligations will extend to include transfers of value made in the previous year to certain non-physician providers such as physician assistants and
nurse practitioners;</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and
activities that potentially harm consumers; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may
apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by third-party payors, including private insurers, and may be broader in scope than their federal equivalents; state and foreign laws that require
biopharmaceutical companies to comply with the biopharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare
providers and other potential referral sources; state and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, marketing expenditures or
drug pricing; state and local laws that require the registration of biopharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each
other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
distribution of biopharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage and security requirements intended to prevent the unauthorized sale of biopharmaceutical
products. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of
healthcare reform, especially in light of the lack of applicable precedent and regulations. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be
time- and resource-consuming and can divert a company&#146;s attention from the business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is possible that governmental and
enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are
instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties,
damages, fines, disgorgement, imprisonment, reputational harm, possible exclusion from participation in federal and state funded healthcare programs, contractual damages and the curtailment or restricting of our operations, as well as additional
reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws. Further, if any of the physicians or
other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government
funded healthcare programs. Any action for violation of these laws, even if successfully defended, could cause a biopharmaceutical manufacturer to incur significant legal expenses and divert management&#146;s attention from the operation of the
business. Prohibitions or restrictions on sales or withdrawal of future marketed products could materially affect business in an adverse way. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if we receive regulatory approval of any product candidates, we will be subject to ongoing regulatory obligations and continued
regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging,
storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market information, including both federal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and state requirements in the United States and requirements of comparable foreign regulatory authorities. In addition, we will be subject to continued compliance with cGMP and GCP requirements
for any clinical trials that we conduct post-approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Manufacturers and their facilities are required to comply with extensive FDA and
comparable foreign regulatory authority requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations. As such, we and our contract manufacturers will be subject to continual review and inspections to
assess compliance with cGMP and adherence to commitments made in any marketing application, and previous responses to inspection observations. Accordingly, we and others with whom we work must continue to expend time, money, and effort in all areas
of regulatory compliance, including manufacturing, production and quality control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any regulatory approvals that we receive for our
product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase&nbsp;4
clinical trials and surveillance to monitor the safety and efficacy of the product candidate. The FDA may also require a risk evaluation and mitigation strategies, or REMS, program as a condition of approval of our product candidates, which could
entail requirements for long-term patient <FONT STYLE="white-space:nowrap">follow-up,</FONT> a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and
other risk minimization tools. In addition, if the FDA or a comparable foreign regulatory authority approves our product candidates, we will have to comply with requirements including submissions of safety and other post-marketing information and
reports and registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may impose consent decrees or withdraw approval if compliance with regulatory requirements and
standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our
third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess
new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of our products, withdrawal of the product from the market or
voluntary or mandatory product recalls;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or holds on clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or
suspension or revocation of license approvals;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention or refusal to permit the import or export of our product candidates;
and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Products may be promoted
only for the approved indications and in accordance with the provisions of the approved label. However companies may share truthful and not misleading information that is not inconsistent with the labeling. The FDA and other agencies actively
enforce the laws and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to
significant liability. The policies of the FDA and of other regulatory authorities may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict
the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption
of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Ongoing healthcare legislative and regulatory reform measures may have a material
adverse effect on our business and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in regulations, statutes or the interpretation of existing
regulations could impact our business in the future by requiring, for example: (i)&nbsp;changes to our manufacturing arrangements; (ii)&nbsp;additions or modifications to product labeling; (iii)&nbsp;the recall or discontinuation of our products; or
(iv)&nbsp;additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, in
March 2010, the ACA was passed, which substantially changed the way health care is financed by both governmental and private insurers, and significantly impacted the U.S. biopharmaceutical industry. The ACA, among other things, addressed a new
methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by manufacturers under the
Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid managed care organizations, established annual fees and taxes on manufacturers of certain branded prescription drugs, and created a new Medicare
Part&nbsp;D coverage gap discount program, in which manufacturers must agree to offer 70% (increased pursuant to the Bipartisan Budget Act of 2018, effective as of 2019)
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the
manufacturer&#146;s outpatient drugs to be covered under Medicare Part&nbsp;D. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous judicial,
administrative, executive, and legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example, various portions of the ACA are currently undergoing legal
and constitutional challenges in the Fifth Circuit Court and the United States Supreme Court, and the Trump Administration has issued various Executive Orders which eliminated cost sharing subsidies and various provisions that would impose a fiscal
burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, Congress has introduced several pieces of legislation
aimed at significantly revising or repealing the ACA. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. The Budget Control Act of 2011, among
other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach
required goals, thereby triggering the legislation&#146;s automatic reduction to several government programs, including aggregate reductions of Medicare payments to providers of 2% per fiscal year. These reductions went into effect on April&nbsp;1,
2013 and, due to subsequent legislative amendments to the statute, including the Bipartisan Budget Act of 2018, or BBA, will remain in effect through 2029, unless additional congressional action is taken. The BBA also amended the ACA, effective
January 1, 2019, by increasing the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#147;donut hole&#148;.
On January&nbsp;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and
increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, in
May 2019, CMS issued a final rule that would allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January 1, 2020. This final rule codified CMS&#146;s policy change that was
effective January 1, 2019. CMS is still considering the proposed changes to the definition of &#147;negotiated prices&#148; in the regulations. These laws, and future state and federal healthcare reform measures may be adopted in the future, any of
which may result in additional reductions in Medicare and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other healthcare funding and otherwise affect the prices we may obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product
candidate is prescribed or used. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Inadequate funding for the FDA, the SEC and other government agencies could hinder their ability
to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation
of our business may rely, which could negatively impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ability of the FDA to review and approve new products
can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency
have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political
process, which is inherently fluid and unpredictable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Disruptions at the FDA and other agencies may also slow the time necessary for new
drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the
FDA and the SEC, have had to furlough critical employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which
could have a material adverse effect on our business. Further, upon completion of this offering and in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital
in order to properly capitalize and continue our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>EU drug marketing and reimbursement regulations may materially affect
our ability to market and receive coverage for our products in the European member states. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to seek approval to market
our product candidates in both the United States and in selected foreign jurisdictions. If we obtain approval in one or more foreign jurisdictions for our product candidates, we will be subject to rules and regulations in those jurisdictions. In
some foreign countries, particularly those in the EU, the pricing of drugs is subject to governmental control and other market regulations which could put pressure on the pricing and usage of our product candidates. In these countries, pricing
negotiations with governmental authorities can take considerable time after obtaining marketing approval of a product candidate. In addition, market acceptance and sales of our product candidates will depend significantly on the availability of
adequate coverage and reimbursement from third-party payors for our product candidates and may be affected by existing and future health care reform measures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Much like the federal Anti-Kickback Statute prohibition in the United States, the provision of benefits or advantages to physicians to induce
or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the EU. The provision of benefits or advantages to physicians is governed by the national anti-bribery laws of EU
Member States, and in respect of the UK (which is longer a member of the EU), the UK Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments made to physicians in certain EU Member States must be publicly disclosed. Moreover, agreements with physicians often must be the
subject of prior notification and approval by the physician&#146;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws,
industry codes or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in most foreign countries, including the European Economic Area, or EEA, the
proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing and reimbursement vary widely from country to country. For example, the EU provides options for its member states to restrict
the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. Reference pricing used by various EU member states and parallel distribution, or
arbitrage between <FONT STYLE="white-space:nowrap">low-priced</FONT> and high-priced member states, can further reduce prices. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or
indirect controls on the profitability of the company placing the medicinal product on the market. In some countries, we may be required to conduct a clinical study or other studies that compare the cost-effectiveness of any of our product
candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval. There can be no assurance that any country that has price controls or reimbursement limitations for biopharmaceutical products will allow
favorable reimbursement and pricing arrangements for any of our products. Historically, products launched in the EU do not follow price structures of the United States and generally prices tend to be significantly lower. Publication of discounts by
third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if reimbursement of our products is unavailable
or limited in scope or amount, our revenues from sales and the potential profitability of any of our product candidates in those countries would be negatively affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may incur substantial costs in our efforts to comply with evolving global data protection laws and regulations, and any failure or
perceived failure by us to comply with such laws and regulations may harm our business and operations. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The global data
protection landscape is rapidly evolving, and we may be or become subject to or affected by numerous federal, state and foreign laws and regulations, as well as regulatory guidance, governing the collection, use, disclosure, transfer, security and
processing of personal data, such as information that we collect about participants and healthcare providers in connection with clinical trials. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable
future, which may create uncertainty in our business, affect our or our service providers&#146; ability to operate in certain jurisdictions or to collect, store, transfer use and share personal data, result in liability or impose additional
compliance or other costs on us. Any failure or perceived failure by us to comply with federal, state, or foreign laws or self-regulatory standards could result in negative publicity, diversion of management time and effort and proceedings against
us by governmental entities or others. Recently, California passed the California Data Privacy Protection Act of 2018, or the CCPA, which went into effect in January 2020 and provides new data privacy rights for consumers and new operational
requirements for companies, which may increase our compliance costs and potential liability. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and
receive detailed information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. While there
is currently an exception for protected health information that is subject to HIPAA and clinical trial regulations, as currently written, the CCPA may impact certain of our business activities. The new California law may lead to similar laws in
other U.S. states or at a national level, which could increase our potential liability and adversely affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to
our operations in the United States, which may be subject to healthcare and other laws relating to the privacy and security of health information and other personal information, may seek to conduct clinical trials in EEA and may become subject to
additional European data privacy laws, regulations and guidelines. The General Data Protection Regulation, (EU) 2016/679, or GDPR, became effective on May&nbsp;25, 2018, and deals with the collection, use, storage, disclosure, transfer, or other
processing of personal data, including personal health data, regarding individuals in the EEA. The GDPR imposes a broad range of strict requirements on companies subject to the GDPR, including requirements relating to having legal bases for
processing personal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information relating to identifiable individuals and transferring such information outside the EEA, including to the United States, providing details to those individuals regarding the processing
of their personal health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, keeping personal information secure, having data processing agreements with third parties who process personal information,
responding to individuals&#146; requests to exercise their rights in respect of their personal information, reporting security breaches involving personal data to the competent national data protection authority and affected individuals, appointing
data protection officers, conducting data protection impact assessments, and record-keeping. The GDPR increases substantially the penalties to which we could be subject in the event of any <FONT STYLE="white-space:nowrap">non-compliance,</FONT>
including fines of up to 10,000,000 Euros or up to 2% of our total worldwide annual turnover for certain comparatively minor offenses, or up to 20,000,000 Euros or up to 4% of our total worldwide annual turnover, whichever is greater, for more
serious offenses. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of
the GDPR. In addition, the GDPR includes restrictions on cross-border data transfers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, national laws of member states of the EU
are in the process of being adapted to the requirements under the GDPR, thereby implementing national laws which may partially deviate from the GDPR and impose different obligations from country to country, so that we do not expect to operate in a
uniform legal landscape in the EEA. Also, as it relates to processing and transfer of genetic data, the GDPR specifically allows national laws to impose additional and more specific requirements or restrictions, and European laws have historically
differed quite substantially in this field, leading to additional uncertainty. The United Kingdom&#146;s decision to leave the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom.
In particular, it is unclear how data transfers to and from the United Kingdom will be regulated now that the United Kingdom has left the EU. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event we commence clinical trials in the EEA, the GDPR may increase our responsibility and liability in relation to personal data that
we process where such processing is subject to the GDPR, and we may be required to put in place additional mechanisms and safeguards to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the GDPR will
be a rigorous and time-intensive process that may increase our cost of doing business or require us to change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and
reputational harm in connection with our European activities. We expect that we will continue to face uncertainty as to whether our efforts to comply with any obligations under European privacy laws will be sufficient. If we are investigated by a
European data protection authority, we may face fines and other penalties. Any such investigation or charges by European data protection authorities could have a negative effect on our existing business and on our ability to attract and retain new
clients or biopharmaceutical partners. We may also experience hesitancy, reluctance, or refusal by European or multi-national clients or biopharmaceutical partners to continue to use our products and solutions due to the potential risk exposure as a
result of the current (and, in particular, future) data protection obligations imposed on them by certain data protection authorities in interpretation of current law, including the GDPR. Such clients or biopharmaceutical partners may also view any
alternative approaches to compliance as being too costly, too burdensome, too legally uncertain, or otherwise objectionable and therefore decide not to do business with us. Any of the forgoing could materially harm our business, prospects, financial
condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Legal, political and economic uncertainty surrounding the exit of the U.K. from the EU may be
a source of instability in international markets, create significant currency fluctuations, adversely affect our operations in the U.K. and pose additional risks to our business, revenue, financial condition, and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June 23, 2016, the U.K. held a referendum in which a majority of the eligible members of the electorate voted to leave the EU, commonly
referred to as Brexit. Pursuant to Article 50 of the Treaty on EU, the U.K. ceased being a Member State of the EU on January 31, 2020. However, the terms of the withdrawal have yet to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be fully negotiated. The implementation period began February 1, 2020 and will continue until December 31, 2020. During this 11-month period, the U.K. will continue to follow all of the EU&#146;s
rules, the EU&#146;s pharmaceutical law remains applicable to the U,K, and the U.K.&#146;s trading relationship will remain the same. However, regulations (including financial laws and regulations, tax and free trade agreements, intellectual
property rights, data protection laws, supply chain logistics, environmental, health and safety laws and regulations medicine licensing and regulations, immigration laws and employment laws), have yet to be addressed. This lack of clarity on future
U.K. laws and regulations and their interaction with the EU laws and regulations may negatively impact foreign direct investment in the U.K., increase costs, depress economic activity and restrict access to capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The uncertainty concerning the U.K&#146;s legal, political and economic relationship with the EU after Brexit may be a source of instability
in the international markets, create significant currency fluctuations, and/or otherwise adversely affect trading agreements or similar cross-border co-operation arrangements (whether economic, tax, fiscal, legal, regulatory or otherwise) beyond the
date of Brexit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These developments, or the perception that any of them could occur, may have a significant adverse effect on global
economic conditions and the stability of global financial markets, and could significantly reduce global market liquidity and limit the ability of key market participants to operate in certain financial markets. In particular, it could also lead to
a period of considerable uncertainty in relation to the U.K. financial and banking markets, as well as on the regulatory process in Europe. Asset valuations, currency exchange rates and credit ratings may also be subject to increased market
volatility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the U.K. and the EU are unable to negotiate acceptable agreements or if other EU member states pursue withdrawal,
barrier-free access between the UK and other EU member states or among the European Economic Area overall could be diminished or eliminated. The long-term effects of Brexit will depend on any agreements (or lack thereof) between the U.K. and the EU
and, in particular, any arrangements for the U.K. to retain access to EU markets either during a transitional period from January&nbsp;1, 2021 or more permanently. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such a withdrawal from the EU is unprecedented, and it is unclear how the U.K&#146;s access to the European single market for goods, capital,
services and labor within the EU, or single market, and the wider commercial, legal and regulatory environment, will impact our current and future operations (including business activities conducted by third parties and contract manufacturers on our
behalf) and clinical activities in the U.K. In addition to the foregoing, our U.K. operations support our current and future operations and clinical activities in the EU and European Economic Area, or EEA, and these operations and clinical
activities could be disrupted by Brexit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also face new regulatory costs and challenges that could have an adverse effect on our
operations. Depending on the terms of the U.K&#146;s withdrawal from the EU, the U.K. could lose the benefits of global trade agreements negotiated by the EU on behalf of its members, which may result in increased trade barriers that could make our
doing business in the EU and the EEA more difficult. Since the regulatory framework in the U.K. covering quality, safety and efficacy of pharmaceutical products, clinical trials, marketing authorization, commercial sales and distribution of
pharmaceutical products is derived from EU directives and regulations, Brexit could materially impact the future regulatory regime with respect to the approval of our product candidates in the U.K. For instance, in November 2017, EU member states
voted to move the EMA, the EU&#146;s regulatory body, from London to Amsterdam. Operations in Amsterdam commenced in March 2019, and the move itself may cause significant disruption to the regulatory approval process in Europe. It remains to be seen
how, if at all, Brexit will impact regulatory requirements for product candidates and products in the U.K. Any delay in obtaining, or an inability to obtain, any regulatory approvals, as a result of Brexit or otherwise, would prevent us from
commercializing our product candidates in the U.K. and/or the EU and restrict our ability to generate revenue and achieve and sustain profitability. If any of these outcomes occur, we may be forced to restrict or delay efforts to seek regulatory
approval in the U.K. and/or EU for our product candidates, which could significantly and materially harm our business. Even prior to any change to the U.K&#146;s relationship with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
EU, the announcement of Brexit has created economic uncertainty surrounding the terms of Brexit and its consequences could adversely impact customer confidence resulting in customers reducing
their spending budgets on our product candidates, if approved, which could adversely affect our business, financial condition, results of operations and could adversely affect the market price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Additional laws and regulations governing international operations could negatively impact or restrict our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in
each jurisdiction in which we plan to operate. The U.S. Foreign Corrupt Practices Act, or the FCPA, prohibits any U.S. individual or business entity from paying, offering, authorizing payment or offering of anything of value, directly or indirectly,
to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose
securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries,
and to devise and maintain an adequate system of internal accounting controls for international operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with the FCPA is
expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the biopharmaceutical industry, because, in many countries, hospitals are operated by the
government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals and healthcare providers in connection with clinical trials and other work have been deemed to be improper payments to government
officials and have led to FCPA enforcement actions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Various laws, regulations and executive orders also restrict the use and
dissemination outside of the United States, or the sharing with certain <FONT STYLE="white-space:nowrap">non-U.S.</FONT> nationals, of information products classified for national security purposes, as well as certain products, technology and
technical data relating to those products. If we expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or
selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and
suspension or debarment from government contracting. The Securities and Exchange Commission, or SEC, also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#146;s accounting provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and
regulations. We can face serious consequences for violations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Among other matters, U.S. and foreign anti-corruption, anti-money
laundering, export control, sanctions, and other trade laws and regulations, which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, clinical research organizations, legal counsel, accountants, consultants,
contractors, and other partners from authorizing, promising, offering, providing, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector.
Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We
have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We also expect our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> activities to
increase in time. We plan to engage third parties for clinical trials and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals and we can be held liable for the corrupt or other illegal
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
activities of our personnel, agents, or partners, even if we do not explicitly authorize or have prior knowledge of such activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our success depends in part on our ability to protect our intellectual property. It is difficult and costly to protect our proprietary
rights and technology, and we may not be able to ensure their protection. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business will depend in large part on obtaining and
maintaining patent, trademark and trade secret protection of our proprietary technologies and our product candidates, their respective components, synthetic intermediates, formulations, combination therapies, methods used to manufacture them and
methods of treatment, as well as successfully defending these patents against third-party challenges. Our ability to stop unauthorized third parties from making, using, selling, offering to sell or importing our product candidates is dependent upon
the extent to which we have rights under valid and enforceable patents that cover these activities and whether a court would issue an injunctive remedy. If we are unable to secure and maintain patent protection for any product or technology we
develop, or if the scope of the patent protection secured is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to commercialize any product candidates we may
develop may be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The patenting process is expensive and time-consuming, and we may not be able to file and prosecute
all necessary or desirable patent applications at a reasonable cost or in a timely manner. In addition, we may not pursue, obtain, or maintain patent protection in all relevant markets. It is also possible that we will fail to identify patentable
aspects of our research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain
the patents, covering technology that we license from or license to third parties and are reliant on our licensors or licensees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
strength of patents in the biotechnology and biopharmaceutical field involves complex legal and scientific questions and can be uncertain. The patent applications that we own or <FONT STYLE="white-space:nowrap">in-license</FONT> may fail to result
in issued patents with claims that cover our product candidates or uses thereof in the United States or in other foreign countries. Even if the patents do successfully issue, third parties may challenge the validity, enforceability or scope thereof,
which may result in such patents being narrowed, invalidated or held unenforceable. Furthermore, even if they are unchallenged, our patents and patent applications may not adequately protect our technology, including our product candidates, or
prevent others from designing around our claims. If the breadth or strength of protection provided by the patent applications we hold with respect to our product candidates is threatened, it could dissuade companies from collaborating with us to
develop, and threaten our ability to commercialize, our product candidates. Further, if we encounter delays in our clinical trials, the period of time during which we could market our product candidates under patent protection would be reduced. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot be certain that we were the first to file any patent application related to our technology, including our product candidates,
and, if we were not, we may be precluded from obtaining patent protection for our technology, including our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot
be certain that we are the first to invent the inventions covered by pending patent applications and, if we are not, we may be subject to priority disputes. Furthermore, for United States applications in which all claims are entitled to a priority
date before March&nbsp;16, 2013, an interference proceeding can be provoked by a third-party or instituted by the United States Patent and Trademark Office, or USPTO, to determine who was the first to invent any of the subject matter covered by the
patent claims of our applications. Similarly, for United States applications in which at least one claim is not entitled to a priority date before March&nbsp;16, 2013, derivation proceedings can be instituted to determine whether the subject matter
of a patent claim was derived from a prior inventor&#146;s disclosure. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be required to disclaim part or all of the term of
certain patents or all of the term of certain patent applications. There may be prior art of which we are not aware that may affect the validity or enforceability of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
patent or patent application claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, which may, nonetheless,
ultimately be found to affect the validity or enforceability of a claim. No assurance can be given that if challenged, our patents would be declared by a court to be valid or enforceable or that even if found valid and enforceable, would adequately
protect our product candidates, or would be found by a court to be infringed by a competitor&#146;s technology or product. We may analyze patents or patent applications of our competitors that we believe are relevant to our activities, and consider
that we are free to operate in relation to our product candidates, but our competitors may achieve issued claims, including in patents we consider to be unrelated, which block our efforts or may potentially result in our product candidates or our
activities infringing such claims. The possibility exists that others will develop products which have the same effect as our products on an independent basis which do not infringe our patents or other intellectual property rights, or will design
around the claims of patents that may issue that cover our products. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recent or future patent reform legislation could increase the
uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. Under the enacted Leahy-Smith America Invents Act, or America Invents Act, enacted in 2013, the United States moved
from a &#147;first to invent&#148; to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system. Under a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system, assuming the other requirements for patentability are met, the first inventor to file&nbsp;a patent application generally will be
entitled to a patent on the invention regardless of whether another inventor had made the invention earlier. The America Invents Act includes a number of other significant changes to U.S. patent law, including provisions that affect the way patent
applications are prosecuted, redefine prior art and establish a new post-grant review system. The effects of these changes are currently unclear as the USPTO only recently developed new regulations and procedures in connection with the America
Invents Act and many of the substantive changes to patent law, including the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> provisions, only became effective in March 2013. In addition, the
courts have yet to address many of these provisions and the applicability of the act and new regulations on specific patents discussed herein have not been determined and would need to be reviewed. However, the America Invents Act and its
implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial
condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and
may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make or use compounds that are similar to the compositions of our product candidates but
that are not covered by the claims of our patents or those of our licensors; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors, as the case may be, may fail to meet our obligations to the U.S. government in regards to
any <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents and patent applications funded by U.S. government grants, leading to the loss of patent rights;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors, as the case may be, might not have been the first to file patent applications for these
inventions;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop similar or alternative technologies or duplicate any of our
technologies;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our pending patent applications will not result in issued patents;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that there are prior public disclosures that could invalidate our or our licensors&#146; patents,
as the case may be, or parts of our or their patents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that others may circumvent our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT>
patents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that there are unpublished applications or patent applications maintained in secrecy that may
later issue with claims covering our products or technology similar to ours;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the laws of foreign countries may not protect our or our licensors&#146;, as the case may be, proprietary rights
to the same extent as the laws of the United States;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the claims of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents or patent
applications, if and when issued, may not cover our product candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents may not provide us with any
competitive advantages, may be narrowed in scope, or be held invalid or unenforceable as a result of legal challenges by third parties;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inventors of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents or patent applications
may become involved with competitors, develop products or processes which design around our patents, or become hostile to us or the patents or patent applications on which they are named as inventors;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents or patent
applications omit individual(s) that should be listed as inventor(s) or include individual(s) that should not be listed as inventor(s), which may cause these patents or patents issuing from these patent applications to be held invalid or
unenforceable;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have engaged in scientific collaborations in the past, and will continue to do so in the future. Such
collaborators may develop adjacent or competing products to ours that are outside the scope of our patents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not develop additional proprietary technologies for which we can obtain patent
protection;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that product candidates or diagnostic tests we develop may be covered by third parties&#146;
patents or other exclusive rights; or</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may have an adverse effect on our business. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may enter into license or other collaboration agreements in the future that may impose certain obligations on us. If we fail to
comply with our obligations under such future agreements with third parties, we could lose license rights that may be important to our future business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with our efforts to expand our pipeline of product candidates, we may enter into certain licenses or other collaboration
agreements in the future pertaining to the in-license of rights to additional candidates. Such agreements may impose various diligence, milestone payment, royalty, insurance or other obligations on us. If we fail to comply with these obligations,
our licensor or collaboration partners may have the right to terminate the relevant agreement, in which event we would not be able to develop or market the products covered by such licensed intellectual property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, disputes may arise regarding intellectual property subject to a licensing agreement, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which our product candidates, technology and processes infringe on intellectual property of the
licensor that is not subject to the licensing agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sublicensing of patent and other rights under our collaborative development relationships;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of
intellectual property by our licensors and us and our partners; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the priority of invention of patented technology. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the agreements under which we currently license intellectual property or technology from third parties are complex, and certain
provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could
have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing
arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and
prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may have limited control over the maintenance and prosecution of these in-licensed patents and patent
applications, or any other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by any future licensors have been or will be conducted in compliance with
applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. We have limited control over the manner in which our licensors initiate an infringement proceeding against a third-party
infringer of the intellectual property rights, or defend certain of the intellectual property that is licensed to us. It is possible that the licensors&#146; infringement proceeding or defense activities may be less vigorous than had we conducted
them ourselves. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would
be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to patent protection, we rely heavily upon <FONT STYLE="white-space:nowrap">know-how</FONT> and trade
secret protection, as well as <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements and invention assignment agreements with our employees, consultants and third-parties, to protect our confidential and proprietary information,
especially where we do not believe patent protection is appropriate or obtainable. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such
measures may not, for example, in the case of misappropriation of a trade secret by an employee or third-party with authorized access, provide adequate protection for our proprietary information. Our security measures may not prevent an employee or
consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Enforcing a claim that a party illegally disclosed
or misappropriated a trade secret can be difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. For
example, our clinical development strategy includes the testing of live tissue samples, and our techniques for preserving and testing these samples are proprietary and confidential. If one or more third parties obtain or are otherwise able to
replicate these techniques, an important feature and differentiator of our clinical development strategy will become available to potential competitors. If any of our confidential or proprietary information, such as our trade secrets, were to be
disclosed or misappropriated, or if any such information was independently developed by a competitor, our competitive position could be harmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, courts outside the United States are sometimes less willing to protect trade secrets. If we choose to go to court to stop a
third-party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful. Although we take steps to protect our proprietary information and trade secrets,
including through contractual means with our employees and consultants, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our technology.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Thus, we may not be able to meaningfully protect our trade secrets. It is our policy to require our employees, consultants, outside
scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with us. These agreements provide that all confidential information concerning
our business or financial affairs developed or made known to the individual or entity during the course of the party&#146;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances. In the
case of employees, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreements provide that all inventions conceived by the individual, and which are related to our current or planned business or research and development or made during normal working hours, on
our premises or using our equipment or proprietary information, are our exclusive property. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our
proprietary technology by third parties. We have also adopted policies and conduct training that provides guidance on our expectations, and our advice for best practices, in protecting our trade secrets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Third-party claims of intellectual property infringement may prevent or delay our product discovery and development efforts.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial success depends in part on our ability to develop, manufacture, market and sell our product candidates and use our
proprietary technologies without infringing the proprietary rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and biopharmaceutical industries, as well
as administrative proceedings for challenging patents, including interference, derivation,<I>&nbsp;inter partes</I>&nbsp;review, post grant review, and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in
foreign jurisdictions. We may be exposed to, or threatened with, future litigation by third parties having patent or other intellectual property rights alleging that our product candidates and/or proprietary technologies infringe their intellectual
property rights. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates. As the biotechnology and biopharmaceutical industries
expand and more patents are issued, the risk increases that our product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover
various types of drugs, products or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications filed in our fields, there may be a risk that third parties may allege they have patent rights
encompassing our product candidates, technologies or methods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a third-party claims that we infringe its intellectual property rights,
we may face a number of issues, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">infringement and other intellectual property claims which, regardless of merit, may be expensive and
time-consuming to litigate and may divert our management&#146;s attention from our core business;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial damages for infringement, which we may have to pay if a court decides that the product candidate or
technology at issue infringes on or violates the third-party&#146;s rights, and, if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner&#146;s attorneys&#146; fees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a court prohibiting us from developing, manufacturing, marketing or selling our product candidates, or from using
our proprietary technologies, unless the third-party licenses its product rights to us, which it is not required to do;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if a license is available from a third-party, we may have to pay substantial royalties, upfront fees and other
amounts, and/or grant cross-licenses to intellectual property rights for our products and any license that is available may be non-exclusive, which could result in our competitors gaining access to the same intellectual property;
and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">redesigning our product candidates or processes so they do not infringe, which may not be possible or may require
substantial monetary expenditures and time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of our competitors may be able to sustain the costs of complex patent
litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise
the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. Furthermore, because of the substantial amount of discovery required in
connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our collaborators may assert ownership or commercial rights to inventions they develop
from research we support or that we develop from our use of the tissue samples or other biological materials, which they provide to us, or otherwise arising from the collaboration. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We collaborate with several institutions, universities, medical centers, physicians and researchers in scientific matters and expect to
continue to enter into additional collaboration agreements. In certain cases, we do not have written agreements with these collaborators, or the written agreements we have do not cover intellectual property rights. Also, we rely on numerous third
parties to provide us with tissue samples and biological materials that we use to conduct our research activities and develop our product candidates. If we cannot successfully negotiate sufficient ownership and commercial rights to any inventions
that result from our use of a third-party collaborator&#146;s materials, or if disputes arise with respect to the intellectual property developed with the use of a collaborator&#146;s samples, or data developed in a collaborator&#146;s study, we may
be limited in our ability to capitalize on the market potential of these inventions or developments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Third parties may assert that
we are employing their proprietary technology without authorization. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There may be third-party patents of which we are currently
unaware with claims to compositions of matter, materials, formulations, methods of manufacture or methods for treatment that encompass the composition, use or manufacture of our product candidates. There may be currently pending patent applications
of which we are currently unaware which may later result in issued patents that our product candidates or their use or manufacture may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies
infringes upon these patents. If any third-party patent were held by a court of competent jurisdiction to cover our product candidates, intermediates used in the manufacture of our product candidates or our materials generally, aspects of our
formulations or methods of use, the holders of any such patent may be able to block our ability to develop and commercialize the product candidate unless we obtained a license or until such patent expires or is finally determined to be held invalid
or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, our ability to
commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors access
to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize
current or future product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parties making claims against us may seek and obtain injunctive or other equitable relief, which
could effectively block our ability to further develop and commercialize our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee
resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#146; fees for willful infringement, obtain one or more licenses from third
parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. We cannot predict whether any such license would be available at all or whether it would be available on
commercially reasonable terms. Furthermore, even in the absence of litigation, we may need to obtain licenses from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these
licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our product candidates, which could harm our business significantly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated
trade secrets. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As is common in the biotechnology and biopharmaceutical industries, we employ individuals who were previously
employed at universities or other biotechnology or biopharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently pending, and although we try to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ensure that our employees and consultants do not use the proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in their work for us, we may be subject to claims
that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties.
Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending
against such claims, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In
addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse
effect on the price of our common stock. This type of litigation or proceeding could substantially increase our operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources
to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Uncertainties
resulting from the initiation and continuation of patent litigation or other intellectual property related proceedings could adversely affect our ability to compete in the marketplace. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in obtaining or maintaining necessary rights to develop any future product candidates on acceptable terms.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because our programs may involve additional product candidates that may require the use of proprietary rights held by third
parties, the growth of our business may depend in part on our ability to acquire, <FONT STYLE="white-space:nowrap">in-license</FONT> or use these proprietary rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates may also require specific formulations to work effectively and efficiently and these rights may be held by others. We
may develop products containing our compounds and <FONT STYLE="white-space:nowrap">pre-existing</FONT> biopharmaceutical compounds. We may be unable to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> any compositions, methods of use,
processes or other third-party intellectual property rights from third parties that we identify as necessary or important to our business operations. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all,
which would harm our business. We may need to cease use of the compositions or methods covered by such third-party intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual
property rights which may entail additional costs and development delays, even if we were able to develop such alternatives, which may not be feasible. Even if we are able to obtain a license, it may be
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement
technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we sometimes collaborate with academic institutions to accelerate our preclinical research or development under
written agreements with these institutions. In certain cases, these institutions provide us with an option to negotiate a license to any of the institution&#146;s rights in technology resulting from the collaboration. Regardless of such option, we
may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to others, potentially blocking our ability to pursue
our program. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business and
financial condition could suffer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The licensing and acquisition of third-party intellectual property rights is a competitive area, and
companies, which may be more established, or have greater resources than we do, may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our
product candidates. More established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. There can
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be no assurance that we will be able to successfully complete such negotiations and ultimately acquire the rights to the intellectual property surrounding the additional product candidates that
we may seek to acquire. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which
could be expensive, time-consuming and unsuccessful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Competitors may infringe our patents or the patents of our current or future
licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that one or more of our patents is not
valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question or for other reasons. An adverse result in any litigation or defense
proceedings could put one or more of our patents at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of not issuing. Defense of these claims, regardless of their merit, would
involve substantial litigation expense and would be a substantial diversion of employee resources from our business. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may choose to
challenge the patentability of claims in a third-party&#146;s U.S. patent by requesting that the USPTO review the patent claims in
an<I><FONT STYLE="white-space:nowrap">&nbsp;ex-parte</FONT></I><FONT STYLE="white-space:nowrap">&nbsp;re-examination,</FONT><I>&nbsp;inter partes</I>&nbsp;review or post-grant review proceedings. These proceedings are expensive and may consume our
time or other resources. We may choose to challenge a third-party&#146;s patent in patent opposition proceedings in the European Patent Office, or EPO, or other foreign patent office. The costs of these opposition proceedings could be substantial,
and may consume our time or other resources. If we fail to obtain a favorable result at the USPTO, EPO or other patent office then we may be exposed to litigation by a third-party alleging that the patent may be infringed by our product candidates
or proprietary technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, because some patent applications in the United States may be maintained in secrecy until the
patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until 18&nbsp;months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot
be certain that others have not filed patent applications for technology covered by our owned and <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents or our pending applications, or that we or, if applicable, a licensor were the first
to invent the technology. Our competitors may have filed, and may in the future file, patent applications covering our products or technology similar to ours. Any such patent application may have priority over our owned and <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patent applications or patents, which could require us to obtain rights to issued patents covering such technologies. If another party has filed a U.S. patent application on inventions similar to those
owned by or <FONT STYLE="white-space:nowrap">in-licensed</FONT> to us, we or, in the case of <FONT STYLE="white-space:nowrap">in-licensed</FONT> technology, the licensor may have to participate in an interference or derivation proceeding declared by
the USPTO to determine priority of invention in the United States. If we or one of our licensors is a party to an interference or derivation proceeding involving a U.S. patent application on inventions owned by or
<FONT STYLE="white-space:nowrap">in-licensed</FONT> to us, we may incur substantial costs, divert management&#146;s time and expend other resources, even if we are successful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the
priority of inventions with respect to our patents or patent applications or those of our licensors. An unfavorable outcome could result in a loss of our current patent rights and could require us to cease using the related technology or to attempt
to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all, or if a non-exclusive license is offered and our competitors gain access
to the same technology. Litigation or interference proceedings may result in a decision adverse to our interests and, even if we are successful, may result in substantial costs and distract our management and other employees. We may not be able to
prevent, alone or with our licensors, misappropriation of our trade secrets or confidential information, particularly in countries where the laws may not protect those rights as fully as in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that
some of our confidential information could be compromised by disclosure </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or
investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and
other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Periodic maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime
of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent application process and following the issuance of a patent.
While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent
application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to
official actions within prescribed time limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees and failure to properly legalize and submit formal documents. In certain circumstances, even inadvertent noncompliance events may permanently
and irrevocably jeopardize patent rights. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Any patents, if issued patents covering our product candidates could be found invalid or unenforceable if challenged in court or the
USPTO. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we or one of our licensors initiate legal proceedings against a third-party to enforce a patent covering one of our
product candidates, the defendant could counterclaim that the patent covering our product candidate, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or
unenforceability are commonplace, and there are numerous grounds upon which a third-party can assert invalidity or unenforceability of a patent. Third parties may also raise similar claims before administrative bodies in the United States or abroad,
even outside the context of litigation. Such mechanisms include <FONT STYLE="white-space:nowrap">re-examination,</FONT> inter partes review, post grant review, and equivalent proceedings in foreign jurisdictions (e.g.,&nbsp;opposition proceedings).
Such proceedings could result in revocation or amendment to our patents in such a way that they no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the
validity question, for example, we cannot be certain that there is no invalidating prior art, of which we, our patent counsel and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity
and/or unenforceability, or if we are otherwise unable to adequately protect our rights, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection could have a material adverse
impact on our business and our ability to commercialize or license our technology and product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Likewise, our current licensed
patents covering our companion technologies, licensed from UCSF are expected to expire in 2036, without taking into account any possible patent term adjustments or extensions. Our earliest patents may expire before, or soon after, our first product
achieves marketing approval in the United States or foreign jurisdictions. Upon the expiration of our current patents, we may lose the right to exclude others from practicing these inventions. The expiration of these patents could also have a
similar material adverse effect on our business, results of operations, financial condition and prospects. We own pending patent applications covering our proprietary technologies or our product candidates that if issued as patents are expected to
expire from 2037 through 2040, without taking into account any possible patent term adjustments or extensions. However, we cannot be assured that the USPTO or relevant foreign patent offices will grant any of these patent applications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in patent law in the U.S. and in foreign jurisdictions could diminish the
value of patents in general, thereby impairing our ability to protect our products. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in either the patent laws or
interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming that other requirements for patentability
are met, prior to March&nbsp;16, 2013, in the United&nbsp;States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. On
March&nbsp;16, 2013, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are
met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. A third party that files a patent application in the USPTO on or
after March&nbsp;16, 2013, but before us could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant of the time from invention to
filing of a patent application. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we or our licensors were the first to either
(i)&nbsp;file any patent application related to our product candidates or (ii)&nbsp;invent any of the inventions claimed in our or our licensor&#146;s patents or patent applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The America Invents Act also includes a number of significant changes that affect the way patent applications will be prosecuted and also may
affect patent litigation. These include allowing third party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including
post-grant review, inter-partes review, and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third
party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a
third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. Therefore, the America Invents Act and its
implementation could increase the uncertainties and costs surrounding the prosecution of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patent applications and the enforcement or defense of our owned or <FONT
STYLE="white-space:nowrap">in-licensed</FONT> issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the patent positions of companies in the development and commercialization of biopharmaceuticals are particularly uncertain.
Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the
validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material
adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We
have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the world. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have limited intellectual property rights outside the United States. Filing, prosecuting and defending patents on product candidates in all
countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries
do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or
from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent
protection but where enforcement is not as strong as that in the United States. These products may compete with our products in jurisdictions where we do not have any issued patents and our patent claims or other intellectual property rights may not
be effective or sufficient to prevent them from competing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many companies have encountered significant problems in protecting and
defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of, and may require a compulsory license to, patents, trade secrets and
other intellectual property protection, particularly those relating to biopharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products against third parties in violation of
our proprietary rights generally. The initiation of proceedings by third parties to challenge the scope or validity of our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other
aspects of our business. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated
or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be
commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent
is generally 20&nbsp;years from its earliest U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> filing date. Various extensions such as patent term adjustments and/or extensions, may be available, but the life of a patent, and the
protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products. Given the amount of time required for the development,
testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with
sufficient rights to exclude others from commercializing products similar or identical to ours. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we do not obtain patent term
extension and data exclusivity for any product candidates we may develop, our business may be materially harmed. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depending
upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term
Restoration Action of 1984 Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend
the remaining term of a patent beyond a total of 14&nbsp;years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be
extended. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to
expiration of relevant patents, or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension
or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations, and prospects could be materially
harmed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If our trademarks and trade names are not adequately protected, then we may not be
able to build name recognition in our markets of interest and our business may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our trademarks or trade
names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we
need for name recognition by potential partners or customers in our markets of interest. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be
adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Reliance on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct certain aspects of our preclinical studies and clinical trials. If these third parties do not
successfully carry out their contractual duties, meet expected deadlines or comply with regulatory requirements, we may not be able to obtain regulatory approval of or commercialize any potential product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We depend upon third parties to conduct certain aspects of our preclinical studies and clinical trials, under agreements with universities,
medical institutions, CROs, strategic collaborators and others. We expect to have to negotiate budgets and contracts with such third parties, which may result in delays to our development timelines and increased costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will rely especially heavily on third parties over the course of our clinical trials, and, as a result, will have limited control over the
clinical investigators and limited visibility into their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, including with respect to their compliance with the approved clinical protocol.
Nevertheless, we are responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards, and our reliance on third parties does not relieve us of our
regulatory responsibilities. We and these third parties are required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for product candidates in clinical
development. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, clinical investigators and trial sites. If we or any of these third parties fail to comply with applicable GCP requirements, the
clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to suspend or terminate these trials or perform additional preclinical studies or clinical trials before
approving our marketing applications. We cannot be certain that, upon inspection, such regulatory authorities will determine that any of our clinical trials comply with the GCP requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure or any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients may require
us to repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare
privacy and security laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any third parties conducting aspects of our preclinical studies or clinical trials will not be our employees
and, except for remedies that may be available to us under our agreements with such third parties, we cannot control whether or not they devote sufficient time and resources to our preclinical studies and clinical programs. These third parties may
also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other product development activities, which could affect their performance on our behalf. If these third
parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the preclinical or clinical data they obtain is compromised due to the failure to
adhere to our protocols or regulatory requirements or for other reasons, our development timelines, including clinical development timelines, may be extended, delayed or terminated and we may not be able to complete development of, obtain regulatory
approval of or successfully commercialize our product candidates. As a result, our financial results and the commercial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenue could be delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our relationships with these third-party CROs or others terminate, we may not be able to enter into arrangements with alternative
CROs or other third parties or to do so on commercially reasonable terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Switching or adding additional CROs involves additional cost
and requires management time and focus. In addition, there is a natural transition period when a new CRO begins work. As a result, delays may occur, which can materially impact our ability to meet our desired development timelines. Though we
carefully manage our relationships with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial
condition and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties for tissue samples and other materials required for our research and development
activities, and if we are unable to reach agreements with these third parties our research and development activities would be delayed.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third parties, primarily hospitals, health clinics and academic institutions, for the provision of tissue samples and other
materials required in our research and development activities. Obtaining these materials requires various approvals as well as reaching a commercial agreement on acceptable terms with the hospital or other provider of the materials. While we
currently have agreements in place with the institutions from which we receive our tissue samples, we do not have any exclusive arrangements with such sources and there is no guarantee that we will be able to maintain or renew such agreements on
commercially reasonable terms, if at all. If we were unable to maintain or renew such agreements we would be forced to seek new arrangements with new hospitals, clinics or health institutions. If so, we may not be able to reach agreements with
alternative partners or do so on terms acceptable to us. If we are unable to enter into such agreements, our research and development activities will be delayed and our ability to implement a key part of our development strategy will be compromised.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Because we rely on third-party manufacturing and supply vendors, our supply of research and development, preclinical and clinical
development materials may become limited or interrupted or may not be of satisfactory quantity or quality. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third-party
contract manufacturers to manufacture our product candidates for preclinical studies and clinical trials. We do not own manufacturing facilities for producing any clinical trial product supplies. There can be no assurance that our preclinical and
clinical development product supplies will not be limited, interrupted, or of satisfactory quality or continue to be available at acceptable prices. In particular, any replacement of our manufacturer could require significant effort and expertise
because there may be a limited number of qualified replacements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The manufacturing process for a product candidate is subject to FDA and
foreign regulatory authority review. Suppliers and manufacturers must meet applicable manufacturing requirements and undergo rigorous facility and process validation tests required by regulatory authorities in order to comply with regulatory
standards, such as cGMPs. In the event that any of our manufacturers fails to comply with such requirements or to perform its obligations to us in relation to quality, timing or otherwise, or if our supply of components or other materials becomes
limited or interrupted for other reasons, we may be forced to manufacture the materials ourselves, for which we currently do not have the capabilities or resources, or enter into an agreement with another third-party, which we may not be able to do
on reasonable terms, if at all. In some cases, the technical skills or technology required to manufacture our product candidates may be unique or proprietary to the original manufacturer and we may have difficulty transferring such skills or
technology to another third-party and a feasible alternative may not exist. These factors would increase our reliance on such manufacturer or require us to obtain a license from such manufacturer in order to have another third-party manufacture our
product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates. If we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality
standards and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop product candidates in a timely manner or within budget. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to continue to rely on third-party manufacturers if we receive regulatory approval for
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidate. To the extent that we have existing, or enter into future, manufacturing arrangements with third parties, we will depend on these third parties to perform their
obligations in a timely manner consistent with contractual and regulatory requirements, including those related to quality control and assurance. If we are unable to obtain or maintain third-party manufacturing for product candidates, or to do so on
commercially reasonable terms, we may not be able to develop and commercialize our product candidates successfully. Our or a third-party&#146;s failure to execute on our manufacturing requirements and comply with cGMP could adversely affect our
business in a number of ways, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an inability to initiate or continue clinical trials of product candidates under
development;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delay in submitting regulatory applications, or receiving regulatory approvals, for product
candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of the cooperation of an existing or future collaborator;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subjecting third-party manufacturing facilities or our manufacturing facilities to additional inspections by
regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requirements to cease distribution or to recall batches of our product candidates; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the event of approval to market and commercialize a product candidate, an inability to meet commercial demands
for our products. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on a sole supplier for the manufacture of PLN-74809. If this sole supplier is unable to
supply to us in the quantities we require, or at all, or otherwise defaults on its supply obligations to us, we may not be able to obtain alternative supplies from other suppliers on acceptable terms, in a timely manner, or at all. We also do not
have long-term supply agreements with any of our suppliers. Our current contracts with certain suppliers may be canceled or not extended by such suppliers and, therefore, do not afford us with protection against a reduction or interruption in
supplies. Moreover, in the event any of these suppliers breach their contracts with us, our legal remedies associated with such a breach may be insufficient to compensate us for any damages we may suffer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we contract with fill and finishing providers with the appropriate expertise, facilities and scale to meet our needs. Failure to
maintain cGMP can result in a contractor receiving FDA sanctions, which can impact our ability to operate or lead to delays in any clinical development programs. We believe that our current fill and finish contractor is operating in accordance with
cGMP, but we can give no assurance that FDA or other regulatory agencies will not conclude that a lack of compliance exists. In addition, any delay in contracting for fill and finish services, or failure of the contract manufacturer to perform the
services as needed, may delay any clinical trials, registration and launches, which could negatively affect our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Future
collaborations will be important to our business. If we are unable to enter into new collaborations, or if these collaborations are not successful, our business could be adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A part of our strategy is to selectively evaluate partnerships in indications and geographies where we believe partners can add significant
commercial and/or development capabilities. Further, we have limited capabilities for product development and do not yet have any capability for commercialization. Accordingly, we may enter into collaborations with other companies to provide us with
important technologies and funding for our programs and technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our existing collaborations and any future collaborations we enter
into may pose a number of risks, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators have significant discretion in determining the efforts and resources that they will
apply;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not perform their obligations as expected;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not pursue development and commercialization of any product candidates that achieve regulatory
approval or may elect not to continue or renew development or commercialization programs or license arrangements based on clinical trial results, changes in the collaborators&#146; strategic focus or available funding, or external factors, such as a
strategic transaction that may divert resources or create competing priorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a
clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators could independently develop, or develop with third parties, products that compete directly or
indirectly with our products and product candidates if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than
ours;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product candidates discovered in collaboration with us may be viewed by our collaborators as competitive with
their own product candidates or products, which may cause collaborators to cease to devote resources to the commercialization of our product candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may fail to comply with applicable regulatory requirements regarding the development, manufacture,
distribution or marketing of a product candidate or product;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators with marketing and distribution rights to one or more of our product candidates that achieve
regulatory approval may not commit sufficient resources to the marketing and distribution of such product or products;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not provide us with timely and accurate information regarding development progress and activity
under any future license agreement, which could adversely impact our ability to report progress to our investors and otherwise plan development of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disagreements with collaborators, including disagreements over proprietary rights, contract interpretation or the
preferred course of development, might cause delays or terminations of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates, or might result in
litigation or arbitration, any of which would be time-consuming and expensive;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary
information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation
and potential liability;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if a collaborator of ours is involved in a business combination, the collaborator might deemphasize or terminate
the development or commercialization of any product candidate licensed to it by us; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborations may be terminated by the collaborator, and, if terminated, we could be required to raise
additional capital to pursue further development or commercialization of the applicable product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our
collaborations do not result in the successful discovery, development and commercialization of product candidates or if one of our collaborators terminates its agreement with us, we may not receive any future research funding or milestone or royalty
payments under such collaboration. All of the risks relating to product development, regulatory approval and commercialization described in this prospectus also apply to the activities of our therapeutic collaborators. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, if one of our collaborators terminates its agreement with us, we may find it
more difficult to attract new collaborators and our perception in the business and financial communities could be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
face significant competition in seeking appropriate collaborators for our product candidates, and the negotiation process is time-consuming and complex. In order for us to successfully establish a collaboration for one or more of our product
candidates, potential collaborators must view these product candidates as economically valuable in markets they determine to be attractive in light of the terms that we are seeking and other available products for licensing by other companies.
Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large biopharmaceutical companies that have resulted in a reduced number of potential
future collaborators. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration and
the proposed collaborator&#146;s evaluation of a number of factors. If we are unable to reach agreements with suitable collaborators on a timely basis, on acceptable terms, or at all, we may have to curtail the development of a product candidate,
reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or
commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional expertise and additional capital, which may not be available
to us on acceptable terms, or at all. If we fail to enter into collaborations or do not have sufficient funds or expertise to undertake the necessary development and commercialization activities, we may not be able to further develop our product
candidates, bring them to market and generate revenue from sales of drugs or continue to develop our technology, and our business may be materially and adversely affected. Even if we are successful in our efforts to establish new strategic
collaborations, the terms that we agree upon may not be favorable to us, and we may not be able to maintain such strategic collaborations if, for example, development or approval of a product candidate is delayed or sales of an approved product are
disappointing. Any delay in entering into new strategic collaboration agreements related to our product candidates could delay the development and commercialization of our product candidates and reduce their competitiveness even if they reach the
market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Managing Our Business and Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may encounter difficulties in managing our growth, which could adversely affect our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, we had 62 full-time employees. As our clinical development and commercialization plans and strategies develop,
and as we transition into operating as a public company, we will need to expand our managerial, clinical, regulatory, sales, marketing, financial, development, manufacturing and legal capabilities or contract with third parties to provide these
capabilities for us. As our operations expand, we expect that we will need to manage additional relationships with various strategic collaborators, suppliers and other third parties. Our future growth would impose significant added responsibilities
on members of management, including: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying, recruiting, integrating, maintaining and motivating additional employees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">managing our development and commercialization efforts effectively, including the clinical and FDA review process
for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and any other product candidates, while complying with our contractual obligations to contractors and other third parties; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">improving our operational, financial and management controls, reporting systems and procedures.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to continue to develop and, if approved, commercialize our product candidates will depend, in part, on our
ability to effectively manage any future growth. Our management may also have to divert a disproportionate amount of its attention away from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities in
order to devote a substantial amount of time to managing these growth activities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently rely, and for the foreseeable future will continue to rely, in substantial part
on certain independent organizations, advisors and consultants to provide certain services, including contract manufacturers and companies focused on research and development and discovery activities. There can be no assurance that the services of
independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if
the quality, accuracy or quantity of the services provided is compromised for any reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain, or may be substantially delayed in obtaining, regulatory approval
of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, or at all.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and
contractors, we may not be able to successfully implement the tasks necessary to further develop and commercialize <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidates and, accordingly, may not achieve our research,
development and commercialization goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may acquire additional technology and complementary businesses in the future. Acquisitions
involve many risks, any of which could materially harm our business, including the diversion of management&#146;s attention from core business concerns, failure to effectively exploit acquired technologies, failure to successfully integrate the
acquired business or realize expected synergies or the loss of key employees from either our business or the acquired businesses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to develop current
product candidates or identify and develop new product candidates will be impaired, could result in loss of markets or market share and could make us less competitive. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to compete in the highly competitive biotechnology and biopharmaceutical industries depends upon our ability to attract and retain
highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, scientific and medical personnel, including Bernard Coulie, M.D., Ph.D., our Chief Executive Officer and President, Keith Cummings, M.D., our
Chief Financial Officer, Johannes (Hans) Hull, J.D., our Chief Business Officer and &Eacute;ric Lefebvre, M.D., our Chief Medical Officer. The loss of the services of any of our executive officers, other key employees, and other scientific and
medical advisors, and our inability to find suitable replacements could result in delays in product development and harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
conduct our operations at our facility in South San Francisco, California. This region is headquarters to many other biopharmaceutical companies, biotechnology companies and research institutions. Competition for skilled personnel in our market is
intense and may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To induce valuable
employees to remain at our company, in addition to salary and cash incentives, we have provided restricted stock awards and stock options that vest over time. The value to employees of restricted stock awards and stock options that vest over time
may be significantly affected by movements in our stock price that are beyond our control, and may at any time be insufficient to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our
management, scientific and development teams may terminate their employment with us on short notice. Our key employees are <FONT STYLE="white-space:nowrap">at-will</FONT> employees, which means that any of our employees could leave our employment at
any time, with or without notice. We do not maintain &#147;key person&#148; insurance policies on the lives of these individuals or the lives of any of our other employees. Our success also depends on our ability to continue to attract, retain and
motivate highly skilled junior, <FONT STYLE="white-space:nowrap">mid-level</FONT> and senior scientific and medical personnel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our internal computer systems, or those of our collaborators or other contractors
or consultants, may fail or suffer security breaches, which could result in a material disruption of our product development programs. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our internal computer systems and those of our current and any future collaborators and other contractors or consultants are vulnerable to
damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While we have not experienced any such material system failure, accident or security breach to date, if such an event
were to occur and cause interruptions in our operations, it could result in a disruption of our development programs and our business operations, whether due to a loss of our trade secrets or other proprietary information or other similar
disruptions. For example, the loss of clinical trial data from future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption
or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability, our competitive position could be harmed and the further
development and commercialization of our product candidates could be delayed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We could be subject to risks caused by misappropriation,
misuse, leakage, falsification or intentional or accidental release or loss of information maintained in the information systems and networks of our company and our vendors, including personal information of our employees and study subjects, and
company and vendor confidential data. In addition, outside parties may attempt to penetrate our systems or those of our vendors or fraudulently induce our personnel or the personnel of our vendors to disclose sensitive information in order to gain
access to our data and/or systems. We may experience threats to our data and systems, including malicious codes and viruses, phishing and other cyber-attacks. The number and complexity of these threats continue to increase over time. If a material
breach of our information technology systems or those of our vendors occurs, the market perception of the effectiveness of our security measures could be harmed and our reputation and credibility could be damaged. We could be required to expend
significant amounts of money and other resources to repair or replace information systems or networks. In addition, we could be subject to regulatory actions and/or claims made by individuals and groups in private litigation involving privacy issues
related to data collection and use practices and other data privacy laws and regulations, including claims for misuse or inappropriate disclosure of data, as well as unfair or deceptive practices. Although we develop and maintain systems and
controls designed to prevent these events from occurring, and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as
technologies change and efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of our information systems
to vendors, engage in more electronic transactions with payors and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and
information systems. In addition, there can be no assurance that our internal information technology systems or those of our third-party contractors, or our consultants&#146; efforts to implement adequate security and control measures, will be
sufficient to protect us against breakdowns, service disruption, data deterioration or loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage
attacks or insider threat attacks which could result in financial, legal, business or reputational harm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our current operations are
concentrated in one location, and we or the third parties upon whom we depend may be adversely affected by earthquakes or other natural disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious
disaster, including earthquakes, outbreak of disease or other natural disasters. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current operations are located in our
facilities in South San Francisco, California. Any unplanned event, such as flood, fire, explosion, earthquake, extreme weather condition, medical epidemics, power shortage, telecommunication failure or other natural or manmade accidents or
incidents that result in us being unable to fully utilize our facilities, or the manufacturing facilities of our third-party contract manufacturers, may have a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material and adverse effect on our ability to operate our business, particularly on a daily basis, and have significant negative consequences on our financial and operating conditions. Loss of
access to these facilities may result in increased costs, delays in the development of our product candidates or interruption of our business operations. Earthquakes or other natural disasters could further disrupt our operations, and have a
material and adverse effect on our business, financial condition, results of operations and prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that
damaged critical infrastructure, such as our research facilities or the manufacturing facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to
continue our business for a substantial period of time. For example, in December 2019, an outbreak of a novel strain of coronavirus, or the COVID-19 coronavirus, originated in Wuhan, China. To date, this outbreak has already resulted in extended
shutdowns of certain businesses in the Wuhan region and has had ripple effects to businesses around the world. An outbreak of communicable diseases in China or elsewhere, or the perception that such an outbreak could occur, and the measures taken by
the governments of countries affected, could adversely affect our business, financial condition or results of operations by limiting our ability to manufacture products within or outside China, forcing temporary closure of facilities that we rely
upon or increasing the costs associated with obtaining clinical supplies of our product candidates. The extent to which the COVID-19 coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be
accurately predicted, including new information which may emerge concerning the severity of the COVID-19 coronavirus and the actions to contain the COVID-19 coronavirus or treat its impact, among others. Global health concerns, such as the COVID-19
coronavirus, could also result in social, economic, and labor instability in the countries in which we or the third parties with whom we engage operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The disaster recovery and business continuity plans we have in place may prove inadequate in the event of a serious disaster or similar event.
We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which, could have a material adverse effect on our business. As part of our risk management policy, we maintain insurance
coverage at levels that we believe are appropriate for our business. However, in the event of an accident or incident at these facilities, we cannot assure you that the amounts of insurance will be sufficient to satisfy any damages and losses. If
our facilities, or the manufacturing facilities of our third-party contract manufacturers, are unable to operate because of an accident or incident or for any other reason, even for a short period of time, any or all of our research and development
programs may be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Unfavorable global economic conditions could adversely affect our business, financial condition or results
of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our results of operations could be adversely affected by general conditions in the global economy and in the global
financial markets. Portions of our future clinical trials may be conducted outside of the United States and unfavorable economic conditions resulting in the weakening of the U.S. dollar would make those clinical trials more costly to operate.
Furthermore, the most recent global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn could result in a variety of risks to our business, including a reduced ability
to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy or international trade disputes could also strain our suppliers, some of which are located outside of the United States, possibly resulting in supply
disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The increasing use of social media platforms presents new risks and challenges. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Social media is increasingly being used to communicate about our clinical development programs and the diseases our therapeutics are being
developed to treat, and we intend to utilize appropriate social media in connection with our commercialization efforts following approval of our product candidates, if any. Social media practices in the biopharmaceutical industry continue to evolve
and regulations and regulatory guidance relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such use are evolving and not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business, resulting in potential regulatory actions
against us, along with the potential for litigation related to off-label marketing or other prohibited activities. For example, patients may use social media channels to comment on their experience in an ongoing blinded clinical trial or to report
an alleged adverse event. When such disclosures occur, there is a risk that trial enrollment may be adversely impacted, we fail to monitor and comply with applicable adverse event reporting obligations or that we may not be able to defend our
business or the public&#146;s legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our product candidates. There is also a risk of inappropriate disclosure of
sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face regulatory
actions or incur other harm to our business. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The estimates of market opportunity and forecasts of market growth included in
this prospectus may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market opportunity estimates and growth forecasts included in this prospectus are subject to significant uncertainty and are based on
assumptions and estimates which may not prove to be accurate. The estimates and forecasts included in this prospectus relating to size and expected growth of our target market may prove to be inaccurate. Even if the markets in which we compete meet
the size estimates and growth forecasts included in this prospectus, our business may not grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many
risks and uncertainties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our employees, independent contractors, consultants, commercial partners, collaborators and vendors may
engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are
exposed to the risk of employee fraud or other illegal activity by our employees, independent contractors, consultants, commercial partners, collaborators and vendors. Misconduct by these parties could include intentional, reckless and/or negligent
conduct that fails to comply with the laws of the FDA and other similar foreign regulatory bodies, provide true, complete and accurate information to the FDA and other similar foreign regulatory bodies, comply with manufacturing standards we have
established, comply with healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws, or report financial information or data accurately or to disclose unauthorized activities to us. If we obtain FDA approval
of any of our product candidates and begin commercializing those products in the United States, our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws will also increase. These
laws may impact, among other things, our current activities with principal investigators and research patients, as well as proposed and future sales, marketing and education programs. In connection with this offering, we will adopt a code of
business conduct and ethics, but it is not always possible to identify and deter misconduct by our employees, independent contractors, consultants, commercial partners and vendors, and the precautions we take to detect and prevent this activity may
not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any actions are instituted
against us and we are not successful in defending ourselves or asserting our rights, those actions could result in the imposition of civil, criminal and administrative penalties, damages, monetary fines, imprisonment, disgorgement, possible
exclusion from participation in government healthcare programs, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of
<FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws, contractual damages, reputational harm, diminished profits and future earnings and the curtailment of our operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Pandemics such as the COVID-19 coronavirus could have an adverse impact on our
developmental programs and our financial condition. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, a novel strain of the COVID-19 coronavirus was first
identified in Wuhan, Hubei Province, China. Any outbreak of contagious diseases, or other adverse public health developments, could have a material and adverse effect on our business operations. These could include disruptions or restrictions on our
ability to travel, pursue partnerships and other business transactions, conduct clinical trials, make shipments of biologic materials, as well as be impacted by the temporary closure of the facilities of suppliers and clinical trial sites. Any
disruption of suppliers, clinical trial sites or access to patients would likely impact our clinical trial enrollment progress and rates as well as our ability to access capital through the financial markets. The extent to which the COVID-19
coronavirus impacts our business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the COVID-19 coronavirus and the actions to contain the
COVID-19 coronavirus or treat its impact, among others. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We use and generate materials that may expose us to material
liability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research programs involve the use of hazardous materials and chemicals, which are currently only handled by third
parties. We are subject to foreign, federal, state and local environmental and health and safety laws and regulations governing, among other matters, the use, manufacture, handling, storage and disposal of hazardous materials and waste products such
as human tissue samples that may have the potential to transmit diseases. We may incur significant costs to comply with these current or future environmental and health and safety laws and regulations. In addition, we cannot completely eliminate the
risk of contamination or injury from hazardous materials and may incur material liability as a result of such contamination or injury. In the event of an accident, an injured party may seek to hold us liable for any damages that result. Any
liability could exceed the limits or fall outside the coverage of our workers&#146; compensation, property and business interruption insurance and we may not be able to maintain insurance on acceptable terms, if at all. We currently carry no
insurance specifically covering environmental claims. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with environmental, health and safety laws and
regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the
handling, use, storage, treatment and disposal of hazardous materials and wastes. Our research and development activities involve the use of biological and hazardous materials and produce hazardous waste products. We generally contract with third
parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials, which could cause an interruption of our commercialization efforts, research and development efforts and business
operations, environmental damage resulting in costly <FONT STYLE="white-space:nowrap">clean-up</FONT> and liabilities under applicable laws and regulations governing the use, storage, handling and disposal of these materials and specified waste
products. Although we believe that the safety procedures utilized by our third-party manufacturers for handling and disposing of these materials generally comply with the standards prescribed by these laws and regulations, we cannot guarantee that
this is the case or eliminate the risk of accidental contamination or injury from these materials. In such an event, we may be held liable for any resulting damages and such liability could exceed our resources and state or federal or other
applicable authorities may curtail our use of certain materials and/or interrupt our business operations. Furthermore, environmental laws and regulations are complex, change frequently and have tended to become more stringent. We cannot predict the
impact of such changes and cannot be certain of our future compliance. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and
regulations may impair our research, development or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we maintain workers&#146; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees
resulting from the use of hazardous materials or other work-related injuries, this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
insurance may not provide adequate coverage against potential liabilities. We do not carry specific biological waste or hazardous waste insurance coverage, workers compensation or property and
casualty and general liability insurance policies that include coverage for damages and fines arising from biological or hazardous waste exposure or contamination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compliance with governmental regulations regarding the treatment of animals used in research could increase our operating costs, which
would adversely affect the commercialization of our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Animal Welfare Act, or AWA, is the federal law that covers the
treatment of certain animals used in research. Currently, the AWA imposes a wide variety of specific regulations that govern the humane handling, care, treatment and transportation of certain animals by producers and users of research animals, most
notably relating to personnel, facilities, sanitation, cage size, and feeding, watering and shipping conditions. Third parties with whom we contract are subject to registration, inspections and reporting requirements under the AWA. Furthermore, some
states have their own regulations, including general anti-cruelty legislation, which establish certain standards in handling animals. Comparable rules, regulations, and or obligations exist in many foreign jurisdictions. If we or our contractors
fail to comply with regulations concerning the treatment of animals used in research, we may be subject to fines and penalties and adverse publicity, and our operations could be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in tax law could adversely affect our financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative
process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been
made and changes are likely to continue to occur in the future. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal
and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our ability
to use our net operating loss carryforwards and certain tax credit carryforwards may be subject to limitation. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2019, we had net operating loss carryforwards for federal and state income tax purposes of $58.7&nbsp;million and $60.7&nbsp;million, respectively, some of which will begin to expire in 2035. As of December&nbsp;31, 2019, we also
had available tax credit carryforwards for federal income tax purposes of $4.7&nbsp;million, which begin to expire in 2036, and state income tax purposes of $2.1&nbsp;million. Under Section&nbsp;382 of the Internal Revenue Code of 1986, as amended
(the &#147;Code&#148;), changes in our ownership may limit the amount of our net operating loss carryforwards and tax credit carryforwards that could be utilized annually to offset our future taxable income, if any. This limitation would generally
apply in the event of a cumulative change in ownership of our company of more than 50 percentage points within a three-year period. Any such limitation may significantly reduce our ability to utilize our net operating loss carryforwards and tax
credit carryforwards before they expire. Private placements and other transactions that have occurred since our inception, as well as this offering, may trigger such an ownership change pursuant to Section&nbsp;382. Any such limitation, whether as
the result of this offering, prior private placements, sales of our common stock by our existing stockholders or additional sales of our common stock by us, could have a material adverse effect on our results of operations in future years. Our
ability to utilize those net operating loss carryforwards could be limited by an &#147;ownership change&#148; as described above, which could result in increased tax liability to us. Net operating losses generated after December&nbsp;31, 2017 are
not subject to expiration, but may not be carried back to prior taxable years. Additionally, the deductibility of such federal net operating losses is limited to 80% of our taxable income in any future taxable year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Common Stock and this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>There has been no prior public market for our common stock, the stock price of our common stock may be volatile or may decline regardless
of our operating performance and you may not be able to resell your shares at or above the initial public offering price. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
this offering there has been no public market for shares of our common stock. You may not be able to sell your shares quickly or at the market price if trading in shares of our common stock is not active. The initial public offering price for our
common stock will be determined through negotiations with the underwriters, and the negotiated price may not be indicative of the market price of the common stock after the offering. An active or liquid market in our common stock may not develop
upon the completion of this offering or, if it does develop, it may not be sustainable. As a result of these and other factors, you may be unable to resell your shares of our common stock at or above the initial public offering price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, an inactive market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to
enter into strategic collaborations or acquire companies or products by using our shares of common stock as consideration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The
price of our stock may be volatile, and you could lose all or part of your investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading price of our common stock
following this offering is likely to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this
&#147;Risk Factors&#148; section and elsewhere in this prospectus, these factors include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement, enrollment or results of our planned Phase&nbsp;2a clinical trials of <FONT
STYLE="white-space:nowrap">PLN-74809;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delay in identifying and advancing a clinical candidate for our other development
programs;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delay in our regulatory filings for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or our other product
candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority&#146;s review of such filings, including without limitation the FDA&#146;s issuance of a &#147;refusal to file&#148; letter
or a request for additional information; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse results or delays in future clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our decision to initiate a clinical trial, not to initiate a clinical trial or to terminate an existing clinical
trial;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse regulatory decisions, including failure to receive regulatory approval of
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidate;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws or regulations applicable to <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other
product candidate, including but not limited to clinical trial requirements for approvals;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse developments concerning our manufacturers;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to obtain adequate product supply for any approved product or inability to do so at acceptable
prices;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to establish collaborations, if needed;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to commercialize our product candidates, if approved;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or departures of key scientific or management personnel;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unanticipated serious safety concerns related to the use of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or
any other product candidate;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">introduction of new products or services offered by us or our competitors;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us or
our competitors;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to effectively manage our growth;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated variations in quarterly operating results;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our cash position;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to
the public;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publication of research reports about us or our industry, or product candidates in particular, or positive or
negative recommendations or withdrawal of research coverage by securities analysts;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the market valuations of similar companies;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the structure of the healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overall performance of the equity markets;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of our common stock by us or our stockholders in the future;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trading volume of our common stock;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in accounting practices;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ineffectiveness of our internal controls;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes or other developments relating to proprietary rights, including patents, litigation matters and our
ability to obtain patent protection for our technologies;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant lawsuits, including patent or stockholder litigation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general political and economic conditions; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other events or factors, many of which are beyond our control. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock market in general, and the market for biopharmaceutical companies in particular, have experienced extreme price and
volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating
performance. If the market price of our common stock after this offering does not exceed the initial public offering price, you may not realize any return on your investment in us and may lose some or all of your investment. In the past, securities
class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#146;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of
management&#146;s attention and resources. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We do not intend to pay dividends on our common stock so any returns will be limited to
the value of our stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently anticipate that we will retain future earnings for the development, operation and expansion
of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Furthermore, future debt or other financing arrangements may contain terms prohibiting or limiting the amount of dividends that may be declared
or paid on our common stock. Any return to stockholders will therefore be limited to the appreciation of their stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our principal
stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately following the completion of this offering, our executive officers, directors and their affiliates will beneficially hold, in the
aggregate, approximately &nbsp;&nbsp;&nbsp;&nbsp;% of our outstanding voting stock. These stockholders, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acting together, would be able to significantly influence all matters requiring stockholder approval. For example, these stockholders would be able to significantly influence elections of
directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel
are in your best interest as one of our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If you purchase our common stock in this offering, you will incur immediate
and substantial dilution in the book value of your shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial public offering price will be substantially higher than the
pro forma as adjusted net tangible book value per share of our common stock after this offering. Investors purchasing common stock in this offering will pay a price per share that substantially exceeds the pro forma as adjusted net tangible book
value per share after this offering. As a result, investors purchasing common stock in this offering will incur immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, based on an assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the price range set forth on the cover page of this prospectus, representing the difference between our pro forma as adjusted net tangible book value per share after giving
effect to this offering and the assumed initial public offering price. Further, investors purchasing common stock in this offering will contribute approximately &nbsp;&nbsp;&nbsp;&nbsp;% of the total amount invested by stockholders since our
inception, but will own only approximately &nbsp;&nbsp;&nbsp;&nbsp;% of the shares of common stock outstanding after this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
dilution is due to our investors who purchased shares prior to this offering having paid substantially less when they purchased their shares than the price offered to the public in this offering. To the extent outstanding options are exercised,
there will be further dilution to new investors. As a result of the dilution to investors purchasing shares in this offering, investors may receive significantly less than the purchase price paid in this offering, if anything, in the event of our
liquidation. For a further description of the dilution that you will experience immediately after this offering, see the section entitled &#147;Dilution.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are an emerging growth company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth
companies will make our common stock less attractive to investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an emerging growth company, or EGC, as defined in the
Jumpstart Our Business Startups Act, or the JOBS Act, enacted in April 2012. For as long as we continue to be an EGC, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not
EGCs, including not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in
this prospectus and our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We
could be an EGC for up to five years following the year in which we complete this offering, although circumstances could cause us to lose that status earlier. We will remain an EGC until the earlier of (i)&nbsp;the last day of the fiscal year
(a)&nbsp;following the fifth anniversary of the completion of this offering, (b)&nbsp;in which we have total annual gross revenue of at least $1.07&nbsp;billion or (c)&nbsp;in which we are deemed to be a large accelerated filer, which requires the
market value of our common stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> to exceed $700.0&nbsp;million as of the prior June&nbsp;30th, and (ii)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in <FONT
STYLE="white-space:nowrap">non-convertible</FONT> debt during the prior three-year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may choose to take advantage of some, but
not all, of the available exemptions. We have taken advantage of reduced reporting burdens in this prospectus. In particular, we have not included all of the executive compensation information that would be required if we were not an EGC. We cannot
predict whether investors will find our common stock less attractive if we rely on certain or all of these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common
stock and our stock price may be more volatile. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the JOBS Act, EGCs can also delay adopting new or revised accounting standards until
such time as those standards apply to private companies, which may make our financial statements less comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We will incur significant increased costs as a result of operating as a public company, and our management will be required to devote
substantial time to new compliance initiatives. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we will incur significant legal, accounting and other
expenses that we did not incur as a private company. We will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, which will require, among other things, that we file with the SEC annual, quarterly and current
reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and the Nasdaq Global Market to implement provisions of the Sarbanes-Oxley Act, impose significant
requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and
Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas
such as &#147;say on pay&#148; and proxy access. Recent legislation permits EGCs to implement many of these requirements over a longer period and up to five years from the pricing of this offering. Stockholder activism, the current political
environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our
business in ways we cannot currently anticipate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect the rules and regulations applicable to public companies to substantially
increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have an adverse effect
on our business. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, we expect these rules and
regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount
or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees
or as executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to maintain an effective system of internal control over financial reporting, we may not be
able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate
disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition,
any testing by us conducted in connection with Section&nbsp;404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material
weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported
financial information, which could have a negative effect on the trading price of our stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will be required to disclose changes made
in our internal controls and procedures on a quarterly basis and our management will be required to assess the effectiveness of these controls annually. However, for as long as we are an EGC, our independent registered public accounting firm will
not be required to attest to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effectiveness of our internal controls over financial reporting pursuant to Section&nbsp;404. We could be an EGC for up to five years. An independent assessment of the effectiveness of our
internal controls over financial reporting could detect problems that our management&#146;s assessment might not. Undetected material weaknesses in our internal controls over financial reporting could lead to restatements of our financial statements
and require us to incur the expense of remediation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our disclosure controls and procedures may not prevent or detect all errors or
acts of fraud. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, we will become subject to certain reporting requirements of the Exchange Act. Our
disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not
absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally,
controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or
insufficient disclosures due to error or fraud may occur and not be detected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Substantial amounts of our outstanding shares may be
sold into the market <FONT STYLE="white-space:nowrap">when&nbsp;lock-up&nbsp;or</FONT> market standoff periods end. If there are substantial sales of shares of our common stock, the price of our common stock could decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after the <FONT
STYLE="white-space:nowrap">lock-up</FONT> and other legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline. Based on shares of common stock outstanding as of December&nbsp;31, 2019, upon
the completion of this offering we will have outstanding a total of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock. Of these shares, only the shares of common stock sold in this offering by us, plus any shares sold upon
exercise of the underwriters&#146; option to purchase additional shares, will be freely tradable without restriction in the public market immediately following this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements pertaining to this offering will expire 180&nbsp;days from the date of this
prospectus, subject to earlier release of all or a portion of the shares subject to such agreements by the representatives of the underwriters in this offering in their sole discretion. After the <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements expire, based upon the number of shares of common stock, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, outstanding as of December&nbsp;31, 2019, up to an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of common stock will be eligible for sale in the public market. Approximately &nbsp;&nbsp;&nbsp;&nbsp;% of these additional shares are beneficially held by directors, executive officers and their affiliates and will be subject to certain
limitations of Rule&nbsp;144 under the Securities Act of 1933, as amended, or the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, shares of common stock
that are either subject to outstanding options or reserved for future issuance under our existing equity compensation plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules,
the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and Rule&nbsp;144 and Rule&nbsp;701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the
trading price of our common stock could decline. Additionally, the number of shares of our common stock reserved for issuance under 2020 Stock Option and Incentive Plan will automatically increase on January&nbsp;1 of each year, beginning on
January&nbsp;1, 2021, by&nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares of our capital stock outstanding on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation
committee. Moreover, the number of shares of our common stock reserved for issuance under 2020 Employee Stock Purchase Plan will automatically increase on January&nbsp;1 of each year, beginning on January&nbsp;1, 2021, by&nbsp;&nbsp;&nbsp;&nbsp;% of
the total number of shares of our capital stock outstanding on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
board of directors or compensation committee. Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience
additional dilution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After this offering, the holders of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock will
be entitled to rights with respect to the registration of their shares under the Securities Act as provided under the terms of an investors&#146; rights agreement between us and the holders of our convertible preferred stock, subject to the <FONT
STYLE="white-space:nowrap">180-day</FONT> <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above. See &#147;Description of Capital Stock&nbsp;&#151; Registration Rights.&#148; Registration of these shares under the Securities Act
would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule&nbsp;144 under the Securities Act. Any sales of securities by these stockholders could have a
material adverse effect on the trading price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have broad discretion in the use of our existing cash and cash
equivalents and the net proceeds from this offering and may not use them effectively. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will have broad discretion in
the application of our existing cash and cash equivalents and the net proceeds from this offering, other than the payment required to be made to UCSF pursuant to our license agreement with them upon the closing of this offering, including for any of
the purposes described in the section entitled &#147;Use of Proceeds,&#148; and you will not have the opportunity as part of your investment decision to assess whether such proceeds are being used appropriately. Because of the number and variability
of factors that will determine our use of our existing cash and cash equivalents and the net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. Our management might not apply our existing cash
and cash equivalents and the net proceeds from this offering in ways that ultimately increase the value of your investment. The failure by our management to apply these funds effectively could harm our business. Pending their use, we may invest the
net proceeds from this offering in short-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders. If we do not invest or apply the net proceeds from this offering in ways that
enhance stockholder value, we may fail to achieve expected financial results, which could cause our stock price to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions under our charter documents and Delaware law could delay or prevent a change of control which could limit the
market price of our common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws, which are to become effective upon the completion of
this offering, contain provisions that could delay or prevent a change of control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a board of directors divided into three classes serving staggered three-year terms, such that not all members of
the board will be elected at one time;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken
at a meeting of our stockholders;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a
resolution approved by the affirmative vote of a majority of the directors then in office;</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance notice requirements for stockholder proposals and nominations for election to our board of
directors;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that no member of our board of directors may be removed from office by our stockholders except for
cause and, in addition to any other vote required by law, upon the approval of not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of all outstanding shares of our voting stock then entitled to vote in the election of
directors;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement of approval of not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of all outstanding
shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the authority of the board of directors to issue convertible preferred stock on terms determined by the board of
directors without stockholder approval and which convertible preferred stock may include rights superior to the rights of the holders of common stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the General Corporation Law of
the State of Delaware, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These anti-takeover provisions and other provisions in our amended and restated certificate of
incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also
delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take
other corporate actions you desire. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our common stock to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock
price and trading volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for our common stock will depend in part on the research and reports
that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the
trading price for our stock would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about
our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to
decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> will designate the Court of Chancery of the State
of Delaware as the exclusive forum for certain state law litigation that may be initiated by our stockholders, which could limit our stockholders&#146; ability to litigate disputes with us in a different judicial forum. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our amended and restated <FONT STYLE="white-space:nowrap">by-laws,</FONT> as will be in effect upon the completion of this
offering, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common
law: (i)&nbsp;any derivative action or proceeding brought on our behalf; (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty or other wrongdoing by any of our directors, officers, employees or agents to us or our stockholders;
(iii)&nbsp;any action asserting a claim against us arising pursuant to any provision of the General Corporation Law of the State of Delaware, our amended and restated certificate of incorporation or our amended and restated <FONT
STYLE="white-space:nowrap">by-laws;</FONT> (iv)&nbsp;any action to interpret, apply, enforce or determine the validity of our certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws;</FONT> or (v)&nbsp;any action asserting a claim
governed by the internal affairs doctrine, in each case subject to the Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein. This exclusive forum provision will not apply to any causes of action
arising under the Securities Act or the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. The forum selection clause in our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> may limit our
stockholders&#146; ability to litigate disputes with us in a different judicial forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our issuance of additional capital stock in connection with financings, acquisitions,
investments, our stock incentive plans or otherwise will dilute all other stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to issue additional capital
stock in the future that will result in dilution to all other stockholders. We expect to grant equity awards to employees, directors, and consultants under our stock incentive plans. We may also raise capital through equity financings in the future.
As part of our business strategy, we may acquire or make investments in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or investment. Any such issuances of additional capital stock may
cause stockholders to experience significant dilution of their ownership interests and the per share value of our common stock to decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_4"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, including the sections entitled &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion
and Analysis of Financial Condition and Results of Operations&#148; and &#147;Business,&#148; contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, concerning our business, operations and
financial performance and condition, as well as our plans, objectives and expectations for our business operations and financial performance and condition that are based on our management&#146;s belief and assumptions and on information currently
available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to our strategy, future operations, future financial position, future revenue, projected
costs, prospects, plans, objectives of management and expected market growth, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this prospectus include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success, cost and timing of our product development activities and clinical trials of our lead product
candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> as well as PLN-1474 and our other product candidates; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success, cost and timing of completing <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies of <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> in uses for PSC, and the timing of our planned Investigational New Drug Application, or IND, submissions for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in uses for PSC; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to initiate, recruit and enroll patients in, and conduct our clinical trials at the pace that we
project; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy to obtain and maintain regulatory approvals of our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy to obtain funding for our operations, including funding necessary to complete further
development and, upon successful development, if approved, commercialize any of our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefit of orphan drug designations for <FONT STYLE="white-space:nowrap">PLN-74809;</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to compete with companies currently marketing or engaged in the development of treatments for
fibrosis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy regarding obtaining and maintaining intellectual property protection for our product
candidates and the duration of such protection; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy regarding the manufacture of our product candidates for clinical trials and for commercial
use, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy regarding the commercialization of any products that are approved for marketing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth potential of the markets for our product candidates, and our ability to serve those markets,
either alone or in combination with others; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding government and third-party payor coverage and reimbursement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expected use of the proceeds from this offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In some cases, you can identify forward-looking statements by terminology such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148;
&#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;potential,&#148; &#147;continue&#148; or the negative of these terms or other comparable
terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and
which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
things, those listed in the section entitled &#147;Risk factors&#148; and elsewhere in this prospectus. If one or more of these risks or uncertainties occur, or if our underlying assumptions
prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this prospectus and the
documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially
different from any future results expressed or implied by these forward-looking statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this
prospectus represent our views as of the date of this prospectus. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the
future, we assume no obligation to update or revise any forward-looking statements except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date
subsequent to the date of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, statements that &#147;we believe&#148; and similar statements reflect our beliefs
and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited
or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to
rely unduly upon these statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_999"></A>MARKET AND INDUSTRY DATA AND FORECASTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We obtained the industry, market and competitive position data used throughout this prospectus from our own internal estimates and research,
as well as from independent market research, industry and general publications and surveys, governmental agencies and publicly available information in addition to research, surveys and studies conducted by third parties. Internal estimates are
derived from publicly available information released by industry analysts and third-party sources, our internal research and our industry experience, and are based on assumptions made by us based on such data and our knowledge of our industry and
market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that
other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires. In addition, while we believe the industry, market and competitive position data included
in this prospectus is reliable and based on reasonable assumptions, such data involve risks and uncertainties and are subject to change based on various factors, including those discussed in the section entitled &#147;Risk Factors.&#148; These and
other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from our issuance and sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
of our common stock in this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise in full their option to
purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the price range set forth
on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share,
the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the net proceeds to us from this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming
the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the
number of shares we are offering. Each increase or decrease of 1.0&nbsp;million shares in the number of shares we are offering would increase or decrease, as applicable, the net proceeds to us from this offering by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming the assumed initial public offering price to the public remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.
We do not expect that a change in the initial price to the public or the number of shares by these amounts would have a material effect on the uses of the proceeds from this offering, although it may accelerate the time at which we will need to seek
additional capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal purposes of this offering are to increase our financial flexibility, create a public market for our
common stock and facilitate our future access to capital markets. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently expect to use the net proceeds from this offering as
follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million to fund the clinical development of
our lead product candidate, PLN-74809, including for conducting our currently enrolling Phase&nbsp;2a clinical trials in IPF and planned Phase 2a trial in PSC; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million to fund the ongoing clinical trial
of our second product candidate, PLN-1474; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million to fund the preclinical development of
our early-stage programs in oncology and muscular dystrophy; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the remainder, if any, for business development activities, working capital and other general corporate purposes,
including early stage research and development activities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under our license agreement with UCSF, we are
required to pay a sum of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, based on the assumed sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock in this offering and an assumed offering
price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the price range set forth on the cover of this prospectus. We plan to make this payment shortly following the completion of this offering from our
existing cash resources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our current plans, we believe our existing cash and cash equivalents, together with the net proceeds
from this offering, will be sufficient to fund our operating expenses and capital expenditure requirements through &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, including with respect to PLN-74809,
through &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and with respect to PLN-1474 through &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also use a portion of the net proceeds to <FONT STYLE="white-space:nowrap">in-license,</FONT> acquire or invest in new businesses,
technology or assets. Although we have no current agreements, commitments or understandings with respect to any such <FONT STYLE="white-space:nowrap">in-license</FONT> or acquisition, we evaluate such opportunities and engage in related discussions
with third parties from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expected use of net proceeds from this offering represents our intentions based upon our
present plans and business conditions. We cannot specify with certainty all of the particular uses for the net proceeds to be received upon the closing of this offering. Due to uncertainties inherent in the product development process, it is
difficult to estimate the exact amounts of the net proceeds that will be used for any particular purpose. We may use our existing cash and cash equivalents and the future payments, if any, generated from any future collaboration agreements to fund
our operations, either of which may alter the amount of net proceeds used for a particular purpose. In addition, the amount, allocation and timing of our actual expenditures will depend upon numerous factors, including the results of our research
and development efforts, the timing and success of clinical trials and the timing of regulatory submissions. Accordingly, we will have broad discretion in using these proceeds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pending the uses described above, we plan to invest the net proceeds of this offering in short- and immediate- term, interest-bearing
obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_6"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any cash dividends on our capital stock. We do not anticipate paying any dividends on our capital stock in the
foreseeable future. We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. Any future determination to declare dividends will be subject to the discretion of our board of
directors and will depend on various factors, including applicable laws, our results of operations, financial condition, future prospects and any other factors deemed relevant by our board of directors. Investors should not purchase our common stock
with the expectation of receiving cash dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_7"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash and cash equivalents and our capitalization as of December 31, 2019: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis to give effect to (i)&nbsp;our issuance and sale in February 2020 of an additional
28,527,313 shares of Series C redeemable convertible preferred stock for gross proceeds of $52.2 million; (ii) the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into an aggregate of&nbsp;131,861,966
shares of our common stock as if such conversion had occurred on December&nbsp;31, 2019, and (iii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation immediately prior to the completion of this offering; and
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis to give effect to (i)&nbsp;the pro forma adjustments described above, and
(ii)&nbsp;the issuance and sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock in this offering at an assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering
expenses payable by us. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this information together with our financial statements and related notes
appearing elsewhere in this prospectus and the information set forth in the sections entitled &#147;Selected Financial Data&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December 31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>As<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except share and per<BR>share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">102,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock, par value $0.0001 per share; 149,501,221 shares
authorized, 131,861,966 issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, par value $0.0001 per share; 181,000,000 shares authorized, 13,199,073 shares issued
and outstanding, actual;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized, 147,221,857 shares issued and outstanding, pro forma;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
authorized,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma as adjusted<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001 par value per share; no shares authorized, issued or outstanding,
actual;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares authorized, no shares issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">109,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">Each $1.00 increase or decrease in the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, each of pro forma as adjusted cash and cash equivalents,
additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; (deficit) equity, and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that the number of shares
offered by us, as set forth on the cover page of this prospectus, remains the same. We may also increase or decrease the number of shares we are offering. Each increase or decrease of 1.0&nbsp;million shares in the number of shares we are offering
would increase or decrease, as applicable, each of pro forma as adjusted cash and cash equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; (deficit)
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">
equity, and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming the assumed initial public offering price per share, as set forth on the cover
page of this prospectus, remains the same. The pro forma as adjusted information is illustrative only, and we will adjust this information based on the actual initial public offering price and other terms of this offering determined at pricing.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Shares issued and outstanding, actual, pro forma and pro forma as adjusted excludes 2,160,814 unvested restricted shares subject to repurchase. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of common stock issued and outstanding pro forma and pro forma as adjusted in the table above is based on 147,221,857
shares of common stock (including our redeemable convertible preferred stock on an as-converted basis) outstanding as of December&nbsp;31, 2019, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">28,527,313 shares of common stock issuable upon the conversion of our Series C redeemable convertible preferred
stock issued in February 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,593,137 shares of common stock issuable upon exercise of outstanding options issued as of December&nbsp;31,
2019 under our 2015 Plan, at a weighted-average exercise price of $0.45 per share, or pursuant to rights to purchase restricted stock at a weighted average purchase price of $0.01 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,054,837 shares of common stock reserved for future issuance under our 2015 Plan as of December 31, 2019;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock reserved for future issuance under
our 2020 Plan, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock reserved for future issuance under
our 2020 ESPP, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be diluted to the extent of the difference between the
initial public offering price per share of our common stock and the pro forma as adjusted net tangible book (deficit) value per share of our common stock immediately after this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our historical net tangible book (deficit) value per share as of December 31, 2019 is determined by dividing our total tangible assets less
our total liabilities and redeemable convertible preferred stock, which are not included within stockholders&#146; deficit, by the number of shares of common stock outstanding as of such date. Our historical net tangible book value (deficit) was
$(76.3)&nbsp;million, or $(4.97) per share as of December 31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pro forma net tangible book value (deficit) as of December 31,
2019 was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. Our pro forma net tangible book value (deficit) per share represents the amount of our total tangible assets reduced
by the amount of our total liabilities and divided by the total number of shares of our common stock outstanding as of December 31, 2019, assuming (i) our issuance and sale in February 2020 of 28,527,313 shares of Series C redeemable convertible
preferred stock for gross proceeds of $52.2 million and (ii) the automatic conversion of all outstanding shares of our redeemable convertible preferred stock as of December 31, 2019 into an aggregate of 131,861,966 shares of common stock, which
conversion will occur immediately prior to the completion of this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pro forma as adjusted net tangible book value (deficit)
represents our pro forma net tangible book (deficit) value, plus the effect of the sale of shares of common stock in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the
midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Net tangible book value dilution per share to new investors represents
the difference between the amount per share paid by purchasers of shares of common stock in this offering and the pro forma as adjusted net tangible book value per share of common stock immediately after completion of this offering. After giving
effect to our sale of shares of common stock in this offering at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the price range set forth on the cover page of this prospectus,
and after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of December 31, 2019 would have been $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. This represents an immediate increase in net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to existing stockholders and an immediate
dilution in net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to purchasers of common stock in this offering, as illustrated in the following table: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value (deficit) per share as of December 31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma increase in net tangible book value (deficit) per share as of December 31, 2019</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value (deficit) per share as of December 31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma net tangible book value per share attributable to new investors
participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value (deficit) per share after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters&#146; option to purchase additional shares from us is exercised in full, the pro
forma as adjusted net tangible book value per share after this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the increase in pro forma as adjusted net tangible book value per share to existing stockholders would be
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and the dilution to new investors purchasing shares in this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each $1.00 increase or decrease in the assumed public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the
midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, our pro forma </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as adjusted net tangible book value by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, and dilution per share to
investors in this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, assuming that the number of shares offered by us, as set forth on the cover of this prospectus, remains the same and after deducting underwriting discounts
and commissions, and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase or decrease of 1.0&nbsp;million shares in the number of shares we are offering would increase or
decrease, as applicable, our pro forma as adjusted net tangible book value by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and would increase or
decrease, as applicable, dilution per share to investors in this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, assuming the assumed initial public offering price per share remains the same and after deducting
underwriting discounts and commissions, and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters&#146; option to purchase
additional shares from us is exercised in full, the pro forma as adjusted net tangible book value per share after this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the increase in pro forma as adjusted net tangible
book value per share to existing stockholders would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and the dilution to new investors purchasing shares in this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows, as of December 31, 2019, on a pro forma as adjusted basis described above (but before deducting
underwriting discounts and commissions and estimated offering expenses payable by us), the differences between the existing stockholders and the purchasers of shares in this offering with respect to the number of shares purchased from us, the total
consideration paid, which includes net proceeds received from the issuance of common and redeemable convertible preferred stock, cash received from the exercise of stock options, and the value of any stock issued for services and the average price
paid per share (in thousands, except per share amounts and percentages): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average&nbsp;Price<BR>Per Share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing stockholders before this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Totals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing tables and calculations (other than the historical net tangible book value calculations) are
based on 131,861,966 shares of common stock (including our redeemable convertible preferred stock on an as-converted basis) outstanding as of December 31, 2019 and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">28,527,313 shares of common stock issuable upon the conversion of our Series C redeemable convertible preferred
stock issued in February 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,593,137 shares of common stock issuable upon exercise of outstanding options issued as of December&nbsp;31,
2019 under our 2015 Plan, at a weighted-average exercise price of $0.45 per share, or pursuant to rights to purchase restricted stock at a weighted average purchase price of $0.01 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,054,837 shares of common stock reserved for future issuance under our 2015 Plan as of December 31, 2019;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock reserved for
future issuance under our 2020 Plan, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock reserved for
future issuance under our 2020 ESPP, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that any outstanding options are exercised, new options are issued under our stock-based compensation plans or we issue
additional shares of common stock or convertible debt in the future, there will be further dilution to investors participating in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_9"></A>SELECTED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present selected financial data for our business. We have derived the selected statements of operations data for the
years ended December&nbsp;31, 2018 and 2019 and the selected balance sheet data as of December 31, 2018 and 2019 from our audited financial statements appearing elsewhere in this prospectus. Our historical results are not necessarily indicative of
the results that may be expected in the future and our operating results for the year ended December 31, 2019 are not necessarily indicative of the actual or expected results for any other interim periods or any future period. You should read this
data together with our financial statements and related notes appearing elsewhere in this prospectus and the information in the section entitled &#147;Management Discussion and Analysis of Financial Condition and Results of Operations.&#148; </P>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders, basic and diluted<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used in computing net loss per share attributable to common stockholders,
basic and diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,608,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders, basic and<BR>diluted<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing pro forma net loss per share attributable to
common stockholders, basic and diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See Notes 2 and 16 to our audited financial statements included elsewhere in the prospectus for an explanation of the calculations of our basic and diluted net loss per share, pro forma net loss per share and the
weighted-average number of shares used in the computation of the per share amounts. </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheets Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">102,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. See our financial statements and related notes appearing elsewhere in this prospectus for details regarding our current assets and current
liabilities. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_10"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>You should read the following discussion and analysis of our financial condition and results of
operations together with the section entitled &#147;Selected Financial Data&#148; and our financial statements and related notes appearing elsewhere in this prospectus. This discussion and other parts of this prospectus contain forward-looking
statements that involve risks and uncertainties, such as our plans, objectives, expectations, intentions and beliefs. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or
contribute to such differences include, but are not limited to, those identified below and those discussed in the section entitled &#147;Risk Factors.&#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical stage
biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set of proprietary tools designed to discover and <FONT
STYLE="white-space:nowrap">de-risk</FONT> product candidates quickly and efficiently. Our wholly-owned lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule dual selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. We
have completed a Phase&nbsp;1a SAD/MAD trial and a Phase 1b <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-mechanism</FONT></FONT> trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF. We are currently
enrolling two Phase 2a trials of PLN-74809 in IPF. We also plan to submit an IND for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of PSC in the first half of 2020, and plan to initiate a Phase 2a PSC trial thereafter. Our
second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 for the treatment of liver fibrosis associated with NASH, which we have
partnered with Novartis. <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is currently undergoing a Phase&nbsp;1 trial with top-line data expected in the second half of 2020. In addition to our clinical programs, we currently have preclinical
integrin-based programs in lead-optimization stage targeting oncology and muscular dystrophies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, we entered into a
Collaboration and License Agreement with Novartis, or the Novartis Agreement, for the development and commercialization of our then preclinical product candidate, PLN-1474 and up to three integrin research targets. PLN-1474 is an internally
discovered small molecule selective inhibitor of integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, currently being developed for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis (&#147;NASH&#148;). In
December 2019, we received an upfront license payment of $50.0 million for the worldwide exclusive license to PLN 1474. Pursuant to the Novartis Agreement, we expect to receive research and development funding totaling $33.0 million and are eligible
to receive developmental, regulatory and commercial milestone payments of up to $416.0 million if defined development, regulatory and commercialization milestones are achieved and tiered royalties, on a product-by-product basis based on annual nets
sales of products, at percentages ranging from high-single digits to low-double digits of the applicable licensed products and mid-single digits to high-single digits for the applicable research products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 19, 2019, we issued 26.4 million shares of Series C redeemable convertible preferred stock, or the Series C Funding, for aggregate
cash proceeds of $48.2 million. Novartis purchased 10.9 million shares of the December&nbsp;19, 2019 Series&nbsp;C redeemable convertible preferred stock offering at $1.83 per share, which as at fair value as the Company sold Series C redeemable
convertible preferred stock investor which is at arms-length transaction as $1.83 per share was the purchase price paid for shares by other unrelated investors who participated in the funding round. In February 2020, we issued an additional
28,527,313 shares of Series&nbsp;C redeemable convertible preferred stock for aggregate cash proceeds of $52.2 million. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our
inception in 2015, our operations have included organizing and hiring personnel for our company, business planning, raising capital, establishing our intellectual property portfolio and performing research and development of <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling and integrin biology, medicinal chemistry, translational screening technologies, and clinical insights to create tissue-specific inhibitors of fibrotic diseases. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred net losses since inception and expect to incur losses in the future as
we continue our research and development activities. To date, we have funded our operations primarily through private placements of our redeemable convertible preferred stock and from revenue generated from the Novartis Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, our revenue has solely been generated from the Novartis Agreement. We expect revenues will continue to fluctuate from period to
period and there can be no assurance that new collaborations will continue beyond their initial terms or that we will be able to meet the milestones specified in these agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception, we have incurred significant operating losses. Our net loss was $30.3&nbsp;million and $0.6&nbsp;million for the years
ended December&nbsp;31, 2018 and December 31, 2019, respectively. As of December&nbsp;31, 2018 and December 31, 2019, we had an accumulated deficit of $71.5&nbsp;million and $76.3 million, respectively. We expect to continue to incur significant
expenses and operating losses for the foreseeable future. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities, as we: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance the development of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> through
clinical development, and, if successful, later-stage clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance our other preclinical development programs, into clinical development; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approvals for any product candidates that successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increase the amount of research and development activities to identify and develop product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire additional clinical, quality control and scientific personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand our operational, financial and management systems and increase personnel, including personnel to support
our clinical development, manufacturing and commercialization efforts and our operations as a public company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain, expand and protect our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a sales, marketing, medical affairs and distribution infrastructure to commercialize any products for
which we may obtain marketing approval and intend to commercialize on our own or jointly with third parties; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">invest in or <FONT STYLE="white-space:nowrap">in-license</FONT> other technologies or product candidates.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not generate revenue from product sales unless and until we successfully complete clinical development and
obtain regulatory approval for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any of our other product candidates. In addition, if we obtain regulatory approval for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any of our other product
candidates and do not enter into one or more collaborations with third-parties for commercialization, we expect to incur significant expenses related to developing our commercialization capability to support product sales, marketing and distribution
activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy.
Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity offerings and debt financings, government funding arrangements, collaborations,
strategic alliances and marketing, distribution or licensing arrangements. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter
into such agreements as, and when, needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties associated with pharmaceutical product development, we are unable to accurately predict the
timing or magnitude of expenses. Even if we can generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at
planned levels and be forced to reduce or terminate our operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, we had cash, cash equivalents and short-term investments of
$102.8 million. We expect to continue to incur losses for the foreseeable future and will require additional financial resources to continue to advance our products and intellectual property. We believe that the net proceeds from this offering,
together with our existing cash and cash equivalents, will enable us to fund our operating expenses and capital expenditure requirements through
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. As a result, we will need substantial additional funding to support our
continuing operations and pursue our growth strategy. Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic
alliances and marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may
include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to
take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing
arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or drug candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise
additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, or grant rights to develop and
market product candidates that we would otherwise prefer to develop and market ourselves </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Operations Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue&#151;Related Party </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2019, we entered into the Novartis Agreement with Novartis for the development and commercialization of our then preclinical product candidate, PLN-1474 and up to three additional integrin research targets. Under the terms of the Novartis
Agreement, in December 2019, Novartis paid Pliant an upfront license fee payment of $50.0 million for the worldwide exclusive license to PLN-1474. Novartis will fund our research and development activities for PLN-1474 through Phase 1 after which
Novartis will assume responsibility for all future development, manufacturing and commercialization cost of PLN-1474. Novartis will also fund the research and development activities associated with the integrin research targets as outlined in the
Novartis Agreement. We are scheduled to receive up to $19.6 million in funding for PLN -1474 development services through Phase 1, and are scheduled to receive up to $13.4 million in funding for optional target validation and research services
associated with the integrin research targets. The research and development funding payments are scheduled to paid periodically throughout 2020, 2021 and 2022. We are eligible for milestone payments of up to $416.0 million if defined developmental,
regulatory and commercialization milestones are achieved, and tiered royalties on a product-by-product basis based on annual nets sales of products, at percentages ranging from high-single digits to low-double digits of the applicable licensed
products and mid-single digits to high-single digits for the applicable research products. Novartis became a related party to us following its purchase of 10.9 million shares of our Series C redeemable convertible preferred stock on
December&nbsp;19, 2019, representing aggregate holdings of 7.4% of our outstanding shares on a fully diluted basis as of December&nbsp;31, 2019. See Notes 6, 9 and 14 to our financial statements included elsewhere in the prospectus for more
information. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Research and Development </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development expenses consist of expenses incurred in connection with the development of our product candidates. Research and
development expenses include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee-related expenses, which include salaries, benefits and stock-based compensation for our research and
development personnel; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred under agreements with third-party contract organizations for pre-clinical studies,
investigative clinical trial sites and consultants that conduct research and development activities on our behalf; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depreciation of laboratory equipment and costs of equipment and supplies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with technology and intellectual property licenses; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facilities and other allocated expenses, which include expenses for rent and other facility related costs and
other supplies. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our research and development expenses for the years ended December
31, 2018 and 2019: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended<BR>December&nbsp;31, </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside and consulting services for preclinical studies and research and development activities by
third party contract organizations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinical trials expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of lab equipment and costs of equipment and supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Technology and intellectual property licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facilities and other allocated expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expense all research and development costs in the periods in which they are incurred. We do not
allocate our costs by product candidates or by preclinical programs as these are in early stages of clinical trials or development, and our internal expenses are not allocated between product candidates and programs. Although external third-party
costs are allocable between product candidates and programs, we do not perform this allocation. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2018, we were eligible for a
research and development tax credit. The tax incentive was available to us based on research and development activity within the United States and California during those years. These research and development tax incentives are recognized as a
contra to FICA payroll tax expense when the right to receive has been attained and funds are collectible and is capped at $250,000 per year. In 2019, we longer qualified for the research and development tax credit as we generated revenue in the
fourth quarter of 2019. For additional information, see Note 2 to our audited financial statements included elsewhere in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and
development activities related to developing our product candidates and our preclinical programs and as they advance into later stages of development. The process of conducting the necessary clinical research to obtain regulatory approval is costly
and time-consuming, and the successful development of our product candidates is highly uncertain. As a result, we are unable to determine the duration and completion costs of our research and development projects or when and to what extent we will
generate revenue from the commercialization and sale of any of our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our general and administrative expenses consist primarily of personnel costs, allocated facilities costs and other expenses for outside
professional services, including legal, marketing, investor relations, human resource </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and accounting services. Personnel costs consist of salaries, benefits and stock-based compensation for our general and administrative personnel. We expect to incur additional expenses as a
result of operating as a public company, including expenses related to compliance with the rules and regulations of the SEC, The Nasdaq Global Market, additional insurance expenses, investor relations activities and other administrative and
professional services. We also expect to increase the size of our administrative function to support the growth of our business. In addition, if we obtain regulatory approval for any of our product candidates and do not enter into a third-party
commercialization collaboration, we expect to incur significant expenses related to building a sales and marketing team to support product sales, marketing and distribution activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Income </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our interest
income consists of interest income earned on cash and money market funds. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2018 and 2019 </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$ Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,430</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(96.0</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(167</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(97.9</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">NM:</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Results not meaningful </TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Revenue - Related Party </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue-related party consists primarily of revenue generated from the Novartis Agreement. The increase of $57.1 million in revenue-related
party for the year ended December 31, 2019 compared to year ended December 31, 2018 was due to the recognition of $50.0 million in upfront license fee revenue and $7.1 million in research and development services revenue. We anticipate revenue over
the next several years will be derived primarily from the Novartis Agreement as we continue to recognize revenue-related party from research and development services and potential milestone payments to revenues in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $22.9&nbsp;million, or 94.0%, for the year ended December&nbsp;31, 2019, compared to the year
ended December&nbsp;31, 2018. The increase was primarily due to $18.1&nbsp;million of increased consulting and outside services costs, $3.7&nbsp;million of increased compensation costs, $0.5 million of increased rent expense, $0.5 million in
increased stock-based compensation costs, $0.4 million of increased depreciation expense, $0.3&nbsp;million of increased sponsored research expenses and $0.2 million of increased miscellaneous and other expenses partially offset by a decrease in
equipment and supplies expense of $0.8&nbsp;million. Consulting and outside services costs increased due to increased <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and <FONT STYLE="white-space:nowrap">PLN-1474</FONT> development activities.
Compensation costs and stock-based compensation costs increased as a result of headcount increases. Rent expense increased due to the move to new office space in South San Francisco in <FONT STYLE="white-space:nowrap">mid-2018.</FONT> Depreciation
expense increased due to increased leasehold improvements installed at the South San </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Francisco office. Sponsored research expenses increased due to increased research sponsorship activities with universities in 2019. The reduction in equipment and supplies expense was due to a
decrease in purchases of laboratory equipment during the year ended December 31, 2019 when compared to in the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $4.4&nbsp;million, or 68.2%, for the year ended December&nbsp;31, 2019, compared to the year
ended December&nbsp;31, 2018. The increase was primarily due to $1.9 million of increased compensation costs, $1.1 million of increased stock-based compensation costs, $0.8&nbsp;million of increased professional and consulting costs,
$0.2&nbsp;million of increased miscellaneous and other expenses, $0.2&nbsp;million of increased rent expense, $0.2 million in increased travel expense and $0.1&nbsp;million of increased equipment and supplies expense. Compensation costs and
stock-based compensation costs increased as a result of increased headcount. Professional and consulting costs increased primarily as a result of increased legal, marketing, investor relations and accounting fees. Travel expenses increased primarily
due to increased executive travel associated with equity financing initiatives. Equipment and supplies expense increased primarily due to increased purchases of office supplies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Interest Income </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased by $0.1&nbsp;million for the year ended December&nbsp;31, 2019, compared to the year ended December&nbsp;31, 2018.
The increase was attributable to interest income earned on higher cash and cash equivalents balances resulting from preferred stock issuances in the second half of 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2019, we had cash and cash equivalents and short-term investments of $102.8 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our current cash balance
and our ability to control discretionary spending, such as research and development expenditures with outside service providers, we have evaluated and concluded our financial condition is sufficient to fund our planned operations, commitments and
contractual obligations for a period of at least one year following the date that these financial statements are issued. Further, our cash position is expected to improve in 2020, as we raised an additional $52.2 million from the issuance of an
additional 28.5 million shares of our Series&nbsp;C redeemable convertible preferred stock in February of 2020, and have achieved the first patient dosing milestone of the Novartis Agreement triggering the receipt of a $25.0 million payment expected
from Novartis in the second quarter of 2020. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Funding Requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our primary use of cash is to fund operating expenses, primarily research and development expenditures. Cash used to fund operating expenses is
impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable, accrued expenses and prepaid expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future funding requirements will depend on many factors, including the following:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, progress, timing, costs and results of preclinical studies and clinical trials for our product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the clinical development plans we establish for these product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and characteristics of product candidates that we develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome, timing and cost of meeting regulatory requirements established by the U.S. Food and Drug
Administration, or FDA, and other comparable foreign regulatory authorities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we enter into any collaboration agreements and the terms of any such agreements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property
rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of defending intellectual property disputes, including patent infringement actions brought by third
parties against us or our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of competing technological and market developments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost and timing of completion of commercial-scale outsourced manufacturing activities; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of establishing sales, marketing and distribution capabilities for any product candidates for which we
may receive regulatory approval in regions where we choose to commercialize our products on our own. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, our
operating plan may change, and we may need additional funds to meet operational needs and capital requirements for clinical trials and other research and development expenditures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we need to raise additional capital to fund our operations, funding may not be available to us on acceptable terms, or at all. If we are
unable to obtain adequate financing when needed, we may have to delay, reduce the scope of or suspend one or more of our preclinical studies, clinical trials, research and development programs or commercialization efforts. We may seek to raise any
necessary additional capital through a combination of public or private equity offerings, debt financings, collaborations and other licensing arrangements. If we raise additional capital through debt financing, we may be subject to covenants
limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional capital through marketing and distribution arrangements or other
collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish certain valuable rights to our product candidates, technologies, future revenue streams or research programs or grant licenses on terms that
may not be favorable to us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Flows </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December 31, 2018 and 2019 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summarizes our cash flows for the periods indicated (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,931</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 56,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Used in Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $2.8&nbsp;million for the year ended December&nbsp;31, 2019 and $28.3&nbsp;million for the year ended
December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash used in operating activities in the year ended December 31, 2019 was primarily due to our net loss for the
period of $0.6 million adjusted by non-cash charges of $2.9 million and net change of $5.1 million in our net operating assets and liabilities. The non-cash charges consisted of $1.1 million of depreciation expense and $1.8&nbsp;million of
stock-based compensation expense. The changes in our net operating assets and liabilities were </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
primarily due to a decrease of $7.1 million in accounts receivable, a decrease of $1.5 million in prepaid expense and other current assets, a decrease of $1.3 million in accounts payable,
partially offset by an increase of $4.3&nbsp;million in accrued expenses, an increase of $0.2 million in other non-current assets and an increase of $0.2&nbsp;million in deferred rent and other long-term liabilities and tax credits receivable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash used in operating activities in the year ended December&nbsp;31, 2018, was primarily due to our net loss for the year of
$30.3&nbsp;million adjusted by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.9&nbsp;million and a net change of $1.1&nbsp;million in our net operating assets and liabilities. The <FONT STYLE="white-space:nowrap">non-cash</FONT>
charges consisted of $0.7&nbsp;million of depreciation expense and $0.2&nbsp;million of stock-based compensation expense. The changes in our net operating assets and liabilities were primarily due to an increase of $1.5&nbsp;million in accounts
payable and accrued expenses and $0.4&nbsp;million increase in deferred rent and other long-term liabilities, partially offset by a decrease of $0.8 million in other <FONT STYLE="white-space:nowrap">non-current</FONT> assets, prepayments and tax
credit receivable. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Used in Investing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2019 and 2018, cash used in investing activities was $17.9&nbsp;million and $2.3&nbsp;million,
respectively. Cash used in investing activities for the year ended December 31,&nbsp;2019 was primarily due to the purchase of short-term investments of $51.7 million, purchases of property, plant and equipment of $1.0&nbsp;million and
$0.3&nbsp;million of accretion of short-term investments, partially offset by $35.0&nbsp;million in maturities of short term investments . Cash used in investing activities for the year ended December 31,&nbsp;2018 was primarily resulting from the
purchase of laboratory equipment and leasehold improvements. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Provided by Financing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31,&nbsp;2019, cash provided by financing activities was $45.5&nbsp;million. Cash provided by financing
activities for the year ended December 31,&nbsp;2019 was primarily due to net proceeds from the issuance of our Series C redeemable convertible preferred stock financing of $47.9&nbsp;million and proceeds from the exercise of stock options of
$0.2&nbsp;million, partially offset by the payment of deferred offering costs of $2.6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended
December&nbsp;31, 2018, cash provided by financing activities was $87.3&nbsp;million of net proceeds from the issuance of shares of Series A and Series B redeemable convertible preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Other Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our contractual obligations and other commitments as of December&nbsp;31,&nbsp;2019 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments Due by Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 to 3<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3 to 5<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;Than<BR>5 Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We enter into contracts in the normal course of business with third-party contract organizations for
clinical trials, <FONT STYLE="white-space:nowrap">non-clinical</FONT> studies and testing, manufacturing and other services and products. These contracts generally provide for termination following a certain period after notice and therefore we
believe that our cancelable obligations under these agreements are not material and they are not included in the table above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not
included milestone or royalty payments or other contractual payment obligations in the table above if the timing and amount of such obligations are unknown or uncertain. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-Balance&nbsp;Sheet</FONT> Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the periods presented, we did not have, nor do we currently have,
<FONT STYLE="white-space:nowrap">any&nbsp;off-balance&nbsp;sheet</FONT> arrangements or holdings in any variable interest entities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and
Qualitative Disclosures about Market Risk </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary objectives of our investment activities are to ensure liquidity and to
preserve capital. We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities. We had cash, cash equivalents and short-term investments of $102.8 million as of December 31, 2019
which consisted of bank deposits and highly liquid money market funds. Historical fluctuations in interest rates have not been significant for us. We had no outstanding debt as of December 31, 2019. Due to the short-term maturities of our cash
equivalents, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our cash equivalents. To minimize the risk in the future, we intend to maintain our portfolio of cash equivalents in
institutional market funds that are composed of U.S. Treasury and U.S. Treasury-backed repurchase agreements or short-term U.S. Treasury securities. We do not believe that inflation, interest rate changes, or exchange rate fluctuations had a
significant impact on our results of operations for any periods presented herein. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Polices and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management&#146;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which
have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and
the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors
that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from
these estimates under different assumptions or conditions. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in more detail in
Note 2 to our financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, all of our revenue to date has been generated from the Novartis Agreement. Effective January 1, 2018, we adopted the
provisions of ASC Topic 606, Revenue from Contracts with Customers (&#147;Topic 606&#148;) using the full retrospective transition method. We did not have any prior collaboration agreements and did not recognize revenue during the year ended
December 31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Topic 606, we recognize revenue when our customer obtains control of promised goods or services, in an amount
that reflects the consideration which we expect to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of Topic 606, we perform the
following five steps: (i)&nbsp;identification of the contract(s) with the customer, (ii)&nbsp;identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations,
(iii)&nbsp;measurement of the transaction price, (iv)&nbsp;allocation of the transaction price to the performance obligations, and (v)&nbsp;recognition of revenue when (or as) we satisfy each performance obligation. We only apply the five-step model
to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to our customer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><I>Identification of the Contracts with the Customers</I><B><I>
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluate every contract to determine whether it in its entirety or in part represent a contract with a customer, or a
collaboration agreement and, based on this determination, apply appropriate accounting guidance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We account for a contract with a
customer that is within the scope of Topic 606 when all of the following criteria are met: (i)&nbsp;the arrangement has been approved by the parties and the parties are committed to perform their respective obligations, (ii)&nbsp;each party&#146;s
rights regarding the goods or services to be transferred can be identified, (iii)&nbsp;the payment terms for the goods or services to be transferred can be identified, (iv)&nbsp;the arrangement has commercial substance and (v)&nbsp;collection of
substantially all of the consideration to which we will be entitled in exchange for the goods or services that will be transferred to the customer is probable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><I>Identification of the Performance Obligations</I><B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The promised goods or services in our collaboration and option arrangements consist of research and development services. The arrangements also
have options for additional items (i.e.,&nbsp;license rights). Options are considered to be marketing offers and are to be accounted for as separate contracts when the customer elects such options, unless we determine the option provides a material
right which would not be provided without entering into the contract. The determination as to whether such options are material rights requires significant management judgment, and management considers factors such as other similar arrangements,
market data and the terms of the contractual arrangement to make such conclusion. Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered
distinct when:&nbsp;(i)&nbsp;the customer can benefit from the good or service on its own or together with other readily available resources and (ii)&nbsp;the promised good or service is separately identifiable from other promises in the contract.
In assessing whether promised goods or services are distinct, we consider factors such as the stage of development of the underlying intellectual property, the capabilities of our customer to develop the intellectual property on their own and
whether the required expertise is readily available. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><I>Determination of the Transaction Price</I><B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate the transaction price based on the amount of consideration we expect to receive for transferring the promised goods or services in
the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, we evaluate the amount of the potential payments and the likelihood that the
payments will be received. We utilize either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a
significant revenue reversal would not occur, the variable consideration is included in the transaction price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All contingent future
payments, which include research, development, regulatory, and sales-based royalty payments, have not been considered in the initial analysis, as they are contingent upon option(s) being exercised or are subject to significant risk of achievement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Allocation of Transaction Price </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We allocate the transaction price based on the estimated standalone selling price. We must develop assumptions that require judgment to
determine the standalone selling price for each performance obligation identified in the contract. We utilize key assumptions to determine the standalone selling price, which may include other comparable transactions, pricing considered in
negotiating the transaction, and the estimated costs. Certain variable consideration is allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the
performance obligation and the resulting amounts allocated to each performance obligation are consistent with the amounts we would expect to receive for satisfying each performance obligation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Recognition of Revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We considered the license to PLN-1474 as functional intellectual property, as when control of the license was transferred to Novartis at the
inception of the Novartis Agreement, Novartis had the right to access its technology and it was functional. The license was distinct from the research and development services as the services are not transformative in nature. As such, under Topic
606, the Company determined the $50.0 million was standalone selling price PLN-1474 license and was recorded to revenue at the inception of the Novartis Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize revenue as we perform the research and development services based on an input method, as such costs have direct relationship
between our effort and the progress made towards satisfying its performance obligations to Novartis. For Consideration allocated to material rights is recognized upon exercise or expiration of the related option. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Accrued Research and Development Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We record accrued expenses for estimated costs of our research and development activities conducted by third-party service providers, which
include the conduct of clinical studies and preclinical studies. We record the estimated costs of research and development activities based upon the estimated amount of services provided but not yet invoiced and include these costs in accrued
liabilities in the balance sheets and within research and development expense in the statement of operations. These costs are a significant component of our research and development expenses. We record accrued expenses for these costs based on
factors such as estimates of the work completed and in accordance with agreements established with these third-party service providers. Any payments made in advance of services provided are recorded as prepaid assets, which are expensed as the
contracted services are performed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate the amount of work completed through discussions with internal personnel and external
service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. We make significant judgments and estimates in determining the accrued balance in each reporting period. As actual
costs become known, we adjust our accrued estimates. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed, the number of patients enrolled
and the rate of patient enrollment may vary from our estimates and could result in us reporting amounts that are too high or too low in any particular period. Our accrued expenses are dependent, in part, upon the receipt of timely and accurate
reporting from clinical research organizations and other third-party service providers. For the periods presented, we have experienced no material differences between our accrued expenses and actual expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize compensation costs related to stock awards and stock options granted to employees, nonemployees and directors based on the
estimated fair value of the awards on the date of grant. We estimate the grant date fair value and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model. The grant date fair value of the stock-based awards is
recognized on a straight-line basis over the requisite service periods, which are generally the vesting period of the respective awards. Forfeitures are accounted for as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option-pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards,
including the expected term and the price volatility of the underlying stock. These assumptions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fair value of common stock</I>&#151;See &#147;Determination of the Fair Value of Our Common Stock&#148; below.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected term</I>&#151;The expected term represents the period that the stock-based awards are expected to be
outstanding. The expected term for our stock options was calculated based on the weighted-average vesting term of the awards and the contract period, or simplified method, as allowed by the SEC. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected volatility</I>&#151;Since we are not yet a public company and do not have any trading history for our
common stock, the expected volatility was estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a period equal to the expected term of the stock option grants. The comparable companies
were chosen based on their size, stage in the life cycle or area of specialty. We will continue to apply this process until enough historical information regarding the volatility of our own stock price becomes available. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-free interest rate</I>&#151;The risk-free interest rate is based on the U.S. Treasury yield in effect at
the time of grant <FONT STYLE="white-space:nowrap">for&nbsp;zero-coupon&nbsp;U.S.</FONT> Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected dividend</I>&#151;We have never paid dividends on our common stock and have no plans to pay dividends
on our common stock. Therefore, we used an expected dividend yield of zero. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Determination of the Fair Value of
Our Common Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As there has been no public market for our common stock to date, the estimated fair value of our common stock has
been determined by our board of directors as of the date of each option grant, with input from management, considering our most recently available third-party valuations of common stock and our board of directors&#146; assessment of additional
objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined
in the American Institute of Certified Public Accountants&#146; Accounting and Valuation Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For stock awards and options granted in 2018 and 2019, we considered the use of the Income and Market approaches. Under the income approach,
the cash generating ability of the company is valued. This approach focuses on determining a forecast benefit stream that is reflective of the subject company&#146;s most likely future performance. The forecast benefit stream is then discounted to
present value based on the appropriate risk-adjusted discount rate or capitalization rate. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Market approach, we referenced
actual transactions involving our company or similar assets and/or enterprises. The Market approach generally consists of two primary methodologies: The Guideline Comparables Method, or GCM and the Guideline Transaction Method, or GTM. The GCM
involves identifying and selecting publicly traded companies or guideline public companies, or Guideline Public Companies, with financial and operating characteristics like the subject being valued, and subsequently deriving multiples and other
metrics from such Guideline Public Companies to apply to the subject being valued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Taking the stage of our development into consideration
and expected liquidity events into account, we elected not to rely upon a pure application of the Income or Market valuation approaches. We determined that the PWERM was more appropriate to value our equity classes as the approach is based upon an
analysis of future values for the entire enterprise assuming various future outcomes. We did consider elements of the Income and Market approaches for gauging the appropriateness of certain PWERM inputs and assumptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to considering the results of these third-party valuations, our board of directors considered various objective and subjective
factors to determine the fair value of our common stock as of each grant date, which may be as a date later than the most recent third-party valuation date, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prices at which we sold shares of preferred stock and the superior rights and preferences of the preferred
stock relative to our common stock at the time of each grant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the progress of our research and development programs, including the status of
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> and planned clinical trials for our product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stage of development and commercialization and our business strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">external market conditions affecting the biotechnology industry, and trends within the biotechnology industry;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial position, including cash on hand, and our historical and forecasted performance and operating
results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of an active public market for our common stock and our preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the likelihood of achieving a liquidity event, such as an initial public offering, or IPO, or a sale of our
company considering prevailing market conditions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the analysis of IPOs and the market performance of similar companies in the biopharmaceutical industry.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For financial reporting purposes, we considered the amount of time between the valuation date and the grant date of our
stock awards and options to determine whether to use the latest common stock valuation or an interpolated fair value between the two valuation dates. This determination included an evaluation of whether the subsequent valuation indicated that any
significant change in valuation had occurred between the previous valuation and the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The assumptions underlying these
valuations represent management&#146;s best estimates, which involve inherent uncertainties and the application of management judgment. As a result, if factors or expected outcomes change and we use significantly different assumptions or estimates,
our stock-based compensation expense could be materially different. Following the closing of this offering, the fair value of our common stock will be determined based on the quoted market price of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, we had $0.7&nbsp;million and $0.4&nbsp;million of unrecognized stock-based compensation expense that is expected
to be recognized over the weighted-average periods of 2.2&nbsp;years and 3.7&nbsp;years related to restricted stock awards and stock options, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, there was $0.4&nbsp;million of unrecognized compensation costs that is expected to be recognized over the
weighted-average periods of 2.2&nbsp;years related to restricted stock awards. As of December&nbsp;31, 2019, there was $4.5&nbsp;million of unrecognized compensation costs that is expected to be recognized over the weighted-average periods of
3.0&nbsp;years related to stock options. Based upon the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the midpoint of the price range set forth on the cover page of this
prospectus, the aggregate intrinsic value of options outstanding as of December 31, 2019 was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
million of which related to unvested options and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million of which related to unvested restricted stock awards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See
Note&nbsp;2 to our financial statements appearing elsewhere in this prospectus for more information. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company Status and JOBS Act
Accounting Election </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012,
or the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have elected
to avail ourselves of this exemption and adopt ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> <I>(Topic 842</I>), Leases when the standard is effective for private companies which is for fiscal years beginning after December&nbsp;15,
2020. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we intend to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain
conditions set forth in the JOBS Act, if as an &#147;emerging growth company&#148; we </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
intend to rely on such exemptions, we are not required to, among other things, (i)&nbsp;provide an auditor&#146;s attestation report on our system of internal controls over financial reporting
pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002, (ii) provide all of the compensation disclosure that may be required <FONT STYLE="white-space:nowrap">of&nbsp;non-emerging&nbsp;growth</FONT> public companies under the Dodd-Frank
Wall Street Reform and Consumer Protection Act, (iii)&nbsp;comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report
providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv)&nbsp;disclose certain executive compensation-related items such as the correlation between executive compensation and
performance and comparisons of the Chief Executive Officer&#146;s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of this offering or until we no longer meet the
requirements of being an emerging growth company, whichever is earlier. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_11"></A>Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical stage
biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set of proprietary tools designed to discover and <FONT
STYLE="white-space:nowrap">de-risk</FONT> product candidates quickly and efficiently. Our wholly-owned lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule dual selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. We
have completed a Phase 1a SAD/MAD trial and a Phase 1b <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-mechanism</FONT></FONT> trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and are currently enrolling
two Phase 2a trials in IPF. We also plan to submit an IND for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of PSC in the first half of 2020, and plan to initiate a Phase&nbsp;2a PSC trial as soon as possible thereafter. Our
second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 for the treatment of stage liver fibrosis associated with NASH, which we
have partnered with Novartis. <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is currently undergoing a Phase 1 trial testing with top-line data expected in the second half of 2020. In addition to our clinical programs, we currently have
preclinical integrin-based programs in lead-optimization stage targeting oncology and muscular dystrophies. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis refers to the
abnormal thickening and scarring of connective tissue due to the production and deposition of excess collagen in the extra-cellular matrix. Fibrosis can occur in many different tissues including lung, liver, kidney, muscle, skin and the
gastrointestinal tract, and often causes severe and debilitating disease potentially leading to organ failure and death. Fibrosis has historically proven difficult to treat, which we believe is due to the complexity of the disease biology and the
challenge of targeting fibrotic tissues selectively without affecting healthy tissues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that tissue-specific inhibition of
TGF-&szlig; may hold the key to successfully treating fibrosis. In normal tissues <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> is activated in response to tissue injury which initiates a cascade that results in collagen production and,
ultimately, scar formation to heal the tissue. In fibrosis, however, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling becomes dysregulated, with <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> being continuously activated, leading
to excess collagen deposition, even in the absence of acute tissue injury. <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> while implicated in fibrosis pathophysiology, is expressed and intermittently activated across all tissue types and plays
important, context-specific roles in tissue homeostasis. Therefore, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> cannot be blocked systemically without disrupting these homeostatic functions and causing significant toxicities. To more
precisely treat fibrosis in specific tissues, we believe it is crucial to discover and treat the underlying mechanism causing excess <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our scientific founders are pioneers in elucidating the role of specific extracellular receptors known as integrins as a key element in the
activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> While the role of integrins in <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation has been well-characterized over the past 10 years, integrins have historically been
difficult to target therapeutically using small-molecules due to the difficulty of engineering molecules with high receptor selectivity and bioavailability. We believe that we have addressed these challenges with our platform. We have built a
library of compounds that includes bioavailable, selective and potent inhibitors of multiple integrins that may be used to target a range of fibrotic diseases across different tissues. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Pipeline </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g06c08.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We plan to submit an IND for PLN-74809 for the treatment of PSC in the first half of 2020 incorporating the data from the completed Phase 1a/1b healthy volunteer trials and plan to initiate a Phase&nbsp;2a clinical
trial for PSC thereafter. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead wholly-owned product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an
oral small-molecule, dual-selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 that we are advancing in IPF and PSC. While expressed at very low levels in normal
tissues, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are upregulated in the pulmonary tissues of IPF patients, and in the liver tissues of PSC patients. They both serve as
activators of <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> leading to increased collagen production and fibrosis in these tissues. By blocking <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by both <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, we believe <FONT STYLE="white-space:nowrap">PLN-74809</FONT> may slow and potentially halt the progression of fibrosis in these patient
populations. <FONT STYLE="white-space:nowrap">PLN-74809</FONT> has been granted orphan drug designation by the U.S. Food and Drug Administration, or FDA, for both IPF and PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IPF is the most common and severe form of progressive pulmonary fibrosis, affecting approximately 140,000 patients in the United States. While
the underlying cause of IPF is unknown, the course of the disease is well documented, with progressive scarring that destroys the structure and function of the lungs over time. The average life expectancy for patients with confirmed IPF is between
three and five years. There are currently two <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapies for IPF. Both have shown modest slowing of disease progression. However, both therapies have raised significant safety and tolerability
concerns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PSC is a progressive liver disorder affecting approximately 30,000 to 45,000 patients in the United States. The disease is
characterized by fibrosis originating in the bile ducts that ultimately results in bile flow obstruction, or cholestasis, causing liver damage and progressive fibrosis of the liver. Patients have a median survival of 10 to 12&nbsp;years without
intervention and carry high lifetime risk of developing gastrointestinal malignancies. There are currently no <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapies for PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our live human tissue assay, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a greater than 50&nbsp;percent decrease in the
expression of <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes, such as collagen type I alpha1 chain, or <I>COL1A1,</I> and collagen type 3 alpha1 chain, or<I> COL3A1, </I>that are responsible for collagen production in human IPF and PSC
tissues. Additionally, we have completed a study in <FONT STYLE="white-space:nowrap">non-human</FONT> primates in which we showed that inhibition of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 reduced <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by greater than 75% in cells isolated from the lungs after seven days of treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have completed a Phase 1a single ascending dose, or SAD, multiple ascending dose, or MAD, and food effect clinical trial in which <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> was shown to be orally bioavailable and generally well tolerated with a half-life that may support once-daily dosing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also completed a Phase 1b proof-of-mechanism trial in healthy volunteers
evaluating PLN-74809&#146;s ability to inhibit TGF-&szlig; activation as measured through pSMAD2/3 activation levels. pSMADs act as signaling molecules directly downstream from the TGF-&szlig; receptor, and therefore pSMAD2/3 activation is used as a
reliable biomarker for TGF-&szlig; activation. In the Phase 1b trial, PLN-74809 was shown to inhibit TGF-&szlig; activation by up to 70% in alveolar macrophages collected from healthy volunteers, in a dose- and exposure-dependent manner.
Additionally, PLN-74809 was well tolerated with only mild adverse events and no drug-related adverse events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently enrolling
two Phase 2a trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF. In the first of these trials, we plan to enroll IPF patients and utilize a positron emission tomography, or PET, ligand to measure av&szlig;6 target engagement by <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> in the lungs post-treatment. The second trial is a <FONT STYLE="white-space:nowrap">12-week</FONT> double blind placebo-controlled trial involving IPF patients across four cohorts consisting of three doses
of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and one placebo and will evaluate safety, tolerability and pharmacokinetics, or PK. We also plan to employ exploratory efficacy endpoints including Quantitative Lung Fibrosis imaging analysis,
biomarkers and pulmonary function. We plan to submit an IND for PLN-74809 in PSC in the first half of 2020 and initiate a Phase&nbsp;2a trial as soon as possible thereafter. This trial is expected to be a
<FONT STYLE="white-space:nowrap">12-week</FONT> double blind placebo-controlled trial involving PSC patients across four cohorts consisting of three doses of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and one placebo and will evaluate safety,
tolerability and PK. We also plan to employ exploratory efficacy endpoints including biomarkers and evaluation of liver-stiffness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
second clinical stage product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule, selective inhibitor of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by the integrin
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, in development for treatment of stage F3/F4 NASH. <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 serves as an activator of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> and its
expression has been shown to be upregulated in hepatic stellate cells in stage F3 and F4 NASH-associated liver fibrosis. In October 2019, we entered into a collaboration and license agreement with Novartis in which Novartis licensed global rights to
PLN-1474. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NASH is a severe form of <FONT STYLE="white-space:nowrap">non-alcoholic</FONT> fatty liver disease, or NAFLD, that is
associated with the development of liver fibrosis and potentially life-threatening liver dysfunction. NASH is highly prevalent, affecting approximately 16.5&nbsp;million adults in the United States, including approximately 3.3&nbsp;million with
stage F3/F4 fibrosis. Over time, NASH-related liver fibrosis may progress to cirrhosis, resulting in impaired liver function and increased risk of liver-related complications and mortality. There are currently no FDA approved therapies for NASH, and
to date investigational NASH therapies have only shown modest anti-fibrotic benefits in clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have shown through our assays
of live human fibrotic liver tissue that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is able to decrease the expression of <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes such as <I>COL1A1</I>, the gene associated with the production
of the most abundant type of collagen produced in fibrosis. We have also shown in multiple animal models of NASH that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> has a potent anti-fibrotic effect. We are currently conducting a Phase 1 trial of <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> in healthy volunteers with data expected in the second half of 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our
collaboration with Novartis, Novartis will reimburse us for all development activities associated with the PLN-1474 Phase 1 trials, and will be responsible for all development and commercialization activities following Phase 1 trials. We will be
eligible to receive up to $416.0 million in various developmental regulatory and commercial milestones as well as tiered royalties, on a product-by-product basis based on annual nets sales of products, at percentages ranging from high-single digits
to low-double digits of the applicable licensed products and mid-single digits to high-single digits for the applicable research products. In addition to PLN-1474, during the research term, Novartis will also collaborate with us on up to three
separate integrin research programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our clinical programs, we are developing two additional preclinical integrin-based
programs. The first of these is our oncology program. As TGF-&szlig; biology has been elucidated, it has become increasingly understood in the scientific literature that TGF-&szlig; plays an important anti-inflammatory role in the tumor
micro-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
environment, preventing T-cell infiltration and inhibiting release of various cytokines. This mechanism is becoming increasingly recognized as a potential cause of the resistance to checkpoint
inhibitors such as anti-PD-1 therapies seen in many tumors. We are targeting the TGF-&szlig; activating integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><FONT STYLE="font-family:Times New Roman; font-size:6.5pt">v</FONT><FONT
STYLE="font-family:Times New Roman; font-size:10pt">&szlig;</FONT><FONT STYLE="font-family:Times New Roman; font-size:6.5pt">8</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">, which is upregulated in certain tumors with the goal of
sensitizing tumors to checkpoint inhibitors. This program has generated positive data in preclinical tumor models and is currently in the lead-optimization phase of development. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second preclinical program is an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor being developed for
treatment of muscular dystrophies, including Duchenne Muscular Dystrophy. The target integrin is upregulated on muscle cells across multiple muscular dystrophy indications, acting as a substitute for dystrophin and helping to anchor muscle cells to
the extracellular matrix. The program utilizes an allosteric agonistic antibody to activate the target in order to augment the naturally occurring compensatory mechanism. Because the antibody is not mutation specific, it could potentially be
effective as a single therapy or in combination with other treatment modalities across multiple muscular dystrophy indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant
was formed to build upon our scientific founders&#146; pioneering work elucidating the biology of fibrosis and its underlying causes. Our mission is to advance the understanding of fibrosis by building a biology-, chemistry- and screening-based
engine to drive drug development across the spectrum of fibrotic diseases. We have established what we believe is a leading capability to both identify relevant fibrosis targets across different tissue types and address those targets with product
candidates that have been optimized for potency and selectivity. We have established collaborations with medical research institutions and tissue networks that provide us access to human fibrotic tissue from patients undergoing transplant to use in
evaluation of our product candidates and share insights with thought leaders to further engage them in our mission. By refining the development of biology-driven product candidates in our laboratories through testing in freshly obtained human
fibrotic tissue, we believe that we may be able to increase the efficiency of our development process and maximize the probability of success. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assembled an executive team with highly relevant experience in fibrosis, small-molecule drug discovery and clinical development.
Bernard Coulie, M.D., Ph.D., our CEO, has 20 years of experience in drug development, previously serving as CEO and CMO of ActoGeniX, as well as holding senior roles at Johnson&nbsp;&amp; Johnson. &Eacute;ric Lefebvre, M.D., our Chief Medical
Officer, brings deep experience in clinical development in liver disease. He previously served as head of clinical research and development for NASH at Allergan. Prior to Allergan, Dr.&nbsp;Lefebvre led HIV and HCV development at Janssen and later
served as CMO at Tobira. We were founded by world-renowned researchers Dean Sheppard, Rik Derynck, Bill DeGrado and Hal Chapman from the University of California, San Francisco, who bring broad experience in fibrosis biology and small-molecule
chemistry among other related disciplines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have raised over $220&nbsp;million from investors including Third Rock Ventures,
Cowen Healthcare Investments, Eventide Asset Management, Novartis, Redmile Group, Farallon Capital Management, Cormorant Asset Management, Surveyor Capital (a Citadel Company), Logos Capital, Schroder Adveq Management, Menlo Ventures, SCubed Capital
and Agent Capital<B>. </B> </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to become a world-leading fibrosis company, developing and commercializing disease-modifying therapies across a spectrum of
fibrotic diseases. To achieve this, we are focused on the following key strategies: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Rapidly advance <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and PSC through clinical development
and commercialization</B>.&nbsp;&nbsp;&nbsp;&nbsp;We are developing our lead oral small-molecule inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 as a novel therapy for
both IPF and PSC, each areas of high unmet medical need. Both IPF and PSC are orphan indications that we believe we can commercialize on our own in key geographies using targeted sales forces. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Rapidly advance our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> through Phase
1 for subsequent trials in NASH</B> associated liver <FONT STYLE="white-space:nowrap">fibrosis.&nbsp;&nbsp;&nbsp;&nbsp;PLN-1474</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 in development
for the treatment of stage F3/F4 liver fibrosis associated with NASH, an area of high unmet medical need with no currently FDA-approved treatments. In October 2019, we entered into a license and collaboration agreement with Novartis, under which
Novartis licensed global rights to PLN-1474. We are currently executing a Phase 1 SAD/MAD trial of PLN-1474. Novartis will reimburse us for all development activities associated with the Phase 1 trials, and will be responsible for all development
and commercialization activities following Phase 1. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Selectively evaluate additional partnerships in indications and geographies where we believe partners can add
significant commercial and/or development capabilities.&nbsp;&nbsp;&nbsp;&nbsp;</B>Fibrotic diseases represent a broad set of disease indications to pursue. Our focus is to commercialize our assets in orphan fibrosis indications and to selectively
work with partners in larger indications and in geographies outside of North America. In October 2019, we entered into a license and collaboration agreement with Novartis, under which Novartis licensed global rights to PLN-1474. Given the size and
competitive dynamics of the NASH indication, we believe that our collaboration gives PLN-1474 the best chance for success. Furthermore, we will evaluate and potentially choose to partner our unpartnered product candidates in indications outside of
fibrosis. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Explore opportunities for our pipeline assets in additional fibrotic
indications.&nbsp;&nbsp;&nbsp;&nbsp;</B>We are evaluating the potential benefit of our product candidates outside of their lead indications. Our product candidates have shown anti-fibrotic activity in multiple animal models as well as human tissue
in indications outside of IPF, PSC and NASH. We will continue to evaluate additional indications to maximize the potential of our pipeline. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Leverage our industry leading tools and capabilities to advance our mission of becoming a leading fibrosis
company.&nbsp;&nbsp;&nbsp;&nbsp;</B>Since our founding we have endeavored to advance the understanding of fibrosis biology, uncover new targets and advance novel product candidates. Currently, our proprietary capabilities include a target expression
atlas, an expansive library of over 7,000 integrin inhibitor molecules, integrin screening assay platform, live fibrotic human tissue program, <FONT STYLE="white-space:nowrap">PET-ligand</FONT> imaging program, and biomarker assays. We continue to
expand our integrin inhibitor library and develop tools such as additional <FONT STYLE="white-space:nowrap">PET-ligands</FONT> as well as novel disease biomarkers. In addition, we have a library of over 70,000 compounds for <FONT
STYLE="white-space:nowrap">non-integrin</FONT> targets. We intend to leverage these tools and capabilities in a target- and modality-agnostic manner to expand our pipeline with a mission to become a world-leading fibrosis company.
</P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fibrosis: A Condition of Uncontrolled Scarring </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis refers to excessive scarring often resulting from aberrant tissue repair processes. In normal tissues, fibrotic pathways represent a
repair mechanism by which the tissues heal themselves in response to injury or disease. These pathways are normally deactivated upon completion of tissue repair. However, when they become dysregulated and remain activated, excess collagen deposition
can cause tissues to thicken and become stiff, ultimately impairing their physiological function. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis is a disease of connective
tissue. Normal connective tissue forms a supportive network between cells, lending structure and integrity to tissues built up of many cell types. Connective tissue is composed of collagenous and elastic fibers, as well as a number of supporting
cells such as fibroblasts and white blood cells. These supporting cells are embedded in a <FONT STYLE="white-space:nowrap">gel-like</FONT> matrix made up of proteins known as the extra-cellular matrix. The most important protein in this matrix is
collagen, which takes the form of elongated, fine fibers, providing flexible support to the surrounding cells. In fibrotic tissues, initial insults such as tissue damage or inflammation spur the deposition of excess collagen. Normally such responses
are balanced in finely controlled feedback loops, but in fibrotic disease these feedback loops are dysregulated,&nbsp;resulting in progressive scarring, thickening, and loss of function. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis occurs in many organ systems throughout the body including the lungs, liver,
kidneys, gastrointestinal tract, skin and muscles. While the exact pathologies of diseases in these organs vary, the development of fibrosis involves many common cell types and biochemical pathways, including the TGF-&szlig; signaling pathway. The
ultimate result is similar across many tissues: secretion and extracellular activation of growth factors that stimulate fibroblasts to secrete excess collagen, leading to runaway growth of scar tissue. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g22z44.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Role of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> Signaling in Fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that selectively inhibiting TGF-&szlig; activation holds the key to successfully treating fibrosis across multiple tissues and
organs. <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> is secreted by nearly all cells and organs in mammals and stored in large amounts outside of cells, in the extra-cellular matrix, as part of an inactive complex. In healthy tissues, <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> is transiently activated in response to tissue injury which initiates a cascade that results in collagen production and, ultimately, healing of the tissue. In fibrosis, however <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling becomes dysregulated and perpetuated, with <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> being continuously activated, leading to excess collagen deposition in the absence of acute tissue
injury. Moreover, induced activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> alone in animal models has been shown to be sufficient to induce fibrosis, and inhibition of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation
has been shown to prevent or attenuate fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> can be activated in multiple ways in
response to specific tissue injury. One important class of cell-surface proteins that activate <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> in fibrosis are integrins. Integrins have a variety of functions, including signaling inside the
cells, providing tissue structure and stability through adhesion between cells. Integrins are heterodimeric proteins, meaning they are composed of two different protein subunits paired together. These subunits are known as <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> and &szlig; subunits. In humans, there are eighteen distinct <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> subunits and eight distinct &szlig; subunits, which combine to form 24 known and functional integrin
pairs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain integrins bind the inactive <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> complex. In response to tissue injury, the
cells expressing these integrins are induced to contract, exerting physical force on the bound <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> complex. This mechanical force changes the shape of the complex, releasing active <FONT
STYLE="white-space:nowrap">TGF-&szlig;.</FONT> This activation triggers a biological cascade which results in collagen production, and when dysregulated leads to fibrosis. As depicted in the figure below, this cascade involves (i)&nbsp;binding of
active <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> to its receptor, the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> type I receptor kinase also known as ALK5; (ii) phosphorylation of immediate downstream signaling proteins known as
SMAD2 and SMAD3; (iii)&nbsp;formation of a transcription initiation complex by pSMAD2, pSMAD3 and SMAD4; and (iv)&nbsp;subsequent transcription of target genes that encode fibrotic proteins such as collagen. Importantly, whereas certain <FONT
STYLE="white-space:nowrap">TGF-&szlig;-activating</FONT> integrins are expressed at very low levels in healthy tissues, the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> cascade can lead to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upregulation of the these integrins resulting in a <FONT STYLE="white-space:nowrap">TGF-&szlig;-driven</FONT> positive feed-forward loop which further increases
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. Furthermore, as fibrosis progresses and the fibrotic organ gets stiffer, it becomes progressively easier for contracting cells to activate integrin-bound
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> It is because of this continued, tissue-specific upregulation of integrins and their key roles in continued <FONT STYLE="white-space:nowrap">TGF-&szlig;-activation</FONT> that we believe that
integrins provide an avenue to selectively inhibit <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in fibrotic tissue without affecting <FONT STYLE="white-space:nowrap">TGF-&szlig;&#146;s</FONT> important physiological roles in
healthy tissues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>
Integrins promote fibrosis through activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g99f54.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Model of integrin regulation of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Historical Challenges to Drug Development in Fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis has historically been a difficult therapeutic area to target pharmaceutically. The biology and underlying causes of fibrosis are
complex and, in many diseases, poorly understood. In the past, many patients with fibrotic disease were treated with anti-inflammatory agents such as steroids. While steroids may have a mild anti-fibrotic effect in some forms of fibrosis, they can
exacerbate others, such as IPF. Additionally, the negative effects of chronic steroid exposure make it difficult to treat patients with these agents for long term periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More recently, it has become well understood that regardless of the underlying cause, TGF-&szlig; activation is at the heart of several key
processes that drive fibrosis, including collagen formation, deposition of extracellular matrix proteins and activation and proliferation of fibroblast cells. As such, much of the historic drug development efforts to treat fibrosis have been aimed
at systemically inhibiting or disrupting the TGF-&szlig; signaling pathway by either (i)&nbsp;blocking TGF-&szlig; binding to the TGF-&szlig; receptors with an antibody or (ii)&nbsp;preventing the type I TGF-&szlig; receptor, also known as ALK5,
from activating the SMADs using a small-molecule kinase inhibitor. However, because of TGF-&szlig;&#146;s role in normal physiology, these approaches cause substantial toxicity and dysregulation of normal functions. In fact, documented toxicities
that arise from systemic inhibition of TGF-&szlig; signaling include cardiac toxicity, inflammation, and focal epithelial hyperplasia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
potentially safer approach to fibrosis therapy is to inhibit specific <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> signaling molecules, such as connective tissue growth factor and autotaxin, which operate downstream of TGF-&szlig;
activation, thereby mitigating the tolerability issues associated with systemic TGF-&szlig; inhibition. While tolerability has been shown to improve with this approach, the efficacy shown to date has been modest, likely because TGF-&szlig; activates
multiple <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> signaling pathways in addition to those targeted by these approaches. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Another recent approach is to prevent TGF-&szlig; activation by stabilizing TGF-&szlig; in its inactive form. However, it is not known whether
latent TGF-&szlig; stabilization can be accomplished in a tissue specific manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the historical difficulty in targeting
<FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> clinical development for the treatment of fibrosis has also been limited by the lack of tools to understand this complex multicellular process. Only certain parts of this process can be modeled
using cellular assays. More complete representations of fibrosis can be generated in animal models, but these models tend to be acute in nature and do not accurately represent disease pathology in humans which, in most cases, develops over decades.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Integrin Inhibitors as a Potential Treatment for Fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An ideal approach to fibrosis treatment would be one that inhibits TGF-&szlig; activation in only those tissues where fibrosis is occurring.
One potential way to accomplish this is to inhibit the integrin proteins that are known to be overexpressed in specific fibrotic tissue and cause the abnormal activation of TGF-&szlig;. In several forms of fibrosis, namely IPF and PSC, TGF-&szlig;
activating integrins such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are over-expressed. These integrins are normally expressed at low levels in healthy tissue. Therefore,
we would not expect <FONT STYLE="white-space:nowrap">off-target</FONT> toxicity effects by selectively inhibiting <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1. By inhibiting
fibrosis-specific TGF-&szlig; activators such as these specific integrins, it is possible to block abnormal TGF-&szlig; activation in the specific tissues where fibrosis occurs, without affecting TGF-&szlig; signaling in healthy tissues. However,
integrin drug development has historically been challenging due to the difficulty of developing small molecule integrin inhibitors that are both selective for specific integrins and bioavailable. Notably, a recent approach targeting integrins
selectively with a monoclonal antibody was terminated due to safety concerns, which we believe may be related to antibody-mediated immune activation. We believe our pipeline of bioavailable highly selective small molecule integrin inhibitors has the
potential to address these challenges. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recently, large biopharmaceutical companies have begun to recognize the potential of anti-integrin
approaches to treat fibrosis and made large investments in the space. AbbVie recently <FONT STYLE="white-space:nowrap">in-licensed</FONT> a set of preclinical integrin inhibitors for the treatment of fibrosis including an <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 inhibitor targeting IPF.<B> </B>The AbbVie product candidate is a single selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6; however, it has been shown that the expression
of both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 is upregulated in IPF. We believe that our dual-selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6/<FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 inhibitor approach has the potential to provide a more potent anti-fibrotic effect than a single selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 inhibitor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that recent developments in the field of integrin inhibitors validate our initial focus on integrin inhibitors as a treatment for
fibrosis. Utilizing our proprietary discovery and development capabilities, we believe that we have overcome key historical challenges to the development of integrin inhibitors, including potency, selectivity and bioavailability. We have identified
two bioavailable and highly potent and selective integrin inhibitors. Our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> has completed Phase 1a trials and has demonstrated potential for a once daily oral dosing profile.
</P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Capability and Approach to Fibrosis Drug Discovery and Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach to drug development in fibrosis combines our deep knowledge of the biology of fibrosis with various cellular, tissue, and <I>in
vivo</I> assays developed in house to interrogate the biology of fibrosis and uncover pathways and potential targets. We developed an extensive panel of cell assays, precision cut tissue assays and animal models covering various types of fibrotic
diseases. These assays allow us to evaluate target expression in fibrotic tissues as well as the anti-fibrotic activity of our candidates after treatment and begin to establish proof-of-biological-mechanism in both animal models and human tissue
prior to initiating clinical trials. We believe these collective capabilities uniquely allow us to (i)&nbsp;efficiently identify targets, (ii)&nbsp;optimize the potency and selectivity of candidates and
<FONT STYLE="white-space:nowrap">(iii)&nbsp;de-risk</FONT> product candidates in advance of human proof-of-concept. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first tool we use
in our discovery process is our target expression atlas. Utilizing samples from normal and fibrotic human tissue, we developed a quantitative atlas of gene and protein expression across multiple fibrotic diseases. This database represents a wealth
of data that we use to quantify expression of tissue specific targets for potential therapeutics. The atlas is continuously expanding through acquisition of additional samples as well as additional analyses. To date, we have advanced multiple
potential targets to our early discovery pipeline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second important tool in our discovery process is our compound library that we
screen for activity against targets identified through our target atlas. While we are agnostic to treatment modality, our initial targeted chemistry effort has been focused on integrin inhibitors, and our medicinal chemistry team has developed a
proprietary library of over 7,000 potential integrin inhibitors. The goal of the library is to maximize structural diversity while targeting optimal absorption, distribution, metabolism and excretion, or ADME, properties. We expect that the library
will continue to grow as we investigate new structures. We have designed the library based on in silico known <FONT STYLE="white-space:nowrap">X-ray</FONT> structures/homology models, structure-activity relationships of structural motifs of known
integrin inhibitors, and de novo molecular design. In addition to our proprietary integrin inhibitor library, we have a <FONT STYLE="white-space:nowrap">non-integrin</FONT> compound library of over 70,000 compounds that we screen against <FONT
STYLE="white-space:nowrap">non-integrin</FONT> targets. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once we have identified a potential target through our target expression
atlas, we screen our library of compounds against the target. We have developed screening assays for 20 of the 24 known integrins and use these assays to evaluate the potency and selectivity of binding for our potential drug candidates prior to
preclinical studies. Given the selectivity and potency challenges that have hampered integrin drug development, we believe our integrin assay panel represents a major step forward in integrin-based drug development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe a key advantage of our development strategy is our ability to test our product candidates in live human fibrotic tissue, which
helps us to bridge the gap between animal models and clinical proof-of-concept. We have developed proprietary protocols that extend the viability of live human explant tissue samples which allow us to reproducibly perform multiday experiments. We
also maintain an <FONT STYLE="white-space:nowrap">on-call,</FONT> around the clock team that obtains tissue samples following transplant procedures and transports those tissues to our lab within hours of explant, in a highly coordinated process. Our
access to these live tissue samples allows us to evaluate the effects of our product candidates on multiple markers of anti-fibrotic activity. The data from these experiments increase our confidence that the tested product candidates will show
anti-fibrotic effects in patients. In this way, our human tissue program serves to further <FONT STYLE="white-space:nowrap">de-risk</FONT> product candidates and increase their likelihood of success in the clinic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once in clinical development, we continue to <FONT STYLE="white-space:nowrap">de-risk</FONT> our programs by designing clinical trials that
allow us to show proof-of-mechanism in advance of clinical efficacy data. Because fibrosis is a chronic disease, proof-of-efficacy in human trials is expensive and takes years to complete. We utilize pharmacodynamic biomarkers and advanced imaging
techniques, including PET, to evaluate target engagement by our product candidates over relatively short time periods and observe whether the product candidate is having the anticipated effect. We believe obtaining these clinical data points in an
efficient manner will allow us to optimize our clinical development strategy and resource allocation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and our partners also
proactively conduct observational, natural history trials in target diseases to better understand disease pathophysiology and progression and develop new molecular biomarkers. Through these trials, we have gone on to develop patient registries and
establish relationships with clinicians at leading medical research institutions dedicated to bringing novel fibrosis therapies to their patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are developing an extensive biomarker discovery and validation program. We are seeking to develop biomarkers to (i)&nbsp;identify patients
at high risk of rapid disease progression, (ii)&nbsp;identify patients more likely to respond to treatment and (iii)&nbsp;monitor early treatment responses. We are conducting clinical studies and other research with leading academic centers to track
disease progression and collect biological samples such as blood, urine, and tissue biopsies which we can use to discover and validate novel biomarkers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g75i13.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our systematic approach to identifying and targeting integrins in fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selective inhibition of TGF-&szlig; activation in fibrotic tissues could potentially be the safest and most effective approach to treating
fibrosis. One way to accomplish this is to inhibit the integrin receptors that drive excessive activation of TGF-&szlig;. Given the importance of integrins in regulating the initial steps in fibrosis, we have focused our initial drug discovery
efforts on a dual approach. This approach includes both biological profiling to identify which integrins are important in various diseased tissues and chemical profiling of libraries containing proprietary integrin inhibitors to help determine their
selectivity and potency for individual integrins. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilizing our extensive <FONT STYLE="white-space:nowrap">in-house</FONT> medicinal
chemistry expertise, we have created a library of over 7,000 integrin-inhibitors. We screen this library against the integrin targets that we identify through our expression atlas and or biological profiling process. To our knowledge, this type of
industrial-scale, systematic biological and chemical profiling, seeking selective inhibitors of one or more integrins, has not previously been carried out. We believe this combination makes our approach distinctive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Central to our integrin inhibitor discovery process are our integrin assay panels. A key challenge in integrin inhibition, historically, has
been selectivity for specific integrins. To address this challenge, we have developed assays against the 20 most relevant known integrins. We use these screening assays to measure potency and selectivity of potential candidates against these
integrins. This allows us to quickly optimize the integrin binding profiles of potential development candidates in an iterative process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Integrins can undergo conformational change. This results in different binding affinities. We believe an ideal integrin inhibitor should
potently bind across the spectrum of conformations. Through the use of specific assays, we can measure the potency of our product candidates against multiple integrin conformations and seek to optimize for candidates that are able to potently bind
to all conformations. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our deep understanding of integrin biology, we have gained significant insight in
structure-activity relationships that determine integrin selectivity and optimal PK profiles. Utilizing this knowledge, we are now able to precisely engineer bioavailable integrin inhibitors with high potency and desired selectivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our integrin inhibitor profiling capability has enabled us to quickly identify inhibitors that target individual integrins such as <FONT
STYLE="white-space:nowrap">PLN-1474,</FONT> which selectively inhibits <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, as well as dual inhibitors such <FONT STYLE="white-space:nowrap">PLN-74809</FONT> which selectively targets both <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1. Combining the data from our biological profiling and chemical profiling sets has enabled us to identify compounds that we believe have the
highest potential for therapeutic activity in specific fibrotic diseases. Our iterative drug discovery effort focuses on drug-like properties of compounds early in the testing process. Compounds are screened for <I>in vitro</I> potency/selectivity
and ADME/PK properties. This enables us to move from compound optimization to <I>in vivo</I> testing in a matter of months. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to PLN-1474 and PLN-74809, we continue to evaluate our broad proprietary library
of integrin inhibitors to identify additional product candidates to treat fibrotic diseases. Furthermore, our approach allows us to use our discovery and development capabilities to develop <FONT STYLE="white-space:nowrap">non-integrin</FONT>
therapeutic modalities to treat fibrotic diseases. Our rich library also provides a deep series of potential backup molecules with structurally unique chemotypes that we believe can enhance the probability of clinical success. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As with all of our development efforts, a key approach to preclinically <FONT STYLE="white-space:nowrap">de-risking</FONT> our integrin
inhibitor candidates is evaluation of the candidates in live human fibrotic tissue obtained following transplant procedures. The ability to observe effects of our product candidates on gene expression in human tissues prior to entering the clinic
provides a bridge from animal models to clinical proof-of-concept and helps give us additional confidence as we move toward human trials. Similarly, if our <I>ex vivo </I>live human tissue studies show little or no effect on the target genes, we can
quickly reallocate resources, saving time and money, and minimizing unnecessary patient exposure. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A second important <FONT
STYLE="white-space:nowrap">de-risking</FONT> strategy involves biomarker measurement in both preclinical and early stage clinical studies. By utilizing specific biomarkers such as pSMAD2/3 that operate immediately downstream from <FONT
STYLE="white-space:nowrap">TGF-&szlig;,</FONT> we are able to measure the effects of our drugs on <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. We believe understanding the ability of our drug candidates to reduce TGF-&szlig;
activation is crucial to gaining confidence in the anti-fibrotic activity of our product candidates as we move forward in the clinic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our Phase 2 clinical trials, we are using an advanced imaging technique to generate mechanistic data and
<FONT STYLE="white-space:nowrap">de-risk</FONT> the development of our candidates. Fibrosis is a chronic process and it can take 6 months to a year to see a clinical benefit with a drug candidate. We are utilizing PET imaging to evaluate target
engagement in patients and to determine if PLN-74809 is having an effect in the tissues. We have an ongoing collaboration with Stanford pursuant to which we are evaluating Stanford&#146;s <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 PET
ligand in IPF patients. We are using this ligand to evaluate the level of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 expression in the lungs of IPF patients, as well as to measure our product candidate&#146;s ability to bind <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6. In addition to the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 PET ligand, we are internally developing PET ligands to other integrins that we will use to evaluate subsequent product
candidates. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our product candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of IPF and PSC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule, dual-selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins which we are developing for the treatment of IPF and PSC. We have received orphan drug designation for <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> in both IPF and PSC. We completed a Phase 1a trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in healthy volunteers and a Phase 1b trial in which we assessed target engagement and
proof-of-mechanism in healthy volunteers by examining the inhibition of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in alveolar macrophages. We are currently enrolling two Phase&nbsp;2a trials of PLN-74809 in IPF patients. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Idiopathic pulmonary fibrosis background </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IPF is a debilitating, <FONT STYLE="white-space:nowrap">age-related</FONT> lung disease of unknown causes that has few treatment options. It is
a form of progressive pulmonary fibrosis that leads to thickening and stiffening of the lung tissue resulting in the loss of lung function. As tissue scarring progresses, the lungs&#146; ability to transfer oxygen into the bloodstream becomes
increasingly impaired. Average life expectancy at the time of confirmatory diagnosis of IPF is estimated to be between three and four years. Approximately 60 to 80&nbsp;percent of patients die within five years of diagnosis. These survival rates are
worse than those of many late stage cancers, such as stage 3 breast cancer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patients with IPF experience debilitating symptoms, including
shortness of breath and difficulty performing routine functions, such as walking and talking. Other symptoms include a chronic, dry, hacking cough; fatigue; weakness; discomfort in the chest; loss of appetite; and weight loss. IPF is a rare disease
that affects approximately 140,000 people in the United States. There are an estimated 30,000 to 40,000 new cases diagnosed each year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, there is no pharmacological cure for IPF and only a small proportion of
late-stage IPF patients may be eligible for a lung transplant. The current <FONT STYLE="white-space:nowrap">non-transplant</FONT> standard of care aims to slow the disease progression and improve the quality of life. Two therapies to treat IPF have
recently been approved by the FDA: Esbriet<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (pirfenidone), marketed by Genentech, and OFEV<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nintedanib), marketed by Boehringer
Ingelheim. After decades during which the FDA approved no new treatments for IPF, the approvals of pirfenidone and nintedanib represented a major breakthrough for IPF patients. However, while these therapies may help slow the decline of lung
function, neither drug has been shown to stop the progression of IPF. We believe that, despite the approval of pirfenidone and nintedanib by FDA, there remains an unmet need for IPF patients that we plan to address through our product candidate.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite its mechanism of action being unknown, pirfenidone has been shown in registrational trials to have a modest effect on slowing
the progression of IPF as measured by forced vital capacity, or FVC, in approximately fifteen percent of patients. Recent studies suggest that pirfenidone may have an impact on survival compared to placebo, but these results have not been confirmed.
In March 2020, the FDA granted breakthrough therapy designation for pirfenidone for treatment of unclassifiable lung fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nintedanib
is an inhibitor of multiple tyrosine kinases that are receptors for growth factors such as platelet-derived growth factor, or PDGF, fibroblast growth factor, or FGF, and vascular endothelial growth factor or VEGF. Nintedanib reduced the rate of
decline of pulmonary function in multiple trials by approximately half and led to significant delays in the time to acute disease exacerbation. While treatment was associated with a trend towards increased survival in<B> </B>registration trials, it
has not been shown conclusively to have a survival benefit. Recent exploratory analyses from pooled data from six clinical trials of nintedanib suggest that nintedanib may extend life expectancy in patients with IPF. The FDA approved nintedanib for
the treatment of lung fibrosis associated with systemic sclerosis in September 2019, and for the treatment of chronic fibrosing interstitial lung disease, or ILD with a progressive phenotype in March 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Elevated liver enzymes have been observed with both of these drugs, requiring monitoring of liver tests and potentially temporary dose
reduction and discontinuation. Cases of drug-induced liver injury, including one fatal outcome, have been reported in patients treated with nintedanib. Pifenidone&#146;s prescribing information also carries a similar warning about elevated liver
enzymes. Despite the remaining unmet need, combined sales of pirfenidone and nintedanib in 2018 were over $2&nbsp;billion. IPF remains a major cause of morbidity and mortality and an area of high unmet medical need for which a commercial opportunity
remains. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Primary sclerosing cholangitis background </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PSC is a progressive liver disorder characterized by inflammation and fibrosis of the bile ducts which transport bile from the liver to the
intestines. This type of fibrosis often results in obstruction or interruption of bile flow from the liver, a condition known as cholestasis, leading to liver fibrosis. Cirrhosis eventually develops and many individuals ultimately require a liver
transplant. PSC patients are also at a higher risk of developing hepatobiliary cancers, including a 5 to 20&nbsp;percent lifetime chance of developing cholangiocarcinoma, a typically rare form of cancer with an especially poor prognosis. The exact
cause of PSC is unknown. PSC is normally diagnosed at middle age, with a median age at diagnosis of approximately 40 years old. The prevalence of PSC in the United States is estimated to be between 30,000 and 45,000 patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the absence of liver transplant, median survival of PSC patients is 10 to 12 years following diagnosis without intervention. There are
currently no approved pharmacological treatments for PSC. A number of immunosuppressive and anti-inflammatory agents have been studied in patients with PSC, but none has been conclusively proven to slow progression. Liver transplantation is the only
available treatment for PSC patients; however, disease has been shown to recur in up to 20&nbsp;percent of patients following transplantation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our solution, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> is a small-molecule that selectively inhibits both
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins that we are developing as a potential therapy for IPF and PSC. We have determined that
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in fibrosis </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
associated with IPF and PSC involves both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins. It has been shown that
expression of both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 on epithelial cells and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 on fibroblasts can lead to excessive activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> in fibrosis. Epithelial tissue includes any tissue that lines the surfaces of the body such as alveoli, bile ducts, urinary tract, skin, and gastrointestinal tract. Each of these tissues contains
multiple cell types including epithelial cells and fibroblasts. An important secondary effect of the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> cascade is that it promotes upregulation of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 on epithelial cells. The increased expression of these integrins on the cell surface contributes in turn to further <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in a <FONT
STYLE="white-space:nowrap">TGF-&szlig;-driven</FONT> positive feed-forward loop. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g729258g91e38.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Activation of TGF-&szlig; by
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> leads to:</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Activation of TGF-&szlig; signaling pathways</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Expression of pro-fibrotic
genes including <I>COL1A1</I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Subsequent collagen production and deposition</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Additional upregulation of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB></P></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Epithelial tissue fibrosis is driven by two types of integrins</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Data from our lab, as well as scientific literature, have shown that <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 proteins are overexpressed in at least two different fibrosis indications: IPF and PSC. In lung tissue from IPF patients we and others have shown that alveolar epithelial cells have elevated <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 expression, and that the level of over-expression correlates with disease severity. We have also shown that in these patients, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 expression is
upregulated. In liver tissue from PSC patients, we have shown that <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 is upregulated in cholangiocytes, the epithelial cells that line the bile ducts, and that
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 is upregulated in whole fibrotic liver tissue. <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are normally expressed at very
low levels in healthy tissue making them ideal targets for selectively inhibiting <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in IPF and PSC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g51g23.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 is upregulated in the lung
tissue of IPF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>patients and the liver tissue of PSC patients </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g78q60.jpg" ALT="LOGO">
 </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">= p &lt; 0.05<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A p-value is the probability that the reported result was achieved purely by chance, such that a p-value of less than or equal to 0.05 or 0.01 means that there is a 5.0% or 1.0% or less probability, respectively, that
the difference between the control group and the treatment group is purely due to chance. A p-value of 0.05 or less typically represents a statistically significant result. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 expression is upregulated in lung and liver fibrosis </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have conducted a <FONT STYLE="white-space:nowrap">non-interventional</FONT> clinical trial in IPF patients to assess the expression of
integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 using a PET ligand. This trial confirmed that patients with IPF have high levels of integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 expression, which tend to be <FONT
STYLE="white-space:nowrap">co-localized</FONT> with fibrotic regions of the lungs. This trial was published in Nature Communications in 2019. The specificity of this PET ligand can be seen in images from an IPF patient who received a unilateral lung
transplant. The PET ligand is only taken up in the diseased lung but not in the transplanted healthy lung. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g82l26.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pulmonary </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 PET ligand uptake in
an IPF patient with a unilateral lung transplantation is confined to the IPF lung </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have shown that inhibition of both
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins is required to maximally inhibit the expression of <I>COL1A1</I>, a key gene that encodes type&nbsp;I collagen, in models
of lung and biliary fibrosis as well as in human IPF tissue. <I>COL1A1</I> is a <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> regulated gene that is expressed in fibrotic tissue. The expression level of <I>COL1A1</I> correlates with the amount
of collagen deposited as measured by the standard biochemical method of quantification of hydroxyproline, an amino acid that is a major component of collagen. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical development of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Completed trials </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
completed a Phase 1a SAD/MAD and food effect clinical trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in healthy volunteers. In the SAD portion of the trial, single doses of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> were
administered to 32 volunteers across four cohorts at doses of 15, 30, 50 and 75&nbsp;mg. Eight additional volunteers in the SAD portion of the trial received placebo. In the MAD portion of the trial, <FONT STYLE="white-space:nowrap">PLN-74809</FONT>
was administered orally to 27 volunteers, once-daily over 14&nbsp;days at 10, 20 and 40&nbsp;mg. Six additional volunteers in the MAD portion of the trial received placebo. In the food effect part of the trial,
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> was administered to 12 volunteers, administered as a single dose with and without food. <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was shown to be well tolerated with no dose-related adverse
events. All but two adverse events reported in the entire trial were mild except for a moderate adverse event of dental abscess (SAD, 30&nbsp;mg dose cohort) and a moderate adverse event of viral syndrome (MAD, 40&nbsp;mg dose cohort). All adverse
events resolved or recovered and no dose relationship for adverse events was observed. No notable findings were observed for laboratory abnormalities, vital signs or ECG/telemetry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adverse Events Reported by Participants Receiving PLN-74809 in Phase 1a Trials </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g48d12.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was well absorbed, and
displayed a half-life of over 40 hours. <FONT STYLE="white-space:nowrap">PLN-74809</FONT> reached steady state plasma concentrations after seven days of dosing. <FONT STYLE="white-space:nowrap">Co-administration</FONT> of <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> with food decreased drug concentrations relative to the fasted state, with AUC decreasing by approximately 40&nbsp;percent and C<SUB STYLE="font-size:85%; vertical-align:bottom">max</SUB> by approximately
50&nbsp;percent. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Phase&nbsp;1a SAD PK</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Phase&nbsp;1a MAD PK at Day 13</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">


<IMG SRC="g729258g08e28.jpg" ALT="LOGO">
</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also completed a Phase 1b proof-of-mechanism trial in healthy volunteers that was similar in
design to our previously completed non-human primate mechanistic trial. The purpose of this randomized, double-blind, ascending-dose, placebo-controlled trial was to evaluate PLN-74809&#146;s ability to inhibit
TGF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> activation in the lung as measured by pSMAD2 levels in pulmonary alveolar macrophages collected from BAL fluid and to further characterize the PK/PD relationship in humans. Additionally, this trial
will serve to inform dosing in our planned Phase 2a trials. We conducted this trial in healthy volunteers due to the safety risks associated with performing multiple BAL procedures in IPF patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We enrolled 18 volunteers across four dose cohorts (each cohort randomized 3:1 active to placebo). Two cohorts were dosed at 20&nbsp;mg once
daily and two cohorts were dosed at 40&nbsp;mg once daily. Volunteers underwent an initial BAL procedure prior to treatment to measure baseline pSMAD levels. They were then treated with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or placebo
for seven days, after which they underwent two additional BAL procedures to measure the amount of pSMAD reduction post-treatment at multiple time points. By utilizing two cohorts each for the 20 mg and 40&nbsp;mg doses, we were able to measure pSMAD
and drug levels at 4 different time points post treatment for each dose (3, 6, 12 and 24&nbsp;hours post-dose on day&nbsp;7), allowing assessment of PK/PD relationship over a <FONT STYLE="white-space:nowrap">24-hour</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the Phase 1b trial, 16 participants completed pre- and post-treatment BAL procedures. Four out of six participants (66%) receiving the high
dose of PLN-74809 experienced <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>49% reductions in pSMAD2 levels at six hours post-dose relative to baseline levels. Notably, all four of the volunteers in the high dose cohort with reductions in pSMAD2
levels also achieved plasma concentrations of PLN-74809 corresponding to the predicted plasma protein adjusted IC<SUB STYLE="font-size:85%; vertical-align:bottom">60</SUB>. The two volunteers in the high dose cohort who did not achieve these
concentrations did not experience reductions in pSMAD2 levels. In the low dose cohort, no volunteers achieved plasma protein adjusted IC<SUB STYLE="font-size:85%; vertical-align:bottom">60</SUB>, and only one volunteer experienced significant
reduction in pSMAD2 levels post treatment, relative to baseline levels. These results demonstrate PLN-74809&#146;s effect on reducing TGF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> activation in the lungs in a dose- and exposure-dependent
manner, supporting a PK/PD relationship in humans. These data support the biological activity of PLN-74809 and will guide dose selection and trial design as we move into Phase 2a trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g73w81.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treatment with PLN-74809 was well tolerated with no drug-related adverse events. None of the adverse
events reported were observed in more than one participant. In the 40-mg dose cohort, two trial participants discontinued treatment prematurely (one participant receiving PLN-74809 and one receiving placebo) and did not undergo post-treatment BAL
procedures; these participants were subsequently replaced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adverse Events Reported by Participants Receiving PLN-74809 in Phase 1b
Trial </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g89q84.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Current and planned clinical trials for IPF and PSC </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently enrolling two Phase&nbsp;2a trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in patients with IPF. The first of
these is an open label trial utilizing a PET ligand to <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 that allows imaging of target engagement by <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in the lungs of IPF patients during
treatment. Patients will receive a single dose of PLN-74809 across a dose range starting at 60 mg. We will obtain a PET scan at baseline to evaluate <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 expression levels in the patients&#146;
lungs and then initiate treatment with open-label <FONT STYLE="white-space:nowrap">PLN-74809.</FONT> A post-treatment PET scan will be performed at approximately three hours after administration of the dose, which will enable us to evaluate <FONT
STYLE="white-space:nowrap">PLN-74809&#146;s</FONT> target engagement in patients&#146; lungs at maximum drug concentration. When <FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6
receptor, we would expect to see decreased PET ligand uptake in the lungs post-treatment when compared to <FONT STYLE="white-space:nowrap">pre-treatment</FONT> levels. The relationship between dose and target engagement is important to guide dose
selection in future studies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second currently enrolling Phase 2a trial is a randomized, double-blind,
placebo-controlled IPF trial evaluating up to three doses of PLN-74809 in IPF patients. We plan to explore doses up to 160mg per day at the highest dose. This trial is a 12-week trial evaluating safety and tolerability, as well as PK in IPF
patients. We plan to evaluate exploratory endpoints including pulmonary function tests, biomarkers, and imaging, including Quantitative Lung Fibrosis HRCT imaging, or QLF. This is a multinational trial with over 40 sites in U.S., Canada, Australia,
New Zealand and multiple countries in Europe. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12 Week Safety, PK, Biomarker Trial in IPF Patients </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g82d54.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Design of 12 week Phase 2a IPF trial </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our 12-week Phase 2a IPF trial, we are utilizing QLF as a biomarker for early detection of changes in lung fibrosis. QLF is a fibrosis
biomarker assessed using high resolution CT imaging, and utilizes quantitative image analysis to measure the density of lung tissue and quantify the volume of fibrosis present in the lung. QLF technology was developed by MedQIA, and has been
validated in over 5,000 ILD patients, showing an ability to predict FVC decline in patients with IPF. While we will measure both endpoints, we believe QLF may allow us to detect changes in lung fibrosis in a more specific way than FVC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QLF has been utilized in recent clinical trials to evaluate early treatment effects in
the amount of lung fibrosis present. In Biogen&#146;s Phase 2a trial of BG00011, a mAb targeting <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6, dose-dependent trends in QLF were seen at 8 weeks, with the 1mg/kg cohort actually showing a
decrease in the amount of fibrosis present with a r=-0.49 correlation to FVC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g04r02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Biogen&#146;s Phase 2a 8-week QLF Results </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, Fibrogen utilized FVC in their Phase 2 trial of pamrevlumab, their anti-CTGF mAb, in IPF. Fibrogen showed 71% and 50% reductions
in progression of fibrosis versus placebo at 24 and 48 weeks, respectively, as measured by QLF. </P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03g67.jpg" ALT="LOGO">
 </P>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the two Phase 2a trials, we are currently conducting an extended Phase 1 dose
escalation trial in healthy volunteers. Based on preclinical findings and the results of our Phase 1b healthy volunteer BAL trial, we believe the human effective dose range for PLN-74809 may be between 40 mg and 160 mg administered once
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
daily. To efficiently evaluate safety and PK at these higher doses, are conducting a single center, randomized, blinded, placebo-controlled, sequential SAD/MAD study. In the SAD cohorts,
volunteers will receive a single dose of PLN-74809, starting at 120 mg in cohort 1 and increasing to a max of 320 mg in cohort 4. Cohorts 1 (120 mg), 2 (160 mg) and 3 (240 mg) of the SAD have been completed and there were no new safety concerns.
Cohort&nbsp;1 (80 mg) of the seven-day MAD portion of the trial has been completed and has been deemed to be well tolerated. Subsequent MAD cohorts dosing will increase by 40 mg per cohort, up to 160 mg once daily in Cohort&nbsp;3. The selection of
doses in the SAD cohorts was chosen to provide daily plasma concentrations (area under the curve or AUC) of PLN-74809 similar to steady state concentrations expected to be achieved in the corresponding MAD cohorts. The results of the continued
SAD/MAD trial will guide dose selection in the 12-week Phase 2a IPF and PSC trials. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g36z34.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Design of Extended SAD/MAD Dose Escalation Trial </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to file an IND for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in PSC in the first half of 2020 and to initiate our third
Phase&nbsp;2a randomized, double-blind, placebo-controlled trial in PSC patients as soon as possible thereafter. We plan to utilize a similar approach to the previously described IPF study enrolling PSC patients, evaluating up to three doses of <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> or placebo. Regulators have suggested that composite endpoints including biomarkers such as Alkaline phosphatase, PRO-C3 and ELF coupled with liver histology may be sufficient for approval in PSC. NGM
showed changes in PRO-C3 and ELF at 12 weeks in their Phase 2a PSC trial. Gilead and Dr. Falk&#146;s are both including liver histology as a primary endpoint in their Phase 3 PSC trials. The primary endpoints for our Phase 2a PSC trial will be
safety and tolerability, as well as PK. We will also employ exploratory endpoints including fibrosis biomarkers including PRO-C3 and ELF, which are predictive of transplant-free survival in PSC patients, change in alkaline phosphatase, and liver
imaging. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12 Week Safety, PK, Biomarker Trial in PSC Patients </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g60q90.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Design of 12 week Phase 2a PSC trial </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Other Potential Development Plans for PLN-74809 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently exploring the potential effects of PLN-74809 in fibrotic diseases outside of IPF and PSC and may choose to explore the
development of PLN-74809 in additional indications in the future. For example, we believe PLN-74809 could provide anti-fibrotic benefits in several pulmonary and hepatic fibrosis diseases where there is over-expression of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6, including pulmonary fibrosis associated with systemic sclerosis, pulmonary fibrosis associated with rheumatoid arthritis, pulmonary fibrosis associated with other forms of interstitial lung disease,
primary biliary cholangitis, or PBC, biliary atresia and progressive familial intrahepatic cholestasis, or PFIC. Additionally, we believe that PLN-74809 could provide anti-fibrotic benefits in the setting of end stage renal disease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical data in IPF </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-TOP:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8; padding-left:8pt" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #ffffff; padding-left:8pt; padding-right:2pt" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Summary Preclinical
Data in IPF</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt" BGCOLOR="#4b61a8">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff; BORDER-RIGHT:1px solid #4b61a8" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Preclinical Findings</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#4b61a8" STYLE=" BORDER-LEFT:1px solid #ffffff; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Observations</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced collagen gene expression in live human ILD lung tissue</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Greater than 50% decrease in expression of <I>COL1A1</I> <I></I>relative to DMSO vehicle control
seen in lung tissue from five IPF patients and one systemic sclerosis patient</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;An antibody to <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 did not significantly decrease expression</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">pSMAD3 was correlated with extractable collagen levels in patients suspected of having IPF</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;pSMAD3 and extractable, or newly formed, collagen 1 were measured in biopsy samples from 18
patients and 5 controls.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;pSMAD3 and extractable collagen 1 were correlated with an r value of
0.7807 (p&lt;0.0001)</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 expression is elevated in
mouse bleomycin IPF models</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In both acute and chronic bleomycin IPF mouse models, expression of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins was higher in bleomycin exposed animals compared to healthy controls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">Dual <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 inhibition decreased
collagen more than <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 or <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 single inhibition in live human IPF lung tissue</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Dual inhibition of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 at 10x IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> significantly decreased expression of <I>COL1A1</I> and other profibrotic genes relative to DMSO vehicle control</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Single inhibition of either <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 at 10x IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> did not show significant decrease in<I> COL1A1</I> expression</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a dose dependent reduction in collagen fiber density in a mouse bleomycin IPF
model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Three weeks of treatment with PLN-74809 utilizing second-harmonic generation resulted in a dose
dependent decrease in collagen fiber density</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Fibrous composite score was significantly reduced
in a dose dependent manner vs. vehicle control</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> decreased <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in chronic bleomycin
mouse model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After two weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> levels of
pSMAD3 were significantly reduced compared to PBS vehicle control</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Post-treatment pSMAD3 levels
were similar to those of healthy controls</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">Inhibition of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 blocked <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in the pulmonary cells of <FONT STYLE="white-space:nowrap">non-human</FONT> primates</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After seven days of treatment with dual <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6
and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 inhibitor pSMAD2 levels were reduced by greater than 75% in pulmonary cells of <FONT STYLE="white-space:nowrap">non-human</FONT> primates</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;An
<FONT STYLE="white-space:nowrap">anti-</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 antibody showed approximately 50% decrease</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Dual inhibition showed a clear PK/PD relationship with maximal pSMAD2 suppression was achieved and
maintained while drug concentrations were in the effective dose range (i.e., above the plasma protein adjusted IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>, or p.a.
IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to all conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 in biochemical assays</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">&#149;&#8195;&#8202;PLN-74809</FONT> binds both bent-closed and extended-open conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1</P></TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced collagen gene expression in live human ILD
lung tissue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In an assay using live lung tissue from five patients with IPF, application of
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> for seven days led to significant decrease of &gt;50% in expression of <I>COL1A1</I>, a key gene responsible for collagen production. The degree of inhibition observed with <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> approaching that of a complete blockade of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
using a direct inhibitor of its <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> type I receptor kinase, also known as ALK5. In contrast, an <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><FONT
STYLE="white-space:nowrap">v&szlig;6-specific</FONT> monoclonal antibody, or mAb, that we synthesized based on publicly available information regarding Biogen&#146;s antibody, 3G9, was unable to significantly inhibit <I>COL1A1</I> <I></I>expression.
In the same assay, using live lung tissue from a patient with systemic sclerosis-associated pulmonary fibrosis, application of PLN-74809 for seven days also led to a decrease of &gt;50% in expression of <I>COL1A1</I>. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g19w26.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Combined inhibition of </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 and
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 provided increased anti-fibrotic activity in live human fibrotic tissue as compared to DMSO vehicle control. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>pSMAD3 was correlated with extractable collagen levels in patients suspected of having IPF </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Open lung biopsies for histologic confirmation of IPF diagnosis were performed in 18 patients with interstitial lung disease, or ILD, who were
suspected of having IPF. As part of this analysis, five controls <FONT STYLE="white-space:nowrap">(non-transplanted</FONT> donor lungs) were also included. Multiple biopsies were taken from different lobes of each lung. Total pSMAD3 and extractable
collagen 1 were measured by western blot. Extractable collagen 1 is thought to be collagen that has been recently formed and has not been cross-linked to the extracellular matrix. Total pSMAD3 and extractable collagen were significantly correlated.
Higher pSMAD3 levels corresponded to higher levels of recently produced collagen. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g69b59.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>pSMAD3 levels are correlated with extractable collagen in lung biopsies from patients </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>suspected of having IPF </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I></I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;6 and
</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 expression is elevated in mouse bleomycin IPF model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We used the
increased expression of both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins in human disease samples to select animal models with similar characteristics which we then
employed for higher-throughput and more extensive testing than would be feasible with primary human tissue. The bleomycin model is the most extensively used model of IPF due to its ability to reproduce many aspects of the disease. The pattern of
expression of integrins suggests that the bleomycin model can serve as a valid preclinical surrogate for evaluating the effects of integrin inhibition in IPF.<B> </B>We confirmed that both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins are upregulated in a mouse model of pulmonary fibrosis induced by exposure to bleomycin. In both acute and chronic versions of this model, expression of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins were higher in bleomycin-exposed animals compared to healthy controls. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g90l67.jpg" ALT="LOGO">
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 and </B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 expression in murine bleomycin model </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Dual </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;6 and </I><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 inhibition decreased collagen more than </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;6 or </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 single
inhibition in live human IPF lung tissue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To further understand the anti-fibrotic effect of single vs. dual integrin inhibition, we
performed assays on live human lung tissue explanted from IPF patients during transplant. We incubated the samples for seven days with either a single selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 small molecule inhibitor, a
single selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 inhibitor (<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 mAb), or a dual selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6/<FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 inhibitor. Dual selective inhibition was accomplished with either <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or a combination of the small molecule
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 inhibitor and the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 mAb. In this assay, we also compared against an inhibitor of the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT>
receptor kinase ALK5, as a positive control. We measured effects on <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> gene expression through the mRNA counts for <I>COL1A1</I>. The small molecule inhibitor of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 and the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 mAb, each dosed at 10x their IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>, failed to show a significant reduction
in <I>Col1a1</I> expression when administered individually. When the small molecule inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 and the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 mAb were incubated as a
combination therapy, <I>COL1A1</I> expression was significantly reduced. PLN-74809 also showed a significant reduction in <I>COL1A1</I> expression. We also evaluated gene expression across a broad panel of additional pro-fibrotic genes. Similar to
<I></I><I>COL1A1</I>, dual inhibition resulted in a greater reduction in gene expression across the panel versus single inhibition. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g86p37.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dual </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6/</B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 inhibition blocked profibrotic gene</B><B><I> </I></B><B>expression more than single inhibition (</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 or </B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1) in live human IPF lung tissue </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>PLN-74809 showed a dose-dependent reduction in collagen fiber density in a mouse
bleomycin IPF model </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluated three doses of PLN-74809 in a mouse bleomycin IPF model utilizing second-harmonic generation to
evaluate the amount of new collagen formation ongoing post-treatment with PLN-74809. We evaluated a range of doses against vehicle control and saw a dose dependent reduction in collagen fiber density and fibrosis composite score. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g56q12.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLN-74809 resulted in a dose-dependent decrease in collagen fiber density in a mouse bleomycin IPF
model as measured through second-harmonic generation </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> decreased <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in chronic bleomycin mouse model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We confirmed through biochemical analyses
that anti-fibrotic efficacy of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in the bleomycin model was due to blockade of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. A key biochemical marker of
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation is the phosphorylation of SMAD2/3. In the bleomycin model, two weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced pSMAD3 levels in a dose-dependent manner
to those seen in control mice that had not been exposed to bleomycin in the acute IPF model. In addition, levels of newly formed collagen, or <FONT STYLE="white-space:nowrap">neo-collagen,</FONT> and total lung collagen as measured by hydroxyproline
content were significantly reduced in a dose-dependent manner in the treatment group. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g09c15.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> blocked
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in a chronic bleomycin model </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ability to measure <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation
through SMAD phosphorylation also provided us with the opportunity to develop SMAD2/3 phosphorylation as a biomarker that correlates with <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrin inhibition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Inhibition of
</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;6 and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 blocked <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in the pulmonary cells of <FONT
STYLE="white-space:nowrap">non-human</FONT> primates </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We conducted a <FONT STYLE="white-space:nowrap">non-human</FONT> primate
study to validate pSMAD as a biomarker for <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation for future clinical studies. Given that this study will not be part of our regulatory package for our lead compound, <FONT
STYLE="white-space:nowrap">PLN-74809,</FONT> we used <FONT STYLE="white-space:nowrap">PLN-75068,</FONT> a close analog to <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> with a similar binding and PK profile for this particular study. In the
first stage of this study, we treated <FONT STYLE="white-space:nowrap">non-human</FONT> primates with <FONT STYLE="white-space:nowrap">PLN-75068</FONT> twice daily, or with the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 mAb at
1&nbsp;mg/kg every other day for seven days. We performed BAL procedures on the monkeys <FONT STYLE="white-space:nowrap">pre-</FONT> and post- treatment and measured pSMAD2 levels in the pulmonary macrophages. BAL fluid collected three hours after
dosing showed a significant reduction of pSMAD2 levels when compared to <FONT STYLE="white-space:nowrap">pre-treatment</FONT> levels. The <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 mAb showed pSMAD2 level reduction as well, but the
effect was less pronounced than for <FONT STYLE="white-space:nowrap">PLN-75068.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g06j64.jpg" ALT="LOGO">
<B></B> </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BID Dosing of <FONT STYLE="white-space:nowrap">PLN-75068</FONT> reduced pSMAD2 levels in <FONT
STYLE="white-space:nowrap">non-human</FONT> primate alveolar fluid </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A second stage of this study was designed to evaluate the
PK/PD relationship between <FONT STYLE="white-space:nowrap">PLN-75068</FONT> and the inhibition of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. In this stage, we dosed monkeys at either a low or high dose once a day for seven
days. We designed the study to obtain multiple BAL measurements after the last treatment in order to understand how changes in the pSMAD2 levels relate to serum levels of <FONT STYLE="white-space:nowrap">PLN-75068.</FONT> Dosing of <FONT
STYLE="white-space:nowrap">PLN-75068</FONT> in <FONT STYLE="white-space:nowrap">non-human</FONT> primates showed a decrease in the pSMAD2 levels at both doses. Soon after dosing, when drug concentrations were at their peak, the levels of pSMAD2
levels showed a reduction of more than 75&nbsp;percent. As the drug concentration decreased, pSMAD2 levels gradually returned to baseline levels. Importantly, both dosing groups resulted in similar levels of pSMAD2 level reduction; however, the
higher dose stayed in the effective dose range longer, and therefore maintained pSMAD2 level reduction for a longer period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g40z73.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QD dosing of <FONT STYLE="white-space:nowrap">PLN-75068</FONT> reduced pSMAD2 levels </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to all conformations of
</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;6 and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 in biochemical assays </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Integrins are cellular adhesion proteins having a high degree of structural flexibility with two predominant forms: an extended form with high
affinity for binding to ligands, and a bent or closed form in which the ligand binding domain has low affinity for binding to ligands. The conformation of the integrin can also dramatically alter the binding of potential therapeutics such as
antibodies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Biochemical profiling of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> confirms that it can inhibit both <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins in both the high-affinity, extended open conformation as well as in the lower-affinity, bent closed conformation and thus has the
potential to block integrin interactions regardless of the initial state of the receptor. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g16d60.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to both high-affinity and low-affinity
conformations of </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 and </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical data in PSC </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#4b61a8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Summary Preclinical Data in PSC</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#4b61a8"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Preclinical Findings</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#4b61a8" STYLE=" BORDER-LEFT:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Observations</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are overexpressed in human
PSC liver tissue as well as a mouse model of PSC</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;We confirmed that the widely used <I>Mdr2</I> knockout PSC mouse model shows upregulation of
both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1, similar to our observations in diseased tissue from PSC patients</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a dose dependent reduction in fibrosis in a mouse PSC model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> resulted in a
significant dose-dependent reduction in fibrosis compared to vehicle treated mice</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;pSMAD3
levels were also significantly reduced in a dose-dependent manner</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced cholestasis markers in PSC model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> at the
highest dose tested, we observed a significant reduction of alkaline phosphatase and total bilirubin</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">PLN-74809 decreased <I>COL1A1</I> expression in live human PSC and PBC liver tissue samples more than OCA</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After two days incubation with PLN-74809 we observed dose-dependent reductions in <I>COL1A1</I>
gene expression in live liver samples from a PSC patient and a PBC patient after transplant</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Incubation with OCA did not achieve the same level of reduction of <I>COL1A1</I> expression as
PLN-74809</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I></I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;6 and </I><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 are overexpressed in human PSC liver tissue as well as a mouse model of PSC </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to our approach in diseased tissue from an IPF patient, we examined the expression patterns of integrins in live, diseased tissue
obtained from a patient with PSC. We found that both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrins are overexpressed in these tissues. We then went to the standard
animal model for PSC based on a deletion of the <I>Mdr2</I> gene in mice<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>and confirmed that in this model both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;6 and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are overexpressed compared to normal control mice. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g729258g39k78.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Both </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;6 and </B><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 are overexpressed in a </B><B><I>Mdr2</I></B><B> knockout model of PSC </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a dose dependent reduction in
fibrosis in a mouse PSC model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In <I>Mdr2</I>-deficient mice that have developed biliary fibrosis resembling PSC, dosing with <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> for six weeks resulted in a significant, dose-dependent reduction in fibrosis compared to vehicle treated mice. Similar results were observed whether the analyses were based on collagen levels as measured
by hydroxyproline, pSMAD3 levels or histological staining. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g08x81.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed reduction of fibrosis in the
</B><B><I>Mdr2</I></B><B> deficient PSC model </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g729258g96g32.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed improved histology score in the
</B><B><I>Mdr2</I></B><B> deficient PSC model </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced cholestasis liver biomarkers in
PSC model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treatment of <I>Mdr2</I>-deficient mice with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> also reduced in a
dose-dependent manner serum levels of alkaline phosphatase and total bilirubin compared to vehicle controls. Both are markers of cholestasis. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g06h77.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced cholestasis markers in PSC model </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>PLN-74809 decreased COL1A1 expression in live human PSC and PBC liver tissue samples more than OCA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We assessed the anti-fibrotic activity of our integrin inhibitors using liver samples obtained from a PSC patient and a PBC patient. We used <FONT
STYLE="white-space:nowrap">precision-cut</FONT> tissue slices to establish <I>ex vivo</I> tissue culture samples that mimic the multicellular characteristics of organs. The use of these <FONT STYLE="white-space:nowrap">precision-cut</FONT> tissue
culture assays not only provides the opportunity to assess the effects of our compounds directly on diseased human tissue, but also allows this to be done in a three-dimensional, multicellular context that better represents the complexity of the
diseased tissue environment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g50q98.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Assessing anti-fibrotic activity of compounds in live human liver fibrosis tissue </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Live tissue samples from a PSC patient and a PBC patient were incubated for two days with varying concentrations of PLN-74809 and obeticholic
acid, or OCA, a drug approved for the treatment of PBC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Incubation with PLN-74809 led to a significant dose-dependent decrease of <I>COL1A1 </I>expression, while incubation with OCA did not. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g68h73.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> blocked fibrosis in live human PSC and PBC liver
tissue </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> for the treatment of liver fibrosis and NASH </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is a selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrin
that we are developing for the treatment of stage F3/F4 liver fibrosis in patients with NASH. <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is a bioavailable inhibitor that has shown anti-fibrotic activity in multiple animal models of liver
fibrosis as well as in live human NASH fibrotic liver tissue. In October 2019, we entered into a license and collaboration agreement with Novartis under which Novartis received global rights to develop and commercialize PLN-1474 for NASH associated
liver fibrosis. We are currently conducting a Phase 1 trial of PLN-1474 in healthy volunteers. Novartis will reimburse us for all development activities associated with the Phase 1 trials, and will be responsible for all development and
commercialization following Phase 1. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Background on liver fibrosis and NASH </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NASH is a severe form of NAFLD that is associated with the development of liver fibrosis and potentially life-threatening liver dysfunction.
NAFLD is characterized by increased amounts of fat in the liver, or steatosis. NAFLD is believed to occur due to a combination of factors including high caloric diet, obesity and metabolic syndrome, type 2 diabetes mellitus and genetics. Early
stages of the disease often have no symptoms other than slightly elevated or fluctuating levels of liver enzymes in some patients. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
excess fat builds up in the liver, it can eventually cause lipotoxicity, resulting in inflammation in the liver and leading to injury of hepatocytes, known as ballooning. It is this combination of steatosis, inflammation and hepatocellular
ballooning that defines NASH. Over time, NASH can lead to fibrosis of the liver. Fibrosis can progress to cirrhosis, resulting in impaired liver function and increased risk of liver-related complications and mortality. In fact, liver fibrosis is an
independent predictor of liver-related morbidity and <FONT STYLE="white-space:nowrap">all-cause</FONT> mortality in NASH. There are currently no FDA approved therapies for NASH, and to date investigational NASH therapies have only shown modest
anti-fibrotic benefits in published clinical trials. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is estimated that 30 to 40&nbsp;percent of adults in the United States have
NAFLD and approximately 30&nbsp;percent of these patients, or up to 12&nbsp;percent of adults, will develop NASH. NASH is already highly prevalent, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affecting approximately 16.5&nbsp;million adults in the United States with approximately 3.3&nbsp;million at stage F3/F4 liver fibrosis. NASH is a growing problem with U.S. cases expected to top
27&nbsp;million by 2030, with approximately eight million at stage F3/F4 liver fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While NASH is becoming more common in the
general population, identifying patients with increased risk of liver-related morbidity and mortality is important for clinical management. While steatosis, inflammation and hepatocellular ballooning are the measures used to diagnose NASH, to date,
the presence and severity of liver fibrosis is the only proven independent predictor of poor clinical outcomes in NASH. Cirrhosis associated with NASH is the fastest growing indication for liver transplantation in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approximately 10 to 15&nbsp;percent of NASH patients will ultimately progress to cirrhosis over time. On average, these patients advance one
fibrosis stage every seven years. NASH patients, regardless of stage of fibrosis, have an estimated annual mortality rate of 1.5 to 3.5&nbsp;percent per year, mostly due to cardiovascular complications. However, when patients progress to stage F2
fibrosis or greater, liver-related complications become the highest risk for mortality. Each progressive stage of fibrosis correlates to a dramatic increase in liver-related mortality risk. Moreover, patients with F3 and F4 fibrosis carry
liver-related mortality risk that is 17 times and 42 times greater, respectively, than NASH patients without fibrosis. We believe treatments with a potent anti-fibrotic effect would be more likely to have a meaningful impact on clinical outcomes for
NASH patients with F3 to F4 fibrosis. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g66o21.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Stages of liver fibrosis </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are currently no FDA approved therapies for the treatment of NAFLD or NASH. Lifestyle changes and exercise to reduce body weight and
treatment of concomitant diabetes and dyslipidemia comprise the cornerstone of treatment but are not sustainable in the majority of patients. For patients with cirrhosis, liver transplantation is the only potential treatment option, but transplant
livers are not widely available, and only a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
minority of these patients will be eligible for a transplant due to the risks, costs and complexities associated with the procedure. NASH is the second leading indication for liver
transplantation in the United States, but is also the most rapidly growing indication and is expected to eventually overtake alcoholic liver disease as the largest driver of liver transplant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are many candidates in development for the treatment of NASH that target various aspects of the disease. A number of these candidates
are directed at reducing the underlying causes of the disease such as obesity and diabetes or addressing fat accumulation in the liver by altering lipid metabolism. Other candidates are focused on suppressing the inflammatory stage of NASH with the
intent of preventing the progression of fibrosis. To date, only modest improvements in liver fibrosis stage or severity have been reported with investigational compounds evaluated in patients with NASH. Our approach is to directly target the
fibrosis pathway with the goal of preventing progression or reversing advanced fibrosis (F3/F4). Given <FONT STYLE="white-space:nowrap">TGF-</FONT> &szlig;&#146;s central role to fibrosis pathophysiology, we believe that directly targeting the <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation pathway via <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 integrin inhibition holds the potential to provide a more clinically meaningful anti-fibrotic effect than current
investigational therapies, and ultimately prevent disease progression to cirrhosis and liver related complications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our solution, <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is a bioavailable, small-molecule,
selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 mediated <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. We are developing <FONT STYLE="white-space:nowrap">PLN-1474</FONT> as an anti-fibrotic therapy
for patients with F3/F4 stage liver fibrosis associated with NASH. We have shown that in human fibrotic liver tissue from patients with NASH that the levels of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 are significantly elevated in
tissue from patients with stage 4 fibrotic disease. Overexpression of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 is correlated with <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation as measured by pSMAD3 levels. Therefore,
we believe a single-selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 is a promising and differentiated approach to treating NASH associated liver fibrosis. In October of 2019, we entered into a license and collaboration
agreement with Novartis through which Novartis obtained a global license to PLN-1474. We are currently conducting a Phase 1 trial with PLN-1474 in healthy volunteers and expect data in the second half of 2020. Novartis will reimburse us for all
development activities associated with the Phase 1 trials, and will be responsible for all development and commercialization following Phase 1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical data </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#4b61a8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Summary of Preclinical Data in NASH</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#4b61a8"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Preclinical Findings</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#4b61a8" STYLE=" BORDER-LEFT:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Observations</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 and <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation are upregulated in
human F4 NASH liver biopsies</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Levels of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 and pSMAD3 levels are both
significantly elevated in tissues from patients with stage F4 liver fibrosis</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Levels of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 and pSMAD3 levels are highly correlated in NASH liver biopsies</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is associated with anti-fibrotic activity in live human fibrotic NASH liver tissue</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After two days incubation with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> we observed a
significant reduction in <I>COL1A1</I> gene expression in live liver samples from three NASH patients after transplant</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Gene expression of <I>TIMP1</I>, a strong predictor of mortality in patients with fibrosis, was
also reduced after incubation</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in a broad decrease in expression of
<FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes in an abbreviated mouse model of NASH</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In an abbreviated <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> mouse NASH model, after 3
weeks of treatment, mice treated with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> showed decreased expression of a broad set of profibrotic genes relative to vehicle controls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> showed dose-dependent reduction of fibrosis in NASH and liver fibrosis mouse models</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> resulted in a
significant dose-dependent decrease in expression of <I>Col1a1</I> and <I>Col1a2</I> as well as hydroxyproline in a <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> NASH mouse model</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After one week of treatment with <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> we observed
significant dose-dependent reductions in <I>Col1a1</I>, <I>Col1a2</I> and <I>Col3a1</I> in a CCL<SUB STYLE="font-size:85%; vertical-align:bottom">4</SUB> liver fibrosis mouse model</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> decreased collagen fiber density and characteristics via 2nd harmonic generation analysis in a
NASH fibrosis model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> utilizing 2<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP> harmonic generation, resulted in a dose-dependent decrease in collagen fiber density and fibrosis composite score in a <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> NASH mouse model</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> potently binds to all conformations of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">&#149;&#8195;&#8202;PLN-1474</FONT> binds both bent-closed and extended-open conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1</P></TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 and TGF-</I>&szlig;<I>
activation are upregulated in human F4 NASH liver biopsies</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We measured <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 protein
expression and pSMAD3 levels in a group of late-stage liver fibrosis biopsies. In F4 biopsies, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 was significantly overexpressed relative to F0/F1 biopsies. Similarly, the pSMAD3 levels were also
significantly elevated in F4 biopsies compared to F0/F1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g01c33.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;1 and pSMAD3 levels are both
upregulated in F4 liver fibrosis </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is associated with anti-fibrotic activity in
live human fibrotic NASH liver tissue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We assessed the anti-fibrotic activity of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> in
live human NASH liver tissue. Precision cut tissue slices from multiple F4 NASH livers treated with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> exhibited a mean 50&nbsp;percent reduction in the levels of <I>COL1A1</I> expression compared to
vehicle treated controls. In the <FONT STYLE="white-space:nowrap">PLN-1474</FONT> treated tissue slices, we also saw a significant reduction in the gene expression of <I>TIMP1</I>, which encodes the tissue inhibitor of metallopeptidase, or TIMP-1.
In a recent study, <FONT STYLE="white-space:nowrap">TIMP-1</FONT> was shown to be a strong predictor of <FONT STYLE="white-space:nowrap">all-cause</FONT> mortality in patients with fibrosis. <FONT STYLE="white-space:nowrap">TIMP-1</FONT> is one of
the three components of the Enhanced Liver Fibrosis, or ELF, score, a <FONT STYLE="white-space:nowrap">non-invasive</FONT> clinical diagnostic test to assess the likelihood of having clinically significant fibrosis. These results suggest that
selective inhibition of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 could have clinically meaningful anti-fibrotic activity in NASH patients with advanced fibrosis. </P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g02m36.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> significantly reduced </B><B><I>COL1A1</I></B><B>
and </B><B><I>TIMP1</I></B><B> gene expression in human NASH liver tissue </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT>
resulted in a decrease in expression levels of a broad panel of <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes in an abbreviated mouse model of NASH </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mice were treated prophylactically with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> for 3 weeks in an abbreviated <FONT
STYLE="white-space:nowrap">CDA-HFD</FONT> mouse NASH fibrosis model. A broad panel of profibrotic genes showed decreased expression in mice treated with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> relative to mice that were treated with a
vehicle control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Profibrotic Gene Expression After Treatment with PLN-1474 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03w96.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in decreased expression of
a broad set of profibrotic genes in a <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> mouse NASH liver fibrosis model </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">PLN-1474</FONT> showed dose-dependent reduction of fibrosis in NASH and liver fibrosis mouse models </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
tested the ability of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> to inhibit fibrosis in a mouse model of NASH induced by a choline-deficient high fat diet. Treatment of these mice for six weeks, beginning at week five of the high fat diet,
resulted in a dose-dependent reduction in collagen production as measured by hydroxyproline levels compared to vehicle-treated controls. Similar dose-dependent decreases in the expression of <I>Col1a1</I> genes and picrosirius red staining, a
histologic marker for fibrosis, were observed after treatment with <FONT STYLE="white-space:nowrap">PLN-1474.</FONT> Treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> also led to decreases in pSMAD3 levels indicating that <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> was able to block <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. </P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g04z63.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> inhibits fibrosis in NASH fibrosis model </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> also inhibited fibrosis in an acute CCl<SUB
STYLE="font-size:85%; vertical-align:bottom">4</SUB> model of liver fibrosis. In this model, liver fibrosis in mice is induced by two weeks of exposure to CCl<SUB STYLE="font-size:85%; vertical-align:bottom">4.</SUB> Treatment with <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> for one week reduced the expression of <I>Col1a1</I>, C<I>ol1a2</I> and <I>Col3a1</I> compared to vehicle-treated controls. Treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> also reduced <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling to baseline levels as measured by pSMAD3 levels. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the chronic version of the
CCL<SUB STYLE="font-size:85%; vertical-align:bottom">4</SUB> model, fibrosis is induced by 21 days of exposure to CCl<SUB STYLE="font-size:85%; vertical-align:bottom">4</SUB>. Treatment of these mice with
<FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in significant reductions in the expression of collagen genes beginning as soon as two hours after dosing. These results suggest that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> has the
potential to lead to significant and rapid changes in fibrosis even in livers containing extensive and established fibrotic lesions. </P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g14d54.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> inhibited collagen expression in a chronic CCl<SUB
STYLE="font-size:85%; vertical-align:bottom">4</SUB> liver fibrosis model </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT> decreased collagen fiber density and
characteristics via second-harmonic generation analysis in a NASH fibrosis model </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluated three doses of <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> in a NASH fibrosis mouse model utilizing second-harmonic generation to evaluate the amount of new collagen formation ongoing post-treatment with <FONT STYLE="white-space:nowrap">PLN-1474.</FONT> We
evaluated a range of doses against placebo in a NASH fibrosis model and saw a dose-dependent reduction in collagen fiber density and fibrosis composite score. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g51k61.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in a dose-dependent decrease in collagen
fiber density in a NASH fibrosis model as measured through second-harmonic generation </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT> potently binds to all conformations of
</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I>v&szlig;1 </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to our observations with
<FONT STYLE="white-space:nowrap">PLN-74809,</FONT> we have shown that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> binds to both the higher-affinity, extended open conformation of integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1
as well as the lower-affinity, bent closed conformation and thus has the potential to block integrin interactions regardless of the state of the receptor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Planned clinical development of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently enrolling a Phase 1 trial of PLN-1474 in healthy volunteers. This trial will evaluate safety and tolerability as well as PK of
PLN-1474. Once the Phase 1 trial is complete, Novartis will take over the program and be responsible for further development of PLN-1474 in NASH associated liver fibrosis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Applying our fibrosis expertise in developing additional products </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are pursuing potential uses of our existing product candidates, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and <FONT
STYLE="white-space:nowrap">PLN-1474,</FONT> in additional fibrotic indications. We use our precision cut human fibrotic tissue assays in addition to our animal model data to inform our clinical development programs and potentially select additional
indications where we think our pipeline candidates could have an effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our mission is to advance the understanding of fibrosis by
building a biology-, chemistry- and screening-based engine to drive drug development across the spectrum of fibrotic diseases. While our initial focus is on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
small-molecule integrin inhibitors in lung and liver fibrosis, we are actively pursuing additional treatment modalities across fibrosis indications in multiple different organs. We have
identified other potential <FONT STYLE="white-space:nowrap">non-integrin</FONT> targets related to <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling as well as other pathways across multiple fibrosis indications, such as regulators of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">epithelial-to-mesenchymal</FONT></FONT> transition, a critical process in fibrosis. In addition, while our initial focus is on small-molecule drug candidates, we are agnostic to treatment
modalities in the development of our pipeline. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our oncology program-TGF-&szlig; signaling in the tumor microenvironment
</I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past several years, the checkpoint inhibitor class of immuno-oncology drugs has changed the way many cancers are treated.
Checkpoint inhibitors work to block signals that prevent the body&#146;s immune system from recognizing tumor cells. By blocking checkpoint signals such as PD-1, these drugs have the ability to sensitize T-cells, allowing them to recognize and kill
tumor cells. While checkpoint inhibitors have led to dramatic improvements in survival rates for certain cancer indications, there are still a significant proportion of patients who do not respond to the drugs. Much effort is being devoted to
understanding the root causes of checkpoint inhibitor resistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As TGF-&szlig; biology has been elucidated, it has become increasingly
understood in the scientific literature that TGF-&szlig; plays an important anti-inflammatory role in the tumor microenvironment. One of TGF-&szlig;&#146;s core physiologic roles is an anti-inflammatory effect that it provides in the wound healing
process. In the tumor microenvironment, however, certain integrins, such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8, can be overexpressed on multiple different cell types, resulting in increased activation and signaling of
TGF-&szlig;. This over activation of TGF-&szlig; can lead to a strong anti-inflammatory effect in the tumor microenvironment, resulting in decreased T-cell infiltration and decreased release of pro-inflammatory cytokines such as granzyme B and
interferon <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT>. This mechanism is becoming increasingly recognized as a potential cause of the resistance to checkpoint inhibitors such as
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> therapies seen in many tumors. We are targeting TGF-&szlig; activating integrins such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8 that are
upregulated in certain tumors with the goal of removing the anti-inflammatory effect and, ultimately, sensitizing tumors to checkpoint inhibitors. This program has generated positive data in preclinical tumor models and is currently in the
lead-optimization phase of development. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g19e55.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Integrin Upregulation in the Tumor Microenvironment </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are developing small molecule inhibitors against <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8 as well as other
TGF-&szlig;-activating integrins that have been shown to be upregulated in the tumor microenvironment. We have shown in an EMT6 anti-PD-1 resistant tumor mouse model that our small molecule inhibitors of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8-mediated TGF-&szlig; activation are able to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sensitize tumors to anti-PD-1 therapy and extend survival. Additionally, our molecules perform similarly to monoclonal antibodies against the
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8 integrin receptor. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g75w00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Small Molecule </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B>v&szlig;8 Inhibitors Enhanced
PD-1 Activity in an EMT6 Anti-PD-1 Resistant Mouse Tumor Model </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently in lead-optimization stage of our oncology program
developing small molecule inhibitors of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;8 targeting multiple potential PD-1 resistant tumor types. We have identified multiple potent and selective molecules and plan to nominate a developmental
candidate in 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Our</I></B><I></I><B><I> Muscular Dystrophy Program</I></B><I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Muscular Dystrophy comprises a group of inherited diseases, all characterized by inborn errors in dystrophin, a protein that anchors muscle
cells to the extracellular matrix, or ECM, and facilitates contraction of skeletal muscles. Mutations in the gene that codes for dystrophin can cause the dystrophin protein to be misshapen and ineffective in anchoring the muscle cell to the
extracellular matrix. The lack of dystrophin anchoring results in damage to skeletal muscle cells upon contraction. Over time, muscle cells are unable to regenerate, and are eventually replaced by fat and fibrosis, resulting in loss of muscle
function. Severe forms of muscular dystrophy cause progressive weakening of the heart and diaphragm, leading to death. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The most common
form of muscular dystrophy is Duchenne muscular dystrophy, or DMD, which affects 1 in 3,500 boys worldwide. Disease progression varies, usually presenting with muscle weakness around age four. Most DMD patients need a wheelchair by age 12, with most
dying in their 20&#146;s. DMD is caused by mutations to the DMD gene, which codes for dystrophin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treatment for DMD is mostly focused on
mitigating the symptoms. Aggressive management of dilated cardiomyopathy with anti-congestive medications is used, including cardiac transplantation in severe cases. Assistive devices for respiratory complications may be needed, especially at night.
The steroid prednisone is given to improve the strength and function of individuals with DMD. Prednisone has been shown to prolong the ability to walk by 2 to 5 years. While a new treatment, etiplirsen, was recently approved in a subset of patients,
this remains an area of tremendous unmet medical need. There are a number of novel modalities such as gene therapy and CRISPR being explored as potential treatments for DMD, but they remain years from approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have identified a target integrin receptor that acts as a natural compensatory mechanism that anchors the muscle cell to the ECM in DMD, as
well as other types of muscular dystrophy. It is expressed on the surface of skeletal muscle cells and has been shown to be upregulated in patients with muscular dystrophy. The target </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
integrin is able to bind to laminin in the ECM and serve as a substitute for the dystrophin complex that normally holds muscle cells to the ECM. This compensatory mechanism serves to stabilize
the muscle cell membrane, which decreases muscle damage upon contraction. Moreover, mutations in this integrin, or in the laminin protein that it binds to, have been reported, and result in congenital myopathies with phenotypes similar to those of
muscular dystrophy. Like other integrins, our integrin target can exist in various conformations, some of which are active, and others that are not. The natural compensatory ability of the target is limited by the number of integrin receptors in the
active conformation at any given time. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g44e96.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our muscular dystrophy program utilizes an allosteric, agonistic, monoclonal antibody which binds to the
alpha subunit of the target integrin and stabilizes it in its active conformation. By maximizing the number of target integrins that are active, the mAb is designed to increase the overall binding of the muscle cell membrane to the ECM and to
stabilize the membrane. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g21y89.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Allosteric agonistic monoclonal antibody binds to the inactive integrin inducing conformational change
increasing laminin binding </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed a humanized antibody that is highly potent and selective for the alpha subunit of the
target integrin. Our mAb candidate has been tested in an mdx /DBA2 DMD mouse model where it showed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
significantly decreased muscle damage as measured through clinical biomarkers including serum creatinine kinase and troponin. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g95c69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Treatment with mAb resulted in decreased muscle damage in a mdx/DBA2 mouse model </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to protecting against muscle damage, the antibody showed an increase in diaphragm contractility in the mice tested. The antibody
was able to return diaphragm contractility to near the same level as the wild type controls. This is crucial, given that the primary cause of death in patients with muscular dystrophy is cardiopulmonary failure resulting from progressive wasting of
cardiac and respiratory muscles. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g65k14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Agonistic mAb restored diaphragm force back to the same level as wild type control </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lastly, our mAb showed a reduction in hydroxyproline levels in the gastrocnemius muscles of the test mice, suggesting less fibrosis in the
muscles, possibly as a result of decreased muscle damage. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g61n50.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Agonistic mAb significantly reduced collagen content in gastrocnemius muscles of treated mice </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have nominated a development candidate and are currently conducting CMC scale-up activities. We plan to initiate IND enabling studies in
2021. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
biotechnology and biopharmaceutical industries are characterized by rapidly advancing technologies, strong competition and an emphasis on proprietary products. While we believe that our technology, knowledge, experience and scientific personnel
provide us with competitive advantages, we face substantial competition from many different sources, including larger pharmaceutical companies with greater resources. Smaller specialty biotechnology and biopharmaceutical companies, academic research
institutions, governmental agencies, as well as public and private institutions are also potential sources of competitive products and technologies, including through collaborative arrangements with large and established biopharmaceutical companies.
We also face competition in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and enrolling patients for clinical trials, and acquiring technologies complementary to, or necessary for, our
programs. We believe that the key competitive factors affecting the success of any of our product candidates will include efficacy, safety profile, convenience, method of administration, cost, level of promotional activity and intellectual property
protection. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are currently a number of companies targeting the treatment of various fibrosis indications through inhibiting
various parts of the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> pathway, including AbbVie Inc., Gilead Sciences, Inc., Indalo Therapeutics, Inc., FibroGen Inc., Galapagos NV, Bristol Myers Squibb Co., or BMS, Biogen Inc., and Novartis AG.
However, we know of no other companies currently in clinical development with a bioavailable small-molecule, selective integrin inhibitor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although our novel approach is unique from most other existing or investigational therapies
across the disease areas where we are focusing our development, we will need to compete with currently approved therapies, and potentially those in currently in development if they are approved. We are aware of several marketed and investigational
products in our leading disease areas, including but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>IPF:&nbsp;</I>There are currently two approved products for the treatment of IPF; Esbriet, marketed by Roche
Holding AG, and Ofev, marketed by Boehringer Ingelheim GmbH.&nbsp;Other companies currently developing product candidates in IPF include AbbVie, Galapagos, Indalo, Kadmon Holdings, Inc., Biogen, Prometic Life Sciences, Inc. and Promedior, Inc.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>PSC</I>:<I>&nbsp;</I>There are currently no approved therapies for the treatment of PSC.&nbsp;Companies
currently developing product candidates in PSC include Gilead, Allergan plc, NGM Biopharmaceuticals, Inc., or NGM, and Intercept Pharmaceuticals, Inc.. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>NASH:&nbsp;</I>There are currently no FDA approved therapies for the treatment of NASH.&nbsp;There are a
number of companies developing product candidates for the treatment of NASH including Intercept, Pfizer Inc., Gilead, Allergan, Novartis, AstraZeneca plc, Eli Lilly &amp; Company, GlaxoSmithKline plc, Amgen, Inc., BMS, Johnson &amp; Johnson, Merck
&amp; Co., Inc., Roche, Sanofi S.A., Takeda Pharmaceuticals, Novo Nordisk, Genfit SA, Madrigal Pharmaceuticals, Inc., Viking Therapeutics, Inc., Cirius Therapeutics, Inc., NGM, Akero Therapeutics, Inc., Conatus Pharmaceuticals Inc. and Metacrine,
Inc..&nbsp;Most of the drugs currently in development for NASH are focused on decreasing liver fat or improving liver inflammation as opposed to direct liver anti-fibrotic approaches. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability of reimbursement from government and other third-party payors will also significantly affect the pricing and competitiveness
of our product candidates, if approved for marketing. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we do, which could result in our competitors establishing a strong market position before we
are able to enter the market. </P>   <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We strive
to protect and enhance the proprietary technology, inventions, and improvements that are commercially important to the development of our business, including seeking, maintaining, and defending patent rights, whether developed internally or licensed
from third parties. We also rely on trade secrets relating to our proprietary technology platform and on <FONT STYLE="white-space:nowrap">know-how,</FONT> continuing technological innovation and <FONT STYLE="white-space:nowrap">in-licensing</FONT>
opportunities to develop, strengthen, and maintain our proprietary position in the field of fibrosis that may be important for the development of our business. We additionally may rely on regulatory protection afforded through data exclusivity,
market exclusivity, and patent term extensions, where available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial success may depend in part on our ability to: obtain and
maintain patent and other proprietary protection for commercially important technology, inventions and <FONT STYLE="white-space:nowrap">know-how</FONT> related to our business; defend and enforce our patents; preserve the confidentiality of our
trade secrets; and operate without infringing the valid enforceable patents and proprietary rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell, or importing our products may depend on the extent
to which we have rights under valid and enforceable licenses, patents, or trade secrets that cover these activities. In some cases, enforcement of these rights may depend on third party licensors. With respect to both licensed and company-owned
intellectual property, we cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any of our existing patents or
any patents that may be granted to us in the future will be commercially useful in protecting our commercial products and methods of manufacturing the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 1, 2020, we own or license over 30 pending patent applications, worldwide, including in the United States and corresponding
foreign patent applications. At least four pending patent applications have been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
filed in the United States or corresponding foreign jurisdictions by or on behalf of the Regents of the University of California, which have granted us exclusive license rights to the technology.
To date, two patents have issued to us or to our licensors. Our policy is to file patent applications to protect technology, inventions and improvements to inventions that are commercially important to the development of our business. We seek United
States and foreign patent protection for a variety of technologies, including: research compounds and methods, candidate compounds and antibodies for modulating the activity of integrins, methods for treating diseases of interest, and methods for
manufacturing our products. We also intend to seek patent protection or rely upon trade secret rights to protect other technologies that may be used to discover and validate targets and that may be used to identify and develop novel products. We
seek protection, in part, through confidentiality and proprietary information agreements. We are a party to various other license agreements that give us rights to use specific technologies in our research and development. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Company Owned IP </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We own multiple families of patent applications that are directed to small-molecule compositions capable of modulating integrins and methods
for treating or preventing diseases associated with integrins. Certain applications in these families relate to our <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and <FONT STYLE="white-space:nowrap">PLN-74809</FONT> small-molecule product
candidates, backup compounds and structural analogs, various unit dosages, dosing regimens, and routes of administration. We are also pursuing innovative ways to modulate integrin function using antibodies, and have one pending patent application to
that technology in the United States. Patents that may issue from these company owned applications are generally expected to expire between the years 2037 to 2040, subject to possible patent term adjustment and/or extension. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Licensed IP </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have obtained an exclusive license from the Regents of the University of California to two patent families, which are expected to expire in
2034 and 2036, respectively. Included in these families are two issued U.S. patents with claims directed to small-molecule integrin inhibitors and methods of using such inhibitors for treating fibrotic and other diseases, as well as related patent
applications that are pending in Canada and Europe. The molecules currently being developed by us as product candidates are not within the scope of the agreement with the Regents of the University of California. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Trademark Protection </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have two registered U.S. trademarks for use in connection with our products. We may pursue additional registrations for future products in
markets of interest. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Trade Secret Protection </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Finally, we may rely, in some circumstances, on trade secrets to protect our technology. We seek to protect our proprietary technology and
processes, in part, by entering into confidentiality agreements with our employees, consultants, scientific advisors, and contractors. We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical
security of our premises and physical and electronic security of our information technology systems. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the above, we have
established expertise and development capabilities focused in the areas of preclinical research and development, manufacturing and manufacturing process development, quality control, quality assurance, regulatory affairs, and clinical trial design
and implementation. We believe that our focus and expertise will help us develop products based on our proprietary intellectual property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>License Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Novartis Collaboration and License Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, we entered into a collaboration and license agreement, or the Novartis Agreement, with Novartis Institutes for Biomedical
Research, Inc., or Novartis, for the research, development and commercialization of PLN-1474, and up to three additional integrin targets, or the Research Targets. Under the terms of the Novartis Agreement, we will be responsible for the clinical
development and manufacture of PLN-1474 through the first-in-human study and Novartis will then be responsible for all future development, manufacturing and commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the research term, which shall initially be three years and extendable, we will collaborate, through a joint steering committee, with
Novartis on up to three separate research programs, to biologically validate certain potential Research Targets and identify and synthesize potential research compounds for each Research Target in accordance with the applicable research plan. We
will be responsible for advancing product candidates targeting selected Research Targets to development candidate stage and Novartis will then be responsible for all future development, manufacturing and commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also granted to Novartis an (i) exclusive (even as to us), transferable, sublicensable license to certain of our technology to
commercialize licensed products in the field and (ii) co-exclusive (with us), transferable, sublicensable license to research, develop and manufacture certain licensed compounds and licensed products for disease treatment worldwide. Upon the
completion of the first Phase 1 study, such co-exclusive license shall become exclusive for Novartis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the
Novartis Agreement, we have granted to Novartis and its affiliates an (i) exclusive (even as to us), transferable, sublicensable license to certain of our technology to commercialize certain research products in the field and (ii) a coexclusive
(with us), transferable, sublicensable license to develop, manufacture, and commercialize certain selected research compounds and research products for disease treatment worldwide. Upon the selection of relevant candidate small molecule compound
selective modulator, such co-exclusive license shall become exclusive for Novartis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis paid us a nonrefundable, non-creditable
one-time payment of $50.0 million as an initial license fee in October 2019. Novartis will also pay us a certain specified target validation fee for each candidate target that achieves target validation and is deemed a research target, for up to
three candidate targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis shall also pay us certain development and commercialization milestone payments, in total up to $200.0
million for the licensed products, and up to $68.0 million for the research targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis shall also pay us tiered royalties, on a
product-by-product basis based on annual nets sales of products at percentages ranging from high-single digits to low-double digits of the applicable licensed products and mid-single digits to high-single digits for the applicable research products.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless earlier terminated, the Novartis Agreement will expire upon the expiration of all royalty obligations. The royalty period will
expire on a product-by-product and country-by-country basis upon the later of (i) ten years from the first commercial sale, (ii) the expiration of all regulatory or data exclusivity and (iii) the expiration of the last-to-expire valid patent claim.
Novartis has the right to terminate the Novartis Agreement for convenience on a target-by-target basis upon sixty (60) days&#146; prior written notice, so long as such right is exercised prior to the first commercial sale of any licensed product or
research product with respect to the applicable target. After the first commercial sale, Novartis has the right to terminate the Novartis Agreement for convenience on a target-by-target basis upon six (6) months&#146; prior written notice. We may
not terminate the agreement for convenience. Either we or Novartis may terminate the Novartis Agreement if the other party is in material breach and such breach is not cured within the specified cure period. In addition, either we or Novartis may
terminate the Novartis Agreement in the event of specified insolvency events involving the other party. If </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
we terminate the agreement as a result of Novartis&#146; uncured material breach or Novartis terminates at will, we retain a royalty-bearing, non-exclusive license to certain Novartis technology
in order to develop, manufacture and commercialize certain compounds and products as set forth in the Novartis Agreement, subject to certain conditions. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adimab Collaboration Agreement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2018, we entered into a collaboration agreement, or the Adimab Agreement, with Adimab, LLC, or Adimab, for the discovery and optimization of proprietary antibodies as potential therapeutic product candidates. Under the Adimab Agreement, we
have initially agreed with Adimab to collaborate on an initial research program. In addition, we may select up to three additional biological targets against which Adimab will use its technology to research and develop antibodies pursuant to a
mutually agreed upon research plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the ongoing research period and for a specified evaluation period thereafter, or the
Evaluation Term, Adimab will grant us a worldwide, <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license to Adimab&#146;s technology to perform our responsibilities under the specified research plan and to evaluate the program antibodies to
determine, at our election, how to proceed with any antibodies discovered as a result of such research program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On a research program by
research program basis, Adimab has granted to us an exclusive option to acquire the rights to up to a certain specified number of discovered antibodies for development and commercialization as biopharmaceutical products. We have also granted Adimab
a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> non-sublicensable license under our technology during each research program, and during the relevant Evaluation Term solely to perform Adimab&#146;s responsibilities under such research plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon execution of the Adimab Agreement we paid to Adimab a <FONT STYLE="white-space:nowrap">one-time,</FONT> <FONT
STYLE="white-space:nowrap">non-creditable</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT> technology access fee in the low-five figures. For each agreed upon research program that is commenced, we are required to pay Adimab an agreed
upon rate for its full-time employees during a given research program, a specified discovery delivery fee, and an optimization completion fee in the low-six figures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we choose to exercise our option with respect to a specific research program, we are required to pay Adimab a <FONT
STYLE="white-space:nowrap">non-creditable,</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT> high <FONT STYLE="white-space:nowrap">six-figure</FONT> option exercise fee, payable in installments. If we exercise our option with respect to
more than the specified number of antibodies resulting from such research program, we are obligated to make an additional specified payment for each additional optioned antibody. To date, we have not exercised any options under the Adimab Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to make certain milestone payments to Adimab upon the achievement of certain clinical and regulatory milestone events in
the development of therapeutic products and diagnostic products which use the antibodies we have obtained pursuant to our exclusive option. The milestone payments total approximately $12&nbsp;million for each therapeutic product. For any product
that is commercialized pursuant to the Adimab Agreement, we are required to pay Adimab low single digit percentage tiered royalty payments based on annual aggregate worldwide net sales thresholds for such products, subject to reduction as specified
in the Adimab Agreement. Royalty terms with respect to each product will expire on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis upon the later of (a)&nbsp;ten years after the first
commercial sale of such product in such country and (b)&nbsp;the expiration of the last patent related to any antibody acquired by us pursuant to our option from a specified research program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Adimab Agreement, we are required to use commercially reasonable efforts to conduct certain research to discover and optimize
antibodies directed against the targets that we select. The Adimab Agreement will expire unless earlier terminated (a)&nbsp;in the event that we do not exercise any option pursuant to a research program, upon the conclusion of the last to expire
Evaluation Term, or (b)&nbsp;if we do exercise an option, on the expiration of the last royalty term for a product in a particular country. We have the right to terminate the Adimab Agreement at any time upon advance written notice to Adimab. In
addition, subject to certain conditions, either we or Adimab may terminate the Adimab Agreement if the other party commits a material breach of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement and fails to cure such breach within a specified cure period after written notice is provided. Upon expiration or termination of the Adimab Agreement, all licenses granted to us on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis will continue on a <FONT
STYLE="white-space:nowrap">non-exclusive,</FONT> fully-paid, worldwide, royalty-free, irrevocable basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates, PLN-74809 and PLN-1474, are small molecule inhibitors amenable to standard formulation technologies. We have validated
the synthetic process and manufactured large kilogram quantities similar to the campaigns that will be required to provide drug product for our anticipated Phase 2a clinical trials. The manufacturing process of the drug substance for such product
candidates is robust and accessed from readily available starting materials. The synthetic route is amenable to large-scale production and does not require unusual equipment or handling during the manufacturing process. We have obtained an adequate
supply chain of the drug substance for PLN-74809 and PLN-1474 from our first North American contract manufacturing organization, or CMO, to satisfy both our clinical and preclinical requirements in 2019. We rely on a sole supplier for the
manufacture of PLN-74809. We are engaging secondary raw material suppliers in addition to North American and European CMOs to mitigate global supply chain risk and ensure continuity of supply of drug substance. To maximize flexibility, we have
established relationships with non-overlapping vendors for manufacturing of not only raw materials but also drug substance. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
currently rely on third-party manufacturers for the GMP production of larger quantities of our drug product candidates for our clinical trials. Our internal personnel have extensive cGMP manufacturing experience in order to ensure seamless
technology transfer and to manage the manufacturing and development processes conducted by third-party manufacturers. Our agreements with third-party manufacturers include confidentiality and intellectual property provisions as well as routine
quality audits. In some instances, we have reserved resources from third-party manufacturers for the development and manufacture of our product candidates for near-term clinical programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not own or operate facilities for clinical drug manufacturing, storage, distribution or quality testing. Currently, all of our clinical
manufacturing is outsourced to third-party manufacturers. As our development programs expand and we build new process efficiencies, we expect to continually evaluate this strategy with the objective of satisfying demand for our clinical trials and,
if approved, the manufacture, sale and distribution of commercial products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA and comparable regulatory authorities in state and local jurisdictions and in other countries impose substantial and burdensome
requirements upon companies involved in the clinical development, manufacture, marketing and distribution of drugs, such as those we are developing. These agencies and other federal, state and local entities regulate, among other things, the
research and development, testing, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, approval, advertising and promotion, distribution, post-approval monitoring and reporting, sampling and export and import of
our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>U.S. government regulation of drug products </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations. The
process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the
applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#146;s refusal to approve pending New
Drug Applications, or NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of
government contracts, restitution, disgorgement or civil or criminal penalties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The process required by the FDA before a drug may be marketed in the United States generally
involves the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the
FDA&#146;s good laboratory practice, or GLP, regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Submission to the FDA of an investigational new drug application, or IND, which must become effective before
human clinical trials may begin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approval by an independent institutional review board, or IRB, at each clinical site before each trial may be
initiated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Performance of adequate and well-controlled human clinical trials in accordance with good clinical practice, or
GCP, requirements to establish the safety and efficacy of the proposed drug product for each indication; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Submission to the FDA of an NDA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Satisfactory completion of an FDA advisory committee review, if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product is
produced to assess compliance with current good manufacturing practice, or cGMP, requirements and to assure that the facilities, methods and controls are adequate to preserve the drug&#146;s identity, strength, quality and purity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Satisfactory completion of FDA audits of clinical trial sites to assure compliance with GCPs and the integrity of
the clinical data; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Payment of user fees and securing FDA approval of the NDA; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Compliance with any post-approval requirements, including the potential requirement to implement a Risk
Evaluation and Mitigation Strategy, or REMS, and the potential requirement to conduct post-approval studies. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical studies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preclinical studies include laboratory evaluation of product chemistry, toxicity and formulation, as well as animal studies to assess potential
safety and efficacy. An IND sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data and any available clinical data or literature, among other things, to the FDA as part of an IND. Some
preclinical testing may continue even after the IND is submitted. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to one or more proposed clinical trials
and places the clinical trial on a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may not result in the FDA allowing clinical
trials to initiate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators
in accordance with GCP requirements, which include the requirement that all research subjects provide their informed consent in writing for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among
other things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part
of the IND. In addition, an IRB at each institution participating in the clinical trial must review and approve the plan for any clinical trial before it initiates at that institution. Information about certain clinical trials must be submitted
within specific timeframes to the National Institutes of Health, or NIH, for public dissemination on their www.clinicaltrials.gov website. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Human clinical trials are typically conducted in three sequential phases, which may overlap
or be combined: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 1: The drug is initially introduced into healthy human subjects or patients with the target disease or
condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 2: The drug is administered to a limited patient population to identify possible adverse effects and safety
risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 3: The drug is administered to an expanded patient population, generally at geographically dispersed
clinical trial sites, in well-controlled clinical trials to generate enough data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate
information for the labeling of the product. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Progress reports detailing the results of the clinical trials must be
submitted at least annually to the FDA and more frequently if serious adverse events occur. Phase 1, Phase 2 and Phase 3 trials may not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend
or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution
if the clinical trial is not being conducted in accordance with the IRB&#146;s requirements or if the drug has been associated with unexpected serious harm to patients. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Marketing approval </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming successful completion of the required clinical testing, the results of the preclinical and clinical studies, together with detailed
information relating to the product&#146;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. In most cases,
the submission of an NDA is subject to a substantial application user fee. Under the Prescription Drug User Fee Act, or PDUFA, guidelines that are currently in effect, the FDA has a goal of ten months from the date of &#147;filing&#148; of a
standard NDA, for a new molecular entity to review and act on the submission. This review typically takes twelve months from the date the NDA is submitted to FDA because the FDA has approximately two months to make a &#147;filing&#148; decision.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under the Pediatric Research Equity Act of 2003, or PREA, as amended and reauthorized, certain NDAs or supplements to an NDA
must contain data that are adequate to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the
product is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from
the pediatric data requirements. An Agreed Initial Pediatric Study Plan requesting a waiver from the requirement to conduct clinical studies has been submitted to the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA also may require submission of a risk evaluation and mitigation strategy, or REMS, plan to ensure that the benefits of the drug
outweigh its risks. The REMS plan could include medication guides, physician communication plans, assessment plans, and/or elements to assure safe use, such as restricted distribution methods, patient registries, or other risk minimization tools.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before accepting them for filing, to
determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the application must be resubmitted with the additional information. The
resubmitted application is also subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT> substantive
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
review. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective and whether the facility in which it is manufactured, processed, packaged or held meets
standards designed to assure the product&#146;s continued safety, quality and purity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may refer an application for a novel drug
to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under
what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve
an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving
an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After evaluating the NDA and all
related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response
letter. A complete response letter generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for FDA to reconsider the
application. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#146;s satisfaction,
the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if the FDA approves a product, it may limit the approved indications for use of the product, require that contraindications, warnings or
precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#146;s safety after approval, require testing and surveillance programs to monitor the
product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may
prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and
additional labeling claims, are subject to further testing requirements and FDA review and approval. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Orphan drug designation and
exclusivity </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may designate a drug product as an &#147;orphan drug&#148; if it is intended to
treat a rare disease or condition (generally meaning that it affects fewer than 200,000 individuals in the United States, or more in cases in which there is no reasonable expectation that the cost of developing and making a drug product available in
the United States for treatment of the disease or condition will be recovered from sales of the product). A company must request orphan product designation before submitting an NDA. If the request is granted, the FDA will disclose the identity of
the therapeutic agent and its potential use. Orphan product designation does not convey any advantage in or shorten the duration of the regulatory review and approval process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a product with orphan status receives the first FDA approval for the disease or condition for which it has such designation or for a select
indication or use within the rare disease or condition for which it was designated, the product generally will be receiving orphan product exclusivity. Orphan product exclusivity means that the FDA may not approve any other applications for the same
product for the same indication for seven years, except in certain limited circumstances. If a drug or drug product designated as an orphan product ultimately receives </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
marketing approval for an indication broader than what was designated in its orphan product application, it may not be entitled to exclusivity. Orphan exclusivity will not bar approval of another
product under certain circumstances, including if a subsequent product with the same active ingredient for the same indication is shown to be clinically superior to the approved product on the basis of greater efficacy or safety, or providing a
major contribution to patient care, or if the company with orphan drug exclusivity is not able to meet market demand. Further, the FDA may approve more than one product for the same orphan indication or disease as long as the products contain
different active ingredients. Moreover, competitors may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the
orphan product has exclusivity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>U.S. marketing exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market exclusivity provisions under the FDCA also can delay the submission or the approval of certain applications. The FDCA provides a
five-year period <FONT STYLE="white-space:nowrap">of&nbsp;non-patent&nbsp;marketing</FONT> exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA
has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an Abbreviated New Drug
Application, or ANDA, or a 505(b)(2) NDA submitted by another company for another version of such drug where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be
submitted after four years if it contains a certification of patent invalidity <FONT STYLE="white-space:nowrap">or&nbsp;non-infringement.&nbsp;The</FONT> FDCA also provides three years of marketing exclusivity for a NDA, 505(b)(2) NDA or supplement
to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, new indications, dosages
or strengths of an existing drug. This three-year exclusivity covers only the conditions of use associated with the new clinical investigations and does not prohibit the FDA from approving ANDAs for the original
<FONT STYLE="white-space:nowrap">non-modified</FONT> version of the drug. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or
obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pediatric exclusivity is another type of regulatory market exclusivity in the United States. Pediatric exclusivity, if granted, adds six
months to existing regulatory exclusivity periods. <FONT STYLE="white-space:nowrap">This&nbsp;six-month&nbsp;exclusivity</FONT> may be granted based on the voluntary completion of a pediatric trial in accordance with
<FONT STYLE="white-space:nowrap">an&nbsp;FDA-issued&nbsp;&#147;Written</FONT> Request&#148; for such a trial. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Post-approval
requirements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the
FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the
approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval. There are continuing, annual user fee requirements for any marketed products and the establishments where such products are
manufactured, as well as new application fees for supplemental applications with clinical data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may impose a number of
post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#146;s safety and effectiveness
after commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved
drugs are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from
cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of
production and quality control to maintain cGMP compliance. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once an approval of a drug is granted, the FDA may withdraw the approval
if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity
or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to
assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market
or product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Fines, warning letters or holds on post-approval clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of
product approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Product seizure or detention, or refusal to permit the import or export of products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted by
a manufacturer and any third parties acting on behalf of a manufacturer only for the approved indications and in a manner consistent with the approved label for the product. The FDA and other agencies actively enforce the laws and regulations
prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant liability. On
May&nbsp;10, 2019, the Centers for Medicare and Medicaid Services announced a new pricing transparency rule, which was set to take effect on July 9, 2019. The rule would have required direct-to-consumer television advertisements for prescription
drugs and biological products for which reimbursement is available, directly or indirectly, through or under Medicare or Medicaid to include the list price of that product, except for a prescription drug or biological product that has a list price
of less than $35 per month for a 30-day supply or typical course of treatment. The final rule was vacated by the D.C. District Court prior to taking effect. Several states have adopted price transparency requirements and those as well as any future
federal price transparency requirements that may be implemented in the future could have a negative effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Other healthcare laws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians, and third party payors play a primary role in the recommendation and prescription of drug products for which
we obtain marketing approval. Arrangements with third party payors, healthcare providers and physicians, in connection with the clinical research, sales, marketing and promotion of products, once approved, and related activities, may expose a
pharmaceutical manufacturer to broadly applicable fraud and abuse and other healthcare laws and regulations. In the United States, these laws include, without limitation, state and federal&nbsp;anti- kickback,&nbsp;false claims, physician
transparency, and patient data privacy and security laws and regulations, including but not limited to those described below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, or AKS, which makes it illegal for any person, including a prescription drug
manufacturer (or a party acting on its behalf) to knowingly and willfully solicit, receive, offer or pay any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, that is intended
to induce or reward, referrals including the purchase recommendation, order or prescription of a particular drug for which payment may be made under a federal healthcare </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
program, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a
violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil and criminal false claims laws and civil monetary penalty laws, including the False Claims Act,
which impose criminal and civil penalties, including through civil &#147;qui tam&#148; or &#147;whistleblower&#148; actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for
payment or approval from Medicare, Medicaid, or other federal health care programs that are false or fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay or transmit money or
property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of these
statutes or specific intent to violate them in order to have committed a violation. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional
federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the
money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material
fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates that perform services for them that involve
the creation, use, receipt, maintenance or disclosure of individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Physician Payments Sunshine Act, created under Patient Protection and Affordable Care Act, as amended
by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, and its implementing regulations, which require manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare,
Medicaid or the Children&#146;s Health Insurance Program to report annually to the Centers for Medicare and Medicaid Services, or CMS, under the Open Payments Program, information related to payments or other transfers of value made to physicians
(defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January&nbsp;1, 2022, these
reporting obligations will extend to include transfers of value made to certain non-physician providers such as physician assistants and nurse practitioners; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer
protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services
reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated
by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing
information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration of pharmaceutical sales
representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance
efforts. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the breadth of these laws and the narrowness of the statutory exceptions and
regulatory safe harbors available, it is possible that some of a pharmaceutical manufacturer&#146;s business activities could be subject to challenge under one or more of such laws. Efforts to ensure that business arrangements comply with applicable
healthcare laws involve substantial costs. It is possible that governmental and enforcement authorities will conclude that a pharmaceutical manufacturer&#146;s business practices do not comply with current or future statutes, regulations or case law
interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against a pharmaceutical manufacturer, and it is not successful in defending itself or asserting its rights, those actions could
have a significant impact on its business, including the imposition of significant civil, criminal and administrative penalties, damages, disgorgement, imprisonment, monetary fines, possible exclusion from participation in Medicare, Medicaid and
other federal healthcare programs, reporting obligations and oversight if we become subject to integrity and oversight agreements to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance,</FONT> contractual damages, reputational
harm, diminished profits and future earnings, and curtailment of operations, any of which could adversely affect a pharmaceutical manufacturer&#146;s ability to operate its business and the results of operations. In addition, commercialization of
any drug product outside the United States will also likely be subject to foreign equivalents of the healthcare laws mentioned above, among other foreign laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the U.S., numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy
laws, and federal and state consumer protection laws, govern the collection, use, disclosure, and protection of health-related and other personal information. For example, in June 2018, the State of California enacted the California Consumer Privacy
Act of 2018 (the &#147;CCPA&#148;), which came into effect on January 1, 2020 and provides new data privacy rights for consumers and new operational requirements for companies, which may increase our compliance costs and potential liability. The
CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for
civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. While there is currently an exception for protected health information that is subject to HIPAA and clinical
trial regulations, as currently written, the CCPA may impact certain of our business activities. The CCPA could mark the beginning of a trend toward more stringent state privacy legislation in the U.S., which could increase our potential liability
and adversely affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event we decide to conduct clinical trials or continue to enroll subjects in our ongoing or
future clinical trials, we may be subject to additional privacy restrictions. The collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the European Economic Area, or EEA, including personal
health data, is subject to the EU General Data Protection Regulation, or GDPR, which became effective on May 25, 2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including
requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to
protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to countries
outside the EEA, including the United States, and permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#128;20 million or 4% of annual global revenues, whichever is greater.
The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. In
addition, the GDPR includes restrictions on cross-border data transfers. The GDPR may increase our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to put
in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require us to
change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. Further, the United Kingdom&#146;s decision to
leave the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
particular, it is unclear how data transfers to and from the United Kingdom will be regulated now that the United Kingdom has left the EU. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Current and future healthcare reform legislation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In both the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to the health care
system. In particular, in 2010 the ACA was enacted, which, among other things, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate Program to utilization of
prescriptions of individuals&nbsp;enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and provided incentives to programs that increase the federal
government&#146;s comparative effectiveness research. </P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous judicial, administrative,
executive, and legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example, portions of the ACA are currently undergoing legal and constitutional
challenges in the Fifth Circuit Court and the United States Supreme Court, and the Trump Administration has issued various Executive Orders which eliminated cost sharing subsidies and various provisions that would impose a fiscal burden on states or
a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, Congress has introduced several pieces of legislation aimed at significantly
revising or repealing the ACA. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August&nbsp;2011, the
Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013
through 2021, was unable to reach required goals, thereby triggering the legislation&#146;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2%&nbsp;per fiscal year, which
went into effect in&nbsp;2013, and, due to subsequent legislative amendments, will remain in effect through 2029 unless additional Congressional action is taken. The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several
providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. The Bipartisan Budget Act of 2018, also amended the ACA,
effective January 1, 2019, by increasing the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#147;donut
hole&#148;. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legislative and regulatory proposals, and enactment of laws, at the foreign, federal and state levels, directed at
containing or lowering the cost of healthcare, will continue into the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Rest of World Regulation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For other countries outside of the European Union and the United States, such as countries in Eastern Europe, Latin America or Asia, the
requirements governing product development, the conduct of clinical trials, manufacturing, distribution, marketing approval, product licensing, pricing and reimbursement vary from country to country. Additionally, clinical trials must be conducted
in accordance with GCP requirements and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we fail to comply with applicable foreign regulatory requirements, we may be subject to,
among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, to the extent that any of our product candidates, once approved, are sold in a foreign country, we may be subject to applicable
post-marketing requirements, including safety surveillance, anti-fraud and abuse laws and implementation of corporate compliance programs and reporting of payments or other transfers of value to healthcare professionals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Coverage and reimbursement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Successful commercialization of new drug products depends in part on the extent to which reimbursement for those drug products will be
available from government health administration authorities, private health insurers, and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which drug
products they will pay for and establish reimbursement levels. The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford a drug product. Sales of drug products depend
substantially, both domestically and abroad, on the extent to which the costs of drugs products are paid for by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health
administration authorities, private health coverage insurers and other third-party payors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A primary trend in the U.S. healthcare
industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular drug products. In many countries, the prices of drug
products are subject to varying price control mechanisms as part of national health systems. In general, the prices of drug products under such systems are substantially lower than in the United States. Other countries allow companies to fix their
own prices for drug products, but monitor and control company profits. Accordingly, in markets outside the United States, the reimbursement for drug products may be reduced compared with the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, the principal decisions about reimbursement for new drug products are typically made by CMS, an agency within the HHS.
CMS decides whether and to what extent a new drug product will be covered and reimbursed under Medicare, and private payors tend to follow CMS to a substantial degree. However, no uniform policy of coverage and reimbursement for drug products exists
among third-party payors and coverage and reimbursement levels for drug products can differ significantly from payor to payor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Medicare Prescription Drug, Improvement, and Modernization Act of 2003, or the MMA, established the Medicare Part D program to provide a voluntary prescription drug benefit to Medicare beneficiaries. Under Part&nbsp;D, Medicare beneficiaries may
enroll in prescription drug plans offered by private entities that provide coverage of outpatient prescription drugs. While all Medicare drug plans must give at least a standard level of coverage set by Medicare, Part D prescription drug plan
sponsors are not required to pay for all covered Part D drugs, and each Part D prescription drug plan can develop its own drug formulary that identifies which drugs it will cover and at what tier or level. However, Part D prescription drug
formularies must include drugs within each therapeutic category and class of covered Part D drugs, though not necessarily all the drugs in each category or class. Any formulary used by a Part D prescription drug plan must be developed and reviewed
by a pharmacy and therapeutic committee. Government payment for some of the costs of prescription drugs may increase demand for drugs for which we obtain marketing approval. Any negotiated prices for any of our products covered by a Part D
prescription drug plan will likely be lower than the prices we might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in
setting their own payment rates. Any reduction in payment that results from the MMA may result in a similar reduction in payments from <FONT STYLE="white-space:nowrap">non-governmental</FONT> payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a drug product to receive federal reimbursement under the Medicaid or Medicare Part B programs or to be sold directly to U.S. government
agencies, the manufacturer must extend discounts to entities eligible to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the average manufacturer price, or AMP, and Medicaid rebate amounts reported by
the manufacturer. As of 2010, the ACA expanded the types of entities eligible to receive discounted 340B pricing, although under the current state of the law these newly eligible entities (with the exception of children&#146;s hospitals) will not be
eligible to receive discounted 340B pricing on orphan drugs. As 340B drug pricing is determined based on average manufacturer price, or AMP, and Medicaid rebate data, the revisions to the Medicaid rebate formula and AMP definition described above
could cause the required 340B discount to increase. The American Recovery and Reinvestment Act of 2009 provides funding for the federal government to compare the effectiveness of different treatments for the same illness. The plan for the research
was published in 2012 by the Department of Health and Human Services, the Agency for Healthcare Research and Quality and the National Institutes for Health, and periodic reports on the status of the research and related expenditures are made to
Congress. Although the results of the comparative effectiveness studies are not intended to mandate coverage policies for public or private payors, it is not clear what effect, if any, the research will have on the sales of our drug candidates, if
any such drug or the condition that they are intended to treat are the subject of a trial. It is also possible that comparative effectiveness research demonstrating benefits in a competitor&#146;s drug could adversely affect the sales of our drug
candidate. If third-party payors do not consider our drugs to be cost-effective compared to other available therapies, they may not cover our drugs after approval as a benefit under their plans or, if they do, the level of payment may not be
sufficient to allow us to sell our drugs on a profitable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These laws, and future state and federal healthcare reform measures may
be adopted in the future, any of which may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any product candidates for which we may obtain regulatory approval or the frequency
with which any such product candidate is prescribed or used. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Outside of the United States, the pricing of pharmaceutical products and
medical devices is subject to governmental control in many countries. For example, in the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a
reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost effectiveness of a particular therapy to currently available therapies or <FONT STYLE="white-space:nowrap">so-called</FONT>
health technology assessments, in order to obtain reimbursement or pricing approval. Other countries may allow companies to fix their own prices for products, but monitor and control product volumes and issue guidance to physicians to limit
prescriptions. Efforts to control prices and utilization of pharmaceutical products and medical devices will likely continue as countries attempt to manage healthcare expenditures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31,
2019, we had 62 <FONT STYLE="white-space:nowrap">full-time</FONT> employees, including 21&nbsp;with Ph.D. or M.D. degrees and 37 are engaged in research and development activities. None of our employees are represented by labor unions or covered by
collective bargaining agreements. We consider our relationship with our employees to be good. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We lease a facility containing 32,974 square feet of laboratory and office space, which is located at 260 Littlefield Avenue, South San
Francisco, California 94080. The lease expires on February&nbsp;28, 2025. We believe that our current facilities are sufficient to meet our current and <FONT STYLE="white-space:nowrap">near-term</FONT> needs and that, should it be needed, suitable
additional space will be available. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus, we are not party to any material legal matters or claims. We may become party to legal matters and claims
arising in the ordinary course of business. We cannot predict the outcome of any such legal matters or claims, and despite the potential outcomes, the existence thereof may have an adverse impact on us because of defense and settlement costs,
diversion of management resources and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_12"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers and Directors </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table sets forth certain information about our executive officers and directors, including their ages as of March&nbsp;1, 2020. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="61%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Age&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard Coulie, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">54</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">46</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Business Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&Eacute;ric Lefebvre, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Medical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith Cummings, M.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara Howes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">55</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Human Resource Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Non-Employee Directors:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">50</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lead Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Suzanne Bruhn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gayle Crowell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">69</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Curnutte, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">68</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Exter<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">61</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">71</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Raidy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">51</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Smital Shah<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Audit Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Compensation Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Nominating and Corporate Governance Committee. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bernard Coulie, M.D., Ph.D., MBA,</I></B> has served as our Chief Executive Officer and as a Director since February 2016.
Prior to joining us, Dr.&nbsp;Coulie cofounded ActoGeniX N.V., a biopharmaceutical company, and held roles of increasing responsibility there, including as Vice President R&amp;D, Chief Medical Officer and Chief Executive Officer, from September
2006 until February 2015, when it was acquired by Intrexon Corporation. Prior to cofounding ActoGeniX, Dr.&nbsp;Coulie held various positions with increasing responsibilities in drug discovery and clinical development at&nbsp;Johnson&nbsp;&amp;
Johnson Pharmaceutical Research and Development Europe. Dr.&nbsp;Coulie previously served as a director of ActoGeniX from April 2010 until February 2015, Biogazelle N.V. from July 2015 until November 2018, Myoscience from June 2016 until March 2019.
Dr.&nbsp;Coulie is currently serving as a director and Chairman of Calypso BV. Dr.&nbsp;Coulie holds a M.D. and Ph.D. from the University of Leuven, Belgium and a MBA from the Vlerick Management School, Leuven, Belgium. We believe that
Dr.&nbsp;Coulie is qualified to serve on our board of directors based on our review of his experience and expertise in operations management and executive leadership at various biopharmaceutical companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Hans Hull, J.D.,</I></B> has served as our Chief Business Officer since March 2016. Prior to joining us, Mr.&nbsp;Hull held roles of
increasing responsibility at Avalanche Biotechnologies, Inc., a biopharmaceutical company, from March 2011 until December 2015, including Vice President, Legal and Corporate Development, then Senior Vice President, Business Operations and interim
President, and then Chief Executive Officer. Prior to Avalanche, from May 2008 to December 2011, he served as a legal and business development consultant for life sciences companies, including Second Genome, Inc., a biotechnology company, and
Aprecia Pharmaceuticals, a pharmaceutical company. Mr.&nbsp;Hull was also the Vice President and then Chief Executive Officer of Orthobond Corporation, a medical device startup from March 2005 to April 2008. Mr.&nbsp;Hull also had an earlier career
as an intellectual property attorney at Heller Ehrman LLP and life science consultant at ZS Associates. He holds an A.B. in Chemistry from Princeton University and a J.D. from the University of California, Berkeley. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>&Eacute;ric Lefebvre, M.D.,</I></B> has served as our Chief Medical Officer since May
2018. Prior to joining us, Dr.&nbsp;Lefebvre served as the Vice President of Allergan plc, a global pharmaceutical company, from November 2016 until April 2018. Prior to Allergan, Dr.&nbsp;Lefebvre served as Chief Medical Officer of Tobira
Therapeutics, Inc., a clinical-stage biopharmaceutical company, from January 2012 until November 2016. Dr.&nbsp;Lefebvre also led global clinical development and global medical affairs at Janssen Pharmaceuticals for 10 years prior to starting his
pharmaceutical career at GlaxoSmithKline Canada. This was preceded by 15 years of providing primary care at Clinique Medicale L&#146;Actuel in Montreal, Canada. He holds a B.S. in Health Sciences from Edouard-Montpetit College and a M.D. from the
University of Montreal. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Keith Cummings, M.D., MBA,</I></B> has served as our Chief Financial Officer since December 2018. Prior
to joining us, Dr.&nbsp;Cummings served as a Director in the Investment Banking Healthcare Group at Citigroup Global Markets from September 2014 until December 2018. Prior to joining Citigroup, Dr.&nbsp;Cummings worked at Lehman Brothers and,
subsequently, at Barclays Investment Bank from August 2009 to September 2014, where he served as a vice president of investment banking. He holds a B.S. in Biochemistry from North Carolina State University, an MBA from Duke University&#146;s Fuqua
School of Business and an M.D. from Duke University School of Medicine. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Barbara Howes</I></B> has served as our served as our
Chief Human Resource Officer since May 2019. Prior to joining us, Ms.&nbsp;Howes worked full time in consulting full-time in October 2014 where she served as the interim Head of Human Resources for several biotechnology companies, including Pliant
prior to joining us full time. Ms.&nbsp;Howes has over 20 years&#146; experience designing and delivering creative and impactful human resources, leadership development and change management solutions with a focus on optimizing organizational
performance in the areas of innovation, collaboration, culture and strategy. Prior to founding her consulting practice in October 2014, Ms.&nbsp;Howes led the executive and organization development, career&nbsp;&amp; learning, diversity, and
workforce research teams at Genentech from June 2008 through October 2014.&nbsp;Prior to joining Genentech, Ms.&nbsp;Howes spent 12 years at The Walt Disney Company, where she held various development positions at The Disney Stores, Walt Disney
Imagineering, and Corporate. She holds a B.A. in Liberal Arts from Mount Saint Mary&#146;s College and a MBA with an emphasis in Organizational Behavior from California Lutheran University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Non-Employee Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Hoyoung Huh,</I></B> <B><I>M.D., Ph.D.,</I></B> has served as Lead Director of our board of directors since December 2017. He is the
founder of pH Pharma and Healthcare&nbsp;&amp; Humanity Foundation. Dr.&nbsp;Huh was a Managing Director of Konus Advisory Group, Inc. from January 2012 to September 2014. Prior to founding Konus Advisory Group, Inc., Dr.&nbsp;Huh was Chief
Executive Officer and Chairman of the board of directors of BiPar Sciences, Inc. from February 2008 until December 2010. In addition, Dr.&nbsp;Huh has been involved in the formation, management and board positions of multiple biotechnology and
innovation-based companies. He previously served as the Chairman of the board of directors of Geron Corporation from September 2011 to December 2018, and CytomX Therapeutics, Inc. from February 2012 to December 2018, a member of the board of
directors of Rezolute, Inc. (f/k/a AntriaBio, Inc.) from 2013 to January 2019, the Chairman of the board of directors of Epizyme, Inc. from October 2009 to February 2012, and as a member of the board of directors of Facet Biotech Corporation, Nektar
Therapeutics, Inc., Addex Therapeutics Ltd. and EOS, S.p.A (Milano, Italy). Earlier in his career, Dr.&nbsp;Huh was a partner at McKinsey&nbsp;&amp; Company. He holds A.B. in Biochemistry from Dartmouth College, a M.D. from Cornell University
Medical College and a Ph.D. in Cell Biology and Genetics from Cornell University Sloan Kettering Institute. We believe Dr.&nbsp;Huh is qualified to serve on our board of directors based on his significant leadership experience in and familiarity
with the biopharmaceutical industry. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Suzanne Bruhn, Ph.D.,</I></B> has served as a member of our board of directors since July
2016. Dr.&nbsp;Bruhn currently serves as President and Chief Executive Officer of Tiaki Therapeutics, a preclinical biotechnology company, since May 2019. Prior to that, Dr.&nbsp;Bruhn served as President and Chief Executive Officer of Proclara
Biosciences, Inc, a clinical-stage biotechnology company, from April 2017 until September 2018. Prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Proclara, Dr.&nbsp;Bruhn served as President and Chief Executive Officer of Promedior, Inc., a private clinical-stage biotech company developing targeted therapies to treat diseases involving
fibrosis, from May 2012 until November 2015. She currently also serves on the board of directors of Aeglea BioTherapeutics, Inc, a publicly traded biotherapeutics company, from February 2017. She previously served as a member of the board of
directors of Novelion Therapeutics, Inc, a publicly traded pharmaceutical company, from October 2017 through January 2020, and Raptor Pharmaceuticals Corp., a publicly traded pharmaceutical company, from April 2011 until it was acquired by Horizon
Pharma plc in October 2016. She holds a B.S. in Chemistry from Iowa State University and a Ph.D. in Chemistry from Massachusetts Institute of Technology and completed her postdoctoral fellowship in the department of human genetics at Harvard Medical
School. We believe Dr.&nbsp;Bruhn is qualified to serve on our board of directors based on her expertise and experience in the biopharmaceutical industry, including her expertise in the development of treatments for rare diseases and diseases
involving fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Gayle Crowell</I></B><B><I>,</I></B> has served as a member of our board of directors since December 2019. Ms.
Crowell serves as a member of the board of directors of Envestnet, Inc., a role she has held since March 2016. Prior to that she served as lead independent director of Yodlee, Inc. from March 2014 and as a member of the Yodlee, Inc. board of
directors from July 2002 until November 19, 2015, when Yodlee, Inc. was acquired by Envestnet. Ms. Crowell served as an operational business consultant for Warburg Pincus LLC, a private equity firm, from June 2001 to January 2019. From January 2000
to June 2001, Ms. Crowell served as president of Epiphany, Inc., a developer of customer relationship management software which was acquired by SSA Global Technologies, Inc. in September 2005. Ms. Crowell also currently serves on the board of
directors of Dude Solutions Inc., a provider of facilities maintenance software, and of Hercules Capital, a specialty finance company, effective February 4, 2019. Ms. Crowell received an undergraduate degree in education from the University of
Nevada at Reno. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>John Curnutte, M.D., Ph.D.,</I></B> has served as a member of our board of directors since August 2017. From
February 2011 through his retirement in May 2019, Dr.&nbsp;Curnutte served as Executive Vice President of Research and Development at Portola Pharmaceuticals, Inc., a biopharmaceutical company developing product candidates for thrombosis and other
hematologic diseases. He remains as a consultant to Portola. Prior to that, Dr.&nbsp;Curnutte served as the Chief Executive Officer of <FONT STYLE="white-space:nowrap">3-V</FONT> Biosciences, Inc., a biotechnology company. Earlier in his career, he
served as a President of Schering-Plough Biopharma and previously held several senior management positions at Genentech, Inc., a biotechnology company. Prior to Genentech, Dr.&nbsp;Curnutte was a tenured faculty member at The Scripps Research
Institute, pursuing basic and clinical research in inflammation biochemistry and the molecular genetics of congenital immune deficiencies. He was an adjunct clinical professor of pediatrics at Stanford University School of Medicine and a member of
the medical staff from 1993 to 2013. From May 2015 to June 2016, Dr. Curnutte served as a member of the board of directors of Diadexus, Inc., a cardiovascular diagnostics company. Since August 2019, he serves as a member of the board of directors of
Orchard Therapeutics, a company focused on ex vivo autologous bone marrow gene therapy. Dr.&nbsp;Curnutte holds a B.S. in Biochemistry and Molecular Biology from Harvard University and a M.D. and a Ph.D. in Biological Chemistry from Harvard Medical
School. We believe Dr.&nbsp;Curnutte is qualified to serve on our board of directors based on his experience in the biopharmaceutical industry, including his operational experience in drug discovery and development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Neil Exter, MBA, </I></B>has served as a member of our board of directors since June 2015. He has been a partner at Third Rock Ventures
since November 2007. Mr. Exter has more than 30 years of business development, strategy and operating management experience, across the spectrum of emerging and established biotech and technology companies. Mr. Exter is currently the interim chief
business officer and a director of Cedilla Therapeutics. Prior to joining Third Rock Ventures, Mr. Exter was CBO of Alantos Pharmaceuticals and led the sale of that company to Amgen. Previously, he served as Vice President of Business Development
for Millennium Pharmaceuticals. Mr.&nbsp;Exter presently is a board member of Element Science, Goldfinch Bio, Pliant Therapeutics, Revolution Medicines, Celsius Therapeutics, Decibel Therapeutics, Motus Therapeutics, and NEVCA; he previously served
as a director of Rhythm Pharmaceuticals and Cibiem. He is a member of the Research Committee of Children&#146;s Hospital Boston, the investment committee of the Innovation Research Fund at Partners Healthcare, and the board of directors of the New
England Venture Capital Association. He holds an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
MBA as a Baker Scholar from Harvard Business School, an M.S. from Stanford University, and a B.S. from Cornell University. We believe that Mr. Exter&#146;s extensive experience in the life
sciences industry as a venture capitalist and senior executive, as well as his service on the boards of directors of numerous biotechnology companies provide him with the qualifications to serve as a director of our company. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Charles Homcy, M.D. </I></B>has served as a member of our board of directors since July 2015. Dr.&nbsp;Homcy joined Third Rock Ventures,
a venture capital firm in 2010, where he was a partner until October 2019 and now serves in an advisory capacity. In 2003, he <FONT STYLE="white-space:nowrap">co-founded</FONT> Portola Pharmaceuticals, a clinical biotechnology company, and he served
as president and chief executive officer until 2010. Prior to that, Dr. Homcy served as the president of research and development at Millennium Pharmaceuticals, Inc. a biopharmaceutical company, following its acquisition of COR Therapeutics, Inc. in
2002. He joined COR Therapeutics, Inc., a biopharmaceutical company, in 1995 as executive vice president of research and development, and he served as a director of the company from 1998 to 2002. He was previously president of the medical research
division of American Cyanamid-Lederle Laboratories. Dr. Homcy was a clinical professor of medicine at the University of California, San Francisco Medical School, and attending physician at the San Francisco Veterans Affairs Hospital from 1997 to
2008. He was previously a member of the Cardiac Unit of the Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. Dr. Homcy holds a B.A. and an M.D. from Johns Hopkins University and currently serves on its
board of trustees. Dr. Homcy is a cofounder of multiple biotechnology companies including GBT, MyoKardia, Relay, Goldfinch, Pliant, Ambys and Maze. He is also a cofounder of BridgeBio. We believe Dr.&nbsp;Homcy is qualified to serve on our board of
directors based on his significant experience building and leading successful biotechnology companies and his scientific expertise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Kevin Raidy</I></B> has served as a member of our board of directors since July 2018. Mr. Raidy is the Managing Partner and Portfolio
Manager of Cowen Healthcare Investments. Until October 2017, Mr.&nbsp;Raidy served as Head of Investment Banking at Cowen and Company. He previously served as <FONT STYLE="white-space:nowrap">co-head</FONT> of Cowen and Company&#146;s equity capital
markets group, which is responsible for the origination and execution of all equity capital-raising transactions. Before that, he was a managing director at Ramius LLC, where he was portfolio manager for direct investments and convertible bonds,
managing a portfolio in excess of $1&nbsp;billion. Mr.&nbsp;Raidy also was the founder of H4 Capital Management LLC. His sell-side experience includes ten years at Shipley Raidy Capital Partners LP, a boutique investment banking firm that he <FONT
STYLE="white-space:nowrap">co-founded,</FONT> where he was responsible for sourcing, evaluating, and structuring numerous debt and equity financings and also performed M&amp;A advisory services. Prior to founding Shipley Raidy, Mr.&nbsp;Raidy was an
associate at Philadelphia First Group. He started his career at Cantor Fitzgerald before moving to Merrill Lynch as an analyst in the municipal finance group. Mr. Raidy is currently serving as a director of Repare Therapeutics Inc., and he
previously served as a director of Semma Therapeutics, Inc. until October 2019. Mr. Raidy holds a BS in economics with a concentration in finance from the Wharton School of the University of Pennsylvania. We believe Mr.&nbsp;Raidy is qualified to
serve on our board of directors based on his significant leadership experience in the investment banking industry. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Smital
Shah, MBA,</I></B> has served as a member of our board of directors since March 2019. Since October 2014, Ms.&nbsp;Shah has served in roles of increasing responsibility at ProQR Therapeutics NV, a rare disease company, including as Chief Financial
Officer and most recently as Chief Business and Financial Officer. Previously, Ms.&nbsp;Shah managed the multi-billion-dollar debt, cash and investment portfolios of Gilead Sciences, Inc. Prior to Gilead, she was an investment banker at Leerink
Partners and JP Morgan focused on capital raising and strategic transactions in the biotechnology space. Previously, Ms.&nbsp;Shah held various research and development roles at Johnson&nbsp;&amp; Johnson Company. She holds a B.S. in Chemical
Engineering from the University of Mumbai, a M.S. in Chemical Engineering from Virginia Tech and a MBA from the University of California, Berkeley Haas School of Business. We believe Ms.&nbsp;Shah is qualified to serve on our board of directors due
to her extensive experience in the life sciences industry and her leadership experience as a senior financial executive. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our executive officers or directors.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Composition of Our Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors consists of nine members, each of whom are members pursuant to the board composition provisions of our certificate of
incorporation and agreements with our stockholders. These board composition provisions will terminate upon the completion of this offering. Upon the termination of these provisions, there will be no further contractual obligations regarding the
election of our directors. Our nominating and corporate governance committee and our board of directors may consider a broad range of factors relating to the qualifications and background of nominees. Our nominating and corporate governance
committee&#146;s and our board of directors&#146; priority in selecting board members is to identify persons who will further the interests of our stockholders through his or her established record of professional accomplishments, the ability to
contribute positively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape, and professional and personal experiences and expertise relevant to our growth strategy. Our directors
hold office until their successors have been elected and qualified or until the earlier of their resignation or removal. Our amended and restated certificate of incorporation and amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT>
that will become effective immediately prior to the closing of this offering also provide that our directors may be removed only for cause by the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the
votes that all our stockholders would be entitled to cast in an annual election of directors, and that any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of
a majority of our directors then in office. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Director Independence </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, we expect that our common stock will be listed on the Nasdaq Global Market. Applicable Nasdaq rules
require a majority of a listed company&#146;s board of directors to be comprised of independent directors within one year of listing. In addition, the Nasdaq rules require that (i)&nbsp;on the date of the initial listing, at least one member of each
of a listed company&#146;s audit, compensation and nominating and corporate governance committees be independent, (ii)&nbsp;within 90 days of the date of the initial listing, a majority of the members of such committees be independent and
(iii)&nbsp;within one year of the date of the initial listing, all the members of such committees be independent. Audit committee members must also satisfy the independence criteria set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT>
under the Exchange Act. Under applicable Nasdaq rules, a director will only qualify as an &#147;independent director&#148; if, in the opinion of the listed company&#146;s board of directors, that person does not have a relationship that would
interfere with the exercise of independent judgment in carrying out the responsibilities of a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to be considered
independent for purposes of Rule <FONT STYLE="white-space:nowrap">10A-3,</FONT> a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other
board committee, accept, directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has determined that all members of the board of directors, except Dr.&nbsp;Coulie, are independent directors, including
for purposes of the rules of Nasdaq and the SEC. In making such independence determination, our board of directors considered the relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with us and all other facts
and circumstances that our board of directors deemed relevant in determining his or her independence, including the beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. In considering the
independence of the directors listed above, our board of directors considered the association of our directors with the holders of more than 5% of our common stock. Upon the completion of this offering, we expect that the composition and functioning
of our board of directors and each of our committees will comply with all applicable requirements of Nasdaq and the rules and regulations of the SEC. Dr.&nbsp;Coulie is not an independent director under these rules because he is currently employed
as the chief executive officer of our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Staggered Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of our amended and restated certificate of incorporation and amended and restated by-laws that will become
effective immediately prior to the closing of this offering, our board of directors will be divided into three staggered classes of directors and each will be assigned to one of the three classes. At each annual meeting of the stockholders, a class
of directors will be elected for a three-year term to succeed the directors of the same class whose terms are then expiring. The terms of the directors will expire upon the election and qualification of successor directors at the annual meeting of
stockholders to be held during the years 2021 for Class&nbsp;I directors, 2022 for Class&nbsp;II directors and 2023 for Class&nbsp;III directors. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;I directors will be Hoyoung Huh, M.D., Ph.D.. and Neil Exter. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;II directors will be John Curnutte, M.D., Smital Shah and Charles Homcy, M.D.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;III directors will be Bernard Coulie, M.D., Ph.D., Gayle Crowell and Suzanne Bruhn, Ph.D.
</P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated
<FONT STYLE="white-space:nowrap">by-laws</FONT> that will become effective immediately prior to the closing of this offering will provide that the number of directors shall be fixed from time to time by a resolution of the majority of our board of
directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The division of our board of directors into three classes with staggered three-year terms may delay or prevent stockholder
efforts to effect a change of our board of directors or a change in control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership Structure and Board&#146;s Role in Risk Oversight
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D. is our current lead director of the board and Bernard Coulie, M.D., Ph.D. is our current chief executive
officer, hence the roles of lead director or chairman and the chief executive officer and president are separated. We plan to keep these roles separated following the completion of this offering. We believe that separating these positions allows our
chief executive officer to focus on setting the overall strategic direction of the company, expanding the organization to deliver on our strategy and overseeing our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business, while allowing a lead director of the board to lead the board of directors in its fundamental role of providing strategic advice. Our board of
directors recognizes the time, effort and energy that the chief executive officer is required to devote to his position in the current business environment, as well as the commitment required to serve as our lead director, particularly as the board
of directors&#146; oversight responsibilities continue to grow. While our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> and corporate governance guidelines do not require that our lead director and chief executive officer
positions be separate, our board of directors believes that having separate positions is the appropriate leadership structure for us at this time and demonstrates our commitment to good corporate governance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Risk is inherent with every business, and how well a business manages risk can ultimately determine its success. We face a number of risks,
including risks relating to our financial condition, development and commercialization activities, operations, strategic direction and intellectual property as more fully discussed in the section entitled &#147;Risk Factors&#148; appearing elsewhere
in this prospectus. Management is responsible for the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risks we face, while our board of directors, as a whole and through its committees, has
responsibility for the oversight of risk management. In its risk oversight role, our board of directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning
as designed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The role of the board of directors in overseeing the management of our risks is conducted primarily through committees of
the board of directors, as disclosed in the descriptions of each of the committees below and in the charters of each of the committees. The full board of directors (or the appropriate board committee in the case of risks that are under the purview
of a particular committee) discusses with management our major risk exposures, their potential impact on us, and the steps we take to manage them. When a board committee is responsible for evaluating and overseeing the management of a particular
risk or risks, the chairperson of the relevant committee </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reports on the discussion to the full board of directors during the committee reports portion of the next board meeting. This enables the board of directors and its committees to coordinate the
risk oversight role, particularly with respect to risk interrelationships. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of Our Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has established an audit committee, a compensation committee and a nominating and corporate governance committee, each
of which will operate pursuant to a charter adopted by our board of directors and will be effective upon the effectiveness of the registration statement of which this prospectus is a part. Upon the effectiveness of the registration statement of
which this prospectus is a part, the composition and functioning of all of our committees will comply with all applicable requirements of the Sarbanes-Oxley Act of 2002, and with Nasdaq and SEC rules and regulations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, Smital Shah, Gayle Crowell and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; will serve on the audit committee, which will be chaired by Smital Shah. Our board of directors has determined that&nbsp;each of Ms. Shah, Ms. Crowell
and&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are &#147;independent&#148; for audit committee purposes as that term is defined in the rules of the SEC and the applicable Nasdaq rules, and each
has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated Ms. Shah as an &#147;audit committee financial expert,&#148; as defined under the applicable Nasdaq rules. The audit
committee&#146;s responsibilities include: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, approving the compensation of, and assessing the independence of our independent<B> </B>registered
public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the overall audit plan with our independent registered public accounting firm and members of management
responsible for preparing our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management and our independent registered public accounting firm our annual and
quarterly financial statements and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending based upon the audit committee&#146;s review and discussions with management and our independent
registered public accounting firm whether our audited financial statements shall be included in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as
they relate to our financial statements and accounting matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the audit committee report required by SEC rules to be included in our annual proxy statement; and
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing all related person transactions for potential conflict of interest situations and approving all such
transactions. </P></TD></TR></TABLE>   <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, Suzanne Bruhn, Ph.D., John Curnutte, M.D.
and Neil Exter will serve on the compensation committee, which will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
chaired by Suzanne Bruhn, Ph.D. Our board of directors has determined that each member of the compensation committee is &#147;independent&#148; as defined in the applicable Nasdaq rules. The
compensation committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">annually reviewing and recommending to the board of directors the corporate objectives relevant to the
compensation of our principal executive officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and
based on such evaluation: (i)&nbsp;approving or recommending to the board of directors cash compensation of our principal executive officer; and (ii)&nbsp;reviewing and approving or recommending to the board of directors grants and awards to our
principal executive officer under equity-based plans; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving or recommending to the board of directors the compensation of our other executive
officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and establishing our overall management compensation, philosophy and policy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing and administering our compensation and similar plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating and assessing potential and current compensation advisors in accordance with the independence
standards identified in the applicable Nasdaq rules; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving our policies and procedures for the grant of equity-based awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to the board of directors the compensation of our outside directors;
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the compensation committee report required by SEC rules, if and when required, to be included in our
annual proxy statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the retention, termination or compensation of any consulting firm or outside advisor to
assist in the evaluation of compensation matters. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, Hoyoung Huh, M.D., Ph.D.,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and Charles Homcy, M.D.,&nbsp;will serve on the nominating and corporate governance committee, which will be chaired by Hoyoung Huh, M.D., Ph.D. Our
board of directors has determined that each member of the nominating and corporate governance committee is &#147;independent&#148; as defined in the applicable Nasdaq rules. The nominating and corporate governance committee&#146;s responsibilities
include: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors criteria for board and committee membership;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for identifying and evaluating board of director candidates, including nominees
recommended by stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the composition of the board of directors to ensure that it is composed of members containing the
appropriate skills and expertise to advise us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying individuals qualified to become members of the board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending to the board of directors the persons to be nominated for election as directors and to each of the
board&#146;s committees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors a code of business conduct and ethics and a set of
corporate governance guidelines; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the evaluation of our board of directors and management. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">Our board of directors may from time to time establish other committees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our compensation committee has at any time during the prior three years been one of our officers or employees. None of
our executive officers currently serves, or in the past fiscal year has served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving on our board of directors or compensation
committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Governance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
intend to adopt a written code of business conduct and ethics, effective upon the effectiveness of the registration statement of which this prospectus is a part, that applies to our directors, officers and employees, including our principal
executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Following the effectiveness of the registration statement of which this prospectus is a part, a current copy of the
code will be posted on the investor relations section of our website, which is located at https://pliantrx.com. The inclusion of our website address in this prospectus does not incorporate by reference the information on or accessible through our
website into this prospectus. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such amendment or waiver on our website or in a
current report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Liability and Indemnification Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation, which will become effective immediately prior to the completion of this offering, will
contain provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any
breach of fiduciary duties as directors, except liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of
the Delaware General Corporation Law; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our amended and restated certificate of incorporation and amended and restated bylaws, which will become effective immediately prior
to the completion of this offering, will provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated bylaws will also obligate us to advance expenses
incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in
that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as
determined by our board of directors. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys&#146; fees, judgments, fines and settlement amounts incurred by any of these
individuals in any action or proceeding. We believe that these certificate of incorporation and bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain
directors&#146; and officers&#146; liability insurance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in our amended and
restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative
litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders. Further, a stockholder&#146;s investment may be adversely affected to the extent that we pay the costs of settlement and
damage. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_13"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion
contains forward-looking statements that are based on our current plans and expectations regarding our future compensation programs. The actual amount and form of compensation that we pay and the compensation policies and practices that we adopt in
the future may differ materially from the currently-planned programs that are summarized in this discussion. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation
provided to our named executive officers for the fiscal year ended December&nbsp;31, 2019 is detailed in the 2019 Summary Compensation Table and accompanying footnotes and narrative that follow. Our named executive officers for the fiscal year ended
December&nbsp;31, 2019, which consists of our Chief Executive Officer and our two most highly-compensated individuals (other than our Chief Executive Officer) who were serving as executive officers on December&nbsp;31, 2019 are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Bernard J. Coulie, M.D., Ph.D., our Chief Executive Officer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Keith L. Cummings, M.D., MBA, our Chief Financial Officer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Hans Hull, J.D., our Chief Business Officer. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2019 Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table provides information regarding the total compensation awarded to, earned by, and paid to our named executive officers for services rendered to us in all capacities for the fiscal year ended December&nbsp;31, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;and&nbsp;Principal&nbsp;Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-equity</FONT><BR>Incentive Plan<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard J. Coulie, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">428,108</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,673,280</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">219,193</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">49,905</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,372,486</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith L. Cummings, M.D., MBA</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;<I>Chief Financial
Officer</I><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">340,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">252,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">964,285</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">122,403</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,200</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,689,888</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull, J.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>&nbsp;&nbsp;&nbsp;&nbsp;Chief Business Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">355,137</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">268,560</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">136,369</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,200</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">846,266</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP><B></B></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B></B><B></B>The amounts reported represent the aggregate grant date fair value of the restricted stock awards granted to our named executive officers during the 2018 or 2019 fiscal year, as applicable, calculated in
accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. Such grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date
fair value of the restricted stock awards reported in this column are set forth in note&nbsp;11 of our financial statements included elsewhere in this prospectus. The amounts reported in this column reflect the accounting cost for these restricted
stock awards and do not correspond to the actual economic value that may be received by our named executive officers upon the vesting of the restricted stock awards or any sale of the underlying shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represent the aggregate grant date fair value of the stock option awards granted to our named executive officers during the 2018 or 2019 fiscal year, as applicable, calculated in accordance with
FASB ASC Topic 718. Such grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the stock option awards reported in this column are set forth in note 11 of our
financial statements included elsewhere in this prospectus. The amounts reported in this column reflect the accounting cost for these stock option awards and do not correspond to the actual economic value that may be received by our named executive
officers upon the exercise of the stock option awards or any sale of the underlying shares of common stock. For Mr. Hull, the grant date fair value of his performance-based stock option award is reported based on the probable outcome of the
applicable performance metrics and the grant date fair value of the such performance-based stock option award, based on maximum level of achievement of the applicable performance metrics, is $178,920. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents amounts earned by our named executive officers under our short-term incentive program, based on the Company&#146;s achievement of certain corporate performance goals and the named executive officers&#146;
individual performance during the 2018 or 2019 fiscal year, as applicable. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents a one-time discretionary performance bonus that Dr. Coulie received in connection with the execution of the Novartis Agreement in October 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represents $11,200 for matching contributions made by the Company under its 401(k) plan, $20,000 for travel reimbursements, and $18,705 for tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> paid
by the Company for such travel reimbursements. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Dr. Cummings was not a named executive officer for the fiscal year ended December 31, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents a one-time discretionary performance bonus equal to $250,000 that Dr. Cummings received in connection with the Company&#146;s issuance of Series C Redeemable Convertible Preferred stock in December 2019 and a
one-time discretionary performance bonus equal to $2,000 that Dr. Cummings received in connection with the execution of the Collaboration Agreement. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amount reported represents $11,200 for matching contributions made by the Company under its 401(k) plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents a <FONT STYLE="white-space:nowrap">one-time</FONT> discretionary performance bonus that Mr. Hull received in connection with the execution of the Novartis Agreement in October 2019. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative to Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Base Salaries </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From January&nbsp;1, 2019 through February 14, 2019, the annual base salaries for Dr.&nbsp;Coulie and Mr.&nbsp;Hull were $413,631 and $344,793,
respectively. Effective as of February 15, 2019, the annual base salaries for Dr.&nbsp;Coulie and Mr.&nbsp;Hull were increased to $428,108 and $355,137, respectively. Dr. Cumming&#146;s annual base salary for the fiscal year ended December 31, 2019
was $340,000. </P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Annual Bonuses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, our named executive officers were eligible to participate in the Company&#146;s short-term
incentive program, pursuant to which each was eligible to earn an annual bonus based on the achievement of certain Company performance objectives and individual performance. For the fiscal year ended December 31, 2019, the target annual bonuses for
Drs.&nbsp;Coulie and Cummings and Mr.&nbsp;Hull were 40.0%, 30.0% and 30.0%, respectively, of the applicable named executive officer&#146;s annual base salary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Discretionary Bonuses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December 31, 2019, we also provided our named executive officers with certain one-time discretionary performance
bonuses for the successful execution of the Collaboration Agreement and the issuance of a Series C Redeemable Convertible Preferred stock, each as described further in our &#147;Executive Compensation&#151;2019 Summary Compensation Table&#148;
above. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Equity Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, we granted stock option awards to each of our named executive officers, as described in
more detail in the &#147;Outstanding equity awards at fiscal 2019 <FONT STYLE="white-space:nowrap">year-end&#148;</FONT> table. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>401(k) Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
maintain a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> 401(k) plan that provides eligible U.S. employees with an opportunity to save for retirement on a <FONT STYLE="white-space:nowrap">tax-advantaged</FONT> basis. Plan participants are
able to defer eligible compensation subject to applicable annual Internal Revenue Code limits. We provide a safe harbor matching contribution equal to 100% on the first 3% of participant contributions and an additional 50% on the next 2% of
participant contributions, which is 100% vested when contributed. We may also decide to make nonelective contributions, although we are not required to do so pursuant to the terms of the 401(k) plan. The 401(k) plan is intended to be qualified under
Section&nbsp;401(a) of the Internal Revenue Code with the 401(k) plan&#146;s related trust intended to be tax exempt under Section&nbsp;501(a) of the Internal Revenue Code. As a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan,
contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Perquisites </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally do not provide perquisites to our employees, other than a travel reimbursements and related tax gross ups to Dr.&nbsp;Coulie. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Employment Arrangements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We initially entered into an offer letter with each of the named executive officers in connection with his employment with us, which set forth
the terms and conditions of his employment. Each named executive officer also entered into our standard confidentiality and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Offer Letters in Place During the Fiscal Year Ended December&nbsp;31, 2019 for Our Named Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Bernard Coulie, M.D., Ph.D. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;12, 2015, we entered into an offer letter with Dr.&nbsp;Coulie, who currently serves as our Chief Executive Officer. The offer
letter provided for Dr.&nbsp;Coulie&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment and set forth his initial annual base salary, initial target annual bonus opportunity, a $250,000 <FONT STYLE="white-space:nowrap">sign-on</FONT>
bonus, annual travel reimbursements of up to $20,000 and an initial restricted stock grant for 2,759,780 shares of our common stock, as well as his eligibility to participate in our employee benefit plans generally. Dr. Coulie&#146;s offer letter
also provides that, in the event of a termination of his employment by the Company without &#147;cause&#148; (as defined in Dr.&nbsp;Coulie&#146;s offer letter) and other than for death or disability, subject to Dr.&nbsp;Coulie&#146;s execution of
an effective release of claims in favor of the Company and his continued compliance will all legal and contractual obligations to the Company, Dr.&nbsp;Coulie will be entitled to a severance benefit in the form of a lump sum payment equal to six
months of his then-base salary. Dr. Coulie is subject to our standard confidential information and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Keith Cummings, M.D., MBA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, we entered into an offer letter with Dr.&nbsp;Cummings, who currently serves as our Chief Financial Officer. The
offer letter provided for Dr.&nbsp;Cummings&#146; <FONT STYLE="white-space:nowrap">at-will</FONT> employment and set forth his initial annual base salary, initial target bonus opportunity, a $100,000 <FONT STYLE="white-space:nowrap">sign-on</FONT>
bonus, a performance-based bonus of $250,000 based on the consummation of a collaboration agreement in which the Company receives certain significant payments, a stock option award for 1,612,247 shares of our common stock, as well as his eligibility
to participate in our employee benefit plans generally. Dr. Cummings&#146; offer letter also provides that, in the event of a termination of his employment by the Company without &#147;cause&#148; (as defined in Dr.&nbsp;Cummings&#146; offer
letter), subject to Dr.&nbsp;Cummings&#146; execution of an effective release of claims in favor of the Company, Dr. Cummings will be entitled to a severance benefit of 12 months&#146; base salary continuation, payable in accordance with the
Company&#146;s normal payroll schedule. Dr. Cummings is subject to our standard confidential information and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Hans Hull, J.D. </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
February&nbsp;10, 2016, we entered into an offer letter with Mr.&nbsp;Hull, who currently serves as our Chief Business Officer. The offer letter provided for Mr.&nbsp;Hull&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment and set
forth his initial annual base salary, initial target annual bonus opportunity, and an initial restricted stock grant for 927,000 shares of our common stock, as well as his eligibility to participate in our employee benefit plans generally.
Mr.&nbsp;Hull&#146;s offer letter also provides that, in the event of a termination of his employment by the Company without &#147;cause&#148; (as defined in Mr.&nbsp;Hull&#146;s offer letter) and other than for death or disability, subject to
Mr.&nbsp;Hull&#146;s execution of an effective release of claims in favor of the Company and his continued compliance will all legal and contractual obligations to the Company, Mr.&nbsp;Hull will be entitled to a severance benefit in the form of a
lump sum payment equal to six months of his then-base salary. Mr. Hull is subject to our standard confidential information and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Severance Plan </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with this offering, our board of directors will adopt an Executive Severance Plan, or the Severance Plan, subject to the effectiveness of this offering, in which our named executive officers, and certain
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other executives, will participate. The benefits provided in the Severance Plan will replace any severance for which our named executive officers may be eligible under their existing offer
letters or other agreements or arrangements, except to the extent such offer letters or other agreements or arrangements provide for greater benefits; provided, that, the defined terms in the Severance Plan will supersede the corresponding defined
terms or other similar terms in such offer letter or other agreements or arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Severance Plan will provide that upon a
termination by us for any reason other than for &#147;cause,&#148; as defined in the Severance Plan, death or &#147;disability,&#148; as defined in the Severance Plan, outside of the change in control period (i.e., the period of one&nbsp;year after
a &#147;change in control,&#148; as defined in the Severance Plan), an eligible participant will be entitled to receive, subject to the execution and delivery of an effective release of claims in favor of the Company and continued compliance with
all applicable restrictive covenants, (i) 12 months of &#147;base salary&#148; (i.e., the higher of the annual base salary in effect immediately prior to the date of termination or the annual base salary in effect for the year immediately prior to
the year in which the date of termination occurs) for our Chief Executive Officer and nine months of base salary for the other named executive officers, (ii) an amount equal to the named executive officer&#146;s target annual bonus in effect
immediately prior to the date of termination, pro-rated for the number of days employed during the year of termination, and (iii) an amount equal to the monthly employer contribution, based on the premiums as of the date of termination, that we
would have made to provide health insurance for the named executive officer if he had remained employed by us for up to 12 months for our Chief Executive Officer and nine months for our other named executive officers. The payments under (i), (ii)
and (iii) will be paid in substantially equal installments in accordance with our payroll practice over 12&nbsp;months for our Chief Executive Officer and nine months for our other named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Severance Plan will also provide that upon a (A) termination by us other than for cause, death or disability or (B) resignation for
&#147;good reason,&#148; as defined in the Severance Plan, in each case within the change in control period, an eligible participant will be entitled to receive, in lieu of the payments and benefits above and subject to the execution and delivery of
an effective release of claims in favor of the Company and continued compliance with all applicable restrictive covenants, (I) a lump sum amount equal to 150% of the base salary and 150% of the target annual bonus in effect immediately prior to the
date of termination (or immediately prior to the change in control, if higher) for our Chief Executive Officer and 100% of the base salary and 100% of the target annual bonus in effect immediately prior to the date of termination (or immediately
prior to the change in control, if higher) for our other named executive officers (II)&nbsp;a lump sum amount equal to the monthly employer contribution, based on the premiums as of the date of termination, that we would have made to provide health
insurance for the participant if the applicable named executive officer had remained employed by us for 18 months for our Chief Executive Officer and 12 months for our other named executive officers and (III) for all outstanding and unvested equity
awards of the Company that are subject to time-based vesting held by the participant, full accelerated vesting of such awards; provided, that the performance conditions applicable to any outstanding and unvested equity awards subject to
performance-based vesting will be deemed satisfied at the target level specified in the terms of the applicable award agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
payments and benefits provided under the Severance Plan in connection with a change in control may not be eligible for a federal income tax deduction by us pursuant to Section&nbsp;280G of the Code. These payments and benefits may also subject an
eligible participant, including the named executive officers, to an excise tax under Section&nbsp;4999 of the Code. If the payments or benefits payable in connection with a change in control would be subject to the excise tax imposed under
Section&nbsp;4999 of the Code, then those payments or benefits will be reduced if such reduction would result in a higher net after-tax benefit to the participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal 2019 <FONT STYLE="white-space:nowrap">Year-End</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards held by our named executive officers as of December&nbsp;31,
2019: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Awards<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Awards<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options&nbsp;(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock that<BR>have Not<BR>Vested (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value of<BR>Shares&nbsp;or<BR>Units&nbsp;of<BR>Stock that<BR>have
Not<BR>Vested&nbsp;($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Bernard Coulie, M.D.,&nbsp;Ph.D</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/8/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">253,125</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">641,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158,334</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Keith Cummings, M.D.,&nbsp;MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/31/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">403,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,209,186</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Hans&nbsp;Hull,&nbsp;J.D</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/7/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/9/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,938</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/8/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,188</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,625</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each equity award is subject to the terms of our 2015 Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Based on the fair market value of a share of our common stock on 12/31/19, which was $0.99. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">25% of the shares vest on the first anniversary of the vesting commencement date and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the named executive officer&#146;s continuous service
relationship with us through each applicable vesting date. Notwithstanding the foregoing, the shares are subject to certain acceleration of vesting provisions upon the occurrence of certain events or termination of the named executive officer&#146;s
service relationship, provided that the named executive officer is in &#147;good standing&#148; (as defined in the applicable restricted stock award agreement) at the time of such event and subject to the named executive officer&#146;s continued
service to the Company through such event or termination: (i) acceleration of vesting of 25% of the shares subject to the award upon the named executive officer&#146;s death; (ii) acceleration of vesting of 12.5% of the shares subject to the award
upon a termination of employment by the Company; and (iii) acceleration of vesting of 100% of the then unvested shares upon a termination in connection with or after a &#147;sale event&#148; (as defined in the applicable restricted stock award
agreement). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the shares vest and become exercisable on each monthly anniversary while the named executive officer is providing continuous service to the Company through
each vesting date. Notwithstanding the foregoing, in the event of a &#147;change in control&#148; (as defined in our 2015 Plan) (i) pursuant to which the award is assumed or continued by the surviving or acquiring corporation in such change in
control, as determined by our board of directors, and (ii) we terminate the named executive officer&#146;s continuous service without &#147;cause&#148; (as defined in our 2015 Plan) or the named executive officer terminates his employment for
&#147;good reason&#148; (as defined in the applicable stock option award agreement), in either case within twelve (12) months following such change in control and subject to the named executive officer&#146;s execution and non-revocation of a
release of claims in the form prescribed by us within sixty (60) days after the date of such termination, the award shall be 100% vested upon the date of such termination of employment. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">100% of the shares subject to the option shall vest upon the closing of a partnering transaction approved by our board of directors between us and a pharmaceutical company; provided (i) that such closing must occur by
December 31, 2020; (ii) that the definitive agreement for such transaction provides that the we shall have a right to payment of at least $10,000,000 at or within 90 days of closing, a right to payment in the event of the achievement of
developmental or sales milestones, and a right to receive royalties in the event of commercial sales; and (iii) that the named executive officer must be providing continuous service to us through such vesting. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employee Benefits and Equity Compensation Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2020 Stock Option and Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, our board of directors plans to adopt a 2020 Stock Option and Incentive Plan, or the 2020 Plan. The 2020 Plan
will become effective on the date immediately prior to the date on which the registration statement of which this prospectus is part is declared effective by the SEC. The 2020 Plan will replace our 2015 Plan, as our board of directors will not to
make additional awards under the 2015 Plan following the closing of this offering. The 2020 Plan will provide flexibility to our compensation committee to use various equity-based incentive awards as compensation tools to motivate our workforce.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will initially
reserve&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, or the Initial Limit, for the issuance of awards under the 2020 Plan. The 2020 Plan provides that the number of shares
reserved and available for issuance under the plan will automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2020, by &nbsp;&nbsp;&nbsp;&nbsp;% of the outstanding number of shares of our common stock on the immediately preceding
December&nbsp;31, or such lesser number of shares as determined by our compensation committee. This is referred to herein as the Annual Increase. This number will be subject to adjustment in the event of a stock split, stock dividend or other change
in our capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares we issue under the 2020 Plan will be authorized but unissued shares or shares that we reacquire. The
shares of common stock underlying any awards that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without any issuance of
stock, expire or are otherwise terminated (other than by exercise) under the 2020 Plan and the 2015 Plan will be added back to the shares of common stock available for issuance under the 2020 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The maximum aggregate number of shares that may be issued in the form of incentive stock options may not exceed the Initial Limit cumulatively
increased on January&nbsp;1, 2020, and on each January&nbsp;1 thereafter by the lesser of (i)&nbsp;the Annual Increase for such year or (ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
common stock. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant date fair value of all awards made under our 2020 Plan and all other cash compensation paid by us to any <FONT
STYLE="white-space:nowrap">non-employee</FONT> director in any calendar year may not exceed $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for the first year of service and
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for each year of service thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
2020 Plan will be administered by our compensation committee. Our compensation committee will have full power to select, from among the individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of
awards to participants, and to determine the specific terms and conditions of each award, subject to the provisions of the 2020 Plan. Persons eligible to participate in the 2020 Plan will be those full or part-time employees, <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors and consultants of the Company and its affiliates, as selected from time to time by our compensation committee in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan will permit the granting of both options to purchase common stock intended to qualify as incentive stock options under
Section&nbsp;422 of the Internal Revenue Code and options that do not so qualify. The option exercise price of each option will be determined by our compensation committee but may not be less than 100% of the fair market value of our common stock on
the date of grant. The term of each option will be fixed by our compensation committee and may not exceed ten years from the date of grant. Our compensation committee will determine at what time or times each option may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee will be able to award stock appreciation rights subject to such conditions and restrictions as it may determine.
Stock appreciation rights will entitle the recipient to shares of common stock or cash, equal to the value of the appreciation in our stock price over the exercise price. The exercise price of each stock appreciation right may not be less than 100%
of the fair market value of the common stock on the date of grant. The term of each stock appreciation right will be fixed by our compensation committee and may not exceed ten years from the date of grant. Our compensation committee will determine
at what time or times each stock appreciation right may be exercised. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee will be able to award restricted
shares of common stock and restricted stock units to participants subject to such conditions and restrictions as it may determine. These conditions and restrictions may include the achievement of certain performance goals and/or continued employment
or service relationship with us through a specified vesting period. Our compensation committee may also be permitted to grant shares of common stock that are free from any restrictions under the 2020 Plan. Unrestricted stock may be granted to
participants in recognition of past services or other valid consideration and may be issued in lieu of cash compensation due to such participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee will be able to grant cash bonuses under the 2020 Plan to
participants, subject to the achievement of certain performance goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan will provide that upon the effectiveness of a
&#147;sale event,&#148; as defined in the 2020 Plan, an acquirer or successor entity may assume, continue or substitute outstanding awards under the 2020 Plan. To the extent that awards granted under our 2020 Plan are not assumed or continued or
substituted by the successor entity, except as may be otherwise provided in the relevant award certificate, all awards with time-based vesting, conditions or restrictions will become fully vested and nonforfeitable as of the effective time of the
sale event, and all awards with conditions and restrictions relating to the attainment of performance goals may become vested and nonforfeitable in connection with a sale event in the compensation committee&#146;s discretion or to the extent
specified in the relevant award certificate. Upon the effective time of the sale event, all outstanding awards granted under the 2020 Plan will terminate to the extent not assumed, continued or substituted for. In the event of such termination,
individuals holding options and stock appreciation rights will be permitted to exercise such options and stock appreciation rights (to the extent exercisable) within a specified period of time prior to the sale event. In addition, in connection with
the termination of the 2020 Plan upon a sale event, we may make or provide for a payment, in cash or in kind, to participants holding vested and exercisable options and stock appreciation rights equal to the difference between the per share cash
consideration payable to stockholders in the sale event and the exercise price of the options or stock appreciation rights and we may make or provide for a payment, in cash or in kind, to participants holding other vested awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will be able to amend or discontinue the 2020 Plan and our compensation committee will be permitted, at any time, to
amend or cancel outstanding awards for purposes of satisfying changes in law or any other lawful purpose but no such action may adversely affect rights under an award without the holder&#146;s consent. The compensation committee is specifically
authorized to exercise its discretion to reduce the exercise price of outstanding stock options or stock appreciation rights or effect the repricing of such awards through cancellation and <FONT STYLE="white-space:nowrap">re-grants.</FONT> Certain
amendments to the 2020 Plan will require the approval of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No awards will be granted under the 2020 Plan after the date
that is 10&nbsp;years from the date of stockholder approval. No awards under the 2020 Plan will be made prior to the date of this prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2015 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors adopted, and our stockholders approved, our 2015 Plan, on August&nbsp;19, 2015. Our 2015 Plan was most recently amended
on January&nbsp;1, 2019. The 2015 Plan allowed for the grant of incentive stock options to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock
awards, restricted stock units and other stock awards to employees, directors, and consultants, including employees and consultants of our affiliates, subject in each case to compliance with applicable tax laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Plan will become effective the day before the date that the registration statement of which this prospectus is part is declared
effective by the SEC. As a result, we do not expect to grant any additional awards under the 2015 Plan following that date. Any awards granted under the 2015 Plan will remain subject to the terms of our 2015 Plan and applicable award agreements. As
of December&nbsp;31, 2018, options to purchase 809,200 shares of common stock and unexercised rights to purchase 32,600 shares of restricted stock were outstanding under the 2015 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The maximum number of shares of our common stock that may have been issued under our 2015 Plan was 21,150,000. The maximum number of shares of
stock that may have been issued pursuant to the exercise of incentive stock options was three times such maximum number of shares. Shares subject to stock awards granted under our 2015 Plan that expire, are forfeited, are repurchased or otherwise
terminate without all the shares covered by such stock awards having been issued, or are settled in cash, do not reduce the number of shares available for issuance under our 2015 Plan. Additionally, shares used to pay the exercise price or purchase
price </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of a stock award or shares reacquired by the Company to satisfy the tax withholding obligations related to a stock award will return to the share reserve under the 2015 Plan. The shares issuable
pursuant to stock awards granted under the 2015 Plan are authorized but unissued or reacquired shares, including shares repurchased by the Company on the open market or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s board of directors or a duly authorized committee of our board of directors administers our 2015 Plan and the stock awards
granted under it, and has the power to interpret and administer our 2015 Plan and any agreement thereunder and to determine the terms of awards, including the recipients, the number of shares subject to each award, the exercise, purchase or strike
price, if any, the vesting schedule applicable to the awards together with any vesting acceleration and the terms of the award agreement for use under our 2015 Plan. Under the 2015 Plan, the board of directors also generally has the authority to
effect, with the consent of any adversely affected participant, the reduction of the exercise price of any outstanding option or stock appreciation right, the cancellation of any outstanding option or stock appreciation right and the grant in
substitution therefore of other awards, cash, or other consideration, or any other action that is treated as a repricing under generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the 2015 Plan and subject to applicable law, the plan administrator may, in its discretion, delegate to one of more of our
officers, the power to designate <FONT STYLE="white-space:nowrap">non-officer</FONT> employees as recipients of options and/or stock appreciation rights and to determine the number of shares subject to such stock awards to be granted to such
employees; provided, however, the plan administrator must specify the total number of shares that may be subject to the stock awards granted by such officer and such officer may not grant options to himself or herself. The board of directors may not
delegate the authority to determine the fair market value of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2015 Plan provides that in the event of certain
specified significant corporate transactions, generally including: (i)&nbsp;a sale of all or substantially all of our assets, (ii)&nbsp;the sale or disposition of at least 90% of our outstanding securities, (iii)&nbsp;the consummation of a merger or
consolidation where we do not survive the transaction, and (iv)&nbsp;the consummation of a merger or consolidation where we do survive the transaction but the shares of common stock outstanding before such transaction are converted or exchanged into
other property by virtue of the transaction, unless otherwise provided in an award agreement or other written agreement between us and the award holder, the administrator may take one or more of the following actions with respect to such stock
awards: (A)&nbsp;arrange for the assumption, continuation or substitution of a stock award by a successor corporation, (B)&nbsp;arrange for the assignment of any reacquisition or repurchase rights held by us to a successor corporation,
(C)&nbsp;accelerate the vesting, in whole or in part, of the stock award and provide for its termination before the transaction, (D)&nbsp;arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us,
(E)&nbsp;cancel or arrange for the cancellation of the stock award before the transaction in exchange for a cash payment, if any, determined by the board of directors, or (F)&nbsp;make a payment, in the form determined by the board of directors,
equal to the excess, if any, of the value of the property the participant would have received on exercise of the stock award before the transaction over any exercise price payable by the participant in connection with the exercise. The plan
administrator is not obligated to treat all stock awards, even those that are of the same type, or all participants, in the same manner. In the event of a change in control, awards granted under the 2015 Plan will not receive automatic acceleration
of vesting and exercisability, although the board of directors may provide for this treatment in an award agreement. Under the 2015 Plan, a change in control is defined to include (i)&nbsp;the acquisition by any person of more than 50% of the
combined voting power of our then outstanding stock, (ii)&nbsp;a merger, consolidation, or similar transaction in which our stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined voting
power of the surviving entity (or the parent of the surviving entity), or (iii)&nbsp;a sale, lease, exclusive license, or other disposition of all or substantially all of the assets to an entity that did not previously hold more than 50% of the
voting power of our stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our 2015 Plan, the board of directors may provide for limitations on the transferability of awards, in
its sole discretion. Option awards are generally not transferable other than by will or the laws of descent and distribution, except as otherwise provided under our 2015 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has the authority to amend, suspend, or terminate our 2015 Plan,
although certain material amendments require the approval of our stockholders, and amendments that would impair the rights of any participant require the written consent of that participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has determined not to make any further awards under the 2015 Plan following the completion of this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2020 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, our board of directors plans to adopt a 2020 Employee Stock Purchase Plan, or the 2020 ESPP, which will
become effective on the date immediately prior to the date on which the registration statement of which this prospectus is part is declared effective by the SEC. The 2020 ESPP will initially reserve and authorize the issuance of up to a total
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock to participating employees. The 2020 ESPP will provide that the number of shares reserved and available for issuance will
automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2020, by the least of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, &nbsp;&nbsp;&nbsp;&nbsp;% of
the outstanding number of shares of our common stock on the immediately preceding December&nbsp;31, or such lesser number of shares as determined by our compensation committee. This number will be subject to adjustment in the event of a stock split,
stock dividend or other change in our capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All employees whose customary employment is for more
than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hours per week and who have completed at least&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;days of
employment will be eligible to participate in the 2020 ESPP. Any employee who owns 5% or more of the total combined voting power or value of all classes of stock will not be eligible to purchase shares under the 2020 ESPP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will make one or more offerings, consisting of one or more purchase periods, each year to our employees to purchase shares under the 2020
ESPP. Offerings will usually begin every six months and will continue for <FONT STYLE="white-space:nowrap">six-month</FONT> periods, referred to as offering periods. Each eligible employee may elect to participate in any offering by submitting an
enrollment form at least 15&nbsp;business days before the relevant offering date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each employee who is a participant in the 2020 ESPP may
purchase shares by authorizing contributions of between 1% and &nbsp;&nbsp;&nbsp;&nbsp;% of his or her compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated
contributions will be used to purchase shares on the last business day of the purchase period at a price equal to 85% of the fair market value of the shares on the first business day of the offering period or the last business day of the purchase
period, whichever is lower, provided that no more than&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock (or a lesser number as established by the plan administrator in advance of
the purchase period) may be purchased by any one employee during each purchase period. Under applicable tax rules, an employee may purchase no more than $25,000 worth of shares of common stock, valued at the start of the offering period, under the
2020 ESPP for each calendar year in which a purchase right is outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accumulated contributions of any employee who is not a
participant on the last day of a purchase period will be refunded. An employee&#146;s rights under the 2020 ESPP terminate upon voluntary withdrawal from the plan or when the employee ceases employment with us for any reason. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 ESPP may be terminated or amended by our board of directors at any time, but will automatically terminate on the <FONT
STYLE="white-space:nowrap">10-year</FONT> anniversary of this offering. An amendment that increases the number of shares of common stock that are authorized under the 2020 ESPP and certain other amendments will require the approval of our
stockholders. The plan administrator may adopt subplans under the 2020 ESPP for employees of our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Senior Executive Cash Incentive Bonus Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, our board of directors plans to adopt a Senior Executive Cash Incentive Bonus Plan, or the Bonus Plan. The
Bonus Plan will provide for cash bonus payments based upon the attainment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of performance targets established by our compensation committee. The payment targets will be related to financial and operational measures or objectives with respect to our company, or corporate
performance goals, as well as individual performance objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee may select corporate performance goals from
among the following: cash flow (including, but not limited to, operating cash flow and free cash flow); sales or revenue; corporate revenue; earnings before interest, taxes, depreciation and amortization; net income (loss) (either before or after
interest, taxes, depreciation and/or amortization); changes in the market price of our common stock; economic value-added; development, clinical, regulatory or commercial milestones; acquisitions or strategic transactions, partnerships or joint
ventures; operating income (loss); return on capital, assets, equity, or investment; stockholder returns; return on sales; gross or net profit levels; productivity; expense efficiency; margins; operating efficiency; customer satisfaction; working
capital; earnings (loss) per share of our common stock; sales or market shares; number of customers; operating income and/or other strategic, financial or operational objectives, any of which may be measured in absolute terms, as compared to any
incremental increase, in terms of growth, as compared to results of a peer group, against the market as a whole, compared to applicable market indices and/or measured on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> or <FONT
STYLE="white-space:nowrap">post-tax</FONT> basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each executive officer who is selected to participate in the Bonus Plan will have a
target bonus opportunity set for each performance period. The bonus formulas will be adopted in each performance period by the compensation committee and communicated to each executive. The corporate performance goals will be measured at the end of
each performance period after our financial reports have been published or such other appropriate time as the compensation committee determines. If the corporate performance goals and individual performance objectives are met, payments will be made
as soon as practicable following the end of each performance period, but not later than 74 days after the end of the fiscal year in which such performance period ends. Subject to the rights contained in any agreement between the executive officer
and us, an executive officer must be employed by us on the bonus payment date to be eligible to receive a bonus payment. The Bonus Plan will also permits the compensation committee to approve additional bonuses to executive officers in its sole
discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_13a"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, we provided compensation to our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors for their services on our board of directors, other than those associated with Third Rock Ventures or Cowen, pursuant to our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policies generally provide for an annual $25,000 cash retainer;
however, Dr.&nbsp;Huh&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy did not provide for any cash retainers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon initial election to our board of directors, Drs. Bruhn, Curnutte and Huh were granted a certain number of shares of our
restricted common stock (approximately 180,000 shares for Drs. Bruhn and Curnutte and 668,228 shares for Dr.&nbsp;Huh) and Ms. Shah was granted an option to purchase 180,000 shares of our common stock, together, the Initial <FONT
STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants. Ms. Crowell did not receive an Initial Pre-IPO Director Grant. The Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants vest on the last date of each calendar quarter
after the applicable <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s commencement of his or her service to the Company, at a rate of approximately 11,250 shares for Ms. Shah and Drs. Bruhn and Curnutte and 41,768 for
Dr.&nbsp;Huh, subject to continued service to the Company through each applicable vesting date. Upon a &#147;sale event&#148; (as defined in the applicable <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy), the
Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants will vest in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or following each anniversary of the
Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grant, continuing <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are generally entitled to receive a grant of an option to purchase approximately 25,000 shares of our
common stock, or an Annual Pre-IPO Director Grants. During the fiscal year ended December 31, 2019, Drs. Bruhn and Curnutte were each granted an option to purchase approximately 25,000 shares of our common stock as their Annual <FONT
STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grant; however Dr. Huh did not receive an Annual Pre-IPO Director Grant. The Annual <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants vest in equal quarterly installments over one year
from the date of grant, subject to the applicable director&#146;s continued service to the Company through each applicable vesting date. Upon a sale event, such grants will vest in full. In addition to her Annual Pre-IPO Director Grant, in March
2019, Dr. Bruhn received an option to purchase 29,000 shares of our common stock, which was fully vested as of the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Employee directors received no additional compensation for their service as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We reimbursed all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred
by directors for their attendance at meetings of our board of directors or any committee thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to adopt a new <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation policy which will become effective immediately prior to the completion of this offering, pursuant to which our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors will
be eligible to receive certain cash retainers (which will be prorated for partial years of service) and equity awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the total compensation that was earned by or paid to each of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors during the fiscal year ended December&nbsp;31, 2019. Dr.&nbsp;Coulie, who is our Chief Executive Officer, did not receive any additional compensation for his service as a director. The
compensation received by Dr.&nbsp;Coulie, as a named executive officer of the Company, is presented in &#147;Executive Compensation&#151;2019 Summary Compensation Table&#148; above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>Earned&nbsp;or<BR>Paid<BR>in Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Suzanne Bruhn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Curnutte, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Exter<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hoyoung Huh, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Raidy<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Smital Shah<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">153,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gayle Crowell<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represent the aggregate grant date fair value of the stock option awards granted to the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in the fiscal year ended December&nbsp;31,
2019, calculated in accordance with FASB ASC Topic&nbsp;718. Such grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the stock option awards reported in this
column are set forth in note&nbsp;11 to our consolidated financial statements included elsewhere in this prospectus. The amounts reported in this column reflect the accounting cost for these stock option awards and do not correspond to the actual
economic value that may be received by the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors upon the vesting of the stock option awards or any sale of the underlying shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Dr.&nbsp;Bruhn held 209,350 shares of restricted stock and options to purchase 54,000 shares of our common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Dr.&nbsp;Curnutte held 209,350 shares of restricted stock and an option to purchase 25,000 shares of our common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Mr.&nbsp;Exter did not hold any outstanding equity awards. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Dr.&nbsp;Homcy provided us with technical consulting services and received fees for such services. As of December 31, 2019, Dr. Homcy held 500,000 shares of restricted stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Dr.&nbsp;Huh held 713,288 shares of restricted stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Mr.&nbsp;Raidy did not hold any outstanding equity awards. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms. Shah has served as a member of the board of directors since March 2019 and her board fees were prorated accordingly. As of December&nbsp;31, 2019, Ms. Shah held an option to purchase 180,000 shares of our common
stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms. Crowell has served as a member of the board of directors since December 2019 and her board fees were prorated accordingly. As of December 31, 2019, Ms. Crowell did not hold any outstanding equity awards
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_14"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the compensation arrangements, including employment, termination of employment and change in control arrangements, with our
directors and executive officers, including those discussed in the sections entitled &#147;Management&#148; and &#147;Executive and Director Compensation,&#148; and the registration rights described in the section entitled &#147;Description of
Capital Stock&#151;Registration Rights,&#148; the following is a description of each transaction since January&nbsp;1, 2017 and each currently proposed transaction in which: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have been or are to be a participant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amounts involved exceeded or will exceed $120,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the
immediate family of the foregoing persons, had or will have a direct or indirect material interest. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placements of Securities
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series A redeemable convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From August 2015 through March 2018, we sold an aggregate of 56,000,000 shares of our Series A redeemable convertible preferred stock at a
purchase price of $1.00 per share, for an aggregate purchase price of $56.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All purchasers of our Series A redeemable
convertible preferred stock are entitled to specified registration rights. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series A redeemable convertible preferred stock purchased by members of our board of directors or their
affiliates and holders of more than 5% of our outstanding capital stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series A</B><br><B>redeemable<BR>convertible<BR>preferred<BR>stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>purchase</B><br><B>price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Third Rock
Ventures<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">pH Pharma Co., Ltd.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 39,750,000 shares held by Third Rock Ventures III, L.P., or TRV III, and 15,250,000 shares held by Third Rock Ventures IV, L.P., or TRV IV. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Hoyoung Huh, M.D., Ph.D., our lead director, has a majority ownership in pH Pharma Co. Ltd., or pH Pharma, and has voting power over the shares. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series B redeemable convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From July 2018 through November 2018, we sold an aggregate of 49,501,221 shares of our Series B redeemable convertible preferred stock at a
purchase price of $1.3767 per share, for an aggregate purchase price of approximately $68.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All purchasers of our Series B
redeemable convertible preferred stock are entitled to specified registration rights. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series B redeemable convertible preferred stock purchased
by members of our board of directors or their affiliates and holders of more than 5% of our outstanding capital stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series B</B><br><B>redeemable<BR>convertible<BR>preferred<BR>stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>purchase<BR>price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Cowen Healthcare
Investments<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,895,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,999,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Eventide Asset Management LLC<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,895,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,999,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard Coulie and Barbara Leyman, as Trustees of The Coulie/Leyman Family Trust<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">181,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 10,154,302 shares of Series B convertible preferred stock held by Cowen Healthcare Investments II LP, or Cowen II and (b) 741,317 shares of Series B convertible preferred stock held by CHI EF II LP, or
CHI EF II. Cowen Healthcare Investments II GP LLC is the sole general partner of Cowen II and CHI EF II. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 7,263,746 shares of Series B convertible preferred stock held by Eventide Gilead Fund and (b) 3,631,873 shares of Series B convertible preferred stock held by Eventide Healthcare&nbsp;&amp; Life Science
Fund. Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund are registered investment companies for which Eventide Asset Management, LLC acts as investment advisor. Eventide Asset Management, LLC has voting and investment power
with respect to the shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 181,594 shares of Series B convertible preferred stock held by Bernard Coulie and Barbara Leyman, as Trustees of The Coulie/Leyman Family Trust, or Coulie/Leyman Family Trust, of which Dr.&nbsp;Coulie and
his spouse are the sole trustees. </TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series C redeemable convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From December 2019 through February 2020, we sold an aggregate of 54,888,058 shares of our Series C redeemable convertible preferred stock at a
purchase price of $1.83 per share, for an aggregate purchase price of approximately $100.4 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All purchasers of our Series C
redeemable convertible preferred stock are entitled to specified registration rights. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series C redeemable convertible preferred stock purchased by our executive officers, members of our board
of directors or their affiliates and holders of more than 5% of our outstanding capital stock. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series C<BR>redeemable<BR>convertible<BR>preferred<BR>stock </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>purchase<BR>price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Novartis<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,928,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Cowen Healthcare
Investments<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,723,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,999,999.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Eventide Asset Management LLC<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,464,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,999,998.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redmile Biopharma Investments II, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,661,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,999,999.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith Cummings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,999.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,999.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara Howes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,999.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 10,928,962 shares of Series C redeemable convertible preferred stock held by Novartis </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 2,548,025 shares of Series C redeemable convertible preferred stock held by Cowen Healthcare Investments II LP, or Cowen II and (b) 184,215 shares of Series C convertible preferred stock held by CHI EF
II LP, or CHI EF II. Cowen Healthcare Investments II GP LLC is the sole general partner of Cowen II and CHI EF II. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">Consists of (a) 3,825,136 shares of Series C redeemable convertible preferred stock held by Mutual Fund Series
Trust, on behalf of Eventide Gilead Fund, and (b) 1,639,344 shares of Series C redeemable convertible preferred stock held by Mutual Fund Series Trust, on </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">
behalf of Eventide Healthcare &amp; Life Sciences Fund. Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund are registered investment companies for which Eventide Asset
Management, LLC acts as investment advisor. Eventide Asset Management, LLC has voting and investment power with respect to the shares. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Investors&#146; rights agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into an Amended and Restated Investors&#146; Rights Agreement, as amended to date, which we refer to as our
investors&#146; rights agreement, with certain holders of our outstanding redeemable convertible preferred stock, including entities with which certain of our directors are affiliated. After the completion of this offering, the holders of shares of
our common stock issuable in connection with the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into common stock, are entitled to rights with respect to the registration of their shares following this
offering under the Securities Act. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into an Amended and Restated Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement,
as amended to date, which we refer to as our right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreement, which imposes restrictions on the transfer of our capital stock. Upon the completion of this offering, the right of
first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreement will terminate and the restrictions on the transfer of our capital stock set forth in this agreement will no longer apply. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into an Amended and Restated Voting Agreement, as amended to date, which we refer to as our voting agreement,
under which certain holders of our capital stock, including persons who hold more than 5% of our outstanding capital stock and entities with which certain of our directors are affiliated, have agreed to vote their shares on certain matters,
including with respect to the election of directors. Upon the completion of this offering, the voting agreement will terminate and none of our stockholders will have any special rights regarding the election or designation of members of our board of
directors or the voting of our capital stock of the company. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Consulting or research agreements with related parties
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain employees of Third Rock Ventures, one of our stockholders, provide consulting services to us. Consulting service
expenses of $54,000 and $36,000 were recorded for the years ended December&nbsp;31, 2018 and 2019, respectively. The consulting fees were paid in consideration for certain ordinary course business operations and management consulting services
provided to us from time to time by individuals related to Third Rock Ventures. There is no written agreement for the services provided to us by Third Rock Ventures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Charitable contributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018 and 2019, we made charitable contributions to the University of California, San Francisco Foundation (&#147;UCSF Foundation&#148;),
which were directed to support research performed in the laboratories of two of our scientific founders. Charitable contributions made to the UCSF Foundation were $0.5&nbsp;million and $0.3 million during the years ended December 31, 2018 and 2019,
respectively, which were directed to support research performed in the laboratories of two of our scientific founders. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officer and
Director Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the sections entitled &#147;Executive Compensation&#148; and &#147;Director Compensation&#148; for
information regarding compensation of our executive officers and directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than as described above, since January&nbsp;1, 2017, we have not entered into any transactions, nor are there any currently proposed
transactions, between us and a related party where the amount involved exceeds, or would exceed, $120,000, and in which any related person had or will have a direct or indirect material interest. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection
with this offering, we intend to enter into new agreements to indemnify our directors and executive officers. These agreements and our amended and restated certificate of incorporation and amended and restated bylaws will, among other things,
require us to indemnify these individuals for certain expenses (including attorneys&#146; fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our right, on
account of any services undertaken by such person on behalf of our company or that person&#146;s status as a member of our board of directors to the maximum extent allowed under Delaware law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies for Approval of Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, we have not had a formal policy regarding approval of transactions with related parties. Prior to the completion of
this offering, we expect to adopt a written related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. The policy will become effective
immediately upon the execution of the underwriting agreement for this offering. For purposes of our policy only, a related person transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or
relationships, in which we and any related person are, were, or will be participants and in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or director are not covered by
this policy. A related person is any executive officer, director, or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related
person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our audit
committee, or, if audit committee approval would be inappropriate, to another independent body of our board of directors, for review, consideration, and approval or ratification. The presentation must include a description of, among other things,
the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction, and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated
third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer, and, to the extent feasible, significant stockholder to enable us to identify any
existing or potential related person transactions and to effectuate the terms of the policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under our Code of Conduct,
which we intend to adopt in connection with this offering, our employees and directors have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering related person transactions, our audit committee, or other independent body of our board of directors, will take into account
the relevant available facts and circumstances including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs, and benefits to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event that the related person is a director, immediate family
member of a director, or an entity with which a director is affiliated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The policy requires that, in determining whether to approve, ratify, or reject a related
person transaction, our audit committee, or other independent body of our board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our
stockholders, as our audit committee, or other independent body of our board of directors, determines in the good faith exercise of its discretion. All of the transactions described above were entered into prior to the adoption of the written
policy, but all were approved by our board of directors considering similar factors to those described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_15"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information concerning the beneficial ownership of the shares of our common stock as of March 1, 2020 by: </P>
 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person we know to be the beneficial owner of 5% or more of our outstanding shares of our capital stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our current executive officers and directors as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have determined beneficial ownership in accordance with SEC rules. The information does not necessarily indicate beneficial ownership for
any other purpose. Under these rules, a person is deemed to be a beneficial owner of our common stock if that person has a right to acquire ownership within 60 days by the exercise of options or the conversion of our redeemable convertible preferred
stock. A person is also deemed to be a beneficial owner of our common stock if that person has or shares voting power, which includes the power to vote or direct the voting of our common stock, or investment power, which includes the power to
dispose of or to direct the disposition of such capital stock. Except in cases where community property laws apply or as indicated in the footnotes to this table, we believe that each stockholder identified in the table possesses sole voting and
investment power over all shares of common stock shown as beneficially owned by the stockholder. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Percentage of beneficial ownership
in the table below is based on 175,688,337 shares of common stock deemed to be outstanding as of March 1, 2020, assuming the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into common stock, immediately
prior to the completion of this offering. The table below assumes that the underwriters do not exercise their option to purchase additional shares. Shares of common stock subject to options that are currently exercisable or exercisable within 60
days of March 1, 2020 are considered outstanding and beneficially owned by the person holding the options for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the
percentage ownership of any other person. Unless otherwise indicated below, the address of each individual listed below is c/o Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco, California 94080. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and address of beneficial owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares<BR>beneficially<BR>owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of shares<BR>beneficially<BR>owned<BR>before<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of<BR>shares<BR>beneficially<BR>owned<BR>after<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>5% or Greater Stockholders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Entities affiliated with Third Rock
Ventures<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Entities affiliated with Eventide Asset Management
LLC<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,360,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Redmile Biopharma Investments II,
L.P.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,661,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Entities affiliated with Cowen Healthcare
Investments<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,627,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Novartis Institutes for BioMedical Research,
Inc.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,928,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Named Executive Officers and Directors:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Bernard Coulie, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,266,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Keith Cummings, M.D., MBA<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Hans Hull, J.D.<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,412,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,713,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Suzanne Bruhn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">257,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">John Curnutte, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Neil Exter<SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Kevin Raidy<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,627,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Smital Shah<SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gayle Crowell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">All executive officers and directors as a group (13 persons)<SUP
STYLE="font-size:85%; vertical-align:top">(15)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,137,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than one percent. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 2,000,000 shares of common stock held by TRV III, (b) 39,750,000 shares of common stock issuable upon conversion of Series A redeemable convertible preferred stock held by TRV III and (c) 15,250,000
shares of common stock issuable upon conversion of Series A redeemable convertible preferred stock held by TRV IV. The general partner of TRV III is Third Rock Ventures GP III, L.P., or TRV GP III LP. The general partner of TRV GP III LP is TRV GP
III, LLC, or TRV GP III LLC. Mark Levin, Kevin Starr and Robert Tepper, M.D. are the managing members of TRV GP III LLC who collectively make voting and investment decisions with respect to shares held by TRV III. Each of TRV GP III LP, TRV GP III
LLC, Mr.&nbsp;Levin, Mr.&nbsp;Starr and Dr.&nbsp;Tepper disclaims beneficial ownership of the shares held by TRV III, except to the extent of its or his proportionate pecuniary interest therein, if any. The general partner of TRV IV is Third Rock
Ventures GP IV, L.P., or TRV GP IV LP. The general partner of TRV GP IV LP is TRV GP IV, LLC, or TRV GP IV LLC. Abbie Celniker, Ph.D., Dr.&nbsp;Tepper, Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV GP IV LLC who collectively make
voting and investment decisions with respect to shares held by TRV IV. Each of TRV GP IV LP, TRV GP IV LLC, Dr.&nbsp;Celniker, Dr.&nbsp;Tepper, Mr.&nbsp;Muir and Dr.&nbsp;Pfeffer disclaims beneficial ownership of the shares held by TRV IV, except to
the extent of its, his or her proportionate pecuniary interest therein, if any. The address for TRV III and TRV IV is 29 Newbury Street, Suite 401, Boston, Massachusetts 02116. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 7,263,746 shares of common stock issuable upon conversion of Series B redeemable convertible preferred stock held by Eventide Gilead Fund, (b) 3,631,873 shares of common stock issuable upon conversion of
Series B redeemable convertible preferred stock held by Eventide Healthcare&nbsp;&amp; Life Science Fund (c) 3,825,136 shares of common stock issuable upon conversion of Series C redeemable convertible preferred stock held by Eventide Gilead Fund
and (d) 1,639,344 shares of common stock issuable upon conversion of Series C redeemable convertible preferred stock held by Eventide Healthcare &amp; Life Science Fund. Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund are
registered investment companies for which Eventide Asset Management, LLC acts as investment advisor. Eventide Asset Management, LLC has voting and investment power with respect to the shares. The principal business address of each of Eventide Gilead
Fund and Eventide Healthcare&nbsp;&amp; Life Science Fund is One International Place, Suite #3510, Boston, MA 02110. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 13,661,202 shares of common stock issuable upon conversion of Series C redeemable convertible preferred stock held by Redmile Biopharma Investments II, L.P. Redmile Group, LLC is the investment
manager/adviser to Redmile Biopharma Investments II, L.P. and, in such capacity, exercises sole voting and investment power over all of the shares held by the Redmile Biopharma Investments II, L.P. and may be deemed to be the beneficial owner of
these shares. Jeremy C. Green serves as the managing member of Redmile Group, LLC and also may be deemed to be the beneficial owner of these shares. Redmile Group, LLC and Mr.&nbsp;Green each disclaim beneficial ownership of these shares, except to
the extent of its or his pecuniary interest in such shares, if any. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 10,154,302 shares of common stock issuable upon conversion of Series B redeemable convertible preferred stock held by Cowen II, (b) 741,317 shares of common stock issuable upon conversion of Series B
redeemable convertible preferred stock held by CHI EF II, (c) 2,548,025 shares of common stock issuable upon conversion of Series C redeemable convertible preferred stock held by Cowen II and (d) 184,215 shares of common stock issuable upon
conversion of Series C redeemable convertible preferred stock held by CHI EF II. Cowen Healthcare Investments II GP LLC is the sole general partner of Cowen II and CHI EF II. As managing partner of Cowen II and CHI EF II, Kevin J. Raidy exercises
sole voting and investment power of the securities held by Cowen II and CHI EF II. Mr.&nbsp;Raidy disclaims beneficial ownership of the shares held by Cowen II and CHI EF II, except to the extent of any actual pecuniary interest. The address for
Cowen II and CHI EF II is 599 Lexington Avenue, New York, New York 10022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 181,594 shares of common stock issuable upon conversion of Series B redeemable convertible preferred stock held by Coulie/Leyman Family Trust, of which Dr.&nbsp;Coulie and his spouse are the sole
trustees, (b) 3,209,780 shares of common stock held by Coulie/Leyman Family Trust, of which 225,000 shares are subject to repurchase by us at the original purchase price as of March 1, 2020 and (c) 875,000 shares of common stock underlying options
held by Dr.&nbsp;Coulie exercisable within 60 days of March 1, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 537,415 shares of common stock underlying options held by Dr. Cummings exercisable within 60 days of March 1, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 36,319 shares of common stock issuable upon conversion of Series B redeemable convertible preferred stock held by Mr.&nbsp;Hull (b) 27,322 shares of common stock issuable upon conversion of Series C
redeemable convertible preferred stock held by The Sloger Hull Family Trust, of which Mr. Hull and his spouse are the trustees, (b) 1,002,000 shares of common stock held by Mr.&nbsp;Hull, of which 56,813 shares are subject to repurchase by us at the
original purchase price as of March 1, 2020 and (c) 346,875 shares of common stock underlying options held by Mr.&nbsp;Hull exercisable within 60 days of March 1, 2020. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 1,000,000 shares of common stock issuable upon conversion of Series A redeemable convertible preferred stock held by pH Pharma Co., Ltd., or pH Pharma and (b) 713,288 shares of common stock held by pH
Pharma, of which 292,376 shares are subject to repurchase by us at the original purchase price as of March 1, 2020. Dr.&nbsp;Huh has a majority ownership in pH Pharma and also has voting power over the shares. Dr.&nbsp;Huh disclaims beneficial
ownership of the shares held by pH Pharma, except to the extent of his proportionate pecuniary interest therein. The address for pH Pharma is 9th Fl., <FONT STYLE="white-space:nowrap">The-K</FONT> Twin Towers, Tower A 50 Jongro <FONT
STYLE="white-space:nowrap">1-gil,</FONT> <FONT STYLE="white-space:nowrap">Jongno-gu,</FONT> Seoul 03142, Korea. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 209,350 shares of common stock held by Dr.&nbsp;Bruhn, of which 22,500 shares are subject to repurchase by us at the original purchase price as of March 1, 2020 and (b) 47,750 shares of common stock
underlying options held by Dr.&nbsp;Bruhn exercisable within 60 days of March 1, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 209,350 shares of common stock held by Dr.&nbsp;Curnutte, of which 67,500 shares are subject to repurchase by us at the original purchase price as of March 1, 2020 and (b) 18,750 shares of common stock
underlying options held by Dr.&nbsp;Curnutte exercisable within 60 days of March 1, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Exter is a partner of Third Rock Ventures. Mr.&nbsp;Exter does not have voting or investment power over any of the shares directly held by TRV III and TRV IV referenced in footnote (1)&nbsp;above.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 500,000 shares of common stock held by Dr.&nbsp;Homcy, of which 15,625 shares are subject to repurchase by us at the original purchase price as of March 1, 2020. Dr.&nbsp;Homcy was a partner of Third Rock
Ventures until October 2019 and now serves in an advisory capacity. Dr.&nbsp;Homcy does not have voting or investment power over any of the shares directly held by TRV III and TRV IV referenced in footnote (1)&nbsp;above. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 56,250 shares of common stock underlying options held by Ms.&nbsp;Shah exercisable within 60 days of March&nbsp;1, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See footnotes 6 through 14 above; also includes &#201;ric Lefebvre and Barbara Howes, who are executive officers but not named executive officers. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_16"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, our authorized capital stock will consist of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
common stock, par value $0.0001 per share, and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of preferred stock, par value $0.0001 per share, all of which will be undesignated, and there will be
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock outstanding and no shares of preferred stock outstanding. As of March 1, 2020, we had approximately 122 record holders of our capital stock. All of our outstanding shares of
redeemable convertible preferred stock will convert into shares of our common stock immediately prior to the completion of this offering. In addition, upon the completion of this offering, options to purchase
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock will be outstanding and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock will be reserved for future grants under our equity incentive plans. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description of our capital stock and provisions of our amended and restated certificate of incorporation and bylaws are
summaries of material terms and provisions and are qualified by reference to our amended and restated certificate of incorporation and bylaws, copies of which have been filed with the SEC as exhibits to the registration statement of which this
prospectus is a part. The descriptions of our common stock and preferred stock reflect amendments to our amended and restated certificate of incorporation and bylaws that will become effective immediately prior to the completion of this offering.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of
this offering, we will be authorized to issue one class of common stock. Holders of our common stock are entitled to one vote for each share of common stock held of record for the election of directors and on all matters submitted to a vote of
stockholders. Except as described under &#147;Anti-takeover Effects of Delaware Law and Provisions of our Amended and Restated Certificate of Incorporation and Bylaws&#148; below, a majority vote of the holders of common stock is generally required
to take action under our amended and restated certificate of incorporation and bylaws. Holders of our common stock are entitled to receive dividends ratably, if any, as may be declared by our board of directors out of legally available funds,
subject to any preferential dividend rights of any preferred stock then outstanding. Upon our dissolution, liquidation or winding up, holders of our common stock are entitled to share ratably in our net assets legally available after the payment of
all our debts and other liabilities, subject to the preferential rights of any preferred stock then outstanding. Holders of our common stock have no preemptive, subscription, redemption or conversion rights and no sinking fund provisions are
applicable to our common stock. The rights, preferences and privileges of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate and issue
in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to completion of this offering, all outstanding shares of our redeemable convertible preferred stock will be converted into
shares of our common stock. Upon the completion of this offering, our board of directors will be authorized, without action by the stockholders, to designate and issue up to an aggregate of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of
preferred stock in one or more series. Our board of directors can designate the rights, preferences and privileges of the shares of each series and any of its qualifications, limitations or restrictions. Our board of directors may authorize the
issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of common stock. The issuance of preferred stock, while providing flexibility in connection with possible future
financings and acquisitions and other corporate purposes could, under certain circumstances, have the effect of restricting dividends on our common stock, diluting the voting power of our common stock, impairing the liquidation rights of our common
stock, or delaying, deferring or preventing a change in control of our company, which might harm the market price of our common stock. See also &#147;&#151;Anti-takeover effects of Delaware Law and provisions of our amended and restated certificate
of incorporation and bylaws&#151;Provisions of our amended and restated certificate of incorporation and bylaws&#151;Undesignated preferred stock&#148; below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will make any determination to issue such shares based on its
judgment as to our company&#146;s best interests and the best interests of our stockholders. Upon the completion of this offering, we will have no shares of preferred stock outstanding and we have no current plans to issue any shares of preferred
stock following completion of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 1, 2020, we had outstanding options to purchase 9,795,947 shares of our common stock, with a per share weighted-average exercise
price of $0.45 under our 2015 Plan. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, the holders of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, including
shares issuable upon the automatic conversion of our redeemable convertible preferred stock, or their permitted transferees, which we refer to as our registrable securities, are entitled to rights with respect to the registration of these securities
under the Securities Act. These rights are provided under the terms of the investor rights agreement. The investor rights agreement includes demand registration rights, short-form registration rights and piggyback registration rights. All fees,
costs and expenses incurred in connection with registrations under the investor rights agreement will be borne by us, and all selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares
being registered. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Demand registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning 180 days after the effective date of this registration statement, the holders of our registrable securities are entitled to demand
registration rights. Under the terms of our investor rights agreement, we will be required, upon the request of holders of at least a majority of our outstanding registrable securities, to file a registration statement and use commercially
reasonable efforts to affect the registration of these shares for public resale. We are required to effect up to two registrations pursuant to this provision of the investor rights agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Short form registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, the holders of our registrable securities are also entitled to short form registration rights. Pursuant
to our investor rights agreement, if we are eligible to file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> upon the request of holders of at least 20% of our outstanding registrable securities to sell registrable
securities with an anticipated aggregate offering amount of at least $5.0&nbsp;million net of certain expenses related to the offering, we will be required to use our commercially reasonable efforts to effect a registration of such shares. We are
required to effect up to two registrations in any twelve month period pursuant to this provision of the investor rights agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of our registrable securities are entitled to piggyback registration rights. If we register any of our securities either for our
own account or for the account of other security holders, the holders of our outstanding registrable securities are entitled to include their shares in the registration. Subject to certain exceptions contained in the investor rights agreement, we
and the underwriters may limit the number of shares included in the underwritten offering if the underwriters determine that marketing factors require a limitation of the number of shares to be underwritten. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our investor rights agreement contains customary cross-indemnification provisions, under which we are obligated to indemnify holders of
registrable securities in the event of material misstatements or omissions in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registration statement attributable to us, and they are obligated to indemnify us for material misstatements or omissions attributable to them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Expenses of registration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay the registration expenses, subject to certain limited exceptions contained in the investor rights agreement, of the holders of the
shares registered pursuant to the demand, short form and piggyback registration rights described above, including the expenses of one counsel for the selling holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Expiration of registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration rights granted under the investor rights agreement will terminate upon the earlier of (i)&nbsp;a deemed liquidation event, as
defined in our amended and restated certificate of incorporation (as in effect prior to the completion of this offering) or certain other events constituting a sale of the company, (ii)&nbsp;at such time after our initial public offering when all
registrable securities could be sold under Rule 144 of the Securities Act or a similar exemption without limitation during a three-month period without registration or (iii)&nbsp;the fifth anniversary of our initial public offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Delaware Law and Provisions of Our Amended and Restated Certificate of Incorporation and Bylaws </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of the Delaware General Corporation Law and of our amended and restated certificate of incorporation and bylaws that will
become effective immediately prior to the completion of this offering could have the effect of delaying, deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, are expected to discourage
certain types of coercive takeover practices and inadequate takeover bids and, as a consequence, they might also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover
attempts. These provisions are also designed in part to encourage anyone seeking to acquire control of us to first negotiate with our board of directors. These provisions might also have the effect of preventing changes in our board of directors or
management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders might otherwise deem to be in their best interests. However, we believe that the advantages gained by protecting our ability
to negotiate with any unsolicited and potentially unfriendly acquirer outweigh the disadvantages of discouraging such proposals, including those priced above the then-current market value of our common stock, because, among other reasons, the
negotiation of such proposals could improve their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Delaware takeover statute </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, we will be subject to the provisions of Section&nbsp;203 of the Delaware General Corporation Law. In general,
Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a three-year period following the time that this stockholder becomes an interested
stockholder, unless the business combination is approved in a prescribed manner. Under Section&nbsp;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">before the stockholder became interested, our board of directors approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and
also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or after the time the stockholder became interested, the business combination was approved by our board of
directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock which is not owned by the interested stockholder.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 defines a business combination to include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, transfer, lease, pledge, exchange, mortgage or other disposition involving the interested stockholder
of 10% or more of the assets of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock
of the corporation to the interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other
financial benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines an interested
stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Provisions of our amended and restated certificate of incorporation and bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and bylaws to be in effect immediately prior to completion of this offering will include
a number of provisions that may have the effect of delaying, deferring or discouraging another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with
our board of directors rather than pursue <FONT STYLE="white-space:nowrap">non-negotiated</FONT> takeover attempts. These provisions include the items described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Board composition and filling vacancies</I>. In accordance with our amended and restated certificate of incorporation, our board is divided
into three classes serving staggered three-year terms, with one class being elected each year. Our amended and restated certificate of incorporation also provides that directors may be removed only for cause and then only by the affirmative vote of
the holders of <FONT STYLE="white-space:nowrap">two-thirds</FONT> or more of the shares then entitled to vote at an election of directors. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an
increase in the size of our board, may only be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>No written consent of stockholders</I>. Our amended and restated certificate of incorporation provides that all stockholder actions are
required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder
actions and would prevent the amendment of our bylaws or removal of directors by our stockholder without holding a meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Meetings of stockholders</I>. Our bylaws provide that only a majority of the members of our board of directors then in office may call
special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our bylaws limit the business that may be conducted at an annual meeting of
stockholders to those matters properly brought before the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Advance notice requirements</I>. Our bylaws establish advance notice procedures with
regard to stockholder proposals relating to the nomination of candidates for election as directors or new business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must be timely given
in writing to our corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days or more than 120 days prior to the first
anniversary date of the annual meeting for the preceding year. The notice must contain certain information specified in our bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Amendment to certificate of incorporation and bylaws</I>. As required by the Delaware General Corporation Law, any amendment of our amended
and restated certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our amended and restated certificate of incorporation, must thereafter be approved by a majority of the outstanding
shares entitled to vote on the amendment, and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions relating to stockholder action, directors, limitation of liability and
the amendment of our amended and restated certificate of incorporation must be approved by not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares entitled to vote on the amendment, and not less than <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of each class entitled to vote thereon as a class. Our bylaws may be amended by the affirmative vote of a majority vote of the directors then in office, subject to any
limitations set forth in the bylaws; and may also be amended by the affirmative vote of at least 75% of the outstanding shares entitled to vote on the amendment, or, if the board of directors recommends that the stockholders approve the amendment,
by the affirmative vote of the majority of the outstanding shares entitled to vote on the amendment, in each case voting together as a single class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Undesignated preferred stock</I>. Our amended and restated certificate of incorporation provides for authorized shares of preferred stock.
The existence of authorized but unissued shares of preferred stock may enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For
example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of us or our stockholders, our board of directors could cause shares of preferred stock to
be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our amended and
restated certificate of incorporation grants our board of directors&#146; broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount
of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or
preventing a change in control of us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Exclusive forum</I>. Our bylaws provide that the Court of Chancery of the State of Delaware
shall be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:&nbsp;(i)&nbsp;any derivative action or proceeding brought on behalf of our company, (ii)&nbsp;any action asserting a
claim of breach of a fiduciary duty owed by any of our directors or officers to the company or our stockholders, (iii)&nbsp;any action asserting a claim against our company arising pursuant to any provision of the Delaware General Corporation Law or
our certificate of incorporation or bylaws, (iv)&nbsp;any action to interpret, apply, enforce, or determine the validity of our certificate of incorporation or bylaws, or (v)&nbsp;any action asserting a claim against our company governed by the
internal affairs doctrine. This exclusive forum provision will not apply to any causes of action arising under the Securities Act or the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Although our bylaws
contain the choice of forum provision described above, it is possible that a court could rule that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer agent and registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The transfer agent and
registrar&#146;s address is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to list our common stock on The Nasdaq Global Market under the symbol &#147;PLRX.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations of liability and indemnification matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a discussion of liability and indemnification, see the section entitled &#147;Management &#151; Limitation on Liability and Indemnification
Matters.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_17"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our common stock. Future sales of our common stock in the public market, or the
availability of such shares for sale in the public market, could adversely affect market prices prevailing from time to time. As described below, only a limited number of shares will be available for sale shortly after this offering due to
contractual and legal restrictions on resale. Nevertheless, sales of our common stock in the public market after such restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price at such time
and our ability to raise equity capital in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale of Restricted Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares of common stock outstanding as of March&nbsp;1, 2020, upon completion of this offering,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock will be outstanding, assuming no exercise by the underwriters of their option to purchase additional shares and no exercise of options. All of the shares sold in this offering
will be freely tradable. The remaining shares of common stock outstanding after this offering will be restricted as a result of securities laws or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements as described below. Following the
expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period, all shares will be eligible for resale in compliance with Rule 144 or Rule 701 under the Securities Act. &#147;Restricted securities&#148; as defined under Rule 144 of the
Securities Act were issued and sold by us in reliance on exemptions from the registration requirements of the Securities Act. These shares may be sold in the public market only if registered or qualified for an exemption from registration, such as
under Rule 144 or Rule 701 under the Securities Act. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, a person who has beneficially owned restricted stock for at least six months would be entitled to sell their securities provided
that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, a sale and (ii)&nbsp;we are subject to the Exchange Act periodic reporting requirements for at least 90 days
before the sale. Persons who have beneficially owned restricted shares for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to additional restrictions, by which such
person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the number of shares then outstanding, which will equal
approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares immediately after this offering assuming no exercise of the underwriters&#146; option to purchase additional shares, based on the
number of shares outstanding as of March&nbsp;1, 2020; or </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume of our common stock on The Nasdaq Global Market during the four calendar weeks
preceding the filing of a notice on Form 144 with respect to the sale; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, in each case, that we have been subject to the
Exchange Act periodic reporting requirements for at least 90 days before the sale. Such sales both by affiliates and by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> must also comply with the manner of sale, current public information and
notice provisions of Rule 144. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 701 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rule 701 under the Securities Act, or Rule 701, as in effect on the date of this prospectus, permits resales of shares in reliance upon Rule
144 but without compliance with certain restrictions of Rule 144, including the holding period requirement. Most of our employees, executive officers or directors who purchased shares under a written compensatory plan or contract may be entitled to
rely on the resale provisions of Rule 701, but all holders of Rule 701 shares are required to wait until 90 days after the date of this prospectus before selling their shares. However, substantially all Rule 701 shares are subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements as described below and under &#147;Underwriting&#148; included elsewhere in this prospectus and will become eligible for sale upon the expiration of the restrictions set forth in those agreements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, we, each of our directors and executive officers, and holders of substantially all of our securities have
agreed with the underwriters that for a period of 180 days following the date of this prospectus, subject to certain exceptions, we and they will not offer, sell, assign, transfer, pledge, contract to sell or otherwise dispose of or hedge any shares
of our common stock or any securities convertible into or exchangeable for shares of our common stock. The representatives of the underwriters may, in their sole discretion, at any time, release all or any portion of the shares from the restrictions
in this agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Trading Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the completion of this offering, certain of our officers, directors and significant stockholders may adopt written plans, known as
Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plans, in which they will contract with a broker to buy or sell shares of our common stock on a periodic basis to diversify their assets and investments. Under these <FONT
STYLE="white-space:nowrap">10b5-1</FONT> trading plans, a broker may execute trades pursuant to parameters established by the officer, director or stockholder when entering into the plan, without further direction from such officer, director or
stockholder. Such sales would not commence until the expiration of the applicable <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into by such officer, director or stockholder in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are party to an
investor rights agreement which provides that holders holding &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock, including shares issuable upon the automatic conversion of our redeemable convertible preferred stock, have the
right to demand that we file a registration statement or request that their shares of our common stock be covered by a registration statement that we are otherwise filing. See the section entitled &#147;Description of Capital Stock &#151;
Registration Rights&#148; in this prospectus. Except for shares purchased by affiliates, registration of their shares under the Securities Act would result in these shares becoming freely tradable without restriction under the Securities Act
immediately upon effectiveness of the registration, subject to the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period described above and in the section entitled &#147;Underwriting&#148; in this prospectus, and to the extent
such shares have been released from any repurchase option that we may hold. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Incentive Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As soon as practicable after the completion of this offering, we intend to file a Form <FONT STYLE="white-space:nowrap">S-8</FONT> registration
statement under the Securities Act to register shares of our common stock subject to options and other equity awards outstanding or reserved for issuance under our equity incentive plans. This registration statement will become effective immediately
upon filing, and shares covered by this registration statement will thereupon be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates and any <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements.
For a more complete discussion of our equity incentive plans, see &#147;Executive and Compensation &#151; Employee Benefits and Equity Compensation Plans.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_18"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion is a summary of the material U.S. federal income tax
considerations applicable to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined below) with respect to their ownership and disposition of shares of our common stock issued pursuant to this offering. For purposes of this discussion,
a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder means a beneficial owner of our common stock that is for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien individual; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign corporation or any other foreign organization taxable as a corporation for U.S. federal income tax
purposes; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign estate or trust, the income of which is not subject to U.S. federal income tax on a net income basis.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address the tax treatment of partnerships or other entities that are <FONT
STYLE="white-space:nowrap">pass-through</FONT> entities for U.S. federal income tax purposes or persons that hold their common stock through partnerships or other <FONT STYLE="white-space:nowrap">pass-through</FONT> entities. A partner in a
partnership or other <FONT STYLE="white-space:nowrap">pass-through</FONT> entity that will hold our common stock should consult his, her or its tax advisor regarding the tax consequences of holding and disposing of our common stock through a
partnership or other <FONT STYLE="white-space:nowrap">pass-through</FONT> entity, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is based on current
provisions of the Code, existing and proposed U.S. Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, all as in effect as of the date of this prospectus and, all of which are subject to change or to
differing interpretation, possibly with retroactive effect. Any such change or differing interpretation could alter the tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders described in this prospectus. There can be no
assurance that the Internal Revenue Service, which we refer to as the IRS, will not challenge one or more of the tax consequences described herein. We assume in this discussion that a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds
shares of our common stock as a capital asset within the meaning of Section&nbsp;1221 of the Code, generally property held for investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances including the alternative minimum tax, or the Medicare tax on net investment income, the
timing of income accruals required under Section 451(b) of the Code, the rules regarding qualified small business stock within the meaning of Section&nbsp;1202 of the Code and any election to apply
<FONT STYLE="white-space:nowrap">Section&nbsp;1400Z-2</FONT> of the Code to gains recognized with respect to shares of our common stock. This discussion also does not address any U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
taxes or any other aspect of any U.S. federal tax other than the income tax. This discussion also does not consider any specific facts or circumstances that may apply to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and does not address
the special tax rules applicable to particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders, such as: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> or governmental organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers or dealers in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulated investment companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pension plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds,&#148; or entities wholly-owned by a &#147;qualified foreign pension
fund&#148;; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
partners and investors therein); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or
other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who have elected to mark securities to market; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who have a functional currency other than the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise
as compensation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain U.S. expatriates. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is for general information only and is not tax advice. Accordingly, all prospective
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders of our common stock should consult their tax advisors with respect to the U.S. federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences of the purchase,
ownership and disposition of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions on our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions, if any, on our common stock will constitute dividends for U.S. federal income tax purposes to the extent paid from our current
or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a <FONT STYLE="white-space:nowrap">tax-free</FONT>
return of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s investment, up to such holder&#146;s tax basis in the common stock. Any remaining excess will be treated as capital gain, subject to the tax treatment described below in
&#147;Gain on sale or other taxable disposition of our common stock.&#148; Any such distributions will also be subject to the discussions below under the sections titled &#147;Backup withholding and information reporting&#148; and &#147;Withholding
and information reporting requirements&#151;FATCA.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion in the following two paragraphs in this section,
dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the
United States and such holder&#146;s country of residence. If we or another withholding agent apply <FONT STYLE="white-space:nowrap">over-withholding</FONT> or if a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder does not timely provide us
with the required certification, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may be entitled to a refund or credit of any excess tax withheld by timely filing an appropriate claim with the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends that are treated as effectively connected with a trade or business conducted by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United
States, are generally exempt from the 30% withholding tax if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder satisfies applicable certification and disclosure requirements. However, such U.S. effectively connected income, net of
specified deductions and credits, is taxed at the same graduated U.S. federal income tax rates applicable to U.S. persons (as defined in the Code). Any U.S. effectively connected income received by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder that is a corporation may also, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such
holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our common stock who claims the benefit
of an applicable income tax treaty between the United States and such holder&#146;s country of residence generally will be required to provide a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or successor form) to the applicable withholding agent and satisfy applicable certification and other requirements. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is eligible for a reduced rate of U.S. withholding tax under
an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing a U.S. tax return with the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on sale or other taxable disposition of our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below under &#147;Backup withholding and information reporting&#148; and &#147;Withholding and information reporting
requirements&#151;FATCA,&#148; a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to any U.S. federal income tax on any gain realized upon such holder&#146;s sale or other taxable disposition of shares of our
common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct
of a U.S. trade or business and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a <FONT STYLE="white-space:nowrap">fixed-base</FONT> maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder in the United States, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be taxed on a net income basis at the graduated U.S. federal income tax rates applicable to United States persons (as defined in
the Code) and, if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a foreign corporation, the branch profits tax described above in &#147;Distributions on our common stock&#148; also may apply; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual who is present in
the United States for 183&nbsp;days or more in the taxable year of the disposition and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to a 30% tax (or such lower rate as
may be specified by an applicable income tax treaty between the United States and such holder&#146;s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S. source capital losses of the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any (even though the individual is not considered a resident of the United States), provided that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has timely filed U.S. federal income
tax returns with respect to such losses; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are, or have been, at any time during the <FONT STYLE="white-space:nowrap">five-year</FONT> period preceding
such sale of other taxable disposition (or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period, if shorter) a &#147;U.S. real property holding corporation,&#148; unless our common stock is regularly traded on an
established securities market and the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds no more than 5% of our outstanding common stock, directly or indirectly, actually or constructively, during the shorter of the <FONT
STYLE="white-space:nowrap">5-year</FONT> period ending on the date of the disposition or the period that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder held our common stock. Generally, a corporation is a U.S. real property holding
corporation only if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business.
Although there can be no assurance, we do not believe that we are, or have been, a U.S. real property holding corporation, or that we are likely to become one in the future. No assurance can be provided that our common stock will be regularly traded
on an established securities market for purposes of the rules described above </P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Backup withholding and information reporting
</B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the gross amount of the
distributions on our common stock paid to such holder and the tax withheld, if any, with respect to such distributions. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders may have to comply with specific certification procedures to establish
that the holder is not a U.S. person (as defined in the Code) in order to avoid backup withholding at the applicable rate with respect to dividends on our common stock. Dividends paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders
subject to withholding of U.S. federal income tax, as described above in &#147;Distributions on our common stock,&#148; generally will be exempt from U.S. backup withholding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information reporting and backup withholding will generally apply to the proceeds of a disposition of our common stock by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and satisfies certain other
requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder where the transaction is
effected outside the United States through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, for information reporting purposes, dispositions effected through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of
a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advisors regarding the application of the information reporting and backup withholding rules to them. Copies of information returns may be made available to the tax authorities of the country in
which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is incorporated under the provisions of a specific treaty or agreement. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules
from a payment to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder can be refunded or credited against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, if any, provided that an
appropriate claim is filed with the IRS in a timely manner. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withholding and information reporting requirements&nbsp;&#151; FATCA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions of the Code commonly referred to as the Foreign Account Tax Compliance Act, or FATCA, generally imposes a U.S. federal withholding
tax at a rate of 30% on payments of dividends on our common stock paid to a foreign entity unless (i)&nbsp;if the foreign entity is a &#147;foreign financial institution,&#148; such foreign entity undertakes certain due diligence, reporting,
withholding, and certification obligations, (ii)&nbsp;if the foreign entity is not a &#147;foreign financial institution,&#148; such foreign entity identifies certain of its U.S. investors, if any, or (iii)&nbsp;the foreign entity is otherwise
exempt under FATCA. Under applicable U.S. Treasury regulations, withholding under FATCA currently applies to payments of dividends on our common stock. Currently proposed U.S. Treasury Regulations provide that FATCA withholding does not apply to
gross proceeds from the disposition of property of a type that can produce U.S. source dividends or interest; however, prior versions of the rules would have made such gross proceeds subject to FATCA withholding. Taxpayers (including withholding
agents) can currently rely on the proposed Treasury Regulations. Under certain circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may be eligible for refunds or credits of this withholding tax. An intergovernmental agreement
between the United States and an applicable foreign country may modify the requirements described in this paragraph. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the possible implications of
this legislation on their investment in our common stock and the entities through which they hold our common stock, including, without limitation, the process and deadlines for meeting the applicable requirements to prevent the imposition of the 30%
withholding tax under FATCA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_19"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc., Cowen and Company, LLC and Piper Sandler&nbsp;&amp; Co. are acting as joint book-running managers of this
offering and as representatives of the underwriters named below. Subject to the terms and conditions stated in the underwriting agreement dated the date of this prospectus, each underwriter named below has severally agreed to purchase, and we have
agreed to sell to that underwriter, the number of shares of common stock set forth opposite the underwriter&#146;s name in the following table. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cowen and Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piper Sandler&nbsp;&amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Needham&nbsp;&amp; Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the obligations of the underwriters to purchase the shares
included in this offering are subject to approval of legal matters by counsel and to other conditions. The underwriters are obligated to purchase all the shares (other than those covered by the underwriters&#146; option to purchase additional shares
described below) if they purchase any of the shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares sold by the underwriters to the public will initially be offered at the
initial public offering price set forth on the cover of this prospectus. Any shares sold by the underwriters to securities dealers may be sold at a discount from the initial public offering price not to exceed
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. If all the shares are not sold at the initial offering price, the underwriters may change the offering price and the other selling terms. The representatives have advised us that the
underwriters do not intend to make sales to discretionary accounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters sell more shares than the total number set forth
in the table above, we have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares at the public offering price less the
underwriting discount. The underwriters may exercise the option solely for the purpose of covering over-allotments, if any, in connection with this offering. To the extent the option is exercised, each underwriter must purchase a number of
additional shares approximately proportionate to that underwriter&#146;s initial purchase commitment. Any shares issued or sold under the option will be issued and sold on the same terms and conditions as the other shares that are the subject of
this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, our officers, directors and holders of substantially all of our securities have agreed that, subject to specified
limited exceptions, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of the representatives, dispose of or hedge any shares or any securities convertible into or exchangeable for
shares of our common stock. The representatives, in their sole discretion, may release any of the securities subject to these <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements at any time, which, in the case of officers and directors, shall
be with notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our shares. Consequently, the initial public offering price
for the shares will be determined by negotiations between us and the representatives. Among the factors considered in determining the initial public offering price will be our results of operations, our current financial condition, our future
prospects, our markets, the economic conditions in and future prospects for the industry in which we compete, our management and currently prevailing general conditions in the equity securities markets, including current market valuations of
publicly traded companies considered comparable to our company. We cannot ensure however, that the price at which the shares will sell in the public market after this offering will not be lower than the initial public offering price or that an
active trading market in our shares will develop and continue after this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to have our shares listed on the Nasdaq Global Market under the symbol
&#147;PLRX&#148;. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the underwriting discounts and commissions that we are to pay to the underwriters in
connection with this offering. These amounts are shown assuming both no exercise and full exercise of the underwriters&#146; option to purchase additional shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Paid&nbsp;by&nbsp;Pliant&nbsp;Therapeutics,&nbsp;Inc.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that our portion of the total expenses of this offering will be
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. We have also agreed to reimburse the underwriters for certain FINRA-related and other expenses incurred by them in connection with this offering in an amount up to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters may purchase and sell shares in the
open market. Purchases and sales in the open market may include short sales, purchases to cover short positions, which may include purchases pursuant to the option to purchase additional shares, and stabilizing purchases. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Short sales involve secondary market sales by the underwriters of a greater number of shares than they are
required to purchase in the offering. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Covered&#148; short sales are sales of shares in an amount up to the number of shares represented by the
underwriters&#146; option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Naked&#148; short sales are sales of shares in an amount in excess of the number of shares represented by
the underwriters&#146; option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Covering transactions involve purchases of shares either pursuant to the underwriters&#146; option to purchase
additional shares or in the open market in order to cover short positions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To close a naked short position, the underwriters must purchase shares in the open market. A naked short position
is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To close a covered short position, the underwriters must purchase shares in the open market or must exercise the
option to purchase additional shares. In determining the source of shares to close the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price
at which they may purchase shares through the option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stabilizing transactions involve bids to purchase shares so long as the stabilizing bids do not exceed a
specified maximum. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases to cover short positions and stabilizing purchases, as well as other purchases by the
underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of the shares. They may also cause the price of the shares to be higher than the price that would otherwise exist in the open market in
the absence of these transactions. The underwriters may conduct these transactions on the Nasdaq Global Market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. If the
underwriters commence any of these transactions, they may discontinue them at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters are full service financial institutions engaged in various activities, which may include securities trading, commercial and
investment banking, financial advisory, investment management, principal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
investment, hedging, financing and brokerage activities. The underwriters and their respective affiliates may, from time to time, engage in transactions with and perform services for us in the
ordinary course of their business for which they may receive customary fees and reimbursement of expenses. In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array
of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (which may include bank loans and credit default swaps) for their own account and for the accounts of their customers and may
at any time hold long and short positions in such securities and instruments. Such investments and securities activities may involve securities and instruments of ours or our affiliates. The underwriters and their affiliates may also make investment
recommendations and publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and short positions in such securities and instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Affiliates of Cowen and Company, LLC purchased 10,895,619&nbsp;shares of our Series&nbsp;B redeemable convertible preferred stock in our July
2018 Series&nbsp;B redeemable convertible preferred stock financing and 2,732,240 shares of our Series C redeemable convertible preferred stock in our December 2019 Series&nbsp;C redeemable convertible preferred stock financing. Those shares of
redeemable convertible preferred stock will automatically convert into &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock immediately prior to and in
connection with the completion of this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriters against certain liabilities, including
liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make because of any of those liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the European Economic Area and the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area and the United Kingdom, or each, a &#147;Relevant State,&#148; no shares have
been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant State or, where
appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that offers of shares may be made to the public in that Relevant State at any
time under the following exemptions under the Prospectus Regulation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to any legal entity which is a qualified investor as defined
under the Prospectus Regulation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to fewer than 150 natural or legal persons (other than qualified investors as defined under the
Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) in any other
circumstances falling within Article 1(4) of the Prospectus Regulation, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require the Company or any
underwriter to publish a prospectus pursuant to Article&nbsp;3 of the Prospectus Regulation or supplement a prospectus pursuant to Article&nbsp;23 of the Prospectus Regulation. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to any shares in any Relevant State means the
communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, and the expression &#147;Prospectus
Regulation&#148; means Regulation (EU) 2017/1129. References to the Prospectus Regulation includes, in relation to the United Kingdom, the Prospectus Regulation as it forms part of United Kingdom domestic law by virtue of the European Union
(Withdrawal) Act 2018. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is for distribution only to persons who (i) have professional experience in matters relating to investments and who qualify as
investment professionals within the meaning of Article 19(5) of the Financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">196 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended the &#147;Financial Promotion Order&#148;, (ii)&nbsp;are persons falling within Article 49(2)(a) to (d) (&#147;high net
worth companies, unincorporated associations etc.&#148;) of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section
21 of the Financial Services and Markets Act 2000, as amended, or FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as
&#147;relevant persons&#148;) or otherwise in circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the FSMA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it
as basis for taking any action. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in France </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this prospectus nor any other offering material relating to the shares described in this prospectus has been submitted to the clearance
procedures of the <I>Autorit&eacute; des March&eacute;s Financiers</I> or of the competent authority of another member state of the European Economic Area and notified to the <I>Autorit&eacute; des March&eacute;s Financiers.</I> The shares have not
been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares has been or will be: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">released, issued, distributed or caused to be released, issued or distributed to the public in France; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">used in connection with any offer for subscription or sale of the shares to the public in France.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such offers, sales and distributions will be made in France only: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to qualified investors (<I>investisseurs qualifi&eacute;s</I>) or to a restricted circle of investors (<I>cercle
restreint d&#146;investisseurs</I>), in each case investing for their own account, all as defined in, and in accordance with articles <FONT STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">D.411-1,</FONT> <FONT
STYLE="white-space:nowrap">D.411-2,</FONT> <FONT STYLE="white-space:nowrap">D.734-1,</FONT> <FONT STYLE="white-space:nowrap">D.744-1,</FONT> <FONT STYLE="white-space:nowrap">D.754-1</FONT> and <FONT STYLE="white-space:nowrap">D.764-1</FONT> of the
French <I>Code mon&eacute;taire et financier</I>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to investment services providers authorized to engage in portfolio management on behalf of third parties; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a transaction that, in accordance with article
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.411-2-II-1&deg;</FONT></FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">-or-2&deg;</FONT></FONT> <FONT
STYLE="white-space:nowrap">-or</FONT> 3&deg; of the French <I>Code mon&eacute;taire et financier</I> and article <FONT STYLE="white-space:nowrap">211-2</FONT> of the General Regulations (<I>R&egrave;glement G&eacute;n&eacute;ral</I>) of the
<I>Autorit&eacute; des March&eacute;s Financiers</I>, does not constitute a public offer (<I>appel public &agrave; l&#146;&eacute;pargne</I>). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be resold directly or indirectly, only in compliance with articles <FONT STYLE="white-space:nowrap">L.411-1,</FONT> <FONT
STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">L.412-1</FONT> and <FONT STYLE="white-space:nowrap">L.621-8</FONT> through <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.621-8-3</FONT></FONT> of the
French <I>Code mon&eacute;taire et financier</I>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No securities have been offered or sold, and no securities may be offered or sold, in Hong Kong, by means of any document, other than to
persons whose ordinary business is to buy or sell shares or debentures, whether as principal or agent; or to professional investors, as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong (&#147;SFO&#148;) and any rules made
under that Ordinance; or in other circumstances which do not result in the document being a prospectus, as defined in the Companies Ordinance (Cap. 32) of Hong Kong (&#147;CO&#148;) or which do not constitute an offer or invitation to the public for
the purpose of the CO or the SFO. No document, invitation or advertisement relating to the securities has been issued or may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or
elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted under the securities laws of Hong Kong) other than with respect to securities which are or are intended to
be disposed of only to persons outside Hong Kong or only to professional investors, as defined in the SFO and any rules made under that Ordinance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">197 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been registered with the Registrar of Companies in Hong Kong.
Accordingly, this prospectus may not be issued, circulated or distributed in Hong Kong, and the securities may not be offered for subscription to members of the public in Hong Kong. Each person acquiring the securities will be required, and is
deemed by the acquisition of the securities, to confirm that he is aware of the restriction on offers of the securities described in this prospectus and the relevant offering documents and that he is not acquiring, and has not been offered any
securities in circumstances that contravene any such restrictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Japan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering has not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948 of
Japan, as amended), or FIEL, and the initial purchaser will not offer or sell any securities, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan,
including any corporation or other entity organized under the laws of Japan), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan,
except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the FIEL and any other applicable laws, regulations and ministerial guidelines of Japan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this
prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an
invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore (the
&#147;SFA&#148;), (ii) to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275, of the SFA, or (iii)&nbsp;otherwise pursuant to, and in
accordance with the conditions of, any other applicable provision of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the shares are subscribed or purchased under
Section&nbsp;275 of the SFA by a relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business
of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, securities (as defined in Section&nbsp;239(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be
transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to an institutional investor or to a relevant person defined in Section&nbsp;275(2) of the SFA, or to any person
arising from an offer referred to in Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures)
Regulations 2005 of Singapore. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solely for the purposes of its obligations pursuant to Section&nbsp;309B of the SFA, we
have determined, and hereby notify all relevant persons (as defined in the CMP Regulations 2018), that the shares are &#147;prescribed capital markets products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as
defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">198 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is not a disclosure document for the purposes of Australia&#146;s Corporations Act 2001 (Cth) of Australia, or Corporations
Act, has not been lodged with the Australian Securities&nbsp;&amp; Investments Commission and is only directed to the categories of exempt persons set out below. Accordingly, if you receive this prospectus in Australia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You confirm and warrant that you are either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;sophisticated investor&#148; under section 708(8)(a) or (b)&nbsp;of the Corporations Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;sophisticated investor&#148; under section 708(8)(c) or (d)&nbsp;of the Corporations Act and that you
have provided an accountant&#146;s certificate to the Company which complies with the requirements of section 708(8)(c)(i) or (ii)&nbsp;of the Corporations Act and related regulations before the offer has been made; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person associated with the Company under Section&nbsp;708(12) of the Corporations Act; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;professional investor&#148; within the meaning of section 708(11)(a) or (b)&nbsp;of the Corporations Act.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that you are unable to confirm or warrant that you are an exempt sophisticated investor, associated
person or professional investor under the Corporations Act any offer made to you under this prospectus is void and incapable of acceptance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You warrant and agree that you will not offer any of the securities issued to you pursuant to this prospectus for resale in Australia within
12 months of those securities being issued unless any such resale offer is exempt from the requirement to issue a disclosure document under section 708 of the Corporations Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> <I>Prospectus Exemptions </I>or subsection 73.3(1) of the <I>Securities Act </I>(Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> <I>Registration</I> <I>Requirements, Exemptions and Ongoing Registrant Obligations</I>. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to,
the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may
provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit
prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these
rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of
a <FONT STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> <I>Underwriting Conflicts </I>(NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the
underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Israel </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares offered by this prospectus have not been approved or disapproved by the Israel Securities Authority, or ISA, nor have such shares
been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent the publication of a prospectus that has been approved by the ISA. The ISA has not issued permits, approvals or
licenses in connection with this offering or publishing this prospectus, nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an opinion as to the quality of the shares being offered. This
document does not constitute a prospectus </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">199 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the Israeli Securities Law and has not been filed with or approved by the ISA. In the State of Israel, this document may be distributed only to, and may be directed only at, and any offer
of the shares may be directed only at investors listed in the first addendum to the Israeli Securities Law, or the Addendum, consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers,
investment advisors, members of the Tel Aviv Stock Exchange Ltd., underwriters, venture capital funds, entities with equity in excess of NIS 50 million and &#147;qualified individuals,&#148; each as defined in the Addendum (as it may be amended from
time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors
will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">200 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_20"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the common stock offered hereby will be passed upon for us by Goodwin Procter LLP, Redwood City, California. Attorneys at
Goodwin Procter LLP have a beneficial interest in an aggregate of less than 1% of our common stock. Certain legal matters in connection with our patents and intellectual property interests will be passed upon for us by Morrison Foerster LLP, San
Francisco, California. Legal matters in connection with the offering will be passed upon for the underwriters by Cooley LLP, San Francisco, California. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_21"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements as of and for the years ended December 31, 2019 and 2018, included in this prospectus have been audited by
Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein. Such financial statements have been so included in reliance upon the report of such firm given upon their authority as
experts in accounting and auditing. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_22"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> under the Securities Act with
respect to the shares of common stock being offered by this prospectus, which constitutes a part of the registration statement. This prospectus does not contain all of the information in the registration statement and its exhibits. For further
information with respect to us and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to
are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You can read our SEC filings, including the registration statement, over the Internet at the SEC&#146;s website at www.sec.gov. Upon
completion of this offering, we will be subject to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will
be available via the SEC&#146;s website at www.sec.gov. We also maintain a website at www.plianttrx.com, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished
to, the SEC. However, the information contained in or accessible through our website is not part of this prospectus or the registration statement of which this prospectus forms a part, and investors should not rely on such information in making a
decision to purchase our common stock in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">201 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_23"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="index"></A>Index to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page(s)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Audited Financial Statements as of and for the years ended December 31, 2018 and
2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_2">Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_3">Statements of Operations and Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_4">Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_5">Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_6">Notes to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-8&#150;F-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the stockholders and the Board of Directors of Pliant Therapeutics, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have audited the accompanying balance sheets of Pliant Therapeutics, Inc. (the &#147;Company&#148;) as of December&nbsp;31, 2019 and 2018
and the related statements of operations and comprehensive loss, redeemable convertible preferred stock and stockholders&#146; deficit, and cash flows, for each of the two years for the period ended December&nbsp;31, 2019, and the related notes
(collectively referred to as the &#147;financial statements&#148;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&nbsp;31, 2019 and 2018, and the results of
its operations and its cash flows for each of the two years in the period ended December&nbsp;31, 2019, in conformity with accounting principles generally accepted in the United States of America. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These financial
statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s financial statements based on our audit. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the
purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Deloitte&nbsp;and Touche LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">San Francisco, CA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">March&nbsp;13, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have
served as the Company&#146;s auditor since 2018. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
   <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_2"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Balance Sheets </B></P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>(In thousands, except share and per share amounts)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma&nbsp;as&nbsp;of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 85,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Tax credit receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">66,529</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">119,064</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Liabilities, Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued liabilities (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other long term liabilities (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Commitments and Contingencies (Note 13)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series A redeemable convertible preferred stock, $0.0001 par value; 56,000,000 and 56,000,000 shares
authorized at December 31, 2018 and 2019, respectively; 56,000,000 and 56,000,000 shares issued and outstanding, at December 31, 2018 and 2019, respectively; aggregate liquidation preference of $61,516 and $62,468 at December 31, 2018 and 2019,
respectively; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series B redeemable convertible preferred stock, $0.0001 par value; 58,109,973 shares and 49,501,221
shares authorized at December 31, 2018 and 2019, respectively; 49,501,221 shares and 49,501,221 shares issued and outstanding at December 31, 2018 and 2019, respectively; aggregate liquidation preference of $70,587 and $75,860 at December 31, 2018
and 2019, respectively; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series C redeemable convertible preferred stock, $0.0001 par value; 0 shares and 44,000,000 shares
authorized at December 31, 2018 and 2019, respectively; 0 shares and 26,360,745 shares issued and outstanding at December 31, 2018 and 2019, respectively; aggregate liquidation preference of $0 and $47,947 at December 31, 2018 and 2019,
respectively; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common stock, $0.0001 par value; 147,682,655 and 181,000,000 shares authorized at December 31, 2018
and 2019; and 9,745,453 and 13,199,073 shares issued and outstanding at December 31, 2018 and 2019, respectively; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(71,470</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(76,295</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total liabilities, redeemable convertible preferred stock and stockholders&#146;
deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 66,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_3"></A>Condensed Statements of Operations and Comprehensive Loss </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(In thousands, except share and per share amounts)</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue &#151; related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing net loss per share attributable to common stockholders, basic and
diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,608,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders, basic and diluted
(unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing pro forma net loss per share attributable to common stockholders, basic
and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive Loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(632</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_4"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except<BR>share amounts)</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT><BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,171,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,566</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,565</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series A redeemable preferred stock, net of issuance costs of $16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series B redeemable preferred stock, net of issuance costs of $315</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting of founders&#146; common stock and restricted stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,573,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,628</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,745,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands,<BR>except share<BR>amounts)</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT><BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series C redeemable preferred stock, net of issuance costs of $293</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting of founders&#146; common stock and restricted stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,152,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option exercises</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">952</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,031</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,199,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_5"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Statements of Cash Flows </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(In thousands)</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credit receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,458</TD>
<TD NOWRAP VALIGN="bottom">) &nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent and other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maturity of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(964</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,931</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series A preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series B preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series C preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of deferred offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,582</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosures of noncash investing and financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of restricted stock awards from liabilities to common stock upon vesting</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant improvement paid for by the landlord</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred offering costs in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_6"></A>Notes to Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Description of Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant
Therapeutics, Inc. (the &#147;Company&#148;) is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis with an initial focus on treating fibrosis by inhibiting integrin-mediated
activation of TGF-&szlig;. Fibrosis refers to the abnormal thickening and scarring of connective tissue due to the production and deposition of excess collagen in the extra-cellular matrix. Fibrosis can occur in many different tissues including
lung, liver, kidney, muscle, skin and the GI tract, and often causes severe and debilitating disease leading to organ failure. The Company is located in South San Francisco, California, and was incorporated in the state of Delaware in June 2015.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Presentation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of
America (&#147;U.S. GAAP&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Use of Estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets, liabilities, and expenses as well as the disclosure of contingent assets and liabilities as of and during the reporting period. The Company bases its estimates and assumptions on historical experience when available and
on various factors that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, useful lives assigned to property and equipment, the fair
values of common and redeemable convertible preferred stock, stock-based compensation expense, accruals for research and development costs, income taxes and uncertain tax positions. The Company assesses estimates on an ongoing basis; however, actual
results could materially differ from those estimates. </P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2018 the Company adopted the provision of Accounting Standards Update or ASU, ASU
<FONT STYLE="white-space:nowrap">2014-09,</FONT> Topic 606 <I>Revenue from Contracts with Customers (</I><I>&#147;</I><I>Topic 606</I><I>&#148;</I><I>) </I>using the full retrospective transition method. ASU
<FONT STYLE="white-space:nowrap">2014-09</FONT> provides a single, comprehensive revenue recognition model for all contracts with customers. This standard contains principles for the determination of the measurement of revenue and the timing of when
such revenue is recognized. Revenue recognition will reflect the transfer of goods or services to customers at an amount that is expected to be earned in exchange for those goods or services. Subsequently, the FASB has issued the following guidance
to amend ASU <FONT STYLE="white-space:nowrap">2014-09:</FONT> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2015-14,</FONT> Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date; ASU
<FONT STYLE="white-space:nowrap">No.&nbsp;2016-08,</FONT> Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net); ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-10,</FONT>
Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-12,</FONT> Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and
Practical Expedients; and ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-20,</FONT> Technical Corrections and Improvements to Topic 606, which clarifies narrow aspects of Topic 606 or corrects unintended application of the guidance. The Company
must adopt ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2015-14,</FONT> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-08,</FONT> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-10,</FONT> ASU
<FONT STYLE="white-space:nowrap">No.&nbsp;2016-12,</FONT> and ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-20</FONT> with ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2014-09,</FONT> which are referred to collectively as the &#147;Topic
606&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2018-18,</FONT> &#147;Collaborative Arrangements (Topic
808)&#148; issued in November 2018. The Company assessed and concluded that they are not under ASC 808. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date all revenue has been generated from the Company&#146;s Collaboration and License
Agreement with Novartis (&#147;the Novartis Agreement&#148;). As a result, there was no impact of the adoption of Topic 606 to the Company&#146;s 2018 financial statements. See Note 6 for details of Topic 606 application to the Novartis Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Contract revenue consists of the strategic collaboration and license agreement. The Company&#146;s licensing agreement includes upfront
signing fees, cost reimbursements, research and development services, milestone payments and royalties on future licensee&#146;s product sales. The Company has both fixed and variable consideration.
<FONT STYLE="white-space:nowrap">Non-refundable</FONT> upfront fees are considered fixed, while funding of research and development activities and milestone payments are identified as variable consideration. A contract liability is an obligation to
transfer goods or services for which&nbsp;the Company&nbsp;has received consideration, or for which an amount of consideration is due from the customer. A contract asset is a right to consideration in exchange for goods or services that&nbsp;the
Company&nbsp;has transferred to a customer when that right is conditional on something other than the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration (i.e., only the
passage of time is required before payment becomes due). Receivables cannot be netted against contract liabilities and are presented separately from contract assets. Contract assets and contract liabilities are netted at the contract level and are
then aggregated and presented separately each reporting period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining the appropriate amount of revenue to be recognized as the
Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&nbsp;identification of the contract with a customer; (ii)&nbsp;identification of the performance obligations in the contract;
(iii)&nbsp;determination of the transaction price; (iv)&nbsp;allocation of the transaction price to the performance obligations in the contract; and (v)&nbsp;recognition of revenue when (or as) we satisfy each performance obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company&#146;s performance
obligations include providing the worldwide license rights to compound <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> provide research and development services for <FONT STYLE="white-space:nowrap">PLN-1474</FONT> through Phase 1 of its
development and provide research and development services on initial candidate targets, which services are combined with a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license to the initial candidate targets. The Company concluded that the
worldwide license was distinct because the customer can benefit from the license on its own or together with other resources that are readily available, and the research and development services are not transformative in nature. The Company
concluded the research and development services on initial candidate targets were not distinct from a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license for the initial candidate targets, primarily as a result of (i)&nbsp;Pliant being
unable to benefit on its own or together with other resources that are readily available as the license and (ii)&nbsp;the research and development services, including manufacturing in support of such services, were expected to significantly modify
the initial license. Therefore, the promised goods and services were considered a single performance obligation. Significant management judgment is required in the identification of performance obligations and to determine the level of effort
required under an arrangement and the period over which the Company expects to complete our performance obligations under the arrangement. If the Company cannot reasonably estimate when the performance obligations either are completed or become
inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company estimates the transaction price and records revenue in the amount for which it is probable that a significant reversal of
cumulative revenue recognized will not occur. At the end of each subsequent reporting period, we <FONT STYLE="white-space:nowrap">re-evaluate</FONT> the estimated variable consideration included in the transaction price and any related constraint,
and if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative <FONT STYLE="white-space:nowrap">catch-up</FONT> method. The estimated period
of performance and project costs are reviewed quarterly and adjusted, as needed, to reflect the Company&#146;s current assumptions regarding the timing of our deliverables. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone
selling price of each performance obligation identified in the contract. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company has never sold the performance obligations separately; therefore observable stand-alone selling price does not exist. Accordingly, the Company estimates a stand-alone selling price
through maximizing the use of observable inputs such as market data, project cost estimates, and targeted margins. The Company determined that each of the performance obligations is priced and delivered at the stand-alone selling price. Therefore,
no reallocations are needed since there is no material right and the license and services are provided at the stand-alone selling price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, the entirety of the Company&#146;s revenue&#151;related party is related to the Collaboration
and License Agreement with Novartis. The Company did not have any prior collaboration agreements and did not recognize revenue during the year ended December&nbsp;31, 2018. Receivables from collaborations are typically unsecured and are concentrated
in the biopharmaceutical industry. Accordingly, the Company may be exposed to credit risk generally associated with biopharmaceutical companies or specific to the Novartis Agreement. An allowance on the receivables will be recorded if circumstances
indicate collection is doubtful for a particular receivables balance. To date, the Company has not experienced any losses related to these receivables. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Fair Value Measurements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market
in which to transact and the market-based risk. Fair value accounting is applied for all financial assets and liabilities and <FONT STYLE="white-space:nowrap">non-financial</FONT> assets and liabilities that are recognized or disclosed at fair value
in the financial statements on a recurring basis and at least annually. The carrying amount of the Company&#146;s financial instruments, including cash and cash equivalents, short-term investments, tax credit receivable, accounts receivable, prepaid
expenses and other current assets, accounts payable and accrued liabilities approximate fair value due to their short-term maturities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Concentration of Credit Risk and Other Risks and Uncertainties </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, short-term
investments and accounts receivable. The Company invests in money market funds, treasury bill and notes and government notes. The Company limits its credit risk associated with its cash and cash equivalents by placing them with banks and
institutions it believes are highly credit worthy and in highly rated investments. The Company performs credit evaluations of its customer, and the risk with respect to accounts receivable is further mitigated by the short duration of customer
payment terms and the pedigree of the customer base. During the year ended December&nbsp;31, 2019, Novartis accounted for 100% of the Company&#146;s revenue&#151;related party and accounts receivable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s future results of operations involve several other risks and uncertainties. Factors that could affect the Company&#146;s
future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of results of clinical trials and reaching milestones, uncertainty of regulatory approval of the Company&#146;s
product candidates, uncertainty of market acceptance of the Company&#146;s product candidates, competition from substitute products, including those that may be developed or marketed by larger companies, securing and protecting intellectual
property, strategic relationships and dependence on key individuals and sole source suppliers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s product candidates
require approvals from the U.S Food and Drug Administration (&#147;FDA&#148;) and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any
product candidate, it could have a materially adverse impact on the Company. </P>     <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Segments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company operates and manages its business as one reportable and operating segment, which is the business of developing and commercializing
novel therapies for fibrotic diseases. The Company&#146;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance. All long-lived
assets are maintained in the United States of America. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash and Cash Equivalents </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in Money Market Funds and U.S. government agency securities and are stated at fair value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Short-Term Investments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s short-term investments consist of United States (&#147;U.S.&#148;) Treasury securities and U.S. government agency securities
with remaining maturities beyond three months at the date of purchase and one year or less from the balance sheet date. As of December 31, 2019, all of the Company&#146;s short-term investments were classified as <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> and were carried at fair market value. The unrealized losses on the Company&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
securities are recorded in &#147;other comprehensive income and losses&#148; (&#147;OCI&#148;) in the Statements of Operations and Comprehensive Loss. See Note 3 for further details. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Short-term investments are considered impaired when a decline in fair value is judged to be other-than-temporary. The Company consults with
its investment managers and considers available quantitative and qualitative evidence in evaluating potential impairment of its short-term investments on a quarterly basis. If the cost of an individual investment exceeds its fair value, the Company
evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than cost and its intent and ability to hold the investment. Once a decline in fair value is determined to be other-than-temporary, an
impairment charge will be recorded to other expense, net, in the statement of operations and comprehensive loss and a new cost basis in the short-term investment will be established. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Property and Equipment, Net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are recorded at cost net of accumulated depreciation and amortization. Property and equipment are depreciated using the
straight-line method over the estimated useful lives of the assets. The useful lives of property and equipment are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Shorter of remaining lease term or estimated useful life</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are
removed from the balance sheets and the resulting gain or loss is recorded to the Statements of Operations and Comprehensive Loss. Repairs and maintenance are expensed as incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Impairment of Long-Lived Assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated
future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. There was no impairment of long-lived assets during the years ended December 31, 2018 and 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redeemable Convertible Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company classifies redeemable convertible preferred stock outside of stockholders&#146; deficit because, upon the occurrence of certain
change in control events that are outside the Company&#146;s control, including liquidation, sale or transfer of the Company&#146;s assets, holders of the redeemable convertible preferred stock can cause redemption for cash. At any time on or after
December 19, 2024, the holders of a majority of the outstanding redeemable convertible preferred stock can also require the Company to redeem the redeemable convertible preferred stock by providing the Company a written notice requesting such
redemption. The Company recognizes changes in the redemption value immediately as they occur, for example changes in fair value of preferred stock, and adjusts the carrying amount of the redeemable convertible preferred stock to equal the redemption
value at the end of each reporting period. In the absence of retained earnings these accretion charges are recorded against additional paid in capital, if any, and then to accumulated deficit. The Company analyzed all embedded derivatives and
beneficial conversion features for its redeemable convertible preferred stock and concluded that none requires bifurcation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Research and development expenses consist primarily of personnel costs for the
Company&#146;s research and product development employees. Also included are <FONT STYLE="white-space:nowrap">non-personnel</FONT> costs such as fees paid to consultants and third parties for preclinical and clinical studies, research and
development services, laboratory supplies and equipment maintenance costs, license costs, contract manufacturing costs and allocations of facility related costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimates preclinical and clinical studies and research expenses based on the services performed, pursuant to contracts with
research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company estimates these expenses based on discussions with internal management personnel and external service providers as to the
progress or stage of completion of services and the contracted fees to be paid for such services. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual
accordingly. Payments made to third parties under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and are expensed over the time when services are rendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments associated with licensing agreements to acquire exclusive licenses to develop, use, manufacture and commercialize products that have
not reached technological feasibility and do not have alternate commercial use are expensed as incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Tax Credit Receivable
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is eligible for federal and California research and development credits for its research and development activities
performed within the United States and California, respectively. The credits are generally </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
available to offset federal and California income tax liabilities. The Company has applied $0.2 million of federal research and development credits to offset its federal payroll tax expenses for
the year ended December&nbsp;31, 2018 due to its small business status. Starting in the fourth quarter of 2019, the Company was no longer eligible for federal and California research development credits as it generated revenue during the year. As
such, all federal and California research and development credits generated and accrued during the first three quarters of 2019 were reversed. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation</I></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s stock-based equity awards include restricted stock awards and stock options that are granted to employees and consultants and accounted at fair value on the award grant date. Stock-based compensation expense is recognized over the
awards&#146; vesting period on a straight-line basis and recorded as either research and development or general and administrative expenses in the Statements of Operations and Comprehensive Loss based on the function to which the related services
are provided. Forfeitures are accounted for as they occur. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option-pricing model, used to estimate fair value of
stock-based awards, requires the use of the following assumptions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected term</I>&#151;The expected term represents the period that the stock-based awards are expected to be
outstanding. The expected term for the Company&#146;s stock options was calculated based on the weighted-average vesting term of the awards and the contract period, or simplified method. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected volatility</I>&#151;Since the Company is not yet a public company and does not have any trading
history for its common stock, the expected volatility was estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a period equal to the expected term of the stock option grants. The
comparable companies were chosen based on their size, stage in the life cycle or area of specialty. The Company will continue to apply this process until enough historical information regarding the volatility of its stock price becomes available.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-free interest rate</I>&#151;The risk-free interest rate is based on the U.S. Treasury yield in effect at
the time of grant <FONT STYLE="white-space:nowrap">for&nbsp;zero-coupon&nbsp;U.S.</FONT> Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected dividend</I>&#151;The Company has never paid dividends on the common stock and have no plans to pay
dividends on the common stock. Therefore, the Company used an expected dividend yield of zero. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the
common stock has been determined using independent third-party valuations based on relevant valuation methodologies as outlined in the American Institute of Certified Public Accountants (AICPA) Practice Aid, <I>&#147;Valuation of
Privately-Held-Company Equity Securities Issued as Compensation</I>&#148;. The Company also considered the amount of time between the independent third-party valuation dates and the grant dates and used interpolation of the fair value between the
two valuation dates to estimate common stock fair value at each grant date. This determination included an evaluation of whether the subsequent valuation indicated that any significant change in valuation had occurred between the previous valuation
and the grant date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Deferred Offering Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deferred offering costs, consisting of direct legal, accounting, filing and other fees directly related to the Company&#146;s proposed initial
public offering (&#147;IPO&#148;) are capitalized. The deferred offering costs will be reclassified to additional paid in capital upon completion of the IPO. The Company deferred $0.2&nbsp;million and $2.7&nbsp;million as of December&nbsp;31, 2018
and December&nbsp;31, 2019, respectively, which is recorded as other Non-current assets in the Balance Sheets. In the event the IPO is aborted, all capitalized deferred offering costs will be expensed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Leases and Rent Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company records rent expense on a straight-line basis over the life of the lease. In cases where there is a free rent period or future
fixed rent escalations, the Company records a deferred rent liability. Additionally, the receipt of any lease incentives is recorded as a deferred rent liability which is amortized over the lease term as a reduction of rent expense. Building
improvements made with the lease incentives or tenant allowances are capitalized as leasehold improvements and included in property and equipment, net in the Balance Sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company provides for income taxes under the asset and liability method. Current income tax expense or benefit represents the amount of income taxes expected to be payable or refundable for the current year. Deferred income tax assets and liabilities
are determined based on differences between the financial statement reporting and tax basis of assets and liabilities and net operating loss and credit carryforwards and are measured using the enacted tax rates and laws that will be in effect when
such items are expected to reverse. Deferred income tax assets are reduced, as necessary, by a valuation allowance when management determines it is more likely than not that some or all the tax benefits will not be realized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for uncertain tax positions in accordance with ASC <FONT STYLE="white-space:nowrap">No.&nbsp;740-10</FONT><I>, Accounting
for Uncertainty in Income Taxes</I>. The Company assesses all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing
authorities. Assessing an uncertain tax position begins with the initial determination of the position&#146;s sustainability and is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate
settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and the Company will determine whether (i)&nbsp;the factors underlying the sustainability assertion have changed and (ii)&nbsp;the amount of the
recognized tax benefit is still appropriate. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of a tax benefit might change as new information becomes available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company includes any penalties and interest expense related to income taxes as a component of income tax expense, as necessary.<B> </B>
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive Loss </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Comprehensive loss includes net loss as well as other changes in stockholders&#146; deficit that result from transactions and economic events
other than those with stockholders. For the years ended December&nbsp;31, 2018 and 2019, the Company had no net unrealized losses on short-term investments and an $1,000 net unrealized loss on short-term investments, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss Per Share </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed by dividing net loss attributed to common stockholders by the weighted-average number of shares of common
stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock.
Net loss per share attributable to common stockholders is calculated using <FONT STYLE="white-space:nowrap">the&nbsp;two-class&nbsp;method,</FONT> which is based on an earnings allocation formula that determines net loss per share for the
Company&#146;s common stockholders and holders of participating securities. The Company&#146;s redeemable convertible preferred stock contains participation rights in any dividend paid by the Company and is deemed to be a participating security. Net
loss attributable to common stockholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and participating preferred shares are allocated to each share on <FONT STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis</FONT> as if all the earnings for the period had been
distributed. The participating securities do not include a contractual obligation to share in losses of the Company and are not included in the calculation of net loss per share in the periods in which a net loss is recorded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Diluted net loss per share is computed using the more dilutive of
<FONT STYLE="white-space:nowrap">(a)&nbsp;the&nbsp;two-class&nbsp;method</FONT> or (b)&nbsp;the <FONT STYLE="white-space:nowrap">as-converted</FONT> method. The Company allocates earnings first to redeemable convertible preferred shares stockholders
based on dividend rights and then to common and preferred stockholders based on ownership interests. The weighted-average number of shares of common stock included in the computation of diluted net loss gives effect to all potentially dilutive
common equivalent shares, including outstanding stock options and preferred stock. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Common stock equivalent shares are excluded from
the computation of diluted net loss per share if their effect is antidilutive. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is generally the
same as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been issued if their effect is antidilutive. The Company reported a net loss attributable to common stockholders for the years
ended December&nbsp;31, 2018 and 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited Pro Forma Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to the completion of the Company&#146;s IPO resulting in net proceeds of at least $45.0&nbsp;million to the Company all
outstanding shares of redeemable convertible preferred stock will automatically convert into common stock. Unaudited pro forma balance sheet information as of December&nbsp;31, 2019, assumes the conversion of all outstanding redeemable convertible
preferred stock into shares of common stock. The shares of common stock issuable and the proceeds expected to be received in the IPO are excluded from such pro forma financial information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma net loss per share for the year ended December&nbsp;31, 2019, was computed using the weighted-average number of shares
of common stock outstanding, including the pro forma effect of the conversion of all outstanding shares of redeemable convertible preferred stock, as if such conversion had occurred at the beginning of the period, or their issuance dates, if later.
The unaudited pro forma net loss per share does not include the shares expected to be sold and related proceeds to be received from the IPO. Net loss attributable to common stockholders used in the unaudited pro forma net loss per share calculation
was adjusted for the accretion of redeemable convertible preferred stock, as preferred stock is not considered outstanding prior to the closing of the IPO. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Recently Issued Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2016, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standard Update (&#147;ASU&#148;) <FONT
STYLE="white-space:nowrap">No.&nbsp;2016-02,</FONT> <I>Leases (&#147;Topic 842&#148;</I>), which requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases. For public entities, ASU <FONT
STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> is effective for fiscal years beginning after December&nbsp;15, 2018. The ASU will also require new qualitative and quantitative disclosures to help investors and other financial statement users
better understand the amount, timing, and uncertainty of cash flows arising from leases. As a result of the Company having elected the extended transition period for complying with new or revised accounting standards pursuant to Section&nbsp;107(b)
of the JOBS Act, ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> is effective for the Company in the fiscal years beginning after December&nbsp;15, 2020, with early adoption permitted. The Company is currently in the process of
evaluating the impact of the adoption of ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> on the Company&#146;s financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2018, the FASB issued Accounting Standards Update 2018-18 (&#147;ASU
2018-18&#148;), Collaborative Arrangements (topic 808): Clarifying the Interaction between Topic 808 and Topic 606. ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC
606 when the counterparty is a customer. The guidance precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that
transaction. The guidance amends ASC 808 to refer to the unit-of-account guidance in ASC 606 and requires it to be used only when assessing whether a transaction is in the scope of ASC 606. The guidance will be effective for the Company for fiscal
years beginning after December&nbsp;15, 2020 and interim periods within fiscal years beginning after December 15, 2021 and has to be adopted using retrospective approach. The Company is currently evaluating the impact of ASU 2018-18 on its financial
statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Financial Instruments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s short-term investments in U.S. Treasury and U.S. government agency securities have been classified and accounted for as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale.</FONT></FONT> The Company classifies its U.S. Treasury and U.S. government agency securities as short-term based on each instrument&#146;s underlying contractual
maturity date. Unrealized gains and losses on U.S. Treasury and U.S. government agency securities classified as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> are recognized in other comprehensive
loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assets and liabilities recorded at fair value on a recurring basis in the Balance Sheets and assets and liabilities measured at
fair value on a <FONT STYLE="white-space:nowrap">non-recurring</FONT> basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value
provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in
an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether
such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to
valuation techniques is briefly summarized as follows: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B><B></B><I>Level 1</I>&#151;Inputs are unadjusted, quoted prices in active markets for identical assets or
liabilities at the measurement date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 2&#151;</I>Inputs are observable, unadjusted quoted prices in active markets for similar assets or
liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related
assets or liabilities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 3&#151;</I>Unobservable inputs that are significant to the measurement of the fair value of the assets
or liabilities that are supported by little or no market data. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s cash equivalent Money Market
Funds are classified as Level&nbsp;1 because they are valued using quoted market prices. The fair value of the Company&#146;s short-term investments are classified as Level&nbsp;2 because they are valued using observable inputs to quoted market
prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency and include U.S. government agency securities and U.S. Treasury securities. These Level&nbsp;2 instruments
require more management judgment and subjectivity compared to Level&nbsp;1 instruments which include determining which instruments are most similar to the instrument being priced, determining whether the market is active and determining which
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
model-derived valuations are to be used when calculating fair value. The Company performs its analysis with the assistance of investment advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables show the Company&#146;s cash and cash equivalents, Money Market Funds and short-term investments by significant
investment category as of December&nbsp;31, 2018 and December&nbsp;31, 2019 (in thousands): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Market Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December 31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Market Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Treasury securities included in short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government agency securities included in cash and cash equivalents and short-term
investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,567</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may sell certain of its short-term securities prior to their stated maturities for reasons
including, but not limited to, managing liquidity, credit risk, duration and asset allocation.</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There were no liabilities measured at
fair value on a recurring basis as of December&nbsp;31, 2018 and December&nbsp;31, 2019. There have been no transfers between fair value measurement levels during the year ended December&nbsp;31, 2018 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company records interest income and accretion income earned on Money Market Funds and U.S. Treasury and U.S. government agency securities
to interest income in its Statement of Operations and Comprehensive Loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Property and Equipment, net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction-in-progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, gross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense for the years ended December 31, 2018 and 2019 was $0.7&nbsp;million
and $1.1&nbsp;million, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Accrued Liabilities and Other Long Term Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Accrued Liabilities</I></B><I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued liabilities consisted of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits consist primarily of accrued bonuses and accrued vacation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Other Long Term Liabilities</I></B><I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other long term liabilities consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000" ALIGN="center"><FONT STYLE="font-size:8pt"><B>2018</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000" ALIGN="center"><FONT STYLE="font-size:8pt"><B>2019</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold incentive obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities &#151; deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other long term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Novartis Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, the Company entered into a Collaboration and License Agreement with Novartis (the &#147;Novartis Agreement&#148;), for the
development and commercialization of our preclinical product candidate, PLN-1474 and up to three additional integrin research targets. PLN-1474 is an internally discovered small molecule selective inhibitor of integrin
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>V&szlig;1, currently being developed for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis (&#147;NASH&#148;). In accordance with the Novartis Agreement, on December 7, 2019,
Novartis paid to Pliant an upfront non-refundable license fee of $50.0&nbsp;million for the worldwide exclusive license to PLN-1474. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis will fund the Company&#146;s research and development services for PLN-1474 through Phase 1 after which Novartis will assume
responsibility for all future development, manufacturing and commercialization costs of PLN-1474. Novartis will also fund the research and development services associated with integrin research targets as outlined in the Novartis Agreement. The
Company is scheduled to receive up to $19.6 million in funding for PLN-1474 development services through Phase 1 of its development, which is expected to go through 2020. The Company is initially obligated to perform research and development
services for the integrin research targets for sixty days, and Novartis has the option to terminate the services with 60 days notice. Novartis has the option to continue the research and development services through 2022. If any of the targets
achieves </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
target validation and are deemed a research target, Novartis holds the rights to exercise its license options to obtain an exclusive license for those deemed research targets on a research
target-by-research target basis by paying an option exercise fee for each target (up to three in total), including all license compounds that are the subject of the applicable research program. Upon exercise of an option, Novartis will be
responsible for global clinical development and commercialization of each licensed research target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Novartis Agreement, the
Company is eligible for developmental, regulatory and commercial milestone payments related to PLN-1474 and the integrin research targets of up to $416.0 million if defined development and commercialization milestones are achieved and tiered
royalties ranging from the mid-single digits to low double digits on product sales upon commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon execution of the Novartis
Agreement, Pliant also entered into a Financing Side Letter with Novartis (the &#147;Financing Side Letter&#148;), whereby Novartis committed to provide up to $30.0 million in equity financing of which $20.0 million was provided for 10,928,962
shares of Series C Redeemable Convertible Preferred Stock on December 19, 2019 and the remaining $10.0 million will be provided for common shares in the event Pliant completes an Initial Public Offering.&nbsp;The Company determined that Novartis
Agreement and the Financing Side Letter are separate agreements, they were not entered into for single commercial objective, the consideration in each agreement are tied to separate and different types of performance obligations and they are not
considered a single performance obligation. The Series C Redeemable Preferred Stock was issued to Novartis at fair value of $1.83 per share in conjunction with its issuance to other investors at the same price. In addition, the contingent issuance
of shares upon an Initial Public Offering would also be at fair value. Further, Novartis became a related party to the Company following its purchase of 10.9 million shares of our Series C Redeemable Convertible Stock on December 19, 2019,
representing holdings of 7.4% of our outstanding shares on a fully diluted basis as of December 31, 2019. See Notes 9 and 14 to these financial statements for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company evaluated the Novartis Agreement under the revenue standard Topic 606 and concluded that Novartis is a customer. The Company
identified the following performance obligations at the inception of the contract. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide Novartis worldwide license rights to PLN-1474. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide research and development services for PLN-1474 through Phase 1 of its development. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide non-exclusive license rights to integrin research targets and research and development services on
integrin research targets, together as a single performance obligation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company determined the transaction price at
inception of the Novartis Agreement is the $69.6 million consisting of the license fee of $50.0 million and research and development funding of $19.6 million payment to be allocated to the various performance obligations. The Novartis Agreement
includes variable consideration for the funding of research and development services and potential future milestones and royalties that were contingent on future success factors for development programs. The Company used the &#147;most likely&#148;
method to determine the variable consideration. None of the regulatory or development milestones were included in the transaction price. The Company will re-evaluate the transaction price in each reporting period as uncertain events are resolved or
other changes in circumstances occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considered the license to PLN-1474 as functional intellectual property, as when control
of the license was transferred to Novartis at the inception of the Novartis Agreement, Novartis had the right to access its technology and it was functional. The Company determined the $50.0 million was standalone selling price PLN-1474 license and
was recognized as revenue when control of the license transferred to Novartis, which was at or near inception of the Novartis Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimated the standalone selling price of each research program based on
internal and external costs to perform the research plus a reasonable profit margin. The total estimated cost of the research and development services reflects the nature of the services to be performed and the Company&#146;s best estimate of the
length of time required to perform the services. The Company selected an input method of costs incurred to measure progress toward complete satisfaction of its performance obligation to provide research and development services as such method
faithfully depicts the Company&#146;s performance in transferring control of the research and development service to Novartis. Changes in estimates of total internal and external costs expected to be incurred are recognized in the period of change
as a cumulative catch-up adjustment. There have been no changes to the Company&#146;s estimates to date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December
31, 2019, Company recognized revenue - related party of $50.0 million related to the license fee and revenue - related party of $7.1 million generated from research and development services performed during 2019, the remaining $12.5 million is
expected to be earned in 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, there is a receivable of $7.1 million related to the Novartis Agreement. There
were no contract assets or contract liabilities as of December 31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. License Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>UC Regents </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
August 2015, the Company entered into an exclusive, worldwide license agreement (the &#147;UC Agreement&#148;) with the Regents of the University of California (the &#147;UC Regents&#148;) relating to the use of certain patents and technology
relating to <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>v&szlig;1 compound in fibrosis indications. Pursuant to the UC Agreement, the Company is obligated to (i)&nbsp;make a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront license
fee payment of $0.4&nbsp;million and annual license maintenance fee payments of $10,000 per year beginning on the first anniversary of the UC Agreement escalating to $25,000 per year thereafter (ii)&nbsp;make royalty payments to the UC Regents of 3%
of net sales of a therapeutic licensed product or 1% of net sales of a method of use licensed product, subject to an annual minimum of $1.0&nbsp;million, (iii)&nbsp;make milestone payments up to an aggregate of $18.2&nbsp;million to the UC Regents
upon the occurrence of certain events, (iv)&nbsp;make a milestone payment based on the number of outstanding shares and a price per share as defined in the UC Agreement within 30 days of the closing of an IPO or change of control, and
(v)&nbsp;reimburse the UC Regents for prosecution and maintenance expenses of the licensed patents without limitation. The Company will expense any payments for milestones to research and development expenses prior to receiving Federal Drug and
Administration (&#147;FDA&#148;) approval for any of its product candidates.&nbsp;These costs will be capitalized when FDA approval is obtained for any products being selected for commercialization and amortized over the remaining life of the
patent. If the Company sublicenses its rights under the UC Agreement, it is obligated to pay the UC Regents a percentage of the total gross proceeds received in consideration of the grant of the sublicense, which total amount would be first reduced
by the aggregate amount of certain research and development related expense incurred by the Company. The UC Regents have the right to purchase an amount equal to a low single-digit percent of any securities offered by the Company to investors other
than to Third Rock Ventures III, L.P. (&#147;TRV&#148;) or an affiliate of TRV. This participation right expires immediately before the completion of the IPO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The UC Agreement can be terminated at any time upon the material breach of contract terms by either party to the agreement. The Company has
the right to terminate the agreement at any time upon providing written notice to the UC Regents. Unless terminated early, the UC Agreement will remain in effect from the effective date until the later of (i)&nbsp;the expiration or abandonment of
the patent rights licensed under the UC Agreement, or (ii)&nbsp;ten years from the date of the first commercial sale of the first licensed product under the agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
   <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Research Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Adimab Development and Option Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the Company and Adimab LLC (&#147;Adimab&#148;) entered into a development and option agreement (the &#147;Adimab
Agreement&#148;) for the discovery and optimization of proprietary antibodies as potential therapeutic product candidates. Under the Adimab Agreement, the Company will select biological targets against which Adimab will use its proprietary platform
technology to research and develop antibody proteins using a mutually agreed upon research plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Company&#146;s selection of a
target, the Company and Adimab will initiate a research plan and the discovery term begins. During the discovery term, Adimab will grant the Company a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT>
<FONT STYLE="white-space:nowrap">non-sublicensable</FONT> license under its technology with respect to the target, to research, design and preclinically develop and use antibodies that were modified or derived using Adimab technology, solely to
evaluate such antibodies, perform the Company&#146;s responsibilities under the research plan and use such antibodies for certain diagnostic purposes. The Company will also grant to Adimab a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> <FONT
STYLE="white-space:nowrap">non-sublicensable</FONT> and <FONT STYLE="white-space:nowrap">non-transferable</FONT> license with respect to the target under the Company&#146;s technology that covers or relates to such target, solely to perform its
responsibilities under the research plan during the discovery period. The Company is required to pay Adimab at an agreed upon rate for its full-time employees during the discovery period while Adimab performs research on each target under the
applicable research plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adimab granted the Company an exclusive option to obtain a worldwide, royalty-bearing, sublicensable license
under Adimab platform patents and other Adimab technology to research, develop and commercialize up to twenty four antibodies selected by the Company (the &#147;Program Antibodies&#148;) against specific biological targets (the
&#147;Commercialization Option&#148;). Upon the exercise of a Commercialization Option, and payment of the applicable option fee to Adimab, Adimab will assign the patents that cover the Program Antibodies to Company. The Company will be required to
use commercially reasonable efforts to develop, seek market approval of, and commercialize at least one antibody against the target covered by the Commercialization Option in specified markets upon the exercise of a Commercialization Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Adimab Agreement, the Company is obligated to (i)&nbsp;make a nonrefundable upfront license fee payment for access to
Adimab&#146;s technology; (ii)&nbsp;pay Adimab at an agreed upon rate for each full-time employee (&#147;FTE&#148;) during the research period; (iii)&nbsp;make additional payments upon the Company making other research related elections;
(iv)&nbsp;pay up to a dollar amount in the low double digit millions for the achievement of certain research and development milestones for each research target program which can vary by target type; (v)&nbsp;make royalty payments to Adimab on
Company net sales of its products covered under the Adimab Agreement, subject to varying royalty payments on certain product types. Currently, no product types have been selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2018, the Company recognized research and development expense under the Adimab Agreement of $0.1 million
related to the technology access fees and FTE costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2019, the Company recognized research and
development expense under the Adimab Agreement of $0.1 million related to antibody discovery fees and $0.2 million related to the FTE costs. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9.
Redeemable Convertible Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Company&#146;s Amended and Restated Certificate of Incorporation (&#147;Certificate
of Incorporation&#148;), the Company is authorized to issue two classes of shares: preferred and common stock. The preferred stock may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be issued in series, and the Company&#146;s board of directors is authorized to determine the rights, preferences, and terms of each series. The following is a summary of the Company&#146;s
redeemable convertible preferred stock (in thousands except share amounts): </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred stock consisted of the following as of December
31, 2018: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redemption<BR>Value/<BR>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,109,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,109,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">132,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">132,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred stock consisted of the following as of December 31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redemption<BR>Value/<BR>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,861,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, the Company entered into a Series A Preferred Stock Purchase Agreement (the &#147;Series A Purchase Agreement&#148;) pursuant
to which it agreed to sell, and the purchasers agreed to purchase up to $45.0&nbsp;million of Series A Redeemable Convertible Preferred Stock (&#147;Series A Preferred&#148;) in three anticipated tranches based on the achievement of defined
performance milestones. The Series A Preferred stockholders may not assign the rights to purchase shares of Series A Preferred at any future milestone closing tranches separately without a transfer of already purchased shares. The Company determined
that these future tranche obligations did not meet the definition of a freestanding financial instrument because, while separately exercisable, they were not legally detachable. Further, the Company determined that the embedded future tranche
obligation did not require bifurcation for accounting purposes as it was clearly and closely related to the economic characteristics and risks of the Series A Preferred and would not meet the definition of a derivative on a standalone basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series&nbsp;A Purchase Agreement, as part of the initial closing, the Company issued 6.5&nbsp;million shares of Series&nbsp;A
Preferred at $1.00 per share in exchange for cash proceeds of $6.4&nbsp;million and the conversion of convertible promissory notes in the amount of $0.1&nbsp;million representing outstanding principal and accrued interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2016, the Company issued 5.0&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of
$5.0&nbsp;million in an additional closing of the first tranche. The final closing of the first tranche occurred in September of 2016, when the Company issued 5.0&nbsp;million additional shares of Series A Preferred at $1.00 per share in exchange
for cash proceeds of $5.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Company issued 8.0&nbsp;million shares of Series A Preferred at $1.00 per
share in exchange for cash proceeds of $8.0&nbsp;million in a closing of the second tranche. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2017, the Company issued 12.0&nbsp;million shares of Series A Preferred at $1.00 per
share in exchange for cash proceeds of $12.0&nbsp;million in an initial closing of the third tranche. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2018, the Company issued
8.5&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of $8.5&nbsp;million in an additional closing of the third tranche. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, based on the amendment to the Series&nbsp;A Purchase Agreement, the Company issued 11.0&nbsp;million additional shares of
Series A Preferred at $1.00 per share in exchange for cash proceeds of $11.0&nbsp;million in the final closing of the third tranche. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, the Company entered into a Series B Preferred Stock Purchase Agreement (the &#147;Series B Purchase Agreement&#148;) in which it
agreed to sell, and the purchasers agreed to purchase, up to $70.0&nbsp;million of Series B Redeemable Convertible Preferred Stock (&#147;Series B Preferred&#148;). Under the Series B Purchase Agreement, the Company initially issued
45.1&nbsp;million shares of Series B Preferred at $1.3767 per share in exchange for cash proceeds of approximately $62.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
November 2018, the Company issued 4.4&nbsp;million additional shares of Series B Preferred at $1.3767 per share in exchange for cash proceeds of approximately $6.0&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series C Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, the Company entered into a Series C Preferred Stock Purchase Agreement (the &#147;Series C Purchase Agreement&#148;) in which
it agreed to sell, and the purchasers agreed to purchase, up to $80.5 million of Series C Redeemable Convertible Preferred Stock (&#147;Series C Preferred&#148;). Under the Series C Purchase Agreement, the Company initially issued 26.4 million
shares of Series C Preferred at $1.83 per share in exchange for aggregate cash proceeds of $48.2 million. Novartis purchased 10.9 million shares of this allotment of Series C Preferred at $1.83 per share for cash proceeds of $20.0 million. Novartis
became a related party following its purchase of 10.9 million shares of our Series C Preferred, representing aggregate holdings of 7.4% of our outstanding shares on a fully diluted basis as of December 31, 2019. See Note 14 for additional
information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series A Preferred, Series B Preferred and Series C Preferred (collectively, the &#147;Preferred Stock&#148;) have the
following rights and privileges: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of shares of Preferred Stock is entitled to the number of votes equal to the number of shares of common stock into which such
shares could be converted and has voting rights and powers equal to the voting rights and powers of the common stock, and except as provided by law or by other provisions of the Company&#146;s Certificate of Incorporation, as amended, shall vote
together with the common stock as a single class on an as-converted basis on all matters as to which holders of common stock have the right to vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series A Preferred, voting separately as a single class, are entitled to elect two members of the Company&#146;s board of
directors. At any time when at least 12.5 million shares of Series B Preferred are outstanding, the holders of Series B Preferred are entitled to elect one member of the Company&#146;s board of directors. The holders of shares of common stock,
voting separately as a single class, are entitled to elect one member of the Company&#146;s board of directors. All remaining members of the Company&#146;s board of directors are elected by the holders of the common stock and Preferred Stock voting
together as a single class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Conversion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of the Preferred Stock are convertible at any time at the option of the holder into such number of shares as is determined by dividing
the original issuance price by the conversion price in effect at the time. The original conversion price is the original issuance price for each series of Preferred Stock, or $1.00 for Series A Preferred, $1.3767 for Series B Preferred and $1.83 for
Series C Preferred, subject to certain adjustments. As of December&nbsp;31, 2019, the Preferred Stock was convertible into shares of the Company&#146;s common stock on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of
Preferred Stock will automatically convert upon the completion of an IPO resulting in net proceeds to the Company of at least $45.0&nbsp;million or the vote or written consent of a requisite majority of holders of the then outstanding shares of
Preferred Stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common stock basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series A Preferred were originally entitled to receive cumulative dividends from their respective dates of issuance at the rate
of 8.0% on their original issue price. In July 2018, in conjunction with the execution of the Series B Purchase Agreement, the Series A Preferred accreted dividends were cancelled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series B Purchase Agreement, the holders of both shares of Series A and Series B Preferred are entitled to receive cumulative
dividends commencing on July&nbsp;10, 2018, the issuance date of Series B Preferred, at an annual rate of 8.0% on their original issuance price. The Series A Preferred and Series B Preferred dividends accrue from <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day,</FONT></FONT> whether declared or not, and are payable only when and if declared by the Company&#146;s board of directors. As such, the Company recorded accretion charges to adjust the carrying values of the
Series A Preferred and Series B Preferred to their redemption values up until the date the Series C Purchase Agreement was executed. In December 2019, in conjunction with the execution of the Series C Purchase agreement, the Series A preferred and
Series B preferred accreted dividends were cancelled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series C Purchase Agreement, the holders of Series A, Series B and Series
C Preferred are entitled to receive non-cumulative dividends commencing on December 19, 2019 at an annual rate of 8.0% on their original issuance price. The Series A, Series B and Series C Preferred dividends accrue from day-to-day, whether declared
or not, and are payable only when and if declared by the Company&#146;s board of directors. Since inception, the Company has never declared or paid any dividends. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation Preferences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon liquidation, dissolution, or winding up of the Company or a deemed liquidation event as defined in the Company&#146;s Certificate of
Incorporation, the holders of shares of Series C and Series B Preferred Stock will receive, on a pari passu basis a per share amount equal to the Series C purchase price of $1.83 (plus any declared but unpaid dividends) and equal to the original
Series B purchase of $1.3767 (plus any declared but unpaid dividends), collectively (the &#147;Series C and Series B Liquidation Preference&#148;) or such amount per share as would have been payable had all shares of Series C and Series B had been
converted into common stock immediately prior to such liquidation event. The payment of Series C and Series B Liquidation Preference is to be made before any payment made to the holders of Series A Preferred Stock and Common Stock. Thereafter, the
Series A Preferred holders are entitled to receive their liquidation preference before any distributions are made to common stockholders, a per share amount equal to $1.00 (plus any declared but unpaid dividends) (&#145;the Series A Liquidation
Preference&#148;) or such amount per share as would have been payable had all shares of Series A had been converted into common stock immediately prior to such liquidation event. After payments of the full liquidation preferences of the Series C and
Series B Liquidation Preference and the Series A Liquidation Preference described above, any remaining assets of the Company shall be distributed to the holders of the common stock in proportion to the number of shares of common stock that they
hold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series&nbsp;A Preferred were redeemable at any time on or after five years from August&nbsp;19, 2015, the original issuance date of the 6.5
million&nbsp;shares of Series A Preferred, upon receipt of a written notice from the holders of a majority of the shares of Series A Preferred. The initial redemption price was the greater of (i)&nbsp;the Series&nbsp;A Preferred original issuance
price per share, plus any accrued and unpaid dividends, whether or not declared by the board of directors, and (ii)&nbsp;the fair market value of Series&nbsp;A Preferred as mutually agreed upon by the Company and the holders of a majority of the
shares of Series&nbsp;A Preferred then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, in conjunction with the execution of the Series B Preferred Purchase
Agreement, the Series&nbsp;A Preferred redemption provision was amended as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Preferred Stock shall be
redeemed by the Company at a price equal to the original issuance price per share, plus any accrued and unpaid dividends, whether or not declared, together with any other dividends declared but unpaid in three annual installments commencing not more
than sixty (60)&nbsp;days after receipt by the Company at any time on or after five years from the Series B Preferred original issuance date, July&nbsp;10, 2018, a written notice from the holders of a majority of the shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the changes in Series A Preferred redemption provision as a modification as there was no significant difference in
Series A Preferred fair value before and after the modification. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, in conjunction with the execution of the Series C
Preferred Purchase Agreement, the Series A Preferred and Series B Preferred redemption provisions were modified as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All
outstanding shares of Preferred Stock shall be redeemed by the Company at a price equal to the original issuance price per share, plus any dividends declared but unpaid, in three annual installments commencing not more than sixty (60) days after
receipt by the Company at any time on or after five years from the Series C Preferred original issuance date, December 19, 2019, a written notice from the holders of a majority of the shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the changes in Series A Preferred redemption and Series B Preferred redemption provisions as a modification as there
was no significant difference in Series A Preferred and Series B Preferred fair values before and after the modification. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The voting, dividend, and liquidation rights of the holders of the common stock are subject to and qualified by the rights, powers, and
preferences of the holders of the Preferred Stock. As of December&nbsp;31, 2018 and 2019, the Company had 147,682,655 and 181,000,000 authorized shares of common stock, respectively, at a par value of $0.0001 per share. The common stock has the
following rights and privileges: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of shares of common stock are entitled to one vote for each share of common stock held at any meeting of stockholders and at the
time of any written action in lieu of a meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of shares of common stock are entitled to receive dividends, when declared by the Company&#146;s board of directors. Cash dividends
may not be declared or paid to holders of shares of common stock until all unpaid dividends on the Preferred Stock have been paid in accordance with their terms. No dividends have been declared or paid by the Company since its inception.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After payment of the respective liquidation preferences to the holders of shares of Preferred Stock, the holders of shares of common stock are
entitled to share ratably in the Company&#146;s remaining assets available for distribution to its stockholders in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or upon occurrence of a deemed
liquidation event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Shares reserved for future issuance </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I></I></B><B>As of December&nbsp;31, </B><B><I></I></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,861,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercises of outstanding stock option awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">809,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,563,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares of common stock available for future grants under the 2015 Equity Incentive Plan, as
amended</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,029,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,054,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares reserved for future issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,340,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,479,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Founders&#146; Common Stock Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2015, the Company&#146;s board of directors granted common stock awards to the Company&#146;s founders in exchange for services provided
to the Company. The purchase price of the common stock awards was the estimated fair value at the issuance date. The shares vest from one to four years and vesting could be accelerated upon a change in control. The vesting of certain
performance-based grants of restricted stock awards were contingent upon the filing of an Investigational New Drug Application by the Company with the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the holder of founders&#146; common stock award terminates their relationship with the Company during the vesting period, the Company may
repurchase any unvested restricted common stock held by these individuals at their original purchase price. During the vesting term, holders of founders&#146; common stock awards are deemed to be common stockholders and have dividend and voting
rights. The Company issued 5,328,500 shares of founders&#146; common stock during 2015. No founders&#146; common stock awards were granted in subsequent years. Total compensation expense was $25,000 for these founders&#146; common stock awards,
which are recorded to operating expenses in the statements of operations over their respective vesting period. As of December 31, 2018, 333,729 shares of founders&#146; common stock awards were expected to vest and vested in 2019. As of
December&nbsp;31, 2019, all shares of founders&#146; common stock awards were fully vested. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. 2015 Equity Incentive Plan and Stock-Based
Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, the board of directors adopted the 2015 Equity Incentive Plan, as amended (the &#147;Plan&#148;), which
provides for the grant of incentive stock options, nonqualified stock options or other awards including stock appreciation rights and restricted stock awards to the Company&#146;s employees, officers, directors, advisors, and consultants for the
purchase of up to 11.0 million shares of the Company&#146;s common stock. In July 2018, the Plan was amended to increase the number of shares reserved thereunder by 7.2 million shares. In January 2019, the Company&#146;s board of directors and
shareholders voted to increase the number of shares reserved for issuance under the 2015 Equity Incentive Plan by 3.0 million shares. In December 2019, the Company&#146;s board of directors and shareholders voted to increase the number of shares
reserved for issuance under the 2015 Equity Incentive Plan by 3.0 million shares. As of December 31, 2019, 4.1 million shares remained available for issuance under the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options under the Plan may be granted for periods of up to 10&nbsp;years and at prices no
less than 100.0% of the estimated fair value of the shares on the date of grant as determined by the board of directors, provided, however, that the exercise price of an incentive stock option granted to a 10.0% shareholder shall not be less than
110.0% of the estimated fair value of the shares on the date of grant and the option is not exercisable after the expiration of five&nbsp;years from the date of grant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Common Stock Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company granted restricted stock awards under the Plan. The purchase price of the restricted common stock awards was the estimated fair
value as determined by the board of directors at the issuance date. The shares vest from one to four years and vesting could be accelerated upon a change in control. A holder of an award may pay a total purchase price or a part of the purchase price
for granted shares at any time during the vesting periods. Upon termination of employment, the Company has the right to repurchase any unvested restricted shares. The repurchase price for unvested shares of common stock will be the lower of
(i)&nbsp;the fair market value on the date of repurchase or (ii)&nbsp;their original purchase price. During the vesting term, holders of restricted stock awards are deemed to be a common stock shareholder and have dividends and voting rights. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for restricted stock awards as early exercised options and recognized a liability in other liabilities when cash was
received for the purchase of shares of restricted stock. As shares of restricted stock vested, the Company reclassified the liability to common stock and additional paid in capital. As of December&nbsp;31, 2018, and 2019, the Company recorded a
liability included in accrued expenses and other liabilities of $52,000 and $22,000, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company used Black-Scholes option
pricing model to estimate stock-based compensation expense related to restricted stock awards with the following assumptions for the year ended December&nbsp;31, 2018: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">69.60%&nbsp;-&nbsp;76.20%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1.80%&nbsp;-&nbsp;2.48%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.92&nbsp;-&nbsp;2.16</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying common stock fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$0.26&nbsp;-&nbsp;$0.33</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There were no grants of restricted stock awards for the year ended December 31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes restricted stock activity during the years ended December&nbsp;31, 2018 and 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT><BR>Grant&nbsp;Date<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,603,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,428,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,003,725</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,027,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,819,169</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,160,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock awards of 30,000 shares with a weighted-average grant date fair value of
$0.005 per share, were not purchased by the award holders as of December&nbsp;31, 2019. As these shares of the restricted common stock awards were not issued, they are not included in the table above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate fair value of restricted stock awards vested during the years ended December&nbsp;31, 2018 and 2019 was $0.1 million and $0.4
million, respectively. Total intrinsic value of outstanding unvested restricted stock awards was $3.6 million and $2.1&nbsp;million as of December&nbsp;31, 2018 and 2019, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options and Nonqualified Stock Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options issued under the Plan generally vest over a four-year period and expire ten years from the date of grant. Certain options provide
for accelerated vesting if there is a change in control, as defined in the Plan. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company used Black-Scholes option pricing model
to estimate stock-based compensation expense for stock option awards with the following assumptions for the years ended December&nbsp;31, 2018 and 2019: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">81.80%&nbsp;-&nbsp;82.50%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">74.80%&nbsp;-&nbsp;82.53%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2.78% - 3.07%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1.43%&nbsp;-&nbsp;2.59%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.78 - 6.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.00&nbsp;-&nbsp;6.08</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying common stock fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$0.39 - $0.72</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$0.59&nbsp;-&nbsp;$0.74</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company granted 809,200 stock options during the year ended December 31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A summary of option activity under the Plan is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average&nbsp;Exercise<BR>Price per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Term&nbsp;(in&nbsp;Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">809,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,316,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(300,726</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(262,084</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,563,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,631,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,563,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Aggregate intrinsic value represents the difference between the fair value of the underlying common
stock and the exercise price as of December 31, 2018 and 2019. The weighted-average grant date fair value of options granted during the years ended December 31, 2018 and 2019, was $0.48 per share and $0.61 per share, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the components and classification of stock-based compensation expense for the Company&#146;s stock-based awards
for the years ended December 31, 2018 and 2019 (in thousands): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended<BR>December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock awards and founders&#146; common stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2018, there was $0.7 million of unrecognized stock-based compensation expense that
is expected to be recognized over the weighted-average periods of 2.2 years related to restricted stock awards and stock options, respectively. As of December 31, 2018, there was $0.4 million of unrecognized stock-based compensation expense that is
expected to be recognized over the weighted-average periods of 3.7 years related to stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, there was
$0.4&nbsp;million of unrecognized compensation costs that is expected to be recognized over the weighted-average periods of 2.2&nbsp;years related to restricted stock awards. As of December&nbsp;31, 2019, there was $4.4&nbsp;million of unrecognized
compensation costs that is expected to be recognized over the weighted-average periods of 3.0&nbsp;years related to stock options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Income Taxes
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No provision for income taxes was recorded for the years ended December 31, 2018 and December 31, 2019. The Company has incurred net
operating losses only in the United States since its inception. The Company has not reflected any benefit of such net operating loss carryforwards in the financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the U.S. federal statutory income tax rate to the Company&#146;s effective income tax rate is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax computed at federal statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State taxes, net of federal tax benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General business credit&#151;federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">295.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.2</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50.0</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other permanent differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.0</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2.4</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32.5</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(267.7</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective income tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.5</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net deferred tax assets and liabilities consisted of the following (in thousands): </P>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(110</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(139</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(249</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,929</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net operating losses and tax credit carryforwards were as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Expiration&nbsp;Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, federal (starting from January 1, 2018)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Does&nbsp;not&nbsp;expire</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, federal (before January&nbsp;1, 2018)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2035-2037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, state</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2035-2039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits, federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2036-2039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits, state</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Does not expire</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilization of the net operating loss carryforwards and research credit carryforwards may be subject
to an annual limitation due to the ownership percentage change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in the expiration of the net operating losses and tax credit carryforwards
before they are utilized. The Company performed a IRC Section 382 analysis through December 31, 2019 and does not expect any previous ownership changes to result in a limitation that will reduce the total amount of net operating loss and tax credit
carryforwards disclosed that can be utilized. Subsequent ownership changes may affect the limitation in future years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the years ended December 31, 2018 and 2019, the Company recorded a full valuation
allowance on federal and state deferred balances since management does not forecast the Company to be in a profitable position in the near future. Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2018
and 2019 related primarily to the increases in net operating loss carryforwards and research and development tax credit carryforwards and were as follows (in thousands): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance at the beginning of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,240</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increases recorded to income tax provision</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance at the end of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s U.S. federal and state income tax returns are generally subject to tax
examinations for the tax years ended December 31, 2016 through December 31, 2019. There are currently no pending income tax examinations. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated
may still be adjusted upon examination by the Internal Revenue Service and state tax authorities to the extent utilized in a future period. The Company&#146;s policy is to record interest and penalties related to income taxes as part of its income
tax provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The entire amount of the unrecognized tax benefits would not impact the Company&#146;s effective tax rate if recognized.
The Company has elected to include interest and penalties as a component of tax expense. During the years ended December 31, 2018 and 2019, the Company did not recognize accrued interest and penalties related to unrecognized tax benefits. The
Company does not anticipate that the amount of existing unrecognized tax benefits will significantly increase or decrease during the next 12 months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">855</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions based on tax positions related to current year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reductions for tax positions of prior year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Purchase Commitments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has contractual arrangements with research and development organizations and suppliers; however, these contracts are generally
cancelable on 30 days&#146; notice and the obligations under these contracts are largely based on services performed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>License and
Collaboration Agreements </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Potential payments related to the Company&#146;s license and research agreements, including milestone
and royalty payments, are detailed in Notes 6 and 7. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018, the Company leased approximately 18,000 square feet of corporate offices and research facilities in Redwood City, California. Rent
expense, including common area maintenance expense, was approximately $0.1&nbsp;million per month. This lease expired on June&nbsp;28, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2018, the Company entered into a <FONT STYLE="white-space:nowrap">non-cancelable</FONT> lease agreement (the &#147;Lease&#148;)
for premises consisting of approximately 32,974 square feet located in South San Francisco, California (the &#147;Premises&#148;). The Company moved into the Premises in July 2018. The Premises is being used for the Company&#146;s corporate
headquarters and principal operating facility. The term of the Lease is eighty-four months, which commenced on July&nbsp;1, 2018. Base rent was abated for the first two months of the lease term and thereafter is $0.2&nbsp;million per month during
the first year of the lease term, with specified annual increases thereafter. The Company paid a refundable security deposit of approximately $0.4&nbsp;million, which is included in Other non-current assets in the Balance Sheets at December&nbsp;31,
2018 and 2019. The Company has the right to extend the lease term by seven years upon written notice not more than twelve months nor less than nine months prior to the expiration of the original lease term, with monthly payments equal to the
&#147;fair rental value&#148; as defined in the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2018 and 2019, rent expense, including
common area maintenance expense, was $1.8&nbsp;million and $2.5&nbsp;million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under the Lease
as of December&nbsp;31, 2019 were as follows (in thousands):<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year ending December 31:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Operating&nbsp;Lease</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024 and beyond</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Legal Proceedings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company was not subject to any
material legal proceedings during the years ended December&nbsp;31, 2018 and 2019, and, to the best of its knowledge, no material legal proceedings are currently pending or threatened. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such
agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third party actions. In some cases, the
indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to
defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against
liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#146; and officers&#146; insurance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain employees of Third Rock Ventures, a stockholder of the Company, provided consulting services to the Company. Consulting service
expenses of $0.1 million and $36,000 were recorded for the years ended December 31, 2018 and 2019, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018 and 2019, the
Company made charitable contributions to the University of California, San Francisco Foundation (the &#147;UCSF Foundation&#148;), which were directed to support research performed in the laboratories of two of the Company&#146;s scientific
founders. The Company made a charitable contribution of $0.5 million and $0.3 million for the years ended December 31, 2018 and 2019, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Company entered into a consulting agreement with the founder of Healthcare&nbsp;&amp; Humanity Foundation (the
&#147;Director&#148;) pursuant to which the Director provided consulting services to the Company at a rate of $5,000 per month in 2018. In addition, the Company granted the Director 45,000 shares of restricted stock at a purchase price of $0.01 per
share with quarterly vesting over a one-year period contingent upon the Director providing consulting services during the vesting period. The Director became a director of the Company in December 2017. In February 2018, the agreement with the
Director terminated pursuant to its terms. General and administrative services provided while the Director was a director of the Company amounted to $5,000 and $0, respectively during the years ended December 31, 2018 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, the Company sold 1.0&nbsp;million shares of Series&nbsp;A Preferred to pH Pharma Co. Ltd. (&#147;pH Pharma&#148;), an entity in
which the Director has a majority ownership, for $1.0&nbsp;million. These shares of Series&nbsp;A Preferred represent 1.0% of the Company&#146;s outstanding equity on a fully diluted basis as of December&nbsp;31, 2019. In May 2018, the Company
entered into a research services agreement with pH Pharma. In the year ended December&nbsp;31, 2018, the Company was reimbursed $51,000 for services performed in connection with the research service agreement. As of December&nbsp;31, 2018, all
services were completed under this agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2019, the Company entered into the Novartis Agreement with Novartis covering the
development and commercialization of Pliant&#146;s preclinical product candidate, PLN-1474 and up to three additional targets. Upon execution of the Agreement, Pliant also entered into a financing side letter with Novartis, whereby Novartis
committed to provide up to $30.0 million in equity financing of which $20.0 million was provided for preferred shares as a part of a Series C equity offering and the remaining $10.0 million will be provided for common shares in the event Pliant
completes an Initial Public Offering. As of December 31, 2019, Novartis owns approximately 7.4% of the Company&#146;s outstanding shares on a fully diluted basis. See Notes 6 and Note 9 for additional information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Defined Contribution Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company sponsors a defined contribution plan under Section&nbsp;401(k) of the Internal Revenue Code covering substantially all full-time U.S. employees. Employee contributions are voluntary and are determined on an individual basis subject to the
maximum allowable under federal tax regulations. The Company made contributions to the plan of $0.2&nbsp;million and $0.2&nbsp;million for the years ended December&nbsp;31, 2018 and 2019, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Net Loss Per Share Attributable to Common Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share
attributable to common stockholders for the periods presented, because including them would have been antidilutive: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended&nbsp;December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock (on an as-converted basis)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,861,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">809,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,563,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock awards granted and not purchased</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,027,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,160,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares of founders&#146; common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,704,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,615,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the numerator and denominator used in the calculation of the basic and diluted net
loss per share attributable to common stockholders is as follows (in thousands, except share and per share amounts): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Numerator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add: accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Denominator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares outstanding used to calculate net loss per share attributable to
common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,608,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company&#146;s unaudited pro forma
basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data) assuming the automatic conversion of the redeemable convertible preferred stock based on the
<FONT STYLE="white-space:nowrap">mid-point</FONT> of the IPO price range of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, upon consummation of an IPO as if such event had occurred as of the beginning of the respective
period: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Net Loss Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustment to accretion to redemption value and cumulative dividends on redeemable
convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to calculate net loss per share attributable to common stockholders,
basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustment to reflect assumed conversion of all redeemable convertible
preferred&nbsp;stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to calculate pro forma net loss per share attributable to common
stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent Events </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2020, the Company issued 28,527,313 shares of Series C Preferred at $1.83 per share in exchange for an aggregate purchase price of
$52.2 million in a closing of the second tranche. The sales of the Series C Preferred Shares are at a fair value of $1.83, which was the price the remaining share of Series C Redeemable Convertible Preferred Stock were sold to other investors in a
closing that occurred on December 19, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2020, the Company achieved the first patient dosing milestone of the Novartis
Agreement triggering the receipt of a $25.0 million payment expected in the second quarter of 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent
events for financial statement purposes occurring through March&nbsp;13, 2020, the date these financial statements were issued, and determined that no additional subsequent events had occurred that would require recognition in these financial
statements and that all subsequent events that required disclosure have been disclosed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g83b31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P></center>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRELIMINARY PROSPECTUS </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </B></P>
<P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P></center>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Joint Book-Running Managers </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Citigroup </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Cowen
</B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Piper Sandler </B></P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P></center> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Lead Manager
</I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Needham&nbsp;&amp; Company </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Through and including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 (25 days after
the date of this prospectus), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#146;s obligation to deliver a prospectus
when acting as an underwriter and with respect to an unsold allotment or subscription. </B></P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Information Not Required in Prospectus </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;13. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the fees and expenses, other than underwriting discounts and commissions, payable in connection with the
registration of the common stock hereunder. All amounts are estimates except the SEC registration fee, the FINRA filing fee and the Nasdaq Global Market listing fee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Paid<BR>or to<BR>Be Paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasdaq Global Market listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and mailing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent and registrar fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To be completed by amendment. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;14. Indemnification of Directors and Officers. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the Delaware General Corporation Law, or the DGCL, authorizes a corporation to indemnify its directors and officers against
liabilities arising out of actions, suits and proceedings to which they are made or threatened to be made a party by reason of the fact that they have served or are currently serving as a director or officer to a corporation. The indemnity may cover
expenses (including attorneys&#146; fees) judgments, fines and amounts paid in settlement actually and reasonably incurred by the director or officer in connection with any such action, suit or proceeding. Section&nbsp;145 permits corporations to
pay expenses (including attorneys&#146; fees) incurred by directors and officers in advance of the final disposition of such action, suit or proceeding. In addition, Section&nbsp;145 provides that a corporation has the power to purchase and maintain
insurance on behalf of its directors and officers against any liability asserted against them and incurred by them in their capacity as a director or officer, or arising out of their status as such, whether or not the corporation would have the
power to indemnify the director or officer against such liability under Section&nbsp;145. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted provisions in our amended and
restated certificate of incorporation and amended and restated bylaws to be in effect immediately prior to the completion of this offering that limit or eliminate the personal liability of our directors to the fullest extent permitted by the DGCL,
as it now exists or may in the future be amended. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; any act or omission not in good
faith or that involves intentional misconduct or a knowing violation of law; any unlawful payments related to dividends or unlawful stock purchases, redemptions or other distributions; or any transaction from which the director derived an improper
personal benefit. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These limitations of liability do not alter director liability under the federal securities laws and
do not affect the availability of equitable remedies such as an injunction or rescission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our bylaws provide that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will indemnify our directors, officers and, in the discretion of our board of directors, certain employees to
the fullest extent permitted by the DGCL, as it now exists or may in the future be amended; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will advance reasonable expenses, including attorneys&#146; fees, to our directors and, in the discretion of
our board of directors, to our officers and certain employees, in connection with legal proceedings relating to their service for or on behalf of us, subject to limited exceptions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to enter into indemnification agreements with each of our directors and executive officers. These agreements will provide that we
will indemnify each of our directors, certain of our executive officers and, at times, their affiliates to the fullest extent permitted by Delaware law. We will advance expenses, including attorneys&#146; fees (but excluding judgments, fines and
settlement amounts), to each indemnified director, executive officer or affiliate in connection with any proceeding in which indemnification is available and we will indemnify our directors and officers for any action or proceeding arising out of
that person&#146;s services as a director or officer brought on behalf of us or in furtherance of our rights. Additionally, certain of our directors or officers may have certain rights to indemnification, advancement of expenses or insurance
provided by their affiliates or other third parties, which indemnification relates to and might apply to the same proceedings arising out of such director&#146;s or officer&#146;s services as a director referenced herein. Nonetheless, we will agree
in the indemnification agreements that our obligations to those same directors or officers are primary and any obligation of such affiliates or other third parties to advance expenses or to provide indemnification for the expenses or liabilities
incurred by those directors are secondary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will maintain general liability insurance which covers certain liabilities of our directors
and officers arising out of claims based on acts or omissions in their capacities as directors or officers, including liabilities under the Securities Act of 1933, as amended, or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement filed as Exhibit&nbsp;1.1 to this registration statement provides for indemnification of us and our directors and
officers by the underwriters against certain liabilities under the Securities Act and the Securities Exchange Act of 1934. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;15. Recent Sales
of Unregistered Securities. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the three years preceding the filing of this registration statement, we have issued the following
securities that were not registered under the Securities Act. No underwriters were involved in the sales and the certificates representing the securities sold and issued contain legends restricting transfer of the securities without registration
under the Securities Act or an applicable exemption from registration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(a) Issuances of Capital Stock </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, we sold an aggregate of 8,000,000 shares of our Series A redeemable convertible preferred stock at a purchase price of $1.00
per share for an aggregate purchase price of approximately $8.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2017, we sold an aggregate of 12,000,000 shares of
our Series A redeemable convertible preferred stock at a purchase price of $1.00 per share for an aggregate purchase price of approximately $12.0&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2018, we sold an aggregate of 8,500,000 shares of our Series A redeemable convertible preferred stock at a purchase price of $1.00
per share for an aggregate purchase price of approximately $8.5&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, we sold an aggregate of 11,000,000 shares of
our Series A redeemable convertible preferred stock at a purchase price of $1.00 per share for an aggregate purchase price of approximately $11.0&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, we sold an aggregate of 45,142,960 shares of our Series B redeemable
convertible preferred stock at a purchase price of $1.3767 per share for an aggregate purchase price of approximately $62&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2018, we sold an aggregate of 4,358,261 shares of our Series B redeemable convertible preferred stock at a purchase price of
$1.3767 per share for an aggregate purchase price of approximately $6&nbsp;million. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From December 2019 through February 2020 we sold
an aggregate of 54,888,058 shares of our Series&nbsp;C redeemable convertible preferred stock at a purchase price of $1.83 per share for an aggregate purchase price of approximately $100.4 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offers and sales of the securities described above were deemed to be exempt from registration pursuant to Section&nbsp;4(a)(2) of the
Securities Act, including Regulation&nbsp;D and Rule&nbsp;506 promulgated thereunder, as transactions by an issuer not involving a public offering. All of the purchasers in these transactions represented to us in connection with their purchase that
they were acquiring the securities for investment and not distribution, that they could bear the risks of the investment and could hold the securities for an indefinite period of time. Such purchasers received written disclosures that the securities
had not been registered under the Securities Act and that any resale must be made pursuant to a registration or an available exemption from such registration. All of the foregoing securities are deemed restricted securities for the purposes of the
Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(b) Grants and Exercises of Stock Options and Restricted Stock </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2017, we granted stock options to purchase 14,181,083 shares of our common stock to our employees, directors and
consultants at a weighted average exercise price of $0.45 per share under the 2015 Plan. We also granted the right to purchase an aggregate of 4,055,136 shares of restricted stock to our employees, directors and consultants at a purchase price of
$0.01 per share under the 2015 Plan. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuances of the securities described above were deemed to be exempt from registration
pursuant to Section&nbsp;4(a)(2) of the Securities Act or Rule&nbsp;701 promulgated under the Securities Act as transactions pursuant to compensatory benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of
such securities were the registrant&#146;s employees, consultants or directors and received the securities under the registrant&#146;s 2015 Equity Incentive Plan. The shares of common stock issued upon the exercise of options are deemed to be
restricted securities for purposes of the Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;16. Exhibits and Financial Statement Schedules. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(a) Exhibits. </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1.1*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Underwriting Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amended and Restated Certificate of Incorporation, as amended, of the Registrant, as currently in effect.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.2*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Amended and Restated Certificate of Incorporation of the Registrant, to be in effect immediately prior to completion of the offering.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.3<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bylaws of the Registrant and the amendments thereto, as currently in effect.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.4*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Amended and Restated Bylaws of the Registrant, to be in effect immediately prior to the completion of the offering.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4.1*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Specimen Common Stock Certificate of the Registrant.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4.2</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amended and Restated Investors&#146; Rights Agreement by and among the Registrant and certain of its stockholders, dated December 19, 2019.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;5.1*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Opinion of Goodwin Procter LLP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.1#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2015 Equity Incentive Plan and forms of award agreements thereunder.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.2*#</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2020 Stock Option and Incentive Plan and forms of award agreements thereunder.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.3*#</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2020 Employee Stock Purchase Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.4*#</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Executive Cash Incentive Bonus Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.5#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.6#</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Executive Severance Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.7#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Offer Letter, by and between the Registrant and Bernard Coulie, M.D., Ph.D., dated October 12, 2015.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.8#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Offer Letter, by and between the Registrant and Hans Hull, dated February&nbsp;10, 2016.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="top">10.9#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Offer Letter, by and between the Registrant and Keith Cummings, M.D., MBA, dated November 29, 2018.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.10#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Offer Letter, by and between the Registrant and &Eacute;ric Lefebvre, M.D., dated February&nbsp;28, 2018.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.11#<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Offer Letter, by and between the Registrant and Barbara Howes, dated May 1, 2019.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.12*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form of Indemnification Agreement, by and between the Registrant and each of its directors and officers.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.13<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Office Lease, by and between the Registrant and 260 Littlefield Avenue South San Francisco, California 94080, dated February&nbsp;6, 2018.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">10.14*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Collaboration and License Agreement, by and between the Registrant and Novartis Institutes For Biomedical Research, Inc., dated October 17, 2019.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">23.1*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consent of Deloitte&nbsp;&amp; Touche LLP, Independent Registered Public Accounting Firm.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">23.2*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consent of Goodwin Procter LLP (included in Exhibit 5.1).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">24.1*</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Power of Attorney (included on signature page).</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">+</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Previously filed. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents management compensation plan, contract or arrangement. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(b) Financial
statement schedules. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item
17. Undertakings. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers
and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in
the Securities Act and is, therefore, unenforceable. In the event that a claim for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby undertakes that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The undersigned Registrant will provide to the underwriters at the closing specified in the underwriting agreement, certificates in such
denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) For purposes
of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Signatures </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-1</FONT> to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Francisco, California, on the &nbsp;&nbsp;&nbsp;&nbsp; day
of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PLIANT THERAPEUTICS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;Bernard Coulie, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;President, Chief Executive Officer and Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Power of Attorney </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person whose individual signature appears below hereby authorizes and appoints Bernard Coulie and Keith Cummings and each of them, with
full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney in fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person,
individually and in each capacity stated below, and to file any and all amendments to this Registration Statement, including any and all post effective amendments and amendments thereto, and any registration statement relating to the same offering
as this Registration Statement that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorneys in fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys in fact and agents or
any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Bernard Coulie, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director (Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Keith Cummings, M.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer (Principal Financial and Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Hoyoung Huh, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lead Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Suzanne Bruhn, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gayle Crowell</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">John Curnutte, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Neil Exter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kevin Raidy</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Smital Shah</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>filename2.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLIANT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Pursuant to Section&nbsp;242 of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">General Corporation Law of the State of Delaware) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pliant Therapeutics, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware
(the &#147;<B><I>General Corporation Law</I></B>&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DOES HEREBY CERTIFY</B>: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the name of this corporation is Pliant Therapeutics, Inc. (the &#147;<B><I>Corporation</I></B>&#148;), and
that the Corporation was originally incorporated pursuant to the General Corporation Law on June&nbsp;8, 2015 under the name Pliant Therapeutics, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the Board of Directors duly adopted resolutions proposing to amend the Amended and Restated Certificate of
Incorporation of the Corporation, declaring said amendment to be advisable and in the best interests of the Corporation and its stockholders, and authorizing the appropriate officers of the Corporation to solicit the consent of the stockholders
therefor, which resolutions setting forth the proposed amendment are substantially as follows: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED</B>: The
first paragraph of Article Fourth of the Amended and Restated Certificate of Incorporation of the Corporation be amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FOURTH</B>: The total number of shares of all classes of stock which the Corporation shall have authority to issue is (i) 200,000,000
shares of Common Stock, $0.0001 par value per share (&#147;<B><I>Common Stock</I></B>&#148;), and (ii) 160,501,221 shares of Preferred Stock, $0.0001 par value per share (&#147;<B><I>Preferred Stock</I></B>&#148;).&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED</B>: The first paragraph of Article Fourth, Part B of the Amended and Restated Certificate of Incorporation of the Corporation be
amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;56,000,000 shares of the authorized Preferred Stock of the Corporation are hereby
designated &#147;<B><I>Series</I></B><B><I></I></B><B><I>&nbsp;A Preferred Stock</I></B>,&#148;<B><I> </I></B>49,501,221 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B><I>Series B Preferred
Stock</I></B>&#148; and 55,000,000 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B><I>Series C Preferred Stock</I></B>&#148;. The Series C Preferred Stock and the Series B Preferred Stock are collectively
referred to herein as the &#147;<B><I>Senior Preferred Stock</I></B>&#148;. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock shall have the rights, preferences, powers, privileges and restrictions, qualifications
and limitations set forth herein. Unless otherwise indicated, references to &#147;sections&#148; or &#147;subsections&#148; in this Part B of this Article Fourth refer to sections and subsections of Part B of this Article Fourth.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the foregoing amendment was approved by the holders of the requisite number of shares of the Corporation
in accordance with Section&nbsp;228 of the General Corporation Law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That this Certificate of Amendment to the Amended and Restated Certificate of Incorporation has been duly
adopted in accordance with Section&nbsp;242 of the General Corporation Law. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(signature page follows) </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Certificate of Amendment to the Amended and Restated Certificate of
Incorporation has been executed by a duly authorized officer of this corporation on February&nbsp;27, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PLIANT THERAPEUTICS, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bernard Coulie, M.D., Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard Coulie, M.D., Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLIANT THERAPEUTICS,
INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Pursuant to Sections&nbsp;242 and 245 of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">General Corporation Law of the State of Delaware) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>P<SMALL>LIANT</SMALL> T<SMALL>HERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>.</B>, a corporation organized and existing under and by virtue of the
provisions of the General Corporation Law of the State of Delaware (the &#147;<B><I>General Corporation Law</I></B>&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>DOES
HEREBY CERTIFY: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. That the name of this corporation is Pliant Therapeutics, Inc. and that this corporation was originally
incorporated pursuant to the General Corporation Law on June&nbsp;8, 2015. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. That the Board of Directors of the Corporation (the
&#147;<B><I>Board</I></B>&#148;) duly adopted resolutions proposing to amend and restate the Certificate of Incorporation of this corporation, declaring said amendment and restatement to be advisable and in the best interests of this corporation and
its stockholders, and authorizing the appropriate officers of this corporation to solicit the consent of the stockholders therefor, which resolution setting forth the proposed amendment and restatement is as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED, </B>that the Certificate of Incorporation of this corporation be amended and restated in its entirety to read as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FIRST: </B>The name of this corporation is Pliant Therapeutics, Inc. (the &#147;<B><I>Corporation</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECOND: </B>The address of the registered office of the Corporation in the State of Delaware is 850 New Burton Road, Suite 201, City of
Dover, County of Kent, 19904. The name of its registered agent at such address is Cogency Global Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIRD: </B>The nature of the
business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FOURTH: </B>The total number of shares of all classes of stock which the Corporation shall have authority to issue is (i)&nbsp;181,000,000
shares of Common Stock, $0.0001 par value per share (&#147;<B><I>Common Stock</I></B>&#148;) and (ii)&nbsp;149,501,221 shares of Preferred Stock, $0.0001 par value per share (&#147;<B><I>Preferred Stock</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a statement of the designations and the powers, privileges and rights, and the qualifications, limitations or restrictions
thereof in respect of each class of capital stock of the Corporation. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">COMMON STOCK </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>General</U>. The voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights,
powers and preferences of the holders of the Preferred Stock set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Voting</U>. The holders of the Common Stock are
entitled to one vote for each share of Common Stock held at all meetings of stockholders (and written actions in lieu of meetings). No person entitled to vote at an election for directors may cumulate votes to which such person is entitled unless
required by applicable law at the time of such election. The number of authorized shares of Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by (in addition to any vote of the holders of one or
more series of Preferred Stock that may be required by the terms of the Amended and Restated Certificate of Incorporation (the &#147;<B><I>Certificate of Incorporation</I></B>&#148;)) the affirmative vote of the holders of shares of capital stock of
the Corporation representing a majority of the votes represented by all outstanding shares of capital stock of the Corporation entitled to vote, irrespective of the provisions of Section&nbsp;242(b)(2) of the General Corporation Law. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PREFERRED STOCK </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">56,000,000 shares of the authorized Preferred Stock of the Corporation are hereby designated
&#147;<B><I>Series</I></B><B><I></I></B><B><I>&nbsp;A Preferred Stock</I></B>,&#148;<B><I> </I></B>49,501,221 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B><I>Series B Preferred Stock</I></B>&#148; and
44,000,000 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B><I>Series C Preferred Stock</I></B>&#148;. The Series C Preferred Stock and the Series B Preferred Stock are collectively referred to herein as the
&#147;<B><I>Senior Preferred Stock</I></B>&#148;. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock shall have the rights, preferences, powers, privileges and restrictions, qualifications and limitations set forth
herein. Unless otherwise indicated, references to &#147;sections&#148; or &#147;subsections&#148; in this Part B of this Article Fourth refer to sections and subsections of Part B of this Article Fourth. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Dividends</U>. The holders of Preferred Stock shall be entitled to receive, on a <I>pari passu</I> basis, dividends, out of any assets
legally available therefor, prior and in preference to any declaration or payment of any dividend (payable other than in Common Stock or other securities and rights convertible into or entitling the holder thereof to receive, directly or indirectly,
additional shares of Common Stock) on the Common Stock at the applicable Dividend Rate (as defined below), payable when, as and if declared by the Board of Directors; <U>provided</U>, <U>however</U>, that any and all dividends on the Series A
Preferred Stock and Series B Preferred Stock declared and/or accrued prior to the Series C Original Issue Date (as defined below) are hereby canceled. Such dividends shall not be cumulative. After payment of the foregoing dividends, any additional
dividends or distributions shall be distributed among all holders of Common Stock and Preferred Stock in proportion to the number of shares of Common Stock that would be held by each such holder if all shares of Preferred Stock were converted to
Common Stock at the then effective conversion rate. &#147;<B><I>Dividend Rate</I></B>&#148; shall mean $0.08 for each share of Series A Preferred Stock, $0.1101 for each share of Series B Preferred Stock, and $0.1464 for each share of Series C
Preferred Stock (each, as adjusted for any stock splits, stock dividends, combinations, subdivisions, recapitalizations or the like). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Liquidation, Dissolution or Winding Up; Certain Mergers, Consolidations and Asset
Sales</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.1 <U>Preferential Payments to Holders of Senior Preferred Stock</U>. In the event of any voluntary or involuntary
liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, the holders of shares of Senior Preferred Stock then outstanding shall be entitled to be paid, on a <I>pari passu</I> basis, out of the assets of the Corporation
available for distribution to its stockholders before any payment shall be made to the holders of Series A Preferred Stock or Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i)&nbsp;the applicable
Original Issue Price (as defined below), plus any dividends declared but unpaid thereon, or (ii)&nbsp;such amount per share as would have been payable had all shares of Senior Preferred Stock been converted into Common Stock pursuant to
<U>Section</U><U></U><U>&nbsp;4</U> immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event (such amount, with respect to the Series B Preferred Stock, the &#147;<B><I>Series B Liquidation
Preference</I></B><B><I>&#148;</I></B><B><I> </I></B>and, with respect to the Series C Preferred Stock, the<B><I> </I></B><B><I>&#147;</I></B><B><I>Series C Liquidation Preference</I></B><B><I>&#148;</I></B>). If upon any such liquidation,
dissolution or winding up of the Corporation or Deemed Liquidation Event, the assets of the Corporation available for distribution to its stockholders shall be insufficient to pay the holders of shares of Senior Preferred Stock the full amount to
which they together shall be entitled under this <U>Subsection 2.1</U>, the holders of shares of Senior Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which
would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full. The &#147;<B><I>Original Issue Price</I></B>&#148; shall mean $1.00 per share for
each share of Series A Preferred Stock, $1.3767 per share for each share of Series B Preferred Stock and $1.83 per share for each share of Series C Preferred Stock (each as adjusted for any stock splits, stock dividends, combinations, subdivisions,
recapitalizations or the like). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.2 <U>Preferential Payments to Holders of Series</U><U></U><U>&nbsp;A Preferred Stock</U>. In the event
of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, after payment in full of the Series B Liquidation Preference and Series C Liquidation Preference as set forth in <U>Subsection
2.1</U>, the holders of shares of Series&nbsp;A Preferred Stock then outstanding shall be entitled to be paid out of the remaining assets of the Corporation available for distribution to its stockholders before any payment shall be made to the
holders of Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i)&nbsp;the Series&nbsp;A Original Issue Price, plus any dividends declared but unpaid thereon, or (ii)&nbsp;such amount per share as would
have been payable had all shares of Series A Preferred Stock been converted into Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;4</U> immediately prior to such liquidation, dissolution, winding up or Deemed Liquidation Event (the
&#147;<B><I>Series A Liquidation Preference</I></B>&#148;). If upon any such liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, the remaining assets of the Corporation available for distribution to its
stockholders after giving effect to the payment of the Series B Liquidation Preference and Series C Liquidation Preference shall be insufficient to pay the holders of shares of Series&nbsp;A Preferred Stock the full amount to which they shall be
entitled under this <U>Subsection 2.2</U>, the holders of shares of Series&nbsp;A Preferred Stock shall share ratably in any distribution of the remaining assets available for distribution in proportion to the respective amounts which would
otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.3 <U>Payments to Holders of Common Stock</U>. In the event of any voluntary or
involuntary liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, after the payment of all preferential amounts required to be paid to the holders of shares of Preferred Stock (including the Series C Liquidation
Preference, Series B Liquidation Preference and Series A Liquidation Preference), the remaining assets of the Corporation available for distribution to its stockholders shall be distributed among the holders of shares of Common Stock,
<I>pro</I><I></I><I>&nbsp;rata</I> based on the number of shares held by each such holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.4 <U>Deemed Liquidation Events</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.4.1 <U>Definition</U>. Each of the following events shall be considered a &#147;<B><I>Deemed Liquidation Event</I></B>&#148;<B><I>
</I></B>unless the holders of at least a majority of the outstanding shares of Preferred Stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Common Stock basis (the &#147;<B><I>Requisite
Majority</I></B>&#148;), elect otherwise by written notice sent to the Corporation at least 5 (five)&nbsp;days prior to the effective date of any such event: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) a merger or consolidation in which </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(i) the Corporation is a constituent party or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(ii) a subsidiary of the Corporation is a constituent party and the Corporation issues shares of its capital stock pursuant to such merger or
consolidation, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">except any such merger or consolidation involving the Corporation or a subsidiary in which the shares of capital stock of the Corporation
outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting
power, of the capital stock of (1)&nbsp;the surviving or resulting corporation; or (2)&nbsp;if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such merger or consolidation, the parent
corporation of such surviving or resulting corporation; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) the sale, lease, transfer, exclusive license or other disposition, in a
single transaction or series of related transactions, by the Corporation or any subsidiary of the Corporation of all or substantially all the assets of the Corporation and its subsidiaries taken as a whole, or the sale or disposition (whether by
merger, consolidation or otherwise) of one or more subsidiaries of the Corporation if substantially all of the assets of the Corporation and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale,
lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.4.2 <U>Effecting a Deemed
Liquidation Event</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) The Corporation shall not have the power to effect a Deemed Liquidation Event referred to in <U>Subsection
2.4.1(a)(i)</U> unless the agreement or plan of merger or consolidation for such transaction (the &#147;<B><I>Merger Agreement</I></B>&#148;)<B><I> </I></B>provides that the consideration payable to the stockholders of the Corporation shall be
allocated among the holders of capital stock of the Corporation in accordance with <U>Subsections 2.1</U>, <U>2.2</U> and<U> 2.3</U>. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) In the event of a Deemed Liquidation Event referred to in <U>Subsection
2.3.1(a)(ii)</U> or <U>2.3.1(b)</U> if the Corporation does not effect a dissolution of the Corporation under the General Corporation Law within ninety (90)&nbsp;days after such Deemed Liquidation Event, then (i)&nbsp;the Corporation shall send a
written notice to each holder of Preferred Stock no later than the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;day after the Deemed Liquidation Event advising such holders of their right (and the requirements to be met
to secure such right) pursuant to the terms of the following clause; (ii)&nbsp;to require the redemption of such shares of Preferred Stock, and (iii)&nbsp;unless the holders of the Requisite Majority request otherwise in a written instrument
delivered to the Corporation not later than one hundred twenty (120)&nbsp;days after such Deemed Liquidation Event, the Corporation shall use the consideration received by the Corporation for such Deemed Liquidation Event (net of any retained
liabilities associated with the assets sold or technology licensed, as determined in good faith by the Board), together with any other assets of the Corporation available for distribution to its stockholders, all to the extent permitted by Delaware
law governing distributions to stockholders (the &#147;<B><I>Available Proceeds</I></B>&#148;), on the one hundred fiftieth (150<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day after such Deemed Liquidation Event, to redeem all
outstanding shares of Preferred Stock at a price per share equal to the Series A Liquidation Preference, in the case of Series A Preferred Stock, the Series B Liquidation Preference, in the case of Series B Preferred Stock, or the Series C
Liquidation Preference, in the case of Series C Preferred Stock to the fullest extent of such Available Proceeds, in accordance with the payment priorities set forth in <U>Subsections 2.1</U>, <U>2.2</U> and <U>2.3</U>. Notwithstanding the
foregoing, in the event of a redemption pursuant to the preceding sentence, if the Available Proceeds are not sufficient to redeem all outstanding shares of Preferred Stock, the Corporation shall first ratably redeem each holder&#146;s shares of
Senior Preferred Stock together to the fullest extent of such Available Proceeds, and after paying or setting aside for payment all such amounts and redeeming all shares of Senior Preferred Stock, shall thereafter ratably redeem each holder&#146;s
shares of Series&nbsp;A Preferred Stock to the fullest extent of such Available Proceeds and shall redeem (with the same priority of the Senior Preferred Stock over the Series A Preferred Stock) the remaining shares of Series C Preferred Stock,
Series B Preferred Stock and/or Series A Preferred as soon as it may lawfully do so under Delaware law governing distributions to stockholders. Prior to the distribution or redemption provided for in this <U>Subsection 2.4.2(b)</U>, the Corporation
shall not expend or dissipate the consideration received for such Deemed Liquidation Event, except to discharge expenses incurred in connection with such Deemed Liquidation Event or in the ordinary course of business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.4.3 <U>Amount Deemed Paid or Distributed</U>. The amount deemed paid or distributed to the holders of capital stock of the Corporation upon
any such merger, consolidation, sale, transfer, exclusive license, other disposition or redemption shall be the cash or the value of the property, rights or securities paid or distributed to such holders by the Corporation or the acquiring person,
firm or other entity. The value of such property, rights or securities shall be determined in good faith by the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.4.4 <U>Allocation of Escrow and Contingent Consideration</U>. In the event of a Deemed
Liquidation Event pursuant to <U>Subsection 2.4.1(a)(i)</U>, if any portion of the consideration payable to the stockholders of the Corporation is payable only upon satisfaction of contingencies (the &#147;<B><I>Additional
Consideration</I></B>&#148;)<B><I>, </I></B>the Merger Agreement shall provide that (a)&nbsp;the portion of such consideration that is not Additional Consideration (such portion, the &#147;<B><I>Initial Consideration</I></B>&#148;)<B><I>
</I></B>shall be allocated among the holders of capital stock of the Corporation in accordance with <U>Subsections 2.1</U>, <U>2.2</U> and <U>2.3</U> as if the Initial Consideration were the only consideration payable in connection with such Deemed
Liquidation Event; and (b)&nbsp;any Additional Consideration which becomes payable to the stockholders of the Corporation upon satisfaction of such contingencies shall be allocated among the holders of capital stock of the Corporation in accordance
with <U>Subsections 2.1</U>, <U>2.2</U> and <U>2.3</U> after taking into account the previous payment of the Initial Consideration as part of the same transaction. For the purposes of this <U>Subsection 2.4.4</U>, consideration placed into escrow or
retained as holdback to be available for satisfaction of indemnification or similar obligations in connection with such Deemed Liquidation Event shall be deemed to be Additional Consideration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <U>Voting</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.1
<U>General</U>. On any matter presented to the stockholders of the Corporation for their action or consideration at any meeting of stockholders of the Corporation (or by written consent of stockholders in lieu of meeting), each holder of outstanding
shares of Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Preferred Stock held by such holder are convertible as of the record date for determining
stockholders entitled to vote on such matter. Except as provided by law or by the other provisions of the Certificate of Incorporation, holders of Preferred Stock shall vote together with the holders of Common Stock as a single class. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.2 <U>Election of Directors</U>. (A)&nbsp;The holders of record of the shares of Series&nbsp;A Preferred Stock, exclusively and as a separate
class, shall be entitled to elect two (2)&nbsp;directors of the Corporation; (B)&nbsp;the holders of record of the shares of Common Stock, exclusively and as a separate class, shall be entitled to elect one (1)&nbsp;director of the Corporation;
(C)&nbsp;at any time when at least 12,500,000 shares of Series B Preferred Stock subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series B Preferred
Stock) are outstanding, the holders of record of the shares of Series B Preferred Stock, exclusively and as a separate class, shall be entitled to elect one (1)&nbsp;director of the Corporation; and (D)&nbsp;the holders of record of the shares of
Preferred Stock and Common Stock, voting together as a single class, shall be entitled to elect all remaining directors of the Corporation. Any director elected as provided in the preceding sentence may be removed without cause by, and only by, the
affirmative vote of the holders of the shares of the class or series of capital stock entitled to elect such director or directors, given either at a special meeting of such stockholders duly called for that purpose or pursuant to a written consent
of stockholders. If the holders of shares of Series&nbsp;A Preferred Stock, Series B Preferred Stock or Common Stock, as the case may be, fail to elect a sufficient number of directors to fill all directorships for which they are entitled to elect
directors, voting exclusively and as a separate class, pursuant to the first sentence of this <U>Subsection 3.2</U>, then any directorship not so filled shall remain vacant until such time as the holders of the Series&nbsp;A Preferred Stock, Series
B Preferred Stock or Common Stock, as the case may be, elect a person to fill such directorship by vote or written consent in lieu of a meeting; and no such directorship may be filled by stockholders of the Corporation other than by the stockholders
of the Corporation that are entitled to elect a person to fill such directorship, voting exclusively and as a separate class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The holders of record of the shares of Common Stock and of any other class or series of voting stock (including the Preferred Stock), exclusively and voting together as a single class, shall be
entitled to elect the balance of the total number of directors of the Corporation. At any meeting held for the purpose of electing a director, the presence in person or by proxy of the holders of a majority of the outstanding shares of the class or
series entitled to elect such director shall constitute a quorum for the purpose of electing such director. Except as otherwise provided in this <U>Subsection 3.2</U> a vacancy in any directorship filled by the holders of any class or series shall
be filled only by vote or written consent in lieu of a meeting of the holders of such class or series or by any remaining director or directors elected by the holders of such class or series pursuant to this <U>Subsection 3.2</U>. Notwithstanding
the foregoing or the provisions of Sections 223(a)(1) and 223(a)(2) of the DGCL, any vacancy on the Board to be filled by the holders of record of the shares of Common Stock and Preferred Stock voting together as a single class pursuant to clause
(D)&nbsp;above, which such holders fail to fill, may be filled by a majority of the directors then in office, though less than a quorum, or by a sole remaining director, and the directors so chosen shall hold office until the next annual meeting and
until their successors are duly elected and shall qualify, unless sooner displaced. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.3 <U>Preferred Stock Majority Vote Protective
Provisions</U>. At any time when at least 35,000,000 shares of Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock) are
outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Certificate of Incorporation) the written
consent or affirmative vote of the Requisite Majority given in writing or by vote at a meeting, and any such act or transaction entered into without such consent or vote shall be null and void <I>ab</I><I></I><I>&nbsp;initio</I>, and of no force or
effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.1 liquidate, dissolve or <FONT STYLE="white-space:nowrap">wind-up</FONT> the business and affairs of the Corporation, effect
any merger or consolidation or any other Deemed Liquidation Event, or consent to any of the foregoing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.2 amend, alter, waive or
repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the powers, privileges, preferences or rights of the Preferred Stock; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.3 create, or authorize the creation of (by reclassification, alteration or otherwise), or issue or obligate itself to issue shares of, any
additional class or series of capital stock, or increase the authorized number of shares of Preferred Stock or increase the authorized number of shares of any additional class or series of capital stock unless the same ranks junior to the Preferred
Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.4 purchase or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on, any
shares of capital stock of the Corporation other than (i)&nbsp;redemptions of or dividends or distributions on the Preferred Stock as expressly authorized herein, (ii)&nbsp;dividends or other distributions payable on the Common Stock solely in the
form of additional shares of Common Stock and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iii)&nbsp;repurchases of stock from former employees, officers, directors, consultants or other persons who performed services for the Corporation or any subsidiary in connection with the
cessation of such employment or service at the lower of the original purchase price or the then-current fair market value thereof; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.5 decrease the authorized number of directors constituting the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.4 <U>Preferred Stock Supermajority Vote Protective Provisions</U>. At any time when at least 35,000,000 shares of Preferred Stock (subject
to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock) are outstanding, the Corporation shall not, either directly or indirectly by amendment,
merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent or affirmative vote of the holders of at least two thirds of the outstanding
shares of Preferred Stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to Common Stock basis (the &#147;<B><I>Requisite Supermajority</I></B>&#148;) given in writing or by vote at a meeting, and any
such act or transaction entered into without such consent or vote shall be null and void <I>ab</I><I></I><I>&nbsp;initio</I>, and of no force or effect: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.4.1 effect any Deemed Liquidation Event that could result in payment of proceeds to the holders of the Series B Preferred Stock with respect
to such shares in an amount less than the Series B Liquidation Preference per share of Series B Preferred Stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.4.2 effect any Deemed
Liquidation Event that could result in payment of proceeds to the holders of the Series C Preferred Stock with respect to such shares in an amount less than the Series C Liquidation Preference per share of Series C Preferred Stock; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.4.3 create (by reclassification, alteration or otherwise) any new class or series of capital stock ranking senior to the Series C Preferred
Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption if shares of such new class or series of capital stock shall be issued at a per
share price below the Series C Original Issue Price (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series C Preferred Stock). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Optional Conversion</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of the Preferred Stock shall have conversion rights as follows (the &#147;<B><I>Conversion Rights</I></B>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.1 <U>Right to Convert</U>. Each share of Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from
time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Common Stock as is determined by dividing the applicable
Original Issue Price by the applicable Conversion Price (as defined below) in effect at the time of conversion. The &#147;<B><I>Series C Conversion Price</I></B>&#148; shall initially be equal to $1.83. The &#147;<B><I>Series B Conversion
Price</I></B>&#148;<B><I> </I></B>shall initially be equal to $1.3767. The &#147;<B><I>Series</I></B><B><I></I></B><B><I>&nbsp;A Conversion Price</I></B>&#148;<B><I> </I></B>shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
initially be equal to $1.00. The Series C Conversion Price, the Series B Conversion Price and the Series A Conversion Price shall each be referred to herein as a &#147;<B><I>Conversion
Price</I></B>.&#148; Such initial applicable Conversion Price, and the rate at which shares of Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2 <U>Fractional Shares</U>. No fractional shares of Common Stock shall be issued upon conversion of the Preferred Stock. In lieu of any
fractional shares to which the holder would otherwise be entitled, the Corporation shall pay cash equal to such fraction multiplied by the fair market value of a share of Common Stock as determined in good faith by the Board. Whether or not
fractional shares would be issuable upon such conversion shall be determined on the basis of the total number of shares of Preferred Stock the holder is at the time converting into Common Stock and the aggregate number of shares of Common Stock
issuable upon such conversion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.3 <U>Mechanics of Conversion</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.1 <U>Notice of Conversion</U>. In order for a holder of Preferred Stock to voluntarily convert shares of Preferred Stock into shares of
Common Stock, such holder shall (a)&nbsp;provide written notice to the Corporation&#146;s transfer agent at the office of the transfer agent for the Preferred Stock (or at the principal office of the Corporation if the Corporation serves as its own
transfer agent) that such holder elects to convert all or any number of such holder&#146;s shares of any series of Preferred Stock and, if applicable, any event on which such conversion is contingent and (b), if such holder&#146;s shares are
certificated, surrender the certificate or certificates for such shares of Preferred Stock (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably
acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate), at the office of the transfer agent for the Preferred
Stock (or at the principal office of the Corporation if the Corporation serves as its own transfer agent). Such notice shall state such holder&#146;s name or the names of the nominees in which such holder wishes the shares of Common Stock to be
issued. If required by the Corporation, any certificates surrendered for conversion shall be endorsed or accompanied by a written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder
or his, her or its attorney duly authorized in writing. The close of business on the date of receipt by the transfer agent (or by the Corporation if the Corporation serves as its own transfer agent) of such notice and, if applicable, certificates
(or lost certificate affidavit and agreement) shall be the time of conversion (the &#147;<B><I>Conversion Time</I></B>&#148;), and the shares of Common Stock issuable upon conversion of the specified shares shall be deemed to be outstanding of
record as of such date. The Corporation shall, as soon as practicable after the Conversion Time (i)&nbsp;issue and deliver to such holder of Preferred Stock, or to his, her or its nominees, a certificate or certificates for the number of full shares
of Common Stock issuable upon such conversion in accordance with the provisions hereof and a certificate for the number (if any) of the shares of the series of Preferred Stock represented by the surrendered certificate that were not converted into
Common Stock, (ii)&nbsp;pay in cash such amount as provided in <U>Subsection 4.2</U> in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and (iii)&nbsp;pay all declared but unpaid dividends on the shares of
Preferred Stock converted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.2 <U>Reservation of Shares</U>. The Corporation shall at all times when any shares of
Preferred Stock shall be outstanding, reserve and keep available out of its authorized but unissued capital stock, for the purpose of effecting the conversion of the Preferred Stock, such number of its duly authorized shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding
shares of the Preferred Stock, the Corporation shall take such corporate action as may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including, without
limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation. Before taking any action which would cause an adjustment reducing the Conversion Price of a series of
Preferred Stock below the then par value of the shares of Common Stock issuable upon conversion of such series of Preferred Stock, the Corporation will take any corporate action which may, in the opinion of its counsel, be necessary in order that
the Corporation may validly and legally issue fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Common Stock at such adjusted Conversion Price. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.3 <U>Effect of Conversion</U>. All shares of Preferred Stock which shall have been surrendered for conversion as herein provided shall no
longer be deemed to be outstanding and all rights with respect to such shares shall immediately cease and terminate at the Conversion Time, except only the right of the holders thereof to receive shares of Common Stock in exchange therefor, to
receive payment in lieu of any fraction of a share otherwise issuable upon such conversion as provided in <U>Subsection 4.2</U> and to receive payment of any dividends declared but unpaid thereon. Any shares of Preferred Stock so converted shall be
retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of
Preferred Stock and the associated series of Preferred Stock accordingly. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.4 <U>No Further Adjustment</U>. Upon any such conversion,
no adjustment to the Conversion Price of a series of Preferred Stock shall be made for any declared but unpaid dividends on such series of Preferred Stock surrendered for conversion or on the Common Stock delivered upon conversion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.5 <U>Taxes</U>. The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or
delivery of shares of Common Stock upon conversion of shares of Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;4</U>. The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer
involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity
requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.4 <U>Adjustments to the Applicable Conversion Price for Diluting Issues</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.1 <U>Special Definitions</U>. For purposes of this Article Fourth, the following definitions shall apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B><I>Option</I></B>&#148;<B><I> </I></B>shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire
Common Stock or Convertible Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B><I>Series C Original Issue Date</I></B>&#148; shall mean the date on which the first
share of Series C Preferred Stock was issued. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B><I>Convertible Securities</I></B>&#148;<B><I> </I></B>shall mean any evidences
of indebtedness, shares or other securities directly or indirectly convertible into or exchangeable for Common Stock, but excluding Options. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B><I>Additional Shares of Common Stock</I></B>&#148;<B><I> </I></B>shall mean all shares of Common Stock issued (or, pursuant to
<U>Subsection 4.4.3</U> below, deemed to be issued) by the Corporation after the Series C Original Issue Date, other than (1)&nbsp;the following shares of Common Stock and (2)&nbsp;shares of Common Stock deemed issued pursuant to the following
Options and Convertible Securities (clauses&nbsp;(1) and (2), collectively, &#147;<B><I>Exempted Securities</I></B>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(i) shares of
Common Stock, Options or Convertible Securities issued as a dividend or distribution on Preferred Stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(ii) shares of Common Stock,
Options or Convertible Securities issued by reason of a dividend, stock split, <FONT STYLE="white-space:nowrap">split-up</FONT> or other distribution on shares of Common Stock that is covered by <U>Subsection 4.5</U>, <U>4.6</U>, <U>4.7</U> or
<U>4.8</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(iii) shares of Common Stock or Options issued to employees or directors of, or consultants or advisors to, the Corporation
or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(iv) shares of Common Stock or Convertible
Securities actually issued upon the exercise of Options or shares of Common Stock actually issued upon the conversion or exchange of Convertible Securities, in each case provided such issuance is pursuant to the terms of such Option or Convertible
Security; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(v) shares of Common Stock, Options or Convertible Securities issued to banks, equipment lessors or other financial
institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved by the Board; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(vi) shares of Common Stock, Options or Convertible Securities issued pursuant to sponsored research, collaboration, technology license,
development, OEM, marketing or other similar agreements or strategic partnerships approved by the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.2 <U>No Adjustment of Conversion Price</U>. No adjustment in the Series C Conversion
Price shall be made as a result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the holders of at least a majority of the shares of Series C Preferred Stock then outstanding
agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common Stock. No adjustment in the Series B Conversion Price shall be made as a result of the issuance or deemed issuance of
Additional Shares of Common Stock if the Corporation receives written notice from the holders of at least a majority of the shares of Series B Preferred Stock then outstanding agreeing that no such adjustment shall be made as the result of the
issuance or deemed issuance of such Additional Shares of Common Stock. No adjustment in the Series A Conversion Price shall be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives
written notice from the holders of at least a majority of the shares of Series A Preferred Stock then outstanding agreeing that no such adjustment shall be made as the result of the issuance or deemed issuance of such Additional Shares of Common
Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.3 <U>Deemed Issue of Additional Shares of Common Stock</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) If the Corporation at any time or from time to time after the Series C Original Issue Date shall issue any Options or Convertible
Securities (excluding Options or Convertible Securities which are themselves Exempted Securities) or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities,
then the maximum number of shares of Common Stock (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained
therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be
Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) If the terms of any Option or Convertible Security, the issuance of which resulted in an adjustment to the Conversion Price of a series of
Preferred Stock pursuant to the terms of <U>Subsection 4.4.4</U>, are revised as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to
such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security) to provide for either (1)&nbsp;any increase or decrease in the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange
of any such Option or Convertible Security or (2)&nbsp;any increase or decrease in the consideration payable to the Corporation upon such exercise, conversion and/or exchange, then, effective upon such increase or decrease becoming effective, the
applicable Conversion Price computed upon the original issue of such Option or Convertible Security (or upon the occurrence of a record date with respect thereto) shall be readjusted to such Conversion Price for such series of Preferred Stock as
would have been obtained had such revised terms been in effect upon the original date of issuance of such Option or Convertible Security. Notwithstanding the foregoing, no readjustment pursuant to this clause&nbsp;(b) shall have the effect of
increasing the Conversion Price of a series of Preferred Stock to an amount which exceeds the lower of (i)&nbsp;the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Conversion Price of such series of Preferred Stock in effect immediately prior to the original adjustment made as a result of the issuance of such Option or Convertible Security, or (ii)&nbsp;the
Conversion Price of such series of Preferred Stock that would have resulted from any issuances of Additional Shares of Common Stock (other than deemed issuances of Additional Shares of Common Stock as a result of the issuance of such Option or
Convertible Security) between the original adjustment date and such readjustment date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) If the terms of any Option or Convertible
Security (excluding Options or Convertible Securities which are themselves Exempted Securities), the issuance of which did not result in an adjustment to the Conversion Price of such series of Preferred Stock pursuant to the terms of <U>Subsection
4.4.4</U> (either because the consideration per share (determined pursuant to <U>Subsection 4.4.5</U>) of the Additional Shares of Common Stock subject thereto was equal to or greater than the Conversion Price of such series of Preferred Stock then
in effect, or because such Option or Convertible Security was issued before the Series C Original Issue Date), are revised after the Series C Original Issue Date as a result of an amendment to such terms or any other adjustment pursuant to the
provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to anti-dilution or similar provisions of such Option or Convertible Security) to provide for either (I)&nbsp;any increase in the number of
shares of Common Stock issuable upon the exercise, conversion or exchange of any such Option or Convertible Security or (2)&nbsp;any decrease in the consideration payable to the Corporation upon such exercise, conversion or exchange, then such
Option or Convertible Security, as so amended or adjusted, and the Additional Shares of Common Stock subject thereto (determined in the manner provided in <U>Subsection 4.4.3(a)</U> shall be deemed to have been issued effective upon such increase or
decrease becoming effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(d) Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible
Security (or portion thereof) which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to the Conversion Price of a series of Preferred Stock pursuant to the terms of <U>Subsection 4.4.4</U> the Conversion
Price of such series of Preferred Stock shall be readjusted to such Conversion Price as would have been obtained had such Option or Convertible Security (or portion thereof) never been issued. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(e) If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or
the consideration payable to the Corporation upon such exercise, conversion and/or exchange, is calculable at the time such Option or Convertible Security is issued or amended but is subject to adjustment based upon subsequent events, any adjustment
to the Conversion Price of a Series of Preferred Stock provided for in this <U>Subsection 4.4.3</U> shall be effected at the time of such issuance or amendment based on such number of shares or amount of consideration without regard to any
provisions for subsequent adjustments (and any subsequent adjustments shall be treated as provided in clauses&nbsp;(b) and (c)&nbsp;of this <U>Subsection 4.4.3</U>). If the number of shares of Common Stock issuable upon the exercise, conversion
and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise, conversion and/or exchange, cannot be calculated at all at the time such Option or Convertible Security is issued or amended,
any adjustment to the Conversion Price of a series of Preferred Stock that would result under the terms of this <U>Subsection 4.4.3</U> at the time of such issuance or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amendment shall instead be effected at the time such number of shares and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of
calculating such adjustment to the Conversion Price of such series of Preferred Stock that such issuance or amendment took place at the time such calculation can first be made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.4 <U>Adjustment of Conversion Price Upon Issuance of Additional Shares of Common Stock</U>. In the event the Corporation shall at any time
after the Series C Original Issue Date issue Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to <U>Subsection 4.4.3</U>), without consideration or for a consideration per share less than
the Series C Conversion Price, Series B Conversion Price or Series A Conversion Price in effect immediately prior to such issue, then the applicable Conversion Price shall be reduced, concurrently with such issue, to a price (calculated to the
nearest <FONT STYLE="white-space:nowrap">one-hundredth</FONT> of a cent) determined in accordance with the following formula: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CP<SUB
STYLE="font-size:85%; vertical-align:bottom">2</SUB> = CP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>* (A + B) &divide; (A + C). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
purposes of the foregoing formula, the following definitions shall apply: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a)
&#147;CP<SUB STYLE="font-size:85%; vertical-align:bottom">2</SUB>&#148; shall mean the Conversion Price of such series of Preferred Stock in effect immediately after such issue of Additional Shares of Common Stock </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) &#147;CP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>&#148; shall mean the Conversion Price of such series of Preferred Stock
in effect immediately prior to such issue of Additional Shares of Common Stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) &#147;A&#148; shall mean the number of shares of
Common Stock outstanding immediately prior to such issue of Additional Shares of Common Stock (treating for this purpose as outstanding all shares of Common Stock issuable upon exercise of Options outstanding immediately prior to such issue or upon
conversion or exchange of Convertible Securities (including the Preferred Stock) outstanding (assuming exercise of any outstanding Options therefor) immediately prior to such issue other than, in the case of Convertible Securities, such number of
shares of Common Stock issuable upon conversion of Convertible Securities that will convert into the shares of capital stock to be issued in the transaction for which the calculation described in this Section&nbsp;4.4.4 is being made); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(d) &#147;B&#148; shall mean the number of shares of Common Stock that would have been issued if such Additional Shares of Common Stock had
been issued at a price per share equal to CP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> (determined by dividing the aggregate consideration received by the Corporation in respect of such issue by CP<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB>); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(e) &#147;C&#148; shall mean the number of such Additional Shares of Common
Stock issued in such transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.5 <U>Determination of Consideration</U>. For purposes of this <U>Subsection 4.4</U>, the
consideration received by the Corporation for the issue of any Additional Shares of Common Stock shall be computed as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) <U>Cash and Property</U>: Such consideration shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(i) insofar as it consists of cash, be computed at the aggregate amount of cash received by the Corporation, excluding amounts paid or payable
for accrued interest; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(ii) insofar as it consists of property other than cash, be computed at the fair market value thereof at the time
of such issue, as determined in good faith by the Board; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(iii) in the event Additional Shares of Common Stock are issued together
with other shares or securities or other assets of the Corporation for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses&nbsp;(i) and (ii)&nbsp;above, as determined in good faith by
the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b) <U>Options and Convertible Securities</U>. The consideration per share received by the Corporation for Additional Shares
of Common Stock deemed to have been issued pursuant to <U>Subsection 4.4.3</U> relating to Options and Convertible Securities, shall be determined by dividing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(i) The total amount, if any, received or receivable by the Corporation as consideration for the issue of such Options or Convertible
Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the
Corporation upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange
of such Convertible Securities, by </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(ii) the maximum number of shares of Common Stock (as set forth in the instruments relating thereto,
without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible
Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.6
<U>Multiple Closing Dates</U>. In the event the Corporation shall issue on more than one date Additional Shares of Common Stock that are a part of one transaction or a series of related transactions and that would result in an adjustment to the
Conversion Price of a series of Preferred Stock pursuant to the terms of <U>Subsection 4.4.4</U>, and such issuance dates occur within a period of no more than ninety (90)&nbsp;days from the first such issuance to the final such issuance, then, upon
the final such issuance, the Conversion Price of such series of Preferred Stock shall be readjusted to give effect to all such issuances as if they all occurred on the date of the additional adjustments as a result of any such subsequent issuances
within such period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.5 <U>Adjustment for Stock Splits and Combinations</U>. If the Corporation shall at any
time or from time to time after the Series C Original Issue Date effect a subdivision of the outstanding Common Stock, the Conversion Price of each series of Preferred Stock in effect immediately before that subdivision shall be proportionately
decreased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be increased in proportion to such increase in the aggregate number of shares of Common Stock outstanding. If the Corporation shall at
any time or from time to time after the Series C Original Issue Date combine the outstanding shares of Common Stock, the Conversion Price of each series of Preferred Stock in effect immediately before the combination shall be proportionately
increased so that the number of shares of Common Stock issuable on conversion of each share of such series shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding. Any adjustment under this
subsection shall become effective at the close of business on the date the subdivision or combination becomes effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.6
<U>Adjustment for Certain Dividends and Distributions</U>. In the event the Corporation at any time or from time to time after the Series C Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common
Stock entitled to receive, a dividend or other distribution payable on the Common Stock in additional shares of Common Stock, then and in each such event the Conversion Price of each series of Preferred Stock in effect immediately before such event
shall be decreased as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record date, by multiplying the Conversion Price of the applicable series of Preferred Stock then in
effect by a fraction: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately
prior to the time of such issuance or the close of business on such record date, and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) the denominator of which shall be the total
number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing (a)&nbsp;if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made
on the date fixed therefor, the Conversion Price of each series of Preferred Stock shall be recomputed accordingly as of the close of business on such record date and thereafter the Conversion Price of each series of Preferred Stock shall be
adjusted pursuant to this subsection as of the time of actual payment of such dividends or distributions; and (b)&nbsp;that no such adjustment shall be made to a series of Preferred Stock if the holders of such series of Preferred Stock
simultaneously receive a dividend or other distribution of shares of Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of such series of Preferred Stock had been converted
into Common Stock on the date of such event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.7 <U>Adjustments for Other Dividends and Distributions</U>. In the event the Corporation
at any time or from time to time after the Series C Original Issue Date shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in securities of the
Corporation (other than a distribution of shares of Common Stock in respect of outstanding shares of Common Stock) or in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other property and the provisions of <U>Section</U><U></U><U>&nbsp;1</U> do not apply to such dividend or distribution, then and in each such event the holders of Preferred Stock shall receive,
simultaneously with the distribution to the holders of Common Stock, a dividend or other distribution of such securities or other property in an amount equal to the amount of such securities or other property as they would have received if all
outstanding shares of Preferred Stock had been converted into Common Stock on the date of such event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.8 <U>Adjustment for Merger or
Reorganization, etc.</U> Subject to the provisions of <U>Subsection 2.4</U>, if there shall occur any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not a given
series of Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by <U>Subsections 4.4</U>, <U>4.6</U> or <U>4.7</U>) then, following any such reorganization, recapitalization,
reclassification, consolidation or merger, each share of such applicable series of Preferred Stock shall thereafter be convertible in lieu of the Common Stock into which it was convertible prior to such event into the kind and amount of securities,
cash or other property which a holder of the number of shares of Common Stock of the Corporation issuable upon conversion of one share of such series of Preferred Stock immediately prior to such reorganization, recapitalization, reclassification,
consolidation or merger would have been entitled to receive pursuant to such transaction; and, in such case, appropriate adjustment (as determined in good faith by the Board) shall be made in the application of the provisions in this
<U>Section</U><U></U><U>&nbsp;4</U> with respect to the rights and interests thereafter of the holders of such series of Preferred Stock, to the end that the provisions set forth in this <U>Section</U><U></U><U>&nbsp;4</U> (including provisions with
respect to changes in and other adjustments of the Conversion Price of each series of Preferred Stock) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the
conversion of the Preferred Stock. For the avoidance of doubt, nothing in this <U>Subsection 4.8</U> shall be construed as preventing the holders of Preferred Stock from seeking any appraisal rights to which they are otherwise entitled under the
DGCL in connection with a merger triggering an adjustment hereunder, nor shall this <U>Subsection 4.8</U> be deemed conclusive evidence of the fair value of the shares of Preferred Stock in any such appraisal proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.9 <U>Certificate as to Adjustments</U>. Upon the occurrence of each adjustment or readjustment of the Conversion Price of a series of
Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;4</U>, the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than ten (10)&nbsp;days thereafter, compute such adjustment or readjustment
in accordance with the terms hereof and furnish to each holder of Preferred Stock that has been subject to an adjustment or readjustment, a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash
or other property into which the Preferred Stock is convertible) and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation shall, as promptly as reasonably practicable after the written request at any time
of any holder of Preferred Stock (but in any event not later than ten (10)&nbsp;days thereafter), furnish or cause to be furnished to such holder a certificate setting forth (i)&nbsp;the Conversion Price of each series of Preferred Stock then in
effect, and (ii)&nbsp;the number of shares of Common Stock and the amount, if any, of other securities, cash or property which then would be received upon the conversion of each series of Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.10 <U>Notice of Record Date</U>. In the event: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) the Corporation shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon
conversion of the Preferred Stock) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities, or
to receive any other security; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) of any capital reorganization of the Corporation, any reclassification of the Common Stock of the
Corporation, or any Deemed Liquidation Event; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) of the voluntary or involuntary dissolution, liquidation or <FONT
STYLE="white-space:nowrap">winding-up</FONT> of the Corporation, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, and in each such case, the Corporation will send or cause to be sent to the holders
of the Preferred Stock a notice specifying, as the case may be, (i)&nbsp;the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii)&nbsp;the effective date on which such
reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or <FONT STYLE="white-space:nowrap">winding-up</FONT> is proposed to take place, and the time, if any is to be fixed, as of which the holders of record of
Common Stock (or such other capital stock or securities at the time issuable upon the conversion of any Preferred Stock) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other
property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or <FONT STYLE="white-space:nowrap">winding-up,</FONT> and the amount per share and character of such exchange applicable to
the Preferred Stock and the Common Stock. Such notice shall be sent at least ten (10)&nbsp;days prior to the record date or effective date for the event specified in such notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U>Mandatory Conversion</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">5.1 <U>Trigger Events</U>. Upon either (a)&nbsp;immediately prior to the closing of the sale of shares of Common Stock to the public in a
firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $45,000,000 of net proceeds to the Company (after deduction of underwriters&#146;
commissions and expenses) (a &#147;<B><I>Qualified IPO</I></B>&#148;), or (b)&nbsp;the date and time, or the occurrence of an event, specified by vote or written consent of the Requisite Majority (the time immediately prior to such closing or the
date and time specified or the time of the event specified in such vote or written consent is referred to herein as the &#147;<B><I>Mandatory Conversion Time</I></B>&#148;), then (A)&nbsp;all outstanding shares of Preferred Stock shall automatically
be converted into shares of Common Stock, at the then effective conversion rates as calculated pursuant to <U>Subsection 4.1.1</U> and (B)&nbsp;such shares may not be reissued by the Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">5.2 <U>Procedural Requirements</U>. All holders of record of shares of Preferred Stock shall be sent written notice of the Mandatory
Conversion Time and the place designated for mandatory conversion of all such shares of Preferred Stock being converted pursuant to this <U>Section</U><U></U><U>&nbsp;5</U>. Such notice need not be sent in advance of the occurrence of the Mandatory
Conversion Time. Upon receipt of such notice, each holder of shares of Preferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock in certificated form shall surrender his, her or its certificate or certificates for all such shares (or, if such holder alleges that such certificate has been lost, stolen or destroyed, a
lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to
the Corporation at the place designated in such notice. If so required by the Corporation, any certificates surrendered for conversion shall be endorsed or accompanied by written instrument or instruments of transfer, in form satisfactory to the
Corporation, duly executed by the registered holder or by his, her or its attorney duly authorized in writing. All rights with respect to the Preferred Stock converted pursuant to <U>Subsection</U><U></U><U>&nbsp;5.1</U>, including the rights, if
any, to receive notices and vote (other than as a holder of Common Stock), will terminate at the Mandatory Conversion Time (notwithstanding the failure of the holder or holders thereof to surrender any certificates at or prior to such time), except
only the rights of the holders thereof, upon surrender of any certificate or certificates of such holders (or lost certificate affidavit and agreement) therefor, to receive the items provided for in the next sentence of this <U>Subsection 5.2</U>.
As soon as practicable after the Mandatory Conversion Time and, if applicable, the surrender of any certificate or certificates (or lost certificate affidavit and agreement) for Preferred Stock being converted, the Corporation shall (a)&nbsp;issue
and deliver to such holder, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable on such conversion in accordance with the provisions hereof and (b)&nbsp;pay cash as provided in
<U>Subsection 4.2</U> in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and the payment of any declared but unpaid dividends on the shares of Preferred Stock converted. Such converted Preferred Stock shall be
retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of
Preferred Stock accordingly. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <U>Redemption</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.1 <U>General</U>. Unless prohibited by Delaware law governing distributions to stockholders, all outstanding shares of Preferred Stock shall
be redeemed by the Corporation at a price equal to the applicable Original Issue Price per share, plus any dividends declared but unpaid thereon (the &#147;<B><I>Redemption Price</I></B>&#148;), in three (3)&nbsp;annual installments commencing not
more than sixty (60)&nbsp;days after receipt by the Corporation at any time on or after five (5)&nbsp;years from the Series C Original Issue Date, from the Requisite Majority, of written notice requesting redemption of all shares of Preferred Stock
(the &#147;<B><I>Redemption Request</I></B>&#148;). Upon receipt of a Redemption Request, the Corporation shall apply all of its assets to any such redemption, and to no other corporate purpose, except to the extent prohibited by Delaware law
governing distributions to stockholders. The date of each such installment shall be referred to as a &#147;<B><I>Redemption Date</I></B>.&#148; On each Redemption Date, the Corporation shall redeem, on a <I>pro</I><I></I><I>&nbsp;rata</I> basis in
accordance with the number of shares of Preferred Stock owned by each holder, that number of outstanding shares of Preferred Stock determined by dividing (i)&nbsp;the total number of shares of Preferred Stock outstanding immediately prior to such
Redemption Date by (ii)&nbsp;the number of remaining Redemption Dates (including the Redemption Date to which such calculation applies. If on any Redemption Date Delaware law governing distributions to stockholders prevents the Corporation from
redeeming all shares of Preferred Stock to be redeemed, the Corporation shall ratably redeem the maximum number of shares that it may redeem consistent with such law, and shall redeem the remaining shares as soon as it may lawfully do so under such
law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.2 <U>Redemption Notice</U>. The Corporation shall send written notice of the mandatory
redemption (the &#147;<B><I>Redemption Notice</I></B>&#148;)<B><I> </I></B>to each holder of record of Preferred Stock not less than forty (40)&nbsp;days prior to each Redemption Date. Each Redemption Notice shall state: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a) the number and series of shares of Preferred Stock held by the holder that the Corporation shall redeem on the Redemption Date specified
in the Redemption Notice; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b) the Redemption Date and the Redemption Price; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(c) the date upon which the holder&#146;s right to convert such shares terminates (as determined in accordance with <U>Subsection 4.1</U>);
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(d) for holders of shares in certificated form, that the holder is to surrender to the Corporation, in the manner and at the place
designated, his, her or its certificate or certificates representing the shares of Preferred Stock to be redeemed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.3 <U>Surrender of
Certificates; Payment</U>. On or before the applicable Redemption Date, each holder of shares of Preferred Stock to be redeemed on such Redemption Date, unless such holder has exercised his, her or its right to convert such shares as provided in
<U>Section</U><U></U><U>&nbsp;4</U> shall, if a holder of shares in certificated form, surrender the certificate or certificates representing such shares (or, if such registered holder alleges that such certificate has been lost, stolen or
destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such
certificate) to the Corporation, in the manner and at the place designated in the Redemption Notice, and thereupon the Redemption Price for such shares shall be payable to the order of the person whose name appears on such certificate or
certificates as the owner thereof. In the event less than all of the shares of Preferred Stock represented by a certificate are redeemed, a new certificate, instrument, or book entry representing the unredeemed shares of Preferred Stock shall
promptly be issued to such holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6.4 <U>Rights Subsequent to Redemption</U>. If the Redemption Notice shall have been duly given, and
if on the applicable Redemption Date the Redemption Price payable upon redemption of the shares of Preferred Stock to be redeemed on such Redemption Date is paid or tendered for payment or deposited with an independent payment agent so as to be
available therefor in a timely manner, then notwithstanding that any certificates evidencing any of the shares of Preferred Stock so called for redemption shall not have been surrendered, dividends with respect to such shares of Preferred Stock
shall cease to accrue after such Redemption Date and all rights with respect to such shares shall forthwith after the Redemption Date terminate, except only the right of the holders to receive the Redemption Price without interest upon surrender of
any such certificate or certificates therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Redeemed or Otherwise Acquired Shares</U>. Any shares of Preferred Stock that are
redeemed or otherwise acquired by the Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or transferred. Neither the Corporation nor any of its subsidiaries may
exercise any voting or other rights granted to the holders of Preferred Stock following redemption. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <U>Waiver</U>. Any of the rights,
powers, preferences and other terms of the Preferred Stock set forth herein may be waived on behalf of all holders of Preferred Stock by the affirmative written consent or vote of the Requisite Majority; provided however that this Section&nbsp;8
shall not apply with respect to any provision hereof expressly requiring approval in excess of the holders of a majority of the outstanding Preferred Stock or of a class of Preferred Stock voting separately from the other classes of Preferred Stock,
including without limitation the provisions of Section&nbsp;3.4.1, 3.4.3 and 4.4.2. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <U>Notices</U>. Any notice required or permitted by
the provisions of this Article Fourth to be given to a holder of shares of Preferred Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic communication in compliance
with the provisions of the General Corporation Law, and shall be deemed sent upon such mailing or electronic transmission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FIFTH:
</B>Subject to any additional vote required by the Certificate of Incorporation or Bylaws, in furtherance and not in limitation of the powers conferred by statute, the Board is expressly authorized to make, repeal, alter, amend and rescind any or
all of the Bylaws of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SIXTH: </B>Subject to any additional vote required by the Certificate of Incorporation, the
number of directors of the Corporation shall be determined in the manner set forth in the Bylaws of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SEVENTH:
</B>Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>EIGHTH: </B>Meetings
of stockholders may be held within or without the State of Delaware, as the Bylaws of the Corporation may provide. The books of the Corporation may be kept outside the State of Delaware at such place or places as may be designated from time to time
by the Board or in the Bylaws of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>NINTH: </B>To the fullest extent permitted by law, a director of the Corporation
shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. If the General Corporation Law or any other law of the State of Delaware is amended after approval by the
stockholders of this Article Ninth to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted
by the General Corporation Law as so amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any repeal or modification of the foregoing provisions of this Article Ninth by the
stockholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of, or increase the liability of any director of the Corporation with respect to any acts or omissions of such
director occurring prior to, such repeal or modification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>TENTH: </B>To the fullest extent permitted by applicable law, the Corporation is
authorized to provide indemnification of (and advancement of expenses to) directors, officers and agents of the Corporation (and any other persons to which General Corporation Law permits the Corporation to provide indemnification) through Bylaw
provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification and advancement otherwise permitted by Section&nbsp;145 of the General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any amendment, repeal or modification of the foregoing provisions of this Article Tenth shall not adversely affect any right or protection of
any director, officer or other agent of the Corporation existing at the time of such amendment, repeal or modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>ELEVENTH:
</B>The Corporation renounces, to the fullest extent permitted by law, any interest or expectancy of the Corporation in, or in being offered an opportunity to participate in, any Excluded Opportunity. An &#147;<B><I>Excluded
Opportunity</I></B>&#148;<B><I> </I></B>is any matter, transaction or interest that is presented to, or acquired, created or developed by, or which otherwise comes into the possession of (i)&nbsp;any director of the Corporation who is not an
employee of the Corporation or any of its subsidiaries, or (ii)&nbsp;any holder of Preferred Stock or any partner, member, director, stockholder, employee or agent of any such holder, other than someone who is an employee of the Corporation or any
of its subsidiaries (collectively, &#147;<B><I>Covered Persons</I></B>&#148;), unless such matter, transaction or interest is presented to, or acquired, created or developed by, or otherwise comes into the possession of, a Covered Person expressly
and solely in such Covered Person&#146;s capacity as a director of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>TWELFTH: </B>Unless the Corporation consents in
writing to the selection of an alternative forum, the Court of Chancery in the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i)&nbsp;any derivative action or proceeding brought
on behalf of the Corporation, (ii)&nbsp;any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation&#146;s stockholders, (iii)&nbsp;any action
asserting a claim against the Corporation, its directors, officers or employees arising pursuant to any provision of the Delaware General Corporation Law or the Corporation&#146;s certificate of incorporation or bylaws or (iv)&nbsp;any action
asserting a claim against the Corporation, its directors, officers or employees governed by the internal affairs doctrine, except for, as to each of (i)&nbsp;through (iv)&nbsp;above, any claim as to which the Court of Chancery determines that there
is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested in
the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery does not have subject matter jurisdiction. If any provision or provisions of this Article Twelfth shall be held to be invalid,
illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provisions in any other circumstance and of the
remaining provisions of this Article Twelfth (including, without limitation, each portion of any sentence of this Article Twelfth containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid,
illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIRTEENTH:</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To the extent certain sections of the corporations code of any state set forth minimum requirements for the Company&#146;s retained earnings
and/or assets that would otherwise be applicable to distributions made by the Company in connection with the repurchase of shares of Common Stock issued to or held by employees, consultants, advisors, officers, directors or other service providers
of the Company or any of the Company&#146;s subsidiaries at a price not greater than the amount paid by such person for such shares upon termination of their employment or services pursuant to agreements providing for the right of said repurchase or
upon exercise of a right of first refusal, where such agreements were authorized by the Board, such distributions may be made without regard to any &#147;preferential dividends arrears amount,&#148; &#147;preferential rights amount,&#148; or similar
concept </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp; * &nbsp;&nbsp;&nbsp;&nbsp;* </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. That the foregoing amendment and restatement was approved by the holders of the requisite number of shares of this corporation in accordance
with Section&nbsp;228 of the General Corporation Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. That this Amended and Restated Certificate of Incorporation, which restates and
integrates and further amends the provisions of this Corporation&#146;s Certificate of Incorporation, has been duly adopted in accordance with Sections&nbsp;242 and 245 of the General Corporation Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF,</B> this Amended and Restated Certificate of Incorporation has been
executed by a duly authorized officer of this corporation on this 19th day of December, 2019. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PLIANT THERAPEUTICS, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bernard Coulie</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Bernard Coulie, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL>
<SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>C<SMALL>ERTIFICATE</SMALL> <SMALL>OF</SMALL> I<SMALL>NCORPORATION</SMALL> </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLIANT THERAPEUTICS, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>December&nbsp;19, 2019 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIS AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT </B>(this &#147;<B><I>Agreement</I></B>&#148;), is made as of the 19th&nbsp;day
of December, 2019, by and among <B>PLIANT THERAPEUTICS, INC</B>., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), and each of the investors listed on <B><U>Schedule</U></B><B><U></U></B><B><U>&nbsp;A</U></B> hereto, (together with
any subsequent investors who become parties hereto as &#147;Investors&#148; in accordance with <U>Section</U><U></U><U>&nbsp;6.9</U> hereto, collectively, the &#147;<B><I>Investors</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>RECITALS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company and certain of the Investors are parties to the Series C Preferred Stock Purchase Agreement of even date herewith
(the &#147;<B><I>Purchase Agreement</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, certain of the Investors (the &#147;<B><I>Prior
Investors</I></B>&#148;) are parties to that certain Investors&#146; Rights Agreement dated as of July&nbsp;10, 2018, by and among the Company and the Prior Investors (as amended, the &#147;<B><I>Prior Agreement</I></B>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, <U>Subsection 6.6</U> of the Prior Agreement provides that the Prior Agreement may be amended with the written consent of
(a)&nbsp;the Company and (b)&nbsp;the holders of a majority of the Registrable Securities (as defined in the Prior Agreement) then outstanding (collectively, the &#147;<B><I>Amending Parties</I></B>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the undersigned Amending Parties desire to amend and restate the Prior Agreement and accept on behalf of all of the parties
hereto the rights and covenants hereof in lieu of such parties&#146; rights and covenants under the Prior Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,
in order to induce the Company to enter into the Purchase Agreement and to induce the Investors to invest funds in the Company pursuant to the Purchase Agreement, the Investors and the Company hereby agree that this Agreement shall govern the rights
of the Investors to cause the Company to register shares of Common Stock (as defined below) issuable to the Investors, to receive certain information from the Company, and to participate in future equity offerings by the Company, and shall govern
certain other matters as set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, the parties hereby agree as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Definitions</U>. For purposes of this Agreement: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.1 &#147;<B><I>Affiliate</I></B>&#148; means, with respect to any specified Person, any other Person who, directly or
indirectly, controls, is controlled by, or is under common control with such Person, including, without limitation, any general partner, managing member, officer or director of such Person or any venture capital fund or registered investment company
now or hereafter existing that is controlled by one or more general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such Person. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.2 &#147;<B><I>Certificate of Incorporation</I></B>&#148; means the
Company&#146;s current certificate of incorporation, as amended from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.3 &#147;<B><I>Common
Stock</I></B>&#148; means shares of the Company&#146;s common stock, par value $0.0001 per share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.4
&#147;<B><I>Damages</I></B>&#148; means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim
or liability (or any action in respect thereof) arises out of or is based upon: (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus
or final prospectus contained therein or any amendments or supplements thereto; (ii)&nbsp;an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or
(iii)&nbsp;any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the
Exchange Act, or any state securities law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.5 &#147;<B><I>Derivative Securities</I></B>&#148;<I> </I>means any securities
or rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly)<B>, </B>Common Stock, including options and warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.6 &#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.7 &#147;<B><I>Excluded Registration</I></B>&#148; means (i)&nbsp;a registration relating to the
sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii)&nbsp;a registration relating to an SEC Rule&nbsp;145 transaction; (iii)&nbsp;a registration on any form that does not
include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv)&nbsp;a registration in which the only Common Stock being registered is Common Stock
issuable upon conversion of debt securities that are also being registered. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.8
&#147;<B><I>Form</I></B><B><I></I></B><B><I>&nbsp;S</I></B><B><I><FONT STYLE="white-space:nowrap">-1</FONT></I></B>&#148; means such form under the Securities Act as in effect on the date hereof or any successor registration form under the
Securities Act subsequently adopted by the SEC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.9 &#147;<B><I>Form</I></B><B><I></I></B><B><I>&nbsp;S</I></B><B><I><FONT
STYLE="white-space:nowrap">-3</FONT></I></B>&#148; means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial
information by reference to other documents filed by the Company with the SEC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.10 &#147;<B><I>GAAP</I></B>&#148; means
generally accepted accounting principles in the United States, as in effect from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.11 &#147;<B><I>Holder</I></B>&#148; means any holder of Registrable
Securities who is a party to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.12 &#147;<B><I>Immediate Family Member</I></B>&#148; means a child,
stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mother-in-law,</FONT></FONT>
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">father-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">son-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">daughter-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">brother-in-law,</FONT></FONT> or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sister-in-law,</FONT></FONT> including, adoptive relationships, of a natural person referred to herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.13 &#147;<B><I>Initiating Holders</I></B>&#148; means, collectively, Holders who properly initiate a registration request
under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.14 &#147;<B><I>IPO</I></B>&#148; means the Company&#146;s first underwritten public offering of
its Common Stock under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.15 &#147;<B><I>Key Employee</I></B>&#148; means any executive-level employee
(including, division director and vice president-level positions) as well as any employee who, either alone or in concert with others, develops, invents, programs, or designs any Company Intellectual Property (as defined in the Purchase Agreement).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.16 &#147;<B><I>Major Investor</I></B>&#148; means any Investor that, individually or together with such Investor&#146;s
Affiliates, holds at least 1,089,561 shares of Registrable Securities (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.17 &#147;<B><I>New Securities</I></B>&#148; means, collectively, equity securities of the Company, whether or not currently
authorized, as well as rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such equity securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.18 &#147;<B><I>Person</I></B>&#148; means any individual, corporation, partnership, trust, limited liability company,
association or other entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.19 &#147;<B><I>Preferred Stock</I></B>&#148; means, collectively, the Series A Preferred
Stock, the Series B Preferred Stock and the Series C Preferred Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.20 &#147;<B><I>Registrable
Securities</I></B>&#148; means (i)&nbsp;the Common Stock issuable or issued upon conversion of the<B> </B>Preferred Stock; (ii)&nbsp;any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon conversion, exercise of any
other securities of the Company or both, acquired by the Investors after the date hereof; (iii)&nbsp;any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or
other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses&nbsp;(i) and (ii)&nbsp;above; excluding in all cases, however, any Registrable Securities sold by a Person in a transaction in which the
applicable rights under this Agreement are not assigned pursuant to <U>Subsection 6.1</U>, and excluding for purposes of <U>Section</U><U></U><U>&nbsp;2</U> any shares for which registration rights have terminated pursuant to <U>Subsection 2.13</U>
of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.21 &#147;<B><I>Registrable Securities then outstanding</I></B>&#148; means
the number of shares determined by adding the number of shares of outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible
securities that are Registrable Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.22 &#147;<B><I>Restricted Securities</I></B>&#148; means the securities of
the Company required to be notated with the legend set forth in <U>Subsection 2.12(b)</U> hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.23
&#147;<B><I>SEC</I></B>&#148; means the Securities and Exchange Commission. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.24 &#147;<B><I>SEC
Rule</I></B><B><I></I></B><B><I>&nbsp;144</I></B>&#148; means Rule&nbsp;144 promulgated by the SEC under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.25 &#147;<B><I>SEC Rule</I></B><B><I></I></B><B><I>&nbsp;145</I></B>&#148; means Rule&nbsp;145 promulgated by the SEC under
the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.26 &#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.27 &#147;<B><I>Selling Expenses</I></B>&#148; means all underwriting
discounts, selling commissions, and stock transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by
the Company as provided in <U>Subsection</U><U></U><U>&nbsp;2.6</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.28
&#147;<B><I>Series</I></B><B><I></I></B><B><I>&nbsp;A Preferred Stock</I></B>&#148; means shares of the Company&#146;s Series&nbsp;A Preferred Stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.29 &#147;<B><I>Series B Preferred Stock</I></B>&#148; means shares of the Company&#146;s Series B Preferred Stock, par value
$0.0001 per share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.30 &#147;<B><I>Series C Preferred Stock</I></B>&#148; means shares of the Company&#146;s Series C
Preferred Stock, par value $0.0001 per share. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registration Rights</U>. The Company covenants and agrees as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1 <U>Demand Registration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Form</U><U></U><U>&nbsp;S</U><U><FONT STYLE="white-space:nowrap">-1</FONT> Demand</U>. If at any time after the earlier of
(i)&nbsp;five&nbsp;(5) years after the date of the execution of the Prior Agreement or (ii)&nbsp;one hundred eighty (180)&nbsp;days after the effective date of the registration statement for the IPO, the Company receives a request from Holders of a
majority of the Registrable Securities then outstanding that the Company file a <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> registration statement with respect to at least forty percent (40%) of the Registrable Securities then outstanding,
then the Company shall (x)&nbsp;within ten (10)&nbsp;days after the date such request is given, give notice thereof (the &#147;<B><I>Demand Notice</I></B>&#148;) to all Holders other than the Initiating Holders; and (y)&nbsp;as soon as practicable,
and in any event within sixty (60)&nbsp;days after the date such request is given by the Initiating Holders, file a <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> registration statement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be included in such
registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20)&nbsp;days of the date the Demand Notice is given, and in each case, subject to the limitations of
<U>Subsections</U><U></U><U>&nbsp;2.1(c)</U> and <U>2.3</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Form</U><U></U><U>&nbsp;S</U><U><FONT STYLE="white-space:nowrap">-3</FONT> Demand</U>. If at any time when it is eligible to use a <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> registration statement, the Company receives a request from
Holders of at least twenty percent (20%) of the Registrable Securities then outstanding that the Company file a <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> registration statement with respect to outstanding Registrable Securities of such
Holders having an anticipated aggregate offering price, net of Selling Expenses, of at least $5.0&nbsp;million, then the Company shall (i)&nbsp;within ten (10)&nbsp;days after the date such request is given, give a Demand Notice to all Holders other
than the Initiating Holders; and (ii)&nbsp;as soon as practicable, and in any event within forty-five (45)&nbsp;days after the date such request is given by the Initiating Holders, file a <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT>
registration statement under the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20)&nbsp;days of
the date the Demand Notice is given, and in each case, subject to the limitations of <U>Subsections 2.1(c)</U> and <U>2.3</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this <U>Subsection 2.1</U> a certificate signed by the Company&#146;s chief executive officer stating that in the good faith
judgment of the Company&#146;s Board of Directors it would be materially detrimental to the Company and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement
otherwise would be required to remain effective, because such action would (i)&nbsp;materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii)&nbsp;require premature
disclosure of material information that the Company has a <I>bona</I><I></I><I>&nbsp;fide</I> business purpose for preserving as confidential; or (iii)&nbsp;render the Company unable to comply with requirements under the Securities Act or Exchange
Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more than ninety (90)&nbsp;days
after the request of the Initiating Holders is given; <U>provided</U>, <U>however</U>, that the Company may not invoke this right more than once in any twelve (12)&nbsp;month period; and <U>provided</U> <U>further</U> that the Company shall not
register any securities for its own account or that of any other stockholder during such ninety (90)&nbsp;day period other than pursuant to a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a
stock option, stock purchase, or similar plan; a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or a
registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to <U>Subsection 2.1(a)(i)</U>
during the period that is sixty (60)&nbsp;days before the Company&#146;s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty (180)&nbsp;days after the effective date of, a Company-initiated registration,
<U>provided</U> that the Company is actively employing in good faith commercially reasonable efforts to cause </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such registration statement to become effective; (ii)&nbsp;after the Company has effected two registrations pursuant to <U>Subsection 2.1(a)</U>; or (iii)&nbsp;if the Initiating Holders propose
to dispose of shares of Registrable Securities that may be immediately registered on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> pursuant to a request made pursuant to <U>Subsection</U><U></U><U>&nbsp;2.1(b)</U>. The Company shall not be
obligated to effect, or to take any action to effect, any registration pursuant to <U>Subsection 2.1(b)</U> (i)&nbsp;during the period that is thirty (30)&nbsp;days before the Company&#146;s good faith estimate of the date of filing of, and ending
on a date that is ninety (90)&nbsp;days after the effective date of, a Company-initiated registration, <U>provided</U> that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to
become effective; or (ii)&nbsp;if the Company has effected two registrations pursuant to <U>Subsection 2.1(b)</U> within the twelve (12)&nbsp;month period immediately preceding the date of such request. A registration shall not be counted as
&#147;effected&#148; for purposes of this <U>Subsection</U><U></U><U>&nbsp;2.1(d)</U> until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw their request for such
registration, elect not to pay the registration expenses therefor, and forfeit their right to one demand registration statement pursuant to <U>Subsection</U><U></U><U>&nbsp;2.6</U>, in which case such withdrawn registration statement shall be
counted as &#147;effected&#148; for purposes of this <U>Subsection 2.1(d)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2 <U>Company Registration</U>. If the Company proposes to
register (including, for this purpose, a registration effected by the Company for stockholders other than the Holders) any of its securities under the Securities Act in connection with the public offering of such securities solely for cash (other
than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given within twenty (20)&nbsp;days after such notice is given by the Company, the Company
shall, subject to the provisions of <U>Subsection 2.3</U>, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw
any registration initiated by it under this <U>Subsection 2.2</U> before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling
Expenses) of such withdrawn registration shall be borne by the Company in accordance with <U>Subsection 2.6</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3 <U>Underwriting
Requirements</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If, pursuant to <U>Subsection 2.1</U>, the Initiating Holders intend to distribute the Registrable Securities
covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to <U>Subsection</U><U></U><U>&nbsp;2.1</U>, and the Company shall include such information in the Demand Notice. The
underwriter(s) will be selected by the Company and shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any Holder to include such Holder&#146;s Registrable Securities in such registration
shall be conditioned upon such Holder&#146;s participation in such underwriting and the inclusion of such Holder&#146;s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities
through such underwriting shall (together with the Company as provided in <U>Subsection 2.4(e)</U>) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of
this <U>Subsection 2.3</U>, if the managing underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of
Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as
practicable) to the number of Registrable Securities owned by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; <U>provided</U>, <U>however</U>, that the number of Registrable Securities held by the
Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in accordance with the above provisions, the Company or the
underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100)&nbsp;shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with
any offering involving an underwriting of shares of the Company&#146;s capital stock pursuant to <U>Subsection 2.2</U>, the Company shall not be required to include any of the Holders&#146; Registrable Securities in such underwriting unless the
Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the
Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable
discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters and the Company in their
sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities
that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities owned by each selling Holder or in such other proportions as shall mutually be agreed to
by all such selling Holders. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100)&nbsp;shares.
Notwithstanding the foregoing, in no event shall (i)&nbsp;the number of Registrable Securities included in the offering be reduced unless all other securities (other than securities to be sold by the Company) are first entirely excluded from the
offering, or (ii)&nbsp;the number of Registrable Securities included in the offering be reduced below twenty percent (20%) of the total number of securities included in such offering, unless such offering is the IPO, in which case the selling
Holders may be excluded further if the underwriters make the determination described above and no other stockholder&#146;s securities are included in such offering. For purposes of the provision in this <U>Subsection 2.3(b)</U> concerning
apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and Immediate Family
Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single &#147;selling Holder,&#148; and any <I>pro</I><I></I><I>&nbsp;rata</I>
reduction with respect to such &#147;selling Holder&#148; shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such &#147;selling Holder,&#148; as defined in this sentence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For purposes of <U>Subsection 2.1</U>, a registration shall not be counted as
&#147;effected&#148; if, as a result of an exercise of the underwriter&#146;s cutback provisions in <U>Subsection </U><U>2.3(a</U>), fewer than fifty percent (50%) of the total number of Registrable Securities that Holders have requested to be
included in such registration statement are actually included. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4 <U>Obligations of the Company</U>. Whenever required under this
<U>Section</U><U></U><U>&nbsp;2</U> to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred
twenty (120)&nbsp;days or, if earlier, until the distribution contemplated in the registration statement has been completed; <U>provided</U>, <U>however</U>, that (i)&nbsp;such one hundred twenty (120)&nbsp;day period shall be extended for a period
of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any securities included in such registration, and (ii)&nbsp;in the case of any registration of
Registrable Securities on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such one hundred twenty (120)&nbsp;day period shall be
extended for up to one hundred twenty (120)&nbsp;days, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) prepare and file with the SEC such amendments and supplements to such registration statement, and the prospectus used in connection with
such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or <FONT STYLE="white-space:nowrap">blue-sky</FONT> laws of such jurisdictions as shall be reasonably requested by the selling Holders; <U>provided</U> that the Company shall not be required to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the underwriter(s) of such offering; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) use its commercially reasonable efforts to cause all such Registrable
Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) provide a transfer agent and registrar for all Registrable Securities registered
pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) promptly make available for inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to
such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause
the Company&#146;s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the
accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) notify
each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or
supplement such registration statement or prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition, the Company shall ensure that, at all times after any registration
statement covering a public offering of securities of the Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company&#146;s directors may implement a trading program under <FONT
STYLE="white-space:nowrap">Rule&nbsp;10b5-1</FONT> of the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.5 <U>Furnish Information</U>. It shall be a condition precedent
to the obligations of the Company to take any action pursuant to this <U>Section</U><U></U><U>&nbsp;2</U> with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding
itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder&#146;s Registrable Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6 <U>Expenses of Registration</U>. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or
qualifications pursuant to <U>Section</U><U></U><U>&nbsp;2</U>, including all registration, filing, and qualification fees; printers&#146; and accounting fees; fees and disbursements of counsel for the Company; and the reasonable fees and
disbursements, not to exceed $25,000, of one counsel for the selling Holders (&#147;<B><I>Selling Holder Counsel</I></B>&#148;), shall be borne and paid by the Company; <U>provided</U>, <U>however</U>, that the Company shall not be required to pay
for any expenses of any registration proceeding begun pursuant to <U>Subsection 2.1</U> if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case
all selling Holders shall bear such expenses <I>pro</I><I></I><I>&nbsp;rata</I> based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders of a majority of the Registrable Securities
agree to forfeit their right to one registration pursuant to <U>Subsections 2.1(a)</U> or <U>2.1(b)</U>, as the case may be; <U>provided</U> <U>further</U> that if, at the time of such withdrawal, the Holders shall have learned of a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable
promptness after learning of such information then the Holders shall not be required to pay any of such expenses and shall not forfeit their right to one registration pursuant to <U>Subsections 2.1(a)</U> or <U>2.1(b)</U>. All Selling Expenses
relating to Registrable Securities registered pursuant to this <U>Section</U><U></U><U>&nbsp;2</U> shall be borne and paid by the Holders <I>pro</I><I></I><I>&nbsp;rata</I> on the basis of the number of Registrable Securities registered on their
behalf. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.7 <U>Delay of Registration</U>. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying
any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this <U>Section</U><U></U><U>&nbsp;2</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8 <U>Indemnification</U>. If any Registrable Securities are included in a registration statement under this
<U>Section</U><U></U><U>&nbsp;2</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder,
and the partners, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if any, who controls
such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person any legal or other expenses
reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; <U>provided</U>, <U>however</U>, that the indemnity agreement contained in this
<U>Subsection 2.8(a)</U> shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be
liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person, or
other aforementioned Person expressly for use in connection with such registration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To the extent permitted by law, each selling
Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the
Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other
Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder
expressly for use in connection with such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending
any claim or proceeding from which Damages may result, as such expenses are incurred; <U>provided</U>, <U>however</U>, that the indemnity agreement contained in this <U>Subsection 2.8(b)</U> shall not apply to amounts paid in settlement of any such
claim or proceeding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; and <U>provided</U> <U>further</U> that in no event shall the aggregate amounts
payable by any Holder by way of indemnity or contribution under <U>Subsections 2.8(b)</U> and <U>2.8(d)</U> exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud
or willful misconduct by such Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified party under this
<U>Subsection</U><U></U><U>&nbsp;2.8</U> of notice of the commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to
be made against any indemnifying party under this <U>Subsection 2.8</U>, give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying
party so desires, participate jointly with any other indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; <U>provided</U>, <U>however</U>, that an indemnified party
(together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such
indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to
give notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this <U>Subsection 2.8</U>, to the extent that such failure
materially prejudices the indemnifying party&#146;s ability to defend such action. The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this
<U>Subsection 2.8</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To provide for just and equitable contribution to joint liability under the Securities Act in any case in which
either: (i)&nbsp;any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this <U>Subsection</U><U></U><U>&nbsp;2.8</U> but it is judicially determined (by the entry of a final judgment or decree by a
court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this <U>Subsection 2.8</U> provides for
indemnification in such case, or (ii)&nbsp;contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this <U>Subsection 2.8</U>, then, and in each such case, such parties will
contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the
indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to
information supplied by the indemnifying party or by the indemnified party and the parties&#146; relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; <U>provided</U>, <U>however</U>,
that, in any such case (x)&nbsp;no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (y)&nbsp;no
Person guilty of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation; and <U>provided</U> <U>further</U> that in no event shall a Holder&#146;s liability pursuant to this <U>Subsection 2.8(d)</U>, when combined with the amounts paid or payable by such Holder pursuant to <U>Subsection 2.8(b)</U>,
exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations
of the Company and Holders under this <U>Subsection 2.8</U> shall survive the completion of any offering of Registrable Securities in a registration under this <U>Section</U><U></U><U>&nbsp;2</U>, and otherwise shall survive the termination of this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.9 <U>Reports Under Exchange Act</U>. With a view to making available to the Holders the benefits of SEC Rule&nbsp;144 and any
other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,</FONT> the Company shall:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) make and keep available adequate current public information, as those terms are understood and defined in SEC Rule&nbsp;144, at all
times after the effective date of the registration statement filed by the Company for the IPO; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) use commercially reasonable efforts to
file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i)&nbsp;to the extent accurate, a
written statement by the Company that it has complied with the reporting requirements of SEC Rule&nbsp;144 (at any time after ninety (90)&nbsp;days after the effective date of the registration statement filed by the Company for the IPO), the
Securities Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (at any time after the Company so qualifies); and (ii)&nbsp;such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the
selling of any such securities without registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (at any time after the
Company so qualifies to use such form). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.10 <U>Limitations on Subsequent Registration Rights</U>. From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that
allow such holder or prospective holder (i)&nbsp;to include such securities in any registration unless, under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that
the inclusion of such securities will not reduce the number of the Registrable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities of the Holders that are included; or (ii)&nbsp;allow such holder or prospective holder to initiate a demand for registration of any securities held by such holder or prospective
holder; <U>provided</U> that this limitation shall not apply to any additional Investor who becomes a party to this Agreement in accordance with <U>Subsection 6.9</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.11 <U>&#147;Market <FONT STYLE="white-space:nowrap">Stand-off&#148;</FONT> Agreement</U>. Each Holder hereby agrees that it will not, without
the prior written consent of the managing underwriter, during the period ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180)&nbsp;days following the effective date of the
Company&#146;s first firm commitment underwritten public offering of its Common Stock registered under the Securities Act, (i)&nbsp;lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract
to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common
Stock held immediately before the effective date of the registration statement for such offering or (ii)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of
such securities, whether any such transaction described in clause&nbsp;(i) or (ii)&nbsp;above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of this <U>Subsection 2.11</U> shall
apply only to the IPO, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of the Holder or the immediate family of the
Holder, <U>provided</U> that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and <U>provided</U> <U>further</U> that any such transfer shall not involve a disposition for value, and shall be applicable to
the Holders only if all officers and directors are subject to the same restrictions and the Company obtains a similar agreement from all stockholders individually owning more than one percent (1%) of the Company&#146;s outstanding Common Stock
(after giving effect to conversion into Common Stock of all outstanding Preferred Stock). The underwriters in connection with such registration are intended third-party beneficiaries of this <U>Subsection 2.11</U> and shall have the right, power and
authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with
this <U>Subsection 2.11</U> or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders
that are subject to such agreements, based on the number of shares subject to such agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.12 <U>Restrictions on Transfer</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Preferred Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not
recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the
provisions of the Securities Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities subject to the
provisions and upon the conditions specified in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each certificate, instrument, or book entry representing (i)&nbsp;the Preferred Stock,
(ii)&nbsp;the Registrable Securities, and (iii)&nbsp;any other securities issued in respect of the securities referenced in clauses&nbsp;(i) and (ii), upon any stock split, stock dividend, recapitalization, merger, consolidation, or similar event,
shall (unless otherwise permitted by the provisions of <U>Subsection 2.12(c)</U>) be notated with a legend substantially in the following form: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES
MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER,
A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Holders consent to the Company making a notation in its records and
giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this <U>Subsection 2.12</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The holder of such Restricted Securities, by acceptance of ownership thereof, agrees to comply in all respects with the provisions of this
<U>Section</U><U></U><U>&nbsp;2</U>. Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the Holder thereof shall
give notice to the Company of such Holder&#146;s intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if reasonably
requested by the Company, shall be accompanied at such Holder&#146;s expense by either (i)&nbsp;a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the Company, to the
effect that the proposed transaction may be effected without registration under the Securities Act; (ii)&nbsp;a &#147;no action&#148; letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities without
registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii)&nbsp;any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or
transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in accordance with the
terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or &#147;no action&#148; letter (x)&nbsp;in any transaction in compliance with SEC Rule&nbsp;144; or (y)&nbsp;in any transaction in which such
Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; <U>provided</U> that each transferee agrees in writing to be subject to the terms of this <U>Subsection 2.12</U>. Each certificate, instrument, or book
entry representing the Restricted Securities transferred as above provided shall be notated with, except if such transfer is made pursuant to SEC Rule&nbsp;144, the appropriate restrictive legend set forth in <U>Subsection 2.12(b)</U>, except that
such certificate instrument, or book entry shall not be notated with such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with any provisions of the
Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.13 <U>Termination of Registration Rights</U>. The right of any Holder to request
registration or inclusion of Registrable Securities in any registration pursuant to <U>Subsections 2.1</U> or <U>2.2</U> shall terminate upon the earliest to occur of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the closing of a Deemed Liquidation Event, as such term is defined in the Company&#146;s Certificate of Incorporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) such time as Rule&nbsp;144 or another similar exemption under the Securities Act is available for the sale of all of such Holder&#146;s
shares without limitation during a three-month period without registration; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the fifth (5<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;anniversary of the IPO. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Information and Observer Rights</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1 <U>Delivery of Financial Statements</U>. So long as a Major Investor (with its Affiliates) shall own not less than 1,089,561 shares of
Registrable Securities (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall deliver to each Major Investor, <U>provided</U> that the Board of
Directors has not reasonably determined that such Major Investor is a competitor of the Company (and solely for purposes of this <U>Section</U><U></U><U>&nbsp;3.1</U>, Novartis shall not be deemed to be a competitor); <U>provided</U> <U>further</U>
that no institutional financial investor may be determined to be a competitor of the Company for any purpose under this Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) as
soon as practicable, but in any event within six (6)&nbsp;months (or such longer period approved by the Board of Directors including at least two of the Preferred Directors (as defined in that certain Amended and Restated Voting Agreement of even
date herewith)) after the end of each fiscal year of the Company ending after the date of this Agreement, (i)&nbsp;a balance sheet as of the end of such year, (ii)&nbsp;statements of income and of cash flows for such year, and a comparison between
(x)&nbsp;the actual amounts as of and for such fiscal year and (y)&nbsp;the comparable amounts for the prior year and as included in the Budget (as defined in <U>Subsection 3.1(d)</U>) for such year, with an explanation of any material differences
between such amounts and a schedule as to the sources and applications of funds for such year, and (iii)&nbsp;a statement of stockholders&#146; equity as of the end of such year, with such financial statements to be audited and certified by
independent public accountants of nationally recognized standing selected by the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) as soon as practicable, but in any event
within ninety (90)&nbsp;days after the end of each fiscal year of the Company, (i)&nbsp;a balance sheet as of the end of such year, (ii)&nbsp;statements of income and of cash flows for such year, and a comparison between (x)&nbsp;the actual amounts
as of and for such fiscal year and (y)&nbsp;the comparable amounts for the prior year and as included in the Budget (as defined in <U>Subsection 3.1(d)</U>) for such year, and (iii)&nbsp;a statement of stockholders&#146; equity as of the end of such
year, with such financial statements to be unaudited; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) as soon as practicable following a request by a Major Investor, but in any event within
forty-five (45)&nbsp;days after the end of each of the first three (3)&nbsp;quarters of each fiscal year of the Company, unaudited statements of income and cash flows for such fiscal quarter, and an unaudited balance sheet as of the end of such
fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i)&nbsp;be subject to normal yearend audit adjustments; and (ii)&nbsp;not contain all notes thereto that may be required in accordance with GAAP) or on
a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> basis consistent with the Company&#146;s past practices; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) as soon as practicable
following a request by a Major Investor, but in any event thirty (30)&nbsp;days before the end of each fiscal year, a budget for the next fiscal year (collectively, the &#147;<B><I>Budget</I></B>&#148;), approved by the Board of Directors and
prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) as soon as practicable following a request by a Major Investor, but in any event within forty-five (45)&nbsp;days after the end of each
quarter of each fiscal year of the Company, an updated summary capitalization table of the Company; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) such other information
relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major Investor may from time to time reasonably request; <U>provided</U>, <U>however</U>, that the Company shall not be obligated under this
<U>Subsection 3.1</U> to provide information (i)&nbsp;that the Company reasonably determines in good faith to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in a form acceptable to the
Company, it being agreed that <U>Subsection 3.5</U> shall constitute an enforceable confidentiality agreement in a form acceptable to the Company); or (ii)&nbsp;the disclosure of which would adversely affect the attorney-client privilege between the
Company and its counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company,
then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything else in this <U>Subsection 3.1</U> to the contrary, the Company may cease providing the information set forth in this
<U>Subsection 3.1</U> during the period starting with the date thirty (30)&nbsp;days before the Company&#146;s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC
rules applicable to such registration statement and related offering; <U>provided</U> that the Company&#146;s covenants under this <U>Subsection 3.1</U> shall be reinstated at such time as the Company is no longer actively employing its commercially
reasonable efforts to cause such registration statement to become effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2 <U>Inspection</U>. The Company shall permit each Major
Investor (<U>provided</U> that the Board of Directors has not reasonably determined that such Major Investor is a competitor of the Company; <U>provided</U> <U>further</U> that no institutional financial investor may be determined to be a competitor
of the Company for any purpose under this Agreement), at such Major Investor&#146;s expense, to visit and inspect the Company&#146;s properties; examine its books of account and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
records; and discuss the Company&#146;s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by the Major Investor;
<U>provided</U>, <U>however</U>, that the Company shall not be obligated pursuant to this <U>Subsection 3.2</U> to provide access to any information that it reasonably and in good faith considers to be a trade secret or confidential information
(unless covered by an enforceable confidentiality agreement, in a form acceptable to the Company) or the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3 <U>Observer Rights</U>. As long as Novartis Institutes for Biomedical Research, Inc. (&#147;<U>Novartis</U>&#148;) owns not less than fifty
percent (50%) of the shares of the Series C Preferred Stock it is purchasing under the Purchase Agreement (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Novartis that is
mutually acceptable to the Company and Novartis to attend all open meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials
that it provides to its directors at the same time and in the same manner as provided to such directors; <U>provided</U>, <U>however</U>, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with
respect to all information so provided; <U>provided</U> <U>further</U>, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or
attendance at such meeting could (i)&nbsp;adversely affect the attorney-client privilege between the Company and its counsel or (ii)&nbsp;result in disclosure of highly-confidential or sensitive information, trade secrets or a potential or actual
conflict of interest; or if such Investor or its representative is a competitor of the Company; and <U>provided</U> <U>further</U> that the Company reserves the right to exclude such representative from any executive session of the Board of
Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4 <U>Termination of Information Rights</U>. The covenants set forth in <U>Subsection</U><U></U><U>&nbsp;3.1</U>,
<U>Subsection 3.2</U> and <U>Subsection 3.3</U> shall terminate and be of no further force or effect (i)&nbsp;immediately before the consummation of the IPO, or (ii)&nbsp;upon a Deemed Liquidation Event, as such term is defined in the Company&#146;s
Certificate of Incorporation, whichever event occurs first. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.5 <U>Confidentiality</U>. Each Investor agrees that such Investor will keep
confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the
Company&#146;s intention to file a registration statement), unless such confidential information (a)&nbsp;is known or becomes known to the public in general (other than as a result of a breach of this <U>Section</U><U></U><U>&nbsp;3.4</U> by such
Investor), (b)&nbsp;is or has been independently developed or conceived by the Investor without use of the Company&#146;s confidential information, or (c)&nbsp;is or has been made known or disclosed to the Investor by a third party without, to such
Investor&#146;s knowledge, a breach of any obligation of confidentiality such third party may have to the Company; <U>provided</U>, <U>however</U>, that an Investor may disclose confidential information (i)&nbsp;to its attorneys, accountants,
consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii)&nbsp;to any prospective purchaser of any Registrable Securities from such Investor, if such
prospective purchaser agrees to be bound by the provisions of this <U>Subsection 3.4</U>; (iii)&nbsp;to any existing or prospective Affiliate, partner, member, stockholder, or wholly owned subsidiary of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Investor in the ordinary course of business, <U>provided</U> that such Investor informs such Person that such information is confidential and directs such Person to maintain the
confidentiality of such information; or (iv)&nbsp;as may otherwise be required by law, <U>provided</U> that the Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required
disclosure. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Rights to Future Stock Issuances</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1 <U>Right of First Offer</U>. Subject to the terms and conditions of this <U>Subsection</U><U></U><U>&nbsp;4.1</U> and applicable securities
laws, if the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted to it in such
proportions as it deems appropriate, among (i)&nbsp;itself, (ii)&nbsp;its Affiliates and (iii)&nbsp;its beneficial interest holders, such as limited partners, members or any other Person having &#147;beneficial ownership,&#148; as such term is
defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> promulgated under the Exchange Act, of such Major Investor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The
Company shall give notice (the &#147;<B><I>Offer Notice</I></B>&#148;) to each Major Investor, stating (i)&nbsp;its <I>bona</I><I></I><I>&nbsp;fide</I> intention to offer such New Securities, (ii)&nbsp;the number of such New Securities to be
offered, and (iii)&nbsp;the price and terms, if any, upon which it proposes to offer such New Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) By notification to the
Company within twenty (20)&nbsp;days after the Offer Notice is given, each Major Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals
the proportion that the Common Stock then held by such Major Investor (including all shares of Common Stock then issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative
Securities then held by such Major Investor) bears to the total Common Stock of the Company then outstanding (assuming full conversion and/or exercise, as applicable, of all Preferred Stock and other Derivative Securities). At the expiration of such
twenty (20)&nbsp;day period, the Company shall promptly notify each Major Investor that elects to purchase or acquire all the shares available to it (each, a &#147;<B><I>Fully Exercising Investor</I></B>&#148;) of any other Major Investor&#146;s
failure to do likewise. During the ten (10)&nbsp;day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or acquire, in addition to the number of shares
specified above, up to that portion of the New Securities for which Major Investors were entitled to subscribe but that were not subscribed for by the Major Investors which is equal to the proportion that the Common Stock issued and held, or
issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of Preferred Stock and any other Derivative Securities then held, by such Fully Exercising Investor bears to the Common Stock issued and held, or issuable (directly or
indirectly) upon conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held, by all Fully Exercising Investors who wish to purchase such unsubscribed shares. The closing of any sale pursuant to
this <U>Subsection 4.1(b)</U> shall occur within the later of ninety (90)&nbsp;days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to <U>Subsection 4.1(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If all New Securities referred to in the Offer Notice are not elected to be purchased or
acquired as provided in <U>Subsection 4.1(b)</U>, the Company may, during the ninety (90)&nbsp;day period following the expiration of the periods provided in <U>Subsection 4.1(b)</U>, offer and sell the remaining unsubscribed portion of such New
Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such
period, or if such agreement is not consummated within thirty (30)&nbsp;days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major
Investors in accordance with this <U>Subsection 4.1</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The right of first offer in this <U>Subsection 4.1</U> shall not be
applicable to (i)&nbsp;Exempted Securities (as defined in the Company&#146;s Certificate of Incorporation); (ii)&nbsp;shares of Common Stock issued in the IPO; and (iii)&nbsp;the issuance of shares of Series C Preferred Stock pursuant to the
Purchase Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2 <U>Termination</U>. The covenants set forth in <U>Subsection 4.1</U> shall terminate and be of no further force or
effect (i)&nbsp;immediately before the consummation of the IPO, or (ii)&nbsp;upon a Deemed Liquidation Event, as such term is defined in the Company&#146;s Certificate of Incorporation, whichever event occurs first. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Additional Covenants</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1 <U>Insurance</U>. The Company shall use its commercially reasonable efforts to maintain with financially sound and reputable insurers
Directors and Officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors until such time as the Board of Directors determines that such insurance should be discontinued. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2 <U>Employee Agreements</U>. The Company will cause each person now or hereafter employed by it or by any subsidiary (or engaged by the
Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement substantially in the form approved by the Board
of Directors. In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement between the Company and any employee, without the
consent of the Board of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3 <U>Employee Stock</U>. Unless otherwise approved by the Board of Directors, all future employees
and consultants of the Company who purchase, receive options to purchase, or receive awards of shares of the Company&#146;s capital stock (collectively, &#147;<B><I>Stock Awards</I></B>&#148;) after the date hereof shall be required to execute
restricted stock or option agreements, as applicable, providing for (i)&nbsp;vesting of shares over a four (4)&nbsp;year period, with the first twenty-five percent (25%) of such shares vesting following twelve (12)&nbsp;months of continued
employment or service, and the remaining shares vesting in equal monthly installments over the following <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;months, and (ii)&nbsp;a market <FONT STYLE="white-space:nowrap">stand-off</FONT>
provision substantially similar to that in <U>Subsection 2.11</U>. In addition, unless otherwise approved by the Board of Directors, the Company shall retain a &#147;right of first refusal&#148; on employee transfers until the Company&#146;s IPO and
shall have the right to repurchase unvested shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CFIUS</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company hereby represents, warrants and covenants to each of Novartis and Mauna Kea Limited (&#147;<U>Lyfe</U>&#148;) that, it has not
taken any of the following actions: The design, fabrication, development, testing, production or manufacture of &#147;critical technologies&#148; as defined by 31 C.F.R. &#167; 801.204, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary contained in this Agreement, the Company represents, warrants, and covenants that the Company
shall not (i)&nbsp;provide each of Novartis and Lyfe with any material nonpublic technical information as defined in 31 C.F.R. &#167; 800 that is in the Company&#146;s possession; or (ii)&nbsp;permit any involvement of Novartis or Lyfe, other than
through voting of shares, in substantive decision making of the Company regarding the use, development, acquisition, or release of any &#147;critical technologies&#148; as defined in 31 C.F.R. &#167; 800.209. Each of Novartis and Lyfe hereby waives
any such information or decision making rights to which it may be entitled under this Agreement or otherwise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5 <U>Matters Requiring
Investor Director Approval</U>. So long as at least 35,000,000 shares of Preferred Stock are outstanding (subject to appropriate adjustment for stock splits, stock dividends, combinations, and other recapitalizations), the Company hereby covenants
and agrees with each of the Investors that it shall not, without approval of the Board of Directors: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) make, or permit any subsidiary to
make, any loan or advance to, or own any stock or other securities of, any subsidiary or other corporation, partnership, or other entity unless it is wholly owned by the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) make, or permit any subsidiary to make, any loan or advance to any Person, including, without limitation, any employee or director of the
Company or any subsidiary, except advances and similar expenditures in the ordinary course of business or under the terms of an employee stock or option plan approved by the Board of Directors; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) guarantee, directly or indirectly, or permit any subsidiary to guarantee, directly or indirectly, any indebtedness except for trade
accounts of the Company or any subsidiary arising in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) make any investment inconsistent with any
investment policy approved by the Board of Directors; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) incur any aggregate indebtedness in excess of $500,000 that is not already
included in a budget approved by the Board of Directors, other than trade credit incurred in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) otherwise enter into or be a party to any transaction with any director, officer, or
employee of the Company or any &#147;associate&#148; (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> promulgated under the Exchange Act) of any such Person, including without limitation any &#147;management bonus&#148; or
similar plan providing payments to employees in connection with a Deemed Liquidation Event, as such term is defined in the Company&#146;s Certificate of Incorporation, except for transactions contemplated by this Agreement, the Purchase Agreement
and transactions resulting in payments to or by the Company in an aggregate amount less than $60,000 per year; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) hire, terminate, or
change the compensation of the executive officers, including approving any option grants or stock awards to executive officers; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) change
the principal business of the Company, enter new lines of business, or exit the current line of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) sell, assign, license,
pledge, or encumber material technology or intellectual property, other than licenses granted in the ordinary course of business; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)
enter into any corporate strategic relationship involving the payment, contribution, or assignment by the Company or to the Company of money or assets greater than 500,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6 <U>Board Matters</U>. Unless otherwise determined by the vote of a majority of the directors then in office, the Board of Directors shall
meet in accordance with an agreed-upon schedule. The Company shall reimburse the directors for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> travel expenses incurred (consistent with the
Company&#146;s travel policy) in connection with attending meetings of the Board of Directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7 <U>Successor Indemnification</U>. If
the Company or any of its successors or assignees consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be
made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are
contained in the Company&#146;s Bylaws, its Certificate of Incorporation, or elsewhere, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.8 <U>Indemnification
Matters</U>. The Company hereby acknowledges that one (1)&nbsp;or more of the directors nominated to serve on the Board of Directors by the Investors (each a &#147;<B><I>Fund Director</I></B>&#148;) may have certain rights to indemnification,
advancement of expenses and/or insurance provided by one or more of the Investors and certain of their Affiliates (collectively, the &#147;<B><I>Fund Indemnitors</I></B>&#148;). The Company hereby agrees (a)&nbsp;that it is the indemnitor of first
resort (<I>i.e.</I>, its obligations to any such Fund Director are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such Fund Director are
secondary), (b)&nbsp;that it shall be required to advance the full amount of expenses incurred by such Fund Director and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf
of any such Fund Director to the extent legally permitted and as required by the Company&#146;s Certificate of Incorporation or Bylaws of the Company (or any agreement between the Company and such Fund Director), without regard to any rights such
Fund Director may have against the Fund Indemnitors, and, (c)&nbsp;that it irrevocably waives, relinquishes and releases </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no
advancement or payment by the Fund Indemnitors on behalf of any such Fund Director with respect to any claim for which such Fund Director has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a
right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Fund Director against the Company. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Right to Conduct Activities</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company hereby agrees and acknowledges that Third Rock Ventures III, L.P. (together with its Affiliates, &#147;<B><I>TRV</I></B>&#148;)
is a professional investment fund, and as such invests in numerous portfolio companies, some of which may be deemed competitive with the Company&#146;s business (as currently conducted or as currently propose to be conducted). The Company hereby
agrees that, to the extent permitted under applicable law, TRV shall not be liable to the Company for any claim arising out of, or based upon, (i)&nbsp;the investment by TRV in any entity competitive with the Company, or (ii)&nbsp;actions taken by
any partner, officer or other representative of TRV to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a
detrimental effect on the Company; <U>provided</U>, <U>however</U>, that the foregoing shall not relieve (x)&nbsp;TRV from liability associated with the unauthorized disclosure of the Company&#146;s confidential information obtained pursuant to this
Agreement, or (y)&nbsp;any director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company hereby agrees and acknowledges that Cowen Healthcare Investments II LP (together with its Affiliates,
&#147;<B><I>CHI</I></B>&#148;) is a professional investment fund, and as such invests in numerous portfolio companies, some of which may be deemed competitive with the Company&#146;s business (as currently conducted or as currently propose to be
conducted). The Company hereby agrees that, to the extent permitted under applicable law, CHI shall not be liable to the Company for any claim arising out of, or based upon, (i)&nbsp;the investment by CHI in any entity competitive with the Company,
or (ii)&nbsp;actions taken by any partner, officer or other representative of CHI to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and
whether or not such action has a detrimental effect on the Company; <U>provided</U>, <U>however</U>, that the foregoing shall not relieve (x)&nbsp;CHI from liability associated with the unauthorized disclosure of the Company&#146;s confidential
information obtained pursuant to this Agreement, or (y)&nbsp;any director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company hereby agrees and acknowledges that Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund (together with
their Affiliates, &#147;<B><I>Eventide</I></B>&#148;) are professional investment funds, and as such invest in numerous portfolio companies, some of which may be deemed competitive with the Company&#146;s business (as currently conducted or as
currently propose to be conducted). The Company hereby agrees that, to the extent permitted under applicable law, Eventide shall not be liable to the Company for any claim arising out of, or based upon, (i)&nbsp;the investment by Eventide in any
entity competitive with the Company, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(ii)&nbsp;actions taken by any partner, officer or other representative of Eventide to assist any such competitive company, whether or not such action was taken as a member of the board of
directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on the Company; <U>provided</U>, <U>however</U>, that the foregoing shall not relieve (x)&nbsp;Eventide from liability associated with the
unauthorized disclosure of the Company&#146;s confidential information obtained pursuant to this Agreement, or (y)&nbsp;any director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company hereby agrees and acknowledges that Agent Capital Fund I LP (together with its Affiliates, &#147;<B><I>Agent</I></B>&#148;) is
a professional investment fund, and as such invests in numerous portfolio companies, some of which may be deemed competitive with the Company&#146;s business (as currently conducted or as currently propose to be conducted). The Company hereby agrees
that, to the extent permitted under applicable law, Agent shall not be liable to the Company for any claim arising out of, or based upon, (i)&nbsp;the investment by Agent in any entity competitive with the Company, or (ii)&nbsp;actions taken by any
partner, officer or other representative of Agent to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a
detrimental effect on the Company; <U>provided</U>, <U>however</U>, that the foregoing shall not relieve (x)&nbsp;Agent from liability associated with the unauthorized disclosure of the Company&#146;s confidential information obtained pursuant to
this Agreement, or (y)&nbsp;any director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company hereby agrees and acknowledges that PH Investments, LLC, SCubed Capital, LLC, Sobrato Capital, Harvard Management Private
Equity Corporation, Fifth Avenue Private Equity 14 LLC, Portland Investment &#150; EP, LLC and Portland Investment &#150; PIA, LLC (together with their respective Affiliates, the &#147;<B><I>Access Investors</I></B>&#148;) are professional
investment funds, and as such invest in numerous portfolio companies, some of which may be deemed competitive with the Company&#146;s business (as currently conducted or as currently propose to be conducted). The Company hereby agrees that no Access
Investor shall be determined to be a competitor for purposes of Section&nbsp;3.1 and 3.2 above and that, to the extent permitted under applicable law, the Access Investors shall not be liable to the Company for any claim arising out of, or based
upon, (i)&nbsp;the investment by any of the Access Investors in any entity competitive with the Company, or (ii)&nbsp;actions taken by any partner, officer or other representative of any Access Investor to assist any such competitive company,
whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on the Company; <U>provided</U>, <U>however</U>, that the foregoing shall
not relieve (x)&nbsp;any party from liability associated with the unauthorized disclosure of the Company&#146;s confidential information obtained pursuant to this Agreement, or (y)&nbsp;any director or officer of the Company from any liability
associated with his or her fiduciary duties to the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company hereby agrees and acknowledges that Novartis and its
Affiliates are professional investment funds, and as such invest in numerous portfolio companies, some of which may be deemed competitive with the Company&#146;s business (as currently conducted or as currently propose to be conducted). The Company
hereby agrees that, to the extent permitted under applicable law, neither Novartis nor its Affiliates shall be liable to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company for any claim arising out of, or based upon, (i)&nbsp;the investment by Novartis or an Affiliate of Novartis in any entity competitive with the Company, or (ii)&nbsp;actions taken by any
partner, officer or other representative of Novartis or an Affiliate of Novartis to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether
or not such action has a detrimental effect on the Company; <U>provided</U>, <U>however</U>, that the foregoing shall not relieve (x)&nbsp;Novartis or its Affiliates from liability associated with the unauthorized disclosure of the Company&#146;s
confidential information obtained pursuant to this Agreement, (y)&nbsp;any director or officer of the Company from any liability associated with his or her fiduciary duties to the Company, or (z)&nbsp;any contractual obligations of Novartis or its
Affiliates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10 <U>ERISA</U>. The Company will exercise its reasonable best efforts to ensure that, at all times during which any
Investor holds any Preferred Stock or Common Stock, the assets of the Company will not be deemed to be &#147;plan assets&#148; for purposes of the Employee Retirement Income Security Act of 1974, as amended (&#147;<B><I>ERISA</I></B>&#148;). The
Company agrees to provide notice, in writing, to each Investor as soon as is reasonably practicable upon determining that the assets of the Company are reasonably likely to be deemed &#147;plan assets&#148; for purposes of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.11 <U>Publicit</U>y. The Company shall not make use of any Access Investor&#146;s name on its website, via press release or other similar
communication without the prior consent of such Access Investor, which consent may be delivered to the Company via email. Notwithstanding the foregoing, the Company may, (i)&nbsp;if an Access Investor&#146;s investment in the Company has been
publicly disclosed by such Access Investor or with such Access Investor&#146;s prior consent, from then forward confirm in <FONT STYLE="white-space:nowrap">non-public</FONT> communications that such Access Investor has invested in the Company and
provide other information that has been previously disclosed by or with such Access Investor&#146;s consent, and (ii)&nbsp;without the prior approval of an Access Investor, disclose the terms and/or amount of such Access Investor&#146;s investment
and such Access Investor&#146;s identity (x)&nbsp;to an existing Investor, a bona fide potential investor in, or bona fide acquirer or strategic partner of, the Company in connection with such potential party&#146;s due diligence process or
investment (provided that such Access Investor&#146;s identity shall not appear in any slide deck or other similar presentation for or to bona fide potential investors or acquirers) or (y)&nbsp;as required by law, rule, regulation or listing
standard to do so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.12 <U>Termination of Covenants</U>. The covenants set forth in this <U>Section</U><U></U><U>&nbsp;5</U>, except for
<U>Subsections 5.6</U> and <U>5.7</U>, shall terminate and be of no further force or effect (i)&nbsp;immediately before the consummation of the IPO or (ii)&nbsp;upon a Deemed Liquidation Event, as such term is defined in the Company&#146;s
Certificate of Incorporation, whichever event occurs first. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Miscellaneous</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1 <U>Successors and Assigns</U>. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a
transferee of Registrable Securities that (i)&nbsp;is an Affiliate of a Holder; (ii)&nbsp;is a Holder&#146;s Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder&#146;s Immediate Family Members; or
(iii)&nbsp;after such transfer, holds shares of Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations, and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recapitalizations); <U>provided</U>, <U>however</U>, that (x)&nbsp;the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such
transferee and the Registrable Securities with respect to which such rights are being transferred; and (y)&nbsp;such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this
Agreement, including the provisions of <U>Subsection 2.11</U>. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1)&nbsp;that is an Affiliate or stockholder of a
Holder; (2)&nbsp;who is a Holder&#146;s Immediate Family Member; or (3)&nbsp;that is a trust for the benefit of an individual Holder or such Holder&#146;s Immediate Family Member shall be aggregated together and with those of the transferring
Holder; <U>provided</U> <U>further</U> that all transferees who would not qualify individually for assignment of rights shall have a single <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> for the
purpose of exercising any rights, receiving notices, or taking any action under this Agreement. The terms and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties.
Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this
Agreement, except as expressly provided herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.2 <U>Governing Law</U>. This Agreement shall be governed by the internal law of the
State of California, without regard to conflict of law principles that would result in the application of any law other than the law of the State of California. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.3 <U>Counterparts</U>. This Agreement may be executed in two (2)&nbsp;or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S.&nbsp;federal ESIGN Act of 2000, <I>e.g.</I>,
www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4 <U>Titles and Subtitles</U>. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in
construing or interpreting this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5 <U>Notices</U>. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or (i)&nbsp;personal delivery to the party to be notified; (ii)&nbsp;when sent, if sent by electronic mail or facsimile during the
recipient&#146;s normal business hours, and if not sent during normal business hours, then on the recipient&#146;s next business day; (iii)&nbsp;five (5)&nbsp;days after having been sent by registered or certified mail, return receipt requested,
postage prepaid; or (iv)&nbsp;one (1)&nbsp;business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying <FONT STYLE="white-space:nowrap">next-day</FONT> delivery, with written
verification of receipt. All communications shall be sent to the respective parties at their addresses as set forth on <B><U>Schedule</U></B><B><U></U></B><B><U>&nbsp;A</U></B> hereto, or to the principal office of the Company and to the attention
of the Chief Executive Officer, in the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written notice given in accordance with this <U>Subsection 6.5</U>. If notice is given to the Company or
to Stockholders, a copy shall also be sent to Goodwin Procter LLP, 601 Marshall Street, Redwood City, CA 94063, Fax: +1 (650) <FONT STYLE="white-space:nowrap">853-1038,</FONT> Attention: Sam Zucker, Esq. and Deepa Rich, Esq. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6 <U>Amendments and Waivers</U>. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders of a majority of the Registrable Securities
then outstanding; <U>provided</U> that the Company may in its sole discretion waive compliance with <U>Subsection 2.12(c)</U> (and the Company&#146;s failure to object promptly in writing after notification of a proposed assignment allegedly in
violation of <U>Subsection 2.12(c)</U> shall be deemed to be a waiver); and <U>provided</U> <U>further</U> that any provision hereof may be waived by any waiving party on such party&#146;s own behalf, without the consent of any other party.
Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment, termination, or
waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of <U>Section</U><U></U><U>&nbsp;4</U> with respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if
such waiver does so by its terms, notwithstanding the fact that certain Investors may nonetheless, by agreement with the Company, purchase securities in such transaction). The Company shall give prompt notice of any amendment or termination hereof
or waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this <U>Subsection 6.6</U> shall be binding on all parties hereto,
regardless of whether any such party has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any
such term, condition, or provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7 <U>Severability</U>. In case any one or more of the provisions contained in this Agreement is for
any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed
and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.8 <U>Aggregation of Stock</U>.
All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among
themselves in any manner they deem appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.9 <U>Additional Investors</U>. Notwithstanding anything to the contrary contained
herein, if the Company issues additional shares of Series C Preferred Stock after the date hereof, any purchaser of such shares of Series C Preferred Stock may become a party to this Agreement by executing and delivering an additional counterpart
signature page to this Agreement, and thereafter shall be deemed an &#147;Investor&#148; for all purposes hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.10 <U>Entire
Agreement</U>. This Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and agreement <U>among</U> the parties with respect to the subject matter hereof, and any other written or oral agreement
relating to the subject matter hereof existing between the parties is expressly canceled. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.11 <U>Dispute Resolution</U>. The parties (a)&nbsp;hereby irrevocably and unconditionally
submit to the jurisdiction of the state courts of California and to the jurisdiction of the United States District Court for the Northern District of California for the purpose of any suit, action or other proceeding arising out of or based upon
this Agreement, (b)&nbsp;agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of California or the United States District Court for the Northern District of California, and
(c)&nbsp;hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is
exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be
enforced in or by such court. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The prevailing party in any dispute arising under this Agreement shall be entitled to reasonable
attorney&#146;s fees, costs, and necessary disbursements in addition to any other relief to which such party may be entitled. Each of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the
U.S.&nbsp;District Court for the Northern District of California or any court of the State of California having subject matter jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.12 <U>Delays or Omissions</U>. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement, upon
any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or
to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law
or otherwise afforded to any party, shall be cumulative and not alternative. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.13 <U>Acknowledgment</U>. The Company acknowledges that the
Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises that may have products or services that compete directly or indirectly
with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such enterprise has products or services that compete with those of
the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.14 <U>Amendment of Prior Agreement</U>. The Prior Agreement is hereby amended and superseded in its entirety and restated
herein. Such amendment and restatement is effective upon the execution of this Agreement by the parties required for an amendment pursuant to <U>Subsection 6.6</U> of the Prior Agreement. Upon such execution, all provisions of, rights granted and
covenants made in the Prior Agreement are hereby waived, released and superseded in their entirety by the provisions hereof and shall have no further force or effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[R<SMALL>EMAINDER</SMALL> <SMALL>OF</SMALL> P<SMALL>AGE</SMALL> I<SMALL>NTENTIONALLY</SMALL> L<SMALL>EFT</SMALL> B<SMALL>LANK</SMALL>]
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>COMPANY</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PLIANT THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bernard Coulie</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Bernard Coulie, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL>
<SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL> I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott Brown</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Scott Brown</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">VP, Chief Administrative Officer and General Counsel</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>THIRD ROCK VENTURES III, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Third Rock Ventures GP III, L.P., its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: TRV GP III, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Gillis</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kevin Gillis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Partner/COO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>THIRD ROCK VENTURES IV, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Third Rock Ventures GP IV, L.P., its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: TRV GP IV, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Gillis</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kevin Gillis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Partner/COO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COWEN HEALTHCARE INVESTMENTS II LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>By: Cowen Healthcare Investments II GP LLC, its General Partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Raidy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kevin Raidy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Partner</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CHI EF II LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>By: Cowen Healthcare Investments II GP LLC, its General Partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Raidy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kevin Raidy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Partner</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>IST3 MANESSE PE L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>By: IST3 Manesse PE Management L.P., its general partner</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>By: Schroder Adveq Management Jersey Ltd, its general partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Nieuwenhuis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Mark Nieuwenhuis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Monika Pinel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Monika Pinel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>SCHRODER ADVEQ cPl Global 2017-2019 C.V.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>By: Schroder Adveq cPl Global Management III, L.P., its general partner</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>By: Schroder Adveq Management N.V., its general partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sven Gasser</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sven Gasser</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Monika Pinel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Monika Pinel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Proxy Holder</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***]
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>SCHRODER ADVEQ TECHNOLOGY IX S.C.S.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">By: Schroder Adveq Management Luxembourg S.&agrave;.r.l. as general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Nieuwenhuis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Mark Nieuwenhuis</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Monika Pinel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Monika Pinel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MENLO VENTURES XIV, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BY: MV MANAGEMENT XIV, L.L.C.</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Its General Partner</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Greg Yap</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Greg Yap</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MENLO ENTREPRENEURS FUND XIV, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BY: MV MANAGEMENT XIV, L.L.C.</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Its General Partner</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Greg Yap</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Greg Yap</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MMEF XIV, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BY: MV MANAGEMENT XIV, L.L.C.</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Its General Partner</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Greg Yap</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Greg Yap</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MUTUAL FUND SERIES TRUST, ON BEHALF OF EVENTIDE HEALTHCARE&nbsp;&amp; LIFE SCIENCES FUND</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Erik Naviloff</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Erik Naviloff</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Treasurer</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***]
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MUTUAL FUND SERIES TRUST, ON BEHALF OF EVENTIDE GILEAD FUND</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Erik Naviloff</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Erik Naviloff</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SCUBED CAPITAL, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Stevens</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Mark Stevens</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Partner</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">With a copy to: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HARVARD MANAGEMENT PRIVATE EQUITY CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Elise McDonald</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Elise McDonald</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Elaine Chan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Elaine Chan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>INVESTOR:</U></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SOBRATO CAPITAL,</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>a DBA of Sobrato Family Holdings, LLC,</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>a California limited liability company</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew W. Sonsini</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Matthew W. Sonsini</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer, on behalf of</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sobrato Family Holdings, LLC</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>INVESTOR:</U></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PH INVESTMENTS, LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Melinda E. Barber</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Melinda E. Barber</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">With a copy to: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>INVESTOR:</U></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>FIFTH AVENUE PRIVATE EQUITY 14 LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Charles D. Bryceland</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Charles D. Bryceland</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>INVESTOR:</U></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>FIFTH AVENUE PRIVATE EQUITY 15 LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Charles D. Bryceland</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Charles D. Bryceland</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>INVESTOR:</U></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PORTLAND INVESTMENT &#150; EP, LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Weden</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">David Weden</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">With a copy to: &nbsp;&nbsp;[***] </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PORTLAND INVESTMENT &#150; PIA, LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Weden</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">David Weden</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">With a copy to: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>ZONE II HEALTHCARE HOLDINGS, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>By: Farallon Capital Management, L.L.C., its Manager</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/&nbsp;Thomas&nbsp;G.&nbsp;Roberts,&nbsp;Jr.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Thomas G. Roberts, Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Member</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">For Notices: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CORMORANT PRIVATE HEALTHCARE FUND II, LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BY: Cormorant Private Healthcare GP II, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bihua Chen</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Bihua Chen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing Member of the
GP</P></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BY: Cormorant Global Healthcare GP, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bihua Chen</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Bihua Chen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing Member of the
GP</P></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CRMA SPV, LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BY: Cormorant Asset Management, LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Its: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Attorney-In-Fact</FONT></FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bihua Chen</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Bihua Chen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CEO/Managing Member</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Notice Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AGENT CAPITAL FUND I LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>By: Agent Capital Fund I GP, LLC, its General Partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Geeta Vemuri</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Geeta Vemuri</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Member</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CITADEL MULTI-STRATEGY EQUITIES MASTER FUND LTD.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By:&nbsp;Citadel Advisors, LLC, its portfolio manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Noah Goldberg</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Noah Goldberg</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Notices: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Citadel Multi-Strategy Equities Master Fund Ltd.</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:58%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">with a copy to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>LOGOS OPPORTUNITIES FUND I, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>By: Logos Opportunities GP, LLC</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Its General Partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arsani William</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Arsani William</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Manager</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>REDMILE BIOPHARMA INVESTMENTS II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>By: Redmile Biopharma Investments II (GP), LLC, its general partner</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Josh Garcia</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Josh Garcia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CFO and Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">For Notices: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>BERNARD COULIE AND BARBARA LEYMAN, AS TRUSTEES OF THE COULIE/LEYMAN FAMILY TRUST UNDER AGREEMENT DATED APRIL&nbsp;20, 2018</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bernard Coulie</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Bernard Coulie, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Trustee</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Altamont Pharmaceutical Holdings, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Pearson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Mark Pearson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Mark Pearson IRA</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Pearson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Mark Pearson</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Fernando Rock and Carole Hayworth Living Trust</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fernando Rock</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fernando Rock</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Trustee</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Tulum Terra, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arthur Leung</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Arthur Leung</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Member</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XIA BVBA</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bart M.E. Van Hooland</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Bart M.E. Van Hooland</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Manager</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>2017 FAN PIER FUND A, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Henken</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Henken</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Member</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Johannes Hull</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Johannes Hull</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Katerina Leftheris</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Katerina Leftheris</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Harold A. Chapman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Harold A. Chapman, M.D.</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B><FONT STYLE="white-space:nowrap">EVE-IRENE</FONT> LEPIST AND TOUFIGH GORDI</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ <FONT STYLE="white-space:nowrap">Eve-Irene</FONT> Lepist</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="white-space:nowrap">Eve-Irene</FONT> Lepist</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Toufigh Gordi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Toufigh Gordi</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>JOHN T. AND MEREDYTH J. LILLEJORD</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John T. Lillejord</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">John T. Lillejord</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Meredyth J. Lillejord</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Meredyth J. Lillejord</TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>BENJAMEN E. AND JULI M. KERN</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamen E. Kern</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Benjamen E. Kern</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Juli M. Kern</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Juli M. Kern</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rik Derynck</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Rik Derynck</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benoit Dolfijn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Benoit Dolfijn</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Erica Park</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Erica Park</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mika K Derynck</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Mika K Derynck</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James E. Bates</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>James E. Bates</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Karuga Kimani</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Karuga Kimani</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Chon Yoa</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Chon Yoa</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sam Zucker</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Sam Zucker</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kraig K. Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Kraig K. Anderson</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Deepa Rich</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Deepa Rich</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Craig McDonald</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Craig McDonald</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Russell M. Lebovitz</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Russell M. Lebovitz</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Barbara Howes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Barbara Howes</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Keith Cummings</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Keith Cummings</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kim Cummings</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Kim Cummings</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>VALIANCE HOLDINGS LIMITED</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jan Pensaert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Jan Pensaert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Colin Stephen Magowan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Colin Stephen Magowan</B></TD></TR></TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fung Yam Ng</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Fung Yam Ng</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>THE MURPHY 2005 LIVING TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edward B. Murphy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edward B. Murphy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Trustee</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ken Imamura</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Ken Imamura</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>THE SLOGER HULL FAMILY TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Johannes Hull</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Johannes Hull</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Trustee</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Bellini</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Jonathan Bellini</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marco A. Martinot</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>Marco A. Martinot</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>THE CHRISTA RAYMOND SEPARATE<BR>PROPERTY REVOCABLE TRUST</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: <U>/s/ Christa
Raymond&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Christa Raymond</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Trustee</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Todd G. Sears</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Todd G. Sears</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Don Kraft</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Don Kraft</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott Turner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Scott Turner</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>CARLOS&nbsp;AND&nbsp;CYNTHIA&nbsp;HENRIQUEZ</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:&nbsp;<U>/s/&nbsp;Carlos&nbsp;Henriquez&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Carlos Henriquez</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: <U>/s/&nbsp;Cynthia&nbsp;Henriquez&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Cynthia Henriquez</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brenda Henriquez</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Brenda Henriquez</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have executed this Amended and Restated
Investors&#146; Rights Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>INVESTOR</U>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scarlet R. Hamrick</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Scarlet R. Hamrick</B></TD></TR></TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Address:
&nbsp;&nbsp;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
I<SMALL>NVESTORS</SMALL>&#146; R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule of Investors </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of&nbsp;Shares&nbsp;Held</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novartis Institutes for BioMedical Research, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">ATTN: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Third Rock Ventures III, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR>Phone: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Third Rock Ventures IV, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR>Phone: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cowen Healthcare Investments II LP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Cowen
Advisors, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CHI EF II LP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Cowen Advisors, LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mutual Fund Series Trust, on Behalf of Eventide Gilead Fund</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mutual Fund Series Trust, on Behalf of Eventide Healthcare&nbsp;&amp; Life Sciences Fund</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IST3 Manesse PE L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schroder Adveq cPl Global 2017-2019 C.V.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schroder Adveq Technology IX S.C.S.,</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Menlo Ventures XIV, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Menlo Entrepreneurs Fund XIV, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MMEF XIV, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mauna Kea Limited</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Altamont Pharmaceutical Holdings, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fifth Avenue Private Equity 14 LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fifth Avenue Private Equity 15 LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Harvard Management Private Equity Corporation</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SCubed Capital, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Please also copy [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PH Investments, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR>With a copy to: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Portland Investment - EP, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Partners
HealthCare Investment Office</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Phone: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR>With a copy to: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Portland Investment - PIA, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Partners
HealthCare Investment Office</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Phone: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR>With a copy to: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sobrato Capital</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: [***] <BR></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Katerina Leftheris</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Erica Park</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chon Yoa</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karuga Kimani</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tulum Terra, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fernando Rock and Carole Hayworth Living Trust</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deepa Rich</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Eve-Irene</FONT> Lepist and Toufigh Gordi</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Harold A. Chapman, M.D.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Xia bvba</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James E. Bates</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Benoit Dolfijn</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Benjamen E. and Juli M. Kern</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Russell M. Lebovitz</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John T. and Meredyth J. Lillejord</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kraig K. Anderson</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rik Derynck</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mika K Derynck</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Craig McDonald</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sam Zucker</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2017 Fan Pier Fund A, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bernard Coulie and Barbara Leyman, as Trustees of the</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coulie/Leyman Family Trust Under Agreement</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated April&nbsp;20,
2018</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Pearson IRA</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Johannes Hull</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">pH Pharma Co., Ltd.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Phone: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Morgans</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patrick Andre</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sharon E. Tetlow, as Trustee of Sharon E. Tetlow Trust</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hari Kumar</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alandra Mosely</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redmile Biopharma Investments II, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o
Redmile Group, LLC <BR>[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">E-mail:</FONT> [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zone II Healthcare Holdings, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Farallon
Capital Management, L.L.C. <BR>[***]</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">E-mail:</FONT> [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citadel Multi-Strategy Equities Master Fund Ltd.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Citadel Advisors LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cormorant Private Healthcare Fund II, LP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cormorant Global Healthcare Master Fund, LP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CRMA SPV, LP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Logos Opportunities Fund I, L.P.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agent Capital Fund I LP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: [***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barbara Howes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Keith Cummings</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kim Cummings</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Valiance Holdings Limited</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Colin Stephen Magowan</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fung Yam Ng</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Murphy 2005 Living Trust</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ken Imamura</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sloger Hull Family Trust</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jonathan Bellini</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marco A. Martinot</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Christa Raymond Separate Property Revocable Trust</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Todd G. Sears</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Don Kraft</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scott Turner</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carlos and Cynthia Henriquez</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brenda Henriquez</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scarlet R. Hamrick</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[***]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">[***]</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>4
<FILENAME>filename4.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>P<SMALL>LIANT</SMALL> <SMALL>THERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XECUTIVE</SMALL> S<SMALL>EVERANCE</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Purpose</U>. Pliant Therapeutics, Inc., a Delaware corporation (the &#147;Company&#148;) considers it essential to the best interests of
its stockholders to foster the continuous employment of key management personnel. The Board of Directors of the Company (the &#147;Board&#148;) recognizes, however, that, as is the case with many publicly-held corporations, the possibility of an
involuntary termination of employment, either before or after a Change in Control (as defined in Section<U></U> 2 hereof), exists and that such possibility, and the uncertainty and questions that it may raise among management, may result in the
departure or distraction of management personnel to the detriment of the Company and its stockholders. Therefore, the Board has determined that the Pliant Therapeutics, Inc. Executive Severance Plan (the &#147;Plan&#148;) should be adopted to
reinforce and encourage the continued attention and dedication of the Company&#146;s Covered Executives (as defined in Section<U></U> 2 hereof) to their assigned duties without distraction. Nothing in this Plan shall be construed as creating an
express or implied contract of employment and nothing shall alter the &#147;at will&#148; nature of the Covered Executives<U>&#146;</U> employment with the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Definitions</U>. The following terms shall be defined as set forth below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>&#147;</I><I>Accounting Firm</I><I>&#148;</I><I> </I>shall mean a nationally recognized accounting firm selected by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>&#147;Administrator&#148;</I> means the Board or the Compensation Committee of the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<I>Base Salary</I>&#148; shall mean the higher of (i)&nbsp;the annual base salary in effect immediately prior to the Date of
Termination or (ii)&nbsp;the annual base salary in effect for the year immediately prior to the year in which the Date of Termination occurs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<I>Cause</I>&#148; shall mean, and shall be limited to, the occurrence of any one or more of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Covered Executive&#146;s unauthorized use or disclosure of the Company&#146;s confidential information or trade
secrets; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Covered Executive&#146;s material breach of any agreement between the Covered Executive and the Company;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Covered Executive&#146;s material failure to comply with the Company&#146;s written policies or rules; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) the Covered Executive&#146;s gross negligence or willful misconduct in connection with the Covered Executive&#146;s
performance of his/her duties to the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) the Covered Executive&#146;s continuing failure to perform assigned
duties after receiving written notification of the failure from the Company and, if curable, a period of thirty (30)&nbsp;days to cure such failure; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) the conviction of, indictment for or plea of nolo contendere by the Covered Executive to a felony or a crime involving
moral turpitude; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) the Covered Executive&#146;s failure to cooperate in good faith with a governmental or internal
investigation of the Company or its directors, officers or employees, if the Company has requested the Covered Executive&#146;s cooperation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<I>Change in Control</I>&#148; shall mean a Sale Event, as defined in the Pliant Therapeutics, Inc. 2019 Stock Option and Incentive
Plan, as amended from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<I>Change in Control Period</I>&#148; shall mean the period beginning on the date of a
Change in Control and ending on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Change in Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)
<I>&#147;Code&#148;</I> shall mean the Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<I>Covered Executives</I>&#148; shall mean
Tier 1 Executive and those other employees designated by the Administrator in its sole discretion as the Tier 2 Executives, and, in each case, who meet the eligibility requirements set forth in Section&nbsp;4 of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<I>Date of Termination</I>&#148; shall mean the date that a Covered Executive&#146;s employment with the Company (or any successor)
ends, which date shall be specified in the Notice of Termination. Notwithstanding the foregoing, a Covered Executive&#146;s employment shall not be deemed to have been terminated solely as a result of the Covered Executive becoming an employee of
any direct or indirect successor to the business or assets of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<I>Disability</I>&#148; shall mean the following: if
through any illness, injury, accident or condition of either a physical or psychological nature, the Covered Executive becomes unable to perform substantially all of his duties and responsibilities for a continuous period of sixteen
(16)&nbsp;consecutive weeks or for any <FONT STYLE="white-space:nowrap">twenty-six</FONT> (26)&nbsp;weeks within a <FONT STYLE="white-space:nowrap">fifty-two</FONT> (52)&nbsp;week period.<SUP STYLE="font-size:85%; vertical-align:top">
</SUP>Determinations as to whether Covered Executive is Disabled shall be made by a physician selected by the Board or its insurers and acceptable to the Covered Executive or the Covered Executive&#146;s legal representative, such agreement as to
acceptability not to be unreasonably withheld or delayed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <I>&#147;Good Reason&#148;</I> shall mean that the Covered Executive has
complied with the &#147;Good Reason Process&#148; following the occurrence of any of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a material
diminution in the Covered Executive&#146;s annual base salary other than across the board decreases in annual base salary similarly affecting all executives of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company requiring the Covered Executive to relocate (other than for travel incident to the Covered Executive&#146;s
performance of his or her duties on behalf of the Company) a distance of more than fifty (50)&nbsp;miles from the Covered Executive&#146;s current principal place of business; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any material diminution in the Covered Executive&#146;s position,
responsibilities, authority or duties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of Section&nbsp;2(k)(iii), a change in the reporting relationship, or a change in a title will not,
by itself, be sufficient to constitute a material diminution of responsibilities, authority or duty. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) &#147;<I>Good Reason
Process</I>&#148; shall mean: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Covered Executive reasonably determines in good faith that a &#147;Good Reason&#148;
condition has occurred; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Covered Executive notifies the Company in writing of the first occurrence of the Good
Reason condition within sixty (60)&nbsp;days of the first occurrence of such condition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Covered Executive
cooperates in good faith with the Company&#146;s efforts, for a period of not less than thirty (30)&nbsp;days following such notice (the &#147;Cure Period&#148;), to remedy the condition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) notwithstanding such efforts, the Good Reason condition continues to exist following the Cure Period; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) the Covered Executive terminates his or her employment and provides the Company with a Notice of Termination with respect
to such termination, each within sixty (60)&nbsp;days after the end of the Cure Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company cures the Good Reason condition
during the Cure Period, Good Reason shall be deemed not to have occurred. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) &#147;<I>Notice of Termination</I>&#148; shall mean a
written notice which shall indicate the specific termination provision in this Plan relied upon for the termination of a Covered Executive&#146;s employment and the Date of Termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <I>&#147;</I><I>Participation Agreement</I><I>&#148;</I><I> </I>shall mean an agreement between a Covered Executive and the Company that
acknowledges the Covered Executive&#146;s participation in the Plan.<I> </I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <I>&#147;</I><I>Qualified Termination
Event</I><I>&#148;</I> shall mean (i)&nbsp;a termination of the Covered Executive&#146;s employment by the Company other than for Cause, death or Disability or (ii)&nbsp;the Covered Executive&#146;s resignation from the Company for Good Reason. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) &#147;<I>Restrictive Covenants Agreement</I>&#148; shall mean the Employee Confidential Information and Inventions Assignment Agreement or
similar agreement entered into between the Covered Executive and the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) &#147;<I>Tier 1 Executive</I>&#148; shall mean the
Company&#146;s Chief Executive Officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) &#147;<I>Tier 2 Executives</I>&#148; shall mean the individuals designated as such by
the Administrator and who are listed in <U>Exhibit A</U>, attached hereto, as such exhibit is amended by the Administrator from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Administration of the Plan. </U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Administrator</U>. The Plan shall be administered by the Administrator. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Powers of Administrator</U>. The Administrator shall have all powers necessary to enable it properly to carry out its duties with
respect to the complete control of the administration of the Plan. Not in limitation, but in amplification of the foregoing, the Administrator shall have the power and authority in its discretion to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) construe the Plan to determine all questions that shall arise as to interpretations of the Plan&#146;s provisions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) determine which individuals are and are not Covered Executives, designate an individual as a Tier 2 Executive, determine
the benefits to which any Covered Executives may be entitled, the eligibility requirements for participation in the Plan and all other matters pertaining to the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) adopt amendments to the Plan which are deemed necessary or desirable to comply with all applicable laws and regulations,
including but not limited to Code Section&nbsp;409A and the guidance thereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) make all determinations it deems
advisable for the administration of the Plan, including the authority and ability to delegate administrative functions to a third party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) decide all disputes arising in connection with the Plan; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) otherwise supervise the administration of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All decisions and interpretations of the Administrator shall be binding on all persons, including the Company and Covered Executives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Eligibility</U>. All Covered Executives who have executed and submitted to the Company a Participation Agreement, and satisfied such
other requirements as may be determined by the Administrator, are eligible to participate in the Plan. The Administrator may determine at any time that a Covered Executive should no longer be designated as such as a result of a material change in
such Covered Executive&#146;s role, and such individual shall cease to be eligible to participate in the Plan upon the Administrator taking action by resolution to update the applicable Exhibit hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Termination Benefits Generally</U>. In the event a Covered Executive&#146;s employment with the Company is terminated for any reason, the
Company shall pay or provide to the Covered Executive any earned but unpaid salary, unpaid expense reimbursements in accordance with Company policy, accrued but unused vacation or leave entitlement, and any vested benefits
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Covered Executive may have under any employee benefit plan of the Company in accordance with the terms and conditions of such employee benefit plan (collectively, the &#147;Accrued
Benefits&#148;), within the time required by law but in no event more than sixty (60)<U></U>&nbsp;days after the Date of Termination. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.
<U>Termination Not in Connection with a Change in Control.</U> In the event of a termination of the Covered Executive&#146;s employment by the Company, other than for Cause, death or Disability, at any time other than during the Change in Control
Period, with respect to such Covered Executive, in addition to the Accrued Benefits, subject to his or her execution of a separation agreement in a form and manner satisfactory to the Company containing, among other provisions, a general release of
claims in favor of the Company and related persons and entities, confidentiality, return of property, and <FONT STYLE="white-space:nowrap">non-disparagement</FONT> provisions and reaffirmation of the Restrictive Covenants Agreement (the
&#147;Separation Agreement and Release&#148;) and the Separation Agreement and Release becoming irrevocable, all within the time period set forth in the Separation Agreement and Release but in no event more than sixty (60)&nbsp;days after the Date
of Termination, and subject to the Covered Executive complying with the Separation Agreement and Release, the Company shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) pay the
Covered Executive an amount equal to the sum of (i)&nbsp;twelve (12) months&#146; Base Salary for the Tier 1 Executive and nine (9)&nbsp;months&#146; Base Salary for each Tier 2 Executive (ii)&nbsp;plus the Covered Executive&#146;s annual target
bonus in effect immediately prior to the Date of Termination, prorated as of the Covered Executive&#146;s Date of Termination; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) if
the Covered Executive was participating in the Company&#146;s group health plan immediately prior to the Date of Termination and elects COBRA health continuation, then the Company shall pay to the Covered Executive a monthly cash payment in an
amount equal to the monthly employer contribution that the Company would have made to provide health insurance to the Covered Executive if the Covered Executive had remained employed by the Company, based on the premiums as of the Date of
Termination, until the earlier of (i)&nbsp;twelve (12) months for the Tier 1 Executive and nine (9)&nbsp;months for each Tier 2 Executive after the Date of Termination or (ii)&nbsp;the date on which the Covered Executive obtains other employment.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amounts payable under Section&nbsp;6(a) and (b), as applicable, shall be paid out in substantially equal installments in accordance with the
Company&#146;s payroll practice over twelve (12)&nbsp;months for the Tier 1 Executive and over nine (9)&nbsp;months for each Tier 2 Executive within sixty (60)&nbsp;days after the Date of Termination; provided, however, that if the <FONT
STYLE="white-space:nowrap">60-day</FONT> period begins in one calendar year and ends in a second calendar year, the amounts shall be paid in the second calendar year no later than the last day of such <FONT STYLE="white-space:nowrap">60-day</FONT>
period; provided further, that the initial payment shall include a <FONT STYLE="white-space:nowrap">catch-up</FONT> payment to cover amounts retroactive to the day immediately following the Date of Termination. Each payment pursuant to this Plan is
intended to constitute a separate payment for purposes of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2).</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Termination in Connection with a Change in Control</U>. In the event a Qualified Termination Event occurs within the Change in Control
Period, then with respect to such Covered Executive, in addition to the Accrued Benefits, subject to his or her execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of the Separation Agreement and Release, all within the time period
set forth in the Separation Agreement and Release, but in no event more than sixty (60)&nbsp;days after the Date of Termination, the Company shall: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) cause 100% of the outstanding and unvested equity awards with time-based vesting held by
the Covered Executive to immediately become fully vested, exercisable or nonforfeitable as of the Date of Termination; provided, that the performance conditions applicable to any outstanding and unvested equity awards subject to performance
conditions will be deemed satisfied at the target level specified in the terms of the applicable award agreement.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>Notwithstanding the foregoing, in the event of a Change in Control where the
parties to such Change in Control do not provide for the assumption, continuation or substitution of equity awards of the Company, any and all outstanding and unvested equity awards held by the Covered Executive shall be subject to Section&nbsp;3(d)
of the Company&#146;s 2019 Stock Option and Incentive Plan, as amended from time to time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) pay to the Covered Executive an amount equal
to the sum of (i) 150% of Base Salary for the Tier 1 Executive and 100% of Base Salary for each Tier 2 Executive plus (ii) 150% for the Tier 1 Executive and 100% for each Tier 2 Executive, of the Covered Executive&#146;s annual target bonus in
effect immediately prior to the Qualified Termination Event (or the Covered Executive&#146;s target bonus in effect immediately prior to the Change in Control, if higher); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) if the Covered Executive was participating in the Company&#146;s group health plan immediately prior to the Date of Termination and elects
COBRA health continuation, then the Company shall pay to the Covered Executive a lump sum cash payment in an amount equal to the monthly employer contribution that the Company would have made to provide health insurance to the Covered Executive if
the Covered Executive had remained employed by the Company for eighteen (18)&nbsp;months for the Tier 1 Executive and twelve (12)&nbsp;months for each Tier 2 Executive after the Date of Termination, based on the premiums as of the Date of
Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amounts payable under Section&nbsp;7(b) and (c), as applicable, shall be paid out in a lump sum within sixty (60)&nbsp;days after the
Date of Termination; provided, however, that if the <FONT STYLE="white-space:nowrap">60-day</FONT> period begins in one calendar year and ends in a second calendar year, the amounts shall be paid in the second calendar year no later than the last
day of the <FONT STYLE="white-space:nowrap">60-day</FONT> period. For the avoidance of doubt, the severance pay and benefits provided in this Section&nbsp;7 shall apply in lieu of, and expressly supersede, the provisions of Section&nbsp;6 and no
Covered Executive shall be entitled to the severance pay and benefits under both Section&nbsp;6 and 7 hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Additional
Limitation.</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Anything in this Plan to the contrary notwithstanding, in the event that the amount of any compensation, payment or
distribution by the Company to or for the benefit of the Covered Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Plan or otherwise, calculated in a manner consistent with Section&nbsp;280G of the Code
and the applicable regulations thereunder (the &#147;Aggregate Payments&#148;), would be subject to the excise tax imposed by Section&nbsp;4999 of the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of all of
the Aggregate Payments shall be $1.00 less than the amount at which the Covered Executive becomes subject to the excise tax imposed by Section&nbsp;4999 of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Code; provided that such reduction shall only occur if it would result in the Covered Executive receiving a higher After Tax Amount (as defined below) than the Covered Executive would receive
if the Aggregate Payments were not subject to such reduction. In the event of such reduction, the Aggregate Payments shall be reduced in the following order, in each case, in reverse chronological order beginning with the Aggregate Payments that are
to be paid the furthest in time from consummation of the transaction that is subject to Section&nbsp;280G of the Code: (i)&nbsp;cash payments not subject to Section&nbsp;409A of the Code; (ii)&nbsp;cash payments subject to Section&nbsp;409A of the
Code; (iii)&nbsp;equity-based payments and acceleration; and <FONT STYLE="white-space:nowrap">(iv)&nbsp;non-cash</FONT> forms of benefits; provided that in the case of all the foregoing Aggregate Payments all amounts or payments that are not subject
to calculation under Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.280G-1,</FONT> <FONT STYLE="white-space:nowrap">Q&amp;A-24(b)</FONT> or (c)&nbsp;shall be reduced before any amounts that are subject to calculation under Treas. Reg. <FONT
STYLE="white-space:nowrap">&#167;1.280G-1,</FONT> <FONT STYLE="white-space:nowrap">Q&amp;A-24(b)</FONT> or (c). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For purposes of this
Section&nbsp;8, the &#147;After Tax Amount&#148; means the amount of the Aggregate Payments less all federal, state, and local income, excise and employment taxes imposed on the Covered Executive as a result of the Covered Executive&#146;s receipt
of the Aggregate Payments. For purposes of determining the After Tax Amount, the Covered Executive shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in
which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes (if any) which could be obtained
from deduction of such state and local taxes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The determination as to whether a reduction in the Aggregate Payments shall be made
pursuant to Section&nbsp;8(a) shall be made by the Accounting Firm, which shall provide detailed supporting calculations both to the Company and the Covered Executive within fifteen (15)&nbsp;business days of the Date of Termination, if applicable,
or at such earlier time as is reasonably requested by the Company or the Covered Executive. Any determination by the Accounting Firm shall be binding upon the Company and the Covered Executive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Restrictive Covenants Agreement.</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a
condition to participating in the Plan, each Covered Executive shall continue to comply with the terms and conditions contained in the Restrictive Covenants Agreements or similar agreement entered into between the Covered Executive and the Company
and such other agreement(s) as designated in the applicable Participation Agreement. If a Covered Executive has not entered into a Restrictive Covenants Agreement or similar agreement with the Company, he or she shall enter into such agreement prior
to participating in the Plan.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Withholding</U>. All payments made by the
Company under this Plan shall be subject to any tax or other amounts required to be withheld by the Company under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Section</U><U></U><U>&nbsp;409A.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Anything in this Plan to the contrary notwithstanding, if at the time of the Covered Executive&#146;s &#147;separation from service&#148;
within the meaning of Section&nbsp;409A of the Code, the Company determines that the Covered Executive is a &#147;specified employee&#148; within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit
that the Covered Executive becomes entitled to under this Plan would be considered deferred compensation subject to the twenty (20)&nbsp;percent additional tax imposed pursuant to Section&nbsp;409A(a) of the Code as a result of the application of
Section&nbsp;409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (i)&nbsp;six (6) months and one (1)&nbsp;day after the Covered Executive&#146;s separation from
service, or (ii)&nbsp;the Covered Executive&#146;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a <FONT STYLE="white-space:nowrap">catch-up</FONT> payment covering amounts that
would otherwise have been paid during the <FONT STYLE="white-space:nowrap">six-month</FONT> period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The parties intend that this Plan will be administered in accordance with Section&nbsp;409A of the Code and that all amounts payable
hereunder shall be exempt from the requirements of such section as a result of being &#147;short term deferrals&#148; for purposes of Section&nbsp;409A of the Code to the greatest extent possible. To the extent that any provision of this Plan is not
exempt from Section&nbsp;409A of the Code and ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision shall be read in such a manner to comply with Section&nbsp;409A of the Code. Each payment pursuant to this Plan is
intended to constitute a separate payment for purposes of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2).</FONT> The parties agree that this Plan may be amended, as reasonably requested by either party, and as may
be necessary to fully comply with Section&nbsp;409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent that any payment or benefit described in this Plan constitutes <FONT STYLE="white-space:nowrap">&#147;non-qualified</FONT>
deferred compensation&#148; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the Covered Executive&#146;s termination of employment, then such payments or benefits shall be payable only upon the
Covered Executive&#146;s &#147;separation from service.&#148; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h).</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided and
expenses eligible for reimbursement under this Plan shall be provided by the Company or incurred by the Covered Executive during the time periods set forth in this Plan. All reimbursements shall be paid as soon as administratively practicable, but
in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided or reimbursable expenses
incurred in one taxable year shall not affect the <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation
applicable to medical expenses). Such right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits is not subject to liquidation or exchange for another benefit. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company makes no representation or warranty and shall have no liability to the Covered Executive or any other person if any provisions
of this Plan are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do not satisfy an exemption from, or the conditions of, such Section. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Notice and Date of Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice of Termination</U>. A termination of the Covered Executive&#146;s employment shall be communicated by Notice of Termination from
the Company to the Covered Executive or vice versa in accordance with this Section&nbsp;12. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice to the Company</U>. Any notices,
requests, demands, and other communications provided for by this Plan shall be sufficient if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to a Covered Executive at the last address the Covered
Executive has filed in writing with the Company, or to the Company at the following physical or email address: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Pliant Therapeutics, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Chief Human Resource Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">260 Littlefield Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">South San
Francisco, CA 94080 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">BHowes@pliantrx.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>No Mitigation</U>. The Covered Executive is not required to seek other employment or to attempt in any way to reduce any amounts payable
to the Covered Executive by the Company under this Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Benefits and Burdens</U>. This Plan shall inure to the benefit of and be
binding upon the Company and the Covered Executives, their respective successors, executors, administrators, heirs and permitted assigns. In the event of a Covered Executive&#146;s death after a termination of employment but prior to the completion
by the Company of all payments due to him or her under this Plan, the Company shall continue such payments to the Covered Executive&#146;s beneficiary designated in writing to the Company prior to his or her death (or to his or her estate, if the
Covered Executive fails to make such designation). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Enforceability</U>. If any portion or provision of this Plan shall to any extent
be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Plan, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable,
shall not be affected thereby, and each portion and provision of this Plan shall be valid and enforceable to the fullest extent permitted by law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Waiver</U>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of
any party to require the performance of any term or obligation of this Plan, or the waiver by any party of any breach of this Plan, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent
breach. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U><FONT STYLE="white-space:nowrap">Non-Duplication</FONT> of Benefits and Effect on
Other Plans</U>. Notwithstanding any other provision in the Plan to the contrary, the benefits provided hereunder shall be in lieu of any other severance payments and/or benefits provided by the Company, including any such payments and/or benefits
pursuant to an employment agreement or offer letter between the Company and the Covered Executive, other than as provided in Section 3(d) of the Company&#146;s 2019 Stock Option and Incentive Plan, as amended from time to time; provided, that in the
event the Covered Executive is party to an agreement or other arrangement with the Company that provides greater benefits than set forth in this Plan, such employee shall be entitled to receive the payments or benefits under such other agreement or
arrangement and shall not be eligible to receive any payments or benefits under this Plan and the defined terms in the Plan shall supersede the corresponding defined terms or other similar terms in such other agreement or arrangement.<U> </U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>No Contract of Employment</U>. Nothing in this Plan shall be construed as giving any Covered Executive any right to be retained in the
employ of the Company or shall affect the terms and conditions of a Covered Executive&#146;s employment with the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Amendment
or Termination of Plan</U>. The Company may amend or terminate this Plan at any time or from time to time, but no such action shall adversely affect the rights of any Covered Executive without the Covered Executive&#146;s written consent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Governing Law</U>. This Plan shall be construed under and be governed in all respects by the laws of the State of Delaware, without
giving effect to the conflict of laws principles. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Obligations of Successors</U>. In addition to any obligations imposed by law upon
any successor to the Company, any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company shall expressly assume and agree to perform this Plan in
the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.
<U>Effectiveness and Term</U>. The Executive Severance Plan is effective as of [______]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Tier 2 Executives </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Individual</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g729258g01c33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g01c33.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2E"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *2:^$%-#A"24T$!       1QP!6@ #&R5'' (   (  1P"4  6071H=6
MMO<F%L86QA9V4@26YD=6YI;!P"-P (,C R,# S,3,< CP "S(S-3$U,2LP,#
M P #A"24T$)0      $%%DZ<YGSVV<;2%[1=4;.=TX0DE-!#H      .4
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MYS    %P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L
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M1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M  $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F
M<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'
M1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $
M#.?"D  0 " ,Y\*0 !  (X0DE-!"8       X             /X   #A"24
MT$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M     ! #A"24TG$       "@ !          (X0DE- _0      !( -0
M$ +0    8       $X0DE- _<      !P  /________________________
M____\#Z   .$))300(       0     0   D    )      #A"24T$'@
M  !      X0DE-!!H      S4    &              '*   %%@
M !                          $             !18   '*
M            $                         $     $       !N=6QL
M   @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;V
MYG          !,969T;&]N9P          0G1O;6QO;F<   '*     %)G:'
M1L;VYG   %%@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V
M4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M    !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V
M)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&
MQO;F<          $)T;VUL;VYG   !R@    !29VAT;&]N9P  !18    #=7
M)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M$       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O;
M$    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15
M-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6
MT    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;V
MYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&
M]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P
M "/_         X0DE-!!$       $! #A"24T$%       !     $X0DE-!
MP     #BT    !    H    #@   '@  !I    #A$ &  !_]C_[0 ,061O8F
M5?0TT  ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/#
MP/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,#
MP!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,#
MP,# P,# P,# P,# P,# P,# P,#/_  !$( #@ H ,!(@ "$0$#$0'_W0 $
MK_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
M        $  @,$!08'" D*"Q   00! P($ @4'!@@% PPS 0 "$0,$(1(Q!4
M%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$
M7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO
M8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34!  (1 R$Q$@1!46%Q(A
M,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$
M55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V
M=WAY>GM\?_V@ , P$  A$#$0 _ /5&M:UH:T!K6B !H !V"=9KLG*OZCEX%5
MK:?1JILK?LW$&POW;I=L_P2N8=KKL2BY\;[*VO=&@EP#C'*2FGU.UE=NYU]]
M+F5.>!7 K=$_H]UK35]H?_ (-5A?77(?D9Q#VM8P%FZ"0'Z&NISO6;]#])_P
M (S_2+3NSL.BSTK;6LL@.+"==I):UT?RMCT*SJN&&.-5K'61[6N):TG^4\,L
MV_YB2G/W@/_I>?LAP+#4[=N)#6NW^E^9^XMG'(./607F6C6P0_C_"#3W_O*M
M1U3'<S],^MEDGVUN<\1V]SJZO^H4CU3I[?I7L:!R3H!VU)24VTE"VVNFMUMK
M@RM@+GN/  U)56UN=DEMV#EUUX[VL<T.J-A(]YL.[U:OYUKZO^*]))3=5._I
M[[;GVLR[ZMX'L8X; 0-H<QCVN1L2UUV-7:^-SV@NC03Y?207=3QVV65AESS4
M[8\LIL<W= =&]C-KOI)*8CIUP!#<W(U :-Q:8]S7N<WV;M[FMV>]WYZA^R7]
ML[*^!>(XV_N[N_[R61U 65%E(R:'F(L&-8XC^R^LM1!U.F /2R"?'[/;_Z32
M4V,>DTU^F7NLU<=SS+O<2^)_D[D54G=6QF#<^N]C1$N=1: ).V7'T_HJZDI%
M=E8U! OM942) >X-D2&_G']Y[4+/>T8;GBRQC9:390TV/C<W=L96VQ_O;[?:
MU$VXN3[B*[MA+9T=!!][>^WW-380 QFQIJ[_JG)*<AHK@E^3U"L;PR; 0W7=
M[IV^RIONW/>_V*0RJ=@><C,;4TV;B 'Z-?])[F-L=LL]7]$YO^!K_P?HO6O:
M<@65"IC'5EQ%Y<X@M;M=M-30Q_J/\ 5]-ON=5[$5)3A&RH&?M>>(U@UNUGW?
MZ#]S;_ .=K6Q+VWTAS=Y#?:76-+'.('T]KFL^DCI)*?__0[X->_K><W'M%5Q
MQ\>2ZK=$.M+7;_ %-MF]N]GI.].RK^<_/5[IO_ "=B_P#$U_\ 4M5&''KF6S
M'LKKOLQJR7.W/<-KG;/U>:V>E[W^_]]ZO=-_Y.Q?\ B:_^I:DIA5_ROD_^%\
M?_ *O,5Q4ZO^5\G_POC_\ 5YBN)*<S'QK<VBQUV5=M==<W8W8T!K+;*ZVMBK
M?[6L;^>I9'3,A^/Z%.8\ PTBUK+&[/SV;=E>[<SV>YZNT4,H8:ZYVESWZF=;
M'.M?\ ]-ZH]5RV5''#,CTW/OKI>T. TL,$?G>])2?JQCI68X DBBP@ $DD-=
M VL?4YW]3U:U3Z?3U&WIV#93E"EAQZ"ZMU8>Z0UQMFS?\ X3?7_P 7Z/\ +5
M[*=1;@7R6W5>F\/DC:1M.X.=#V?]%4>G8W4'].P7TY9QV>A032YC;7"&N=8T
MWN9C[]S;*Z]_H5_P Q_P )8DIO=._H-'?V#5%KIKJ+S6(]1Q>_4F7$ 3K_ %
M4+I_\ 0:._L&J-5=5<TOI>VQH<YA<PAP#F.-5K);^?78Q]=G[CTE,B"00#!\
M50;T7%^SBB]]]XV;+"_(N(>(VO]1GK;?TGYZON<UHEQ  [G1!P\H9>+5DBM]
M)M8UYIM ;8PN&[TKF NV6LGWL24T\WI>']G.Y^2&[F3MMR+3]-GM]$66;F._
MPGL_F_YS]&M-975KLP'9539Z32S].QY:1+OTC?28ZMUC=NVMGO^F_^;_1JWT
M^]]U&YU;ZF:&KU \/+")9ZK;PVYEW^EKM][$E.?TMF=91?]GM;C[<S*#A8PV
M$@7>QS?TE.S]$U_P#VXKU.5C8V-3]JNKJ-UGHUFQP9OL>YWIU5[W>ZVS\RIJ
MJ]/SJ:1>+MP?;EWANVLNG;8VG_ +3U_P JO^<_2?\ ;3U1ZIUS%P*J&6S<&M
M=?]BQW5OR[Y>ZD4LZ;>SU+L;TWW9-UU5M-M7V/_C$E.QCY&?=FV@TULZ<UK?
M0O]3=9:XAK_494QI8S']_I^^WU?4K_ )KTO3L35Y>7D67,II:VMCPVG)+]['
MLVL<ZS8S:_>RXV4^E_P7J>O_@T+)95AX)?D,#<3':UE6'C5O>P 152STL6M]
MUM?T?T=='HU5_X+]%ZBO8_K>A7]H:QE^QOJMK)<P/CWMK>YM;G5[OH;F,24@
MJ_19GHFNVQUE9L?ENVEGM<UHH^DW8_])OKKKI]+^<_PBMI))*?_]'OV5NLZQ
MF64EU.0*JZFV/&YA:#ZAVU[*W>US_^Y'Z3_K:LXE]./TG'NN>&,90PN<?)@=
MHW7_-4GX3QD7Y5%H9?>RNL.<P/#167.V_28YS7>H_V[T#(I^R].->5D5C$KK
M])Y=69+2/2V_H[&N=99.S]%[WO_FTE,L7J?1\C-<,:]EF4]@:\ GZ-3C^C=/
ML9979D_P W_/?I$7J'5<+IS6.RK-@L<&-'))(<[1GTG_S;OH>]5>G8#&U-RL
M6JG%-HEOZ#:_:Z"TV;;W[GOV,?O=^D_P!(I=1O?CT^G?97<Z\%C,85;C9,,V
M;'6[=FZQC'N?\ H_>DIL8'5<'J+7NQ+-_INVN!!:00&/\ HOAWT;6*MUI@_5
M"VHO(RJGDM-;=6N_X=]>YW_%_I59IHRJZF5LLJJ8UH#:VU;0T ?1:UMNUNU"
MR+,UE]% _3.M=NW-IEK&MC=8^Q]S&-^FS8S^>_T=-GIVI*2]0].OIF4?3.WT
M;"YC&%[C[3[6TU[G6N_D-57IN'F_L_ VY3\=C,:AKZ UKC+&.]3]+>SU?TF^
MO?O;_@?S/TBN^GFSK>R._Z,_\ I5#RL/+NMWTYMF.SV?HV-K</87E_\ZQ[OT
MV]K;/^*_1I*1UVY5/2J;,:D9-C6MFLNV$MG](YGM<WU-GN95^C]3Z'J5+*Z3
MG9M6;D67X>2RG+N8W'W-O):P>G4_[1C['X^.]V3=;=]JI_I-/J79OI?9UL'&
M^RT2[-LKIJ;)<[T0&M'=SC0H81MS*3D,RLAM3W'T][*FDM'MW;33O]W_"LKL
M24MUFC+?57?B>I;;C.WC$K>RMEVX>B6WOOKM8YE++'WUL_TU=:K_5^G/J8*;
MGO;3BL;CN9;0RI]ES0WU,NM^.XTNQ7L<RNMK&?SC+?TBLYCQA4FZ_-N#>&MV
MU$N,%VQC11N<[:USOZGZ1$HHRGTUOLR;V/<T%S'"C<#&H=LJ>S_-<DIEGX1S
M6UL-UE5;';[&5.V%^WW5M=:W]+7LMV6_HG>_9Z5GZ%]E:-0+116+B#:&CU"V
M2W='OV[OS=RIYGVF@5M9?E766O#&MK928_.>][GU5U5L96U[_TEG_!U;[O3K
M1_LM__ ',N^ZK_ -()*98F'3B,>RK<198^YQ<2X[K'&Q_N/YON]G\A85WU=R
M<WK73NN593*OV<'LJH=47$^H\LRWON%S/IXWJU4?H?T/J>HMO)PW9&V,FZC:
M(/I%HW:L?N=N8_]S;_ %'V(6-4?2VV7NKL:7;F-L:^/<[\[TV?]2DIO)*DQI
MBU]N2YM33+'^HP@U[6^_Z#=GZ3U$FUO-SA]H?Z.UH8X/:27R_U&[/3_-9L_P
M )_P!;_P!(E-U)4S3<;:_3M>Z@AV]^]NA]OIPSTG;_ ,__  C/^N*3Z<BMU;
MJGOL]XWM>P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MX2E$1TEE9VAUA[?5-3E(5%9BE)66TF1R='B$B)>BHZ2ELL7&U/_:  @! 0
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M5#TZN9"LZ$+2K-8X^GT"QS$K L[I9Y*)C7;"(@T)*'D$GSAPL1T@FW,O[J=
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MN35O\M5\:7G=SA;;]3;!4*E&+/*MB.5Q)1C55Q'Q"BR_M).+4\9"MV?M"%:
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M\M/9$ >0* "/AY$  .?#Y<\!Y:H"28")@* &$..0Y >WE]7KH9%(_A\1"CX
MX+V#Z/V?#CT^_503('/T0[^?;[OWXT]F7GGCU'CGCMR/(@';R'U#5OL$NX>S
M+P(" @ < ("/(\@' #W[^78?+C5?8I\B8"@!A\S   8>/(!'CR#TU<!"E'D
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M\?J U:H*J?I<AMIW0XOW65FWVK$JT[)5>F7V?QP\LDG%%BH^7LE<!J,\A J
MLJ>1:1+MX,4\>@DDF61:NFX"J=)0PQ'[IMZ&>Z#E[/DA6[7,UR!PGN.VUXJ@
MC_(31UAF H=]BXY]D25S;(@"L@Q;317QT8BP)(+G@)!%DV3(B@[76/,_F_)I
M\2X,R_F5@P0LA\=8MO&2(Z-]L9-I,'JU6DY]JP*X1!0 ;2 ,")>](@)A26,H
M \@ !H;MUZA+"QX9@,W;B,A[>8VFW*9QY7XN<PI/RUH@:#8,@5@+"W@\L3+U
M\^:U5RB408>^NQ9LDG8 FNNBHN@13(-FZHFTRI(P[A_8KH\1FJ&EE1)6)QW9
MI1*,Q8>QO:F?),\9HQ]G$55"48+BJ]?@W6.S(#UN@HB*AR=HG.HMM<@K3DBJ
M.;?,KFQ+6H2S7NQL:A.R%0@V]L8P;^IQ1;(@U,R>6"X-['#?($*R,J\? \+[
M(OA**NN/_.-[<%(V+7,\NYK0]NRF-_R6'H\M^4]A9T89.R.6K^KF("B#<M94
M2G = NJB[BSD6:&,J)DPY"\;Z\6,66X2,HKQ=W;, T&>L]GG9^J6$V.Z],0D
M&A-.*U8):.(DZ^56#%VU<OHE'V3HR9CI-SBNBJ4/BCU$=NK&S5VE3%HDS2KQ
M2@0-DN,/59U;&-9OV1(5E+UBG2UN5;G91$K8BO4DH]FX4.5FLJU8R;ML^730
M4YK&'4*VW98RZRPU3[#9%K1+2MXK\-)2M-L$14YRS8W= UNU8AK(_9H1TE.P
M1Q*HX;-5#IJ) H"*AU$C &](<\!SY\!S]NJZ::::::::H( (" ^0AP/<0[?:
M'?6G>[O;"SW.4VB1:=F6J%UQ!ES'^<L8V@[(LFTC;SCJ83E(5O.1P'0%_ R8
M K'S#5%5%V+5856RZ3A),X:>6/;CN0VO/<Y[K,79&_*9D#(EDKN5LQ8KB:+&
MBKD5.F((0S?'6.GCM5S(PT5\SB.HV#2>+.9 DZX-**NS 8[<W2)+&^\B][I\
M!9#;R$/5K<\V)Y=@\A7"W45:3I5=GL@Y8HTW%XZ<M(-_%K(V6JQ!5!;K$>!\
MIC7S.'Z)B.G(&RMMEVA3>T;,FWG'-3NV2KCBVD;;\B5N7/*KBWHY+E*9#96Y
MW.J0C$A(YM99N2FYA1LLOXU6\,DE'MA!) XC\\8;"<S8=J>6L:TW<766%'R0
MYRFXC'OY'J\2^UA7*]ED["\75M15#JSAXOY8D&K$'Z9B&(#=10I#(D$FO\MT
MT,L8+E-I.-]HN3W];QGAS.&3<C5>2LT'$6@N&JW:L1OX![67J,BLFI:H.UW!
M9P\$Y12F&"LP].U6!,A#DVLP;TXJOB29A923R%.W%P&"<RX<O2CB-81*]PE,
M[9*3R7>;DF#3D(44Y$SJ-BV#0HI-6)D!-[0R0F4QAAWIBN,)X^N..*[8\*R\
M<\QVUQ?39:P8+B7TT^I+6:3D/D3)SES(N"VAJ\C6[2'=!#DA_;*(%FN DRE4
M+^>#Z7<W",]M4,IG4CF-P!;D;@VL*=.;MLBQ2PV-S87=%QY;D9'WRN8RD4W1
M(-S5I<)E%O$M42MCE6,H<?FRZ7=NQ]#0+;#FXYU1)9[BG)."\ER\C1H>R(6C
M&F2<I6[)AEX=F]4\$';:\M:WT)&R9U'+55B!5WC918I>.]..F/2V>/,PXQKN
M0Y>)KV4*]M:JK %XYJ\?0$?MA8Q<=%&67*9'Y2D+6C%D6DEC@W]V66,*"9B?
M1U+ 0! I0'GG@.>?/GU_7\. #T  U=IIIIIIIIIIIIIIIIIIIIIIIIIIIIII
MIIKXKB<J*ADQX.!3"41XX >!X$?$ AY\>8#J(C<WU"LB8*WL89VZQ=5I3V@V
ME3&:%W?SKF3;7634RO<GM3:2=#!!RE&)Q-#*R&7MRLDS>^U:*D21,Q-RH.!;
MGU4,VJ[E-PF%*)%8(C82DIY KV*YJ[R\FT>*VK'L#5)[YP7%09V,BW]3OY;0
M6&HC2,=0SE]--B$4F%6RAA#8.@=4! F ,*YFRKA#+)HO(D!!.;=D'&E983.)
M*A99>T.*6XB7TO+69G-LCL)YN5-\T*Q?E:"L)$)"23*1PK+*V5.H1(P*^,#@
M0P@;P\]R@8?"(  B''H(F$/+GMSK]:W/LC^'CGPFXY\N>!X$>X#P \>0_JYU
M#YNAZ4=/W*9BS+F F5;-1)G)F*8VK0#.)BV2Z&.\PPB(1$5G*M+*'15&RHUH
M"5]= XD,N0@+F=!PF!/WW;I852U41_2HW(TC5FSG:36-L[9VQB6CD6TW6LIL
M<O&R,LBN<$W+J9N;(74M%>,B:Z+YV7VOC,0Y>Y7OI^264*WN7;9!R\=Y;-SE
M3P# V^9AZJA'QD1)X0?MI!26B8X7"@^SLZC8H+-%UC%8>(3)',!"E#(N?]J%
MDO>X/#VZ+%%^B:-EC$V.\@8I62M$ [LU:F:3D5-%90YVD<^8.VL]7YALG)Q3
MCVRC-T!U&CU!1#PB&I,#B;=)T\:%CW%6#Y-MF['MQN\G4(1N%!;M;%1;?D)X
MC-C?KS+,%U/E..<V5]9GDK*.D4F$7&I1+)P14X>V''T_M W![D<F=2#$BUD@
M<<8.SKD#"\1;+'9:-*R%OMU?K=+BPL\KC)\G)L:\T4D7<>:/]Z?1\HW8.%U%
M6W@.FF ;44+;W=II;J$;?;#><A.Z'D6F4G&F-;-;N7D=7(>T8.>5&02IK0B;
M*/,QK[I9%9\U9'\;F136.\-[PN;71E>G;DG(VUMKL\S9E7&*F%Y E!K=V1P]
MBD^/++=,?T2%2C'==DI(TF^*RE; ^80[U[9FZ(2#0K)5LVX2=J & 9;I[[LW
M^7IR@1N8HF,Q/+;&*UM@N66):@QLBM<ZRGD>U&7A(M@E+I.X6^5^@239@G,J
MI+0#X78OG#55TD4B.SEMZ8=0M&'-S.&CWETG7<[2&&9J!57B$G:M.=80J=1K
MU<;S* .2DLC226J3166;^)N15HY<H)"104EDNCVCIH6FPX(D<6L#[8J-9+/;
MUK-8+91\/6N,3A)(*^E7ZY>Z(^4NKBT163ZBD4SR$EGTR\B0-[..7C3,4"IJ
M<I<^FA<\@WN^6.2S-"03&V8 MV#Y"3J]2?QUYR<G::I#UME/YX?FF/D*[R%7
M4BUYB$>M(6.E1>RCSWM\JB!2Z*=,RX)N9?'+#-L;_!JOF3,79FR/25Z<92_O
M+]C!.N/R1U9MX2 ,(NHV:T5&%L$DF]C'DK' U&,C7:;5PJ4V9L=;!3TB6P!)
MCD7Y2'"6:LXY<,D,*9 )XF97TJ\&'\178^YJ0P2( #D05*[,110Q"F.8=24Z
M:::?O^_EK'EUR-2<:0_R]D6[UBBP9Y!O&I3-QGXJM1J[UX<2M&";V8=LFX/7
M!@,5% ASJK 7E(I^!$.V,WB+UN@_:N"O&SI%-9JX;J)JH+ME! Z+A%9(1161
M.F/M$UDC"1=(Q#D$P#R/+ //</\ +JNFFK/9)\\^ .>1'D0Y'DP<#W\^X=M4
M]DGR ^ O(#R \=^0XX'GZN _9ZCJHIICYD*/<![ASW ! !'GS$ $0#GT'C5P
ME*(<" "';S#GR\M?,R")Q 3IE,)1$0Y#G@1#@1#GU$!U7V2?(#X"\E$1 >.X
M"/81Y\^>.WV=O+MJOLD^?%X"^+OW$ $>_GW'X\!S]@?#3V9.0'PEY 1$!X[@
M(^? ^GW: FF " $+P(\C]$.X_$>W<?M^S04TQ#PB0OA\^. X\N/+R\M4]BD(
ME$4R")./"(E ?#QY"'/J''8?,/CKZ:::::::M/XO";P< ?@?#SY<^G.NJ2=K
MAX):/:S\[#0SJ:=DCHA"2DF4>K*/S%$PM(I)RNFH_=  #RV;E46X*)P(*?!Q
MH]M4-%O8V,F)^)B).><*M(&+DI!@QE)AVW*919O%,UUR*OU4T0%91%JDNK[/
MPB)"B8 '[LIIDXF'4+\IL599BW;.G<85ZW5?M4'1C%2769I*"Y;M5C%,1NNZ
M33*J<#$3$X 779]--------?)8QBI'$H@!N! HB'/ B';MZCSV  [B(@ =]=
M"2O]147L:9;M65%*65-.YMR3D492JF49HR)?G$!'@FA5C,ET7Q ?E;E-'J%6
M$HD424-S4)-1MA8QDY!RS&;@Y5JF^C)6)>H2,6_:.DR+-WC-ZS,L@Z:N$U ,
MV4(L)!2$JA#& W&NT:::::::::::H( 8!*(<@(<"'Q#6-K3AS%=VLT#<[;CR
MGV.VU>.E(FO629@8^0F86,FT#MI5A&R#A!1RU:OT%%$W"*2A2'!0X\ )S"/4
MGNV';Q)FL!Y'"N,WRMJJT52+&HZI\*NI-5.#333AX"154:&5<QL:1%$C-!0X
ME0*@B"?A!)/P:F]2&KUZG;%[;5JK"15=K<%,8HCX>#AF3>/BHUBVR/5BH-63
M%N1-NW13XY*FF0 \7)AY,/(R,1Y"E0;B4H )D$1,/Q$$"  _R??KD! ! 0$.
M0'L(#JT4TQY 2%'D/"/(<]A#CC\- 23 . (4 [=N/AY?L#\-5 A2AP   ? .
MP?9QY<?5JA4DRB8Q2 4QNYA*' F].XAQSV#5 23#R(4.XCV#CN/81[>HAV'X
M@ !Y &GLD^>? '/'AY]>.>1#GS'D0Y'D>X]QY'OJ@(I   "9.  0#D '@!'D
M>!'D0[]_M[ZK[)( * $+P0  O8.P%#@ ^/ !VX'MJGL$N>?9EY[]^.X\@("(
MCYB(\CW'OR(CYB.JE23*'!2%*'H !QQY>7'EY ';T#C5033*!@ A0 PF,8 #
ML)C?I"(?$?C]OQ'0J29"@4I"E*     << 'E]?;X^>@))EYX(4/%SSV\^?/\
M=5\)0'D #D. _#L'X>FKM--1O=1ZXY*QI@2:RO$;@K5@;'6/X]W)9(?XLQG"
M9%S!9O?W<=&5R"H!;.O\WH9R^D78M'#E\Q763!PBN1ZS AE TVV%J;QK??BR
MBV6]\,)288(68GZSOBQ+AL\'=H&37*5TUH]CQS8'-JBK&BU$7")7)ODI+VA3
MN&ZGL_9CG?JV;-<O[U<48KJ6'_FVZ>T;(\K:IR'G;0O2G3]E)8^M509*QEH1
M@[&DR5B)&P(R<A'*Q*IIR,;N8Q!VP.N#DF$*I5\];8-Z?3TQ'+[@+?9*QE+$
M%OJV2<3I&;%Q3'3>'\3P[5N]H\=[N#Z,;.9QJM)G*Y<JJ*&4, B43F+J>+33
M3333337Q<+)MT55U3 1-%,ZISCR($(F03&.(!R(E*4!$> '[-1TN^JCL;80>
M9+"ZW"U$&&!IM6O9(%%4YE(>4(\:,RI W,45% 4>.R,4%CG307<)N"D'PH*"
M'=*]U%=GEKRAC7$-=SG4Y:]Y?K:-KH,,U?"89V+=.2-&/N1S 4%5I!05E&I$
MO:$,BU66\94O"8^] >0<_#3333333335B@B!#<>? \<]PYX$>_'V?N&O.YU@
M-K&XS.^9,1V#%>*K7E>)-C1Q0*5)5F2CV;?!V95\LTRT-\K3YI":CAB8UK3(
MR3CSSL:A)R"8MS,?=BB[)QBO?GMVW9[B-S&'[_2]O^4I-:.JF*<:TJ\RLE!1
M+;#>1\2[CF-PR'E^;3;6<YV=4R=C1BX9P$JT:O).:;.RQCU@S'@@=_VB[2.I
ME7MV.^N\9;L]?QI9,_4>C.*KN(K4TADNOQTK7K=*F@JU4<?65FU:Q\?#TPZ<
M:^CW35-)FH9%9-Z^76]IJ1SIFY;S/EK!=X5SM>$LC7_&NY'/.''5T:UZ-JI)
M^&QM>7D##/EX.((FP9KJ,4D@5]D B8Y1$QC"(B,C^FFFFFFFODN &2. @)@\
M)N2AYF#@>0#D0\_7OW#D.0YYU!ZIT4L5_*>\>0'-62"NMX4>Y;2:!#) TQF[
M7M))PLG3$/;^%1XE'LH&)$'RAQYATW!3%]H8A9$-FVV"O[.,"4G %8L]ANL/
M2RO"L[)8U 5FY1)T[.L121 IA2]L1(Q$!!/DARH^W(4HGX#;?33333333333
M334>G5&_M-<@_P#&3&'?_P!)%9'C[1_$./MUOXQ'^(:A_P#@Z/Q[?Q)?JXX^
M_P"/V!^_335IS 4AC#SV*(]N.>?0 YX#D1X .1 .=0<]1#KQ;3NG)N!QUMVR
MW7\C6>VVZ,BI^U2-,8,UHN@UN><J,HN0DC/7C920=K&3,\49L"!["/3,X!R=
MP'NVIH*M88VU0<!981^$A!V.'CYV(>")RF>QTJQ;R+!R5,Y2'(15DY06$BA2
M'#Q]R<\CKM&FFFFFFFFFFFHP^I\2TK[9\D)OYC!4;@8*-:$<QHYHBK_(_*!U
M?<@J#.$0QQ*1TXL#N9X9.6+5-24DSJ,T8OEP?DT:O0G5J"-PR@6,4Q!"R\[C
M^-D&M0ID/N%@;DG!0MTFJFZDI2-S7;+*P".:3\'(1B[2"]G)L')&Z4EX#&%(
MOI@!NB'/"9 YY$> \Q$.!'SX\NW @(!J)O=60"]3_IF%+V#Y(W/&'Z_ZWS3D
M/U<]_4=2U:::H(\ (^?&OPBN;D ,)@'M^B(E+X>>.1.<"E$P<]R>@=P$>>-?
M<1#^_D#[P_ ?XS]G&G(?W\G/V]OP]I_+_-IR'_Q@GIZA^OZ?K]VJ\A_?R?>(
M?_?#]Q^SBTX%.4Q3+)B!@$! P 8.!]! 3]P'R,'/<.0[ .M,S; =E_R/?Z\?
M;GBA6#RU*,9K)K)6MQYD+Y+Q3]_*,9"R@8@C(K-GTH_=$4<*>(RARE$1(0H!
MVF$V8[5ZY?:'DN!P5C:+ON+:]'53'EM;5]@E,5"NQ,<I$L(>"=E*"C1BA'+J
MMO9D-R(&\7B\0<AM(!N0[K)%'_YHA^(_3XY']G&J\A_?R?B'[?'IX@_OY/Q#
M_P"_J@"'JX(/WA^OZ?[.-5\0?W\GXAQ_SG\NGB#O_'DX^H?+_P#?'GZNWXZM
M*8WB /&)N_(E'C]'GL8!#T#GRX]//R /TZM./!3#SQP41Y^P.=<0=\DW]FHJ
MX(D18Y$B"X5(D510PB!2D%0X%,)A[%(0!5,(<"4 [Z_!'6**GP=FAIF+DTXY
MZ>.?GBY!F^2:O41 %F;H[<Z_NKM(1\"S=8I52"($$O!@-KLOLR ''A#COVXX
M_2'DW/'Q'N/QU04B#Q] GT?+DO(AP/(=^>>P\"'P'OJ@))D P@0H"/(\@''?
MC[1^'V?5J+KI2<?DEW'<\B(;\=WP //_ (U9'S^/D'X:E*TU:<?"0P\"/!1'
M@/,>WI]?&HU]['4XP5L*MF)J1E>KYHO-OS,ULCRDUC#./W.09=RVJ1&HS"J\
M6S>MWQ 3*]0/RFFX*4@G4.*9""(ZG?G_ +;=_P %CJ#>@_VJ=J\A]1_JCV^S
M[?AI^?\ MMO'/\%GJ#?XJ=J#MW'_ '1^K\./CQJGY_[;=QS_  6.H-_BIVKZ
MN/\ 7'UY^'GV^ROY_P"VV_\ !9Z@W'KSM2M78/\ ZQ_<.^J?G_MMW_!8Z@WW
M[4[4'GV#_7#U^&OF'7XVT 8!#:MU! 'D?_@I6D?I#W'G^J7'/<>>>_?OQQJ[
M\_WMK 0YVK]07DH\A_G5+5V$ ]/ZH_ ?UZN_/_[;?3:QU!O\5.U?8'^N&J_G
M_MMWKM8Z@P?_ *J=J^S_ '1#UX_;Z:?G_MMO_!9Z@WW;4[4/[)'[?W'0.O\
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M1(",I;&!X)\5Y6X\I5$A,]FFXJ1S4H*$,*[E,"F*;@P>1_I5VW#%8ZAM,K&
M,8[D=IZ<Q1+M4;AMTW%6JBR!4*FS%>SLD:A!6I\AEAHV1M34)$IXWY89E0]H
M;@K,>#39[G^G[>LY;O,7;CZID*L0<-428[D[%!SL([?3R<_A^RR5QIK>MRB*
MJ2<?"6.4=I1UP:<D4,R2%PB!W DXUDOW2RW*R^5LW9LIF7\,1UYR6TL]BKBU
M@H+Z;0KF1,HP-/K-Y.X3?.G"+V!J[.KJ2..2NDUSQ\R]*^61]JB'/Y]UNR"L
M8@V'TM:>LUZ8WC#37$5;5K] R[DR'PU-22>58IX\FI7&JEB+7Y^1FW4D\E)9
MS.QKE1R_<*&)PDW;D3] ;#CV#7@ #^ET@[ !0#A$G]R   =QX#@/7MVUR&FO
MS/'*3-JX=+*IH)-T5%E5EC 1%%)(OC4564-]%-),@"910X@0A $QA H"(>7K
MJ9_T0EC&C[?<HH]-_(%.SCN*QS=(RMWID>M66394&K@[=LK!=63)U'QS2U,(
MZ010C%)*+<OXJ/4<@X>F%)1$=20]%G>+N WS[%,?Y\W)T1*CY'E[)9X$#LXA
MU 1MRKT&X;(1=VCXE\)E6S:9.=RE_2YA9JK-%%&QA(/:6I3L0W81[#Y<\]^W
MIW[>>M<-TNY;&>S_  /DC<9F*6?QF-\85U2=G%8YJ$C)/0 Y&K2,B& *("[D
MY!XL@T;)J.&Z/ME047721*<X:N=-[JB;<^J#C6Y9"V^!=H0^/K"VKERJ-_B&
MD398)V^:J/HQRJ2.DY2/>,))LBJHV6:OCG Z1TETTU"@!\FYKWIU^CVM;"^'
M*O*;BMQBZ7@2Q;0G""D;4 72%1M,9<N1O%"X\@@()%CC)J'FGR8J)P\*_73$
MH= I6S&R9:LT-ES?+;F.9;9'2"4O3<)0Q5F^W7%#Y/DS4T;5UBE-D.U1Q@\
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MO/TUUI*R0JTJ2(+/0RLF"ATS1B4HP.^ Z0")R"S!<CPJR8%$3\)<E IO$0
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MW8E\D6&6L&;,^SR!$K5G;*"S:9N+LJYA<*157;%22AJ#5DE1%1G6:@RC6"9
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M,V7'&3*.K$TL\CDVI6ZY47KX7A53.I%10%2#.@4A"AP!0 /L#]_Y-4!,@ (
M0H (<"   !Q\. [?;]??5/ 0H#X2@'F/(>?EY?9P'''EJ+GI2?V)-QO_ .?E
MN^_]:LC]G[ U*5IJQ0WA(8>.>"F'CD.1X 1X !$ $1^LP!]>L6U/*V.+S9++
M5:;D2G6BRTET1K<:Y V2)EYVLNE3'*5K.QK-TJZC5#"F8@I/4D3E4(8@<CR
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M.<J1  I1X  UP9NF!5@*)OX5F];@ \8".?YP0#CN B -C<\!]@?;Z>>'I2;
M<QVSJ!]3BO94R)<Z%4J1?HZ*&V8;S.1AD&Q6"2?FDJ\G:GT0=>3FV;BH^"2E
M',HW:@WL9SI',HY*9+7H?-TOJOX3<[K=Z_' \_YX"<\N._\ VN/;[A'6?MNV
MU2)VYSMAF(K,6=<F+6..8Q3AAEO(LG>HV+39NE'8/8=J[33*P=KF/[!=T'95
M(H)F$2E\.MPS<B0W<2CP/</,//@0Y#N(>8 (=QU"MUJ\;7V;VPS&1\8T':]:
MIJAQKZ-N]@W-O31456<9627K)K"6"EG*?R*F:3-' C+M)55('+/V24>*LE[H
M@?3?H;OJ/.9]SW8,;NM@$'%'Q!1(Z3H&S ]SFY,KTMIDURVRZ6*V5Z#]DR7
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ME<>Y> I2@N9/V0BH68O37R6 PIF H#XO";@0$ $!X$0X$P" #R   \#P;@1
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MDJAY(2>.<>WJI7IO$N4FDJ[J5AB[ V8.5B LDV>*Q#IVFU<&1."J2"YBJ'3
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M15:-WGL5W+=1,@D&'^L=2CJ-[5-B0YJW"*;(MTLOCJIO;18K11-P[)K>;K#
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MCU5UCDE5),JCI,YB$%2/;@<IC%)Q.,!2AQP4 X\N  ./L^&JZ::" #V$.0^
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M:DX>;02<&]FL9N#_ -U*Y;(NR) LFF8L)6^W^A^SYUS7MANVU_,LI@?&^,;
MK(Y<J5AR-F:W2UB;A)-%32U1D92W3*L;-?(R3R $C=U$%,U?F.9X8Y2E/+%2
MNEGL@I&1*)E*)P[(N[OC::3L-&G+9D[*]V^;TV4HIEDV$9<;M.1J;L$3&3,=
M5B<0Y*8H\E*(2.<!V[!VYX[!VY'D>/AR/<?B.JZ::L4*!BCR(!V'@1].0$//
MT["(#V'L/EK3' VPS:-MGRSEG..!<)5B@93S:]6<Y2MD&M)G>6-1U)#,.TS-
MGT@X81+9W*B:2<MH9HP;KN_XPZ0\  ;HZ::IX2]_HAW\^P=^/+G[-4\(  \!
MQSSR)0 !^W[=8^G[Y3Z8Z@V=JN-9KCJSRPQ< WL,_'0KF>D5"@<L=#(/W+=2
M5D!Y]F1LQ(H8/T1("@E ?TS%^I=:F86N6"X5J#G;.X.TK4+,3L;&S5A<ID%5
M5M QSQRD\EEDR@(G38HKF+P(!](#%#XUO(-/MDO/PU:M]8L<G5GA(RRQ4%.1
MLK)5Q^J0#E9V!JP<KK13TP"/A:O2I*?Q:G)0.4Q0CTZ4?]B3<;VX_P _EN^[
M?^E61U*7IJGA+_M0]1\@\Q\Q^_U^.J> @AP)2B'P\(<?LT$A!$!$I1$/+D-7
M<!\------6@4H>12AQY<  <>OH'Q[ZNTTTTTTTTTU\EO%[)3P\>+P&X 3>$.
M?K-Z?;K6:Z;K\#XTS#C[ -YR+'PV5,DM_>:I7')'1SN2N7AF,85Y)HH&81HS
M,@)HR 1D%D'$L\3%!FFHKP)\9W[J'[1L:W/)M NF8H>*MV((H)6[PY6TDX6;
M_29$-#Q9VS<Z,Y94C24>#B C3N)5$KQ!5=LF4PB&#-_>6L>Y6V SE]HMOAYZ
MJ7-[BJ9KLDB]2;*/&!\FUM-0YFKLR3DBS1R@NR?-CI LU<H.$52$70.4DE;*
MT5Q-N@<]C@_I)-P II>. A/XHJ8 GRX*;Z1@-R!N?I<AZ]OWC:ZZ'^OL+]TK
M'_\ _4'U?9R :?.RN]OZO0GU_P!56'8./_RGZP^(?6'.J?.RN@/>>A./_.K#
M[O\ MGU[_J^O5QK57B\?U>A.X />58>0@/ ]G/U>7G]FJ?.NO?[NPOK_ *Z,
M/3_])\Q] ^X1U3YV5[_=V$^WY58_9Y>\]N1\O,>W';S -LKP!_[NPO/URK#S
M_P#I/^7@?+SU>%IKPAR$]"#Z#_51AV'OV'^F?V\#YZM&UUX!$/EZ$Y\N/E1C
MY]_/^F?+L/D'[-4"V5X>_P NPG'_ )U8?M!P/KS\-/G97N_]783ZOZJ,..WF
M(C[SY!Z]@$/KU4+771\IZ$Y'GC^JK#]?],C\?K_7QJHVNO / SD+Y=^)5AY_
M#_3(?CJGSKKW^[L)YC_KHQ]/APX_'GR^&GSLKO\ N["?_6K#ZO+^F?7GMSQ]
M?&K3VJOF((%GH7GZI6/#_P#N=!YA^_'G^N/EF,H(BP=M7R153<KLG:#M$!#L
M!%#MU#E(IZ^S,/B#U#X\UK2#>UC#*V3,5Q;7%%4IV2Y*L6ME89S"V1YQW6:-
MF>O-F3UFZI]BFVR#DC5-%PZ;SS!"1;+0<H_C&T?,$^3W"X!@WI_84R]CNQY>
MO]^VUX=V?0=Z;5J-B,)8>M[:T12\O!G? ]O4TVA&L;2H>2>M7+=E[&O-_>9%
M!L"LLH=9- 1X#JM[K<U;7<>8=?8CL<-1"9 O=OB;7DZP5 UTBJLQJ^,+A=Z]
M#'B15211>WVTP$73V3IP/A3^4EDVP&=J( &HEDO>_7,6==A.ZB'V#W2XPF(L
M4S5@MCF-S!ARG?.V?S9BV#]^;UVNV^Q,9VOH5>=</&#YI8D&KA8&OB:%52,1
M53?(V\;?"("4>E1F,0[?_"0VT_'D/*X" _7^O5H;Q=[X?]ZGS%]H[C]M/Q_X
MW\>?''X_$=?,V\+>X/B$>E+E\?'P!^=QNVD?&  (<&'YW_3  YXYY  ^K7$S
MF]K>15:_-664Z5V96T178>1FI%1MN$VW.E4(R)9+/WAFK-M;C*NE$6S=4R;=
M,AE5C "9"&.<H#UW&O4%W99?H%.RE1>EOFYY3[]78VU5E[(9ZV\P4@[AY9HF
M\C7#J(EK2UDHYVN@K]-J\;)+I"(D4( ASKOA=XN]\OETI\Q\\@//\(_;5R(_
M$1^=_P"OR\O3C5W\,G?#_@J,Q_XQ^VK_ *7_ +^6JAO(WQ?X*C,?^,AMJ_5S
M;PYT_AD;X?\ !49B_P 9#;5_TO\ W^\.?E_#"WO#XCATI\P@/TC"'\)#;4 F
M$>W_ ,K^P]Q_'6*+[U*-SN+K-BVIW#I@9T83V9+>M1Z$U8YPP!+MY*PH1BDN
MJVE)",LCEM -",45E$GTNJT9&%,R/M_:"4-9:-O%WP&'D>E1F(1#_P H_;5Z
MCY?ZK_OY#[_JN#>/OA#L'2HS%QSZ;D-M7QX];>'^35/X9&^+_!49C_QC]M7_
M $OU7^&1OB_P5&8O+UW(;:@__P!O_?UXU0=Y.^$//I4YB_QD-M7_ $O_ '\]
M6FWC;WS@(#TJ,Q<<#QSN0VT 7N'F/BN)0X#[?7T[:Q71NI1N=R+<<IT"H],#
M.KZRX6GH>LW]J\SA@"):,)><B0G(U*.DWMF08SK=6.'VRCN'<.FS<QBHK*%4
M, :RO_#(WP_X*C,?U?YX_;3^O_-AV_?X:?PR-\7^"HS'Y<_VR&VK_I?_ -?U
M:H.\??"(" ]*C,(!QSR;<CMI* ?#DWSO^CWXY'S#SXUVS'NZ+=]9KU6H"W].
M7*V/*M+R;>/F+S*9\V_6"+J[)<3'7F7D)7[4ZG9%%L( 0Z$<W7<G P"DEX>1
M"0HYA @F*')O"(E#CGD?"(A_UZ\^'5OV:[C-R67L66?%.+$\HPKC&+C&47(G
MGH*+4P/D=SE>G71+,*24VN@LF*%:@W<:>4@.9A!1 K AQ([\)\5;X=H^[;<K
MN2Q7?X' <HZ0;U?$^*J]?Y^YU!&1PA/X;W&,\@VS-:*9'XNFC#*6.F3EA'?)
M7@GE1>C!RJ"0C[(?U;$-@6[_ !UE+/2TF$CM@E7>*Y?&KO/$(K4+M)YMR+(Y
M\M.3F>74H)511%R+2AR\;5Q>68@/TCG78-Q,#?V:.V.)NF1N<PK#6"O8XZD^
M6H6.M-\N>2IU$^(\;NA?6^_S"L]99$5'1%CD%[)JJ+)HIF*D@0?9)E(3L.5_
MX%&^#L'YT'+(#\ PSBK]7+3GRY^_N/(AR-/X%.^#D?\ LH66NWGSAC%7'/V^
MZ\>?I]P@/?5!V5;WP 1_.AY9XXY$?R,8IXX^(?TKV .?Q#MZ:P1F3;'U,*E8
M,',\9]0+*UXA[KEN+J.4Y$V(<9)C0<>N:_8Y)[=TR)-N%SM9B/AXD$%"^R\,
MH*AN 3UG@=E6]_TZH660$ _WF<5#SS]K7OZ^?[.-4_@5;W_7JA9:\P_[C&*O
MK^#7G]@?;V'3^!3O@_PH66OOPQBKG\/=>?7RX[_ >VJCLIWP?X4'+7?U##.*
MOAV#_2WU>?K\=4_@4[X!'@.J%EKZ_P"LOBKMY^H-?W[!Z=@[*=\  (CU0LLB
M'H/Y&<5A\>W)6P#Z>O;U^.L!1.VGJ;N]QMMQZ]W^Y3984BL65*T5_* X?Q@*
M\S?Y>>GV%@IX-CMO9)!$1C&)D?:")@_I\I!'PE -9^#93O@'_OH66N_ESAC%
M/IR'_P 5[^7IV'COYZH&RG?!QS^="RUP/D(X8Q4'?_Z+]7V?#51V4[X![!U0
MLM?'^PQBG^1J \?J[AJG\"G?!SQ^="RU_P#L9Q5Y\  _]K<^8>7'G]6G\"G?
M!_A0LM? ?ZS.*>W_ /+=O+GX\=OCI_ JWP!_WT/+/K_W&,4AY#W\VO/W]P[_
M  '6!L ;8^IY>JY;I',F_P!RIC>;BLH7VM5R)0Q!BUW\LT6'G%V=0M9E/=Q\
M!IZ)(@^.D "FD)S 4>.=9Z_@5;X/\*#EH./CAC%/;[0]U >1X'CD!YY\N0YU
M0=E6^#UZH66A^'&&,4AY]O+W7D0[>GVAYCJAME6]\I1$W5"RUQQW#\C&*Q-Q
MSP(!PVYY'N'8?V=LA8EVK;L*-D2LVJ\[_<D97J<0\47F*!,8QQ["QMA:G0.D
MFT>2<2F1^T!%0P*@JW\)C"  ;DPAS(DH<J:1SF'PE*01$1$>W >H^?W_ (B&
MHP]PG3T0SSN;QWN1;Y5?TSYI(4I[.4TM68SS2RV3%%@D+7C"71F%9)JZB6L)
M.O0<3<4@W4)861#,U'#0RAE=:O9*Z-)<GY(R!DV<W'RK:SVF:_*C5QC\9Q:;
M&JYZD$*FWL]_=-%)Q4U@J\J2H,P945VHW;Q!G*P)2:X@4X]ESATGL$RVTFKX
MCF9BONK[4&=>A6>7\@V*<IL.X6<9(5O$XFO"Q4^2)9GF9&8FT(AF9)RLW!V@
MU*X.JW24)MBTZ:.RA3V8#AQ-4WL_'R2^9#.0WM !0XCX;7W RAC*$.')!*8!
M*.N0'IE;*.. PSQW'M\^<BAV#SXXM?ESW\_T>_?C3\V5LH_WF@\^>]ZR+QR/
M</\ 99V\N?A\/77R4Z9NR<A1,?#(\%$.>+SD41#DQ2\ 'SK$1[#R/''''QYX
MUTVZ=,#:RP;9;"WQE;R@64S=?)JIN*WD^^2A*;1I)2/"MT>3.C;3%0DX($'2
M3EKXC>S,N @8_)N-D!Z9>R@/+#(^??\ S=9%\O,?]E7X>@=_0!X!TRME'8/R
M,B <=O\ -UD7S_\ M9W#U#MY=NVK3=,O92!3#^1@>Q1Y#Y\Y%^\O^JP.X^G?
M]H<Z]7OI6[;'N<\"6J$KL57,9UQMD^-R#2GV0LBM7F0)2SP4.WHOR6F:U&*[
M7K+]C+/E43+IKF*Z 4TE3$Y)L,'3,V3CW_(U\.WSZR)]_P#LK'Z^!#S^L.!U
M7\V7LG],,_#C_-UD3CCX?ZJN0'@![<<?KT#IE;)^!_K-#\0YO61?NY_S5CY_
M=SSY:Q?FWI>;2I7#&5HRGT>-H5PE,<W.,J=VF,A9":1=1LK^O2#2!LL@Z4M@
M%09PLJJTD'*H@8")-CFX-^B/[,7=,O9R&-L>)R6/HZWRR-.K;2;M,3DC(+^,
ML<JSA&;65G8YZWMIDW323D4EWB2P<>,BP&$"CP 9##IE[*  ?ZS1NW(<C><B
M]Q_^U8C]P?;]E?S96R<>WY&1Y\^/GSD8?7L(@%K^''8?J^&K3=,O91]$WY&Q
M*)3 <@C><BA](H@8H_ZK.XE$ $/0?Q#5FT3;E4=NV5=S3+'MAK@T.ZVFA3E<
MQY%VZ6LDOCP\10X^"G6U@93<I)O(5>>G6SB60235*BJ10#BF503 $@&K1*4?
M, '5/9D]"A^ #^T!UQ,S78&Q,?DR?AXR;CO;H.?<)9BUD6?O#98CANO[L[26
M1]J@NF15%02>--0A3$,40YURA$4TRE*0A2E( %(4H 4I"E#@I2E* %*4 \@
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M'WB(_?SW^/;5/9D_VH=^PA\0Y >!^\ _R<ZNX#X!^ :IX2\\\!S^X:NU:<1
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M421C&MB6<&9,R(39E;I$*4A2$ I *!2@4H%*!?T2E  X I?[D \M?;35!$0
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M^O+5EN^;2:\2=9LV5DTG(1<B119\R>"S:+*AV.>ZPNP>M0-,N+W,CI_7KM2
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M\%*'(B(B !R(B' B(^8CQVYYYX[:J!2@/(  #\> U77R6#E,P=^_A#SXYY,
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MLE&%DEDS'<$ A"RT@'  'P  [>6JZ:::::::::::::::::::::L4.4A1,81
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D'[V1EGWLP<R$E)2+EV_?.CII(H$4<.#@BV00;(E3013(7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g729258g02m36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g02m36.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2$,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (/"^A#(X0DE-!"4      !                      .$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0&G/A2         *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  @.__C4  @ ".$))300F       .             #^
M   X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M"0           0 X0DE-)Q        H  0         ".$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             "&P
M!18          0                         !              46   "
M&P                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "
M&P    !29VAT;&]N9P  !18    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   AL     4F=H=&QO;F<
M  46     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
M   '.$))300,     !;U     0   *    !"   !X   >\   !;9 !@  ?_8
M_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X
M @ )  8 ,0  86-S<$U31E0     245#('-21T(               $  /;6
M  $     TRU(4" @
M                   18W!R=    5     S9&5S8P   80   !L=W1P=
M ?     48FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA9
M6@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&
M=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#
M   ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=
M  !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD
M &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ               2<U)'
M0B!)14,V,3DV-BTR+C$
M                         %A96B        #S40 !     1;,6%E:(
M                  !865H@        ;Z(  #CU   #D%A96B        !B
MF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@
M:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI
M96,N8V@
M        9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C
M;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$
M969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M         &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO
M;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN
M9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M          !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %8
M65H@      !,"58 4    %<?YVUE87,          0
M      */     G-I9R      0U)4(&-U<G8        $      4 "@ / !0
M&0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"&
M (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4 ZP#P /8
M^P$! 0<!#0$3 1D!'P$E 2L!,@$X 3X!10%, 5(!60%@ 6<!;@%U 7P!@P&+
M 9(!F@&A :D!L0&Y <$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"
M2P)4 ET"9P)Q GH"A *. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M
M S@#0P-/ UH#9@-R WX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$
M2 15!&,$<01^!(P$F@2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&
M!98%I@6U!<4%U07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'
M!P<9!RL'/0=/!V$'= >&!YD'K >_!]('Y0?X" L('P@R"$8(6@AN"(((E@BJ
M"+X(T@CG"/L)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*
MF JN"L4*W KS"PL+(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG
M#, ,V0SS#0T-)@U #5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/
M"0\E#T$/7@]Z#Y8/LP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,
M$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4
M:A2+%*T4SA3P%1(5-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E
M%XD7KA?2%_<8&QA &&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:
MQ1KL&Q0;.QMC&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY
M'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB
M)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G
M)E<FAR:W)N@G&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@J
MFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MM_ *)"<H-;'!)28T-SA(5='A0D968F6#A=/Q_\0 &@$! 0$! 0$!
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MX>0T<L@1^Q3+&,73A1BH<[9VL+E,X 29II^KSZ5[T2884P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P&!\7 K @N+<I3N 14% AS"4AU@(84
MBG,'F4IC]T#&#S !$0\PP((*;S<[2ZT<N]U<9%-8\.6K#CU7J3L/:=U"V[.%
MC%TF\N'SR/CF1Q;BDYMC:MQZ\H\;* DU;JBFF?HD<IQ"P=@[;W?$;K'A[=X[
M1^M7,KR5W1?(NQ13B;L9$J=H&L[5@]:0>Q6HD,"SF2G5987G1QTC4S^$F0!#
MO!@7(L?;1W-+?'-J$JVM*2^XX\4]#7V_5W:,A*3?O:^["J<DA48^* C508HE
M1E+Y[=!DD$1]L6(S,=#J<.H3.F]^O(TKO\]+-SI7M8^19]QZ-U_O6A\=[M"[
MJT]<=K.F/$:\6#:^R-7(U.M-[(5E>*N'MB2?O@5TX&+2073<.9U4K0O=$@F%
M7EOWZUI[T=],M)OY_,<\W.SZYV7KG#9.3+^1TS*:<U]I;9L?JRKQUP5,38\E
M/M89"7LXW"+046C81=J20BQ;Q;5=9PS!PHVD% <$$@5,*=::UM/[KR2:84P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P,#N;W$&P\H&^F+EK79@
M:AWAQPV479NI;L]@4+57D)=Q&JPLS%62NJJ(A*P\O%+';+$(JDX14[BJ1@,4
M,%>>ZY],_-F/%N[-/9&X^/FRZ)OSE5<;UNV^;3HVZX'94=!M(VFZJONL'J4E
M06E U\<RK%K5F#M(#33!VLJO- H=5RJ"P%-A*WQOIAUZ^-;XN#4[-[?&SY/8
MFU>2_*"-V9R!D-'7C16FIFM4$E/UQI^!V"S(QM]E85=%VN[F;9/-RE1=23QU
M_P V;E!%B1(HB("L6C72<ZWM$8:WZKY\(>,/*?B["T[6FQN0^OMD:5USKV/H
ME.I=7U(WILNR&+2;-(F1>V C]RJ[%)%)7VE#PP%PJL*YS"8!$1;E^-QZ<EDI
MKLLYRTZ!OO'VR[M5_#N^^3]KWER3G(2(=QL_LBD3\X:5;ZN9.R/!&':F9(1<
M1)RPF456:,S @5/Q1* K'B*]EU^,?9L:\XC\F;;NK2MGL,=2KIIN$U?/4"T3
ML_<7HR-7G%G]?F&-AG7[M9DQC6"ZD8A!I]$&Y1[Z7=+^S@B:]NO3XRYKY<..
M+:O%RF['AIFV)WRX;4W7LG<UMM1(T\8+M]>IQ1ZR8>S"HMWO<D4#2+(L)^\O
MX K@4O>Z )]KY1A'/E:O.]\,Q<*8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQCVB-62P#U !Z"'4.O0?4/W#TZAU_GA3 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MSQE</"F!&=5O[V[:G^A)1_\ >LO@28X# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# P!YV<M;QQB9Z@C-?06IWECV[=96K-;'N_9"6L-9UQ.
M%KK^R+C+V$6SQ<9&318&CXAF1$A'#U0I!5 XD3..Z_'&'9EVVYI^ NU^6U(M
M9Y-:3([5TE=S[%UX=-L^5;MAA[6+=L#Y4J2?1\F"75LY Z0^1>HR.>_/-,Z5
MRGOXPF/FW+(0"ATZ#^UY=!$0#J;Y]>@ 'F/G_'*1%(IO?+)7N@ B( '4?4>G
MK^7GA4<7'_\ O%.>W^8?%O\ V'?\F<SRCTK]I'SQ>\I'LJF P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P&! [VHL/8[ER-T[6]&M-[N>0D7
MI/8-K?N-2[[C./D4RTJSLL$G.IS$^_CWJECF)"R!&DB(EOW$&9DS/GJB*1"F
M%GY^,MT[I%<YC'3QG/YM5)?P>ND+L;BEI.Y5Z9V#/1DQ4TQ]Z[4FB6;8*[UA
M(OXZ40M%B2 $9I\RE&SQHG+-NK9ZV;HKI"*9RF$E)K:+3C,32]<:7K.'7.V%
MK- <HMS[,Y@\F] ;%UC$:ZJFHZKKRS:^4),)S=KLD3;GMC9C.3RS508J/1E!
M@A<QT2B4[EBW, .W)UE!(D6<,^V.^6>"QT'SGW>CSRM6CMEUR!UAH)M9+14M
M83=@UGL(;#N.1J=&):Y9:GWE.4"J*+MSE>"C%# JJRK=BX1C'"KH (:;CGNZ
M]\?3'>Y=4XP<A]9\CNU*W/;-7N[.ZA8CAU2H9X>TT6X4)Z1^GM%90Y4HVZ0T
M%)N6_<$.ZZ1:':F, ]Q4W7SIE6;==TS318# 8# 8# 8# 8# 8# 8# 8# 8#
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M?4OIK%OS2F%^S5*:S]XDL"87J^,0L$/!0HF939$3Q P8I']YPYC-A%I)R@)
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M@'JAR#"]"5@ $W=LH"9R;H #%%Z^3>_5)[]JUW-)OXO26I*6VV==F5>GU1%
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M..FR*Q?H!)'?E76,9!OX/0PORB]ZS7/*>>4<^5)[)%O;JM:)9I+0D,RJ2$+
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MDH>6!'75NG^5NVIZ?^Q)2!#^/]*JP"/\>@  C\N@8$F. Z!UZ]//TZ_GT^6
M]?7!BH  'H !Z!Y!T\@] _E^6 Z!TZ= Z>?ET\O/U\OW_G@5  #T  _AY8#
MH)2CZE ?(0\P ?(?4/X#^?SP4C3>YGRK@4Z!UZ] Z_/H'7\@]?X  ?R# XJ?
MD'<1!S$JPB'D^^C8Q^_9P4<HV2D)ETU;*KH1;)5XLW:)NWZI"M6ZCI=%N554
MIEE2)@8P!&Y+\\M_5^*DIZ=[.#DE#0<&P>2DM+2-XT2SCXV+8H*NG\B\<J["
M*D@T:MT3KKJ'$ (F0QA\@P;\[]F/_'+MFD^7$39IKCCPQWGM>.ILRI V8T!>
MM(>V1+\AC%2.Z8N;XBX]A>"FL9A(D3%F^33\5JLH3O"44]+WOO'EIR24<?\
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M)HE\G!_@?Q?Q_P L_P D1'_4XN*9_M%(BG%>.=8RFLS-IN^F_D_YA_M/YO\
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MGWCF'H CUQORFEL[VI>->4TMTC&KL>&C C.JW][=M3_0DI'^]9? DQP& P&
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M*8$</'_^\4Y[?YB<6O\ 8>P/W?\ C_C^4SF>4>E?MF/GB_\ KK\=XSD>RM&
MP& P& P& P&!#OVHA]\Z"T?OKEOKSDQON(8Z^J#62B-)Z]@M>N84)!(Z,>5R
M:3F*=.S2#%59R60EES*.O 12,5-,@&\A&-.>N]>5,K40)]GUVFFZ>2'XSG^5
MW:![4XIT.FZ[AYDMELK+5#:-N5PF+P\KC<E.D):@-%I&,2CFQ?>#!!BX6:2'
MB',Y!N F#I/#Q?UK$12V$5F\>NN<QKFL\?\ +'^7_P!O/^/$</\ 2.**\,UX
ML*17"O%'%6)G3";/4%QHU%L%E)UK;GQR;0Y*:SL5:5>0,1-1VM_P78&<PFBI
M'6%K+U*LQSU=1H0AS-/"?%;*"J?VA,PE*!.$QQUB?[13.*>VN.E>]*9F.*./
MBCBM2?\ UIA><ZTK7TRPIGEFU,!@,!@,!@,!@,!@,!@,!@,!@,!@, /3H/7T
M_/KZ=/WX'GR[7I+8KOD'QB0HMAI\_(!"R4A6-/VW>Z^@TE[(QM409>[1LL[7
M9UNYN3P1WM9/!/72LG&$>EDXQ@X-WSD)%[ZW_?/])<^'5$V)K+C+IVB[3LR%
MOOM>JR;6PS;:9<6-NH=9\]=LV"-@=E*YG"PD>X9PX2J_];(>P"Y,(^( B,YZ
M_&?/XHR:PI@1G5;^]NVI_H24C_>LO@28X# 8# 8# 8# 8%D]\:3B]]4E*D2U
MXV506J<U'3 3FK+:YIMF,LP!8",CR[5%<XQS@JX^UM12[JX$((B E#"8=:Q7
MTC.<Z4CGW8?#V8]%'_WFN:'[O^L%-^7[O./'%(T5I'LQZ$0!,;DSS/[I0$QN
MO(*: !  $1[P^[P\NGJ/4  /7YY*;QYY\_:-(,+Y,">SOX%T'9&G=C3 \B>4
M$8I&\F^0]=*E3MZR,>R52A=CRK%H_>(-6JZ:LQ)-DBNY1Z<2J/7*BCGN% Y0
M!2)QC>\-$F:6UIEGI7GZ9Y,^/\F11@_]YOFC^X/B"F^G^'NX/+]WEBD:1X5<
M?4/!JI:?O\+L"-WKR;N+N&,\*C7]@[@E+/5'QW;=5LH9_"N6:"+SP2*>(@'>
M[J*R95"@)@\[2-$K6T;M$U]:=\&<V%,!@G"=_7O"P&]^,NF.2T7#0NY*LYM4
M9 /EI&(;M['9JZ=L\<)@14_CUN6B%G!#)D "E<*JIE$!$H .$SQIX]/-.T8Q
M+R#?\HFXINN+T5QFEN&E.VQ3X6Q/-@LMFR5)M&QYYD=][12V5'9S+Q[-RJ<<
MY=2#^09Q:!%$#R+AP=$A%SD*0"QOGSMJF7[/SLU./.PN&/'JX[_U-<W&XK)K
MB*?[!7L]]VC#3BT^X*J+I24BDK6S39*J!W!\!-JAW [O[ =<;WB;WO\ ,W=2
MK,/2*O6Z=6V)H^OU:&C8"%8^TN7PLXN*:HL&34[QZNL[<F;MDTBBY=+KN%^X
M914YU#"83-:4SKA2,_.=9GMF[-AHP& P& P& P& P(A.U8M41*4&I4JHVARQ
MVNSNC0T0JVV]K?7%/J$F\B7KF)E-RLMC-Y6'L%/<)-5EVU>]R.Y246;]Z+,D
MJGXQ1'/<5[>*LQ.$#_9+_C5KG^EW8FF=IWINR=L96XZ$:)-M9OB,WBR31M#)
M-UEFGM#!L5)M(JM00;+OD5U4&C8IP2*2VLXT_&E]?$HN^,',+;TKS2EV.R]S
MO9"GV"7Y6QVQ]5SPPD?5=#0&E;S7*[JF>9E2CF\M7_Q?$2!GCUU8I9TA8%)5
M-9@5$C8A1;WOW7?WOW=JI/(C>3#M#[Y7)K9[S;5/O4_M*'TEIW6NSJ>[J]*#
M7.LH&8)"[8JIZD6>K3V=DR23N.L[NT U))R[!JLR,W[@BWOQ[G:=\\+:1-O"
M[/!>X;0NO-OGC/;>U1_0U;S57C.V-3!N$-=?#CTH2^ RD??4&4K 1?=Y01;=
M050\,.\4.\.3ZCYY[UG*3I&>ELXK[_F)HEXRJ8# 8# 8# 8 ?(!'Y?+UP(\)
MCM"FD1+RT2/$7FW(#$RDC%C(1G'JSNXU^,<\69B^C79#=QW'NQ1]H9.D_P"K
M<-E$EB")3A@<#(]H1"2[%Y%RW"KFY)QL@W5:/H]_QJLCMD\:KD%-=NZ:N 41
M7153$2*)*D.0Y1$I@$,#SS<\](\>>?7*1&C2W&GFGI>%U_QKKCBC0NKN-[MM
M/PDB[V?*'G))WKI--DR7K$HQ$L<C+F50!.735*B*BA1+BLS%)K$:<ZU[WW,-
M?WX_[?W_ +3_ &P_M,S,TI2E9K6.6')-5QDY+4+BEH+5G'G7W$3G^_J&IJHS
MJ4*]F^/EE=S#Q!F9155X^63 J)EG"RRJO=1("*13@B3O=SO"W[8,S,\4UF:S
M7&V-XGOK^V257Y^M[/9(*NAQ.YI09I^88PP3,]H*R1L'%B]7(V"2F)%8YD8^
M+:@J"[MXH'<02(=10?(0P>N^F]$A0>0?/]X^O\\!@,#9%,;Q#=0/T.01$O>'
MJ7NB/00Z]?(P>GRZ^?RQ-N&NE=*S2^GW[0Q_Z\<\,3$Q-)\Q7K7'KZL,N3')
M6^:4MVKZ]6-72EYC[;-MTI^18.FA$H^*4.I'J$6%PX0/&G)+/8+I*NBBP\%=
MRB/]=X>>'^;_ #H_AXN'AC^.>*>*8C&(B\S%+Q:-9FU*V?;_ /&O^,_X'^\_
MQ?\ ._F_RO\ 8\/^'_)_C_QSQ?Q1Q16O%$1Q6O\ ^7%,<,Q'!%)F:7BLQ.:3
M151=JV662\!95NBHJCW@/X*ITRF42[Y?V3^&<1)WR^1NG4/(<]L36(G6*Z^N
M;X[^3AX>#CX^#AG^W#P<?%P\/%2G]N'AF8B:3>*Q%:9-QE8,!@,!@,!@,!@,
M!@,!@," ;M+GTOR*F:YJZX:8Y@R^DV+R[0MSI.F=#4BUV>\.8%["%96F/OEG
M/)RM+JCQ*15:Q,C7X@KZ770='2D69VQ"GGFT[ZPD<J4RHEFXBQM0A.-NGX77
MU/N]!IL14FD= 4[8SE9W>JZQ8K.&WNVTKN7D@LI+)JIJJ+E.[/W.^1(O=*3P
MRU)K$Y8:7F?,3:*=NSG:#R4T+M#85TU7KO;5,N.P]>*K)7:HPLRW>S$"9!?V
M)P#E A@ 2L7H@S>F;"X!H[,#9T*2PE)A<._729M$U\1=MFW*#0#S<SCCXSVQ
M4'FZ6A3&?:X;2)E[$S\-F62.#E!)(R390D>;VL&ZZB:IT1 _=]!P?K?7#Q1B
M;5@'_*V[4\O7A)2.G[_^E9?"I,<!@,!@,!@,!@,!@<3/2Q8&$F)L[&2DR0\8
M^DS1L.S4D)9^5BV5<BRC&"/]:]D'()>"S:I?UCAP=-(G[1@P(DM^<ZEMJZ2V
MMK:H<<>>U"M%[H5LJ4!<FG&:\IN:U*S<.[CH^9(=(@K%(V<N$S'4;B5PD0#*
M(F*H!# WO?1.M*3%,:W^8IG6_E"IV&$5R#[.V*WXKR(TIS;LB6RIN,3K5*KV
M@=AST2R"#<R!G=^<+/B]Q.=MY7J .&Z*8./ ;$,_.98 [C?IZ;SDK'+&W7"G
MOSQ>ISC_ ,CV7(!O/.66I=Z:L+ K-$E$MTZTF=>*RQGH*F T&68$!DDVPI"#
MH4"B"0G3*(@(],%_U-=,=)Y5PK:6270/D&%,"AAZ (AZ@ B'H'Y?,?(/Y^7S
MP,)-T[QY?TB^/J_J3AB.Y*8W:1ZS.\EW=1J2#YTX0[[YJ$#.)*2"'L*_]2"B
MH]Q<O[:8]/+#-)U]ZVPSCE6*:ZK4_$]VA(CY]F^8.H=.OQ,ZN'H'GZA[. B
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M<?'PQQ1''Q<$3-_Z\4Q:*3%=8C*L-Z'0   Z=.GET].GY=/W9O ]3 8# 8#
M8# 8# 8# 8# 8'EZ[5VF0&O.85>N]5CM]VN\;#U*[<W)K&<M);06OJE5G=XK
MU50=QCM1K(E29+2RK5Q8V#0$(:,;@2;>BDIWC&)$S2\4GMOYRP33]G2ZJTAP
MKT$I2*^%2K9J>^;M8(MO?7Y2,=M[!,MI)/\ &DBDDZM"II1)ZNI-G2*B^54,
MLU S4R1L&=/F\[QM-81F<6.+?*?0^]HZ\SFD7+N+X[UGDW%,I6&MU7*ZY&/]
M\;E;WBM+Q)E%DEV!X*!,HO,*6<I ;OV@-FQSBJ0 E-Q2,_JW:USEKCTI3?>5
MTJWQCWO%]H'*[1U_KB_:EK=WV!=[3O+9S_:<#:J'L*B3FN4J_56=0I:C'WQ5
M[Y$6%%FLDF*(MHKW<JX5>OFCWV8*5I%YKEE%9W6SG^,>H9C3/:F;EKTUN/:V
MZ5Y+AO29)*P[;E(25G&*8;/52-'LG$' 5]H5B!OVRI&;**%-_:4$>HB5-!@,
M!@,!@,!@,!@,!@,!@,!@,!@/0/X!Z!_X!@;)R^:-2=7;MLT*<1(0[E=- IU"
MAU,4@+'3[P  =?V3]>G7TZ".$[TGS2:=NOX>6W_E+7.?;G&V@<<-;ZG_  -)
M5[;5FF[9;UIF+6GWK>5TY8Z!;:86,<-)1LBQ:N)05"RJ*R*QWK4 01.@<3G,
M.^[T]^]$XG 3D19.1G#SC]N_9C^JM+SLC7D39;*T@RI1$6E)O 5!1)E'NW[I
M=FW3 A *FJX6-WC=>\ = P7KK'7";Q/ZURQEFLFJ18B:J*A%452E4(HF8JB:
MB9@ZD,F<@B!BG 0,4P")1+U_+!-:Z1WG.VG>\]*5K]<*8# 8# 8# 8# 8$)?
M:E3MLCGL))[!TYI%_I6O(R,16-G;#Y+*Z9EW$_L.N2-2L=81BDH5^=^*\:^5
M.T %%!*Y01>@1,&HG%OH1\TP\:[TFS,+LXZ>C2.*U3B"H,D'RT]<9&;79;9#
M=8O9M]9I)24>.]ABQCB2D@9YX@/&Y6#<8Y9,S(4A.D)C$_>E/;?)GD'7IY^O
MY]/3KA8PBN.9@1Q<?_[Q3GM_F'Q:_P!A[ R9]H^?PD?/%[RD=RJ8# 8# 8#
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M;S.]V>@,H"4I2F,)Q H )A  $P@  )A /(!,/F(!Y>?EA6K 8# 8# 8# 8#
M8# 8# \\O:'.]P5S<<7KZU[_ (&XM-OMIAI7=9L^&%6VRZH.JIR080+LURML
MA8$3MJY+606$0D=0J"DK*+-4B-SJ(@<"1O>B6OA#+UV=XH:1DJM.14] ?@YN
MU92D-2&VMX\WNU\\8.69*,T450K+B+>MG$6]C"JJ%2>-7)S"85!$1/?MV]>E
M,;7BK*_"J= ^0?/T_/YX$9]6 /\ *W;4'IY_!)2 Z_GT_I67\L"3' 8# 8#
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MY93GV_69\=/#3ZHM%_<JK?J6"L<_$_35\<W#82B<.4&C1* @ F_I)JW= 1]
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MMI/Z)@:B<5.,21R*I\>-))J)'(HFH35U**=-1,P'(<A@A0$IR' #%, @)3
M@(" 8%^4DDD$DT44R(HHID2223(4B:2290*1-,A0 I"$*4"E*4 *4H     &
M!],!@,!@,!@,!@! !\A#J'R' = ^7R_U>8?X#YA@,!@,!@1,\X><VP=)RVR=
M0TR#@HZPVO7Q8S0^V4;'$2<(TWJZ1462U7LEB8XIZYL=D8"FIK23LYV\/890
MP-3'*HF!#M[]!]NRRV3R?O5'O;;?D=M=S#1LHS>U>P;NA$X#8+&2E0<FG-=N
M3)I(I6EE3!:MC'N"**#)^ZEC,HXJK5F"F$GIE>V/+?-+ '3H'3TZ>7\,*8#
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M-OR]<WH2O47I;^/EKD85'7E-K]"%\UV?KNT,T4X[9%9V>1%464W4Y(LBZV+
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MQBX] K:/CF;9@Q;%$YB(,V:!&[9 IE#'4,5)%,B8"<YCB!0$QC&ZB(;S 8#
M8%##W0$WKT 1Z?/IY^N!YL+IO:!YSV60WMKVY[(@^37$.XJ6G4O".SNDJ^G+
M*ZKL4FQV3;X)FQ.W':87^G^T)0,BJ1RUKJY&L<1 CITH8P23:"X!\866RF?,
MB,J=O>[7O$Z^VC5)"^2$BWFM3,;]'HNYK7]=AA\ M?@C.W"SB7@E45$U985E
M5A$Q2]"3?"DTM,?/6-Y4DJPI@,!@8W\F^3FO.*E :7R_EDGA9VS0]*J-=A4
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MD<^UL-^E:),\Z?'/\X5\,\! !\A !#Y#Y^@]0_P'S_CE4P& P& P& P& P&
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M(?F64EYV-526(_DX)JNL=W6*J_55AZXX<.3-4% $A2DY??//?K"3\ Z  ?(
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M1$96;:O.R%?0@ 8MT$WX*J%,XZFR4WT3=]^N'5)7E4P& P& P& P& P& P&
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ME;Q5XF8C4:E=YB)90SN;*YCA7FF2:#!C'-7;2&>@BW0D4VI <&752$YS-S=
MR#P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P&!H4225*!54TU2@(& JA"G*!@\P, & 0
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@4FFFB0J:29$DR^12)D*0A0Z]>A2E "AYB(^0>N!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g729258g03g67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g03g67.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[15X4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %5R^5&@X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!HF?/         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              >0   39
M  $                          0             $V0   >0
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   >0     4F=H
M=&QO;F<   39    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   'D     %)G:'1L;VYG   $V0    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ /@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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MZ"!R( YJ.8<P)+14?7U]&?G?EE\H& [(2X.K\WFP:R]M!LJHLQ*96L5.4-(
M]?)EUTD3BA)KKHD7-E6UPB2NAVGQFHS!2:'L9*QQ@E;<2C6OF.IUKIXZ\?\
M'EXF3/IFR]RY6FKA+CUZ+:[8S;Z^Q7<=G9A#4IA^ORM;5J;LU3WL#KZPR%1
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M&KLEWTB\/M3F9,Q+$0EE9AMP:X\N2\WB1A'Q.R^T,K*OLKN52JJ6Y*G#NV#
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ME=?).]*;X GD1Q;CU%/#(6FTC2Y:8MQ1@PKL>TUA'<;5&<JPK#:+>R0"&7>
M:I\I'KX%U1ZY[E[)2+5#MNS]&@MP7V=K+2^U;K3J<!?94D]<;+.I5;M@ZD5$
M;(:?4_)/EVW&(K,B5A+L6,^^U[L@54W&OGP1*L1WMM/"I&RJ49%:Y@M:E["P
M52VU&B_%2&/):W;EQ'(]_D55HOM6OW+D$"M>3DA"I)UIB2%V00+"W'O;UGI>
MP*[K.9=#EAL]@!4^TO9H&O=@[&!5.K;!>S'HMDV!9:/63P&AA+<]C/T%/M)
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MR_B(XB.(CB(XB.(E9NQVX]FZ<8H<VBZUJ%_A7*[UG7TA=DV23H<@4?N)B,'
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MV5JPD$H-JUC1[O6]93]O$=9[U*=K>P$V6P]; M\'TDLQUM)#YNM:];XT6YJ
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MHYP2Y$@AI 0BY.:W[*M@N]@"W=F6YMR-I4TO9-6<<D6:++0&L:S'3^HZ*J9
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MF!6DR%8:]AK(.2A*BW#MKJRJ=CG4;Q::2=$JZV=Q:I*,W=O6R/IM;\Q/LTN
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M49U#\:5ING28S[2L*:?CR!R'F'FU8\<*;=:6AQ"L9SA2%8SCX9Y3_@?V^O\
M$GKKU/IZGT^O67$Y(CB(XB.(CB(XB.(CB(XB.(CB(XB>88,BJ^.E%S9"(+&0
MF\NRILUY#$=E&/RJ6O.,95G/@E"$^*UJSA*$J5G&,HD.**W;:R_15O)"AZ]<
MQ_5;5(8PQ;+1&5\,IK8^2C*P(YY'CYI@BSB<ZA25PX;>/![*)*-6J%>I@Q F
MNC68$;SE.ON8RIV9.DKSXNS"$U[*Y4Z6\K.5.R)+KCBLY\/'"<83A$R!]EJ2
MR]'>1AQE]IQEU&<YQA;3J,H<1G*<X5C"D*SCQ3G&<>/CC.,_'B)#&L>N>E=-
M&#)_65"&U(O86LM&YL&87?<*8RIA67)B2!&6V])5ZK&0J4I'K.6H[+.7<M-H
M1A*23X_XDV<21Q$<1'$1Q$XSG"<94K.$IQC.<YSG&,8QCZ\YSGX8QC\N<\1X
M>,KA=.U>H*H9>J0@H3V7?V\Y0F@:K$3+Q9$O?#"6R/T0AP2 3E><(4_8"8MA
M&<Y\YS\57AY+,VA&**6NM\JJ%-C_ !X^RH]2S#TZGI/R7:/VU[!P<AL&BZ[M
M?M1>G\+[%HL[2S QWH7#'#4XH)Z<\NZA ?%NAUA&'^W^W',^KQJKU?IKWPP]
M.^C]G[?F1EY\/%$-K.*#57U(QG/B](M+\=2\)]'YZ,KQS!SK_ )AUG_Y:NO(
MZ]= ]VF^GB6(]\^=R^WG;I]E,+[&=GL?Y[#3VUV_8A\N[7_Z5@/KKMG[1*[U
MK8Y3+J?U,U%73C-QLT(SMN_M>:O%YVX6>NYF,_CQRIT-!(IQ7ZTGSL^+;->#
M#$-)2A*?'*?.SM,&A6[QPU]O3=E[&QNGAQ#>RNO+BHUZSWX'V(["Q<E.T,RO
M([=[54AAVGV[>W:.2CZT6QJ[0,3"!WT3#QZ% UH;&SX?;I"&ZQI-"$(0A':#
M0*$(2G"4H3B[1L82E.,8PG"<8^&,8QC'ACPYZ]>'NG[!0 "   %T!KH/ #0\
MM#PUX2VO+)'$1Q$<1'$1Q$QXW4JI9I(2;8ZS7K!,K)))FN2S84:5DU\PAI;"
M"H1^?&D.BB267'&4SH"X\I+3BV\.X0M6,@ &#@:=0RAQT8*PTP#>(##HP!T1
MX[EV>)79XL067?LDJ=J2/ E2203X'PF0\21Q$UQ7_J3V*WILW7R]\;\US8-"
M:IW="WA5*12-.3JGL4V7JLLC-UU7[;>YM\/"D"*L_.944DURKB)]J3!;9F.0
MF),IMW%*<7JNN/>74U9%:< $K9\G&NQ++74AV)[F]P*U8('TYV %G2UU(M2E
M#75;W);FQ>Q.ZLKN*HP"+IK:U/)E+*GLC1):1QJWR<VQ*05TUK>R;W V?J7U
MRW<>WQJ#5T76[XO9+UCD3[<:I%:OVQW+9.%FJIK<[=2Q(.V(J <D9]1 L%Y>
M4#7%2]XY>HXMEKM9=A8;8>.X)12AQ#V>EMJ^T6M3 9\<!72LLQL*D^S&18+6
MR.[45IF7"_)!]I@PR$RVJI8<0M3Y5:6MM2X4=R&X;)S3<G0>Q;I(;2V-9ME@
MI6YSNQ]:G=3E3-2E'M?ZZU;IJ_BK[3-33:G]-#)A@1;C0O)W:9"(7&3+"?D0
M'(ZVQ]9!Q6N:(:UK92K7?>3DY+6#FENJ\C&HI0=#75C8^0S4ZZ_>FLR&!9P$
MVUJMRK*L*!CBFM4(5T=VHNON8Z(L:Z^D(P8:^ZK72-:8MZY/H;,)](1W4A6Q
MX$4MB^U[8Q>[0ZFN."P:A]@8&_#HNO4]!OSPM==(,S*Y71ZC4I088N&Z\[.7
M'<;>ZU\:7[+X<FK[,/9_#F0;+DP%10+'  YV!.K<2%Z#B0)EK2]F;:ZHK9HS
M>0K'%*VRUL7:J=["%]G9!<\CL%MB/>RGDWI&V.Q=H[$T.9UWF&=DZ]I>O]@5
MSLEUZB[T%0UZ_?L&*W;]?24VRISZX7R-LDT:=#2WB($ZF&)E2&&'X2LO<*JS
M4V2 5[O)N7)8Z_%KN6FK'?@W\K5V54U HZG@Z%U)YL(:T,N-M27QJWH'M:2R
ME[3< P Y+978[D.K#DK!2!Q#2/MK>3 VU:0/8K56L^Q=)UOHGM%*I-LV13\Z
M3;*'@=[I]5IM8D,Z\*1;H+"5J@V9N@UAV77'0$^>!BQ9<"OEXB93<B+T4/RK
M%KM;5C]ICM*@,Q[TL<VO.>FZP[+K]X5[4=0K%K"KAJQQ.ENX>TBA+&[-L[/L
M(UW8#XUV+WU5?@K-3:4=6+KTY+I],/1[#>31W!M@AVBK5 [(U?7NG>W7X+S^
MTZT5U$JUW.'=-75&J4Z,NJVKVR$CX%7M8^CUAT_!F )IB(Y$G8"%X*R&'XH
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M>CO^4MOVN(B7OCJ[?&P]Q=$2N@B3=6L=!W3LVQ$[\5I6;Y3JC DZ#V('BIO
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M9"DX<QG"4:Z[\QK]=^A]/KQ%M14F;-%CIA$<L00E08DB<*<DL3%C)CS#;DF
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MOQ7B."@#8[7CYK32$82G'2O"QZV[PJ;;>GXMQ[Q^GF"W1??P"CW3Z'9OV*[
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M-VEVOO77E9>Z]Z1=PTR-C S%]VG8AX2C@S MAN%/BP(85PC9;:[#6A+B\0H
MV)GSTLN3&WL.-M\Z<Z_+K#XN,1OHSW.%K1O,#CMK-=#T Z]/?/!V7]N>V_M9
M@U9'V5^S;(MFZ[^TNV\RK'[-Q<A#QMJJ3&-V;GM4?YC71CU'H.]#;59-1U?L
M.PTID=DMO6G:#+B\/+U_55/ZSU:PK.<*]5?#5J8T?LT9OXMX3:+ 08>3XJ=A
M^=G'F]?N;6]<N][A_P#B3=-(Z@]50AGT1_W-U'B)](?8W*[5 ?[7=O9O;()Y
M'LO!+]C=B*?_ (-C8=BY696 2I7.R[T<:+5[EF*?1J;KX+&KM&JP&I XB$H8
M%U\7#%0T^;C&//4S#::PZZKP\7'W?/><5G*W%J5G.<^RNNNI0E:*BCP50%'Z
M?WG[# [.P.R\9,3LW"Q<#%K "48E%=%2@>?"M5!/JQVQ.R229E7-SVQQ$<1'
M$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$
M<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$3RSDMV
M$,3V90Z"]"%D);4TPM38B&[&B//-RBCB%MK;'1U(P[.6AQM2(R'5)6C.,*P@
M>(_QX_"?SN^2+LL#9_:SL!?25AU?:SZ15R+Q2^F31TYIZ7,OMS!$KD;U7/M.
MPI%GE"SI,9!?-Y):YP,B2VXL2OVW$)*X$E+U^ _N=_M^7AUFU;MAK#<6Q[EI
MW\% V<(^@BA(F:VE OTH),IJF&T+$#8U+^D8@NP0CI+T'M23FPS$F/5X9((,
M&*FFVYP] \_K_!_QUT?*83HW279BNZ8N%=D;#G:3/3KB$+@V2KH[?<X>'$:Y
MK=?O?I)]GFY8Q'V-L4;8[Y":3+6^)C%F\JCPI9&:.@H)'I\OT\O+S)WN2EY/
ME#K?2/J\V^_ZR^WING-OR?1(8]9>0.0EV1Z!O.6V?3N84[Z%O.6VO/\ ,1^*
MG'$A&B?S/]_A+B<1'$1Q$<1'$1Q$^;KK3#3C[[K;++2%..O.K2VTTVC&5+6X
MXO*4(0E.,Y4I6<)3C&<YSC'$2%)=\L5]DNAM3M,H&-NKCE=DDXRG04/S%90\
MU6(JLMYL1%&?'")&,X$,J3G*WW\^".(F:T[7H&F>MRXOK)2P%,X<-V@P[ZX<
M+O?#.<ORE8QAB,E7CEB!$2Q#CI\$M,X\/'*)G"E)0G*UJ2A"<>*E*SA*4X_=
MRK.<8QC^/.>)"0!LD #Q)Z ?&1#=>P6CM=94B[;:U_79*<Y3ZA/M(G!12L8\
M?,;%,RG23B\^'AA+<52E*_%QC*L^'.%F5C5?U+ZD/AHNO+?IQ!+'Y3X7:/VH
M^SG9)UVEVYV7AOL@579M"W$CR%(<VL>G@$)WT\9%:NX5%,XRC6E!W1MIQ?CA
MB13-8V&*#>5XYQC.++;6:T"RTKPPKTS4UY'FYPKQ\/CSA]_J;^C5D7[\#72_
M'TZLX0 ?XZSXO_OSLW(Z=D=F?:'MPGHK=G]C9:8S$^&LW/7#Q"I\>27,-=1N
M=56RNW5KSG%0Z]4Z@1'/#T1+;NRF)4U"%>/@MRMT*$75Z1/P5EEP\QG'Q3E6
M,_'$[[.?^GBUU#IIK[@3Z]4K!/N(Y_$ZU,'M?[=9O3 ^RV!V6AWJ[M[MA'M4
M> )P^RZLD$CQ*MF)Z>^?9O57:6T?CW?LH,J4=S&?2B=/ZU$#EMXSGQ\Q%BNT
MNTSE9Q_M</-CXJ_#XXQC/PQ>XS7_ *F6*QKJN/4HZ^Y["Y^.@9H=B_;/,Z]H
M_:ZG!4^-'8'9%%) .N@R^TGS["1U'):JR?=L:_6>F>KC+B9&QK%M7;4GQPMU
M-_V59Y@MUS_=*S7@\P, PA6?^U9&J;QCX8QX<?P^D];6NO.][MN<C?\ ^JE5
M'AY#])?_ &!V-D$/VME]M]NOXL.U.V,VRACO9/W/'LQ\31]#20!T'3I,'[,]
M8>OXSK%N5L/J6E!%U77-VN@"6%#1Q1$?9*Q5#!$,222@X8GOJCR6L9=8DR7H
MTMI3C$IIYIQ:<Z? PVK-9QZPG0^R.#;&]>VNF'B?/77K/3D_8'['9F#_  VS
M[/\ 9]>(;$MXXM/W6X6)L*ZY&.:\@, S D6>T&(.P9:#3-&J>N=84RITH)$
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M<-ZW6P8$[XMM6&M$>T;?\YRQQ$<1'$1Q$<1'$1Q$<1'$1Q$QRXR#,.HVF77
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M&<9QG7/AG&<?7C_!\>/A]>D=/7IU\OUUT\?SE7$=6:PVG*4=+]2IQFP(LO\
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M@."V .BG!T$BY//Z^O/W'IZ2[Z=.AZ^ON('S'3^\E#8O4#8VT+EK6?9&-?\
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M7;:WOU\AY:\>GGL#_4CY/93294.P?K'3&JE!)Z(A%8<40<ESHA(0C7J[O.O
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g729258g03w96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g03w96.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3]44&AO=&]S:&]P(#,N,  X0DE-! 0
M    /SB^%AA#A"24T$!       *AP!6@ #&R5'' (   (  1P"4  6071H=6
MMO<F%L86QA9V4@26YD=6YI;#A"24T$)0      $# B&$=48S>)-,D!?0X<T_
MTX0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0
M!0<W138F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6
MYT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $
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M!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M        !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M            !2<VQT56YT1B-0>&Q 9-M#H         IV96-T;W)$871A8F
M]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U
M)L=                %1O<"!5;G1&(U)L=                %-C;"!5;G
M1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F
M]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M  #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M   #A"24T#[0      $ "FVAT  0 " *;:'0 !  (X0DE-!"8       X
M          /X   #A"24T$#0      !    !XX0DE-!!D       0    >.$
M))30/S       )           ! #A"24TG$       "@ !          (X0D
ME- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M$ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M   '   /____________________________\#Z     #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z   .$))300(       0     0   D
M    )      #A"24T$'@      !      X0DE-!!H      S4    &
M        ))   "%0         !                          $
M       A4   ))                      $
M  $     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %
M)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G
M1O;6QO;F<   ))     %)G:'1L;VYG   "%0    9S;&EC97-6;$QS     4
M]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M=G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6
MX    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M   $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W
M @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "20
M!29VAT;&]N9P   A4    #=7)L5$585     $       !N=6QL5$585
M$       !-<V=E5$585     $       9A;'1486=415A4     0      #F
M-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6
MAO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0
M )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M    MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F
M]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M     ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M     X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24
MT$%       !     ,X0DE-! P     )"P    !    D@   *    &X  $3
M  )!  &  !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D
M="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M       0  ]M8  0    #3+4A0("
M                               !%C<')T   !4    #-D97-C   !A
M   &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=6
M5D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "
M1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/
M  " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F
M0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M       !)S4D="($E%0S8Q.38V+3(N,0
M                                      6%E:(        /-1  $
M !%LQ865H@                     %A96B        !OH@  ./4   .06%
ME:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M      %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='
M1P.B\O=W=W+FEE8RYC:
M                    !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F
M%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C
M$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                      9&5S8P         L4F5F97)E;F-E(%9I97=I;F
M<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96
MYC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                       '9I97<      !.D_@ 47RX $,\4  /MS  $$P
ML  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                   H\    "<VEG(     !#4E0@8W5R=@        0
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M,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#QP/3 ^ #[ /Y!
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M!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,#
MP,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@
MX4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,#
MP,# P,#/_  !$( *  D@,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'"
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MJO3#/4 I9Z5<MKIL^G8ZM[:[:F>K1]JM]+W^FM'I[&5]?ZE6P!K&8^&UK1H
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M#CLG_VXO3HABS2) MQLQCC]8^INWG:&XS?3@1.QY]3='J;MOLV[O34^F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MYZ[,]6\40UQ =HSLRS@76MF)2QI/DO-O[2]M%'Z*:5[U8F9A?H]J&OD;V.;
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M=636]K<K.'LH[?KG5 %2=DI?X5[Y2YS5Q5#47$VVMC2] 0'8"'HRC6%,QO8
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MNBDHKV# 8X4D7(8(<PA@NX"([" [:[#]!-'TC1-*M7A!%IM11&(8ESLD1,,
M[KRE^T[K&PUAJ:#LB-F&)WA=R\P)N;IAA>P"W&==KKP<I%/Q<9QD0\_QBAUV
MZ[Y\-2L1AN,),JWJ$M/,2-\\I\EHAPB'KKI\49S  A^%'>,!\ )*M2AG/(1[
M.P[Y'IT#S!ZQK2(:XTL !H8;&$."Y'8PS+RGN%:+]/\ ]F:U$'H7H[D;1MM.
ME@!&,GN?R:2]F9J4H%QU-MN(; /=W]_,/?KK01G8,A47$&;_ ")N,R<5Z.M;
M<0PV9A$,1,1)?^)@S%WD#,<<?$SC?V>Z?#"H !DO%-9+& '&3U,B4<]>R4!$
M<!N!NN.?9GJU.UK>R!#?=Q&596]GPK^J\W_M'VY/HMI(D9@M.G86SM-C,"G'
M+>^(."I^.W_%,.WP^&=>G?\ $BZP7Y@B0A'5"?%<FLEDFB)HB:(FB)HBL#XV
M9ZI7LYPX60BJODK?TS?^[RE(W JZ&>GB)E2CH:D9RI7U&P,\D8BL+-5HM&HQ
M:4@W43=IQX2)&9RN3)&U.L_#FH*OE(>9H7J17,3*HY4#Z@>%&M):C.&*LS2=
M>W*J.U]K4[0U54<K4=M;?5A4AJBED+B3;IVNZFHN1D*2BY55Y"L9= )I2-B#
M&;I+/".%*EW.E>%W=>O-Q]\+M7<O[;;AWJ:<@5:CM?Q%U(_JNJ[<?*$33==4
M30]F(RIED5V*[]X[:JQ%7W)IF(GF(.3H.7$?CM$.91$CKKJ:2#O0XL+[\1/F
M:E?!0ESKE6EJ7C\NY<2[ZMQ'M+5M;6S=L4JGC58JA6U5.X.'>L:<IBF:6:G<
MJIGJBNVT"\6037F)B0C5"+N"&*)R%6H+FQPIUW%U/3G$Q/WDMQQ-T;Q(UP^M
M#3MI:DME#S5PZ!AGM%51-+U&WBJGD+91\.\>5#+?*4^V6;4\W")%.>>QTV4&
MJ#1\8%"P_3'+/ONJI?P_2Y\;^"NEX,J-K:E;=W'D:@85'25$UK6,E4=H;959
M-KU!4UMJ"4I^/9(14O(.7+]5J_FY-I(5*M!'D'@P*DN,8=854E "]R&\"K=.
MT^4\%1_T.XYX,&PY <WSXC>73^;+5^0\PZ^/+;&BI\L[VQZPDLI6B)HB:(FB
M)K&*'::;,B\=6NU(U:;NI^='Q'^5ZY<;^?N\]:&DE]'TDT^XCYFSBGWA]R^W
M5@;6&@YZ?HAI_P"_ >BM*IZ&7SX P ^VO._]T*[=^W=SWUY>UD-K3=+]TM[1
M:L7<AHR,.B]Q(7[/^AEG:Q:CU08;21U9H1 (FWLUF=P9^.2^,2COD>_]CG;?
M;O[_ (ZV[9V& @=YOF6G?ENX+E78DDO$'=I@OTRE[(;B.VP=/+N'PQT'?F([
MZNT;H?+Q [IJ161A:8+OC<WS4>SSWW#'(!VWSL #U[P[AZYT>+\E<QWK'8.(
M[_DH=C;8>?AT^.CG\O?P\^4Z)L'$=_R40+X@./#Q 1#8>_X9TAB+AX"SA_"\
M"[IDV#EW_)>IH?'W94OMD2S3$!W#'Z\7(CW@&<]_,!\/OU=:646GV4# >^)B
M;S+2\,>\['K>TCBU7IX%G$W9VD]J8]PSIA.4@!Q5_ *!@ #M .P<]NFP?DZ=
M!'7/XXA 8(7A(($R)!Q)IS.%*AJ%=$FTABCB!,0.U%*LP9B=&.(FZEW,(FVW
M !WR(\A#&WO\=@V#6L38P^[%"YH[ 8&\.)$5,LA)4@&EI$!QR/<1+)1[(Y#<
M,!X>.?>'O[_'4VM'_)6LANPZD<$8?YD7^K=BW=51/VC ':$-AYAGQSGIW8Y=
M0\[#V4^S&SC($%Y, U>=]RPBA$FM2_[SE\JYNH% 2CD!W#/[$?L/NU:_B'&$
M8FN3S\64  F+:?'YSGEFHBJ;(  ]K(= QGW]!^&_T8Q%@6(+"0V0'RD"1R>L
MJ/@;2.XF.C"FU24WKNX+P%,[\>_H_1 !*(W.KTPYR/9[-#JEV$,CU#;F&/+7
M*_17:[<F(AC#$\F)<2 -[87$G-=!>OJ.(ZF@K""6(B+FD4GD]\^.*VL=<\7D
M%2'_ !>\-MO,Q<=.F^L?Q_\ ;YK&(L.([I^2T6Z40]HN7Q1'[(A_/27B#<<A
MM*-AQW;"./';7F#UC _;.FEGE9,T_P#!LQW3ECN=?I9^S;:;7HI968+;-KIA
M>KO$"_>T]X7O/9P$,=D<@;&X\]Q';._+D'4=\;#KK79:$B^)L97L<GO:6:]&
M&U)$,)BG!&Q+B;DSE,3DQ7@JJ;@G<GAB. #OQ2V0 0WS_FI3#.1W$,DS]?4=
M=G>K0;.MK&8G9$FL@;>S/5+\EYX_:)CVO1K2@;@-W]Q:_-JDRFMZ-,V2E\/I
MV-KTT/C.[Y+\SG?9+-,RW")<NLUDFB)HB:(FB*W2]/%78^P$I$0=S:O<Q4W-
M,5Y9G"PE*5?6DPG"ME?4+S<A'4;!SKF(ADURJH_*DJDT8G425326.HBJ4KKR
M4GBW)QX@KNZII2R/%#;2!-4$93MS;<U&G&5;2TB)E#-S*E3,O$5%3\BW,A(1
M\BW(J8[1ZR4;O$!.=,3$'UA-$)X87OPK?-F,L%Y9OPF<.K*@Y"VZ5LJ="EY2
M=;55(D,"YYE_5+ 43LJJ6J$RYIY6HF1D4"M)07_M*!"E01$J)A3$C];Z.[<J
MW*:)M?P^6#-2E00U%P=).XY9S1M.S,=%2$C("[N--1ZDPW5=LT7KY5>HYEC&
MKS$J_P"V)SLDE'3E)% #%)TSAOG5QP,EZB;L!9NI*5JJ@Y>@X-W3%95-]VU3
M1P$43&0J[Y2;3C>ICN$5BNDYAK+,VC]F]0536;.6:!FX=A/)2F%S2[V 9K[V
M848D*ETSP5\)SRC):E9JU%+*4I)UM'7/J%%T[?D"2KJG(I&)C:QF9,[XCIU,
M1[!HV*$DNYRDJB1QVP4*"FBLZ/=AWB9I3?,R9>[L.I9-6TP%X?W\7+6U0?57
M'L)**DGTRP<2D7(R49/^RRDBNX7? A+-':!ETEEFIP)VFBAT#$.)#N?*KF[=
M2^4ZR5G/H=P .#!J4.7W\N(W'E]^:K_S^>BMXNE25[=>*REZ(FB)HB:(FB+Q
MU9"56DZJ( X[<#,D$1 1#)V2V,AX .1#<-M?+I(;1](%_814-3L1#AT5]NK3
M_;]!O;3M$>M!;0D\6W;Y+3:>4>H>0?@#T""9\\QE,1Q_)"AMQ%3?/+ %P.>6
M<"'G#3=$B.EZ3$X;M[4\XR]'/?C1?L-Z(:PC^Q=4B G9&KM# N+#1X -]"9B
MDGN'SC1B^=Y @[COZHP9#R[6P\]]QY==?'%H5H\A"95)'R7)1K2TA<;1J3?*
MYI,-S"7!T^XU0/QI GA^HF'ZQ[\?1W:P.B6L/X89O0CJ]9#6D1?:BB#"4B:F
M=7P^E"'W'&'_ $R*'_B3?G'OZ?FUC[+:?EAYA/M/]\L]\)IP:?4T^XXW+Y1(
M(8ZH&^GST]EM/RP\PK]IC\\34;8N'F0UXF]060*.-D,/R<\!^H#U'SSUY>[5
M&BVA(&S#,@5"#63D>_%,_EO) P=FS.#WKVMMZ$/(W"HZ/+(E3%W4$>@"OLXF
M !.OV2A@3[@8P8SR#GTU]FJ-6&TUI9PPD"(1PEW#!B[@%Z2-#.69XOZ4Z_.K
M=3ZRM=DQ00V-J1"WO1#98@DT=XB:BZJRG#PXN +O4Z&>>\>H B(XSN"P%'EC
MEX   &W:%KJ>';LQ@(1)Y[.-W?OG)>6CZQFM(R=#)>.(S$#GWB9^\S]34WX.
M+CK5" #C(@#%3;/^Z-NGOYZRM-5V8C+M0.PB8>Z&S.<[EC'ZQXC$2-$D=ST:
M@('@H?@XN/[*D?\  %/_ (C6'V98]0Q+'^L:+_I.X?[E$.'%<1WJE'',/Y .
M(=0W 5QV\<YSJPZMLH3B_P"[%SZQ3^L:+_I/#_<GX-ZV_9JI$1SR&.,(8ZXP
MMMW;_3MG/V"R-W=%OOZ=4>L2.*4.B!\V '':[K\5QFX<'F<EJ9$<<@!@L&1'
M CN"W9Z9#H'/ = U=9$M0DAI1;-]>!J#7DM>'UA[(VHM# (8[4.P2"!5S$"X
M$Q>K?)VV*UON.CT=3U:73D@D+KW#:^J3;F2,D9&ACK <3&.?M <!$HAG;&0+
MG6_ZDT7L;<0AKZ$L!D#S-Y.]=*^MSTI.M]! (B ,30B(#.;PO(#FY<K9@URM
M>=U(;<!QTR ^8" _0 #K%O>>[9;OYK$^\"!TQ^BT<*$;F&X?$\<>7X4]YQ'
MCC 2K<.>!Z"&_=Y:\R^L:"+[8TP5VH;&(!Q(&RA -93AI<<ROTA_9NB,/HU9
MQ.-DVFED3#D"*':SX2#ASG4@S/.X"("(]H>SGGG(<M]L\^_XZZW$$1A)P:M6
M8COD.$Y,O0AT@#;C>(P]H X#D/,$AJ.9N3G.M-ZV;@6X'#"8NXCQ3V/ 1'J
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ML0?\6MKQV5A*[^[(G+Z-FOT+]0$4 ]&[ 1@?%I3F9_%#O?>?)U5SV(>SD P
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M)RB B9,HDZZZW+JT>,BKK:R]2T/$VQG+CV^M)?2VG#S-W>JBXC$E45E4-?\
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M*QG"Y@$F!75$ ,; _KAN>0P'N !\==>:4/O[5ZF.)Y_0>,B[L5[;U);$:LT
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M>P@^'-FI/WG/?49R9;=KF&&'5T<8B>*&&+W>!88T[P<5=B ;9R(CN'9$<AD
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M':]4SEK6+/VPC6-C?62DJP93;J29-$E0]D6<$%#2>7-^NY5A1R35R"+JO08
M TP62> GXFIH.'J.#>$D86?BV$U$OT<^J>QLHU2>LG:?: A@(X;+IJE Q2F
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MH0?JK+>-)N8D5PV&[(A_/E<.)<CL.]9$ !V#?.?AGEUY5Z*V>QI B#;6PVT
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M&<"/+QUB=%A#L:9&\9Q92O&)JI_22**79G'XAG3W7?=YJ V[+G)9$V W_6L
M/?CYP>[GWX[L/9Y^9$I[B>0F+E!Z0%W%FQ>^*<YC\/S?N6.[BLIDL%QH^C!6
M]I%<%[XW13P).R(8MP(E'81W 0SSZ[Z^VQL3 8=DR839I\WITX9;#KW6D6DV
M40BA-P-#,AJ@"@)JS87#-5K[UQ)0, "&X9W#ZPTZYU3KDM:#@<1[<)Q-FP 8
MXR^($NX#D/Y?1O9[\;B XWR.P]1#JGTFLP=96D3?X=B36?N5^M,5Z ]!+4_9
MVC[1,31VL(F& $<A("68QNFU[GJ,CN.^.X<#L/ES\<<NFX:XN8!""),;K^FE
M+D+NPHK2$1PTH:R.%0XEQ$S.BLFXX&XIP'#4IC !QG<-P&$<  9K(@!OMD!$
M-<M]'((.V!$+>X\P9#;A!)#SRPR7!?3J,'5.D &;Y%P;.T)#BD^X,Y6RR 8[
M&-@Y8SWE,(ACQ' _Q:[0%!N"\[49L3Q=SXS7)JJIHBL6](!;BQE36!JZN+T6
M\5KU"W$+*/(%M&SCZEYL'51^SP:\.C4T8L@]AX>=5<,VTXIZP6H,0.X72,#<
M-% 9RN>;WR^N["BQ=\&5'_>LXLZ.B[FVBI2,EH.5J6U5M:BHJ^5S:\7HA\%&
M0]3/X4]+UC(R3"2IF0B7+>/-4<2+)%NK'D%5N"*Z( 0GYX>3</!;%@     &
M     [@Z!HJHZ(FB+7YEK:<1;#BDN-=ZA*!JZ+J3BCK6^-FW]7JQ3L&MN:"H
M]A;>F:-KUX*J $:L/D2F*\F:3(H/JYF;?1'JS&0?JF*QSZJGE/?UG)4]M5PL
MUK 6O3A'MM+EA3% 62XE+R-J-20J"(-6MS+K5P_C;>TQ--$2(.IBH*;I>EVS
MQ&,>>M.V<2S1ZH0Q?5F$.NOFR+[;IVQK>P%(S4 U2NVZ<U+8WAHM%/5$RDZC
M=U?=*MJ^N2#NY"D(X6.=Q(U90%NX21.R&*#VV/:+>RI8!(1/.NO._&Y*]_=N
MZQ95H;5=-V'I:\MP;76 NG5-N:[N%:RE;*4?6-!5S4/R=5T' "6K+\U#2)XV
M1J^ I]B\;E.L8\.SD)N=BB*M 1+)ED4W0R\5)/6?S?@:%9#N$JD(&#M%-U<Q
ME*SJ2J+I3M05M<6K*]I67H6H*BK%9L2*>N0I";:,)"GX&.:QK:)IN-.V[*$,
MS:CZY=0ZBRM1Z_2C5GFXGX*W?T.HB/!@V$>8WTXCM]PS_-FJ[?'CSY[>_16C
M"DJ+*;HB:(FB)HB:(NGE@ T=)E'D#-WC_;H*=KX[8[M:=K_=1_PE:NC%M+T8
MBO;6;?SP_,X>2Q**&_DA<1$,^N6$ Y?LS[<Q\/AY:X5I /;6DC\1H#\KUZJU
M3%MZ!H9) ,>CV1+4#0C'G63(!\\S% 1$=AY_7Y\]:.R<#R6YQD/(BGS40, \
MC%^'_P!7VV[]&.!Y%8.,1S^JB YZ@.W0-_K'Z<:;)P/)9V>P2T409GD;Y;TR
M'V# ?$<!]MM-F*X'D<9K4BAL0"1'08YUI7IE#M!D=RX\_M]OH;,6!Y+#[N7O
MUI,?+Q7IJ','W:4M@2G+\ML@'!<]D/6%'(B [!SP..60'OU]&B$C2(2T)),G
M$I$$"1!NOE-;!Z3Q&WU3I8(@A[.RB,.R""?=(9MHO(_HLAA! "@.!S@.8CMM
MW=-^F^VVN6 D@.'>HV37B6;-\.'01LG).W#,GQ3'B;J( &,>>X#W;^6/(X-8
M7-_N\GKE1\5G#"  "82U2YH^_KA. AWY]X%Z_P"U';8! .N,[=*"* &M0&'0
MO67NC\E0TR6%+[]S9LF.>!,.X9V*&V._ ]^.OYFU^Z>(KB)')VO;<@8E_<RX
M[VRY-NCC8<"8<9Z%_%V_M>?P#0D2!!NJ SGSW.H=EG.QP?/<15F-YK<@"81V
M,<?<..O<&=MN[GJ%@"=D"K.U>GO>2P)@F1#"]Q),B,;[I+&GQE@ \9?HN $.
M=]+H9SX6S5/]90S[\;ZSLHS@#-IB= *XW[UMVG%[(EIR(E> *9&]9?-?0MH3
M1%K><!K?UM-<3)A+N;C/XA"CD.0EJ",P'3&1$>@[[9SG'6GI3"+/6$(AF+2"
MR<F; !@!+#%WXKN_T)MHX=7V%-GM+5CA[^+\GG@KZ08]DV.SM@1' #OY=^>F
M=N@],<2,/::1:V40.S!"""/B^%YDO@+@15UV%#;PVEK!#$1,,XNF'&#X5ES-
MBW'BB*-+\-@[A_/H\-@9'?\ %K(IASC'7 "&_,0UR?T6B,<<9.R-GW9 LVU"
M79W?"ERX-Z;6_P#9+6R&R1$?>>98V5H9$$3>5,=ZV0"AD""/,  ?B7&/+?/G
MKM"&@W#P70Y#'<3YB:GU431%36[,Q:N%H*ICWGEZ-AK;OXMW'U6O7DE&1=-K
M13M(4'2$BXEEV[,4%$E.R<AC@;YP"40-@=%&+ROKCE*_NNW*PKAWJ'T8S&\#
MBHK$UO952\$W'LZ:CED:O;+SSV)9-$V:+&E$II\45VZC-)%%16$(LHZ032(L
MJH0@8*GSG7KZ.ZR;^M4'<$P$!W 0[6X#N [%$-PYX$0#H(\]%&!F0#FPGXJP
MOB&XJ+A6_OW2-@K>0=LV$[4M J5S$U%>&JWM)P=<2))EW$EMM0:B#(49.KB%
M:I2,ME\=2+82,6O\FN2N3'(ZZZ\4G.\;J;\GY/A3VS;C0MO3+"C(N]2,E:VY
MLW P4M6E!DC9BM6]L5YUW\G-"UM5])QDC3=-Q;IZ4WR=*U ]BT7K0Q790*D5
M42%5]%5\<W#/1$_6\!45PE4'=MWL-%5V\84K5\O TU+5(M!MZ;AY.H(J"?0J
M<O.+5'$)Q,<G('=O1>%,DB8A%#D/\N?ZK%INQ=B-[7B;4!POHOD<<9EJ*@I^
M&F*%JB).X=W31MA*QM=Q-84;+0TPQ@7M:U&P>0$I3[6<82K6A(YY4T8,DT9,
M'\85)ZF[.W61%9UUU\T8SJ7!K-P];L6N#RP*I'<7C=X3ZJM_4UT8=PC<23L7
M;R5XB:!).4O5=.QTPA%QCV(:S]%3U00T?&38'5D3PB[N'</C-EY))/L^O43#
M15KGJ?%Y2<RRP58*)XS;:UQ;*J:WAF583=1V^@J7?5O;^$H:LDZI;2-4QC21
MC&L'#SD+&/)J.?F<&393[0JD.=NDN^5D$VB"JQ2;\?TW4O[J+TW#!?*7XD+!
MP]XINAG%N5:P^ZT\92LA)-Y.0;0$=,2<=!O'SIJ'LH.Y*-;(/W:#8ZZ+=9<4
MDEU2%[8D.9>YP#7%N$I2XJU/T.X"'!BV <9^_GQ&[ /:*'\V:KMBF_9 &V!#
M #S -.NG5+N)7"NX-E.OAGE+T1-$31$T1-$75R10!F^R.0%HN80[P[!@$HYS
ML(#SZ=VL+2<!'YI<UJ6 ?2;"HV;2 T_>%ZQ^K4W" =01CT1$5E $1SD1 Y\B
M.!WR(9$/'G@!UQFTL@+6-YL6=FI??UN7?>@:QMX=%T80Q$0BS@ &U1@V#;Y#
MQ"XON<A-LQZ(],Y-X].7V[]8=G#6;XR?FR^Z/6>D0Q2C+,X][+<09W_)0"GH
M3]C'H@([CDQO'8 SW]>7=G5[.'/N^2Q^U=)_,?YO_P!5'[GX;][D1Z#^-MWB
M @.^!Z"&<=-.SAS[KN'7!/M323^*(;HI^'=1/N>AL@ QZ..N!.(=<YR;RYAC
M?;EIV<.?=\EB=9Z20VW'_-W_  ^#)]SL( @'R<B&?[KG@>X,;#OG(;=.NH;,
M3,Z7^'.N(D5B-8Z2&]^(_P#<9]?JZ[ZEH*)3J2"539)$.G)MCD$ $!*83<^?
M3D'=@=\ZU-#L8>V@C<2,,B)GW@*OD]-U%\&MM8VT6KM*LXG/:P1!]JCPF=)S
M!.;L:*\@J*. _4^@=<!]6M^8_FEN#MF2_A-=111VKD".\W$W_P 2D,W((B(8
M*'0,9QMWYWWWY>&J'O+YT5%K$TR2<7(OPW9J'LX=1#^]#\^JKVIS_F/R3V8.
M\/[P/SZ)VIS_ )C\E$&Y0'? ^ % /SZ*&TB(:?-U.""8CRYC]OIW^V=0B5QP
M><UAM18E8Q.-1,B?&7Z+D0#M#]_>Z77'*V"^/?[_ ,NLH(0T)!ENW%B<2_5%
M\^E1DV<;S9I8O7]2_DLN&M=;<@\AVSUQY:(M97@#NQ:Q*H>)*S:U>4T2ZKGB
M]XB9YI0!Y-J%5.().99.B2Q8@5?:Q9&03.H984P(0A1, B ";77'I8&UA8Q2
M<BR#,Q_%C(YW5-*]Q^B=M#9:JL21/M+6;M6.35#AWXUDLGA6@B8QL '3L 40
M$!\P' B.V^^VPZXQV&QI%K&8B=J$0MLM<9AR6K1AC>".6V-N8K6$0DY&8&,P
MY!8Y;EC!](!=>UH3W#A9L*[IH+KI\6_#C4BMO_E) :I)!#5OM"4J$2!_:C,%
M&Y"+"[%,J14C]KM& H@/)_1C1#9&(=IM;;1?"Q ,4(IM%Z[V(*XEZ5QQ1V=H
M]&+M1Q9Q4P-9M5PS4V2Z@E7L- RDE'PKRH9!A'NG3*!8+-$'\PZ00,=O&LUW
MRK=DDN[5 J)%'2R:!1/DYA( B/8U-D/E?@?UO'%=-@DF.LB\YU.$I5:;TN5H
M?!3?F\%]X&\[N\U'0% 57;Z^-96[;4A 2!IQ.%AX/V12,:R4T4$T)66(@Y(,
MB[9HH,O:A53;D,BF0YJARF>KU>[HJ*!ZWJV?B0H:@Y*CY:Y-51EN%IVVD#+S
M5*5#=ILYDZ#I1RF7U[F8EHY)RW Q2IHE*8Z9O;#@F1% X&-V3%.[E/KSQIB6
MI"\5T>*>33M$BRX.9"2F8Y>;IN#N3PRW^MH6KX^,(156;H.3J^1I].?:QOK&
M[I1U3CE1R@U50=IF!,Q%!G7Z25SZZW_-9WZ:BUH>G8*)< B1>,B(Y@N1D+E1
MF19HT105(S.^57>&:D43,5N+I=9?U($!550X"8:BQ^\3'#3Q!7@>W5I%I)V4
MK^U%TF<<%/,[MP,NI4%C)A*&1B)"6HYS J(JRJ;E=$LZQ1%W%R#.9 QBRGL@
M@@4HX$J7"YZ45%'?HW*T)<&;6/6L16E&5\2TZ->516<M5QZS-#6XIN$IF9I=
M&"BI!M3-0-:J:0QW+9[+D,:'<RKY15-Z() 2 -P1^?$W#B:_HOINWPW78IF!
MM9;"@&$+/55=#C"F+\7!J&0@)!U1+.EJ-5DJUI*GZN79@55 J PU&4I#NE3#
M[.\;%>)(+$; B>R'A\A=2Y'RE+.K7B3#JCGMJFX"[OUPYK2LZAK^DFUP+C*W
M=JRHDXME)A3]/UU5]L*>L];P( %A]J68T70D=(%DGKC#F6EGRBR"35N?V=,C
MO3PZ=Q1N]>WN-P)35:OTF$;4=.Q5$1MM; VIA( 62_98TK0-RV5<W50!,A11
M*6OXJ)BH))$Q0*0"'5<[B B1_P!"PX5E-A?7E7JF>'ZKZ8E>*RJ8^HH8M37O
M=L&] K@V<>R473E/4!'4E 0[L"B!U"-I1"1FCE0'LD,_,D0?F8TQNP1WN+2X
MN_<V[=C56S5L&=EK'T#:MBHDZ0M_;Z*I,'20#V7(PL25FJY#M?.PX6(HJ';_
M %0>V/K!$XF$2A(>X[F?&7!Z8X.K'?0[;\%[00Y#?+B,$ P 8 ;RU=@,!MMH
MLCY;\.F^2RF:(FB)HB:(FB+KY$F6COJ)VZQ YB.13-MCKR'N[M81_#UFW>SM
M-EJ6$K>SBJT<!X @G<_)V-ZL<59O3&/AB[$ 5.;/LZ@@(=HPY 0#&X]0''/R
MUQ^U![6.1/O&DQS"[DT#2+(Z)HQ=GLX3-G >^<EQBQ?YV8O,@'5NK@-Q\-L_
MD'6FQP/(K[8](LHBXBE2HSS$LV 4OL+_ &PQ=!@1_J!\]X[@ [#N&WNSRU88
M#$[-)G)+5=J[EAV]E^9/8'P#_E)W@0W$$%<Y^ XY^/4!UEV44_AEFYOPW=33
MM[+\R>P/@Y,G>0Q_4%,#R[BCGZ<"(CX@[*/(;RWBG;V7YE'V!]L/L3L>OZR?
MI[@W\\<QSRP"*QC:*E,4[>R_,NVI]!VA.1*RK==%)%^W56553,0A")B(B(F$
M,  YZ[<M:FB0F&(&*0!AOQ+\@*W/N6WZRM(;71K2R@<Q10Q2N^$C&N$E<V6<
MB0* #(M,@  ("X1# XY#DX &MX>&Z.$\<*U8+K^+1-(<_=Q5-Q>N#.IOER(_
M?%I_A"0_2!Q#Z?IUB8X!(Q"Z_&?6%ZP]ETC_ "H^2?+<3^^#3_"$O\?5$4!I
M'#S^B>RZ1_E1\L$^6XG]\&G^$)?X^CP?G@YGY*^RZ1_E1=WS3Y<B?WP:?X0E
M_CZI,(_'#S/R3V32/\J(<O(E G8@! 1D&@;AS<) '3F/;^WPSCM0F0CAI=$'
MX9CR5.B:0Q^[*QE\:3YF\XR?1=>R.D51)?FYZAO5JD5$R?WM3E$N"B8 $PCV
M0'(>& UJ010O" 1N!X M2]N5*'X-,L+2"SBVH2"2*AA2LPY'SYY>=:RVU-$Z
MZZFM=#T>-"4@Y9\2M=*TK JUD3C+XB8PE5*1;0]0$8$G&2 L4Y0R0NB-!1,=
M+U *"0Q!,0  !UP#TH,)TZP$0F.SNH"2 7<-]6S7;'HQ#!%JNS,_NXK2(\8G
M!&):IS9EDK,W$#8 G: ,#@"AC @&P#W;@'>([=P#L&D0M:B&$-M38BC"0G*_
MY%@N4V5I! ;*,/L1")@6VI$#=7A.BQJ>D2H6D46/#C77W*T\6LS<8W#)%C59
M8II]T/R<6L02%B,J)/:_9A2_4_5"J)1)MV<@ EY'J(BSM-F(DG9%TOCA;.=P
MRW!<7](HS:65I%"?<,,0:L]@W<"936Q45,HE*/9R(@4<".W+W[!G/7EKG;N!
MA=QFNIF )QH37QHK<.'ZRDK9R8OS(2DPRER7;OC5MU(PK1%5$\5&U&A'IMXE
MV97!57+4S17*B0 F)#!S-N!0F4Y/W,'P(E]<E<IHJK(^-:L[.*6]G+*W1J:8
MIA2YM'U/*HSL+$*S TK$4.FVG'%53A"(KH)1#&3(P039N">LG'*@Q#5-9=<"
M@ZZ91IO?3A56#<--U[PWUXBK*)<5"IZ()0T?5,O8)BWL55-J4+P2:\,S9R$R
MYGZ@J^K$HX6,(#9^WHLJ=.R#A1VH=PT<-T"(('[T,O G !Z5?S6=(1#]J(^(
M  AX8T54PE*;&0 <<M%&$\ZUZWXWJ7U9,=GLX#P$0Y\PR @.!ZAR$=%5-V0P
M ;X#8-QVVQW]W+NZ:(K,N-6Y]=T)15NZ-ME+I4O6]\KO4C9Z(K-9!NZ-1K*>
M1D9>HJA9-W9%&BLPA3\+)MX$KTBK7Y<<,1625* )'=;E-U ]U_U>Z=\P2K3^
M(6.NEPF437K^QO$E.5=6M0T=25(QMM;PU(6L)UK<2X5P8"AZ9NE#OGOM3Z%8
M \F'K=U %C#4X\=%;BW*Q(U6[:^O#SQ1A@!-Y==<%Z>1XWKT0,(6H(BT=,5A
M1],7<HGAKJ&=7K@\;4-272=S431=<3]-P_R0JFO2])U8XD6SHBZB,B^:L'TF
MBBFS; <Y6_G+EX>:]EP/R]V;G!Q"WSNI,.U6E67.N%1]O*>9U5*2=+0E$VYF
MI"CVJD53Z[-G&L32KJ$<2X2R)#O)%-]EQV$_5=I/#J?TYJ%L'ENN+SNHS[G7
MF/0[  <&#4 #!?OY\1O9QR[/WYJNQ_ (]-%2[\/(-W=893-$31$T1-$31%\S
ML ,BH!MP]6<1#_:CCEOW^>L(I@@3^8+M3#.YJF>=F2(X2/S#Q"MY.4I3&+@
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M# #D0W[N?A]&@BM0Q$3L)!R>.9;-BG8Z.Q]V$AL!-\''@K"^(T _#4]&3M@
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M4=/ZL=*_?Y'YI_371O\ +@;#>V5S3X-11_3(;/\ ]BE>]?\ 2]CT_P!V^?\
M!UH]6.E/6(/B#YDSD;OKA'Z9Z/'#LB"$&4W8,#ND"_192_ID%G\#FE:]Q@=_
MD]EL 9ZF?8SCRWTC]6&E[,31?A.5Q6I#Z76#3V:?F-9@N#OH,[E0*8XHZ&X@
M>.GT=4/2D344:ZIZZ]PY9P>8;-$$E$EZ$,V(1(R3M83*%/@PE -RB&!Y".QZ
MS]%;;45E#':$O%$ 9L938!^#2)NRVO6VMX=/LX>S( ,BTY4:F\&E3A+9DULZ
MX^FB+!/Z--N"UO>)@<;_ (;O$@ #C/XM0L#!MW9VY]X>.N':UL]J,DWL.X,\
MN$\KEV!J*/:L+.R,MEXL)N*MF>F<9'@8_B@.1$ $,9'&1\=\ATQ]>X:VWL!'
M9$D#W9"3S-YR O!WR(??+.W>UBA!^ LXO<$L)BZK7L5CD]):AZNW/#>8 W_#
M<X8BX'&,?=IG?D.W9#GX^&MRU=(P0B@(\:B^8.%;KEL>O(S'9-<YIF(LN-];
MUG3)^(7^Y+]0:YA#0;AX+@$53O/BIM51-$5F/&A,4^M:N;H:X]&70D[45O'*
MQ]7UQ:N(^ZN9HDK5ZV=(.'M,QR,A4CMFZ,BF5-S!P4VJEA<'#9 " J)059Q4
MY,+@\A*7-L%CING+<'M_*J6&R58\4 5M<"#8T=<ZW]C:$K:EV=ZJ>8M$(].(
MN0]K2EHND*8<N(WMQ#VK'$K3TR:-759FD#^K*D6?/?EUSQ2>5+[CN'S.&:S=
M4=&-H2DJ8AH^&4@&$3 1$8R@U%$G"D,T8L&[5M%J+IJ*D6.P12(U.J150IS)
M"8#G >T-1@:@/.[EW+U6BJ:(L9G'I4EPKE2%'<(=HZ3=UD\N,1.K[ZHMY@M-
M-HRP\+))IRU/+5*H@Y(P?W-?MS4JV;)HG<N(<E1=DR(@DH)08LT[Y%\L;RX/
MFK%[/7*J"A;3V@L'<>I9;ABM935SN)ZF[@3,+(BR=Q:5 5$1Y:RTL'5R39'V
M=6HH.HD92,5C"MW\RE3:D<Q!47"J!ROTZ=KNY^*X9&NEZ.N#?&\/WV[KSM34
M'8>P%I*,DJL=(4=,0Z=WJ@6<.KAUC"RC%:%IZ+:1TK3;:7J5]$+_ ":\C7;U
M9NK(F !)X[_H%STCQ.4W3EK.(5SQ#+$NK;6E[^VLMY9FF)^XCJM8&IKIA34-
M6II(;G5#$4\F\H1"270FGC^19J0$82.>(1#9X0K-HM'[KNMWS"E3P-WGW\,
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MFO."^2VLK*TB[01#W!M!C)PQ:68NX&Y>WX7@ /2(\"HB(B!:ZK?("(<QI8@
M.1[A$,X -=5>M#1K*&RT2W:$$[4 P_%XN)Y36[ZO#69?!^9IDPG@_?NI:Z66
MX*!N0^0_5J14.X\)%%A']&$W*M;/B84$,#^'!Q(@ XS^+/QP9#N_&W#ISWSK
MC.L:FL@'Y'=3B-Q"YGJ>,0D S8-+-CW/EABLE7L8B.=A -P#LAW@._=CQ#'/
M;IKXMC;L3<0Q#UF3)JSJPD[.ZW(6O]H,Y.7GD2&%:T8NSLL;/I.VX(VQX;U-
MM^-[AC#  ']F8[;;;>'AD,Z^W5\&R88B 'B&1!<UJ68--[R&H?@UK'M01 4
M)X[-SN9K-H7D'E]6VN3KA*CHB:(I2D(4! I0 !$1'GS'.1^GIHC?*IZXU7S(
ML&;<YE&[9!N=0P&4,W2(@900$PAZPR92F4YCD#B("(B80SHHW5U )!Z2I-?7
MHJFB)HB^8S9L5<SH&Z .CD31.X!%+V@Z29SJ)HBJ( H8A%#G.F03"4ASG.4
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MXB\ 1>1C];U#M-TT=>J<I*):*%Z@![N,LJTOH*3(LX]#L(?@8M@+CLA?3B.
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MUA\?$?#R^K0M[<Q65IM11S@B!)BB<2(KM&FY8]E )M <GKPO4]F:4B8'T@O
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ME^: G "B8""81QDV R.P%UU[ZP8K**QT,6<;Q2B(VMKW6<5)I,9.,5N&CP$
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M"5(287JN;<)D7581A(P!1*60*H1U^G=X*#&3SH<+KJ4#\W=7!3'&+3OW9U7
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M 1%MVA=C2&(D%BU : YW-25W'HY>R'I)^#D!V'[I:N 0[//%/@(!R#( ;(@
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MMT;I-+ET/#TY3ZCVFUZFDFA%:QGE:-J1*2:P"L_*MV\V[8(+J-VTTH].Q(1
MZ?9 -UUWS4,0 QNXYF@KDLR+",CHMBTC(QBTCHYB@DU9,&*";1HT;($*1%LV
M;MRII(()$(4B:*9"IE*4H%*  &JJONT1-$31%9_Q.<8%KK H)T0:Y%IHZ_\
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JLNB7C<?&%1T531$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g729258g04r02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g04r02.jpg
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M 0$! 0$! 0$! 0'_P  1" %! ET# 1$  A$! Q$!_\0 'P !  (" @,! 0
M          <(!@D%"@(#! $+_\0 71   00# 0 ! @0" 0\%"P,5!0,$!@<!
M @@ "1$2$Q05%A<A,0H8&2(C)#9!45AQ=IBUUC=A>;:W&B4X.5EU>(&1U? R
M-$-24U>2E]$F,T)41%5T=Y25EK&XU-?_Q  9 0$! 0$! 0
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M,0ZK0@[J1G9W07-CB50^04W^?A@)]'UG%O@0I4;6[J5OQF(\V6,*-=I Q>E
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M6F4=PX6VDH?$VD]'&<I/R/&N_DOK^P+4CE4..?>I*_)VI6]@6ES<=LBO(K%
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M8*)%0(;8BX8"C!EZ_/'P8,2$#%"1(JV1;8PH(DZG"A6EMX2W9K6H3N)[+_D
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M53\53'HR@'('QK=2&:>Z\@'8Y 6$F!'C<A\6W,4X'GQ$H74YAC@*P1K"YWR
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M=!PEG=/;133"B2F^F=D]]-]<;?73;7;&,X U[5_\2?QL57.(C95=\;4K$)Y
MY$)ED.E(:/N&Y:/20$]1(AS U?9]OA)Z/?-T7+=3.FV-54]<YUSC'T\-NNMJ
M'4VF;$_#!I"^&3_#3Y@?^F%ZO_W17'HL=ZO5FZ\4?L7K4;O?4P/ 4:K#_P 8
MIV/_ .BQP;_VA]W>FKZ+UJ+HNK]*2\OJ0> > > C.H?\!FO^L4\_Z^R;VJ_F
M?;T1FCY5W]629[)H> > > > > > > > > > > > > > > > > > > > > >
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M-A<*CYHJR*R9\Y*/F(MNV#M'BJY1^Q'):[O7K9!45)N83<9A3'78F#P@\ \
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MOECD7I[G;F7LWA6S>3?DV )V>SKGH\M)99(8!U4^D8J6L)0KB3LI0M$I$^-
MC*[,2SRRET0UD8MED/* ,F=BHZL.GXDM-TU*JB596X=E$*$K+?S,M^(WA+F[
MY@J9Z%[Y^0:,G.@+ONGH*QHB%_5[#L $SI""1AF!=1Z&0%C%)*"U!*!ESZ^1
MNRVJZ0T*TC[(:S9ZY,*F@KJ=#5--DDL1\3:NWOW7D=BCKF^ ?QR<"69<[,87
MG@[F>F0HR*"I,:<.R\M+C40< @C:62/*6SQPH8D#X%B4'=4-WJB2Y$@DANYS
MJEL.5*XJDL2SK=3^P/D2LWN7X%+![H#<S-@]H6G,[6J9;GW2<C"T81G5=08R
M9KJR0LS)&6ZQ6.B7,6<#S<;*D&"SEX=&NGK_ &'LB+Q[^QU2I5/XG#-J8<QO
ME->GF]+-R/Y4/DRMVI>S>Z>583R*)XVXVM.QX*UKJW!UGEKMNJ+TUH)?6--4
MY%')&)C$5_& E-#$;%?D=%6JZ+X2]V-J#D'IL3@I3II;;=25U9)O"B'/6=L7
M.0Z&^:6\5K@Y-C%92CF;C*FNE^.ZYZ<A5W]G0JU)G I[8U@;-'.U#I3*OCL2
MC,#2B(]WMB62P^ZS^"JWU=:*#D2D?;FWOWL%0HJGBJ=-7#%,3"_RB&X.>[G^
M92TJHZ[)\?UK<?&/.3VK*%AUH67<O20>TYY#[!L^<!1$ACE4U.+K\F'=L8TX
M!F1YHA-CVS]WD<]WPT8-70Q-(\)31-/$U4TVTE2KPM79ZVCK?>)YM\[_ $#)
M>5OCDNR/1VG>6PG7!>Z8I?/1]SP"U[3H^DIK3I9S&A( 2!@A8:<12MHXP5>@
M'LF-/$(\&6<H.UR:8"1R80+^6N*I7?"DTE:IIQ>Z>)NL_7LC<X3B33V@:OGT
M\FM-6!))'#&!TY/N?B!,E2DKW7T45TD==O3+TD3WC1)GA%X@F\)$5&JJB[7#
M]YHAHY5'-Q-I[Y--KKY$.ZG/'I'Y2PD=YJVY 8KO[ 9<TO(E8^>A3'-0J=K1
M=Q.][PULA"!"[4?QUJO.V$'S4#V--1BB$?=R1P9_$=ZC?"N+@OQ8EM1,8B)B
M;3.-#EXF#Z%F'SF6;(LRCG$S AG$G/)UBB:IZ>D)>SHDW>]VEH^!BIQQ;F@R
M/VQ^[A+@U()TI'W46*#D(PV:U\+*!%B;X2WY:5YXJNF*>4Z[[F^[PP/ / /
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M1!D-&,&Z#1FU1TU20;I)IZ:XUUQCT7U?DV6MM\#;E\"N^M1<WY>/_%>][_\
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M9/DV[QLN@F#342LW7,F#P@\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \
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MYU3TVSC33;;./IKG.-4I\2L]=.3,55)II/R>Y+O]<SSG_P#9ZIS_ .Z5#O\
MWQ[,/9^#-<=._D_L9S#;*KNQ=2&\ G</F^@G9KJ5WB<D#R'4;L]PXRSU?;"7
MCO#39WAJZRVPOE/*V&Z^4\;82W^TTUE-=2IIX9FWH4> > > > > > > > >
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M;,&[59/"7XF4?IOLN]:[8W^Y/;/TUTVU^W.,_=]?KC'H/.9K_'F'?_J^2?\
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M*7_UI/\ ^TU_^][)H\\8QKC&-<8QC']&,8QC&/\ 1C'\O 42^3/_ ,!N^_\
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MS:ZK:LV;1!$<FV\[)=E@E+PAJ#J+Y=:SZ!^1M7A:FH(?DL.#599DO/\ 0)=
M[%H\3G57S!G#I-"Z\!FHXVWFH0"66>!SLW;%&@Q.1CGXH2W*M6OZHN-.EJGB
M>K22Y--I^6,Z[3M\\,FD+X9/\-/F!_Z87J__ '17'HL=ZO5FZ\4?L7K4;O?4
MP/ / / / / / / / / / / / / / / 1G)O^4FK_ /\ 9YW_ +I&^TOEJ_\
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M7QI):X&?%Y0QWGZ&=X(%RE-E9*6+&1UZ2"N@*OXD1*6^P&M*]&2-=XW<28-
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M W$1.?MU2!/6L=CLHR=VBN[1TW=;:C5/S4-_-PU<4YF*XFV8C.5'?:147/\
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MU R;+28NB"$L!"162'W>Y [("28]NWT?&S3]11Z6*NL*OR3M3=R\<++;[;Y
MCV*\^T+!9B4L2$4C4,.L WN[4-3J*UK#(],2ZC_.V7RA23B K,V0W>YWWR[W
M=OE=G.=MLK9WSMGZBR\2XVD^F'452%=G9+**_INJH-)9GJKI,)%#J\B,9.RO
M1=;\POI)2X40Q('=5G&,+JZE'#K"BW]UWQMO_;>"6\MON>,(H:C:S0D[6MZ8
MJ>OFTVQOB9MX1740BB$NPKHX24Q)T@(=@F?PHD[=)[X*ZN_OT<N--OKJLIC8
M27N?7**6IR;P<96,TJ:LY?6H1N+:!J]E$$BQ^#B&H-IA@%;#(F6%.P#!N'8X
MPR%HM!Z28]IC#=IJBCC&GA9>[.5TK*MTX>+KU.OH0G  FXA4+!](F!TAXA2/
MDVQL"H+C.K# 5AN$,LF9<1NT9);#2;1L_991=H)*Z"'-[QB-J21O,E(\#4E[
M,(\C325;B6&TD:QP@^9%'\?;G-F^2B 1\3&CB+P4DZU8.7S!D[60W<-4%$P.
M<\ \ \ \ \ \!A=D0P-8]=SVO)$NX:Q^>0N4PPZY:+)MW3<-* ;X&37;+JZ[
MI(.$63Y=1%933=--377??7;77.,@=(&Y0E*!::KWGJK_ )GN!$B.>9T^!^IY
M%+ KU4;*>?*LN662^AI;6;*&L)2+4MROX/)7D3?O'Q]!F0?J.28^;X>X9&FH
M[I-MM_AU9=2AVEK%UAZQTAQ!WFH\TT'@ ;!,D[,Z,@XQIH7?JX7?%=&S)!'4
MD]7QC7"SM]C3#IPKC77"BRN^^,8^OT\.!S'@'@'@-(7PR?X:?,#_ -,+U?\
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M*DM!9LUK2:#3J<A8V(^=MGKQ,9!64=T*EY<73:C":[P1'QQ FP3&$]GS1O\
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M+$OD?X:G,%M2RHKTO6I:$TBB#>6P;T?OVN(,)DSM%C')$;'/A[4LG%#[A;7
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M_B9.OH&YET5KV1]D20L86C;@W'H8>Q10?]D&B[[+-R,!$L2!NGO%GI!5LO\
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M4*)RTFXY+73)Q?\ 5!!=M6_,U<=A5AU),:5Z7YFF@8IS?%X5-&*0B]C5D3&
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M@'@'@'@'@'@'@'@*]57_ ,L_4/\ KK6W_8W"?5XIZ?5@L+Z > > > > > >
M> > > > > > > > > > > > > > > > > > > > > > > > > > > > > >
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M#O*V9>IB"6[!=*."/S4A:LE76^HI^+:%$]ME&6F/"UJ'4E2DD\Q]3LM^',>
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M-NBO[WZ/(-8M9U>#K;DCB8EJ_LT&OS/<1:?C8)("IAK#2L=FPY8K&,#!A!H
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M-^IC51Z_<8T_%=NM]<;KK[[J;8QG;./0')> > > > > > > > > > > > >
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M^+0O-316R+9F&]4U?V9"9/\ %CKR\>JFHAT*PG99V<=.-:IJHDYD5:&0HD:
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M);Z:BO\ #:RZ%UJ2,G_L\-$?YEWR?_[%4L_XB\)P/]5'\T/[/#1'^9=\G_\
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M!P/]5'\T/[/#1'^9=\G_ /L52S_B+P<#_51_-&\/PP/ / / / / / / / /
M/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
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M?D,!:?".XTS27-C8WHU<:[R,CNB1,X=:ZN6B&K?7"@Y/I%O'G<L'X0> > >
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M<^I*HXJHQQ..DET_#(\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \
M\ \ \!JF^2[MY2K.5>R0G(5I5O,.V*3J5&9;5-&I)$YC:]=1AY(8V.F-D/:Q
MU(.ROX]?0(T8GC-N;$;C=G0X-DJU7'DD$'@U33+4KX6XEV3Y3SQNLFG5_%."
M^X&7"O"L'Z,O_OYQT'*+FZ>>]<R;IS$SZSX;=U]5H,H')Y#JQ%^SJR,S"=-Q
MD1_AS,QP(6*/;.,-0D@DB,<* IC?U]^]7??Q4\3:5-E2Z>'X:DY3],K*3OOV
M'N0.*Z_X_$V"Y#3>TKDM:XY")E5SWW>4J2F=MV>7CP5*.15 ^::C0XUI'H9'
MDM0</C8@2P& ANZ^NB;AZ\?/75.;<Z))82LE[]V@N+X0> PVQ*]A-LP285C9
M$:%S* 3^.%XC,8J;0_,BC\</,5AQ86]2QMIO^"[9N%4_Q$5$G"&^=5VRR*Z:
M:N@8P==(A\)W5;,9"^0 O6-?RWXW(/?->WK7 ^U8=))!U_SVE7TF_<S:L:3L
M-BY;1;0&2QL\CJ<L/[Z/H^#+O40T:21V(L3;W[\SIQJ]33XFFG$*FJ5$U*+O
M5Q";2P=E_P"F,?7Z8QCZY^N?^?/TQCZY_P N?IC&/]&,8_Q>',> > > > >
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MBJI^"E]^V?P]/H*FUAM='!D;*KZS'9@FP^NX*PVJU)^WK+9E$0#7-=(%1*H
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M.8H)M6+!@Q:II-F;)FV22;M6K=)-!N@FFBBGHGIKK@0J/SQQQ":*@ECU*27
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M!)B1R%49EZIIL2>.-EG:PY-MV;;2PFY@L;X0> > > > > > > > > > > >
M> > > > > > > > > > > > > > > > > > > > > > > > > > > > > >
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MRKPR14' &)4R^_(MT%=]V8P<]?J;:920:JJYQID$I<++LC/M'3=1!!SJMI^
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MW4=AP&P9Y:A",Q9S3LTZ/3EEN3U1K>M<6(WU8"2\^#C+7+$IS+6!=\08Z/\
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M?\N/\F?YY_\ ;X#]\ QC&/Z,8Q_/.?Y?Y<_TY_TY_P ?@(7ONB(3T; 6E<6
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M*-<,CC@6E@D#1:++,]BMY^;DDPTU9I1Y1YHRNNJ!ZHBL>G+22]150_EI6)H
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-#P#P#P#P#P#P#P'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g729258g04z63.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g04z63.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2C64&AO=&]S:&]P(#,N,  X0DE-! 0
M    *+J^$$)CA"24T$!       1QP!6@ #&R5'' (   (  1P"4  6071H=6
MMO<F%L86QA9V4@26YD=6YI;!P"-P (,C R,# S,3,< CP "S(S-#@S,"LP,#
M P #A"24T$)0      $ NN#.K+H8@F]\&F?%CBH]@X0DE-!#H      .4
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MYS    %P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L
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M1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M  $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F
M<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'
M1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $
M#A_;(  0 " .']L@ !  (X0DE-!"8       X             /X   #A"24
MT$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M     ! #A"24TG$       "@ !          (X0DE- _4      $@ +V9F
M$ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M    $ -0    $ +0    8       $X0DE- _@      '   /____________
M________________\#Z     #_____________________________ ^@
M  _____________________________P/H     /____________________
M________\#Z   .$))300(       0     0   D    )      #A"24T$'@
M      !      X0DE-!!H      S4    &              (W   %D0
M     !                          $             !9$   (W
M                $                         $     $       !N=6
MQL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"
M!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   (W     %
M)G:'1L;VYG   %D0    9S;&EC97-6;$QS     4]B:F,    !       %<V
MQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M     &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R87
M1E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F
M1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&
M5F=&QO;F<          $)T;VUL;VYG   "-P    !29VAT;&]N9P  !9$
M #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M    $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F
M]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP96
M5N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S97
M1L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V
M5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
MP    "/_         X0DE-!!$       $! #A"24T$%       !     0X0D
ME-! P     #3<    !    H    $    '@  !X    #1L &  !_]C_[0 ,06
M1O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$1
M4/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,#
MP,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,#
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MM;_P!\0G8W77$M<^E[/<1N<=2'-- <TT/_ #-_JN_TGIV5_N(M6!EWU%G4K
M\AP+6LVO9[=KVO(OI_G&7?]\24RQL=F30S)9?D[;FA[/4)8]K7!OLVO8VQG]
MM7#6#7Z9<Z"W;NF'<1NW#\Y*JMU;2'6.M),[GQ/P]C6*:2FE^RZ1736VVUM=
M#&L8QKX'M+7LL=I_.>U IVY&8^FB[(?50"VVX/&SU9;^@'MW/LK;N]39[*_P
M";L_2?0TGL;8QS':M>"UPF-#IR%''QZ<:EE%#!756-K&#@!)33M9C5WU8P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! ?_  !$( /$"70,!$0 "$0$#$0'_Q  >  $  00# 0$
M            !P$&" D" P4$"O_$ &00   & @( ! (%!@@(!PL'#0$" P0%
M!@ '"!$2$R$Q"105(D%18187&%=QEB-3@9&3T=7P&20R5:&QT]0G-CEXE9>V
M)28H,S="0U98P=8X1E)WTN'Q-#5$14=(5&-G=H6&LO_$ !H! 0$! 0$! 0
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MN-;34Z@BV8@^<)'%=TFB;H2'. 1KV3[4O\GQ ^'Y[-8JB;>-5;3%63N:TO\
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MR5W1T>#/A&#.6S1?A_3$7,Z,L>T.0UMVO(:"NWY3TEM)4ZJ5V*;Q#:A&H$7
MG:1" KE61CA(_?3:[MP[>/P$Y$VI#="*]::+C=-R*6/PDZDB23@GNY;1+4&
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MQ;7%O1C7$/&?*+.U./S?0(-SF YCI)$BD"SY3D %/I$0;@(-REZ!XM=,L\3
M#9OPJMYU2PU356A'Z[W4,]7./$%LN[3$[7FR4PMI+8*UJ)(S]==-CRS!PWC%
MCHQS>KJN&T@Z,B9Z+;R3&4!T@O&\N9(J\Q/T?-B"DW02$?%Y2*2?BZ /$)"
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M)-KNIRZ .^@ ._?\?VX*.@^X, =!WW]O77?X8 P!@# & , XF,4A1,<Q2E*
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M!%7 X^X@(#Z?=]X^O[/]7V8)-45%@TFG/B9RP48 P!@# & , 8 P!@# & ,
M8 P"--Q:[2VQK&[:Y6>MHU.X0+N&%^\C23#5H+@2&*NO%J.&A'J9#D QDOFF
MQQZ 2+I' IRA=\F%_'"D;:KE@@-=-N1O'>1H&J_$W5UYJ&HQI[4]C$5UDSM[
M$L[LDJ_JGG2 J*/SM2N55WAET5%Q$YAP-I2^C8UT'8CUZB'0_L_O_/Z?<& 0
M=R;  XW<@1 .A_,IM+U#W_XD3GV_ZONP#XN*/KQ?XZ"/O^8[58_=[T>$^P/3
M^K[, G_ & , 8 P!@# & , 8 P!@# & , 8 P!@# & 6%9-H:XI\BUB;9?Z5
M6)1\4#,(RQ6F#A9!Z!C 0#-6<D^:N%B"<0(4R29_$<>@[[* B1AK@N^F5.2]
MDETW $404350.F14BR2A5"'*< ,02F((E,0Y#%.FH4QBG#U#L/40K75NWW*C
MN=^"F$-0_P"4&W/_ ,VO5'_;2WX!F]@&%O.KD-9.+6B+)O1A9=7U.L4(/G;?
M);00LCIHNP6.DU8L8!O6"G>N)AZ^6(@DB=,Y.A$X@!2''!(NKXPK!DRA7".)
MC-Q_Y+\Q=_#./JQ-<0"04;:&<) 2*;_8JYKO'N*_$VA27KZ0^694A8V6*D9%
M,JGD*IJ**"5,@=KK[WLPEX>&;3UA5]S;,AYWDH_,^7\QY2?G^3XO)\[P!YOE
M>/Z_E>/Q>7X_K>#KQ>O>"[O>1VX!3H!'O\.O<>NOV?\ O]\$:+X7>B$46;5-
M9LU]I^QWIY="Q4E*2;1)6DJ_:QKA&41!!PE*Q**A64@!  J[7Y@@G35(0P&Z
M "A/U15>NK/)N(>YZOQ_SNOT?2]3TDZ4ZNGU4955(HC1_6"JB*Z8+%,VE< Z
M  ^X #^;*>8K@# & , 8 P!@# & , 8 P#6Y\4MDY<<83/VSE! (39FNY-XF
M(/4';Z);RR@2T6QEXR"L4O .Y%JIY*4M$1WSC8 $ 6335.(B)J\+71?:#N71
MPNNL:KPN@[?57D*Q914%:W4>XL=PF+#!Q3B),Z/U/626C(B72CVCA'S)(%XU
M!9DV(L"9.P ,!8+)(JR+Q#RNV)@(T^*SN-NWU]**5?4]NKL[)6&6;S]4FI Q
M=MTR/N+2E1Y=91"BB[]O/.'BKV50920'=.XAB1\+-)%P B%QOQH>&C\73<RK
M4K4:5J3Z0)8?I=2:+.3'Y-JU0M>2LXZ[26,7S!VJ=!;Z$(U*?ROI=(Q!:]")
M0%,GN//Q&[UM&S;:;SVH9"Q1M7AF%FK53U.S=V38T*T=W%[3E*U>(AVLT;M)
M]N+$T\X BC?R8QPD/DF[ P@MW]*2U\.*S*7"K<G+.I7Y^K&G.9.\7AJ_:F(1
M=CAQ%>!3*TF8T%%OE'O2?F&1!94"IJ)F\8@8,)#OW5QA=Z+K0V-8!\KUTV9,
MW;QXH5%HU;+N'2QP$Q$FZ*9E%E#E* B)2)E,8P  B( /0#@&&/"MWPR&J[$9
M<,9^A3515VA9[1?24!R5XQ8[%M[HTK.)/E2)$\A<ZAO$FP$3?()=(D*F3HH+
MO7N146$<,:3DR5PCXS8P48!U'$0 WH   "/8]]!T'??H/^K]@Y%5KQ(KM""_
M<3PWE@BXM6/0EI)BQ<2;LK.,3<O$&YY!T<IS%;MBJ' ZZHD(<X))E,<0+WD7
MKZ$5E7IZ7D_4D9,B/%_-$9S?H?C?D>MT=?7T>GU^IT>DG[=?5T='5U=/3TT7
MJ5$5$22HZXY%PYHR, 8 P!@# & , 8 P!@# & , \^6*D>*DR+E<G0/'O"+$
M9^/YLR1FZA5"M?*Z4^8,01!'RQ _F"7PB ]8!^>3X3S/3I.6V]G.N:W9JY+(
M5Z\1<RPE&L N\ [3:;D7$Q>9E@Q;2_Y36191%RPA9%0Z<:Q8*JI^-5XLJH!N
MSY/;8D=&:!VGMJ(:1S^5HU5>3,:SEU548UR^*HBV:(NU$ %4$SKN"=%)X?,.
M!4Q.0#"< -<<ISAN.P^!EIN%QTEL2T6N[ZCWM"V573E:&SUBG25?C9Z!\%F=
M*2*7T4JY;BC**)-U)!)!L"YO.-X!( D?MX\(C>#8IQ2'P<8N.J8B A^8_592
M&#V/U1X3O]GMZ=]=]] 'IZ@B-RK9O'6$>ZZ3^/L/[!]O?^3!5MK4A/D#O[77
M&'4UJW;M^3?0>NZ4@B^M$S'Q3V:-$QRJY6_SJS-@DHZ,W3443!=5-,XI <IC
M%\/K@B22>*OXG#3[+AU#M2I[LUQ2]KT1V_?4S8, QLU7>2<6[AWCV%D$S*LG
MBD:](FZ:%=(B1=,BY"F%$Z9^NE"]!O.F>5YPB29@HP!@# & , 8 P!@# & ,
M 8 P!@# & :-/B6)25,WCI:3KE;TVHPV'*UZ+NDW?Z/'6)XT ]JCXE>0DI6:
M@YLWT0>&6+%0L1!.X9VA-N%)!PL9,R1BB)64Z=GS-V-=@XNM0<5 PC-&/BHI
MBW9,&3<5!0;-D$P*DBAYQU%013#ZJ13G,)" !0'H P4]K ,(:A_R@VY_^;7J
MC_MI;\ S>P"U+C1*5L.%6K=]J5<NE><+).7$%:86/GHA=P@(BBLM'2;=RT54
M1$PBF<Z)C$$1$H@/K@&G+3/".F;)Y67+<[&]7K7)^+/(J?#7.N]?O&,+KP49
MRDP4?,HR\ @S!%RUD8<Y(SY) 4$&:""?DI@;OPKOV)2=(KBF,)&[(JGB$>C>
M@'Z'L.O3KQ" "(^H>H !@ /7T_'!$@[K#MSEJU)H=V#0P#""Z4[F"\YJ:OLE
M1V9!1O#U&BV%;9M%<0;->QNK]'F!K7VS&856(Y2BYI.0(_6%)!0K4\(NB<0%
MXET(BI%D:,93DTYRY,W\%*"/0"/^H._]'K_JP18I!6S.D3E2Z,H<>A#H.P$?
M<1$/\D!Z] _N(9415@B2B^7+5,KU=/3_ ,NI9X:X(]P@6Q9[I6*>V9O[//,(
M%B]?L(EDYD7";9%Y*2:Q6[)@F<_LX<KG(FD3T$QC= (=".153IG-\X-/*/LI
MZ?QOQ/R?S?V_]-T=7J?]/I7U.I.E>E&Z$FO^[]98,JJZ,\4+K(8#E P"(@/K
MV(=>X=_<'8=?:'H/N'IBX1."(T'56QOYU.>"G'QE$>NQ[[Z_R3?Z^NL&?VZ7
M9XRDOP!,'8!WZC[=>OMZ_<(!_+^.3J1T6#Y;[&L<IWCE, (]B _R#T(=_P"@
M/[_9]N9Z45%B[,S.^&?'L"H" ]]?9[YLB*BNU%;<K@HP!@& /Q(K9+U#C/*2
M$(\L,0Y=W:DPSFYP-@LU9;Z^8RDKY#F\6J2I<=*692H0 >!2>:1+)5RY;JD3
M#P%*<P"5O^U_E>[X>[""G^(M58NZC\O$3#FU-94TN\G[#&[(*ZDUT7UW06NK
M1I8'L)="!\ZV;S\<U=?+G,DLV!,0\0*C^RU^\<F2J.9.1&@=&P"5<1@]0:UB
M$J?++SU43CJ77F9*Y-N4Q27EH0K>/3",D54A%,[QF"2YB?5$_08"HBSOV7=S
MF&A=) T*P#4FN08ELX74&@4V ^6"W M\P%E\CY#RQF@7Z5"1$OS0* "GF>,
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MB8!,5QWDDL$97Q^)!XY7BL['T5J2[TFI3-'I5DHE=D:?5I^/)%2\)5E(MN6
M:O8PO8L#!&$;"FW,(&33,F!^A-T =_Y66<]HLA-N"C & , 8 P!@# & , 8
MP!@# & , 8!I<^)RO<%MH:&C(ZHTZ9K"LW35)"2MEZD(5BJ]/L-@"E8<59G-
M1:,H]E44FKR >.4ER&>,7J10$6X)X"?.5;UF;%M\<A(KC[&ZW<3=1M-D_.'?
MJUKQLI5V:2\97G\^NDV))6"0<G23C8E ZG@24,0ZSHQ?*1(!P$<$3)I;<8:*
M1Q=N;%$H?(QCQ_FH"=*FHR;%F=@E.T_)ZO6&4A7UFB*^]8@<91P+RO1CZ1-)
M-43MFH(@@J453 &"[_61$NA-QZVW+SLWE8]8W"+N$&PX\:GC7CZ,3>ID:O\
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MM4G3%ZT5#ZIT'+<Y#I==&(7T,4H^@4X*JNRJ_5!>I5:,W7?B+H75@I\R1P4
MQNE2@7OT4$.A .^^@#L>@_\ N_ 1CIZOV>"HB.BJL-%17PW>4")MF;3CM6-(
M!V]@+791L5A8P#9O589>7<,UGGB.+V0*F)0:L&Z0>8HN<2@8QR)=@8P#DZ^O
M]>E>KJDBIW6E,SW_ .-_QW7^=ZO5Z?1ZWI^DJRZO6ZEZ>E'C%43J9$1%C+-7
M+!J/)^N6VQURN-:/LUA(6.6LD2BK*5!ZTCV"E9$0?.Y)Z<2HMV*X"E\DOXC
MN)_X/S *80Y)Z_I]3,\<DA@\3]?\_P#TWZ_X'I]?J>I^=^!ZB='1^[>EZOJ*
MO5_XHB^DC=2?^2HBTC/)Q,?%XC!["/\ -]O7\G>=CYKI2>?4JWP=F#0P!@&
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M(<YD@36<H@=FY.HU4,F RD-U@NLHSC)%73!\X,&A@# & , 8 P!@# & , 8
MP!@'S/%CMV;MPF@=RH@V763;)B4JC@Z21CE0()Q @'5,4$RB80*!C )A .\
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MB;!H@T34.%TMX <Y$$TRG.!>B 80$?  %[Z   $OA+C'9C.H0 0$! ! ?<!
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MCI,4G!77DD, @])KA!_)":/PTN6@1R9C1%432_+$L>-2'8ZZD>B[&"2@R<B
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M-@PU>>MZ==K?1+)3XG84>P;C8*\O,Q3MBRD&[XA"/#!&.UTGJ2 +@0%42F*
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M@*<T<3+*F2(/A%[W6T-H>FT-BL]84=EMM[&R.RFM?8H7%]$>$8]W,I$$JSE
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MT[/5X&XPKVOV2(C)J*?)&(LREHYE*,Q4 !\I<6<@@Y:G5;G\*J)E$3^!0I3
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M@WD;620";KC9:\1IGLO,N8]JN=K4C)>!K%&>+,6"ED4.BNNHH=(@")EVNT;
MVA[SY1ZKXX&HK;9<E)HN+X_69Q)(6(=2P(,V"L4WF+!)"A_^05V&6FHOY]^?
MS00*^0Z(H'B\((^#:X^R)I&:9TG.5FHX#?$'QT=RCM?8DW3%+^)6R3/Z&B:L
M0ZQ DIB0</FXM4S@@HL4$T''A;@"ZHII"!L"-6:&OP[Y_<'ZNM]6M_/[=3^I
M62!LS!'C=J9NN\@9=A+M$US76WCY2CF/7<(IK 3ZP(G."@@(&Z\(A@IL#P!@
M# & , LNYZ^IVP(UY$VR!:2S=]$R<&JL<%&T@A%S)$TY5JQE6AD9"/!\1%(K
M@S)TW45!,@"?TP3FE_/:)B.?X:O#%22:S*FHO,F&+1U'LI=2Z7T\HT8/C(G>
M,FT@:S"[0:.SMFZCANDL5)8Z"1U"F,F00%W\?!;&O>$=HU/RSA=J:_W;L*"X
MT0NKI&!;<9CV>8E:B&S'TH<Q[H)I9R]=J-#Q"RH'CU7:@!*@1V40*4"8)AY6
MYK*D]C8G@HP#'W>W)G5_'A&O?EZYGW,G:59$(6O5*NR=JL+IE#-A>SDT,3%)
M++I0L(T#YB3D%? BW*=,@"=50B9A'A@N<G=O/\)7IUUK5_J]<NE0ED)RL6R&
MC9^ F6@*"SD8F5;INX]VCYI2*%*Y;JE.!#D*JGZE5(4Q1 !'7!<7@R9<(KX+
M!XHJ77@T8U\F-#2V^*Q3(RNWTVN[%0]AUS8L#8!KD9:VWTE7SN#(LW\)*G39
MNVC@KDP'\9@,0Q2G((&* X)*N6ZK''9))+!OS\\R^.ULXG:JW I+\IM1+62V
M[[KG*(CIMK"+@=[C,M):$*Y9TLK!X>/0C1^A?JMD&I_$A\YT('6.4P)&-_>2
MD&<26.G>0W'ODD_G-S[3L.TEJU!U'6M7<VU]3IN^,J6A+3M;@UZ"Q,FG:T(:
M:DG2S5!PBJ=PHNNBI]3OPBW=]S=QP)VCN:[[&NT-;;UL[8%#8:PH<JWE=DZM
M+KEQ$; >J*IV2#C.V# TFU:IE((&\*Q2#WTL8?K8)]YI&Y;&U7!1@# ,!.=>
MS.*$%5Z9JOE8G:W,5LBP-Y"GQ=0@KO(RCZSU XR;-2/DJ.V/(,)1KXA<H)$<
M(KK)E4\'F)E4#$+NBD1\&=5>,N+WG.O& VKCZ<K?YFT;:WU\(O"PZ%X;VIK8
MR'%81="]3NA4["!3']4_G  !*'\#]00Z"2OBR+)-%>O\;.UY;A/QIFGU+D)3
M6<8\6H,_.62 *JN[,@60L4JO.2B,D@*WE2T:M,KGDR1CXJS-%Z!%R) 8/4.>
MUQMBU ^'EQ#^C/HDNI(WY4MT+>A4^D)070RZ8%3*P,\,\^8&O?+%*R&O>8$4
M++MJ*'EFZ$'[RAEVWC/:6M7<:-*:;LMWN.MJ3'5R>V(\(XL;I$55$U")N3.O
MH^.9N5#-XJ,^=%5]]'L$T&XO53N@)XQ <$580G]/1_?12"N"1"E#ER!2@4 Y
MK[R$     ]:X'H'V!]OIUZX-&>F 67;==TB\(^&TU*L3[I)JX:L'T[7H:;=1
MH+D,'C9'E63SR!(<05 I  AE"@)RFP# G@UQ/VAJNK;#3Y6R.MMO75UMRSO-
M=2S;6U%BOR>UBR>@E3$4E(R&04+).FB))%Z98?.;N?"F40.4#8)&#)K1D\OM
MP;*2E*4 *4 *4 Z I0    ]@  ] #\ P4"(  B(]  "(C]P=>H_;_J'!%DNA
MJMV7\*?1^SN<U8YKV&;G52Q%.DJ_9-.>6T7H%OFW!E/E;-+M3%\2RJ2*ZAGK
M$4C_ #CI-JY%8HIF2."+]0PA&47T\MK,UG$_"TV7RPAJ]QLTW!0[NF\HK]'\
M@U;32). @W\LVUO)*+.XIU8"),$JRT=,U7/R!/EOEW"+A\=LDV6265%I'M?]
M-UD[P/X*[6BZT_E>/.E;A!M9*.M-:?MX&*=QZCQ#M1@_8NF0F;/6ZA3>9X"*
M*M710**A%"E <$=F>4$?/O/V5S,2!@8:KPT77:[&,X:"A63>-B8F.0(V8QS!
MJF"39HT;I@5-%N@F4I$DR !2%     ,%/5'V'KWZ'K ,!^;?+^X<9J/<'M'X
M_P"Y]I6.*IZEA8V>HT-6S:_@@\]5%X\L#IC)H2BYX)FDM+NX>.8+O'J22#=N
M8#+%4((B8Q:58I-5S?C=3%SX?/Q++ER=AE_IO3F[+S7W%^;U6I;UKFDI2C4:
M8C5HYDO(.[)$V"=%[!DKLFX=,'<BS3?,'+9)!9,?F2.D4X_MWOY%9[7$W.92
MK%%3$8">+K]G 2E#U @"/?W!W^WVP1DC!,UEG/N84V?GIQYJ&TI?4TU+6Q.R
M0-ZJVM)M^VH]C>52+O%R2B5ZW OK0@R/$MWC].;BP)YC@I$S/" J8O?I?U1Y
MI))JJ(ZP9L=.RD_?_:WZ=2K^RI)5ZF1TXJZKIB9G%0 5BJ@)@$!$PAU]40$H
M@'J/V^H"(>O0]AZ9$A!-"?J_4G4\GAFS;UBVDSZ\&Q@# & ?)()H*L'J3HQ"
M-5&CE-R=02@F5 Z)RK&4$X@0"%3$PG$P@4"@(F$ [P#3-Q!TSQ??<AE;'H'E
MGN:^6'5S*QQ\A2ETGB%';U.3NC^0EJNC(NZE%L).#1M9E?*0CI5ZJ0S9,Q%!
M0#QG$6/L_E&RBC1T-PUGJ]<ND#)U>VPD98Z[,MQ:2L),,T7\;(-A,4_DNV:Y
M3HKI^,A#@0Y1 #E*8.C% 0!>+?V,5K[IC66CN&F[M<ZOJ4;5:?#ZBW7(QT*U
M)YJ+5W.URS2\DN0ZPG4$SE\\56'HW1 $J0=%3  >XFROXXYG4DCBCZ\8..IA
M]QT=JOL?M'_O(A/<<%)^'KH>_0.A['\,!8?<#3AR@Y&<L]A;;WWP:UQPT<6A
MA*Z5?34%N>3VI#56I2,%;4UZ^R>$&0A'!/I5C+E51?P15CO2$3(J @BH"@B-
M%%U_FGNU9^EI/?FS-M[,>?#IY#\():O5NK\?ZRZV+>IB^5B[ZQG*RZB$*_%M
M&16<8U&8>2TG&/$'4<D;YF'.BDNX#HQ# NWGW\B\-7QQ2":LIMG@86,KD+%5
M^%9(QL/"1S*)B8]L0$V[*-CFZ;1DU1(7ZI$T&Z1$R%+Z 0I0_$026=8-NJ9H
MQZI_0AA^X!'KH1[Z]>N@ 1]?;T 1#W#UP%=E:=XFGSXF-=^'?HSC=\_RBT V
ML.M;KO:F6%S7=<TARK)R^TY.8;E0MDJ>NHHF$P)BN$DL\4[DVZBD<BDLNY*0
M 1X:83FVCS9$=*J3UH%S"K\PM\KUQF,=6U]): 5@6JC92/!K#*QTH,8T&/7(
MFNQ.W9>2D#54A#M_"9%0A#)B&!+1M?OS\[!2B3Q% A@$!#Q>G0>@!T'0!T @
M;U] #[!'W#!$9%9$XASB\667D[!^J4PE* CZCUWUXA^X1Z'W'[?7!8(FB>$-
M8G/RW\9-7'CMB<@.2&^M1NDZVX1@Z;I[95IKH6!%B\$PNU:[7&+Q!-TY?/&\
M42?FG$;&>8JV:JNT13[P$TK@U.^VE%-,?-V^T,-'%K55N/,B)V2]V!3HNQ5/
MD%R4E8&N59DA(5.XPD@_?"$A$3*EHB9)DZK16#\JZ )2,BH _0ZB1Q;O<DN(
MV_&6)S4IR'O/*J+J"@:49VFMVGF+:8[:DY);I<1T>VD-15I"+*C;JU5UI BK
MR333%&70;O!: S,U4$PG'%*IN?HVT_JICIZL?DG&W/8]Y;&>KR!IC:5Q?WBS
M%47(F3Y8)B0336(Q3!,!1;^'PD.*A@,8QS"(0?-9[2?NVA+&"JK$!<@=V5#2
M]-=2USK-VM,/),9EHZCZ95).T+&;H1KA9TE()1Q#G8M7+<JB1'2Q03 1'LP8
M)/Z6ONV:,?GGX*\\^%\#NB%=UCAEN_2\@?6U@BJ3;9"PR6PV[:MKNJE-/*K&
M5Y5T;\GT9",E:U/*G;%!!%F=@F83$,F!!6ZE=9RDDHQ>,_AV/T_0DTPL$3&3
M4:KY[&69HO6IP\(F\E9,IP!4"&.4BA!'P*D\0^6J!DS#V4<$B\:IQVJBOL>O
M@HP!@&G;XDEIXP0]KKC;=M'WQ;)<M%;N9)?3-D;5M%"GN+VR80[6S YL$">9
M35N@LU8QBC\\9%V1-R=)%/M0R[O4EYS7M)C("P\:M,<RM5<>;@SLVQHVN5BO
M&/7GJSX1L<[3+!] FL-4N*THFZ644D5ZQ%HR+M-3Y@BC1;R%E$UO'C/1.)!V
MAB]$AFL=6JNI?<SPQJ%KVK0]GVZY66S&H1UW,=77[. )&/7?R,G#LBO'[:-2
MEU8AM"2;F-=5\7IXF3#RG3M ZZ0& 'S^VFTWT2*8D<Z6UMK_ %CSQW="Z\IM
M>ID4[XZZH?NX^NQC6+:N'GY8VY,'*J#5--,5@3 ""?P^(0*'8CT&/OO<"FQ3
M *"/0"( )A !$ #W'H/8.^@['V#L0P#"+B=LSEG>;KR)8<E=-M]7U.%V4N&@
M99M)Q3\]EUB9(6K49I%@]=*MI]-RU,_<BL5-,S>2;II!XDCB DONYX(DZ&;V
M"C & , " #UW]@]A^W^XX P!@&->^N,E%WV:LO[!.; IECJA)=C"W#65H<5"
MU$A;&@5O8:XYE&J*XKP,PBDC\\Q42'QJH(+)'(LF7L9><8PTS5H0:#O%JP>8
M:!1ZYK>EU.@U&/"+J]+@HVNUU@"AE191,4S38,D!5./F*'!ND0RBJ@>,YQ,8
MP>(<":HL<:1AAI!794I4O/!H#]OIWV'K^/X8!C;R8M^L-3Z\E-NW_63+8AJZ
MK#Q;2.;UB!F[*[<S<HVC8Z/C%9A("I>-Z\3$2BY333$1./A]38)6Z-'.B+-)
M1FBV5QSV#K/<4S>$FW'_ /-%>-33L;%2T7::E4F,ZQ=2T824:/8U["D=)@BJ
MU4Z!=NY*;Q>(.^A[$19+&"5GJ^.#1E-Y9C] 'L !@T, 8 P# 3X@<Y.HZIAH
M77^X=7Z=V8O<(.9@K+L&QU&N2;.NQ9W(6=S3G-O6(U0FCMU$&!7Z29P;H.G
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MAL[]ZF[C@'$Z&I''2F:AXY/+[(ZXU$F6H,WVR8:UQ=G77(D60657&W1D2]>
M<SWL5VK8&+;L6R!2@F4N4BK%$>*KPB/_ #EF,W\&CRY28C(5N5U+24?&-CJ@
MB162>-F2*BIN_ D59PHF05#%*8X$ 3&$"CZ!T."*CPC%%PTPW3<U!?$%O^\#
M6=LWU1:]DJ5/\UEI&@AHB>I*@.M[%,H$,QW.6<E&XCKTS,4 (BD51FN R@NA
M(LFW P56<,=*=WKLQ9'PP^>&FT]!<=M)6MS)Q%N50DM>R5Y3B&K'43_<4660
MG+11(6Q_.IF4EFB1'BY5%HU&,64(HV;R*RXIHF%O2[0W-5V\T^WBX"IV^L6;
MY1<S=W]!3<;+"V62-TX0<?1[E<454^P#P' IBF'I0/4,$G[HKR6<)19DGBZN
MQ=V"EMVZVURBUR7MENE6\%6X)F=]+R[SS :L6B?7F+K"D113P%[#L2D,/X8(
M[T5ZHDT?.%Q/RW[AY5Z-7Y-[5=Q.Q[D?1LGR^T;9KRQCMEZV9LK!=8=CK8C6
MWUZG2]36NR]'AG#.!_*,K:53555CGIFP  I%P/,8ZVFK'Z>-=[)H^U*XWMNO
MK)'VJN.5W#9M+Q9EC,U56Y@!8@"NFD<3)F^H8? !0-V4OVX%7BZXK*4&?)X8
M+$OS!1@# & ?#)AXHV0+Y"CKQ,78?+(F3(LX[04#R$C*B"15%O\ Q9#*""8&
M, G'P@. :+OA9VRTJ[VW?17%>W9 UBKJ7ANG 7FW7N5I-$6)L)P:(@HZ*MT)
M&1![#,-%Y&66>U%Z_B6[ I&B)$D0(<XD.5[M\&]TP]%'UZ]! !]^A'T#T#U'
MU^P,!75&2#UP(-Y-&[XV\@1'U$-)[2[].A["CSH^W?H AZE]1]!]\!(-[)*L
MG]YGR<4/_DO<=/\ ZCM5?]AX/!2?\ Z1;H"J5<44A6*04RK"0OF@F)O&*?F=
M>+P"?Z_@$?#XP _7B !P #9N#@78((@Z,D"!G()$^8% IA.5$5O#Y@I <1."
M8F\ &$3 '8]X!W?W_O\ S!@%!]OM_D]\ AG>.BM=\AJ0&N]HQCJ5JYIR)GA:
M,G[B/6&6@W/SL2Y^8;?PA1;.>G) [ "+D34*(&*40$BF=,(OQ&CM%&J:&]B_
M"YY)ZEVQS)Y&:VO<UN^&GM51K;CCH-:_6FL3BEOC% $S:SVH7W;Q"#;J/%HQ
M(BQ#3CE9!JX.T* F$'BVO9IOB_OF;MN'Q-HI\9]*H[FI*&N=FM:'"MKC2T;"
MK:@A)9%J0BK92<<'5<NG'0 =R5==PH@L=1 RZOE@<788W!N\5RKODF?OPFZ'
MKT'U]1Z#[1]/7OKVZ^W!;Q,#.5_!V"Y02;J45V)-40]FUO)::V:RCZ[7;2QO
M6K)N1+*N($&UC07_ "=E6D@99[&V6,$'K197S!26,@@8J9'QR[IA%9O.B9'Y
ML>:VQZOQ?USNC3L VK][:5+>U)0MG'2Y5@]UOLGJ.AG@ C-X/-YS(./GIUTP
MC&-?CJ_\P#>&BI56&)%"JBN85W?)39;'\](Q^\J_S^L>'E@VHVBM0+:KVM7)
MAO):PTG6=H)V(D?&;-GU$C3-<=59&N&;'"%<L62[^68MFR4=Y@F5>>$]_<&W
M7B)O.7Y#:?:[ G8:'BIAK:[E3)%S67JLG3[$ZID\[@EK729-< 7?5*PJ-32$
M*NL94PMU1+YRHE%0PE7:<U:-ZZ5._F3M&[Z6XQ;EVCKA.)/>:=3WDK61GFKA
M[")2A5D$$'$LU:"#E:/;BL*SHB @IY)#"4?3!<,_A5]C\[C;XO'..CR&Y]=;
M$I^@>29J[IN,V-^66D2RS&L049-QLTC(1DV$O(,57#ML9NF=8$4UBI)D.0Q1
M,IX2BIT_LO+NTE[\;FI3X<] V?N?D_5'&OZIJOD')-ZO<+U-:FO4Q9==56!B
M9&D:Z8"2.EOHL$A2BY&;;1S:(:B[24"%*Z!4&I6:ZPVB-TJ\(Z\P6#I.UW"\
M*=9_$9U5O34.O+MJ7D73:E6M_7!]=9:,VRYG^.K+54F_FGL7 0$ ZE%2.H)M
M\TT*R<?(E>E$H%,5+L_8PK*NTLD1$_L]5/U1=AV ?;UWU]H!]_\ /Z8,O+.[
M9YX%<%& :4_B124#;]J:Q@(^3K<?9=>O8J4DGEPLK>N1\:S=SD:_>?)UJ3I$
MX\V6F_@D'K<\=6)(%VCI1,@IINB^( 3F[<V]TI_ 2-6@'E:;HMZXZAV#B&;H
M1KB'11CEDB&:@G$.D&J\>D!  0;N&R"Z0"!5$BB!L&85VHF*KO6E,7O   /8
M #]@![8*R8)'O;F$50_Y0;<__-KU1_VTM^"F;V , X^$H"(@4H";H3#T'8B'
ML(CUV/7V=^V R89[XG+ & , 8 P!@# '0#[AW@BHBS1%U'0?<'OW_+]_[<%&
M , C';^IJ3O"AS.L]A,7<A5K"#87J+*0=1;PBS!RD]9KLW[-1)TU<MW2":Z2
MJ)P,4Y 'OKT$2J1^_;WFS,6EH_CIK?C\WLY*"G8UGEUEF\O:)BTV23M$S*OF
M34K%J=U)2RZZ_@0:D*BDDF8"%#V+V)AP1WA*,8I1=46,*3G"!/>#0P!@# -5
M?Q.:X?\ )[4^SST?1=X5H-W9LJM![0UW;M@W.<O=J$T3!U77\/6I2*0D5K 0
MRB#Z)FG 1[OR2*G51\@#X%WRADOPBNJ5YXZU">"&HE;?&=R\=+5?7%-DJ% 5
M>98/#-Y&"<5*67=O8:8CG!#(R[<SA=+YD!,FH8@@;!E4945%5Y)]U:L],#&G
MGC5>2TSM?1$WH8FR9@8,L@0U=@# PUD^FWT@9#Z3V9/MY)I(1;.&8>%ZP*FT
M?MG*R0('2^L/0J02-)W>QKI;:V^(V,-&!]%\DRPA=DJK,8]:R(!:6VS/HN,2
M4NTPJ,J8WYF#VXLD^:MC'52)$G.8\>5$2$ 4S)XKTKX@,9:N0!9R3?5VRO5(
MD$[!NPDA9];6&\!9Y%:4G-;1,'*MWS:J'I1HJ.;E2-'()2:2GF-!, G$#(+X
M<*-S:U/DTWV%(5^2NB?,O>!;#(59F]CX!Z_\^!$ZD6QD57#UNU\L4TP3<+K*
M 8ACB<>PZ7]D7C/#DV/8*, 8 P!@%!$  1'V !$?M] ]_3[< @[?=*V%>M-[
M-J.F+VCJ7:-LJTNPJ&P4(QL_"MV-RR,DQFET#)B*IR"1-$7/0N6I0(NV[41(
M C*25619R2:>[\1Y\/B?K[<NKN/VL*'O_:7YY]P5NO-V%WV2,<G'#8Y$ACG%
M4$B% 7 H)&2:FD%@!T^,C\RY#SE#8+HT%[5A!HOPJQ,CL%-?GQ(-73FW- ,Z
MU&4R<O,6UV'4)6[1=(03<;+:45%XJC8I'6B:SMFD%J19.!115,N5=-BJ_.S
M7A4,$2-K:ZFD*T:XD-*Z^8P=FT+7J052I[2N.J)/;^J;+L#9>X4HV;=M=>:=
MNRE6D7S:K7-[#':*O9 R_P!*O4WK5P10JK1]T*01P;XZ\0]Z:^U;,V/C5=J
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M9E&IC$(813)NI\[>4/$>K6?2GY&<B^.\A7&BMIT9IIWQF9[/;3AKULVY2K2
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M,$TNVD/HP%3.RN0$%BFMY'ZFN@^X/3V],%G/Y ^P]>_V?M^SOKUZ ?4>O4,
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M?[[US]O^<< ?I Z+_7%K+U'K_CO7/?\ Z1P#@._M(B?HNX-9] /?07>MCV4
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M:9_6MKO]\J^'^M_ATSW14\H#B&\=-"(_\*VN^NQ* !<:^/?0_P"5V#_[0ZZ
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M"RTM=).2JZ],E6C8KM5!5I%,&=B0<+*2;55([Y$"-G)3F.D!,7^#VXS>_P!
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M>@9,/* 2"!@Z$2[>%U<G']#[BU^H'57[G1'^[X#:\K\C]#[BU^H'57[G0_\
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M8KUTKDW4[9#,+#6K%&NXB<A)1L1W'RD8]2,BZ9.VR@"15%=,PE,4>OL$! P
M( MMD0?HKB9QYXUN9YYI;6L+29"SD;HS<BW7D9*4>,&1E#Q\65_,/7[QM%,!
M4.+2-;*I,TA'L$A,!3 &%W3$OG=^I*]O;5%WU):7#YE!W>&/$O'T69$LBQ.5
MP@]9OF8N$EFYG#)\U;.DTUT5$512\M4ADSF# (+UYPAT=5]>UVC7RN1>Z9"&
M>V.8>W#9<)#R$],3%OE#RL^^<-6C1M%L@?N12!1HR:)M0*@D!4^P$PB82?7=
M=?9WR6\"<,N*292D3X_:M3(0I2$(G5(XA"$*'12$(5("D(4  "D* %*
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M "&<K-F+-!140\1DVR11]"!@%[X P!T >P>_J/XC]^ , 8 P#$ODWR7'1<;
M)UJ%1OUQE'3J4<4:.5=&L+FB0R#D]JL,-\LT=,".H("HN&S:;<1[68417B6C
MOZ2603,(ERBRU;QA,A#X>5\Y9[$JENM_)!5E)UBQO&<YK&=191$8LZB7ZSPQ
MT(V/BV[9Y^3GT>$4Z;*6!NUG6C]>0CG22J+9-PH"I+7!5\;+A!#9'@HP#J67
M1;IG5753023 #'55.5-,A1'KQ'.<0*4.Q .S" =B =^H8!V@("'8>H#@# &
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M +T1_P#M,%(TE]^?#^G=H5/=$WM+3$KLZA5JQ5*EVZ0LC9W(56!MCF.=V5M
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MU%5RO;QUU,3LX_;QD1%,+$R</9!^Z-X&[5L@F<3J+*F^J0H!ZCZ8!DA@# &
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M2Q2&'ZZJHG5$YBIB46_%VKR=@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M,[!BTC&;9@P;HM&3-!%JT:-DB(-FK5NF5)NV;()%(D@@@D4J2229"D(0I2E
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'453LXDZ$! 1*(=#Z=
M!@$1]NC%'L.OV=]@."/E*<UH]-8/%9,<@/[B("  /A#L! PB'?V"'7A'W*;L
M ^_K Q^WX;B;E?%]8"]>_?N( /H #Z![C[^OL(?=UZX#X8M&$IM"+6I3Q@ @
M B "8WA*'0^H^'Q=>WOX?7[OY<%=,<M\"H& ?#[]F[ZZ ?</?W#T_#OKO!'U
MX4IXOK  AZ"(@ _9_P"[KU^KUZB(]=!UZX#\3BBHW.^&E3G@HP!@# & , 8
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M!@# & , 8 P)# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M!RN(>54:H+NHQ7QE(856:BHI'-X.C@ &[*/U<7?8D8;O[+-<.^1>>"C & ,
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MJ[ 3"T8XE86+DEH5X$A$JOF+9T>-? DJ@#MD*R9_EG)45UDRK)>%0I%5"@8
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M\X8WP79@HP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MC$&:2"AP\MRY4*Q2<&<@"9E%%50$OH&1+ND&N:J)'7&<%7)ZX8F0&4HP!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &"=,DT3P,%
@& , 8 P!@BSZ=?91@HP!@# & , 8 P!@# & , 8!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g729258g06c08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g06c08.jpg
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MOZ9[#[=$ORGCAQ^+3S5]5-[_  F\X^NGE=:_IGL/MT2_*>.''XM/-7U4WO\
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M,@MK.YCC)15B1#KLP.]&-.0GE)1G4%[8G&T;B5F8 6TF_$"QM(#&8Q)D+*A
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M3R9SNP0!GVP3<#MF [L\G&8B\!AVP$CN5!._)QS51MY9-@/]DNU08KW46/\
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MM*;1#,@I,>+0"@U]Z0A[272+=4EB#R".3W@"VX:$\59E9)1 )F*R(I42R2*
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M+SF&HC$F0S5+,L(3<'8R/L147<S-L>0@#(ZD1V//J'AP*S2-I"V"H"KN9F.
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MCZV+[]/.;>R+^M__ -9&JOCMQ[8-*^,-]1/^'3M5?>)'UL7WZ><V]D7];_\
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MUL7WZ><V]D7];_\ ZR-5?';CVP:5\8;ZB?\ #IVJOO$CZV+[]/.;>R+^M_\
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MJ1]ZG9-OXU/IKV\^ [&1Z]+27M_+_-_(]H_2W] :A]4/O5CV9:^.3Z3ZJ>?
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M=<!Q)%JIN'<UILTZ5L86NML.'4B#RAR&5F$REO)#SE*3'RSAI.7,.(]'T2T
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M6DZ3'8='\WO1IK73EM8K]+N*^TFVL[R*58YYR=1O]/U95E0ND>G3QA(H!B/
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M+V1K?,;3-$L%JL#LTH*;KB7B.TS)&S(O) 2QD(W8 [$^?/JZM.*54,_(I?\
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M:JKMR%6]4Y'5CP]_OG'R?)U?MJ)@.Q\[(I.OAFMJ-U)1 M>8!:#&'G'-;7*
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M9*E6="[@G 4#N50X. &S'G!;G*=2[SO>R[K%R:;!!Z76Q%\-ES57\:2*N=3
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MOUK_ &^T1:>!08E]XSW\S5*[!:DNS&&)!FY6<-4 $-Q^ -+26,339T?$P_B
M\RRI[#LM<:*AZ2SG&AD;:/@NY/+DL:-(QYE1R52>O/@R< G8(NX^%5'7S+L$
M4<@3S9@.KRX'.M>)G65J'#57(AW;(8!&Y,J47*XI=ZA. *8Q0O+AN^I%/51P
MB5K+S9&K0\%&F8HK$>PH((*.K9AP"NV-/N,NK;%90-J\2,[I#+P^$2'PKC#G
M:>Z[C&WF2*#=184C<03S.Q\JNS>'QMYJ<H,\AW6<Y&#YF=76OP]DM8,\U('C
MZZ!-&8UHBPK<5KTV0!-;S@D1!$C$IG@H*<P'T38#J,/ORL%F9T9FLIL#&8,\
MJ%A(R(R$$LRJ4)C5P'6W(909,L-URB\L$$'?M(( W2*S*P("JQW .5.TS @D
M)W)Q"QYY!R-NX8)D@WJ@UP^X_$,,6H'.BV\U2W\.T^U3QJI]<M8S7YLXR5A!
M5LLTZ-?B:*G'LQ=H3&ESXLY[#+40<1>AX-92C!4HP,:RCW1 <,AE5<%AF3AC
M>47<0".^1F1<QGKW*=Y3WK$95A&QR!R02';N. 2,]59<HE[KNR*[&M=4<)R:
M_.<7@81) S(%)6,E+:VR8M@Y!'RIX>6ES"AY>.PL<2:QF0/DR8RD/+HEB>%S
M')M#@<PK*^T_!8J2 P[ZDY7J(!Y5:CK(H9<[3U$J5S\H! R#WB.1ZP2*F/*Z
MSIQ2G%*<4IQ2JAGY%+_Q*/YRQQ2M(]V=;=+T7N<3J"R4&]F6I0;31D]=Z\_2
MUA:NSOC;1_2M :D!"]L$7&P/.W4 Y@RQ3Z_8)@L-*:*YB2&F):&/9Z+T*O=<
MT:;5[:_L82LVL0P65P+P373:'I4&LWY6:*UEM+<"SG'!:[GMTEF4Q;U9DW<^
MXU&.VN!;O%*W<6[O(G#VH+F=[>+*M(LCDR(=PC1RJD-@C..1WKWZ;<D!\N%L
M2N2M>Y!;-+6'9#TZ8-!U^5K WJP :@)B$!;$HY':)[7"P"QD,J2,KA2.\)+.
MMS\2F8,#H)TCX<BOI]PFH"?38K?3E1))KA=3AU.>%]\<K) QCTN9XH9@LMQ$
MRRQ IM+SVRM,@B9#%MF+2Y(53"T"L,$ M@SJ&9<A&!5L'.)+4NM[I8O4HN/J
M6WA!LF! V6QEA$8+;&S,2!334"O6N)D/) ,$WK#73!8-#+U*/$>M<'QV#D/A
M4130M^7K770KI19)#)=:3-#%//;6T4K36AA>2\A>XM6XRW!C6WN(8I7BNF86
MK\&=5F+0RJF2:C92%@DZL45W8!7W 1L$<8*@ED9E#( 7&Y3MPP)I2'75TG"1
MPPH1W(%AQRP2[V1EEX);DDH(/6I$P'V$2/AL5[)>KQZ07 E15J\I((EP$2CM
MP22(\J9":D91]!^E4LDL4>CS.T,UE;L1/:<-Y]1CAFL([>7LCA737L4\4MKV
M,\HGC8O&65'*P=2L5"EKA0&61@"LFX+"S+*779N01LK*^\+M(P<$C.PU4OU.
MO+]JCU&P0; NDV9=-M"QV776!5F:!@[&\(7*RVF-*D,AK(%F/+@O26&<SL17
M'DS&),=GS]U87EB+5KNWDMQ>VPO+82 *TML9I[<2A<[E5IK>9%#A6.S< 496
M;:CECEW\-P_#<QOCJ5PJN5SU$[74\LCGC.00)?S4JRG%*<4IQ2L(7?KAZ0^F
MJPRJ)OWJ*U5J2XE&8ML'5N\VJ"#+3:U/80(AFX\24I+C@Z23!&(+,A..X7)&
MRVL9[IE7.SI_1[7-6@-SIFE7M] DC0/+;0/*BS*%D:,LH(#A)(V(ZP'4]^JF
MFBC8AW52<$ GGC &?I!J)^>R]C4]>WT\>Z&(^$YOCH5TL/\ ^7M4_59!]HK'
MLFW\:GTT\]D[&KZ]KIX]T(1\)Q[2NEO\GM4_57IV3;^-3Z:]L=EB[&MGTNMG
MIX]T(1\)Q[2NEO\ )[5/U5ZCLNV\?'YPKSY[#V-CU['3S[H0CX3CVD]+?Y/:
MI^JOZJ=EVWCX_.%//8.QL>O8Z>?="$?"<GVD=+C_ /EW5?U23U4[+MAUSQC^
MT*\^>O\ 8V?7K]/7N@B?A.9>T7IA_)S5?U5ZCLRU^,1>>*]L=E<[&WGTNM;I
MZ]T(1\)R?:)TQ/5T;U8_^4D]51V;:?&(_.KV\]:[&[GTNM3I[S_X@B?A.9>T
M+IF>KHSK!_\ )R>JG9MI\8B'E8#[<4\]9[&]Z]/I\]T 3\)S+^#_ *:_R8UC
M]3DIV=9_&8?/7]G/G\U>WGJ_8X,^EUI=/F?_ !!$?"<G^#WIO_)?6?U*7U5C
MVPLOC4/GBK4%[*AV.5B&\A[K.Z?VUJ+'GL)7?Q.,Y:D'2,AAS&,N?K7676W4
M9])2%I5CT,\G^#SIP>KHKK1\EE*?L%0-1L1UW4 YD_E!WR:N_GJO8XO7H]/W
MN@"?A.9#V.>G9ZNBFMG_ ,E+ZJ=L;#XW!]8M//5.QQ>O0Z?O= $_"<R'L;]/
M3U=$M</DL9?53MC8?&X/K%KSYZGV.3UY_3__ "_%>_YE_!IT_P#Y(ZY^HR^J
MG;*P'7=P#_Q%]=>WGJ/8Y?7G=/\ _+\3\)R?X,_9 _DAKOZC+ZJP[:Z;\=M_
MK!3SU'L<OKSNG_\ E^)^$X_@S]D#^2&N_J,OJIVUTWX[;_6"GGJ/8Y?7G=/_
M /+\3\)Q_!G[('\D-=_49?53MKIOQVW^L%;!PNH#25[IX"W4S:=(M-8L$RL$
MPA\$?@DQ12 Y8!JDR8<V*ZXP\WCN'$.=RO*FG6W&7$H=;6A/G;G0-:LKB6UN
M]+O;:Y@<QS030/'+&XZU=& 8'J(R,%2&!*D&MM)X9$5XY%='&Y64Y5AX01UC
MD?)@^"IOYK&M?IVKOMBS_7S7[5ZC\2N?JF]59[U\/V^JGFL:U^G:N^V+/]?'
M:O4?B5S]4_JIO7P_L/JIYK&M?IVKOMBS_7QVKU'XE<_5/ZJ;U\/[#ZJ>:QK7
MZ=J[[8L_U\=J]1^)7/U3^JF]?#^P^JGFL:U^G:N^V+/]?':O4?B5S]4_JIO7
MP_L/JJX"]AT8U.8&B;6#GD).58CQ(\]E;[ZD(4XI+3?=8RXK"$J5W*>VKN4Y
MSC&>UGF$NGWL*-)+:3QQKC<[1L%7) !)(P!D@9/?-2&!Y U*)7I,?OIC_;YI
MU-57%*<4IQ2G%*<4IQ2J6/\ )IW[Z1_,H?%*JN*4XI3BE.*4XI44L7RVHG\*
MY7X$W'DCJ;R>D5!ZU\OH-2OD5-.*4XI3BE.*4XI3BE.*5%*W\L;K_"M/X+5C
MBH'5\[?::E?%33BE4K<Z"[+D#VID5R?$;9>E0FY#*Y<9F3W?@[LB,E>7F6W^
M]N=Y<<0E+O<+[C*NY5VLBCA5<HP1B0KE2%8KC<%;&"5R,@$D9&>NF1U9YCK'
M@SU55<QI3BE.*4XI5M+_ "ND?Z'_ '[7%8O[T_-]HK %AJX*W#8PNPPLSX,8
MD(-,,8ES8?>R@*='*AYF'($F*]ET<3BQ9\7"G,H;F1H\C".^L-*3FCM&2R'!
M*LI. >Y8$,.8(Y@D'Y"1WZEE####(R#\X.0>7@(S6'X^J]#1K2JF1*PUBQ-5
M&%+DC(CMM?BP*>OS/JV+9*2F)+@87!*IT;31HH:2DQG3[5&.8@19[6+FJ3?Q
MKDIQ"_<<0@,1&"9/=6;:"-S%>R)"2H.SB+DCN,5<.'=LVC=M!(&[DG<*,GJ
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M*@=7SM]IJ5\5-.*5T5]ETV1L266UG1](V4_1+KKX@J\F-B4V=("VH;,F1%Q
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M9M9LR8]0OX6 B6, A;&7 (N)XG(8OD&U ,!9V9TA]IT=@O(X7DE8K:R#,,3
MEF8D9F7)[A&'(#!XF=^  K/WB<^-5Z2G%*<4IQ2G%*NP .<.G! VN,R'C+Q"
M,J%F*M3+D=UIS#F)>9"<I\%;B]SWY<E2T)82COF58SC'*+F:"""26Y*B%5(?
M> P8'ELVG.\M[T+@[B<8H,YY=?>KMBK\4M"""XAX@T5,QX3+1$@RQX.U+E)3
MVG'4M=OYOH)RYW+??E)R]WECOG>4?++AHGGE>",Q0L[&.-FW%%)Y GT9.!RW
M-C<;QG'/K[]7CE-33BE.*4XI3BE4L?Y-._?2/YE#XI55Q2G%*<4IQ2G%*BEB
M^6U$_A7*_ FX\D=3>3TBH/6OE]!J5\BIJ#[)5K[R&L;.UO)M6O)L%(VTM6],
M-=:DCRDE@<F$7;(8S#=C3I4J/#PS(QE#SS[37:RI:<94JU;#JVJ"$=XULJMU
M4FP3'1=8R)]A#1B>9@?8-JK8UBGO*=C2''!-DMJ*PA^ YCP%X@P/DRL)3&P\
MVIY*P_&T!T;V F;&#M4:6+$MGQK!9SJQ%8 2_*V(!M\A5FE2R@V,MB4Q"NUU
M*K+P?"TMK.VJRN28KDDR?5(5.3X34VATGITUA=S5S$U;6E-V!*BT@4?(@Q(@
M=8L0KR6'ZYHCA.")83+C1K.1JPZG""[\1ILBQ4F0^)KD"KY9'*BJ!'25TRMI
MMZ6M$ZP:3?S,BQW)#-2%,IL5BE7-G8K]A(I;CI2X>7?XT>ZX,HP@DW:F&CS<
MI!-M,G"IR>O)SX?V?9RK,50IU3U]6A%,HM:!T^HU^-F$"K-:%PPH$-#RZX_X
M(+%#V8\*!%P\\ZXF/%9:90I:NY1CM\5%23BE12M_+&Z_PK3^"U8XJ!U?.WVF
ML6=1/4%4^GFEQ[)8'HSQ4V0P&JP5^1F.HJ2[TJ3)<<6AMUUN .AH7)F/I:SC
MNU18>%MOSHZN>DZ+]'+KI+J'8D.^."&,SWEPJ!^##G:H5255I97(2-2PY;Y"
M"L;"N/KNKC1[%[D1K-.QX=M"S%%DD()R[ ,1&B@LQ R>2@@L",1:+ZIC.Z8U
MN-YCT>J4VCAW"UFMY*=/R)$MX8DRL*F/S)8R%&BQH,*:3)3))!AB"/BJ>?6V
MAU"\>@Z5=$]*Z+PVS376H7%S=R,(K;;;0>XQ8XLK2;92H!9$0<,[G8\R$->6
MZ.=)>D/2"[N8NPM,L[2UB!DNB;JX8SR$B*)(A)"K A6=VXH*JN,9=34&B:2U
M5NXK%N$??6LMBB+59"<%4VDNABWE"<APWC9<&%,C[R:@Y*P13#Y"5!C1)DD>
M+8<E+BMQ&<K1?![(,=E8I::?I,L+0PK#;M+J*2Q1A5VJSQ)I\3R8QN_+(6.2
MS$DFM+^#^_GU!KW4->@G2:=I[E(=*DAGEWL694G?4YHX@<X7-O($  50 %K>
M%)V@4FMDDK/U:LU37$2()./2S0P:'I42"'&3HD([+E2FHP)+ (@(GH03=C*P
M,GCYN>W'F1W7/G$TTMQ-+<3NTDTTCS32,<L\DC%Y'8^%F)8_*:^F1QI#''%$
MH2.)%CC1>I40!54?(J@ >2KQ.LU;%Y)X)V &.R$"HL9G$XM B9$5YQ4Y*#Q/
MPB0WX %6H822@I+[U!4H?.QA_.8DC#==9U$@VY-0V.Z%-;U[:NMSNQ >9N#5
M"#7FL%+H'R-=2P1P4JT$H^<'Y'OJ2S-Q+@L^"NJ2V_WM><)RI62.*5;2_P K
MI'^A_P!^UQ6+^]/S?:*P^C]8G_LI^]CBLJ]N*4XI3BE.*4XI3BE.*4XI3BE5
M#/R*7_B4?SECBE:OW3J1P!W7$T32M4;"VS;A]4K-^V),ITNAC FLZ3<+(7J]
M<+'9EWN-5<+DRDRNV8A%K588,&UA:Z3G9C)==$Q"GI++HYQ]&?7+W5;#2K22
MZN;#3TO$OI9M2O;2WBN;B*!+*SNA%%$EQ;QM<W+10B:XCCW$"5H]22[VW MH
MX)9W")+*4,2K#'([(C,9)$W,Q1V")N;:A..:AL7Z>[(;TW;3U@]L,A=1E)GA
MXE?>M=+)**DK %E6VV&*35!PIB&$:DW>;8;*%F@AS%,@FGW#[,@!EG!:,]%3
MT]7]C_I%IFIC3X[*6]CF>=;6]C$44$ZVMI%>W4DI>8K9I;VTR3R->20J("L^
M[A.K&BWU6TGAXID6-@%+QG<SJ7D:- H"@R%G4J!&&.X%<9!%2(?UOZ5*6XJ,
M'%G"U%A:?H>VAVQ*_#.V9HWB[['V?K3-3A4\ !(6SQ\ .:O+(,Q<0')T"2N6
M/(C1\D//SBB3H3K,5I%+)$(KY]7OM*DT^X>"V,/86G:;J79;WD\\=KP)X-2B
M,+<01NH62.2194K(:E;-(RAMT8@BG$J!G#<66:'AB-%+[E:%MPQD=1 *FI5"
MZS>ETE9:148&Z:?,/[&%U(U3(L=V>[&,B[X*G&Z5+\:I@Y$#D6L>,(KKZ"LZ
M"Z5DP)8^$V\1CNQ4ZC]#^DT=M>W<FC7:0:=)=0WC,(PT,EC*D-XG"W\60VLD
ML8N#$CB)761R(V#58-0LB\<8N(RTH1HQDX82J6C.[&T;P#MR1N(*CF"*Q?9>
MR(]-@N R;K]I5=ZY%;L<JT$ T O"F#!0;3MQW4-G@!!X2,=O35JJ-/>G@7*V
M_('R0I(?:%$4UZ0Q-D=2V]C[I'+(T%Q;"RN6-NEK'-)"Z2RS:O::-)'/-!-(
MMB;6[NQ'/V2%=9HY+;A]D*R+2^JVBC<CF1!O+E58%0L#W *JRJ9=\:939D%2
M'SMYFSZEZF.C^G8+JH-7IFHZU;XNJK(*54:&P$L>PSNTJ]L"RP8\[7%(K.;8
MHP% :]M!4@2(#9K&0HXR;1-;"BYD_-NK=&NEUX8A?W-[JUS:-JEO+V7?-/;Z
M?!IEQ86SM'J-[<]B\&:?4+6*.*.1&$TD,)0S2*@Q@O+"/=PDB@200LO#C"O*
MTR2N 8HDW[E6)R6((VAF!V@FK?9>N0A6W[$S(K5([H90.L38@L>Y<WT6TG%Z
M2-^0M43J]BH+%MNJEWNKH.60&8C&7LLFPY4,Y7G8@.81E66W0F.Y6W*W-[B2
M_P"B.GRR"S4VD3=*]!DU5+@W?$P$L;DP6\\+0C,,T4PN \R1KB^I%-^4B[F*
M_E4<3NR+&Y$!7AXZY4#NK!CAE9=N%)KL4Y\]KK4XI7PO?HE:LV0SU\:]E!Z\
M<+16^EG7\=<D:)GSF$/HV;N9Q3*WHL=UM+J6W6EJ;RK"\(<;5E.$K3G/Z3]A
MZ:&/HQ>K)+'&QURZ(#R*I([ TT9PQ!QD$9ZL@^"N-J )G& 3[FO>^5J^?%-#
MO/:QCR,M?;_:\G3'[?[SY]5%U;9/\8@Z_&Q^ ?SJT<'P'Z#7OY!7KZ2[9_)P
MQ^1\R[)M_'P_6I]ZHJH30[SV\?\ $RV>GC^]TQ^1\=DVWQB#ZV/[U4;6^"?H
M-<_D'>/I,M?\G2_Y'R1<V^1[O#UC_M4\/]*F#X#]!KRFAWGMX_XF6OT\?WNF
M/V_WGS86ZMNZ_C$'O3_VL?WJP=6Q[T]?@/@-<_D'>/I,M?\ )TO^1\V%NK7<
M/XS!W_\ MH_ ?YU58/@/T&JM%#O/;S_Q,M?I?2Z7_P '_0^7QW5K@?QFWZE_
M[:/PK_.I@^ _0:J$42\8[?;IMKQZ7IUXO_A_Z'S;CNK7G_&8.]_VT?R_SJK=
M6.,*QZ^\?DKF11+OW6/^)MJ_D\7_ &L_]#YLB[M=S?QFW[W_ &T?@_I564?*
M]RW7\$^ _)52BBW?MY_XG6KTOI>+_MX_Z'S;%Y:8/\:M^8Y>[Q>$?SJHV/\
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MNRY,>*UEUQ/?)#[+*.Z<<0G.W8V-YJ=W#8Z?:SWMY<,4@M;:)YIYF"LY6.-
M68A%9B #A5)/(&L9)(X8VDE=(XT&6=V"JHR ,DX R2 /"2 *QM5NJ[IYO &O
M6BF;_P!7VNNVR]#M85PQ7M@@#$ OL<O%DSQ=$B/P"3Z56TA!B29L.OK[@I(B
M-*DM1E,92O/2NNC'2*RGN+:\T/5+6XM;&34[B&XLKB%XM.A=8Y;YA(B_Q2.1
MU1YQF-7.TMG(JI+VTD5'CN8'2240(R2(P:9@2L0P3[H0"0O7CGC%3)6ZM:HV
M&0U(O9U41M 55/+HEKY=I')N$&F>$)BYM$FOJF8)- T2%MM.$51\1FU.L]\<
M3AYK*],:1JAT^/5AI]X=,ENNP8[\6\IM'O-I;L99PO#,Q4$B/=N.&P"0<6<>
M#BF#BQ\94XC1;UX@CR!O*YR%YCGC',5?ZQL"MW6I![[4K<,L5)L :/80EK$&
M&IH H"E1\2XY>$49>5$?'NQL]_3*0[EGO7;7E6$XSG&O<V5W97<UA=VTUO>V
M\S6\UK+&R3Q3JVUHGB(WB0-W)4C.>6*R21)$65'5HV4.KJ0592,A@PY$$<\U
M&JGO+5U\I!?9E+VI3[3KH Y8FS5[ VT83J(S-2[_ .4SDRQ19K@EF.#3&?=)
M2E2\1HK+2WW'<,X[YS9N]&U:QO8=-O--O;74)Q;F&QGMI8KN3LO;V,%MW42E
MIRRB--FYF(4#/*L$N()8VFCFC>)=^Z574QKP\[R7!V@+@DG. .><<ZQ(<Z[.
MD:LUFE7.P]46G M4V/#,SZ%826R $03;X5=+. CTJOS7B"62; @TR\*(N1E+
M3$(-.Q'LH>;6C'5AZ%=+KFYO;.WZ-ZS-=:<\,=];Q6%P\MH]Q$)X%G14)C::
M$B6,-C?&0XRI!JAM1L$2.1KNW5)0QB9I4 <(VUBI)YA6!4^ @CK%9&G]1^EA
M</4Y EN:B086^)0>%I>3*N(MEK:4NP,CWPK%%RY-3FRN$VBXI4/ O$G#V28]
M"<]W-C)<YZ:!K<KZK''I.H.^AI*^LJMK*3IB0&03-?87^+",Q2[^+MQPI#U(
MV+6NK91 6GB N2HMR77W8OC:(^?=[MRXQGWR^$5F'PN7ZID?=G/?<Y%;%/"Y
M?JF1]V<]]Q2GA<OU3(^[.>^XI7.U*E9:E9S)?SG#*,XSEYSMXSX0SCMX_5>A
MZ&<X^MGM<4K7#8?5UHC5-]/:PV!LY%<O=:TE8^HHM7I FVRWT:?J3IQNPVJ#
M+'!9@TQ*'8K1]]55#S9UQD0A,PA%K[\%K,C/H-/Z+:]JEC!J=AI[W%C<ZU;]
M'HKA9[5%.KW0@-O:NDDZ21+)V3 O94J)9J\J1O<*YVUJ2WUK!*\,LH25+9KM
MD*N3V.F\,X(4JQ&Q^X4F0A20N.=5[G5/I5G:;NEI&RXT79#&I7-Y/@9<6P1(
M[&L&);<2187S\D<U7&)$;+K4R5772R+/&$NMFWPS8A:9N<!T:UQM+&LK82-I
MQU4:(LZR0LS:DREE@6!9#<,K$%%N!$;9I085F,H*5/9EL)NQS*!+P.R=I# "
M$'!<MC8".LJ6WA2&*[2#5KH'5UIS9F-<^3%EN;6=NES(?6:;5K+;%#5=E@Z+
MC9<HJ!Q=Z=7O#*Q*HV4GP]LQE-;.-95 $%)I9E^ U;?]%=:TWMCV3#:L-)BA
MFU(VNJ:7?"S$]]VM2*?L*\N-ERM[F"6U/\8A(XDL21%9#$5[;S<'8T@X[,L.
M^">+B;8N,67B1IE#'W2O[QNI26! RKK;:57V[1:ULK7MADGZ7;Q^"M>,YBF!
M69\'+ST?OV1QJ(.*1,]^8=1WJ;"CN_J.Z[CN%)4KEZEIUYI%]<Z;J$/ O;23
MA7$/$BEX<FT-MXD+R1/W+ Y1V'/&<YJ^&:.>-)HFW1R#<C89<C)&<, PZN^
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MN^;0T-W7C>P9QW=UU[V^]Y/$LM9QW1/M]QEKN,M]K]3WON>Y_4]KD]IM8/\
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MN?-?9<TG5M:Z!ZS8:-')/>,+:8VL)Q-<V]M<1SW$,2Y!D<Q(SB)<M(%*@$D
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M[D]J=5/5IFH'O?\ 4KGK\'Y.IXL?C$\/OUZO#UUY\V#IYSZ6\]?9_P#&P?\
M&[D]I]6_1>H_J-S^%4<6(=<D8_MKZZ\^:_T]_5QU_P"[7 ^-O)[3:Q^BM2_4
M;K\*G&AZN+'GP<1?73S7NGOZN.O_ ':X'QMY/:76?T3J?ZA=?A4XT(ZY8Q_X
MB^NGFO=/?U<=?^[7 ^-O)[2:T>K2-4/_ )"[_"J./!XZ+ZQ/77GS7>GWZN%
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MZU6624-$I"%W9QS[719(T>WN)]]JT!A>*.2?$K;U992LDC) 4"E0D"A3N//
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MM@[2&*VM+:..- \C,[N0TCD@,Y5459M;2"T$G!WEIG,DLDDC2R2/C&YW<DG
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M3#DEO+><8<PXPES+J.XSG&%]TC'<YSC"NUGC(ZL\_!2JWBE6TO\ *Z1_H?\
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M_P#35<G>^?T54H]+/U_Q8YMKUCRC[:UGZQY/2:JF_23]?\?-V/K'S?WFK/\
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M\V'=94J!2WDF1T>:R-+,$74CU <'EDX[Q\F/F_;R\G.).]C7/'2[C5IE:<=
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M65='4J\4J%HY8V22-FC96/MXI8YXTEB=9(Y%#(ZG((/[00<@@@%2"" 014F
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M_.6.*5UR]5_8_P"#U176R7E6V3.N#1>A:GH08C7JXB6:K,*CV/>.+W*@F,V
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MRTA+;3:4H0E*4XQCY<[,[,[LSN[%G=R69F8DLS,22S,22222222<UV@
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M+'.!E<9#9&Q^J-A.[%K+D\B!*5>R@I[==N%?*LQ&G15G8#B"TZ/%<@$S$5^
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M34M-=*NF"EKT> U<J)KPR76C5Q&I;PLFRF\T<U#T33Y1T%?@-GD,6E*1VO5
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M'=(3G$CO^3TBH(&1R'7X/D-2CP*'ZDC?<&O><BIP/ /H%/ H?J2-]P:]YQ3
M\ ^@4\"A^I(WW!KWG%,#P#Z!3P*'ZDC?<&O><4P/ /H%/ H?J2-]P:]YQ3 \
M ^@4\"A^I(WW!KWG%,#P#Z!3P*'ZDC?<&O><4P/ /H%/ H?J2-]P:]YQ3 \
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M^I(WW!KWG%,#P#Z!7C,.%C&<YBQ<8QC.<YRPUC&,8]'.<YRGM8QC'IYXI@>
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MKFXL[VW8O;W-I(\5Q$Q5D+121D.I*,RG:1E68'D36,L<4L;1S(CQ,,.K@%"
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MY/+B.M*;=C?69M?Z*:)T,32-"N)[[I%>1KV??+9RVUM#)<8:Z*37/#FD:WB
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M>/IGT.-]H[\-Q3>? /V^NGCZ9]#C?:._#<4WGP#]OKIX^F?0XWVCOPW%-Y\
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&Y?Y^>O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g729258g06h77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g06h77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1E(4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &2R^9$0X0DE-! 0      $8< 5H  QLE1QP"   "  ,< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0ZEZPJ5\QR](\0ZR,"!]+/3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!F@           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              HL   2X
M  $                          0             $N    HL
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   HL     4F=H
M=&QO;F<   2X    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   *+     %)G:'1L;VYG   $N     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 5@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M.V5/M-VQ\O/-3FTM=9O].GV6>VK_ $G_ &P$]*^L#O0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MIK?$U I&9&:5E\+55EF"A(:'E*2GT];_Q  ; 0$! 0 # 0$
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MI!WP0 I12I'#/CE/B;X\^Z1V9/& N2MT9/6;Q.2D%04,8SV#"A@'.!D'()'
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M0:HZHZ&VK<U]/> *JM6?\.D55U-.W33TW+)R,U+RE8$EN)+ G&GE )0,E*1
M;DTJ0D*3)T^ETN4EY&F4V48D:=*RC8:E963E64,,2C#*0 RRPTVAIM  "4I
M X9(?9@$ @$ @$ @$ @$ @$ @$!YRY[4MZ\*%5;9N>BTZX+>KLB_3:S1:M+M
MSM.J,C,I*7I::EGPI#K3B24J2>(R"G!&8#2O3GHV-B72*^:=J'8^@=ITJZJ+
M/&H6[,NNU2IR5LSN#^FK?IU1G9JGTEU!4H(5+RZ2C>5U>YD9#[.J/1Y['.L^
MHR]5]2M#;1N.^YIZ3F*K57DSLNW<#U.*54]ZO24K-R\I6'912$]2Y-R[JT[J
M<J( $!F=G9^TEE-7J;KC)VC3I34^D6,G3BFW)++>;=E+'0^)E% :DTK\&3)M
M/)"V\,Y24IPO'" P9JAT>6QMK'J!6]4M2-#+5N*][AD13Z_6WDS\M\.LJ2IE
MJ8J<K*334M/SLLA:@S,OL+4T<*204I,!D2B[(.S_ &]<6D=V4?3ZF2=>T(MB
M;L_2N=3,31^Q6W9T.IF:=*-ETAQMWK7,J6'5#>/$'& \\=A?9B^UUJ+I2-,J
M5]@6K-[.ZD7Y0A-3W4UV\W9UBI&K/N%_K&W%SDNT\4(4 5H2 ,<(#;2C4N1H
M5*IU&IK*96G4F0DZ;(RZ2HIEY*1EVY:69!42<-,MH0,X.$@D9)@,/TO032FB
M:SW-K]2K9EI35>[+>D;4N*[T//&9GJ!3G>ODJ8XRM88#33A+B5-M[^3A2^&(
M##FK^P)LAZ]7VG4C5;1*T[JO<HE6:A6WTSDA,5J6DB%2DO<+<C-2C%:EI<A)
M91.MOX 2#E((@/5ZQ;'>SEKO1;"M_4_3"A5ZCZ73,M.Z?2DN'Z0;2,HRU+MR
M](<I;\H]+2JV66VUL(/5J;0E*@1O9#$]W=&3L-7W<-X73<^@-GU"M7U)R\I<
M;Y-1:8FW9?J"U4FI-J;3)RU9Q+RZ7*BVQX6L-IWG.)R&>Z%LUZ,VWJ;0M8*1
M:,M+:BVUIS):4T:YE3$P[-RMBT]23+4)+:W>J<;2I"2MQ:%.J*0=_)Q >4VB
MMC+9YVKG[4FM=;!8O";L9V>7:LW\(U*E3=*7/I0F9\&F*=-2KR%/)2DK*5X.
MZ#QX0'P-#]@792V=;@J%WZ3:24>B7?5J3,4*<NN;G*K7;A32)H*\)I<M4ZO-
MSC\K*.[RBM+!;*R3E122(#ORFP[LPTZUK1LF4TRIS5MV%J;-:PVK31-3_5TO
M42<?7-35PLK+^^N:6^ZI9;6HLG(.YG@ [EP[%FS==<AK+3:YIO3I^2U_K-*N
M#5EEU^<2FZJO0UM+IT[.K2\%,.RY89"0QU:%;@RD\84UWCT^K6RSH5KKIG1]
M)-5=/:/>5@6]\&?8]1JBAU*J&[1F4,4Z9ITXTZU,RLQ+RZ4LH?;=2LHSDG.8
M#&%G]'SLA6%2M1Z-9NC]OV_2M6[1DK&U#DY*9J&+EMNGN%QB5GEO3+CRW>M.
M\^^%AUTDJ4L\H4T[<1UM,.CKV,=&;ZH>I6G&A-I6[>5L2Z).W*LD3\VB@JZ@
ML+FJ1*3DV]*4^=>9.X_-RTNTZX3DG>S@/15+8;V8:O;>JMJ3^FE-FZ!K7?%.
MU&U+DES<V4W'>5(F69FGUJ97UP4T\P^RAQ"6E(;)3@IQS#(=,V;]'Z1J_+Z[
M2-GR4IJE*V-*:<2UTI<?\*19\B=^2I!;4LMJ::6-XN!(6I6[E9QQ#/DN EO"
M5;P2=T8.4C=2$^+V@<,X/& YX! (! (! (! (! ("W?3Y20?2.'R>: ZJG7
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M /'B,@\>>.[/; 4ZIO&"A)]/$\.7$\>'I@+PD 8 X !..? < .,!:IIM1RI
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MI)T+WBX#O$IYC$!MK (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! 6;X\E?LF M44J&"A9XY'BD<2>/$XQG)SQ$!@"4V7- )#5"L:SR>
MDMJ-:FU^6G)2K7:*>V:A.M5&7,I4%.H5O2J7IV6)EYN8;82^^RHH<<4DX@//
M4?8QV6[?L>]=-:/HE9<A9.HDZW4;RMYBF)\#K<XPL/2KTP2XIU!DE@*D@PXT
MF4/]3ALY@,M6GIS9&DU@L6)IS;5+M&T:'29YJET.D2Z9:3E4EAYU:@D94MUU
MPEQYYQ2W75E2UK4HDD-1>C/0C[D:RE;GC)NW5%04,@@G4:X\YQ@')))SS/&)
M&.R>T3W$@"%X2!NKX=NZ3GB>WC%%V^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@
M&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)
M7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@
M&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)
M7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@&^/)7[!@
M&^/)7[!@*%0((*5X/<E0^J XG4M+0I+C1<2KFAQ&\D]^0L%/'MR#W=T!X&W=
M,;$M*Y[NO2V[7I](N6_'*>]=U8DV0W-5MZE2R9.GN3BDG!,K+CJT=4E ()4I
M*E<2&H.SP<;:6W-P Q/:,JP ,D_:_D.)[2?? 2!;X\E?L& ;X\E?L& ;X\E?
ML& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;
MX\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?
ML& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;X\E?L& ;
MX\E?L& ;X\E?L& JE6]V*']\,?E@+H! (! (! (! (! (#Y55XR53!X@4R;(
M'(@EAT'CYQP@-%NC-_!!LSSW9JA_[1KD_)$KIV33E$]QOXCXH^7ZS%%T @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$!0I2>) )[\
M<?7S@(^]G89VU=N@'LG]&A\@T_D#Q]6("06 0%N^CRD^T/? 79&,YX<\]F.^
M M2I*L[ISC@><!= (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M (! (#Y-4P*?45[Q*O 9T'A@[J95PCARP"",\SG&>!@-%^C-*?N1++3D#-V:
MH'D<#^B-<?>>)R>^)&._9JC5WO&_B/BI\X!]?'\L470" 0" 0" 0" 0" 0"
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M" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" C\V=OPU-N;_ --T8_\
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M9H4?N]MO<!L<$:,<>''^=>:]?S<_/$^^<\KX$E6Z/) ^010P.X>H0# [AZA
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M'J$ P.X>H0# [AZA ,#N'J$ P.X>H0# [AZA ,#N'J$ P.X>H0%< <AB 0"
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ML$Z6V*!PY8MNG#.3E6]C(WB2<<!PYAFE"4H2E">"4C R23CSDY)]),!= (!
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M7 SC>X<\<(";]384$\5#=SC!P./84_%4!V B (;2A.ZGD22K@..>>< ?GSS
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MEQ1\%</C+9*%'B28#U8& !W #Y!RYP%8#YE75BFU!. <T^>X]H_2SIP/3CC
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M;]2MNW:^KU+<_P"5JZEW_6(I%T8:L-1=MI2GQ2E=>O?IV^P9 2@ 9 '#CCL
M' #D,8&/-GMB68F(I,S,XS(Y8H0" 0" 0" 0" \!?%95;-IW+<3=M52\7:/2
M9^H?8M1V&)NK5UR594M%-ILE,+;EWIR>(#++;JT(658</',!"AM*ZZ:D[3NA
MM^Z$V'T<6M5 NK4VD)MJCW%?UJV;0K6MU^>FF-^O3]4E)^8F99-)2%3>9=OK
MPX@%LD@$OQGX$S.D%I5:Q-+=.[*K4\*A5K3LJVJ#59\+#@G9ZETR6DYI;:CX
MZD*=;*0ZH9*2"./,,J)& !W#Y^V K ?*K'];Y_\ P=/?Z*] :)]&;^")9O\
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M E+:$-I2A*$  )2E("1P   @.;[[_<_I0#[[_<_I0%R=_CO;OFW<_/F N@$
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M'")&CYM=9$U0W^T)'RG/R]GJ)BC0[I/M\; >U0H$ C2:O9()!Q]XR >P^?G
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MC4Z;IW:<E/R<TV=Y,S+3DO2VIEA\* *7FG4N)/$*&,P&9$RY3VA7'/'ARP0
M>)&#PWL@D<. $!S*W]TYW>SD23V<L\/DY'S9@(_=GC/W:6W/W>&Z,^;C]K^0
MQR\V?DY]T!()X_XOSP$(EJY_1WM5 /[3:R #Z+AG0//GMR/]42M]-D3QKX$W
ML4(! 10=&M^J7TAG[[^Z?XOT6 E=\; QNXP.^ P-M-;WW.^N !&?M57ICT_
M50SQX<SR[H#3?H:OUN79M_Q:J'\+SL!*' ("&WIR?P'YG]V#2O\ C2S#N)9[
M(*A95H;J=[^=B@]H'_>N4[R/J@/3*2M:0#A)YD9)[^'#A]<!"CTC>J6U0SM9
M['^S?LWZVIT41K73K\<N*OKH-/N!!>MY"7Y):Y2;8=((0E3:<$#*N/;#'1\]
MAVT[&W2K* 5^B52H)'$#2BB8SVXWI,G'I]4!CV;Z.'I'I[4^CZQS/2)2SFH5
M M.I633*W]K&CI2S;=6GF*A/2!E!*AE9=G)9E_KB-_*$IX!(@,BG8VZ5?_\
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M+$.[76WSZ[9II_\ PP:I^VO_ *F.,1X3>HXH2?-^6#*^ ^-7_P"L=<_P5/\
M^B/0$.G09$#9+OE/'\(S609]%SNG\SW\,0$T2/B)_O4_4("+_IG_ -;*VL_W
M/6_X<I,!N5LM_@V:"_N0Z>_Q6ID!GB 0$)?2T_JS=&O^^RH_\%3$3&=T=;2X
M1OGI939)YK_OA_F)BH+^*?D^L0$'UN_K[^I'[SZV_P"$T0$X< @.O-_U+,?\
MRY_F& A;Z% G[7NU\D]FVMK<0>_-69/?V?-$B:])WP:MGF9[IK(HT-Z3_CL
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M%8! 0?:0#/3D[4GFV6].#ZZFD?EB:MOY[9Q)P$\AZ!]44=2<)$O-D<_!'?\
M-7";XF-8A@Z$PD:2[4)[1M@:R<_\*,P,:[(C@FJ2<Y/XRAZCN_D@*P$>'2O
MJZ/?:B2.7VMIOT_U?(GT<@8#.>Q;^"5LY#L&CE@@?]'I* V<@$ @$ @$ @$
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M"$:U/U]_5/\ ><61_&.>B8SNCK:$WL4(! 10=&M^J7TAG[[^Z?XOT6 E9#R
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M+'^33 "VO'QP?-N ?..(^2 T V=][[M/;G QQG=&>?9_0^D^SEVCTG.8#?\
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MH145@$!!]I K=Z<G:E/:=ES3?E_A1!/S _5 3@#D/0(#JS?_ &B:_P#1'?\
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MSJQLUV10-.=5[8O"MR.O.E=:F:907)V?G&:33:\A^HU!;+,FLIEY)D=<\LC
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M'U[K<PE]UX[JW7%+2" V,&D>F@*0=-K!* <8%J4(!"0,#='@(!.  > P.">
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M*?.U^JVY1%J5:TU-*6V\Q)S;+(+*<##F$P$L .0#WC\^?& K (! (!C/N@$
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M (! (! ,CO@$ @$ @$ R!S/Y\OK('RP" 0" 0" H2!S(';Q/9WP&L&TQM?Z
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M=M:919,Y56:Y+5Y=T2]_5BITJI3=PV]5:(N<D9Z1JDQ/S;'72C;X3E0" 0"
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MC8][VUJ')U6ARM71=FGU=M"J3+T];4PW-L+9F*K3*=DS")>7>G7I>=,N&[T
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M)3[(]T W$>2GV1[H!N(\E/LCW0#<1Y*?9'N@+5H24J ;221P&$C)YC.>',"
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M/5&Q6).Z9X=Y@(H0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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M 5\(:R$[PRHD#GQ4.:?3RX=N>[C 7]8CB-X<#@_7]1!'>#D0%\ @$ @$ @$
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MN6_7Z?.L*90NEUN:53Y><E2VMS<3OM9&>--&;KGZ+D.)&\E:F=Y*MTA1P4\
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M$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$!U9@!0(4 06U@@@$$8/
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1$ @$ @$ @$ @$ @$ @$!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g729258g06j64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g06j64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2UT4&AO=&]S:&]P(#,N,  X0DE-! 0
M    +5B^$6"#A"24T$!       1AP!6@ #&R5'' (   )G91P"4  (<G(S-3
MDP.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !"FQWK(KQ'(Q1YUN4.I,!8(.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0&<%RL         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  N"
MY6  $  @"X+E8  0 ".$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             "N0   QD
M   0                         !              ,9   "N0
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "N0    !29V
MAT;&]N9P   QD    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   KD     4F=H=&QO;F<   ,9     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    &.$))30
M0,     "+S     0   *    "-   !X  !"&   "+7 !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
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M "$0,@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M !<! 0$! 0                 ! @/_Q  N$0$  0(#!P4!  (# 0$
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M.6W!O2IHM(I@@W;D0:QT6T31303*1-NW8LD0(7D*4  @-D$2@0A0  Y0Y0
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M>R,Q6RZ99)-AP,$3UK^UV67N71=$:)V?%QZZR;"23,L<.66:.E6 E*8QC]H
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M(N42E7\#,'6-Q1L?Z/\ /^+]-DGAS,>6\F9EM*7N6PXC%<9&R[B7=QSEPW)
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MX2T+TC[DT9LX][>DV^/%'@KL2DK;3NA(+9,B\5=<XLU 2'VP2;$!4VY1Y!W
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M&@KR%Z] Z]^W3U^'KV'X0#R"@<A/\T._?Y?,?/Y:"G9)[B/(&X@ ".W78!W
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M0'O\/E^$*"@$* \P% #=>NW7KWAOY=.Z@Y4"@"&X" ]P]!H./(3_ #2].@=
M[O+^SR\*#EL&VVW3NV\-O*@X@4H=Q0\ [@\.[YJ#E0*!0*!0*#Y#M4Y"*F;B
M"BA2JBBF<Y@!18=^S2.8!'E3%7E$Q]A$I!Z%-L-! *SU/<0[$.M#3/C'.N0,
M+W8]U+Y#R!'S^EK'=NE=S6(<,6^A*.;>R:%\H/5GJHE;M&:LVK,-463E9=1F
MT$%@$"+N\!9S ?$JU$Y;UR3./KVU!VGAS%;G4E>&,\88XO+3S=\>CD^UK6?
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M H% H% H% H%!Q$I1W 0#KW] Z_#0.4O0>4-PVV'8-^G=U[^E!42E'O !^$
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M=U4*#6=S[_*3])G_ -EVZ/\ O"@V8J!0*#6@TI?RBW7E\0%D?SD30;+] H%
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M=])'(=,J@+."G S>'W2]J++*N.>)M:+%#)>?^*=I_P!.OIKT$8:V('%\;$V
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MP;[" B.WEZ^\0B8X%P!^Y_V^/B.8\Z;CY_\ .;-T$Q*7U(GW(4'904$I1VW
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MDQ.#;,)'VU!J.G#UVCSQL+&)HL8U R"1#)H-D2%* @(@ [T1GD4! A0'?<
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M8I)FLS.LU2 D  ( ;AL!>\!Z>OJ'@'G1&$VH[6;C73SD+'6*+UL7-=URN85
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M;M7S9_)J\@HG1.Y,NX*423/E=">%-<XSQIC?%NL%WY2[]^P;]!#\0]:J.0@
M]X /PT%-@[M@V\MJ"@[  E#8!VZ &P"&_3< ^'N\!'I0>'7N^U$KJ)8WNHA
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M7CP?;TT'_@RR'^NTI.L]O@/<+QX/MZ:#_P &60_UVE)UGM\![A>/!]O30?\
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MXOSB@^9QJ,JK*N<938S2$ H@JZ;%0;29A[!5V!SG;![\$%!#EH,V2CN4H^8
M/SAZNGS=/+I05H% H% H% H*;AYAY=_B/<'RT 1#KU#H'Y>[Q\?#SH,,,-:4
M([#VI?55J.1O)[+O=3[_ !VZ?6PXC46K>U!L&W MY%)J_(Z7-)A(@(.#"=!O
MV CV0=H&YA%WT9GAW!\ ?MTH*T"@4"@4%   #;P\O5Y?!X!ZJ"M H% H% H%
M H% H% H% V#RH&V_P"W[=U H% H% H%!3</,/#Q#O'N^?PH/%W%>-H6JHS)
M=%T0%LFEWA6$8$W,,(LTB_.(<K6/*_71(Z6.'*42H\Q@$P ( (A0>P2.15--
M4O+RJ$*<@@)3 (&+N7E.41*8!*/02B("'=TH.V@4"@4"@4%.8O7J'3;?J'3?
MNW\M_#SH&X>8?/05H&P>5 H% H% H% H%!CCJ8U 6WI=PU>6<[PMZ]+FM:QT
M&+V=C;$A5;@N%",5?HM'TRA')#VBK*+;JFD)(Q %1%@@LJ4IA#:@B\NOC7V)
M&K_15L; N2\FZ)H:=@;5OS5O:BT>YMZV+AN!K'.P/[CU#!/O+?@_;5BQN"4,
MD@#%\HHU(D<Q2\TTTG;>HFD@)^*NN#A[C@WS>3@K@8,Y6&D&IR*M7\<_;D>,
MGR*@;&.BY;G(8 , #ZA'NH]8'<&WD%!6@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4%-RCXAT]8=!H,)-<ESZD+/PLZFM)TUC!/-<3<43-Q=E9-5019Y
M4@8=<7D_CRW%EGS,[.XY]B06L8[3!4".!*7=$5@6 -775EE&3U]97ALYJX5R
M-DW"4_84!@;-N+[<MZ7NK43H;R?;-P+R=\J0>-2OF(,9;(R23>,MS)'HSALV
M1 J^Y7"((5*9[SINV^U.,?;9\X?C+.#'2WCQ'.T$K:%RIHR3>U+,?'=+7':&
M+F;U5KC2"O=XY?R:CV^4+2;1*]T.#O5E EEW*)Q*=,R9*,YT]^0HB&PB "(=
M.G3U?C]=!SH% H% H/@R+QG'-7<E(NB,V#)!P[=O'*I46K5J@B91=T[54'LD
M6K9%,ZZRZP\J1""<>@=0PFT[\1C2IJGR?=N'\,W[(SUZVBR<2G8RUJS]NP]V
M0[!\M&/IZPIN68,X^\8=H_0.V=2,,JX;$W*<AC)G*896)ROG?:1GH0=B%WV
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M+L5;QEU1?S=PN6+A<$I*27(FY$2;$O'E?$N[^$N!0Y2E#Q  #S^'K\-!RH%
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g729258g08e28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g08e28.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[12P4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %)2^4F@X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!7_)O         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              ,@   )=
M  $                          0             "70   ,@
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ,@     4F=H
M=&QO;F<   )=    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   #(     %)G:'1L;VYG   "70    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      *,     $   "@    -0   >   &-@   *%  8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ -0"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( ,@"70,!$0 "$0$#$0'_Q  >  $
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M@Q1:E^E5Y<.2GQ)S0B4IV@F#)L#PTXVY"_H>4G@L9O9PV=?($Q)TX9Y2ILW
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MP84064*J6IX]=S\14BX@"!D(N(\[ZVFPX+1>:OX_#BF8M)U$P;@&UI(T,D7
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MC(9*[3@22:&%J<R"#?"\@>J]5JK=5\P15J>+4G=.ZM2HU/SD"TC,<-!(U$1
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MDWQP/P^Z^^^K^RC]_P#_ -:*=]O'X'[*(9T:F0J0XO8QA_&F8Z6S%]&CUHV
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M"A[:KR#W@X7X918@@7!SL9@YKY!,$C(Z0+G2A6;7C9"3CY!9:MLQYG)!V_2
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MUZ -6DSQAH<X-EU-L$1()<3$386]CW,6#9QN<.N8ADL;)SY[&<+LC!PN>E"
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M;/<@P0P/D<CQKCT7G"<8NOO(M$@D,J#'9^S@4"APPZL?%"T26,I1\+EBA8:
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M<7E1H^@I2U#A>)\>D/C%@2;&G3UN/)9$>MJ6,+$MGTJ>OGSPA(Q"-6+'S1%
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M! XJSA^']R AJZ8O8")%#&P>!0#<A'XV)D#T2VIZ0?%QN8HA'RD?*<,EE,7
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M_F+;S]!GE3FDG6.*U';@T;[8=MMK.V-A]B57,Q5/#R 'L#I8ZVX22&D#D)(
MB8,_/'_PZV+_ )CK=H0U^'K/ (?2J%I%0?F> !8NTAY:T%X  +0S(Y,>[G<<
MU6[L!RJ RP"LI9\,9S*+08?IL\7DJM-<DPEHB^/TJ1"L -5*J]RGISR3C-D5
MQ.*PQP#I:'.IW (%R&DPT7-@YQ@1Q)[#=G=H]G$C";1&TJ'BW:>): \#>EH[
MYA#JCN)>&M  MHH,W$;P2.,L;D6&:\(3F$$RKL6-'N13B/RZ+%GZ$VY!+ B6
MC#3!M0[5J*OOZ&\C8QXDM+:I4&*B)2O8V1V5.V*^YLK&8;$N$N+7U/P[R)+;
MM<"XB;;P,$1QOQ=N]O<1V:HNJ;4V16P[Y&XYN[5H&8<?YS7 AP:7&S"00V1F
M1DOC;=;@G(HL.]#9*AE#HHQ:/;8-](0XZ0,NJLHX1F2"N'/6-'K7O86E4YI5
M.W/Z57&QVP]HX.J:=7#NW@3E)!&A$ SPF3,2;RO2;-[5;/VA2:]N*8 YL[KG
MACFDB[7 QE!N+.F3=9(6'[%S;MU6'C._352M5NJQ=I<4^G*>+[N_*\JB<+RG
M/?7)[JJP>-CAZ$CW@3^R[XKT:PWVU:)')S3/E<6!SXA>];EJ]0OAJMUHG/SH
MN*O/'''AI^_^I/3C5)(_JW;QF/M/.+JW\MTV[P9:CGQB.$QGE9>:MJWKY\;5
MK4B?^\V43_\ I[^GJG/W+J#4+;FJX#6_KGIJ;\U3N:1SP]+R(^UEKXW0;7L0
M9.R-@,I)\4LI*Y=Y"(!W[^R30:OE%4(FDJ1D7;V7+!#C+K8ZW.I0_P#%2GE;
MD9V0Z0I);E/$57,(=2:7  DVB!NMO89R!8AUXS(CPO:+^&_97M'7PF*VELZA
M7?2J%P+FEN^'-?+*NZ6&HW?(>=XF2(R?5WY%JV.X094+7"$R#C&_4O%NK'62
M\BPY@W7T\=J,#9);BB5?-5\@J2KCE47U2WXRKP S^,<9](N/2VTSL+L/",IT
M]G,Q&SB#^;"XBK3)!S!!<6@2?R[MM"(7DJV\9WC5-%S'>[&;7;-'*4C,GPZ"
M3P=Z)Q^5!B(!):EYY7Q52%4[)Z_.S:V$'^Y3+=/$&DY9Z1Z<52IV?V]3MLKM
M%6IMSW:]"EB3)O&\XTW!N5FD:Y:<K1/?#$;M=#Z.X-R\/H3FS6T-3+%)!5X5
M556UT1DYGQZ)PCU.?L].;&G@J@AKB+R+MGV.<WT@3,V!%*>([:X $XG"X#:\
M'\M)U;!N,R9FIWS0?-QCY<+NYW+T<HH7(FU?+ >A4_+$H55#<GB$Y_P;47D:
MRZI%15^E\(TKV7T[*L?AJ)($G*_B!$R;2)%AGG&47D96=HMMT?\ K=AXG#N%
MQW#J6); _P";',W3P&Z9S519[Y]O=J[2UE<J(XY(5T^YK:Y-B4NQHMN[V3IJ
M;\W#@&U?R7A'RKPG*:H<+P<8&0)O:YO!S.4@3>=59G;K8C7-IXFJ_"8@V-/$
M82K1W'7$/-1HIC7Q.>&S:5D#$,KXYR"U1[#YE&9,UX5*7(<T/(V.4[]G(QPY
M15X3[TX7NB]N==]&JV\"+B9$^<3>>I7H,'MK9>.DX?%4JCQ$ACV/BPS#28!R
MG6^8!)HV<GK2O"F8?K+=.<8SU.??TIRJQ@TB?->:E7A$X55YX7NJZ"E4D#==
M,QE\;9<SHMX8C#&34JT@T#Q$GP@1<F8D6OESE2[[ZB]WM7J;M/KS2JU)Z?/C
MA$_:O;CY]EU0M<W,'+,CV' S?V66FZF\>%XC2+YRN=5Q:U\2IPJ=D3C[%5>Z
M*JI^_LOV<:IX_P#C\59<O%;_ -S_ .75JR)[VY_A?U4_Z-$7W\E2G=%J7[.>
MW[TXXY_G5/\ *56EQS%N.7[KO_UK_P##_P#]=%94QVX5LVO7_<7G=3>PYO\
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MU\7/LM?NJU,#@/8*JZ^;J=E5$X^ZGC^I%U!<UG+R$?8(NB]1QXJ43^;U3O\
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MEQYLW#))'64<D<+E\5D5PL8&.Q#5L@4\('O?!UCOPD2*45-1:)S54B)4J;.
M[']H,>8H8;\3KO-<T#2# =)TD:Q! &6MM3M_V?V11=6KXDAPRIG"52XNF(AS
M!E!+KP  0"2 LML>9@QQD\$/D<+E(HP-),;!%A59O)1>2R\:H^LK?85+U3._
MX51%'OF:NVM2*BI34BTZXV)V17PKB*E G=L2&D1E8&(@YS)O(-VD#N[.[1[+
MVI2:_ XJFT.;(:"-\6R<R=YKA)!$7SR<I0H=VNR=8VN(G/\ ?T<_+G]&I/\
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M"+EB67 L9J:M/(QIH&(\)^KHV*T*K@<//4TM.1I6OEMS5Y;LCMOMOL/8[?\
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M6:*B=T\1^E$]$3YZGN-AU@0_%XK#0?S%H=YFSFD6C,@<BK5<7VBH$'#X&AC
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MB[@[O [!N%I #:@EPCA %HE8A6J-L6$&!D)F;D'2,O"9F\Y28#W2>U1VB1?
MF4++R=D!,L(QDO&FN/9_CS+6,YO==2-H[$?4(_+<:H5?/6:O%5$I'J*3I.*B
MHKNNMK ]E-OXNH!A,&[$ Y.:6[L$$@DM(,&!_3!B#8E8*F-#6DSXC_3%XF0"
M8<)XPZ]W6R6P/">XO$>?8/$YOCG(D(DS&8 0YRRUC\D;/735##1F[\N<#GK0
M*>9O67BZ!6L@CPDK2OB0J)%+XF:<;$[,Q>$J5F5\-49ND!Q--VZ8$SO!I;!!
M!D$\)+A W=YFCVDF_"?>Y/T@ZPLA$O*GK4G\U-*K_5QK1DBX9[$2I7Q.4]>4
M3^=$_P J?Y=0.\ZCZPJ^$_VGV*^<<^J>OS6GGU^_A5X_9Z_SZL6 _FOQG[9*
M9&0(\OT7?13]!4\/B2KYIV7]GIS]_?LO/IPNJQ _VQ'F#]"I776E%7'CLHOS
M3QHJ?=VY7O\ +0OJ-%A\;>MX^ZKW;76CKUE6L5 BCK-R/(L&SUB^LWV+YH[L
M-W+1TQOV^G<-G5MSPCQD\L\HO--2+2JI5RG9<M&O7HU*5=M<L<V#+3!F9$&Y
MC>@\O65AQ&"H8BF6.HAS72TDC\S2;M)T(BT$$1,3$0]MPA,5@^.;#&(@A,>&
MWY','EP>#&M1K>Y?^+2[!'#BRSM(EUSTC1NW55YY:-6O?CP)3M;7VEB-JXYE
M>M6<XQD29(  SF8-S>Y)))A8-E;-H;/HFG1  ))!@"\ZY3_2T F#:V962E'Z
M%/\ Q:?\B:U%OKEHB:(L+]W6;R6$XF)?!8LQE1:55'XL(9,9RD8R1?+OF[*^
MP'XQC@R'3&53J2/JEO/:0D>'55#6XI"93@4BDACH(>43K\XF\$VGD=%/N,9)
M*9;CJ&RF9P0GC.5'0#(N>QZ5,!3I.)/7#9+SB/DC(!R@,M?:=VZ/F7 Y%Y\2
M4U<I23KKCZ?25*>B)HBMPVU)/&%]L,*W0A"M+*6R5IHV?JWYO)ZMGG#/CCCA
M.>?W>%2=9+6[[+ZVX;P;=XV>.ZGKRQ[1C?-2Y?56VS='3A<Z2/J7/3L>59_2
M7CE53LJ(OZ7&B+:+HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB
M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB*S:HA%?B6Y+ZHL 277F:BZY54)'?
M$-8KQ>'RU3G1H]Z'U51Z/T54Y^2*NBF?EUKRF^NFJO+10FB(OHO_ *=$6EOV
M;5=+K+&YYQ41-%?%NUWOJCZ1!/APZ\_..TKBHF$0*!1A4JJOCI0 S6W4JT^&
MCA$UK,HX9C!1 DSG,DSQT.FGG<2:]W4G\1S( D@7C4G,%LQJ5N5MKPM--"?=
M\NR)Z\\IRB_N7Y_+O:&4W4Z;*8B\0(W0!GY^?NK$EP-YMJ<LA]LE[]9T31$T
M1-$5/5/"G''**B<+W]/GQZ?Y.?L35'M8X[YSXB#KY9ST%#9W0WG<<Y_98\"
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MMNT:)K=F=HXK#:[@=-M(O,@WU\)E>U[.;>V-B\6T=I<,,4P@MWFQAWS(LX@
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M$-;<B0)W8LJ5:%.K(+1F8D3!B)N;1G$P-9S5)H]G1LD<QH!'S>U/;X^K!!1
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M\?\ QH%<HG^V7]RU).FF?):]O91V'+;%>Z5JYLWF[FQ[0C>U9<M7*?EV]_\
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M:]^5-FG5@<,&IXBI<JZ:BJ45>ZNNNOJFMYT]N7W_ $72 E<:DM1=8O)P<BK
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M9*[X+%A$1B>/ACA&RO%1@P%0R'1>/C!@^EF)%BQ354%>*JJI8ZZZ\DR@_KK
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DL U"E-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g729258g08x81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g08x81.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1Q:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '#Z^<C X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!F33^         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              F0   1E
M  $                          0             $90   F0
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   F0     4F=H
M=&QO;F<   1E    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   )D     %)G:'1L;VYG   $90    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      1V0    $   "@    5P   >   *,@   1O0 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 5P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MU&KMKM9OJ>U[)(W-((EIVN$C]US=J'BYE&6+32211:ZE\B/>S1\2FPOYI_\
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MU;[4VPUN?0+'4[MW#=FP4N==^B\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M=7FSX?$H.D5B<X*2M-)#1$9'9W2#U#1)5O_$ !H! 0$! 0$! 0
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MQ^LXF#@.GD0Y !X$.0]_5Z@;L' \![M!RM T#0- T#0- T#0- T#0- T#0-
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M0-!;;*RR[;'61UVZBB*R-!MJR*Z!S)+(K)5^1.D<BQ1***I%"%525*/)!)R
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MZZ?H)3,X2*0*XDE(Y@8WM#I%BB/F.54T^E,I@Y]! 0]L0P=(?.ZN?>/K\?<
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MQ^D>X>[04*V1* %*F4.DO2 ^\ [<^OQX#GXCWT&KR$O42 (]77R;N/4( 41
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M6S3_ "K3=2<;//XD9G)_<%^K5&O0- T#0- T#0- T#0- T#0- T#0- T#0-
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M9%">A@YYT$LI1Y !^( /Y0T%= T#0- T#0-!;7+".47-)FFV&I.G0^0U$2#
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M6>2D[-B#%L8B"Z?LC8!\YR;J O' Z&L]<%XMO.4,GY6H1;/E'#DAA"T#+OF
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M5E*35'HN?[1!1$Y.UY*>B,26)[$RCV!=*,) T:[;-UDW+;VE Y45"'#KYX$
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M2U%GS?MV;4S:OOIA?/;#<]7FM5IY)I6E<8QFN%V%]TYLH4C=1 'CCCYOQ#L
M=P^C7B;;F@@N\6"A6:Z/Z'+72G;=76+:7) O3;;E;-ETQ/8V5QFTDF3MI&'J
M;IDH],L4J**  LJHF02G.4GJ+5.U_09@>&Q3G-"VZ)PKUC18Q0;C97X-L=Y-
MLN6( OG'0,'F6FUO7TJG(<\"YC5EP(V$"^6F0#]PD/*/)2C\0 >X<>[X>[0:
MM!A=?/W<NWO\"V:?Y5INI.-GG\2,SD_N"_5JC7H&@:!H&@:!H&@:!H&@:!H&
M@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@Q-WF+0R6V;+RD^_M<2P-6BMR2-+<F
M:69E(KR;)"*>1C@%FY&RB4FHT,J[66(U1:E5.Z-Y!5 T&%FQS/N9KGD.+HF6
M[^ZLR[JFV1=C'-TJI(-$)"E3(5^3^6)"%5,_\]0/*=M'RB/R?)*BKY"AOF:&
M_P!.T)5+);8:EP$G:;3.Q,!6(".<24S/2[E&/C(UDR1,LY=OG;A1-!N@5(AS
MG.<P"4W"90,8>!#'R?WO[7*U5<=7>:S52V55RT@1YCF7.^.LC:(XRR*!Y:/3
M:IJK_(Z"KA%-Q*JID9(&<(@JJ7J[!VK;>'ML=9 LF*4<UT$;_589]/SD&>90
M(I'Q49&EEI1=5R82,E%8J+,62D&J+@[AHS,59RDF0PB >CPIN.PUN)BIF;PQ
MD"O9!BZ^_"'F7,$N90T=(*HBX1([04(DJ1-VWX<LG'0*#MN(*(J'#OH,.?"M
MY_4RW&<AP/\ 9C9^]P@/:>9CW W ^@A[O3\7(2A:!H&@:!H&@:#P>4$RFQQ?
MC#W_ -I=G*(>X2C"O0$!_+H8H>/L?5(B_AQ54RA"&$,R9P*')2\ 4+V_ "
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M,3WRMW<4I-C9:;8D358EB9UJ3L,>T:D/)MXZ7>.6R+($$U2'<.E%2D12/U&
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M!-QQH(T_"MY_4SW&]RC_ .6-G[N7T_X>9_ ?K_BT$H6@:!H&@:!H&@\-D_\
M:WO_ .\RS?R,]T$/7V/=][?JOX9LY?IV_P!!-]H(.?LA7[W19?PL8=_3F*T$
MS='_ .)M/_>M!_R8RT$'_@[_ +I[Q>_X9Y?T7)HLX6>7S*>O1&#/B:=_#XWC
M_P 'O)7Z.O-!YWPL51)X<FS0X!R)<!T?J#WCQ%IB(!](CP  'QY^&@Y6>_$T
MV3;:,AN,2YOS9#T_(36+8S;RJ_)-AFI)E%R28*1SU\G"1<B5JF\*'6@5P*9S
MASP4?701,>(UXJ&Q/,^&\=5S&V;"6B9A]P^&+I),VM-NQ5FE=K-J1D)V5,5S
M7T2"A'M"&<*)@85.GL0AQ'C4K&&NLQ=E.9?RU]^W!( 3QL/#.1 3GW(1H 4H
MB952FWXI2DZ.M3A4]9*4$RE*)A, ]! #J$>-4I.%+]R0_#69\=;@,>5C+6(K
M5&W;'5R9'D*U9XOS?891LDLJV6.B"Y$UR"DNBHD8JB1# =,P"'(#H+I*CP0>
MW/IV$.>P#R/;D/<&I,TB9QH,;]S6<G& \53]^;U:<MKUNR7;1[6#9)NTFLJ[
M*#2)6F"*NFIDHQ23<,VRYTC'6X5^80#<"'N_2?!S^H^*V>Q_<LV8M6X\WFM1
M9_CC,6<9\WEB:1EC2YC:VXV=F9OK?Y;IZ5F*Q'6G.:PM1M-W*7'/-CO<18<?
M3]/;T6,I\<N\E8PC--2X+Q97%QB1.60><'8O'#<S% "^:1@;S'*OFB! ]GZS
M^D[/]/G86O/8VD[6=I:LS8MQ;CR>:8LS%J+INBEK*LTHQL=K^[$W4B*4NX7\
MN5W*YG7KXSL:!H&@:!H&@:"$'Q=:W3K?.;8J^6J7&>S.ZM-Q5Q#(P.:D,"0$
M&JVBFQ[ M8+VY=H)D.JS%)-FP*0YW1P.4O <\C6%=<U\_"[OM&G,!O*Y"RMN
M+;ZG?KE!7&MY RLPRS86]EBG:*,JZ@;4W>.'$W3A5,0(=X1,K8"]9N1,41T$
MHA40,!3&Y P@ B'// _0/ =^!$.KU'GD=!4$0Z1 1ZA[](B'8 YY ./01#TZ
MA#GCTXT&&=Z#C?)M[#UXPOFKOZ<_[+4[@>/=S\/=J3C9Y_$C,]/[@OU:HUZ!
MH&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:"@^[Z_=[NP]
M_4./K[_5H,3-YDC6XC;)F"0N%>>6BNL:V"SB)CY).'>J+DD&9V#SY:<"5&-1
MC9'V62<OEA%)FV9JK*D,4@@(8(; <.V:IY&>VF\Y)HV5WRM8FE*R\A<IUBVR
M59;VV02F9IJU@ZV5))X63<"0[JP.N5E" )0^:H.@DKS^YR,UPSDAWBJ<A*U?
M6-0G9"O3MD8.I..AW#!@X<+/%(]J<JCIPFW1,=FCR*8+@0ZQ3)]11#YV,V>)
MUGZB;$-I<G%VB:8Y;OM5H&0\J9L=46:D(5>NJ7B+AI:KPKN,C'L*VM%D(NX.
M#=XLW(SCVRA"%.Y<MTS*Z[?5:3?OBN>ZOTO[5P<6W>(YNGBKS=+O0\@K6V:D
M+9GJE-]N#NL-BC0\>X\QLUL%)RZJQ.W3LJ:SA^JK*/',@4C"23/[(ER "F!/
MMO\ CUY,RMFN[G.ZL?F-BV5N.^*-J\9@^QP4_4?M1CI1A8<G4XT]>ZHK(@[C
MX1=G3I,/+39&74DHLBA6BR8' Q=!?SP@9F1L.#<XSLQ7)&H2TMNUSJ^D:O+'
M;*R4"Z6FF)E(U\HS46:G<MQ$2J&05.D8>1*8?0&M:^Y+'H&@:!H&@:!H/#9/
M_:WO_P"\RS?R,]T$/7V/=][?JOX9LY?IV_T$WV@@Y^R%?O=%E_"QAW].8K03
M-T?_ (FT_P#>M!_R8RT$'_@[_NGO%[_AGE_1<FBSA9Y?,IZ]$8,^)IW\/C>/
M_![R5^CKS0>>\+(@*>'#LT*8Q@ <"43D2F$H@/R:F4>!X'XB'XQ[AZZ#!C!-
M8KEA\=7?TWL,##3R+?;-MX5;IS44PE"(G.+PAS)%>H+E2,8I0 QR 4Q@#I'L
M.AK6KNZ:_P#4JQD B(8[HH#ZEXJ, ''O'TC^1Y[_ (AXX'1*1&N7TA:[.&+L
M:HX8RVJECZCD42QG>U$S%J4 4Q5"UB4,0Q3%8 )3$, "40X, @ @(<!J3A/+
M6_VE6 W@+)@/A7;7#\\"6*N?;CMP%]LH  >XH ''!2@!0]P=](PC##+#IP$P
MBWW'N]2]S>@<#SS[N!#CGD..X?#5&-.Y' $%N-J,)2+(X690[2VP5A?%05=I
M&?M(AU[4[BN6JR7(OQ213$ZO4F! ,8  X%$/=^G>.VOZ9MOW]A9LS;BS,1YH
MB8\TUBM\3%;YROPK$,;39QM;/EM3-TQ,7]-\93-*88[W3;:-K%*VZ-["X@06
M>6&W3,K)3$HH\?K)^PN7OGQ\>FV>+JE K!$B"'M!B^T*F(/F*'+QQU_5/U3;
M_JENQ:VD6=G&SLQ%FS8LV8CS?[6KHC_+&D4OOF]G9;&SLHF+-]<YW,M-?,=3
M0- T#0- T#01$;_<I>&A)7.LXOWP0Y+98ZDV-9ZG&O*=>IQ&'":(#=1ZTD*L
MU%LD[=I)>6=-185@2('($*.BTUK=G.$/=;"\(>'F@P=9YV48NAJLVDOE.HNK
M&QB[9 .G)FZI#2C!6+LRI#@!U1(8[CV0 <F#J*N(%T2LSC7JD\*("4H@ @ @
M'8?4.WI^+05T&%U\_=R[>_P+9I_E6FZDXV>?Q(S.3^X+]6J->@:!H&@:#945
MZ# 4  1$ $ 'MR'/ CSZ  ? >X^[L&@P0W.^)ALSV=76%QYN)S%%8\MM@ATI
MV(B7["1=*/8Q5PHU(Y2.T05)TF7242*4PE.8X!P7N&AK6OEAYD#[(1\,?'ZL
M*@XS)*3ZTM*)1BZ-?J,PX7AR*#P>1E$W1&@H1[;_ .\K)^:*?J!3>F@F$QUD
M&IY6HU5R1199"=IMUA&%BK4RVY\B2AY-N1RS=I@;YP%52.4>DW!BCR4P (#H
M/::!H*"( '(CP'8/RZ  ]Q#@0X]_N'ZA^/Q#05T#0-!MJ'Z  >.0$P /?CCG
M\_\ 7ZM!M(K&5$0,3HX#D2B \EY ."F'D0 _?GIX^YX'GOH.3H&@:!H*"/ "
M/KP CQSQ_'[OKT .1 !$.!$ Y#X#\-!70- T#0- T#04'O\ 1_X#Z?\ =H,(
M]Z#C(,7C.7G*U,U&*J#"#L37( W11,(KY,?M46S)T+11J])).4'1A0;1BB)4
MWSAPF@81Y -!@MX>'VV1V:9>+NL6-+??: K)P57LV,(_&]BF8([HC<L[7R-D
M>J1@DU1336 %R&;=11.W*0>0";=5D@[1526(15!R@=!5!5,JB2B"R8D415*;
MDJA#D$Q%"FY*<IA 0X'@0\P;'-&/5D*2:HUL:@U3;D:U<T)'C -RM%R.V9$H
MD4!9ID:NDDW"!2)!Y:Z9%""!B!H.,GBS':-C?W!&CU!&V2C#Y*D[*G6X@L])
M18I%1/'/Y4&OMKMDHB7R5&JRQT3I "9RF(4"@&_4J!2,?L',51*C6J=&.W3B
M1=L:O!Q\&S<R"PB*SQ=O'-VZ2KE3G@ZQRF/T\!U<=M!'KX5W?&>XP?4?[,7/
MW(CQSS\O,N/0 ]WY@#W:"4+0- T#0- T#0>&R?\ M;W_ />99OY&>Z"'K['N
M^]OU7\,V<OT[?Z";[00<_9"OWNBR_A8P[^G,5H)FZ/\ \3:?^]:#_DQEH(/_
M  =_W3WB]_PSR_HN319PL\OF4]>B,&O$S#GP^=X_N_\ )[R5^CKS1)^8][W0
M>%?S^MR[- ]0_4#H??Z0CT@]=%89;<OO[?B ?P8MNO\ VCW03HZ"U>=/VD\O
M_@QOGZ+RFI:PGE/L(SO 4^]6;7?^BKG^GUETLX1RCV6UC/.?=,$<@'*)1]![
M#VYY >PA]'(=N=5&R+<IAY,81[=/H(=@X$ Y ?=P'T>[05!N4%"J\CU$$PAQ
MR'(F+TCSP/<..X!QP ]P]1T'(T#0- T#0- T#00\^)S'Y\N#S$^-]O.4HK'=
MHL+3(,R^1C J:5ZL;RJ0[:1KL0R<63J*WAEE_/:2:Q2"9-1PU4*/04X U]?3
M4#W/A.2&5G>W">0S1+RLQ>X_+-TCI EBL%>L%IAD$#M"EB;"I5R$AF+YFIYI
M21S01%% Z1U.#'TUS$IA>.D..P<!QQ]6@KH,+KY^[EV]_@6S3_*M-U)QL\_B
M1F<G]P7ZM4:] T#0- T&THF!@/\ $P=A'N " #TCQV[<\"(<@';U#UT'S4>+
MKX%5U\1+<MCS.U+S<PI+-C7(NH76!L;-V^!C&1<BJZ))5$K4W";URBZ<$.@X
M\M+VA-%3S1ZA &O?ZK6ZFJ_:^G%A3A/P"<!;S,=RQ;#E:^5.R8(SYD'%;RRQ
MK1@^7OE/K#UHF1.5;O#)BSEW!SJ >136<>6')?9S=(\M:U>E9QB;][ZX<*XH
MJ>"\4T'#U&2<(U+'%6AZE E=J^>[-'P[--HBJY6 I 4<+>6*JQBID**AC=(=
M/  %T= T'C[[:TJ-3K3<EX]W*MZI79>PKQK$4RO'J,2R5>JMVIESD1!PHD@<
MB7F'*7J-W,7UT&"?AV^(;6/$$I-XN-5QW:Z,TI%N>5AP-D\H$Y$Z;A8K95F
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M/?XOF&\+O\N;=KW+4R,/EN[.K'2HG(N1,LW?&V':I%1K%!VX):'56?('";D
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M_M^LH>H<_F_)I9PCE'LLXSSGW2[G=@(<*="13F#I.90A.GCL<?V0>!,0P<@
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M=5N'(F42.9,0X$..1#4K-<,YBM8I3?=7'=ZG76[)L9,7\S&M_P"Y>U,M(&,
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MX^'(CSI?NRRFLUW7>E$U[_;NC0\!M<J7A6;72& P&"'NPCV'^\OUF*8 $P
MCR(=(CZ^O AJ3-O=_P#UCUPIWGHLWSO]5GI<W'V1%251X IO#ZLHE*//4/\
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MIG^BM963S;N$E<VIV9C&/8!C+TF%I[RK"9$%G;==.)*4RSE050(NDMR"!TS
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M6!9?<'9YFA81S#>X!9).<IV,+M9H8ZZ1%D$I."KLC),3JIF#]E2*Y;IF42,
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M "')0'G1'N3G G'("/(\=O=\1'Z #N/T:#B.#D42'GK*4.1$1X*8W''W/KU
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MY#N <CV[:#:%VGUB0 ,(AR >@"(^X.!'G@1[ ;TT&'%Z$#;Y-O8AZ#A;-/\
M*M-Y_(/8?I =2<;//XD9GI_<%^K5&O0<471"G,02F'I,!3"4.0[AV$..>1Y[
M"4.1+ZFX#D0#<\\OIP(#SWY]Q>>!, _WP /;M[]!NE-U  A[_IYX_)[]!70;
M1R&,/44>X%$.G_"[\\"//;OZ#QVT%KKQA7%F39&ORN0\=4RZ2-4<^V5M_9H&
M.F7L,[$Y5//8.'K=8[8Q5"$. )B =9"G[B4-#6[6MRXZ+4R:)$0Z"$('24I
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M5)J@L8J)#&-U<#\.]N;QNXWR;?R(+HKG0PQFE-4J2R:QDSA+4SYBOE&-Y9Q
M1'I-TCVX !]=-W#Z3'R,VD_N"_5H-0F OKV#CGGW?5]?T:",7Q4/$+BO#?VW
M+YN=TEW?IV6LK.H5&N(KF:1ZDX];K+@YF7A $[5BDW14%7H*<RBHD(40ZA,
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MQCQ^[VGB*[*[;0MG61+O*[VMS5EB8YWCUX[B;;,UPL*=FXO5=2]IERIQ#=P
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M3ZE5>E8SS=Z]CW3)-%5%9\5G(1S=V^CG3MD1=JTD&[-PHT<+IKD3."?&AO\
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M*4/ <_K?=F'GCOP-W;\?CX'@?351/1H-)^Q1_)V^ CP/\0Z""[P2! P^(>8
M .-_.8P'XFX<(@(CV]W]1T6<N7S..L*)T]$- T#0- T#0?//XG6W. 2SY&YW
MRIGK%] P?D6 J5,NM5R&RGY*U3BE"DW-B:TJE,X85E5JM='BC).]-$FAA49)
MB90W!P 2QPKTYZZLV?"FQ?3L7[6/)H^4*5E."NF2+S?2/\;-G,;1JL>Q2GM
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MT1@SXFG;P^-X_P#![R5^CKS0=!X5P_[W-LSX[?[@5$'M]+!'G089[<OO[?B
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M[MH_>)=:G/FR&C+P]CF8..FCM*E9;# >1\F2\M& F81<%%LW%R5NJBFY\O\
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M=:,+8JS+7Y*8BX-4D@]AF,BYDD$#@8[<1 2%:UW%Q=OVZ7"NZ"+L,KAJUN+
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M3Z36,B4+PS-S%CI=RAF5@K,ZTF*$#66AY%$KAF_; K)D5\APB<BB8J$(8Q3
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M#W )KZ??=ZC,;5#0- T#0- T ?0?Z_Z_S#H(H_$*VV;L-QT]0JQB0,3*X-0
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M=L7I+T"N?@?G=P]\!S&$.X]/?N'5U=C<<B!0'U 0'OV_B 0W.W^&K_\ "/\
M]&@T'.4@<F44#UXY 0YX[\!R0._ "'UB&@VU1$2@!3"8>H/FF$.! >0#JX !
M />/?N "&@\Y*4Z F):!LDK$M'\]55'RE=D5R"+B)-(I$0>F;& ?V,%T4R$/
MV$1(7@1'WAZ!(P>8 =0B/28 Z1,)@+R!NKI !#YW8.O@>0[=AYT'*[?X:O\
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M]T(]Q.<1#D#!]SP ]/;GU'0<O0;142%4%0 X,(=(\=@$O/(![^P"(CVX[C\
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M'I!)];*:LU:/V3:3$)0J(UKFGS*;J* \"'/N'U#OQ_7W?#D-!JT#0- T#0-
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MVAAZ[XN6FL;9 K%$KN04;5+L,BL*X?)S*1Q[?[2\##TI#V.NI+NI6N0TY4)
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MQTCW !]!$?NO4.X=/'<-!R>HHCP @(_ ! 1_)]'OT#D.X!W$..0^OZ]!70!
M!]0Y^O04$P% .1  $0 .1 /7T]>/XM Y#CGD./C[M!0#%'T'GGZ]!7@!]0#\
MF@J  'H !]6@:!H..=FT4<HO3M6QWC=)9!!V=!(SE!%P9(SA%%<2BJFDN9!
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M B =Q #<<\>[OH..U\Y$YDU3JJ@H<RA>H"&*WZBA_:Y13(41(!@$Q3GZC#U
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M.O2:>\2O(-$\:3GMG/9D'U8RN/T^_P"4 '0[]:?$0#1O&F'USGLR_P V%O\
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M T#0- T#0-!H,0AP$#% 0$! 0$ $! ?4!#W@/O =!J H%#I ."@' !P   ?
M  /308R[G]T.(-HN+Y3,^<9B0K]"BIB)AW$C%PLC-NB/IEV5BR$&$>15<$ .
M<5'+H0*W10(8ZA@X !#YO\M^(EG#<98]QNVAW>*)+8LNEAIE@P9E?%"<DJFR
MH,P^:#&TO,\/&G&Q?:7<3G6K=KLC!-)U7)!=-NZ3%JKUB$FVQWP\G% F)#(.
M8\?U2C0\7:XZT8,V^5F>>7"LX$G&34K>;M%!NKLZ,W%,KNYZGDC4&RXUWH*B
MNLS%P82@UKZ>XF=;E'R2]?KWYXY+[^>W''O]_P!7 \ ' <C0- T#0- T#0-
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M$C8"!F;+='3115"!K29THUDR9L&R#=%<Y3^9(O1Y6?N \Y8 -ZAG00HE  X
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MREKWQI)/D8)R<RGE,&LL^8L'3=81,9PT?-6Z;M!<W28Y5>!*'3H,J] T#0-
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MH+QU^C*S&X[VJY+V]T.)"#.^2K\]D>,@:\^O[8AE^DJ\37XAPPCFQ"E72.]
MPK !1*:B/IEX.2>8\E9KLMY"Q8[HL13</47;Q RRK%^R9Y$Q6Q@V<QF:6JC
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MI"5>(MY&1%1;V!%X4YF"*)%3@(28@' <!Z!V#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0-!P1_NRO_M$_P#1T'))ZC]7\X:#=T#0- T#0- T#0- T#0-
M T#0- T#0- T#0- T#0- T#0- T#0-!P#_=H_P#//_/H-:?W:_\ [13\Z>@J
M']T#ZE/] N@X@^BO_.'_ +$N@WD/N"_B_,;1+.$<H]F\?[D?Q?G#17 )_??\
M]'_35T&Z3U'_ /:E_P!(^@WE_N4__:!^<F@V5ON__P"-3\YM!RDO=_[$/YM!
MH/Z'^M/\X:#AD_NX?4X_TV^@Y"'H/_M5OSZ)&'6U[RWP^Y2__D_/HK9+_P#Y
M/_O!_P!F70:1]%_^<I_V)-!K+_=U/J#_ $4]!H:_='_]S_L-!O\ _P!BI_SU
G/S#H-:?W:?\ ^W#\Y=!R- T#0- T#0- T#0- T#0- T#0- T'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g729258g09c15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g09c15.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[21.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )#*^DF8X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!F^<K         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              94   2'
M  $                          0             $AP   94
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   94     4F=H
M=&QO;F<   2'    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   &5     %)G:'1L;VYG   $AP    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      9S@    $   "@    .    >   &D    9L@ 8  '_V/_B#%A)0T-?
M4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$
M &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !     -,M
M2% @(
M        $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K
M<'0   ($    %')865H   (8    %&=865H   (L    %&)865H   )
M%&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,
M  0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I
M9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M     !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y
M-C8M,BXQ
M              !865H@        \U$  0    $6S%A96B
M        6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8
MVEA96B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W
M=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                         &1E
M<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@                            !D
M97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0
M=FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M3 E6 %    !7'^=M96%S          $                        "CP
M  )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@
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M&EEI
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$!_\  $0@ U )= P$1  (1 0,1 ?_$ !\  0 ! P4! 0
M           (!@<) 0(#! 4*"__$ &40  $$ 0,# 04$! <)"@@)#0$" P0%
M!@ '$0@2(3$)$Q1!414B87$6&(&1%R,R4J&Q\"0E5I;!T=76XB<S-D)35UB7
MF/$*)C<X1F?4X1DH-3E'57*"TC1#16)C9'9W>(:2M;;_Q  = 0$  04! 0$
M             0($!08' P@)_\0 0Q$  @$" P4&!00  P8$!P    $1 B$#
M,4$$$E%A\ 4&<8&1H1,BL<'1!S+A\10C<A46)"4S0E)38H((-%1S@Z*R_]H
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MW.V&$R\$C0ZGNRK)]PMND[CP[?'IK5H]5Q,?7C\>?8/_ !\F/+AAI,%ULO\
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M\7M[^LC,4UO<['7#=1N#6LR&)3ZTN0'G6UQ7GFTQI;*N6'/>A:2E<09&= -
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M4;%4IO+A%C%C[=TES*NZJK4PF(PXJ1#G2Y+B9ZR774NAMXJ[$!($XA^/]O\
MW?30#0 \\'CU^7/IS^.@/%?L&6 Z94MA@- %\K?:9;C(<)2VIXNK0&VU<'AQ
MP@.'PWR>.0-R)"'D%QA:7TI/:5M.H=2%I4$?RFUK1VM>?>)Y*O!Y]#H#UQP4
MCT((X/T/R/K\CH#3L3Z]J? X]!Z'Y: %"%>J4GT]0/EY'].@-.Q"?(2 >. 0
MGDCZ?CXYT!$3K"G9Y7[88^K!4S/=R]W=HX.;/5P=5-C[?3L_I(^5J"6O*8;E
M8XZS;K3R$5+DU]?8A"EI Q6]1?3AN9>=5_5-5;#[>Y94M/\ 0I"_@9S!FOM:
MO#D]0,;-K^_3)I<J<<8K49H]"E129K<A+RFW$,/.+80I"7(':OT9Y8;"9#ME
MB_2_N:S?L>SERR/:[GF+DD3*)6[T^# JY6V<S'50D'),]FY!#^WXUPW-E36F
M [):<2W+*E",_;ZIQYZDD^E?!=_-H^F/:VYCX-BECF66[?815;H2KY=OMADN
M"85CN"!MR1.I)$2X?R#/*&W?LA,7*?A.VC[B7G)+"4!*(77C[_5CC]L^6=N/
M3(_^Q3E;D6]%E&5Y''SNWPW+MK-KKN%G^3_:D6HOLU1:9<QE,&GB6)<1:S6V
M409EKE,5Q29YE,17#W14C10[KK7[DQ#^OB6AWDPWJNQ25U&MX%A>1[\;>YO!
MWFRC"7<AV_R.FWJVKRR5GT),W )D]N0W#W%VWR?WDAS EL>ZL8-#&9<9*83
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MTEI$M:JS::DP;.NDLS(,R(O_ 'N1$D,K4T_'(24H<:4I+@/<">#H"H- - -
M:$ ^#_;D<?U'0&TI1Y!2D]P ((YY'D<'Z@^AY]1X.@.-EB-&:1'CM-,,H'#;
M32$MMH3SW<(2D!*4\GD!( Y]/.@/ IL1Q+'IUY9T./4=/8Y//%ID4ZMKXD.7
M>624!L3K5]AM#LZ4$ (#\A3CG: .[@#0%2=B0>0//CSY^7IH!V)^@\^O/GG\
M^?Z?K\] 44[MIMZ^K,UOX3BSRMQF&XV?%VCKG#F<=J":QMC)^Z.?MIENN)@H
M;L/?H3%)8 ]V2G0%045!1XQ35N.XY45U%0TT)BMJ::IAL0*NLKXJ U&A08,9
M#<:+%8; 0TPRVAIM("4I  T!ZO:GTX'KS^W_ -WR^F@':D?+^D_G]?Z- <3D
M6,\XRZ\PTZ['4I;#CC:5K96I)0I;2E EM902DK20KM)'/!.@.4)2""$@$>AX
M]/[?Y_J= ;M - - - - - ;"TVKU0D\'D<@>#_8: BQU?A/\$E?X'C=S94<<
M#T&Z.*D<CT/GSR= 2JT T T!H?0_+P?[?+^O0%M=QLSL, Q2RRF'B>59[(AN
M16DXUAT>-*O)GQ,AF+[R%%D.QVEI9#BGY)4^GW;3:U)X(XT!&#:'K5C;R99-
MQ7'MC-\*M-%EDS"\KOKZAKH=-B^0US#3TF);/HL7G>U+;[)4Y&:=02M(^8.@
MZ_LG2DD@<^O Y_/CS]/G]0/RT!KH#:4H/JD'SS_)^?/KZ<\_U_EH#=H!H!H!
MH!H!H!H!H!H!H!H!H!H ?0_+QZ_30%.3[F+3,O3K>PC0*]D!UV7,?;C,L(*T
MH0AQ3BD@>_7PAE/E:E'M2"I0  Z=/EV.WTJP@4F05=M.J9#+%O"KY\:5)K79
M31D1D36FG/>QENL_Q@2M*.4@D#@: JX'T_'QZ<?7_-H#70#0#0#0#0#0#0#0
M#0#0#0#0#0 CD$'T/@Z V]B>..T<< <<?('D?N.@-V@&@&@&@&@&@&@&@-J_
MY"O'/W2>/7G@<\>A_JY^GG0$/=Z^D#:/J*ND7VZS-OD;]5#<B8>T)$>*[M])
MD_"_:,[%9,6(W8,R[=,",)S$V7,AGW?>W&;6LJT'KEY.Z_'/WM2N'="/3!M'
M SZPP[;FK<C91A]Q43J*\_OY0JKY5E-RNS+==8ID-!ZRR62_<S''0XOXISL9
M4RT&VT@>_P"S\:;9Z-NGIEI"6VH^#-1V&T\A#3#%M;-,M-CD]K;33:&VT#PA
M"0D>!H"9^@&@&@-O' )')/!\%1/G\.20/W: L)O'M3+W.C588W+W,V]-*JPD
M]^W=^Q2.67Q$=*>RW6]#F_%,L+:[HZ&0V&E+)/@DZ=:7Z\O0G=3OO*W-J?93
M]%J13Z$MO<JN-LMMMYLRWTWHSR^M8%VW8T64Y1"FXS)>9M[&L:?<K8];%[EL
M1HK2D.>^X+G<L@D^$0WQR?O_ "'2T[J/IZZRGS1D;''<D\'M[N/7_*..3_;Q
MZZB5,:^#_HIOPMXW](^_X.]J21H!H!H!H!H!H!H!H!H!H!H#0^A_(Z C]E^_
M.,83FU9@\RHRZXL;%U")#]#4"?#JO>MH<8^*0F2)LM:P2Z45T66MEO[[X;04
M'0%_6EAU*'DD]BVTD!22E0[@%#N2H!25 $ I(!!\$ Z BWU?^=I:\_,;M[*I
M_8-T<6(Y_'R?/TT!*G0#0#0 \<'GTX\_EH#8$('! 'CT\#T^7'Y<G]_)Y/G0
M$&>C#@Y!U<*]2.J;.1S\Q_>C'0?/KX'=^0!X]- 3I_+0#0%@[6HW<=WDQVZK
M<GK8^TT>JLV+W&UCNLY=HXA/P4E"_@E'L#H!2PB0GM2VZY[XA26] 7['H/(]
M/R'I\A\OR^6@-= - - - - - - - - - - - :*X((/H01_1H"%/67T\9AU&
MX3AE!A.?.8+;X=N%19LVXN181*^V>IU*<@-S7(*''W%ULSW5O"84RY'D3(C;
M+_#;BE:!]=?DL%TW>S^RO:*[W<F[@;TY)F/\)&).8M(OJ&?-QS)K!^SN9.17
M&7393"6VZG(&;"8Y750KG'!%JDA*%M?[UH"M>D*EMMN^HKJZVC;SO<#,\/PQ
M.R5EB[.X&36.6V%._E&.9)(NFXEE9*+_ ,-,>AQWO=!7W%('/)Y&@,C^@&@&
M@&@&@&@&@&@&@&@'(^HT T T T T T T T T T T T T!HKPE1/H 3\_D.?E
MY_=H#RNY* 4):\I2%! 4$\>I[CRH%+8 )*R?*@4<Z \G(2W]@7JDJ:4LTMHA
M91QSRN!(<;!"5*[0H$K!\!0*5#_BZ C#T ^.CO8#_P#@P?TW-Q_7H"96@&@-
MJARDCGCP?/TT!X]G;5]#5V-Q<SHM94U<&58V-G.?;CP8$"$PY(ES9<AU2&F(
ML6.VX\^\XI+;3:%N+4$H) E)MI*[;A)<2,;W67TH.L/H;ZCMG7''HSS;:1GE
M 4K/N5E(0!-)Y5W)5W=W"TD%(X\Z\GC44SO8E"7BK6GJ)>:RF+NGLW;:[T;-
MCMPHBBITMU2D[*%X<B+O1-U9],6.=+^U=1?[^[45-M"@7;<BNL,UI8DJ.%Y)
M;/(1(;=E!:5>Z6EU!6 5(6".0>3*VC!Q&W352I<1/Y_B65?['[4P5NXFRX];
M5W53AUU*&I2F-$G;EG!D1P3<K -T:C](=NLUQK-\?3+7#7:XO=1+>O3,:(+L
M4R8*W6TOM@@J;*PL ^4^FJTT\FG&<-->JZ]2UQ<'&P7NXF'515_X:TZ6DHEP
M[K/5+SR+AND!M9)X 223P3X'KX'D_@!ZZD\S'1OIU"]86T>2T+-7LIL1D>'9
MQN=5[<X%:3-Y\QJ[V0Y>MS':>TR2J;VQEPZQ!:A/&PC0;"S<844)8,D'D 2X
MVLM]YK.D=>WIQ7!,0R46*VH]?MYEUSF52Y5>[0IJ4]87.-8Q+;FKD>^;7%37
MO,H90EPR 21H"\8_M_;Q^S0 G@$GT'DZ VA:3Z$'0&[0#0#0#0#0#0#0&"[J
M[IWMLNLC;[)W-O\ ;"-.WIW$V^C8CNBN;8JW*C"LM<1K,MI&3/"Z6D$NNJX\
M>&ZE $R'(DQXKR9SSHT!G03_ "1^0]?7T^?X_70$5^K_ /\ )) ^O\+FRO[O
MX4,5X_?H"5.@&@&@-".01]1Q^_3KK,'S!]0/MH>IO;?J WJVKPO;':R=CFV.
M?VV'5LR\EW2;.='K$IYGRU1P6$%2C_)2?IP/ UOO8?<;:>V=@P]JPJZTZXB%
M34KQ=JT.7X<Y+#:=M6SUI-?++3;5[+)-M)^S=H@B/M3[6[JKVFE;F3*O;_9Z
MQ=W0W'M]QK%$F1D#7V?97D:'%=@1P@'OBLB"VL/'A0[R"D:VS%_23::<.BKX
MS3B:DT[VF/VU0WEQR/"OM7"5*BS<9WSY?G/D9^/9B]9FXG6KL]G^>[D8[CF,
M9!@^Z]OMXF+BCTMRKG0H5!CUPW, F@O)E%RW<9*"2DAH$<<D#D_:_9E?97:6
M/LE=3;PG$/5-9Z?30R6#B+%PU7'[E].LC)>Z\XTVZZ$N.>Z:<<2T@ N.^[;*
MPV@*X!<7QVCD@=YX)'(.L8JDYY./Q[%>K\OO_!CQD]>S\/<"OVSD=+/4>G,[
M:@M\JKZHX_C'O9N.4MC%K9UFVO\ 2#M$:+,L(:$I)#I]^V.TD]HJ)\>NM>!/
M6BM)%M4U=D]7SJIZ?!C37JVQ"&;"L<ELASX*:AIQYGXR.26I26W2A+B3VJ4.
M#H"IAZ#\AH#70#0#0#0#0#0#0#0#0#0#0%+.9+1M6XHW<AI6KIQ:2U3&RB"U
M=0H*+?\ >XO?%]BD_?*T,E)0"K^2GN(%3!M'!!2GR>2.!QR?4^GS_']F@-%-
MHX)[4\\'U'/RT! G8/QUL]<0 X'P'3H?''J<6ROGP!X_J_?H"?6@&@&@&CR>
M@-H^Z#R>>/[?75"^1.7-[6B_7TX@V>]Y].W]I_[M4NNIY)\X4_:W7 EIK-->
M)Q]H_G.__P")UZ?-Q7H_R4RGDTPG@*207#Y^8X''X\D>/_?^6GS6RYV:]+LD
M[.I!HH\)4>.?!\<\<^/KXX_/Y: A'U)7_734WL![I>P_I\R3"F:)^3D$S=K+
M<JH;IFX8<<7\/71J*BLXKL%,-"27G9#;GOR1V!()T!#[HVZG_:1]4>+[=[OO
M[6=+5!L_DV67=1D*6L\S5_-H-1BF36F,7LJN@_HVJMD352ZF0Y71GIC2'&76
MEOK;[O &9X<\#GCGCSQZ<_/C\- - - - - - - - - - ;'%!+:U'T"2?G\A
MS\O/Y\>>- 6FQ[>?:O+,LN<!QG<;$[_,L<)5?8Q57L&==U@[AXF067?>M)1W
M %*D]QXX/)"M 0@ZK=CMZ=UMS93^ P,VQVAD[5WV&RL\Q+<YNC=?G9)/JE)"
M<+FOJ@/N8^S7J?BRRJ!)<7+L&TRVRXURZZZ\,AY?CPX^Q16TO3!U?8+9[R2\
MNWY;ATMQM]<5&(V58V[?M5\M.3SKJI>9H+E;K;+E1B:V<?F.R)#[TA[N]PXX
MRVAP@2:]GRT^UT9].C+[JGY+6!L-29#@0AR0^U:V:'I!:3]Q"GW X\MM([6^
M_L3Z : FMH!H#17H?R/]6@(S=8P/ZIG4W_\ R#W8*1Y\ X)>^./ESY!X\^3]
M=>&.ZO@XCR:PZW:UUE^>?@7G9Z3V[8TTFGM. FG=-/$I37FCYHL#P_$EX)A*
MU8Q1+<7A>,K<6JKB=SBOL.O^^LEK[Q^\KDD\G_C$G7,=NVG:/BU)8M=*F(56
M2N[/+._O9GZ$=V>[78V+V9V=57V;LK=6R4NJIX:EM3FWJEQA*65<,/Q(%)&,
M4 /*?2IA#CM\)XX:'H/ \>!Z?A;XNUX].'A[N-B*R<JIYRESNW,OPGEL&/W<
M[(>%3_RW96J:'=82T47]=,FEP,I_LAH,2'M;OK&AQ6(L6/OYDWN8S#2&F64_
M 0U<-M( 2CDJ]$\#DGYZZ1V-557L&%76W575+J;S?#RX>FEOA+]4MFP]D[T[
M3A8.&L*A46PZ4DHWM$ER\V9;4J6L!()X(\!0(!'T/(X/TX^?IK*G-YY/QZNO
M-(A3UHI[6NFH?=!_6@VU\CC@_P!S7P''R)X/'U/I^!E..<J/I[\"9I5ZLLE=
M*^G'@YX*2:W:GWR5=H)2L\*(\@*/:3S\N1R/E\QJ =M7\E1^7:?0_A\CY_?H
M1JUI"^\_8I>[R"GQFLF75_<0::H@(]Y96MG,9@P8+2BEL//2'R&FVRM2&PI:
MPD*5_*\Z7>G+WMZ_P$J5+53<YR[+CY\?K=ELF^H;8E:D-,;R;:O.N*0VTTUF
M-(MU2W/]Z3V)EK45N_>[!V K/"4 DZF'>SMG9V\24JJOV4NO_3>WE)=]E\K0
MEQLI[74H<2M"RZE:'?O H4"!YY!!X\)(]/.H*?\ ,GYJ4H\9C[<-;L[H6OE/
ME7!(XY'KYX/R_P _&A5?7/4[>@&@&@&@*63?53EF*IF[K5V +REUB;.(Y8I]
MPH%Q0B-NKD%"5*2EWO0GW(X21R= 8AO:&SD2^ICI!HY%3!6R[FN,S)%J6I/Q
MS#B,[I5PX[,QK+\?0PI"D+<[55%P\6GGPEDL./-J S'+DA)6/>H!:[0X%.I2
M6^[GL<*"4D()!'*RD+]$GGC0$7.KQ]$K:."EA]LE&[FRB75-N)=+;B-U,6"D
MJ]T5A"QX24N %*OY2?')=($MAZ#CSXT!KH!H!H#X$^J\C]<3JV''_P!.V5#E
M(^J8_J ?7D^>3P?7Y:^G?TQQ?^0X#23:>ZM[C3>4VW'[5'UAVU_M6NE5)>/A
ME#E>/GRF"Q?' [@?O=W))X^@\G]WT_,^.#TK:Z]HQ*J*:*&DDFXC+6;1&3>4
M)R8OY:J%4G=6EVRCUUROEKG]-7L  %=.&_\ S][_ .,S?D<^?Y.!X(4GY^AY
MX/U]-?)_ZAM?[R[2J4E\F'/^K<<NW%J7KF;1V>V\"E3P\4G9SXN>5^9GM1X;
M6L^H/KQR>.!SYX)X\_T:T-K<I;E^2C*6_7ZEYUTB#^2D_P#PAVTW!/)Z6]TQ
MR/4\9_@Y ///(Y \:]03E+2%>J0?3GGSSV^G//T/D?3\O&@.30#0#0#0#0#0
M#0#0#0#0#0&BCP"?H"?W#0&"J)CV U?M9[RXL;:6QG4JTB6-/62MLJ.7)E5$
M[;Y42QG#<MR.JUHL;AR(C$6)&5:QFK&?)D1&("U=X=BW]_7[?P#.@D$'O6?D
M$I \#CU]/Z>!Z>3J0<I(*3Q]#_ET! ;8/_SV>N+\('3G_3BN5?YM 3ZT T T
M T!U72OP3X^Z3XY _'GUX^7]O&J;-2\HGFO?Z#ZF)7>_VM&UNT&[&ZFQE1LQ
MO_N=GFT_V? R*PP#!49#B]?=7M4Y:44:;.:LVGVVGF^QQWE@.>Z2OM22 #8;
M3VILFR-4XN(DYB)B/6%;+UX,\,7:</!?^8VEFV[6XWU?CSREK#K;>VE]JLQ*
MCIJ>CW%)L*5:.1UNN;?;E-O5U:\XLL3)"/M,?$%M 2)0:X(</W1P?-L^W>SO
M_JL)7M\T3XITN?9O13!"[0[,UVB<L[77IK'&.)+CIS]M)O9#H\MD]7G2INK'
MM8\R/*Q5[9':_(WJQ-%'A./7+V0JRBT0ZW*;DH]XP8W>W\,%$D'SJ:.V>SJJ
MJ4MLI;J:2IWDW54X2IC=4\+*9>9#V_8*JE3AX]+J>2J:NW:%X39^IG&Z;-^<
M4ZG]D-N]_-OV+J'AFY=*;^AB9%&3"O(\1-A+KW(UC!0Z^AI],B$_W)2\OM3V
M@^-9A.4GQ2?J7)?\@$<'R#X(^H/C@ZD'DWB$?8=N $@"KL". .!_<CPY_P _
M]>@,9_L=4(/05MBHI22,UWG() /!.[N: D?0G@<__9 ^7&A"S?C]D91]"1H!
MH!H!H!H!H!H!H!H#AD-(?8>9=0'&W6UMN-G@AQ"TE*D'GQPL$I_;H# UBN7;
MNV?7[)V<Q;*,;3B^+[GYAE:,=7C[5185F(T]-CS;5?1V8P&L8?I(#]M,7;0%
MY):SIME,;D19@C-EIMU]?S]"//KI.+^IGF#:%(*5)20H%*@0".#X(/(/J/7G
MG0D\?)&T?HW?I"0!]BVOH./)@/\ )\<>2/74-PF^"D$4>@( ='73^G@#C"T_
MGQ]LVWCS^0_:=2"9>@&@-%>A_(_U: C/UCD#I+ZG%<@]NP.[!'GYC!;S_/\
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MN*;@YPA&P#DS),.P^3A%*[ <QG*C"A-4$J^R-YI^$@*0]*5:.!]2POM24\:
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MKN9M9N3M!D&X+-O?7T9U-9;5EJEC,9F+P(C#L)N'D%2U$F09\B*V5QHX2E
MK?JXZV<JZ9<SKZ&OP_$<YJ['$IEI)99RI^)F&/W!LZR#23+:@1">!Q.T^+F1
MUV$5]Z3$E1&G'XZ8S_>D.NO8MKLW[1RUWQ8W2A+V W'K6L6P'(<@BU5;$^,R
M6<NJRVSP.3%$"8(4934]R&K(*UX20MRJ=0?=.]H6H"2OL^GW7NC'IVE%M;(D
MX&Q)5$>3V28RY%O:/J9D=RN0[&[_ '3R$\]KR7$I/' T"_/6?6BT)LCT'RT
MT!HKT/Y'459/P!&/K$!_5+ZG ./_ "";M^3\A^@MZ/H?F1SP#]0#KPQG_P -
MBM_^77[)E[V?5N[?L=3R6U8#<<L2F>O2#Y6<'ZBML(V%X='=?RPN,XECD<A.
M#Y*M"7&J6$T\A*VX*VY*0XA2F9#3H2I!! (^[KE6U15CXB:<J4K3=N=4HLGX
MK.#]#>[O;-6%V9V=%%EL=$J%ES3AWU6=KJ&56.HS:U13_'Y>>2./_$3*>#]
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M+78/<[9['9]/47N-W.X5A@DIK*(%PS\2Q]F1<1RN_FQ5M1RTZ^FS8A% >;"
MXKO"0)1#P!\O'YG_ -_[M ?GP=96#8M>]:75M.MF9+DE&^65CO:MY\-"./AO
M5B/(;23Y]2GY\ >@U]%?IY3L;["PIQ(KJLTJGFW$/SX1Z9:]VC7&)4FDVJGN
MWTEWYQPT@CT=J\#5P?AIA'(_](K8?URQ\O4CQ]?/&NA8VS['550_BS5":>\E
M>,H3A_2\9EO\5.A))7T<SQM9W>GVB#ZH?_![*ROJ^F#?6OJPI$.-U,9&EM*Y
M#LI8XP?"> I]Y3BW3SX!)) _$\Z^8>_+7^\&TQ,?+"RCY7*OX93$F?V1/X2<
M.Z3\+M9]9HS_ "/1S^W_ !=:=0Y3?&IOZ%T0<R3G_P"$/VDX!\=+>ZA^GIGV
M##@\^GDC\M5@G3H#8ZM+;:UJ4E"$I4I:UD)2A*4E2E*)( "4@DDD #R3P#H"
MQ;O4-LY&A2+![<O%&X<2\B8X\^+5DM1[:;WB%&4 2I:7T-N/KD'^YT,-O.EP
M(9<( JZGW*P>_P CL<5I,LI;;(JB&U-LJB'.;?E1(BGBR)7"3VK;;>4$2>TJ
M4RI;7O0%+1R'77N7(2>0#]1SZ$?T'SH#70#0#0#0#0#0#0'1M&GGZZ>Q'7V2
M'H4IJ.LK6V$/.,+0TLK;^^@)<4E16GE2>.4_>XT!\\_3[MQNSM[[03&\<SS*
M[?((=!89)*FW:\PWCR7%T7%O227X>+M_I792J$W2:Z:TZ'/@VZF*VKX:%*;D
MA,< ?1$$(/:>T \?3T\?+Z?CQZGY^O( MH'*NU)(20"0/ )YX'T'/[?QT! G
M80 ];'7&.!P8'3H#^/.*Y5\_7T''K^.@)]: : : : XEE122 1R!X( (/</7
MG\-45Y+Q^S!\T%85?K]^TGX)[?X2=E!XY]/X.IO(''D_\4_NURC]0GM*VW8-
MRIJBK!Q-YT\F[)S9<6U-EFI-4[PU-;JIM:\<7:?*',9Q=E_2I1/E2OG_ ,97
M^?\ K/.N=MX*MOX^G_<M5Y^JM[&JK#M:NI>#=_?Z%/9>H_HAEOD_\%<B'J?_
M *FF_/GS_G_'62[.>$MIV>*]H;>+1:IPG\V473F<M?<]<"C_ #L+_,?_ %*7
M^[.:H>KOGHB9_L=./_@T>E!7'E&"693YYX)S7)@2#^/'S^7YG7T'LE\#">2W
M4H>>27K;K,Z;A_LI\"T/MIVFG=DNG=EUIIUE?6'L6'&GFT.M+2;]TE*VW$J0
MI)/DI4DC5GVO7N;)C--J,'$RX[K:^E^.4H\]I;6SXSISIPZGZ(M Y2X^'%@T
M5$#W*\?8E2/G^,37"JMKVAUU5+&J_=5G6T[-KP7H<WJ[1VO>J^:G-K]\9.,H
M-AI: \\4=&2KU!I:D@_GQ#[CQY(\^/EJFK;MJI3J^.VDG;>E^'F]=%X$?[2V
MK6I1RJE^EOJ4IT=1(D7VKUBB)"A0FU]&,LJ1#AQHJ%J3N1!^\M$9II)4!R I
M0)'@ ^==0[FX^/M.S/$K;<*S?"ZO:ZX<5Z&[=C8[QMG3;;E)\5JL^-K_ -3]
M#BB5MJX//'D>#SR/0 #C]@'')X^O.MYIWI:>BU_.NOH9HI;),MQ_#*69D65W
M<*AI*Y#"IMI92$QX<9,B2U$CN.NJY" Y*?:BH[N![Q:4DDGG58+/0.J+96VP
M>RW#B9O 324\IZNL(L@NM7#-XEJ>]%H'ZHM_%HN[%%=)<JJLMB5/):#"%AYL
M* N3@&XN';GXY R[",@C7U/)68Q?A.CMCSTI:7+KIR ?[ELX)=2S.@K/OHKP
M6TM*5I(T!<G0#0#0#0#0%#[G17)NW&?0VFGWG96&Y-':9BOQHLEUQZFF-H;C
MR9O]QQWEJ4$M/2_[F:64K?\ XH*T!A$]FYCNZF*[YNU-O5]1N.8*G'LH:LZ3
M<?=3ISR;;Y64LM4B6W:G$]H$-7R+543^,3:S6S"6PI1D.*FK\B?3Q4S[\^'D
M]#.!8;=X);7$C(+/$,<L+N96FGE6TVF@R;&15*["JN=EOLK>7#);0?AU*]T%
M(2KM[@#H0:VV/TE93Y/.KJJN@S9E#.:E2XD*/'D/M1J]]+#;KS3:5K0T.0VA
M1*4\^ #R3#<)O@I!&;H!2/U.NG\<>4X8D@^OD7-O]>3]?)/))Y)/&IZ]03+T
M T!HKT/Y'^K5-7[7UG8$9NL7QTE]3)]%#83=LGM\>N"WO'GR"?4GP?Z]>&,_
M^&Q.>'B+_P#6I]9%]V:E5VCL*>3VO9UY/%H77V/G#P)M P7!N&V^1A&+CDMH
M/'%'7E/GM'U\<<\ ^=<MVA1M%;F\N/HW/43-I/TA[M=G[&^R]@JK2<[+0VUG
M:SG7QG7).2L@$ I 2@_0]C?(/(^7:./S^?/[K*C$Q-])/59-J;K+-1KEI8S6
M/L6P_"56'NSNM0FW-4T\[<Y]VS)C[)+_ ,F6_:0 $IWZR0)2.  1"AE(
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MS]D3R0RRWX;:;0"2KA"$I'<1P3P !R1X)]3\]"#>KT/K\O3U]?EY'G]H_,:
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MM3.)O-Y3$7A65_)IK-A<<H^WKKX+@T2H+3:&P4-IY0GE "0 . 2   >.!XX
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MHXC.^[Y)\8T*L&NM8E*;J2:2CFVW*;:M;-KE:;_>AT/)2GI!Z90E( &R.W?
M'' YQJ!_;Q^S7QUMJG:]I3<QM&+K.5=5IU2R-HH_;3_I7G99DKM6Y406Z+_^
M$'5Q^/5/G/\ _JL=/^31Y/0$Y..4?=/H>202.>#Y'U]!QQZ'5"6[2_/+B[?R
M#Y0/;R#CJQV ^7^XGF)/R_\ 2BM 'X\@\<?($_0C79OTF5%6T8^^U^[72:$G
M,VOEJ\S$]JJMX=+IRAS?@[^3E+*YAD[B1X4>0?(Y/@$#S^T<\GT^NOH'::<6
M<!TI4J5,*G*<I3RR<3_.%IQ-ZAW;NVVI5I:EZW^^>AE&]BM_\X8V3\NFS<0^
M3\SE^'D^/GR/QY(X\>=<,_6&NOXFQT.E12W%IA.J\/2;-I<.!E>R4XJJ=FYL
MU>9>;S5I_L^I;J&ZC-I^EO;.QW@WNRI[$<"K+.HIY-S'I[K('/M&\E-P:N,S
M5X_"LK-\S93B6$)8BN=A)4HI'G7$<# QMHQGAX-+Q*JDHPT[K)3&2EM?5VDS
M=H;X)OE"3;?EF88NKGVM_0MNE@&#46&;J9/=6%/O]L)F\^,UM'NE&3$QO"-R
MZ'(,EL7')>)QT.(KJJ%)E*CH<5*?+?N(S+CJ@C63P^[_ &Y5BU*CL_%Q/E4+
MX57RS=WF&\OM%CSIVG!WJJ553*FESI.M_2=4\KR3%QCVROL^LRRO&\.H=Y[Y
MR\RZ_J\:H8\W:G=:L9F7%W,1!KHSEC8XE%A1&Y<EQ##;TIUEA!^\IQ/"N+?:
M^R>U=B3KVG8\7"P]'5A59_ZICV\RFC:<&MN*G:V24Q:TPG?Z/4RK\CW84"O^
M3R#_ ,8\^GC\?'K^_CG6/C>2F5RD]B.>^F8[]8E2QK;9;;?;K/%0(]I89/%W
M W#M,#5!@P(AE,OU3E3A^6)LGWBA:'6Y KVVU@?QRQSVU MATD;X=1&_6+X[
MN/N7M%MCMSMWG&&0<JQ25B>ZESFN3/2I[C2H]==4\W!,<@PFTPO>NO2XEM-(
M?;;9#*D*4XEUU[ F\#R >..0#Q]/P^7]6@-= - - - =>6PW*C/QG0HM2676
M' A2D++;S:FUA*T%*TJ*5$!2"%#U20?( P*[:X/MYMG[3]S;3"\%IUNU[*\D
M@9O-W$RF8YCM?)QB:Y=XLY7V$R6W<YE;V4UJR%4^MJ%65#;<QE/O#VZ SQ3*
MJLL6DL6-=!GL)6ET,3HC$MI+J?*7$MR$.(2M)\I4$]P^1&@.5N#"CEQ<>)&8
M4X$^\4RPTT7/=I[6_>=B4]_8GPCNY[!X3P- 00V#\];/7"/'":_IU2!^"L6R
MLD<?0_/Z_30$^M - - - -(2R4 VA*1Y"4@_4 ?YM "A!]4I_<.?'IY_#5+H
MI>=*Z_H&O:GGG@<_7@<Z*BE9)< :ZJ!Q%EHGDH3SR3S\^5?RC^WYZ W>[1P!
MQX'/@$CU]>>#Y_;H#7M!/D @>GKZ\<'P20?']CZZ T#: 20A()]3Q_D]/VZI
MW:9F+S,\U;Z"=.!M>3W,NH2 "IM8 ]/)20/0>//'GCQJ6DTY]>'.X/BGSCI#
M]N+TM4&]MMM'B6S^3;4UFX^YNY.-XY3R$91G]Q79?F4VU9:KZAIMMZ99*C36
M7! 2L>[")!65%'&M=V_NMV=MCW\;$KKKJ;JFJI-IS-YITF=7I-BPQNSMGVAT
M_$HWG;-)J;K)K)ZZOE$D+D[_ 'M[O"OU4LV_#C9R<?QX'\;X^8]?4\?(#5C3
MW)[,M\^+E::DU-WPM=Z?6"W?8>S7BBE)_P#I5WSB4KP[VM=HD_C/3/[>+J]V
M4?AY7@6U&%[?[@R6J3),7S= PS.XM75WL21+D?94A+TB)[]4,.Q72ZHOL^4
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M)=6!)#K64I72-U,H4I1*MD=R> V5!:DG%[-)((2L]Q5]U':@JY_DCQJ=G?\
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M.;?7^%_-M27GND_S$ GCN^[R/'R'D<< >O&O>%,M9%+G1QG[]<5SG(YM22-
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MM%$VYQQK+:K*<CG;V=/L.;@EE4QW=_=H2Y8/VE7)88XR^ >'&HTEQ8)4!P$
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M%[BA!(60DD CD\'P1Y'Y$<?T?+0&_D?70#0#0#0#0'$MM!'\D<#SZ \<$J'
M_P#M>1^.@+/[Q[RXCL;@]GN-GK]U'Q:B^'7:R*2CLL@F1X[S[3!DO0JIB5*:
MAQRL.39*F0AEHE7([5: HS;_ *K-C-TK',*S"MP:FP<PB&Q99%(E2/LV#'JE
ME33EJU,G%EIR!%E-N0)SZ"$PYK98?[5_=T'7UCZ$5=B]X-IH_6;ULSGMS<#9
MASZ_IZ,&4[EE&W&EEC%<J2_\)(7/#3ZF5J0E]+:C[I12% $IY G2-]]F./.[
M&W'^.6/_ .2QT _AVV8_YV-N/\<L?_TAH#JM[Y[->\5_NN;=*[%<%"LUQPI2
MHC[B 4V/(5VD*(5P3W>#\M =D;[[,_/=C;C_ !RQ_P#TB= :_P .VS'_ #L;
M<?XYX_\ Z0T .^^S'GC=C;CG@\$YGC_ X^O]\?3\M =<;Z;,H*>[=K;I(\!/
M.;8Z"2>24D*L1W ^J"G[W!\Z ['\.VS'_.QMQ_CGC_\ I'0#^';9C_G8VX_Q
MSQ__ $AH!_#MLQ_SL;<?XYX__I#0&AWVV9(X3NSMN%'T)S+'R.?R^T1^WS^
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M^_G_ ->>XW^6^/[_ .@<:C=7!>B!N'2K@I/ SC?CS_Z\]QN/K_\ 7ND+@O1
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M>TY_/#*?_+')'Y: ?J:=*/\ T>MIO\3*?_V;0&AZ->E$ D]/>TW@$^,,IP2
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M':(!]0#^8&@-I;0?^*GP01P./(]/30&_0#0#0#0#0&P-MCCA"1P21X^IY/\
M3H &T @A"1QSQX^IY_K_ ,G''&@-_('J= <*B4]YY^YQSR5<>>.3VGD$?F2
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MC0I]E'CQ$6SL)!$4V*HS3LL-I??;2M0&@\?+U_'N7?62$*/')"3X'S\>>/\
MO_:/70'18#KCBBM2BA0(< )#:E>0"A)[NWD>"/><<CGM!5R .^D)[0$\=H\#
MC@@<?E]#_3H#KK5VN !7DK]"2 >1R4@CD#Z\\#@\#\P.=8)0L))!*5!)3P2"
M0>".01S].1QH"@[O<3#<2DR:N^R2$Q?0\2N,Y=QEA3MOE3N(XZ[%C7-]7XK4
M-SLCM8,&7.A0G7*VKF+<G3(L%A#LJ0RRH".'2_US]/W5I,SC']N<XQIS.,"S
M;,\:LL!=O&6LV-+BMNQ"A9HO$[%BKR:%1W=?8TTXF;3,_94NQ^QIKIGQW$J
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MU+*6D!(&YM2ENG^-(0@H_E *2M!)!2GGR/'!+A\\@]H[?) ]!*4I " $I X
M3X''KX \?/GG\= 1FSWI4V]W+WZP/?K+I^16-CM[C HJK!A.:8P2RM8.41LM
MQG+,BJV&&Y5[<8=;-2)F-1+"<]10+*0S>FJ<O*JGL(($F2E)'! ]/4_UGGR?
MKY)_'0&B  .>>Y7@*5X!41Z<@>G@^GRY\^= ;7'.T<#CN/@>> "?J?/'U'/
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M68+L[AM?@NW&/QL:Q:L=6Y!JHCK[[;96&V^2[+<=>44(;;CM\K5VL,-(3PE
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MLZ#-J)K(HV=6<--U4QH$E^GV^R7(L7R.RK6G70S;)JY6.2+"X@QY'VA5UTV
M^J.^7BAL#;3^UTZ:[;)ZC$U566PK>5<XO1WL>16PR<?F9K;8C3XMW+#P1:">
MYG-!,E-P%E^MAN2'7FUAH)4!ED0RR4C^*;X(_F)^?_W= :^X8^3+0/!3R$)!
M[2>2 0 0"0#P#QH#E]- - - - - - - - - - - - - - - - - - ;0E(YX
M \\<CCP>/ \>F@'8CU[4\_7M'^;0'G7$AR%63YK24*7#A2Y(;6>T.*8CN.I1
MW#R I2 DGQP"2/(X(9&)K:GVBFX>XTO:-Z7LBY0XQNQN?A^W%7E<R9/9JU6&
M0/[A,6\6K5(80+B1CK6"MR9<F$IV$X+N,RE:7([O<!>>1UPL4O4?;]/N:8PW
MB39O9<G"MR9LAU_!,RPO'<73>9XM-XV$0J/,L/D/Q#+QR<^M<NH>7;1_XJ.^
M&PZN6^WN]H+;[%56_6XN2XGM[8[.;=[<4^=[2Y73[H5TNUW7E9&PK[!II56B
M+[G&OMIZ+:/53[\F0F9!AHD-#EY*4G;GX L]C'M>:S)[R[QYK:YZ!.K8$*Z@
M^\NF935I1)HY.13[*JD1@6K>L?K8:V8%Q#=^%:O5/8]-0BPA2-"+QE+X9??K
MAH25Z,^NY_JVSW?7 9FT&9[3V>STK'G4(RYIV--M:G)I^11*9R;"?C1U5L^;
M!HV+YB,%N)?J[B"ZTM24%:Q/G]?P9&TI': 4CD  \@<\\?/C\SX_/Y: W=J?
MYJ?W#0 @'U /'IR.>- :Z : : : : : : : : $<^#H#9[M'!':.#Y(\GS^W
MT^7'&@- T@< (2 "% #T!\\D#P/GZ_CZ: Y- - - /7UT!Q%ADGDLM$@D@EM
M'()]3SQZGYG0&BF6NU7#+7/!X'8@#GU]>T\?GQH#'EN;[0+;S:_?G(M@K/!,
MONLEQY[;EA^101H=@J4K="-D#M#*AUC?,]ZIK'<<F-Y+9)1[JDCO19KP<94L
M) WV?7]@E)TN;7]65CMUG<G;C<2YK8=A'H(,.ZO\+QV=-L(LK,[ZOCJ0MR@H
MV:]ZRO505/R8->A<A++R6U\ 7JF=0\67L_:;N[?X38;N,HD6*\6Q;;VWQVRL
MLXJ(-DN"+R@L+"96U2:UV.VY8EV5*;:;CM%KWADE+:@(VY7[2W:G \7VRR+,
M<"W J).Y6UN9;MIHFJJ#;6&)X[ACU&W/C93]E290CS S?1K5Y,5,M4>H8E6#
MB5--I#@=?WUH6_M/;#]+M)CZ,IM(65+I$UL25(L*2OAW,9R7<5^46N-1:YR(
M\?CHN1P,2LI%=8(+2&TOP/BVF0Z[[D.M/O!.+IUZBL)ZE\,NLNP=B3%;QK.<
MDP#((4Q,=XQ<@QB:F//3&F1E*8FU[Z'&WX,QI0#K+I]XVVM"D "27N6?3W37
M'T]VG\OI]/&@-0TV""$@<$'P./3T]/D/IH#?H!H!H!H!H!H!H!H!H!H!H!H
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M6WO) 0ZX_+M[S(9[]I=WMI+=[G)EG93WG7Y3KBBHE00TA#3:$ /Z+T: : :
M \^= - - - - - - - - - - - <?N6N>>Q(/!'('' )Y/'TY/G0 M-E(04)
M[0. ./ ']O7Z_/0&ONT'U2#^8Y^?/SY^>@!;;/JA/[@#]/4>= :>Y; ">Q/
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g729258g14d54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g14d54.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2X64&AO=&]S:&]P(#,N,  X0DE-! 0
M    +?J^$7<#A"24T$!       1AP!6@ #&R5'' (   (D'1P"4  (<G(S-3
MDP.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !#V_"KD#KD0_M@GX%A%'ZH>.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0&?W @         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  O[
M@0  $  @"_N!   0 ".$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             "/P   M@
M   0                         !              +8   "/P
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "/P    !29V
MAT;&]N9P   M@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   C\     4F=H=&QO;F<   +8     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    $.$))30
M0,     ".5     0   *    !^   !X   [$   "-Y !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
MKS"PL+(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0
MT-)@U #5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@
M]Z#Y8/LP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@
M<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA
M3P%1(5-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_
M<8&QA &&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.Q
MMC&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY 'FH>E!Z^'N
MD?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB)R)5(H(BKR
M+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N
M@G&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@JFRK/*P(K-B
MMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_
MXP-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#
M43-4TUAS7"-?TV-S9R-JXVZ3<D-V WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C
M8Z=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC
M_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519
MI%WD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FD
MOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G4'%0NU$&45!1FU'F4C
M%2?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RU
MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
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M*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<70
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%"-2@O_:  P# 0 "$0,1 #\ W^. X#@. X#@. X'!A$ $0#8@ B ?[_^'G\
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M3-U7=1%G89LZA'E?=-8Q6)IL&0D1:\9U3Y1="GUJZKE_L.5<,&IGQ]&22[O
MDIPB+]=U,:'E3,W4[?.C'ITR#9KCE'&3CJ\GKGB[+-UA%8FT9#Q+CE@LY;3L
MTR.U12<1X21$C-73A,J;KP8O=[".&/:L99\//*,[E><:PM7Z=_B$_$OZB%Y+
M+>28[IOPG'0TC:%C*V>Y$NU_ UEF6=18N ".CV$.P59MV31 A6R";4RCC>@
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M:%Q?65'R $$AQ?2,>E(.5%"B!1!51=R910# )A.81'8['@BZ.&N_=>'PIP'
M<!P' <!P' <!P' <!P..T-[^OX[\AXUH!^@?E[;\\ )0'W^N_'T\AK_-XX'7
MTR^ T'@=AX#QKQX_+7C]0CP.>TN]Z\^//U#0 '@?</;@6C=>H!_69]3/@/\
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M9]3&OKA^Y;_^4N/_ "X'AT#_ ,3;IP_R85;]FDX%X/ :#VUX_#@-!^' :#\
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MD!Q*(D 1^]H1 0#>@J64  H![!^0B&_SW[^??W]N!V  #V  W[Z#6^!R :X
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MD6,KT3=1TE&O&S]@_P +VQVR>LUB.&KILO#JG17;KI&.FJDH00,0Y#&*8!V
MZX'MT$?Q-NG#_)A5OV:3@7@\!P' <!P' <#J8"ZV81  $!V B&AW^(:'SO7
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M+ZJ %#6P#[-)X^@;#]? B?4;U@85Z5DH5;+\G8(MG-MW[UN]B*W+3K)JTC2
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M-@.PX'OP' <!P.IM@&PT&A\[_#0^WY[UK\?;@2T4Q/TE0+W&]7[+4'M -D[
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M,1=$VJTCK/VGG%]O=WFD05H?Q"T(O,-2.U(]8PF.V#0%+W  =Q#', B9,WL
M@ ^=\^_<MYG>-VV6UMQ,6ILWUO\ ;5><N-XWX5L/"/$=]W3=]X_S['8[6;-C
M:1$7Q6;ZUI2E*4^X56(.R$'\2A]-?3\.?8X[MP' <!P' <!P' <!P' <!P'
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MO( /U;/96=E6+,1%FE(B+HCC=SZWK.TG:5G:VK5O&LS-;59I'_*:S6.:;@7
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M\:Q6Z(XXX5(LS$39CC6:\8SG+VJMV<8 KJN7CY>5DW_VLFB5N,8([CS(@D)
M,4@G#:XG[E0..A#N[1#>QYRK7ADV[=K:3;FS$VJQ$3,1C,XQ6^ET\N-[V-C^
M9;Y_X.S_ !^QL;'X[.[_ "3$5O\ *>.>%][Y*=T\5ZH97F<JL99^YD+ #KUH
MU;N,S:%.<IT3M^XX@BJA^Z)B)0$3 H(:#ZW=_#;6PVL6XVLVHB;4TF9F+[XG
M*^LW4BZ;V7B/\SWS?/ MW_C^TV%F+&RM69G:Q3\I_&^*Q%T1:SICSHN3 0,4
M!*.P'V'ZC^(^P>-AX_[OKSK3/6:SJ9>-FS^,_C-(F(KGEEACK-$>$. X#@.
MX#@. X#@.!CN^(S@G">2\0.,G9?JMSMBN$8V<L%8BZ/8W%7F7CR;:)Q3B/\
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M7?Z6UX0,!"@/F79AL=!]X0T':8VQ#\=\,K<3$3$\OA^L!0A[*'2"E'0!4:X
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MG&TLS:B=I9K,6K-FM;,36ZM<)F<%;\CG$U;R(&E"E_J;6 Q==P)[!G(AOMT
M=_CSXW[?CKGI8K_VI$URX:XOS*[GY4U[9-)=X @]?@(@.G[WV(! T+I4==H
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MBS#]'#",BNZ3*!0!,V^!>YTU=150ZEL9QV0:LV?1+Q!TXA+A5)=LLUFJ?;F
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M:\M:O8:)8HN5=UN[TBTL5V,M5[;%F%"7B#'7(F5VW37V+-\AWI.41*<@@(B
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M?&',];BEZKE--KM4"5R4WZ4\C,/B2X%NV(NJRJUNS6.L.V2TG:*(19"LG+(
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MG'%TT83F^IR9H&-+UA[)$' 4<[R\YARE?)]Y)SBV5@<$=0[G$=Q4,H*E1ES
M#Q9DS,,>LP<"@HB8.[N'3KZ=+]7TN;$E5J%<ID62(K4+&0C,%/761BH]I').
M7AR$(N]<),T4$E'3@2 9=82=RAO(FX5,XAL!#\?' M>ZC>E'%/4>G2W]UCWC
M"UXXM,9;Z->JZL,7;ZO*1RY%3IQTRB071(V21*9I*, /\NY;',!R&, " UK7
MRN&;HF*1%(!,<$DB$*8QN\.XA0)W'$=&.J<"#W&$H;[@$2_B$430*0!^IS
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M?1\PZ3<XH=Q]5<1KRPNF[ZOJMH)W7A$\.XD54W!B1ZL28#?*"L8AFIATGH1
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MCBI0%,J;-5A6ZS'-XF&:KN%7;DD<R("3-!R\<=SER#9,/22,X444 @ 4QS
M<*G_ -N X#@. X$(F9AA"1LA*R3M%C&QC-R_D7S@W:@R9-$3KN7*PZ'2:"29
MU%#:-VE*(]IAV !B7ZXNM+IX)BNN4".L&0+T\SM75+%3)K ,@Q_22,@8]Z1J
M6[5]\XD(XLLO%R8E,6)8BZ>."IK)J-/3#C$G7KJ^G7!8[TF]&MCS-.+RMB2N
M5>GH=X2-R;>;0B6VXIZQ</64JISL;%#.W2Z<)D&##T4'Q&Z:;F%D43J(G H
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M;,1%(I^YP]NR<,(_#E1Q'FVB976R(I:T:A7X^&2CWK=VT7:.8^-78$^R@;.
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;!U^T3&$#KJ)"H;8B.S#L1'>RH]P' <!P/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g729258g16d60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g16d60.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[21 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )"2^DE(X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!5%ZX         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              ,,   (4
M  $                          0             "%    ,,
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ,,     4F=H
M=&QO;F<   (4    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   ##     %)G:'1L;VYG   "%     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      9P     $   "@    .P   >   &Z@   9I  8  '_V/_B#%A)0T-?
M4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$
M &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !     -,M
M2% @(
M        $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K
M<'0   ($    %')865H   (8    %&=865H   (L    %&)865H   )
M%&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,
M  0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I
M9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M     !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y
M-C8M,BXQ
M              !865H@        \U$  0    $6S%A96B
M        6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8
MVEA96B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W
M=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                         &1E
M<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@                            !D
M97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0
M=FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M3 E6 %    !7'^=M96%S          $                        "CP
M  )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@
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M4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+U@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M2B)1$HB41*(E$2B)1$HB41*(E$2B*-O3& #E;5T40 2AEZ)$ $-P ?*G'<P
M>0#Z]78)-=D\]Y5'T BE?=;F5JLDHB41*(E$2B)1$HB41*(E$2B)1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB41*(NLP!N [@ @'+<^WA^<WY^SL/\ JK'$<01
M!$5UK"OKW[(6V#H>)I1^2*4J\-)X5!,3MS7+D/(P*E'8!$P ;D #VF+L/"7U
M^6X[AOX*Q.D$2TAHV%M*S8UN?*DQ;DGH_'PM:6-('S0"'&(J:'92-M8&=1'<
MW$!1*40V+SW _(!X@[0#GOR#;_56F$XR 7$DDW,T$Q>HX<8HN"YIUW&(#:4H
M#E[92;JM<A0E$2B)1$HB41*(J#R#?PAS ?$(=@AXA"H=8[@2I;<;R!XJ*S6A
MZK+2R/A-;=\\0^$V\U:9AXA\.YN8[]H\QYUD[\/TCU6K?Q?4?12WV8 "9UN
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MQ X2OV>DMPFG"=@B&/U;DG[UKDGFJY"(@.W,!W[-@[.6^_K[[]G/P>*CG%V
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M/DS12GS+/HV?Y"&DK\ .,/DS1$^99]&S_(0TE?@!QA\F:(GS+/HV?Y"&DK\
M.,/DS1$^99]&S_(0TE?@!QA\F:(HS^D/Z/S0U85VZ'6ME:0M-]IM;QU4&MB[
M$+?PU8,0C<MN$POE68+ SA&,"@64B E8R.DO(YX"S7NY@T==5US=(Y=,)H>\
M-(D1O]%5SBUI.[UFG=YJW-0^EWHX=-N'[QS->.BG3F[MFS&K!>31B\&8\6>&
M"3EF$.W.W(%NF!0Y',@B)BB @) ,(ARWKZ0T3!('RF8%=9W;8^RXAQL0DC6
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M(E$2B+K,&X@8?X&W+MW[X0W]GE_R-2QLM=4DZSHF*5H)(I!L+6WK3"QCJXS
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M.W6,D+YS3:=AXZ8@Y?W%+14>9DQ()T6KERX0(NHJDEL5-),%.L/OPBF CQ&
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M&([[!4AS7DM;),$Q)BE8O4YP@:X7@"<@!7>(V+Q+SRSCC'4*XN:^;Q@+1MY
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MTJFX\151.*BBR8E*)C&!($R@!0NZ,9H:PD1\IB1!%R8B9DBO&IOCJ.ZQY@D
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M2H!<#.L3N)D<^&Y>_MSW]8I>>V^Q0V !'8!';MY^$1\=0U@:202=:)F,IB(
MVJ7.+@ 0!$V%3,7.=J;$JRJE$2B)1%95_P!L'NRUI&,;FZJ72*WE[==#S/'3
M<&Z3?Q2FX[EXA>$3(KPE R[51=NJ8Q#][C!@R*WSD5%:Y5.W?9:@V,[!E!-:
M1&X1:AI=<<?W4:[;<;.7"?<\NP.,9/,CB(+M)9J'5."J@(B*95C "Q#&+MLJ
M4A0$!$Q):^@H>WP\>S8H+)DSW[<YY_>]"%X0,&^X<1MN7,H?.F'?8Q@\)@
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M2@7;90%2@8.(JPIFXQ,GPE$@F-T/TAH>FZ+C/T?2,)V 6/<-5S8B"03<91$
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MQ -=Z 2[5D"L2;*@#N "'A\=2CFEI+3$B+6J)5:*$HBH([!V"/, V -Q$1$
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M:J>L9^8)!V'N*X'N^TAVVNFW/#_\N1GK?_2JH][3$.&>?!-5QR/;3S1.[[2
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M6X;AO_=3\7/V*))W=P]E7YDOH#^H<^_#)GS^M.B2=W</9=9^B;T")@!BX/D
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M'B  HF<ZB9E03#J#ISX;Z6^'G.9CZ)B83(U@X@%K@3 ((-"2-@J,Z3VCT/\
M$&@=,X;<7"Q6#$DMU)&M( ),$$W=MWB;#9+80X0'AXN !'@V ! 3' HB7<=A
M$H ._8/@$0"OSV&_7:"?O?B!D'94&TD&-M5]QY=K0?NP"TS,S4TL,K7O6Y5=
M550$0$!#M"B+F*AQ 0W[?7'^FB+KHBPQD3 F*<J2D!/7E:;.0G(&;CI..ET4
M46\@1>*<D?IM71A340?Q*@I"D_82"3HJR2PB@LDJ4 '#?OK3C0\=FZ]PMA$0
M8 @Q7,9B<AD9ME8KTY+#%D+J=T124I:<DL)NJDK/DG4.+0W:54D:NK(PJJH;
M  $=QKAJ(;AW,41Y6#3O$^%[C8;<U@N%A6(W3$6C9?LH(M^5LZR393A!K+MR
MY(MD52MO)R/1)&WC&$4Y%<2T:+@D+-H$VX7#E@,&JD!@,A'.E-TS14&M8O6^
M<2<MV>2"-4FQO%XN) IWY< (R) W'!W,U5=0,@C(I-G"C5UU93IK-G*8<2C=
MRV521514(&_(Z1>( ,)1,!1&KM( -8DV)'[>6Q5<#-IID#[F;7]E[7_'L]?;
MMJ\C;O[-JI!V;NW8E$2B)1$HB41*(H2NFJ]*[&GMG4_V9U7<OV5?S=,^AODN
MJ_M$_DZ-])_J<HR,1^K&TL>T?3A^KBTJ[,Z=_P"&ND_]3TG_ .9I*ZYZ&_SW
MH[ZL+^AB^O /WHW^<6O)[KGB?->F&?<;]+?(+KJ%9*(E$2B)1$HB414-V#[
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M16[>=W6Q9%NR-UW=.1]O6W#-S.I6=DG:;1A&-.13.G+A0#IIIE$0V,8HAN(
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M6BS2B)1$HB41*(H2>FK]*W&OMF5_V5U7<GV5?[QI/TM\EU3]HW^[Z/\ 3_\
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M*2RB+SWRAR 3J^'?F/?',40 >].)2 02JF @CPI"HEQCL '((@<I%^0JPJ%
M# HB8# =4G&&Q-N_ Q#B8VQP-L<J9NL(*H%2,($,(4YYE.>8\?58BRAF^WL7
MW!9=IN(FZ[NO7(;R49VK9EFLX=S.2HP,,_GI9X"T].6_$-6#6*C'JRYW#]-4
MYR 1N198Q$C$7L87RU9V<<?6MDRP9%Q)6I<K,KUBL];G8/$CG*45&;QH<ZXH
M/&BINYW#7K52)+D,1-ZZ*4#'(LP411L](I_?6BW[>K3/^LB!HBDFV#Q!1%38
M.7(.7,.0<A\8>*B)L'9L&WBV^Y^3E1$X2@  !0  [ V#8/!R#P<N5$0"E#L
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MBAB^1W$<NY3B!B<(<.U>M!TET.W1='QQCX.JS1L,'_$;K!VJ 0/F!XR(DT(
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MD!@<[4(U6[((F^4$!7#A*&R3+-7&)'^.\G3]B7#<4?.OHVU(9=.:93S!LI'
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MXTU0]LWA,6!<4AK"T_,H6]X)".=R]KR3B^X4K6>8(2K9U'+N(U4Q5TTG;19
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MO>E(!E995T$30FABH(R)&W;6ZH^0T$&NMNS!S],HR*Y>8!JRW ?FE.I3<!W
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MG/<YSW.()<XR:"+KFC5;AX>$QC6,PFZC0T$4F:U,GA'!=M$2B)1$[:(N $
M "B8I0["@/+_ "N0[[@8?1 .Y?$ !4$!PJ 3;6(^;//M[KJ6G5(( @?A_#W"
M#OO==3IFS>I"@\:-72/??N;ANBL0.(=Q[U0A@';T)>+?A+L4-@  #;!QL7 $
M86(]L376,YG(BTTV+/&P\+'$8F%AD;FC/C,]J_ RMZ!CC&/'PD2P4-Z)1E',
MVBAAY"(B=NBF83&$-S&$>(VX[CL  &C],TIY&MI&*0)@%[B*[B33<(&<+'^$
MT:(&#ABT$-:"(DT(&TSGN7K"&^W,=@WV#??;F(@&YN(P["/>\0B)0V !
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M.RMF!!D0+$=Y'H%W5=42B)1%0!WW]81"H=\HD;!??'NK:HEHK43X%.$-Q$0
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MHK),SHO%F'&(QV*V &DM,P'&*R()!$#,C?NS>.K>S#-2\2"#( )+?FUH-P;
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M]T01,7AH+#+=L3,VX[?!7M\T.O+ZW3K^]PM*_P#:LHB?-#KR^MTZ_O<+2O\
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5)1$HB41*(E$2B)1$HB41*(E$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g729258g19e55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g19e55.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1MH4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &TR^:8@X0DE-! 0      $8< 5H  QLE1QP"   ")!T< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0]OPJY ZY$/[8)^!811^J'CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!J79F@        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              B    4R
M  $                          0             %,@   B
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   B      4F=H
M=&QO;F<   4R    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   (@     %)G:'1L;VYG   %,@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 00"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M)JG<6N:6R>!Z;7Q^BVS_ ,+9_HU>?CXMNZ@UNIR[6P&9)0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MCLE/?[).88B>0+=X"DQE^=E5:D)&K0DI)&BRE:NA6%59VT7%L9V3Y<J)$WJ
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MI1S!)HU;L&[=N@P:$1019-$T_::(HM40(1NV(FE[;=(B9$RII^A,H%((%IZ
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M<P300VV-@Q)DL.0%MXM@Z$*/&64EB:7&3LYLK%D(\+86]K&\+-B(GO#92B(
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M[(BS%#&RDR!MH.:N\OSERZ+<(6LQ;4J)#,U8*;?RBJJXG$%".$WD5'E13*F
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M%A3-X_*FN$2@H00]ST^1 I:?9/5%V=WW4D=G&WWK?"XV.(@'787=ZUS*" -
M^$.VNVS7INN/8S@AQZ8]D=UG[F,[ARGM#ZIO+T,?)3/@>GX\9CV7^\T9NF!8
MG;%:LK)L=M7339NQ5Y<O-=U?&+GD^?W:7N]FF6^B:1*:C496PP$E"%CF9&$Q
M(N5JQ(L)!-9O$MX=I',V[0[Q(&9$4O&'PUUA,SE9%DO;W'W]C9W#7=W.MQ<O
MD+>6>)XCI4D8M;M&P(C6-554V..AMNK.L,7[7.C?9_ADAZ5Z7ZPPW5.?P]KA
ML99RX#I^WZ9RMIC[^WO#-,TUE;HF2MYX"CWCW4MQ+),83XI=^\?2;YWJGW]I
MU-CHF5=8HQ$8^DY4L]=U&UZ@\,8#.;9?D62PN6T$EX*6(B"K'!10J;AJZ!,C
MIS(R#PY+UB9A)%; ?!%LH\A]3(-[ 'D!Z^>QZX,^6PWL=L8<=TY/@>I?:%<N
M)\MU+%%'E,;T]"H CQN%>4".2\<EO>KDH&5-I(FVB2#2QVQZRO\ KYMS_-:X
M^4N49+1Y+35$(TBDE9&E??.'I$8ZP1S--1=&3CQ9+E.X31^6D&!6TLG\O\TJ
MR:::ZM#!,8T)D!4N@ )8+O[K  ]QOS_O#T'I]9>S7V@P]<=(PY^^A&*N+:9L
M=DGN&2"PEO88XB\]C/(RHUO.TJL4)#03,]NQD9/&DBN1H\4(NHDT=*D;'(FY
M.FW5.5NHJH"22:PE+X2455$$DR*"4QU# 0H"8?',0(Q_NMZ>AT-D>?R\_P!>
MU=%,L2LJO-&A<%DY.NW4+R+*.0+ ("Q*]@H+$A06&V?H+G[WK?V)@'78JC3U
M E])J:T'CDQ86!/P=:R3#MB+B,.];JN$HJPR44(QS5I("U>H"]6CG3=NM)-R
M+;BPB-M< W$9C+IPA9NX+Z'(;'921O0/<[._/M\T^VG-P=>="WL?0F7L\W;X
M')QW755I92_VI+&UAG\*Y$+ /<V,%P/>))(2\1$ G0R+"Y7]#/-]7Q!3BE/
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M^\77D ?J=^H]?U[_ %]:F[[T?"-XQ@)_90_Y6+8D.?U#^0J;=ND)U#"8QO\
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MS&P"&WM($@C)^*9T4LX,TI^.1F=V<\CH,QXA1H#93JN!Y+M3%-KHE-C9EVT
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M8!BC'8-%6N?>;KL8O[>U"N]PLQ9__47/+&#?/]SC&)1_.\E,R=NW-4N"K=(
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ML)0.6X[_  ^27*^+(MCD+..)@ ]]#% )6VXXQ!9Y&?2IS;:@!679Y%E&F\
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M]/V;6.4%A?8RY)R%['DL4\POKJRY+!<V"00Y"$A2L4D3O6Q6K1^)Z)-T?L1
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MI-(Z,9MF#%JF8YE3$;,VJ:3= AE3G4,5),I1.<QQ 3&$14JTXC*\PK]MF[]
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M8^FND\:^ Z=6037"M-*^4RT[1D2'*7*SND]N&9C%:D&-#Q9>*+'''L,[/@G
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M>S$O+@YI3J*RO)6.VQ\C$);W+G^ 2(Y3PTU3Z*8IRE.0Q3D.4#%,40,4Q3
ME,4P?0Q1 0$!#Z" @(?3DY[$;&B"/Q!!_J#4^\_*K)T;.*3K--GJ!H==CK14
M;(Q48RT/)(%5163,/K3714^BK1ZT6 CIB^:G2>,7:23IJLDNF0X8UY96N0MI
M;2\A2>WG0I)%(-J001L>JL-[5@0RL RD$;K<]/\ 4&9Z6S%CGL!D+C&9;'3+
M/:7ELY1T8=F1Q]V6"5"T<\$@:*>)GBE1D9E,'\8NUTZMZE ]4-JL4C:\]N'S
M!.K6SV!;UR4NBT*"BN*W^1.)4G%U@&XA^R<J8$S6B'(DV3(5^DFP0BV-NKG
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M %_#D*'D/IV_3]*F-.5I6+]P8J2>+:]&HK$;*R&7W]BDX5 1304=U.7;D64
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M?\&7'P)1]!W1%E_*9Q+_ 'GM((JB F*DJD0ZB9LZ*]C@(,5E;%O\=PHN-_\
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M?+\O/Y"JPJJFBFHLLH1)%%,ZJJJIRIIIIIE$ZBBAS"!2$(4!,8QA "E 1$0
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MG\U$X!#8N^/Q>09+>21">X\G12/K^=:+J>%+CIS.Q. 5.)OVT?G';22*?R9
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M66=M"TALG7]$BSFL:[IP^=/HXL1&QTNL94T<I6_OBE>)3]\W\^*5U !'[?\
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MORJ& ?:#>R?P'H._GOM\OE7I!KR'EV ';S!]?U[^>]5!D1\B/\//D/IX_P
M_P!N71V 'RJZ!ZGSUW_KK]:XXJM.*4XI7("(?;Z?U_7UXI6Q/ K2M9: U0>*
M"J]KSE2$44.(F45:(I)+1RAA'ZB!&BQ&A1$/)OE!,(B(CRRXT=_.K! !.NWY
M^OF>WE_4^?>LNL8QA&B^,P:IMADGZ\H^%,3C\S(.BIE7=*>LQO"BI4DP,!/2
M0/0'I*'U\^=[_+M5*]_%*J]>KMCN5C@:9389U8K?:I).'KL&S*(K/WRI#JG.
MJH("1I',&J2\C+R2X@VBXQJ[?N3 D@/FW--!;03W5U*L%K:QF6XF8C2)O0
M.VD=BJ1QCXI'=50$DZH2%!)\@"?Z:'XDGM7ZO<$S17&\8S/+G$@66=4>GP\"
M^DDP.5%Y(-6Q1D%VQ%/"A&9WIW'R::@>XFU!$A_S%'GSMF<@,IE;_(K&8EN[
MJ69(R=LD;-J-6/JX0+S;U;9]:PG/)B?F?W\JRYS65YJ$W<Y7\<3PK+R"5?\
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MD;I?(11&5!+)-+9V8"<ASU)=3:!X[ ;PI0"0>#CL=E=^T3HFUA=SU1BBP1N
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M98FS9=?KI&A5$J.I&&+6+ID5)*\>S]NM-=BF8$?ZW$.D_G'24",8SF74O*L
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M()C>3*B@@4HF5 Q;8&SK\?WO_O\ /OJK:CEY=M_/L?\ 7_2KV15*LDDJ4IR
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M;C[2ZVO;CSAZ=Q<%C%ONOOV49KFX=#K09+:.&)]'?Q 'RKW9J?Y7N;VA9'
M_%<[P&92 ?( =-JSNT0H8 'Z"'K3(0?IY^@ //>.8KUAU+'_ /5Q^"G'?O\
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M>M'8[=^Q[C=0;FI^0F')G\[*K/'"AQ_O7KC\A3&]1O;2(<P)(E /(@DB4A"
M'Y2@4.='@@M[5!'!%'"@]$ !/GW8_>8G1)+$DG>R=5H&=Y"2SM(2=$C94GS
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MLLC>/&2'9G0G7)@.1Z+A/MD+<C+BRVKQK:R6;2,98],7:4.L85P>([1*I.V
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M8WNA;3G3, 3$1,I5E7F"DSE%91.D+LBOLQU7X1"7N#S=H^@6(LGFA!(7:BX
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M6.*-%2.- %1$0!555'95     KKD444$4<,,:111(L<<<:A$C1 %5$50 JJ
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MMK'I2%1:MB)D9.Q5?_L9(M&ORS@ZQ@*B8>1+)=09"UC+6'2^1O%U\-S/- \
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MKHMD">/6JNH5-,OGZ  F,(!ZC#]"E#R8QA I0$1 .>E1G8*JLS'R502Q[;[
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MK1$.H"S0<18X)\1--["ST:QEXEXFBJ19(CJ.D&[AFX(FLFFJ0JR)RD4(0Y0
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M7W(>1#YBO144L8!$IE#%\ &MR?5V=RL;037GN]L_W[6Q06D,@_PS>%J6=?\
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M<)4.IVF=+FT"[G_9C9;$]::YVRM[>9%DR:R![0HWS&M?A=BC'\:O%K"^<MD
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M+PR38;(7F'22'15X; QQ1G:GX@#S168+(R*AD4/RJ:: [;WY:_#7E^7E5O\
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MD 0,TDQ^2ZIA3BE.*5#@0&C]XRC]4HW=L-,7_I(M;LDGO7Y$1 /6N>JV80
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M5J",<Z3=MF98I4%0H%1D%$B ](_!2;E6/E$Z 1[Q1(W@&>=E(!A@!5MG:RR
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M]O $:0"!2?"M9%12VK@AFD4%6X*@!'B=N4^T'K*\PUYCL9AVY7J2QWUZ%4R
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ME(Y[;)-5K%&/'*$^7D(^M(V&4C#$.W7BRN$Q;\M^)WXHI<CL==E'T+'MV_\
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MJ35:\E6H"/@"F1<MHDSMO&C\N"?RT660=*PS,"',H(*1D8HT8'7 2@X5;J.
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M=I.?60DD7+=Y'I*.6TZS:'C74<X34(06C@Z9"(B58#'(* IE$P$4163<('4
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M)87*+(I$@$3&:L$"D>NTP\"4%#JLS*'  ;I+D.10==-D53EX:A@N]NVPO;U
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M>. Z]2LN_J!_%\M]ZJ2&%Y\0H [:2<F'CP(.Y9XAZOX>HL6:.3$/H'V*'Z^
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M+Q)& UY[T?P[=\FPU"IM?,@I%5Z,1<MS =%\LA\](I' !*!TY)^+E\4WI$0
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MC@9IN=: ;HQB*"S&<5C),46*M:5+3BE.*4XI3BE.*4XI7I3])4_4(>1 1^H
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MD?$-7IH1]'U\^ ^OZ?3Z#?B]A_6$A'B7.$@!\^=Y<L1Y>0BLI =?C\JQYO\
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%G%*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g729258g19w26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g19w26.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1E\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &6"^9)8X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8)2\         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              /T   )A
M  $                          0             "80   /T
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   /T     4F=H
M=&QO;F<   )A    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   #]     %)G:'1L;VYG   "80    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 0@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M!4,7&%V<YMQ)8]N0?0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #\ ET# 1$
M A$! Q$!_\0 'P !  $#!0$!              @&!PD! @,%"@0+_\0 9!
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M;H>/EX9@^F8KD/;GMA++X]A]!_R.]-!M5\?'PS?+/_UQW(O!##U#A/+Q *
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M"*^WJEH9QL[9+]/VJ]7=PYLD4*\BVCTY:7J\7770,_;"B+U"6%5=F4&J:0'
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MNA()RX;]?1YZ#>3>-E5$NL.GS"E$@& 2\\Z"DO[K;:__ /:+PG__ ')J/_\
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MB,?25]M,FXCHF ,HJ9JDQ4>&:KN#& TH[1<2PD3%\*9 DIR ^@A^W04A??\
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M1724*HDLDH0#IJIJ$$2G34(('(<HB4Q1 0$0'G0<O(=^X=O7N';MSW^7;O\
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M&N?Y,.OAW_#?Q?\ 7_U#S&)_'^3_ (Z?DPZ^';\F'7PR%^$[^<BV:?IUIO\
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M_0'O_P !UK;RO'[X</Y'.)__ +^^?O*M^O3PW?CTCO+/YO\ A_BF[J./X/\
MG_U__I5?@J?E+^*S^F7;O^YV4UYW>+NO%WE\'W1_R&VG9X(!R(>(9@_@/F/W
MB9GX#^4=%>:VL?AQDT+JQO-9B2IO+<>2J:S:P-NEI7A<(BWB7)/9_I.B(QY5
MSK_B^8]<AZE)KM,YV5BVR["^Z:3/S=2JV83/.SE;CO-0V:<Q0DO6LZXD=HDC
MK3$XCG9PZ!)!N]173=,'AUF21TR$,$@U3%%T9(?H@R6*7CH((A)I&DQ--:4I
M;;2GS2ZR"DQ$3WIV_3] [9-^1GM&_5BP+^ZBI?+O^S7'ANC2.R(.[W/&+V4;
M,3WRAWNT.KUE>HK1,7-X9K3-PXL*GOU)HZ*HZ<.FP1C=DE%/2/%%%%S\H"*8
M$%43<4B)F?Y3^HV1?BV^%"M=$[JYRI3V<*OBD'7N9S59DLFA.FDFLD,0I'^[
MS(!, U R"A04\DKKJ2(MT:?W'?0IOXKXJF]M*\5?8WN^GJCCW!V54'>0+-"R
MLI$XXDXB2A[&TBZVV5<2!5VZJ!F38&3)N9P<B3I0H(B4"B)N2@+HQWKHR;'_
M !#?^Z;^8=!'ZT3F9F=\;QM4J<#)4U>%465E9!XJW7&5*4YBME/+^DF4% 2(
M42?P?08QC<GT-[WVMHBF6[<H_D\:ELM&JS6+E'EB3O#EL^,=Q%,V;HY(E=+H
M.8B;E9#H\M HJ%<<'\P2"702ZT%/6Y&"<52SH6A5)&LKUZ:1L2RZZK5%*"4C
M7))=59TW.FNV23CS.#J+HG(JB0!43.4Y2B 8E=BK7'*6=LNQ>.SXSD*HO DD
M(&2J5NG;+87U<?R3M"/;V*%D%G"=?(U*DJB@C-F2G7Z9A6<)"F8%#-^Y;G';
MSVK9/*4E<#;:[/BC+]LMSL[I] /VSUE"GEL@VRW)Q$?(NV\@YBJI79DPL*NP
M5<(-S/R%.X.J9HV3;G*@F)!"+VYG*&\6%R!N-B<2)VYY6X&Q8?1KJ\?"'4-#
MU>3Q%>I:UOZJN9O_ '^Z/D]M2(E_Y8N%DDWBS4_2@=10I)F(OLZ5W95$F4S-
MXLH-ISWS4)Z-7"'R6:U!#12:IJ](1=;W$+X5)42IIF364M4W!X93L1$?-*HK
M*)IN111D''EELLK6EG*=[E+/Q/)7>"&Q+.H5.JX<&G/]G>3U<Y*VN3LJ%MA7
MZN/9X;8A14(P_NAW[)'++&9#)@8%7H="HB0. #)]@/\ B2Q+^C>C_P!F(K0?
ME,^)!^<.WV_KC;F/WSW?6..[I/?A>F+N+3S"%JGP_E_X:GX\>GEO\>/3R]3O
MW)G^6]N#_58EOWLXLUN+^+7Q#C^?UQ_C'>7IV\=[\UWN)_TW%G[WJ5K7#?&L
M=W/@]4=>TL)K'_%&O^C(?T-=WG_)ZN'>'$ZRU?Y,6/\ \AF/ZO<:G%=.D]DX
M;XUCNSN>!M^:^VL_ZNV_]X5HUP=V)[Q1_P [#7?U4F/]K%M7AOC6.[/'Z9Z=
MX6BUW>?C],].\+/V;\I38O\ K24O^@MK''=TGOPO1^.Z?\8_]R]L%IE%(.I6
M:;23*JK#0$O+)I&$0*HI&L'+TB9^GOT',@!3 'J41#7)IXY*]XUWB47<DA/5
MB-V_-(#W[8(Z,;25?DCOBM8J6=,VQ7"J:P <YDDB=9@ .1Y -!QU7Q5O$TJB
M<RA'--NQD)FT6*W."*P<N)@?V236E'P)"9?@$2KKG23((!P4Q1#\7M*33GGA
M7K6ZMW8LTNWA[,Q'A ;^MP.]"2W$5K<#%49G8,-6.M1T<]HK)RQ8NVL[$@]4
M(Y2<**"=5)3J$IP$/HFX^&J;N9O] T#0- T&(WQ,9;$$4\HR\V>@H939>ZIT
MHY KEYEH:8QQ$/9OSJ@$I3D%E8Z5LL\Z74@H], DYHT++,& &<+-^$\MV3YI
M]'[WN^92=RIM^CMPVWJ@TV1;PJ[]A7:9,QII1A.0,=[P1K:+4"D)!2+.PUU(
MZ:S@WDLWQEVJ7_-[@%DQ$P"++KXQFW^\UY,&8S=8HQQ7J&<(5NV@FZB#6.K;
M%PR@XU)0ZKE9)C[<NZDW8N7ZR[QT\EW*\BN\<N%EU3B?J$+VI ()E 2](@'
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ML6RK-FL]:I.7HJ),6ZSA)-P\.@@9PL1JB<Y5'!TFZ9UU2I%.9-$AU3@!"F,
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M6MJ\-\:QW9X_3/3O"T6N[S\7IG>*S]F_*4V+_K24O^@MK''=TGOPO1^.Z?\
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MH!S]8J&  _E$!#[0$/@.M\-\[_Y<3/%,4X[8]7#C_P#E7M:_5OF1#W++]_\
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M8N]ZUB(B^O/=$<'#PU_TTB*S2LQ,TFMGQ\UNM93O#:W/V_:KLJPI@')VS_>
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MNV+<%86T'8Y:J3:T;36RJ<?9H!V9C+Q*_7+%X?,7::C5ZEV("J1B\@74F?\
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M"MB?)Z>)A12R<I0+87'RK@2$0)=5(&03JQU5%B*(%3+,BV%0RJ9R)E IS!P
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MK8XAPD^.#5\9TQ;"RS<TGETNFB9F@TZB\]/47J[_ $>0Y[  CV]>P&*(_(#
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MK%OCB V-(0T@[>N%JTJZ,862!'[$77]\@E-WX8:;M&0O5&P3EX$ ,3G@>PB
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MN)JI.Y R'.MJW3JTB#Z9FET7SE-FV.*:8J"W8-GKQ0@ HD/EMVZ@BJ*B@@!
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M*R@KPXL=:=2,<ZCE75=,W8RL'!S4/$GI]Y*BV<WJANF+.RPZ$C'%>*R+??\
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MAF^_;[N&3K&^,:GBR 8UFHQ";%JPCXV/]L, KRD@C%I U9^\Y-8#NWYV;;^
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M2"T>W'V<ZI)7#>1SW;_)1&VP[(+W=;X\SENL5>O[*I9$[ TK#IV1Q[78HL3
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M4$$4B(I(I$3323*!$TR$ "E(0@  %*4H      ?#0<PG(4!$3E  Y$1$P
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M K:AI:M0DX=0[![=TW;L](=BW=S==<1HK*%"S>SC$UMRQ=8G=MD?"E5PG=I
MKQ=](1EC4M5KR2\<-C-0?.SIU^$A*?6G &,_,SJ@RK*V.#HSZ[TAS 0P99X]
MJ1J1%%)$J"*)!(FDFF1%)/J,83 F5)-(  >.1)Y94R]A*(\B80[;0- T#0-
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MG63GCJ+SSQQU!SSSQQZ^O/;CUY[:!UD'T,4>.0'Z0=A 3 (>OP$A@'Y"4P?
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MU'HIMXUN[,V17TPWEXG'(GWRY^_OGR65VX[O,@9&>T@,PM,7XYBLCX+J&6Z
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M+=TB02B0Z3IL\9-72*Q%"B4R3ANBL3CK$X)G)UA<70- T#0- T#0=5(-S+B
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MFFB  0@$Y O "0"_5H.TZR< /47@0Y >H.! ?00'GN _5H'63CGJ+P/H/4'
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MRB8[8$0514*DFH0XMA,D!R*\]!A !X,*8#^]_N7*=HW6$?.:IJ)G$P#U)HJ
MH)RC](R8-^@HJ<^6( <3&2$1'U$=#>]^'72L)'S$5(0\FU3<1TDU<,'J7)41
M7;.DS-UD!4(9,2E.F<R9C(*$6*F81*)5.XAK$P,?!QT7"QK!!JPB6;6/C&H$
M,)&S6/0(V;)$5ZU%A*BBF0I#*G\TQ"!S_"")Q%MU9FF;[S( =0JQTN2B'TC*
M"0Q@3'J*!14.)E#B8W^:94O2 @")BCU (;TV[;Z(>0F7GK,7D@=/' ]1Q,<!
M4$!+]$P>6 "(<F,!3<F#ZT>A$R:9 3(D & I2D*40 OXQ^2JE3(GW !3*GU
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M]U;6U[9\:3-2CX.J15QKS,5HN8D+K O8L7CZ0B!8R:C4I D$UX^-CYPL'/R
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M3',"1CEZA#I("1C ;Z!Q[])N ['0- T#0- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0/70<7DI=($$@"4! P /(\&
M >H!Y$1'GGOSSH*/KN.:/4XZ2B:_68N/CIA_(R<NV!$SHLH^EG[B2?KR)WIW
M"CT57KMPLFFY.JDV!046I$4"D3*'VA2*84JA"U.N%(J"Y5"EA8XH* Z5(NY
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1H(4I0X "%  Y'YCR'+H/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g729258g20r95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g20r95.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[21:4&AO=&]S:&]P(#,N,  X0DE-! 0
M     &$< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  (<G(R-C<X.30< @4
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M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q ;*JGX         IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ /      0 ! \     !  $X0DE-!"8       X
M    /X   #A"24T#\@      "@  ________   X0DE-! T       0   !X
M.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M      H  0         ".$))30/U      !( "]F9@ ! &QF9@ &       !
M "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M   &       !.$))30/X      !P  #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@  #A"
M24T$"       $     $   )    "0      X0DE-!!X       0     .$))
M300:      ,U    !@             !"0   ?D          0
M               !              'Y   !"0                     !
M                         !     !        ;G5L;     (    &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !"0    !29VAT;&]N9P   ?D
M   &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S
M;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N
M=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N
M=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
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M;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M"W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M.$))3001       ! 0 X0DE-!!0       0    &.$))300,     !FT
M 0   *    !4   !X   G8   !F8 !@  ?_8_^(,6$E#0U]04D]&24Q%  $!
M   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0
M    245#('-21T(               $  /;6  $     TRU(4" @
M                                                       18W!R
M=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4
M<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9    E0
M  !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0
M _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U12
M0P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y
M.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@
M245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M %A96B        #S40 !     1;,6%E:(                     !865H@
M        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M             !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                            9&5S8P         N
M245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@
M<W!A8V4@+2!S4D="                             &1E<V,
M+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M             "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ                                  !V:65W       3
MI/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?
MYVUE87,          0                        */     G-I9R
M0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $
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M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !4 * # 2(  A$! Q$!_]T
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MDE*22224I))))3__T?54DDDE*20,G-Q<1H=D6-K!X!Y/]5H]SE6_;W2?]/\
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M%\K))*?_V3A"24T$(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@
M;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O
M '  ( !# %, -@    $ .$))300B      %&34T *@    @ " $2  ,    !
M  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q  (
M   >    ?@$R  (    4    G $[  (    )    L(=I  0    !    O
M .@ (OY2   G$  B_E(  "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD ,C Q.3HP-3HP." Q-3HP-3HQ-@!R<C(V-S@Y-        Z !  ,    !
M__\  * "  0    !   !^: #  0    !   !"0         & 0,  P    $
M!@   1H !0    $   $V 1L !0    $   $^ 2@  P    $  @   @$ !
M  $   %& @( !     $              $@    !    2     $X0DE- _T
M      @          /_A 4A-30 J    "  ( 1(  P    $      1H !0
M  $   !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(
M @   !0   "< 3L  @    D   "PAVD !     $   "\    Z    \     !
M   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$Y.C U
M.C X(#$U.C U.C$V ')R,C8W.#DT       #H $  P    '__P  H ( !
M  $   'YH , !     $   $)          8! P #     0 &   !&@ %
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M<V#5FY5:'&(V*T;.I-P E:'50"W,K$0[<Z)FRK9!5(P[SZC^R'I#J,//B_\
MN_D7TW*R0&S=G4-^+CV9(QY?3>E>W/(,&#%2*P-GG[B'2S?CQ[(VY]_@Z\2?
M7_W ^"-"K('$[JR\/.6014)"7I/6FRY$$T?NRV>JTKLTX?'#M[2O3!US5RT&
M4, ^V0B9,\JJGV.M%-3"*9>>^J/LNZLZ7,LTUD<CCH]G[QQH>XA5!^]/"%]1
M;:'YFDC[2GP)6^:D]KD[2Z "R!'/\.0@-O7P#\'_  ._Y>:DQ 0$ $![@/U
M0^H" _W" YKJLA3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*KK]8'?IKU:H;CQ695VC6M:.D+7L)W')E<@ZOZT7\P@V()$.7
MWAM;U5TK9_8>1BN]B6K5L(LEZ[Q,!Z)^R'ITV5I-U%<Q*;C)*UKCTD)4ICUE
M[<\F];C^\;I!;!_E<?:Y*=3Q0FM=]5YA6N5QT3_AVI#W)71'J"H9$^1LP1-S
MX[.YY;="-FH(9BF !3I"BBT41,1)-)0WJQ+%5DLFW;MU'?90JL3"R%0:,5GP
MJ']:J:=NUC#R-9&RCK>,=QY!V6!!)(\2R!P68\?!$DT=VSA"!JZRMG!X].W&
M,Q7!&OIKZ;]@(.CH[(*J8R.1_AV\C_OC>![+I.*DOP0+*19OCBFA&$5**3M=
M42J-(QB]; "H(R*SB9U]$R!2&.HC97EL9>H/R5R9#)PY22/S.Z,GDRZT54;#
M2.K;\QA8;^6/>@;=;9]?BJ#?13_ 4D'8T#\_[H/Z$EHU/DZ<N/A?&W''3J4<
MZ^&Q(R+AKH?<.ID%B%:T;9)'EF9I17:&7:A"3)EB6NL%>1LY"+1S5C+N(1$)
MAF;Y4Z.H4IH?U#]G/1?5G<EEL_NK)E26O<?PMI#)^,&[T7$VMR4DAF$CR1"8
M]IP95T2,_9YJYM^*F3O1>-(_N]OM*Z/YEVK*0 =>1NKCG#'EC2.:.A*OO&DL
MG4(237>PEGJS]9-R_J=NAQ2),0;ATD1--XB0J[5_&OBI("^B7[!THV:+JJM$
M.2>K^E[WH_.7.&O768QJDUM<HI6.ZM9=]J95;90DJR2)MN$J.H9E 9IG9W<=
MY L\?@'893\JP^0?^(/U!!K:K(Q5U3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I6&M_;;9Z2U79KXHV+)S#=)O#TVO\ J DK:+S/N$XF
MHUQ$P_\ @"3FW31-VX[>FPCBO9%<2-FBQRYSIS"R9_+VN.5NU"Q:>]N-;%IC
M[93->W+?KVH%<HOS)*8XEVSJ#B<WE(\/C;B]8!Y%XQ6L).C<7D[".V@'_KE9
M>9_<C#R'2H2*JMD9/)J2D[+,6=])R4N\>6:3MZ<><[V1?R2JEP?WA%FJ9)99
M=^9=QM>%BE .JHZ7XLTPQ .X%$O6L 2"**V@M$CB@CCM8;,R#A%'$!91V+..
M2A8RJXJ:0: 5.J;P'2;.A_5M([323EVD8SR3Z.W9_P =KCCL,Q<$WB(1O<F&
M@U[R#C:4IH)F.AZ#-F=+R:!'N!*X@&2C8YXCY2[>^9P<5N(7IZE0E7_D<'NN
M-)[7L904^WY3R%XEP=<B78-[N:^V=P0)NZJ>.-Q,MX+N)->S(YK%VQT;$B*\
M2?Z>%(.BI\QJ5+)Q+:.XT:!HF;>VM[&ZFT1."^.9*F ['TRMK!*>Z_)3:K&]
MM/2HO/0;IL'!P.Z!I9Y@;JRAGC@0.,=M/=]\=]S#KLY\NTN>&SN"+C[BRCE!
M%PY$NHT@>VA](\J#8[F,PUBO^OBKQ)R?'O;Z#>A(2=#1^=2'NJA^JW-W,?(M
MS6-)>H@*2BQE%%$!3.[^:,VH%;>BJ@:9&<CF!P1$[5=JBK>86,*0!^6H\?JV
M4!&4^EVEQY   8'CVW)Y;#"'LO(-Z97/HII=D<SG;@Z$=7L=P?#<MCYY:\':
MEN0&AX*[F1"/CTD8\N=6YNF;QI?\8>+-<K4^Q&(M]^F9#:=LK_T\:J_M+.,;
M152\@ HK.:U6(F"B91R8I3.IIO)..WBH3.2?M(ZBCZDZHN;BW?NVEA$F,M9_
M]J2V>5I;O^2W-S+/+$NSQA:,;V#6T\+:O:X^)905EEW,Z'^&7 XQ_P!Z1A%;
M]7#&I \@59:F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2H:^;6PS;0V$2DQ:QW]2UZI)0(Q;5045;'<I3VM;MPLW8?@0>+I6".T;5W_?
M^S)Z_;#LB9DU]=+*H;Z^S_$?=&*]?,HCO<JL5T)7&UM;"$/=V/<3Y:-?33=1
M7D?\6VQN+M&!7*(&T=UQG!D\KZ"!C)9XQY+4Q(Q4W-\Y6VO C#P'+3PX*U?^
M'<WV1N-@XURNA+Z)'\3\T\8O8#2IK%&Q7BF E]6U#;HZ*3!(!;$,@MMJO0@@
M</39\2Z.5("."(%V$&_ABV__  BVEFV?D6?HY9FW[SM<-<W&Q[FZRR&_86,0
M6?\ ?-Q].Z9XX_;KBUT;J.,<=J54Y6WB_L?]E[+0[@6NF2%3\!%H1LS:F2,$
M>6&>F*O M#MU$:Z2O2#XQ1%6NQJM59ZXG)(QC@\UUICD-:Q]3[=.#O*ZS@^\
ML[\AW.^@XW#APUR;F.,:U<S+=G)V\6@4R.=Z;L] V"B.[236ETJE2$[3'<:%
M3V!$TA/NAC>W]%+)YY6>)S-SHBYV_1I&K)/2F[_:B93=D\!3,B+6T32;]+N+
M8O?US-;I86FQ"H'[ )F.Z^3SP@%,MJ\#Y<+,8_\ 9860D[!Y6T#1DCE\)RL;
M=L>S [T^%Z71O"Y30NDE5M &:0,!]-3OR /$K[M7$JW<:D>2,CF63YLMG:'@
MYQ@:[CWU$2]@12E*7K!2/V%9W+=$"P,]+-YHSJE0[%(.Z0P=ON<0YO,<P,3T
MR:DUGI!L(':2GXH?U[U,V$P$L-N3%>Y428^U5C^T01-"%OIW/AN_9V<J6,L@
M._O?(YH_FA\2[I:Q^\LBC..5O9A;F=ALQ22=P]B-?)'"XF1KE%UKT-M8_(D!
MJRKG,E;=IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K#
M^\-AGUU0Y!_'NV+2RS'JPE65DA'V#.369NGCJ?DR@)3&A:C"LY2VSGB8IC14
M*Z12-[A9 II#TQB!F,I%%+'+)96P6YOEA'XLD"R1QQVD)^!<Y"YE@L+;?Q/<
MHQ'%6U&.K<X,%AY9XY8H[ZZ)M,>TQ_"CG:*266\F^OI<;:17&1NS_L]K(H][
M*##\\KH*E]OX/G?JF%L9@[#T;$[]R!8KY2X>]@%.VR1;FG4%Y #^37;F]-J6
M/U /KH56F_EN-$ON) HY]U#RM$"<I^_'%L[L(ONXWZQ$'G@>F\':$$9;C)SR
M-L0-RN6TO9D]MX_+C!Z=W^1D)3D4Q\DI_J^H>I<Y<[_H8M%U9Y%]BG?#.H$
M.\F:>917=DCX>=I^UC*, @@>+;_*G&VH2$$O8\+3>+E( O\ :Z"!JP?>H_3,
M?X0MI)OQ#\67H9)M[$S&9<'<W&O%Q?=9Y'XMW:JJS  R&Z0#^M]5'">T  U[
MZV.'0!AXPOG+>#1_9K/H_'_-RBUU-[5O$?EX,FR9BB6,)6WZ@&C"F(HG6 JC
MR2$3=XA-6'9ZBG)<YS$7J=,Y/7,YC$LCARM76YV.YS<^.\;N-=2E64W?K4B\
M?C,L[9NW@ VMYD.D+#PUJJI74E2(PJJP_"]+(P,2E6%IZ-Y0/ZI7@7#W$Y.F
MML?U5?$\9V)Z<_@$G2:BJLE8Y))RF*YI!FR,WM$DW>(*2:DFS;^/DVN<RROZ
M]N9( 3S9[HY*:]B!*5;6G@WN$E*$ 16T)4\1%)(&M(GC81"*1O >Q@DQHLW?
M]_!=*9.?\N5Y-<)*'&^[<2AAR+JA6YD5U$I=5^EY-'?K=!?W,OU'8P$<K @3
MM\6]+%T?JB+@'[=BG<; N:UWQ2.* ,DK')-FJ"<!%F 1$*[281G$TBK(^7@A
M7J]'$*4IA/WYRZNSOW_F9KF)I#8VRBSQPE/XAM8G=C<S#P/4W]P\U_=MK;7-
MS(3]*WWTWBCB,7##*$%W-^TWO#\BSR*H$$9V?P+2)8[2 ;T(8$_4UL9D8K/4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5'IN.SC>[8X
M>MWD>,%"D/%0 R)/4ASM4'*CY]+20>1 5B9J9K;J?G0[G!36&K)1ND/M=C-@
M<[EZ;QPQ6.2.2*;U=R1<7G9VMR)'18H;>#YXW%K;7T5G:DZXY[/P,WOPLG#G
MSJ[-??67DFBGM_068:UQYN &M##'(\UQ>W'D!K2\N\;<9"]()!Z8Z6N0A[74
M,7=PD[A/4$R0E>. ./MC,E_R9]R"X+Q!HQ9W^6"-I>A:'M74D/6\&NTMN[+L
M8G\=<@HA(UFXZ8&-->\2)[K1 O&X$ZQ[):PC]#'?+#Q+28+I["VG'>9"O&>/
M(E-3/O\ #[,FTOFY%K8V[2'2KDICDGQKS<@L?4O4W4%[O73Q9.O.6!C#[LLL
M@!P-\P+,-(GS:$.55O8RV-G% 4YC1B;AFPV/#P7X3*0]9XV4+P,I/&;*U@?W
M#;MHCM>FDN )""&LS9R3^!WV623#W-UY N;SK+*;"VG,>A)\2BZ0Z_&]5%;D
MQCS'?>NBM^)8P>R+.6MIKD;.TZ%Q !>^X-U=Y D*068M6Q4? S$81ZL!H\J!
M4%:\:O/)<#F$8PC&&<:VFYWS\35RM\E]@^IXV%NX6N$GV>YS8L2)?4QH1,6+
M+="Z2WTI[Q>Y3,6]MH'U=[T=BN.[5T7WKC^'Q5=?A>FD<&%0%-F;22Y'S"J6
MTF&N+OD0;2PZUR_+C<([; \8M0#;[ZG=9A5Y)5ZE/&\P#J18>Q/8+@X._G8'
MW3,Y2BW>(O+'-;@M,>"8$C+3>:35#>FOJTC=O#^M,X,?C3CH%CAO,BCP=N&7
MNBUQZ+%:W7"3SSC9+2WP-E+O<UGC<C>^5S/)IWT/B&R61^\9FDFL\<ZS=R:(
MQ&YOY.Y<VP:,@<) UU/GKZ'X@O,EC[ Z?#<5E S3-;IIBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE:W;/Y4ZLU;*+0+\;+:9]J<4GD/28)2;69. ,@F#
M-T]6781)'XKNV348XLB=^F]D8MDJV(ZE8U%U,L)T-G,Y MU$;*QM7&XY\E="
MV65-.>Y'&J2SF+C'*XF,0B,<,\@<I!,R0?J#[0<!T].UI.+_ "%VGB2WQ5H;
MIHFVJ]N25GAMA-S>./L"8S"26"-HU>>%7Q&3J ZO/V$NNMSB4Q2'(<M7KIR'
M(H"!DSIG);S$4(JFZ:+I'()B*MWK%RF8R#UHHM(O]$N=_P#..FP=D$&^NP01
MR!# X\$$%'4@@%7CE1@&BD"1-OMKZ>77]!]4L" 04Q]DP((5E*D9(AE97C96
M&PR30NI*S1EOJ+SVUD8!$=?;D3 I?,PJ56#*!" 05#'./VJ[$(FF1=14QQ J
M2;.0.H)21[T6_P _T29W_P WZ;^=#^D+GR=Z '[!Y))50!Y+21*-F:(/;O\
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M#J*X!W;#CK&2$H/!T/G:J/81IPR*2OY7C66-->X6V/3]\@Y 9[ *55(I%B,
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M)N$@,8S209',HQE&"H@XCI)LZ8N2D<-U"%4JI[RP_P 69P@_D?$?MSR%_O\
M_C_]SY^O]_\ R^G^/_2GZ?Y^IJTMR,XM\?.7%#:ZQY)ZIJNX*$RL#&U,ZU;6
M[E=BTL48U?L6,NV,S<LW2#QNSE)!J51)P4#(/%TE"G(H(9]I50_XDWIL<%N(
MO NG;-XV<:=>:AOK_D12:H\L]51F"22]=D:=L-^^B3F?RSU'VKE[%QSA0 1
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M:V4UKP8X=:A(@&O.-.G*^X;>/HR9J/"S$Z D$1*8]@GFTI.*J (C^8K('/\
M^IOH'; 9#K+JO*;]=U!EIU;YB%Y-##Y^@@@:*$#^0C _E59+:WC_ "0QJ?UX
M@M_^QV?_ .UM*V:M62";9FV0:-DB@1)NV13002*   %322*1,A0    *4
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:Y\$_<-@>LE@07],GJI>*G@7R\04K*F*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g729258g21y89.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g21y89.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2M*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *RZ^$05#A"24T$!       1AP!6@ #&R5'' (   (  !P"4  (<G(U,#
M T.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !#4Z%[[EQ*3W+9^:*TOU=7E.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+
M    $  0$L     0 !.$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             #5P  !+$
M   0                         !              2Q   #5P
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #5P    !29V
MAT;&]N9P  !+$    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   U<     4F=H=&QO;F<   2Q     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    $.$))30
M0,     "#*     0   *    !R   !X   U<   ""N !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
M5@5V"J8/QA3V&B8?5B26*<8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG/6
M>39^EH/VB6:.QI0VF::?%J2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$;Q
MYO>&_1<"MPAG#@<3IQE7'P<DMRIG,!<UUSN'04='!TS'4H=85UX78^=IMV^'
M=6=[-X$7AN>,QY*GF)>>=Z1GJE>P1[8WO"?"%\@7SA?4%]H7X!?F)^PG\C?X
M1_Y8!'@*B!"H%K@<V",(*2@O2#5X.ZA!V$@(3CA4>%JX8.AG*&UX<[AY^(!(
MAIB,Z),XF9B?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D :0;I#6D3
M^1J)(1DGJ2XY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)
MK5FT*;KYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%
M:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:
MZAKQ:OB[  L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-
M&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7 <,#LP6?!X\)?PMO#6,
M/4Q%'$SL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK
M;/-\^XT#G0NM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=
MIVVOO;@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@
MWFEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.] [\SP6/#E\7+Q__
M*,\QGSI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_M
MS_;?___^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0
M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M! ,! 0             (!@<)"@,$!0$"_\0 0A   00" @$# P(#!@0$ PD
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M('4JVW3#OQL*%Z^=2B^TU)DP8':O6:Y;(C=]&;$ N5HM<AI.@CWS8$M?:2'
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MVA8]PD1^^6W,C@3P[R<M=PB/>M_VAX?Q?#NJ#*RO!C,C/' +EX;&[E2V,+W
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M%LICDV7 #:Q6F"#FI=Z 1(D1@)D1B0.!,SMKV8&(KF4GM)YH.-J\ES"LNK8
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MX!IJW4C"F2K3L:*^ZA\YM8R'4YJ;-Q'>6LAD6$)<P.9G5W6(+*K&1EB(D94
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ME^-FOGNABC1GL$2BF*'K'J+%93'PV=GW)K@3I.S/!)";8*CAD/=56,C<PI5
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MWK8!KAGV8=5Y?IOJ[#&RN9VM;_(6MA?V =F@N[>[F2!N41)7NQEQ+#( '5T
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MKX944M"RGY,)0O'7DDZ\@D'E;V=7&1MNN.F),49/>VS%G$%CW]Y;S2K'=QN
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M:RCHG P]3]6]/=/W$S06^6RMI:7$J$!UMWD!F[1(($K1*ZQ;!'<9=@CQ6O\
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M3(8UE98FD"+(P0M62=(+T\W4N''5=Q=VG3_O8.2N+$2&YBB6-VB9#"KSJOO
MA$SP(TZ0F1H5,H2M>OKQ%[K%[$2C.K*X/*;,K$IEXN!L.-7+I=<;%*Q$V!ZM
M93(,!*CPE%K!L)6O39.5KK3ZX\#,:X^V"]R!T5:]8P];W7V+A^EVS=E<H<E
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M@Y#?C:]S?GQXK7OZO7^RU?LMKVVNRYITW>[M'5>\G/.YR_;VK_)LPIJYM?\
MF*P/,R05A$1G.$BG10:&,-C)6PKB'V8]5Y=?:3C[R>]GG;J"_>TR8=V9;D7Q
M8(74G0[%PT4L6@.V(PB@(2I^B?M?Z,PDOLFR^.MK"VMXNF,8N0PW;C56LCC
MKN(FUR!N+19X)MD]WNEWY2!7&R!SNNOFW7$^PP4RZ,2RT0.^VME]A]M#K+S3
MB<H<:=:<PI#C:TYRE:%IRE2<YPK&<9SCCT]*@0""" 01H@C8(^A!\$5I_=O^
MN<=H3NBZ9NZH/.:MVEMNR[2:GM3/T\6?(UL_9%$D ,0Z9VNRT/*"1!X=*PV>
M&S'%.#F$Q3DV%&DXYM[ WPONG_=L':LN:LH4#3NL:(LK.29&N)">Z)D#J(F#
M;_"RK&H<<8>T#I_[ ]H9R76U^DO1N<OKB:*SMI)I9Y;%4 ]VBL+?MFU>SDDB
MW<JT>M=V*269FB.SIU*U]H_7FBJ6-UZ^03K.U!HO,7-GDFES%E?LHXS[LW./
M2#0Q:)5T=D4%\%T,#$0T Q#MQX#0"!&=8Y2YOKN^N)<DS->!S%,&55*-%\'
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MAB( .1)A14)F@S)D=RQS2_N D9&J>E&<SZRZ>R%RTN>58> AB]XM8BQFA1$
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M ,TWJ9S;_P#2_P"H-?K\(V:CV3_$OT]3]=?3Z^/U\?G7*5W.B14F*7H?L8K
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MB?'_ &Y6$.!+RX:T^]<O3LC?'U/]AQWO7R)\^ML^NS\COUUKB/3_ ,&M_/\
MGXKJ-_;,#9]O,EZ<% ?'_ ?N>KTRGP/3C&?'I]K[OZ\YQ_\ )_7'GDY[G+SV
M]Z??EOK%SWXWO?:U_/\ 2GG?GZ'?U]1O_,K]#ZU^D?9?<7[69#V\Q?\ *\_&
M]/Q,5EOT>G"L^?=_3'CQY_&7OS_3C[W0Y<-]SXM[WR]X.]^-Z]X]?G_CNH^=
MC>O!_EOG^7_?/RW\QZ4>S%8#&P_F0]K+YN"?P+ZLI^*'@_W/&<>&_B?:LXRG
M]V,__7D!W.3:[>])K\6OQ/PX_GR[FM^-;^6J#>_&O&M>/S.M$_GR/^OH*QU=
MPXV<TGNC5_;>@"&XB(:XYH?:( 1MMA,WJ6;<( 'M1[@Z75$XU_<R(PR/:4,L
MHV2=KP;I+$2(5C%PL^=Q +(F,!PLEJ26\2K!)\+?3G!R\#TT3^(UC.966QO,
M?F;=1VTD6VR:C?QV<D4BI*^CY,!8:.B2YA4D*#60V%D:],B4Z7@S7I$&5#BI
M*&D170R CQ3I$\J'-^0TI33XQ4D\0^R\PI3;S"VUH5E.<9Y;W#@3APHUS##X
MAK448<+X]>UP'GR->F]BLD5E=>:E61P'5E\JRLBGDA4Z*LA!!^GGYUV$9BOB
MD81]R]K#P'Q<?X7*\*^/)X"]O\YQX^%]V]SU?Z>G_MP>YR&^'H_(_'Z<H^9/
MS_'V_3QNIO/CR/F#Z[^1/U\["_R^?K3'V3UH\9D/;^V/>K_ROI^-^FD>O/XS
MY]W],>SZ<8_];QG\?GD?O?/A-]P:WR_'[QX_+_F.7U\'SYH>7GT/GY>///Y:
M^?/]?T^=?"/MF1D9>S(8Q@PWY&4X%ROQ[<<B0]?G/CV\)^S^/]?]\>//F"]S
MD=!/PQ\=<@/60QZ\;)_M?4_7SO6GG_37U/EM>GD>>7^]"H : R#_ '\_J*^[
MDG&<L]></Y9]K"\&?IQG+^$>K/I\JG,"H1_I[*G<J_=C&.:RZ8Y__6'[0-<?
M['I7COEKC]CW7'>_EV>6]_O:UXK;?5W_ +K/91K^/K'7Z?:L?U_[N_YUD$&S
M'Y77ECYD/DY=%]CS@3\YR?*9#^1CSGQC,E]S]7H\^,>/ZXQXYLYNY]^#V^.F
MY>6^21\N/H2>':]1Y_(FM2$'XM^  =_R"[_P''Y^?U]?F/M663O;S(>QY P)
M^!O7GP&:D3VOSX_^%?=/7ZL?[Y3^?'B7[S:;[>_O WXOXDWR^GWO:]-'TW0[
M\;UL\M^OU&_!\>O'T^5<*L0OI']?W'VOMY'R/P-X^/\ IIK#GJ\?GU8K7Q,_
ML\)]W^N<?NSR;[[DWX.7->.B^]BX.M?GW^?KYU\B2*>=GR/7QKT/Q#__ '_Q
M]#]*_3_VSV2/>^X^OY1WO>,#9SX]V*^Y>/SX]/N_8_'^N?\ 3\><<+W?@UPU
MQ37XA\I>WY]?G+_/>_3P&]^/D/Y[\Z]/7][U_GXJUN_M,T'L-J3:^D[ZP>]6
M]D566K<FXV@1;L=)%3["XZ;C?5G&,2,#?&@)F-6O.&TE LJ7C*,9QE$\D9A=
M>'P%6 ^+RJPDZ.@1HVX(\ _7UW5#D;"#)V%Q87 W%=1&,_-E/$-'(/HT9TZ?
M]Y1OT J$WTQ-T6&U:GE^NNXGRD]BNGUS%TE?TX?9><L5;CDR1.I;XSDC"27X
MNQP*SQ6SW?61)$P[\LZM.))G&:J\1U=W4H8IHVD'('8.D6;7CSX$1&]>"1KQ
M5BZ4OKB6TN,5?L/M+"2>XW0+;:6%-"UN03Y9)8550YWSX%V/QBLF./M/^/\
M:^?['I$^'X^-X]'VTSV/:QG/_P""_<O/K_K^?'*/[W2;[?+XN>N6_P :\M_+
M^UX>GIO9\UE7GQZ;\\O7?RWO?YZ_\_-8Z.OOV_\ OP=]/F_-]OSUE^+Z,#Y<
M]C^$A7M_(]6?1[GQ_:\>WGQZ_5Y_'-;]*<_Z_P#M-X\-]WIGEOEK?V?=!N/S
MURWZ_*MN=8_^[/V4?7AUEO>__P"-P:U^6]Z_+YBLCJO@*,>PYD[*L^KSG_#X
M3@S]2M^KQXPK.?%F\8_/X]OSY_KXYLC4G$$<!X'CXA\)MSY/H#]QO0&__74F
MCH'8^0'Z<3Z:\?A)\^=?2NH-]K]N%^/F2]WY(OL><">?;]Z1^V^[YSX]'R?N
M_GT?G^GG&<8\\F;O;E+=LC3;\MZ_ 7U\]Z[?K^?H:CIOB'C7GT_4$Z_R_P _
MG7,WF*_QN&<G?'^,)\+\#>GV<1!&!_:\_P!58@\G^?7^/5G/C]OGD#W?AWPY
M;;N?B)WW!O?H-=[A^'Y>?3Q4#O\ [N_/+7KZ^?\ ]VO3Y>M=9S,*H8++^9'V
M\MFY.\?&]7C,('DC+N,9\><P68[T^C/CU>GS_P!YAW@SZ[>P5">&UKO-QUX!
MUWN?J/3T]/$?BV?0?0?ERUH'R!I@?TKP;U3Z9L"JWZC7:-)F:W<(>P5JTQ1*
M15#R$/-Y"CK"+C_5/O.$1:$.8SAQK.?<:4EQ.,X@C2J863@ H4J?BWX60IO?
M_=[N]:/U&J\+B".YMY+>=%>WN(GBDC/H\<BLI4_/RI;T]/!&M5C)^FA<)C5,
MMMSZ>FU9.3.O74^=5_"69+;99<OG72RV1,GKB<96Y^#2JO8)-%<FTB>H&&:(
MA(%MQPF/+]%3<AFX7"!-3H&?>]AA"%?0!].R.2^ 2//SK$NE9IK-[[IF[<O<
M8AP]G(W@W&*F :WE7ZF)6$;:)"!XX^1XFLJC.8CXX>!\R/K44#AO&<">O+?F
M6S&85XSG'H]>)KU>/*O.,8_I^>4S";;\N&N+[_%K>HNYKY[T8?(T/!]?%9F2
MVSO7H3H?7:\@#KZ\?UUNNVC,6EPO#*C_ (_P!\#8Q@7.%"+@U(:PC/GUYSB!
M]]?[O'\Q/X\^4\E/=TFPN^;%OQ;Y=X$[UX)[V@-$^/'C1J!W\];WYU]>7KX]
M?B\?J/\ 'HN_9LAA>_\ <O;]9WS?&!_<SG$1%_+]WSGT^G,-B*]'M_\ 7E7J
M_=YY.O>Y/Q[>]1\/+$:,LG'1UKQ-W=[^6M[\5,.7Q:U^[K6_3D=:_P#%O\]:
MKNO?;,E3^'\R'OX=(]_\"^CU_<X_)OL?_N7VKQA7XRCQ_3]WF4=SC!KAQTO#
M\6]=M^&__P!/N^GG6]GTJ'G2^FM>/4'P#K?_ (>7\M?.OTCX/O1GHR?[GAKV
M?/QO_,?J![T>]_7/G]1^_E6$_P#I_P#?\<EU(5D'P:.]_BUQ]W7\.]#^PXC_
M %W4/3?^>_314>/77X2-_P OTKHL9AO8:R-]R\Y) ]G\#>K*/:F<QGC\^,-^
MU]\SGSY5_3_MR=N[L\NWH+)L?%K\4/<_S[/T'^=1._._S_QVO(CY?P_+T^==
MIE43AUSV\G8:^V#99\X&]'QL5K&&_'[O5[F*ZIU2O/\ ZV%9QG^GF#=T@;X>
M)&WZ[Y^\'?Y?V^M:^1_6GGQK7J2?4'?/_7GK6O\ TKK/YB4QX?NYDL-Y>D_D
MYPD3+V,X$C%&Y>]6?3C&!,164>GS^?5Y\><9Q,O<+L (]ZCX_BUKG)PX_7;]
MS>_T/TJ(]3K7[NO7ZG6M^O[WK]/TKMO?:LFV++OSL/Y<=^5XP-EOWOO GR/C
M?G&?_C/V_P ^O_IRGS^?/F0=SA!KAQXCCY8-Q[3@<M@_W0D_#^?S(-0\Z7P-
M:\ [WKB=;_\ #R]/]2#7UKX.%PGM_/\ =\L?']6!/_%S.E?']_/G^N9[Y7GT
MX_\ #]'^OG/#<]2[X:TW+\7IV%WQW\NSP_\ /SJH?)OY[]?3CYUZ^BZW\_3Y
M[KHM?9/97\?[EZ??"^/Y^-ZO3\2;Q'^CSG_)\'[SY]6?/GT>?SXSB?[W9WV]
M\7Y>NOQP\]Z 'X^UO7C_ #IYV=^OG>OK\/+9_P#Z?I^7K7;;^T8=S_Y[VOMR
M/'JP+Z/B?IQG'XRG/GW/TWX]7G/CW/<\?].>2DRZ_<WS.]<M\O>3\M:/[1Z?
MGK?@$4\CUUZG>SOSR.];]?B_\SZ5UG_MGP!_?^X^GY<E[_C F'/5[49]P]S_
M *?1Z?M7H\?Z^O\ &,<F7N<VUPWQBU^/B!REX<=C>_[3>_EZU$>OCU\:_P 3
MK7\]_E]?E7=<^U?<9WUYD/=]QW+_ /Y;T?*^_#^[@?S^?S/_ !O.5?CT_C'X
M\\D^\X0ZX:U\/XM\>R=<_P#]#EK7G6_G3SI?3\M;'CC\_P#P[UO\QZU5=%^)
M\H?V/E>O[$]X]_#'_EL2[GI]SVL_^+]PS)?C'[?1X]7[O'*>\Y:?EQUWE_#O
M7+M#TV/3AV_SW\O)KSDW\_J/\>(^8\?AXZU5TN6^O*G%*<4IQ2G%*\R;C$S<
M-+PRC3XY,O&'QBI"+(P+)@)/%=%R9'%90Y@8X7#OOB/Y;7ADA#;GH5Z?3F>-
M^W)'(%1^VZOPD')&XL&XNNQR1M:8;&P2-BH@Z(/T.ZAZCI7$H'2.G>W8/&$A
ML!)5B]CI]#;%/(IR5-XQ#_LS\,C)&,8SE*7$^UC'M*SXO_\ 6*4DDX[%DEBQ
M_9V\DSK.=_>_Q+Z_,_%ZBO7O'^%?7?H?KOZ^N_._KYU4<NX77IG4'6?<.S(S
M;>Y;(?3JH?+B05JN*3Z_)OECU>O*;EQ!XX-XEM#$8T4CVB&%_)RC.590RE*L
M?ZIZSN<-@,IE(<1A;B6QMUN(X;FTD>!VCN>XJR*DR,5!E;6F!4@,#NLLZ%QB
M=0=78/"SSW%G%D;PVTES9.([J)6AF;E#(ZR*K;&CR1@59AXWL7;UST]BYK7=
M-EG-V;X"58*9"R3H<?=V& @,SCE9M+H<>RJ)<RP$*_&-!C,K4YZ1E8RI65MI
MY<L9U'(V.QK#&8E/V&R(2.U9$3C9]H*BB7X4592$79XJ./D$U9,R3#E\K#LR
M=K)7L?<E)>63MW,J<Y&\<I' VS:&R3X\U7+73*,:)%)3O?L)ZA"!2$)_7K&,
M*4+:SK8G"LXA_/G)9RV?4GQE/H21C^;G..5IZAD*LOV;B],K+_RS$::!8#_>
M?P*!Y/X?A]*MO>/\*?GX/T ^OT&OTT/E7&)TNBA$A)3O?L(O 68G*?5?!L9<
MS$C3PS659Q#?CW4SQ"E?C/IRWC"?PXOP/44K<MX[%_%SW^S-KXS$3_>__"7]
M?!_=%1[Q\_"GDD^A^>OS_(;^N@?E7XQTJB$CI8QO;L'C"1$AX7B]C8SA"::J
MF84G'V;PG. L_(\?T]>,,>/:_I'^L4N]_9V+_$6_Y9O4W'O'G[WS\?S^IY>M
M.\?X5_P_/?\ \_U\T,Z5Q)B2D*WQV$0DE$DE6,7P;.,9DXV$C7<JQF&QA?A$
M(PYG'[?<4YZ59PEI'"]12J5(QV+VO#7[,W[CR.-?>>-&5M:]-D^=^(=X_P *
M[_0_(DCY_+?C^?UJP^Y=#:K!)G=;3&SNTFT[#<8>2)G-<5";B+,8S6[%9AII
M1ME7-B154@HL\R&? C\VF;CU32V37(M@YV/)]B\8VXR%W"+M;/!6%I"XB6]O
M4D@B::.!HC% L1EN)W1)07%O#)VE8+(R"1>5NO<E;1 VLL)N7DC^*VBB$C=M
M@5Y2!V6)%/D+W'78#<00&(B_UIU=OVJ50NM[UI79V*(I-N;A]59TG?=6 UT[
M4M9E7)2EN3=?LNSLO5>RJ<,/8DX2'DY># 80$F,.7Z'<9N-P$D),5_TJPD1C
M+W;?,$]R2)(GT1C3R'%%&V )'P^@%6C&YN^BA>*_Q@0Q2-';>Y+ L1M$14AY
MQRWA,<NE/-%=XPI55;0-7[$H&661,-PWU 76QDQ:4*Q?M#*2O[3&SL6WE/IV
MHI*<N-3CZEX3C.4Y:PA/X<7X\BK/L^^](?$7\^[YG]]XG/G[,^L2[^O@GRHJ
MXG/#SO'WF_/[MI\]?6]_+^?CZ5<+7&C]=[,7*UX'=O:*L6^!C&\3='NMD'@;
M9'1<C4OT.),8#Q&E@34&6R&ZD>>KLI+P3AP[\5]PP0,\.BWY&ZR&,$4TF/PM
MQ:S.>S>6D;3VTDB3^\M%S#H\4ZEPS0SQQ3!6$O;XL":NURD-YS6-2DJ:9X9D
M,<J L2K<>15T+ @21LR%@06Y BKME]*XHM!;:M\]ADI+^Z>K_GT=64YE68%E
MW^L-CU83B!'5XSX]S+F<*SX:1YM2]12KQUCL7\/#7[,P_ 92-?>>/,K?IY^3
M$56]YO'PK_@?S_/QZG^>_J14#]!]:0)[O+WVJ[FU]P@(K3F@C?O4=;6F)Z=7
M8XAJ[.8L)^8U>)+,89%-@Q:_99R,(\YG.''<)5C6/3.8>/VB^T6865@QG@Z5
M7MM 3%$(<1<VH[*<_@[B.6D\GD1KT)%;=ZOD(]EGLG/%?+=8C6O _P"+Q#QY
M_D?R\5/@?IG%#NQSJ=Z]@\JC7XYYK/Z\&2IS,=/3<\A#BL0OGT+>FWV?"/3Z
M$-(6GRI:_.S3U#*>?_#L7\?/?[,W[\<<9_O/I$N_J/!]!K4/=/\ "GS^7U '
M^@ /U'CY"N!GI7%,-#LIWQV%R@=J.:3C-\&QC'VZ#F8-M;>,0V/;6XS,O.JS
M^[PI'MI_8XO.)CU%*23]G8OR6)_9F.^<D<I!^\\C<8W\R?.]@4[K?PI\_D?F
M03ZGYD?[T-<:ND\0H?(^=[]@_3D4D7*OUV/Y4@FHBU%67,?9_"_2&(AY*?PG
MSGX^<>TG&>!U%*#O[.QF^2M_RS>JSM/_ -3U+,?/KR^+UIWC_"OR^1^N_J?G
MY^N_/RKG+Z7Q1:3DJWOV%3\Y<JXK.+Z/E3>99VONO)1G,-_E1FO#8QC/Y7[F
M<JSY:1R"]0R+QUCL9\(0#]G;]P2@?WG_ ,5CXUH[UZFH]YOX5WX\Z/RW^?Y_
MRV?K5J[OJS25!G'HFQ]J-XKMQ>7#FJ% 7AZWWLI#EQ8N>'PJ+5:[,VQ]K)K"
M1?FIB5"H2YE]UYM?E6+G92YF_B$UO@[#W53P-[-;BUL5(M_=N+7MS-%:J0IW
MP,O+7PA2*HI\K:6I,<LL0ET"($#2SZXZVL,?.76OF%UHD;\U 2=Z7[*5VCUY
MV6T21ON K[=<*J&]0-B7RI4[8NW*]'2"Y>F'U9V,?DW(R7@BWFV,-[#&B'GX
MR(C(I*8=I9!'+H!;*9??+[#K.Z%$BL[&[O+.(LH5N_(W:!] 2]F)QKYOY!Q*
M>28Y^'.6%LT2O:O9Y*&;MQM>PC1AD11(Q6:)@NFE",4C1" I)K()JWKM2=E5
M\D^$WCV:BSH,P6LV:JV*XAQUEIU@B*D7#JB9B/9CC!F"7HBQC3(1D>;(1,K&
M&@2,/(G1<@R4NT9/(7F-N%BGL,/*DJ&XM[F"%Y+>Z@DN!)WH7+HQ7NPM&ZR(
MDL<J.DR)+&RC,+7(1WD?=C3B58I+%(O&2)_A<I(H) /$JP*LR.K*ZLRD$Q)T
M3U;CK?W.[R4Y_;FYHMK77]W,(><BK<P//V-,KJXC/N68Y<8XD]<>D)+$9A#+
M&!177&/WXSA6-2=)YE[?V@^TRX6RL'-W)TN[(\+&.+ACKKQ$ XX\RW)R2>3
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M$1;3"<JRK.4+]S.?6A..07J"10B_9V+T@4#]F;]V%X1_>?PN=?0?#Z&G>/\
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M1ED?LRLA64T=]E7OHEB>ULX.,HEYV\)C<D1+%Q)+MM>*@D:V2%\_#4K.6&M
M>=^/TU]?]^/IYD%RUU)3BE.*4XI3BE.*4XI5D^Q^GL=@-&[+TUF?S5\[!K;T
M$BP8CON^(IU1 Q3)2HWYD=\UM+HR$N,8.%4MM2O2\A6,9Y9^H,3]NX7(XCO^
M[>_V[0"?M]WM$LK!C'SCYC:@%>:G1.CNLBZ3SW]5^I,1U![K[[]EW:W)M>]V
M.^H1T9!-VY>V2KDAC$X! VI%7,J4 BJU6LU=LE1C=;K\- -F+;PRLM$/'#1R
M"5LI6XEI3Z1\.J;2M>$97E.%JQCSFXVL'NUM;6W+G[O!#!SUKEVHUCY:V=<N
M.];.MZV:L]]=&^O;R]9!&UW=7%T8P2P0W$SRE Q +!2_$$@$@;T*J#GO5+3B
ME.*4XI4 *W4J7>2.Q5,V+5Z_<#9/=-F=O]9N,+&V"/EHM+L1):K=D(:9&+$.
MB1Z %27();PSHK1L6\X+G!X9*D9Q?@M8X4IIK,X>W6V"^4$J&09!2!X[OVC[
MRT@/Q?$A/PE*Q52RW=Z6)687DA<^5;@0O8(.]\/=S&%(.O!'J&K%K10NPG77
M3O1V@:8U)?\ 7Y[^JNLLWNF)JNI',0MFN\I;-9U3<XVSFJ]HRZGMWN%UZ%83
M+1)W[8>H%B@/)/A92WVB.4S6+*"Z+$%4@:7E\/@[(!WH'SKU+%3YV"Q]+@1$
M[3%V4^6"_%Y4!205VP\<O0*K#QYTI.ZNT_2^TT.K4>OH9K:6GZO-2=?BK_:J
MSKJHMV,"N!:Z[LVQP0Z?N]!M; 8B=D!Z5']\X5U\ BPQ4/&O@8M[[<@42;5?
M*@D<B N]?>GU(/ST=^?I\Z.82&?X78;(!)T3]T/0$?+E^IV3O0U/G5,Q=['*
M=%I>Y!OQV[I2@+L6Y8UR-3"RT9 2>C"E[&#G(5+;3T-'-;I,UT,N,=999#L
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M4FYPIQA6NB:O,1%\/MU[D+N\DY74\UQ* .,DLKR$$?&$3D2$C(72J"-> $
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M1>WCLIA;3"V$A17GF,<P=9)">Q;&%R=B4,O-0U("57<)&6&C>]4C7C"["NJ
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MPR+/ 7WP,BJR%'(!(62.22,L 2O(-H\=''[NK<.OZ[<*!);3TCN9&UXF'O\
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M>55=4M;KW2:!&CS-ZM]9IL07*!P@LI:9R,@8\B8D/<^#%LF2A(H[D@7AIY3
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ME$*&0@$ \-;S?[<O8PIGCQ63AX]TM#WK"Z/  (ON<ZW4!E'_ 'KZ$L=\8TC
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MD@,HQ(:)-J0C5 ^XV\0X)EUOT3EY>T96M;998NX#+*Q*[175'5(SIR&TP!/
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M.6-?</OQS5RH:/C*I([;AANK+5GH+VVL<;&(@]05]V"*BH_!4A?<1=:FHU2
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%G%*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g729258g22z44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g22z44.jpg
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M$ $?\/WTTUXZR_ZQ?]X?\]-->.XG_KD_[1?^>N,CXC^(TUYZR#]CE'_^0?\
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MRJV* 6?U+<UR"RQJ_ T*J1Q>HR8*L)&9?))_<1<R#Z308J 0 Y$Z<2U*'D3
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MTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTUJ
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M _3S]O[PUYR2D#*8!W?,<?#@<_<?GKOY3'L,^N"<X_CD^O.,ZYO\2(=(@*@
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M_H_IRDEW@L/+:JZJZ<I"Y((SNCFEC*MD,)&./=UMY>*H0W'I>FWA#67J=-N
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M@<Y],G;C'8<'X:]IXH[/:9:P_623H84W9RDC8QCY+N#<Y!P>=;XB% A"D*
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M+K,YN*LL:D5JY2>(G+16_I/HNT=.V[J2V=&]*TETZ?>W5D-QM/3-FIZMY>F
M*ZMKJ:Z4M"MP)NDO3%Z59!52)7T-SIE4D5*2&JK.H.I[E>ZVQUW4M_J*"\I7
M4LE#<;Y=)*=4OQ-)34DU!/4M1XH(NH+42@IE:DJK?.6V^2ZCDW6-,320Y%9(
MU/&DLPCK39FX6Q&H5276>Q5HL-/G'THO<'D+*2/NJK 9CCF<8YCY9I]*=4U0
M'A2M%4U$+JWA_P"'U;!U1$G2W1M8D=_NPEO36"Q7":JBOUPMEXJ*M[FU#45A
MDME)U:M/330UD,M)+:07WQM'MMPZPZQI)K!(U_ZFIF>SVXQVI;O=J.."2T4=
M?;(:9;>M9#3!:^JZ<:>>.6GDCJ8[E[N'#@XC>(JC6K'>2+:O6ZO)V2=PG7;A
M*S#V-K5@MU5M+/&-PKDM G=/&+^8KSJ.G:-#.UE .T>'>.)ERW7:KL7IBQ#J
MVQ='=1](=:]0W'ISIFNZCK?#:EOU7=)[5:+E>K7?*;I*\6NLMS5E72SU=OFM
M];T_2/&%]GJ5G-;)"(WIIW22=/77J2R=1]+V:CO-\I;+2=;55HIJ"&ON-%:K
MA:9NH[;<*6N6FIYXJ:MCK:6]5*2$^=!Y(I%D+K/"K:A=?*G6_NMS7I>NW!Z/
ME1@83>U;6J#=H@//0#A]$+HN1+^G4*<>TZOUX G/Z:^E_P!!&IF;I;KZD8GR
M(+_:JF,?LB:JMTT4Y'S*4=/N^076C?TLH8UO_2-0,>;+9Z^%SZ^7!6QO%GY!
MJF;'S+:VC:WQUJ7IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
MIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIKHL?Y2UMEDL>;M:=N5C(]
M0:AN$I,;%34DFD(I(9+QBQ9UMZT=*$ 4T/J%$+2EXP%A(J^4C9T404)'KF)N
M=]'KJ*.OZ7J^GI''M5BK))88R>6MUQ=ZA&4'D^76^UK)C(020YP9!F"=34IC
MK$J0/<J4 8X[2Q *03VYCV$?'#? ZW,^AU(8IS9Z2=>QWE)2#D:IC:^Y)K%J
M"6D_H):PZ3O"N2J[-MK"W=1CZL34.>TQ<Y7[1&R;"7A)9!K)14DT?M$54L/^
M,L=QM/BA65M#YJ5%?26ZIIO+C\WST:A2@FB:%E=*B*7V:6&:"1'BFC+QR1M&
MQ!OEA:.:T1H^"L3RH^3C:1*95.005*AU96!!4X(((SJ3LJ>K;MRV/QKRMY"W
M+4+=NP8(NFU/'%-CKUHS\U<-VBRT=7<I,ZR<V.93@R)6BN1AFZ+**$<,"2=
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M--?1,TT*Q+%,)EH%DC>)88EA$1C2&.-(H42)506:7P@\9):I:MNE*OS41XT
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M6]['.<X')]?0^F-4#0S0'ZO=*K$%\\$+CWNQ(X^'KCY\9!6\E% P,WG4BO\
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MGA3C&1Z\9/Y'[N-2NAL\,(#$;FX.YADG^)]WD>@U&;&#;-@(1,B9>.//QZO
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MQ0+VC0 GXMW=O_>8D_CK\^7B-UG7>(77'4W65P9S-?KK4U<,4AR:2@5O)ME
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M)). !\23VU!W\2+SDO\ J^%8)O'5M7P?,F1(N2;UE=(?(.,?44J\-9\B$5*
M"VGGSVDT1TT=M9NMVBZMTEXI2H\J.+F=B6_V$1&[[I9,,L7_  @22 @JZ1G!
MUY>8TGZH87_:N#M/_ F59_\ B)5,$%6?D#+:9B*MU26-;)%W+WO(B[55D[R-
M>'#65M ,G!DSN8N"3:,X^ I, Y.B@HYK=%A*U /'""<@_CGDJ9=^MTDF9QL
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M:Q0=7=!2]05<%9+54UUH+[5VFHDAE6(?H^MAA7RYH$>(LDP?S465T15]YGB
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M^.5L]D2=-L?U%4:RK>:3&"<1*Y;8D:G"@JFYFXY*I]IV)/&0?MITAX<OX/\
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M:M!64U9ZZL@I&%/,VVJD:!8H"#YA>>:.*!\$8"B5T?<Q"A1O)"9;5THJ.2K
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M=)I'$/D0#$$##-Z&X4EQA$U),LJ9P<9!!^:L%<?B-0JKHZJAD\FK@>"0C(#
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MZM5FJ8+EH=1O61HQLL0@@H#%)E&8V9/6Q3\=L2=2*X<^':8AW I72YRY#VR
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M <1\@Y0$0'A0>-;,V;JWIGJ"-);+?;7< X!$<%7%[2N>PEI'9:J%O[DT*/\
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M&S?A[^ N>H[-WM0A_JOXJ%AB_*F-PK/?^J1OT3N_Q+^L_6.U+='T7Z?]+/\
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MO4K2T]**(W9ZI(.3-+9*>_33=+30$]RZ;2+=03BZLK9 \BY-T$D0EF;1NT+
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MTTTTTTTTUZ$FK9 QSHMT$3J>3F2233,<?OR<Q"@)O/GR(Z[,[N &=F [!F)
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MD@^$H@Z?IL$:\S[+N79N-5W4,=PNUZH^DZ&EEJJV>ZTL%9"B>?/-<)IT>J,
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MRTJY @/9N>E7*CB4L$_)&3*K*3TT]D)F4<<N)!\Y7,908\\CR'<[%B!M'8
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MO&C*G1\L^20Z8AVG)RM0K]<@(Y G:!RV6GVIIM@=#E@+2.<RZ9E3(-TU]F?
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MQ<K:U1-7L=WG2>;64*QI&45(*/R@,,K#89M#@6,+AEO)HI D:SV6V2 B)2E
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M&NVDD;A-,T_2Y%8B933B&J#Q32C\1_#^S^*E'!&]UM'DV/K2"'AEVLL<)*
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MLAI9B<=FQL##ONSGOK;GLPN BXL]*74#YI)3K+[>#(&29OB\"(^3IKL1+P'
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M$Z"@+H!U)O1;.6Y2KF JJ!R)E.43%XIZ]&CH*69V9HIZAJ>C\R0LTL1IH*J
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MR:UQ:VS#(1"4VUQ+(94<U1*@Q^0CM5T6"E>>3Z*K:TJ$HCE5&]&+6Q:8/?\
MR_EWUC[?>ICN[UG'UQQ>]D2U.[YGQ7C>&MN1L89@J=7R!#Y*EY*,CI3$TVXI
MJ#&W'F!BW(P4VFM^%FI#,)*Q/XR(FH)[)M,'GY#.IGPCN$QUN%BI6PXQ+='U
M88+(A&VRP8ZO5-JUR8.7<JQ;SE L%L@(>+NT&HZA9 OU"NN7Y$F_TV17*E%S
M]?>RC7&,?U_6-3?IIKCY:)BI^*DX*=C(^:A)J/>1,Q#RS-O(Q<K%R+=1I(1L
ME'NTUFCY@^:+*M7C-TDJW<MU5$5DSIG,4>58J0RDJRD,K*2"I!R"".00>01R
M#K@@,"K $$$$$9!!X((/!!'!![Z@JM[3-LU-J;>D4_!6,:G6F4L^L$<RK%2B
M8!S%6&1310=V.'EXENTF8>Q*-VS1LG/1D@TEV[9FS;-GB2#-LFE4-65;N9'J
M)G8J%)=V<%!G",K$JR9).T@KDDXR3KR%/ J[%AC502P"J!AC^T",$-Z;@<\#
MGC7W?PTR/4OGC++DLO'I^$Z=F1HYR?"IH%_,,A&W,9.#RJU?.E %,TO;+ID)
MJQ2/RWKRP)E1-QYL3_K85!_?@(B;[RF&A('[J1Q$^K^NGENOV)3C]R0>8/P;
M(DR?BSN!^[I_%RUU;\O*V)+37T">%+7C;WN9:0)C^4DP3KD+'939F*0#*/WT
MMBF.KL:!3"M85$@[PO)1_P!3,C?W)?J9/^\3"?D!,6/HOIIYC+^LC8?WHP95
M_P"Z/,_C& /WM2;4+S2[_&&F:-;*Y;XI-P=HM(5N9CYIJV>I<=]B[5CW#@K1
M^W$>ARQ<]IVV4 4UT4SE$H>3QO&=LB,C=\,I4D>A&>X/H1P?37HKHXRC*P[9
M4@X/P..Q^7?65:Z:[::::::::::CG,#=R[Q)E%JS*<[MUCJ[-VI4^>X9RO6I
M-) I.//6*IR 7CSSQQKANQ^X_P M<J<,I_O+_,:ZIF$T4U&+$P 81[:? %+\
MN>@!X+X#Y"'@ ^_G6.+Q*4DJ-HRT<;RH/5I!*JJJ?WB'.LCV=,PYW!28XRI.
M>##)'/S\<B,@? D'53\*1HY>W0S?ORD/!M<O6NU.%5OD@X@X%RA.I-C@)CE7
M:JO(>E0ZI!$""U?/$Q#A<X:DOC LE')T1T[$/_H[T+TW#Y:CCVB[4<]=<5"G
MD-4U H^#SDIGOK8#P$GCZ8\!/%7Q 7ZNY]?]<72VTU0>)D@MHBM5))$QX\N"
MGFOKML)/GQ1L/U9(^Q(Y[IE_*F93J&=Q[/<!3ZW!OAX437CW#JU09@14 !_*
M-"1E)=)%ZAY1=HB;^;S,O%-7Z;Z"\'>DW4PU;6R6]7*#L(JRLHX(@LB'GS5F
MJZM2<8^KDYSWQC]$&9+MXR^+UW>3S%K^G;G8Z&7T=;?!21NP88!C/L;2 #)P
MP)P<ZL_AMJDTQ2BH4I"&3M&2"*G O!C"3(-IZ1Y_7I)T@'/Z>/\ # < =PRD
MYVU#H3CU5N3G'S_GG61O'U53Q0O<GNCS:.QO\_J[!;(,'X<PDY'&"!WSJ)FS
MIPA;W\^U1,Y,VD4TE4!.! 59D,FDXZ3&#I$PEZ@3 W23GJ$YR%XY@GC+=:?]
M'6;IQ?+>Y3U$,\8X^ICE?8A<$[CYLON1E>-W&<YUC3H:A=J^X78NT='L]C?N
M2\CK[K+C]E3PPSG=VSK:+4]F5)W!P\!F''5KB&DXYBT$9I#DCZ$F7+4A$4$I
M,69U'L!-LT421K\_8=E72;HJG8@JF=R[N/0,%=366&GK*>171BRK@<'XD>F
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M5#W/W.=,G5QT-5R%+VTB](E14$IDN0,X*(F(!?/'J5]WOZ]NWR_#/?MJXO\
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MMK+=?>G.J5@,E(T%!0MM!.*ZU7)KJ >0-K4NU7!/O 8  YU#O#FM26@N5O\
M=>>*<5K(PX]F7!E/?CD'!)QR.-31AZOY5PY:3*P;RTUJT'4"1;H0\K(QK*QL
MT5#$:G.9HJFA,L7B2BS4B:YE2-W"P H4BS86Q\Q=,7:BN4$-3!D&LI/-VY&
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MW;<8D=XYSE3F6,R.(W' 5F&",G5F\4.HNB.G;+5_H*LH:FLND<3M%%L=!3K
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M/!X'Q!R3C*_07@O_ &AI8;WU'/+06N0[X[="-U74IW)EP D41!!1ED9FR05
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M%(CB4217$"JJHM991TW3[@=TO;$J@@<!*6CG6*WU,-/2G]5%AI S-GL"F>V
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M58-\#ECP"-4YW$RTE/QCV"KZ"11,=U-S -"-H] J33@AEE@3%)/I]PH4H$,
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M+IJ\M:\4Z)R!HHI1Z-1661::1O9*2&-CP9:C%5...P$BK3+C/NE*99%X^L.
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MW'<.^..<\?'TQ%^K^II[S<*R\594>="(J>-6RD48((C1<E54'LH &<' SKM
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M8QY:4\9(TAXUKL,QD6JL:_EU+.XN%A=G8QJ-<:R0JRT.,Q*D3(HU9U>4<.B
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M.<UCW.;J<=UE9ZB>P,SF2*L@=HFLET%7 BHG5\' $S.#&*"H#R0YN5 $#*&
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M8_L\'=:/8IFI6ZM2"$M7[)7Y!S%3,/(MC=2+QA(,U$G#=8O)BB*9P Z9CI*
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MM1+Y879$G$CMP/B=OIV[ ^I^[6"LL=E<61)S*H=THG]PBW4+^6)2G*=(54C
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MD#X?(?=Z_AJ'WBKQ%QPS,5&#[WS/X #GD>F-=E8I2D "E*!2@    '
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MG2FRTJ4D]&:$T9DJIJNGN<%<94VCSIJ83S1R3,I[1+N;N&9<XN5E[<#N&P/
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M8O\ MN/9M&1'3Y!NW*"[Q)R8B:<<H:N@%=3T%#/[)F4_I"Y5J^:WEXY"QMN
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M>8I#Q$_ 2(6C)^0;.N4EC<X#>]W*-E7 ^:, P^\C&I,UY:]->! # )3  E,
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MP(<C]A$?^_\ ;_EJU2C=[O;'^(U=TYP3QGOVX]/Y#XG42VX_;9*E-P'4!O\
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M)%V=,[ARL)$^LC5NT;-[M?.HKOU'/#47:I]HD@C\J%5CCBCC4X+[8XE5=TC
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MF5=3B#I6'<UQ5S*+,T3.!;)QC^.<H*ND$3%<*L3*'%!9-H55UWEFITT%>V<
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M^,/_ .\T_P#XNGGQ_P"\_P"QF_\ #UY'<1B\O\ZU\2^_E?#F8D \??D5J&F
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M96^K3DNV2K$J1P?757!8KW[/U!73T=EI+J;<DE'<+%2^R7*E\MXP(HJO=(Y
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M?AC4 +'#CX@Y[YP01V[?@-3GL>GH4<US#!\"7U%[2Y%."64YZ^\WD(U:103
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MS:F.,8VK(K>HXNI$I%0]HNME1JK.0DV\5$/)EEWD8Z.E)-1$556[!4"<&:Y
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MB.2//N#@A0=OKACQ\\&;(B&<8P=IU::3%W&.T#M4 64,N5$QP,F1$_<,H<$
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MGC:*1*0$4D&RJQTC/% .NY GE4B7"04E?!%"33X\V4Y.4/"R-W"[<]N>3@\
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M,#GQP2:<%,'D>#@(QQP P%Z2FZ@/W"@4!Z 3*&NG]EKEN=R:?<PQ^M..^?\
M9_>#\CKU;JJ@>D%,RU& ^[B-2.0?]YQJ/I'T_<])S:LK##1OSC!U@YL3@AA+
M\>?Y(?@>>/M^WWY\ 'C+TM>-T;Q>R[E;)S,RC'R^K[_@!J\4?6UH]B:DK?:]
MH!5/+@5_=P,$AI>#WS_CKW2VP[<9*M!:&&AH]TP)J*!970]M W '%,@0P<G
M!,)2B/'/'(Z\)^DKW4L#)[(.?]NQX]?]7^7YZYH.K>FZ&<RK[<PQE?\ 1U!+
M>@(\X8&?R^&I(J_IYOZXD0!CX)^L9,Y5#OYP[E,ACAY,5 (M)$QN?N82B(?Z
M EX#1.BJ\$[UI2,>[]<W!SG_ &?W_B>#\?.H\0WE9]DU0D8?ZI1%^QSC/UF
M>?X?=K(T=DEI8K^YCH6G(K\B8#_4U X,'\IB@,><@&^_!Q()B\CP'/G7=.BZ
MN.3S%BI<@#_7'/<_[KG\AJC?K<3+LFGJ'0]U,7'_ .4[XU[/Z(F71 Y2_A5
MI_ BG-KB($YY$@<QP?</B(B''2(AQSYU5_V7N60?]&'.<><>.>P^K_#OJW'J
M*W[F(%1@D\>4OJ?COR<?=K[&VTG*[7R4*J=3Y "AI=3J+R)1 X&&-'Y% !Z?
MCX'I$0$.0'E^F+FPP#3_ &@3]:>V/^#C\.==TZDMRMG_ $C _P!TO/X;_P"L
M:^L-J&51Y.?\,=\$^T"@3*_/'GD2_P";1Z0^0CTB!AYX\_8 I)>DKLPPOLO
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M78,\GGG^/?5GN_4EMKK-44$(G\^0Q["\0">[(&.6\PD< \[>QQZG6SC4Y48
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g729258g36z34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g36z34.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[20*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (^Z^D9@X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              S8   =D
M  $                          0             '9    S8
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   S8     4F=H
M=&QO;F<   =D    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   ,V     %)G:'1L;VYG   '9     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    "CA"24T$
M#      9B0    $   "@    1@   >   (-    9;0 8  '_V/_B#%A)0T-?
M4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$
M &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !     -,M
M2% @(
M        $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K
M<'0   ($    %')865H   (8    %&=865H   (L    %&)865H   )
M%&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,
M  0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I
M9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M     !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y
M-C8M,BXQ
M              !865H@        \U$  0    $6S%A96B
M        6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8
MVEA96B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W
M=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                         &1E
M<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@                            !D
M97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0
M=FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M3 E6 %    !7'^=M96%S          $                        "CP
M  )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@
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M4GQ2QU,34U]3JE/V5$(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                              #_X3_V:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E
M:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E
M.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V
M-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR
M9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R
M,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^
M4%-C<FEP=#4N9&QL(%9E<G-I;VX@-2XR+C(\+WAM<#I#<F5A=&]R5&]O;#X*
M(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C M,#,M,3-4,3DZ,SDK,#4Z
M,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^
M,C R,"TP,RTQ,U0Q-CHS,CHU,BLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @
M(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C M,#,M,3-4,3DZ,SDK,#4Z
M,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B
M/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%C<F]B870@1&ES=&EL;&5R(#$P
M+C$N,38@*%=I;F1O=W,I/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L
M96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @
M(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X
M+61E9F%U;'0B/DUI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I
M;VX\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \
M+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^<G(S-3DP.3,\+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R
M96%T;W(^"B @(" @(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R
M;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @
M('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y
M<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C
M(CX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HV1#<U-$5$
M,C,R-C5%03$Q0D0Q,D$Q1#)"-S$U.3 Q03PO>&UP34TZ26YS=&%N8V5)1#X*
M(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HV0C<U-$5$,C,R
M-C5%03$Q0D0Q,D$Q1#)"-S$U.3 Q03PO>&UP34TZ1&]C=6UE;G1)1#X*(" @
M(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C9"-S4T
M140R,S(V-45!,3%"1#$R03%$,D(W,34Y,#%!/"]X;7!-33I/<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I
M;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.FEN<W1A;F-E240^>&UP+FEI9#HV0C<U-$5$,C,R-C5%03$Q0D0Q,D$Q
M1#)"-S$U.3 Q03PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.G=H96X^,C R,"TP,RTQ,U0Q.3HS.#HU-"LP-3HS,#PO<W1%
M=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E
M;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.C9#-S4T140R,S(V-45!,3%"1#$R03%$,D(W,34Y,#%!/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(P+3 S+3$S5#$Y.C,Y*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @
M0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N
M+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R
M86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R
M=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I
M;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.FEN<W1A;F-E240^>&UP+FEI9#HV1#<U-$5$,C,R-C5%03$Q0D0Q,D$Q1#)"
M-S$U.3 Q03PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C R,"TP,RTQ,U0Q.3HS.2LP-3HS,#PO<W1%=G0Z=VAE
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O
M8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E
M;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T
M.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HV0S<U
M-$5$,C,R-C5%03$Q0D0Q,D$Q1#)"-S$U.3 Q03PO<W12968Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HV0C<U
M-$5$,C,R-C5%03$Q0D0Q,D$Q1#)"-S$U.3 Q03PO<W12968Z9&]C=6UE;G1)
M1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N
M9&ED.C9"-S4T140R,S(V-45!,3%"1#$R03%$,D(W,34Y,#%!/"]S=%)E9CIO
M<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R
M;VT^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H
M;W ](FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @
M(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-
M;V1E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\
M+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M/#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_;
M $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 0<"70,!$0 "$0$#$0'_Q  ?
M  $  00# 0$!            !P4&" D#! H! @O_Q !5$  !! ,!   $ P,'
M" 0)" L% P0&!P ! @@)$1(5$Q06(3%8%QD:EI?6UQ@B05%25Y35(R4X80HD
M)C(S-3EQMR<T5G1UD;;%0D9R<W9W>(&QM+7_Q  = 0$  00# 0
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MNC;_ )=\#"V,+%7:-@L41.R"RHY#^YO<LIA1.=3&_16P%F#MEGU@!B]CS2R
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M2TO\B*KLBPZ/A]1(S.@/#,FE+GZNF"3:*"8GVCH[.X@YX=OR_1YO7YN_@TU
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M&(F&Y2*%V8R.DY"C;S:8"8\S>2'I<%8%?EF[,>_6?H/3P3AAP(/@4S+19[Q
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M[?C:^KTGW\/.IUJ3XCLDOTQ2P&H?.RAPI<GG%SZ&;MY):["*<1I@!NP32\Q
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M9Z7J2#<!($=FD9BHR.3J:>A7M,NCQ4BA6$EDKUU'S@MP-1482CF,FHNMT:1
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MZGO/M5W$/-U EIIU8Q.G:[?SSN0QN6]2YU%1*Q_J3PX0YC\3/]$NVVW.R\:
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M_P"]0Z2?SML5^U,W_P#C:?S4GHS_ .E=.?UDF/\ <#'WP.Q?YOVE_P %C/\
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M)A$PB81,(F$3")A$PB81,(F$3"+'B'MO3W'HBW',Y(5,MY@6C,-XI8> 0/\
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MUK7105SVF@42YVIQ^&_326ZQUTE]&E/;:H;M(0U-HZL6[6MN^+%>B8"6T;I
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MU@^2(..]5M]0^:G99K'-'O,)98AL00RUO>N=;ZWOY:UK>][W^[6M:^>][_\
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MV!:_QAQ]\8?T1'[;/^5)]K#/RQWZ@?6I_1?-?QI;_L"U_C#C[XP_HB/VV?\
M*D^UAGY8[]0/K5^^_P#P8'M32?*GM93OE+C\-+7=";ZTGQ]6^OH3UU<6]<<?
M5UUU]//RU]76]_+Y[WD#[(O3739!HU.ITS>FI[S_ .BN)\Y4G9D'0&\\@#0
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M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%#_H2*/)Y0UT0<?"
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M#PN#I'.G=1MV(YK+G3R/\FK#JYK<\DTO5P1F22630.>?1CY+\EQ3S-$_GO\
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M[([5Y4;0#;+"U*,T]_$ZWFR[/FS59O20EV/$K+&\UO5S=7&[XS@MF,;D@*8
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M%P>-$I*_8CDOEO2CYVV&*MVG.]?3M=1/ZO\ -^>$6K>#?$LMAS9$B\\.O/\
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MZ-TE2LSKIF1O?#9GFDBZS<87<O+&26*C[/63Q0,:)!(=]SG'5TAT<[0@/<
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M:6._N?C[O&W?^YOV<_\ >D^ ,;_9R?KG_2G]'7^'I_MWM_:6._N?C[O&W?\
MN;]G/_>D^ ,;_9R?KG_2G]'7^'I_MWM_:6._N?C[O&W?^YOV<_\ >D^ ,;_9
MR?KG_2G]'7^'I_MWM_:6._N?C[O&W?\ N;]G/_>D^ ,;_9R?KG_2G]'7^'I_
MMWM_:6._N?C[O&W?^YOV<_\ >D^ ,;_9R?KG_2G]'7^'I_MWM_:6._N?C[O&
MW?\ N;]G/_>D^ ,;_9R?KG_2G]'7^'I_MWM_:6._N?C[O&W?^YOV<_\ >D^
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M<_K+_M3^E_\ ^H"Y?_B+(\^CFS'_ *M;/?\ \'B?_P#!76,+O^N6_P#WF?\
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M$>GY^WBLV?2'LVU(-/\ U'"*6BU>E7WCCR_#/4EB#[)ZD3=>TA4R=6\Z;UY
MRH,BQ0A+UG':6D"[B?&A<X%<GY%'P_<5X;LRI'DHTY><Z>CE]/N4"0GXDEY3
M*<HET*_JUK2G^7#1_E;;9ZE-1]L.XMZ+\]U9<D,E*R2I-Q' ,DA!*T1(J4BU
MVI9I)FO!!!AS$W(E)Z<*2 .WL/M!(T]'#GX&2'Q"O7ME^4HJW,5@%@,B+-:D
MOVWWX.2"IG,I,99TC'8X<3!AX7!'P@D#BIA0ZHVFEWR,KQ!JFVF ;F1)\O-(
MZ*7* -? ^<_S\W-4JOO7=V^@Y#-WU%A*5"PNH;(JNL+,"VT2E#27J+6;2%=V
M\[F\<-A7S84V9156VX@#!0PK'%G%H+!I+IC-(7TY#]]DT[^T:CVZ?,L+Z/\
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M>.'<%;;SQ+YG?'34D<5^2^\2&Y(]Z#,.&]CVDS0>7/$AC()&+!V.9S5 :@;
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?OR#]=V3,&C19Z^,GCQ=Z^-'C3]^9,OWQ-\[=K$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g729258g39k78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g39k78.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1;,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %K"^6 @X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!9[?/         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              2\   *.
M  $                          0             "C@   2\
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   2\     4F=H
M=&QO;F<   *.    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $O     %)G:'1L;VYG   "C@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 2@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MR+J*J7"7%C"RT7W64NWMN]]?JU?3W^_^=_T1+/H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 1D"70,!$0 "$0$#$0'_Q  ?  $
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MHJ&CU3B4SAC<I$P5E%G>U6JF@;CO0T,YS'JZ^9?"=M#+;/D84N9+]M&<SSR
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MJJD2*"95#F @B4 $2/<T"@4"@4"@4"@4"@4"@4"@4"@4"@4&Q0HF(<H>HE$
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MB4NOC& - &A$=" B&H.6XJ EYR8*F*8Q4A, *&(374<I!T8Q"B( )R@)0$0
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M"@4"@4"@4&Q0X$ !$-['0=P#O\@;]1'W![Q[4&A52FW[M:[>H]]AWUL '8"
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MB#;][_M?P?&Y0\]LQXJY63PQ%UQD3A3#N9>*^,[ILKX':OQORU\\(7&ZNV\
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M(6@Y:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<*GTX?W(_P"<*"(OA?\
MGG_B[?K[A7^ Z8HNB-\]+*7JB% H% H% H% H%!U'/1OX_H!!-\O3H=;T "(
MEZA*4_H'2/<:#&I\46*C<D\W,*W+C%+C)RAO#&>!KK)<?%7/U[MH:S&D+,7H
M[BBY2@I1PX"UD[X;R:PV\^BY=RG)? :)G#=N82D.#.>1&.J=>O9,W1$8\[\5
MV/@J66C86&,YV^K=.-U[F+GFYI6Z\4X@DY*:QE@I_+I)N4<?6I*/2>6]21;B
M=V_7C%58X[PPE;"40,6F.<YO$UR8B)""(" B4HB ZWO0?((A]T:#=0*"P[A)
M^6_GK^WIO7\ _'B@OQH% H% H% H% H% H% H% H% H/,7I^5"Z_[VIS_13V
M@L#\(+\[4X@?X*&?^EY:K./".D)'K/64D=12@4"@4"@4%,<K6W-W?C/(-K6O
M<![7N:X[,N>#@;D(H=$8"8E(1VQ8RH*I&(NF#)ZJ1V#A(Q5$3$,HF8#EW0X5
MW_1BO\1.&G)"W<^8FM,<+XWQ'"PV:L+Y;?9\@<Z,KC6OQ;!5L7I:&6G5HQ+-
M^:X;PELS*78B-RA,*.D(-!!VC*"NL9%1%.-,W7;8QF)K6FR:W(UZ-W*)PI=7
M:RL[\M1.^K)NRS%9FX[>2NRW96W%I^T),(.Z8=*99KL%9:W9DJ#@8R8:I.3+
M1[T$3^R.2D7T I[ (0/#3+A_A:MXE,7*RQK%Q#CGF7\S<9.77)R<LL+=U:=K
M,&KB1G9,SF3FY65EWGG/I=Z==R_DG;Q==8Q13 @SF(SJ1ZY#:R3W+-_XVCD5
MQY07+XW>),NV9UQ+IW=;_"?S-1+UE?T7* U<*A8#"U0>,SOT!:QB"17#%8Q5
M5@H:[]5W7TY+T?%ZNOFHYMB-@)[%>%&7%M#E7QF&$R%'WW//,L/6X9*M19F=
MY9IXLL.@8\J=Z@NB20'RV:2*Q5A6.8M$SM\].]D2L#F.W3$P]6DD0WOL(]'?
MI#8@!/3I$1,<1Z@.(B4**[U H% H% H% H% H% H% H% H% H% H% H% H.%
M3Z</[D?\X4$1?"_\\_\ %V_7W"O\!TQ1=$;YZ64O5$*!0*!0*!0*!0*#JN0Z
MOB;4 #%$!%,-?* =1_7I 1 1+KIT.C[*;L)BMR!;DGX8'@]#R5E\T\DSVM:%
M\Y"M==:4QY<N89:QK;N%X\N)T_5R(G%MIZ)FD999PT4B!2C)1O; H-SB:)4?
M=;L93?SGN5NU1==AAA<OKX3VUX?V&+<?X=X33>)F,:]D'5T2]M6+D$+QEWK]
MR0".)5XM)S\_./ 23 J8*.'*B*20$+L!#=46\Y<\1#)5B<P)[$T-9=DO\*XY
MS+QIP%D"2DGEP$R/(7GR6A).=@[FM 66[>2MZTD4XUC(Q4DV=/91<TBHDX8^
M6191F?IF=XXL[^(EE'%O+!?%]NV)8LMA^R<L\=<*Y!=33R>2R#)71R5&5;6]
M-VBJQ*%OH1=I/&\<,JTDVJ[N30</BI/6)O(4(%1N,_,W+<WD_DOC;EG"8CQH
MYP1'VE=A9VSY:YTH@EKW<O()H%=.+J!(9YA$I(,&ZEY1";&%=RCAXQ+&H.$3
M%,T^N@G-_;%[#P^+QM;(,ES?O"RYZ,N6V)CG'>SB*G(E=-S'ODB80P"B=5JL
M7K*(F4_&5  "")2E$NNPB6Z[7ISGO([1"@4"@4"@4"@4"@4"@4"@4"@4'F+T
M_*A=?][4Y_HI[06!^$%^=J<0/\%#/_2\M5G'A'2$CUGK*2.HI0*!0*!0*"EV
M6;.DL@8PR)8\1-*6[+7C95SVU&7 B90JD*^G8-U&M)$@(""X@S77*JIY)@5
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M,&K\57AJX,9@&Q$+E3 !,!=A_P#";4Q@$Q1V8-&*)=[UW =:T(8;GQ_[7[M
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MZ#ZE[=AV =R@4$2GC0_T(MI?MI^+OX7;?H)9D/J"/ZDG_$+0<M H% H% H%
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M\M0Z8&]J=%$P$,)>HW2&MCKZU=6;,VHK$QYPYFW$32_/%QCR6GQ[_,[%[#L
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M]SW(27(0"Q;9**EK;C69F:ZHG.Z6.Y!4A=&(4PDU07RD  (0"AH *4 #Y
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MKGB4[J![-$14AVAH077P@5Q*E71&/2,W [H%"BD4Q=F +!/&:<IK\1K3 O6
MEY3\7=@)#&V/SWH !* I H!A P"41 1* @/QM (@$M34X'02U[DTP'N Z,!0
M 0["/<-=_P#: @ =B@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'0E?YV2'ZR=
M?>3U+6$[IZ+9QC?'5%<[_);K]<+??#5KX7P1PZ0PM_%/#I#KUHY*!0>^Q/\
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M0*!0*#!J_%6'Y8L:?WSD_P!3V-!AN4"@4"@4"@R0_P 2Y_GCJO\ @FO/?_\
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MVX(^\+VF6OLK-D:;;N3PB#I0/94  #" J !6<Y]1DOD^D+W$?BAW-KJ'M[]
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MF*%M^U8;Q!^4,U;5\GQ]C16\I!"[KFD!5FK,2@FB(R,.M;J@*S,@(L)8$F
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M2)HR,9QX/W9M@9X[.T1(==X("/6NX\XZFQ^.'50>HH% H% H-IC%+KJ,!=[
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M)R=,2"8YDQ3)L% 4,!2@'4 ")^L0* %$-[-K8AZ_*$2_(KQ(,-I7!</&FS;
MR%F[(-_0,BRM2(QU(1$9%9%LX]LW$ZO^X,>WZ>6+%R+O'@Q+^ G8UNY2FF5S
M*-FB#,2&5<H!9+Q"P'?O+YA)Y?B,QY$QI W&SQ[8F2WDE:6[ERM8.,)@LI9,
MQ;-Z'=H2-G7>9)@O9^3&;1=ZV,\CW:GE]3HAS#??C??6_;7EV9(S-/RFR*74
M8_E$!(#'$1,8$]D QC#W.(@78G'N?Z<>YAH.S0*!0*!0*!0;3'*0 $PZ 1
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MO6N JQP/5@(L=0IB(E*1,HB*;MM^.%_->A0*!0:"8I=;$ V.@V/J-!H)B@(
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MJV(*WT56UO04/!M5E 56;0T<QC$%3](E\PR35!-,5 *(E WEE'OV,'<1#T!
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M+02* 71A-\H!V'N(?6 ?DH-]!M$VO<8?L (_YJ#4!V&]"'V0$!^[0:T%D/B
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MY-\F>DY3D. W9CP!$BI1*H "&, %,3%$0 Z8D4(/<IP&N?SEJS?^Z_9XK_\
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MB7+64K;N"W,F&Q%;KR>GK7M*[85>3$6BI4A9KK(JO21QCF,8H*N$3:.0Q13
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M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#XB_Y+6_7;#^(%!RC]6/\
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K!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g729258g40z73.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g40z73.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1>24&AO=&]S:&]P(#,N,  X0DE-! 0
M    %W:^8 8X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!DZ&)         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              7@   0A
M  $                          0             $(0   7@
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   7@     4F=H
M=&QO;F<   0A    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   %X     %)G:'1L;VYG   $(0    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      -$0    $   "@    .0   >   &K@   ,]0 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ .0"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M'?-#FZ;7L;7_ --$I^L#+<JN@8.8UEK@P7/I<UH<>?4W>]C6_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M?-$QSJ-ZE_:5X-QOTBV]=-TW?&K]P8KO+*?4_F3&6!G,@T^S6XZJ:_0K??I
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M/3\_'W).^$63A%37D'9]#X^A_/[\(J=I].]7_P"G_+V[X14[->BE@?;8(_\
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MNYNO.7(W^#KF+BS4)4AE3,8(6BG):26TH!&^A09AGXNM\.NQ[BX5 T/F-^3
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M'FD,42];LI=.KT909.C\1'6IOO[?EV%;&SSR_B'9^!VC_:4=H4]YHJM#71(
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M/F^Y/ZCO_(>%9'/T/X5R>X*!5W$;\CS_ )..^^^JA/)QZ S]EE4@*V4K &O
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M1'G+5E*"_=1DW[2TCW]I5!U':[(F#W](<=#I$A)( Z3<3B<,\,KM+J4P*IF
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M9</J("1R[B?I[+[#*4Y[V%'<]V&O>1XSA93L)9+K#;A:2DCY$ME7:E&R$I
M Y46:5W_ ,7[OMV%$GOV.X ?H @:&_7N5M(/GSK7"* '._0WU#9 ZDLSU?$5
MH/XI8RM%R B_\O3<DR*]:&3+/KMA+H=K6JBQ5P6%4*XH]>2V9,IEQ7X?"_CV
MY3Z5>Y!$H?2#T1YN=M_.CV4YMS=+\K(D7"%L4&)B2Z(";F:8PO9T2V*E7?Q+
M\.5#8C73,BN.AGX54AZF.-%YU#@43QN@%I)(N3#2+VC47C3SE43F)M;U,_4>
MJ:)CS"#%D^UGO3$-9R/DG*$9RU<>75*NJ^+A+UWD0Z142U&;JU*:@K;B,+<#
M8+26EN-DH<!0I25:O&-%3:.&D6B8(G(D#VX<3(NOKVP*[J/@'Q 60#4ITQ>^
M]#XU%X.FL1PGZ!)]@4&HJKRI#U="+EI]*I=0+-?JK);BT5OW,)4%+,A"8$DM
M>)<J(&GIRB#*4M20.;[<; D7B^?6??V7QZIBZM*JTM(:QP!W2 <P"<P;3IE?
M6%CGX]MZJ"X6Y4BX0+GIU-I=4+%?JK/NHU*0TW#>IA9E(-.F.(8;$J3"#3TK
M:R^I94I/,C2 X Z<S%YZ<9M R!6;<?6$!L0TDV:($DWRSUR.=KV6>=8-O5)R
MMKD.U])N2GTZE3RS7:I'4F-1UH7',+W<E @2%*;'Q$B+[IZ2DE#RU;),-( &
MPD<SG'*2+#736%FW:%4.8Z9 <3$=)/S1ED!?I*9[9G3;G6'G"_<@WKD>Q:I8
M^0Z?2J!<%O6Y0:_1;GC6[;#D[^"3=-N!-:46JEVRVA6I@;/QI;6$!ON(YI:.
M Q)Q56L7-#*CBV - 2;$BQZB\+W6T?$NQ:VR<+A,%AZC:^%:7[U6H',?6J27
M'=$%P:"=P& #;0)W%1Q[;U01<;4IRX FZ:5 HU32Q7JK']S#IC268JX'NI8_
M#9:T)29,N$6I$E>U/N.*))V[* IT@PWO-Y^H@:9?NOG;L?597J5-T?[CB2TB
M+$DR1H3>+G/-7S[!H-537%2'ZZ57#2J?0YRFJ]4XQ$>F$*C.0O=24&G2%E +
M\J(6WI!'\<M1.N<I8RJP-> Y@!M!FQ&=IM.IX6B9S=CGU:>Y3'PMUP+:EI:[
M=@VX6M,B('-,GSG8B\"W9-SE94:LO8HNU,"E]0UE6_(GM5!EIEQMBGY1H9AN
M-NL5*F**F[J>86A^=3BF2\M1BD'0UZ+\&]S\* *+C_N"3D1^IIDG>!M!L.EU
M],\-;5H>)L SPYB:;:VU0]_^FXIY:T-^(T-^!4WIEI@AH))DR!-EUUE=2'3#
MF:]*OCVR[JO.NW'>-NTRE3$0A=D:$S1J9$?739,2J(2U$I'Q: \4U1EUERI^
M[(5(=4@CG)1VQA'XBE0#7.=$EP:2">+HR$C2 .EUT/$?@3Q-X4P+\7M/!_!H
MA^[3>]P.^0!+"8 %0 @EO^,F+2'4U&P;?JC5;$A==;_A%1:=0JC\/7ZI'U I
MZ1[@05-/H,&2H) >G1?=RWO/O7%$^=MN[SP&@D&"<\B==+CH)X+P7]_4#0\T
MVQ&HUN#!@:Z'AD#87U"PJ'4S6W)2ZYW7#2:?19P8KU482S"ICRWHAA);DH%/
ME+<452IL0MR920E#ZUA(UR5*6ZX0R8$QO9@6O<R.6O-2GC<1NN<6R2XAA@ -
M,0,N5[CT"MG8_H<T5IQU^O(7<%#I]O5%#-?JC %/I274Q'XJ&Y"4P:@H.N"3
M48H:ERP4?$.+#:1S !EI:!G<DVN+$ST,1<<[KEJXO%L8'[@$D@DB9FXXP#Q
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M 5_"U4KEUV;U'1[G31U7Y2*U$:I=9LG^%=7J\V/*E0I+J*O\*\VRZ&VBI'<
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M-I/?H#>RP%)G]G0)%OA-<3<RXB<B>)O[Q*\IMG%UW[0QE1[RYYQ%9LFY #W
M6@B  !E==$[:-J2$R$2+>I3XEUIBXY1=ALK,BOQ=?#5AXJ3W+GQP &7U$K;
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MEKP+P%K-I992U2'JG4'6Y<B&5H>(D J?2'4)V>T'G7?LRJP.%.JYH !&]=O
M6M/ 'VS7HZ/C/86T!0P^/\.X2O5JFDW%8BF?@U_D-W-+1;>&8,\9-@HB<=7_
M .T9B=6^18%'8O>OWR]%K5'J,Y^@1*=11"BLRF;0KCT*L!-/11XRRJ3 B2W
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MO#=QU7+%LY)AYIR-1*!0&(;,W%=,DP6;%K_PR'$..U5@M&0%RRL+D%I:0I2
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M_5[3K"QW9%=9R*Q&QZ@-3+[P7>-&;JMV1T!':S6:#6HIDK:;[2E#4%">T'M
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MMK!PM\[7-@B]P;9C@.!O"\>A=/5XTG$]SXT>ZC,OUJL7%4OQ"-DZH3*>N]*
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M901IY1Q&77)8FFY](U2-ZYF,]220;:3:/)7%8[NY8]V"VHC1[!\B-$DZ'DI
M_7H#0X+H+FG,M-K']-S8Y "8@\IXYX4M;B:+GC<#G#0#]( GZSU-R)4>&-,J
MT>I];F641[<O.+$N>T[7MNCUJ?:-6ATEVI6ZF2*F455Z,AA+1.@AWO*'NX%*
MM$<\W@ZU&IM3$DTR20UN_H( !TM-K\1!"^T[2H,Q']-MFX=FT:8K8;:.*Q-3
M#MJ?-\-\[L-F^D"PL%(:^EA]*&'FV)"4H]WV/-(?:4#X^9M86@^=[)!UOP/'
MG?FE@VYT@\Z0 8Z6MY6]U\?IX_$43\.A7+38$@N!,& 9#@8!SC.,XNDGO7I_
MPGD(=UXXNLRMOZ(^+<H<)J6G_?-R6&FGD._9U*PYKZ@#G6J;.PE<RU@IDYG(
M\  1:3S!C4V6\P7B3;FS"*C*]2HT?,)W7M%K6=,Q'&!/!(=.Z*K'IKB)N+\D
M9=Q-/;VIMJW;ZJ$^A,+)/AFW:T9E,0V/ [?=>?4:YP?Z.RD=YE6H+BP>T3GD
M,YYR;G4KT%+Q^_%[O^M8?!XUH$0Z@VB\-C])?3L<F@VDQ><Q>;"ZS[-8/\$<
MV6)E"*RD=M-RC:;D*H/ALGPBJVQ*I<5IYQ'R^^>BK2%?,I)YB^ACJ!FE7+A_
MW1[03Y&8,D\2N:KM+P3M  4=DU<%5+035IXC?;O2)&[NCY3,@P8@#57HSOU*
M6BCMR1TMU2M-L$>^K6)+EB78I].AMQJ@.M,S&4#2MI,E92-:WK:L6X_&T894
MP[JL2=]H.['.TSRF,S/#C_\ 1_8.-I_'H[<HX<GY/[6LTA[73(DRV09$6Z9P
MMRE];F"GY+=/O%^Z\65-0]W^&Y)L^OT E[O\H^*5"?A*+6NU17*0GT(5K7.P
MW:E*/]VF6V,ES;2!<$WN-+6ZP5JZ_@O$.!_MMW%DF&_ >#+1)#B'@>H)$=+.
M#M;).,KU;#EH7Y:-RJ=2%(12;@I$UY25#8'PT>6N2GUTH.,I4DZ"AL\[-/'X
M-WZ2QLWGC[F/9:;&>&MHX(D5L!B0_=WB#3=#6B/F+FB-W(R76MT7=*#B"06R
M2L=R4D$H5^8T=$@'?D@CSX^O.?XS'_\ 3 -I!$1?U(B9SS'DM*]E>D=PM>P&
M?EAP))&0 $3S$Q%^"PZ[25/+ 2#Y4#OL/W/J KZ GR!XUXUQ_N&=X_+&0N(Y
M7G.]\[GFN)S6T]TU6N:TZNGI,3&4"1)BT6A7]K1(2C2D) 4.WN/WVH$ZTO1'
MD?3>A]N0,,WXGAY&(B.4_OE\.@X2QV]#9W0!<"YO&O+73A:'$A:$J9+H6I(4
M .X^/1( '@^1ZG1'IZ;Y@\!GS%T 9B;D&W#CK&6>949B',>UC*0<YWR@GYM(
MM,P8)G+T40F.\_=1]:]HK>/3Q6.IG!]:Q=:5OT&_F[9I]O1V+HKK%R5FX*6W
MC>)4!6'.VXJ"U2H\N?(3'<=6AT;C-I)[>+^YI[^Z('F9C+]P=(GKOJ^P-L?V
M;,<^B6TP=XPP"6 V+IF00#<P3,FTI?,?I4KVJV:00 H])&*@% $%(-WW&/EU
MI(.O)UXUX'G>\JE1OP@V9@DF.!)M:TR?.1.0*Z+<36J4_@.;NM83?_N.Z2,\
MH(!L8-U*8WY0GR2-#1.OL/MSA62OX1'"(X1'"(X1'"+ ]KY=G1V>W]?:?R.O
M (]1O9'GA0Y&TVRX\E:V@GM5WC?IKZZ!V1Y_H_;KU)PM%_S<WMW:5?(0AUEQ
MIU"%M.H6VZAP=R%MK24K2M)\*2I)(*3X()V"/0JOCTZA\6S\)]7>0:W9/29@
MZS\<G/=(I=O(J?3S>.0;BO*Z*E.BU*'6J+76'7:)37KFA*J-1ITY$84JESX?
MNI02XZGCGY=]VOS5OE/OYJ;#VGN2,BXYQ-A^XK;H]SN6&G(M'=R_4+*Q^SD2
M\*5;T>F"33:-2[;7!J26H]Q5Q,>BU2>U#6(,5;G:6R"L3O[Y9_>5/NF;^S3B
M=2- ZHS_ &23>DI>2<'U'*.<;:KV.XEM6;A>Z;AN%$G&%D6%68U(A;D2+7=<
M_A#0?C)KD=^.VN2EE0*#4Z=.O,S?OJOHE:.VT'S^@/4C^?7U\>GT]/7?"+&X
MR5K[@H(\$;2-+.QH[5KZ'RG8(WZ@^G")NTWI:P*_FIKJ$?QI;2\P,Q$1V[U,
M,":'FV$PV:F\V-,.5AF"E,%FK.-+FM10&4NAI('%R8 )[]5' 09='MSF8C3Z
M\DPGVJF.[TR19V(+8;GVO)Q[5<M6A3JO;E<IDV=+J55ERG8K"WGVI+;#E*:;
M?=,J)[D2'1W*8=;('/.>(:AI4L,=\M!K-!$Q))&I-@+=.=ROKG]+\5X;PU7:
M%7:FS*N/Q-#"5:E*H'PP"'0TL+77R),6UX#VNE&O7ITX7\>B'-E>_&50Z3)N
M?IQR)-]\PS?=DN.+G52Q0]*6M+U?L)YYZ)&B%Y4R11&FG?=J0R5'TU  TZ9;
M<FDPN(N9B(.9M'H<LE\JV_B:>/VGB\5AL.<-AJE5QI4I/^V;?*=22)(@:1G*
MD@4-$^/ V.[SY5L;&CO20/(7OYB2!X'.5:. #)N.@OGI.6H(LK.%"028L$<*
M(X1'"(X1'"(X1'"*X$CS]/0^-CR/S\;\?S<))X\_/BCY=^%$$^A4.U._H"K9
M WZ#>MGP-^G+GWP'[=!K"MSF?4I+,O9NQ9@>UW;ORG>-,M6E[*($=YTOUNO3
M%>&J9;M$C^^JM;J#[G8TS%@17G%+6.XI!"N #GPZ??IGQL+Y4?+!/4#4Z9<.
M)Z04RY3W5-UF$MQT7#TD=-DT;^,<1\-U$9,ICI*BF,U(+C6-Z+/;2A/>Y%<K
MBHSSBVI#2U)[*=W=($@Y2(X\=1PM]BK+K')HR!FYF>IU(R!O).CS<-X,Q9@2
MUT6KBRTX-NQ7'/B*O5-&3<-RU!827ZM<M<>[JA6:I(6.]V5+>65GQI( Y6D
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M4B>,HE!8Z&[MD46Z:M=TJK8AN>HW%4JM=CMV2F:[)MN0N7'<EO2)"X8!(48
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MRV,!H(CC86CTUYKT&%\8;3IM!?6=6W2(;B/]QKF#_BZ8.Z18@R,N2;Q<N/\
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MD,:T#OWJ2!^L@ZV=;_4=@:(Y-PZVS]HYZ_93=R!,2>7+@>)Y\81\3%_QJ/\
M\JC^GC<//T'_ /TN3<;Q'_\ ;\(^)B_62P?R2ZC?^7^OZ_!;A_F(]B?HH6-T
MCU=?E<*GQ44_^O;_ .,DC]^P/^_C</$>_P"%Q.+ 2#I;/[03]57XF+_C#?\
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MT^T>(/ZEX[;'@ZEL_:6R\/4KNPHP9VEOM#]QH<-\;HAU4EP<6VC(BTF6.MX
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M@I8:3[]923([4)U(<[0 MQS0<V"$[5H#MX45?<OJ([OF 2=A1("U]NVU )4
MD!6^])V#X&B/ (L);F;[4IT>T=SA6 %>#K0U\JTGR=#M*4@'T\$4&77[TY]3
M&4&[>K-^6[<F:I%E7Q>-;P&>GHT"TJEC6N5>U_PJVI>3Z5>S-9I=Y4EVI*:9
MG.1HC(BQ_>N$(2I*A/,^WX3[]]\TWVD]'W5W-ZGL;2[[Q='F7%5\O=.&<;IZ
MA:$_0(E!M*AXPQHW:U]V#!;:6FH07I=>1[YNA0&TTV4EU3R65H62G"I=H!F[
MA<:>]N9RMI9<K/A;AWF[[MX$ R=1T@9\YC0PG:]1G3YEG'][8@O:Z^J/)63K
M<JV?[<^%QU<U.H,2WZ<F?,D/Q&XKU+A-2R*:CM9BAU:DN-@%>U'FOVE195=A
MG$Q%5HC,3:^4R;6ROTCUWA:K3+\>UC11(P3SO@F203#29/RW)<!!X%3(,06G
M.X*CM!*VPI20RA)2H@I)!5ZJ]//;K8^5)'GFS;+0!,0($:#^;]3YKQU8,>]T
MMEP=>H;EW2<AGQ-\U%[U=V/<'2_ERE]?6*:)(JMO,4^F63U<8[I; =1=F*42
M U"R7 IK:.UZ[L</N,3),E 6]-MN/(C+24,%0SWW1&\8TOK/'-<7PV?XC\J2
M&SKAM&^K8MZ];0GTNN6G=5#I]P4"LP4L/4Z;1ZA':DPY4=UI)2Y[UMU)WOY/
MF0KM4@@-]]_F-\^^_=3X;#>,^0^XGU75(B0ED ,,$DZ!$5&CXWW>4@A.M:5Z
M'Z<Q3<Y_?WM]+<UG--B?^PCZ^O\ >[?I^P<*?#-YCW[^JP_ 0AZQH^A]1';/
MZM$I_=]OYN6;R;]\H5^$SA[#\*OP-/\ I'9'ZF$?O].)/&.EN_.Z?"IZM!Z@
M($6F^?XE@Z)"ML(/;K[_ "^-_P _[.7><-?O]4-&G_@!Y#[@JHB4Y1*2PP%#
MZ!A )^VAVDD?<??Z\;[CK]/LI\&G_B/1OX31NH[K"PETYN0[8J)DY S#<C2T
MV/@['E/3<V3+OE_,B.B/0H")#](IRGP&WZY6$0Z9$05.NO\ :VK8O=$;QC@"
M>])X3U60I,%MT<;@#\?OZ)K$#IAZB^LV5!NCK6K*<4X=#[51HW23BJK+BKJ+
M)6AYIO-M^P'!/N%](:9]];]OR(5+:47F5ONI<4@M]P,[Q-HS)^\^B?#9$;H\
MO+3RUG\R8V9CZS[ MVG6G9EKV_:EL4>.B+2Z'0Z;'A4^&PVA*$-MM,-("E*2
ME*G772X\XKN4XM:B> YPU/?=^.J&FPQ\N1GSGGWIE9=2B##"MJBL#[K#+9"O
MLD?*%'0^^CK7&\ZUS;+AZ+'X-/\ Q'H/QW)6<PZ>?_N[ _4PC?\ DXWG<?HG
MP:?^(]!^%3X&G>ICL$_3;"=_LT-<DF9FXXW5^%3T: .  CZ(,*GG6X['C_\
MH(_HY2XD0;_;TCW4^"P9 #R'X5/@8'_LF!^7PZ?'Y>G)/(>_V*GPN3?3]D?
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M4_A'N4?G^_A+\!ZG\*ON4?8G]9/_ &:X2_ >O[!'NF_\'^=7]/"J/=-_X/\
M.K^GA$>Z;_P?YU?T\(CW3?\ @_SJ_IX1'NF_\'^<_P!/"AG03YQ'U5/<H_/]
M_"7X#U/X6-U*$)WLCZ@GR/S'Y'Z_L^OIPF]ND3;F+Q'D/3U209U6DX4RVV%
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MX15^*BGP)+!/V#S9/W] K?IPB/BHO^,Q_77_ )9OU^WZ7KPBI\7$_P 9C_\
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MF1B:U<+8_O2V:A_9TN%EUR[*_7:O K3!K@B!4Y+<*%%4F$I2A'[U+*05@\*
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M2;-L6O9#7%-XU6WX[$)NHK>K?P;'='J,Z7&C =T=MHGYB)^L56W%I  ]WH*
M\@=VR@ _0]OE0T//@[/@$6ZI00E2B=!/U/I]->GYG7"+0F-_%PI#+OA#S#K;
MH;*NXLN(4VOM._"^U1*00/.O/"*+J^O998;OFQL+8]B93S):EMX&NFOWI9T:
MWKAI?NY-TW!5Y%9<K-?A3J1,@56;2Y$MQNCNKC[IP'>V0^"XHBDHMVDN4"CT
MFCO52H5I^DP(4-ZLU9Q#E4JAB-I95,J#C3;;;TR1VA;RFFFTDGP@)^4$TGOL
MZ="NMV""001Y]?R]=CUX1>)4&T2&GX_:HJE-OQ5J'HA#K*T.)2K^0%(.VSHI
M[P-[]211RW5[,3!MT8XQYCNGW9DBU%8XJV0)]OWC;E9@-76[2,IN3!D&TZA.
M?ILB*_;MQ1)KU/E1!'0\A@I4TZE:>_A.SS/\*07'MEV]CBQK2Q_:<14"V;)M
MZD6M082EJ<5%I-"@L4Z RIQ7S.*;C1VTJ6?*B"?'IPB['A$C.>\54_.>*[UQ
M#5KHN>SJ/D&@3;<JMP634Q1[KAT^H-EF4FDU(LO_  3K["ELKD!'<AM92E0[
MSPBC\=]DUAAS#V/\/2,LYK?@XOGUN)9MSL5ZBQ+HI%E732X5'N['!DQ*,Q%>
MM*YX4)D59EV*9CKI<>3*#CBB"9J3BQ[3H=A6O;-C6M#;IML6A0*9;E#IZ 5)
MBTJC0VJ?3XR%J.],1F$()*1WZV-#QPBZUWN[#V@DZ.M'2N[Z:^A^OC_6")'\
MW8KAYRQ1?V)ZE<]TVA2<@V_/MJI7#9,\4BZ*; J#7N)RJ34NQ9A2W62MI$A*
M5%"'5#1]>$3"X/LE^F:3@2%T_9!DWGE&V;<B5>FV!7KOJ%--UXYIE=BPV:C2
M[0F4JGT^-#BRU16Y<XOQWG)<I3CTA;BE**2*0_'=E6_C"Q[1QW;49R+;MET&
MDVW0FW%EYU%.ID-N!$+SVMO22TR%R%I 25*)&AXX1*0G]$?7P-G[D>-_S<(J
M\(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA%8IM"B"1Y&B"/!\>GZ]?GOA$S#
MJMZ(,-]6LNRI^1W[LI-4M)BLT1BHV?7'*)*K5HW(J&NY;)KJT-NB?;5>$&,F
M?"6$=Z&R$J05$DB=E;=)I=OTBDV_1(C<*C4.E0:128K0(;B4^F1V8,2(E)T4
MAAAAMM.P-I2"/!X1=!PBL<_05Y V/4_4^/YSZ>F_37IPB:KU-='73WU:6M(M
MW-V.:+=NJ)5Z)2*_)@1'+DMF'6E-KGHH-2?;=>IRWW&67"ILA"EM(*TD) X3
MU[S2VV#9]O8]LVTK"MBG,4BW;-H5(MJW*<PTVVW!I-(@,P(4= ;0$$IBQDE]
M2 D*62>T$^")0!_7_M_G]>$1Z\(FF=3W2;CWJBBV<B\*O=EJ5^P*G5ZE:%X6
M/630[DHW\(J6[0[A@LRE-/M.0Z[1GWZ=,:6@DLN?(4J^8$2W8DQE:.&<;V9B
MRPJ>JDV;8= @6U;M.<=6^[$IM.:#3+;SSA4MY\D*6\Z5;<<6I1&^$[[A*+PB
MTY:0I.O/<4D [(TDGYBD@?IA(V//CZCR.$2#9!Z?[$R'D?'>6:TNKQ;NQ91K
MVH=IRZ9,^&:@LWY211JO(4 VH+F-Q@EV&ZE2?<R$I</G>B)&^D#H3QIT:RKN
M&-+VRA6X-Z3YU;K%(O:Z!783E<JDUR?4:\I)8;>>J\Y]PH?GRG'GW&&VF@H(
M; X3KP[_ !V$^GA%8Y^@KY>[Q^B#K?\ 7UX1-_R%@:P<EY(Q!DZZ8]0>K^%Y
MMX3+/;9?0S!6_>=OO6U7&ZI'6D_%LOTU]U#*$*0 HE2@>$2+=/\ T&80Z;<C
M5[)5@+NM^HSX5=I5L4FXJZNI4#'E#N2NO7)7J)9$$MI%,IU8K4AR4\TI3Q0=
M(;*$#MX3OOL)]+>^Q!/@E()&]Z)&SYT/\G"*_A$P3,'01C/+O4A:?5!5L@Y6
MH&2K(ID.B6XS;5U)AT*%2F9;$V;2V*6Y&>:CMUUQA+=64TMMV<P?=+7V> 1;
MN#^@O!N!LRW9FVRFKH7<U>:N6-1Z16JT[4K9L")>U::N.\H%DTM: FDM7%76
M43J@.Y84ZC2%)05)).^^B?'%65A8(/A7YD $>@)"2=#6_&O'@:'"+(]H]J3L
M[WI .N\_79'G2?4Z\G>OOPB83G;H,QMG[/V/NHFX;_RO;5]8LI"J)9S5HW3^
M%T&DPGYZ)]0D,TYV,ZB/,K"FFXE1F1E-2),)I$52PCP2<0-8.69RT^_X"Z*R
M>@GI8QWGVC=1UBXLM^TLFTNV;AMAF;0:;"IT*3_":>U4:S6IL2/'2%W!+>;6
ME<\K"RQ*?0O?O#LB>RGT_KXW^>SO]8_R[X17<(CA$<(CA$<(CA%8M 6 #L:(
M4"#H@CT/"*U#*4':=Z^B=^$D[[B!_OB23^9X19>$1PB.$6!3"%*[B3L>F_.A
M]0"=Z!/G6];\ZV.$65*0A(2/0#7"*[A%A<8;<5L@[.@KSL*2/Y)!.M'\A^OA
M%0QFSZ@D?0;(&O'VUOT _(>.$56V$-$J2#L^/)]$CT'CU'VWL_J\\(J2%=J0
M=ZT21Z:)"3Z@^#KP0#X)\<(OFAI/MDLL3+-M>WY%(J*<J5'KL9P;6;B7B*X6
M<3LXF5D$6\\PQ>?_ / #<R*+W*7($TO(DCN#'=I((GKR?;"8@I;%5N6NX<RQ
M0L6SZ;E&5B+*$IB@)MW,\K#XEN7=2[7B-U0U.DRGD093E'-?CP&JHAE2T.)/
M@$759:]JUBS%KLV C$V4KPK;%NX"KE,H=NLT4SZQ)ZAY\BG691XGQ=199;G0
MYC245I;ZVX\=E:7VENH"^.QS"=]]^T+TL3^U&M+)W4U_:N3L.WUC^^HDQNB5
MP7E7++A2Z/7S;K-R/16Z"U67*M6:6W&?3$;K=)9EPI$M#B4$(25 G??4]\92
M4QFQOYE$G9!W^CL'P /IY) .];\<(J"(SV%M2=A2>U7JGN^8*V>W0!WZD:)_
M?PBV$(2A(2D:2!H#]7CR?4G\SYX17<(L2VD+4DJ'Z(((&M*!UX5]2!Z@>G\W
M"*@CM@DD;WH$$#1 &AOQLD#ZD\(JAE"5^\3L$CM5]>X?R0?_ ,._'V_9PBO4
MD*&B-_4:\$$>A!^A'TX16AM.@%;41]23L_F?H3^O?"+!\&T0H$J/?LKV=]Q(
M "OR*0 !K]O"*XQFSY^8*UHD$^1Y'H- ;'KH;T=<(MD   #T T/U#A$<(CA$
M<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(L+K*72@E2TE)_DG6P?4'P?!^_C7W
MX19$H2C?:-;._P"OY#A%=PBH0%#1 (^QX16%I!).M$C1.R=^->03HZ_/Q]^$
M5BX[2@!VZ'UU]OJ/L =#>A^7IOA%G UX'"(X18U-I4"/N=D'2@3X\Z4#Z:\?
M;?CT&B*Y*0@:2/'J?N2?4D_4GU/"*[A%%GUW=:=W=*?4-T;6S&IU6K6,\NU[
M)%-R51;4LZ;>5ZSHU"MEF90S;M/IO?4=L5%\.3_A6'28O<7 EM)6")IF!/:Z
M7;=U+NRGR<17OF')UPYOS53\88LMNCTVPKDM_"V+6H#TNK7G_"B=!8B56(ER
M:T(SQ^-GRPTP&DA7?R:_S^(]T3E:7[7'!5;LG)=_V[95\5*BXOP=9&;*TE#%
M/8F.P;SNJ9:"K5:9<DZ37:!5X,ENI=Z_A"ELJCNN!22:D:Z3'F._/1<#<_ME
M+9H-MY/OR-TV9>J&-L:WQ3L8R\@B;:S% E7]4H-(J"*7):74OQ"E4N+&K$=R
M;6Y<?X)H>.[O4E/"*2/IJSU3.I?#UJ9<H](_ Z==+<K_ ,%_C=%N$Q78<A;#
MJ#5J!+FTU]"U("FE,O\ >E"DA]MIS: 1+X8S:NT$$]OH3KT'C0^VP=;'G0'"
M*OPS0(.CZ:(^A\#1^FB->.W7J>$6<#0 'TX15X185QVUJ*^T!1*2H@?I!/C1
M_9Z'U&AKA%:J,TK0(/:!Z ZV?.B2-$D;\;\C[\(LJ$! \$DGU)/D_;?TV!H;
MUO0X156A*]!0V!_.#ZC?J-^/3SXX18/A&3V[22$^0DG8/V!\^0GZ;V 3L?31
M%41FPXE>B2CR@;T$G7:?31)(\G?C8WZ\(MCA$<(CA$<(CA$<(CA$<(CA$<(C
MA$<(CA$<(CA$<(CA$<(L;C:74]JMZWOP?Z_L^Q\\(F*Q/9V]/,/&%(Q$U&NI
M5GT7/R>I&)'<N*2Y).1TW$+G+CLA2?XRC+J0/O*4I!94RI3?=OYN$27PO9+]
M*S-8N214QD2XK5JM/R) MK'%>O2?/L+&_P#949DMWK*L&@K0&Z#+J/QLDQWF
ME*5#]XI+*>W?'?!%BM#V2_37:TMNJS*_EN\:XBIXCJ0K5X7Y.K4]/]A"JR:I
MCVGM+>:0EJF4E4DQ5P@DH>BMMMJ([=\(E&JWLYL$W!U(4/J8N"IW_6;MMJ[E
M7_0+=GW.XY:E*N]5'50DU.)!1'1*3%;@+5[NEKF+@)DDR UW^I$_P)"?3^?S
M]-?U_,GA%7A$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(C
MA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA$A60NG;&^3<LX8S3=$:
MK.7O@:9=$['\B%5'H<"._=])%%K)J<%M);J2'(("&4/$!ES^,3Y\$G9Y]F#Y
M)J%U^RQZ9;E>J-5I\O*%CW?4LAW[D=^_+%O^IV]>**CDUB/%O:AM5AAMQQ%K
MUF/'2VY1>PLM*6XZTM*U$\(O"N_V172+=C%)IS$3(EH4"%C.@8FK5N67?=2M
M^CWM:5LUQRY*,U>L>,VHU^:Q6GGISTR2M+LIUU9?[M\)Y\TI;OLZ,!-8SO;%
ME$FY"MJA7WDM&6JQ4*)>,N-76KP:IU)I0>ASW&7DM4Q<&C1&':6XR[&6"Z5#
M:_E(EPZ;.F3&'2GC"!B;$\6J1;6B5FL7'(56:D[5JG4J]7Y8FU:J39KH;[WI
F4@!SW;3;3#?:D(:&O)$X;A$<(CA$<(CA$<(CA$<(CA$<(CA%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g729258g44e96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g44e96.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2OR4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *]:^$2(CA"24T$!       1AP!6@ #&R5'' (   (  !P"4  (<G(U,#
M T.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !#4Z%[[EQ*3W+9^:*TOU=7E.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+
M    $  0$L     0 !.$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             #,0  !%
M   0                         !              10   #,0
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #,0    !29V
MAT;&]N9P  !%     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   S$     4F=H=&QO;F<   10     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    $.$))30
M0,     "%R     0   *    !V   !X   W4   "%6 !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
MP,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !V * # 2
M(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$          P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$!_\  $0@!!0%A P$1  (1 0,1 ?_$ !X  0 !! ,! 0
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M/]PX?DW&W!U3R'#/T\RB6O+\S$IXU(@O<SK( )(4 #1)#VLLK:55 : Z+%#
M [))\?;6]$^/M]OT]OU'G8WIN:8R..,8XQCC&.,8XQCC&.,8XQEK-XW&U:[T
MQM>^T:JO7FYTO75RM-4IK"7UO6FQ :_/)AP+;<7&93JBD^,Q$PS%QF4]\7X4
M?&7EHQRHIQ13VZT$TOHPS6(8I9CH"*.215>0DD =JDMLD :V2!YQFN+Z 7;G
M?6Y-L=G=;WFNCY]%/F;IV/.7 :">%-UW<&P;@$8-UE<A"UQ,0;5&E%"H</(R
MJ<-14YORSCT5<KX&P.N.)HTZW'6(9&6Q&D/')$SAS+4KPOVR#[@PE41G [6,
MH[M, "!V-_;V'CV^_G[_ 'V/'D?RS:-YK?&.,8XQCC&.,8XQCC&.,8XQCC&.
M,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,9UI
MCC[,24[&8^:DM1GW(\;+B6L2'T-*4TQEU6,I;^,YA+?Q%8RE'N]V<9QCQR(T
M2 3H$C9UO0^YU]]?EC-2WTD>W7<K8OJ5[UK.QZ$Y&%[E*6&S]BP:J<Z"_9%8
MJ!5%@:1(7(=C(("<Q5" VODB3$IY9GZE]5>3(*,/35;/ZHXKB*_3M&2M8!:H
MJ14&]4/\U'-,'F';O3%@SV"ZCZ0G:"$( AOR?'@:U_C[Z_/^[-MOFK\CCC&.
M,8XQCC&.,8XQE)6Z_4:@1(L^]7&K4V#.EI@0IEIL FO19DU:<J1$BR"\R&U(
MDJ3C*L,-+6[E.,J]GMQG.)T%:S99EK5Y[#*O<RP1/*RK^9"*Q _4@#]<M_(\
MOQ7$1QR\MR?'\9%-((8I>0N5Z<<LI&Q'&]B2-7D(\]BDMK[9:?L+V?U1UEI8
MR\;*(D5#SI)L57QM<@MF#)R8N,N:OZ?&5*B1<QH\-M4F1-E38L-M"F&OCJDR
MHC#];Q?$W.7L-7J(H:-"\KS,8XXE![?K/:QV6^D*JL2=G7:&(Q[K+KKI_H7C
M(.5YR:<PVIUKTX*40LVK<A0RL84,D<?IQQ#ODFDECB4%%[R\D:/::)ZBG4.=
M5 ]G1M>)\4Y%R]%J4<.;+WJ/(PZZPH<0J8""6*0IV'V5H0EYO$:0WEJ5%DR(
M3[$AVM/2W.":2'Y)M1MHSF2-*Y'@]ZRR.@9-'W V""& 8$9C\7QE^',M"K?'
M4,8-M=Q\>E:W9Y2-^XH89^/IPV9XI RG7<O8ZE9(W>)T=L3OIL>IQTWI,?LE
M5]A7DGK"Q['[>[[W("&VVGG6/@TO8)T=/KOUJ> AG!8F?'9;<CD&9LY,2&_C
M#3<UY"VG',MYOHKJ*X:3TZB6S3XNE3GBCL1+.LL",'9()VADDC8D%6C1M[\J
M#L#*K?6/3]*.I9LW'2A>C5ZO*1UY['&3%N[]W\[6CFACE4*>Z.<QL-'W[6[<
MB9WU;ND 7:M8U3'V:_9I%G<$1T7JIC6SNM@LPXMML=#-VB/.2IE[*WHZ9SD
M>1B!ENY;,R1[D6<B+:X?AUU7+Q]CD&H"!:XE8U++F*]*D()D>& H01H'L#R(
MTVMPK(&4M9YOB;TA%R5?C5Y!K!L&(?.UHQ-0A:;78LU@."#Y42&..1(B>V5D
M97"SRM^T=;:_E@X%[V!2J7-LTO,&N1+7:0=>E'YJ5-)5$"QRT^(\4DI6\RA3
M,)#[B5NM)RG"G$85B%:C=NK*].E;M+"H>9JU>6984.SWRF-&$:Z!.V(&@3[
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M:G7Y,J2^I#,>.PTA3CSSRT-MMI4M:L)QG/(JK,P55+,Q 55!+,2=  #9))\
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MJ66%DT'4VTB%=BZCN@XNZ.O&_)>H3=)8.KVS-C1YD6NLHLD:R+ /K8+XQE\
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MW*> Z5M<]#/82S%6AB<Q(71I6DE559E[58=J .NW.SMM*C$$B!('O]_\?RS
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MXECXLB'(Y_G%Z76#CN(BJ#OCG=H6]20U"S@QN%$@ $C-*PB;P2I?0#D-3Z\
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M&"RSQ'NA]5C'I1*4?O5?CO\ B+_%I\'^I_B!7CZ;L<OR]/B*'[&N\_4X^/\
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MHJU0($/2Z2_"_P!(37X.UFXH&!2CKLFJY*2F1=B^KSY@Z0.L-;M8@DS'%IG
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ML[<A%>FB[8HS#&S%WD$R"/)GU]]-[6O:OKAKW:>E+R:U+?6EFZQM\7=("]A
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M/>$&(8%0T-!V!4ZVY/B%L<?;KPW)*\L\22%VC*N'8%6*@B2)6![/"MV$+W:
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M(^WU;V22-^ !XUK7OD4'(15HO1X^!.,A8*W[L*UN8.#VM+>/?9?N"'<2RQQ
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M?0[/5' <6+G803\QZESM$@'L_P K\M[^>PI]M9D2YNO.>\B+W8ZYU3L?HRS
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MG5;JNV?+YC@*;=R@AD<]K\M,RZ_\H\L6$'$@A,BN,U9)$DLQ";9D#EP4;O\
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M(IP<[;I0R*Q.B))ST!?DQ3TAJ.1?BON(;SD,G*T(8H9GG!6PBRP+&CS2R1L
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M^HO_ ,(SVO./UQ]_R^^.0SWCSC]<?SQQC'G'ZX_GCC&8HO6=SC/24SXSC/\
MYRM>?]XR^:P^+OGHZ;7VY&AO]/WC9NW\/W_I$K_]D<K_ +E,C%ZL?_61]&K_
M -K,3_WYI[FX.(_\CM__ *1/]W)G+?6O_G[I3_MN8?U_,4_']QS/UYQ^N/YX
MY;LS?'G'ZX_GCC&/./UQ_/'&,><?KC^>.0V/S&,><?KC^>.1QCSC]<?SQQC'
MN3_>Q_/'&,>Y/ZX_GCC&1 [O+:GZ7%4Q2\?^<?<6D:4\UC/_ $H0_M"LG[3$
MSC']IN14*_8&WD_EEC+N,_N^>3H->J-_8,=?G])'^TC+!U*W_)3Q;T;-FE7_
M .LC6HGE7[^\*2;^Q&P?&=?E6WN=>=^?[?.8MCD,9TB9&&'&D"Y%Y,<>*@RR
M,Z0O/A#$."PY)E/*S_!+3#2UJS^B<\@SK&KR.0$1'=R?8*JDL?[ <@2 "3X
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M[3:EMK3C*,S(2!+$2BR 21DH^RC@."58#R58>" 02#[CWR(]QOVV-[]O?[Y
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MM+8\)*>FSW5PGU(ELUU:E6425GY#BFCD[U0+:C+"1)XTC?14^3&S@ZWOZ-;
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MB)@MN-NMH=:6AQIU"76W$*PMMQM>/<AQ"TYRE;:TYPI"TYRE2<X4G.<9\\K
M0?((/\B#[^0?Y$>Q^_VRJT?<>1]B/8C\]^VB/.1)WG>ZSJ_>?7>VE#,"&^><
MNVK;&/5EQR;%I=X37B$"YSFV4.?3Z\ V55:+69ITGF()@.WQ##DQ,F6PP]16
M)$ALUI.X;(DBE \]L+E-2N0"%1)EC3O8A09"-[8 TD[K%8JNQT6+P./N(I>Q
MED8#R$2:.-.XZ53+K?Y7ZVEL$7JS7]IOI5F1-9KPU;\,1!0M\G83DEQN#7:L
M'C,I<>F'+0>E#J^%@QT./S2A&)&90MQU.,U4K^E&SZV1X5?8NY(5$'_2=V5!
M^K#*F1_15I"">WPH'\3N=!(U WMG<J@ ]RVOSRPFAMBW75^KJ913VENP\ZQB
MA#*+:3@:Y)(%D[F6O$=R]&1^%3T?T!DL;L1IORE*L1I'O7GV84\G;/&<'#2X
MRE6?DN)]6*N&F/S<>VGDKM8F.PNM?-D@>^E]_J^DY/1K"M4KP.Z%XXU]5NX?
M5,REYF\?G,QT1[@ _?+U5/?)XH;IHU_2G8@:V0.5:&].+Z_GQ!X[!0S8(,Z:
M9D+GKQ&%PF( R5.?=2I+$92GG$83[/C5=CCX5BL.M_BF(BL,%2TA=@D<+1I&
M -F1BTH4#]-;)T*HJFCY0>&UH[_(@>/[/;>R,GQS%\I\<8QQC&<>?SXQGS[$
M_EXQ]_UY#0_+V_\ G_XG&0"]4>*_+Z'=@&(D=Z2^L53%(9CLK>=4EK95,>=4
MEMM*EY2TTVMUQ6,>$-H6XK.$I5G&#?$I&;HCG512S&*H0%!+'_E&F2=#SX )
M/V &_89M#X,.B?$SI9I&5%]?D06=@J@MP_(JH+,0!W,0HV?)( \G)SU]OV @
MR%(RA:!8]"T*3E*DJ3$92I*TY\92I.<>,I5C&4YQG&<8SYYFE==00@@;]*/8
M(^X0>_Z^^:VLG=FP0009Y2"/(.Y&.QKQH_IGK^U/Z8_ER;H?D/[,D9Q[$_W<
M?RQX_3\O\/\ G[8Y'7^/Y^^,Y]J?TQ_S_P"__CR&A^0_LQGPO*4)4O*<>$XS
MG/Y8^V/SSG_#'^/V_+C0_(?D/&\>V8?NQ^S]GE>N%^[-N#7;S0HE1M-ZAZ51
MN:WZ$#-Z9' C!.+-F6:@46[6&ZWRW"&(,D@!/O"Z="C&7!L5;#@EV8>SJPE?
M@"U*K2HV+=4A;]V[6BN/);4:GCK168YJT->"3NBC98/7E[#,\OUK$F,+(_)D
MM-/.D$^Q!7A8Q*(6)"F9HVCD=Y(SW."YC4-Z:H>TN]HCEATKU$U49UQFJ;'U
M?==?ZLVM=JEJO7F\^S<?1A6Q4BB7/=$RAT78TMBACR,LE5 !>T%ID"EPX(^0
MW88*LRS8J3#>E2\Y,S$RU.(:4COVW!<00VEWKN:@-_2!]O('N3O/-?C(8(TA
MJO8@K(>Q(XKEJ-$5GT2L*6 J@NQ/CSL^0-Y=!O=&A1Q]-:,7;L5"L";>1K3\
MRL;7[0V^O5B,C<IS1(,[;S\R?$! 4$M@A\ I<6<P1@P9LER3'FFZK FV= \N
M3H-1X<AB00.#XE01WE/+)21P"VAM2&!(T?ODSY20?4MBV/ ()OVM[[ Y 5IW
M4D [V00![Y+6#7IVW*]N?J7N"SF;*.-Z]CRA-]C-"Q=N)4*[/':\Y&+.1!Z
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M]^<)\YQ.@.I5\>"&77Z%2-?;[ZU^H&6+J1"W$6) -FM)5M>VSVU[4,DI'_\
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M4+9*)7BKWV>.K:JU$B9L[#?3/N<\5B$T][+76FV),*84'#0<BQQ[-\,"S!7
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@C&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g729258g48d12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g48d12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1I^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &F*^9U0X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!CS,S         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              @$   ,-
M  $                          0             ##0   @$
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   @$     4F=H
M=&QO;F<   ,-    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   (!     %)G:'1L;VYG   ##0    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ :0"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MF?\ >"N$/
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M            _^%  FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X
M<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC
M.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX
M;7!T:STB061O8F4@6$U0($-O<F4@-2XS+6,P,3$@-C8N,30U-C8Q+" R,#$R
M+S R+S V+3$T.C4V.C(W(" @(" @(" B/@H@(" \<F1F.E)$1B!X;6QN<SIR
M9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN
M<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @
M(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\B/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/E!38W)I<'0U+F1L;"!6
M97)S:6]N(#4N,BXR/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z
M36]D:69Y1&%T93XR,#(P+3 S+3$S5#$X.C$Q.C0V*S U.C,P/"]X;7 Z36]D
M:69Y1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,C M,#,M,3-4
M,38Z,S(Z-3(K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP
M.DUE=&%D871A1&%T93XR,#(P+3 S+3$S5#$X.C$Q.C0V*S U.C,P/"]X;7 Z
M365T861A=&%$871E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @
M/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL
M;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @
M(" @/'!D9CI0<F]D=6-E<CY!8W)O8F%T($1I<W1I;&QE<B Q,"XQ+C$V("A7
M:6YD;W=S*3PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q
M+C$O(CX*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @(" \<F1F.D%L
M=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT
M(CY-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N/"]R9&8Z
M;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L
M93X*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @(" @(#QR9&8Z4V5Q
M/@H@(" @(" @(" @(" @(" \<F1F.FQI/G)R,S4Y,#DS/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]D8SIC<F5A=&]R/@H@
M(" @(" @(" \9&,Z9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @
M(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS
M=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U
M<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(^"B @(" @
M(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z0T9"030P.48R-C8U14$Q
M,3@U,#,Y,4$P04$S1C=$-$(\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @
M(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z0T1"030P.48R-C8U14$Q,3@U
M,#,Y,4$P04$S1C=$-$(\+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX
M;7!-33I/<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#I#1$)!-# Y1C(V-C5%
M03$Q.#4P,SDQ03!!03-&-T0T0CPO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$
M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z0T1"030P.48R-C8U14$Q,3@U,#,Y,4$P04$S1C=$
M-$(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C M,#,M,3-4,3@Z,3$Z-#$K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I#
M14)!-# Y1C(V-C5%03$Q.#4P,SDQ03!!03-&-T0T0CPO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP,RTQ
M,U0Q.#HQ,3HT-BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N
M861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F
M<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O
M97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z0T9"030P.48R-C8U14$Q,3@U,#,Y,4$P04$S1C=$
M-$(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C M,#,M,3-4,3@Z,3$Z-#8K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @
M(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z0T5"030P
M.48R-C8U14$Q,3@U,#,Y,4$P04$S1C=$-$(\+W-T4F5F.FEN<W1A;F-E240^
M"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z0T1"030P
M.48R-C8U14$Q,3@U,#,Y,4$P04$S1C=$-$(\+W-T4F5F.F1O8W5M96YT240^
M"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^>&UP+F1I
M9#I#1$)!-# Y1C(V-C5%03$Q.#4P,SDQ03!!03-&-T0T0CPO<W12968Z;W)I
M9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P
M/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @
M(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D
M93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X
M.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_
M>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!#
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $W =D# 1$  A$! Q$!_\0 '@
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M_A7[K?\ Q78!_P!B'S)6_P"U^U#[W:(X1>8HOK2_NT/;*O\ I_E^+]X'7_\
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M@G_CQMCD\KYPZU?[N]K'X*W./Y2+[4?N%/;*AH-F^3+>+/=('T%_3^^IQ?\
M&+V$):>.5V2RNS\)3^[O:S/,WL_&>_BD_<*.V5'CLVR6?_CNC_K\3_&+V"?^
M/E/_ !Y8>$*T/=[MD-((9X#FC]PH[94.&S;)8_\ CNC_ *_%_P 8_8)_X\?_
M (LJ/"!3^[O;#6%]R/W"CME7_1MDO_Y[H_Z_$_QB]@UTT;WZ+*OOS'4_NYVS
MN#@C]PI[94.&S;)8_P#CND?K\/\ &+V#_P ^.[_*ROT)_=SMAK"#K9*.T4=L
MIZ=FN2O/GND?8_B_XQ>P+,K$/^UE_( \4/N[VPB<+[1S"#VBGME(_P#[;9*
M_P#QW2+?_6N?KZNC$/\ &/V"Q_\ 7C'_ &\L!O,)(W[+$'N]VN$.8' J"1.X
M$N9;3*6"5/:*^V4C0;-<EGCK[NJ3Q&IO=[Q<-/$1C>3_ (S^P 2^6):$C[.2
MRL1?%H0=56-BUD_87:7(.2 E9$+=S._DKK*_:->V14[-66*C,V:Y+3#IU>IL
MV4M&=Z4I26(\IIUSP>6.^0E!(M?PN'3CRQ?Q@]A1=GR\.FB>.&,OF90D_9BE
M]T7].'Z#V+VD-]@B8=B+\:  L]MP"WC;CVDOMB6<=K.<<T9?V<Y-=HU6E178
M*W<ZTQM9;:ALLJ*FRZ%).^E1\( $=/1CS=B_B][&R'9\E#IH@T$+PYF4D7)F
M1!:7EB9D%:B]B9>N9OB%)  SH/"MJY:GM%7;)TW)V9Y+<40 FV=Z22#_ #07
M1PZK\ <?4@_C'[NQ0F'*9<DQ2?195A5WE)ME'FN ]B9<DODH?LT.>*&1H2]U
M,1:WIGL>>UD=M1[&XU&?DS9'DP5VH.2FY<\;2*:U K%+E,*8>H68*2'N:U.G
M$*#@#R5*;6@6(Q^5]L?Q ]U?:DLI$,I"(\^#.R>5&;$&:*$YLBX)81,7-TO=
MDO9/:LF/LPL]Y%OB\ZSDUB[E6.Q*[<+5*YLMS33-A^S/+-7V;PIM.>I])VA4
MYK*>9XDZ/)C.-U*@!Y,=D\E).K8 59&AZ/GY#WT]U-'E\EENT1Y2'*Q0DQ10
MY010F%@,R+->$0M:2S7 !=_@/:!S1##"0*3&IS/@*2)K/!E'L/.VWY2HV2:3
MW@MF\]S(N>*[G.*Y&VEP*=!K+-=E*EKR_6X;;V[(C4]9*(+A\-E' "^CM/OM
M[L9:/*Y2'M.6(RL$&3,,,$?V(( 883"8H223G3,P6#V(.P=N  (A^R29,14&
M<Z:F=S.:S9%[$#MM&2(.9J>KL=]E^8FLU9RS?G"I2*KM1CKEQ4YP8>C/Y?CR
M!("DTZ T\>; 'BA*; $#'/M7OM[O93*9+*9+M48$&1R63S#D\I+1D$1/FM%$
M2')#BH856!V#M[D@0AR;0 7MJ93-?"O(NR([4_VRK:+DG8YLRI62LF5W+>S*
MCSWXU9F9SIS-63,KDU^H2<N2GG'R9L2CNR%,PEN A*$(*;6MCZOLC^)/L'V;
MVSM':8,M%",M%!'E/L99HHH(1"X#$,6F;68F_EEO9?M#*0B$P@S) >$$.7NG
M:;ZNR\I_N%';*;W&S7) )3J!GJE:D^,/:GCI;3A?06_3Y/\ C-["TL<<>7B:
M($0@9/*M;-LU_&IJ0O)![$[7$XRD$P9/$)/7986K;,*VRQVC3MD5.S9E2J3=
MF^3$PJ7F6B5&9NYXI)M%AU!E]]:6^5NI3;:%;J1>ZK#73'B[3_%WV%ELB8-/
M$7B=]'E7+%Z$,]#MDTUN'V'V@1/F4$F,.%KC:QF"1)=WK/:C>V-9=[+.5M^R
MELER'F6#0MH;&<\NTZJYWIT2-5>9EM;+,[==Y5IIQ;>ZX;@A)) TQ\WM7\2/
M=WM?LV'L64[5%! <GF"*#)Y3/A^RQ+YE18PD2'"[9+V5VG)97/A@:)P8ONL;
MA5P&,Y-(F<BO2-/[%7MM=&KE>GT#L:MDE'H&:JKG;,-<RY$VDQ@U(S3G2(J"
M_76I@?Y5+M,841#0 4D\>%\?G<K[T^Z46B,':LJ,KD\G! >T19.,Y2*& @B$
MM")%IOKJ%[_A.W!P<G"7)( 8DN+2*4D) "VU8=FO87]M-R_D/+&RO-FP#9S6
MJ3"<72:QGIS:7#.8A09&8W,Q.*0A3RDN2F'7.:MN.;RE--B_''AR_O9[OGM?
MQ63R^4S@'S!#E#DR2&+!K'>;EWH)"#LG;9 0PLS.3#YVRPK;16W9(]KR[/'-
MG9";#-O&S;9!ERN2=DKPG'*>8MH%-C4!4J&A]N&(CB5H?;0^'0[)6" 70;:$
MC'N/OQ[%B]E]J]FQ9=H>U0DF/,C<&)@Y&;#G%@U#)ABK\)VT10G,9A(.P ?&
M0F*;68E7F9.Q_P"VVYPKTS-5?[%O8RK-<R@9FRDK,]-VD0X55C99S X^[#@Q
MG&Y!2Q(HCKQ5'J 2'G@ '"H''S?9GO)[O]CR>4R9[7E##%%DLK"-'%][)!VB
M$,,\XB0)(J0T@@[+VXQ.(',P?M!F,@9RF*SD#2JQY5['+MJV5X-)CR>Q-V/Y
MAJM&RFG)T&OU/:A$<G+B<FZ@SY=GK2)+I=*W5V2+IN?"5CTP^]GL+)019/)]
MMRFCCRVGS88<I"/O9V82822QJ!28<O+G\%V]XF@@E*<0'[XU$VG1:_4>Q5[;
M-/CYD9;['+9=39.:,N46AR*G3MI\1F? F9>D%Z!48DGEU*YJMO=CRJ>$AI]M
M5E=8ZP>^OL5X3\5%]G*11@#)Y0@9XS8G&:SAS.9>;BW/]G^T/M!H26 J),9-
M1Y .:&1O)U;:]V$G;/\ ;;3\K4O./8M[*1'HN<:7G6L+C;4HK)K=5I%+;I4>
M/'2)!33H[S;+3[AC@$/[Q!U..OLWWV]A>S<IE#D^TQ"$P1"'[.4B(SHLXN\)
MF]"Y9J3)6A[/[7&^DA $RTH9N UFI[)B=#Y'RQVE3MC@VU95S]5]E^48--C[
M3:1FZJQQG^G5%R!38E48E+BL/.O+?EEB.@I;*B5$I'@X^[E/XG>P\IV"/L\7
M:"3E(3#%]C* YT0(#@P@"NIJ!C+RY/V1EX<H8\R@D*@L00Y=[A*8X+]JGN*S
M+\&)^=-8_AO]HY#O'\L'TK]'HCW!^8KE&WNHU&/M!4Q'J$Z.T:=%):9E/-MA
M9"C<(0L)OK?K/2>C'@[)#"8((B(208J@%YGA+BO22 P:9>;T:QOV7'#6*PDH
MO6*H=Q06H\^D#>4!IH%G2]KB^O#'TM% 1"<R";'[@&S4:/KE)9,4\T!S>Y#;
MOWN6)=;K+B]_NM5 ;[W@SY-][QD+U&GWI\>.>4R$$3-!"TW^R+6Q\&2$9KX]
M=,UMDD@K5:X=UZKHHJL)\GB;@WNLFVO#KQS'9!"Y$<1+N 1"PP&JRYKU2 ;-
M\^O).-:K)00:O5=--9\F]]+'[_B+GR_7UAR<(<100Q'-)G#"23>X%=29TQ"U
M9N^O98K_ #-4JLBI,<G5JFD"DT]6ZF=(2G?4VHJ64ARQ6L$;QXDV)\?ER78Q
MDQE (<[21YY</FS=@34;F%X5:7KYG4=:H^ZE;T_ABI@ #A.D?5RUCCK'V?/,
M,A!F@"4+.U2:/$;V)MQ1(JKU=*@.ZM2UMQG/@BYMPY0W^CR8W\.)S#NX,G'Z
M;+T,35B.]9#5:P>-6JA\LU_]=B#LS5(.P#_:JY%"0D[J5CX6J?SU_P#78OPX
MPX?2CF\[T[NI5SQJU3OXYK_ZP_7B?#"_^7Z$<BA(VIO=2K_"M3^>O_K<7X<8
M</I1S>=Y3NZE7M_E:IW_ -M?_6?;B?#A\/\ 2W\K]7(YO.]8UUBLI('=:IZ]
M<]\?^*<7X<8</I620*D#6G"K58GP:M5 ?]M?_6C$^&.(Q(A;A"M%^\^_S"8:
MQ6-_=[JU*]QKSY^_"_#E/MP^'E4/>P\,W8IG69VQ[\,5D[JU<\:K5#_77_M=
M.'PU\7"$?[2JY%"1M2=U:P.%6J8_KK_Z[%^'& W><)1R:DG:L:JQ6-[=-6J=
MAK;NA(%S;0E/*F_0 //A#V<0ER(8J.X#F8P E/9QQ$0Q#AV9G JA57K"@=ZK
M5,K-@H\_D@)(L=Y Y3P%#HX]=[XL?9Q&0T$(8$G- V4:RV_A,\7:K_#HRHY#
M16*R2HFL5-=Q:ZZC)/@@^)R^H/$X09&&!LZ"&*3-FOP)D7M?!99IPQ!S8(1$
MP.T2I/A-":O6$ J%7JI)!'A3I&B+$;MBY8@<1Q(ZB#C0$).4(R4'_J9/,G""
M(37.A+!C;>\W*R^4/XZFC"LL7FT[%&EYCJ=-@R)KE6K);B(4\ZEB1*?D2$V-
M@TRA84MQ!.EKV!O;6XY1Y*",0 9, P0YI+.\ZD28@/*;LUP3.R@=XMXIA6S>
M*6*!0\\3LPQG7X-2S*RTRYR+HJ*Y<20XX4[V\E#K@):2  =+<1>^F-Y+)C)P
M& 9*$N27(=\ZVS&8+8H!%$6$<0D3?YB4RT[KE<*K-:-KUNI@IMN$39)" 1JD
M6<%Q?R6 MT8YY/(00?\ #!$S1JSQ<3DM9N4%(G$ZL:ZR\M?F@5BM\16:F@\%
M*$V2 4WW@4H+MDDVU.H(O:W0B[)DXX1G0 G.))82!9@V <5?:ASPSQA[1FCB
M<Z5MC:@$O=NM#[VL5.P)*"9[^\DGBH7<T)\8N.N^N.YR.2.2AR>B@E(QA@8@
M*/\ 9DULRZWG PB8!M+@W6)!6*P;)-6J1%]/X0D7%S<B_*W-R;ZZ]&.8[-!#
M"(88801^*IVRZL9 ;X@7I0>:SFJU<_RM5//.?/\ XHP'9Q>^[RA"VY%"0@52
MKWUJM3^>O_K3]6![.,-C/QA9'-YWE!JE6Z*K5/GK_P"L&(.S"_8<WRA\T<WG
M>4Q56K"1<56I]7^//CZG3U8I[.+VU-YPGIU";SO/-*:O6=VYJU3X7L9S]O3R
MOV8#LPOOLANPA&U'M?:D15JNH$]U:GQMI.>(\_W3Q\,#V87@;O.$JYQ-(B=J
M%U>L)%S5JF=;:SGP.G_K3B?#"]]WE"%':UMK)R:K5R >ZM3!.M^?/D#_ /,O
MB_#"PM^7;^$JYQ-I(UICE7K"2/X6J2KCIG2!];F'PX:^9JV%T._8IG-:VUED
M%4J_35JG\]?_ %IQ#V<6<,WSA5<WG>4BJI5P">ZM3T!/^.OCHZ^5'IMB_#AK
M!N)UT9,XWG>4Q-6K*@=VKU0=8Y_)%CUG[H+G^YUQ@9#-)D(K)P M;(ANM3+&
M:')(9[03,;&4R%5JTF7$!K%34.=,^#SZ1;=*P"+;^O62;CQ8L.0AAR463, B
MSA%]HPS#O2KS+L[FU:OZ:84_,-6K K4Y*:Q4TI*DI 3,?"02A/ )< %NH'A:
MXOAD>S0PY'1&&&(@'[<0>)ISG.1I,LP:C%XUO?JN^LE2FKUQM25)K55*@20>
M?R!;2QM=T\0?_/&!V/-CSH8@+QFACK<5MH+*J'-%PUD<@D55:R$E?=BJDJ5O
M$"=( -^((*U:7XVMZ^H[.)&(9XMA.:!PA#,; 57>VR5O00FL5I6\E-8JJ=_1
M"3/D6;UOX)*_'TW\5['$BR&1/V1D80=8B;@P7$B/.;/NU3P=]CXR"UMW:"\S
M6VZ"9V;34%.H;Y9#<[N==:3]T,O>Y(BP\(WL3T"]\:&1R</_  H7:0H[&Q@1
MLJPI.:+/A8Y[O\MV#M/!L+5L9J]:"E*[L5,;Q!4CGTC<WTZ7MRG7T7X^C$CR
M4$>3, R0A>D0$V-A:9E*HEC-4&,!S$#A;M<[:TP2)J]80A2$UBJ&ZBYNJGR%
M)2M5@I21OBQM<#\6_'7&3DP,B,EF!J9^;.V1<N1@]C:[%&;FLJXMH<+I^2$U
M:M*L!6:I9/ =T'SQ-^AP=6FGBQ@=G8AA(!F$#>:U"2:AL;^&^:D1:K6N>0_X
M9J8)F1@H\^D:I+J=Y"ONA\%0N%#JQF+L;P9I# O,0L6O O\ "HJM87]=:U:Y
MBJM7:K=6#=7J2 B0M+2$37TMMH4FVX$;]MWB;7'3PT..L.0AS<G!%DP1#"(0
M:$M,$EB"9D'5L6(BQ:C@_:NQ:4Q*V2HT5RMH2$BKU(I%R1W0?L2>FW*:>;S<
M,==#DRSY* MC_2LYLFTAUO/Q3$UJMI24=V:H4E5RE50?((O<I-W-1?I%K8WH
ML@:Y""=H,[9_=U6W[#1 -I1*\.=ISIIZ:Q6""!5ZGO&Z;F;)L-X ;MN4!L.-
M[\3Z.9@R8AT>AA,W=AG6, 6F)2%!.U9.?#(QDM20Q:VCV%UK2]H,AJLIH3E2
MS:N8I0CHD)1.53P5H)45RTJY/=_%5O "PZ0 >4'9Q!G- #G$U 8$F1MQ)-)M
M\RHSXRV>0P=P&PO,ITM+6K9#5:TE.ZJL50[MP@\^D72D7%DJY3@1TFY'T#4/
M9X<QHH827)HS:F>4\&4^V"V?23M?:9XVR%BQFKUDZ&LU6W@@@5*0/!200D?=
M"1?6Y-[WX#&H.SP0#[D!V-Y'J=5IC;E 9W 2NE%NN605>LJ5<5BJ)%[G]_R%
M6Z 1]TNDVL+WMQ-N Q3V>"(1 PPC.A,+@.0Y>4A3THND!8DF+.D0P  <VFII
M9,'B+&E5.L*J]*+E9JJ]^H1&U SI%E)Y46W@7""#^$/P@;$]./+%V:')P&!W
MSK6&<'>VUKR-R$!WG5ZFN^RB^AUGORZ_I]K'S-'CP]55X[[(+_VAN?[!!_L+
MQ]#L?^6/]7\R1?@V_P"Y<5<)N=3T_P!H8^J:0ZO,\AN7*"<1><N2Q@V"=;:F
M_IZ>O3'*%S$2\@<:39= "\1L+,FDZD@\2?%TXZ*IQOR:C?4Z@^2PU)Q"<)L6
MIA+:2%S,XP,&.T%=KJ>S>?5W(-1:K=.CMOTJG;K#R7.42>2-PHILE6IOXK<=
M,>0]K BBA8!B9DWOPL#/L6V%Y&N(T%;57]Z6I@_QBI/5:SUO1;3 =M FP>\D
M<U&O/&(?[BG=Z2H'568*22.G==-NGB1IC8[:X)+"^0-EJN8#/QBGQ+I>]-43
MPS#2CYG</C0:1 [/5,U[_P Q'B4O>EJ/YPTOXKV+\9C^E7-Q_5ZIO>FGGCF&
MDG_==Q/C1WAN'-1ACO/-.[TM2_."E_%>Q?C,?TJYN/Z_ZDG>DJ/P_2OBNXGQ
MT+MG![F#[G4S=?YCS0=DE0/&OTH^5#I^L8OQF/Z4S :L?]7JCO25$<,P4H?[
MKN(.W0FD0.H ^!3->_\ ,1XE!V25"^\:_2K]92[?TXOQ@O#?]/5J& 5_W.?%
MT=Z>H?G%2O0[B?&CO#<.:,,=YYI>]-4?SAI7H>Q?C1>/R^J,,=YYIO>DGDW]
MT%))Z]UTGQ8GQH/X@=@YJ9L)LWD\T'9+/! ]T%)!*A>Z'>&MS?3A;IX^;$/;
M<VT6F8 Z_=U<R&X;W\">JIPV15!0&YF&EJ4LV;1R;N\NVIW0+G0=)N/'UY/;
M6G*9=[[)3!\@]%,R&[9/FF*V15/X>I:K$^ 4.!6AL21XB>'2!Y<9^-A <@3E
M1ZEAB+G87JB "8(%)SUTFXO#-K!3N])4M]1&8J4L&ZEHY%VR 19*FEDFZ;"Z
MDD$ WZM0[=,2 :<@:RPOI-L)R &;D&GX0*7WZYF2#LEJ*P <QTIO?-O!;65G
M=T"0=!=1%R3>P.AP/;9?A9S="UTZ'!Q7<;F@.)6$M*4F+L#;9N0K9'4@HCW0
M4B^ET[CMTC@3K8G@3<^73#XT69I;$>(.YP?%0PAYU&)/%TG>DJ/ 5^E7X^"A
MPC=O;B=/[WX6OH=M!9V#"R5=6-;0]%,R$UKK.^I2JV1SP0.[])/E0YIH>C7J
MM;U8U#VT4E.=\\;W%Q3,A,I/K//;ZI.]'/\ AZD_$=]6-?&8_I5T8N'YAS3N
M]+4OS@I?Q7L/C,?TJYN/Z_ZD=Z6H_G!2_BO8'MH <D 7F%AXIFX_J]4=Z6HC
MAF"EC_=>Q!VT&D0.H/X%1ACO/-(=DM0Z<P4KSI=^W%/;0*D#7#ZH8!;/_4_F
M4=Z6H$6]T-)(ZMUVWHQ/C0?Q#<.:9HI9<Y;Q9'>EJ"=!F"E)Z;;KH\^'QH%2
M!_I]4S0/2(^10=DE1/&OTH^5+I^O%^,Q_2KF UG_ *_ZD=Z2HVM[H*5;JW7;
M>C#XP .2 /\ I8*9H'I%Y H.R.H'C7Z2?*AWU8@[:#2('4 ? IF ^L7,I>]+
M43QS!2S_ +KV![: )Q "DP -55<UK?U$^!2'9+40#_ZP4JW44N@:]?EP^-!#
MN"+V#;W:O%3-EA_U'P=UC[TE2Z,Q4E/DY8?WMT<!C![8',AO \U&N+;3S"D1
M=DU23)CK[OTDA#[:S9+NH2I)L/)8VOY^C&?C Y)(-K6UK5SZZUIGMW$@SE8S
MZL=;3JWLKGR*K,?%?I24K4FP4EP'1('1QT&G#JXXU!VV3G[.O7)P]9>*C#'>
M>:K>])4#PS!23_NNXZ?&@T(/^GU3,!]8N91WHZB2 *_2M2/P'=!U^;]N,Q=M
M8;6HR&$-A=G/P!2#9#4E$A.8:3?=4M)"'% I23=1 .AOQ&A-CT:XP>V@S(&U
MK-<QU8IF0W<2G=Z.K;J?_6&EEL(%E<BLDDVL;:*3;I%^&M],9^,!,LTBM0^J
MLI/.LS*YF@U<[3S2+V1U,:FOT@%0NE(2Z-/Q@. X\.C2][:WXP6@; >9W)FP
MW<3S3#LCJ0.N8J3\5T?5]>-?&AJ #6V\..*F8+AQYH[TM2'#,-('R_KP^,AM
M X'_ '!:88[SS6:-LDJ:9,9SW04HAN2PZ1NO'?"' HI%SQ/ &W3TZWA[8&U8
MS%*3+%J-R*,+S^8\U85O994)=6J,E->I3:79!6$*0X%) 3:RO'<7X=)X=-A[
M:& ,,(9JU)8"K$R:<FF2YFQA*F#WG$XJK[T4_P"'J3\1WU8Z?&8_I31BX?F'
M-'>CG_#U)'7X#O#IZ.J^(>V,"21*<X6&\T31PW#\WJE[T=1()]T%+!T*06W;
M%!TWM#UWT/3U8Y0]M8N"&,VQIJLUX/-3,ANXGG^ZR]Z2J)4;YAI02@!!!:6D
MC? *=Z^I5;4$$V!OA\9_T@@/:SX'J=MB"$"DJT)&RNQ8U;):BI1OF"E$WL06
MW0 .@ :W'E/CUOC</;10YKF<F+1'!W=MXN5S(3<3C%LM*;WHI_P]2?B.^K&_
MC,?TIHQ</S#FF]Z.I"^[7Z0+Z'P'3]:;>@#&/B01:-GJ4S6F&%\W\#Q93*?L
MHJ3-1I[QKU**69L=U02EVZ@VX%$"]K&UP+^/K&.$>5</,F<B^)] '57MCF:O
M?#?H'KQ\O/BOX#DB\7=D$/\ ^(;I_P"P0O["_6,?2[&/_3A-ASFQ^TH3.$:]
MC/S7%'#X1&A-R+>.X.OHTZ^GQ_4B($(D7#OJ<GHRVK$ 89SR8^/HL:KZ7 'D
M_P#/&88LYY,RV"#0IN-*IRDW95I?0]?7P\0-OMXXA;[3R%-A WFS@HP)F+GV
M8=747KYD 0**H  &C0-"/^J(U&FH(XFY/DMCX.4A@.4C>,OG,6%)2LX3-\Z+
M:;?+J0IJ4*-^";>0>K@/+AHH2 P>D[Q?]\">K8JG7/4@_%T\7'U^7&M"!:TK
M"9Z_M5Z9$:CB$'SH/U'#10V2U9WU(BYZD?1Z\-$+SQ^I$7/4CZ/7B:&'I^:)
M?,V/+;["<4Y+YHAO\R427\2/H]>)H0[YQZXHEU/0WYRD?6K%T0[QWGZD27\2
M!Z/L)QG0 4B(1%_$CZ/7C6B%#$3K?FB7S-CT?83B:&'I^:)+GJ1]'KQ="+SQ
MYHBX''<'F/V7'HQ-# !4@WNW3:U"]X Q'F_DFDGAI8C4 :'RW%]/%@,E :DQ
M&]TSA>%Q';I4<ZTNF925E$34T>;FF'$SQ/I+9?K5-H+JT(<D4]D GD_"4'5I
M&\A))&(<C"99YK(."S6;$!!H77%\V;6]N63G9](R/L_EYOH\.M0(--KU6;<%
M0?H<MRYJKX!3REFR$6W=\*(NFXPT(!^\9@RP,GI?LML5ZZGJXK7ZIMUV_O5(
M*<V<2Z51:7-9+ZFHSG(3FFFU/27D2!=:(K#2%*DH5;>*MU )XS1"K2K4BEG/
M<2TD5'![*#L@<PTVDOTC9:VN%7Z;6JC!S3$@2'(#+<&0_'0SR"_"YRE3(;0V
MI)WRLK3H,-"*$D5F\S3&ZZDWFFV[A);'W\NR%B4: BF[*9,USGM*@S9-1;7R
MPA362Y-K2?"!4F*Z SS<"X"[E)"2<:T(#@D,U2)O^VIJHO4F1Y^?:^BB9BS
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M*%V;[.S.;<SJRQ>_T]<<$HK=6/\ *DX>62L?;BZ+)B@+8L3X*(%;JI_E6?\
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MHO($?LLMJCU,SK79^1JQ3'Z?.5*RGEQNEOA_N!&0RZ_%J94V'7JG)2ISD"T
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M*K"[]</)'A=-O,2/IPS8._#X>$(02+C^:&8N2:DA)^^-@+$CB;#HMZ?/B9L
MM!MKPFWFM'.()!#7.#9J(6O.9JI#%830E]T>?..H:WA3W3'WEZW,FW)6))/'
MS:XT(1.18UJ?-(0(JV  "@M<F?':66QD^$I.AL2.)' VZ!;T$^(X BAB :\]
M34,)$P163GG)'A::) \_T:# B ES%#JE/?#YA1KYG_JA\W3-]7X/U ^3B#Z1
MH?-?&8LP%F?5([6;FN@D)D G4/W4N&29D*_OJ+T"]^6&@T^CAP%L8^S.MM:"
MK>7-JY,1 D14ZVLZU*WS,;5ZK6-P)7001?=3IKZ?(+6Q83"(H!>&HX$A1KJ&
MWB5!&6F;"TM>^8;:;EK_ (?\WZ<;S8._#N'TJ,+OUP\D>%_-\U_4?JQ0(07S
MX>'E"$  FWZX>2"H@@&PX=9T] &*XLB!U%40FLJWVX %I6/?.2UUS-E(;K2:
M"ZFHF>5\@E2:<^J'RBAO#>F;I;39-K*)XZVUQ!!"&B<FX2ZO:\7&F\P>=PQN
MN:6RQMD(L2!IU7X7\H OJ#?SX'->9&!(\'%)^E0N<08X2MI2TTK(TXIOA_S?
MIQ,V#OP[A]*,+OUP\DY!"E6-CIT$^H?W.$@"006%P\@+ETAA9^;^05G2 16:
M20-!4HMOE=./3IZ+7QYLJ20YH6#3%XEA7:M+Z.7/4?H]>/DL+AN"+0<\-2%U
MYU3;86D16@FYW3Q-Q8^?0>CIQG)Y(QSLNFYW#U\4Z_9>=MKF1LW9RI=$8RK4
M5TF?3*E+EO/A\M* ?AN1V%C="@2R\M+B ;@%(-KV./1%DG #$&4YUPQNINDJ
M//;SMN>ZU<.H78X[:&Z:ZQF/;779H]S]5I"LO%U$BFU1VIQG6P[4Y/(ID MN
M.;WW,W2D"W5C$.1;.<YQKN%KNRC$]4O)PF*R4ZI;!=HDB+ENGHC9<A'+&58V
M7Z/FNFSI2*]$J/.D/S9#[92$2(;S"2RWRRE[AN0 >%T0=@!;6<]QEA8*7(U^
MI^M=C57KAF%*1'C,.-E:V8T9E2]\'?<:8;:<4;JN2ZM*G"#Q*KZ7MC0R68<X
M"LA9S;8TWV7JNWK'%<)SU0JY+S-+?C4:H.L<WCH0MMA92HI2;D$6N+\"#UZ=
M&/;!EFAAF' 8T>1W;3.R2YQ0DEPS,TQOL(M"U$Y<S'<VH%4M<V_>R\=!E9"<
M1E?ZIFX#\QY)/<YF3X JGS9>&EQBW^J9H[H_,>2/<YF3X JGS9>&EQBW^J9H
M[H_,>2/<YF3X JGS9>&EQBW^J9H[H_,>2/<YF3X JGS9>&EQBW^J9H[H_,>2
M/<YF3X JGS9>&EQBW^J9H[H_,>2/<YF3X JGS9>&EQBW^J9H[H_,>2/<YF3X
M JGS9>&EQBW^J9H[H_,>2/<YF3X JGS9>&EQBW^J9H[H_,>249<S)<?P!5#X
MN;+&(<J6D8@>L5#!< ,7)\DHRUF,_P @U0'I'-%W_OY.CHXXV,N0&G9U6J&"
MX;HN<*7W-9C^ :KKUQ'/LQ=.U.#C94*YC_A'YCYAMZ/<UF/IH-5Z;7B.:VXD
M>3ZQKBC+DO\ :LM?=4]'6@R9N?:;:4AW(]S68[7[A52PZ>:+Q-/FRS@";GYI
MF8-JB-NN$H]S.8^F@U4==XCFGEPTUK@O@=]>K$S/E'YHN23W-9CZ*#53Y(J[
M>G6WHN.K%&6D"(@TVF=K34S?DVYQ;782R7W-YCOKEZJ*-K6,99%M+BQ'1H0+
M'0WOB:=J-/#'$R+TM6X087N=Z&0HUQ%D[F2C+681H,O5,:Z[L18OH3O*W4C7
MHU\VF+IGF2#O!X\EB*"(SL))P$ZW6V7H]S68B=*#5!UCFJ[CT_9?$/:,V0D-
M<J7N$S#4SQ?A,5VIHRUF,W/<&J@#I,55OKXX'M!%K[_,A-&:9I!N)Y0E+[FL
MQZ_P%5/FB]/1I]8Q=.]36POKO5T9%E93)\H0CW-9CT_@&JV/3S50^L@^@8:=
MK0+9/Q8K)AFV8=AEM<2Q=DGN:S'\!57C;_%%\>KJ]/GPT[V@C%V.J?6I:S"/
MPO;4TO\ NB27W-9CM<T*J_-%XARK7;'Y^B9H[H_,>2:<MYC&G<&IGKM&6?LQ
MC2N3.*MEF%;W3-P'YCR2>YS,GP!5/FR\-+C%O]4S1W1^8\D>YS,GP!5/FR\-
M+C%O]4S1W1^8\D>YS,GP!5/FR\-+C%O]4S1W1^8\D>YS,GP!5/FR\-+C%O\
M5,T=T?F/)'N<S)\ 53YLO#2XQ;_5,T=T?F/)'N<S)\ 53YLO#2XQ;_5,T=T?
MF/)'N<S)\ 53YLO#2XQ;_5,T=T?F/)'N<S)\ 53YLO#2XQ;_ %3-'='YCR1[
MG,R? %4^;+PTN,6_U3-'='YCR4J+EW,29,51H%4LF2TI1+"P+!8N3K?H&G1T
M8SIP9&)WPP%26%]MSS=9,$3TW$>BGYAR_F!VM3G&Z#4UH4I&ZI+"R+[@OIQX
MC@;ZWOB#+BD)8%C0.1=/@0=E4$,0LD3-VZMJ)BQ4WN<S)\ 53YLO&]+C%O\
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ML0]V"UGB_@5QW->RS8;FV'5(<N;!@&NU2/5JPY 6ZV9[T=P.J"FU(+3+;Y2
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MX@B#8\9NAC $B'E)CZ*<,R92M_&6!;H\%W[1CIHX^Z5,\_*-_E1+[I,I?G+
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M6WR-96+EUUUY*@1V5E9G4EF5$V19@A2Y-=71$F3'E%@(;<6TN8V3&"R4 !Q
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M%<_68OPX[W&'FKG?+#N3AM5K@O\ P72A_NN>V?LQJ#L\+,3,48@[*^,O,XM
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M[,L3*G'>L@DNX(ZQ"3D99!(AS; VUA."^O46AA\0'9@^J%C6DN:%P'<G"7)
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ME;HT"%28,%]B])?8Y2K5 RSO[XIY5OLH)27.3*+F]\1B9L]K$VL!,,)WS#6
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MZ2==.O2VQ#*>?,JP,WN;1);,VLYBK,&:QS:4Y):91&@",\XV2 &4/.CE$H
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M[_C"]_J&O[(QVR?^6-<7\I1:2M1NH7T)!(ZR +'S=&.P (#@&0K-$TDGS:=
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MLH>2XA3)6D(<004&V*3?9^_G7DJ=E!3JM_[+8N=9>00A3F65*0KP^47 ;*D
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MX^D]JUI6U39&M59BHS!E4O99JC5(K26V&5BGU:04;D:2H)W2XLN((W"M*=X
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MCNG.]_3/EU^UAH8>GYH@5.<2!SZ9K_UZ_:PT,/3\T3NZ,ZP//IFIM_AE^/\
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MF;RNOQ]'7;#/AO\ %$H4;BYTN.@=!\F(8H2"'J)5K9JG?X(O/^T):1FR: M
M CQC:X%CN&_G.OIQ]+)QB')P,ST-)S-MPD]JYO')WM,@">@=1GJ6D*<4+GE$
MVZ!O"]B=+7QU$<,7V9,7M%D[&H%H&QHM9##RV21ON7MO&_E']SYL5H,-_JM(
M"UGBLCJ%Q?Q\2.'VX9L#5;%^$W0RL)?JW4EWU?CGTI]HX"&&]]H\E 2;#PYN
MDY172NWG3]JAX\##!>VT>:/@3N\R$N^K\H?2GVL,R$T).T<D?Y3PYHWU?CG]
M'VL3-@[W$(YN/#FC?5^.>OBGAU_?89L-_$<D<W'AS3 ZH\%W\X\?J.*T&&_U
M53]]7XY_1^T@_1B9L%_$*/@>'-&^K3PSJ+C5.HZQX7#%S(;SO')'-QX<TF\H
M<%ZZG\&_CM8G7#-@G-[P2.+("]A&MN: XKAO@'B=[='22.C7C?7[-9$886I4
M&LOWE+E421.9>P"DO-9$N'@7&[W!U4!X/$\+&P&IT.EAH,-(+9;1CJN\5@Q1
M6"+=KP.&Y>+=M&6>R&FYESF[LOG36Z!F2!2Z:VDS$M*I2Z?-:D/U"B#4M.36
MN59?W[$HX6O?$BCA,(:(&=X<5LX=.M@-MK,F=IF2FM9O[,"'3)!9R-2I:J94
MX\& Q+Y-+\VBL166N?)<2OPY+[@4M>_N@KOJ H6Y9\(($B;)B3BM:@.UKO@K
MJZ_=7M J/9'0]I#KLRD%>3<T5;+\J?/F)86JB1HL3^%:>S$!W&&5O%:"\A16
MM02HWN<,^$C[P(%HV2O-;'%31%H6<*KV1V1,^5]644R:K1\W3I+>6:C66VY@
M@R$ALMTL1A]R3$4$K4U)40XD>#P).!B%)&E)SK)VI:9#<BVIK.'9?[\YKW$T
MAEMJEE##SX96Y)JJHZBTZAI*]TI3("?N)(&X;FYP.4A K#8]_&E<'1;SD%G;
MGG'+M7H^U.8QE.J!FDN4ZM4N.PT7'%W<JL5QI*K!*2E#;2[#[\VX8ZP1PYM0
M)&>NTMN!>P,9NLQ/*LG<!\+CYOQ;T4PDL1(L=4@N.1H[<=3J]%/!A*6P^X3K
MOO6WST7.&D N.+U\VN>;54!B%02!A:1Z%S-V">%D* *Q;Q$6OP%^&N@^C &&
M(EV9KY./W*T[BA&N1YH2I7'>MPM]Z>-^L@?;C6; ;1L/[]4J49J G:3XEDG*
M*O8+^D#AZL&@O&_U51RB[@%=KFW$8-!AO]43M]7XY_1]K$S8.]Q"CFX\.:0N
M+O\ ?DXK07C?ZJI.47^,<&@PW^J(Y1?XQP:##?ZHCE%_C'!H,-_JB.47^,<&
M@PW^J(Y1?XQP:##?ZHE#B[CPR/'QP:##\WJB=RI_' ZP5)!]!"K>:WDQ3E!1
MJ6@"?&:SG1 D/&UC -ZJ3"=//(A*P1SED&RA^..I(_;C.E@%H?%N94<V9VT!
MJ&YE8YD6.[=0"5"^^@\>I"=+?5IKQQ,X1B&C."]XK64CKPFR0F,D.["PC X8
M>"HN47^,<::##?ZK:4.$GPW"D<;W .FMA?KX8S%FPAPUU:/;7K&BS$2!*KW.
MN4;;*1FVO[/ZA3\@39E.S6F= ET>3!>2R^TN'(;DF.\I5T\TF!!8E(.H;6;#
MA?G#E )6TF]]C-,&TSI1<F-Q>MNSK6O);-)[+ING9UDSX<B5F2KU)55I:F)C
M285-=BAM42F4Q)L4TY\I4)"5"Y)5KUZ$;$, [7/3T:M01549PH#-J!^>O;<R
M].;#5;2UPLY5#:DP_3ZE5:W3WZ9"?6A3,."U3TM3!##:@.0,M!*;J"R256M<
MGKI0+!2;6$@ !S.==9FZW!G/,';?J,FV;EW$K"?!2L;H%M5I\+IOIO6!\1&F
M&E%S!WH-<_"M%3$099PU $>%<;P]4WE2>"C_ '\Y^SAA%%!E)LS6YS.^HC:J
M'M+[ %)B+29D'>4/\<BD^$ ?\,FYT/$$D^73&3# QI0LY>;8G9/:L'/H'F3=
M233L5OF92>[M6LH \[MQX&R;C4Z'CX_HP$,#"E \VGOZH@SIUVVE\<)726O<
MHO\ &.*T&&_U71*'%7\)1M8WX<+'KP:"PC?ZJ%V+5LZ*1Y0,:4DA3@<AR6T,
M)6$N$N-*0V OH<*C=!N+$ D6&+I0*  A@[ AWJ"6)?"E%EX\:7.U2SR<ZI.=
M_B*ET?LHLF5))I;B,S463'J3T.567P]5Z6)DDN,4N6S9++S<9)"6G@HJ#0 5
MKIBG+#"PAFL(E7'409&86?MBCVB_ U??N*]KTYV8NDTURI%I-673HBJHAE0Y
M)-1+"#+2RC7<0'BL)2=0!UZXAS8IEG(E-K?WU'4N@=@]6FLW*+_&.(T&&_U5
M61MRY.^NPMH2K=%_2,'@@FX%DY^+W(K*E+;-8I("DD]T8GX5].53>W'Q ^4:
M\<8RD8+$3!J;&FY:0D 7.^B7==4HOHY9'B]/[<?%5<WG>583LMTVHRER9L5#
M[B@E*5E2DE*4C34)L==;G7H%\>=11/<;1#<J@MIU&@6= .D>#TCC<^4X(F^X
MVA[Z@(#0:M=!"SO WU&J"E(N?QR3J;:6P1"LF46X A-*)5=5W"BZ>D&S9WA<
M7'7;4ZC!$U63**!=,-!(N"%.*2#<7U.X2JVGX(\0P14,_9-DJHOJFRZ)&?DK
M0E*EJ<4!X*K#P@A2C9.@\$#IXX[0]HRL,A$BB(V*[/K@+H#*K[V^5**KGB"#
MNIMND )UX<,4]IRQK%UUU(*[!QGQ\&3.\OD"V\JA-+4E7@)<=6 +<-=S>L ;
M  *'6<33Y7O*#?K]&69&Q;9\%%2J$P3<$$.*)2H::#=L .C@3TC#XC*]XXXZ
MTZZZ=8).QO9S$C29+U';#,=#LIPJ6;-MMH4MPD@?>I2%*MT6'&V&GRO>V=3X
MHO+L+:WV+52IN3:I3Z97W8>>JI(H>65C*F81(JLN(S*>>Y!@PN5#;?-'6E/.
M)0@.J90#O.HNT^5[S=8NFSK?U8NQYLH6PW(V5)&<LS1VX%(BFFLJ6M3CLUN3
M5I#$2GPU0VN4?:E2)<AJ/R+J&U-.JL\&PE1$T^5'XB>K+^)DE>G;UM5E&RML
M0EQ8\AMRB(5(=<CM(>J<=MY$QI#:I,.0A;@#,A@N(1(0L@(4;*4/!)OQ&5[U
M>KTV===555E^G;",QJS<*:U##>2JZ,LUN=/>5#@-U9R#&GKC193H0W+3R$MG
M<<C[X*U%"-XI.'Q&5[W7125H>M?WY[5HU$SEV+^9,WU')]#?I\N90X;<R?.W
M7VJ(AF1)YBRMNJNMMPGTKG!R(0AW>$A"D;I()Q!E\KWB=V^3(NAS*/L#B5%B
MER)N7&ZF\FH)CPNZ(,F2NG-M.5!#33:5\HF(A]E;Y;*N32\"2 "<-/E7^^=4
MN6"+G6?,X=C'LNJ^8*%GL]QJIEK(L;:%4F$P:C*81EJ94W*/&%.E,1U,SZ@]
M/;+0I<93LTA3;G)AM:%&_$93O.Z;/&6KP]4M2SAV,U.IF:)\M$H>XVFY:JU:
MIS-+J+M:BQ\V-,O4-ABF-L*ERYLM+Z&UP8[:Y3+MVG6TJ!&'Q&5[WBE_6ZR?
M3%PMYR/3=A.T6G2ZMEAAEUJ#5)="J,><AVESZ?4Z:H"3$EP9J69+#K=T*.\B
MRDJ'B&'Q&5%8L2_[^LRCO3SLD:J0W0=@TJ<8$2H93>FA3*4M(K31?+S[G)-(
M4A"R$I=7=MA.I<(N@*&*.TY4?B#6N*J[!QYK555;L;V:W6<N.3::BM4=%-<$
M9+KZVYR:NAY444AUI!34B%LK:>$<J4P^4LN;CB@G$/:,J1,@C5UNOQ4>NRSP
M)W2.M6BW>Q^YY0X:)5,G2:\IYE',9I?;IR8D=Q]R155H/\&Q$;BV%2)1:090
MY 7<!2)I\HS9S:AT$XB=H+:V/E6MJVR7DK8Q&APIDM^C1HM194] <<J:6XTA
MAD%3S[3A59Q"1X2W$W0F^I-CAI\IWM<JZ^K$6 9/V%N,H?5(R^ZPBGJJS3RZ
MBTJ.U3&W.274$+*MQML.>!RI4@DWTMAI\I:07G,=4=D5?-A; X].K50;GT"2
MWEFGFIU1N+56Y3D5AUAQ^.MQ#"W%J=DM-KYJE%UO*&XA).N&GR@H0)73;#:J
M_#7;+F6QF&DJC*[O8ZYSATVHTV32DM52GPYT:+4GG*?(>BU!GEH<A$:6$..A
MQ6^WO6N'V7639ULHQH=IRH9H@+L?V&[>H[W2XMMK*@5O6Z/L%R_E2?GBI/4K
MW,T\.)75FY2)$=Q;3PC*982UOJ=D(D%#'(H&_P JK=*1Q-^)RTOM4I)./6"D
MTW*^PZ<F#R1I*)-14E+<.;.:8FI=<9$@QG8ZE!:)#;*MY:+'DP+K*01?/Q&5
M,\Z=:,BE0\G;%I3$J5%31Z@U&I\VJE5/FF4#3:>XXS)E?<DJ!#+K;C+FX3]T
M24??;UGQ&5[W[<A14;-KRW>JXKD[:EV*^T"DBL98C5>?$<K&5*$TTYERM1)+
MLO.B>5HC[,>5$;6_#<CI5(E2F=YN$RA:Y!01833Y7O=7;**/QZEU1=KK.1MC
M5 C&975Y>I,$/F.),NI-H:60FZFU+*@EMY*;J4/""$^$LA.HNGRO>)ZP9-QG
MUX;%!J=%['^D(=74JIEN&VU(CQBMRK1M)4IDR(\4 +4HNO,6>:0D$J:NH#=P
MT^5)^^>FOZ\C[+J\\'6"33=@<3+L_--072XE+I=+DUF>J2^6I<>G0PKEI"X)
M(E6"4[R0EE1W5MJ.CJ"J#M&4D,YZ\)'R3I^NI*$Y&V$-JR8A=*>"\]Q)-2HB
M##EA2*5$BJF2:K4+I',8#;6X3(?W$W>:3]\XD&_$90?B2['KHK6]IF9>QHV2
MR,M1LY,/QG,V19$^B]SJ55*N'Z?%E4Z$].<[G,/EF*F15H" ZM(!#V_8I2HI
M:?*]Y%M.2:=L1SX_FJ-2J!/@2,H9D>RM5FJ_3IE$4JI,L,R2N!S\,]T(;C+[
M:VI<7E&E[P%P;X?$93O=;T5J[E_8"S(J,1R;EM,FDNQF*BP:M'2[">F.J8AL
MR$EWP'93Z5,L(^^=<2I*02,/B,IWO%%#9I?8_2:F_2(SU'E38?/!4A%E<O'I
M3D%*5R&*G);*F8;XWMQMIU06ZM*T(25(4 ^(RG>ZWHL2Z9L*5F:+E&!"CUBN
M2J [F=,:DJ5/2W1&W"RU-==84II")<@%B(DN;SSAW4@D$"Z?*=X<<.? HH61
M(VPK:)19M<HE&G16:=)KT69!JU/F4JJ,KRU*<@U9PT^6TF0N.S+9=99D)269
M) 6PI:% X'+Y7O/+'=5%JU"S?V,E8A9,KD)+K,+/-68H^3I<VG3XC5:GO(4X
M$15/-)24MEM33SCFXEIZS+A2Z0C$&7RH_$^L#DBL\K9F['#:#FJH9<I<>0W6
MV'Z\P%5>FSZ5"J7N8J#5*K#M)GSV68M2C1IKJ&DR(KRVWA=;*E)%\7XC+4SR
MU&UFDJN[31_WZE^VM;Q7,K;#\NH;-69IL9UQ4-(BB4EZ3:H241(CG(M+6KDG
MGG$I#MMW6X*@#::?*]Y.M:P(H?8]O1E2V:CEAV,F4Y"4\W5XZD"6RHH<CA1<
MW5.H< 0I*2=Q=DJ*3I@>T94AL\M=78Q<(L65J)L/S?3(E6HT6/\ OV+*GMPY
MKG,JHB!#E.Q)$^3$D%#K$=+C"UI<<0@*:*%I)"DW#+Y4!L[@/$"6QK4V4ZFI
MPRSL(/.%)FT)8B-*=?4FJH46&4D!;CEED-M#>!"C8*N"DDD##3Y7O)58)] V
M T]2T5"HY<C+:$,%$FL1FUMFIV5!;6E;H*%3+@LH6 7#P&HP^(RG>5V">/KX
M[%JE0G=CC3,VOY+GKB1JU%H],KDD*)5"8I]5FO4^.ZY. ,=!;DL[DD%S][I<
M:+@2'$W?$95C]H@8<G\E%N<7*>PN:]#BP7J%/E5$23 C1:BP^],$(J3-YLVA
MS>=5%4#SA(U: )4$C 9?*-6G73!%21XW8_O9KJF5V>YW=7+(B/5)]4E#<&#-
M>)<9ISDQ:PR)X: D+C7*D,$.KL@@X?$94AL\MA9XB]-FV?-N"VIO)VQ>M3V"
MTNB3:A6E2GH;3%48=>G&+I*,9I"R7T,$6<=;!;3^,!B:?*]\\$5ZWL<V<. D
M4)@6)!!<-PH&Q!%]"//BZ?*]Y%D[S&SCX$CCQAP^O#3Y7O(F]Y;9QQ[C-7'4
M];T])]/5TB^&GRO>1.&QG9V-11VKFU[NG4CR$'TDGK)Q!E\H/Q<*821 V,;.
M!_(D?4W/W0Z^@C6^MS?%^(RM,Z5T^:7R$^NG1WF-G'P''^4/KPT^5[R)#L8V
M<&P[B,:FW@N*O]!.GC.F+\1E36(G?S196MC&S]AUMYJBI0XTM+C:DN$;JTD$
M'A<Z@=.G1T8FGRG>=%T'N1!_)'XW[,<G-YWE%9XB(P1&"(P1&"(P1&"(P1&"
M+7,WT!&:LK9@RTY.ETUNO4F=2'*A 6&YL-N>PN,N1%<.B'FD.%3:KBR@#<8(
MO,M0[&W)%(J>0\Q4^LM99IFR_+$FDQ8SL2,]1&D2)$:;5<QE3S[+5/K1YGX=
M3)*HP<>58WP1:]6^Q)R7F.;4)-(JU:<RKG^5(J^>'9V9YE7[K-N15.49Z@M+
M6[$I[;<IY%59G,$%+L=DMC<5?!&%-?/B:K)-["_9S-CUQ$FO9K*LPT^-&K#Z
M:HMMIQR% 9A,RXP#FY#:DIC,2JNTRI*JG);#KKB+J&"=;_52:;V.64IVSG*]
M%H&;?=;W SJQGMNL2Y;;U.S96J*P]2&X-?53G;2XD1*41P IQ39AM-N!2T7)
M%IV7.PKHKK+;F=JHPY-;E2VVZ=1 IBC/4%^I3JPU"DM LN+ET^I5%U^FSEK*
MHRVT$-K(N(TWM9NMJ 2]7\9KM5%['VG4:?E&KP\P&1*RI$[F134:9#F"33)!
M4U4P^IPEQRI5.(EAF;4%**WRPE:DC2TS16IO)-B.>NL2M7VN]B3D3;/7)U>S
M-5*NFI2T"+$5&6WS"-30S&0JF.Q[D2D-28K<^,EQ2.:R]Y;:5;RP-(J/,'8I
MY&>KM(S*G-\O+]<;DY.$UYM,;=S-6<J5U5:IDNH1'WR9#TR0>:/1P%)7%0AE
MJP1B:K.FP3PH_*>-^Y7B.Q/V..UBE33)S(<RT.NU?-DA<3-$R"Y5*WF.:N74
M*A6H4=;;4YMQYP(CM/A3;<=*&&SR8MBJ-MZENL6DN]@GLU;9?53<R9JI=2DP
M*+#=JT:<3//N>J@J=.F-NN+^Y36D$P!(('*,+LH;Q&"$?O)QO65_L+\M0\NU
M&)E',]4;KC<&4:!4:H6Y!B3U9BBYFA<XD <L[%:J,01R&UWYK(?0DV4<%2+^
MNJ[BL*.PBR.Y3(RZC7:Y%S!(H$"DU^9 ?6F!4N:5^+F7D"P%)7W/:GHEQ6VU
M*2\N')<#RU"P!%U'.78WY>SMF&BUN16JI3Z?168,1C+33:%4-QF#"DP5Q6XG
M*)"*?4VYBW*C'2J\EQF.LK261<S;9HM<B=B#E2GT5.74YDKTZEIS$SF)N/6'
MN>EUM"5-/Y8E+"FE/914RL&/12H-L/-MO<HM0(,'6)O4(>7775%KLOL'\A+J
M*JA2,U9HH;<B# IU1BQ)*5QJFS3ZNY5&),M*U$*EQFU"EQ'U%0CTW?9W5;Y(
MI#U1K-V%V[]W42K=A9E!%.ENY?S#56*ZQ3Y5-HRY[CG<:$>[,NMTM\QV2%(-
M$ESI)A+0L)-TLJ!0D8R(0)M/;YDJJ]J_8FTW->SS)^1,P9MGQ&\NTK,]-K4C
M+;',(>8G<V&.N;4)<(EQ*:BV^PF:Q+%UL2W5OHW21NZZZZFH1;:';;U@EJ78
M99"JE,:@',N;HU0CP6(#&8HE16Q7(RH<9J&'F9R5'DG*@RRE-;46U+J;F^LK
M9WK8(WB_6NW65UJ!L;B4W)69,CTVIMT>F5FA*H,&12*:U FTH2V_X3E,R$K=
M<4:C(4])<05[K;CJB-23@JH<'8%DNA(V71:%&11:5LP5-=@4N PW'CU9^90W
MZ"EZIN>$ZHPVI3TF,"I:F7E!3>[8#!%QJH=AGE1$RFTN@U*ML9.FUS,U<SW%
MKU<GUZI5MVOT:11U0*2Y,<**<REJ4Z\V^SJPXE"FT;Z-[!1K@+SS\MM;]GHO
M8?[-J5EB-EEU^J3V8=&K5(IM1J"R_5BNIP7*3$J]1DO%1GUZCTMYV%#G.!M?
M)$$)N 055#5NPDR14FJ.'<WYN0[1ESV&Y2YI>5)I=9HS='K5,J33BBU,:J"6
MF'U.O(/(+80&4I()P1=NJ&R2._6\M9@IU7?ID_*>3)61*(R]&8E0FZ=/?IJJ
MA*EL+.Z^Z]'IC3#:%$)0'5CP@K!/).KFQC+68\_T;:+65(GU;*N6)^6,L1I4
M-ARG40U$MJFU"+'6KDENO+9C*+3B%-IYLT$$%"2"C#@VQ:#4.QARWF>B4>+G
M_,^:<RU.A9EJ.:(U8IU1D96?E3I3T=U**DS3'"*C'9,5EIGE]$LE24IW21@J
MN>Y=[#7+_.Z;F7.59D53-\6I5AZ0A@K70Y]+=KTVMT%F7"<6VF56LOIDL\QJ
M[JU.-%M0#13I@C<^#>"W>3V)^0TS8-1@52MT\14QGY#,62.3K5236*A6IE4J
M0!!G2JB]49+"@\5);:(2$V0+0AZWO<EK]=&W4$[9AV+= V1IK3>3<V9C:F5#
M+%1RM1)E36BI2<O4N=6WZ\T$O/J2[+,&9)<9C(<< 0QNI&B;X  !A1+CNW-X
M%=)RMLVK&6:#)H:LV&>#250&ZPW2XD6J,U!][EI=1=4E:BZMUPEPQU[R5K*]
MY:MZ^! ->A+S"+CP[#_)7<E5+>K-2=?8STUGZAU!#+;2,KU%^L-URJPJ#'2X
M6X5-K$]M(=CLC<9:4MEO=0<3- +BNLGSFIAB#NZU824F'V&>S:;ER%0<S53,
MM<[FY8FY0IM09J;]%F0://KR\Q2W6'H:^53594[<$JHA:7'F6TM$;HQKUZZV
M,C65&-=OGN6:N=B1DNH,0HD;,F;($*EY9IF6(#/=!<F28E&JK%6@SI<Y]2I$
M^HL3&D"/*<*'&62II0<!&,Q0B*TC5B9[3>KUU<M$F]A116:S"8RY6&H.2%OY
MD<KE'J#;TU]UK,K#2IC$$A:4L2(]8CQZM"G;Y=COAY"1N+*<:$@!<BZSE?L9
M,M98I6?:="KE85-ST^VKNT^M!JU'BB-!C.4J'*#F\*/),#?>@I0VD\YF)!!D
M*(*-UL9:G2NPYRI2).7Y@S9F!Z?EX2-UQQ2##KW.)0E")F2&5E-7I].3]PI<
M59;$5G=!6O=&"JCU?L,=G.8Z;58=6K%;<?J=3EU-NK[X15V9KDMJ7 >>DE:^
M</4%Q+K5$\!*(L5U+80OD@<%"'ZNF./4U :[";(K[DXU;-N:JF[/C5B"N6^\
M$2Q3JJY"=$1+^B@J/,@(F-J)4%2'GW0E*5D JQ\>? *WR9V+2,F[1W\RQ*U&
M?RVU1<Q4>! 6RXJL4J5F=A0GU>%+#G)1)S[[JP^I"?"CA  !U)%"HW83Y+ID
MFL/R\U9JK2ZW&I46JM2Y24L2X](@)I[:G$(7OJG5&.@-U6:7"],C@-DHU5@B
MV[(?8N96V;YB;S)0*Y4WY<9X.4Q-5!GM9<@O.WG4;+)6[_!5&FQQS5<4!Y0(
M#A<4H X==<4OOZZMJO5+(0L'=*@03O"Z3NF_ G=(WNDC0C2XP19N3'XROT?9
MP1')C\97Z/LX(CDQ^,K]'V<$1R8_&5^C[."(Y,?C*_1]G!$<F-/"5H;C@/J3
M@BR8(C!$8(C!$8(C!$8(C!$8(C!$8(M8SA"KU2RS68&6:BU2:[+AO1Z;47TK
M4W#D.#=2^0@;X4V+E"T7*%;JK**=TD7G2E[*MJ,W91GO9IF>OTB14LT6;5F!
M,F=*:5"KC;#.8:>Q&=:2]!;9BMO-4]P*<!?D*?4VE(W24GJQ\>L5,H>R?:5E
M;9"=F67<ZM,U>D/4-JA9EE.RG5&CP9T9<^BNL\GRL6.*-&53&'$..J4N0Z_9
M .X'755599]R%M.S+D*7DO*&8(>65KJ,^([4Y<V9+GU'+,JES$(2F8TT':?.
M:JK[:D!*'$B'&0BX6X=PHW1FXQ4-O8SF:%L87LYH%9AY5K;K-'C/5JCR)@8C
MN,<T=JT^"@M-.L2*H\W(,I@$(=Y=UPO!;FCK>J);*+A]5[&OLC\QJD)J.W)N
MD,/4R%RKU&344J?K%'S J73"EA2T\WI<FBJ1 J<=+JG'U-M*W_ 4"4ZY3\9>
MN^Y-V0;6<A1\\U[.>T:H9Z=C0\S(R!2X$QV B'%KT=QIN'5DSUHC2Y4"8\ER
M!4%/,\V; 0$$(!656DY;['CLBH#E,EN[9A(@.PLEU!VBSG9[O<>LTJ))A9F3
M$EM%8F,Y@8?CS7E.;J6ZA&5N)4A:5X(I+?8M;6:1)3-H>U?G,Q#"8[U4KBZE
M+FU#=HB&5.!"UOL4^2BO!Z?&EL!;K#2PD FXP3KQ6+,^P[;#7-JM3IE+S]+R
MUE>72J5FFEUN'.7*DTRH0*.C+4^AKC+>8FR6W)CGN@@O*:YHU)02ZM3I2W@I
M5M^W=QDH([&WLD)2VZG5-MK3TUEC*KXI["ZFW J=9I,Q+=8>JI"TDQ*Q2RMQ
MUA@!/=#<7_@TD%T.'6Q7J]>OMD>3:ID3(M$RE5I3<V30D2(;4]N5+FKGL*?6
M\W+DNS=U\/NEU8+2EN!I"4H"R+6(NC<@@JZ2"HDI*4E)4HV62"KBH"P T \^
M"+,6=$I2I20/"2#9001I9/A"W$\--=<$2K9"MT[QL  0!J3T&]Q;7Q&YUOTX
M(F<V"3O)4M-A8[MMVPO<%))N+W5;A>UL$6!V$'"A>^I*D[JDFP-]PE02I._N
MJ2=;C2_7T$BSH:W4D7WDZ;PW0+D\2?#%[F_60-!II@B:ED)NM%TG0*L!90!T
M)3O6W@#H;GIOK@B54<*4@E2]-X$:;JTG56^ H7/4=>%K6P1.+:5'=U%A862G
M2Q)T)43P-C>X(P1-3'0E9(ONE2SN$"UU&ZC<+Z>GAIH !@B=R"2HZD[R#Q2"
MG72]BJX4!H"+=9O@B:8R2@#>6"FXN2"22; VN0;=1T/BP18S'/**.]O)6L;Z
M2D:[@\'=)4=PA5B56-R.&E\$64,=&\%'4;RD))L2;@^%J="01K>VO#!$U,1L
MDJ\(;VNAZ0"!<$D=-R!H?&=<$2",E*4A2E.$#>WEI!5O V2K[X"]C;@;C16F
MA(E,8;@WEJ).H4$I"D*N5)*;*\$#@$@D>37!$XL!94E1!-K$[@X;H3H0;@VM
MY#>W'!$WD B_A*-]2K=05$C06)4+6 %B03J>&")XC)*T+4I2MT'=!  W2+%)
M T(L1:_ ZBV")R4)2H@C2^@(!.O WWK>D'QX(DYN!8A1OQO87N#Q!N+;VEP.
MK6W01(4;P(1X%AH0D:#>"B1]T-R>LC4X(@QP/O202 "I/WUPHFYN3P!/7]."
M)5,!2O"-RG[Q0 WD Z6)/WW#C:X\>"+$F*D*OODW45DD7U&B0DWND) 4!ITG
MQ8(E+ O92E*W5;X-@3O$^"JY-_ !LD< ";8(E$5%SQ"000$@))6#JM9!LLWU
MLH6T\0P1.+-DZJ<-A:Y*23H!<ZBYT'U\<$2<@%CS$$;J0-18Z!=M1;KUUO<G
G!%E9:Y($7N.@D 'SD$W)Z3TV%S@BS8(C!$8(C!$8(C!$8(C!%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g729258g50q98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g50q98.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[13H4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %,R^4R0X0DE-! 0      $8< 5H  QLE1QP"   "  ,< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0ZEZPJ5\QR](\0ZR,"!]+/3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!83=,         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              )0   )E
M  $                          0             "90   )0
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   )0     4F=H
M=&QO;F<   )E    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   "4     %)G:'1L;VYG   "90    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ )P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         /_A0 )H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y04V-R
M:7!T-2YD;&P@5F5R<VEO;B U+C(N,CPO>&UP.D-R96%T;W)4;V]L/@H@(" @
M(" @(" \>&UP.DUO9&EF>41A=&4^,C R,"TP,RTQ,U0R,SHT-#HQ-2LP-3HS
M,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR
M,#(P+3 S+3$S5#$V.C,R.C4R*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @
M(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,"TP,RTQ,U0R,SHT-#HQ-2LP
M-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS
M+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^06-R;V)A="!$:7-T:6QL97(@
M,3 N,2XQ-B H5VEN9&]W<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z
M1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O
M96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @
M(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<]
M(G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@+2!0;&EA;G1?0VQE86Y?=F5R
M<VEO;CPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @
M(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3YR<C,U.3 Y,SPO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z
M8W)E871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF
M;W)M870^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-
M33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @
M(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E
M9B,B/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.D,P-3E&
M0C8P-34V-45!,3$X,D1#0C T-31!0CE#-39#/"]X;7!-33I);G-T86YC94E$
M/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.D)%-3E&0C8P
M-34V-45!,3$X,D1#0C T-31!0CE#-39#/"]X;7!-33I$;V-U;65N=$E$/@H@
M(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z0D4U
M.49"-C U-38U14$Q,3@R1$-",#0U-$%".4,U-D,\+WAM<$U-.D]R:6=I;F%L
M1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @
M(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D)%-3E&0C8P-34V-45!,3$X,D1#
M0C T-31!0CE#-39#/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$S5#(S.C0T.C T*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$
M/GAM<"YI:60Z0D8U.49"-C U-38U14$Q,3@R1$-",#0U-$%".4,U-D,\+W-T
M179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N
M/C(P,C M,#,M,3-4,C,Z-#0Z,34K,#4Z,S \+W-T179T.G=H96X^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O
M<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC
M871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V
M=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC
M;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P
M('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D,P-3E&0C8P-34V-45!,3$X,D1#
M0C T-31!0CE#-39#/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$S5#(S.C0T.C$U*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y
M/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N
M:6ED.D)&-3E&0C8P-34V-45!,3$X,D1#0C T-31!0CE#-39#/"]S=%)E9CII
M;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N
M9&ED.D)%-3E&0C8P-34V-45!,3$X,D1#0C T-31!0CE#-39#/"]S=%)E9CID
M;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N
M=$E$/GAM<"YD:60Z0D4U.49"-C U-38U14$Q,3@R1$-",#0U-$%".4,U-D,\
M+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$
M97)I=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP
M+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H;W1O<VAO
M<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D
M9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ D@)= P$1  (1
M 0,1 ?_$ !\  0  !@,! 0             ! P8'" D"! 4*"__$ %T0  $$
M 0," P0%!@@'"P@+  $" P0%!@ '$1(A"!,Q"11!414B87&1%A<C,H&Q"D)2
M5Z'!T? D)3-#IM7A&#4V8G)UDK6VTO$F*#=35'>"@RDT.$559':3E+*T_\0
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MA+]IBS"KD6V-[\SI#<%;3ZHV195' DE94A12JW)XXY('Q!/?Y3BY3BG, /Q
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M'>U.38 7.$TD2/O,4.GDN;P_X;\3Q*M>.4U! !(U OYS!I85FF87\)WV97*
ME>'7<AF.5GJ<9N\>>6E/4>.6_>  0/4>G/S!Y%IWM;E8%&P;01,=:C0CQF%E
M'^%^>8)&,"\BH-*ZZ2*A9K; ^WC\#&]T^!39#E%QM+D%G+:BQJ_/((C5RGWB
M&VD.7D4NUZ2MP\(2M: KU*@.>-EE>/Y3,1#N4TUU[]_6BY_/^P_%\K+1ESCQ
M(/("8(FM:2?VBZW(X_EF,957QK3%\@I[^ODMH>CRZBSBSXKS3Z$J0XV[&==;
M4.""!U=O3@=QK=A[7 .:X08(KZ_1<EBY;%P'N9BX+F.:2UP+;$4()$@0:=;*
MK$);6..""D=R/CZ=^W/KJI6EV/31$T1-$31$T1-$31$T1-$31$T1-$31$T1-
M$31$T1-$31$T1-$31%(2A"DA9YYX//)Y].Q]?N[:@"!"$Q4J"F6QRK]4\<<G
MCD_(<^O )/;[3I V'DHEUM-I^@!'Q76'/R ^'8_#Y>G]&J.9_P#M^!^ZE3"$
M<'N3V_O\-3+]AZ\45EY4K-QO9"BM,SAMZ=MYDF7(;;2*]&7#(8[45DO$%:9Q
MJRZ4H'+99ZN?K=.H!Q"?RMBNM?F([S$*7<K<,/F 217X:?2:]%/P*OS&%DVZ
MDG*),I51/RN+)PU#LA"FVZ/Z,:9<#"0.IM'OGF*Z5?6ZAU<%/;4SB5EH@6@Z
M"I^MOI41#6NFCB1VL /&>^BHBHA;KTVQ6YB)1L)6Y2(.ZLW#4)<:ESEREHN'
M\*8BA(#:W5+->W':5V4L!*NQU+2'02*34$7MO&WP4%LT)(!H:VFF]-]/C6]V
M(_2CV.T"[PNBW%17FT#R?+>3/#"/>PXCMY;H<!2ZG@I!ZDI/''-3O[HZ]9^D
M'0*7-8#0S4P=33>:S\(Z*JB&E ]20> 2D\ \*(*?0CMR"1\^DD>A(U#>8"I\
MHI;0?MU5)()Y2:VBNWV4I: M"TA/*E)7QQP"5*3TD\_ E/8JY]/4\: N#A00
M(-Z^O#Q4%HY2+2(WN(U/: M>^^/LQO!MXB]VX&]6ZFUS-UGS'N2Y=C&GR(43
M(%UL=+$-5["93T6):80E/4%(Y0VE"RI*>-86+D<+%Q!B.T,@7^!!'??Q(6WP
M.,Y_+Y1V49F,08;F.80'$&"(,08%#0Q2L+-[$,.QK \?KL7P^FA8[CE2VXU5
MTE7'1$@P4/RWIKR8[;8"$^=*D//.)"4@N.*5ZDZRV,9A-Y6@ ":TU,]-?4U6
MK/,]Y>_$+J".8EQ.E34D ;U%E7FJU":(FB)HB:(FB)HB:(FB)HB:(FB)HB:(
MFB)HB:(FB)HB:(FB)HB:(FB)HB:(O/Y!*N/@M0X]!SU'GY>I^.HD5/\ MG;Z
M[_%4M%' 3<VN/VB?BOB\_A,._0R#>S9GP]UE@I4#!,/F9YE,5I\EA=SE4]5=
M4Q9;05T)D0*NG?FME8*O+N6N" K@\+[5YP?AG!#C4&!-BXZ7I$>-MS[1_#+A
M7XC,7-<K206PX@$D- J*2#)((G0:6^7PE1)ZB2KD]7/8\D]^1\._J-<"T0!V
M'R7M+1RB!0@038GOUFIZJ')^9_'54G<^:DUO7O50U")HB:(FB+L:B!L/(+'%
M+4[4^2BA#CBTL@%2BZ&6>/B?N]#P.#WXYY]>-5<QW/F5>>_>ICQ@ BXK-(U-
M.RKS)7V*1M%#6=#?7$9^EY+8"WI+J7 PIGN"I#;CC:W%I!Z2".?3O=?04O85
M\[4/3;0RL'"YG$EY+JTF3YS/ZD=*V^3^LH#GCOP/V]OV\:LD3>OQ68X!K1
M(U%-#*XDGD]SZD>OPY]-1 V'DJP 0) - ?&+]UR!6!V X( ^\>O?O\^_WZNM
MQN3\IY8I[KN7Y?)1R@W#3W;)\:WZJ\VW?B"WRVHFU]EMSNOG>'OU3J7Z\TF3
MVT:/'<1]9(;@IE*A $^J7(ZD*X^(]<_#XIF\"#S8D ")>ZH,0-Z1.NPU6CSO
M LAG)_'R>&T$DEPPVBLU-!)GQJ=ZKZ#_  (_PAK<C;YZJP+Q=U\S<C%O>/)=
MW/KN!F56U)<"FW;2$ B-;QXJ7"5EE+<PI2.E0 X/2Y'VIY0W"Q!)U)),1))D
M[QK;O*\W]H_X=L=_6X2.6A):Z()H+"@O8 0=B%]A.W&Y>';L870;AX%>Q,AQ
M+**UFTJ;.ODM/,OQ)+8+:EEIQ?E.M)(:D,*4'XC[:X[B/,.NYRV8PL?#:_"=
M,U@Q0FI!G8S>?@O',QE,? Q7X..TM>UQ:8$ <I(!!I>)%JWZ7&ZB ..>R>W!
M/P';U//)_P#'C5U@B\WGK%.]58=0>[4Q\?(4^*]#52)HB:(FB)HB:(FB)HB:
M(FB)HB:(FB)HB:(FB)HB:(FB)HB<#TX[?+1$X!]1SHBAP/D/P&B(0.#V'I\@
M=$5F94[,4;UUU4AE\8$[MS.L9KX83Y",K1D++$1!E ]:)!K"X0PD'J1RKL.-
M$TC0::=O';52\ CYNWE>ZCF5KFN4DC+(KN$B6XVMENA%8REY$0-\*;:]]#G+
M;I+A_6!Z?5?Y5"=[:=/15#5"]W:G8S<F5:"PE[EQ8>ZT[$6Y1:DS'9#+5U)P
MIEE#?2TXVKI@(B1U<*)4VAP_K'4#M'11^OK7UIHK[XFY92,=H'[U"V[AZJKE
MV33J$I4BP<CM*EI4A/U6UAXNA3:2I*>..>-2I56<#Y#\!HH@3,"=]4X'R'X#
M12G2GY#X? ? <#\!V'R&B*'0C^2G_HC^S1%RT1-$31$T1-$31$T1-$31$T1-
M$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$724GI3Q\2XZ3^U0/X:MX7Y3K
M[SK]T7YR?MLI%C)]IGXFDV,A4E4:UP9J+[P21'KE;:88Y%8;!/"4)"NH) X*
MU*7^LHG7E'M'B<^=<V7#EQ7M-2 (<X4&E#3H%],_PYP\/"X UXB7!KB1 -6
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M);(D09];+;<7%GUDY!;76V$10C264/)2F.ZS(9:N.Y' LPR/>!;-Z$1O2)K
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MF2X$:RBQ+!EM95!E.093$U,=T)68\IEP A0.@COV/Z%00=#$=CZU51J]4?\
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M&I^$-.-*;CR1E<94RFG3EA*I$2$B-S(D(:4AQ#GDQ6U-.O(=%_'Q\++8'X@
M<(, @'FEIH8I6U8'4&%8X=P]^?S^%D'8APB7LPW.KRMG$#9O3E)N= 9B%CAX
M$?:*7'BEW(N=M,OP*OQN\C44K(JNQQMR:Y6>Z5<J%%G0["/.D3'6U=<QHQIR
M9"&@LF$IMQU:7$XN4XGA9O$&'^&6N!$4/;X1,VBUZ;7VA]F3P3#P\08WXX>0
M"X1!ZT)I),=-JSMNUMUR2XK6EM"UK4E"$)4M2UJ"4H2D$J4I2B$I2D E2E$
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MY)=E^>XR\A.N:QL#-,S;>4..&'@N@_VZS?I,Z>(7IG!\Q[,X'"L;#QGM.<.
M\8()$_B$4H8-3-=1\=Y%Y#RNNVNV6KMP)[-ANDQ/Q=FZF1"DO27XL)?Y3O\
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M78]_AHH(!!!L00>RHR]8KD^[6DVR50RZUY:X%W'L1438#[H*%MQ[!IULE$H
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MHR_QP^+/($N=;4C?K<V,POJ)#D.GRJ?3Q%=N>0MFO1R/3C@:\>XOB$Y]W_\
M(Z)W+R-*S3NOJ?V586\$X9I&6RT1$#^AAF! $7)WK6)KAYP1V5ZCL?O'K_3K
M =<]S\UT+OS._P"1^:D'NH\?,ZA7A6U>RYJ_43^S]QT5MOYW>/S"[L*4["EQ
M9["DH>ARF9C)<2%$2(SB'6E%!Y"FO,0E)2000>#R">+K*#O6P/WGZ;*7,_$H
M(.EIG>^W:.MXKC<]#0S2YE-S:BR:M%Q[1$FC9]UK%"P89DK]VCD<QBVLJ26S
MV04J'\<<48Q/XH&PT%":SKI\Y[*WES#"(%"1/_W'KY7UJN.2PUO83M]<,U"8
MD?W;(,=F6OOP?<NK:KR";;I6_'*E*AF%475)6A/"4%EA*^.5<FO%KAV[UF2
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MAL.+'6H\@=OCQW[ZH<YC:.(&M?+UO97&,+@3!H":;P3?:B[R%MK0AQ!2ZA2
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MX^_B;K'_ )[*_P#5'D57_AV<_P"B[R=]D_W4_AT/;\]&W'/I_P ,*7U]./\
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M!C>4F!(Y6F3)K2IIWNL7*E%A9OM1H$67-E'ZB&(D=V0^[SS^JVTE2N.X[]/
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MA^&B)TI//(!YXY[#OQZ<_=P./EQHBCHBZO00DE:^ 00.YY].Q']FK4%\F=8
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M%L/P)+#L9\I^JF6VI*24\:RFEN/A@P(<*]9O7M\ALM/B8.)E\9V%CM+7,/O
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MU+O<HL8;T.'7*1$<@5DMYI:$M,1JAIYV2U'0I4B2^?*Z$\IU:X?D3E):23-
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M(4AUE]M"O/0[PM*5#D&SG,G_ #C7LI+Q$1K]:;]EG\(XWQ'@^-A8F78'-PW
MF0'4@B30R:3KIJJ'\*OAVVQ\-=[>9?@V07F>[D6M-(QVL$V%]$U-!&GJ:<<D
MSR\4=:U+CM+6AM*BM+26VN%+Y-C(\/&2+K$0:D _?:LBNRS.-^T/$N,-!Q&
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M\^V1AE->0<3H,8H6W7;/,\IF5K=Q+;/E=T5U?'?;;=:*VPXL.K4KNV#C9OB
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MUO%\KI+:7$KEJ<=35V5/)I>3#4X5.HBV$:W;6&CUAIV&^YR1)"1O'N#\)K3
MJ)  F# TBM?EM3GBS$Q,0X3?[1S W',PG30$_OJJ,M\IVYP+;#<3Q%[RR%#
ML!F7\6-#(==:@Q\;OE8M*DB(PH*F6MGD423#KBHJ0(;\1!!4^X4V<7,#+8),
MD  GK#0 *P=_/97,FW-9O&&7'YG/#&-H 7&!X&)BEE@ML_[1_P +_B5R6\QO
M:VKOL"W#Q^HN,FJ(5C!6Q5YM28]"=LK6L(0I<9#IK(T@Q>4MN,O)\Q1)'&L'
M+<0&,_DB.;W!69DQWVK?X%;C/\'S7#L%N+B#W<1IDBM(!(B;U@&L7W6PZV4?
MHJS4"01!G*'(Z_UF'@L(Z1S^CZ".!V^.MCM2*#]J>CYK2+P(.X.\6.6^QN*4
MLK"$X5D6TK.12C80KAZ]B0\-Q&HFV3*'8X]T=>EAU28Y[)"@ HZE-8/?P]?J
MN\UXV<",G'6K#&<MKC?PHMJ$2H+?O,*@LK9%+1W+[+;REEF?+4M;3386ZW':
M4^\E*3W(O-L_&K2G):?&L9Q:QLK.3F5#2S"MV*IDX[;2\CKI%Q'=8?<;,EB=
MCSX,52PX&R%^IXT]>NZ>?>];??M%5Z,#QKX<^N).M</S2CQ]357-?OY\-@08
MM7=)MU5MI(0R^M\,ON4<YEQH-E;*0TI2>'1P43$R.VL_KIWL5,I?&IA^4HK8
MV-8?EMO=WMI#K<?IF8K*'+5%E29'?U\H27'D1F4K@8I;^8AQT+8D!A#J>'D$
MDGIZB:_)5=M;XGZ'<6MW;S"7"D8]M]MQ58ID43)9R0A,O';[;''MQITR5&25
M/-2*V'<.!UDH(4EMA2.5J4C1363-M-XZV7G[ ^*.AWLS?=ROK9M$C#<3CX#8
M87;1[!IRPO:O*V\L:DV5G$ZN:\/R\97(KF' E]=?(9=?0AQ10DG19G<#Y#\-
M$4=$31%C;XJ<JR/!_#_NME6)V;M3D5/C;TJIM&T-..P93LV)%$EIITEIQQA#
MREH2Z"@]([$'1%AWN!NENAX>K:JK+C<O(-S*/.-M5922_$IX.18K;U5YCD93
M\.5$8+!J[9FW7&*)S:^AUMQ+2^I0X* (M;;[>KE5BYXW[:#:[D4SVUUD;/"H
M%M-HJ!RPE-9-DC-3:U->_/@UIJPBQ@AJT%FX]C[]N6(K+C;C?GN--J*53DWV
MA :KL8CU6!&^S*[1FUE/IJF==SXM958=(AQ/TXB8Z]:P;:W?FH9CUEG5PW(9
M:693@0I!421ZW_;NKKT_BHS//6;BSV^VN>EXQ0M4%7>S\FOF,8O:S*,KP.OS
M2NB?0-G';?7#A*NJ"OL%.K;E>?+E^1%=]R4ATH!Z;&L:]/NI6(^(K<"M\'.S
MV^&4XQ'R//\ .XVR-.[0P+:+ A65_NYF^'8#73!9*8$:#"]XRJ+<2$%I9BLI
M>9 <6$*+UZI\84[?:.T5.D+K0/%AG5WF<_::BVLAS=V\6D;D*S"DDYA&B8]7
MUNWD':>[:E5UZ8:V[)_((F\>$&/%$=M=<57"9RQ]'D/-ZV4&=/CV^.EOHK7;
MG^-O-K/:[+LLV-P)F;&K?"72>(]W)LDO(]><<8S/&\CMJ*L%*N+)-G,A*I4O
MRF6W4QGD(6TV^%I25P#-O7KZ[))VK%I&LT_7RLJ_@^*3.!F]_MQ2X0O)=QV[
MI<B766630*W'J>II]I=N<MR%=;:IB*]Z;3:9<S AL%E3CTF4_-+C4-*4HE3Y
M2;#3[Q5>/!\<]K>^]7M!M?(<PG&(6V4K-[67D<:/.J9.X-ID-'(A5U=[J?I3
MZ L<=L$/NA]MJ:VE#D;A*TJT21NME">.E/'8<#@'L>..W(^&B*.B)HB:(FB)
MHB:(H< ^H!_9HB<#Y#\!HB< ^H!_9HB=*?Y*>_KV'?1$Z4_(?@-$3I3_ "1^
M T1.!\A^ ^?/[^_WZ(G /J!^ T1"E)X)2DD<\$@'CGL>/O'8_/1$X'R'Q'H/
M0]R/VGN?GI %A")P/D._KVT1.!\A^&B*.B)HB:(FB)HB:(H<#Y#\-$4> /0<
M:B ;@'P10X'R'X#4HH* "5$ <@$CT'P^?P^_1%9:7CN3KWHK\L1+4,2C[<S:
M25#$E?3]/OY"Q-:D)B<=#BTUR%MA]7!3R$CDG13>FG6W<^K*?@&%V^,Y/NC<
MVEC[U"S'*XUY41PXZXJ##9K&8BXW02H,A3B/,Z4!(*B3QSWT45^W14+6[9Y?
M2;'[E8(Q9ID9ADD+=-6.V E/H3&G9:FX<Q]*99*EQU0GI<3E:3_@X:*D)'3Q
MIW2-@KUXG L*W',>@6KH>LX576QISJ7 _P!<QAIIAY05P"\EPMNJ\Q7?DE7'
M/)#UNE_6RK+@<<<#@>@X[:(H=""."E)!YY'2.#SW/P^)]?GJ" ;@'NBXH9::
M 2TTVVD$D)0A* "?4@)  )^)^.@ %  !L!"DDFY)@0)T&W9<^!\A^ U*A1T1
M-$4%?JJ]/U3Z^GI\?LT18L;RUCM+E=%G"D=53,JTXA;2E*X17/B>N=4RY!^#
M$V1(>@E\_5;4F.TKCS4ZD'E<"; @GP,J6_F'4CY^'S\EASXCO#1M9XD\2M]O
M=X,7GY/@M[8U^0HD4<A$?(L1RFM@IK6;FJZUH;=ASH##;<Z.%A86CS2AWS$!
M.%G<EAYXP?[C.][F+&E.T325DY/C&-PC-#%P9GG;6O,2"(M-JU^"ICPK^%#8
MCP;89FN'^&?&LG9O]Q6V*[)-Q,JZFI<2''1,0@1T2%-.NRJQB7*<AQXS BKF
M.I?+SC:%-FO*\.PLHR ()FIN!86]&FM1G<7XQB\7.'B9AT.'+#9N23>9FUJD
M BI654BID5D&B<QLLPK/#IM?98^AP$Q4OP&#7" Z$<J]UL:1^=3S%M<N(B3W
MEH^LD$9K<-I:8=0[0)D4IWCI%3NM- /*= :1TB1?[>"Q W3\#/@6WFW9D[X[
MD[!WJ]T)UFBWNJR IX5F1W+:4..SI28CXJ9R'GT%QR1)=CN3.LNNLI=!2K68
MW#<%V-AXI:WF8]KYAM>5Y=,D&OPU&BW67]HLU@99V2:X\CVG#)DCW7M+2)FM
MZ3-)BL 9=U$*0N9/MI%=#I0]7TF-TV/5Y;,*@Q3&&I[-'6!3/2WYK:)\YQPM
M ,H;DM1T<MQ4J.>T\LAM =CI0C;:!>BU>+B\[@_:IF3)DFLW^Q5N-RMM,$W0
MV[=VBW<H+6VPZNN9.08?D] D.6-!(EO3GEHD1T*\\"*NQDL1EMM.LO0)*67&
MTJ:456,? 9F,-V&\4<"V8K!!'KX+)R'$'\-QFYK#)Y\-P>VI$D3M:)IY:*WF
MS'AGVOV=8EUNVE1D"(MO(@2,GR[*ELHM+F#62$SXE!!@ A35>[,0P]-<=;;<
M4EEM"&RKZPM9/A>#DVNQ&22ZHJ28$Z"=1)[^*KXGQK'XPYIQ29;W(K0^OD:J
M_-_11)S620;.@CY=B&:U;=-F>+270T9T=@*3%L(#KO"4S(:%+:;;60'0H%"T
M.(YU>Q@W$!PG $8E-Q?4'RU6'E,;$X>\9G!<YN(P\S'=10=M[5$QUL-A?AA\
M.>W>5P\WVVV:R&-F<)SS:61EUFRNAH9?24HGB-[[+]X=8)\YEH(2XKI(2XA7
M!U9PLAA-<"T"E: "LF\=*#76JV>8]I,[G,(8.+CN(-""X@&;W,:6 K,+(9G&
MT+Q^72RGW7G[$RW[*>. ^[:RG52GK$.<$"0W-Z)3"^.H+;;[E2.H9H9AAKA-
MP1 F)J+^,T_5:7$J'.L0"08$TK!-ZZZZK$]'@Q\,+V[<?>K.MB9-YN)"M&<@
M798W+:?QRZO(\D+:N9]!)EQ68\U3B4RW6%>:VMSET*[](QAE<(.#N7WAJ0#2
M9&E-(^2VF!Q3'_DS@-<0.4BE*1!$$P1N8TI4PLRK"RNLKR1G([B&FL@U4&72
M8Y1HD)?]UAS'8,J?-G/H".9TU=;5>6E*?+BQV/=@LN//*-_W1$F*@3\NM*ZK
M78&*[\5PTBLU-9DT)DF_03354/E6)4F185G^U.<XJYG6T>Y;,IS(:&(M#%I4
MSI(8<GOUZ7ULH>9L;6/%NF4!QEZ%<^_O!2T]"&Z<3+LQ0YH/,*R3,U[F9H".
MMXF5=RV([+9D8K".88C7-F@#FDWC0T'03XX4[&^SPV"V1S.RRO;?%,JB3+&-
M.KG[;-K&(]-JJ6R\QJUH<?@PGGF>BUANKAOW,IY:T05R&F4ATI6G%;D68;VN
M%',(= @6@Z0":"]#L(KL.)<<S&:9AY=\%I/);0F"*S6P$;5)"SWR"1+D1X]#
M3)$C(,D6:NJB%*N [)+ADRY '^3BQ(:G94UXGI0V.>>X!S+_ 'I6#:WV(IK,
M:E9-,;:XP&\86[!$F5B6-2L0J)BW%I=:IYM8Q5SF.GZO>0Q'0%$\'IZ3R?C*
M*@[7PY[46R\=D2L86#BU5'J(3+$QZ.S-J(4L384"U:;^M/C198,AIETI"'"H
MH)23R3P]>A*\>M\)6R]>M<N%16#,OWB%+BO_ $K+\ZN<K+6==Q&(*P0J-$;G
M6<U2F4%74S*>9*BE1&D?;KYHJL_,-M8J#'KW\8;>A1XU/$,-UQQYAV-3/3WZ
MQEQ*R0XTT]9304*)"D/%#G"4]B'UJ>W[#5=7$/#EM?@\Z!/H*5]$RIMV;NK>
MESWY9J7HE7:TT:+!#G"&($:NO;1J/" \MGWA9Y40D@B][ MEL!V\CVL7'*%,
M6NOJ.AI;:ID/*F5LJ!BU)^3=.E<)_P V.7OH-IBMF.+"C*C0H33H4&4Z(*>J
M[>I7NT.VF XU>7N0T.+4%399) Q^NN5PZ^'$:?8QI-H*EGR6&4-A41%S-)(2
M.?>/4_ BN;HB:(FB*WN?810[D8OD.#99&,_&<G@/UMO"1)<ANO0WE-]:&Y<=
M2)#"PIM#C+K*T*2Z. 2>^B*S-1X4MF:N!=0E45G>*R&N@T-G99+D-Q>7?T)4
MV,:VA546SLI+LN%7HGQ&)2XD52$K=;2M:5@]R>O7KLI,GPD[)3[>XMI=!</S
M+2/9-1DOY#>+C8\+F7"GV,G%HYE<8W)F3:R#)D2*OW5;CL5E2CRV$Z)'KU\U
M2EAX</#576>/8).L9-3F]N[E-S6.G<2QK-RLH8O$1F\K+UBFQ8R+(:N8BOBM
M6"7B_'"8R LH+222?OKZ\%5K6Q6Q,V^&753+):Q29 B7$"HRB6,4-Y@D 4<)
M[*J*/-753LAQNOCH@KDVK7OM8Q$CB2MI41DMD5(9#L9M;N+L'7;"[<YE&CX)
MAV;;/9+YU9D3N0/55)@FXN!;QL4,:VC6:IM4U:8_51&J"49:$5-5:5<Z%YD1
MIA"B&H%J1&NYI'H3:BH:VI/ K$%-0V&\>"T5_%7;7;%XG?"OJ\]O6-TZ^CN+
M*1;Y$C(FL@O*K.*B!B4A0F.O0[>LKL>]T4[$:B*))$U[G2YU.Y,WJJ]R7_<;
MXO\ E%MWD>8[2XR_>[9TFSEQB%GG6.4,H[=40O*BHQ1JGDVD>3"AQ!.N*^*D
M,H=;6AQA:DKCI2";ZQM7PZ'UJJND^%O9FQA1%MP,@9FB2Q<-916Y;=Q,DD*_
M).DPUPO9)'F(LI,.TQFDJJ^R;6ZIB>TRER2%NJ*]+>O6R?3K\_U50Q?#GM'$
MI[?'HN+,QJ:\K\.J;*N8?>80] P,35XRP4)<_1JAN6$Q]Y:%)<DJ?6Y(#CBB
M219#-GE"">.2A)/'IW ].>#Q\N0-$7+1$T1-$31$T1-$31$T1-$31$T1-$31
M$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%#@?(?@-$4>!\AHBAP.W8=O3M
MZ?=\M$3@?(?A_?YG\=$4=$31$T1-$31$T10/H?N/IZ_LT1>1:U<&XK9=98Q&
MK"OG,NL2HTAL+;=;6@I6VM"AQPH$_+@]P00#J")!&X(\T6.,_9?)*IY:,.RB
M*:M:BMJKR>&_-5%1R#[I#LX<IB08[8^HTN<F66T\-H44@(U&&/P@(-C3Z=._
ME*E@PY!Q # !DBLBQK46]$+H';+=4D'WK#21SQR+/MSV[?6/J/7Y? 'OJM[G
M/!DW! C21&@^^ZLXN'^,9;03,"( %>X':UMEQ&V.ZP*0)&&_#CO9]N>._!('
MX:M-#Q )!'R$^?Q/55L'X8%9@5ZTKX+G^:_=;D</X?Z]RD6G;[?U^_[.!\M7
M/I95>X:@1-; ]9FD>2B-K]U1R/></'/'\6S![=AQ^D!/;D<=^W;Y:BNP\S]E
M! ,3I4)^:_=;OQ)Q GT_5M/P)"SQV^'&H<'$$4$ZS,=8@(0""#8B% ;8;KCU
MD8?SSSZ6AYY^PD#D?T_?ZT-:]MW C;MI7?X*6!K+"H%#\YWE<E;9;K<']-B'
M/S*;+_O_ &]M3[\S ^'SF?BJ@07>]8FL;>J+A^;#=;MQ(PW[>?I/X_>KCD?9
MQ\>^JO?V'K3U*/&"(Y14V$"^D])[+D-L-UAW,C#^W?TM1^T_6]/7G]^DN!GE
MMU"H+08G1<1MENI_[3AI^S_&??[.ZN/NU5SO-"(&M1] I!#2-!,0.NGBGYLM
MUE=B]A_?U[V1]>!W XY]!V^SC4$3!VJ/UNKA.'!@$$@UY6C2*D.7([7[J@$F
M3B''!Y^K:=^Y/_K!\23ZCN2>03SI78>9^RH!@@FP()1&UFZ;XZ/IG#X';I#J
MJ^TGJ [?50W[XPWU#^(%J6@D_6'!/,F9K,SN?#;R*F6.ET5K'T/@;CKO574V
M_P!LZS#93]F\_*O<CF(2Q*O+/RB^Q$4M2T08,9E#<6%'2%)2_P"[)+CZVVG)
M2W7"5DJ5=[@?(?@-$3@?(?@-$4>!\AHBAP/D/P&B*/ ^0_\ 'U_'1$X'R&B*
M'2D^J4G]@_O\!^&B*.B)HB:(H<#Y#\/V_O[Z(H\#Y#1%AUXIKO)ZU.V+(GYY
M2;:668S8NZ=]MK"R>9EE=6-5CBZ%M+F&0)F6UU+,L_,;M;.DBH>BJ;B-N36&
M)!2Z3UZ_18W>%O%-Q+SQ$2MRMQV-RI"&-AZ:CQ&[S%C(:T65,C=G<Q%/]-5\
MZ/#AQ<K_ "5CTME80+&/"NHXL4V<R*E^P6Z^4"G7K!\.FAG23I*J;:?<&DH6
M_$CM)=46Y-=F^4;V>(BTQZ*YM'NU(HK.!D%AD%K46$?/(N$O82B%:0@78LES
M($B45,P0??7T1%%.X\32YWZJQ4+!MVL)VYVIQG"<4S"(_P"+#PU;5;&9Q)A5
M5DT]M3FN*)KZJXSN_P"8H_)VT_,GE.?E-C9?1Z/I[:G$,<*OI6VJVG%*3Z[*
M.UR+F@I:9M?];+M14QMH_$/XC*47.48%B#6Y^U#N+4-?X3MR=V:C(<1J/#-L
M!C ?H,ZQO;_(*Z'7^_X[8T"($.PZJNXIIWF!!)T]>BIW[]]AZLJ:M]GO$=9Y
M-XU+G;NO@U\&SN>N/C.5[;QIUMN-3.Y)N>[:(P+*<DYKH=S*I9J$U3[\2WKD
MSID"3-BN,.!#I4UK('U(K T$_"NBVO;*,T479_:R%C+&21\?KMN<.KJ*-FD2
MRKLM8J:K'ZZ!!CY16V;3,N-D;,1AEN[3):;?;LDR4O-H<"DAZ]>NRJ'E%*_?
M7O)5X$@< \=^!W[$^@]5#U^_XZ(N6B)HB:(FB)HB:(FB+JR)"(C+TB0L)8:0
MMQ:^_P"C;0DJ6HA(ZB$H23]4$GCYG1%COA'BEV#W'R5&%8-N?0Y+ECB^@4L!
MJT]]'F,.R4F3[Q7($=7NS2U%$PH7RT1V)YT]>:?17GMLDH:&731+BWAUTO(K
M)-33,2G0R[86:T%Y,.(D_K/J:25J3P .X^6B*J]$5*6V44-):453:6D2!99-
M)DPZ.#)=X>M)D1A,A]F*#V4MJ.?-(Y''4/EQHBG,7U3*NYM!'L6%6]9$A3IU
M<V>946)-==;BN2$_!,A33B$\'_-'1%4NB)HB:(FB)HB:(FB)HB:(FB)HB:(K
M:9WN!B.V6//Y7G^35>*T+#\*O^DK67Y#+DZS?,2MKXD?I,N;:S)<M,*#70&W
M+&R=^JTTH]M/JG7U]E2E1O[LU<T5=D-1N1C5G3V2<@<BRV)CKB^O$H!L,FAR
MH89,JMM::"VY)MZB;$C6,)HCS(">-$M57N;6TM#:T<J"_KM_ \'XGT  ^WG[
M.=$78T1-$31$T1-$31$T1-$31$T1-$31$T10X'R'R]/A\M$7%?"4*5T]72E1
MZ0.2> 3P  3R?3L">?0$Z(K0;B[Q[8[0)J5;CYI4XFC))$F-0(LC)\RSD5T:
M/-FQ:]B#&<>/N<9YJ0^M:>$)D$J/2=$^OJJ[^(;H[>YO QVUPW,<?R>OS!F]
ME8U.HK1JUAW3&.S&X=U[O*BI6V'Z>2X(=G#><3)K9BW:UUKS62G1%5LFVJX<
M^KK)EC!CV5RN0FI@RYD=J;:+@L&7*$.$XIM^<XU#BKERBT@F(RGK('?DB\:Q
MW#PBDNXN/VN0UM==S)M%!CULM_RYK\W*)$B%11$M']:39283[49'JHL'X=R1
M5ZL<H4._I\.>>?@1QR>1Z_O[:(J?K+RJM9UA!@6D"?*II"8MI%A38\J16R5H
M"T1[!EA2G(;RT'SDM/A)(/)'QT42#2DB_KUYKUK"="JX$ZRLI<6OKJZ')G6$
M^:^U%A0H41E<B5+ER7UH9CQ8S#;CTA]Y:&FFD+<<6E"204P-E8+&_$UL/EK=
MP_CNZV*63%!]#O6RQ.<:<B1;^W8HJ*<AB<AIZ366]U*9JZVWALR:Z9+<3%C2
M.>%:*)'T\;1ZWHKRT&04^0Q%6%'81K"")TZ"N1&(*$2ZZ48<N.KL#U1GVU1B
M/@H$D\ Z*54FB)HB:(G ^6B)HB:(FB)HB:(FB)HB:(FB)HB:(FB*"DI4"%)"
M@1P0H @CY$'L1HB< >@'X:(H=*>>>E//SX'/X\:(H\#MV';N.P['@CD?+L2.
MWP)'QT10*$'N4I)[=RD'T]/A\/A\M$7+@?(:(H  >@ ^X<:(HZ(FB)HB:(FB
M)HB:(FB*!'((/H01^/;1%KQL<4SS$[+QQ91CN#Y/96M_3X?*V\CX_*^@+?*9
MM5B5Q#ELXK>M*:EPI+,IUII<N&MJ2V\I"HZTNNH4%_G;U^B@37:D5FT]OJ:Q
M)HL&X^V?BYR1%Q78&]F%1]'[D[:9'MOD>5XON;!JZV-^2.3M9Q+@0-TL\R/*
MZ:4_8)K(,FYOIT=M5NZU;MXRAL(=D*=DN;&FO37P[P-=E7NYL/?O(V\!.)5>
M^6W^'5^WE_43*FZQW>;</*F=]6+.,PY9JDXANSM];28;J$+>QG,,IL9V!3&D
M+E2(]:W)=<6@[:3O1)&^L1UVM*R8\1>$WEQ4>%67G--NAE</$;%4O<Z9MM%R
M-G*V)<G#(L239V47![QZ]5%F6Z5?2D"CL+Q3DM2/+=EQ&')"'[V3]/CZ'JV.
M]?CGB993CASN)O;,VX8>VV.>5]+;W[^=R-NVD;B>=#1^3]BJ_M;Z&_)P89Q"
MQJ=.R:R:80F6F6A$Y#I0*7F8J>@F)-IW5%6#NY9R2VP[)/\ =/.OO;1;K7.P
M&,T>09\[DE8Y8[L9]$V.M,_;K+?Z1KKV)1(QZ+'M\^DO0J*OBOP\TEQI*5"2
M^DS/EK\/@A.]=0>M@*03?;S5PZ3 /$';[QW.)Y#;[QEW<.IS[&,LS1:MR,63
MM5'M-M)3%7E.+996YC-V@S+%8N81J88'C5'CN-[AX_=6ALK+AN#=+F )B:"=
M#]2!T^M+JBE*"10^%M-(J:2LH/"MD6\FZ>TN>[RY2X[4YSN"P:+!<<FV!G8W
MCBMJ\7&$2+.*SWARZ_+]X(>=9? NH<0HN,*N<2<2M2(\5>BJ!F#]H'3:\Z1N
ML7ZNCSY&*;=-MX[XM6J!B1ML?%LFSR3/'KRZM(^/96UE3&'5J;HY?D#RL^?Q
MZPSFRVTD2<7R?!&A452KE*/HQA'2_P ;3^JCL;'IK,4H8&]C$"LJ94[8^)?)
M%6EA!F[PUIQ?:O>RUV"A9/FF5U_NN1/YU0C:AO<6,UD;#EU>,4"[ERJH\S=D
M2(- \Q&N&6;.$6(1(L3I:F^IU!T(L;TLK=UN&^(K\@KY3N5;R1L>1/VZ=FUZ
MMIM^&X9R&&W+_*E-Q266_MMO-DM9)<4W'RFRV\?KZ6RE*AVT$9#%9E)2[II0
M^.T=*"D6_5;6/#E*RZ1LU@#N=4-OC.5BG+-I57UQ87UO'#=A,8AO3I]XMZ^=
M?EP419B(=TZ_:U\>0S!FR7ID9]6BD560&B)HB:(FB)HBP_\ %SC[E[@^)/?D
MKN3=MT&Y-)D(RC:*9$_.)M@]#K,@9A[AT.,6$2QC9Y[A-D,8_:8<W5VRK"GO
M[6U%7<(AFJG3X$^O7Z*)B3,1&GG6;[46OR\PSQ&WU#=9#6XKF\R?%>\0TC"=
MQ',$I-K-T<X7?;!UV.8YE.;8OB;&/"KRR3DL,8K32S2XS9VD&EI758Y7B-$E
MSXB9H:7!!MV/S2?&M#2I.MQ4R9C8JXN5TN_!B;NMX]"W]5XCGI^ZB<9O(UUE
M,;9^)A<S$Y+6"F"S+O8.!6*&>(K-30T3\7+XV=ERZF,UK3KUR)WH.G@.G>3V
M$[)M4S!VI7J3VZ5"N]X3Z'>6LQS>82;[+9D"?4TZ-O(698-N/A+-9ES5!:(M
M7J^/NSNAN#FTM$RV76"\ER5U5$_8-+DT3DYER;+5"#Y;_>:Z?O06-B4FY QG
M'FHN/^*I+K-GB!\3+TW(\]2JXC1LADKRUG X#UL_>7\E<93;R)6VCZH<O& B
MG@/29J55Y0H)$V)W@Q O>TU^]ERQ_;#Q&Y'997-KI>]%;44&!;RV7A[A93F^
M85;S-M)M;1&U3&:0YN119EA;0X[C#M?!SQ;KM9#7'1:!HH4TV4COV[;&IGP/
MP5N:##?$:[A%^F5F&]<2H2G;160PVMJ=[FXPRV,[D;N9O753>[[6^Z6;TE@E
M^JC98K:=^LJ[&8U56= NX"+EH(/<Z3KY#Z)OTO6WVI'JJVA>&%_-7-E=OTYY
MC]WC>2-PEL2:^_NKNWN%P8LMZ-6V$^5DC\O(XZ[:O;CV)J\BFS<CKO.367#R
MI<>0M*(]?#PM][J1X^OF#]?!9*:(FB)HB:(FB)HB:(FB)HBXK3U)4GO]9)3V
M)2>X([*'=)^T=QZCOHBPE\2$B=B^\WAJW"5A&<9EBV)KWHAY&<)Q*?F,VH7D
M^*5,*EE2:VK9DO!B9.96R9#K*TMI*EJ20"%/"?EX^M#LH.E8OXZ?":=36:+#
MB9M[OXJ3NQE^+4.[FV&*[RY!XD\]H<=PY$-G+L1BV.TGATPC%K.?C]7D=8Q6
MY3EF48/GV=0,;1D,"_A.Y*^RVNLRA^S4R\#>_GO\/A2R(ZR"8BD  4D]X'6%
M2<?!-Z+2!A.0S\2W2#^'9=O;1X-E..+W?H_>QENS%-'H,@C8-G.3W^<;<8XC
M,J^54B+E%M85L2[;G3H\EB#=M.S5]Z13:U!&DGM<25$&E@3(H=8H8UH/6GMY
MULEN%6M8-6V=3O\ YA@E6WX5LNRM4'*,[R;+&\C@Y!?66Z=G#L)&1RLE8L(W
M5'E7L.BFQK!H.(;K6.HAM123?2VYJ:6OITJ;*HX$[Q$8:U=RFZ+?FXPO)-M=
MY\9V>K ,FOLHK)T_+<+L]OE9P)TURTQJV35Q,O74WN7/QGZVD<@T\J=6RG&Z
MY+P32*ZQ,5_>-($7B*6MM-M]^J&PNO<*_<ZF@9)G.&9-NC;JI=V\[:NZA6V4
M.%!4S4[=9YAV5VAC9>U(3?UV-7#KD)U4:79U<B)RXT04&VL>'P\.^I6:VS>+
M[B/>&3=;'LZILOW2;O%YU#QG"LF@93MI?VN(6,-R,G'*U_.\[W$S*I9F-KE)
MQ^;E5Y'L8KJT(=8KDK2\T/J:*!)&G0"13O$^06*,G#]U<DJ+7&L4QW>;-<4K
M\=VN@"3O7M9CF/9[@5A0;U[<7(P?$,UK:&AM=P\9C4-=<V-W*L&<GA1$U$68
MG)Y4F4MEF#V![_LI!DR3)BLW$V'E$SLJRK<=WC8R22K=*F\1EK5_^4!V?B;=
MW>7U[S&=JWDS26^O))]+.;JZ.!,PQS#6X%QG:4X>,5;M:Z+(,UZ3!GR)U]6O
M?7Z*>_AW]:*A\9Q#Q:O7&Y7Y0Y=O'!S"9B?B(CY>UA^%YDW+>B746WC;<OXC
MG66;P(VBM;2!+./V^VR=O,,J[ZIC0IU!:/8HBRL6W%?6O7YJ.YK6W@=S:FI'
MA"S7\$@W#AXQGM7F=7D#5;&SV.O%,ANX>Z6.1\HK)&(8L;6;4;>[R9)E6=X#
M6P+UBPA/ULFZD5=ED"["XJ$(BSY+LR>_[>OA5!N#?I^U_L1USJU"E-$31$T1
M-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31
M$T1-$31$X'R&B)P/D-$5+&JJ_P L_IKZ-@?3'Y.,UOTM[G'^D_HY-C,DI@>_
M^7[U[DF2Z[($7S?(#[KCH;\Q:E$BCF]96W&&9?4V]?"M*JUQB_KK2LL8C$ZO
MLJ^;5S(\R!/A26W8TR'+CO.L28LAIQA]EUQIU"T+4DE(N.X^:Y895UE+B&*U
M%/70*FIJ\=I:^LJZR''@5U= AUL5B)"@0HK;4:'$BL--,QXT=IMEAIMMMI"4
M(2 0W/<_-5-P.2>!R?4_$\>G/W:*$_O_ '_$Z(FB)HB:(FB)HB:(FB)_?\/3
M1$(!]0#P>1S\#\_OT1-$31$T1.!SSP.?G\=$31$X'R_OW_M/XG1$T1-$31$T
M1-$31$T1-$31$T1/7UT10X ] !Z_#Y^OX\#GY\:(H\#TX''R_;S^_O\ ?HB<
M#Y>OK]NB)P/D-$4.!\A^&B*.B*' 'H /V?/U_'1%'1$_O_?\3HB?W_O^ T1-
2$31$T1-$31$T1-$31$T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g729258g51g23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g51g23.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2804&AO=&]S:&]P(#,N,  X0DE-! 0
M    )?2^EQ8X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!7\U0         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              ,\   $"
M  $                          0             ! @   ,\
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ,\     4F=H
M=&QO;F<   $"    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   #/     %)G:'1L;VYG   ! @    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ @ "@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M%K!6
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$!_\  $0@ SP$# P$1  (1 0,1 ?_$ !X    & P$!
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M/C@A&G));SPS(UL T?+MND;5Y4XKEYM.832"&'=LI!  !=SKIH+5?&/AZ/\
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MV3#;"=W;%E8_4L&*)CQPH^=S*<P 9U&HKX7BV#QU9*N)\1R*Z\[,5N>KE?\
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M+81 3QV,[@ 5=V!G/ML:O&#E<?FY?#GA\V]5HL*C&CZOT+DZI^&Y6?\ ]Q#
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M?SD *[=O#(X'*SN)JX8G\5P]5 ?$2>5I:A$"(V>KQ.$S_P **R0 ZB4-9B+
MG7KJ3 N7]%.L8.IAL]<?7Q4.=XN.\#-*5S6,C6TD&B<59@R1\K":LJ5%=#8L
M;TWJY&,1&[<+\!\/S> S.(HS%^&)J12"9Y=@( EL[$VUOA?%_B,ZI]>MU[KJ
M-CIBS]NW*W9-DY4V3??9-O;?Z[?GQKA(*R"[:8]#CWCN)AN=0^9*3Q]YN7 U
M&\BS^[]O*(J;(BJOA4_3;CA%C=?VZ=&)$X?^'E<13#9 ^XPTD"0B/ZS%V(="
MZ)[F1=!T[7)OO^?W?AOCPG*OTX3KZ!23O<BTG]+AC'ILVDD#8AE((>YVV>LX
MX0BRJ++,>R:%DZMBBE=RN?RL?SHZ51$5ZL5$W17)S;+Y^O%:Z1$WV:>W4>;Z
MX5HS<QD$E"!&EAW,#OYO&W3CD;)+!*Q6I.B*O.]B,YF\ZR=)Z<SD7I;[N3==
M_*^5X 0B+1,%6C?IW9.R#%.?F=1=OR*A=(( 3\PDD;145$GCG:.]BNB7[UTG
M,NZK#&J[M>Y?*-V^555/Y -R+@DG71B"M-2A96NX:C52"8)IV2)&I]+ZVP:0
MMDG=!() Z7GF<LB2NV= BL5=G-_A<U%5'-5=T7F1/9=N4@,3TU'<W:3\[H7S
M<Y$SK"8L3!1,%S9OJA@+,D!!30W2N@6-=W;.29'2IX8O)Y39R[*B)OM_9Q26
M8@&')(9!D%S!?Z3BV53_  R1?8!0V?M H!]>%A#)$J3I(Y[A_E?,L6T37*FS
MN9-DVV7?=//E%XEKS/36P_3^UN9-7\;4SRVV(3/E)OO."\.>'NR.I$CE7IJ3
M(KDA8U%C18U8[=?DG39S5W\HY=E\;\2FHLC8P.V^D/O]</YE:??H61'4-V#B
M),C M829A(VE0(-!-))VR];K\T;5<D:IM].54=X\_NWGCN92;_U3LF02/V!(
M$] EZ2&8F7(U+5D#:VA73 98HX16Q*WIH(4\AL.RP<\R\[5<KE]T^;SNNZKY
M]MDX7L3JFHVW!>QVZVQT7,&Y9=I,:1+AWPGS$46>4:")LX3Y4E)C_P"T.)(5
M5\_I[I_--DWWWL%(]"UWN0#]=.SU%?H;NYBQ.B4@$:"9?)-AHX83(55).LDL
M\$HLZ0;_ ._1-U_?OY[(FR>?=4,EKW\NPGR>"54Q(E0[!Z[NP<)(.<('*&"2
MASP1)'-)'%!-)&LB=>5-D\*OY>/&WYIOXY4XK9=4/<S827;22BBR4YBHZ) %
MIMIZ,E"-SKB:VGRN3!,-1Z*C_P!EZ+F\*OGX:-O[;I_=X_+A^D_*+^A_;'A<
MRH>)7(_/5J/ZCB)GKK]7UAZ,\.HM2G46F.4XV0?<09#BN8ZPUNE&>WL8@E:\
M ?20.\H[6LU"R7JR%H9C!!-21/&M="&:U7(Y-$$56G27N>D"'MNL9YI/AU'V
M!W74ZG9ASU[Z!>K#"O6%I#F]U1:?Z[Z/F!8HU]_B^NFEV1:99(#7Y336<E59
MTYEBPJGR$.:.M*GAM<8L[N01HS83QA)G5K$L:_"+)1!($ZR-?=X4XO*-? 9I
M$"K*KEM$TF;%)DG6RN!BBW(!\5TK)QK'-+,FGS*QHQVTSJR3$!9:-P>.VE0M
MS-E^1A#%1/.HZLF9ZAECQ0E@J^4"-C*QB(EFT\1G"L@NFJJJH2$:34Z3)F"
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MD*ND0KE1FR^Z2;.D1)&_[E$>]$V1.9R*BJG6))#N5%@R5Z%LZ3OCTV;4J;"
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MYBY42>1%89(V9@N\JKP_Q7"CB/GU10GO'[)EHQC)X7,=28()B3N1!G3N+ F
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M*4>FL"O4QI^;'D8MCC.0R6-(*'?RET-%)9-/Q"XKVUMF^R-DILC"$M1I(#)
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MCCM'!F1NCE(3<Y1D$'PHC4&YSNQO,K*+6VKNI=C86#8N964H[8I(H+&V24F
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M1*-UD6=1U=#D<Z,"%?:R0-:C$Y5%DGP\C.R*S_$9SLM[5NH'5JZ+W G'S/\
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MF#]TW\(B[<3'?^H<0DPME'I]W.-EP&H3IJ\@Y7HCT217C*0B+[;?NGA?U_\
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M/  "" &NFO4G5W]$7IIQC_-U%(L9WJO];,9W"I]=_'GW5%VV_DF_$\ =/O\
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M,797,A[OYT7;Q\J+[;<J[)Q.8;L(!LJ7U;U<[%2<<'P[)@,'4W-[,CV TWD
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M4*=F4DNO7I:Q(>/3\)E'\/5(D,M)]?JH#$-/ C"LAP_58K-<5G+TOJS4J K
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M*E5*_I1]A7PK(/$LS@X$>SRZ("7M4G;;).77U;T]+L3Y$:B"Y7GYJ(!0L U
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MCF,=,T)JO=LYB)S*N_ :J)(;>Q=MA*Z]L&JH^7F8!&B1(6T1H"&E.Y1:&!'
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M9+*J(4QAA+'=!.^<C&A2I$CDB%G1I+MD2%$\;.Y"Y5;YKL)=M//Z),<!4/\
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MA>L@-JV)D%N](X4:3.+85<CD<\U&T*SCJY&H]41(IL>KZ7"<>6TK'?&L8$D
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M<ADX1XS(HR \GYBF+RV'L02K/0D#"0K-+]3<6/REV&9;CU+A>6WEAD=DXD.
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MNL1=BQ@2 5)6RE3(Q4_%QG?2Y(@^=V+!%%,R)+TA.G_6#ECS3']4-(\I8RE
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MPGPN&13)8C8W*LI!;X8W$,2+FC8Z!6)/"*:+WLM& %Z>^N&\ZK*SLI,P-V1
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MJ-'LBX\PV;4?OIU2V/UPFR>]I*. PP(4FQ(0A5/(NBK.&Q/0DP;XHI+A$""
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M3T'[7ZW&"NYEQC%Z:VO;>2EIJ''JHZVM;6QE"K*>EJ*H>6P./M;&=RB 580
MTQI)4ZM;6B,=,Y=G+OS'?"RQ_*%V &DVZ>6BPG,<S32O,+,VGP_*,+R6X!I\
M>R&RK<<MZ6WLA*/*AR"<8NK 8!SIPZW(AAB9*6S)1 + *"9X>[7-5>O1Z=KD
MWW%[]?/G@Y;/RA1_+2?.T$ZR;*)PXL==7HQG[D&W9J;(@L+$;X\HC7.1S4_1
M41?S3B,]/0?MCG)EB-N@_;'3X:"O_P"WBN_7MH//_P#8G$9Z>@_;$Y<O[']M
M<)\HS'Q+<"G(EIH+:X@,*K:HF6M'L+&"LD';8%5]>JJ8>/7RFBN-)8U4 :9
M]VRS^>8)RTM\H>\:[[_HM,)[,LJTZTW&IC,O,H<=AR?**O%**0T5&QV657;2
M5K*H=8 U53CXQ27QINNZQR*JJO$Q#32;T@^4>EL-A>>J'TG8K?9OBV2>H?0+
M'\CTV'A-U#QNYU3T_J[7!A"2&A#$Y=7'7C+'&XI#)&"P+80B,0MS()%[A[4X
MC*DV]!^W[8KX=/K:S=YWF=+:WQQ7U4>DM+ >K;ZAM 6VI&)KGPM>NK.GK32L
M$C%8;)FD0R73G28P@,D14MO$O8(%-"9*J,?$YW=>XF-.GE:W2!BO)E_^-X1
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<<3$QG$Q,9Q,3&<3$QG$Q,9Q,3&<3$QG$Q,?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g729258g51k61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g51k61.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1DF4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &0J^9! X0DE-! 0      "4< 5H  QLE1QP"   "   < E  $4UI8VAA
M96P@4F]S96YB97)G #A"24T$)0      $"S"?,'HOVNR;I_"@R#Y[C0X0DE-
M!#H      0,    0     0      "W!R:6YT3W5T<'5T    !0    !0<W13
M8F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX
M=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585    !  00!: #  ,0 U
M #$ +0!8 &4 <@!O '@ +0 T #(       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q 6)\*0         IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4
M @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"24T$#0
M    !    '@X0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          $X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      S4    &              $V   ";0         !
M                          $              FT   $V
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   $V     %)G:'1L
M;VYG   ";0    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   !-@    !29VAT;&]N9P   FT    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!$       $! #A"24T$%       !     4X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M]C@2!^9[6MK:_?\ Z1K/
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                 /_A/TMH='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP
M0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O
M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q
M(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @
M/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R
M+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY-
M:6-R;W-O9G3"KB!7;W)D(#(P,38\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^36EC
M<F]S;V9TPJX@5V]R9" R,#$V/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @
M(#QX;7 Z0W)E871E1&%T93XR,#(P+3 S+3$S5#$U.C4W.C0S+3 W.C P/"]X
M;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C M
M,#,M,3-4,38Z,#0Z,#$M,#<Z,# \+WAM<#I-;V1I9GE$871E/@H@(" @(" @
M(" \>&UP.DUE=&%D871A1&%T93XR,#(P+3 S+3$S5#$V.C T.C Q+3 W.C P
M/"]X;7 Z365T861A=&%$871E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M
M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @
M('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y
M<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^
M=75I9#HP.#0P-34S,2U!1#$R+30S,T0M.35"-"U&.#8Q,C0R049",$8\+WAM
M<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM
M<"YI:60Z.$-%,3-$1#,W138U14$Q,3DX,C0Y-S4X,3DT-$0W044\+WAM<$U-
M.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT
M240^=75I9#HP.#0P-34S,2U!1#$R+30S,T0M.35"-"U&.#8Q,C0R049",$8\
M+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI
M<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D0X0S(Y
M13@W-T4V-45!,3$Y.#(T.3<U.#$Y-#1$-T%%/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$S5#$V
M.C Q.C$P+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T
M:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.$)%,3-$1#,W138U14$Q,3DX,C0Y
M-S4X,3DT-$0W044\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IW:&5N/C(P,C M,#,M,3-4,38Z,#0Z,#$M,#<Z,# \+W-T
M179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G
M96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T
M=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO
M/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T
M97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I
M;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N
M861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.CA#13$S
M1$0S-T4V-45!,3$Y.#(T.3<U.#$Y-#1$-T%%/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$S5#$V
M.C T.C Q+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @
M/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z
M:6YS=&%N8V5)1#YX;7 N:6ED.CA"13$S1$0S-T4V-45!,3$Y.#(T.3<U.#$Y
M-#1$-T%%/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z
M9&]C=6UE;G1)1#YU=6ED.C X-# U-3,Q+4%$,3(M-#,S1"TY-4(T+48X-C$R
M-#)!1D(P1CPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C X-# U-3,Q+4%$,3(M-#,S1"TY
M-4(T+48X-C$R-#)!1D(P1CPO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@
M(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M
M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @(" @
M(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/DUI8VAA96P@4F]S
M96YB97)G/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @
M(" @/"]D8SIC<F5A=&]R/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E+V5P
M<V8\+V1C.F9O<FUA=#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O
M,2XP+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H;W1O
M<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \
M+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!+@)= P$1
M  (1 0,1 ?_$ !\   $#!0$! 0             $!08! @,'"@@)"__$ &H0
M  $# @0$ P4$!08&"PL%$0$" P0%$0 &$B$'$S%!"")1"0H487$5,H&1%B-"
MH? 8&K'!T>$7)"4S4O$9)B@U0U588G*6U2<I-D535W:2EZ73-$1&9X34-SA'
M2%9C9&5F@H.&LK.TUO_$ !L! 0 " P$!               ! P($!08'_\0
M1!$  0,# @0$!0,# P,$ 0$) 0(1(0 #,4%1!!)A<8&1H? %$R*QP3+1X084
M\2-"4A5B<C-#@I(D4Z*R)43"TF.#XO_:  P# 0 "$0,1 #\ D?M@/;D>T5\*
M7M >/_A_\/W'&C91X?\ #^=EYJBY?JG!_A7F5-/=JN6:95)!^W:UE:96YOQ,
MN:74M2Y$A#:G%<QT640?]L?O]_+2H8>9>"1/A7S:?]Y3]KZIG]1XD\I(>U'[
MWAXX)*%K[;_HK8C\+GJ0.@5+>W-5@^\H^UZ^*CFH^)/*RHFH<],;P\\$D+";
MBYU#*R5':^R2!\L*5AD^\I^V#YB_A?$ED[EZU<L+\/'!35HU'1JOE;KIMJW)
MO?Y84I*/>4_;'DG_ '2>2K ;#^3SP3OV[_HG]>VP]>RE.=+]Y.]L XZA-0\2
M>4.60-:V/#QP2&D]";*RLE77;:_;ZE2E-2]Y%]K]&="H?B:R>^P;@(=\._!-
M#FW2Q_12Y^I/UQ9_I^^:I8;D3W_;[>%(GO>5/; ".E3?B,RFAP6#BG/#UP2
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M8H$V"4^'C@G>_P!3E4;'N2<*4\-^\D>V 6D-K\1N46WD_K5J/A[X(E/)2+*
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MJ5\=L*484HPI50#Z;]?X'?\ LPI5R5J1T[=/X^OK^["E"E%9*U*45*!!3O8
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MX'F5^MUP=99M&@Y\))%!+DEH\\QL(@8PS&H#)2D.N)2- )N$$ : H I%AL;
M]MC\[X\M=6;:B$AR"6B()'8?SBH#3]M]^U715!EQ+BS="/N^HN38]?4D7Z#&
M*$\9>4Z'Y58!Y0'@'+%W]3-&C(WT?37QQT.M2W+&6:SG.I)@T9AEZ40Y,6=;
M:$,1F4V4\^^XI#;2/(0"I0NI)L.AQW>$^"<7Q !)DR2Z?#4?OG9Z,&!T=CX[
M>]HR3&G(K\2HR4D\TP77 I0/ZM?+64J*5$$$:TD"Q)(LH;$7TN*X6[PE^[84
M9M+*3(RP/O/D30],2W;]O3/6F^2\]*?=D;I+BU.%! 2$7MY1>P(V^0Z6ZXU2
MM8!DL,L'UPP&^F]12N%$2Z\A+ZPCF*2$#4D7*SY1:YL"-KGU^6-O@^'3<7SG
M*CS$'L9/U!B8V;-2'!Q+MNQ^S[9Q6Q*YDRI0J?3'"_%62$I$<.M*64.I!:0E
M(-W" 4WTC:USTQUK_!I" 7#:S.-)ZM$;U)?V1V[@>DQFH0JGN0985-8LRVM2
M%L)46BM2"4J3<G905L;WZ8Y*N&"=A_\ ('['R#/4$",Z._76-/7O6.5+6^M0
M!Y4=!_51@G4#;L5 &Q]238]1OBDCD@ ZLP,_Y_%"T,^-6_%(VW"XM,9!.A)U
M)!L-R#>U_GZ]K_+"Q^H^'YSM4#S[T[5"+$;@(;6Z^NHLR[K22I21%*>H6+H5
MN/NW*K7VPO\ ZAV\L5/OKXZ>5-'+26=?[9VT7-Q?UN/3KT_#M5R*VSVHQ]]V
M^]6I8"%Z%@;=0".W7<&U@/PL=L04J ); )TJ/44YTA;T"<W(C69>4ZV8_-'Z
MF^M)2=:O* %6)Z6 ]<9<'<6%)<EP79I@P6(\?/Q5NC+[%+IV6<X3:_7(K-<K
MZ8=.@LH:3*6RPS*0^J6G2%*1O=)*;+T#:XM;UUE:!86HD<Q0IL9Y2PU(<EL=
M),5.3/BP\S^?.M>U:AQHD]TTJ=%JS<1AJ2_):=<2I25)YCK2=920K3J38="=
M^IQSUFZHLSSD;G2-O'[BI+?\CH,9 ;]H?QWJ.MTQR7+;8A,./2I"M;49)7S0
MO]DW2=0(5:RAN-SMB@</<4H'E+<SGV-PSQXG-%<O*6)?? G7W,#O6Q:O0ZI0
MEQ%9FS TK,BVH:V:;,<^U!'COH*E.RGD*>9CQTMD LJ4E6JVQL<9W;18$N3I
MDXUEGG1B^PJD$S#AIEHP3+$]SAF!&!]Y?:+L07/9<^R4BSIT=BEN0,Y-SY[#
M8=;1%5,BA]44)20%Z;I0BUP5)'2X&C\DJ4I#!RI(R,Y/9]_.K.'4!>MDX23#
M9!=ADP[>)UDU\K^&?#3(2<P)J5,CRN(^2LT1YE'EP6DQV\R95"'TI<K$J+(+
M*##CLA;JW6DA26&EKZ X]A\&X %(YP9;(,;G.K1TUFN9\6XHI*N6"[P,AH:(
M)C.O:IQ7N!^6LUY%3PUX60_MRLY6JM9S! S/)1$99J%"6ZXTN.S4&'[.RF4K
M6%0Y:B]H!4A-TI(]&KX1PMX"TL@@I5',2(#@RL$3J'/>N/PG&WSQ"7?E8@AH
M/TJTY>P<D.[A]?(9\/W$"$)K\K+B7F*=(6S(>C5*-(<6$)U.F/#9?5)<*47_
M %C;12VK45';'SKC?AX1\2%A(="EL^A +9)_->@5Q2OEX(#9(+],#J!T9]"W
MJ;(W 'A[,X03:W&9CUKB-'J\83/M-Y^B4MVE)+BG85/7.^&9?G)06TF2TI3:
MUZD@J-\?8N#_ *1X+A_Z>5\1MI!OLE)(SRJ@N]T@00?TB1RC,^<7QUP\4$DE
MAS%HAGPR9.IG5X:O.53X7S<EYFI;N?*.O+67:]-5\&U&G1Y\JGQ'EAE%0 BO
M/J>4A;J="5A2%(6H;&V/F]K@K*/B:D+( YU  ECEG_6[=B['27]'PW%K^4"\
M@:[LT_2Q[Z.!K3_G+ASG&H5+,$:'28$/*]"<BU:JU*!R P4*@+;@3W6KZXVJ
M*B[X:"65RI0U_K2D8WN-^$IYOF<*PN*278\SH)F'(9P'AW.7K*U?5<NJ!<02
M! (((&&=G);MH&->=&'G&9#H)*$O,K(?4AU*I$=;B6PA0&E0Y[9T JW2"%J(
M"21XRYP?&6^(EQ]0#GEF7D8?^*ON#Z6U?(.G9O+O7JMK(-:XD\/\I/BI45JL
M4MNI46&S7*U%+M99?6W)IJDN*?'PBHC+)AMM/E)6%7WL,>I1PW$W>'LIN$JY
M9  2P+,[IG!SN[UI$H!).#X;L,MK R=-JA&36:A5N)%!RS-A-Q<T46IL1V#S
M^9#0*+J<E1Y"2LH2AUIM8:>!M<)4%>9-]E5GB$6V2F0D0&_+Y>-O0QSVL@@A
M] K&,^W,16M.)CC=3S=7ZG!B_"0%U:HH ?>==$>09+A6PGFE02E2R5M-HWTJ
M-]ACR?Q"WQ=^Y;2I)9*R,#H#( RP8;=S5]J[;0%<I?F'7'X9^O6GW(^7\]P<
MJ5;..7GXZ(K#Z8*UK1$,A3C6O];",@Z[Q=?G6S>ZG +$HQV?AO!7;* M8(!"
M=/\ CB8A@7B0=V%%71<8##$#5GU@:N_E.2%,[,^>X+M<J%88^*FU6D08%1JL
MIHNN)B\QQ<8MOL!2F'5 /*"$D(7H\XND8WN+^+JX8VK5LCZPIP)_20$O])U)
M;J*H-KF8M^D^>AE^PV\JF]=D53BKE:E3PSER5G:)!8%4J#DQ<3,$B/"NQ#:9
M;D%N$\&V E)Y:E*)*0=Q;',XBWQ'%V_F,[S@/U9@#N[MLQ)>K$?Z9U&PR.O\
MMX.[B*O4_,.5<NS8<Z W&J-85&=<+LE!F(B,*!5R%H6I#"G22EUQ"@G3Y5&_
M3<^!\+R6>)/$,%?.3RNSE(1+,69]Y;H'K)5Y3CEQNSZP)Z9.&VI\4F@5?)U>
MRY1ZG 5,>J='J4:$Z"EA+KS2H\]%-+H24RQI0E:D&RR=0N"3CH\3:X>\DH"D
MF"#)=RV)#8\C+9K#YRRW5\AF:--Y,^<"M7YCR3(RDTTBM/-)K+WPRVZ8F2U+
MY#*6UH:=D.QUK;#BT( 9N;MK20H"XOY7BN -CB$BV"4\@49)^HJ4#J7! #?;
M?8MW722K]3Z@M(#%F#ZY<S3]6)_V1ES*Z*35:34FJC0YJJU%^SE-5*ER7)BV
MN75W'$)5*?\ ,R4J0I6IDMD$I3<1?^8BT !D3 !WD2?$,S0<M9SIP\9\8'CT
M;O%1,TVKHI":B^ME4)$U,(,NO*0J8NP)^$2D@EA%_O(-D6(-L8<+\W^U^;I\
MQ23 W'0XD?O5"R"H,7U.8R(C#Y\7AZV5PYDUN)E[B+FF+'75$4ZC?H^]39@?
ME@4ZHK"5/L*LHI3&2L@%&PT[J&,[5^Y<4TG$!B#DAXQ^^E8*#L($O/ELQ/0E
M_"HKD[/"LJP,P4"= :JV7LTHAQJM 2K0\J+#4^XRF)(7;DK:<6VI0NE06% '
M:V*KW,F\I"@_Z0=Y0"-6U'^:N2 0X)<>3@J C<$/CPFHR,I27,M2,U%$>/1A
M-52H+;[P$AV<AE,HM<O4'%IB,*2P9('+=6RK2I14<$V"L.&VUYH81HW0_M4D
MB0.KO&I)$!]P) _,JF99I% H-/JSU8AUN37*6E#<*GO$2**X0%,F<%;.,!04
M>3NI)4%6MUV4<-;M#G4"Y&#'8P3'V. YBP%TN.I(T!=O%YQWWK7U;APH:8*H
MDQ,Q3C*%2M2;*;>(!4 K[J@#?24&UB >^-;B46[@"07@N[_@B.M3]NWE[^](
M69K;,B.X&4/J;25+4]=20"+!*!W3M:P _*^.=S_+/(Y^GZ1&SYS.-3XZ'AO+
MM)^_N!7Z(WNIKW/]GIGMW2ELN>(3.BU-H&E""JE4,Z4#_13LD=.G3%:U\P'1
MSYMT&K[U'OW[\ZY,/> &G$>UV\82U A*JOD-8)VNE61LO+3^:6'+>MAZXK]^
M=*^.)(!TW%R2!OUMA2LF@V![DD%%E:D@&UU#38)^8)%M^F+19N$. --=ZEO?
MO[9>*H$*)M:QO87OO]#:V_4?+&O=N"R66%.'!8/@MWJ*-)[?V'T]>AWMZXS$
M@'>E4/7;\/EA2J84H_C^/X_JPI51:XN; G<^@OOA2B_0A/G2L:%@D*";W]>H
M].Y^6(4"00,D%N[=:D00=B*JO2W>Q41?4=NY[C&" H0KV=ATJ/?OM[:E\%K6
MEU?ENVC6+_>&QM8=^HV-NO3%R5-&GO%2_O\ ;:F]QY3RP;W5K*5;6ND7[_(C
M^-\%%R_OQJ*$F^I.]]A;I?K?K\NY_#%)03<289SK+LP]>M2\ -AW.^W6LK#2
MGW$H2$W42/,0 + ];]CV-CV^>+N56WJ/WJ*O?9Y2E(5IU(M?2H$;WZ6Z^GUV
MOVQBKZ1S'$8S./?0U(!+=??OM2;$I!40!KCQJ*6Q9"8[J'=(64#:X)L=O,.E
MB!??YXN2@VCSJ;EPP+DDR([C.[5.(/8UCD2 ^^[)7I0I7[(!\ZB;7*C<A5K>
MFQ-^F^-Q848?(/HU"0<#;P8-X_QU-.$"DS*A%ESFV=3%/ 4^24@IU$!)2D[J
M )'IV[G&*,GM^11\]0WJ#^*;UDA=TE0%[$BQ(V%K_E^>+"\,6W@';WCO4G1A
M# 8U,QY^58G2JXNHJ&]E'KVVQ6MXE\_C;]J@AH.=MO?<UA4K24_,_CU'3Y[X
MPJ*=WH#S,:/)<2D(D*(;\P*KI .X[6N+[GKZ84I/ 434(-^@J,'KU!$U@6L-
MK6WZ[X4KH5]XB"!Q7\"MB2K^0SPJ.XMN&;[#T%_GVQF@@.^K-ZO^* MS;DCR
M(8GIMI7/,)#JTZ%$E-S;?IZ7^O:_J<05$F"1,>_8I5"HELH'F3J*AV(VM;Y]
M!MUOB"2<TK&E2FM8:4I)4DIM\[[[_OM:WXXBE9X$=R0X&0I)7YEDJ(2+) )L
M3L?X'6PQD 3(WZ:4J1T]V*VZVVMLOLLNI6^$*T+6V3=;86#O8 ;#^O'3X>_:
MMCZ^:&@ G'9OR?L)\<:-TDRX]Z0*=\RU6!5Y4=%"BNQFXS:$MPEJ5*)4E%G%
MV-^65J\QWV) ^6,N)X^VM[5KF8 04L[[9[07.IIOY>_*H9\+(<6LA"M8<TK0
M;E86=SL=]*3<#T%A;;',Y>4\UP%BY+!]1^^_F8J*>:5 @NK0*DIYI%U7$=-G
M'"E1205*V%B"F]MK#'2X=:PA*[0'RY;F/*3+*<-$NP[5(C.C%LN_\=>E3FFY
MMHN7G%Q(=%7(@-N_$!IV2N.[-D*0$ 3Y#"DN.QDD>5A"@V>JDDDX[-CXU<X<
M$<L; N08Z/\ M1G]0&SOZ/[TC[\J'-14"41XJI3I>2ANX0WJ45%I%[J"$7T@
MDW(!OZC5XGBN"XE:[ZTJ^;</,LA)(!(;16@&S>- 0XC^? N'V_-12I(;2XA3
M0_5JZE'3MT['N-OJ,<FX$$GY9*0,.PB.\>^P %YQB,ON=/&'.:7TR Q,;?7(
M6S'90EM2)2D+U-J3?4G8V*^]A],6<+:O%7,"D@L02H G(#^^QHSC)G'AOTV.
MC&GB6VTI"'X-;$A<1R.XE1#[4I*P$C9AVZ2@$_>3<  6%L;7%756D@*)."2'
M/A'6((QK4Y:.Y@._9MCKY5E<K[D9FJ/26HTR=.2MEQ]Y"7$A%[:V6[6:>5U4
MX-[DF^,%W^$%L%ASJ2"2!J0'<$Y=Y8M-9?+4V4S_ -P\/'[>=0-2'T(0Y;2E
MS[H!NK<=P+VMVWW]+6ORUWBI1Y%?2>@?K[&]/EJW3_\ 85C25I.I-M0(W[]/
MG;U V'K?MC$7$V2HK)E@X#R9GWFL&8D'3;?1^GK2]R8Z\^V74 @FSO>XWW'7
M<BY^5^V"KB;Q!02S,Z@TCSBD0VTD_8?CO0J4CXK6VVBX-RR2;FR@=D@6)M;:
M_P#6,7(NVULP+Z?208_GPFI;+N_\//MRQ@4O<EMSW];D)-])7I:/+*;759:0
M!IV&XW[_ #M;R Z1 @.VWC/V%&VD[9&SN"0[F'[PX%)Y\Q;O*;* EE('E3=(
M2/4*(!-K;D;]P-\4+5:MCZ>=R6_28(89'IWF:CM!TQ]W#4JIR42I;(<?+;*-
M/->6%+6& ;.);3^TKEZ@@[$JMC8X6Y<N7K2>9(0;MM*G(!Y>=+F>A(V#Z9K%
M;\JF$\I;NV?< ::UM:%0\L1ER9428O,$%<4L0:9%=^'J!J#R" 935AI0'2 %
M*6$D V./:V."LK/Z[4ME:1NX=Q[DQ6B1Q+/]+2)(; $1D,-/1VV=6.'N2>'>
M68M2JV8GXF:JM$6]$I4%T39CC3Z"4(;DHNW'2A2@EQU2@6K>;<8Z'$<!:L\'
MQ%[GM$(M+6PNI*SRI)9(!D[!G.6(#&$_/YAS-RN'^H'TR[8V>*T)F.*[0D3*
M76(OQ685").3)^*$Q'P"V#H"W-1)= %E)*M(_P!&^/*WK;6C>(^F")+MAV[]
M^AFME)"BZ6&V0'_>=F/C7W]\?>6IF<O91>R>:IH3%A1<J9YGRWTH4MB*1+B-
MH6M*=2U+<?*&DI .E3@40 FXJ^#</_U+XC:LV>4&Y<@W"$(=-M1+DP"6#8>=
MZB\HV;2KAP@2Q),J @0(?\U\O<G4/E*KCF0()HV<Y^5SEJFLURI?".Y@G3HJ
MXM1%,@**6=9BN2%@NJ05H%DG41?Z&KX=>X!!*KG#@@?[;Z5;L,G,L=H=ZXQ/
M]R05!PX. )SG(,8AFWIBX!L9<R+Q+H]"SAQ"J&3J@U6&Z?6X#B'S0J;.<8>9
MEQI+C2[H4 XI\G5RN8 5DIOCSEWC.*7Q!L<-<MJNJ?E2;@ 8)4I1=CRP"==(
M$UTK?"V?EN ><,Q;KWU .@[DD5)\Z9/D^'+C;%SA4*PG/.6:G6ZO'C5*C3G)
ML1<.II= ?7(;<+;CT5J2DM,-H-U)"%][Z_"?#N+XKB@HA"K@,_7 :<C2!_MQ
MA]<[HMI04.08@!P^V9\<"&AZB.=N+4S,DJGTNOP:I!X497D,4R5'I83%E5PI
M<6ZV[+4M"'53=+P6M*""A(!U'KCWW"_%N(^'(5P7Q E/#?)6&M_7_J$?3 "2
MSF=&<M(KB'@2J]\U(2H3DAP#@Q+QO@PV*T/Q)BQ:+F#XK+56D3*%*CMSZ(F=
M*-4<ALN:%B.ZXXI:D)9L0N,.JRE8^X!CY3\5O7K7Q!?$VR/E%3I^J6)<NDO$
M.TN(>*[W#(0E 21(=V#=/,/OV;-,D'B=G*))$]BL/(=,9R*^V5%<6;%4@)7'
MJ<5:BU,94I+9:"DDLEM-C8'%7!?U-R<2H+*RGY%Q(^D_J*@9((U<O$D/5B;:
M4+*VAFB/]PB)TG+EMJI2ZI2LPO5J1F:7\(XU0GC1&HL9KEFIA3:6X:D)3_FU
M\U;J%VLVEL(&QQ3Q''\3Q%TW$ <KAG/*6TR#.1/\G)1YD_2YG;3RECYY8,:=
M>&M&AUZJOPZO4*A%I-.CQZG,BT]$A-0?$1:#)8AELW8?)4I3:TZ2JVVUP?5?
MTQQAX[B5\)Q! *;06B0 X4 6+CRR>F*X_P 2-RW;MJMASS\I!.A!(,@^N!VK
MVQFK@OE:#4\N5?AO,<CS)*Z'F>F5#,4M<20[2IX::G0*A*D:1S0$N\QU:E'<
MHOT./J=WX;PO"V$W.(%OE*0 4J"E,0#+*$MES/A7#^9Q)<%V+N1,R=L Y;1\
MP:9^+F0:;$.9EY"RSE7.=$S)6X#]=?IDM4^K93J 0XW-<I[#1+BF"E2UK>0E
M:5%"4D )WX__ $WX;Q1-RPCG%H\UQQRD X(^HN8\6$Q5MKB+R% 7>8<P 0!K
MN\.!AR]:LXGO\+X>5LM95R+4W*M38MJ4G6[(I=4IM?E<CFU>L,'2'XBI/.;*
M-2PA$>ZPD+23POBW&?#+%L\/;3>%T?2 +2FWR"8! #D&"SR:]!PUJ[< 5 26
M+$L8TQH[^XTE6Z!GG*CU:@39+B:0RBD(K:HDIJ>V^)J9(A2V5**G'$2 E\H#
M2;1@A078K2#\XO!:>)1>OV[JK;DI*+:ELDD.X B69]?3?86V"B/J$2X(CN'E
MNHT=ZF]+S9P[8RS HE6ILFKZ)"'8<E*U4Z3#0D*#O/G,EMV0@O)2>6;6"0-P
M1CW' ?&/Z>-E-FZ>(1<8 A7#J2D[25#QGR%:URU<7S%# 2&)8XAW?'N<Q_.]
M3IU;@P)M =?$J$IR'4&T//O(CTPV4A:TN!Q20.A4#8D$];XTOC/+> N_"UI5
M:"2+CJ""%%VAU:,[LTPU38MJM!0N@$J+AB\ -[ZS%:<CRGH$MAR.XXVE+R5I
M<4RA97&+I!4SJ3K#B2%J2L&WW=KC'CK?$<6BZ I1/U $."Q\@S%G[=9V $;;
MN[C'V:'UZAZVY ICV8YRZ],=I\J@T%T&8FJ*^'DSZ<ZB,)"V "')3S:UI0E:
M >18J&P./:<!PQXFQ\^\D'E6I#D%^5("@PC_ )3NS/6K?NI1=3;#CZ0<0Y)$
M]7$"2,"I%Q!H%(S,YEO-.0T!--J2E45^CA:"_!FP76T-*=!"?BH[R;N<YPA0
M\NH$ 6UN,X:W>!1;'U3^KZ1#3GIMLTS6))0GF,!L@"7QO^^YQ3?68F8,N9)G
MY>K4!EH4^J,U*ER)G)=6RB2LK<<B\HJ4I,E1*=!60V =M]L;?!HX;X64W>7G
MY[A'*72Q8I/<3#0\O6:'NCYJ?TN1(8ALP1W8Y+:"FC(N=\Z(K]&BP9:E,2GD
MTERG&,PW3I4>2M3CT.H?JPVXR^"2GF*YUC9M2;VQR> -D\0$'F8$M&"YQO,O
MFH60),$R[EXV_P 8!J.<1%J5FZL%Z"U0_A):FUTYAL-,QRV$H2EIH^8(>L'6
MP-1*'$FYO</BM@J^(7C; ^41:()+?^U;< ;.[3^]66EAAKDXG)R=W;+QCJJI
M%0:;H;5.FTD5I"ZHB8TWSUM&(IUL-*44WT#6T$F^GO8V(.+^%"4) 6 68AO
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MS)A78B/?IIUJ2>WD/V'OL*:5I27  #:X&_<;W%]_2_:X/Y4U%+9[;45;0B.
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MHF>ZBMJ9]GCGII8*5(\0><@1?N*50P;=^H._X=0<12N3+V_Y_P"^\^,.XO\
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MEVQY*_?1>)4 KF)YG( ^HESJ3N!ZU;#-[_CP@^$O%'>IC$Q#U62Y.B,OAUZ
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M&#T?&/'6FW?WVK*VB3#D>9I3:U N(2Z#=22+@6(40H^A 'J3B3;41S0RI&7
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M#>X5<J\WH3L/3K:VU_SQ%*J%;$&]^H/6VVQW_,84K&H*TA/-6;?/RGU[_O\
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MU4?@)>4W5,P:@RRYS7HTV*F88\1QM;04.6S)6\ E #9O;'G1P*SPMRY;!:3
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MZ0A*BM/6^_W;@'IN<!]!<R)&HV\_>STPVN#/O>*?(\6EQVZLS694AB2Q%:7
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MHF<*CG.0O*M)XAT>''E.OIHM-S)1V+M.4UZ,["HSU0=2H-L/V*$N"R0K00"
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M[3C,ANH/I/(AU&%&*=45U80D@(V*O-M88?&.+XFXM%MR[@L^79W=73#N=FJ
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MJJNIWD5#XO\ QEB8VHAQM3J-+K3BD[ZB0D :0GTT^(3=3:''<Y6D HY68N@
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M(_Z*B 1;>P MZ=!:*5(*+5E4>6X[%"'0]&0T^U*0'$A"VQK6V@V 4BY/7<
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M@;X_!^/L?!^/%I'!)XD<Y'/\]=HZ%@D)N-,%E%P<DXU>)2OBDL1\MXR"(.<
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M[C4+*P0O"DG8Z/\ Q4LWN-_R/S4FB9JF0'ZE+C)2U(J<4Q7RRG2CE<M2%BQ
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M^PU7MUN/J,*51UYR0A+;BW#R@0@N*)"4$WT)!V&]K?(?2RE*8T<2G$-7#5D
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M<):EO,H?0V$SFGE)*E,A3:6DLKL I=Q;2#CN?$.(X?B%\Q(4 Y@OJ9<'!'2
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M7&,^:YN)S)]9_>H/CX^XVU?IBDS*$S7'G6TEGX1E:_UO..L!1)"2H$W5??\
MYQ/0$#&*?FBX[_2)>6>(&^9?I.:)0ZR7)YOTLW,"!,2=#,Y\MA9%S'6J&F/*
MH*7D28T@+@.!AVS50>)0Z5.(TDM%K2;)(4E1.XN,?1?Z9X[A;;"Z4/#OR9W^
MI0/7N)-5<9:^@LY+F8D$A]/X<=*G&<LRTNCL-9<:IKC<J3)^VLQY@2Y(=E3*
MB\E*_AM2RMI,5E2E*:1RN:E2E$N*OMT/C?Q2Q\Z\FVI/([@ HY0&!;Z5F<[:
M9K4L<-]"%:E)G>6;$CIN,UIH5JGHJQF_#R'X[;RBRR\%%*T*/5U*$(-_F"D6
M[;V'A%\3;7<)T=V)&'P?JST^U;X'*.4& -PS;=<LWWIDJ$AI^9)EH0&&GWW7
MFV4-NZ64.**@WNE1L@*"1O;:Y..9=(-RX0S%:B&PQ)(]/'>:DY/X]FD8>;<6
MG2I8/<%MSKL/]'>W4>OXV&%14F<<C1X26%!1<=;2L*TK!&I((.Z-NNVVPVN<
M;85;"4X)8?\ ';6<@YW?2I$;;RWY^P+TE89IZD OR2E6QTAM=A<=""VK\_7I
ML1B>>V_^W#O],=ID^G6@8.\XV^_X&9D-2=IRFE3@<== 1]TA"M_J"V?Z!OTQ
M7[]_Q_@[Q'E^WO>KW6F&EK"GTV78']4[M]!HZ_B>^(Q)AVSIT^]/Q'W;U?\
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M0/4U\ 7ZJ]3(JX20Y$D)>+$H.(=0ZZA.X!01N;@;$@ ?.^-D7/E6^4'3Q/J
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MI*(>A\.L+;_QE;JW4+%[]H?%K%]'+<6EP"[E.KME<D.,MH2=*P-@O(.=B_\
MF/*=6-T/B7)D<.\PPLZ4PYF?J3[5,H=1GQP*E22V;2%A9; 2MM/E60G984+
M)%NA=5\)N?#;17=M"[RJY@56$EW($$\SLSN'&D'E.M_;W?GD\I"8/^YM##AF
MZ2(EZBF6ILCAAFUE]<&EUJ/(IR8\IJJPUR*=/IM99;;TCFE2^;"2[S4/(4DI
M>22H% "<>!XG@K"[ROE74D=%H(8G0@%^DD^4]FPA"6"V3RL5#Z?J\5-+-H^[
MFI3QDX9-\)ZCENJ4G-]*F43/E.9F-B@RS.FTN'4$HDR(LQ+)*4.,(66]!0"D
MILI).^-O@>)_LU"T%D<G^FY(.KN&*7R=!,=L+B4&XHC',6;#8CIM^U=_ONQQ
MRU&]GM58>4ZC]KP8_&3-BWY<F*[3I/Q#\&D+4V^AV(DR'$V.J2@<IU14IO8G
M&G\8XA/$7K:R262I(@G!!)_6&=^O@&%8! 3""P<F0">GOK7V_P [>$WPS<2,
MP5?->?>!/"[-N9Z^J(JLYAKN3:+4*U4%0&!&B*D5-^(J8HL, -)(>!*  HFV
M.)650R+X"O!E#7K8\-/" *T!O];DZER$A"0$@!$AIU L !<)!VZX5# MTQ3A
M_(>\'G3^3+P1]-^'&5R3]2::2?F3<G>^,N90U]!^U&&PJJO _P"#U9NKPS<$
M2?GPXRM_V;AS*W]!^U35_P#(C\('*2S_ ":>"O*3NE/^#O+.WX_9U_WXKY$Q
M!CJKOOZ4JW^1#X/O^3/P2_\ 9QE;_LW$\HZ^9_>E'\B#P??\F?@E_P"SC*__
M &;B:4'P0>#X]?#-P1_]G&5O^S<*4?R(/![_ ,F;@EZ__>XROU]?][<*57^1
M%X/O^3-P1_\ 9OE7_LS"E!\$/@^.W\F;@C_[-\K?]FX4J@\$/@^'3PS<$?\
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M#X(?!^>OAGX)&W_U<96_[-PI5/Y$'@]/7PS<$3]>'&5CWO\ \6^N%*I_(?\
M!]J"QX:."J5)(*5(X>9:;4""%)4"BGI(4D@%*AYAV(PI6SLQ<!^"N;OLS]*>
M%/#_ #"JBTN-1*0NLY4HU1<IE(AIT1:;!=E0W7(T..D69CM*2VC]E(Q(41C[
M#]J5%F_"EX:6EA:.!7"T*&PODNA* %[VLJ&0-]]AB>96_H/VI2U'AA\.2+Z>
M!?"C<W\V0\MKWV_TZ<JPV&PV/IUQ/.IB'@Y! /W%0P9FU?:?#WKDU=_)C\.@
M-QP,X4 VMMD/+0VO?_B[UW^I/J<4?+0_,R@=PM8/HH5(B![:/M5P\,_AY2EQ
MM/!/A>EMVW,:3DJ@)941?<M""&]1Z%03<@ $D 8L!(@*5M*E&!I)/OM4,'?6
MJ.>&7PZ.@!? OA*0.PX?Y73VM^S3!<_,[XDE\_8#[5(^DN,[F?N]8QX8/#B.
MG GA,/ID'+(_HIN#]M3^D:^%22223D^&.@BJ_P F#PY?^8KA/_U"RU_V=B>8
M[)_^J?VJ*I_)@\.._P#W"^$XNDH-LAY;'E5>XVIPV-S^>!6HABS#'TI'V J0
MH@@A@1B!^V>N:RM^&?P\M#2UP2X7-I"M6E&2,O)3J "0K2F $W  %[7V]<9V
M[]VT7MW%(/0^K8?KFBR;GZY]/LU4<\,OAV=2I#O _A6ZE9NKFY&RZX5'?<J7
M3U*)WZWOV[#$KXB_<?YEU:GRYJ R4A( "4A@&#L[YR9W-6'PP^')5[\"^$YO
MU_VA9:MM\OLZP_ 8I$%P2_<^DQX5#=_,_O5Q\,GAT(TG@7PF(L!;] ,L6L+6
M'^]O:P_?ZF\N>GD/VHPZ^9_>J#PQ>'($$<"N$H(Z6R!ECZ?\6?GZ][WP<]/(
M?M1AU\S^]55X9/#HHZE<#.$Y5ZG(66;_ $_WMZ>@Z#MTP<]/(?M1AU\S^]4_
MDQ>'(G4>!?"8D>N0LLG]WV;;]V#]O(?M1AU\S^]6_P F#PX^8_X">$HU?>MD
M#+ O^5-'Y#$\ZM_0?M1O;GW[.YJX^&+PYJ5J/ OA.2;;_H%EGMTV^S;8<ZM_
M0?M4U0^&#PXJ2E*N!7"8A LF^0<LDC\?LVY/:Y)-ML8D\V9\ /M4,'??W[_F
MKD>&3PZMA81P-X4I"P$K R'EOS = ?\ )W]'7OC--Q:0R5,-6 EX+QJ,U./;
M_>J?R8O#D>O KA*;BWFR!EA7:W>FG^-^N,7/GT'OWT%0PZ^9_>K!X7_#@"".
M!/"8$&XMD++78W_XN]1?Z[XP*4DN1(+NYSY^F*EH;PK*?#)X=%)TG@9PF*?3
M] <L_D3]FW([6)M;;IC-ST\A^U0PZ^9_>K/Y,/AR* @\"^$Q0DW 5D++*K'Z
MFFD_@3; %FQ!<. 9\11AUG8D?8U0^&#PX&X/ CA(H'JE7#_*ZDD'L4JIA21\
MB",3SJW]!^U34EG<$^$-3H]&R]4>&V3)U"RXPJ/0*1*R_3GZ=1&5D%;=*AN,
M*8@)78!7PK;14FZ3=)(,I6I)<%BY. 9/<4J+I\+GAP"UN'@7PJ<<<5K6MW(V
M77EJ58BY4[3U'H3T.]S?KB%+4K]1=N@'V J"'W\R/M5_\F#PX_\ F)X3=;_^
M .61WOVIOJ+X@$@N&>=!KT9OVTHW?S/[T*\+_AP6G2K@3PE(_P#0#+()WON1
M303^).,%(2H\Q$Q,C'0,*GS\SU/Y_&*I_)>\.&G1_@*X3Z=MOT#RWVZ;_9][
M#L+V';%G.KEY0H@.#])Y2X_[DLK7>=:/3E!\._ 6F-26:?P:X90VIB"U*1'R
M3EYL/-J%E(44P =)'4 B^+D<7Q5IOEW[J&PRU>LSV+U@4(4[I=\N_P"\>%*'
M^ ?!.52E4.3PIR%(HRE-+^RW\L4EZ E; <2RXB(Y&4PVZVEUQ*7$(2O2M:2H
MI40;5_$>.6 %\5=4 7 4IP#V9JP/#VBSHPQ$D?8ZZC'2F9/AA\.:"LIX&\*P
M5A*5C]!LND*"187!@$7 VO:_7?<WUU7KJWYUJ4^7-7)^D<H@,S=)WG6A7A?\
M.*@$G@5PGL"% #(66AN.AVIP_OWOU.-:Y:1<Y>;G^D\PY;BT2Q'^Q27$X+A]
M*QY0<A_$_O2R'X</#_3W'G8/!7A=$<D,/17U,9'RXV78\A(2\RX$T\!3;@ !
M21:^XL=\;2.(OH3R(O7$IB M6FY=SU<SJ].1.WJ?WZ4C_DO^'$A(/ GA-9*0
MA(_0'+.R1T _R;TOO];GKC W%JE2N;_R /D""!U;.M9)/(_+#L[@'&,NWA5X
M\,GAT2DH' SA.$D6-L@Y9N1:Q!5]FZB".HO8[$@D#%8 !Y@E ._(G7P]XQ0R
M7.3,%AY!AZ4X4CP\\!Z#*;G47@YPSI4QD.);D0<EY?C.H2ZDI<2%-0$G2I)M
MI-P/V0,7?/NP1<4EH'(>1O\ ZM6)0E1!*06\O$8/C5B_#KP$<D&6K@SPR^*4
MI2C)3DG+R']2B2I0=1 2L*4222% G%AXWBU)Y5<1>4G!2I:E ]P20?&L@P#
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MJ958J5.J%*;ILC*E/$*?1ZI3ZC EJD/..LE6@I4J24SV77AVIU0R96%U'/\
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M$>+^\5)!!8U3^=I^SW_\V7B-_P"J%$^8V_R[\L*BKA[VC[/8B_\ @S\1H_\
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MDP5!@QW!'83YN^36^BR0 [Q,[C1]3C9@VC55,.+24QY*EJGU9_2[\$@:V&4
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M T$LQ)$S+=YF<4AL2/6==F]:2TH2:@E--C?$/<QXN?"-AQP2'"#8%A)LM2K
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M4*%VXK+H*0T:Z^G[N*M8^@8#P;S?SSFLT5M$1EV0PN0W)=BDH2ZG[[;EDKU
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M#:P+[$=187OVQ?PD\?;T>YW'[&J%_I/O6M_TK[<R_-FJHF:'$U/,67WZG4V
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MG5*8-U#7J*T$J5Y5WN"H ).VUB!T&.!Q%T7;JE".CS$>^M62"'C$MZ]?S38
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M$E5Q_P#442&_W$[C=J"#);?]B-1O^[5AA(?<+Z&2@%+ 4"JU^MR03W^F_4W
M&,+5M"RKF2E6&< GP?M]M:#7'MY]ZMFL*'G&U))!U @[WWL1;;UN 1:W;Y8E
M03;6 @<NX$"6V]O-28(9X$Z'KNV?#6MPYNAT^DY1X<S&@VNH5.FU&ISUL+'Q
M"7'Y 1%C/$><H2A*G$I(M8$CUQ?<4I(^DL6.,R.FG?79C4'7W]H&CC0QO6H)
M<Y^0^%J4M1%@"HE12+BP23?;K^(MOUQK_.NL1\Q;$,1S%B-B-NE1[Q66)$7*
M79M.LM'6I.WFZFQN>]M.YM<@GL<2@I+!3%MY?7>8$YG0U)+@#;I[[OU-2V4S
MEM+4-= EU%LNL+:J J3*5LM2>A+1!/ZM))L1:P ^>-MK11^D.V&Z01I]FH08
MZMCT'>"^]-*4_!R5H@S"ZVA *W_,$740%(0GH0;GRCOVQ@%%(^E03H&=.-WU
M\/NX'M_#.X_S.*Z$\APVIGNX'%\O3F8(:\8-,<;3)25JG.);>(0R0"4* %@+
M"X4!ZXKNRYEPF#XG7.AC,2PH<Z>$BN=-:8RW%.M:4MHTZT+4I+J) 'F0$*W*
M=-U)ZV"?7;&LYW/F:ASOT\-JP..76205$;BY[VOTZ&W4>G[R*B<FE9T-_$M.
M2+DK3H0KI=2=0 !('0;6!Z#IVQ%*1%)OJ%P 2".V][7^8_'^C"E5L";%5AV(
MOU[>GXWVPI2PQ5(CI>4I"DJ<"  05@E*COWMY2+[[E/RPI2<I38_,=-NG7OU
M!VZ_G;"E8UWY=[*4$A1(3:X&]AN0=)/6V]CTPI3O4H$2'&ICD>I0IKLJ(EY^
M/&<6MR$I7_ O!20E!'^B"2#A2F?^O^/Z\*57<#9.K4;?0=;[?C^(MZC"E9E(
M(2@M*)<4;*2F^XVM^&_0#Z;8Q*4JR 6WI6-0*%%)-C<%0[)/7IWMUWQ( &(I
M652KZ4DJ(&Z02; [7M8[>H_MQDY9G+;:>50PV%4U=$DW(MU_CTZ#&+ $D .<
MG>IK&E+C;@< /DL=6^RK]?K8=[[?+&1).= P[5)).:O+O/<*CY2K[_7S*[D[
M[DBU[^GH,145:^A#8 0K5>WFOW)O;^+;=NMK(^7@.^=<X?PQW\9TTSG7_%9&
MK)6A24A2TV-@ 3M;J0#MO]#C4M!:EF20[:D3CRP8@[T.7T,CWTP=JF-(A,Y@
MF--RIL2F(2FYDON*192$Z0".P)3;;;Y[X[=FRDV0%)3S2Y(8D<Q()?I'8=*C
MI^WW\?<4DJD,MU%Z(F6U.0P A$IA14RZ- (4B]C9-])-OO!5N@Q2M*08#2T1
MMW?7RB"6:>?X_>HY)TLZ4K\ZTDA0._11(Z^@(^O7;'/N?,-Q0YSR!F2Y D#2
M<D2QR/*?\^.-]6_8-26]S?3IN+Z0.FWIMM_5BU"%EBEX9C(]6HQRS#>6_-7J
M9(9YA"/O 7)%^W6WY6Z=.N,EH5EB3KF=R'#_ +#2C;3V?WU\:ZU/=>V [1O&
M[=*5)&8/#\4@]$ZZ'Q340F_8DW-N^-=846Y21NQ ^]17G3WEYJHH]I%Q(JS%
M2=D0HN0N&495-.M,9EQVF--.+#95RBXK0$+="=2@G=1Z8]AP7#\OPH7@)4A9
M,S"B J$Z ;OU@@5J@F &,%X=N;KY!IR#7/)E7,%7HF8:=5J9(^#J$92UM2%:
ME)2M)*=8(.H*   4"#:P MMC@?#CS?$0&GF4&=M2[F1_&&HP(,%QZNQ<F0\O
MD_BGG[2J$C,\>3,<DUAUZK-5!YA3[BTS5R91=D,MK6HB&'%K5J5Y0H'?;'2M
MK*;UUI:XH .W^XX[.P+8RU00TMI@# [MELO+EW:*6\5LTLUVN#X")4*72:>T
MB%#HDZ2N<:0A NXVAU2UH7&4[=080.6 =D^NIQW&*=N8P[/ CIS'0L-(!.*C
M$0(&C]9R09TZ:,:C&9*I2*O*@BET[[/AQ(,!EA+NA3CLA0'-=E6%U*7?=1NH
M]SU&-=5U%P   . [ 2[26)=O7%7>S[\CWI^A49RE9,J5=?HL*I4ZN5#]'J)5
M_BU"7%JL99GO2J2RH:G8BXJTM%<BRM ";@#2*E<&I20H:?4Q>6G(2W@2 27D
M!ZEOMYOA@)?7^,MU"JDA+-8@QF'EM5*((\EU;RVR$@ZW$KWW;4KS+0JX41<@
MV%NAP_Q5*P4L-,D/'_\ L+AG!\:HPSDZ[G#,VA&,.-2=HV\IV-+08TDJ=;5?
MFI4;) ZEI75"K; I%Q:UQC5XA9N7$D%AS EX:?\ R]G!K($ND1!R-8Z [2(@
MB )IRCQ8SE*DU9]QPU'X\%$=TE0=U^1<A85<J7HN%.$7(VN03C,V5+^I3MF7
M)ZF0P([STFKFD.1YP.C_ %8\8RU9&:VENCO4=R+$:<6_\0W.0TVF1=/1H/ !
M>F^VD*MWMVQ>B^BP#;('U$2P>0^X('@<Z:P0P/8[S#LTOD.-7B)$OHXJ>;H,
M;(E-3(ERC5E/TFEP4!AJ<O0DZW'C9AI87<?$.D);^\2 "<;B%"^@I $8&(SE
MRT]MA+ TMJP@/$]=.Q!D :=6"K9/FT&?)IU>4S2:LTDN16$R6Y*E!.WPQ>CE
M24J.]QJM?KUQQ[_"E-Y%Q08)+QK+/^D ,7V[M38Z9@%+$L<[- R3@#!ILB5R
M70GD/TMI+4N(HK$E;*5J2Y]W6WJ%]0*B01N#OM:YS3>2@N"'!U )&F"6QYOY
M"0?(8  C>>P9P1C64JJY4I$Y=4???5->D"6Y-92&9"9 M^N#C6EX.[:>8%:@
M"1J QC=^(FU;4L<P*2""D,94 X9:6,Z-$=P0%_2-8D B))UCP9V<M6[."M9I
MSN:'Z-/I4&M3\R!J/!?KI5*IZ'U.I=U2T'6X4+<2%+3N%+L5@HO?UOP'CQQ-
MOZBYY>9R7. Y!*R_LG-:]WA5'K#0^0\_IC!P2-WK9_#J7DJGU/B_4:_1YM2S
M)3I2G*+0,I4]R-2&UTZ3RY<E#SI#$:'';2MVS2 Z=-FTZE#'J_AHM7^/%E3?
M5:O+90#'EM.'!<'RDD.0SC2586@A3%A&QS(D >NFCL8)#I=2S\JM9AS_ )A?
MH>6Z.E4VDPW2V%25/DIC0J2@*UOO D)?<>3<'J=\>>XE*>-XZYPQ 8*4@""/
MI\%XP8[$,U;5OZ=)UG?Q;;5O-Q#G:95T3J?E967G(=;F.B3&JM4CJ,M=+?UN
MP7V>2DM(9"$H+B]84%EL WQSKGP]=OC5<, P%I2SEH4 #"6P\L,RU=!/Z08P
M(?II+PXT[UKZK09Z9556NTXTV8MNHSTNN*49*-;94E;AV%M0)N57MMZ<#XBA
M=FX4$G)!()8MDB!B YR#U+2=#ZO/<R_[!J9(Q<+(0E(;=0XE:$K6%)> =0\%
M+2;A1 1L3M;;KCD+05+L0X-Y()+ZQD L^YU%!MU<^#[3Z?:MC"DUEC)C[[\2
M-\/"KPDNA:4)?_R@T2%!PV5RBD>5-]-[7L<>Y^(_#"?A=M3:))S@I_\ !S!&
M3L9:M%9_UB'[3 ()_( B6? >HM1H\9=5@LR*>])8YZE2FF5MKDR8X7K5&CE:
M@VAQQM)2E]1"V1YD6OCSOPCAT_.6% D #(!#\VC@ /B&\'JWB%%*$EV))'6!
MTZL[>,5N;C7%HT;]%'LNQ(M.H]2HJ*A'H[',?<@$E+*FYTQQ(,N:%MJ4MP%:
M4DV2H]_3\;=19X8L$A@S  ,&=R0H-CJ,5A8ND&)&3.CB0'W&8)8]JTW0:K46
MZNS\&ZIJ2\AV$EQ:4K3HDA*5-DKO]\H38 @**=-["P\W\(X@WK_%M_M59T<?
M5\T.Y)RQQWR(LO,H),&#AH(8RT.R>N0:?,PU*KLT-C+U:BQU.P9,QYF7\,TW
M/5&=TJ6@O)1S5-;(TI4K2-[=2,;WQ'F^40="? 3[^^*SM  $C4Z:D""!UZ1^
M>GSVK^8)^6?9<>R!JU-ETUN6UDFH)C,U6*W+0OGTR<@O+YJ5@?#MJ*D&WE7I
M5>Z;XX/!VU#B!?8E-M27_5)DL6AFP"H'%2IWP\;/O$3+CMFN:6@YW@PG9IS*
M]+$I(>DTQ4:($J<DOA2P\5J3J2TZM5T*!%V["]CCZ,/ZDX9/"?(*4\Q2WZ4.
M^P_UW$MIY16#$'(R)W<ZY$$//K4'9J\9RKOS*_&>G4N4IYVIPXSB8\UQI6H1
M5174$%*^: 70#Y@%:NHQX[B.*-ZZ5P0='T/91\G^[U:@0T."VO3UERP;8Z5D
MI$.9F.8N$)K$"*V5NM_:<IQ#<-L*4&6=U:"Z&DMJ6O91*KGIC*TGGU#,3]4[
M'#?NYPU9 :#\23Z?SI2.MRE1(LFG/QX4AQJ2E#55CK#O-;:58!+A)61U)3<#
M>Y%\:?&CY5V((0!T+DR!LXR"8?>4-!_Q## G=M!6"@?9S\WXJN4^?4J4RK4^
MB&X(B4<P (4'4E+B@DW*TCJ/N[XRX-7S5A*I&Q[=Y:(B 7I'4X]'[].C9$5/
M:EDA4<PS1J]EZ>,QDF#26JTTQ,:C=6VIJY"#R%LHLE2G' '+$]#8]+B/A2EJ
M*T_+Y5, X4# G%MH;0EXWAG\:[GS?IKI4.S#D]W+KS4:9+ITJ4X4A4:GU$3I
M+"B+E"TQA\,L)&R2@75MK.HJ)Y5[@/EPIR^0EX(Z% 88G>:=HSKWCRAOP:4T
M+[-*C1*[+<HU%J#J52I"80,[4CR-NM%*;L(U#EK4E20H J()*K;'#<,D6D98
M\_ZFYOU&'Y8G(\\5"7-T\T'Z9UP-6+>1T?6ME1N"E?B4^J9@J3,*F9.BQ52(
ME>K$Q,9FN-*4E*!06XYUR9"&@$OARRN>'!VVV0@VR0^X=],$L&#B-')WS5W$
M!D[Y9V?$_ASK&SGZ%\)\G\-95&HR\L9HRCGS.7V%+IF0LKTJ+$8S/2*O+@W=
MJ-<5,:::,5JY2A33JWDD$HLK'T;^G4(O<(D%()%M<LEG#S/-AM<@AI#5XR_?
M4GC;J9;YC"8+3_R]&P_5_F?F?(E0R]49R\V56D(J4VI/M2(L.9)ESW7425<]
M)C,):E0A&))6I:[NFR=2ML>*^,_#>3X@I0Y4NH*+ B29(!0_4D$[.]>AX1?,
M 6,""0,3F"-<9\#4)JU&B)J,K[/J;502PI?)DJ;7$0ZPDD(<#;I4ZV\I%BI*
MU*<2HV6K4"<<'C?AUQ'.N2%%\+QW*&.-^C5NMGIMKIZY;4.<4STQ-/,]!J+;
MSS#:'7 EAU3:^9<V0I=PI12;A2C>Y%[]<<ZP/EJY?^((+M,OT][ZAKC&K=]?
MY[4LBMLU.K1H[2#&B/RD(7S5"0\TTHC]M5U7 MJTJ )W/SWN!0+MY28+J.@+
M$OWE].E2Y!><N[,=?0^([TZUJ68AE42(XVFGQ9!##J6$HDE8.X>6$A2D$G8*
M58CL1US^)6DV8@==YDX&PTR_C'O[_MI':L=$RU5JV"AIE*8I)UO/N--))V_:
M4=5MK@;[7]=\/AMG^X60P4!+OT, R \^7>FS_P ]I( _F:D&>ZS2'Z51,NT"
MEQ(],RLP:>]4OAV&ZC6JPHJ494N2AL.RHR+$ .J4+=+"UI^)6Q:4D:,)8#0P
M2 'TDZOC4\=VSG?'6#[-:YA$-R%%7F! "[@&X ^Z=6UK"UKVQJ</E67+8VE]
M=8H-^P#9E\$=NO:KY;K;KMV6"A()V6D;GOV/IVMMUZ8B[_ZB=G#>GO WUJ2"
M"']CQ8@=VU:L3DF7+#*5K<<3'0&V$J6I:64)"@E#042&T#4H!*0!8D=\67 6
M.K@Z2[?G8-BI(8Y.QC0#26(/HU6<LI"E. !0!-@4DE78=2?KU.--18$[ GR'
MA6%9V%N,QUJ96H+62E:0HBZ2 "E=MU V((.UB;]\0A?,'$'WU\Z4"3+#?**0
M&D75H2 D)O<G2D"P)MU-CUN>F-I%QV!9QW8^I..A;05,>W]9UU8:!JD+#KD>
MG"3(BQEIGJ*6DK;07&D(W*V%%)+:S:Q4@C8]1VMQ @G0#/5F)#!O$&-V"WAJ
M#/KVCPDOT"93D,_S<;B3.@14M_#>,N@K*'B%(4L)<)*$$$'40-0'7N;8PN85
MT2 [S#YU)W&GB:'/E!+D>_XTKGDJTU,];DQ;"69LJ2^])&D!@H"DI;4PD )U
M@'22 #I*A?22,:M13+WOWMU'7<;[]?KV-SA2LC3RF]0!(2H$*2#Y22.I%[?/
MZX4JJ3Y%IL+GS 6%_6_XWVV_<<*4F020;FX%K7._?M>_]77YX4K,"H@)!-AV
MN;7W-[#O:_KA2K22#:YVVZG"E )!![@W3?L?47Z=>N%*H $WL -2BI0&UU'J
MH@=_4FQ.%*J=]A^0N=_X^OUMA2LK*D)*BL$BPM8;#Z]-_3UW[X4I?!BJ=>#C
M3!=2%)!"C;2#N2.P(M?IU'3%MM/,^(;/C2ELV$GXX,,,E;CI"4D'65* NJYO
MU3]>^V+3:&P/AT['70?XD#RP3Z[$Z;4QN@I<4+*0I*E)4DWV*38[=KG8CU&^
M*;B>4C&) #8-16/N+'M] "3N/D-R;C\,5TK)K5RM.HVU&]NAV3UW%P>GX],*
M5C";WM\CL.Y%ST!Z'MA2J:;IZ7L>EK[]S_ [_,XEX;1WI3S CI<?940XZ>=&
M08S*=*WD*= 6D*&ZBI/EMZFW0&VUP=H7+@##(<0.NQJ1Z9).G6)_&]/%<B16
M:M,:C0I<**7+(CR=7-;5H3S ;]$%94I %@$%.UACK7[?(M2 " .6-02D$OAQ
M+=LNTN_O03.&QD='I&V\BG*=2\TXHK2GX0K00%I*4E>EP[D)65I-CU21T MS
M[C.<,3VVGSUW?)@Y,(=LXQ$R9SIJW4FL"(;<Z0ZAEM3SI;UML->=]Q^URE!
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M-NQ6XY: #&ATKV1N$E-@K=1WQ?Q'!V395S<05K9OJN X#:IT!!#MMG&(C#@
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M.<M\ZDK:4I(4IA((T*N4E)!OTQP_B5GB!QW& W+ORQQ%[D1SJ*$I^8>4(2S
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ME7Z%X_2!AFDDMAOV\Z;_ ,[^\_=JYX'77E@H7<I04A*3<I2#8G0%7"-2NND
M$[D=+:E15RT-<O5JNY;[O0WWO8=K#K:]B!A2D"=RJ^]C<=_7<?W6PI5^%*
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M&A]_GU?-,:0#9((OL"3?S FPTWV!-^HWZ=>V-13VNERX8:8FP'&'I2$/PE/
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M;@F7.9D-EC#?XV1#'T]?>#2CBO76LS9WFUZ,T] 8J$:#H8E1W&EI!22I(%@
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M$<%MF)'0HZGFGT* +SQ7?DJ-W$W&D@VQCPZSRD/ (;6/-O+I0!XQDE]&]>X
MT\HQ)C.Q'T,N)!*U!=R!< ]]1%[ B]P=]OQQ(-[B$()_6>4>9\<^0C2I,DQ
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MVM/D.I3&&4,F5)::9&Z6G7$@)7L4J"3;3Z@;'\L;_!\?<X(*(+?- 2SC1_\
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MDJ*[]H2_A::\])TA[4=B\I1 0"?VE6%]AUN;[? (M*)) <EG(&<']9\LQV:
M8@&883&[X,O# 9!K)G^7(J%==87485213D)I*)4%U3\-:=(N*:VY8MZ;$*4
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MF?9C-3FH;B,/M*\P,=J1RR\V#MK:2L;;''7X>SR)T#I&6P&D2/ SL^UVG80
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M%,EM"66EARP*M2@023:]B>_96^^WH<;)MNDP>SEF<QM'WUR:D:Y.K;C<GIC
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M"H5E?P]+8ARCS(KB56<DJ9U<QN.Y<%IUQ*4+&Z2=\:G'< FVA5L,?EO; _\
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M K<6FP<S0IB5K?KD)N+$E-I+98DMJ)6MRP&@*Z7/4'ZXWN"XM"T+3<6E)4"
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M5&V 0H@%R'D$.Y( D;ZUJ6P1>02% <\EB1KOHS&3Z17E:K4*3E]V1"E.LK=
MU%$9]N2C5J&H*4TI83:QN38WVZ[X\!\2^'6N&4IE(<!Q]0/@S;8QZQTAW$@M
M.?)\AV8AVV,Q\)+ATZ>NVYV"NJ=_^E8W.PMCFVE)41:2I*N9_I!!)(',6 )+
MAG8:/6+C<>=2/+2C2ZU3*G*AIF,0Y:'76BCF-20G=#*](*5(*R$K&X0FZC8
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M-4^C1Y9;;?4J,VVRZM]6I!#K[C:07"TTC4X5E(2 DDD"QQ9_<'<^_P#Y4_\
M(QK#MEF,N2TYU!EJ?Z)FIFGQYK4J&N5*?I[M*C2VDAJ1!E)=LZI3) 65+1=)
M44WM<@WQ*+JKI%L@J<3X DO)'7&PB"<AEY?.20H1+P&G WTQ3?3E4=%*JLF<
M7G)KFEBGE2T%LN:B9"W-/W7!8:0=]S;I?%UVX+=LIU(B0)>=00VD$AY -6NX
M8=&8 ="#WC=VFHTF6A"P^D6>86V0L7N5B]E)WZIW'])Z8X:4_P#Y"E0?I4._
MU Z!X AL- UIJSN'(RT:3T;&(C-*)U5<E%];[JWG5NLN!;ILK0AEP$ 'S:05
M WZ"PW .-D]]=)RK#;QH\@D@EG &"^=9)R/5R,%]Y@X6($RIMM26(SCS3R^6
MVL(4&GUC;0RZ$E#KE[V0@J5<="!C*W9%X\NR>8#)RQW>2,#R)-1L"1]_ MH^
MQU?):J3Z)/@!)DP7(07Y6TRFWFU*(L?*E24DD;7)%A>VQ.,;O!D21'7&)9TC
M:1K]YAY<= T%YR8'V\)<*12)*G8[C=1@Q7P''4EQU*$MAI(65NEU82@7^X5$
M7-_IB.%X(%:@2D1_&J0WI,YS&Q]Q[S'F].<BHO-PG6U2WILE]7,4^ D!:;E(
M+2U72XW<&RD:D_6XQTKO^A9)&0[MAI.C"#C'?420V-AZAX=MC_DL(MR9#KFD
MK)=6@A"%K0=!.Y<7I/E2BP)4L "XN0"<<6VE7&W5 @'Y2@\&.?F#B%0.0[>.
ME:@Y$X<EO# $N#T;RG8<++D2L4FFU*/)94%SHU/K=. 4]4&8Z%!;U299;)<1
M%+*'D.2%HY(4I U@@C'?M< $VTDP^09US^G.I.W0Q@Y!&!JX$'<1$2--3#O7
M2Q[;Z/1F?9B^R910%OFCM92GHIYE+2IWDF!(N@:3<)2ZE>E*@#;L=SCB<1PX
M7>7^ED*(P1# R6GJT CM6:,#'B7]&C=I,[URI!)-DW!ZBXN.Y)/]>W;\L:RB
M+<X:!RZ1@8[>E9L[])+]_NYJ]M2FW 4@J5L+)!4;7WZ?E^&V(1<5==4EBP+:
M9T<:[Y>,.,R2^??L#]EC,=QUU*5%2$.6"R04@)N25*)L!ON"1;T%[XVK2'R\
M[1.@D=>E.F#UB=O;=36Q:'EJK3&'7(*8;T0'ER'77FRZPPR$K4^VWJ"B@!=R
MX!IN"-0M?';X/A3<M<W_ 'J!=G9@<%/7MF-ZEL^I($:COU[B(Z5/LG'*M(IU
M8F4FISJAQ':>?:HS'.9CY>13GFPEV4J6HI:5-1N&VPZ5J78(%[WZUJTBWK(Z
M@2">G9O+-1)S !8C#=@3TZZQ6+)67N) ^UZQ2J>IAYV!);DU6IO-1"E"E'XM
M^"F5RWY3JE7+I;U"][;6QLVOA5OBKAODAU,DR&9+!VY"3IG=VVU[O$&V2D.!
M!8.TF=4CJ!]JB<^'"I<QI5-A5#,M62A"YKDV*\Q#0\M"5.K0SH2ZXCF$C7NE
MVQ6DD*%XXOX!:"(DY9PPSG_3Z;^356.*4Y!=@>O_ /<SSWZ5B;SEF>E5)B8Q
M'CTN;''ZJ'&HX::<1IU76F6V"D@%1NH'5?6DD%)/F;?%<;\-XRYP=E_DV2GE
M87&',A%Q7Z>0/S*. &+AV-;UI7S$)5'U.-]2,!]M':)>L%8KE<S;/F5>=#<J
MDJ7&3&U&$&FV%IL@!)CMAD$:0;((OU/FO;I<=QG'\7: ^LDAV:X<Z \RI#8V
MSM5A#0/VZ:@ #(Z3-,%6@UN,IB/47EQ/\30Y%;D/AX)02$EIAE2BI@[7T6"M
M[]#<\3C+958X:S=A:$L02Y!YR0X+D9PP).:J5!)8%VT?#OKB)(&M; HG#>KS
M(U%K+52BTF%(DF(*],EB*PT4@?X@V2ZV.>D=25:TDWM;K[3X5\%MGX>E:B 5
M)<X=FB2C3Q(/4U"E!\'1V/XW#DE\'5A3_P MREUQN,]5:W-7*K;5"BU6/*4]
M"2XVE4=*%58J6VY'/01UO*44 $IN+GO?"[-CA2&4(+#]))AP/TID8T&.E<U=
M@FXM7+"EJ(:,J?'+KI)TQ)I+Q1B,4EFGY?FQ'',R4E,]IRMT];*X\Z.[)<^&
MAKCM I+R&0E2W+74F[I5I-\<'^J^)2M!2@A4%F8M_P#56IUZ0(-;-H!(U$-L
M)#]-.@#9S6H'0VN*%.*<0^T VEIE0<"B@:;**"H*78#41<$[].OD.?\ TTAQ
M^D8<.0._[3UK>#D X< ]/RTQ5955BKI-/@_9K4*9$7*<>JEGW':@E2"41W$?
M_-=/W LA(5;8XTUW \*D.\R?//VQ4ZGQ:1[/AX4@I-3$26F1(1KV&D;GH+?_
M ,0 V[GKMBOAO])3RS_[AN23MK02<L_7[YUD_BJE::M*3'UH2Y)E75)GJ'*2
MD[#4ZT C3;J;VV))VN-RY_K!\RT^$#(@1/:IT)C.=^C##29[,QIYGY/EY=F3
M8TUV!+Y:.8R_!<Y3;K5R \TMTA+K:NRT:DJ[&^+;O ?*U#L\.'>7E(PQ@ !]
MQ1O#1Q.VKLTRQ[C%,#:Y$!Q2TJ=8<=!T.-._KDH-]2%@*NDD"Q! ._R..<J\
MJVH$N0""S$$SI(\,#H=3DP3&?3P<[.9-9W:A3_A TU$=7*6"IU]U9 ! W)-^
MM]R#8GKL.D\7Q1X@SK!WV&5&-H%1Z1U\<#$/X;UFH5$K57^,71H/Q1@,N/OW
M4' ELH*G"CJ%.:0K2GNJW?;&/#<"+H4H#4E\'2 0G+C28;>G49$Z;^X_!B?9
M3RK-KE58I^78.9:P[\$Z)T"EQ7I,AB2I)2I*Q'9<5&:*KIYS@0VW;6I0 OCU
MGP=">%4F1$%^4,9:?I=V&OV>J+V'>&UUW>>KYG$UN-J=E?+E4-"S)!K^=,Z0
M2U#;@QJQ&51W'%"Z*3HA*6JS>R)[K*2Y' )=TG'M>&XE/$W[-JXH"U=6E%PF
M0$G]1)+I9I+L ,US;@<* )<CLVH\O#&FC$Q/B*XAPJC,&7ZA%4XRN12:4^]3
MXE*"=E1G43D(;GAM)/-6RI0+B02H=<;2$?">$XI8%RR"%$ \]@'7#$!O =C6
M-NVH@.X) =VG9H)F?7I7WCX@9JI68O=\>+$ZBKFIA,^+^BPDJE@%5XC;S:&T
M VUL^8A&BZ=B0;#'SW^J^)X-7Q)!M+2K_2 24FV0%!:BIN4F6Y2.60((<1T;
M%LIY20V>F@Z,7>,XW!KFS@BB5YE,52%P*H@*T+2HNLSU(;59)7]QM04D!*04
MDN!#8NM03CSR3\V!+GW(<.0YW.&GFK:SX8_:9G03/C46^RIJDO+" 4M*<0X!
MNXA+14E=TV*TI21YR0 G>]@,87OAZ[EI3)5D0Q,A0T"58EW?II4Z]\ZC0F,L
M-WG0TG:IT@AQ92=*"G65?<3J^[J5:P"KC3?J>E[B]G#\,;08I,##$=O]J>Y\
M&UJ-M(#^3=,YS+UC,"2%DD);2;D+) "K#8!70D]OI]3C"]PZOU<NH=P6<ON,
MZYQM0@0 =LP)^S>+TE6"@@*LK5>R@;@Z1N0H6!M<7M<7MC5*"B"&\_5YH7U]
MR=^KU3T'<]-][?3^@[?CVQJ*N;96ZXE";#?S:B$BUK^8D'8FP[7)&]\*4\LT
MV6U&^/=3'#*7>6"AY"7FDV)YI3>X0LC1>Q!) .Y%[;198;/KU]'?L^E2//IO
MY5.*)4F*B$TBO2G(%+9:7(:4RRM1Y@%BH )(=6^GR [@'<6/7T=CB BT 2&$
MR<]<^#S&TT'?&_W& "(R<B*8<P'+C[T:/EQFHP]2D\P5%]IW4M)(+[9'ZQD+
M^\IMRVD=+8YW%\0BXP3H[<Q#ESLYZLYF V*P48D/D=HG2,3YRU-#"GXBGF42
M-+R%J+KB5 )+:@E(65="@$D%1-AJ )%QCFHYT*"DI,1 .-2.[1H_:L-7\0_2
M0YG<:X9V#$3K).<G,C5U-43%:GJ9:6EY3Z5O-J0ZTM*F;-W4@N:_+(< 9:('
M,("A?T?!?$B$E-UP/I9X?S6SG5AXAQ5:T%9"DRSN6,$[LXG3]ZMS:F##FM/Y
M;CU"GQZNQ]J.1*B^S(?;>?65R$(<CW;4P5*NR!N$[* -[3QZQ=MNEQS EC)G
M8.8(QL2<U=;^E/*ILALAV!$ MN)\QI6LW3K<4L)*=1)5>]]0V-KV[W.^_;'E
M0@H*GAR[,WOIVJPJYFD%AN_C6+R@DW%[GJ>G]G].)J*QJW5MO?T_NZX4JW^/
MX_KWPI51;O\ TG\AL?W_ +L*53^/7"E9$D ;6)W)WMVZ;_O/;\L*5:0;DV)%
MST'Y_P!E\*54))2%6('35;RWN>I_ BUO3?IBT6^9 4,L?NTQ[\(EM?>G[U>F
MP /3;>]Q]#OUZ['_ %8H6DD-J-#KT]Q0=?YSIUK"Y<K3:Y^F_8?N]?QP2&2!
MAOWJ*ZTO==R!2O'&"0FV8O#];5M<&A\5-]K_ $M_5B2'U;S_  12O,7O*]0A
M0?:A\2V9$1M^;*X8<-$LN* 4I"##86@;G;R;C8^4;VZG:L*2E1YBP(#.6;![
M$0-8;#T28(ZJP6EV?JX&-7.]<\<B0JI+#3SR&6&$@(LH +"=DD$];CI;UM<C
MIGQ"T*2R5 F,%_?\]*F&ZG/3]WC+M6.,VZ'M"'+M;^<G8#KN?2V]_4WQKH5<
M072[9A_N/\/I5Q2CD<*!88<:[M+N!MK4P@TBL5&/5JG!M/C42"ZN:)4I7Q"8
MCX"&51D2"KR0U'42BR6QOM>^.C9"KH=8P)YM Q)$SC?;L*U+CND!)/81.I/O
M0-I41#3L="7U$MJ6G4";@J3O<I-M[;;C;OT&-;YUQ,%*X)T4!+9F01V=_"K1
MV?+>GX=NM7MI#KR5I7'YBB"$+;6ZI1N.@)7MO;Z_(8R2J^N46[A&X2HL-RQ]
M?*D>C:9\&?NW38U@F23SE6;2UIW6&@.WK8>E^HO?U&"EI3J!L.W1Q]Q57*8@
MG<B#DR[SW(PV*7P*1-KRFDTMIUU0"@JP65* 'F2"@&R[ @6M8FPWW&5M-ZXI
M*;=NXH**0>1)(8EB2SQ^ _?#G"2>90W<GW!QIH\0=@\/H<5_,T=NOPY%7;IR
M5:Z6ZI;STUYA6MB.XE0*A&2I(1(58A#94H]#CM\#P%NSQ8N7F0D%RI;)2)!Y
MB2D;/)>-0]/GEG G^8P8#M[(K!#J-)S/GAV5G*0JDT8RGTSV:9%4'XT."O4W
M2(*00$HE-I,=R2 $MZ^8=AA_47%6[AM(LW$W4ATK-M04 '4)*2VQ)9]69Q3Y
MRB "),")^IV(GV9 FH^Q*HLG,$Q<43H5!?<EM1D27D29B(CFIJ(R^RJZF2VH
M!Q2=]"3<;;XYO HX947+J$#'U+2#_P#M###8 ES#1GRE@PT!V+[0W=\YFEB,
MEP*@PJ;!S/06'&$N*^$G(+4M00;A(\Q 4H V*DBV^_?&U>X'A!_J6>(L+N)=
M24IN(4I1V2D)27([:3-2QRT%@P& ^S/UC7(T%:'FO.5 3\/E_,=9HL,34.RC
M39+2(EVU %\M.72XA-@K0JZ5@:;;[Z#W+:@HI7D200&ZAP-.WC0I+XQI/C.@
MS@0V ":W;GWBC6,_Y;K_ #\QTR#07GZ1%AT55)B-5.M/P8C;4JMOOQT!U"')
M8#Y0"4*"/-?<GL'CK-W@KEA=Q"2OD 25 *^E:5EQS';1+P3 +#$).VX?1I>&
MGH_33.H>'F6F*G74QVJF_P#&1XLEQ#=,BN2)\M/P[JG&(K(!4[S&[H7I!T(*
MU6%KXY8/")/U<19$#]5Q )#]N_4X#FI((P-X&T2[9+8F" !5^6*$*GFM,5FB
MMU.!]JR'44"8^8DFJ_!K*IL*0Z3KC/K2A8*-E!>VQN<;/")X=5YTW+2ARJ(
M6D\T0X9CIK(\JR0"22S,YU=@,%].S '2HCF]^,Y6:H(M-^PXR*BXABD)67$4
MUIM91\%JVYH84-(?.[F^YZXT./61<(26#L6Q$01T&-CXUGL1VUV#^?MG:FRE
ML%R0)#C2GHT5YMV24H*DA(O9*U)!TWO^T1?K8VQ0A'T\Q27U('1R^[ZY>.M1
MAB<'#[^,&LTUIJHU%V33QH:#ETH0L)T-E"@=6HVT[I%K]3]<0I:0.52@#HY
MF,2>K^0:I"@00"# ) +C(V.HSW&PI9 F2(<)%ZC(0[2I27X<=*F@RA9=!4\G
M:S@2DD6%QYN]L76;R;:BH* +:G4MU#D:DY]!).T.T#9L0<OEQY/2Y^I)K04\
MJ9,7.47W'GY9#A=NXDI:9C W0G]L.#K8@;$XFYQ+O]0.L&?0[.!FH.YWW!SV
MU\/+6-2)"7%K0E1"FVU#FA1"BHV!04#L;6(-^G0VWH1Q*D*</.2Y?/4L.[S(
M.:?GP]_8?:42ZQ4LRQ*<P\[#::HL3DH0W'1'.E0V*UI2.:I7*[W((V U8WU7
M[=ZT$KN($%P5@&0T@E1\)]9$OH(##UZY\:34"-2JD7(T^2J,L2H\AYQY:4Q5
M1HI>#S"TFSBI#_-0F(I"@E*TKU@C213P*;=M=QE A2K9+$,R>?) 3]1<L^K^
M."W(# %LYUW8C&/MFIM'S2FATK,;V4:=+@-R&WZ4[7:@MJ9*:BR&UAZ*@@%I
M3RPE/PH0>8R"LJL5W/5O\6E-LBVI+X<&0!C]*XD>'73'E+L0=6Z,#!@] Y#A
MHQ71-[9<+5[*3V0(672I61YANM065?XG-(65)_:6%:G$DFQLFPL<>8O\0H7"
MP/UJ<D$@[-^IM&&=RU9)?,@Z!_MKG=SZ5R\,P)$EX,M(<4XL@(0A*E*42; )
M !4=]@ #OTQG;L7+_P"BVI;G'*3+ZP=ZSE\R>N_6I),RA7J9"$^=3)T:(' G
MFO1GF]3A2#9*EH2""E2; D'<DC;&Q_97.'A=I5LJ^KZD%/1Q C]6^"*::>_!
M]WR,=*P1EQYBVE3D<B)$\BPT/UJRGSV4.H590!VO:UR-L7VC;=N9+G(!#PWB
M6_."U3HSN^@B1 TD8/6=9IQ9G17&*BS!9GAYIUMV+)9><2A,>]G6'T()3H4$
MWW%C>W[-L=&WQ LVU("I<J'U;MH" <-O-5J23@$X!9S)/;P,Z[&7>16Z1\"R
MY3J4_$JK"E+DO$%$=<9(2E)"P -E%5R38DC<=!1=XZY_LYNK%7I]>/*=2#6)
M"F+N=@0"9USY&6G2F6/G"L0)2I+,V4@NQWF76E.O/,.M.'9!;"M*!:VX ]?7
M&QPGQN]PZ0A1($DA15J7_P#U!C1P[9Q5:K 67,&.ACP,'U$YI^<XFU?[/:IU
M'8:H13&4B3)IP8,B85DE29#CZ2I8-S9+9"DBR020,7<5_4-U:&2IWPQ46C/_
M *A;Q,8FL?[5&8.0V?%BF 8\!#5#7<PU /-NB0MT)2$W3;=:@%.**5@J!*U*
M*K[:M6FP*<<8\?S$WE(!NJ)*G2"2T!W45'Z4@2<-@16RA(0D)@,\)8B23!\6
M=H8:TJ5FJMKC)A-U"0Q&U%:$M!M!3J4227$A)(*[FYM8W!O86C_K=X )%A;
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MTKQM[S<\1[5S/QZ!OAEPP02>@/V*PO\ _M4A7H 0?7&7ORJ &\R?,USVAZP
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M+(&0Z@=M#XGH^)[U Y67Y\27+;5(,)5.5*BOF2Y^I2IA]"3'CO$#G)5;4%$
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M$61=)49Y6$SDYD9]Z5B)>1'5_P 9Z37-!3GI.6PFI%"TS$!J5"UZ0A:>HL%
MZDG[WT/RQT+/$#AB.4@,7!\<&1X[^+5D^T9/J^IZ;2PR\8ZSG.K5U^5*J4V5
M(3)TK,?F!MJ.ZE 0 TTGR% 2D$*"0=1(/0XSXCC5<0DJ))Y0$MI$A@%;G[R]
M0-^_OL7;SJ)EYU=BX^M05L0H@D;FP!&W2V]NUQV&.6A;7'R22^=?YS- 6+Y[
M[[^=+:?55TX2$(7I#S>E0(203];[]-OETN<;ERX H.P#;SDR/\5,#V3$R#'9
MM3EL4_T+,PABII5#$YVH4YR(A%TGD$*%G D@Z56)L1Z=,5_-#$%0)\.ATSN(
M@[Z1O,,6ZS Z/FHO*4$NK2X2A=M12M0*DZA<"X[;V'Y'%%Q7,I^@J#[S/6?X
M[5A96D*"BH!(WO?UV_J_=]<84K"5INH7%PI9._:]_P"/6_RPI3E"J,.,U(;>
MBH?4ZUI;65?=5??8G8?@.@.%*E,#-#K5,C4OX6EN,(=0X%+A!3ZTK.G0X_L5
MAO<DDFPL!\NQ\,XL6%)=H.T]'D._5Q]C0JV5$ECDF"/M6S\]9U75<H9;X=)7
M2U0LN?&5AF;2&D&&\_-CI28KK2 EPRFU;*<4HI!'>QQZ'C>/3=M\@(5#DY'W
M?O\ 8&*P%HB6.8_G7Q%:^S3-ID9G+]/IO(>1#B-RYLZ,4I?ES)+*%.-NR!LX
M67"0L[@F]A8X\RNY]1 AB<C4DZZYCU@5L)0 &.P&PCI/F^>]1MZHU)<9/.?=
M7%*N0ZTA9#+H3Y+J4DZ5ZK6*K>:]_3&'S-7P"--&\]\MO#@Y<HF,O@]')D/C
M9O-FE^6Z+6!3I.8Z:T@1Z5/A-<U;J5!B2_I^%4&B"DLM I#I/H;COCK?#.#0
M%"Z6',>8:20[_IP'ZOIK518$YGJ'8.\Z] <QTIYS'28E1#DF;G:B3ZT\"[)9
MBM2B>=<DL'0 "4J!3L+&VQ&UK_B7!VKJ84EV$,"#@;$B,8 J'&HZODRS$^'@
M2=*U\^B)3X8:>96[+;5=8<26E)"MP;&RM)%B"1?H3\^/QWPVW:0",L'Z,'CZ
M7$.^W:M@9'VRY&[>+>L33 )%T/)"+J5T L;@7^?6VXMUZ?3E6_\ 3/TNW[Y;
M%0\OCM%8FY"4K)4@6Z&Y Z=MK_/U_KQM&Z/^7D =)?.N.F7-&&\2P$_MF-G'
ME3K 2S)=)>);:-PE*U\PH/9+9)N$]B!V^?7)"PI:$$CZUI3EX);5]\E]MA0]
MQ W@:Y]]-JE=.R/F?,4>.*/3I$V,)"PER.V5-*4+C3S-P-]KFP W/3'<O_!+
M264EM"[C1S)"!HV\>%4.!B)W..H!\7&S-3I0*K.X?(EOQ:D_!S9\4N.['Y+4
MMJ.S'5Y@D. @/(M=/;4!VQ*"CA;-VT5!UH6E@0/]I&8QC\209(>&#,PT!=P"
MQ\!UC+BK1%S5F672:S5(DB:Q.GZFIICIM+:6^GXFS;02G2E-^9M;KMTQCPH0
MI(+#8X9A TC#!^H>"1@;2CB2# +&3K(E_OI37Q!KT.KYWKU2BL,P8*G&6(M/
M80&0PVB.A@Z$BR&W6W$J<)M<$D[&]]/CRE[A!<@8ZXU#Q_Y14V[:@Q(_20J<
M2T=B/7TC#]>J547&BRYLE<**I/P<(OE4="[@!8:)TA9^0)^??''YST]^-7UT
M"Y/6V/=O>*X6M"-7C+II!4H 62VZ+FQ%C<I38[[[C&*E%3@ZC';;S]Z*YZX<
M.34%23#:4X8:6WWB@C]4FZ4I><).D-H40M0L0I*=/?&=I7*K0#WC#&:D9WSW
M+QYS6^JSG[7P"R?D"+7I,J(SG',N9ZS2&G4!B-/EGX-B<%((+PE-K!0TKRH'
MZQ-B@8Z2KR;ME5I_U %W@@'FG)RS0_:@&<,V3YZ:] ^H:*\\H>96OE)D)2!J
M2@DI4X-1["_7\NWRQR56$_, 8/H1CQCHWAI3!@OUD'WO6W\I909@4:H<1:W4
M68]"HS:DT^,%I,NM5-8+345A!(/*2XHJ?<!NVE M?MU4V!;X<+$R& 8'!#GQ
MC.PAJB?W[^WK5$^HM2EAYQ]M2GUK=(Y@5R"M14H:[DN:@I())V*+7ZWT;W7?
M=\@[]&_Q%2?$%Y\7Z1VUTQ2 261NEU!/H%)O;UZV]/SQ145F^*9L 76P">FM
M.QWMW[^G]>%*JF5'W(>;_P#6']9^7;&:,^'O]Z5?\6UT2\T"JZ5$*&X[?AU[
M@C\<6^_VJ1]O?O/6'IQ93'3!<*Y+:2HI*DFQ&DO,H5J%SI 0IQ5SV"K;C:ZQ
M83?7]4!#*>-3)$$PW3QJNXGF8:.2Y/:79R_V/6MVRT4_*V4\G(H$MJ%+S92S
M5ZY)6><6:ME^H2)%(8TI-DMOH4CXA-B%(>BJ-Q;'I[01PME)20'#Z20R@S,
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MNSYZS[\?!&CW?KV6K<7X)/A\ BZ0A3/Z4UXH*1V ,HZ3L+*38[?,XQ5QE]2
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M#(44Z#;-%=M8];#XG8?+IBT7[@U\W_>IK&?=W/9/*TZO#='5IMIU9FKAV (
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2484HPI1A2C"E&%*,*484K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g729258g56q12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g56q12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2B<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *("^$#:#A"24T$!       1AP!6@ #&R5'' (   )G91P"4  (<G(S-3
MDP.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !"FQWK(KQ'(Q1YUN4.I,!8(.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0&<#[Z         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  N!
M]]  $  @"X'WT  0 ".$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             "(0  !(D
M   0                         !              2)   "(0
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "(0    !29V
MAT;&]N9P  !(D    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   B$     4F=H=&QO;F<   2)     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    &.$))30
M0,     !X;     0   *    !+   !X   C*   !W_ !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
M M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )
MH GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4 ZP#P /8 ^P$! 0<!#0
M$3 1D!'P$E 2L!,@$X 3X!10%, 5(!60%@ 6<!;@%U 7P!@P&+ 9(!F@&A :
MD!L0&Y <$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P
M)Q GH"A *. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ U
MH#9@-R WX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<0
M1^!(P$F@2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<
M4%U07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0
M=/!V$'= >&!YD'K >_!]('Y0?X" L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/
ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M/4Q%'$SL5+Q<C&1L;#P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M;KBPA#:.8G5I2UD* V0/RH).Y]@G<J/L">+BA"RD6N92BH )$R<8W[2<Q0$
M$\B7"2IB'8#V'3\>GQJN</XL<^+7RY'/7S9TK$^.)<:1=<R^J,))94A;X[[:
MLKZD'L@K[:TH6$@$C<C?LZ;X=U^H*24FV#/B+!G@S$B6]QFN<KB5@DCE$%F"
M<;&0!T+?<;5G^&!\5:4AZ32<_O-%?LP83<^6J#S/:EMH"7'"EN"T'<M:7)F%
M(4XM*-U=.WMX/#B/!=5H0.5";AY02P?SW.=I] U6V];;+>!,EI&WK@P/=N]-
M'DOQ%OBC8S+$>[YW^<ZI=4E+B6W^835@-.MGRE;;Z,J4VX?KT(=*QY*O;CC*
MM70SVRDGL6V=N\B(K:YT*,!,AP!!<,P[/@N\_5,?RH7Q)MAOS[\X:3]?^J*U
M9\G_ /FOVW]_'GWV XB(?F$L6AAOL[U( '*0#Y"1N??Z3#BN?Y4+XDOM_A[\
MX.WW?X1>K(_JRS;^CB-8Y4AS.#$=/S^*^]W^#B:U:PZ^?#IA9]KAJEJ!J]FZ
MM:=4:A67:E9=?9MDBJJNE5::^N5=Y%/L+$PH*75IB1C([$=*UAIM 6>%55GP
MX4HX4HX4HX4HX4KHYX0H^=PD[$';^_G;A2M7#ST?$=^(%A?.3S.8GB'.US5X
MOB^/:T9M4T&.T.O>IU324E5#M'&HE;55D#)H\.!!C-@-L18K+3#2 $H0D;#@
M)^OT+5:$ @9EC44_Y4/XDW^OXYP?_&+U:_Y6<*<@ZGZ?U1_*A_$F_P!?QS@_
M^,7JU_RLX4Y!U/T_JC^5#^)-_K^.<'_QB]6O^5G"G(.I^G]4?RH7Q)?]?QSA
M?LYB]6@?_M9PIR)[_F_Y':JB/\3_ .)(2#_A[\X2ALKY5<Q>JZMO!(*M\J)(
M&X]R?W>.(M(+ECL\8/O^&LD!C P=JDGIG\1#XA;N-R+&UYX.;2SL[28&*R+-
MY@-4WF$5\=&\J0EQ>5?F775J+:'$[*2&]TD>>.YH=';OI+A)/0L2);!)?R.1
MALUA0"0X2&&=S]7/T+]MVXU ^(9\27&I*)T/GSYOW*B<XXE@M\Q&JY]+)W)7
M7+/Y5'<MI'4EPDJ4D;;[^^IK]+\BX0D$ &6  R27 _.I(9\ A6$AQMU#^G_4
M;TV*_B?_ !)1Y_P]N<)"?H/\(O5C<G;?8G\JP/8@>/V'Z<:%9" P)?KM]P)$
M5X_RH?Q)O]?QS@_^,7JU_P K.%.0=_STJ5?(G\1_X@6:<YW+#B.7<[7-7E&+
MY%K5@M1?X[?Z]ZG6U)=U<V]C,RZZTK)V3/PIT*2RI3;\:4RXRZA2DN(4D[<*
M* 2DQ. 6<OZ=/KYFMI%PJJCA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA
M2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2CA2M81_"-/'Q:N
M84?_ !>TGWV^NVGM%_;PZ?CP:M1@^?\ 58/N%3HX4HX4KD)ZM_P]]O?]GX_=
MPI59&9>>D,,,M./O/N----(0MQU1)"?T1X]R?)]OK[;G"+8O-S#)]1.(,F#^
M9PQ>.A_/2?H\5(&+6L8E3(BJ<8<MY:._:JZ_#3'@H@QW$H"BM@@>K&Y#BOT$
M[<="W=&E'ADLV3B9Z?F]840)+$[#M/T:,=B33MY!$I'L?P[(ZVWC6-_%>B^M
M@UD60I$&$]'80T]8.E"";-R3WXY2/S8:"'"GW/&TK4INI8L7EY+ P'W=B1V9
MZH1"R2(=GWEND=\/WS46-1:W[.R:R[379B3%"9#2@;-".^H*0E)&P':45-+\
M;E39)\\<V\&G+E_)WCZ5>6$G(:6[[X?N/\5.OX.W^B<\F?T_Z;]4-ON 8D[#
M]GTXHK%S]BO*ML7PJJCA2CA2CA2CA2CA2L67QK_]"OYU/]ARY_\ +87"LIR/
M,?>M4BW_ )FW_P#,3_\ 5'"KDX'D/M7?^_\ ?;A6:$(ZRH!*EK*4_@1['V_W
MO/W>3Q!:@%)2 9@'S<.8>'CZT2H!)4[L8]CG'8EA+ 3FG@T]TQM\K<=GS9;%
M#0QF!+F6]F%L-"*'>TKT<?8KL'.L;!$<*6G_ "MMCQZ3A7PQJ^+)"DA2;>>8
MD!P\NX!V9_\ L<_5ZSY0(!=9#D!V!<X,CMYAJE50JY?*:N%&-([#*W78;\>R
MRN[RIR%9>H<1\TFFKXD-<-J.TH!U#4HJ?2E>Q5[#CUQX3P/AUG]%? 5J%  J
M<%B<^)B&&8W(9R&KA<W&%J)25)&P >-W.(8!S5KFX3AF%)1.Q$FRL^[%LXEE
M:*;D.P(SZ4K$!<4-I2A^O=*@N3TJ[[8&R=_/'#3I^%\'O&_<92"HJM2Y!GE#
M;Y8R':=ZZNG1Q):2%LRARJQ W.9B1'T%6N^O;Z>C>0\XX[*(DO2B4N>HD>G#
M">E*BC9M$?J;< V&Y3U [;<4ZOCVOOK'Z4)2AQ, D;>%XCHYS-;=KAZ'$!^H
M(^KAY<D;#>D8KOMMOLM*)<0MMQ: -P%])'4E#3H 4 ?'L0DE(W]N*+O&M7;2
M#J4)4"0\DY!?R=B[L#M-6G36D.&+F-C.1D#\C=JO4?)Y\&IDT,XL7],^^0NM
MMF$28_2I">HQE2=GXK@=4M)7'<!2 5'V(XMMZS1:M)Y$@JY<- )$YP ?4MTJ
M2+8229)!C:.I=MQ#$/.0*8[/L+A0HOY14,C:O?DEJ73N**YE0Y_DE3B4A#T1
M?LPM'E"?#I4=R.)K=$H$J2?"[PT2[8Z'IDX:K'W )VZ/GU<=V'J::DI*5=!\
MGQY/L=_U<<[ #GH'_.M"073+D%CMCW[8S6QY_@M/^A>0?]GK5X?NF4XXS_.*
MJ(:OH]X5BCA2CA2CA2CA2NCGZ"OU<*5J$?B&_P"?JYM?]G?/_P#SN[Q@8]5?
M<U>G \A]JAQQFLT<*4<*P2P>NS:>L@ ']7ZC[?A]>,._NT]C_>*!3EF/KY/U
MS2@Q^GF7%O6UD)I7?G24--$H4$)2=PZXX1O\C:=U+)&VVY5Q=9MF[<2@ GF4
M!'<M0D %SB3Y9^U2RF-,5<:O@TBC*;J8;#*5.#MN2'4E29JPWL$EMQ\*6%=/
MZ12D*\[<>JL:2YI&:0P+)((?:0!,MWZ57:5S)Q(SAB',9)?.6'O2<MHTR\J+
M&ND)[P#,B4$+:*.S,8"WO4I.P'5T([)V&ZM_?;P=J]PI>KL7KS*/RD+5RN"Y
M"2<&<@.1Y.TU%2PA0$!R!WE1#;.\-N)<Y>+CW4ILI.Z3U$;$#ST[?K]_H?W[
M<>&W(Z;;CSJ^1N[=F[MT)EG]-JH@0#Y /Z_[_P!AX5@$$.*F)\.[_/W\HY^[
M7K3P_P#^111_;QB('Y#?W45AT^7_ %_-;?/C-55QN/O'[QPI1N/O'[^%*YW'
MW_C^S[^%*.%*.%*.%*.%*.%*.%*.%*.%*.%*XW'WC]XX4KG<'V(/"E'"E'"E
M'"E'"E'"E'"E'"E'"E'"E'"E'"E'"E'"E'"E'"E:PG^$:_Z+5S"_CC^D_P#]
MSZB'"K48/G_ K![PJ='"E=5;^P(!/X['W^[;C!!(+0:B7YA,-A\YV_,55MH6
MOH2&SU*( "4%1)W &^X.^_C;?ZGQQE*5-U(S4@Y?\_ZZ#K3V5>/NXPT)C\<F
MX+"2XA6X,)M](*??VDD+'2WN"/!VV'&Y; 3;40)!$[A]R0/2-BU8)'4;YP_0
M_P!9IU\'PO\ +#&,WLBVM5E2NUZH2RX66&TS6'G02ROK+Z);K*(Z$H45"6\@
M[=(XA;3\PJ#/)DR)W<ON'8>^ :3<2#+>)V>=W$>9F1MN"3;ZC(LIH:2SQZ+9
M,P8<H*9G0&F6.\\F,X'B'%*:6^IY+GRA22VI*4 ?Y.W%ZD*0H)?H(<@[XZP7
M(&<"K6# L^<^LDR)ZCJ^YIM\^819X]%M@\N1*KG_ $+CC:06U17B5M+)&Z3V
M'>X%D^0I8W\GC&JM^$*#>A>=WCN?LYAS0,EB^9^N<XA^V*E[\'=)_E..3@[
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MS/7;>6?I4Q/AW_Y^_E('U.O6G@'Z_P HHG!I?L1[M_58662?SO6WP<)"%D;
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MZ=3KMNZRCJ,F8H;A*@=U.(C*V:;5N4#8N;?*>._PVVE*G(!)(E@\]_6-ZBJ
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MY26"([K*)2"EQ:%QP)D8H02 TMY;BF77 5*:"6U)"O ITVINWU7;*S^UXPT
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M;F5V]*@2WK_-<PM\DO)#5/%M(=73NV4Y?<720TW%HZW6^6$RICCY!<7N+O\
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ME*0XRX@@AD%IYHM_G$+)ZM^K](\<OB"U+6#SX4"68.Q&=QCS->MX+93<X-Q
MD. $A\LY W=R.YZ 4C\6U6AQ,9K:.LANUD-5<XBWK1Z6116=RIQ A6PBR@XZ
MW.KD,I5'E)(=6^M8(XW[=Y!0D!+\J1ZDB6!$#>>\G;R)M!*CV489NL=P[9CI
MLWA?IHFV/\5^M6X^EIQT*Z7OG.SI#RQVRRG<I(#?=W=44G8$;3'(HI8#+AV,
MY; D^]3J6GPU(CK?Q.N124Z@H+VI5:P!L?'IER%CQX \/;#;S[@^VPU]8/\
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M,S5JM$+X9MP<,4^8$;X^E6J_M9=U92KET=+\QTN*#25 I4D)WZ4[C9Q\#J(
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MNBW!?I@N)9YS4,]5HK3%U#<0@(0]7,*3[#;MCL[^?/NGS^O?W/&.)&V-<0D
MCY:@#ER>[%\-]L5YIQ:M)AR0P[[ GMVDYP,/K\/([<]7*1_L\Z=^_P".11?[
M_P!?',JI?[3^;BMO0K]%7ZC_ %<8+L6RT535,D)_RG!L?< ;$_M^G]/CQXXP
MEVG^J5VZ6U$?.#L3L"D$^?N.WCZ>?P\\14$/(!._;=_7?=J5W4EL?4)40?/U
M]]]R/KY^_P#]$P$B0!,^_P!J3OU+?G7K7FD#J!+B3[#8#;QOOML-AMO^S]GC
MC'BYA_Z[_G]4JIXE2N.E/^E3]?H/K[_O^O"E!2D^Z4GQMY /C[OU>!X_#A2N
M.A(WV2!OO[ ?7W/M]?KO[\*5STI_TJ?W#A2CI3_I4_N'"E<=*=P>D;CV\#<?
MJ.VX_9]_"E<]()W(!/W[?=O_ +_"E'2D;; #;V\#QO[[?=OPI7/"E'"E'"E'
M"E'"E'"E'"E'"E'"E'"E'"E'"E'"E'"E'"E'&"';(F6\C2M:C\?NE8E?%MYA
M[F<D+@UF/:4+[20/S\DX!4=E#WC_ #$J'E6Q/T^@WVM.0EU$.$C!DEAN&G_.
M*L1@SB?P?ASVK#+8EJ8')1<#[J_D"DAT):'LE/CV 'RI).W@?7B*E?/+O+_M
MPP&WF!_1%'*B ^Y<1C^7'3><,W"H3I:0XM*0C;M(2I0:4=S^;_.JV"COX(]]
M]TGWXB4JMCF(R(R<]0W^7Q6&*?%N3OZN_GYTMXEO*36,FVQEBZJE;5\]R57.
MK6MA+*68RG93@4>\VWUF$\'NIG8!ML?6P+4FPM*DDN[.^"(D]RXZ&*V]+\JU
M=N:S5+')<4E(MN'*G8'E+&7+.[D=ZD1A.?8CI;#DUT?'[3(H=[C,,MLV%@VT
MQ6/,M6<6,KM-M*;DA)ENM26I2"7&>VE);4 KCG<.N647UJ7RD*2J5$,.A?9O
M;U(KTO%=+J[NCTJM/:4JRM!4DD$D"0 "T._<P&<2*NENL'&G%8A<>5 SJ!D]
MJN1,=>D(JIU-.:CNB6VV@*;^U((CF)%9';9[+ZWM_"0/0(OZ86E#YR0I0=RS
M)B 2\-(Z?6O*HT?$5:JP+FE6$)2L* 0HY>3#.1^%S32'.9V15N?8S KFJV(S
M6I9?MF7G7)3CBIC3;Y83U]ILED%M0*CY^\[<>8U!3^H?YR2ZH#AC)W.Q'F[U
M[?@P0G@'&=-<L7 I2K10IE @I4'8<LF'D^5-]CU+)K8K#"(;TJ')0(X>D,J4
M0K<DJZNT/).^Z@?<G=7OQV; 5;2"I(((!D%P" 03V( ;W EJ\0IE*(_;XC_\
M2PAR#_?27BGN@Z1YTY7V,B/$8KF(%:9+R+6SA006FT+=8>C1I\I$E2I"7!Z<
M!HJ?[>[ 41YLL6T7E<Q5RLHD.V'S/6"Q]&+U8M%I*00[J((EY[]@\1[.]2=^
M&<)(^)+R,LR \M<765J*A#PV*$!"G>\D[>RNH_7S]=^+-<4D)9B (.^P,OD;
MP!([OKK_ &G?ZF&$;O[Y,UM$..;55'"E'"E'"E'"E'"E8M/C4CJ^%KSJ)]M]
M'K@;^1X]5"\C;SN%?7V'Z^%&<CJX(VGZUJX=-8GYN?,/5NQ':8"^GJV,I022
M-AO] %=.Y(/@;D<=[@=I*-1<OI)(;E)?).9#]"??RJ_WZ8[[]CY0'9GJ2N+.
M4%=C&4I>0Z<EE"OC4A>@MRH#\=]\"S"5J0'HDZ.E(5#?0-TJ*T+ "COU"FX-
M<Z4O;7!$ ,3)(8,-P0^X$U4H'Q *8D%@X$D.#.1S%NSAS5KQRR32SS9)B-SI
M+74J-UM=;:I2$D-)>9((D,*<5M+:0DE+8\@>./0\/XHC0W56]4RM-RE@H"#F
M'C.(ER6>M35Z.Z46;6DYKFLOK(N)+LD$L_41$D3,4JGZ6168_8N2)S4>[D1#
M)G!8["XD-Z05FMKU;=3;\MMU+C@\J,?9H#<GCR6LMV>)\44KF;3<Y*".I$,'
M,',/UP*]U>OI^&^#V+-E//JKR$_.Y1*2H3(#AGWQA^G2D7 5CC:;2<(@C3WX
M%>W"8"7GYL^.J9$>L9(07?0^ICMPFW#TIC/NI)4 K8^_X=K;F@TBK-Q(1:O(
M=-P  E*@ $@Q)89?RD5\TUEVYJM6A:5J=_%.&+J?&#MD#&:H6&ZW,(M-39W%
M?+5%.>^S\KC%U>15B&WD/*AA2QT3X[#Z3Z5AYOI"P6DD;C;RQX(>*<04DJ*#
M<):ZS*(V(( YRX8 ;^5=:]JC;TR>92B D.'+I8[].\8]*6FIPGXS.K;Y^;82
MV<I:;LZ>)8+3'G/5\2.Q!;F38:>DQI3Q;[K:%I25-%1;<<1U;^LN:9/ N%*T
M5VZJZHVR %**IGE8*);(;[DP>=PWB.JN\2"]*DITVF4ZR@-S$<I()&01^[J<
MLY9L[!#5LRO((#CS3R@W&NX#1>9+$QU!+<I"-@# ?"1\Q&P?/;)V4!Q\YT?$
MM3H-9=9:S;O']@*N7F<##A+26'2>U?2^,<-TG%^&HXSH>56MM<HNV@ 2'(YE
M/B4@L>^[TF$,(4EZUN);$"MCI5UN/* =7N#LQ&#W2I^1L//:"D[['?I''9U/
M%;R$D7RP;PI2^.\P2Y'F2!TKP2[ET(-W3)=9+%)!Y@V"SN.A\QBD.-9I]/\
M:E;1U%,Y7R4I0U*LJYB;8-J21M*8EO;KC/JV22&@>D_7CF'XJUMI7)IT(^5
M/,GF+/)<D^?Y.!P]%X)U.H4H77*N4*<.=FWZ3F8=Z3E_JGGN9LMU]YD]W80U
MH:BQZYV<X80:;4E3;'IFPB,&D*">@NA1)VW/C<\C4\1U>OO@FZLH.4A9:&@)
M!;R'60SFMI%M*&"0T DGL,LS=C((ZUL9OX-K7N5GPUJ2%(3^=9UAU)2O;H "
ME2*M9 [9*=OF/@;>/&VX)XUM<2A2   >1 ,,2>90)(Z[3_DE?N/YG^OJ<U]
M?&O4:.%*.%*.%*.%*\W3LD_<0=S^KSPI6I,^(;I[E'^&;S79*W5RGJ:1KQGY
M;D1FDO=!<M%J0M]IM:W6@H!2D+4V$N'QXW\="WPO57;!5H$&ZD'8'H"IP)@]
M!6%:I-I(2XP^P$PSN/XF9<4RN-Z;C$X]=D>0S*\6ZEID5>/J6LR(4E*D/0I5
MEN.VV%#H?:B-GO$@+<+:0$G.ET_Z>X1KT\APD$<LD003#&I(4+Q<$@1&)W#9
M>"#G#2*N,F2J2TA:2J7.EOK,IO8N.*?4XMUYUE(V*FEG<)VW2!M[CB=ZXE9
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M)/7(;R?)?N^^*A8^9603W6;5+,9YV3ZA<UQ1+96LJ"9"3N?SJP0%)WV  &Q
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M<6TS V6V8@N1CS:I5;$9>EJ2A!6X'^/=RX]F]Z3D^0ST'I'GTBE5JS\5'5?
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M99#-<B/6NLCMHKE,(4AJ)-5'#?<9"?"@G?MM$+/5T@<>FU5O4KTVF\*(80D
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M\N;U0J4"!5KW;4I&Z9LI)WW,A_PI0/GJ9!\ [>=@>.=J=6A7,D!G=ISMOMF
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M->99+TB4I*NW')0^V6PL;E0&^K9Y%7 HC!<DB8(R) [L!&3TIN)4 46O"J0
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MR99YVZUK:Z9U5'A=)3A3?V_)IH0MD];3(CL,J<D)K$/;'\\.OKE'8E:T]H^
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MNZU7S+RU7%D<O,L$EL_N4'CS]:ET@ ;) ! &X4=M^K<[^/?V^OC_ 'KS-:X
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M0#\F\SJ S_M+,I41!C+5(H$;#R/8>1X'M]/][C8V?'GMYUR*YW_5^'GW^_\
MOYX4KGA2CA2J [#8DC;;Q]_MN? \DC]1/X?3A6' /<^<PWVK#'\9?4"]G\AO
M-WC^ N-)@X;I3:6FH>0/QVYT9A];L;[.Q""VX"P];30I,BT*"355_0IU3<N1
M'0K1U-Q1\*0X)"5&"P=G'42_T8P_IN"WK7 UHXEJT%2EHNITJ&"B5*1RFXM
MGE!Y0DEG(?#UKJ-*H3V3X\_.EN)D(AR76YS)[YDK"@7U/.2#MMNDJ 5^B-]S
ML//'N-!9M'@]I:/W ,K<LXSF=]F?>:\WQ&_J=3Q!7$"M1N+)*':.8JB?.'8N
M6AX<[4E6FRZNE8P&OE5DJ+'AFT>ERS)F6LQYMYR:PI+.[!1$D-L(AM^"^AU:
MSY2#QNV[1%RTNV0>8!+ CF!:7#QT[-5-E94I0NN=5/B: !L,O$;/'HQN0Y5#
MQ@QGWNF==E*E)@K#O3"<4 &7YA5X4X H;,#?I/DC8 \5\0XI:T)5I[R?F7%)
M'B!2OE<?^R21@DMGW%6V2HI+@@AY(8R7W+SYMT(+FH^V]K+NI<F98252I3[O
M62OR-@H$)    2/  V V_?Y'4*%P_-$I)Y@-\F&VC?I#16QG?J#D=O,;U;@5
M;=*MB!X&X\C;_F\'?Z?TT)1EV.,D##]?3[4_//\ /[KGB8+>Q'N&I1QBE'"E
M'"E<$;@@?4$?T?W^_A1VGI_?;-5E9:RJ>?&LH2@U)BNE:=D]:%(*>V\W(3N
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MWW#HVW(Z3XXN%X);<=P-_,&1B-H>L$R8<N#[L/R2&$D4_#E;1W4=-IC$U-E
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MJGR+'3ZWF-0<"S">\MY^FEO*'I<*R20HJ5NH$M4-S(4 \T@0)2_4!I3E2/\
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M*:T41ZN.\234XU7JZVZ6L8'2TA+),J6&^[,D/NJ^7*$AWGF.7<)*3!88=P[
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M&V52HW$A)Y'@P'!>LG+C[3#;CCCB6VV&EO.+6H)2TTA/6MQ2ED!*4)W4I1V
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M?3D2Q:/1F1$D3XJ2U*<"UASY$>V_T5/_ )4L)NN;(*#L,><0"S#IF1OXT_\
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M'S[:W7WWGFR7W'G5J=4C],I/6^[Y W[BU;@#R!X \<>58@A)2'Q(Z9)!8S+
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M%0DN=WTS,9N(L!MMY"0^IQ9<Z@G;J[NON_"O&;'RAI1IKG*$<R$\CJY4\Q8
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M)[&(*%R:?.,OL[J-(B%R))8_*2:Q"K*^SE?F6I>Q+CO0I'YL.O=._GCV/".
MZ_B:2;5M188.,P2Q:" P<Y'5ZA>U5BP$I6H P& >8[0"^0[>L6E-=D%W%B5
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M*$):=8;\LM@J<0V D$* /&GJ-!Q#37.51(G8@ !1;J^\/(>=JL1=2M!( D9
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M_P"F=# 0$U*=EASIZ2GRE02?!VXV==I/AKEOFS9MIOBV]OE ;G,D[C#=09?
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MTL]<IN.KMK9C]@%/6\I2^K](?0U6DV4A1N7%<S$A(!+]=^@\@'SBK%FY</\
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MVMR"9\2U^BXHI.JTFG1;4FR06)"N4I\1;F+L&,OON]:W^FZW0+N)U5P7#XF
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M;:-MP..DHHTW(=)RI0GE)!8&,@ E@3V&^7SQ+E_4:NX5ZA:E.0TY+ER3'01
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MJR68JY8P[>>Q./KW-3[%SUZ;=6\XC.32QB+.#BJQU./6OI[&:[=KM>E#Z4V
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MW+[/TC((T@5V$IN()'.1 #DA4;Y$_3R-(F_IVZI^DK(]A'5;W7K%28L?N/\
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M)L>@I),*.(==%78W=O.ER4M,0*6M;4AV;*"5+DO]L]$.N:DS9!#3*E!2HO\
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MW;S$@G/7=Z4EX_7MQL=K*QR;#OIL6IDL(:;4B!*-HITO22XZ@NMRE*6V'V5
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M?I W^X;C_>WXTRL @=Y[?YJBJCB=*Z+( \D?@"?U;G]@_P"?A2H(<[Y!1RO
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M^J*F6%#E(<$M@O\ QG^:I%U.&2+6[L95XG.(UC(CLU.*W,J=3*KWFDN&6_\
M:R6TR!#4_LS%ZW W):Z5/DG<\4CX@U#7^6U=(^8D @!F4.AE@W0M)DS6QI]
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M[^KB?ZJC_=_FS?O]WZ7&:S1ZN)_JF/\ [<W_ ,+A6''4>XH]7$_U3'_VYO\
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MGF?GHDF(I*B)<SMCK1)CR'GVI#2F5I2EULD+".KC46CY:O#)/]/WR3+"=WK
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M4WFE/M_)P\G7_>LL/]TC4_\ Y8\1Y?\ Y*]Z5P?AQ<G0_P"U78G]6I&IY_\
M^QX<O_R5[TJS9)\-OE0DXY?L46F4Z/>/TMHQ3OKU*U/0&+1Z!(;KWBLY>H-]
MF6IIP+Z5=!2%;'IV.0&W)\S2D%H=\,[E^H]'-+Z75[ IE_JE68+C4#4"[:U2
MU.G)M\PAU49J_L&YJ,KC)E)DV*9#QD)C,!T*2H-(!Z>,^OM_EZ4Z_P#)P\G0
M'_L66&P^_4G4_P#I/Y8\1*7W4/(TKK_)Q\G).R=+IQ4=M@-2M3MR""1L#F/L
M0#Y]MOO]BY>ZO>E,=;?#%T87S$8;D%;A$N/H="TKS.IRW&CJGJ:EVQU%FY)C
M4O$[AN!^5"EO)KZ2-D,94P2V0QZM#)9=+@4B5*?(?#AY.MO_ &*[$?KU)U0W
M_IS$\1Y7_P"2O<#["E<_R</)U_WK+#_=)U/_ .6/#E_^2O>E)S,?AL<K$S$,
MIBXOII.B9)+QR\C8[+5J9J<VF+>2*R4S4RE.G+W$M"//7'>#Q0L-*0%E"ND)
M.0&>2?,TI):._#0Y=Z;2?3:HU4T_F76I5;A6,0<\MFM4=398M,MB5,5F^LD2
MT97'3);DV+<E\R$L,=[JZ@TG?IXS^?CTIT/Y.'DZ_P"]98?[I&I__+'B/+_\
ME>]*>/27E8T.T1_*#^+3$)=!^4_V5]M>HRC+;SU?V+]I?9O1]OWEIZ7T_P!K
M3^KTG8[W>3W^YV6.W*E:LKF%;R? ^:S7J)85S9KK_774FP4I8:EQWZQ>H>0M
MM.-N-K6VVRXIXM/I44N)<2E*P%<;(MK 2!)(?8] PD,,1F>M;" X'ED^F):7
M8#+Y9WIF[:PK5&YARE,US]DM33RIL8V=BT!(=*/3K:<'84A"$,!+0Z VLA6^
MQ'%1MJ<!1,'8G+>V_7IY$0%.'\W!F(P<_8,>E6.D><6]!JK-Z9*@^M4TS';:
M4)*V&T];0)5NI,8.H22C?I3X/OL>+T*YF2[I@MF=A]7(/0/60IX=^6&_@]<3
MY;4I;Q^-.KX\"ZE_8+,&4X:V X@RI #S*G67EM@!:8[10GNO%:RLK2/\G;B%
MRX1#-)D]MH/?W%%.Q/4$@/F8$=]HQ7A3S),F JF9<DU-W"]-+3<QG]VI%=)W
M<,0(1[ID_F-D!)4HJ4'0-B3LC50D&   Y2[[R<$MU@@=VJMP6&'D=CG<;OY$
M8I?OWCR8,Z/8P)]K8SS"KV M^1$,>:W%+*GQ%:4 VIMA94"%!I](7U$]('%X
M7:6Q4<, &,='_F8;>'RQCU=F<NV\>IC^K$FD2BU;?<4I35>TGN0PI32YDZ.>
M^\IE#2G%2)$%"W?4)*$O*!ZF=P.-9-QM5S.R0(WV9X:7+8](%2"26W<#R<']
MSC:/:E9-?0B4Q$J4-RH"(49,,V41ZQ;DJMI/K4O.26U;M1ZQWN@N2DJ4T4A"
MB-MN!O ZY*G\/,"<-L_YAB0^XD PY9=BT=';/ET\FD'AM?J+,6-8X+. B1]G
M6#]>X8S,RN Z''6&G$JCH;@R" %GY^E+?D  \>X&OTJ](0Z7Y4@M)$$%H@E^
M^-JYP2I)?Q=6;=SZY]8Z5?:ZOFI0I<YQ4Z@I)KK$:3+CA-C&$9"Y$">XPTI+
MTHH[A:9=425J5W5GI"3QX?7 +NDV\%1ANY;IUG_!K:"BP !8O+D%WVCW_G>]
MUM597 >M:K%)%G7MR["-$NBZRB0PXXSNN2&4*2\O9[I46'EN*\$A/@<0LH"1
MXRD$F 7!E_KW$>0+U<D  D%H.V[P,,'9X9CY$T46+1+>!/R:3#EY%<QYC$>#
M017U,"J<C/K7(LY#4E0;<6CM]Y;?:4HH ;_ VWKB$MXN40EC[$ERQ/0@%J%<
MX9Y/OES#N8(#AZL<"\C1[2UM(+*I<"9M]JSGP\S$7;*:<<#RX38#<)EU20'7
MV5)*RE 4@%8XI 25/!('[=P>V <= V7.:B &,Y((W@=-L,WK)BN:^_L7H]GV
MFH+]1)CNLV-=-#C;<MF6M;CD9#3C0<BH[B&GX;L=7<0I3;@]@>/1:#X@3PWE
M%RSS(<<SI)24N04^V3M@XK7O6>>7D)?=RQR\!X )?NU.I!FX;9X[58_6S9SN
M38U9SXL:L=A&=W&9<-F8*Z1=N.(;4AHLE$-UX;)#BNX=_E'J-5K> <6TXO6K
M%NS=0@CDY&YB 7<D2^1VD9GGVOGH4"0HH*F+NP /^"#YYW%VY<W(T[F(T#RJ
M:U50J]O5C!X%674)9M8TV3D\)IR!U)Z?5NMA+@8 !#  Z5I!X^?:M8O7%V[(
M-I*207 !81!(?'N&-=42DM$' @MW=_-W<C</6T<L@%XE8)45=)QV2"H%05TJ
MJEI)!3\P.Q]T_,/<$$ \<M /S;9!E*DXS^YQZG_IZK(<$%V(:.\?WZUJF]>=
M9=7<7UHSB@QR8NLHYF:VL2!554!*_61TVTN*E+ADH=E.NRG$EUWOCO-R%%S?
MV/'VA?'?B70C0#3_ #56O]H'E26Y>5(DB)#"7W8"N.>%:4J6I=P<WB+%8:1C
MHPR.H8YIS7LM>PDX?C-["C6M-;URH]Q87 9BO3;R1UOBLIG@'?46=4Y+3$6^
MZMIM<A1#H*6QMTOB+CFO%I!U-H6OGH )N!G*D ,,@D8)F9VC3TND0FZ3;!4$
MKR)$;LQB(ZYDU#_4+"'<$E2LCCY8&Y<B1'D5]2[(3.L#'+R4F)+>8 BRGX2^
MA,UA:2TWLI*"OZ_*M?P_]"@\3M7+G-<42R!@D_MYG,'N(CO7IS<1R $$, &)
MD[!ND_??=6:0N7$^ZD7$X3,AN,K"W4QHS?YR6>I?>:>4E.T-A[VZT]*V4M(#
M:MN&FX;>XG9MWBHI5=Y5%*O"H,8YL,5.YB!YFL'4)^60.49 ZX@AAGOY;O4A
MK!VBJJ1Y)I%FXVCR5R7G92JE#<5T+D5\=;I?4XS&D%:);\=AMEY94%JZSOQ]
MG^&=;9T?#46=4E*_TH# RX)2#AP9!<0_E%>9U%JXN\_,0.9V<2,"#(B"1D&)
M#TAJ>HL;>Q4]AL=Z.TA:;*=(KVE+AT-8VGU$PK,LAJ-6J5UEWI0UW6E=DN'?
M8^PLW?U]L\30I-C26)/-X$D R #EL?2M:\R%"R"/F[(=RYW\I!SU?9G\H&8U
MS3RI$?):>[SRYD-2L>Q^JD-=N::T)7&;EL.E<%N-&6P5+[P#0;)90%*3U"G5
M:S3:]!1H0A*B"I5U/A2HVA(YHDD.V9/6M%:KJ#XDD'O#RV?38N=W>E!0IJTU
M\W-5XC0?EXU)@#*I]8RE]NN[3RV)=$RRZIR []H*<8>]?&*&HA"HX:6O8#P'
M$[>GOK7K-8D)_3DI3:&20<A/21.[OLU;VB6JZJ5B3()Y02!!C>6V8XJ+%IC]
M1F6JJLMDT+4"- L7[-R)3]BLCVS-<&W'%M19P$1D-/)2Q)=;"&UMJ4XA"DE(
M'@M8+/$%W-?80+8M@CY9(29<"#+AB_1\P2?3VN>V@) *QETR/?'4^G0"N<DH
M<'R?#LDR7)<A9H[7)LN-CC6)/J8=8A0XBEPK)I^1& 6J4]'27*]EQ(;<8&Z5
MA02#H6>'IU25:A>H2DHD6U+92B,P&=/FTRP&+TW79/(H[$M VR6!8X&Y;</5
M[Q*[JL8TMMUT[+-9+R&_C1<5AUZ@F9Z>" F5)M9S!4Y#:EH4EQU( 3)(0TXI
M0!'&S8O,?DHN)0JTKF+&2QEI\O#U(\JJN6N8PE7[223@$C;#NV#OEGJPO:QW
M%2EFQK[1K[9MY'V3"3*7)DR68T508E/1VEMO+B"++;++92LM!M7RH )!NU'$
M5J=5Q1!@ ER[=&B0W1B[M!K%NW\D@@ CY:GZ.Q#.'QOL1[TR^29/E=%%:DY#
M$G27IC-M#:N&76C6N)D2^ZEMP):[:I4-P[H;\*"7%'Z>-5?$-59MJY;:U6EI
M;GY5%#$N0"<L"''M5B$)N&R5,Z Y!(>1N! ZSEG9A-[Q#7>P@6-9:UD6:[J
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MG#$D1D0! 8-W?#'K5Z1U?# SNX$>C99C!<&JWLHDQMKE26:1N186KTA;I?\
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MM*>06D-!LN&0 .A:D(6.GQ\ZO:?5624VEFZ%*Y1XG#*8.69S$;;#I781?Y$
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M7RD6S#\I99F3H[Z$0IL=.R0Y!5$!,C8K[GS*;!5\W'@+MZ]QA1OZ@D7@Y8N
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MISJ?CL'-HF/1\<OK&BSNYR;%JMK.]-)V60WH<4LS(*67H]5:1E/S\_/YK-;
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MV\A*@@5R([GI4N)(=*04(\CC?^<UM!6>4!( N$@ -# F0P'3#!]JZ_#^%JU
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M(4DE*D$%*DD@C8\*5&3$^5W L'U5QW4+'X=/1X]@.#7V Z5:8XGB=#BF(X'
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MLS)5?*?6Y.6X^0V)"I[3;:FR4+:<;9+I3U'I4DI\<<6WJ1=LIT5_3 A(8+4
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M@8E7< L5'#=SOD&M+4ZO].'9F$&1EX CH-H>,U,[E%P--!S=<MU7%M,8#_\
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M/J/A8CKBRVK-;E.K*:QQQ<)'82LE:E"(X\5J6$)*U/;'?C/RR))&&D_4G(.
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M3A))'8B1#@0-^IWVJ2&,RGAC]=$LV'E8[4M6RQ$381K5BB=F!33C$MUD!(J
MO\\M]:DGOI0QT@) 5N6=0%Z5*-7J;JPGEY;:3S!Q(![=9;<[ S4F".4$DI>-
MAROT/J#GH<L91Y'8XKGC<QN\NF;*NM)** XU)C+@/(4A0BLE#/6EU,YI0#J6
MD=M9*D.@JWWVN%<9.@UQN*42E)/A+<I&1#&7<#;N$O5-S3(N @08D^O=P6B1
MY=*6.:7FL<JU]189+4V4.RK8M@M;<B#&%#WG$E;"&G.A3,V-TE"G&NH+0%MC
MJ 4.(\5XTKC>J92!80EB"0P/*2PA@['#2 \O,;>E%MCS$D'H9SA_/?)AQ%4.
M2W#./M5654EA#AF1#]+DEI40C]J&Q*PXE;S#G8:<4X!W(DUOJ[A4I2T'<#C*
M;R-';&ML+3\PB;:5>(E+!V=NS,16PM N0IX((#P<XG<>4[]+=<YI2:C?SMNT
MF5W4E-8B/->KFYJ'RA)7>/2FT,+2E]Y!(CH#G0LHZ]]CQRKUU/%K@NW%(LW/
M"#SEMPS!I9]MNP#$H2A)2'.9<.8+C)Z-CTAPK\J;LZRBQ.KKZ%-F_P!B9#5<
MH5(E2IK;[+3I4XEE1C.=2T S$I;Z0CI2KQN#W["QI-.+>H197;4 GG07#'=V
M#G&'+X#T9(/-W(+N[DL)V>)S $EF8K+\<M:6^I)CT"8Q%F)A&)U6 :02X\HN
MNL@AMMEEAW=/04AIL;#K  /'$UEH6[J;FE5>0BZH#P@CFYBW*0[L0"V&$DO%
M2Y@2!#PT.<]^OI[P)%YYC\S5JWQ+2G";BH585L)ARTCJ9<@JDOR(R)+DUMQ*
M4BW8BM*6VXM+I<6X &P1LKB"$7E:@Z5/*>98  G)Z@2V^=B^:M*0QY?$7!AR
MR<M+NTX\A+5/SDLH6:SF9Y;\+RK)(%77XEF6""J86PB(9MBSDT?H4Q4O.HD=
M^V7TH&X>^5ON'IW(X^YZ?Y7!_@O563<LIN7=*M/("RE$VU!PEBY#PPDANU>(
MUYNG76PE*E 74D@ _P#N'<[,SER SS-;&?.Y(B8+F$I(*E1\4OWTI]E?F:B4
MX "=P"2/&_@?7?;;C\Y"<%MGZ'#^AKUR3^U6S@X@[M/7W:M9-J7SE7=O>7$;
M1]ER!>6.76D#)JA5"TXS7M&RF0.J/-:\.^N>2M;W4VCP7%!>X\7"_P 03:7:
MLZI0"T%)2DL2\$!NNQ,C::]!P]05>LJ2@+*+B%,"[-()!=P-QD^CFR9I98]I
MY31-8<P91DF;5BV:>E7(F241[^U4U\P2UZA:&T5S:SWY(25H0A"$>=SQSM+I
MKZ21JC<:R71S/XBY+!\,7?,%C %>SX[<TEC0VM4GY0U=WE=*3N&=Q+&1F8]:
M8*IYM,;K@_8R\ M9UPJ4_,3'=RM:J5#DHJ!24^E]<MC<C=KU&X1\IV5YXZ/-
MH6^<NVM=UB   ['(; ]&.Q??QR_B+B%ZRG17KB1IPIP$D.6R&#C #-)Q5!2\
MUT>5DR(=]A=/'Q*<MN)9L5LZQ]8FO<>0\Z&G)3S["@3NTI+C:D]!_1'D&%A.
MF"E7DA*5W"1R$>).0[%YW^SULZ;XFUNG5;L"=(%#G!,E(,A@.C'K!:9J95S0
M0+6MI;*1,;L=-\V;;JZ^0VV&9<?'6-I#T:O9"5^FGP"ZMA)BO-F2ZT"ZT0=C
MP-;I=5I];:U U@3;NW4^#F[M(?<'9W!8R*^B6=1PWXAX9?1H=+\B_8L7%+N7
M$A(4$I<A,.X< ">82V]11RJE;TYSIJJK)4MY6.745IE^*VJ7)=HNV%06W&U;
M>HLI->ZEN>R^$I8? 2I04 >/IFDT:=1HE+44E03*3)Q^YSDC>>K[@?%+Q^2M
M2%> \R@!/4]9=\3@R 8+8MVE9D>53:'#L4E2S,>GS9L65+6B?%MG' 7)L!LN
M>C4&ULHV;D#J;"WD(4H;*/'LV>2[=0F0.9R "/2,;#;<"L@%*7(9R3,>I'LP
M&[;XJL@TLO<]QQZ\QV0;&XK5-2'ZMN)*^T98>DKA6*EAQTQ#Z-UD%#45I14T
M0LGR2==25*/A!()+@;A]C'W\XK)+'^/>?*,NTSUI4ITESFHT\HJQJQIJS)T6
M4X.QKQ<2$8L=]:9+L"NM'P6)/4YO(GM-O!+86EHI 2>-]%LV@CE4E-Q]R<N&
M88 :)&1L:@HDNSORL&8YS&&Q,/W$BON9&14=>I63RJ3*,B;KT%ABI$4,U$!$
MIMA$?TC(2Y.,E8*TNJ;[#*$H6CJZDJ/1OZJ[:M@7%I,83!PY2 ,G&[[L]5V1
M!@@2^,N1 G(=W%)A<^K@9 J)=(7$^VTQ*]V>['AK2)R7&GFD%Q92E<.*A23-
M.^Y4I(&Q2>-+3<0TOS %VPY4 %\I:3E]L]@-G>K"\<KEE!R)@NY=VA\D9R[O
M7ID<VGKE14&68-A(EN-OK><#ZX:%(=:19(K@A2U=U"$B.AM83VUI!44'<XXI
M?ME!^6I*@0P"9,.>F []3TJ4@3[C: )P\N9\S5INJ.*]6N7..2HLVZFH;];*
M:4W">2E$=<>841'FF0S(F-N'J05J6OI5VU[CJXX^DM_-^8D^$D%(<?T=QO\
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M3\B;(EUE^JRFH[JICD*9=55[E[\BO@R$J?<<L5A#;J&RE*L?5B3UZ_;M.U3
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M8U*716^G2L&NY+=G)J9J)5ACMG"D^B;F+?=0B6[';4R]%>6HMI;6I4U@ N=
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MSB\U>,WKK]6V\EYR8PY)] Y(11*;8[3T1IM063L@#C:1< 8. S,Q#")[M![
M%BPJB 8[[B&!AO\ IL.T53Y;BFH-_)<FPZK-'GK>P2Y6.QL?N9%=*JVXZ?4-
M-,LQ>ZV_$=2?3L.L)>!.R=M]^+POH0&_]6WV.8\F[O663$B.X]7&/.*K',5O
MJ.GKZ>\P"Y^S)<-Y4:3)Q*W^T(KS1"VU/I7#?F,/*D] "%I20TZ>WU GBL\K
M-!80''W./.L%MB(8,X8@9Z[;YCW0>37F;0KEB'48=F**F- ](;"!CU]#L'@Y
MVG'3'=1 +452.GL,;,+ 84I"]E$D:EP#P\H8'H1M/K,0QZX-'$8!+Y+C8L^
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MN'(S<E5W+0&(C;4-IH./J)2U(><44E"E@A2-M6I*F2[" =RQR-O[DM!J=M;
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MZ#U0]PCJ^?R?TO?SQGQI\043T&"W1X+C9YJ( !P!Y=O)O?VKN,/Q4 E6+8V
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MK)(]P??8@23(8-N__59CU?T;W_OSKN<>QY14E-)4=&QZT_9<+;?8G?S'V))
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M"/S*!ZCL8X(5UE14M7D[^YXBE*7+(9L%@WIOZY[[5:JZL@>.X7C]Q+;SVZ8
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M<MVE.O[_ "YYKJ%9ZGQ<>U$.1U#3+>39E4XI9U[-9+QO'[%U$%,!RV3=6_\
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*2CA2CA2CA2O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g729258g60q90.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g60q90.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[28J4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )@Z^ET(X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!JAC5         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              CD   4Z
M  $                          0             %.@   CD
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   CD     4F=H
M=&QO;F<   4Z    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   (Y     %)G:'1L;VYG   %.@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !SA"24T$
M#      ;J@    $   "@    1    >   '^    ;C@ 8  '_V/_B#%A)0T-?
M4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$
M &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !     -,M
M2% @(
M        $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K
M<'0   ($    %')865H   (8    %&=865H   (L    %&)865H   )
M%&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,
M  0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I
M9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M     !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y
M-C8M,BXQ
M              !865H@        \U$  0    $6S%A96B
M        6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8
MVEA96B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W
M=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                         &1E
M<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@                            !D
M97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0
M=FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M3 E6 %    !7'^=M96%S          $                        "CP
M  )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@
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M?^6 1X"H@0J!:X'-@C""D@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M96=T=G>%D[6W,E-48W)S=8.$AY*EIK.VUT2GP__$ !X! 0 " P$! 0$!
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MC3UE)!V\ZBK2LG3,JQ_:TF:-Y8PUS@O*4[>)S@S*F?K6>0HO%<0%X&"DX.4
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M1S#)K);".,,BJ8Q3&CK9(N['1@!/7 V,REV .2(B>8@S+1"\C'B2QL8W?4S
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MS27HZ3<X*PPF>M9L0SS3+SE( :DJ3N8_M7-$R]3F94Y3#E!=N/J*<3.4%YA
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MA'>U1)5BFUN:4NK;=WTXHIC&@CL2V.[-)2:GR'LJ1O9@LO(I79B[2UJW=B5
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M"TC%NI)U*LRB8NY,DL2R[AGEYY3VF;2!^T:*4@$5S!E:<X^8-*H1:$3M:%K
MX:Z?D'1N2OP*T>AX$XI?(S[Y^658F#)46%N>+,(ZQ$CN8VMW-*\@/4VD?F]S
M*1LZ1 $)7'*5C:.,'EC9T:98UCB,I2,#*XC52"GN!M[I%[*\FRJTK;[D22!
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MA4VP^_ 8\F)&",,A6Q.0)-,D+'2S^T*1L:HOX8'DX9^8&R5BQ(+TC!M9ILC
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M(")1$LIDM0GN%GAN((X7@F^TKR]9DFV$1LI+#T&AEAZRLTC/$Y/3E/(BUSS
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MN8]=2?!6_CC'MH#(GFCPO[5COH9I[76+[Z)/FQ?KF/74GP1OXXROMG_(E/\
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MI92N1[-RGLQ[!3V8GWMCWS#8D$@;@;[GT#;QW_!Z?>RY:8SJSY:G^]E[H?\
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MC7.2&*E<,I2+U1':"K8&L=LD2C#U,4?T 7/*DD[;Z$KF%7=$N-E+Z5K6_40
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MQ0_BC9UEF=8&R([BT/@V+3DHCV7L5Q>-2NR;XY=2(&6W:R3)P>69)&W8LJ2
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M1IT*6MTQ)&&E4*?WPISJW)SH()JZE0R3F2)]R=68S!3'SF)-\ ,K(3N-SAG
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M[)\V;O&;I*]!RT=HIN&SA%2E;5$5T%K;TEDK[:UMO34LNLNI6M+J5IJ" ?$
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ME67I]0*_)S<NW-R-M_!.:$^PFW"?A[#7TQ-_1'7\_?['-I/H\K.H_P C:O\
M_$?C[Y\2=CZ,^^>V$D^]=/G5OJ./82[A/P]AKZ7FWP_YH_#]^G0_ZG-I)_\
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MP=5/8_\ XC_IW_%CVPDGWKI\ZM]1Q[";<)^'L-?3$W]$=/['-I)\?*SJ1_\
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M/'?<R,)4ZI^Z=)EML*@&8@D#%Q0]C9^;Q!!]U.,'V83N.,43_'-^><-,,0.
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M:O#L=:G+(1*Z0O9LH9U1GGJQ#3ZD\9BKL%:PB7VU.O'O#(;$-2FG7$ME;,_
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M"\,J31,1WCFC.\<J'Q61"=T<;,I[@@@')#,%E0$\DT;0RKZ)(GVYXW'@R.
MRGLP[$$$C,QI2E*4I2G"E*4I2GDI3HI3661F&Q#'4$@"\I<PJ) 8NXG$E>3*
M8+!!S=@K)9800;-7TB-7H66W$"[ILR9MUWSBMZZB#5NE=?5-%.VV$58XUAC
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MB3ZZ!OSG3SFI\.T_]/I_3X\_H_#*WY^/];'LT-IOG$8D^N@;\YT\YI_#M/\
MG"E]/CS^C\,K?GX_UL>S0VF^<1B3ZZ!OSG3SFG\.T_YPI?3X\_H_#*WY^/\
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M.=/.:?P[3_T^G]/CS^C\,K?GX_ULCO+V[_:X8Q-E 0*SYBP@4*8[FPX:P:3
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M3]NW?W^V,<*>2G3\%.G38=]A_,/#Y?YL9*.+H0&FSJ4HEW;E@E'XLO)$UD"
M@8C?:U*BARZ#MX:LHQ:I52*5<4<K.$;+*MJI7<[NU+D_8\(\/Z;K@U=M0GEK
M+IM;3[0D2U1IP=*UK6G:38,\]_EAC$$>HBTI:1 _FYK_ '4Z21W:%:.W+/&Y
M8"*E:MCE9$+&LG4"%I!R(LG=>=B%3[H[@$9E,ZQA$8VX@/J<.E)<-EY.3H*$
MVEC5!%<;&Y&H"O?BDZ-%[J6N44EB5RCBYP@BE;6EMZZ-.^:]'6>%-$TZ]PQ!
M2NW=5I:VEJ>:["D4?/4KZU>TH6ZD3Q<T<<D5&34.6SN8XY5@=@8GG>W<T^M
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MN8LO11<.JM;D4Z7J*(JI.5*FJ\+7--TRIK@,+Z3J1H246Z@-L0:I6O7-/:U
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M%+LJV6EAJ7X:Q9(U//!*MAC,K=0JS+YNP" !'[%9 ''+%\B!/(R?-QPCW&I
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MHRAF7S>"-O-M1D/*418+3 ].7/;<.:W*7CTZSS2ACRUY I9T]/(^V^\8'@Q
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MC) TD,T[1!CTG,;U(VZR R0=-PKH&D#9L)"LE8JW>6"62/E(DZ@26.'FV'4
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M'@3_ 'XI>CQ_W7Y<>,NV3>_1?]FN7>WC_F#\&GL7>4#[UM2_)!]-CV5/)O\
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M]O']^*7;_P!KE/&7[)??HO\ LUR[\?N!^?R=NGL7>4#[UM2_)!]-CV5/)O\
M?SPO\\4OY_MO;\>5IREVR:O5FB_[-<N_#_F#\%=/8N\H'WK:E^2#Z;'LJ>3<
M^'''#'SQ2^7_ ,+\AQXR_9-[]%_V:Y=] =/8N\H'WK:E^2#Z;'LJ>3;[^>&/
MGBE_3U=O]/;QRGC+]DO3^O1?T?[VN7?B]P.GL7>4#[UM2_)!]-D>RIY-N_\
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M.YSHV?)%Y=K@MK;EBLK?5%O";7Z3FVL<301"PQ):;HPL8H3(6:*/=(RBDKF
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M:)+MA^]&ZZZZNV^:<;JUK7^FG$-*<:UXUKPIDKA2E>GA2G#AT>37H1Y9O)R
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M/N[WB?Z:[FTYUW]M';7C=Y.GRZXGM=>+3OMJFB[;;COJ/U'OV_'\F>?/V6'
M@)'J1KW;?OSZ-Z#_ -)_C_T]L^OCA-O/N+R;U\/ZWB?I/Y>CX]/:Z<7>G5-$
M_+J']/F/C\GIQ[;#@3XHUW\YHW]9^_V_#\G?'CA-O/N+R;^UXGZ3]7P]6I]K
MIQ;\::+X$^.H>C;_ ,2^7)]M?P)\4:[[_P!WHY__ .GCQP>WGH_I+R9T]/\
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MJM:YL3N2HC;1&VMEUU_Y_P#*EH:\&<0U]*TK4]7DK2Z57NL;E^2642RV;<+
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MD_6SVOFE3X-7_,Q_JY^O  +\"B?HYG_ Z>=6?A$_YZ3];'FE3X-7_,Q_JX\
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M4&CKQM(RJTM.&20@RN[[L[%B"Q&Y[;#MGM-(L36:$,TQ,DCF3F8[+]S(P&P
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M2-L+'+U5:V@O'AI[O8@DNI?I6>(J"/8IU;3:+(EZ2A#IM/HQ3ZE,*NGQVKJ
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M(/WS=']#8C\I!]PX<>NM>\*=%:\?A[/)I[8;AST:%K7R M1W[CM_OC\6_O\
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4TQC3&-,8TQC3&-,8TQC3&-,9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g729258g61n50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g61n50.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2"V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ()J^@T8X0DE-! 0      $8< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0U.A>^Y<2D]RV?FBM+]75Y3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8             !%D   0-
M  $                          0             $#0  !%D
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !%D     4F=H
M=&QO;F<   0-    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   19     %)G:'1L;VYG   $#0    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !#A"24T$
M#      6-@    $   "5    H    <   1@    6&@ 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ H "5 P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MS06;O\]9/U9=]978=I^L;:F9)M)J;2  *W 7!KG,MM:[T76?9O\ T'_G<O\
MI5J4["2222E))))*?__2Z3H9P[OK)9?1UW'OBVUK.GMLR#>6!FWT;:<O/MK_
M $#OTEEC<#Z=7\Y37^@JT;/J9TV_J'4,O*MOOJZFU@R,9UA:W=4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( 60!3 ,!$0 "$0$#$0'_Q  ?  $  @,! 0$! 0$
M        " D&!PH%! ," 0O_Q !-$   !@,  0 $!1 (!00!!0 " P0%!@<
M 0@)"A(3%!$5%EB7%QHA-SE65W9XE9:TM=37V!@9(C$X57?5(R19F-(RLK:W
M=24F,T'6_\0 ' $!  (# 0$!              4& P0' 0((_\0 3A$!  $#
M @(""0X+!P0#      $" P0%$082!R$3,3914U:3E+(4%18B055T=9'1TM/4
M\!<U-U1A<7-VL<'5,E)7E:&SQ8&2M/$C-.'_V@ , P$  A$#$0 _ ._C 8#
M8# I/](*Z,NWE;QG6;<?/=D/-46:S6!434V3-A+0F.2)O?IRV-KPE+ X-[FF
MV6X(3C4INQ)!BT S>P"+W_:T$$O,9YB:T25%RZA\>_>-5NUJR'K^I8]8C=2M
MAPB:R1;4SHQS$B1I7=L2A?C4S I??DX0K7:3)_9K#$)&E90C] ,"XE@\H/,3
MP]=ZQYU,GD(>O'(D<7CH9MFL>:VE6=&$;!(I,AEU>D))$Y&RJ.R)FC9ZJ.J#
MP,ZUPVZ,1 T"<]V3EX$>K \X?+,,I?E2TV6L>E[(F7::!Z?>>N<J_JY%).@Y
M;%&%S5(%LP5PILE"M V1Q4F3!>&95\?*E3PTJB5B-&(M*\;:PKLX_P#,V/=R
M>9SI6]95>CKR1R\X\V+:_IY_KU.P6?3Y4U7N\"F$4' 9!N+N#=(TL]]@CDC8
M]OYWN@VM6<C5'%!)TJ"P1A\[G'J^A+6Z<E$(Z1K2E8%(*\C%?2FPJA51Y9TJ
M]6@D>5410\[1\YW,=[ -6 C[J>>H]W;6M(VI].RIR*;_ &YR<-A\H^8"B.J+
M%G-%!ISINA^DH;7KC:C=SIT/5A56VG8T'0D^U+<ZX0/K^4S/BE:(9)*9"X/#
M,9\)HU@QA:4+HXH UQ O/;PS:.J.8:[;[SEMO7Q=DKH1BYW;:\9R+TA,UA)S
M<&2K[2AKG,T"*$1)L3.[:XJ9(L?5",EO.7G'A*'')24QANUC\N'*+K3G;=TN
MA%GPQG\?TZDM=="Q*8Q9F;)XADL>,"D2%1=F2RIQ;WM'+G?VK%#5:EY:P/3L
MG.*WI*ET6K,#5UF>;WEFKEG.L==*KZJD%B=7<^M'15%U7"Z8!+[&F$:D2U:F
MCT3W%X_*7%>AG;JE0*GS;886:T-C"2>O>'QO&G/3%A^;)YRN.''CN]NQWAAO
M&),?,,_C-7] 4I)J]2,U_5A-I=*V2',;6^P5UD;>AT2K=7PO85@7\)82VQ^2
MC %W95[84_CWN\/(WYV^24-%R;H&35MU##XCNV6*G:3C\EI9Q;;"ZFDLI802
M2.+^?X0:YZ>I3'G1F,3KP/;N2P("2%[42,_;BYI6\8?"Q^7FI^H*$[JB-:,-
MZ\P];\Y\NW!:*ZF>B*[-K*WXJF;JY?7*+6(SL:Y0[I'1I;W<Q@4C.]81R(YR
M9C%K=[DZ(#U80:YE[;M.8T;X#9)<?8EV1ZS.HII:;;,F2+U5#YLP=.K62<DM
MB:.6U*ETLA2NM6=E;A(R$#S&(K*E2P*U7HYM($C*,5A+FSO2%>0Z\<;[;FFD
M>RK.URU;,HJSH5YKFB=/\2JL$1?#8XX3N3S(N4@C#9#G-X3+TD=&YNC<^NOQ
M6Y*#61"E( ><$@[]\QG+E-1_G!5!XO=_4,_ZQK9#<E(4QS36B^Q+4D54+6TI
MUW/G2-"5-8H^Q)TPE)!FG$X+@->V/*4I"/3*[G(0E?Q?VG1W>5+DW?1#D_#8
MDTF?H++HK,F,Z+SZNK BYB<$A@T\C*@U08R21L*6-ZTQ,%2J3GM[DWK4RDXE
M2'>@K=6]W0ZB>_O*4LLKHV^)W7O)G-M56]*N8R*<B"6!5$QCKJNY XR&JK%U
M8_Q[8DFF!3H-V=&*0Q:&H6EQ?7% F=EQ#>G5JP].J_/GR%:]M<X5RBJWJZ$Q
M#K)<T1NB+XLJD5L-I>=S]VVB3_(1DE:UZ-,>'1M>EZ>+N;JPHG>.D2,7L"G9
M0TB*>3'W^_NB:?DS[)!P'P[?W59+.WR%^K>--J>%L#J8H UNT\FDD9H/"R';
M2,0%IS,FD<C;W%\(0FDK#F5$X 3*$QNPJ"@H6<N7/-&30L'Z^<O,RAB75EA1
MIAM2-\LS2-UK ^=5)3N0U/)U9$J) \IXR:<RLCLD3.3J971R/3E\#>I.T)27
M*AA;A;GD_3<MUES T7!2MJ=!]4WI7I3\X4_PQ#7"_&W;K&FI+NP) Q2$DYI;
M=0E.[A<?B,U0M.<U:9*L"4G5D-+@X%AAZ7SI\3KN-6CLU&DN54P/UYZY@::9
M3UV(R]EO1(D.G0%2DPT+MMM&_C:1DNNE.I!ML]R4$$B5Z=S0M6!^)GF*BD@Y
MZ[,GC+S'UG6%Z\DU:9.7BA[KH5^;9<O$_(?4ATA1(6!Z4H)%"D"U:UOD\.;)
M(A=F&$Z<)#HCW$DM6((?\C>?J!,/CHH3J/NJ*7TVRFP;B'23W/&"B2V2!3&8
MRE=8<M9'^K$P7AMW*ZNB</C88JZOS E=GLF1LQ[2>A?'K:M<>$O9?YP.>8/4
M%&3N04)UZ3<'2#S/6JH./TE*G+^J)(EKE_<([(I(KK-(^&F,48"M;5(F]P>'
M!(L=22E![8VK$R)<H3/]?O\ (-A5/YG.)K-YCO\ ZA=Y#.*A8N5EI;+T16-O
M0Q9$KGJZ3+3@(6&-/,"]X6JU;K+7@?Q!% -RE24[/Q*MG$8E<6YR3(P\KE'S
M(4+U)<R.@UM(]6<Y67)Z\=;:J]HZ2II57*:VJY:4YJT^1P5P"[.J=: UO3+7
M!*2MVB*6)&]>)&K4FI#R0!%DCTE?A9;"81;B&INR#*)D<QU 9A>JB@E!-55+
M+SW)2A01Z=2\B2*V8YZ6(B"9%\4Q-;)'%/'W%M/.3:=% V@E_P!/X?/[G_K<
M2\ZZ\OW/O*-PET W5=T;T]<+9 $MM6#".5ZL/M=QJBK5FM&)9K89I#HV)F-$
MJ2F)G!*C]J>LVVKFQP5EHTCPS&N 8S9'G&X9KRKN1+@1K+=LZ%]MG3IMHW=3
M5FLF<C72>O5+*TOT)?(>6Y(92CF1DH?D4/;6!K:'I4KD@3DV_9(M$KS@C:;Z
M1_R<5&K,5;YH[N%8U'.;S]7>F <[*]SVD88P^["<K)M,X4A#%87#R0JM$^N^
M2%&\ 6)U@%#40B(TX&!L*W^Z8#9?67A]?ZDZON6"UIU^TV/,(E442IR.R&"]
M"L@(]&7),@MR8/\ .H[):H5PP2XP!!#)%)@>K<SG!$L BTC :<$C(OY=^59=
MREU5V,U-=M@J7CRTYE4%L)%<18R9@JE<&.B)#T;$&<N7G('AH&.:L_N*Q<\L
MYYX0+=F(R-D%Z/#!KB\SM!5S)*8KVN:1ZEZ:MNZ^=XEU4U5+SY5B.;3>(4A-
M$)*YED\Y1CDJ%&UK#-'EIS69K6O2HI0(GV@PDKVDUQ=K[]K]8GURMTU778%&
M0N_ZM13-JB,U+<PIV2PXHXPF:L3BRNBMF=FB11MSULY"M1KT1V@&ISUC<O2B
M3N#:N6(51"@P)#X# 8# 8# I:\_O,UZ=<^-6RZ3YSKM?:5I/<^J1W:H>VN;$
MT*EC='IPVNCRJ"MD;PQ-8 H$!!JD8#7$HPP(-@) :9O0-A%OS8>,4RVJ2Y:0
M\0<>5:*Q8=V-4DWGQ]60>J:T?6^KV./38$A7N+T'<0-<&=*[JF(:AI)7K3E"
MKW126W'B2Z-)"OCS^\W6:I\B5%0SG1[9&)S\N=6QGCV]V@E84!Y,057=-6R\
M5F*FTA8G6C3(X8D8X^Y/ DJLDN)160,^]?"X^K@60]R\H=!<V=T^.WNOC[FI
MRZ3JSE2B)/RE-*"@+_&HY/HW7:V/2&/0N10DJ3KVUJ<BVQ-*#4JU,FV)02!E
M1IE(4S8Z*G9I"M>6<$^1ZYZN\^LLFO'B^N;$[M%RO(J*K!!8=:R4;^7$[)3R
M%[CHI(V2M,R;D</B@48I>O6B9FQ=(RG;3&H="-D''!:+Y#>%NF[2X;\;;QSS
M7S#+.BO'Q8?*UZD4#)G]GCS7/5%0PIH;9+7J=[5+R(TE>4;LA1!2G+'4EM/;
M4CRG1+3%JEO">&I:\JWM3LCREU;Y,;MXOL#DZIN*^;;#AU>59)9I!I1=U^65
M(F>P$"QB:VYD>D38TL6@SEQ)9U4C/;6E8J;&H\MS,3R-QW' A3SOQ3Y6*-[N
MC?F(DW,$4>Y_TS>MI0OI/CZ&"K$,YIGG*4EL#7&Y[')4ME:&+.<Y(!%C75\.
M8G8J0R7:=I$_KE)UC30EB#"/+?R+,IEYFZ^Y2JE^(;:C\M[?SW-NJX>V+O8N
MP$'+TM>%<NDHV=*L3^YHC('#02! O4IMZ>9<DD&]GB/)4;V$N?(]+K3I?S^^
M.F7<_4/N^9!!.)[/ 52\;D$:ALC>X,6?=#-($T$729:W1U._1V/J37=E:EAZ
M0EY"UF1Y.I(/<2-A"-5P^.3OKI+C3S*7N[\P.]?WUY$;QYA?Z>Y4-F4,531F
MK6D+5C;L:^S)TT_-T402)Q8#UB]6@5.C:Y@.8'0XUO")V;R# MA\GO('3<I(
M\9?4O,-5-]T6EX][':);(.=5TK9(>IG<+>HU$6R5)(L^/JLJ-)I='C8@E(:!
M*C31 "O/<&PMP5MQ#6Y!$5#RSW#W#UCVMY!+7Y4?N5V==XU;@XVYNHR8S").
M]N6E+)C%I,<G>)84Q.NV6/HA/<@>6M,%]/:QB$JB^B33TC6XN6PP:I_'AV9'
MX!Z.4T/%#O2!QXQLZWGSIM*.0PTP52-4BFS6Z,JUS&3*C2WD"] 0:I 7&3)
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MQD);0U.0!$A<+S7TOY8NB+RKZ*SKA-KY Y@B%02!MZ">KDD;!,9].+9*CZM
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M.]PDZ![U3]31667!8S6(9>C@DR%AKQG?@1-4,@92DI#*UC(M4)3R%29.<G-
M9L,&HKS@>-R^)JUUFAO-54UCOQP2(_"^AX)-:*<'\TTPLE,0RN]ALK/$W)<N
M4&@3-S2FD0WAP4;V2B;SQZ^# MIP&!S1^E@?<H5?Y1U-_JTQP.BNN_M?P7\3
MHQ^Q$.!F. P& P& P& P& P& P& P&!5!=WDGM&HK7G%;,O W2MGM<0>1-2*
M?1!CD2F-2@G25.H^,F<])!'-.8EV(\1&A%+U(?:$F:]I\.MAUU31>CC3-6TK
M"U*]QWPWIEW+LQ=KP,N_CTY.-/-53V.]37G6ZHKVIBK:;=,[3'4@,K6<C'R+
MMFC2,_(IMU<L7K5%<V[G5$[TS%JJ)C>=NJJ>N&E7WS&61%F=RD4F\<G4<<C[
M,D-7N[Z^MS\T,[4A(#ZQZUR<W"O$Z)"D)#_:-4JCRB2P_9&/6LF;'1!IV5>M
MX^-TA\,9&1>KBW9L6+EB[>NUU3M31;M6]0JKKKJGJBFFF9F>U#6KXBR+=-5=
MS1-0HHHB:JJZZ*Z:::8[<U5568B(CW9F8B'\Q_S'6++&9ND<6\<W4,ECSPF
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ML2J4S>-E>R%AP=$> P.:/TL#[E"K_*.IO]6F.!T5UW]K^"_B=&/V(AP,QP&
MP& P& P& P& P& P& P&!"_R*_X&.J/]&9A^H;RY='G=QPO\<8GIHW6/Q5G_
M  6]Z,O-\:G^ [ES_2MH_65N9.D?NZXG^-+WHT/G1/Q3@?!Z/YIQ924H8# 8
M# 8# 8# 8# 8# 8# 8# 8%*WF(B/&EIF<@4WUO4ED6V58%M3M5%":^LJ2U@G
MK:(02M72:W;<4R>(V],RATC%>0!H$XJ&'X5*MR//*);0E*=['L(4>CSR[CA6
MZ6^CH/A^8<ARZUJ]C5ZP>1V!<[I?$EN[FG=@S:KHW*!2%]4&NL!VV3^%R)*Y
M0$P@HE3[PTR),O>VU0UKPAU 8# YH_2P/N4*O\HZF_U:8X'177?VOX+^)T8_
M8B' S' 8# 8# 8# 8# 8# 8# 8# 8$+_ "*_X&.J/]&9A^H;RY='G=QPO\<8
MGIHW6/Q5G_!;WHR\WQJ?X#N7/]*VC]96YDZ1^[KB?XTO>C0^=$_%.!\'H_FG
M%E)2A@,!@,!@,!@,"-/576U)<:4W.+UO&0K&R#5T5"U,K*CC6IE,G0(K G#5
M746< Q9I]J\'-[C+7A*VA6@3>[AV4M,]IL*%3[,)#-[JWN@#Q(%:=2-(:4G7
M$%'%C4-ZHY&E< (G @ A&(EON2U&J$E4A+/"G5)SM@]F<6(0>A@,!@,!@,!@
M4B^:*NN5[F:N4*9Z"=.B8S+[.M.Q8Q7TWYHD2"+2^$UTJJ&3@Z;?YV[.S4^M
MHJ4+IDQS2V>V"97%4Z-JA$E 6!OVZ&!"-7@MN#E.W[$M*25!0UY40_K^=J,9
MZ 9+FFZ&;M3IP[4KE)J;A#M5^D"<@4/2/=N0V>RBS6!T,<E[O/I ;*RGQY3N
MWO(0Z3\!@<T?I8'W*%7^4=3?ZM,<#HKKO[7\%_$Z,?L1#@9C@,!@,!@,!@,!
M@,!@,!@,!@,"%_D5_P #'5'^C,P_4-Y<NCSNXX7^.,3TT;K'XJS_ (+>]&7F
M^-3_  '<N?Z5M'ZRMS)TC]W7$_QI>]&A\Z)^*<#X/1_-.+*2E# 8# 8# 8#
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MWH*:O2P/N4*O\HZF_P!6F.!T5UW]K^"_B=&/V(AP,QP& P& P& P& P& P&
MP.?GN>L'CHCRMT/SVHMJTZRATKY8$_N)]:RE4QJPN3!);S=25($H]GM1AZO;
M.B1JU!Z$U0-&464$P/LBM@[YP1JEGA[HMUS7Z=*TO4LS%XI]3VZ=1QJ;U'8[
M^+HEJ:9JCENQ31V6NNBFFN*8KF9F)WG>HZI8KS-?Q,.<G(L6KF!SU=@N31/-
M1<RJHG;KIWGEB)F:9G:-O<AM[^I=B?SRNQ/I#;?]FR)_#)E^)_"/F%SZYL^Q
MJW[YZGY>GZ!_4NQ/YY78GTAMO^S8_#)E^)_"/F%SZX]C5OWSU/R]/T'PN7A*
M@+R@5M3QUUULZM:\@:9<VN4X95R!:F,U\!B=6C5,1J=209K[ RCBQEBU]@0=
MZS[M]-.?9N47;/"7"EJ[;JBJBY;PKU%RBJ.U5173>BJFJ/<F)B8]R7E7#-FJ
M)IJU'4JJ:HF)IJO4S$Q/;B8FB8F)]V)?XU^$FOV1O2-++USUJT-2 K2="V-<
MW9$#>B(#O>PDI$:1A*3)R@[WO>BR2P UO>]Z#]G>>W>FG/O7*[M[A/A2]=KG
MFKN7<*]<N5U?WJZZ[\U53^F9F7E/#%FBF*:-1U*FF(VBFF]333$=Z(BB(B/U
M/O\ ZEV)_/*[$^D-M_V;,?X9,OQ/X1\PN?7/KV-6_?/4_+T_0/ZEV)_/*[$^
MD-M_V;'X9,OQ/X1\PN?7'L:M^^>I^7I^@TMQA5CQSAY7[/Y^26[:UF0U@YH,
MD:,ZR94J>U0G%]<JU<#31I2]IVH)B02U0G2'E(2SP)S!@$8+8Q[%,<9:I9XB
MZ+-,U^O2=+TW,O\ $D8]<:=BTV:8MV+>HVXB*YYKNU?)3573-<TS5$3$1M&V
MMIEBK#U_(PXR<B_:HP.R1V>Y-<\U=>/,SMU4[QS3$3$;[3,;];H1S@*W& P&
M P& P& P& P& P& P.6_M6 >:'ECI-VNZF>M>6VCC!XZ*LJZS9!U5;4MAD'I
MYIF]/DQ1-6MUI7N6LB9VI]MDC6 ^J(?507I>BM%X22QT;&YO6/&TP60>+R]N
MV.B$,[G_ $-?7CDOZHRTZ-E@LDX*D,ZD_P 6SA*JTH?VJ=+Y0YN3>BV2RJFX
M],UE;3NI8E12E03I(H3C&%N& P.:/TL#[E"K_*.IO]6F.!T5UW]K^"_B=&/V
M(AP,QP& P& P& P& P& P& P*5+:^[J<O_D?2#]?Z'SLNE?D0XF_>_'_ -KA
M]6<CNJP?BVOTLQ=7G&EF,!@,!@,"DZ!?=U;L_)*9O_=56=GS_P A^B_O7>_Y
M16;/=5E_%M/I8J['.,+,8# 8# JHD_F'Y4B<DD,5<V"ZC'*-/CM'W :.#,YZ
M0:YF7J&Y6-*<.7E#.3"4)C-D&B*+$85L(Q%@WO8=7RQT=:_D6;-^W<TWDOVK
M=ZCFRKD5<ERB*Z>:/4\[3M5&\;SM/NRN-G@?6K]JU>HJP>2];HNT<V15%7+<
MIBNG>(M3M.TQO&\[3[KP#/-5R$4'8S6&\"P:^#6QF0-C '6][^#6MB%,]:U\
M._L:^S]G>9?P:<1>$TSSJ[]F9/8%KG][ \YK^I?UKS3\B[UK>H_>6];UK>MZ
M@3)O6];^SK>MZF?P;UO7]V\?@UXA\+IGG5W[,>P+7/[^!YS7]2W10'DQYYZ1
MM!DJ2 ,]IHY0_I7E8A/E$2;&IF"4Q-*QY6Z4+4TD<3BAB2(C@IPA2&:,/V L
M0@!%L88W5N"=8T7!NZAF5X,V+55NFJ+.177<F;MRFW3RTU6:(GVU43/MHVC>
M>O9H:GPIJFE8E>;E58DV;=5%-46KU5=>]RN**=J9MTQ,;S&_7U1UK#,J"LF
MP& P&!2#YI^?K#M=LX\M9HYD<NX*;YJOA_L6^N/F=Q0%.UJ1QYKA_BL7E35'
MG46V^=N582)>!Y(@AB9>9)R714VC1&-ASH84&#>)BHY ?TITOU'!.'I?XU^9
MK%J^K:RC?,LTCK57;_8=IPR12Y\D5[N-2,!*1GKS1,:?V:!H224NC)"%(L=1
M'FCT?\ 7[X# YH_2P/N4*O\ *.IO]6F.!T5UW]K^"_B=&/V(AP,QP& P&!2O
MVEY[>#."[]D7-U\F70&R(NSQE\=-0NM025@TAEK*E?FGW=V%(6_9QWN"PG:D
MOW4'L#O6*]8?J^ML(I?76_BHU_>=TG]"Q?\ _K\#^0^E<^*8>O6 ?TB,._[A
M!I@H6OL?W_9U+]Z^Q@9/"_2B_%]/)C$X.PF]%;?)G)6**,VEM.EID>W61.B5
MH;O>U/RL,]W3>^+"?;G^S'[(KUS/4%ZOJ[#HPP& P& P.=KO!%T*O\N_/R7E
MQVA;)<H^3![CSC8!>S8N2@!)[\'( K0!;'?>SC672TI'OW WX%0BM^L5\'M
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MT_K,.A_^F5U/^99Q_"/'L+T?QVT'RV+_ % ]BFE^-NC>5Q_MJ+W8_5'275%
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M1_4* SH>H_DWT#XYR/3U9=\[N$T;XUO^EJ*X+.>*08# 8# 8%07%/W0SR/\
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M<=R+$O(T]J?I?'VAR)+46A(32##4+@XIU18#BA!-*&,K03"Q!&#8@[UO O\
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MJ2EDKU$;&LM @F(7=T=C5#6H>$*L#*:S*Q-H"512I3[O$]J=QWS8# 8# 8#
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M3LZJRD+<@2%:!\)JE8L/)3D%Z^R,TP =?WX%E& P& P& P& P& P& P& P&
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M#00@,U&PZC Y)I"I5J/C(4?"[O\ IJV;[UZGNFGEQT#U/6]X%ZWP:"5& P&
MP& P& P&! #R<\+E>1WCNP>33K,,J(N=O<">=SHJ)!G VO<'FC++])]1P<CB
M@5FG+;/\7[-^.TWNFE'O6BU/LO8&!,&J(-JL*MK6M N>WH->0"'08+QM)IOV
M[:B4=;F#3GM!I2LTBVOTW^];2:5JM)MF^Q]Y/]3VH@S[ 8# 8# 8# 8# 8#
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MRM(H$2M0G"2/+4[M;>$W<!@,!@1.[SFDJK?A[L2PH*^+XQ-8+R_?,OB$D:S
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M9U:RA!$VL*+\TA_;DK[XZ_\ $XAZZN9L<-$\U1UY[RYF@53<LQ8D\XY&WUU
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M=8\(L2\K OR60=V8D[P]VPQR-JKYC@&C%"IJ;DDA:V)4%0[-RP]Q);6YP5*
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M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'-SZ,UTQ:-Z\&6O+NC+TF%JSAN[
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M_@/K3[Q9?YCU'],K1_#_  'UI]XLO\QZC^F5H_A_@/K3[Q9?YCU'],K1_#_
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MPIOVVM2Z6.Z!J;'-^4$;--]=P6M[&T)#SO6UZQ+>F#ZNO4^'8;SP& P& P&
MP& P& P& P& P& P-%-',M L-_2CJ9FJB(-W0\UB*:!2RW4S?L$S?H:C#'@I
M8XX./M=Z.;" Q2.:+(]D'X-,Z+^U_P +[(;UP& P& P& P& P& P& P& P&
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MDQLR-,G/4JE,@C[Z)'+4,7E5<.@8Z8=,4: D]V_TC>?O\GWZWMP'R*UI.7>
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* P& P& P&!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g729258g65k14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g65k14.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1P:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &_Z^<68X0DE-! 0      $8< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0U.A>^Y<2D]RV?FBM+]75Y3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              O    4
M  $                          0             %     O
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   O      4F=H
M=&QO;F<   4     !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   +P     %)G:'1L;VYG   %      -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 7@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M1_\ ,7NMI?\ X2O^<6OTB_(LZQU=EES[*ZK*@RIY$5RSBIGIUO:RQNRSW?\
MJ6P?UMOHM^J_6JJ[&OL9A9!>QK@7 ;+&^YH^C[F/24[B2222E*GD9>15GTT!
MM?V9];[+;7O(<T5[=VUFQS/\*SZ5C%+'RKK<O(QW5-8S'+0VP/W%VX;_ *&Q
MNS_/6!UKJ3C]9<'$J-K9JM L8-[6DGZ?V8,>ZVQGH?HM_P"C]7TK_P":J_2$
M1/%PBK()^G#Q<20!UV2?69^=U&AN-@6_9O2R*#;:\& 7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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MPEIMS".M5H:6UU.,['8XV-G)IN^E(YDZ0(H4?I ( 'H\]XO  '_J\J/X!_\
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M%$!33$(.[BSR&^V[NZQ@4*0VI!:K PA#5E!FB!F"1Y;;%(+;;,9-'&SDVQ;
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MIUVLM,1K>&L*T=&PSV/C6K**3:!&-"+'_4IW31^M?1_?]IR, 3T.G5R#+79
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M_+_6W\R_LT?WSD0-[K/U/JH&$0 C:GZS=5$RB'_"*X<V^E)G4 ?J '9 0?\
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MTT;%0H.$;RQ#98I(S>%VE%I991(3<R?SK@I<QG<Z$1/<RLMVQ)<N1N\M@IY
M B>S,+;\G F$MS9QY"#.S["S>M8=FV/L&)HKK+ ?<+-U1^7<=C=.KKHC1XW
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MZ"Y%$C#[B#R'F/ S#D!\"(>0$Q@7%W;D!-X(7VW$F\.VSLH@8\#,.0EP(AY
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MN^[OY=W]7?ZW7Q>_,?)NOE//S7RZWRW@""/Q_AF^%X!003$?B>WZ'$"?_J$
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M#A%$*#,7^G5I(^0\?T7,D#S_ *_UGZYR*P?MUR/^3.)_Z3RZW3D/_)[TK_\
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M06&V2&?R57T^WU?+I?(\Y^^%1I^>4ZM#&9K6+!/.JLTAXR*74GI5:3G7<O\
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M)+.DUR+7+WTF,'E$]FJDKJ?9)]A>T)[*XD^M1=6^S<2JMBWJ<^]>AVZK0D1
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M]&8Y';>XFC]JKB7/SU.3N3ZCMXQ"Y#C81ZUN)+1ZSIQ6R$%XA$'0DC&^"J
M18AD_J3>K]L?](G[K^G%UYCOZ,FE7++- ^]79B\5[[9L-&9"^EWV??-XX;[Y
MUQTB DAYN/\ 8WDE@^$D4H\(L3?^JSZM$=U9H?;M?TV\-/FFAJY^C"0"'8F^
M*Z<S-I%LC:=!C.4,N/?:<21E*2C=Q/F74$(>+3<OU_*2)@X19[H_J*>L+E^[
MX'UYL'IR]<7MV[&$OQZ-+5[L_=9JCQ 9S!HV";^_=K;8X#&HB]9+%1@0?$4&
M7?@9HA[3E$W"+O*QWT]9&V;KJ/7N-].OK(A=LDJM"N%EE9/M3<F%(D(S122Q
MX1O6;6KC8L9Z39A#.@G6#8A58D5&@+B/S!/!%J^-]4_U;93K3IW:EOZ;>%)Y
MUD[S3V-D@W/8R](:.^6R:P2=;L@UJD&QW[1G4G[Z)<+5I1LH4LZP4;/&WM(N
M4.$7UNWJG>J]GF7=:-<M?I]=9XNL=K]&P_*\M9+=I[6E9&]R[!-OFJ"PN,(X
MR-!Q62)E R5B.X.NM"N"'1506.4P 1;.>]\?63C^PD%UJ7].OK$:^V')YS8V
M,RCVKN*M!1J]?M,747L<^N!<;^SVMI6DI9LX95]0GS3J,3=/R&!)N8#$70Y)
MZB7K#;/HO8+,:KZ<O7".L'6RVP],O;VU]H+I7:],2DW%.IAHYH4R[QPS>X1*
M39HHF[D6!2(MG1DVYP$YPX1:U+ZL_JQFZ=?TWO\ T:^)ADP-%'@UH>PE]#7/
MA)Z$?-!+^K<<>^U_BC/$%Z5/X@", (3'_P!@/MX1;)UOU$_6%QC0.OV;6KTY
M>N$C.]DKA)4FAO*KV@NEA@8>5BXQM+.'5]F&F.%;T^(.V=))MY)^!T5W0'0(
M'N((\(N\9]]/62?=B)KK,CZ=?6,M^@LCAMH=S*O:JXIY^K59RV2=-:1K.Y#C
M?V>YMB,I$N7+VND(#MK%*-9 YA2<% "+!:[ZFOJ\6;+.Q>O,/3?Z_H5GK%;M
MAI>@1\AV5O#.SS4MB4:$I;'&?0"F.BZN<3)MQ!.H2,>8B5D<_P"0: 4W"+IY
M'U4/5MC.M67]J''IMX4?.]:>YBPK<&W[&7M;1F"VL6"-K=<-9:27'0D()%@_
ME&ZUE5=*&+!1Y'#QS[B(F 2+/[?ZA_J[TCL7CG5R=Z"=3B:GNM,T^^4-%IV[
MLKF 5@,C+7#6\TM,!D) CGA M,5]G-A;+?/>7'@Z7P?ZY%\,Y]1+UAM/W;?>
MO5>].7K@RNO7(N>'O,M8>S]UA:1,%TN 7L<#]Q+6XQLS&W"R9-U$+ # A!AG
MXIM''N4. @18(P]53U:Y'JY?>VZ'IM887-LZ5T9*=@%^Q5[2TQV;,;9+4Z?&
M"H@XZ,G+E?2<.Y<UX4#E^V8M5H_0]J3@@<(MA7GU"?6*SYSU\:S?IS];':G9
M2[Q%!H1H3M'<Y5.'F9JIRUR:.K\=''"A3X5.+AW+9W*/P.@VE56L><!5<$'A
M%VCCOGZR3;L7&=8E/3KZR&T"6QR5V]O,I=J;BIGJ=2B+E'4=S&.KH&-_9R%O
M4EY-NZ;5LY/G%X=-Q)E-\%$P"1='2?42]86^H=B7$/Z<W7!HGUDO-HS_ $ )
MGL_=8M29FJE58NWR3O/B+XX(W.$<1DLV;1DK'B1!_*)NH]( 5;F$2+5EV]7'
MU7Z%U*I7<R9]-;%W.77QK1G<-7(;L#?I35FJ6@OV\="EF<]1QX)6,5:+N2'F
MTUE##%(%466$P$$.$6[+]WV]9#.-;P;&9[TZ^LCNT]B7NAL:1)07:FY2]4B%
M<TJ(72>/>K"AC96E21>Q0@VKZCXIPF);S'-_:MX$2*6'0_NSV8WOL;VUZP]I
M\"S/#](ZO5S K&N7+]4E-4A+"TW2*N\XQ*>3D:I52M5(R-JS$QBHH+B=>1<(
MG$@-BF5(K5>$0?P'^_A_1]O7Y(J)_4QU?N-"UMCIF3UG?,+JV>OI*'N\TWMN
M?+U.QPTC*-6->L:4=5KC-6%HN1^8$OC/85$@L95 'YF2C(I%=H:)HZ=DL%2R
M$V)RD]P DJQ%7N-8AE ".6'G8K10DS@V^P2._,'X<V+=MDZ3HX$S*G;GQ>3L
M6F"6O&5>QWHB '*:)SG@",FXMOL,G@@)Q8F)W:2WIZV[M&TSFIQ>_P"?[?;9
MB_O7=L<ZM=;1G;RNUROOXHCFMQS:'"Y'N[=HY9M6JB[=6M%?I34PN#EL@U0%
M4F&U=!@RNV),3;QD$541KC0K07!FFE ^,\A2>S-5<F,B9G:=P>*)G%W)]GQ.
MJ*^&*Q,>-MXV!JHM![#6@LC+-,,KM,12-![.[B[NS%W./"-N)/NS*0?J!S.L
M5WHYVVGL(-;B;3#=>M7DLK-08]]*W<M^9TV67JXU.,C&SV1?V )<C7[*:,FC
METX>?"3105.8I!A"ABI%@8CU'Z!N<D^-V*[L:)3\X[<^GM&PM>N5)K#VHZ%G
M'92LUD_;->S+5_(X5>6I6>/WLBE'I0TC&U[%U6[H[D&TB NT"*%<-)=Y;#H%
MTV71UO43+V1K?2?O-49>63PB<90>5]F9CL1C0XSG'6*4BL]AXBT4:RQ<-27+
MI,L]9J<_J:$W-JSD<DI>1CWW^_W_ -Y3NS2X]C>TD+T\Z<]JD+NU[ V[MILO
M9'NW5+/#RT53X3(^HFB,YVI4W,4'!#1\QA-VT67Z_P 91I.->RT1:HIM<55Y
M!Y+(S2*#[444VUA[N8QVBN_JH3'66X4.B]@)SM9F=FNZ\V_FKU!8N2@-HKJA
M+Z7@,_3ZZ&4T[,I[KK!V>8MUVNC:OI(ZS-O[(XK47*@JB18[UW[)=V;CB5QF
MY7>>[#RWS.B]*WW9#.ZM4[YHNZX1U,OU(NSJ_;MA\-9<4AWL@^V+1(=0WR^7
MTNW#FU,9KIUS[7,RCWI'W^_^Y%N*2F?5(OF>1C-AK'>:E5BO=??4RTK)+87.
M6E;VS48S)K/F,ATMA]WBWN:NQB-(N)%+"FSKWW=J.BWNI-%&:K-%69L +$7[
MO&D]_HVH=DKY#N>TM(LD[I_2&R?9F.X/HB%MUIBIT4KTUI>=5V[T+&M-F\U^
M=V$RC%U=7M$L]8KUOBDL\MSBNQ,@\!N13Y].VFZ54^_7>*PZJIV]BI77J7UW
MU"L0&M1S^2QUU'RV)Y:UNJ?WT@Z1%YNKJF=Z A,9XE7X:PLGK"N,),K:MNF#
M=630(J_8Z&[I(]^%/44?=4;['YIO6]['U9E[$UE[/*::;JW8JY%8OBQ;5UV+
MGZ5DH],K>H8]';2YO,E8%6B4=I4K).XME&2+9X2G^WS_ +OYOYT6\O0M)VMJ
M4WG^4W%/MJTPVE]%LR:Z15.S>5N<WJV8=F&=N(RKM(P1>3I=2=354-D@+OK&
M:,=6AN5ZG$/;1-EMSYXQ;F]&^QO'R_VHM<T>N[5*W"AW#+Z/*7;:<_\ 5Z]5
M:Q6X3Q;]Y"PMR' -UA,6#0I=LBHTK59F85SD5>AY*;=,8\\;)PC)BX$CAF0]
M46)9[I'J;RV::E=\ZNO?FVR^9]5L[WO8Z]V*QQSG<HOW5SG6ZA<M Z\]>X@^
M=4Z0M>;Z#E<1I5/DJO1T;C3BI.J@6(GU9B5!-1]_OZHI->GCJ?J6:OVX@JMV
M2BMQIN/M&6R]R"2UJJLO6:W(4;L-!9HPP#JM-/7;!!N>QX*_F-2>S]2573EH
MIU!02\FT2,4$P??[^$4?-I6[Q7CU!H)\^A.UUNNF.=\]5G,AS^9RATCTKKF'
ML^I.EQW7.^0^J,Z4E')V6WW"<>PMX=FT!<4G\M)QMLAHYQ$U=P9]?W^3??PB
MQFEZSZC\ED^L/H37/4)BCN^I=*D]^M>V]6;8YG<I[K2>P49I9Z7UEJ51R-E=
MWV>.: OHL7.S&3UK4H#.H$E=NT&K+SR!&"S[_?9%T&C[WZM;UOU*7JD1W!R^
M-D\'K$K11L\!H&@R-@W5+=[Q%V./[/(YQT[LLI:(>5RN*H;BNP6IQW6Q)M4;
M,,_.S1;NA/+1Q%=CZ>7S)>Q/JO)1GC[C%[S0JD1\ # P"\..J_7I;5@8 /T
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M_)1,<14XAW>VV3VOL%V-LJ79N ZR][\S[MXKDLS>7:S?KG&/\XS204ZDSV&
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63A$X1.$3A$X1.$3A$X1.$3A$X1?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g729258g66o21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g66o21.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2>F4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )XJ^$!(CA"24T$!       1AP!6@ #&R5'' (   (  QP"4  (<G(S-3
MDP.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !#J7K"I7S'+TCQ#K(P('TL].$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0%>/.X         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  7C
MSN  $  @!>/.X  0 ".$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             !A    EX
M   0                         !              )>   !A
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !A     !29V
MAT;&]N9P   EX    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   80     4F=H=&QO;F<   )>     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    %.$))30
M0,     !TE     0   *    !F   !X   OT   !T) !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
MKS"PL+(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0
MT-)@U #5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@
M]Z#Y8/LP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@
M<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA
M3P%1(5-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_
M<8&QA &&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.Q
MMC&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY 'FH>E!Z^'N
MD?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB)R)5(H(BKR
M+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N
M@G&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@JFRK/*P(K-B
MMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_
MXP-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#
M43-4TUAS7"-?TV-S9R-JXVZ3<D-V WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C
M8Z=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC
M_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519
MI%WD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FD
MOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G4'%0NU$&45!1FU'F4C
M%2?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RU
MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  #_X4 ":'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^"B @
M(" @(" @(#QX;7 Z0W)E871O<E1O;VP^4%-C<FEP=#4N9&QL(%9E<G-I;VX@
M-2XR+C(\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I-;V1I9GE$
M871E/C(P,C M,#,M,3-4,C,Z-30Z-3<K,#4Z,S \+WAM<#I-;V1I9GE$871E
M/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TP,RTQ,U0Q-CHS,CHU
M,BLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z365T861A
M=&%$871E/C(P,C M,#,M,3-4,C,Z-30Z-3<K,#4Z,S \+WAM<#I-971A9&%T
M841A=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F
M.E!R;V1U8V5R/D%C<F]B870@1&ES=&EL;&5R(#$P+C$N,38@*%=I;F1O=W,I
M/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @
M(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X
M;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@
M(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @
M(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/DUI8W)O
M<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;VX\+W)D9CIL:3X*(" @
M(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @
M(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D^<G(S-3DP.3,\+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @
M(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N
M=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @/'AM
M<$U-.DEN<W1A;F-E240^>&UP+FEI9#HP1D$Q-$-&,34W-C5%03$Q.#)$0T(P
M-#4T04(Y0S4V0SPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-
M.D1O8W5M96YT240^>&UP+F1I9#I#-#4Y1D(V,#4U-C5%03$Q.#)$0T(P-#4T
M04(Y0S4V0SPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R
M:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D,T-3E&0C8P-34V-45!,3$X,D1#
M0C T-31!0CE#-39#/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @
M(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#I#-#4Y1D(V,#4U-C5%03$Q.#)$0T(P-#4T04(Y0S4V0SPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,"TP,RTQ,U0R,SHU-#HU,BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S
M:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C!%03$T0T8Q
M-3<V-45!,3$X,D1#0C T-31!0CE#-39#/"]S=$5V=#II;G-T86YC94E$/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$S5#(S.C4T
M.C4W*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP
M:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P
M;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S
M=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#HP1D$Q-$-&,34W-C5%03$Q.#)$0T(P-#4T04(Y0S4V0SPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,"TP,RTQ,U0R,SHU-#HU-RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S
M:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI3
M97$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-
M.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HP14$Q-$-&,34W-C5%
M03$Q.#)$0T(P-#4T04(Y0S4V0SPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#I#-#4Y1D(V,#4U-C5%
M03$Q.#)$0T(P-#4T04(Y0S4V0SPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @
M(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D,T-3E&
M0C8P-34V-45!,3$X,D1#0C T-31!0CE#-39#/"]S=%)E9CIO<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO
M=&]S:&]P.D-O;&]R36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T
M(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_  !$( 8L":0,!$0 "$0$#$0'_Q  >  $  0,% 0
M            !P,&" $"! 4)"O_$ '00  $$ 0," P0"" P.#08'$0$" P0%
M!@ '$1(A"!,Q%")!40D5%A<R87&1H;$8&2-"4E>!IL'1UO D,S8W6')U=H*3
MLK73X24F)SA48G>2E):SMM(H-4-&4U4T1$56<Y6BH[3#8V1E@X:EPM352&9T
MX_'_Q  < 0$  @(# 0               0(#! 4&!PC_Q !1$0 ! @,$!0<(
M!@D# P0 !P ! !$"(3$#!$%1$F%Q@? %(I&AL<'1!A,4,E)3TN$50G*2H_$'
M(S,T8G.3HK(60X(D-=-CM,+B%R55@Z2SP__:  P# 0 "$0,1 #\ ^_C1$T1-
M$31$T1-$7D3],G:653X<<&D5<^77OKWIQUI;T.0[&<4TK!]Q%*;4ME:%E!+:
M%%'/!+:5<<I!UVSR-$,7+#1PB*'T>,L0#-\CNGT+K?E+%:"Z68LXHH7M0"82
M832+$$%M5)+Y_-D,ORI[>/9YEW)+QUMW<_;MIUI=K-6AQM>5TR5H4@O$*0L$
MI6".""H>FO6.7;*ZP\F6AL["S$7FY$00AB87:0>LZU#-ETZY&]07JP)MK4\^
M$,8XB"Q#R<3WD[6E]LD9?,=GW@266N4E7""#Q]TYSR@GU YY5R.>RB=?/9=X
MGJ(HAUGC%>J DPPDS)AA/4%@1O7E&>/;F937;=6>[U9:4E-6.6:%UF=*Q&XK
MYK]"+&KP-FLJGL--C!H$VME.OY$M65IMG55]*E!0D IJXU<-+;B&7<U3FZKT
M/%K.ER?<UK&8V:;A0:FNM:ZREV5IAWU8ZO$K7)5Y+'CYH_(9=ZDQ&;VZJW7I
M*4F:'EJ0D$XGQUKH,8G[M)V+WL@UD[.[S+(%%!FXMELQG<RDR&XOYL>7(N:R
MGQ_</)LFM*J50.,M-%['),:@L_;$HIX@;AAQ10)Y[P>\*_I>=Y)D])OE<8]/
MW-JZ>UQUBGVUGM8-EC-[$R"!BV46U[:8_BU[%H;!MR-YE6J"JSF8_'M[6(Q4
MUUEY[T5A;&O'&S664NW''%-?;>&7(;R347M/D"LYDI&5RVZ"WR=>YEA$N*V-
MC^.*FOUDC<VH9S?'(;<V1))I\MMKU'UDN;]CN3/QD2ZVJ)GP_?U?*&J.K\2E
M C(\\@6EJR_*W$SC#X]/DF0[@[C?6U5E7B5I<<H<J^U_=2ZJCPBOV\VX8O)U
M;]BLV;!MJZ=$MK*1'KHI9D...)IXFLY28ZJ8'$NN5'WQ\4D=S-YTS;NELX>*
M6KL=G'JG&<X3?RFI-QDV+4[$-V?4PL>M@]/;P^XG6%'?WD&#2+R"R6]&KY%=
M%B.,>.#NAB*E^C.LO&F:Z3)MY_$O*R2YQ^OPZREQJIZ?Y!K,,RZ@D.VN.26P
MU#-HY[;CL^ER3S_+;G-W\DR4-^U&#3>68:2F>H=>&W.O<NSQ[>?Q77$13S^+
MXQ7!$N7+<>C8/N-.?6RQ3-S7**3#N8&%N1I+=D5US5A";O8LEM!>;FR%=+BW
M'%$XXXVM5+K?7Q(L5\!VIQ:(W8V%K<,Y)7VNVVXL:OP-J%]8KQ^.WD%1"S"9
ME;V2B-7A^14XM90:Y,PB3.J?9PTHF)>6X_-SL6?>'2[>PQBAL;^*Q O+"EJ)
MEQ BJD+B0K237QWK&-&5,CQII88F./,LF<RB<66VU2T-OJ6VA5%<VB)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB
M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB
M)HB:(FB)HB:(FB)HB:(FB+%OQ..^'N1CU'3^(FNK;C&Y5^NQH:VSQ6^RY@W=
M/1VCTJP178]3V\ICZMH9%J])LI+#,2%'62[)07D@[=RMKW8VD=I=28+00B$1
M PCUB*Z4IF0G.E2PUKW8V=M!9P6@>$DEB]02,)@;,LUB5#Q_Z.3&K6LOHVV]
M+16=%/8MV;&1LEN;7.T\N@?C33-=E*PAN/"%1,=8?DS9$AN#6N.!;KWZKU'D
M8.4.6K2&T@M;S''#%S7!A:(,7+DSE"6(J(:2EK1\GW:R-G'#  9ERY +S9BW
MWI!V::]38"FW(<=QHH4TZTAQHH'N*:6 IL@%*> 4$$#I2 #V2/37!SGI5<OK
MG6I\5R9[AV!<&58U[4Q<1V;%1+;CF4J*9$=$I$5 _5):F7'4.>SMCGS'N V@
M#A1T4+C)M*U\Q&V;."[]8I4JN+4I@JFA">LN15(>(D(;2"5JC=7<'GOHBWIM
M:YR*[-:L(3L>.7FY$EM]MR.RZR>EY+R@I?0\RH<*0LA:0>_'(Y415ER(Z"I2
MWD 1DI4^T7??:94.4EY)<0AIM:0I;CCX#?2GL?=[$5*%8UMI%1,K9D*QANEY
MEB7 E1YL9Q8<:9_H=QA:V#Y;Z@TM(5P%)42.3HBH0KJKL94N' M84R9"<6U/
M9A2H;LF$XTHMO"6PA1<:)?0XE7*01QZ#L-$XXV*X&>2%*4""H@D=74![H Z1
MZ)! "N!VY)(T1<>8\TQT%U;32%'HZW5!*?,6>&PGD@%94.VB*NQZ'G@D< JY
MY)('?O\ +Y<>HT15^ /0<:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB
M)HB:(FB)HB:(FB)HB:(FB)HBI/<^4O@\'I['@'T^05VY^ Y^/'QT113E>Z5+
MA^18]C=C59=-F9(X&X4NEQFVN:J*M;[3"5VMK";7&JVPM84HO*2E*$.*/9)Y
M)QQT+9"W6H9N9Y%A#53F2+3&H3DZ;.D8M;QJ":PVPT^6Z>\=;$"UDI2\E/D,
MK4^%H<2!U-'@E>."NA@[]XG/PBVS]./[BL5-/;,T\JOD8/D#&2NR91CH,F!C
MR6/K"= 'M22+",VIH!IXIY]GT3C;J_-AK7.G[S8Y7'!4R*C/7_MB(K)%,F+A
M5S+56(L)4&,RWDX;B^7C3C*Y[2I4>P+:H;4>7)=X2TI6G'#*'Q9J\-794T7/
MB[J44K,[K!6ZC+T6=!7S+258R,7MD8_*8BB,MQJNR!UOV*TEN"2CV>)'65OE
MI]2!S'.BE=!%WYQ>9BM]F36/[AM5E!9M54V%)PG)&[N2^\D=+U91%GVNQB D
M=4F,A382E2@H\<@BKS]Z\8KHN'R)%!N"^WFC:7*T1L+O9<B$%O\ D\9 RVUU
M49*^%^5.#9\H=:N #HG%..A=NUNK1/YM9X$FJS$6M5$D3I%@O%KE.//-1XWM
M*T0[Y3?U;,D+1PAN.TLK>>_H=(*O=T1=!"WZQ6?B][ES5!N(U78W,AP9L.1@
MV0-7<A<MSRD/U5,8HFV49!/ZN]$2M$0CWB"-$7-L-[L8J8&"V#M#GLIG<'S4
M5#$+#+V=*K R_#C\Y,PAH_8Z.J:T2;!*!^H/]^(QX(NV9W.HW=P9^VK=5ER;
MBO8$Y^U5C=NUBSC2JZ+/\N-DQ;%;)DAJ8(YCASJ$QEZ /?8(!.,>._)6]7[Z
MXQ9XIDN5L4.XS4#&)K$>PA2L$OXMS*+BF/>IJ=<3VJT:1[0GSW825CAM\\CI
M[$=]73WS7)M=\L6JJW#;EVBS^5&S53**UB!A5Y*G0%/K90@Y##2T7J0-^:GV
MA<T(""E8/="M$7:JW3H_LZ?V\159=]:M0I%BY8*Q2W.+EEF/[2J,UD2FOJ\R
ME('2U$:<\Q;Y#?'5SHFK?CV]RZ"NWSQ:?0Y9D35'N,S"Q"4S"L8LS![V/9SG
M'%/)!HZY<42+UGEA0+T9+B4=:>%>^-$56;OMC%;CV(9'(Q_<-^'F;KS5;&B8
M3>R;. MF2N,3?5J6A*IVBMHK0J4E"'&?Z)'"3W(KD.YE(=PT[;IJ\P%Q[&Y(
M^L_L=M4XL&_9E3>C[)D(-:V_T)+?"G/.4^1'/OG@$5MU>^F-V]%EV0LT>XC,
M7"W6&[2-,P>]AV4]4I]R,E5#6NQ?.O4<M\J$4+#"2GCX:)E+M#[> M;#?#&J
M['\4R)ZAW!?AYE)<BU\2)A-_*MX2T/,L\WM<TS[12,E3Z5A<Q*$/MMO.^G.B
MAVKQT<;UW@W6HQG[6WPJLP%H_ 8GILQC%H<:0S(BMRTM.9 ELP0^$NA*F.OS
M&'$K;(!!T4KI:_>_&;2IRZY9H=P&8V&+6BQ8F87?1[">I"U-J^QZ$^UYEX5%
M/+?LH4%H(4.Q')%QY^^V*0<:QK*WJ+<)^%D\Q<*' BX/D,F]AN-J4@+MJAM@
MS*EGW23)>2&N%(Y("AHBN.1NG0L9[7[>NT^8KM;" FP9MAB]HO'&X_LS\OR9
M60(08,:66F"TB,^OS5OK0UP5N=R+J*S>S&;2+G5A'H\]:CX!T_6K<[#+^-*L
ME*=GMJ3C#+C7FY(5*KW%MBN\Q"4O1G^?U3@L_E/KXDF6N=#3.G56N2X,W??%
M:_#\>SEZAW"<K,GG3H4*NBX+D$F]CN09,B*\[9T4=DRX,60[%<7$E3$(3.;=
M8>02V$ZC<>J77V.G%-;<%3Q$6'([;B0H)6GK'4"#PKN.RN5#L1V5W'H>XU*+
MD:(FB)HB:(FB)HB:(NEG+=;\]R.WYSJ&GELLE8;2Y(2A:4-EQ27 VEQ2!YBP
MDJ0.2I*A[NB+%>OWVS.<]MQ'?K,.BV.6VEE M<;18SIMNQ%K+"P@V%I!D!Z/
M&8J*]F,P](L)\=YE]Y[V2,T'$J6V175BN[ES>;D6V'.P:Q-*Q:Y32ULB(_+7
M>M2<3$-4J?:I<=<B_5UHF6E%:MEEIQ*VU!3KG8:)V=^WN;>I8QW.<7R^;>5V
M/7#4^QQ>4U!O8B6ID>14RI/FKC(E,RV&2ZB0(SRX[[7F,.>4>%'@\$5],!0:
M1U$$GJ/(^(*E%)_"4D$CX'D:(L-_$M=U./;G>'JPN[*CJ8*KW<N.B7D-G'IZ
M_P!JD;<6098^M);S$2&_*#+B6GI?M$1DMEQZ*Z.>.1ND+W3E M2&[SVVU*5Q
MW9L1AMH@&&M]8[A(G:\PU8HW]W*V[F;,[H0H>:;:R7W=KK&-'8K\KJI,R2^M
M3C46'"KH]FY+<DJ<+RH$19<?B++PGKEBPAB/GNC^FV0+UMI.&.C9$Q/@3/*E
M&6*".8)F')#E\1H]FP:Y/Z!4*NNDJSSQ_L=!2[T^Z XEEL$I) !2D@ $>O'J
M=<1%ZT6T]JV@7#YK"#>S:[/L^W&R5^@Q!5+$BUU8]6Y5%LO*D9;,;=HG+>)<
MOE"G(5:FGJ9%%$@14]$M]\RI2E-EM"(4RWX=ZM:\V2W"M:^NC8_A;..6[V97
MF345E];LJ3B^/S)CKU?B%FA,=4F)71.LSD_5KS:GY)1%6 URO11N&OAIJZZW
M9G/IFT&\>+PZEO&[/+\%Q;&Z.HDVA")&48]53(>19,N2RR1&&3RG8[H>Z%.K
M,=*UCU!)Q\_#9N%ZRL6W!RNEWLE6F&3( W6QYO$Z_&WLC,.=#C5&+Y*AZ=(M
MHC!^K%W-E9,U49V,E3D=8;L5\I4AALI(<<=/!?8NU\.F.9KAL')X.48^(4.\
MRN1?U,Y46KK;5MB/C6,5B!>UU,PQ7)E.R8+]= =C-I>D5T%$J<LO/)X)^7'>
M>E1- \,N?5$>]RV#F-O7YI8;B9Y&KHF/JKZ-^KP#<+Q(4N97\I&108[=M/L?
MM;TQAU_MBW35F=*C1B@]#B0H'KBIRQXHZH1<4\74!>:RHN2R7Y\>U>./1Y][
M(>I+)NQN,GJHJHR)33SD*)2T%W29"J.R$-.2\=:K7$N.)5,64<=O&M=5D6 >
M*R]R6ZALV+RZ.-(EBI>LLBFS:^3-KI33N-6IB/I4S'4XA:G;!$1MM'817TOJ
M9#RBC+KEPRYM'@/BKL&4M7^:9)6>QV4N6PB)E+R%2Y\>G;0&GGTQS(?H95WY
MCK,%Y9C+84E"&F6D^7HF6W#?7LVY+6^QSQ7N5D1$&UR)NT3=6KV926LKD)BV
M27!8?8NWA4."U'>JZN ':OZZBMOHBREQY+<AEX.*42E9ZX:S<Q\:HV,B>3(O
MF*6G9NGT+;6V];M5[#=FZDLMM-'S)R9"RIMIM"@H%"$I"4@G&Q71HB:(FB)H
MB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HBI/<^4OCCGI
M/'//\'?^?QT11!#K[I&\LFS7F##]"]@;41&"><"_"LA>1G3D99*E*2TXP500
M0T@%;H]\<].B<5VX<=2F/@?(?'X?/U_'\=$6BDIX/NCT^ !/8'C@?'CX#1%8
MF7YK682S"E6C<AY-@\[':3';0I04PDNE1'5W("N3W^''/;G1%8OV]L1[?T):
M]O3^A&^WX/U;11/(=)\$^WMB/_!+7_HC?RX_]M\NWX-$GD.D^"?;VQ'_ ():
M_P#1&_\ 3:(YR'2?!;OMZ8C_ ,&L_P#HK?\ IM3HP8Q#[N_MFJ><U=?R6P[[
M8@/_ (K:CGG_ .*-CU/)_P#3?$]S]_OZZQF&'$D93'4ZR@1Q&4(.ISX+7[>V
M(CTB6H]?_BC?Q/)_]-\3W/S/?UU=5GD.D^"?;VQ'_@EKW]?Z$;[]^?\ VWS[
M_A[Z)/(=)\%K]O?$O^"VW_14?Z;4,,AT)/(=)\%I]O;$?^"6O_1&_P#3:,,@
MD\ATGP6P[ZXH?_BEKZD__!T?^/4J5N^WOB'QBVGW_P"A6_4?_IA^8:KS?X=[
M/O=0\6K5,^"U^WMB/;^A+7MZ?T(WV_!^K:&$$DN9Z_EN2>0Z3X)]O;$?^"6O
M_1&_]-JPD ,DGD.D^"?;VQ'_ ():_P#1&_GS_P"V^9)_#WT2>0Z3X)]O;$?^
M"6O_ $1O_3:)/(=)\$^WKB'_  .U_P"B-_Z;1)Y#I/@GV]L1_P""6O\ T1O_
M $VB3R'2?!!OMB(/(B6H/S$1OGOZ]_.^.B3R'2?!=C2;P8U>V\6IB1K!,F:\
MVRV76&TIY<"^.2E2E#CI/Q)!T0'OZ0IB: Z$\I /KP._'<\=_F ?W.XT4J+]
MXHF03=K-T86)Y)'PS)Y> 9A#QK+YDAN%$Q.]D8S.:ILD>F.+2W$B4MFY&L9,
MIPH;C(BJ=44\%P$5]5#<IFHKF)+_ +5*$6.A^5UA8?>2T@.OA:0$K#JPI84G
MA*NKE/ (X(NK;RBCEW<O'H\XOW$!M+DN.AF2?(0IEM[I6^EM+ <<96A2$><I
M1!!("B1HBQKW6WWSC!<EL,?H*&AO5RJ6<_CB$.R''C<UJHZI,"X<^N(:'7?9
MGS*3!CMPGT,)ZC*=4KHT4/JKQ/#B3K(3:_+_ +/,#Q[*U!"7;6/)]I;1$>@H
M:F09\NNF,IB2)$M]A+,N(\T$N27U*".L.%*AIQT*5?VB)HB:(FB+CE*/?/3S
MW5U)^^LGWD_(GDGGU[GXZ(K!F[=X5-LH]K)QFJ=L(4=Z'%EF*A$EB,\ZZ_(9
M;=:*%)0\^\X\4=T*<=4L@J).B-X:NA=G!QC'ZVS?NH%- BVDQEN++L&(R&I+
MK#7'EMN.@>\V.!YB_NEJ +A/ T11CMZ!]O'?OMZ5.TA'/?CJK<O*N#\B>_X.
M/EHH%3M[@L@$_<C\ T4JV,CQ7%<L:1#RO'*/)(L=Q3T:->U$"WCL/.,+8<=9
M9L(\AIIQQEQQE;B$I4IIQQLGH6H&(([2&*,"(@%J&1%0X=L\/G!A!J''#CC4
MHAS?'_#SMG13\RSO'=HL)QZL6PJ7D614&*T]=#>?>;8B>?82X3+;;LB6_'0R
MD.%U]X)2A)*%<39VUH3%$\0+F$'2+L6>=9B1SW*!!"&9LB&'%2:=$U.-+-@V
ME3 L:V7#L*V?%:EU\Z \U)@S(,A =BR8CS"ELNQGF%H<96TI32D*!0HIX)I
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M4[MW&2$QFL3[7/\ \EL5LSG:0KKKX:$NJ0A1-I!2E1>*X[:0.OCJ62TD_,*
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M'&8$*-#HY>4UL#%+"GJ)+->N?+R& +!UQW(3%K(/ESI:I";)=X8KFYTA)XF
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M^)$I;=F/#36/"-F<Z<6H/>(K=3E 3TI]EPA24=8"U-H4K%RM80H!/4MQQP]
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M0#N1 RT 0&T *^Z'2._X>W?MV_!IHPY#H"+7RV_>]Q/O'E7NCN> .3V^0 _
M!\M&&0XEV!MB)Y3?)/0GD\<GI'?IXXY^?' X_!J43RV^_N)[GJ/NCU^?I]X?
MN=M#,,:(M0A ]$)''_%'\6J>;@]D="+=JP  82 1-2B:(FB)HBBS>5G+)FUF
MY\+ ;F!CF>2MO<QBX9?V4GV*OH\IF8W8Q\<N+"<67DPH=;=JA3)3ZF)2FH\<
MNICO=*6E$5_UWM'U;#]J<0[)$=@2'6UAQMQX!H.N(6E* M*U\J"@E((/( ]-
M$5E8B <@W!!'/.21@?O@TD$$?N@:(I$0A'!/0GDG@GI'P';X?#1%4"4I'"0
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M!EB)=.1.1SQQP51O;3%E6+38J+539L%M1Q-M,PKV5L'*XL)[ZT=79I;KG:R
MM3.')4?+R1CV6:R'6U<F?. 5.-:,PD&QTJS8AZ@*-$.<GP<R,W?!@982H6GT
MU9C%3CV;;)2JEF_AN3LE9A2ES3DC)M(CVT&>VCSN01+2:\S47KUC#BR)N-26
MDRX*HK#RT)#BNJD40BAB#O+2J'$Q*3.)R.3/-3" "*@C&>0K,L9G>LSRD(;"
MD>Z2$\D$]_=2._?CT2!^YK5BE& */%U46V)@; MS*BH'D\\'4J56T1-$31$T
M1-$31$T1-$31$T1-$31$T1-$5&02&'2!R>D\#@GG[P !)/R'![\:(HG@Q,O.
M[TFP<R..Y@[F#LL1L4+D<S(N1"V86Y<K92GST,*KDN025.EH/K'#77P012]H
MB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(HLWD:R^1
MMCN7&V^LHU-GC^WF9HPJXF.,1XE3E[^.SV,9M);\L^QMQ*ZW$65+>E$,QF4A
MUT>4%G1%?]=[3]60O;%^;*]F8]H=X2GS'N&@ZYPGM[Z^I7;YZ(K'Q4G[(-P.
M%=)&1Q..!R?_ #-"))'<K]0.P' ''KHB[Z1E='!=EQ9EU7,2:YDRIK+DZ&TY
M'840$NR$*>Y90>0!YG3P3R>W&B*XX,MB=%;EQGVY$=\%;+S*PXTXCGCEM8]U
M20H$ @D$@\$Z(N7HB:(FB)HB:(FB)HB@+ OZ^N_W]RMH_P#-F7Z*!6+;W!3X
MGT'X!^;12M=$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T101XB$/.8
M#'1';M773E.-D(I7H\>S4E-BV5"*_+'LR%\=U!XI2ML.)!ZRD:S6+:9=FT37
MM:IW K':2 K6DI],GZZLNC:,1T,.-&F<:><E*8>J%TJ(;C#,JS18.X^'$J6W
M!BK0L9QYO#TAU$X1&W%DG61PTA,-XD19ZM3;\1V\-0-/7FN+(3 \@N."@;A&
ME5+4J0NC51.4"<>IVA(8:Z>H[3=2TI5""6Y8L'4R"TF(&QJ-& T&>+N',J^O
ME7K<0[S+B;RH9";T$/YRFNQ?,1JU\MY56TMBYITOF_\ J=R.F1(SN*G'QD#,
M8%XV<^24M[3>S%3T&<F,)0;GL%"JZ(J16NS$@2HQ<OWJ0X8"9 EMUYN\AEN5
MER XWF&S9\N8VXUGT2-.\R13O2F+!K97<-3T7,_J]2O/SY#4E'UK,AEVK?@^
MPJC.\%#;=H((2(R1]0]HH'_)5)(:=2 )$28.^#YOBY&K+ML!2.%=P". ?[5)
M_AUK&9<UGUU6S#ZHXQ50)"?0<<Z*RUT1-$31$T1-$31$T1-$31$T1-$31$T1
M-$5&0 6'.1R.DGCI"^>.#]R2D'T^*@!ZDCCG1%!%='P<>(6QFMVUBK<->UT9
MJ52&.Y]4-XN<CC>78-S0R(RIRK)33*F4R77O*6>$%'O$G'''>I]T1-$31$T1
M-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$4'>(Z)B]AL1O=7YW
M>S\8P>;M'N)&R_(ZJ,[+M<?Q1W$+9O);NL@L(?E3;"KIES9L-N*Q(><D,ML(
MB25$,ND^7%>.V6JGRC45I8<6\P840L.N-K9<<9+;/E..-. +;6M'2I2% %*B
M0>XT11?B]>\C.MP;55Q:B,+F&PJF"ZY-2.JH@)3,(]D^L?:/,'3R;!#1';V5
M2?U31%!6Y>PV7;AY=EUC:XYMM(Q276+@X]'9R*\I+>R<EA@VKV6RXF$3RXN>
MEA$6+[-+L(]4RTD-09+SQ?:B<^KYJ,=7?QUK)C:C&KK#MO\ ',:R"9%G6M2Q
M+9?>A >RMLNV$N3"ALK]CKE/(KX+\:![0Y!BNR3&,AUKS'%+5*E2)HB:(FB+
MI9-FU%DL1WYD6.Y+>>8AQWWFV7I3K04ZH1P^&C((9ZU*;82M"0R.N2A14%$X
MZ>.F55W""HH25\=12.K@<#GCOP.3P/O<GCTYT18P[H[TY3A&Z^%8;7U4&1C-
MJQ7S,IM9$8K>J8=M9V=1"=]L7;0$1DNRX"$1_8*O)Y:WG5-6%?51$MV3Q%R\
M3W?R6_W+M<8D1*TT0N<NH*YFOB27KF$YAZ8BU6]E,]K=A+A7@E^5%:$&*W&?
M86VW.G%02@BX>UF11;K>WQ NP6+UI4>/MA!DB[QNYQPK?AUN6))@L7D.NF3X
M;I45-6;,9-9(0 8<V23HHQ/2W&)UD2V%9.M*ZFTGGD\<$\<=TDI/;X=P>Q[C
MX@'D:*54T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31% _B*9,C &&
M0S%>Z\HQOW)=E.IFP$V3:BM-I6)7.A.)XY0['02I7#+A0VXM6LED'BJTB:/1
MBL5J["OK3 \<.D/FNM$J:ZZ%+F3 F3)0Z7Y#>:54N0*V5/#+\Z(FI81C[L (
M2FGJ6@6\^2ALJD.)EM^9E;4[RE.M1K#-I2EC*N+)RP<N^+4-&$Z-6LEJNPEE
MM^8)]BTIJ.NZ??%=G3\LO&@J$?6WU *A18R#S4N(.T)1UJ0LW"HWMSCP3'JL
M&KK#$2(%>;)^<*L1J4#%B6<5=W9GF*_PL10R)9<SJFPK=!\YYKV:P:9Z(7V:
MWLEMJ\SBO0\S%B+JS'R&)=L*#&2V3ZFH>T+*2?/50QESVFW/5[,L6#%F8'2-
M7)*D2H6<O0BK/+$$&;^J[8.K#L&W?LJV/"U-+;K\WBU3?1;93+9BJC[-;BN.
MQ:I^_AQDYK4)6YU,;BK/UC=/%^/,2AR.IMN\-(W#'0+C_EJIA+@U-83@" *]
M68UU.Q9:M?<G_!_R$:U3(G:5M0>J-_:5O^(_ ?X/X]4).F!@1XJRUU9$T1-$
M31$T1-$31$T1-$31$T1-$31$T14GD]32QPD\I_7\!/SY42A8 'KSTGC[WJ"*
M$8-LX=\YE4<!##?VNXTQ.Y*H3Z'I:CD$9A6)&P7%;AN-I0?K5##5B\\4,A9B
ME1X)-6KM?PUJ<]$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1=<_*<
M:>6@D)2E(4GGH3SSTC_TA1U)Y/'4A2@5*#9*%@IT1<UE2EMH4KCJ(Y/2>H<\
MGX]*.>/0^Z._([^I(JFB)HB:(H8\0%K'I=D]YK2PQ!&XE=7;59_.F;>+=>:.
M>1(N(W$F7AP]EBV4U0R9EDT:3#J[&3S8.^366+R&XKI%*-6I*ZJO6F,(:5PX
MRA$ 4!%"D,D1O?;95^H AODM-GW>Z$GMHBLO$D)5D&X/4.?]L<4=^>W^PL+N
MG]BK_CIX5]_1%(2&6N0KH25)/ND]R.P';GGN?B?4GN>3WT15DI2A(2D!*1SP
M . .22>!^$DZ(J#JW$N)"2K@@<]D]('6 I9)'/8=N#^R)^&B*(<BWOPW%\BG
M8M8-YU8W5='@2+%O$]I]T\ZK*WZQ!,-J==8/A>2UD-Y]#;CRH\F0A^*PA4B6
MAEF1#<639QQL4A^U6O\ PV'_ /52O_YWJ'.1ZO%2PS'7X+"3Q'5'M.ZF.U]1
MB&!7<B_5CDS*9%EM=+W$OWX"+.93-5F1/L[?9M$H<3LT(J9,>;82J&.8%!F2
M8$AF],>[JQ%-KS#Y\.JGN;Q>1P8MMPIG?4PHU;65]?#9$>)"AQXT9A)>4EEE
MEM*&VTF02^4H2 E/G$N< =1YYU*E==9XCBMU/AVESCE';V5<F0BOGV=7"GS(
M*)3:F928<F6R\]%3(94IEY+"VPZRHLK!;/3HBWP\6QJOL95Q7T%- MIT:/"F
MVD*MB1;&9#B?_!(DJ<PRW)D1HOI&8==6VP"0TE')T10Y@;3:M\]_DJ2"GZJV
MC]P\E!_V,R\=T$])]!Z@^@^0T4#'4>X*?T)"4)2GL   .2>!\N22>!Z ? =A
MV T4K=HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB* /$D64[=M&2[
M2L,?9/C8<>R*)[;3()LF@CVR+[3%#I6OA+ \Q)#Y;4%)([YK#US]DXM)P^!?
MJ6&V)$,L\0_?W'<NG4J,E3H?CI:6B3#3-1<.U,F;'?=DSQ7M9*ZC+W43K2>H
MI^U^I!?53!49,ORBTZTUE+B3EQB<&<G1<4S/UIMFL,,19R:%F GJEKP9M="%
M0+"5IDM"+)5)4DLN1HCU,QE#=TG'*5?U.J5]F;<<;Q^SAIU65ID"N^J5,MHF
M!EIMZ14TF7$\ S%\6E#D,6+LK8Y3 G3 T>9&<M[+D1DPDV\818S;BUV4HP6\
M;%1#D/EG.XGV02,/*LI2N#$IU+>=WHCEMF5E3L>:JH@V4IX5CC: 9N7 +N*Q
M4</2K2FDLZ[<, ,"Q8M/5E9BTPSE&Q;C"L>)<RNK5#<J68:8<ZJ.S.X_LL_!
M$Q<@MEUFUKJ_,&,4TAH.17TV#@=*'4NRI@#")LH@2*%B*UYQ9RQ;NJ27A!:<
M0VR>F<+NSS[\Q6_N3_@_]FC6M%4[3VK:@]4;^TJI_/\ G^+56#OB%9-2B:(F
MB)HBI/.>6@K*ND#DJ/'/"0E14>X(]T J/S"2!R2 3/($C8S]8*+B!]TI7RIP
M*][A0;!0DE*RE*2MMKE0(!!<2$$=(Y/7U:-KZ6[@CRIVN>DMQDMJ)3SKA2A*
M"WT@I7U( )!*5I#B2ZDJ002M/E!*.W#B^>Q%N+SW*N5M)''8@I40/UJE-GI4
MD*/NA76XE1/W*/@1;$OR.' I82KWASTI):///]+XY*0GI 45.=2E<!)XXT1<
MAE]:E)0K@J*>I?!2H(Y'*0%H !]"1UH;ZTGJ02$$$BY7!YYY[?+@?GU#%W>6
M3#M1:ZE$T1-$5)X%33@'/)21V*A^,H"E<?/@'MR#VY.B*(X<?.F]X)4IZ_K5
M[='"6(L7&6G0FQ9RWZX96];KC+AMJ->JL#D5#XL'DB24)1'"CP2C$UR;#;K.
MS"2F'12FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(J?))[+(]Y0XZ1R2DGD
M D<<#CL>#]\\]@18U>(_Q6[2>%S'8-UN5>2W[W)9CE/M]MGB=<O)=T-SLC*2
MMC'=O\-A+%A>V"O=3)EE3%+5)6)%W95D9)=41>']/X<_I@-\/I)-K/&/?[GO
M^';PKD5TR?X:9&\&0WTRGPF%"=B#%LJVYHZAC +'+<H6J/=WCALI\:OFK<CM
M7,E]KIT^?YTXZ$7TJ,'EELDA1*!R0>0>WPY ('_%(]W[GOQSHBJZ(FB)HBC#
M>!O.9.V&Y<;:^P8I]R7<!RYG +><(::^NS:3CEDUB<^8;.#/KEQ:^_-=+?5+
MKK:.V$_T17S6"[#=)OXXXSORO3(36PDRUI<E)C,)DNHX"79"0T'G$])(X6YU
M*'W)X/W"?N03CAU96(_U0;@?WR1?\R0=$4BH]#^'^ :(J;CBDDI!2"0"DJ^Y
M' )5U$=QS\/G\#HBXJW>5@\*XY05J("4*2%A)Z3YJ>$#J)4'$D. >Z21V)QQ
MQL6%N=9%=U?B1H,+H\JR'#F-P*:-,ENQE[964:_D5D>UB]53BZ]N<SS]Z16P
MT(DR[>^NL5PJ(VJ$E,BVD.V,)+CY5!FF^LJCLQX.!68/EI_]JS_TIO\ _@-3
M+,] \5#Q^T?O?_580^(V07=X<#>@"W$^%*HZ>"]38W-FQ19G(X-M/B9U9.XG
M=-IP\U<Z&]"<QZRK9PMG+")*>0[T3ZN...I35QLH^+CQ9OSS\9Y\IKJ'2?+1
MRGOV/2.0.23P/@"21Z'1-BJ:(FB* L"_KZ[_ ']RMH_\V9?HH%8MO<%/B?0?
M@'YM%*UT1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31% _B*>2Q@,9U
M4QRO",JQL^ULUYM7FN;%L<-P4QI9>\SGRU<,KZ$J+G8)*AFL?7-?5(EA2>[?
M-8;?U-3C;Q77DNK"0PZ/,*HHB/H:*$RK&<(/UC)G%,5F6[0*-PW<)6#*L5!7
MV)A90RIL,(6O+$2#B[3)SPH6!&&)V.^*%VJ&>6OI%"=3X9*D^T\N*N,2MQ?L
M3E.BO-I91T>VJHJ9W[&FKD8Z7'H)46Y*MQT],H+5[&'0H.1FZC+I+4UC'<YS
MUBW7EK(P. VRP&WECKE6:$A1E)DVL60E+DBPK?;U5&:0 _)?=^H$KISBZF5"
MMAI>2-RO(*)+P8DF8I*NHXT<'"3OO9]Z@F8!Q(;ID[T9WUD3HRL>6X?LKV52
MN>N4N7G,"P2X(3['UHV_LQN,#<RXSM/7C%ILIP**\.;=2FO0H23#:=D.D3"7
M?5#$*,P?;.M6PD9LJ%WA=O6#L7FQZ#(Y!BU5ETW]R?\ !_[-&M:*IVGM6W!Z
MHW]I6_XC\!_@_CU0DZ8&!'BK+75D31%QI3I90E044^][Q">OW0DJ5VXX]!ZE
M2?O=1X0HBV-N%XD.$ #JY0$J!'=):5R?>!*%'J"@#SP>E/Q;VZ.\%./%6;N2
M]F,3!,HD;<5]7:YVW42OL4@7DMV%3OW2D]$%5F^S&E/"#&>4F7+99CK>DQV'
M(S*F'7D2&H(/M'^WP\=B.W8O,.WE^,%7ATVIHW*W=I&ZU7>W#V76-?=UZK.Q
ME2I&1IP61;74&34(GXTQ8,UTK):AF,S&;KG8$54*>P7PU(A))#DZBP;L4&*%
ML-LR=4IC?J"F3!7_ !$[;[N8W1Y+]FV[>'Y!<JKK#()]FJ%!Q&18TD.RL[B7
M XEHL:Z&^$U$.&AR)%A6*)[]7'8C2PWJVA%EV=RH8X0U2)2 )+YEY,->,U:%
MS:>(&ARC=Z9#QG?')-P%S\_B85[-D\*)LJK%K%EF+MZ:^JDV$EJ';UZGG9;L
M^)CL.S:EL*582[%DAE31BRZPAM(<HNBHW/CL['AZ8KQIUF$8YC&X=3NM?7&%
MT^8TS-UM=FJX\G,\Y,VFL<,R')LBKK'#)]GCSE5+R"H>KI$%%6W91(@GULF,
MGS2T(F&VA(=MNKI+3S3SD.1;-L7F\Y;P,7*E7P\TOBWC>(&IRC=69F3.WF1R
M,Y$NH<R2\NZ^LG-8ACK])46M)/R"3C%;CZ;)60/TU]BU! M%7$"/62NNJLW5
MMUB@BT9L'KBT\^,E,,<,1 F'I(9/*?#+U%<> ;45D\#@<=*N5=QP 5!*>HGL
M.I03SQU$#G6-HPP!#9R\'5Y8=C=Y6Q@N*<YX"4H44KY24DJ*"1T$K5V2.RTE
M)ZE$*;=Z 0;AV#ESB:(N?J431%L<XZ%<\<<?$$C]T)Y)_<T10%!C8@GQ#V4U
MFYM%YTK;2/&E4!;:-.G&CD40HM&UEM+R9PG!ME2A*6SY#A2&"O@$BR T1-$3
M1$T1-$31$T1-$31$T1-$31$T1-$31%UJI3OGJ0WP4<E(! "BM//4A! (!2E"
MW2M7F)6D%M(0XA0TXXS3CMZ-NY>;^[OC:RO,<_MO#MX(,4J][-Y8#IK<ZW,L
MI#B/#]L#U@>U/9WE%:0]E><1@Z@1-N,6<]M4ZXV+VUHQ&E)<)QQ/C*2O[P\^
M";&-I\JG[T;LY19>(#Q/9%$0UDN]>>ML>=5,NJ3[1CFVF.MLFCVWPR)PAF!0
MXXU')8985.DRY*5R%PS</VHLZVV6U-@\* 4!R.HI'IQ]R"0.?7MZDD^I)U*+
MD !("1Z  #\ T1:Z(FB)HBA'Q"UV.V>R.]4#+[N5B^)6&U.?PLJRFO"A/QS&
MI.(6S%_<P^IM])FUM0Y+FQ7$1Y #K#27(T@(+*R?/C?X*5ZI+**BM1'>,AA$
M*(AE]22A3S26V4MN*20"%+0 H\@=SHBL[$?ZH-P/[Y(O^9(.B*14>A_#_ -$
M7'?)!5]T  %>Z#RK@'CT"RKA1'NA('[+D=M$6 7B%S#/-G[!K+VG;ZWCV+=R
M[36#V\<G%(B)];46UXG&X^ -X3:8?:SID6"JOIUVD>=965BXRPI"BP@.D5S9
M_MO,E^)'!,LAK@RW7X$2SL*)2WXUA*H<2RG%F++(&I_L#S+)HKNQP2T36L6-
M>B:Q&F,ICN0;6^CR4^!AT]?4G6\NHMT8+,'RHW_ 8'_1G_\ 0:-%E#]\>"/#
MG%]P^*\]M^L*JV_$;0W <J?KB\L\2R!UNPLK: ?JVM=IZ**J*@Y-509<U$BB
ME^TQH5?+2([M8J0RY(DN%YQ,/GOGVL<%#C.8UME,S#A>DK!"F6E < MH('RY
M2.W8G\Y_"?712JNB)HB@+ OZ^N_W]RMH_P#-F7Z*!6+;W!3XGT'X!^;12M=$
M31$T1-$31$T1-$31$T1-$31$T1-$31$T147EE !"@.RN0>_">W*P."5%'(X2
M/7J[^FB*AYSG*1R #ZJ)2."/UI2 K@'L>2I/WN.-$5=IQ2R0HI44^I0"$@\G
MMPKWB0.._IHB@WQ%+=1M\R6!8%W[*<: -4A#M@$FQ1UF.TXXRAP]//F!;J!Y
M?6>2> <MB^D6]D]W>L-N6@VD8.:S^?5,+J00$M\,M!CSDB-]7H95!*7)-A[6
M*=URP!<A\%:LM4[PN(1(3&0L^ZG-$SR+]^LL 'FTGW8X87,(#2>>$JRI+ ZJ
M:N.Z6@P[U(A"+]6%AKSVF?J--/\ 4-,7$LNBQ+AVR\[H49O GJM%='3Y"4.*
MI.D]FOQ5GG1A,.S,W_QRUKM0X@V(5(1[GUK6JD(M4,H;0^UFD/ZI%LIF<HHL
M1TH&W ;0LRU.Q?:4H<)8U)HQD2X!;(8"3F4W&&:$N 0]0^&#L2XSE.LE8,Y;
MGV8;+-]%JD?9U#<FF2PRV?K%>R^X1=&3!J9(2QFY;*%6S# 7$$8Q?*D+*5 S
M#]9\821J&0U=-*JA$X6H(H=32,S.<6<C(K+MO[D_X/\ V:-:T53M/:MN#U1O
M[2JG\_Y_BU5@X.(5DU*)HBV.-I< "N2 0K@$@<CT)^?2>%)Y]% 'U T11OG.
MSFV&Y;E:[GF%4F4N4XG"K5;1U2#!39*BKG)C\+2$"4N'&6Z._*FDD<=^9$1A
M+@L:*" :JPSX3/#>00=GL,((((-<K@@]B#^K>A'8ZMIQFL1*C0ARZSXK0>$S
MPW@<#9[#!VX)^KU<GL1W/G<GL2#\^3SSSJ-.+/J'@FA#P>*_DM/T)7AN/KL[
MAA[<<FO7R!Z=CYW;MR/P$CXZ:<6?4/!-&$$$"FLHGPE>&U/'&SF%>[STGZN5
MR.?4@^=Z_?TTXL^H>":$.765K^A,\-_[3N%]DE('U<K@ ^I'ZMV4KXJ]3\]-
M.+.FH>":$.764'A+\-P//VG<+)YZN37K)*N@())\[GDI ZC\2 3WT,<1J:[!
MV((80S"G&Q;AX3O#@.>-GL,'(4D_['*]% I4.[I[%)(/WCII19]G7GO5E/%?
M60*J)%@UT9N)#A18\&'&:!#4:)%;#4>.TDD]+;38"$)Y[ #DG547.T1-$5&2
ML-L.K(YZ4'MP3R3V X 4>22 .Q[^O;1%"E99Q3OG.J1@[<>6-N(\Q6X7L:A(
ME-?7T=LXDJ8&_**&EJ-DJ,'.H%H/!'!YT2L\^-?:IQT1-$31$T1-$31$T1-$
M31$T1-$31$T1-$42;N;U;<;&89<;A;JYE2X3B-*TM4RTN)"6BX\>2Q#K8B4N
M3+:SD]!;@UE<S*FS9"@PQ'<<4 "+S:?5XEOI$G4(#6<^$SP92GP9J@Z]CGB+
M\0]&ZKS!'+D9QJ?L]M[<L!MAU<62SF=M&7.8DNPHX0QIQQUHO2S:'9?:W8S
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M*BV=:?O:]4J-(DR<@B(CTJJT69F5\FH?;M':V/$2M<J1#>K"<<<?//OR7/\
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M>Q>RY4KS&V,8QN65-9-DD1LM-R\NOVGY+CC1>KV&$K2H$7I>B.ST)X0$@M=
M2GW4I0H#W4I  2$C@([ I [<<GDBY(   'H!P/P#1$T1-$31$T1-$31%%V\
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M"%%7)!'!X!X.B+9'S"AF6\['XMQ7OWE8TU(L*QF0RN;#9=YX5(CE:5MCTY)
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MI6_X@?>/Y./X]4).D!@1X^"LM=61-$31$T1-$31%Q9C@;:Y/''6@*Y)">">
M5\!1Z.> >WKQW&H<4</EC-*+"]W$,3OMS-S7KO#J:VE3KF!#:DV,;'9LB[#,
M-EWZFII%A8L/5<Y@),IZ3):$5QA"F$!QU21K:8000D5DX #N16@(!9F=RM0\
M^,BF1+ EILY+"3M0&59!=RWMWMS(0VZC#,"L?;'DO>T5^,XC$C7!JI4Y(DUD
M9RW4N(QC"$=&01GTE5V6'%Q@.2AJOG22TQ@YPE-QCM<-/:GFGE)R[@$%P'8/
ML/>TEL?P3;Q,-R6,5V];*F$Y(+,XWB*Z_I%54,G<!,55X'&L.ZG"G[%U+:G]
M:5OI<+1:??".-W<4(%<BPP>6P%W>J161$))#"3OH@.34SH:M.NMER4[;[=PG
MXS1P7"Z@QK@10BTQW$IGU>QD6;(93#EJBV9=E_9R'_(PU4=M*\5,^/'LX:)C
M3L#2SM(G,Y'%C(US; F=2-2FTLAHAV+ "@F2P-6J6+C>KR\-,.-5;:1JF-7O
M4[%;G6[D%FHE/PI,BJ1%W5S=ANM>>@/R8JWHC30BAR)(>A.HC%R$Z_'*'=5M
MXGC<X@,SM1V';3-UEL(=&S('U3.<V)%6J!$\\RLB=8EE31%L< *%!7H1P>_'
M8_?^_P"FB*#(5E!5OY.I$866K%G;=B<[GB7G5>TPTY!&93C*V^@,H2TXI-DE
MT+*W5,EK@(T13JI(4"D]P00>Y'8_?!!'X0>=09 G(%%0$5I/2$A0".X'5R.>
M. 3U<\D)Y')Y))ZU$N<+&(Q&)@6K@..ID53RD?+\@_BU;S>OJ^:)Y2/E^;^+
M3S>OJ^:+84M<'A2>>#QW3ZZ>;U]7S4N<STE<-;X ']+25'A/4#SV_P"+Z]9^
M".1V[]7&GF]?4CG,])0O*'1PV#U*/JA0]U/)5TI 4OD)'N*4D-K/'"^X!>;&
M<^,/FFD<STE;RX._9 !'')'=*N5)!([=0*DG@#@^G[(</-Z^KYH\69Z32O8M
M AM2DJY/4ORR4\]@E(*@KGL> E:DJ5]V%\>\$ZN V).U1N[?'#\UR _QU=2D
M=BD=1]Q 43W;"N5=:D_$I  [<@<ZE%B_XDO%YM1X8**%.SJ;/N<MR26:?;W:
MK"H*\GW/W*R%Q7EQJ3"\/KUN7%J^X\IMJ3+$1%;6MK,RPF1X:%/@G>L.ZCPP
M[V^,NXJ]P?'0TUANU4.:Q<8-X,L3N'G:E);6F5 M]_,N@JC.9GD,=/E>;A=0
M48?6R&U,S9ET\.1%=XH>]07RRQE/PV=<EZJ4]!34-77TM%71*>HJXS$2MK*R
M.S!KX$2.A+<>+#A1T(C18S+:0AN.RVAI*1T]/&I4KN0 !P!P!V 'H!\M$31$
MT1-$31$T1-$31$T1-$4+>(*QI:?9'>FXR/&7,VQZKVGW"L;[#&7)#3N6U<+$
M+:588TV]%(E1UW<%EZK0[%(=;5.#S0\Y'))LKK4HU'E?4U66&1'9,"&IF..K
MAAI33);9'45*_4DD([GGW>X!T16?B/\ 5!N!_?)%_P R0=$4BH]#^'^ :(J;
MJ&UJY5SRGI'(]1R>4_'@@$<\<>H^/IHBP+W]C;70<SLE9GNYC6%.WM3'3*3D
M>/.S<EJ(L032[.P3+QD%:G"7O9T29/M3-39O)=BN3G2N/$+22@M,EC*8QEME
MCXJUO$MF6Z%+NQ7T>.Y;OIB>&NT57+DR-G-MV]SIZ'1.EM6_-%+P6<MIUN(P
MPMJ316^8S5>8X9F+0DMHFRWY4WY=>[)3CCGU'\SE5>AOGSO^#._\_P#_ -.B
M+S]\5F*QX>ZVW&6L.XAC"+7)<,ASLBN,&Q=3%U;MW<FM8J<CW R':+.&:J5/
M6G#JG&HR\OPJPDQ*^V@4<UZVL:AZ"Z!2?5X)QQA/:O1...&&1RD\-H'*$]*.
MR0/=2  E/R' X''8:(M%1VE*ZU))4%!0/404J!YY3P?=)^)'<CW>>GMHBV^R
MM<\CK!ZDKY"CW*1P.?V0X_9<]^XX/&B*!L#92=]M^U#D%%5M'\$DJ K,NX"E
M+2I9XX[<*!^_HH&.H]P60"!TI ')[<]^Y[]_7]W12MVHGF.CYHFI14%O="E
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M?[^Y6T?^;,OT4"L6WN"GQ/H/P#\VBE4E.+"RD)Z@./0'GT'R_BUB,46D0,V
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M@#I"1\^E(2$H4KU*T!*PKNE2=$XXX9<G^?S_ #Z(FB)HB:(FB+B+?<2[T=*
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M2UG*4@3A269>4F89R7"=CI#2NGZV<MU1R7>BKH53U9\BHJ>A[KD5":X9$FL
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M*5H"TDH<0>%>\/=6A*T]B.RDI/S2GT!%O]H'+@Z5<I!Z>W*24I0HI)!)"@5
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M(G[#IJ*%+2U4OV'UV(OO-5LZ3?6%N^;&0X4A]O S=YY-+87SA]IF_P#LGO\
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M,MWS"'7(8M1)$"G7*^M!3T[8R!R&J+Y7V5!"DMC#NGV4LI2Z$]"&TA#5IS!
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MJZRD.-4^-8U0QZ^^S&QM+)IP1)$;%WIT1UZ)$Z2_*DR"W#0@)ZRKJ\LS" 2
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MZ;5OS<?R#+W&XU#04\2&AR:Y*M+1$9+C0 ZE'C1%WSE)])/XANI-O<;8^"3
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MU[E%C2MVOE"#BV/4<N6](\IX3X"^>GQ/RGY3L>4>4OU8M!%"(X2[D<T%V #
MOB)L&+X^D<EW>&PN<+$O(ER&#@"?-!.8!(K5U[",^%3Q1[Z0'#XM_&#;XK7V
M,J"Y>;/>%:JQK9&BB 3YQIJK/-V)659%O3D\JQC)<BX9(H,IP>,Y'<9<?JXR
MTNAGKL4#EYE]@Z)4K/J)7)0Z),XI/,AB<=M),&PJRR8V:\)WAI\.D5Y_9G9[
M#<4R ]4.PRF+!Q.^W<N+E4&OG.55[N)D]Y<9=D&\RY$F1/3-N[Q^E6T\I*VT
M(DQY+M@(@PSA;I!K_#3 EIX*2((7,)B)!!P(!Q:3SK(&JR1C(KP[7IA?4_F"
M]M416,/CXM#+JUYT\]E2<>?DVQ<C)C/+>^WBL-/V5C(59R*<QYZ$PS2 !\!H
MEP:N<,)TYH #DJ;4N ,*DN1%6FH9FK/E+E^&E47[6C @NT;D$9QNRF"YC+*6
ML;<B+W6S=4/ZA;;>=:C5)B)0:Z*P[)C1X2&/9WW6G4/.S;^N":Z(Z@P.\5+S
M+O-TL(G@(UFE&)P+EY@9,TQED1K"LR:(MJSPE1X!X'/!/ _'P>/Q:(H8B6%N
M=[;""O"X;%&WM^U,;W ->I,^79JNH[)Q=5D"I#T-J.I5@B/U)=\UOJ4LHY;U
M!+ G5CQQJ3'B>I\.C+6IB+CG05I+9X25#@+4>P_8I]X\?$#N?AWU(H$<.SC)
MG''BK=R#+Z'%:]ZWR.ZIZ&HC*83(M;NQA5%:T9*VX\5M<^QE1H:'I4MYEJ,T
M[(;,@K\N*J0\.@RQ/Y/M_.;2E-.,NV5=8QR7%?SO%XKM Q,R;&HCV4E"<;;?
MNJQI>0E3;#Q- V[.:<N$^5(84@P$O%QJ5$D-A3;Z4FI<3<-7U33[RD!\,1B,
M<*">Z6(5PB:X2"4)Z"E)/2%*4GJ!/<I*D'H("3[PZP2XGI2D\IYCH/BA$I]H
MIBW!F#L%@;J2D';S,O:%--M*QVS*?,0>$I#!"@Z"I3:T$\$J2L)"5 =*Q[QR
MV<$1B!R())! D?EG7$+%'' Q#D/V] .5%#],B(JNAI?%<7S6XZNR%P,0=F-2
M%4P%2G,6F+@%RV>; 5@"(K/LC# X=207"G-&Q.#S?1<%WV"69E.LJ8-$R(J[
M\[+7.N4QL>O<A,/SUI"HO7];.*(0QBJ9Z\B2JJ+<:0/KT-?;:"1YL>R+*8#4
M-)ZF''A&.HAF'+"ID)8%CF*!@3FRD@T?I)D")D.3,S:5 7*W,B HQ P[!!#[
MZZTT1Q)@OSPO)EW;6&(-LLLY;'8+PW+D/]$63&4_[("A4_R(BEWAC-IRD&?
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M-M1 QLS@X-9DEC)C1YEY3DJQ.+3'UB983$]@8#6SL*K,]K^EI_=_RCK5^O\
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ME"8GD[&K48X;BK<_3#?%UR3]MZ[/5SSRQ%XXZB4A/+'" D$ ]/'40%*Y(UR
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M,H6KMDKH77RTE8QCJ0A:VE,*.OGR&AEC%WS=Z9B3G57U6T$K,/K>6(%!//\
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M5WU_E<=MV_8>@LIK*U4!*([&);L8W0VUBB.ZVVFYJ&=TT(3(C@)>3B]?8?\
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MB+?[H9.RW4U-C%@*3)PERFJK"'<O1:Y]EV3!<?=U8. [ EB0VP@MU^"2+N6
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M%VE?)5]*8./&ONK_ '/V_/X\#Q@Z]J\B?^QV'V[;_P!Q;KS7RA_[O%]B#_\
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M->J_PC\PU6#U1O[2KK<I?3VXY)!('(!/'J._WM614A(2>.W /;GN>E8YY"R
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MBFE.>#RHO-?*..R@Y5THH]$Q" :+4_5PP@NXKL"\]_>/H$_'U4!Z'CY:[R"
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M;7<''VZ0/?9>CW.=L5)2^8GM%FB$M[VEN/!A!YLH6#Z59.0QFS38Q#$3JH!
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M.2Z[Y1M#='Z!K,,7C+-M:^7/GE7/;[D  =^PX[^@_G^#7N(@M(+.4!B,4Z$
M$@2=B[-60(HO-XXX9N6!>>3DU#N#-.5?L?R@:M#$!#"#(@ $,9$!B*8%0(H6
M$WD,"MP"C\$C\*QJVD,QTJ[P^U#U^"]@_HA5^RYGO/-3YS"D8KCS?MD)RXD6
M#1=NI+ 3&H:V),3<,/$EB=,<:\ZDBA,N."TM:F_*OT@0$Q6,0)+N&9X78MSI
MZ-)2#AZL5VKR8)AM+;FN)$1.68G 5(.)$ABO=M?4"&NF0"M#=86F%9,N(I!L
M OV!4Y-%T*QH@>;]G+CC:6)"4P2\6%DGS&!XP(F (+5TGE,!V+T=IYY+O-I
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M'E.;87&F%\6<J2EUE-9;V3:VBEXIY*T\%(/)Z^D=V\E^7KIR38QB\1F$1DD
M0DD%Q(L#@#,U:F*ZWRQR1'RC'#$ !HAFPK%/2>=9@!IEC@L#OTJWQKD_UN<9
M _O_ *#_ $IYY_<XX^_V[A_KKDDES%&94$,4M?J4[RN"_P!)V@^J8IT%HQZ2
M0)46BOHK_&LD<_:ZQO[W3GU!SS^ZY_/[WKJL?EWR?#"]@8Q&[.090EW]:"$/
M3%\4'DQ:69TA9D83M >_4J9^BR\:_ 4=O,< 20KOG>/*ZCSQQT]2R1W)/*5
M =N#TD:_^N[-C";6)B"7A#3:CZ,L-K;2KGR;M"1$U)3A!;81$)ZJ9TGZL^"O
M93Q ^'7;%>$Y=LW>V=F_D5A8OOXSG>&R*^/ DAMQ"J)<W-J5=':N.HZ)-@FN
MF+?C*<C.H"5=0Z+RURM8\HWCSL!.G,,P).)!BH8/X6!=YX'L_)UPBNEEH10X
M^L[-J FQ:3N\MJS 8M-XPF+[5L-E(6A,I4E-9DF$UL9+PD2G8 J61NQ(<J(C
MS3Z$9+%0_(&1NI=<=<A-/(CL\'IN"[S+_58[1HML.%&*Y/0P?!GYP.U]*IQP
M[]B[/>3V3RT["9 )/U44CKNL'56(NO9(D9+#-8SNTT6L%"HRGU84B5RMUQ+A
MN_-2ZZ_(CG5A.9PR( %:#$:L1'FY5RI)@XD[T$]<ZK<_<;O)<\]G83*W1'L:
M^9'%UD>%W ,=>0M7EXBQ+FZC*K!Z$D/-[>NK"&< =,9V)#M(T5$%4V1&ESHF
MRUO69IK>1Q46D$G =FJ>)Y'"3!<O:FYW0P+&%T$O8K/K!Y.6;@6K,A[-]N;*
M8] R+.\ER.O58V,W+O:YE@FOMX34J3+?>DRGV7G9#JWPXI46K:7-(,L' K05
MPGA+JFQA(@+O4G/'/:27?$XUE#[9VY/]CWGG_6O:_P#EGK%/(=)\%E3[9VY/
M]CWGG_6O:_\ EGI/(=)\$6U>YFY*D%)\/>=\'CURG:]0[$'T^S)7/WNWK\O4
M)Y#I/@BBMC/]\&MVIMF[M-D[^%.88TS&P]G,-K6[>/D8N6 J^DM+R1#JH2X0
M<@H6FUD=3K@:5#2"%&?GQ3*9R526<][ [->["2D&RW%W(FP9L9/A_P Z2Y)B
M26 5Y3MGT!3K*T K\O,5JZ4]7)*4+/'HD^FIL?U=H(B0!I#G3+ $.=$,\A0$
M3:>*K:0FTLX@ YBA,C0N"&)WU7S>Y-]&)XS[G)<@MX^W6/(CV]];6##3VX.,
MI?;CSY[LM@2$(D.-A[I=2VMIIQT((Y"U'W=>IW'RZLK"PAL+0Q0P-9P1 0Q$
MF&$-'02T@]29G''H=Z\E+:\7B*U$,)A!TF!YS S )--$ /M,@)=3^E6^-7]K
MG&O^O]!_X];W^N.2O:M/N1?^-4_TG%[D_P!2'Q0_16^-8 \;<XUS\/\ ;_0'
M\G7W_!\=5'EUR6"\)M#$)AX9/@_-S4CR3B!<6;$3?3!9M6.S%<^C^C"\:%9>
MTME(VYQ]3%;;5L^0EC.\<+Q8B3&9+J6@\\ADN*0VH(#BDME1 <4$\G6*]^75
MWO%VCL(8WTP7)@E,3=@=Q!>4@U<EAY.VUE;B,@,X>0P(PTAMF1,+WRIY^[D6
MKJHTS8S)G7VJQF/.$+(L-B1TSH<3V6$,>;9W22FH@N<!=Y'CA)O3R7W8Y*5)
M\QMX[.TMHXX;6(B(DC2THCB9GFN^L C(E=WL+#1LA#$ X9R),U).<:@DDG:N
MU3;;PI:0D;"Y.'$QG7"/K_!%14V*W8BTQ6(B]UUICX>IN,KVK%&UAJ1(4B2F
MP94AQ+^II'>[X8;J[]2OYO,]IZB6:KLTSBMK]KO&L24M["Y0M)8B)BBPR/!K
M#S'E+LS:)O$N;K-M7E8A$]L8Q4NMQHV..-..J-H5QQ$:46>J@\$\V&9^I]M3
MT8 2;%6CF#.\-S"J&8.QN4MKKMR-M<@9;LLHPB9[7CF,9?MYDUV]>+5N-81[
MO-BWATJ%399-C*DPZ>4U20X+3S\JQEY(8@(#,:3-B[%P)SD'<@-,/D%(A:;D
MS)9A7/;@[Y:WR!^V9N1Y?E_H?,]_#]E&V//KU?<_9GS][G6J\1C(T1(2+RPU
M/BRNJWVSMR?['O//^M>U_P#+/5YY#I/@B?;.W)_L>\\_ZU[7_P L])Y#I/@B
M?;.W)_L>\\_ZU[7_ ,L])Y#I/@B?;.W)_L>\\_ZU[7_RSTGD.D^"+"'QV8#O
MQXG=EU;=X/LE=U%R,AJ[42\DS# 6JY35;+#SC(=JLAM7@XK@CWHX*2/10YUS
MGD_?X.3KUZ3$3"::(<4-7 )P:0D<7(?C.5KG%>[(60H6+XLV1(DQ:N<L5XV?
MI6'C5'/3MWCR@/C]G- "KT(4.7 4@]CTG@CX\'7H]E^D*SLP 8S$ T(!!D &
MRG3'H!<CJ<7DU:S($G,V8$5#\Z3RH54_2KO&L>_VN<:[]^^?T /?YCK/!^]R
M>-2?+KDR,F.,V@CB)BB&C$6B,RQ$!!#T;!8_]*1F9L229DBTA <SH\MBT_2K
M?&O^UUC/_7Z@_P!)J?\ 7/)/_J?=C_\ &I_TK:>ZB_JP^*SJ\#/A3\3GADR/
M/;/.MIDV=?D]%75K1Q/*\0=NH\J!/>ELE%M*RW%W:R(YU!%FAI,U5I"4U$4X
MP$.+>ZAY1\NW3E71-E'&!"[0M$7 II!H=H!!+N[4//<C\E6MS)A,( # .7(
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M<<=!5^5NY6Z/U?#;F;"9N_+2PTB4^C*]LU-N2$A'G.(4C+ .A;@4H<@* /O
M$<:MT5K-FSH^YE4$D Z)GK'BNSV\G9=)MLFEY)M_;8DU=VJ;&.+2XQNP4PB+
M!BQ>EY-':SN/-4TMQI84KL1U(![:*RL*ER+<=_?1^IL)&2_4/MN3,3:ES&BQ
MA\#%(M5&?Q.XK<E5CK2)%K:VRY+5@PUE4YU ;0AR#"'9;CCHX"+*2-QY0()/
M4I1ZBI"RL\\=76A*>KTXY4D*[<'D $D5?1$T1-$31$T1<+V10<<<2[P7%*40
M4\I (X"?7E7(]2HGIYX:\M( T14UUZ2M+B%^6L  KX+BB/V8#BE(\Y/W*'2E
M2DH]WTXX(JOLG!)"^>QX+G4XKDIZ>%%:CU)Z2H<'N 3TD$\Z(JR60E(!// X
M^X;  ^  Z/0#@#GD\ <DGDZ(A9Y/W0 _M$_P<?FT1$M<<=1"@GGCW>DGG@]R
M"!V//';C@_/OJH!Q(-:B?!%46Y+8 X/<\GOW'J21\3IHPY=J#7Q^2W="?E^4
M_P >FA#EUGQ10/O=OG@FQK&,2<T.2/NYI=C&<=J\7QVTR:RL[<1ES!%;KJU*
MG"%,MJ*WNDJ2D='6@'C4LP+<%"Y#=$GQ?C*H4=4WBIV*:S3$MN?/O<;R_<-F
MMGQJ>TPJYJA!GY$_+BX[7Y3)]B$6FNLA?KIC=7 GR%O2DLD.N-@H!<2#=,TG
MT9<9[=JRS90IQ'!6>A)"0"D K 2CGS!SP>_;CI;/;LD#@F5 >;EY] R55#2D
M A+A ))XXZ@.>!PGJ)X3V[)' '?@=]%*VN1_,*2M?5T\%(*> DI4%!0"2 3R
M 2%=0)2CL.#R15$LI2 !_DH_,4D#]SC1$+7R('X6T'\P&B+3RC^R3_BD:(M0
MU\R#^!"!^=)T1:^6G^:6_P#P:(MJF4JXYX('!X( Y((4.>CI!'([@\\\#26*
M3>1S>6?!Z5L98+?/6I+A( !* D@#DE( [= 4I10..4@\%1XYU40B%VD[=7YI
MQQQUNJP0D$]AW^0X_,=1H!R3-]W>BINK0T$DI)"CP2">$CC[I7KPD=N3\.>?
M3G4Z$.76?%%C2CQ4;83-T;K:.'"S:9D&-6[-'D]O$Q"T?P['9TF"JQ;^N,K"
M14P8Z8:%/OR'7?*91QYA![:@P"32GF4?4^&+8UZ"W@K[VBWEVYWQJK^[VTO6
M\BIL:RFWPR?:L,.MP'KJA$7VY%>M]+9G1&Q,9#=@RV(TCJ46%N-]*U6(!D=O
M;J[-2"6[C;X-)E+?DG]D/^8/X]2B!DCU4GG_ .C21^71%HM@K'!6  0KLVD<
ME)"D@GCGCJ )XX/;U&B+5+/!Y)!]>W2.$\]^$\\]B>2>KD^GIQJNCSM)QL:=
M!CA1....U;_+3_-+?_@U9$\M/\TM_P#@T1;5,@CLKC_!3_ $_EYU!#@BCCC-
M%L]G!XY5SQ\"GL3QV)'/!X/?CTYU6SA,$.B2^O>#VA#-M5.OQ1,?HXZ5D  @
M#N1P3SW25=/(//! ' ) X&IT869I5::DE^,E52V0?>5U#CTXX[_/D'30ARZS
MXJ%J6TD<<?'GX_QC4B$"@U*"^!;<_@HJWCW7PK8[!IVX6>2)\7'Z^97P%&IJ
MY%Q9/3K62F' B0Z^.5O2'Y4AQ#+:&T]16I(''.A? MN=2X%9CQDH0LO&ELOC
M4"BL<GC[CXTS>.R.EBZVWRUA^GK8\]JK5>Y$$UTAFEIC8O-14S)+OOK<#C+2
MV0IT2C\=%=GY++F,^U*2AQHI4TZA#K+B"VI+K2T(6EU!\M/+:@L!*D]0/8]N
M1HBY7E)^?_V4?^#1%L4P% #J/W2"> !R$J"BD\#GA0'21\02#V.H (=RZ&>
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M/0-K=MM.!(+4L'GLH<?+@@#Y >\>!\/P :K#"02\WIFTZ]3JQ(($F;K58(2
M.WP^^/R<]M-&$X=9\5"ZV?81JZ+-FR041X#+TB0OE:B&([!DO+0E"5E10TE1
M".Q*AT\CGLT(<NL^*+&3 ?%IM+N?17V6T2<SJ<-QRBEY/-S#*,2L<?QJ73PG
M)")$JKNIP$6Q0$L.+;:CJ+CJ WY(4MQ"56'RZ%((#R!?CM Z&4S;:[C8CNK@
M.*[D89/=LL3S"K;N*&Q<8>B*F5SJW&VGU1Y*!(:+A:/2TX/.(()0/00PJT_!
M'W;)54AH0E2$JX(Z@#PI*.0#Z<\HYY_#W^>I4+4M#DGD=T\#W1V/[+MP.?P
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M#\0!^$@:(NOE74""TX].D,1&6ARZ](?;99;'"C[[CA2A)X2202./B1JL44,
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M:^>>Z2GJY/H>VK07FPC#PVD)&W#/8K6W)'*5@'M;I;0C$F&05\"P840$D*Y
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M[>2762Y9:6==@$=R0WBN$UTYR&P]&:*TM3K13*TF:_+00\ZA2U,^^A"5%25
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MT =" 4@#7G=M>KX2&M(C,/4RD'D\M3Z\BOI*Z\CW:[P &ZP<V$ -#"SBDF#
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MFNI2QUAMD+5UG]42D<\<+=8+8"."SBB+^KH@R$QF#M8'8[+TF[65F;.T\_>
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MPX^/\6L9A)B<LSZZ?DKPD ,U/5Q;IW*OTJ">!QU\<<D??]?3Y>GPY^]JX %
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MB:(J9=2"1P20>  4^\1ZA/*AW'QYX^]SHBU\Q/"5<\A7'! ^>B+?HBVA0)(
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MZ.1HBB#>O?K:GP[X:]N#O%ET#"L08L(-4[=V?F"(F?9>>8<8J;2H^8\([I
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M;;X /[(G#O\ GR?]%H.1>4#_ +(^^$^D[K[?5%\*T_3;OH_QZ^(G#1_AR?\
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M_P"O30LO9/W#XII6V?\ >/C3H:^2?Q_Z]-"R]D_</BFE;9_WCXTZ&ODG\?\
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M^_J(>0)P^BF-X%(<PU.+XUAJX[B<7I[FU0NWO$R76W<0Y'C,<$44;Z$3B)\
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MJ\HGY!GFXNY$JRE8^[A=I8U651\DW&G,Q<DKLO47J6NCPI=<J0_(E.7L^2C
M3SR1$03 6T86A$.C"'80D0APTRY)8L*6E\,1E!1P"_.-2"3G,SD<) +%6_\
M%#DN0;P[-;S2:N2C(]I:G:NKD=>12I,K,3M@S71/:+"W7":G15Y'$KRS*2]]
M9(A,2GHP3+:20[M#D^ 0QPZ9&EIS 8O&[T #S)=G-3-8#>K32A/FX8@X,VD
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&T1-$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g729258g68h73.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g68h73.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1?04&AO=&]S:&]P(#,N,  X0DE-! 0
M    %[2^8&@X0DE-! 0      $8< 5H  QLE1QP"   "  ,< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0ZEZPJ5\QR](\0ZR,"!]+/3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!F@           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              A<   2'
M  $                          0             $AP   A<
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   A<     4F=H
M=&QO;F<   2'    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   (7     %)G:'1L;VYG   $AP    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 2@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:  P# 0 "$0,1 #\ ]1KR,>VRRJJUC[*2!:QK@7,)&YK;&CZ'
MM_>4R0!),!9'1V/;U7K#G 0ZZN'-! )%3?'Z7\I7<WIF'G.:[):7;&N9 ) +
M7NJM>QT?O/QZ4E-M)9_2V[,CJ50<XL9E#8'.<Z-]&-<\-]0NVM]6Q[]JT$E.
M=G=+ORL@W,R[*6%M;14V=H-=GK.=[7,_I-?ZMD_\!_->DJU70<UE7I/ZID/!
M>][K)<+"'T_9=GJ>IM_1._6*/9^CO6TDDIJ=/Q,G%98,G)=EV6N8XO<-H!;5
M30\,9N>UC;+:;,G8W\^]6U6PLG[2VX[ZG^E:^H^D[=&P[=EO[ES?\)6K*2E)
M)))*4DDDDI22222E))))*4DDDDI22222
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@!'0)J P$1  (1 0,1 ?_$ !X  0  !@,!
M       "!@<("0H#! 4!_\0 91    4$ 0(#! 0&"PP#"PL% 0(#! 4 !@<1
M"!(A"1,Q%")!40H587$6,CEW>($7&",XD:&QL[2UMC,U-C<Z0E)R=;+!\"1V
MT24F)RHT16)TDL3Q&1HH2%156&=H@I6DIM+AXO_$ !T! 0$!  (# 0$
M       ! @,'! 4&" G_Q  X$0$  0(#!08#!P0# 0$      0(1 R'P!#%!
M47$%$F&!D;$&H<$'$R(RT>'Q,T*"L@@4<A46_]H # ,!  (1 Q$ /P#?XH%
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MB'^B4 WK[:"$%%BB #O0EZ0ZP ""8=B8=A[P:#>@$ _%$._;81@<X@<A5/?
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M6-,XYNN(@&=NN)<;IM.<BU7<1>$0[CS-F,:51LL@>)<1ST".D'J9%B&+M-9
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M@   ".P#?J-!\\];X] "78B78&$P!K8]@ >D 'J]T.H?3=!&9<0$0%0"_BB
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MQM\F9+#@?_2BY:AL>XXWZAV.Q#\&EBZ]=!Z>H  _P41AM^CWE*>_O$\Z@_\
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MV7E@+0KBR'$+'GM1:W"-TX%2 %NF$8:'(T*5L6/]E!,&H(%!($NGH]W5!-M
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M)^6H"*2I"G2.F#^T@/O8& 1]X  NNX#H>VPI.6M>7-8W5=(GYQ^JMG+?Q5N
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MJBBJ)CNT\<[1E/6V].]5&<S.6>=YC=:]IWY9=,F!7Z-* ?L/\V1'0C^W2R&
M=ODPC-B77ILPB)@$1V;O\1VPZ>[3$3-ZKS?.^769GPW>?!O$JVBJ*:L2(IP9
MB9PJ8B(SO/>G+GE''=E9LPUMQ% H% H% H% H% H/A@ P"4?00$!_70=<&I
M#0F.(!L #J'T$-" C_G;V(['T$>U!%[.F(%#OHOI\]ZUU;UV-KL(@'?X[V.P
MA!JF!1* FT)@-Z^H_'J'U-U?YV^PT$(,T]G'J-[QP/K8: 0#I -:UT@'82^A
MM;&@^BT2-Z['T$/0-"4  @]NX]'?IV/8-!WUW"(&Y"@ %$P '4.@'L)C?C"/
MSWL1UZ (]6MT'P&J8:[CV#IWVWZ:]=;WH  1'8CK[1H(0:)@/8QM"4"F 1V
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M74!@[ (AK0!]VJ#X+1,3^8 =!]AW  'X:'U#6Q#MO6P#L';5!$#8@& VS!H
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M(CTE  #O^K>_CO>]B(@(;U01>07U$1$0[%'U$@: ! !^._78]]]_6@C32*F
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M\:I<N&#%G]'IS:9DT;M#...T^JL*"*:9EE1O);WU3$*45#B!2EZS[$"@ ;T
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M:@^ N80]"@/5T#KK,!3:'8"(%[:[#OTUO[Z" ' ZZ1#1_B4=['WC  @&^P'
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M_P >X 'V^E!BZR8]5R!XE6+</WWYKK&5H\>YO+-I6\],<L)<631N@8-=\_1
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MV4'94O.*<IC4%S%IY[D<I6K.Y,L6Y[3B\81EFV;/'NR?;G63CI)TQ":O5O)
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MM=<U5X>#>,*BC=113>TVIB<[Q>9F\VOEM_R90"W9,0$!$81YO6O7V!3_ (
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M7,TDF=TV4]5D+/O*VY-S W7;B[E,4'B<;,,Q!8K-^@(HO6*Y%V:Y!'J2ZO>
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M;TB?6+MFNB% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M8_E8S&5YQMS2,1'LYM=BAYK9RYMZ2<O&49<D:FY(D,C 2CI@[2CIAH"C%T9
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MP[AK*JG$?I1*!BAL/VEAA-L1#1?J10P!HH"(CL=&WKMZ;&@OI\>A;J\*7E<
MAH/P4C@,81'I /KR/][8>H#\/@(CZ[J3PZZMK=<76^&TJ)> _$/91T. \="8
M0[ZW;[36@#?<1^/8-:'=48>_I#QQ/<?AJ]ND3<Q+- I?41.#AN.MAV[@ ZT.
MQ^5!LC2BP?@](%$-">$>" B.@  CU!'JV&PU\=!H/4?G0:X'T8<XDXC\BS
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M.S" :#8B   !5'<H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MH2@H4 (<@$.4.DP"(3.!0WU"4 ,(!L?CL #MOY!\O0?6@" @ ](!Z['>^_\
MI>GQ'X?;00IJ H B "'282CV[;#UT/Q#[: (% PB/;8  CL=B(#V]._I_P!@
M^M!"@X0<E$[=9)<A3JI"=(Y5"@H@J=!9,3$$0 Z*R:B2I-]2:A#D, &*8 ",
MZA2!U&'MZ:^(]]#H!UO7Q^SO0?"* <.H/Q1_%'OW#^+OOT -[#TWOL$HM,@V
M-)WM/8T8W5"/+^MF"@[GN.SV[]%6?A;>N9S*,[?F)..(87#1A,N8270CUUBD
M*Y/'N@2$?*$:"9!,FT,(F.72IND@&["!M#TI)E#U  #\4 V&A'TWH(SNR)E
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M  &@U0=J@X5E.@H@!@*8>Q1,&R[$1 .^M;V'H(@'S^0A WV5+J.8PCH!$#F
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M$S@Y42D.Y6/YCD3J .@N-H% H% H% H% H% H% H% H% H% H% H% H% H%
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MDM%F<+$^V/I-T=1Z]<2<I)RTM)N'<G,3,W+/7LK-3$DZ<O9"1>.GCE4ZJPB
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ME<O&[+&6,/W=;DM,RN3<.L&UT/L?N8)7SI4UTVNHLT=+1*4889(CV).[6(@
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M!E&QZ"39DP:ILVB"0JG!)%(I2% ZBAC*+J>YM1PL8ZJQQ%10PG$QC![= H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MN%'A"^6B0,F["/2CTTV[9)!LT12*BW:-T2(HMTDP J:2)$P*FFF0@ 4I$R$
M   T/K0>C0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"E.6\*8QSK9,_CG+=DV]?ME7.P>1<U
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M;W@*'81$?=].X@&P#T /AW'XT'8H% H% H% H% H% H% H% H% H% H% H%
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3@4"@4"@4"@4"@4"@4"@4"@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g729258g69b59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g69b59.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[18"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %>:^5@8X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!9Q6!         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]       $@ U     0 M
M    !@       3A"24T#]P      '   ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #-0    8              0<   **          $
M                         0             "B@   0<
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   0<     4F=H=&QO
M;F<   **    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   $'     %)G:'1L;VYG   "B@    -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_
M\        #A"24T$$0       0$ .$))3004       $     SA"24T$#
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M 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M**;JSB%@-ME9;59ZC?5W8MWT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_   L( /4"70$!$0#_Q  ?  $   4% 0
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M ^$+=<6EC&SN-0HP%OK34O/'9$?W1BA^Y*>3G'C^1<F,Z65-WKN5#%*8R11
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MQBY<;=0RR*:AB]IC@(B'@=>1#QH1\" ;#ZZ$-@ [ .:E*4I2E=:=XJF!C&*
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M!=3QYT[N!\TH"H0\>9REEW(UKNC]R8.%2E;S"RKQN0#'1%S;\."2YB*?F(
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M,(#H1[?<N_L/Z^PA432N!S^Z']2_XUBH\(?\I>ZC0?\ \;VOZ>9K$O\ #QX
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MJ5-1$%!+V*")#&"K)S3E%SMNJY^GOR[Y7XGX13&/,F91MFSL:7C%3#VY\B6
MGE9HX<(O8>#(A\.D^>MHGX=T[;_$+0+Q5%,YT!6.8V8BP,4S8HE*!0[C (;
M1V&@'N'8CW?0>[YO'GZ",.Y>G3<&2(8H"7L^42]W<)BB8O@! 0$PB8-"("'I
M@;R!@KA))+&-KL#0D.8.XHZV0AS:$Y1,!>XQ0+VCL_G?;NHWU/5:B?N[MJ&#
MR %UVJ"&M (^ UH!'0B&NX '85BL<(0_^DN]1O\ CQO;?V_G6)O'^ _UUE9)
M?NT_^X3_ &0K:9$A]]_<8.\#@ F'11  #1=:$ \!L-CY\UQ"S0[^_1@-X_SQ
M$! OL&AV&OJ(Z[A^IJB2E I0*&Q  T&_?7T_L]JUI2E*4J&!?2IRG$ *&P =
M?4!#6Q_3?T]]52?R$X'</^5TQ;]Q\AL!6!E6>M@Q#0<U<D:J:3:)D4]4C8SU
MDX9N';(I_F!D\.X:AL=)!W&W4I;5G6Q9T!$6K:T)'0%MP$>VBH6#BFR3&,BX
MYDDF@T9LFC<J:3=NV1233122*4A +L [Q$P^EI2E*5H81 !$/(@ B ?<0"I&
M9CY!8IX\V#+Y+S;D.T\;V3!D,M(S]U2C:,;Z(FJN9HR(LH"TD^6315(T9L2+
M.UCICI$:QC<O=:SE7SUNI[@CH^X"NJ=;.GRD)+<I,B1"D18T 0ZAFZTA'$70
M<,4TTTRF5*Y>+K.0 $E"-!$W:$]^(?X?FSTKR9<B.I!DF>YF\B'<@E,JQUT2
M<@OC.VGYQ!96.90SI<#S#-LJ;94BHQ\884P$K)5,1*.21!69:]KQ$? 6S"1M
MO0,2U18Q<+",FL9%1[- GII-6;!FBBV;MR$ "@DDF0@%    #Q5-/(#@-PYY
M3SENW-R#X^8]RG<%J"7\CF;DBU#R35(BGK$:J.V3AFL[9%4^<&3PZ[8!V ):
M$P#4[;EJ6[:$-&6[;,.P@X&%8M8R(AXMJ@RC8V/9)%1:LV3-LFF@V;HID(4J
M:292Z*&]@&J]!2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4J0G)*[+3LK"&9
MKLOB")=%HVKBR]Y^Y[:.4A_S^"C;;DWDI#:4*HEVRC))9@8%$Q#M<")OD[MX
M)G$*<Q1;'++$F2HKIX,;%ML^8\5Q\"_R+R'O"Z+.QB&:X(]W6)<ENV&[>&@V
M#EW;K@30RS9J=FU?J'8)IE,4.WZ!J#U0NDD.T0ULOJ%UW[,  )"E !$1* @7
MN'7<  /=NL>2"YG<X[DZT5AX RI:[3#?'2>Q5E&8L'';=ZC+3-]Q=IW4\MR/
MR1=+OL*#9>>4CEG4/&M030:Q0MNXAUE%EE:A.K!R.SSC><X?\;N/=\$Q3>W+
MG/$-C9]E1O&,9:3LNT4%$',\^@FCXIFWYVHW.4S-4Y-$]$Q"B45!&J%>-/78
MM#C1BW(6-.HAD.=NK*6&^36=^-S3(=H605V?(#?#-QH1 W-,,F*K=%H^<I.T
M 4%$B8.>WUC@98QS#3)T@^3.-.6W7RYTYYQ ]E)"P[ZXT*K03J9C#1,BH2/N
M;%;)8SB/,=0R'\^@H0I3',8Q='WY"LSE$Q3))B4! HD+V@/N  &@W_97)2E*
M4I6TYA*0Q@UL $0W[5C<<D?Q,G#3C7RO><8KAM._;E2MJY"6I?N2X$\86W;2
ME!=?"O/^BUR'D)9&(, B_41<MA*/<!$U.WSD96_.1ES04/<4*]0DHB=C&,M%
MR#4P';/F$@V3=-';<X"('0<(*D52. B!B'*8!$! :[(44C"(B78CY$=F_P#C
MX_JKE -!K[>*4I5A;K:]9)_TJ; Q::S\<1>2,HY??W %NL;D</6MJ1$1;9(X
MTB]E%(U5H^=.#JR2#=FW;.4-&(N9P(AV!7O^C9U7W?5$P+<.0YZP&6/K[L*X
MF]LWG$0JKIU +.GC<[MB_@U'RKEXFT<(D$AV[M9PL58?E6*2KU)AT43>?!1'
M^/@-^WWKQ$[?$!:D3(3ETS\-;\/&(F<OI>:>MHN-9MDR&4.NZ=/%$44TR$*(
MJF,JF!0#P(#X'&7YR_B4\8V#>R''7@A;L7R6SW.RIK:8W"J[3:8QAIE9<[%!
M CTKI%6X7A5^TYDVZK9D4P?O5TS=H>"PUT5N4?/"^H'D;UC\\2U^MB+MI>T^
M,5ARAHVR85D*Z3IO'SRK/L:(,A%8R*L=$I)JK)G4^+=*%4,4<H7%6#,38/LZ
M)L#$UBV_85H0;5%G&0=N1[>.9-T&Y"D2#L03(*A@*7R=43G,(B)A$1J9Q6:!
M1 P ;N 0'N$PB.P_9'__ #_FZT !XU452E*4I2E*4I2E*4I2E*4I2E*4I2E*
M4I2E*4I2E2 Y*3EMVIA/,=SW?;2EX6E!XKON7NBTFY4SN;H@(VV9-U,0B28]
MQC?F4<FX8]P)B"?KBH;92B XE_&_COE3D!E7A]GR,Z5$G:.$[53L92R;N+R<
M@'D23'L6=PXLRZ;SM)%WNZ9.U8QSJ,1.D99LBBW:I)I^CVUF=-F;95))31NX
MI.SN*<=FU["(@ "(@([+O6AT.OI5NO*O"&6O;J(87YOL;Z81<7B#!-RX@7L5
M2%<.'\J\GY^1GB7 2:(]*W:I-DY$K8S%5BHLL*0F3.!5 U3%R2Z<_)#DG;5G
MW'/\G+80SW@KD-_RY<=+Z0QV;\BM2$8'148V'=%O%G <3"2OI"DXD"/F9C@&
MU&_I@<!F7PFZ86../^*;GMW.R%B\D<KY(RK?V<,EY NFQ8D6,ID3(\N:6N1>
MWH>5))N(N)45*D)4A<G4."8*"80,4 M.=/.S;3L?\1]U#;9LRWH:U[>C^-:)
M6$- 1K6(C&95Y[$ZJP-6+))%L@510QCCZ:1>X1$PAL=UEMI>4R#]R%'[>1 !
M'V_B-;Z4I2E4/\V^?O'3@!C$V5^1M[&MB#=201%OPL7&N)RZ+IEP06<?EL!$
MM1*=VKZ*0JKJJ';M&I [7#M,ZB13=+P@ZB7&_J%XQ>Y/XXWJK/Q,,^4B;F@9
M>,4AKKMB1,'>V;3<,JHL=(CI$OKMW[=9:/<$,8B;@5TED4;#O*S\+MASDKS%
MFN1;7/,]9M@W_=?\LLBX\1MQO(2[M^[<G=2Z=O7"J]1;1I))0X)$^-8.S-CK
MBH(=A0K*WLRV(>RK1MBSK>:D90-K0$1;\*S3$QDVL5$,$&#!N0Q_G$B+5!),
MHF^80*&_->EKK3.E0\&V40.)#%*F)S=P&V0  /VA,0 V ;T _>O.IW7&*3+F
MWPG8<)M(OQ2D/^8-32S=F)A*5Q^6 ?XP&YC%,F951,I"G#0G#N* ^S*.R@(^
MX@ CX$/I]O</T]_I5%=U<_\ B'9F:F?'6Y^2.(8'-DL[;,XW'<E=T:UG1>N3
M@#6,<D54*V82[[92,XF0<MI%V=1,K1LN=5(AY7=0KIN\;>I)CNVK&S]!R0GM
M63=RUI71 /"1MP0#]X1NG*ILW9V[I)1E(IMV_P 0T<%3(J=NF<-& :]3P;X%
M8!Z?>(0Q!@*(=1D$\D1F+@FIAR1]/7!+'(9/XZ3=D(@7U$DA%)! @"!$C"""
M6Q[JLT]2K\3/A'A!G"8P'BJP4.1URVU'MOY87%;EZ1C2T;;GG;(CA.WR2;)I
M,)RSYFFLW-,H-UD31KX7,6N8KULLDE2%A?B/U NNK%V[R*YE9T4P+PWN=P$A
M9.#,.2_K2-XP?KF53"8=M7RB#1,!!-LL>32=/U.XZ0,$5NPAK.G.S\/)S;QK
MS-DX;B!@Z?NO MP3T0[Q=>L-<D,F%IQ_IM2'1NQW*RT7)1DG"O$G"KIV*"B;
MDA"N4%A45,@G]#[BU8%ZXQX[88Q_D6:+/WY9N/K4MZZI@K@SL\E-L(U!L_5%
M<YCG5$ZR(@5=4QOB3EV!M#NJG:4K01$ $0#8@ B ![B(![!OQY]JZD[Y7?\
M-"0Y0-H1!,YA#SH>U,OSG[1T4QRZ(4?(B ;UJFZ645*F!C% ![U ],JGCN[/
M3 Y#@4![O.@ P@&Q$?%=M2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*53ARM:
MSS_CSGAC;3J28S[G#F2$(-S!HBYFB2JUFS)&!HUJ4Y3.9#XL4B,FZ8IJ+.#)
M$(<#B4:PPNGGBOC7:V0N.$7>'$CJ20F<HVXK;7G[EEKKO9/'+>Z3.C*/;BEH
M5.3:LD;=<.C"\<MC,_@R-E135*?7S9X# "@V(!.T2[-H2[$!#?CR/N(!H-AH
M/   >*Y%FR2W[8&V.MB4YB[  UHP /:(:]P$/.@W6P&+4 * I%-V"4Q1-L3
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MF696X:)A8R1B91P"#1X"SHC<ZBK!R5OGFQY@,V*(%*78F$0*&@V/G8AL0 1
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M6W+N3"V3/)7(R:NDID[<YN\48@5V:2R!ROI!J CJFW%W15YE<]+S@<\]8CD
M\F8<KM*6A^*MAOBI0D&0515;QD_(,%V\,T$HB9)=K$&E7PD,*:\NBL IDR?,
M'\;,&<<;(BL?83QG:N.K4BFK=NA&VW&),/7]!(B17#YR &>/W9BD 3NGJZ[D
MYMB=4QA$1G1\"U[@-Z11,&O([$1 O[(&$1^8 ^@#L 'S[U%TI2E*4I2E*4I2
ME*4I7$N(%1.(E[P  ^7>MCL-!L 'ZZ^@[]JQH,[=3_GJCRIYA8>X\8XXT2-D
M\1[3;7A/+Y:R$[LVY;EAQBEI9\W@ 69FCG,F"2"Z;=,RQ-J=@ <1.!1NC<-N
M<,)RFX161S(F;:''S2<L5[=5TV^^=%>$A'=OH+)SP1L@JDU"1ABN6;@6+XJ*
M8O$.Q<$B]W;5L[_GUH7'MN\4;@S)83.,:<O,T71$6FJQ3E^VQL*1DPYBX.]I
M@6D5(J7%,SBB* -HZ.13*F1T*ZZB2;83'N8I]33A4YMZP;K4SE;+:*R5D^2P
MM9XNVDLU?O<F0<JI$2UJ.HMTR;/XM\T?$*FLM+(,R$!5)0P%*J03PU\=3W@_
MCBV<@7S=F=+>8P./,A*8<GE&<?-2+UQD\B2+MS9=N0C%@O(WE<3-H=-VY9VT
MA)N4FH',J1(#EW/7C7RKP-RVL0V1>/60X7(5NM7ZT/*J197K21@)9KHRT3<,
M'*MH^7A'R)#%,9C*,F:Z93 84A*.ZH/L+J_8!N3G/R'X@3B:=F1_'W'"UY2.
M29Q9^C%R[^'9/9^^FJZ/Y5\)"1%I6PQ=2*DI)2"0R9P.A'H*"0IE/71G5IX@
M9=L3-:O'?,EKS&0<7XZE;_)!W[#7E9C-6)8I@"-P^E,VVVDY:VO4[?5E(%D_
M2,!MIB;>ZDM@[JBW'=_([$N*[^_Y+66.+QX6J\HKORI;LP_" C'C%P_!^:,=
M3#6.,-MI,&0K@X?)-'9!]7O3+V@4:N,$=3?A+R/D+YC\6YVMN57L"W'MYW&2
M48S5L 6S8LBIGEV1:URQL2C.VR@5!45IZ*5>1H$**@KB!B@-#TCUJ<4Y9Y5<
M6./7$6ZK0R8RSC=E^6M<MQRL5=,:6!/"6A/2D%.P992(C$KAMYS-QS1JXE(I
M9ZQ61.JF@X,H)=5Z]/GEXMS"P"ZOZZ8-G;&2["O>[L6Y8MQFN)V4-?-C32\/
M,%:>H(J)1;X&XR4:!R]WP;A(3',(":I;YJZL?$S$U_-<.6G-7+R#S>^N!A;J
M.(>/\!(Y)NB*>NGR3(REQ+0"3N"MA%D*XN'8W%*1RQ4R*&(BIZ8E#M^HQS7N
M+A7@NT[OLRPV=\Y1RODNTL18UM.=DCQ,.>\+N]0K52;D"(.G+9G&I-%SOA3:
MG]5R )E4* ]U>2Z</.3)?*,.06+,]6#;>-L_\9K^969D&*M"85G+8EF\JU,]
M@9R#<+M6:X(O/AWS15DY3(<%6A?F '0"6WYEWK6YHLG.>8']K8.L^9X=<>^1
ML1Q@RC>LG=+UID5Q>;Q\$;*W%!09(D\;^3PL@"K/X=1^=1X1--9,R0G.FC#Y
M@ZW.9[2R=F+(]B8)LZX>$?&7,^',%YGO61NIVSR6_G,L2K"&4N:SX%*)<1CB
M+M&2EXYJ]9.9$BKU=\W*19!!1RX:1.;>M9F&RLQY8NBP\&V9<W#CCOFK'F"L
MJ7P^NY=KDB0N2^3-&YIRT84D:HP6C81TZ^'73=/2+.01$P'*!BB%1.<>K;)V
MESUXL\.\7X>NJ5M?*65H2P,H9CN^"EH:S&[^>MH+D:VU8$@[9M4;HFT(MRRD
MI.18F<QC5N -074<&4*E?89 5/N1 H$T4! H"4P@ >!*)DP[ [1\ 4!]M#]:
MC%$DU2]JA0,'V'Z?I^OL/\-A]:XA:-Q\>F !X#0"( ( .]#H?81]P^OUW6XK
M9 I@,"9=AO7N(>1 ?8?'@0#7CQJMA6;<F])AY#0[$1$?XB(B(B/\1V/D=^];
MP;( &O3+^R)!\;V40$HE'?N40$=A[#OS7":/:' H'2[^P! O<<YA+O6Q 1,(
M[T&@$1V > $*YT6Z*'=Z*94^[6^W^ : /X 'D=!XV(C[B(US4I2E4Z<J(@L[
M@#-\.-W#8YI+$F061;P,HN@E:'Q%IRZ?\IE56_\ 2$TX4!&05<-OZ0BB@H*'
M\Z!:PO\ @KP(Y+Y0RSBX]C8OX_VMB2R<LX0RD_Y'XNR@WN5^N.++-4MRX)J$
MC&1@EDIK,9R!+74E,&2<(+N5$ERJ]IS#G?1Z@+-BJ .P,8PAX$/'CQH?;SO^
M'VJ-I7 Y_=#^I?\ &L5#A!_E+W4;_P#+>U_]:Q-65FE^[3_[A/\ 9"M]*4I2
ME>=5E#HK.BK*)HIH'5$3K&*FF5,@B)3&,;7: I@"@F$1#M^;8%JRSSKZZ?%'
MAG**XXMR1E>1F?WHJ,X?$6)DBSKL)-0Y$T$).59)NFC,Z1B'%1JB#IR)04 Q
M$S &K5##B7U7^LO*-KPYK9!D^'W$65<I2,=Q[L1VLQN>YX%=8'2#6XQ;JH.5
ME#M12;J*3"AP'7J Q*;WR,>'/ 'BKP8LXEJ\=<0VU9AW35./E[O28H/;SN;L
M!)4RT_=#@%95VV$Z0+&8F= P!41.1J01W5<B;=L<J:H)E-W%*8IA$QAT8 $
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M.2GSV428/(JU6]JKPB2L>U5(*LDL"Y$0,D0Y3AY,(F#R%XB-5$Q"$$H$$B8
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M0 0\!\QAWVZ 0\?L@ !$_#H]A4P3*4A1 Q2$#L* @ E]B=OT$0$!\"'N%<H
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M@P^Y@^H#]A#R'T$*Y  "@!0#0    ![  !H #] K6E0!EP+WG]4Q@[@*(#V
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M*Q3R)M3*D%;_ !^C<3V%:-RW+:<VE#VNTEXZ3?S]^E7?+%(:>N0XF4762*V
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MUV-R9NF<M1&UHK.-_7_BABWQVTAE6+]VG?SI:X/B;ACIIQIQ_P!+E7.BV6;
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M]G9V@-W:EDMD5&%L,7:J7IMOARMQ 2E2'/=8'%1JF(E[=;+V@42Z O@ T/\
M>/U'8^]1E*X'/[H?U+_C6*!PYE&</^)-ZDLG(.V[!A'\9V[MX^=.$VS9JV;S
M>)5G*SE=8Q4T$4T4SG,J8Q"D[/F$"F$:QZ_Q.F=N*/(_E3861>/F<(_*UQPE
MBI6)>\?;X'D+;C#0<I(N&#J.GB"+)VHX^-7*LDT.J0H)I' X@8*HWZ+/3)BN
MI%FR=MN8S[#8?C[)1CW[Z"8R9$LDWG&O"/5)!&SV KH*+H-6;-4LJ\("Q&9'
M"'K(B53S](WAITYN*W!2SFEN8*QG"Q,J5 H2M[2K!K(7E/.1[15=O9@Z'Q1C
M*:$Q4FYBI@!@ 0T U<+0(55(JJJ9/44* F'6Q$ 'Y-B( /<!0*(AH.TVP^E1
M)2E*&B@!0#Z &@\U;XZEJG(!'A-R94XQ(R:F:0QQ*#8009#FFSO@6;!*#$ F
M8JII1.$_,C1Y$@%P=T5(&^UNPHX57X;1;J$DY\2Q;C3S(IAP\%<P9M/D$ERE
MMUO+@*9XTZ_YUVH%N,LB4Z:9$@%T5+X@5"@0!&OHJM!,+9 3]O<*91'M_9V(
M;\: /'G[!412E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4
MI5H#JD<0N57(ZY>*>2N(-[X=LO*_&S+#W),:OFUO<DA:3T[FU9BWTVYH^V&#
MIXX,'YD8ZA57#)," )RJB8 *-O/@MP"ZPO$+(LP]/D_I_/+ RCF*6RAG-U$6
M1DA7(TZ6XY,S^?9P\Z9C'H-@0 _PUOLY$5TFB"2*0F/V&$V4 R4,HW(8P" ^
M2_, %$=:\B %* ;^GRA\NM['8C%TK@<_NA_4O^-8%G)^S,DW_P!33KNVMB-W
M=+;($AP(FUH!K9P@%P30QTUAY^_MYH":+ETL2XHY!W#K-V!$9!9N[62;N45#
ME,&)?@'B=E/D'<=X1$+$3$!&V%9ESWS>=QRL#,+Q=N15ML%7:Z,H9-L)T'+U
M5(K)L*IDA%P;:B(:.%>:XY\C,L\1,VVCG3"%R!;>1L>3'QT!*J-B/8\RB0F1
M41DXQ4"MI.,=I@9-TP=$4;.$3BFLF8AA"OHM_AYNJ_R6ZCM@9:A>1T-;LC=V
M*9-@9ED:VK>3MJ-GX^4135^ E8Y%=1@E,LS'-Z2\8W:MC(>GZC45NXYLFMF(
MBV2$1[A$!V(@)1WW&WL!\[#V$=  ZV   @ >%OR_[7QM"25U7Q=D#9MKQA0/
M)S]QR3&(B8U >\P+N'TFX2;(@(!H515$I?( T,)1$//61E;'^6( ESXTO*VL
MA6PZ+Z24];$TQFX999,P"*:<E%.'* F[@ #B;M$ -W%*70%"9,9 PT>GZC*(
MC62S@"JN3M63-NHLJ)1V=<[9!$%CAW&#O,78[$?<1KN@ "@!2@   :  #0 '
M\ K6E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2N,Z2:@
ME$Y"F$O[(B&]?7Q6WX=#8CZ1-F  $>T/( ;O !_0P[KE*4I0 I0  #V *UI7
M Y_=#^I?\:P:[RYTXMZ>'7&ZH7(S+#.0F(2+P!;MN0ULQ":2LG=%S3MS8B;Q
M4*U*L8J)/4,11R[67,1)!FV76.(]A2FHDR=^)OCY2Z7\#BSAKB2U\-W_ !R\
M)F*%>Q+8;DO9A+F7;S9"2T89#T=M%CG;G$##\1HPC[5=JQ'^&AZ<W);%UL9X
M@93,UJ1>;[9MK(T!"DN)D5.TFMS-V\NK#M"*L5#JIH?$G:!ZQEC D&@-W:&L
MB3AEPCP'P0Q&PP]@*UR6[!MQ*O*2;H17G+BE3 3XB5F)$2 =XZ5$G84O[H@?
M*F4I2ANM]F0$VR12E[0T8>W>Q#N.8X[$1'R(F$1#?@1$/I6-S^);XG<K>6/$
M6QH?BW'SEVGL7(+ZX,A8]MM<Y)JZ(AQ%(M8UPS9D.0\L:%=I/3BQ()E!*^]1
M-$X%,)<&C'',3J>=)YZZPM#7'D' +F:=Q=ZO[$NZ# JCLIB&3;K RFVJQT6[
MA,ABN$VX$]37S!W=HU]/KIZY]O\ Y-<,N.V<\E08VU>^2\6VM<]QQ!4%&93R
M3V*:K.G;1LJ/>@T?&.5T@D?1RIJ@ %JN= QC))F-^T)0$=>//V_4/8?XURTI
M2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*X'/[H?U
M+_C7RSNNQBO,.5^K3S+C,36;>5\A"-K-G;MBK/BWTRX:0;>+MMFA(2#"/(HJ
MLQ1F'T:F'>DH5-RNW,'8;M4)=CZ'/X>W%N8\,I9_YXXGR)%7/_+=%[CNQ928
M-;#&5M:.;MUDG5SV\>(/)K,G[XQ_23_,X\ZR*)BJ)^F8"GSIK/M&W[0M> M6
MW(YG$0-MQ3*&A8J.;)M&49%QJ!6C!BT;$+V(H-6J::*92 4.T-@4O=JK(_65
MZSEJ=*!ICN,:XK<9;R1DI)V_B+:7G!M>%96^R<*-74J_G$HR76%55X0Z"#)!
MB<0$IE#]H& PTO<%?Q.W$7EC?F+\/W[9EY8)RAD%ZW@&Z4JY0GL??RH>./AX
MZ+;W&T29O$@?JJIIM7C^,:)'<*$26(!Q*(Y/Z*1#$*H=,@JG*43G%,H',(!H
M.X1V81 /'D?;QH/:J5LX\..+/(ZXH&Y\^<?<5Y5F+56 T!,WI9L1-2,6#<_J
MHH%=O$3KNF)UOG,P5(LS$X 84Q, "%3\5$1<1&,8N*C6$;&L&K9JQCV#1!JR
M9MFR1$6S=JV022100;HD(DBFFF0B29"D(4I2@ =G2E*4I2E*4I2E*4I2E*4I
M2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*Z)Z=8CHP$$X]Y=$ =@!3=AO/;Y
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MS5GYV ^ T\$=[T&_?^(^]:>A^*P_T?PF_P!;-O\ ?*>A^*P_T?PF_P!;-O\
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M8XS&A7UH6)TY(^W^0"UE-$T8V(OA1JHT;1]YJLTTT/S\]P).E?2D1%\!U$A
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M5H3/O0^X@\A<G9 R;<ERYXM5;+!T39-L^Q<G+PEDWLFD8AC-YB&<1<@L1LX
MG8NA'O621RF, %#?BZ19.)<?8]L6SL;6O;,8SLZP8")MFU(A5LB[2B(:$9(L
M(YHW,X(H8H(-6Z*0&WW"! $1WO?O2L6154ERM&I5T$Q116!!(%44A#0I)* 3
MO33$/ D*8"B'C5;D&;1J4Y&K5NV(H<RJA4$$D2G4/^VH<J92@8YO\XY@$QOJ
M(T0:-6I3E;-F[8JBAE5"H(IHE.J?7>H<$RE RANTO<<P"8W:&Q'05$4I2E*4
;I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g729258g73w81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g73w81.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1K@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &L2^:%(X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!IL0Y@        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              E@   40
M  $                          0             %$    E@
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   E@     4F=H
M=&QO;F<   40    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   )8     %)G:'1L;VYG   %$     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      07P    $   "@    2@   >   (K    00P 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 2@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M)P;_ %"W,IEI:YH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M<%SCTNBJ-3LE:H^(N:A%J/TCQ",5POQ:;?NVWY)$\PA7' ' ' ' ' ' ' '
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M3JKDV_=MQ7+9)GF"*XX X X X X X X X X X X X X X X X X X X X X
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M_P 5X^O)4/'PZ0_,2@8?(#Y$"^?)?[D1^0>1+^01\B'''^?]??\ ]O;^@/<
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MF7=O/:K,BV=LE'GSVQ<^V*?M%)%Q7!55PK3;4(1@F_=J,5'E_3E\<OCZG?\
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M\YR7:; XLEHF9-6#KB*]T9/W-[T%0D-)((-HMNW"90(1U#O#%8I@?WRX%E7
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M_'^OMX!,7T5,]FJ=U9OEN<9UC6/4W;NPNG[+EV2X9=Z7IE)SRA6P(-NS@$-
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ME_#-=LI)QEP_=IIKAKZD^>:,9<< < < < < < < < < < < < < < < < <
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MS.)5).1,CD>DRL+#1T@2ZL30L;$EB9MN^3 W'"_0/S!_)P#SP!P#X)00"-D
M'ZBQ=_D'\J"@<<I>[X!!7TLQ /3EZ4D'Y&#KEF " @/U"ML_(?=\OR^/I^7@
M$^> . . 1C[H62IU#JAV(L=WC6$S6(S'K\>2AY1/WK"6%Q7GC1C&.4_)1$K^
M279M"B0Q%2'6*=$Q52D'FQ]'XV7E]5].XV#993DV[?!].ZI\3J[<BN<[8OA\
M>G5&<_/AJ+4O')9["==>!F3MC&5<,:Z4XR_ADE7+[K_]7M_,H7Z!TZ9]-"S]
M9+O>O8-A_?C+Z!&7"SOFS<BF5;C((.;+1HF2DQ2(NTK=@@ITD>"+E3W24J:1
M=.% 2A@.IW/KW,I^)6/U+AX3:WG06SSK</&A*7&UT4)1QLZVNE-QGDX]]#FW
M%-NI5Q2YMXCJFGH>BE@RGRL3<8]$+IR__KY[B[*HMOVIMA-PCS[37/LV;093
M 8/(#Y#^$/Y>?-*?/DW<\\ < < < < < < < < < < < < < < < < KUZV?
MW]GJ3_\ /74S_L!;\ GD%A@#39JT6<B!L9&(29X ))G]MEC3*^X+(&BO??'%
M8F6_M)78H @*O]K!03_+@',< < < < < KG[?>HS2^IVFT+$XW!>R'978;_2
MY[2&N>=<,]97>:@,^KDNPKS^WV124GJ^RCHM6>DFD4T]VNY66=J""J:!3(F6
M?O\ ?[^H,\]3^QLKV<SR4ODOU]WKK>YCK2]K9*1V&J4;3KG((LH^,>EL,?&Q
MDW/(K5]V:0.R:/%'22JCQ@^3%N4B1%% )/\  (E=\.QCSJ/TX[']DHMG&2,W
MCV46FX5V-FB.%8F2LS-D9"M1TBBS<-':[-[.N(]LX0:NF[E9)0R:"R:IBG "
MDG,?5X[/NNJ-XU*:OG1[<]LLVW=:>NF/TO%XO<:A$YGI/8&95B"NNPD+I!6E
ML^PXY!PC+PB]4209V)*&EFS&6.50CML!8MU#]0)].TKM)']W[#B>.W[IQV+>
M=?-0T2$GW-2Q6UK2-?JUKHMMKZ]]DE)"N#9(JVLXY:O2\Q(.$)=FL"+Q0KI-
MJV B)=^Q>!]@_6U].=YA6S9CL#2M=:^Z+:PN,WNM?N24&XD6%$58(RIX%^^*
MQ4>I-G"C4CD4Q7(@L9(# F80 V$. . :VOZJ0_:_<6_?V=<__AVB\ V/H[_U
M!E_FJ'_5%Y$?9?HO\ ?9R0. ?(_CV$JR=1LHR:2,<^05:O6#YND[9/&JY!36
M;.FK@BB#A!9,QB*HK)G34(82G*)1$. :PGK<YGF\#W,]#MC"9]1X=E.=ZDV,
MTTC*G ,&TNR%Q02BSE$&L>DE(-!*JJ MG9%D?"A_V'[,WD#9>K='I=-!V6H5
M&L54K\R1GQ:W Q<&5Z9 #@@9V$8U:@Y%$%5 2%8#BF"AP)X YO(':. . . .
M . . . . . . . . . . . . . . . . . ?D_\ <C\O/ -4/MKF=FD_4+M-
MD4ZJ=+&UPI^^Y9H,?IVBESN2T??Z)-3^&4Z@TJKMY'6HFWUV[U BVL7VW7I_
M6&S>$95&E0]<A9XD@Y^* V2NPV.0.Z97-4.R6W6:5$K+,IMQ.8IH-ES'0BG@
MEAD2,XRU5-VRF$4'ID?AWC!)<$9%(_PZY1*8/ &N'Z8O8')K?VSSF/AI[LK(
MW2TVO2:S7*??/4)OW8U.%S1OA;348RYZEEDRQ3BXN;1=OE:39X)=TNGG6@C%
M1R<K+RA'1&H&U?Y "@(_(  !_,'C\O\ WCP"MWK9ZDE%[*;0ED\)EFC5"&M]
M?V6VXGIMD<4YS5=DK6!:HTQ[39.(CX&Q2EBJ_P !;G[%>$9VJ+C7<[7G)9=-
M-J<IF10/GZ[>I91.QG;#6^J5>RS0("=R=SH[.4M<N_I;MH1?+[C&TJ7&U5.'
ML3^YYRVMC^32E\N<W.%CB:'6$'4]"^&J @8#MGJ&ZTQIV#7&K5;5ZW1]>D$:
MM)5V&-HE=IER=0PVQ@E*/HQO)S45(*1ZC!K*(+N4 %!5-!XA[9C$4(',/C#1
MU-D]!;>GI%;5[V=VK^5^QK+JM@ZX[3$EE^C.B==JBL93=JA--U]RX:;3Z_\
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M8I1Q;)M3S-=)1YC7/$NFXQK;^[!JM<NJ3++3Y=MU5N)EM?/Z^?R^3[\V)?\
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M&;1_Z;/3!H]:MGC5SULS%%PV=HIN&[A$]:9E42715*=-5(Y1$IR'*8IBB("
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MMKEZ7;+(UDY>>_&;;MQNY^\\:7+2]_2:\]J\W(@/D '[^<B3Y\FPGGD@< <
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M_P#F"9_^&NN1+V?Z/_ $V?U+/\O2&R_S\O\ SN;E]?\ WX=<H V*?(?>'Z>
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MJ_615N#J>S^4EHIB\D6H-(T\2[73D44HE)RHB5N[;G.!9MP!P!P!P"E7LO\
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M.)BNQS57KY-,)TUJUPDZG.:5BBW'E)M=@*<#AY+Y\?U^G+Y/GG\GP8\_0AY
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M.\L;F6<97:,LD;!U*#4+;<-3L=0NE50'$&Q#'IE,B\QML3<5"QPBY DM<*B
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MVJ"J<>^?@BHX%DS>3S]@W<NP0257%LBH=8$4SJB3V"&, &+1[@]3 _\ G/\
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M!#I2XP&\)=,.D/5%AV..:!&@.]D'1'&>)?\ XQQ1K&,\G&61R_.)ZR$P2/\
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MJ[HQC.5G:\0T4<JN#'_9F746,<ZIC_LC'$PF^8CP#M7 ' ' ' ' ' ' ' '
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M[V7N]_,\\X!=5P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#\G(4X"!RE,40\"4P
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M// /HX X X!\,I_Q;(_YB[_FZG (*^EE^UQ]*/WN.7_[-L^ 3XX X X X X
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M.EQA7WQC5(H'9@1+W@C[TOD"0?XQ7KH?Y.#J7_IG'_W&X _&*]=#_)P=2_\
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M.OZ?X _LHWIO (E_'KZH^T'CR'Z^N=>0\^?'D/M_R'GP/CS]?' ']E&]-_\
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M[E3&[YHNA9U$P&C$FHB*19:)&.Z*E*R:E?%S7EV\X1FS."T:JL[ MAX X X
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M%\Q-GHUPK0M6#(AL9@F2V8)IR:7&>&P>!8?8<:$=\*/_  M[[T/=A^_W^_\
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M'.FP$]8K!W&C(FJ=0W&AVBR1%XF:9D%"?RL$]L$H@]-?+'&T%FX>1U;0F5N
M;A#=87""*PI*H"LBFJ*"Y2D71%0H&%)8I3'*55,1$BA2F, ' 0 PA\^ >[@#
M@#@#@#@#@#@#@#@#@#@#@'K.<"!\_/S 1$?(!X#[_(_^'CY??X 0-8?U=NQE
M"WC69SJ5#HWG-+K@A6ZLMVAK.G&@T\A3V#-$C23^^9&P(#_1>MEPK]IKN8Z!
M,*R<9*OK7<8RN9HUG;>S602 E5Z=_IRG@9[1-D[/=4>M6/FL[W/7%$ZPTR)A
M-+SK*M+S(+) 6_?,^<SD4O%T*5VI(*O*)PM.;L5V\+6Z\[L[M[:2N#- +T0
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MP\ ^T0 ?J'G\_ /6"213F4*FF!S@ '.!"@<X%\^R!C 'DP%\CX 1'QY'Q]>
M>S@#@'%24["PYD"2TO&1AW0F*U)(/VC,[DQ1*!@0*Y62%82B<@""8&$!,4/'
MD0X!R93 </:+\P'Z#]_[H?> _D'\O /6X! $5#."I"B4@F5%8""F!"A[1C*>
MW^Q I0#R83?( #R/TX!Q<78H"9]Z6%F8B6%L4@KDBY%D^% JGD""H5JNJ*93
M"40*)P*!A ?9\^!X!]C:3CG:ZC9L^9N'*13G4;H.D%EB)IN%&JASI)G,<A4W
M2*S8XF* %7241$04(<I0/NX X ^OUX!\QV3-0" =HU."8>R0#MTC 0O_ "2
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MMVY$RI$01*D40,5,J1"IE,!O: Q2 4"@(&_9 (  @;YA\_GP#W< < < < <
M< < < < < < < QYJ&LYKBE27ONM7>M9W2VLG!PSNTVV5;0L&TD[+,,J_!-'
M4B\.FV;GDIF19,$#+*$3!9P05#D3 YR@4#>JGZC+648:UTXJ<%;\[C9.3K](
MDNR\]-/:WE!;=#67*[/-YIH*]34'1J1AVMQ-QA,)F=^8%8P<=:[^O"QRRQ(J
M6D6($E.IG0.N:#9T]Q[7]0,2S!S0#9W =4<>C)&!OTIC-$H\,R=O6]HO%40C
M8/2F,UI@/;_1XRW_ (9_@<8L?*L7$5.+JMH\"Z8I?9  'Y^/G_#]?R^1^OGY
M\ _7 *6O5N[.Z54*);NI.<1%PS;2^RV1R<;URWTLVQKU$N&PQTV1S8>MR%P2
M<%>9UJ=[SQE)H9Y/2QHUG+RDP1I R"<S'>T4",];[+6[=^O>?=:?3&ZV;=C$
MMC4*PO6M5O3:E>L6A\YEZ1/1LLOUU?VFTK5]Q>+[ILZO8'SD:Y<R1,PC#*%N
M]JCX"X2#@@$S?34Z0WO"6$?LVPV&P,=(FJ#8<]C<G5C:=&Q.;9\\U&<NU<KK
MUW5GE@=2JC!HLTD(*HREXO4)C:UBMM'H-B=551H5("W#@'@WT'\P_P G *!_
M63VO6GM5LG34M%1JD#V*@L]/U^U^3MZD;F^W:E3+_&V_1.FVIRI$&!<QD=IH
MD O5:,_D)-6$O(S<G!.'[%3W[8 ."FKCVR[IYG0\VZE]1],Z+4SKPWK]WF87
M=:I#8W$631X!XG L\%R^KM&UAK%AJU=A9FVWQC?)ZJ/\W0TBHY5]H5RQPSNQ
M,6H$\_3QZ+FZG4B*LMYL4U8]LL.9U&@6QN:>;RM(I%<J\];K5%4//&K2#@OA
M*S%3EVGWK9HY3=L(19^ZA:2WK5*0BZZS LCX ^GUX!K4>IYK^_6CL'EF VS!
MZI89',>PM.[,]6L^E;"BME??C.*16).,OV(2$I:6C2MU_LSGCV7>:'3:580<
MU^<^RH.0BG#UXU3%4#(NU9AWN]1N*1OU-R-WTXH]'@YK-*%D?8U:J1]^OT'I
MU5>0.K6J>AHF V^H4 E>69UJN5!)Q6I29NN=/]7J+Y6M1=[9OVH%L_4[JA1.
MJ5&=5ZK/;'/6.S%K#V^6RU6JS6Z3G9:LU*&J$6W8O;5*S,I'UF"A89G$5B&6
M?O%HV(;MV[I\^<E5=*@2KX X X X X X X X X X X X X X X X X!C?6]=
MSC"<^L>IZS;HBD4*J,_C9RPS2XI-FY#J$;M6K9!(BKN2E)%XJ@PB8>-;NI26
MD7+:/C6CIXX10.!3OVM]6B1;875=-ZA4R$L[6;OUES*ZO-^>S>$OJ5>X.3AH
M=MD,G!6H*]9:3I-U:R\A9:Y9K<U8TNN52KS5DE5WZXQ$-(@1F]-STTV^EP=2
MU;9E+-H_4.\9XC9:M@G9> A']FO-QL9*P\BM(UC(_P!:ZH4RI:73#Q,Z@.JL
M)?1M!V5.S+6>?T$T [:0ZH&RK"PD17(B,@("+CH6#A6#2*AH>)8MHV+B8N/;
MIM6$;&Q[-)%HQ8,FJ2;=HT:HI-VZ"9$DDR$*4H <IP!P!P!P!P"@7U8*#DEA
M[=]/;3V0ZMZOVAZ_0>*=HH.>KF98S=]C4C- L+W(S48[AC2VYEX*5=HQU@3A
M9AR]CP:+%653=H"45DP(39#;?4WR5?T]\,D$>WE+AX*-ZYU75T'%'9W&CQF1
MZE>] A;*-NNQ<IN;@VA9#07^9PEHE+/JU8<4N9BF[IC7++'#9)E$"S7TKM7[
M,]F(K;YSLI8U[#5<D-']./LEPSJZ]5UC3<;<S[#<-Y;K0S,6\E':8XFJ_"M6
M2#A.(:I0,JV1BVZZCD3@?OT]^M+'):!W+[(4K#8;$-3WK1];84'.HFAM,Z0J
MF7XF_LV=X9!MZJRC8M!O^%1X1UIDC)"S,YGGMY!TJZ=,V\:5$"HS-*OVMKU7
MQ#L7UMEMKB++!>FQTZD;$ZIU$C;=$Z[L5C[@6&2[ TB\KSM1LSF1DF06N]S]
MSB*\^AK.W.Z3FY*122CB@<"1UNU_U8%S[PG2U^S3S5F='[EO-!HLABU9C<>R
MPU0LQS=/W75FYGH[,^D6B\U1-H:3C"V?0UIM-W-.IUA!2\=&LS@9+IVO=]NP
M_86":PUG[78M@MA[<6,B$C*X:C39M/$*STPHEOBHUZPO^=N)&'J-HWE&?2+)
MOD&DW).I!_ QTFQ<*MDF8&>/2QT_N;8GO8^M=HY+;[VG5XJLRM8V'1J'(Y93
M9FQ.U;<C8:]3,VN.%8[=JK*1B+*'DIN(1F=4I,>V=Q#>$MI72CPCH"LKKKVE
M]3O3,'@M I=^[;:54;9D>-3V]W^8P6EA9<SD93L?'5^_2G4!DSS2/C]8?I]<
M@G[&JV29Z(5F[9,9A,#6I8]<X!DVW[AZI$"UQ:T0LYVRO=)9ZUJ,71<^0Q%:
MB[=N^1,M5K+;++AJMJ1ZWW[/*?9I&F#8&#NG:7%8:A)U4$;G)S,',+#\&!*'
M&HGMUC73SU3BY:;?I_LNP[/]D[9D[+2*BE)2(P-BL3>2J]CQH).JQ4!H*SVD
M++S=?8-'%CA'-H9Q<!\,S3.,2<"#^?RO<*E7;?K;6+/Z@L)A.K]HD9:\[\GU
MD8K]J;+%5OI?F\5CB@YF_P ?53;46:UF*DJK9K-!9<@N<86OLIQ[$MIZ7F%
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M8JCMX_K,F_CFCQ_7WLC'KQ+]Y#.ETCKQKIY%NG4<Y<,SHJK,G*[50YD%E$S
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M) _A@A!)VA>J_:[#\(T:TL]5C4K I"?$?:1(521068$E#-@9&>)*-BKBL0Q
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MMD1,GK3.L35L;2LG\0X3L\_'MCEDIKVAD5/BG8%<E^)7]X!FWZ< < < < <
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MN'U2!CNP"64RS"RV'-W6R'2DPA9N*A9Q*BHKF.48@S^-7<A*K$2+[7Q@HF2
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M0J='@%HMFY>I1<O/R;Z4G)-I#0L-!UZOL9.=GYJ6E'S5C'Q41'O'KA98/92
MA5#D U@>V/8_0NXW97),G78Y7W.ZM=A/8M><]>ZG7U8Q3]:N>EI>C4S<<>V-
MPPB+ 3L/DI(>]7W<F5EGZ?2<YKKZ SD&ZEMF4Y7@%ZGIJ]"8CH%U[J^5I72W
M6^R&J]18W0']^OEFSQI8JY&*QSQ[F=2NDU+I4&-G#JC(3$;" R9/9'V54F;-
MF@R8,P+$^ . . . . . . . . . . . . . . . . . . . . . . . . .
M. . >! !^H>?R\AI/W\@\@'@/ ?0/D') X!X$ 'ZAP#Q[!?N_P!8_P#CP![!
M1^H?R\ \^R'CV?'R#\G]?Y/N^7TX $H"'@0^7W< \>P7[OY> /8*'GY?7Y#\
MQ_)_#P#R  'T#Q_7^O\ KX!YX X!^1*4?F(>?T\CA/\ OY_F#] '@/ ?D_A_
MUC\^2!P#K#NE5)];86^/*]%.;G7(2>K<%9UFB2DU$P%H>0<A8H=@_, KMX^:
M>UFONI%LF8$W2T-'G4*86R?L@=E]@OCQX^7GSX\CX\_F\\ "0H^?E]?W1_\
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MN9FF^?P5IF8L9EQ78%1JT6?+*OWY'4DNY=J@2= /'R#Z< < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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M!CI^T!O8,(>1)[0?(PE^@F#Y"(>0^0AP#V< < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
B< < < < < < < < < < < < < < < < < < < < < __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g729258g75i13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g75i13.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1L^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &R*^:48X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8+UQ         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              .@   )B
M  $                          0             "8@   .@
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   .@     4F=H
M=&QO;F<   )B    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   #H     %)G:'1L;VYG   "8@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ /0"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M9W>'EZ>WQ__:  P# 0 "$0,1 #\ ](R7NR'G'9/I,_GW"=?"AI'[W^&_X/\
M1_X3V!^PXW_<9G^8%:/3L%SBXT,EQ+B8Y).YSO[3EG]9MZ=TVEA&/6^^]VRE
MCH:V?SGO<?S&)$@"[H!1(&I3?8<;_N.S_,"7V'&_[CL_S%S=W6 VIM^&*\J2
M[?7=4*ZX!;-==C*F/WMW?Z3?_(73=/JZ9GX5675CAK;FSM<V'-/T7L=_*8[V
MH0R1F+C(G[5'27"=QT8_8<;_ +CL_P S_8E]AQO^X[/\P*U^S<#_ $#/N2_9
MN!_H&?<G7XE35^PXW_<=G^8LS.9U*E]QQ>F4W5->UM,L)<6[*WV6O:U[?\*]
M]3-O^C5WK5G3.F8P>::C?;+:&/D!SFM-COH[G[6,;N]JY+JG5^M],R\=]C^F
MW8N2YH<S8 RKU)]'UGUC[14V]K7^G=OO]/\ PB='O?AJJB=@?H[H_:^\!W2:
M0"\!H#)EI,;'N%NVKV[[/7_X/^:_6*E+$_:-MV.W(Z757582+;!601#9%OOM
M_1LW_F6?I5I=)_9?5.GTYU.,UC;00YCA[F/8YU5U3OY55K'UJY^S<#_0,^Y+
MC'93SQ_:K6M#^F4E^T%[FT.(:"Z'VAGK_I7U_P#<+^<M_G_7_P "IO=GC"#V
M])8,T7!EM)K)9Z9#W>I4]K_TGT:V.?\ X/U%O?LW _T#/N4;,'IM=;K'TUM8
MP%SG$:  27)<8[*<7';GOR:Z[>F5LH<]PNL]."P!OM:W]*_U?TOZ+[1]!_\
M/^DM+[#C?]QV?Y@7)V_6#*R[K'=,P\=F-7:U@;L99;J?I9'JO933N9_@Z_TE
M'^%6O]7.IX?5++L/,QZ&YE!,FF=C@##_ -&_])3;7N;OK?\ ]:_X-THG747&
MN*,3ZH\6W%%%Z T:E?#*O3*OW75^PXW_ ''9_F!+[#C?]QV?YBM?LW _T#/N
M2_9N!_H&?<H[\2EJ_0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #F ET# 1$
M A$! Q$!_\0 'P   0,% 0$!              $'" (#!08)! H+_\0 ?A
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M4!67<D;HIH**J"HH0A0(4H\ZH@)1\U(  P^<GRB;?S]N4<PYS-=\F^?G6!(
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M.)ED9DH4[+QQR(J.6X%3:;$.J)QW]AR;Y-4VUMF5%;65@HT25)QJ5*Q.9A8
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MNGNC=Q$1$1$1$1Z[_H]7Q!L'I[]:Z)\E *4J6 2[,^8_O)/XLS0)3D[=;/\
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MY,C(=JVQ4^WZ/:4WE!(HJ>AH=IIFUDJ75)!Q398GJ$T*$Q12)DQL2R++*MX
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M!R<EC&3F%R6+YN;EW\=>BUHJ.F@HGV"B*"B/*4.Q.DF9+E+]R'9F*)0  #H
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MAW 0$A=BCW[@ @( /G  &#<,9E;P)4439ZD,4F8I=@,R.<']^?5&24N4P
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M(E%'<&7#5+M2/HU"X2;-<A%$'K'-&47+58A@\P4UT;J=$Q3AL(&*<P#OOOZ
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M!)4M@HDA-QD2;,3E:PX%KQH&/\+1L+=G$Q?<D4:(JC*0!ZI(U:T.92?M0-%
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M,XCG/*Y2.=0R)54B%'7P#E+R,VGR?F'?2UF4Y:8RF8/T,.O_  CZ)LW;M-M
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M2Y2L2TI=PDBX<W4;AQT9WRCZ+R:Y!3=HSY:#+F85$<UBURPL+"]Q>XL2XO\
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M6IY)266<,Q$Y^;LV46^.@DOR SEXQN^(<406*I\XKZ\SZF8@IMO5I*FLHXE
M+89:D<#9V=_>;:Y-)V=LJCJI4V6HJE25E.,8@%2PHI4 Y<6"GRTU,?=I5K5%
MW:MUZW5J01?0%G@XJQP[Y%1,R#F*EV;=]'.$S)B8ATG;93<#$$0(([#Z=M/*
M/&@A0ZVU+C5OR/1H\;B4-BE#<1V  W-]T.P=X_"/>/PZ1,+I"+>Q^4VPCS<Q
MMM]N[?8/B]>JJ!(L6]S_ #W0A# ?E+L8 $ #??H(C\?RCMJ1D'X0MI" ?8
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M,%!1>.$UB<QF[,_.<VQ3E-U /3<H),O:])N-H4B%JPEU@[R5BNW.#*2+BZ@
MX;K\O2U51L&I$Z8I9DE5TJ&E^-G!?(EA?H'UI>#NXLUN*K"+9]9%$VV4: [1
MJ>2XP ,BN6;;D$&LKV1RE.5*8;(G<G+R% '";@A=@  U^3>4>QYNQZ]<LRRE
M,PE4H'(()TZ.LO?@"_V38VU$;6I]\EFS):QU!<6+VM>_&.B&N%'8@TA"&W]
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MW]7CZ[? SUQU"<%-=D'3?L"63(&3)YBF8HI&4CC6Z2BFR_9CMN5VG&@X1-L
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M%N(_+J%9'J/X0B'?%9PR+<1:5**WN)ZBO47<V8JP1J<@#TDXC'I'0$B@ !#
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M"@JDT<M&1C'<+R"1@2Y$Q450Y@ NNO)G2-H%.*4D[H82L@$N&N6X<;MH +1
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M?F(4=Q 1W#O$O<(_%I"*@  [@ /B  T :PA"Z0@TA% ID$PF$A1,/01$ $1
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M+!P "68VS.1-VTL'?*/1\M>64S;R\$M2Q(!/,*N:P+)&%P  Y9FR #C+N(
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M&77,WC[-&."%"5I,^LF BXB9E(@$147 Y6,HFUD42D7035+9*L*@>'SVQ1:
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MA#SW4K*.N=V]4,/4ICKBDD'F$1*&VU2HJS.670.B+ !(8!A#K 0@;"!2@(
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M8#)NO)O="?T3*T$=@X2WN^_+L&:&PF$=@W  +B\=PZ_=[;C^#KLJ^@S:B?\
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MY027#I'2"H _E?H>$+^R8&BBH@CPB.#" !L?[-C0Q@#8 VY!Q:<Q?5OOUZ"
M:P57T)U5'*$VHVQ*&,D84TTY886&$IF$/Q# C-XOY\E*4"B6D@?WGXV?N_2U
M/1%9OV3$U1,4A^$=T0PE,< '-;82' #;#L?[%H=VW4-N@@/P;J;Z$*VIEJG2
M-J2%)+X<4E:"6L6"E@IOWYQ*]NRA92,):P +,][EP=<S=WBG^B9FHB'+PD/"
M@/78N9T1*&_40 0Q@ ;?$'Y]9O\ ,7M3([3D)+724!\G]>]N#AW:,8V_*:TM
MQQ&7>.:.UC"C^R96P=?)+>?3.E^K'0?07M,EAM23VRO^ONO#_*"7[/N+_@8
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MK$CZ$=JV K)20_LRP?,V7#S_ "0Y"2[')8[K&$']DR-=O]B4^]/^[6V_ /\
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M8EA^(8-WDYCH?/6",D&D(-(0=VF4(\ZQC (\IC!]J,/0!-U #B @4!#<>@;
M @(]V^JJ25 I22E1# C0G(P<"YR%SU1\]G&3X=(G"3Q)9-X?E.'9S>1QTYK;
M<+.7*Z=>++A8:A6K6)B0_P!CZ=\7%G[.':F DH] X-#@99F541)]2Y+_ $7[
M1Y1[+D5\FJ3+ES9@05+0I2@ LA2BZDD@ &S9"YRCEU6T44RBD@DB[#(AA9V?
MW6U'",I?V3&@/7R2G8!OMS?9I0$/3UZXP$-@].Y1#7I5_0C7H)_^:R5'1.X6
M'Z/3?WYV>-7S[)+_ %;6]9P+.]^P\.-HN?T3$V 0WX3W/7T?9H:!N&_H_K5@
M/P=-5'T*;3(?RV4S&XE*+=+;W(:VBOGV5P]Z?&*#?LF1 !$ X3'&P"("'V9V
MYA#X_P"M9N._\PVZZSH^@VO6'\ZR1UR%_CO+Q<;;DZI.>;_D!E[X"_LF!IRF
M#R25]PW-L7,S8.H]1W#[%H;B/7<1$/CV'<*J^@_:"5!/G2222SB0MAT_VGX>
MZ(5MR4".:0+ W'?E;A<1;']DQLC!L;A&=B ]0 <SMQ =NH;!]C#;XNG3X-3_
M )CMH?M61]PO^) [<D]O!P_5D+Q47]DQM-PVX1W@"/\ WYVX!_[,-0KZ#Z](
M)\ZR+!_[!?QP\]RC;"H=)*? 0#^R8F9=O]*.X[]]@S.TWW]?]S#H/P]_Y]0G
MZ#]HJ (VG*^X7_$^=8CSY)<W##I3?JSBK^B9&P )@X27.^W-M]FAJ(CW==OL
M8;C^?\VH_P R.T H).TY0>SF0OI_[PQ/GN1IF_K)/X!SV!NF*?Z)H1]/"0Z^
MF9M^J_5_\QU?^U9'W"_CAYZE?/\ A%8?LF=N([>20\^F5L/\&+]0?H/V@ ?_
M )K(^Y6/>5M$^>Y/ ^X^YA^(BH?V3(V'IY)+WZ96Y?S_ &+^FJ?YD-H#/:LA
MO_")]P6#$>>Y7!7<G\B?P/YP@?LF%L/0>$E[W#_NUH$V$ $0$3#B\P%* @ F
M'D4'8!V34'8AJS/H3V@A!4C:,J:H,R$R%NIR ?\ 6: DGH!B?/4DVN'Z?!+Q
MV3X#N/EKQJT&"O(4%7'R\PYLJ!80+,I:4@3@),T>1R$LI7JQVQ7 (JF%).(0
M AC?=J 01-\OY2<F:GD[6FGGS,92'+ I23DP25*:P*@Y<C1[GKR9Z)P=+9 M
MT,[O<:@-9RY R$='BF P;AU#7FP7?H+1FA=3"#2$<6?#V@;]KVR#R"(&]M6-
MA$0[]BWJ#'T>KT?].OI7T3X$\L:-2V(P3 0JX8(4P8N,[Y'C'-VH!Y),XM;O
M'Y$]CQ\=7 K#UZP\8G#+7K;"1UEK\YF*C1LS7YEDUD8>:CG<ZT1<1TFR>IJM
M73%VW%1%RV<IG172'LSD,7IK]*\NC4)Y-[:KJ.IF2)E+33BA4K$E:%;ITJ1,
M2RD$&X(/-(<#4^3V?*2J<$J =7$!B P+\ 1J1>U[D#Z)<N\(G#57\1\5DY T
M3&19?/E3>9(QBL-<@'"N)ZU6TH*F39*:F@T*>"["[S#E5T$4LQ#9L0!434(!
MR_ MF<JMN2:ZB5-K-HS54"L$^53KG'RM3&8!/2M:DS5&6&2%A04I7.#L_<\B
MD+1Z( 6Q!*4OH%-8,')8#()S$1.I7@[>'JCYKK)8B.RU+N</<0N.L49#;YLC
M:5(8NS*C=()Z\7E:#',8*/691,>Y13<'BIJ1MQU8XR2IES'4YD_75_T@<H*B
MBJ$S9E)+EULDSJ0[+WDNMH$HF2TX:A:%I)60<,Q3(9;I( (C73LZGQEBGFO:
MSEWOA*;: !U/<OF(T2Y>#*P>OBR6O_V0;%!9#LL=8;_&#&J,W>.(2.-DES5V
M=94IK.AJRS)HV9@ 'N*V0&<0R>@@P-6@3."VK2?I!VW*6A"I4N?2R9HD+1.P
MRJ^<L2D'>E<RH 6A1_U*9!F+9Q.(L*KV=2DH'Z:@[A(:SG@X/%3AN$8*4\&U
M@=?+CG#\+%<6L<XJI[M V+(-EC:6.-K[9("@A:H8:!,-JRQ?1*TC)!V1JTNU
MM[IU#B55&?9NS>;NRN7VW9=%55TQ&REI"94^GDRTSA/IY:IVY4FHP3B5H <[
MWF(WP,K X<SYND.SD!V-TZ7=@.;9OTE9OPC)8LX'<?5K!UC7?U>Q3]ZRYPMQ
M-P2C[5$5YQ-TVX2&8F%+;CCTDG&0)H)Z\9J^+(JS$LHZ[5;=S(-(XRATM6LY
M=[6J-H4\W>R::51UTL3!*74(DS90D%:D50)FI6E)#X, +_HEXR)V?3@ !E8P
M00<.>A26U[^F-XGO!3\,46ZQ\^<VO-41#N#YCCLC0I+CC:UV.-D\2U-O8UTF
MDM'8[C*M'2JJIW#64@$GEO:LUB)LTK0X4!0Q<4CZ2MNSIE=(2JA609$R3-1*
MJY<L2YM2F7A"%S53 0YQ* 0I2;"5AO&*9L^1FP Q82#A.222 H  FP9L3BQ;
M3GSP=6Z@07&C4:=0:! V[$62\EURG)0F?J=1<E6IM4EY;L%EQ<*5MI#14^JF
MN)%Y" 9L]@[(AR*@@ F]SRGEUU=R155U5;.DU]'2S9Q.RY\^DDS%[M9"PB7-
M*E!/-)Q3%AP;F-67+D2YV!)2!I9*CF'#%('4<(.D3;J7#/CCC)XA,R*97JBF
M.J%0LNQ.#J:\P.SQ)AFK-7\Q.S*31"<:L:'>)^YV<&)4%6A&-0CT5FC90T_:
M8Q%-LX#QD[E+M'DOL:C1LVJ143JJ7.JYOG9=755)ER4RC,1*F+G)3*"BHA !
M<BZ1BQD[::6GG$*F!/.PI 9"0 IP72$7;J;B0"#&+K?@V^&(]BP1C*P7'.KW
M(.:;QG^(2E*](4-.N-:[@6W9"8.6D5#O:DI+O+A=X6FM6,$R*_73C9I=W(+-
MY=GRPZ6:M^D+;\ORZ>E- B1(.SI*2N0LK3.K*:GFXE3%K 1(DJF*5,<*QR[8
MI81B79&RZ92 0E)?&HV<GG%@D87)+,,B#9B56V2M>"YX=+5 4O(R\CGK&M4E
M,2Y<R;8L?Y2ME)KUU(M0L@1E)B6K*SI8L=(0U6<MY +%+6]Y2)Q0L*K$.VM=
M;C(*+!HU/TD[>D*JZ<IHYE2B;(IT3T25RZ=&*D5.FS3+Q)#A;A'^DI9DJ_1P
MP&S:8 J"4D!&*V$NRBC"#QR(=)>XM8PV_%1PC<.. .$;B /4H7(-NOM)XM<=
MU"LY,E6[)E(PE8M.'FM\85RWQK^LQCI.$BVEED(*;*R3ASVB_M*E9VKTM>,P
MJ9>SR>Y3;;VQREV4*F9+E4]1LZM5,IY!Q8YE,2@SY2DS587,M$Q!,R:4H,U)
M3B62C#.HY,N7-*  +83Z*@"'(+AB<P;)_1 -F,*/!P"8.,3%1"%W*(W40*!R
MJ$YOL?6DG,FJ03@H42[ DH)SG51 HG,)Q,;7L/I$$E7)FIG%5R4D*)!*4DY8
MA=\+.6N;F\:.STI54%*E6< EW>X;M?++W"/T/\-!_6WJ1A#SAA&(&$>_?LMS
M;_&;<1]8]=?BV?AWTS V'$68-UY,,W?ICWN$)2@!F"$LV65O=9LQD;PYQ1W#
M_A&#Y#" ?FUBA%6D(-(1Y5AVW  W,8X"/P%Z=0'XM^G4?@UAFBP4!S@H :9D
M"_9$A]'Z,^+V_&.!O[(<_P!AG!AOR[9*@-A#_)4 0]7=^CTZ^P_0S,6CE/B
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M85U3@)BMR0PMSOE5E2%$R;9-LH[,4#'0.N  <=65MS9*Z$U?E* E!PG_ $@
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M ]P<PEB8X $0#H(@'=\&WJU^&^4"2-K5!4'+V>Y *C<$N6N>&4>]I$($@D$
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M<++$6FETG"JBJ#J0*HX!9<%4NS='-K'-V-R>K,,NII*:M1+*ETV^3*F(ITD
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M)RDEYLTA1=3K62H.2 ISDYR-@YS.<EO!M&,;C&Q,8W41+=^I^HFVQ]: +O\
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M # A19KRQSI6.&_*>6<HJ9=RVQ1J5VXG>#=O?V$1E,R437&B.(;/&3M-MSB
MM#^DVZ<C9B*BX>YY5;D?.XM[*23MO(5IX$D4?-;$&VJ:6I5+03US).Q=N3*8
MS*69)2)DN;3&1-IRN6)\H+8KDT2%I04"6@"9NI9&:;N%,5%*<1EN7!](+)-G
M)*18J*3SG-L9?0(#'6(,6HV2Q3.-<2\-?$!:.%7CWK%AQ'C3)8W.NO:#'8];
MM,47!VXE;K>%*]99Q0)F#C3>R(K7UM'O+(G&LTHXT8VE-5RFK9%+1KFUE;32
MMM;%J953/I66JIG5@-3+,Q,J6)B)2DT\]2"%"63/!*2"A&%,NE2I"OJPX6"U
M[F4H>B23SBHI!*F8)#&RE:=9>&/@?3JT:G8:MC2F\/K4>%<V'>)6MY6>R.3,
MV/KQ)51+.T5;X(]P=MDUHABXM[F2CF%,JKK'1*^*I")I'69:Z:-K\K9-35E!
MK9E::G:8J:"?3H%+1RY<VH\EG2%!"9DH**:=,J9,J)LF>BHQ2$)P'<R95(S\
MP I2Q2'=FN/2))=2BE(#,$G(A6\V_A8X7H@M)#)O#7B*@1F2.,>Y<.-<FL8Y
M(L5I3+BV>QG.EQ!D>5=L,M7!G&3K>=4KUJE3NCP[B6CV9W3VHM!?*^RFA2\I
MN4JILY"=H[3F+IMG2ZY4J?3TTO%,1/2)DG :="@B?+!E %)7)4LK"\2 4Y!3
MTSNTLABY!2H!V#Z@82<3Y$"X(<1QHXZ,>8[Q%F-CA.A1,6WD,04.I4G)]@A7
M<E*-[AF)-C[+7^6145D5Q3:,9"1"#CDF;5DF@G$J [;)G#L@^Q<B*ZMK=G&N
MK9DR8JNJUU-,F<@),J@6<,D8$I#!:/K;!DJF84LA"!'(KI<M!.!*04N,20D8
ME.3B.%F L+."P)+DPYO@I  >,6J;<HA[2<J;" \Q1_K>3NP@;E+S!MW&Y2[A
MUV#NUSOI:<<GEI<L)LH9G16?7;.,VR;%9%B$F^NNN<?H45'_ %L07_BZ/_\
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M*EJ5*J%3$@G#A4H%!.+"2(*$JO+44AW(2L(YSA17FE+,6=RRL1<!3'6LLQO
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MV8R\6>. 2>: 2 6<@D#-R7'V<[\8['>#GRU3<3<-7&Q/VZ]93HZ22&"RMI7
MUXAJ1EY<#9&1;J#4I:752*FS55<@A/ <5BG@E7[1JD0JQBG^+<OMC5=;MS8Z
M*>0FHWTZ>3OY/E-.D)IIZL4U"@4LD.4I4SD<T. (]!13)8DK)(4H)RZR+>B2
M;AW#$$<+Q-;"ODZ\=E\OF?LF8NQR]KMAN]!Q:Z2N\X>P9:C:A%4YQ'JWZZRK
M#+6'*O5I2R.6S9R^R$R@+])'D&HP<-27()N <^-K:?E)R?E2:+9M772JB3*J
M9DQ$B0I$B:#4E13220B><:-ZI4E"%H:G258P0,&PE<B8Q7*E*! NI.(BP #V
MM:[@LHNUVC9)J%Q/(X.QI'HP]+IE#JO#?Q.TT]HI>1;- 3R<["Y$E8U&KSB3
M#)2I)M&=@&*=LD8J:B7:,J](B9+L8A5I!FUJ.=ML[4F39R:ZHG*VIL^:#54J
M)N!&&2=XA:I*IDOG I$Q)7A:Y"KG)BIU(;!+2"@@D)2&YI)=LKD!F#@VS>,-
M:>%;@,8V+ ;%KCZMN:;+9&QY%UVZL[;#1$3E*ERE9,_N);=,GXC;7;;,[]E>
MW<FFJ_C/&R%6=HJ0S]N5N4I];LG;G+0R]LE4ZJ$U%-4!,G<32JG6)X1*,F4C
M9R9<M9E&R%S%K6D[R6IKC'NZ+5"=+L"&PDYDEG(>P9SAS)!\>#HOAQ9N?;'C
M/#N#8FWY"P-Q)TP:6C9K6K$NUJ/8'#"KN$#V#)AGS.:L,*F5M*.AF$E9T2G>
MQ:+ #$%*E;/Y3^445/4U>U%4LJJV=4S*GR9*5IF3 2J4N9Y"HE"%!("9@5NP
M2)A,0/)0'");E"[$B[Z,X9@]CFUAF(87A.FN'+"%+XL2X\R4TNDA-\/)AN,I
M:*3<\736/)Q]96,3/4FGN8C*J[JU1L4U>OGC1[&K%?N5(QJ5<7K-RX:N.MMR
M1RFVE6;#7549D%%>G<"GG2:K?A-Y:JB5-V?+0@N$L5'482" 8HE=*,0"4!TE
M(=*4J-M DW?4$@-8L06=ZT<,'!"N$6ED2I8MQ5B(F1<6L,.9LIV8Y&?MN>*S
M.-BJW)>\LS7F=08-5W8%&5FT(:L$J(+G9**I* !R\RFVKRRD3*O=KVG-JRBK
M%30*H?JZ(REG<&7+W+RE*OS5"8N:  E@01)33EDA,N^%BX"BDYEL1R%R1AN8
MTB?X5\:6F2R54YKAXX?<7Y'>XFR0XPE6\?YR7E']K/7;;%)56V/Z],9#G8N#
MFGM75<JM)%>WN&%E3,J]&$8K(*%#=H]N<HI<VEFKK=I5%#Y1*%9.G4Y")2IE
M/-QR%*E[."L&_P "3@*E4RN:I1.&)--(Q!(U22+9Y$'TB69V<#H"M'DQYPE<
M&Y\LY)H:V,\;2AV5)P0"-@>W!ED6GU-Q8L?L'M]<258@<^8_M[9&1L"CMP[R
M1"O['#5ERDJQ;-FWBYVQM"=MSE>:*FG>4ULI7E>T 4)1/D3ITJ7-^I2B9-HE
M2U*0CFR))9<T'&I^:T*D2$IR2I3)</B 5D2O"L )NZBY RPB/G(RG!QU9R+>
M*["R4%*Q<':YZ*8OZZY=O(-XT9R;E%JK"O':KA=['"W32\7<N01>&2Y#.0!<
MZ@#]]Y/3IU3LN1,JD*3/,I*E;P 3"<()"^*G=V9CD!<1Y^J4$3+,'T2&'%W9
MLK99-SCIH8["4O0 'F)U#;J/,4?4'H] = Z_#KKHEMB)OEQ(&67;U910GZO-
MRZ;OGSA^(TX1]E7@&_[A]!__ (S(?_K8ZU^2/I;OMN:^BK='.,>RV(3NEE[\
MP/T81:/I(+_??Y0_Q:^/I_2_VC^4=R*M6A!I".+OAZO_ (O>_?\ E9CC_P!>
MH'7T3Z+_ /[KI/\ 97_Z%1H;1M3+;A^8CX+MO.$=N[?8>@==@W ?3ZN[7[0E
M*2"$J+<U) _W=.L\(\ A/UBRSERU[]V;9Y/U0FQNOW6V_38P!T#H'3^>^I,Q
M ) (ST;/IR<],26!(<AL@Y'3P,+L;E$.03  =H(<VYA(78ABAOYI0\_<Y@#G
M H>;\(3Y:5)<^D2.YGZ-7-^&4  HL;BQ#E\BQS XYALM2([L\#F?<$5G!- J
M>6LQ8?6J=2MMEF;OC;+M!NILH4]M(-BE0G.&?(6/V(S#.<F.S(11%]()I-ED
MP$!13.<I_A'+K86V*WE!-K=F;.JEO3R4BLIYLDR5E!("*B74*0$I02P*$KF+
M23A6DO'H:&IDRZ<2UL_/=+:68N 0Q+MHX<B':=<4_!:VX:HBM565J"+%L9!O
M[2[.>74OS*\(Y1-/HWDR!,1/G<I,EKG9+O;B[R@V,*1E(]>+.N  /$I]@<K%
MU:M_2UDP8B2I"DB69>ZP[D"95##+Q7"#)4FP(7=XS+JJ8AN8%-8%.3.";)(<
M6?G%PVEHW];C&X,9&)X@W*%CQ^Z?6'(^4)ZU-K.@_BU,O5.=J+>.IS2)(?#U
M[D;"+!Z4[9G&^V*ANXEZFG**.3(IF5#4')OE13SI$O<5TM*Y2$2DR%RP94U,
MTE:@$54IEJ&:A+F<TE+*+",6_D!R",1&:D@@V#$\PL!I<78@9F&B=<5>%J^W
MP[<\;9WQE1L3UA[@Q*)X>&V%VU@R-4K/7Y-J3)\U(VR0@4"0XN8]1^[4L+&:
MLDI/$5*S9-$G)$SEWINP=O3Y-70KH=H3*V9Y6?*IE2 B;*6!Y/*$J94HQ!('
M-$R3+$JZDJO=O:<A&(I.$ILD6Q-<G"D7!'Z)<D#A;>[9Q5\*#O*$3+W#)N.+
MO.NLI<2$Y6<B-*([G(.AO[I4:^UP[=K5%*U)FI-LJM*MEVRA5(:838/RJN')
M'AT1<!--R:Y4II*Y-++K9(%#LZ6*83DH5,*)Q%13RU2YTT(7@ Q3,4L*2"@J
M+L"*BG03B91)*GPCO&H'0SLQ ,:!D'C PC5:?E)_"Y'Q?=>)UEP\4:KGS'6\
M=,BUR[Y68Y,&1=NJVTF:.RC'[^'I+ENS7M+R"BBJG9H>*F45:I+%V-G;%V]-
MK*-"Q6IV:*U1F4$RJ6F;*DJIERE;Y<F?:5,J$E:9$N9,0$JPJ2D.F+FID)YS
MI!&*Y2Q+ETW4'US(2Q#BX>.6?'O>,<Y,XH+_ 'O%#F(>TZR,::^*\@XH8.->
M3QZ7 $MKI..\48D34<6=.55>*IMB(NG1E7")E4U"J&^N<C9%50[$I=GU^,5<
MDU&)$R8)RQ+7435R 5A2\3R%2V<DL&+$,.-7%,RHF3)=TD(8BUP@!68#%P21
M8%[%@"8<B!NG40#F*?J/0#E^Y-W_ '1=QY3 &X;].NO7%:Q99+)RYVANP/;_
M $C3PJ-\1/!E$CKS:Q&E]>L$#<H[B(#MU 0^'W7IW#T;ZH%2\5E=RNTD:.][
M=/3$X58;DZVXW.HZ#D-;Q.CP;8"/&+B8-NX+N "&P]?L>VD=PVWZAO\ * CK
MP'TFS$#DKM%(406DFV=U]!X7LW9&YLM)3/6]^<E[N,TAG)/$#4AV#M'Z'N&M
M@QM4=N[V#8;?%V(:_%]3_;S=>>;Y^^/H ]%'^R/Q,.:7N'_*/_GFU@A%6D(-
M(1Y?]NV]'-W?@UCF:=OY0C@M^R' #R,H$ V#^N; AT[ON3>KX]?7/H?('*93
M_J_;Z1_&./MD/3HTNN_#FO\ E'Q &*(  [F'G[PWZ; /F@(]>@>@!^/?TC^O
M9%0M:52TA"$I-EA@H\">)Z0]FO'B F8+@J(S8$L+V!%[#W<'M%T.<Q>;<0Y!
M 0*!O[[N#\/IW^7IMK54:>3,,E4N6O>*<S"A)((R4Y#N'-W!!UN6VD&<S@J&
M$>B"0_$&^3ZVMGPBD%!$! =N;<1#<1W+N&P\OQAW\OQZB;(EI6G"QEH(&08@
M&SAF+$L+:6;777-J<2@ X<B[N>O@7 Z]<A%)3K<Y1(8Q3$#8# 80$ #??8=]
MR@(;ATV 0Z;#L.LA1(2A2BE#K)6^%(.(V<6SM8YL.B(WE3HDN+,,6=[7.M^R
M^3PJBBP'$Q3& PB7J!AW,8I@,7?81'<IP Q?2!@W 0'8=*6328>>B7A ( ,M
M-DF[>CZ)S8!C$A4]/.YP42Y"27&9L'X\6:% 5#E^V@;D$HEV$?7MOL!M^_8!
M'NWZ"(#W!"D24+P4J9>/$J8,*4BQ<D.&MDXZ+B)*YRQ<$!Q=].B[7:^6AO"D
M.JF \IS<H&$VP&,&YQ$0 XE =^;J.P[;]1ZCN(ZO.,B<I!F2Y:9@1@*\ "@D
M@%2 K"X!(&(9$@$AP#%DF<  "K(6Q&S=6>1<C\FBD3+&-OUZB0_>8>J>_(/?
MN(D 1 @[#RC]R :(ETLI!^JE$*09">8AF-B,K W)8,K.^LJ74*;,@$&ZB7#N
M'?\ &*A,H*9@VYB'^T@ [F "%/VI2<O=R J G .4>4X<X!S  C@3(I)<^5)"
M)<L2):)I2A"4AT)8*8 7PE3JS8MD2^(S:HOS2><0<_69G+VUX]\9*$G9NL3<
M988*3>1$]!R#.9B))FH9%]&R4>H@ZC9!LJ0P&;.6;U J[50QA34$H'.7<=9)
M\BEK)-4@TLDIG[Q)6, 5.EJ]HX#A0S2HD$7OG$;RH21Z72X+ WR .5W=A9WZ
M9<R_A ^+><M54M<AE8BLU29*:G*N9*B8R0B6EFL$>6.F[,\A6%2+"RMD68N"
MBWL<G'S4\T>D,NSDFJH H'CT<A]@HHUX9,W%/6)4[_3*A*C*02!3!8G%8D)2
M2G<RR)92,"DE+OT4[06 .:G$$@.$I;(N2P+DV=[Y<'B)=BL$Y;YZ<LMDD74U
M/V"3D9Z=E9 YE7TG+RSM60DG[M10.8SEX]<+.%S"!1,JH8P@'<'JJ:FIMG2Y
M"$2T(E844\E("0$2T )0A( &$  #"  &%K1@7.7-Q AVS=^EW-WZ^DY:]!O!
M2[CQC58PB(B-)RJ(]>HC]CR='J([CU](B(]X[B.O _2N4JY.*#@GRB6'<N64
MQUNT;^R@7F$V=*K#*X#,;97Z@1E'Z%%1_P!;$%_XNCO_ $">OQO,L5]:OSCV
MB0R4C@D#W1M.JIR'4/PBT&IA!I"#2$4*?<&^+5#Z:>KQA#99=_N7Y&_\A[5_
M]POM;VR__JE)_P#W--_[D8YO]DO_ &3'Y?%B*4ECF#;AL$K)& -O[X7C@H@'
MHW'F-OU 1YA >\=_WOLZ=-G[)DRYB23A0FX-P "EPW2..<?/9@:<6.I897RR
M!>X/01&% 3@43;&$!$3&'?OW H"8?C  */P% ![@UTPNG5-W:DH22$I("4W
M#)2HL' %DC1\N.,3IB0Z0H:V=M"X_P 7X/"E$PFYQWYB\P\XAN.YBB3?<=Q
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M6M=BI=B@;;4I9Y!6.M2<?/0TO'"/CT7+Q2A%6$FV'?E!9)<A54 +L9,Y0,4
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M3=*DRT K-BRB$N78$\6#=$KFS6.%R2"&)+ OF-".&K=@A"F5,( 4Q]]M^;J
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M[(3XHEZ .P[<F_K W*/?U$>X-<_27RP 6I-52S D .BGG*#I<D/O,[A[B_&
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M-^@Y%^F+>;*!ASIA&3'"<_\ =;LN1EDXBT/@</!P&WY<;Y(3W X=<B//,,)
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M8LX9/E&$->[=4/):=A8=R/Q*>[4L2_&D/!%^#< #B.&+:H  (G,7)5D+V?*
M"(]'W9D A1 QP,/,(CN.LO\ G%Y:E:0K:--+4$@A!E+38:+0%D$MKB+V>*^1
M4!<KQ@DW8AGZ&# =#&VMQ%T/!%>#;*4 ^PG;1W /.#)ME$1 ?3O[(!T$-AZ
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M>TR59B$,3J'9%,J_)U+N;NZ;B(  B/6*3Z0^5TZ5-,NKE 8G)33J3>YRWZF
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M[OZYEE,.P"'0O]4.@^@ #O'X=8YOTA<M9TF8F;-0A*PH+")*T."""24K3H2
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MA6V_&.3+((_!W2'K]0=._17TG<M$N1725 !B?)YKL= 2J_!B1P#Y1/D%.SA
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MW8@VR'O'7T]\;<7;E+MW<H;>GIMZ]62 $I N   >( BL+J80:0@TA!I",1*
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ME0YBJN#$0!0ZQ13+T*CD]M$21-!F3$C$D!R2!+3SB$J.3%RSY/;.*&I&,Z.
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M&^.O%K(V5F)]12TQMD822W.U%4"6>^+Y!?K-"@3E34&;7/R$,82@V(0AMQ*
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M?/#6/>'U#WCQ@QX'N,':HC_MR7SP_CZ?+TTWA]0]X@QX'N\6BV I;A]N2_\
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MP<M# #F2>W^D'DUT+W<S^.9+_P#,:.>)[S$X?[RN^#R:Z%[N9]?]N9+O]?\
MJC3$KUCWF&'^\KO@\FNA!W'F0]/]N9+O]?\ JC3$KB>\Q& ',D]O]( X:Z$'
M<>9#T])F2#KZ_P#5&IQ*.:E'M/C# .)]WA"^390Q[SS7=M_;J2[O5_JCNU&)
M7K&V5S:&[3T^[PA/)JH70>:9W#J ^S,ET'UA_3'34XU^LK[1\8G#TJ[_ .D
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MFQ(6QHA(.U#MRIF3<1SPAOI*]B[/FJ0)2)8 FS$+ "DVW2U)<*LM6,)!P,
M;E(CEKJ%A*KD%02$FV96 ; 9$"Y-R,@#$FYWCY?0K6WR04")DFD:TS M"Q3*
MR]K9&SC$5C-77PW.,[#M*ZSM*J?C,$H8 $J"K(A@7\;*IKDR^3LN:L#>%&$2
MRM12R&F J&[+LH@ DFX&9#$$6\H6%)YHPJ4$BS,1J19L\OS!CVJ\;UJKSZPH
M7:AUN%90<CE*NEE$;(Z6:J3F-JTQMBRSGG8\S6(E(V120YP*=RB^1./1NJF
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MEF-G$9#4%E@?HI"ATDI<,!9_G+*$]8XHLF1<)5II;)C/))[=CRWV6V0L:VB
M?8VDH.<(SC%%W<>LN=HA(E,5@#2600657 5$@-OKLIV;23EE*)*9>"IER99
M(3,2L%SA(#D?W2W$C*,!G3 D'&23**B^84&+ 6 USN>H0ZSCCW<0\ED"$F*6
M@@_JK9N: 1&5#FFTU)F,@U)F1DD/&6;.*;FDDWCX54VB[-),Y#D.?8P8U<FT
M+4@XRH$D%TNXPJ+(!=U$ L'N_0T$52W 8 ,"X(YI/'C>[@6'!XV*R<:\K62M
MV[BOT64<1T(-AG'</>$W47.LPMI:N6)H3L6Q1F[&43&>N(P 4.B4Z#83"=8B
M@:4KD_+5.(&\2%%D8Y824NDJ>8'.$<TAR07;+*,AJ%,?1)#D@.S C(W<DEM1
MQCQV+CJD( E]:_8S?+S.-"-PN#-1XJFA&JV>X,*Y0G!7!T2%,VG(]T:POC&$
M@,6)$ $P"YYR9T<GY4Z;(2)H2B<>8<*0I24R\2^:-4FP N!%5U*@X(+W%BP>
M[.;$<'9B;6L8]<-QC9(M;90*UB-@X?1.-;3DJ::N;&4QWS"L66UULC&L"P(\
M3?+V56L%>Q(N%P\7(Z*W=@"A=QUIO)ZEDU,Q*II+S)<E#(S7-2%(Q LP+F^N
M>9M9%2HD!@'227.02><Q'.+ L.EQI$EL!9I0SO69J[Q$6+.IELTE"U>2,J<Q
MYYI"B1C)2@(*)D!!N::3DFC,I!."[1FB[*?E6  Y.U-GIHIDM+C&E(QI '-*
M@0U@"0Q!![\[YQ-*@H,XN >+:^\AM+P_E/$?LS5<-^GM-<=/_IM]KRM1I_M&
M-^5G_N)_&)H%[A_RC_YYM:L9XMJ (B&Q3#T[P$0#O'U>G_HU56+]'\OSB;:O
MW/\ F(M\I_<&^<.J_6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,'*?W!OG#I]9\
MX86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,'*?W!OG#I]9
M\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,'*?W!OG#I]
M9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,72\X% .7;
MO[QW'O'UCJ'7T]P\(B*MS^H/Y_AT=?3W?TA%HP'$PCR"/Q&$ [O1L/\ ,=3]
M9\M$VU)[G_,13RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,'*?W!OG
M#I]9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,'*;W!O
MG#I]9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUGSAA;B>X>,'*?W!
MOG#I]9\X86XGN'C!N8/[W_S@TY_SAA;B>X>,'*8?[PP^G[H?S:AE\!W)A;B>
M[_J@Y3^X-\X=3]9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.H9? =R8
M6XGN'C!RF]P;YPZGZSYPPMQ/</&#E/[@WSAT9?#H_1RX0MQ/</&#E/[@WSAU
M#+X#]V%N)[AXPG(;_!C\HZGZSYPPMQ/</&#D'_!C\HZ?6?.&%N)[AXP<@_X,
M?2/>/>/01_"'0=/K/G#"W$]P\8.0W^#'Y1T^L^<,+<3W#QA>4_N#?.'3ZSYP
MPMQ/</&#E/[@WSAT^L^<,+<3W#Q@Y3^X-\X=/K/G#"W$]P\8.4_N#?.'3ZSY
MPPMQ/</&#E/[@WSAT^L^<,+<3W#Q@Y3^X-\X=/K/G#"W$]P\8.4_N#?.'3ZS
MYPPMQ/</&#E/[@WSAT^L^<,+<3W#QB_N?U!_/\.H=?3W?TB(-S^H/Y_AT=?3
MW?TA%CE/[@WSA_3J?K/G#$VXGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GUG
MSAA;B>X>,'*?W!OG#I]9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.GU
MGSAA;B>X>,'*?W!OG#I]9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.G
MUGSAA;B>X>,'*?W!OG#I]9\X86XGN'C!RG]P;YPZ?6?.&%N)[AXP<I_<&^<.
MGUGSAA;B>X>,'*?W!OG#I]9\X86XGN'C"@!MPW(;O])AV_#U[M!C</\ E"W$
M]P\8N#S!]P!-^4>HF[A_1Z_X=6YW "_3ET?/8(J;@]1B'V39J'CK/*-I0[@W
MC*2)#I$C73M)4@MD4SD."29RB4Y41*8IN\H[#T$=="FJ5R""DA*@1A.1!!=)
M?-B6XZMQ&I,02<*@X/069R+Z<>L-H3#%1D#A*$2>-XBDP,6E()E;O0CZ2DV(
M\;MEB.B(N!18%%1(KE--4B)Q,0JI"*%+SD 0Z)VO7DI)GW27!Q$$$ALQUFXX
MQC\F0S,XMQ?UAKT/;0 OE'J%EB$7<N]]J\5X[.IG3G784\ <2J:AB'43DUO$
M0,\[4Z29C@H)RG,1,R@&$H;/.]<P3OR0GT4E9(%ADQM:W?UP-,DXN:YM9C<C
MG#/IOJ'$>ET&*WQ7!'M?8NB.COE')'-6.L1=22;%:R*JH*,S]H9\U*5NX,?<
MRZ)2I*B8A2@$>=ZQ+$$CT0"%MD'2,PS9C@]N,5\F3GA.N8N,5K,";EPP;*X$
M6H]'$\6GV<;6X^/2,D[1,BSJ@MRF1?)-V\@10J3,G,5Z#5N5T A]O!LEVH'
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M=%CV*PSV40W]I\-V,$L=:$3]IA!2BECJE74.Q+XCL@<ZI2*BJ0""*I2G$><
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M]%()4<\S<LSQ5:Y:E *O=QF&NPL,P-<QEQC< ,0!(402 R@>8 B4#& !#J4
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MG$%4GI<=%AUL",N/7894I+M5B'424;*D(8Q5#IJ(F*!B?=D.(#]KY1 1$1]
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M,.^91,CDJO*%*?:>S/(%HFE"E8:D;Y*S+//FK*7IU)6B:2,IA(P LD'5Y-4
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M%!,W+IR=J[%1Y*JJ5+5+3M&:H)"02)6%3 NV1(S<#,'*+KEK <!5DWQ/GEQ
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MK]S&#N  3P #9_.N?7#DB._=ORCU#?X?6/<8?WQ?-'T:UB3J7L.C3P/3UF#
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M3%"E7L?;&R JCJ7FH6A"U3$!0EJ2IE()-DD FV9#Y J:+2JB60W][*Q*3A<
M:^B=,KZ"'C3S%B)PSF7S?*>.UF=88I2EB=)7:MJM:_&.)!]&)2,XM[*![%,G
M+MB\9@_?"1/V18O8\!YTC@7D#9.T$+\GET\UR3; L*) Q$7&)\RP!+ O8&,I
MGRQ:S9:-<I;HS(?K!SM&@WWBEP3CF&QS9)S(M8<5[*EUAJ+3)V%G(64@Y.6E
M53)#('FR2GL.VAH7Q1RZEY8SWQ!F5,Q"F._58L'NY3\G=H3TSTIIYA52RS-6
M"A8*4Y)Q)9PM5\*2'4Q86)AY0@._%A<<0#I<#5G9P\9Z$SE2'D)?K):).(Q_
M 8_OLQ0I2<N%KI;.#<OX1*.*,@:29V*09123LTD0J<=8U(NPLSH"$A%,/'8\
M5, V-72IH "EKJ):9H"4*60@DX2  2 K3FG$ <+AS 5"",V )2[]#D#LT#'C
MI&X361Z5 T*3R@\LT*K0HJ#=61S:&,@R?0RL.R;JN%'S9XW<^*NFRA45#)G;
M&$IMR]=AWUKRJ:M77RME*IU>4SF2$X5)4"K($&X%QPSR(C*A2-WF[#TG=NWH
M9M7R>&OH/$OCG)QJ@\J+@CRL7/';C([.T+SE5;-8^*;N6J"[":BPGAF6,DS%
MV OA)'.8R.,@=D]E&S@@)&Z,SD_M/9\V:F>DA$B8)+%*RZCD$DBX.A8..E@<
M$NHEE9R;/,6N7<'(%K\6L.#@1.8,2SU=EK9 Y-Q[-5> 4,6=LL3<ZU)0,,H3
MJ8DK+-)1XQCSD!,XG*\5:"0$QW)WAKGC9-<*]!\GFNQPI*5XRPNR6<L[FV1O
ME&;?27LO3UN^^%NC._:T9"(R9C:>C8>8A,@TF:B;%)!#P$K$6JOR#"<E3E%0
ML5#O&DHLWDI+D 3%81PN'*A0YA;%VZ4F[/KDU""J0M/-.($*3S;AV(!PWS<#
ML,-[*N H$N=1GIH[LSC3.SQ1*9/QK Q#^?G,@46&@8J2-#2DU*VV CHF-EB'
M*!HR0DW;LK-C(@8Y2&CE56SP#&*4Z0[@ R:#:14TNB4Y3BR4Y2SE3-<#CE%-
M_+XFYZ.ECGU]/1G&VL)%C+,6LE$OFDE&O42.V3Y@X1?,GC54 ,FY;.T%C(N6
MRA3 9-1MS$$H@/4-:ZI4]#^42E!2;,Z@01=RY!]WY1D&%5PQ?7/2W5E\F/5\
M'H]7YOX.FM=R,BT6A=Q#N$0TSN<^,(34N>)A!W=0[_7HYXGOA!J'/&$'7T#M
MWAU[NOK^#H&_Q:LA\26U4#T.XN?'.'9&,GH"$M4-*URQQ;";@)IFM'RD1+-R
MNXV08N4C(N6CMJHFH1PV72.=-9$R:A3D,8@$,([#,FMG4M2%!2@2M+-8@OID
MQ<'H?LB"S@,"_0"S.S_DXXZ1I6-L.8KQ TE&6+Z#5J*TEUV[F30K,.RB0D'#
M9(R;560!J@F*IVB(G01[40, G 2E*(CK=K]I3JH2TK4M3*;GJQ!(40%!CD3T
M-<#2))>X ?5@ ,]&;(&')W'IU'IW?!\7JUH.>)B&' =T)HYXGO,&' <,M.$&
MH<N[WXZQ/1IP^>H0:ESQ/?"#4:OKQU[X,!D(-2YXF^?3$$ Y@'K@T<\3WF)8
M<(-1!@<Q!N(]X[ZESQ/?$,. [A!J')S+Q+ 9!H-(0:@Y=J?Q$0<NU/XB%+WA
M\8?PZS#^TI^M'_J5%5Y#K_(Q[.%3_61>O]^_,/\ ZZ2&NKMW_M5/_P#CZ'_V
M$QCI_07_ .+,_P#48TC+'^RFH/\ \W_)/_M&Q;J]/_\ 0Y__ .3D_P#L&,4[
M_M$K_P -7_K1&UCW_@+_  !KB+_M)G^U_P J8VU^@.K_ )C":K$P:0@TA!I"
M#52P)5\_.4(-9$3I*TLIRJ]V +9\1Q_*#Y],&^_IW]7Q:A6%^9Z.D#;Y\8-1
M"#2$&D(-(0:0@TA!I"#2$&D(-(0:0@TA!I"#5ANW'U(4K53W)ZOR8O (6<B;
MY6'^)^3$!.*K$%_LN7L1Y:KV+(//56I=5O=7FL43LY%0)0E+0#$L=;&)[(S=
M5QRLT2;KQS@CKQ=Z5FL8S59900;&]=LBLD291EKJ549<$+2DJ( S2 @A5]7+
M'O$:=1(65*.'%:X+ =H?3.SZ.S&(=PG![G?&TC@ZQRF(JEF]M1L096JTO275
MKAF32NR60+*ZE8.N5Q:PLDHV1:5EDY+'"JHW8%%L9<S-8.4C9;U-/M^AF2:V
MF1M%5.)U733U+2E:E+$A&%>((=@K7$=+N<]+R59<X7!=@2V%RP)))-N@9LS7
M?9*5PCYQQG;<'V)'&].N\A!\+M^Q;+.9.3AG,51;Q*NIB7K;>31D4FDE8JPT
M1>H5,RL.3QT8T7"1&[5J D7PG;-#-E5%.FL4B6:^GFLZR5H0D!2N;Z"EEYC$
M6(!-R\2*28+!CF22$V=WL7!PV%\].EFE^"OBFLE6RD1W064!+W/AD^QHE&$G
ML:0T26]-;HUE_$X:*Q]7ZU%0]1,T470A#NUY*4%ND*\NOVZIV>L]1MW9XD(E
M)J@M**HK05(G%8EE$U Q*65E2R5)N"D:82+F@I)@42PN+W2WI(R%F=*;VL6;
MHD!EK@PR-<V/&/)-:57Y"VY00X>D,32KJ1B/9 OV/XZC$L14)%QRJ5\[21AY
MCE,IV!70 '8'6 VVN33[<IDKI92:@B7(WWE 1B8OB*0H '&Q8@:&[!XSFFF$
MDL?[,)3J0393$]#7UU+ /@%.#?."G$7*34Q&62P5>:XA*1FN+O43<\90;"NP
M]>C8;EK\F:3QY/Y46=PXQ:T&W@8&>9U&P0+U9K(&B%WKYPKT)W*#9:=FT\L5
MH1,\F53JIE4\U6*82V)*TS1)93#GF69P'^L9DG&BD6%K8#TR<6I["YM?FDD.
M,E,XQD#PBYSC+%B.M.<.U5V;%O&I.9WF\_C;8!6>OM#L<S<9DF\5XFC.*/TD
M)V.B;$PEUDCD=UV"5C#33<X&CI&W-GTM/M">C:"T^<*";3&E,M24(7.2G4#
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BA*OJD8"6EE26+.+OQC)+2I(.-6,E2E.S,%$ELSD[/'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g729258g75w00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g75w00.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1>&4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %VJ^690X0DE-! 0      $X< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  (<G(U,# T.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N
M7W9E<G-I;VXX0DE-!"4      !#0" Z1)*A8J _Z6[7 HF_].$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0'7BK!         *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  0.__C4  @ !.$))300F       .             #^
M   X0DE- _(       H  /_______P  .$))300-       $    >#A"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8
M 0"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M     3A"24T#^       <   _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H   X0DE-! @
M     !     !   "0    D      .$))300>       $     #A"24T$&@
M   #-0    8              Y0   B@          $
M         0             (H    Y0                      0
M                   0     0       &YU;&P    "    !F)O=6YD<T]B
M:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L
M;VYG          !"=&]M;&]N9P   Y0     4F=H=&QO;F<   B@    !G-L
M:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)
M1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M#$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M"D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   .4     %)G:'1L;VYG   (H     -U<FQ415A4     0
M &YU;&Q415A4     0       $US9V5415A4     0      !F%L=%1A9U1%
M6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%
M6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX
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MKH:YA!8[>S;3_(L9[_\ 2HN'T_/HR#;D=2MRZRV!2]D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MTM,E-$)B=*&QP1<V0T1356.#U>$W9')VA):RL[2WU/_:  P# 0 "$0,1 #\
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M/.>3+:0HM,KE2F7LY$LMQD5\7%%KLAZ!7@U3A%2NHK;:94R)6:Z"!1G5I^;
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M)GQB+;%A$PBT2?%Z3TW?H;X3BXM.YR_R!/Q(/-23%]DEB*.KP.@;?OVP]6%
MT!%BGZ*0 Z)DRQ-ZPQYS!N&.C-"9#+KDMDBWMX1,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7S$?%GZ[[O\
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MJV&T;.?J=MW(F^0B3_)2]',,&,S@_"\R74KTFY!0(@#CD*Y[R%SV!BVXCO\
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ME:XPJ\H;A2-\PL(MJL5 4+$N.I AZ'3Q\DO'Z17JXC2FQ4J,2ML.--U)-:%
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M)"9CZE:#+U7>&"-V$VDL3E7G+O#4B>QS*"N7DSS_ -6J?MGK_6'[0 @<@-T
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M3AU:QVKH\!-BD*/NU.^/$3AC8REE:U=K'0QZWHD@-S8<0EVD^)TPTXH*)BC
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MB81,(F$3")A$PB81,(F$7CYZ_P .O_GA%YPB81-[UK^O>M?]>$7CYZ_PZ_\
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M* O#7*"K0BB:L+MT(RAM5;KN<+;@TCR>H&$7;T]YE2WX[C?+]-]]Z%_/Y_\
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MZ^[QO<?/XN3!#:X#<>>1.AG>L1(%9I)B9RWLHT$0JM7%$05SKMTWT>UTUXA
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M+K2->]1N8VW/0OUI:ERL;QSUIQX2Q&S;LQ-W9V(78@(7<3!Q,"(29W]QR1S
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M:P4HC ) :T0?$!W'/R(T4>E@>N*\/91$T1>>5>4^'\C\[C_+0*F03O&HX$Z
M,UBZ,Q;.U<X]LGD2UQEW1,Z-^)8)EN+ERI,_^1#3$ER"#[;<1B)IF,T12%T;
MCG)^P4I7..J\VI'1Z"M4!S=.NU8#V:N:=%_+]->0(+PY<%M^!\M:AOMLI=C:
M^>F5HUO?S(L1C>7/-L.YU'HT/@G'HE]H%?B5.CW&+SBHQ[)4:R/ANCAX&N%V
M1")H<4/'O/0($* \PQ!A//18J&6'G6UD675/CO*:%S][E%)YU3*ES*1'/1'J
M!7:X*$5!R):7YLJQQ55Z#%8%[C')!(@\48_&^W,<F25/I7]U?S(NG7Y\X6Y
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M0T*TEQV1,EK0I$:+':=D/J2K3;:MZWA%=.G^MO-70>KO<.I/:J!:.L,T>O\
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M(ALD5C<(F$3")A$PBB+T"#N-FX1V>M\[>(1[]8.5= !TM\1-@C2S%J+54K
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M35J,/2"3:=29++K,=S?VV$813EA$PBU ?$3_ /QM?!F__=_V#_Z4^MX1;?\
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MY]=;\V\RY$!$'V_/?4^4V$[SZJ![#8IMSCU)@=50G5KBU8@1L^LR,;B"/U&
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3,(F$3")A$PB81,(F$3")A%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g729258g78q60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g78q60.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1DR4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &1:^9"(X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8,%(         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]       $@ U     0 M
M    !@       3A"24T#]P      '   ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #-0    8              2H   )6          $
M                         0             "5@   2H
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   2H     4F=H=&QO
M;F<   )6    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   $J     %)G:'1L;VYG   "5@    -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_
M\        #A"24T$$0       0$ .$))3004       $     CA"24T$#
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M 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MJ8W^9_I/Z1,.G?6&BK$9CY3+;*<7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1SJB)1$P@&U?S3: &\*PU\B8.;FT6XV$PG#<3"2S-,@$$VX;[D I0+N(B7E
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MEV3('*'*78A0Y2B(&$"[!T 3  [!L&X /> 4[-,   (0 +[4.4NP>;H&VP=
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ML)A'J)AZB/7>M0(0#"<"% PAL)@* &$-]]A$ WVWZ[;[;]:U$ 'H( (=^P@
M]?3UK02$$-A*40VVV$H"&WHZAW4Y"<PFY"\P@!1-RAS"4!W !';<0 >H ([
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M.4P<A>I=N78>G4.7R=AZ;=.Z@(HAN ))@ @ " $*&X    #L'4  I0 ![@
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M2E*4I2E>7YJL1AE#%-_8YDSR:;&][6F;9<&AKBE[2E0)*L%VP"PN>!$)>!<
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M;A\]?Y3[ G[6\%]CY#U^S6GL8O#Y'?\ E/L"AM_:W@OL?(>OV?K4]C%X?/\
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M-->/>(J$)XD<R1Q+RF.)  *GLI2E*4I2E*Z[L3@V6%,Q"G ODF4 1(4=PZF
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M:G=O'21E3"1'Y&F0W<F0NVP% *^-7X<>A8"%VTEX.*7F#FVL"" ! 1_^L$$
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M,"B8E*41!0@@!@I2\4% N(^+]FW)N:=5V6=&6.\C</9V_P %94QR_8Q)L@9
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M84Y!.<H 8H894[AYPYMA#O 1 -ZG5]5$O]O:_P#*D_\ F5SH/T%!,!EVP;
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M]+/([B#:J(N0EED7DR^91<.T>S+I,AD$W4H[:W*@L_62(4R3=:0-XT"(B!2
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MX\ ?K>HDGM^/^BK;M*4I2E==V.S=4=MP NXE 0*)@ 0W*!A51 HF#H!C*D*
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MPEQG>[_4\C^'=B]_NU;@I2E*5L'VY/>/_DU4G\&^_/5\7/O_ #RK_P"_D_\
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M%11%=LX3,51NLDH=)8ABG3.<H@(P8914(;P@G2L)3D, Z*LY!N4Q1#?QZ,,
M;@(]1*(&V\X" ]VU3O4I593PK\Y?8J'7EE$1U'XB$ Y@VV*TO@!Z[_T(CL(
M&P;AN/6I_=.@@& <&]0Z8FQV&^X=X6I&@(>_[E>W5MYR?HB_K@_?K3M$]]NT
M)OL [<Q=]C"8"CW]QA*8 'N$2F .X=M]*54H\+'.0=/.B  , _RZ=N]P@.V]
MDWJ4-]N[<P"4N_>)1 -Q :MKTI2JCO -$ XGG&+W$ #XIB0>CKZZ''I\_P"\
M.W2K<5*5MYR#OL8H\NW-Y0=-^H;]>FX=0W[Z<Q1[C%^N'[];JV*?*U/H#?<C
M523P3W8,?\1L!'J.L 0V'OW]1)0=@]W;<=O, ;U;>I6AC%* F,(%* ;B8P@
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M!,QV&X.]&-[GF31:I+:&-=S<8S;%:HR8H^JH+G 5F(G(7F5 0"7.E*4I7 Y
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M;[AM7.4Y#[<ARFW*4P<I@-N4V_*8-A'<IMAY1[AV'8:W4I2E:"(!L B "([
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MT;E73YNT2[>88I"<@$.D8QB@;<I052$P].T)OS!5_B]4>8&+?AM\/S4^]?\
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).7U*E*4I2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g729258g82d54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g82d54.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[29<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )D"^EY(X0DE-! 0      %8< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   H  ' )0  AR<C,U.3 Y,QP"!0 E36EC<F]S;V9T(%=O<F0@+2!0;&EA
M;G1?0VQE86Y?=F5R<VEO;CA"24T$)0      $*FW39GJ9M=6D N^.BH=GL<X
M0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0    !0
M<W138F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT
M4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $       ]P
M<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M      IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O
M;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I
M;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M     %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB
M;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!O
MX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M      !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M          !2<VQT56YT1B-0>&Q :HM#H         IV96-T;W)$871A8F]O
M; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L
M=                %1O<"!5;G1&(U)L=                %-C;"!5;G1&
M(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P
M4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M#6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M #A"24T#[0      $ .__C4  @ " [_^-0 "  (X0DE-!"8       X
M        /X   #A"24T$#0      !    '@X0DE-!!D       0    >.$))
M30/S       )           ! #A"24TG$       "@ !          (X0DE-
M _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $
M,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M '   /____________________________\#Z     #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z   .$))300(       0     0   D
M  )      #A"24T$'@      !      X0DE-!!H      S4    &
M      (Y   %.P         !                          $
M    !3L   (Y                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   (Y     %)G:'1L;VYG   %.P    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   ".0    !2
M9VAT;&]N9P  !3L    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !     XX0DE-! P     &\L    !    H    $0   '@  !_@
M&Z\ &  !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="
M(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M     0  ]M8  0    #3+4A0("
M                             !%C<')T   !4    #-D97-C   !A
M &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "
M+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D
M   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T
M96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/
M" QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@
M0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M     !)S4D="($E%0S8Q.38V+3(N,0
M                                    6%E:(        /-1  $    !
M%LQ865H@                     %A96B        !OH@  ./4   .06%E:
M(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P
M.B\O=W=W+FEE8RYC:
M                  !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                    9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@
M0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                     '9I97<      !.D_@ 47RX $,\4  /MS  $$PL
M UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                 H\    "<VEG(     !#4E0@8W5R=@        0
M!0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R
M '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$ Q@#+ -  U0#; .
MY0#K /  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%% 4P!4@%9 6 !9P%N
M 74!? &# 8L!D@&: :$!J0&Q ;D!P0') =$!V0'A >D!\@'Z @,"# (4 AT"
M)@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+! LL"U0+@ NL"]0,
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M?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'80
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MP)5MWC40]NQ8ZC4*P&J(>)9NR&>N F,3"3=K64]!EC;:1 X+I&RK''?'2'S
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ML>QA:K'44P0[(74JLIE:6-7$%QO,C(-I*E:G/&&>,GP:R+Z2DHRR)-);VL2
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MSY6_A*/=_P";/K;^*>P?TF<_2/L>^%_?C7/PJ7YIGE!Q5/W_ *EB/_./W?\
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M)RJ1R[#,X$P==C"KU@!0Z6/-WOT.9!L3'!Q"MRP*CK]CY>)0T-R[#[6Q//\
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MJ;4*_=*W=Z#--U\KW$:W@$L>RA&:>P01&"5RK#AFO0T" 18Q"MQP@X9#>R'
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MC;C^E.;^2N/'=V@>^%+Z-J_DX]0-+_<#\X_\N/@\7DZ/W&W']*<W\E<>.[M
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M?1M7\G'J!I?VN?G'_EQ\'B\G1^XVX_I3F_DKCQW=H'OA2'_1M7_2N/4#2_W
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MV-;-87^^]?=C?4BUO7V7M:[ZQ1UJ&"]H.5G9[MT3,K$*S;Y6,N":P]>@,MF
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MO:/T"<?7!^QOX+=IWT3PI_/''B"XH]]M"^<O_F./=];>^8/6WT[VC] G!_\
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MQ\X+ /+- I4C=9%,\$D/-$SJK@%V5#S9AFAN_M1VK<[O (O.OT8]L"N@^O\
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MCSQ68AHK$63%S4Q$.UZM%W'66!T-EZ(TR1*EQF$+9?2G(ST6/]W:=;5H=JW
M'!/#%/AC4^'M4FD.L:FU?6J\VLZ1J2TX7X:X.UMK->+1]/AEIP1:EKFO:2$:
MI:'/HK)&IGBFA-O#&NZUJ-O4Z5^HL<=*!VI3"I<KM,T>IZK21))+<[I,\E6I
M2MDK)$2+?/\ L;HPQJ0*I6" )B$;5*BRR\.,76B5/PN(.>?;1(D)<)5,(PTI
MMM2U)<\^7A.4^*X_F>*N>7L:#V;>K?"M/3^)9+VG:CKU"EK\JW;\3T-*L6J\
M5FVEC5N"] K5FBBDE<3,;R)R<TL 0%CUXKFO^#:C)8T]8IH*4\M)6AK\LUI(
MV:*)EJZS?D<,P *A8>8'R9 =@9L):>US%&SYL<^05'C*F,9*?5$ D08;K<*Z
MR82Y#3(Y*I*Y*ZX)2F"S(:E/(+^<SG'BRK/WS5^PKLIH:)?U).(-4$4$6HQ>
MJYXJX;LZ=1N0:'QKJ%!+,,.F*;4MN[PSIE==/AMPW'360(]V6)I/GU/CKBJ>
MS6@ETRNLLRP2"H-*U..Q.C3</Q6$B=[)$0B&JWN:Q)$\,;4MG[Q(!&U!K5,/
M5HHL]+Q%,-'X;,923$. \H>D ?GHC,L2V7D945+PH CV9E*T17ID9S*,X;6U
M)^6=FG!_9]Q+P5JTW$5SP3B*+B80U"NNT=/L3:=5X2U_5J>G5JMRM,BG7M=I
M4M$\/99%@L6ZI524,%GU?$NK:_INK4UTV S47TVP\H-&>S'X4=1TVL99)()$
M(%.E/9O" %3,E>5 =V5XMW70 6!LJ0,@Q0-LKT%N-(GMGR<!AO$)4>)(*C89
M!PB''/FF7G7@T28E>&?9:/9B6F&D+<9Z7"/"O#NF=KNKZ-IM'AGCSA+2DCGO
MGB75=.IH=.:"O-J&EZ9J%C5M$TRUK\=F9]%J:E&_0-B!]3ACKU!))'5J>IZA
M9X3CN6)=1T?5)WFAK-IE2R[-.)9X:5N:LM:]:BH2(D5^>$J9!"3 7D9@K\M&
MK=>F(U7$>$AX^#1"UBK2N#.3*D18.23:8!63)3,DJ;<&C42"$27G+<5]B,XM
M3:XSKB5=BGPAPKJ([&:%G1-!IIQ#Z]=*XTL:;>2U8HU(M4L>INOVK,=^S)#8
MTS1ZXU>O:;I5)ZL$A:(U)Y(SHRZKJD!XPG6]>D\ I:+=T86*S0QS6EJ2-:IQ
M0M7B#K:M&&M/!Y<T<DRJ"LJH1 3J4H=<0A>'$(<6E#F,>&%I2K.$KQCU^&%8
MQA6,>/R\_+4BJLCJC<Z*[*K[;<ZAB%;;T<PV.WQY]+0LR(S+RLRJ64^=6(!*
MG[A[OO9Z^89ECC&.,8XQCC&.,8XQCC&.,9:KI4[LG&SBK%.PZYJC&)Z]H)(*
M<Q78UF6,2L(NKYQC/]WK[_M9]4$>)YL!564J385(+?4MB3_6_P"H,G[6).$M
M3CX@ ;LLB5UX/EU0S#5%U46AX;#H&X)?AI5-HW.N17CU7D72R7.K*OY6[<TX
M574:S4SMQ0Q4ZFM4)X.U3ID1/?V\U_<1B'E]L:OOX0.45CG:]S^@.? ,<8QQ
MC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8S3*4YSA64XRI/CA*LXQG*<
M*\/.QC/QX\?#'CX?'X8\?BXQFO&,B79^J*]LEP-+)V:WU(N"AGAXHQ3['@)+
M3 LS8Y@["F0ID8B#-Q9T8;'8]CFQ))F&K/LZ B(49B3HU$M>.5B7YB'KS59$
MYCR2UIW@DFB=?,.9J\6TJ<D\8#+%*BRR![HYWC4*H4A;$%I"PW*3UX[$43@@
M@, EJ8-&X>*3<%T;D7:MDKR=773S\^T+5[I\1JN8JHP?6+A(8AA N=.OZ)=B
M"\DX964EI[7+C(W$>9*F0XI&,HV/C0RA0_)+V2IUA9$C,PM1VX9EWV#0WIM/
MGLQ=P!Y'DTRH%))>*-##$R0[(N<=N:)JLB$"6G+!8AE8<[BQ6>X\4S%RP+!K
MUDNNPBE9@\L;R*'S?+Z":16W:69MCW))%7?6JM;7< O;%E@U.V1DTF/KIFY'
MZD+='5B5?8M,@CPK5BP):2M(T<0DP9!6#&G-V2DRRSS,=GGM)>.VW+%<66*Q
M)9KHP*P26+$*SSK&!"TCRE(T$T@:F!V@\'Z8&]>+P=&8;N]<&7IPRMW-(L2R
MO'&Y/6Z?*KRN%7:1].Z571MC[6VM99M5FVJ_IJ].&3*]@NE:Z#KYHE$J,BT2
MC)"5@KL0M"(M(N)D;&'0I[0:NP68[D<+$<Q$9"0RKR(DUJY+>M&/?I&0Q15H
M$A5MY%CB@A#D.[>WV)R!WEY,9#S/#LS/%5JI5KM+L9N5G>Q.9"NT8YIY&"!%
M'D1JS'RA'%$]KZ":$.[!A[A?L^S*Y9:Y?;%L]HB'O<:(+AFSEBJEU,H(M$Q)
M%F4%:LE*"&F8A9V3[7(BI&QY# &(.%P:HHUA"\C, B.B<Q#<HDCUB$,&(WYT
MBU_5HUD)+L+C-(9'B@>*^2Q),6#*I,B11,%4@NB> $1^2=RKOIE%BH[E: B(
M1I/86;DJ_P!!M% A=)'"BVSO:RH#M51&T,; G1$6I.E;6[<=4D[0\(CP%D2=
M1ERI(Z(3'K&/E@+[8T^LNW"&N0KUVBEC=8T4P212Q1\I"16(=,31C.%W#=27
M3XHJ\ZL3%*L49>+= <PL3R6NLTI#/8%A990.61XK-MK[Q<R[!8TN2368.15:
M&2>;INJR,N23MSK#J#<EG7<+DL_%LS(.KA(!4!:98*4$G46\1]D42SB<QU9Q
M#M5/M\?)0//RE<9UN1+'EX!0;(7$Y2J!)'EC=HYGEJ3"12"R/22["@56#1E)
MJ^HW*MJ*1'CL5YWAD0J3O)FD,20MLT*+:4QL/)=;G@C2<Q&S[J]&M-"ZLKQ2
MQ"1&!R*+[T!T)?(5 'E+!M "YKJ3>#H E4MBRJI8G[MLBUQ+W:]C3["+BL'5
MW4G<X,:Q)(P)\ >S(;6-9%I R)(E[$01K-%-%S1/7JBG6$3,JUX"X>54&Y+-
M9._A+RF1Y^>4R%FGF:27L2212PR\DB6+*7)PZ*3-/# ]:NS$ %16A=DKB/D$
M0"!>Z*()SX[HSJ>",LXR1;-OGL6N]:TV21(6G8#]E+XN6JQ8\-7B^29@=+E$
M_9@T7!8-0["LU!EKC,2XL:#-C1I#.8CC 0*BKR6K=O=-T+/>IMI]A&*D>0U1
MFC0KRS1N>NDHL@3#'K/S2OW$RU(J;;]X$4%CPJ(@;[<RS^40P:)U)ADC>$F,
MZZPZ):+U!)&O4I=\C10V1A 0))W*::$#K<$H#FJP=^8A$F)"7+<'URMNI0'Y
M2Y 9N'&C$70KI]M1=8( CH.XM&\:R )U(C-5KT[$L;\O=+8@K11NY#<B&6&N
M(8)YHI,6D+2&1@#S2B21#N4E"7)KT,4@)W,4%F=Y8U!4M(L<TS2SQ1RK$0WR
M677L<VB.NY[S)06P:Z^V/)7\:Y$1 Q54TZ'X>QJK%D9D#0K45$%U3^?"3"C2
M)292L.X=B*)(7CDCY@T4U:PF[NP$U-]$>NY#,0Q1N'-&W#;A_ EYPW5GZNQ)
M>M2B0/*=I4L1R  +S1VFU=IT\D @2-KNJDE2&7PKR"HAK]*S&C=1YI5QW5L4
M[*IA&];-MPU@Q+IB2V&&*W1PL>NTF)8G#),C)E7AROHC3+@2:;',SICT1AN(
MY$'0I+N4*B.N%"JLD\TEJR4WZ1G8+"T5<MO(M2)HI)(X7=@ENS?F 66U89Z)
MR7EC.\A2"NM>OU=@YB,DDYED50L8FE,JQN\:J'@KU$.Z01)'8G$N(J4N"F5'
M5.:8;E.0\/-YE-Q7G'&F9*X^%>F0PZZR\VV\I&&UN-.(2K*FU8QEL=B=NX$
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M .B,GQ_<1^\VC?'WW?SC'N"=O_/;KOZ)[%];_6C\?C_-C[O(^M[]E'PPX_\
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M_K,[<_,OY?CX]?/ WPTX7^F:?Y>/5_2?MM?P)?R,>^*=6OLEOOT,[<_V4O\
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M,]--;:ATE3Q%G4*3C&O-+ZP O&KS<S+04;,,.!Q+]@*/RL"JZ%BR)$PU93L
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MI-"BK5G++*S;Q<Q !'I2S$,]JD+=J2NPW:3PEZ[0U"P>/DC$+2.9$D=_"8E
MB5 \^SN:]_C>RNJ*1GM#L*!7;QI3;^V#H*IZ^TH9 Q3&J"^A14$+7&IVHS%X
M*U\\U=K7(*1OJD=L1*1/@H $ F(D>,K'F0/J#!9.G3$-Q8RIED:&?4KCFKRQ
M*DCF.C'%3B:,=9I$\(82.YBS:$"R5.JNRR26ZU&)@ZQQH9-,L%K+M*70%KL
MLD,RPI$Y@WY5$N1]'[OV%O?M]M82O;//Z*3KSJS'E4?9-1LFD;MKXUM#>.XM
M0E;?6M<["UK7KQ9LE2@ZGOSQ]A("F)0,;,*5<C*<;BA2%-1G:W;@E8.DUW1H
M*KH5E>LU^I>"1211D%(9+%=7L/)O8K*W69'KJ!%A;01PUFC #PTM9LV% \BP
MM":D[NDQWYY(Z\KK L?ZGE8,A>.8EI-\9\IZ. 6J\5\GI@BT)J4Z',9ND6WS
MC-1<HK]BV_5G[A8CU?H!<17X[!G4,Z,Z0&D+1KP-FPBV[ILJH2AMEC!<H)&F
M2JY01K/)361WD58X4U"F;=)A*Y6-FEV,7/(8:<K!7H7;T<]1K,SUQ#),@DZ@
MBCF8<D<C2.]6>O!:01('?>(V%<HO/91586JM5XYDBSBT^4&9$[+(:^KFGC%H
M'+V $TN"O.+2@/6U;EL4VIP@]<M,V35Y< #5B*;:Q-@VD#/NQB3#&37DTC'L
MP"DRB9YG$:(%>::_%5+EE$@TN2VFH&0&,O%+"E&U-'&L<R2)&JR212R+$<)$
MBA0R-*'$<=*298T+L@U&"&:F5V94>-S8KQ2NSQ&-Y2Z++!'),N 5CL=N>%UT
MZ[ME[),1?=U]OM@=>;3M$O%K)N3KL%!VWND=#GI3" B:7,/N"Z&&UW3YD^M,
M G;$<"SIE=(KS@%/QK@V/42!9747M(%V6?95GFEKZ&VHR11"3K1+9GEC>21
M)$2O#<,(]K1EE@J)J\TB#FJ6NC#$"3$GA&JP4D=F0)(:T,4Y>(LJRNYK1V.G
MSRLN0PNW&R=6[-VCIFPCD;LBT?;-3US6]E&2X:C&);MQZZW#>+(>W(J%&=JI
M$\!GTIX*9E@*]6$0P5MKA10.9,AR62=;VC'2DM/$#T)M;B+(Q5)QI.GPZHK*
M&#%2\#V:DS!BJVZJE8^2>05MF&@LTR1+.1S5-,M2!U5VA&H:Q)HY39.G]@_@
MUJ)&7>2M,^\Y=$$N*O\ E2X+#,><G1I*<+(Z8QM(7)%;"'$''#,&C:GO]@II
M-]NL(KPAP4&VM$;:6]8GKDZ\$?EE=> @QVK%3/1:$K=GI@ANG=BK1R_8K+"_
M$5#AMY]B>]H[FH1RF.!K$0BBL0R68KT,E1:/!_[&V<%ITDZBA3O#,NEZIJR1
M'<C<25M+D"O)T69YX72*2N3./.S]Z]DE7]_CV-6P0U6T]H/L':;<_6-HX9V.
MQ<-0;$M&O9SU#)&M;NU=R"N'75G1!(Y#:E1Y,O&9-?G9&H@E=96WKS66^P2/
M1I$ )&QOV]:IVA+Y.Y2"71IVC:/=Y(A&>F)+#)4VHJ8$VGQL1SV;=F,\ZEXS
M#'2TF]5W0,C%YH]6@65"ZK')U$$K1Q++-QU#\HW?T -5-WG3=:GE]A6^96Y$
MZJ;0)%&Z[ /[QM>D=;3SL#&LD2X&)MAKBV;"5L>*D+)0691:@*MYR-8:/5H,
MC2"+D5%EGTFMJ'>W+ MNSH&I<0"KOY3I$(-.9 3U)U-A D=F*":SFO)72(%R
M[]-;QJ%0O4F,,5S2Z$M@;"-)'ZFHB3D')$HB9))87EKI)M=9]_-C2B6E;#L[
M6H@,,VAI;2-NNQ^%N'.-8T9&W7=F+IQT57W]2YLSQ8[9*R,HQMHI8(D2$3L5
M4@"DEVH\\U+EI=C+%'&7;DC*%]^H]GU)L:E%7C$8?9+*UK"!@LD@FB15C8O&
MLMT],J"5:,+'?U"#8;\PKP:K0TUW>5^59#6\+AF7R(4:$SR22(=TAM)K;MT>
MOFZD:<D::)CE!_1@=AVT5999D-0MA.:\"[+:KTOVUIM6:*@)8,] '#ST6:S8
MGSZ\LR*)#!XS8,9Q$2&<[JL2>$)!(2#U[%.PE:W7Y5WY'60S20,IE2:M7:=V
M@ZL$<NA(!&L?E!I'$+O$ >:."RLSUYBWV)5EC5902I269(X^MR3-%E-KM=T&
M=Q=:51.PS K6)/K[MV]6.D*'4C%=F6"DW'6006;F'9U5?N4%# R]%79L:%;8
M(MQP<*?7%;0R001J@):?4Q(Q*5ZNER0J=E6-[<^IQS,2 "VZU(N4.Q"DN?,0
M!G(O-%16*,F::W:B8IS.\JI#7:*,(2PWYY6 Z:JS;A23W9!!KRA+P%6P<RM.
MHGLT8!O,TRL)LB++</9T?NNBZE(-Q\3Z>*CQH9X?L$/;X<Y,N8Y%Q$* _8,Q
M34(M/RKOUHZ[E3&\^H:-IQC/>8YM5UW4] =W/DGIU;6G&3?EYYHI@"D,B%&W
M'H<KR*DP<1PV+!;D*\T46@TM?BY1S$<\M>V8'4L$CEB#+)-')S)NQG?^80OU
M0URC1Q=ZQ'-BVO69AD9=8<Y+)FI[>MFI2A.F^GK8_-N  EU&9=+I-+_45*K%
M1GCIC$ W)5-C0HKR"Q)710P$T*RR'E)-<!=3%B64;!?!(I]*FJ).KF66S9T^
M(UHS;')KVJS5(VDD9>]DZ2@[F5)DTN6N.[=ELRPZO6F:'E:*.*"_)X2R509>
MQSEF:V.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQC
MC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&8I=[S4=;5<G=;V?'U:
MIA?862Y\LZI@:-00(1!<5Z=(PA:8T94Z;&9=E.X3'C)<R_*=9CMNNHV*M2S>
ML1U:<$EFS,6$4$2EY9&56<JB#O=N520J@LQ&R@D@&N::*O$\T\L<,,:\TDLK
MK''&H\[.[$*BCTLQ"@=Y('?F3LO,R66I$=UI^.^TV\P^RXEUEYEU.%M.M.HR
MI#C3B%)6VXA2DK2K"DYSC.,\H(()!!!!(((V(([B"#W@@]Q!\V69[.1C'&,<
M8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,J_ONU];:=<M-E
MMVU1P]>TV Q^LF0@Z8V#M>PC+3$$/DBZ:I)H=(M\L$=6 @SIRVTK@SIH<>5?
M82_"@$%,XQD"PQC5A8%64LZ(_-X)U(TF!D VZ74DA$B%MN9HBP^P.6\LK5WW
M.]831%U++R";O,+,A.^^X/(Y78," >;NR+:Y Z05J^ZE56M*5ROVC9LDMC5=
MK9T.< PB1'95:MUTN,%FR3JE C S1P)3#<Z]!C3XPPY*]@QST%4Z:PWP(XXW
M%)1$IFJ6JPA5HS')0IQ069H@5)CDJE;JF) S).XL")7,$Y3*4SA&LRO)LER"
M5RSMU8[TCM4ADDC/MD=A3 8P[JK1((U+*)(P\]QNKO7"' JHN)HK5$8=1F'X
M=-A,42N,QJQ!E3/;"2.",MCTH'#'YV,2W1D;#<!;^,.*CY5C&>9\S!Q)N>H(
MUBY]SS&-%941F\[*BNZH&)"AF"[;G*@[!&C#$1M*TY0=R]9P \H4=RR. .=E
MV+<J\Q.PVSF?JS6Q*]@=I$*)5INQJH'F@*U>) . ]:0(,CC/M@'$&5,9GP!T
M[Q_\+A17FV).4HRZVO+:/-Q79'ED3R9)D6.9U[GE1&+HDA'>ZJQ+*K$@,20-
MS@LS1I$23%&YDCC)\A)"O(75?L5;E\GF !Y>[?;.#8H^J=FE*GMTOK$/+N F
M+ANLV&[T-H=?*]&BD'WV(Z,'QK)\/B.0PZ1@L.X9S'?>P0B);<?],K(+TG,B
M;*\L<;,Z$<Q5XB55RO>'2.>2)T;9X^>:%P-Y%)^8<T+$,L<DB;!@\99)-F:-
M@2K1L\:NCJ2D@6.12=D;,!$=<>K]E=.$T==-<Q9;9VPAB,@YJ40&FD93%A*$
MBTR(HD%COD@9<Z5,&(I2)ET4;47(D(SLELG)<?Q1!&L+(%0!(A&J[ QK3EE2
MNA4;&,0LK/ C <L9CD0!#&<SF>1W<2R&5BO,S<_4#>%PP22>6"0S,@B2< EE
MEC:*3:2-P,E.]8NN-GM%BN]BT/J$W<K<$@5NT6LGKRJ3+'8  IV \+$ES3XI
M9&?!&NBA;D!B1(6B&L:/5'PWF%&RU 55Y^4!>I*D\G+W<\\;!TF;;SR(P#*Y
M\H-W[[]^8]1_)',=DC:)-SORQ.K(T8W\R,C,A7[$J2NVQVSWD=7Z6#U*#IC]
M:*O9UY?3)MN54 >O6)%(05EMDKB5-V9@6,R(!ND24)^8U8BOL5V5:9 ]$>:H
MU+A^?+HLX$3]ZPQ<\0+%!$L4B*JP,"ICE5Y@\21%9 !+*@ CD990NG5F5@&<
MA)MRI>82ITF$B-N9XS&@CEYPZ=/E23R2 <!U5T\T[JO7[NI&P[%ZUA"MR[K4
MJML84"MDBJ&WGI<AR2FR3A?U0V>8RN:ZQ!/W*>>M; [S1LFP38J4H2E6.>*O
M%/%'*:T;Q([QIN4>)X&YD55B$CPRSQS2)&CV5GE:P99999),><B262,F/K,C
MR(C'D,B2+*K+N2RJLD<4D<?,8X7C3H+&B1HG.S>GW5,A%=@S>N.DY$)Z*Q!<
MAKUK4L150XX<97V8OL= I+28Z 04.']$E&$*&BAL-:5,08J&A +!SWNK%E;T
MJQL06B0?03:K5['=_N\,<OV:ALRZLFP7G;E4; ;G8#IV(=@/\C:LQ?Y.>5/L
M78'D4=5NM38^P"4:'U,D;:XMEA6>#BB5WV/8(=SG1"=NB&6\P,I)1K,1@0YQ
MUB7Z5HK+CMOS4O.8RK,,B/'TF56CY8D,; %"D$L\\"%3W%89[5F6-2-DDGF=
M0#(Y,]>;G1^K)SQERC\[<R&2*.!RIWW4O###$Q&V\<4:'R8U \8'5/K,+R'R
M-T%J&#FOYB9"*BZ^K#*A2H%GS=8*X*D#<9CKA6Y2[-#6WG"HIQU\DQEN6^\Z
MO+^^#?WRA54^D*D4L"#[BPS2PJ/1%(\0\ABIPYF,9B+,8V+DH6/*3)T2Y(WV
MW8UX&;W6BC;[)%(WD#K)UU%R7)@W1VJH,ET&%K+CL:B5QK*Z[7#[-KKP/*4#
M\(]J@=FCL'Q$#S?8PTPTV1AMLRDX=Q" 1D% $*M4=2ODE7HJJ4G!&Q#5%15K
ML.^$* A49+22.27=W++<1N9B>9-0+F\K;GO6X9'-D'NGYCU.;?,FQI?4&-GY
MW9C5] QN%07ZG%;2Q406-@9 ^9AOVGS;<0?;W(_T6,,XBYG>BPQC#'F^B_8<
M(!%UC&.GX1R]?D\GK<G*5ZNVW/RE$(YM]BB'^\7;%F9UC5B66+<1!N\1@DDA
M-_L02S'8;=[,?[X[\3?NO6B]IGXEJV3J/7UZLL$,[789VTU80:*1@#\KV;("
M,S9\5Y] J1+PF3('X7[%D/)0X\TM2$93"HBN\BJH>01B1@!S.(BQB#G^^$9=
MRF^_*7;;;F.\EW9%C9F,:%RB$GE0R!1(5'F!<(H8CO8*H/F&<>=ZQ]=+.]8)
M-BT9J<W)M:9Z++(*4*M39!QLK( S"C9-Y\<MV6V2EU:MRB"'5*1-D Q;TG#K
MD-A2(6-$)*HJDR),2H )E2T]Y)"1WETNR/;5CWK9=IQM*2V2)) 20[ E#&3N
M=^FU<4V3?S\K5 *S#S&N!"=XP%R$#/D^^N)3;E9VO'U]0AKU9GH/P03&L-</
M9&V]-EG6^3=*K:G:S]6-0M!VQ3<$;06#&T2#;\.$_P"=#FMNS'IA!AE$J,5*
M+$L)7>-X4A:1TA1T*DU>I+-(]9PT4C3V5D#Q3R1F9Y9+$4<4C<R*92ZO[8LO
M52.)F97Y@)5CAACCE3E9$AA"[&-&%X>997D5;JW+2-!:Z-;1V'()QJJ!D!HD
MU8<7),D5R3QF"!&,1A\3&7GEODB,5I6?%*&D+4ZXM+:%9QU-%T:_K^IU=(TR
M)9KUQG6"-Y$B5C'&\K[R2,J+LD;'O/?ML,YNKZMI^A:;<U?5; JZ=0A,]NPR
M22"*($*6*1*\C=[ ;(C,2>X92#WVCJ5^V[4^C4O_ %_/HA[$^T(?X*K?2-/T
MG;]USYIX]NRSX4Q?1^J?F6/?:.I7[9M3Z-2_]=QXE.T+WIK_ $A4_CZNV3X]
M>RSX4P_P#5/S+'OM'4K]MVI]&I?^OX\2?:%[U5_I&G_K<CQ[=E?PIB^C]5_,
ML>^T=2OVW:GT:E_Z_CQ*=H7O57\^W[84_3\?5V_V@8\>W99\*8OX!JGYECWV
MCJ5^V[4^C4O_ %_'B4[0O>JM](T^\=_F]M].W=CQ[=EGPIB^C]4_,L>^T=2O
MVW:GT:E_Z[CQ*=H7O57'W=0J?%W?LGIW_$=_-CQ[=EGPIA_@&J?'_P#HOB_K
MN,>^T=2OVW:GT:E_Z[CQ*=H7O57/_2%3T=Q'[+Y_N8\>W99\*8?X!JGYECWV
MCJ5^V;4^C4O_ %W'B3[0N[]:J_?_ ,(5.[[OMF/'MV6?"F'^ :I^98]]HZE?
MMFU/HU+_ -=QXE.T+WJK_<]4*F_W?V3Y?<].3X]>RSX4P_P#5/S+_;Z,>^T=
M2OVW:GT:E_Z[CQ*=H7O57/W-0J>G;S>V?UV.1X]NRSX4Q?P#5/S+'OM'4K]L
MVI]&I?\ KN/$IVA>]5?Z0J'?Y)/X]LGQZ]EA_P!],/\  -4'\=+'OM'4K]LV
MI]&I?^NX\2G:%OMZDU_I"GM^.7(\>W99\*8?X!JGYECWVCJ5^V;4^C4O_7<>
M)/M"]ZJ_TA4/N^Y(?<_BQX]NRP_[Z8?X!J@_CI8]]HZE?MFU/HU+_P!=R?$G
MVA>]5;Z1I_ZS'CV[*_A3%]'ZK^98]]HZE?MNU/HU+_UW(\2G:%[U5Q]W4*?^
MM^+S^;'CV[+/A3#_  #5/S+'OM'4K]MVI]&I?^NX\2?:%[U5_3_A"IZ/1^R?
MQ]Q]W'CV[+/A3%_ -4_,O]GIQ[[1U*_;=J?1J7_KN/$IVA#_  57^D*A_BD_
MKMCQ[=EA_P!],/WZ&J#^.ECWVCJ5^V;4^C4O\G_];CQ)]H7O57^D:?\ K?Z^
MC?'CV[*_A3%]'ZK^98]]HZE?MFU/HU+_ -=QXE.T'O/J57V&WGU"IZ?^<]'I
MR?'KV6?"F'^ :I^98]]HZE?MFU/HU+_UW'B3[0O>JOZ?\(5/1_SGI]&1X]NR
MSX4P_P  U3\RQ[[1U*_;=J?1J7_K^/$GVA>]5?T?X1I^G_G?Q>?W-\>/;LL^
M%,7T?JGYECWVCJ5^V;4^C4O_ %W(\2G:%[U5_I"GL/ND2]V/'MV6?"F'^ :I
M^98]]HZE?MFU/HU+_P!=R3V)]H0_P57]S]L:G^F0?T[C;?'CV[+/A3%]'ZIZ
M?_@O]GI\QQ[[3U*S_P#M-J?6_P 6I?\ KN/$GVA ;^I5?T_X1I]VW_._Q8\>
MW96?]],7N?M?JH_CI?C\V/?:.I7[;M3Z-2_]=R/$IVA=WZU5^_S?KA4_UFWX
M]\GQZ]EGPIA_@&J?F6/?:.I7[9M3Z-2_]=R?$IVA;G]:JYV_X0J?ZS(\>W99
M\*8?X!JGYECWVCJ5^V[4^C4O_7<>)/M"]Z:_I_PC3]'_ #N/'MV6?"F+Z/U3
M\RQ[[1U*_;=J?1J7_KN3XD^T+WJK?<]4:G^LV_'CQ[=EGPIB^C]4_,L>^T=2
MOVS:GT:E_P"NY'B4[0N_]:J_=_PA4[_N>V?TY/CU[+/A3#_ -4_,L>^T]2O'
MP])M3Z_^+4O_ %W'B3[0O>JN/NZC3_UO]?ER/'MV5_"F+W?VOU7\R_%Y\>^T
M=2OVS:GT:E_Z[@]B?:$/\$U_I&G_ *W^/'CV[+/A3%]'ZI^98]]IZD_MNU/H
MU+_U_'B3[0O>JOZ?\(4_1_SOR8\>W99\*8OH_5/S+'OM'4K]MVI]&I?^NX\2
M?:%W_K57[O\ A&G_ *W;'CV[+/A3%]'ZI^98]]HZE?MNU/HU+_U_'B4[0O>F
MOW_\(T_];CQ[=EGPIB^C]4_,L>^T=2OVS:GT:E_Z[CQ)]H7O57^D*G^B3^OH
MW[MWCV[+/A3%]'ZI^996?N)Y1/KMN[KALO5E%3L.1:K=$ 0Q+1:BD!0[*X=M
M %)2Y9"2_P"@C,M084EU2U^/G>9AM*5+6E.?5<$=D_&VB\6:#JNH:=#%2HWX
MK%F1+M:1DC4,"51'+,02.Y03Z<\KQSVR]F^K\&\4:7I_$<5B]J&@ZI3IP"CJ
M2&:S8J2Q0QAI*:HI=W5>9V5!ON6 !R'>@G?I[3;PK2^YRJW]1R'6H=0M\YQ;
MCVKG7E80T**/JRI3NO'%J3['><_94I2EX\]=64AFN^N[6NR8:@+'$_#%<"^
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MDCYHV'))$/!B&$G,G.\;F-^F1FW#9%>%BB++-X52F6.1?:RE:4R-NX/,"=P
M%Y21S#G7??*W;JZE[KNO8B;?!M3JMWU2%)::(C*M=-P60=(MKM4U3OW65R7[
M 15CD"G//XVS4R6<CE98/8J!*3*:BDY41R10\<LLDTCA(V>YK<L/(6WC35M)
MTZE$0XY)(DJV]/><)&[LJ6=X>62(ARS1QTZ=1.=A7AH"1V"%I&HZC-99&38)
M,UBM/TVD?E!:/IR QL.7#*[T@['! -JCF#HZ\V<.8ZP2!!FQ[=O3L;;M,UU5
M]?!]\Z\/XD#Y[U+&;+DTQQUE]48ZR<7B+BS,M1RI_P!/L+NDAE(ZP;5;<TT3
MA5>U3FTN&G#8E9=HQ9BU*/U96HH\&BE1:T3K"Q1:%8J)460QAZ,*0E1S+5LQ
MW[5EHD#J6:$T+ THV1RV)(P;#*)E1C(6M>I_9"AWW4%CD6J"9KM=A[ A6NLE
M]B'3D(%3;%;=OVBH:^J$Q^N#+.T4I B[4FCPK6Y:'J^;$U5#I:EL2*]4R#-4
M<31];JLUII-*AJ22O(Z2S6JU4PQR*ZE2@DDFF6:283O,B+<]HOO(SVRS1MR=
M!%K!-1DGCC$41CCK3/7,BL-FYSM7::*).FL$MAZY:Q5 5?/HQUD[-Z2N$0QM
MLH&=K[]!,!S0V1L@OLPLS9$DJS$K:JX?EUFK$U!\  $MXS!NDBX/#R4UIZIE
M139:QP7;ZP$59XI#SR-#I^[@=YM154@NN&'(G0D:)7C!@6="W3,K0HB+%^5;
M-LSPJ8XVFN'D/*%%>2S-/64C8N)D67ED*RF%@K'IB0]1X C=+>W"=K[7M,P'
M72%2M>[AEMJ\$GV(NIAR+KQ1WL9)LXAX<4K<F,+^J #M&D")5?A/2!KR 3Z7
MI&6QH_TVE'!)ZGI6EV,P&O$GG9MEU#3+E;3(NK^R.*-PZ;9=F\\M,3KSS .V
M[8MUI9Y'2-@G+I73;8+[=3LZ,UR81*0D1L05M4553SQVQ7;DBED6/AMY=7NY
M<?7=$O#LYJ/8]2=?Z?4K%+INY=@/VHY/&Z4VUKZ^QV9HW6UJ/RI$FX6JG6\<
M5KHR&DG&&2"=H#%3H &Y&VKCCPRW9C"B*W8=.60;1+%;ITXX390<R&"KJ22-
M:60^")5/A*" RW9,U:73%2E7E.SU )FV!9B:]X3RB*4LCO)8TY&CA4*+$E@B
M O(H@C/#YZQ]MML:"TLW4J^*!VRN;^NNP;6Z/[1;,C42;1#@^,X*":\2JAUR
M0U583DJ.%&TXA6H<  FL$&V29'!R8[(R1.E;TU_*:"O'&MKK<LDD@]<FG:O,
M@4EUGA>A5LZ?7$IB:*K8A@(DCA$\^,-E16U))%5Y+0Y*_3'26-DTBWIZR,R@
M2Q2K=>*Y8"]3K6!-8\EF6"/?774_9@!L+06O9-9>D1PEQV'99X\/O38]7S&U
MZ;[(2]A4\!JNRB]3E@<BUPM?P6Z5>J[(L-=RSK^8NJ)G00I6%885=,,+M-IG
M9EJ4-$BF"[/(;-2/4X)3R2-&+.G".Q7FN[L#:>K5$BB6NBRV7G@-2450D;V;
M>I,@,?(.2:/3&#R.I=8[4EB.T*1*$U_";+H6$\BKWXX^+'JSCU8]6<^.<>KX
MLY\<^.<?7\<^/U^6YI9KQC'&,<8QQC'&,<8QQC'&,Z]/*D_Y&&P?]*]2?]:M
M/_MZN?2NR'^Z'P[_ ):U_P!PM?U_BSYIVQ_W,>,_=]1Y-O-Y^M#MY_Z_>SYA
M/7G/J\<Y\/#X_'&?K^/AX>&/7]W&<^/KSS]Y$=VY'G^\1W';;<D;_<[P/,._
MN_F,1W;D>?[Q'<=MMR1O]SO \P[^Y]SUY^YCXLX]6?Y?E]7CX_'Z_BR]!W&W
MGW)[]CYOO^?N^+XMM\O0=QMY]R>_8^;[_G[OB^+;=\>,_>^/\/R^&/7ZL>K'
MR8QXXQS%@ >_?8'Y>[<[;GS>Z>\DG;,6 ![]]@?E[MSMN?-[I[R2=LT\?7X_
M']_.?'U?%GQ\<>O\/^SF6W][YN[OV^/8';N/QD[ >CO&^9;?WOF[N_;X]@=N
MX_&3L!Z.\;XS]?'RX\<^&?\ M^YX_<Y \VVWFW]!V]/N[>Z=_N;>D9 \VVWF
MW]!V]/N[>Z=_N;>D9K^]G/R^KZWWOY?CQGX_'QX/>>[NW\QW]T=W<>\>G;;S
M>YY\'O/=W;^8[^Z.[N/>/3MMYO<\^,>&/7G'C^#U>KP^7^?U?<^7QX/I[R/E
MW[^;T'Y!W^C?!]/>1\N_?S>@_(._T;X\<?@^7&/5\OUL>&/O?'GU8\?#C8_?
M'F.^^_=Z=P3Y]^[N'?W8V/WQYCOOOW>G<$^??N[AW]V:9_#XY^/U_7]>/P_<
MS]_@?=&P\W=L//L3_2#YS\?>'W1L/-W;#S[$_=^,=VY^,Y<ZH:YTLWI[6USO
M8LPV=O);8=<'H$3+,N<:/ULG36:QB+&0RJNQ!$ALZ3CV=V22@D%1V8K]=:<F
MLRD*^:7]<XG?B;7=+TJ:L:FDP:)<D-B*B(J]2_!J+7^HY;PN2PAJPO16.&:(
M.76Z1"R'/K6G</\ !T7!O#^NZY#<%O6;?%&GH*MC4C/8O:5)I/J2L$,8.G15
MY#=GCU5K$]>0P=*33@;$<O-[#NHM9UC<^YZE;Z[;J[JP!9R]%K%_BK,36Z87
M8,L!@AXVN0A46R#/228LZQCL+8E^P7E/B%L.(8A25/B'6[_"W#>I4+NGW->N
MTJ^J6]'D2M%ZIP&O)9M4ZJQGJTIBL;PTY]G03+RV%<%Y8YU+A7AG2N-.+=&U
M+3]5J<+:7?LZ/5UN&6Y,=&LM<@I4M1MO)S0:A"KV$L7ZCM$S5^9ZAC;IPS1-
M8*%#I^R2XLI6P-D#5@H.K<^L5[9,&-)L)J2&'L)E5^3(E3[21#SC4]LC'GC
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M/3*22QE$\HAJ0A.K \?0MO39.PL4B?JO+(:E)C;/JFP;20I=>NU:FOWUF(,
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MQ^UK#<BOQ*@"".Y###7CL*%V <15JP;T2/6KRR!I8(G09I6)9G8DUI:9)/\
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M>?R_X+_)\O.U['^;X9:5_ V^3^SOZ/CSXE[**MW_ /D'J_=_PBGG]S]KO/\
MB^/SX]]G:^UIO_A]?V\_E_P7Y/L?IOAGI/\  V[_ /Z[^/;!^JBK#?\ \@]7
M/N?KDG?[O^#?./<_ES7WV=K[6J__ ,>9_-?\'_9Z^1['^;X9:5_ S^?8]E%6
M^ >K_22>[_FWO]WY/-OW,>5F;SCQQUIV!G[QOQ_FJ_A^_G_9Q['^;X9:5_!#
M\G]G8/U45?NVX"U@[_\ "*_(?UM[MLU]]E1]K1L#^//_ /E_[?O^$^Q^E^&>
MD_P-OS[)]E#7^ >L?2*_HW^O?CWV5'VM&P/X[^_]:K_V^7D'ZG^4?[\])W]
M\$;O_P#KOX_Y,>RAK_ /6/I%?T;GM8\JZ[)7EN-UAV/(<PG*LML%G'EX1C.,
M97E#=54KS<95C&5>'AC.<8SX>./'!^P,QKS2<;:/&OFYGJ\@)/H!:\ 3]_8^
M@Y9']4XDI*P]GVN3,%YBD5TRN!N 3RQZ8QV!(!.VP)'?WYNO?3R?VJ>T_P"&
M2_S2YAXB(]M_7YH/S2;^Y[X?'EWLE)?WM>)/N=6;]$[?CS7WT\E]JIM+'_YR
M9];_ $1_!_V>OCQ$)\.]"\V_=%&?XM1\_P#7SY'LE)?WM>)?GIOT3W_U]/=G
MC[Z@1^U5VEC_ /.R_P TOP_>^[ZN1XB$^'6A_,I_IU#!^J4E_>UXE^>F_1./
M?42/VJFTOX;*_-+D^(B/X=Z%Z?\ <4]'_2'?OZ-L>R4E_>UXD^]--][_  1Z
M?]./?4"/VJNTOX;+_-+CQ$1_#O0OF4_2'\?W\>R4E_>UXD\Y ]NF[]A_FCW1
MM^/.OWO[Y22]VN%U=35M7;>U.H)VPU6=-O0[&9$YNX*%@QB=0W\P0XK,Z.=]
M(WE<"2J;%?\ 8V/2P'_-QYGH>'NQ^GI#ZHUCB31-7%[2+>GQ**T,G@,MD(5U
M \]J;E%;D[V41L.?ND7T]_0.VZ7B5M57UE:YI7J-I%O7-[$LA\.\",7Z@BYJ
M$&T\_5/(1U/L3[6V_=V!>^H$?M5=I?PV7Z_N_P""7//'L(C^'>A?,KW?]89P
M/9*R]W_FUXD^/VZ;N_ZI^[\F/?42/VJNTOX;+_-+^W[_ !XB(_AWH7S*?Z-0
M_K]S8X]DI+^]KQ+\[-^B?O=WI!Q[Z@1\/'W*NTOO>S9?C_T2_GX\1"?#O0OF
M4_2'?][?(/U2LO[VO$GFW/MTPV^72?=_VYKCRJ!+/_T5-I?PV7_LJ6>/$1'M
M_;WH7W.BN_\ XAMD^R4E_>VXD/Q=:;?_ ,)V]/NX]]/)?:J;3_ADO\TN1XB8
MCO\ ^7F@_-)W_<'JAO\ U[\>R4E_>UXE^>F[_P#JG^/-??3R7VJFT_X9+_-'
MDCL(C/\ O\T'W=NDF_H]S4.[S^G;'LE)?WM>)?B]MF_1&P^7'OIY+[53:?\
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M_2.[_P XNA?)3_&/5;?\67>R+UG]ZKB;Y-1_06^/?/[QC_Z'NU/^?.9_FH?
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M^QVW_:(^?S^?[^;SWS^[_:>[3_Y\[^8?\OQ>K/K^+QP/8AI(_P#6)H)_@?\
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M;>G9*&_X]8_KZ>[OR?9&<3[?W*-</_O:O_-_W>[\?FS7WS_9WJ_\CO87K_\
MM=F]7W_[W_'B/T#<_P#G&TGT^>/3_-Z/-K'N>GS9 ^J+XH/_ *I];'=_CZM\
MG[0?Q[9I[Z!L[[3O87\+LOZ/^/$?H.^WC&TGS?N=#],;^;_;DGZHOB??^Y1K
M>WN\^K>?W/[7S\N/?0-G?:=["_A=E_1_QXC] W.W:-I.VWGZ=#XM]_UXWV\_
MH]S'LB^*-_[D^M_=ZFK?S?W_ !9#?8GRF.V"F@MUC8/6#9-,FD-4W^'$M\8I
M:(4BKR9-6*,L6!B6W28+D5T.XM,]#Z)L1;*H^'$R6,IPZG=T[L6T"I?I6CQY
MI-X5K=><TNC1;POHRI)X-R^JLG-U]A'MTWWYQY#;\IWM,[?N)-3U'3].E[,=
M9IQW[M6G);9]5Y:J6IT@:RW/H42<L"OU6YY(UY5/,Z#OSL-\FO8CMLZ&=5+)
M9S)6PV QIZL32QLX0EE2Y28XT[AV80(SW7IDR2[YN,N/R'7'5^KSEJ^/GQ/C
MN"&MQAQ#!7BCA@BU*=8XH46.)%\DA41 %51N=@H 'N9^EZ;,]6!FWYC&-RQW
M)VW&Y/Q[;Y=_GD\V<<8QQC'&,<8QQC'&,^"SRL7<[MG0^_W8.HT'LEO"BU(&
M9K,0/5J?M"Z5RO"V?J)K;SR8 <49BP(GLF2X]+D>@81Z:2^\^OSG'%JS^R>R
MKA/A?4^!-$NZCP]HMZW,=0ZMJWIM.Q/)R:E;C3GEEA9VY4147=CRJH7S#/#:
MWJ%VOJ$L4-F6.,)&0JML 2H).VWI/?G75[OSO)]N!V6^FS8GYP\^B>L3@KX)
M<.?0VG_F^<GU7U+[=G_#_HR1&>TOE(WZ&O9C?9_LQ]1:/9:\%7-^VQF0[&@%
M!X.:2C!7;BV>EAHALL.#2#448\(9+RFQBYJ9N%,)YK\-]G,>H+I;<-\-^'/T
M]H5T*HX5I8YIHHY)4J-#%++#7GEBBED262*&21$*(6S92WK<D#V4LV#"A?=S
M(%WZ8C:0H&V,@B$L75Z?-T^K$'Y3+'S83GO3WUPOT>>V':3#GID1_1YW#LS"
M_3N80IMCS<G?.],XEQ"D-^'GKPM&4ISA6/'?]9/ Q\W"W#)[B?VHTWS#?<_L
M'F&QW/F&QW\QRHZCK \]BV.\#O#>=N7E'V/G;F78>GF7;SC,((]INV)B[5W9
M93?F]B6PZQ +UZJWF;L2[2K8"&D4JP="@[ Z464'Q)B'%^VD"%*::>2M7LEI
M6%9\=J/A;A.*K-1CT#0HZ5AHI[%1-/I+6F="!#-+ (A&[*0.F[*2"!RG?,#=
MU1G$AFM%T+1AB&W5MB63['[(#<E3W@;^;OR12/=7OJ,@"2,CMUV+<C&($@@S
MB'O>\3GX+48O/".L&HT2S//@I_LT>ZI XLW#FN0GX!%MA4$C!??T8^$.!999
MH5X4X?#P.B'GT.G&DADA2=6KR/65+,?3<!I(&D19%DB8B2-U6Y[>L1Q)*UF?
ME?J[@-N\?2DZ;B9-N:+ROL>< ,""I.<*[WT[S1W%,O\ ;CLPR\WG&%M/;FV*
MVXC/AA6,+0L_A2<YPK&?!6,>.,XS\7AR\<#\%, 5X5X<8'?8C2-/(]P[$0;>
MC8_<REM3U-#L]JPIV!V;R3L1N#L0#L1W@^D9Z_=\]X?MO>RGTU;#_.#D^L;@
MOX)\._0]#_49CZJZC]N3?A#^3/L)\@'NO:^Z^JEV*;=V#<-EG!6UCL*)8+U8
MBUJ.(@J$ '6X&"IJ5-FXA1W%NK8C>F] TMYY2$)4XO*OR=VTZ;I^D<8I4TNC
M4TZJ='HR^#TJ\56'J/+;5WZ<*HA=@BAFVW( !/<,]KH4LEBB)9W:21I9%+.0
M20H7;[P]&WNDYWO^8C_ZJ?\ ]./Z.?(]S[I^4YVMA[@^08\Q'_U4_P#Z<?T<
M;GW3\IQL/<'R#'FIQ\24X_!C^CC<GSDG[^-A[@^09KX8^MC]['(QL/<'R#.J
M+RSNU]@Z?Z*[+L^LK;8*-:52*[$B6>J%YP&P#4/V00AY8XN,?C3X3CK.7([B
MX[[:EL/.M*5E"E)S[SLRIU-0XYX?IWJU>Y4GL6%GK6HDG@F5:-IPLD4BLC@.
MJL RD!E!\X!'.U9WAH698F*2)&"K+Y)4\Z]X/I[O1Y_1L03GPZ^[[[Q_;?\
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M^@*SA*$Y4M6<8 Y_8I2G*E*SZDIQG.<XQXYYSCV+=G@[SI,X[P!OJFH ;D[
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M;L$!CU:XHLI4$.*LI.",B*DR CC\A<:$PPRJ0\XMY[*,N.+4M2LY_9F@=D'
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M?_B=8_Z2B/E_V?T\^B]DW]T+AK_E-K_P^WG*UO\ :RW[O37_ +:_)Z>_XL^
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M &<QZ).&9(N&Z>@QVJRM2L4)EF\#VKV8Z&HP7>E:JB;RA<2'I6BLNQ>1I "
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MTP&Y$D7/U>B1)TI>(H9228;8]NUI]A/&#+6U:'684I2MTV]HJ>JRRP[!E66
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M$0+]7K=6I2\K6M2EK5YRE*5G*E*4KQRI2E9SG*E9SG.<YSG.<YSG.<^//IH
M        [@ /, !Y@/1MYL\L69Y"[L6=W+.S$EF9FW9F)[R2222>\D[Y^HOU
M%_R6NN_^I?6WQ?Z(B?5\GQ?%S^;NO_M[K7^=M1_[Y-GU>O\ L,7^3C_^VN6)
MYR<NQQC'&,_.4\L7X>^/=F/#[(ZW_P!!JS_L\/\ OY^Z>QS^YWH'W=2_\5NY
M\YX@_;2;_B1?]@>YG65SZ?G%RX_72A.V?6&U; ,T@/W'::_=M0C@$,B/NTR.
MF!89%N3:(#ZJC8 &&(3[ T/F<1?DL.AV7<2T3X*7O2Y\AQ%?-74M&@?6)-)J
M68M5-N6-Z<9 KUDDKR<UN"<*RRDA %(D8B,H^X7.QI40ECU0BLEF2"C'+71H
MVE(L'4:$&R(FS2,:TUIQ$"Q81%PA$3$6BW#TDT-7;'6R%0NMJ=J&P[^5HE=<
M&E01RM#[+8JR8FZ^@0KPB#/"D*E&OXQ5"+619DE.DC\/V*5&"N0\1"7D=)XW
MX@FK6HK-*JUO3]/ENL]B.:I9M5J-FD+,\M)GA>&W8TRTVH15>E#$LJ+"LI#R
MK3ZT^C4-ELLTM=.;2EN00>VQ5);WJA!=BCE;K%H].NT51W9GD9)T A97J37.
MMZQ5*N1[Y9JP&LX\>'K[LR&R:LTN1)CDYX=MJ*1;@RZX%G)?;(E&IJP3GL)J
M.X/S&S*EI<RIYSZ34NV)=-K79:DKR6569:]=%26."=F>OU$LS1\LD==HO"5+
M\PFZ@1-ME'GYJJ16S4,R1M$(X[$DK%HEM(BBTJM"C$Q)/U$C90_,BA@S<V^=
MENI^M58DCZ/(W+UV8J+IRG$CXTC"GW HX2#E;7JT?579E$:N2;'9"PT3/LLZ
M^EP3X]%&J%J;MDROF#E2^I=_YKK'$EV.;4(](XA-CH6(*TD4L=.%(IXJ^KS7
M9/#_  5H*%-WCIUJ;68Y_#+M7P198XK9NYWJE.!X*DLU)%5A:=7CCDGFDBZ,
M:P!*I:/U0N<Z36EIPM"6A8R%EB,46=4=BALCK ='Q_8?H()DG#8]KIV28_T,
M6:^PW[!)*2A1&'YB$^Q9RD(S+8\R1E*<N>&/JM*5IJ=29^KSRUH)7ZT0@FYI
M(D=NK "1#+N3U(@2(WW0$@;YYV]&D-VW#'R".*U/'&(Y#-&$25U0)*0IE0*
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MQA"""H21E"D'O[@-N_O]W./Y?FOEHND?^6'U@_U[:O\ ^EXKGE>.?[3>*/\
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MB9\&9!6K*42XS\92L?&E+S:F\JQ]W&%>/&,^>"^_J>'K]=;K:KBJZ6J&]:;
M7L4J.DE*4A$TU/?(S/,\<_L&\R9+JD(Q^Q;3G"$X\U..?5*?;+QU0IU:-:[1
M6O3KPU8%;3:K,L->)88E9BA+L$106/>Q&YW.^_(DT/3I9'D>)B\C%V/.W>S'
M<GY<Q+X-SU^^S^V?QA)_IYL^/#M ^WZ'T94_(S#UOZ9^XM^&<?!NNOWV?6S^
M,)/]./7_ "<>/#M ^WJ'T74_(QZW],_<6^<;^O\ )C/ZFZZ_?9]:_P",)/\
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MCY/LC9?@?']/M^A<#A:/<GPZ7<[[D1*"=_/O[9OW^G<]^/@X'87'Q;4KV/\
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M;?X_N=Q^+-,_J<#L+\?ZZE=S_P FE?G'Q[(V7X'Q_3[?H;)]:Z#;EOS #_\
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+.,8XQCC&.,9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g729258g82l26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g82l26.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1:V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %IJ^5X8X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8"BT         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              /<   )=
M  $                          0             "70   /<
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   /<     4F=H
M=&QO;F<   )=    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   #W     %)G:'1L;VYG   "70    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      ,-@    $   "@    00   >   'G@   ,&@ 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 00"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M=%MI3E6-T%MFW^L[^] ZE=U-
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ ]P)< P$1  (1 0,1 ?_$ !X   $$ @,!              8 ! 4' P@"
M"0H!_\0 ;1   0,"! 0$ P0%!P0*"0T1 0(#$00A  4&,0<205$($V%Q(H&1
M%",RH0D5L<'1%A@S0E+A\!<D8O$E)B<W0U-7<I?5-3A&1UAWDM+3-#9C969S
M=H*%AY.BM;8H15569W6#A(:5EJ6FLM;R_\0 '0$  00# 0$
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MC<&\.2#_ #6067E "WIV"^4(9B34V<DU.KD(Q:B*T%%!XNO$VZVM2N.'$90
M!E6I<S)@6F0#/>\;SMBK/#>  S 8".0#RREGU L*.7C,* "23I_$1UI=JZ,4
M8/V/%KXE:CG2KC?Q)2=K:DS$BW8F_<B?61.+O(< \.XO+-BY8$("I 53J@<!
M40^9$(I="-0%7KT844[$)#9OQ5>*!3Y3_EWXE>2)!_VR9D2([CE@_6/GBWG\
M)^&)$/Y:1#[P25P*BH0Z56(YQB"7+'5"BI0!E%JI5XQYIXJ/$Y2,BL1QVXHG
ME)YT#4F904CM(N".T;[X8'AOPN53+2%-I6N+,*>3N(3VQJI (UUNXK HYXQ_
M$TL%QKCGQ, 3=0.JLS]9!!D @[W_ '8EX?A+P[B!LIAHFDCA*!4;1MMH>_,3
M *)F2@ )3R=M*VC.WXU_$HAHA7&WB-S" "=3YB2>ER4D#OO.XB8. ^"N S_Y
M/*8:W]V6JH14^@9PS0?F9FN?]$4 JS6=45=HDZ#QM^(V0IWCGQ%49CRUZES(
M3Z @ $28%A!Z6Q79OP!DT7+Y<!7'NRTV/Z*QV@_,S?8#=WZW%(+&?&AXAWFR
M1QIU\3 M_*7,R=MCRW!^NX]<:QFO V)ADI*@!-" 0+6^:&X2,!F%F+CR(*@V
MZ^B1D9\8/B&=Y.;C1Q$)))MJ?,]I[&"9]8&*?,>&)L-61!7E!U0[%JUO0M+D
MQY?( $L58*'1?(_6<1XJ_$(^@^7QKXBMJ-X_E-F1F;F1)VFUH[>E5B<-Q<!S
MEY9@"CRATZA^E[P[6Z=15O,?6H2&R_$]XE%$^3QSXCR2;'4V9F3TV@Q:W[\8
M2Y;+'^(!;@!@;A@*?8A"4"E2^B,;#H+E;CI"5_BI\4%&F/\ +=Q'@";ZFS._
MY7&Y_P ")DG#<K/1'%DN'%%!35*6C#$EYI5E5:M5/,"EHXZ#X^>)+6'$WAU3
M5'B-XS45&[K/3J,PREO5^:*RW-Z)[-:9M^BJVKBIHZMKG0XUMRDI-L-YGAN#
MAX&,1* 1(H)"$;@U##^8AX,)7%G":"P?UZ1Z7^-4IX0<2UHYD\NA=5J!YCS!
M2<EK(^(_%-MS!F^^*3AP_P 9Y'08^$$VYQ]$A9?XA]U:/$([7Y@)2NNK %$J
M ^T/$ &+$<_RM^S'K+*8>&<&4^SD_@D3W9?ZH.AWI_.AQ@>:9R 9YM50%@QJ
M-76ZQC:JLQ?<0G[95SS0/\X>(Y?_ *2Y]!>>F)9PI&7#D1*\HZATT7I#<DYN
MX%E*H$Z^:=H/<D<JT-N-_::MTD;?:7;$R9_$/7;Y;XJ\T95:64 '^K+1[(1:
MU8F32D<K\JRJ>C"[] 4W@IR&EKEU7GKJ:MMII1M]H>,7M;GZQ/:?2^*<F521
M+(5-Y?E0>D8@%2!97IMK3Y6M!TYF%8AL@5M4D-C?[0\)O;FE=Y]/3KAZ42S\
MONR^5-4W#];M!-AX4E5++YM>O?R@8KM:KR_F#F85!Z1]L> VBWQ$_6-OEB7@
MY,3O+(""*FQJZU 6@%:JL8^T TJRN0BHHMY,MH"<TXE5KH\JE=JB23?[8Z"2
M=B)7UB38F8%[8=P\E)(2>67H  "AN@)/S2IC),QC,5EJ 9F:U4#]"1I 14Y_
M6NK6Z_7U:'8,14/B!VGFO!]I^>)DTV6Y0!AR\P93*"XJI,HT_FR7.6X'G<0
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MT84U#*H(I$[1ZA-'"4H%]OIVDC;ZS)L<0,7+#$55N61^C*SVZ.D23B @$,4
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MMT\X^)4L.#XCRP9D];;=M[SZ],.2*O9_O7]8"BM2WV7@IHM1U67-@L["![V
MN>T3WWWQ'S&5EQWJJOO2E_Y1(DQYZ.2&5J-OJFZC2".DX@YBA0^TLEU$"TG8
M;"#;_6<4V+X>R^.72JT8%WUHWZP_)C8A-2]:%.Q6FU+;WOP.U+3YIQ8X;?&A
MM0UMII*F_,C\6:TO:=B8/[=IT/Q3X=P\#AN:Q0"DLI2W\*[#H'%:DK#LDY]K
M*7LY*N:ASY5\TCUF<9^97"7B@ /A.@=5S%XC)*T;[D1UQQWAS9[)C3,8(_\
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MCJ04)H01&\YKBXQ,J%" A*]@'0EE8@MI6.&LU/5*67IF0(/4[&?7J?[\>H/
M^+AX6'+@WE$O9@.CE%5UN@CQW^+N!CYDG%&!28TJTR,M%HW<JD#>5)^U.!DW
M7MU";6,Q>X(Z=-[8Z-CS^Q'ME#?#YTJ"RQYSPY#(3AXK*I4.=U5UZ"A6+FTU
MIUY2/.2USQUF8C:;?QM]1HW$N- JK!2I-1TNG=]%:'E4-0,J@59EH74$G6MR
M',&7J(*"HCRS:UC<$&?EUZ^\T>!Q7GF1QZ[+9.@70PXY#(64] *KOT[!1 ?5
MO></+_J[GKLH V@&W2_U!QLW#,X,Q-14"OLJ7N^O2(QVJ[:TKI41FRW+6JVJ
M9:;L21)[F=R+=??M,SB?F<V<O(27-1V51L6^:.8;=2BOJVC-JJ6ZHJWUI+2Z
MG"T D<H,3:9'R&PGYWZ2="XWQ7G! HI.K&GF48]54"+ 416 "CH'1"@<[T68
ML]K/Y+]A:F $P) .XCO;IT .QO?&CC,<]U<[6W#]:A:"'@A"K2P^C=5"L_6M
M<XH5OK64$\H=_M#KO:\1T.V]SC9<AFO9E[A!UTJPZC1:F&7!5 '-=U5]DU&U
M3%;:JR-;E"5.#G+1D0@&QM8S)Z"T7&W?<N%\4"L5 6Z]0Z:40E$UAJ>8HS=G
MUJ A.I.^D4Z<G2VM;S2(CWBWUO,#>W4G&UX>:D("FJGS\D5VWZPRA'1_O]35
M#V(LF=JVG/*Z1.]B#%MNL?,C:UX&=QL$64E&5?UI"&5ZS#T(IN2_?M>0KVLP
MJ$<PZ7! )]KF;[2#TQ18/%\/!Q?Z)]YP5%/U9>KT3.:29R0VK.E>H]>\5[F3
M;E*%.. 2)Y@?VP+23OT^HQMV4S.%GJ$8DH'_ $8((3_O1)?=4C#E!5G5NNJ@
MKHWTB@M?\1Z3)Z9ULD@K0^D_'!M;>;D7MOOM<'8\ODS.0 $E"(-0-1HJ(EU0
MN[4^*!\UKS WJRWH"'+$1HEJ'.ZO-*AZL4[Y@<>/6>NYO87WD0!V)QL&#)R,
M >A%:47H  ]A$&>=+N:_S+M4L"!TAU1*=<H%><HN*;9VC:1V^1)_Q$V1)9$5
MB1V2S[WZPO(VZ$-O>U%[B(C+,S<IZU*P;AT3,^I/^+3, XAC,X<^(A!1@C/0
M41Z'J%[)+(5LW>U:J$56/R,;!Z/XD?8GZ:CJ7T(:)N?-BPB\6WM '22+P1#Q
M\F)PI0B@*.$#?)A\#& G]C0(MB]*I8+\5*EXVAR7.Z3-&V.10"EQ?G%["_Y[
MB+[";8U_,8)P54*-59&4%:$.73U$6N F8#$A6 W1P42XN-=P"]EY;"T)$\LS
M),[;CN?V=NL1)@IJJL.]J@)O5WM&(E.&5+.X4HA:R:]""R%R34]3'(KE(_9W
MV)ZVZWFT6PS/@IW8Z>:,U"ZUWAWGY049E=%^E:0^/DCXUQS]SOUM;ZC??>V&
MT)H6+!] FQ8!"4?O&#T9-^[!$L]-7:&[=0&W'"/<;=O?;UQF9% V1?( _ )2
M&D/WIJA0IN4$0.9U/,#/0R1\_P",?LF,2AA\HH0G9;*$L*-1=XQY^GO5:VC!
M :$_&\>A[]$,I*O#7K8B3/'#4O7_ -P7#3I!QPW\30G'LI__ &C _P#S<_\
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MJ5UB=&D:QEM"@VI9),@$S/4;_+:+S/4-#.8$S$[*2@*-OZO"#+8DBU'8N.Z
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M'-<'T&X#-Y5U2.OOC?Q3R[3_ )N742Z=52$/M? X9F/EU&PB#OW'0/#F<Q,
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MI_)0PC$SK6Z(QH2ODXJJ->'N747F(\UT?B^/T',.8P(VO:.GIBOS.7]G.BJ
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M,S@J%>KA0ODUQI6N<Q1SE:.Y/Y&W^!BWRTBN0BHOH&KN/T4PK(A4$,:)7Z1
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M5=)4YJZ\0FF:4@MK-O.(($Q!W@WGYG?2CP>;#Q%5A;J>FE*0_)/YD%2-K*K
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M9%1T+3835-GREWL$GWMW/I [C',I!F!C'%_O$J>I-F5U8HFT<LRF!F1F)L8
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MGF9D5P=!L@9-GT15CF?B;(J9B%<F]B\NPN+CJQAY1UM12MBK9/*DEL),3!(
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M7"  J411UI:^W5HBR*3L&%D[:]^I+1-M1^ILQRGR4%52/-+FWD0+QOV/L1
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M7*5W*H!)))42)FQ))N1N>APAP222[^?1?4(R,JP[B<5]_E1>4\M5!$ONZ(&
M1GH6<N59;65BFVZ>4("0%FP!5^PDDGJ=NN*K.I)+,4-2E*%5TH235*TK&[^'
M,;"Q""970$]2%(546B?)A$^F@SK)Z .(;-2EM*BD'?E L)!^$[#KU$=M63VF
M.4J9C6BJ5M0.M/*.@C$PI,(D@RA!0A 4>A(TM2K- 4=0J+XJ:MDLU3;2TI0H
M&%*7N1(_M$=;6Y@3(&U</RW[O8H4!N*C;1=:,YTSCN9PQ,Q83$/U*T1V)T-
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MK8P,2#(4$IE5NEJ_(@T58RLX4T-C2Y75B"*D599)+%14 >:>5)";VN!M;O\
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M;\(455345+]+K32F7+23((3FE(V -S%CUBPVQEQ#AHDX=FIB%7*XAJB,60(
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MN1A>P)*H4NE[(2*WBTDSF3X61BI5"2I<ES0(YU@!S$I^S.KIB4+ (Z28W,P
M9FY,1..C\$\,9G$D(Y4J"W_M("T[75RD4_%./Y:19RCE1?\ BLE_EY*!YKG]
M2WEC#+52$.?:0E9WM,=9$_OCVQMV#^'>+F@Y>I#-<6# ;Z]]-Q/'&'@T "&K
MT'8DW=!'#+M2YIEF;L.?:%E) ,@#K!)%IO?:1L)V U?Q;^&1P.'YC%);D1!J
MR*H<"Z4.BQ8<-\7G/@Y8X[3&EAS'T3<4V"QNQHVOJ]6LY=3?:I;% ''.:>@0
M8F#&Q, B/:V/'W$^#XG"^)XQ#@+T1:(2A9'HIO"9K+?L_$.<#WT->8H&4&U
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MF>2<4E)(4512'WMW2AAO1YL:9WS%CFYSR&;;$C:"=YGX3W(M.,<:3E!0#O\
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ME=)9QD]965N:UI?\S9(<V%H3$'H=YWBU\)F,?VLH E3E9T6[D68!+HI6&Y9
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MOB)GLKSA"J'S!O=VO1Z7#DF(A(WN:,U/DI0:Q]RQAZG?;=V2P0Z$'I&]IW)
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MG$+$Q)F"U+,WV!K3T*B[-UI\ NFIM#7+=5)R_,VFVDK"%N^2SR$7W$[6VFP
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M?B/3>=O?I8SB8<3W0$3E  %RR=+'HX18SY4!*D=%)'5$T(%GK&-+*FU%1(=
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MIW57$5]K7B-0TKSM'IUI+#+:2T3'DA.Z=S947%C?\L.C+44CITZ,?U/;+F%
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M_P"&V:DX?XPX=AYW_",N<UADAVHH>J.H<K ;0/N)J MN77PZ$OIY;W-U2#!
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MQ45)>O854,U!V:*SZHK*ALAP&9<($3TZ ^@CITL"<;'^$N3.4XOEP0J%#LA
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M%AER.8,R[LK52OFS&/7[Q6ID57##B#3+,!W1&IFQ/KE56.D$V]1CSWD9DSF
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MK$7C>_\ KL('?&*&I(LAH=$+% 3;4JR)"N5/<]_YQ"O*6V9-T D']Q'3;^_
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M )-(A-%5*'\V#=42MMR/,F =K 6@#U,2)!(@8SS,G*!J5U[Z=P%:QH6YGJ4
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MZ_OBQ%AZ#%IBIB :7*'L*APA^Z.</Q/8XC4=U[W^)^I@CR.G3]O0[%B;2WU
MV,G>VYO;')O'O#EX?F<7"_BY2J."JJ4?;H@#/'JS\*O$/M,[E<+$=#+*0'1@
M%1/@BNYB^<BU:C3:W'J9OS2$@&%2HD"\]+*GN9,0)MXCQ/#/$>.\8Q\"REQM
M,"YK5U^-_9&<S.6R_#/;K8%RCF6KFE.KDZG7O6.KG-59\I=2A08;?4V[S+ W
M= @6M$_G>;#'L7\)/ V'X<X.<:9\RA*O5%5*EU "[@!3'B[\<O&_YG+87!W2
M<D#8%76PT1D0 L#&T'#=YAG+VO)2?AAOH9D#>-HO:(];8D<?RQS$\V*0J$A$
M15*,S.FZA(\NXLAD.!EZ"8\R[E52M4=SI<&-@<C355A0OXC\6\7@'?;8;7)/
M2^-+S6'A (I8 5N-@EK( K[Q8% -.K4#Z"H--#1(M[+J5QIIMWS/PQUB3^S>
M1<02 >N(>%AE5J%2G2MZ:*EP80D!*E:,M+_-E@BI*Z1 (YCO(G;KO(_9[8CS
M,3HI^.D+6)A%)YM.5^9>20!$;&?G_$#;#9K1'E*UN@4F]+JBN:'(-[VEGV^K
M=#6 G.LIYY\L&+$S)@]P9VV.'9YE U&[;ZM?[6,=3YMIL+D!/C2*SU!F*\KI
M'FVVY(!$W,DCZ#8=?I:+3(8'.5N$HFM[M1:4=X%!)>B+Y TVH*4C5_6&</9F
M5)"8;\TN&Q_JF.MQ<=H'J3&-YRF4PY<,!38[=$"[T5T,0IZJAZVJJ)1- .ZE
M0.ISQ;T*:?663USP'^<(>8!ZP0Q!VMM$#\[ [EP7'PL-B5%GH71"RLZC=:.P
M271.E74V2[EP:*4M0M%4.BII*5H!L^4!<3];;1>X-O6#CJO"\V9\-P$ZZLR?
MRUBNS6$J$%G +[5N]>SZB[:#)E>2Q55#T[7_ &0")Z&^W:V'<;&3$9AIJJH+
M:]M%>&\+".(49E%SK:HJRCR,2V=YG1Y;E)IG&/-4X/@FP&\=[;B]YW-P3A@<
MQF)!U'G4_#1!2Z8L&4ZL*,1=;+J6+DQ4+&9^>A3.WF&W7N .]O<QBT,I1:E/
MYZJ34N'U6&E;Z7N.M%^H$$NG=),YJ:GF5'(/..U@-[=1_#TQ'QL8RH-0@2Y-
MB;*GT#1D9414=3=$#]8;5&G$4[BH;Y_+-ONQT&\;'K_?M@PL<NI+GL:WKO1=
M8&(:K:!0FC*5^*/"J-.U]9EK]2AS[IL&6Q%[?(R)W%K@ ]"AQQ-B(EB%?H7&
MB4V1Q#AF102^J4T![,UNBP+90ZUDQ>;\DD.6-MR3UG>/6?X/XTG-A^[4$([_
M %T"VU00@G".M'4"BA[-T"PSK5U+]0X\ZKF'4=K1M$1 !]0)O@Y1*@<,NZ]=
M#8OI9G)^9]=]-D7XUO$OE-4:5 J_PJ#H:$".]XVW,P!:Q[PIDYU='=D.OT<[
MDPW9D4D(%70(5J6/1"A@YH*MMT*>4YL#\SO:V_K[Q:#B/B88Z!&0*]!H7W1P
M]8)9T LC-Z>;]P]8M#0]>W3UZ&E P^S$]")D38F9)&UQO G%-F\(A"=5Z!2$
M'VWI$G#QRAE(!2;F-B->J:J2S UBZT$%PEH% @;P2(F/?_68N<5^(F),$8 %
MAVU 1"%*"E:1GTJ!9J!T^S<]/2#^B-JEO^&[6BG5%2D\;=2(!@#X1H3AL0-^
MZCC@_P")4O+QW*#7A&7/_P!YGQ\GWBSR7^2F_P"\F_W9(Z./% T^SXD?$"]/
MPJXX\6!:UCKS/R+]8  O>^T8ZUP"43\!X-+3_%'#7W&4P=K_ "T8199AE\?$
MG5SBXDP[S3&SW*:$*MCKUG?DHI%U;: EQM:0L]3SW)'YFW7:V)>/A(2#\]64
M:(I*C9R%&\^&LU^8Q>2H "-1F=0#Z,5TAK2Y^EFG;9IH4L0IX7M ^*_O/8V@
M\L7J,3!#A4<GSL+E$OWNG8>'8T^'()9: !"E$0!2"- WQB+S1P9L\'$)")#B
M%3T(,'>\ W F/7O5YM<.4M0E4HQ(2UU%:#L-BR,QS,P!O-ZL36CLU]1%39GD
M&;,51J6C#,D J @B3RGH8,3&\0+B(<X9G0<3DW1"A>4D($MHJ '1HSXADP,#
M&VFG55%":=*DKN$>!ZJIZ=JI;4\^#4J(YP-@D^]_H!^1.-ZR^,3A @$A&044
M @Z[:;QR7B.4Q/S14MSS$*20IF**R% !U[B+QTDU1)T^*QEI!=:>Y6U/#XU.
M+)^)O?X2;CNF+18:MQO%,HGG-IB+HQ(3J4[IY[?X>RGMC++1)=15 JD%?-]7
M@[RO):G,D5-76+Y2TD\B.H6.D"=N6)-Q VQS_B'BK#RLHP@BE @<D!0W1Q4*
MX6T=.R'A>;,S HY]Y:L7+DU0A-2]D@=\VKRVH<"2' E2C!N+$BVUX,>L3ZX9
MX=QG#SV+**@@%5 (!L0A6GH&C'/<$.6DGE(7E,\H1BLI(JFPJ38069/G"LZI
MJEI5)Y2F0H*,R"4 @F3U)F#M ])/0LB1@@3A")D*)8OTH79V:.)^-\!,":A1
M49JH-[HI(0J]H8.)>8>*D$AOEA4CL"0+7Z [;;]<;/@XQGPY"JK)(49U U
MJAO;2."X^7GEQ)R"QG,P70DD605V"J1I$GEU> 25KVM%X-H_=:0+>N#%',%#
M%6#,ZCZ,K0F',7E-1KK1-@;4V4L.689GYBI#EDH ;O'QBQW/?K<DR8PWA81!
M)(N5">;(&5*V\@8F*@0:(VMW9F0-1-'T X[T>JLZSYYUQJH=R^F\Q# %@940
MF),Q:QB3[F^S9*3#]G59OZ24H[5HS* IL&B>V,I)#*"497%>8&E!T:A$:T.:
M&U)7GE1EU3R[*/)))ZW@@W/7OOWJ\_P[\QB,0'+61T(( -$4=&M$CVDLDHF)
M4S2@E0SA2%!()^U-[QX$\-<]H]7T->^RJD:84TMU3@_JM.)W3(@V$]MO3#&)
MPW"P,$ DJ@%D,R(U6/=G4(1"R8V&2IJE5)4*C(2B?6RB.X?+JVBJ*)IM+O*M
M(0D* ,+/*!S#MS1,;7WG;7<3#,LR$(72[.UU3=7=[NI*13?SV6Z4:,&<TZG*
M97WX(@@$$FPB+^HWC]^'<!!,- =$UI0*>FFL(:@,-4*L!_2H=G.JQ5CN35S[
MRBR/, *N]P"1>WSN9Q,Q\YAX<THH16[HX<AV.R"D-D.51"2+IZ+3XM8Q-T.C
MZQWD+]IA1WL3!O%A\]X];+-GI/9D $E%.BD/5R$TUN4@$O0"I?6A*/\ ;M!_
M0Z;-"TI:7.8G=/PVW)$23:TCZ7$8I<UQ##+%  R!6=-'2W6XAS#E50#YU;4!
M4.Y]+N7T^4URK'Q 6B>@'<])F^^X[8JSG#.6N2EM0"1U^&D/3R)4DD$*XW^*
M)YB/M%EC: FI?'QK2HIZ6-QTDS;YB1BTP\5991I+*H'^B-QN#>QUAIK!+,'2
M74Z,B!SYIR<RQIU7.9!&Q -AOW[=\/B8HQ#A$)J*:506&T(2[A0'42D(?/N>
MU8=-4%2B.59L!^*]NDW_ &]<,SXHE":T(*?$#[6)']$+I5 $"*@^H!:UX>NT
M=66U)*C$"X(](B3_ (];8PPL=4 *!50TNC@&I>]! Q1:D7TZC7MT"F*TSP-Y
M2\7*I02AQ1Y3:ZIN;'O[S\HQ:Y>4XLO+1@7:4BQ5%M5GC'%F0)HYLFQ12KZ0
MW15,N!"DGS&U@3),7]H([&+7B(VSGP^5@4(!?ZH_EVB/+, =$5Q5++?X)TBC
MN,7$]O13#.7TC+:Z^M2KRT^9M&PZ &#M8SU.V+3AV4]L1,2Y0T2H4L$T8ED*
M@Z8XJ *A*J5L35Z-1[K<K%&9%Q=K7J<-UE("Z\5N.#S"! )DC<$S;Y^QQ<8V
M08 $@$"J-75_5&6L,R3*2RH2J$2Z:!&71;=8K.>(#U;4C[*YY4K2V4^;MS].
MFTQ W(D C#^'DN0 A2P*NX8N:*==*H8QF132K=C6.;'$I60U:LOK&B\'F"5N
M%R\$7(CL#T/][<^3YG)1R69FN5 )T*.-4@$W0_I8Z]+,B.( M3JILV\S.,L<
ME*TGF;]P21)Z@R#.\;7Q-RPY?=(I131 '",Z.C+&$TBTN:5<Z.J=WL\5S3KK
M XL\K*BKX5 V( VZ?+IVWOBPF#2T3U)JOH.D8G#9C^OK]MW99E32VA;:;J42
M8)L0;Q(C>;]L0L;"E#B[H3YI?2\/"90)2ED)^:?$)NRQ"L450WR5-@EQ:DF8
MD"8%@9_U?2#/@ZBNBN:T/FUHRYC0(3JM_3?ZQ9>4Y4BHIV%TWX^8>:0+]) .
M_;>1O'0"PP9N7#0V"@(7VOIUVAJ:8AZJSE]NOQC:_@DMK2]<[6AL.5#C:.=9
M[%77:_:?]6O\6D.*$)Z-I1G;9NJF'L&<:L#OU0!OH\=EO S5=+FO%#AJA(AS
M^6.G"08M.:4LF?KL>E\<L\2Y$X/#\X70Y;$-WJ5V0]&M%KE7FE%J A"FMF",
M#OHD>LOBPKEX8<1')D#16I3'3_L/5]_3]N. 9%\W@A/^GD_WF\B(L!65?YN4
M]6W2/(?0/>:T"9E5CM'I'L9%XZ;X[_+*9,&4K667JIE&B]*U>*D'WYJ/-,]*
MS4#_ %5.\%67-I2H*(N(C83 .X'S]+C%/F\1CU35+,#KV-8S4JAT5.^K?>E\
MU>TXX9 @D&?6=AON-_WQB#E\?D(5 'KW4$V-%'D3&8),P960 I1.@^$*BRE5
M0I <^  R($F#$SV/4"2>LX<Q\_H#OJJ&ENFEF>%)2E.NREW +V4DOU,:;+T4
M[90A8)&]I,_N@GJ/V0*#'Q_SN4EPR/\ (3S$*4*J2M'.M=MWLM)EY,:<RD^W
M0 5(6;6B/6H)#Z1KIK+36<5O$5C-5L<F64K##C;OF>=!:;4T9$6DJ,)WZ#<C
M'/,OX3Q>)^-\AQR:;_!\C,":.95/1$O5>C>E_#_XD\%X9^''$/"D@_QMGI9I
M92 O\0LXN18Z=#_*T.N<I2W* ;J_YI%XZ D1!OCNO$,SAC"8*S!"^_5+JL>:
M,U_EIR3[W-,NH/,_6C4<P6+I.>G2A0\M+AMN"9ZGZ;&.FV-?ES)DG! *GMVT
MU%UU#Q&WWU=?CW]8$*[(#YCBU_$GY$$WB1OT(O ]L;/P_C "2H&%ZMKJ[%.Z
M!4;EE[ JH(2_<I?JE2(J+6N0O!@5++?*&W+3;: ;&XGK[':<;EP[B&'BE!=.
MB@E+E!6FHJXAO%E9J*JH@=4#GX7OH$T%>&@GXH4#,&#!'[MP8'6VUV.)\-'$
M,KF%.IHE5.A"@)5KL8Z!X&XS^R>(X!0U )TJX%]'/D'@OH5_:4.%P\LB9GI>
M( GTZ$WN<>7^/Y3$X%Q S# 4&8Z7*TVW!I9H]\< XME_$7","0Y@*!*" ;D)
MLB4-#6*ZSFC8:#JVX\S[1-]C!._7I>PN8 QW3P%Q3\QD03HNJ%-C;X:UCRO^
M-'!\/ Q)DM-,Y0W"L=0P[V6-P."^2N/Y51/.G\3C'0FPY8,2+=9_8,4GB?,
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M@&--(4UN7[$? ]1T0"A4!2WUV&^OG#BF9>I&PVY_P@_=]0;Q!_9;&!F!I92
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MZEX<564TM6A1?"7(40D$])(Z WB+ #N=AAH9J;#+$U.P6Q5""N[BO6:.'"@
MH';4,%4]?1;07V#):9P-*:Y7 0/+WD[6_=/RC;!B\4.%(O,@+5 W1&Z6.FL7
M7!/"N8XEBS2@! 6.Q+!%3=65 S%2"CR=#C*G<O8=2605N #9,<T1U "C<6GM
MBEPN.C-9B:29^6>:59A1#RLJZ4I14MLW$?P]S&4RYG]C,O+S*0@6MDJ2O0*]
M8.]-9@0AQ"A\;?(0DV(Z7F9(M(CYV@R<T!/*#_6"ZJKD5 JRK1QOS_&P/RT\
MV7($LTDTV&F\IY7 5NVH2D'U*BNS):DH1YR%+2>2!_6(L#WG:1-AOC7<;/C+
MSD !)5 <A$OJ#Y#O#4IM<#J&8?!2"05H$I>FCN':UMJK:MGRU* *( /PJ!CH
M9M _8.N-(XEXBGDQIT8<TP!>@)#>3H(G28)Y1,M1*;:#=DW%5=A!#6:.-/5_
M=A9) (AL&1$VV$=>L@W&&,/Q'B3R$ NE'"DJJ)2C_(T7V$R4O7LBJM4[[WB6
MH-(K>;3SID\J[F;[] )D#L.E^F*O-<:Q)P0%<D4(WJQVJ+F,I<!')Y7-QV*4
M4ZUM:*?UGE+V3URF'65EHD*0K>9@I,DWB>ON;&#L? ,3V\TJK[P!-W-6#HMR
MNRM#6/(@<JE>E@7W0K7=7'VW@I24<I'PC<B;#;KM!'OTQO1D/**%@ G0 $*"
MYNT0BA(9@H=J>;!"Q2NBP]2[RH(<02@?@,?UO?I'Y]<0YI4)0H75_.@)/P;K
M&!0E@Q8(EDU\T8E:QQ34.A<I;N8MWZ[P(]_G.$(!E&R ]P#W:P]!60"2@HE"
MY--%4KT8;0\\QXE7F?""D&TBW[>L$1WMC'# 4W+UKZ#O:I+K&0_B"Z:7N*6J
M$LAN5UVX_P"7UE;I2I_5[E0U4L>94,E!$!2$2"-P-I@V,;8V?@\WM9T8@(#?
M:EQK6S6B+C3?Q6<H7WV;R[Q4G#75RE:?HJ?-*D)KD,H0OS%WE* E2E "Q)!E
M($?2]_F\J -D!5%"Z70?-28C2S'0+1+H:*FJ;]8'^+^09?JBC8S O34T*%*0
M1!!@2(M'[STN<9<.GY)^0 ( %!<-=7);[2,\12 E7NE1T4'=-DC5BHIC2$$C
MXXL;R8@';W_AMC8YY^:4.JIY;&BZK](BRL>X&E:%WLM!9X@WG'"HU")0M+I6
M.8VE'+)OZQ![8CXV9.&&J ZBM-Z!M.FCI&NK.E61@-6=]8<ZG#=6BES-3C2C
M]F0ASEF>< 1M&YW@FVUL5AS85F>9.^JG6FWG&2_^[;K5:=?58QZ=S=O+UI%4
M/\WJ##P _JSUB8$;W[]9P]@XZW+*0=+IN?E4PO*CV[4L:BO7S@KS3)&'&59M
MDCR:JG>'.MEC[Y3.Y*BF+'H1>#(F0<33F$8A64%:^2#6R4@Y"JN%<@$? FS:
M=[@BJE+@72N2%DV)24G>\@ P3U'3#XQ @6I *7*W ];;+&!M1C="%#!UUN%,
M)K+7GTI87*FI"_4!-Q\HOUW@X90J22DMG/GYJ-K4$(JLRI=:CM;SVBX=+T33
M%,&OP M_D!ZQ[Q;M&$,P%5;1-P[]T1BBPQ/,95#J2Z:K]V*718NO0E&%++BH
MY4V;)W)D#V-O?H<4V=/.P(JFM''WUC/"G441334!2[=D/5(W/\/)\OC)PR3:
M%:WTO\C^MZ8C<]-MQ/6,:)XO*</STO\ _0S^7*0GWH(N,I.0Z*20+6("M\!Y
MWCV0<8?]Z?B7_P# 750^:LCK2/K/\<>:.'_Y]EO_ !&%\98M20$6](\?^F77
MGJ,@M[<@!ML  -Y%Q&^T;8]#8LGL\G(7_@D8M4#8>B[I%4?XYD4^\48L%J40
M_!S6@BQ:-#J$^9V'6TVL.O0;=NN-1S<WOA65.S'ZUAU5IJAVB9;J4!LASTM-
MQ_CN/V6Q% "[&PVZ(>KJG:,WK0$)M1$'E?S+$YOUA3H #*@DS))M^PD_G;#<
MV5Q9S10: !DK13 &5QH:_0_,0ZI\S4LJN;[[28@;&)/6?6>@Q&.5_*K)J% >
MY)-K5T&D8S8F7DS,LDB>V- "7^*4LBI4VC<P915N@N_%8WF/4S[B"1WZXGY"
M:3(GV+@3'F9B.8D];L_S$.XOY>;'&8PGSTH(&BLA['976D?60Q1MA#?](2(F
MX$7ZWVC<6VOUPQ,7$QYI@%19A+T4I=-ZTOK@>:8GF'O$O505>[!2FGK#=S-R
M'.5(O>>FW8F\'<"UYMV>PL@K_I7S5V)!1!6JJ22%<IJB?ZJ'SCBNI2\$CK\X
MGO[_ .-L*,'V!JE2"P;0_:*8PEEYB=7J-.@HRJ5B"SBG34(<0ILJM,3?Z3$$
M>M[7'6VX9F\20JP4I0HS::4;4%8PQ<.MT4MH57>JJ"P>-<M3Y&[EM67T$<KA
M48(WN=A/2=K[8Z+D\V#A##(<ZNY>M Y*(!>&/S&)@XGM<$4#D+2@54\U*I9(
M94&;.H2&@ 0K<;7&T=NQDQ'6(QHWBKPEA\4FYR$NAH^Z.M@4K='[_P#A[^(.
M:X;*),3,)[H"5("4= 4L#M:(%*U+S5"7(/FU 6#<GM!&T?2"?;%CX:X".%9(
MBATL$123<]Z13?B7XL_:^+<D@UJ:&ZUH65710(W^X/5C3.6,HCX2ZD0 2+W/
MIVBW;MCFWB?%Q)LYC@:("R: &I3RJ%CE> .7"YBP#E4?47*@JE%C;O*LW2AA
M)2Z 1O-Y'3\K>E[ [Z7BK,ZO2X<)I;R*7-1(!L9D!\J:*]/M(EGZW[0U\:@0
M+@["^WJ9PS@U'7[T'7;M"E2+)HP'<#YB!^C<;;=</OL+W(]1^?3UP[B>K);5
M?B/TA/O[1O)M&B?34.M-DH) '8^D]0??MZ8:_B +=T(TN]18BMXR0*79%&I9
M0($LZS9P)7+EO<CF.\2.Y,3&\&.F)0PDH?>--AJGZ4908P6HN*B_3[[Q6-6M
MRH6I4@2;SU@SV,7O;VP_+)R%P4;R^V0Z%PL,@H5V;8P*ZEI&7<CS!Q8ET,'L
M"+1N-A.\;]^\[!S5'2U#]T-Z=(<,LH5F52%F='U#:(PCIJ\6.4O5>J--LAO[
M@U GV_S?8WCV$]/48[=X"GPYZAQ*JFYNO;J[(%2*G-S@]%W56 -.E4K6*R<R
M@4Z4)4B$P"+"-@-XWM$[7'OCI?YHBY H2CLJ5#$[$)&67P%PBK% 48*"+TWH
MP%2+,ZC)PU54C;, K,D#N?4_GTVOAT3G$!O3MW7N*W[0_;^PQ&#5*!2=&07J
M7-6$7=0MTF09,'W9#KC/3J2-KVWWC:(W&*F>?FF()" N] KT5]->CC.<\X[+
M0JK*Q>N@U+P)5&3&H<;KN0^2Y#Q&W7<75[[[F3M.)V#B(Q1?75*(I'4@,RQ#
MG"N"R=PH:H#+LVAAGG@#-,T4I^&?K(D3WGZ _3!),9BI(+%$VZB4K4?/0FPE
M02@,Q!U)V*.1T:CPX5E26\H;K56<@&;V._4Q$':#[[RN+.<,\M]000?2T'L
M0M+BS([-\C1-(+]*YG3BG-*%PYY5]AV'7Y1!_9BOQI""IJ)2A%5/J_Z7A["1
M$"L=Q17<J0K):(?/J5^L#WG6::?YNWPB8.XW!&^Y!CU>RQ ,M LK@)4]%OW
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M^YI3+#[;OG)7Y[:E\G]F!S<AV_"+"-OK/IK@V>]OEV((FD$P5V,H1'W'KI'
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M)I[)::CDE;#"$DD;DI$GU!,[=_03K6)GIY\4ED!*@5JA][<)KWK&4L@P[U(
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M92B)0@@*%LKZEU,$-7G#&G5#+%TI:=6TA:3R3$I!$&Y,DD$R20/4$U.8Q\3
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MPI)I,Q2[$(X==:EZ*NJH5"(NWVQ<&ZJC(E8TVU34TU55^0VE;7+-P!.T2?<
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M3BWP\NVQ"438 (M-JF\",_6MZJ2-#HPKH!8>8:@RLZ812YDU4&N6TO[*X/M
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MB68S$@!3,I)U4K'B?.?B'^6\69S#RTLLN6.>G$LLM)9/;S"664$$I+*!RTH
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M 'CGBGAK/8<N8Q^7+@RA!8! C6 "N$1T18V&X;\0 A!;J734,.)0RXVK=I(
M]/ZI'4$6L.I\/_BQ^#G$,CBXV<RKR3XV+B88_NSSSS2*K?PS.CGTCVSX=\7\
M.\6\.PI9,?WP)"5-2@5BE'!0BX5:Y>(M!I[4+:W*9-,I02>:3\?-RB0H^AN;
M0"2(ZCGGA?)\6X*)9<70!U"('(1[)N'LD=5X/DLH,IB8.*099I4!4H4 "H K
MA*N X2-=Z71U%1U%14M\H+A0$\D B3  ZD"X WVZC'7,#/8N)E77FY)>9 *\
MKJ 2BDN146>*V3AV7P\S,9%Y1B3B0 (DO,43L!4$[Q8NEN%[6H*A"W4I4L.M
MJ#:G""4-Q!(/6!< $>AOCC'CK/XF!SJB\TR$T7F-$ITO= D66=S0RF7_ '0<
M2@*Q>4;T"DH " ;H$C?WA1I"AR8Y?0-TR$MJ2#6JWY3 Y;]((()BYM!Z>:O$
MO%<2<FRS&JAN9&-2=O*JG@7C?BF8Q9YB"YGF(#$'FF*NP95 5$8HT7#J'3M)
M2KYJ8>8MPE25&!RA))3>Q@  W M%SN==X=GL3$$P-E!"+1E%=!6A4C;6>'X^
M9PLN9Z\PYB%0K,%7HZ(]]X?::H\O98?7FK?,2CS"M<"&TB9&QD 6^<3( ;XA
MC8XQ9)<-5**@**4-; DVTKJSQ#,YC."63+_Y0 <R(G,$$W,P"*W0#>*_UMQ0
MTIDM$^,M<"*NG<=0@4YA1 "D@J,  V^([W!O;&[>!_!7$/$_$LM@+FOWF(&E
M<),A9!0!$&FL;+P#AF+)@^UX@G*)02" *@, #0D,3Y".M37^O,^UWG+E#1O5
M+I+KK:I%TM*<(4F.@2+2!RVN9Q]/_P (/PBROAC+X>;SV!,<486%,)BG-_ "
M]$F=9@E2=&Y[^)GXF9?!RYX#PPL/W&(K SX:X<SJ[RD%JL!!GHG2[>04+:2R
M6UN\I<63<J2!S$]949)$G<3O(ZEQG/S86/[#"; D]SE6@E/*!90$ ;^?EW$$
MQS$^),G-B3S8DQH\\Q)!V4E"/,LLWGF;ERKI:=HCRZ>%JON!!-B)@GOL9'IC
M4YI!//,0"\Q<4KWM]F)1DEF<FM!U*_1KZP<Y+F[%2A+B'AYB4IYP1L($BVPM
M /IZD88Q<)&"@!@?14T/Q\H)<, J2'3F;X/]W@MHL]9+B6R9 44R2;P3!Z6(
MO?VZXBYC+GD!0N 5U.ZJA2EZ*M(P(*IV"A%06UIWAEJK)E9M3!VA91YZ'$QR
MJ,^6LRLD#8F28(CTF,0$]F:[J?4GRV^(AX*@LP^W6&M)EOZEHPT!#JT_>*D_
M"DBX[']EOEB=EY3B(JH@0!+U*5\W?6%F3E+NA^##U\P@U(OF^=MTZRD.Q CW
M MN0)D#H)WW.-BRG#3B"4A'"FNE56O4L7B'/L%H5VLZ^B%>L5]G6H&*YI%"S
M!(45J-[J)!)GU)/;82,/9CAYPWW0HA[DKV?=(>EP^:652"H#5MUKZJU8(](U
M;S:#35)EI7]'O:P $V%A8W':YQ2XP,BV<H#0D$EW1]$L RPOLA8_I9BNB*0B
MQ(Y[D5'F"5DPRZ N%P"#8W G<[P#!]L.8 .( J4%5-OTOS:1C(>68$?UB E&
M)"T/73N8U7XJ<*$9]0.)=IN9U"U%BI38_@/(;R)(@[CH=[#:N!YG$RN."I(3
MHK'1'2ODY2&<8U-'(-"A7U%BBZ$+'6_K7AAG6EJIQ]])>94XM?,420&UJB;F
M3 VD3$QMCM?!\^,82$A"992I&P:R/8T7>*S% LY<E^NEUJM!<16KQJ^13@=Y
M>?[L)C8*VWF.WIOUML\SR:* >A-_6(S^OI]O];Q%2JN%-]F6_P":TT2I05<"
M/E8=ICTZ8HLU*H.O5;FZC5C55WA^6@3^7D$^#[K#"G:J*IY"&1!1<7M&XCT]
MQ.',G@B9E7X!"OVA72BPI3S;SKIHNNBQ/TXJ*0OTM6CS*>I00D#^T=[^AWB.
MV+&3 ()4L#U"BMA]H5"0R9W) -0R@HZ@UUIH%9(XHHDM.); \KE 2D<DV4+>
M@@$1^W$F08<CH+7JB]36P:#G)(YB3L[IV=.E(/,@TY79LXBGID5!7,.*$@*1
M:(%A!'3KM/:/F,82J4&H9Z-I0_!3K&(4Z]"F^WDA?X[(:6T#396EFIJD%VH1
MRP+@@VD1?L9^1M?%'C9HE0&"N0RHM$1RX=K1DP+!3=0P8JU>_I%P9379CDU;
M2YCE-749=74+S3U'54R_+J*5;:2.:GJ('*L3?8S8XJL<39B4R8B&4@@@NN@(
MT(K^L2!/RH72P-B=EJ-G18V X2>*'C5P6U2YJS1^N\];KJVI749Q35]3^MLL
MSD.E!J1F-)F]/7TK[SP2EM-0RA-:R+,1 Q1<6\*<)XA@"3-R)*@3E67E_P!'
ME,I"70C1#&8SA )5PY8'S"$6>Y(WCLVHN)WA$\>>6,Y%Q2R^BX*\<2PE=-JK
M+FZK+LKSK,0E++A4MI+>7N-.$I<?<SA"*E"E'R4I4.7'.9LAXB\'XQQLA[3.
M<.),W(Q,L@)1ZS)*40.>KQ*E,N* \HI_"J3*Z$-REA1;E0J1H3XAO!;QA\/E
M6JLS?)G=1Z,JGE'*M8Z=4G-LGJJ4<SS3M0JC"W*57E%)4Y5,43-Y2^4PK&\\
M"\7<&XJ)!,#)GP/>DQ)#+,)T=R5E=6*DT!4/&Q\HQYG)H58^E.@]*UOX>Z G
MC#PU6I,<FMM+7%O_ ,,4W0%0O.X4H;GF.Y<\4SB;A><(OEL4HC/+-J[*W0F#
M!"8DLMPFZ(;IT=Q\ ?9#Q4MPSX@H!D#1>HY!['*JKK Z=L>:LE_G>67_ +;#
M/E,#%R7E)UE^4>0M#;J2DR"/,5'L3(N?I>-L>ALLGL@@1)95_P!443Y17J\R
M53LH)5 FM4UUAR6PM4'[T^I, ?*+DDS,D^YPF+C^SV0/U_3MZL>C4"$KI>@Z
M)>X$FTA0^[B! ,&^\^DGM_B<4F8G4DJY76]/FYIZ0"BJM2K7<T]7APFD0M!2
M5;FX)B(FW:_]W;$>7-' +GJRVO16WU6$,Q%E&J]/+YQ&N4_(XH@>9 B>@%^T
M>Q-S$B.]YAYOVF$%T"("^U5Z=61X6PJ$= !KH_\ -VLW4[Y:""  =OG\ORCO
M88SR^&N*"Y)T;XDZM\X0!#4J;69RKZ[W1WB/^TNJDH2/6P/K<']UL64N5J0*
M$E JE#6]=X$ "[FZ*Z:A6#"/B'7%+Y7"2#)@@;CL1].L8D8<O(7"(:54Z&MT
M&RNT F))9&8W0D/\^R1)TY"6S.V_[X_/\CBFS^&9\0 H;4^*_6J1E0LZV\AY
M 5W36)&G<4OX.:+[=]O0^ES?WC%-FL#D?TT[,=?A<1D>CW2GHNNP=$%Y%MVJ
M;#G(DBU[;0!)Z7B_J-N^(DTV'.$N@T2]E:A"=CI C4/4AOOS7:(IRO>YB%(^
M(&+JOVV !FW?Y&<2\/*X?*"%%T2GJES9UC*8)<,YM5!0,/G$]IW*'\R=\U2#
M_2I L;G<]P1 D]KWZXU7BN/AX0F>A*ZZ;,J,OG#_ +)4"LB*0%VO;HH7J099
MOIZJIRSY#BDJ<_J";^VQC?H;6Z8I,+/E1Y4'0*Y 5D >Z(83V,J.>Z)6E_C^
MD3VF,O>:0H5EB' !S[6,=1<#YCY#&$V;YR000E5W<$I45W](=E:1>I\M:K]-
M8-6V^17F-V@DR!;<3-X'N=N\C$:>?G#]R*]DLVC]%52B 3/]JU#LSO!+0?:.
M5/..018];3T-[=+ ?M,3%#DH0=+==%?>I[,1 YLP\TI2PS-C F1N=O4 ["^^
MUB965#NR.2PJ%?JA6SEX 4NBC5%VWZ,MH'G<S<IA= 18 S)[]B+6Z3<1)Z2I
M\$TI4D,XZIJ%M\XR("*:,H35Z$  :5@&U!J=UM3;0!7)L('L 3'\2 (V.)F#
MER3*KW1_U^Z,80I:GF>E-K:U@*I:BLKZE1,>6"3<V$FW6";CI;>)(Q+FG&'A
ME0+CR!%:"SOJY)A) DP?F(J_4AGZA34!P%BGN)N6BII*JEGF*VWVB#<B09^1
M^5ML;?X+S1_-,:_0GS";DGLC>9JHONUMZ@B]M1'5!K+*%97F572EL^:'GU)1
M:]^ON/0"PGKCT!D\=<,&X2I?M6_4TVBC*@V+N7TMU;Y1.Y?35BM.TU(TRM:G
M'_C1<;@#T]=K1UPW-./:DDG7JI)IH!JNB44!^%T^U^P8MK1W#D5!0]4(*-G2
M.I.\?+M[F;XK\UG2I W=ZBH=56G4]1#@P]4&@[* H(I<#2-C,KTHU2MLMLMH
M^#IR]XZD;&)F;G:>M#B9A:]%4J>VB: ;P_R@@U*T-.Z&PU>M(L[)5B@+;2^@
MO,]HMUM W,&9$DXK<2>2:8S"4FFJ=&3IM7:,RRJ0"Q*"U*H1T%5!HK& #+Z$
MA0!D3$GKZP+'IUZ=QC'#&$@YB0040=U!*'K6ZK1,2] #OLSHJJH0M8#56CN3
M,.@7Y;;Q(,[ CUG<SVN3AK'S'L,+ +DS.:! 4)9QYA34;9XJ.ECO9:?8 H+&
M.S+]'A54>;4'&/@EF2_,R[6ND,WS?+Z5PR7<ZI:3+13VCK]E%<-O_4N.<>-Q
M+A9G(9["1</.2^\06D83(45P1T58F9-0H2H((9.9DT 1TW>.M/6&3.Z:U!G^
MEZN]3DN<U^4U! B7LKJ54P-P=OLOI?Y8W_(XHQ,#+S2E1-*"$H1,*V0$4!4H
MEWB'("#," R[4=Q30%/D$ ZZG\Q@(;23U$29F0=P;B9W%QM,G%G)-R3.44&I
M*]5L&1 $^$)B*!1"#9D^9K6^NH.]3.H\Y#S?W<B)V,F_^)/8=<64D]Z@?*R;
MBOG13#,Z&C+^I*^NR(\-:5IOS"@MVCUV^?I'SMMC#$3FL1=T0J!;>I+CXV/"
ML7$PL30BAZ_8:VNHK5Y.S39XQF -PZ?,G81:^_;\A:2(RR^)S87*:=U*D?#L
MW2)W%<SB8ZE : "Z!U1VV%"J*"8].?Z*>H+WAPU&5JE2.+6?-['IHS0"M^OX
MOW=,<+_$:7EX[@#_ .6X/_Y>=W/2W2\1<GAS8>#RS!"9B0-DE'Q!3:.I3Q-,
MAWC=QK\S\/\ E<XFCM;^6>==[]+][$0!;?."\V3X%PO%PW,V3R<Y?^ME\(^9
MN&I0Q%QI<0YO#& !RJF( /Z2J2 !6JFY:-$]196ZY5 TCP2@*<#J#;FDD&-[
M[Q^1VPOBKPUB^,.'Y;#Q?X1+AD %464%AMK4,NHZ?^''C?*> N+<3S^"V:QL
M+$!0?TYB3,+%IJ6%34PTIJ!+(0D-R2H!2@ )B)(O)!,&"(DB)B<67AKPSA^'
M\MEL*^7R^#@ 63"PY<,6J1*EVN*1J_CCQ_G_ !3F\3$QB?W^+BXQ"E3[6>;$
M*HJ/,1J5<54SH,M;*%K0(=;#92>I,B>OL8G^M;:,7^9QAB3&5&4BE$I\7 0-
M>^IY?F&7*N3*005J!NEU!M41;VF<Q-0A-/5H1YU- ;4>H((2>WTWO,]-5XJ9
MY)3RD"5T<N%(915;.::)#LA!EE&P2C4L!ZUJ6@Y?RVGJFRV\RA:%H45P-Y$D
MF9W,D@[S&QM2Y3/G"G550HU050:4.B$-,X@5DI<'9RIY:D(-7%D,4_G6GJ[)
M7CF.1+6&D?$]1B0$HDGS9F.50),7 ^N-DGRF5XUE.2<^\9!S(!_$0I4'N%(5
M$41LW ?%6-X<QY<3#1D*LK!KG2Z.:N8:4FJ4.-DU:UAX_"4J DKV/;X9F+2=
MR(C'+N-?A5@YS,38N'*OOS$%5!YICL7+JI1T2/1OA;\=\0X,N7S9]SE$HNH$
MH%0H\U;=(Q.9IRN(>:YOA7/*=C\4VO(MUF#VC&O8GX:XDDLT@!'LYII&+^Z3
M*&5*AU \UCI/#?Q<RF:Q91[:6@'*KA$(E-:=B:((GLAUU4T.<MNJ-0AL)'-R
M%4)&T)MS%*9,1)BT'''O&/X39S,&>:7!YI9IIB">5UFF(V1"I<>K=&X?XIX-
MQ.5,;'0S 3(6"D&8E%*6L1;2-K=$\8PPMI13#9"B73//!_K$0 3WZ[VWGSMX
MF_"?/8 Q!^7_ (9IY2!UF1&H@#@HY2(_&/#'"^+RRXN4S 6>66>R^\!,2Q4+
MS M;81;M)QERO,W6Z=YX\R4K@D;C^T2+W$'<])(C'.)_PYXO@DD99)5]WI_1
M1=+T'DAUK'\%Y_+2\F 01.%!U6AJ0%477JI,"NM.+;U%0+;I*GRZ9QIQ(=#G
MX01;E$$"UK[>NV.C^ OP5XKXFSN7PL[@)A>T9;RJ4&H9*,>P$88W#.#^&<J>
M(<5QTQQ++,955"6F U +/95L8T9S;/\ -]35]51Y14U#@>J%+JZM;AY(6LE8
M'823R[F)%MC] O OX/<+\#Y/"Q9AE99QRD\P683  S H$4$(6"T"5'GS\0?Q
M=.9GQ<AP=\.66;#)+\PD]T%2 @-=A=1%G:2T?398PAU:&W:E1"WGE_TJB1S*
M4@Q(!-P0?63)QN'%N)R@38. B &642T0'E!"H1*0%J5!UKYWQ9\?.XQS./6>
M:;$G(4!9R9B+J\SGSJUBJ2TV@A$^8&U@3^(@>G<;F8QJ$L^)//.J/,0-2Z'2
ME*V+4AV664BP2Y4L+TNVQ5(KG-6W6RMY/Q.QSE)$6-P-^DQ?M(Q88.'B8R2R
ML1[JN0CKH:]XPYBIT!(!13= 0+IILJK 2[G-93+*T.%E9)Y3SV$VL-P+@028
M'H,7N6X)B8B$DDD*DJW /9%T-=F8GQ0"14J75AYN H3>)3)-;5"*EENI?*'/
M,@$D_%!,*ZR"DS.YW@VQ/Q^!XOL2Q("7$UD0D  &R66M(QDF5^53K+H?);5W
MT>]<BU;]H4EM3AWCUZ;7!GKT@'N8QH?%>&8F'.C,5>]57HGH4*")^'.42;9"
M6[_)VTVE=0YHTBE4ZIV$I;621S"0+=B/WB#'?$7A&4Q,QF.1P99N6F]D"EM;
MHL+B8B2H"'_0+NW5-%C3K6.K*FIS LT=2MMI*U)))C942-S$#KN#V )[+PGA
M)P<*4H_)*2H%4!4@BAOYW*0IID!V4,#5[H+VLA%6$?E%<0X@N5'F+*[F)YE&
M23Z&3-NO68P_Q#)<\K61!1*,$2KBFO? XE4HC+6FI*&GE6+@RW-5--)4A9;6
M (5-MIL3/<WZ21?&F9O@>)B3E"$*J.IIO\MH=YP999D-%4 ! UF5+49^A"QG
MQJSR/.73"0=S:TF1>_I!.V(.+PC$PPCA E5#;6&P5T4 ",3-W=_T-";U5++#
MJJ=%2QY2T)<;( B3<1Z;F!W^N,\O*<N1J-+$>72VL()W_J_?H?U$4_JOAWDV
MH4+;?IJ:'4K%VY.YW/4B=S &_MMW#.*^SY?]$ T=MJOO](:GPE)(=5)UJ"3U
MZ;4H=/=<>'#RW'EY;\#=^7E$ 228'40.GS-KXWS*<:YA*"M DI0"EBP 8W!V
M$-3X(0"X0=D&MO-U2-:L]X4:ARDN-+IEU*)4$*2"2()Z]Y'[Q.+G\S@XH"DB
M8\I7<C>NBOZ(6O9$%0:.$2B%UH!U#T ,"-!HC5##Y*LM=6E!@<MC"C8'>(MO
MU&,Y,7!P[@?=@CW7K353(2 @/8M2C*!Y0?Y-PIU#F06':(H;4M)E<0D&\&)N
M+I/K/R3$X@%(E]X4/NDZI<$! -8;_+J7N7)45)1M/Y.:VQD? Q"%M.5JRZA"
M@5)5/*-R0!(L)C:8O(VQ Q,],EI5)1=]@[DBC'I"C+"Y78$NP)(-] @<FT7!
M2:6RO(J9#=+24[;@M/ER51UGU@'ZGUQ!Q,8%S,IF+*P9;+8%B2M -Y$X]V4(
MJ  W("(5-QUT1[2=)2(<5\4 "_IOL)&P!%NP,S.(D^+J]M&[=W17$/Y; .*3
M6GHWU5T741GJ &P6TJ%P8GT.VP@>]_7"23.E5>V_T^BQ)S.7'+2B-UNK@JZK
MT%(8A!0;[G;VP[,#*JZ+%+_"9AU&M"XTI6,M.A;*A4I=+;P<2ZTII09J$*3$
M%*C<GL>HOUPSBY23'PR&=DUJIT7[M#D@Y30D$U4BRHJJRZ#U '8OX<?T@6N^
M&M,WH?BLPKBUPM=812.Y#J9F@S:LHF 0V4457FB%JKTI946TTE57-,(2$MIY
M4CEQSWC?@B3-XDV/E?\ !,T23+/(3+S3%2"4(5;K*2'(+Q+DS9%$-&(I9G4%
M HZ*89UV?\']3^)_1.;\%-*.Z5TC5ZXTO4M4%2^\E2JE_-J-Y]3=,]6U],PA
MIQ:TAFG0&&PGD:2&PC#<^3S&7\.9V3.SC$S,F4QI><#EEF$HFE8 !D" LYN*
M/84RXH(#$@D%3,_F5"TTCU*<4D^;PSUXF;?R/U#>VPRFK[ #Z"/0;8X3E6Q\
M%?\ M!ZG?K%E*4(^ZMM\8\D*V$MA0-Y)V$7GTCIU_P 'MV6Q.3"DVDE4;('H
M0ZHG2*Z9S-U.FI!6JIIJFA$?6J=3JV[?"#;ZGYD3?8CU)P8F90%"[@]$[E4!
M]&C% 'TW9:=M-!H(FOL[;7EK49N!VCYCT]/KBOQ,4S@ING4;5J(S$Q4:N0"_
M7X^<-WGVD*Y8WO)_.\]#ZW!MZK)@.Y*M1+AF"*O07O"^T)#)UI]?AY1'U2%N
M!12+ "#>X,1'K;<8L,OBB2M!V*AM[6WU2&[)*0JK8]137:(=;2@DD=R2.L[3
M^6TXV#+9DLX#6<%AZ_5G@#AT-BA^GJ T86D22#L))Z  '?J3(]9V%A?$W%QE
M T14MU733O @EHYIU->@_2[1F\EMN5)W]8[WV B/I\XQ!ES!!K4LCA06JVNW
MI :%770$$[5O&1(21\!D@G8 7!O.X,&\[G&&+/[[BP4TKL!^L(:@(7WL0CK=
M*C45*F)*@_I$?\P?M/M^S%?Q&@ZS?":%G_A/;XB"RFIV$)65Q]X!%S.T]+=>
MI@F??&GXQ_>W8G>SV/DC:NHSJKG6SE.HI9 J&&;N7TP*U+)Y^D6WVW%N^Q&Y
M]</8F8Q),,(I"HP53JI%]4NS1E0"HNI5R'4*0#9%#ZQ9FBFV$TQ'*@JFT7[F
M.O?J(%O2=/S^)[3&5/-!MMZ$-4)#NE^X<=OO:#.L:;<6T[Y=Q].GO/7<'8VM
M.(6-2Z-J[N*T0.B;EX0! C?3HI=_3HL-7G%H *;B-S-B/G:WUBV'\$FAO0:A
M B?5](S #W3=&=]=&C&QFC;;I2[8%8@?3??^_M:<.XLIN+DDK]D ]J1B9?X2
MP/:AHI*M7I=XL[+*JGJ&TG\0,&8@["#8F3^7:QQ73X00A'T-/L]1<%*P\"I(
M(((I5"-R"$9.YL8<UE-252'&S&PD3%OE^W;Y8,,JUM79Z[[:A=C&27\K*'JJ
M&MJU&H-69QEC0<<;::@3M,>VPN>_];N.UAA9CV=$-B5(IU)0="!\(8#L22[/
M4&PK1M%0K: VMT@T2M]?+\8DQ,C]G4B=NY]79\V4HF]22E'+=81 02*Z)=;D
M:$JXJ8>91I:G0PZ\1#8 V_;<F(]][P3B-+G,7VKH_FZ=/GTTD?-_/K%'<0<M
M:IJJH:=(A5Q[;3$>@$'87M?&W\(SN(<3+W4H0J?;DWV>IC9@>ZBIJSI4/HU(
MZT>).04C^K:Q3C(+8<^ZL=Y,=B?2WKUQZ+X3C'\L$*>Z 14J@+K5^U.L46+(
MZIH04N&94J-=3$_I+21KBE+;!^[@WZ]+@W/8]YF;7QS6:]^J;A2BWHI-Z;W$
M$DH"J%U5.H)/F*$U6-@,JT_4T;8YF_+0 /2-ID3W["/48HL?-23L"M2;WUUH
MO=F,295 )0KK0)K];;B"]AMV&DEOXCV!O)(W[>FYZ=,5QG68\I:B>1O<*BI$
MF0LGE]$^F^AB=8R]:W"I2>0F=MX[]O>?I<$-D@58?;:GMH5A1[U#_"]D4&Y>
MS!RNY!4GI*<@ID&8A/4]1^0$&Q$D]HQ S&8 "!T<@U/K1:+9D=V,21V16IN:
M/1%J32NTD:=4E;31,B\7OV'2+P9/M%CBKQ\[SX[EK* /K<'>Y6[Z$(5#):K:
M"I%A8"+BX"\5ZC@=Q4TYQ%115.84^3)S%%;E5,;U]/F649GE2J4[P5U=3]N-
MR *3:2)A\=X?A\3RGL>8R@H5"$K*075BA" /70&%!Y9A<F^TS  U0+470,K5
M5Q<U+2\1>)6J]:Y;E!R*EU)G-7FB\N2O[04OU+X?J5638JJQ*HC8CJ!BZX+E
M3E,O)AJ9S)+++S$.1* %*$_Q5._9 ^\29EJ2 2XT8L6V"(ZN8$*6BI>5/,A"
MO3U'?UD3]=R8Q9G%'M #UJU&"CL7"?$HB@T)#4H-+%P3H-$2&&99#2N-J6VV
MPFW<Q\^NXL#O\YP[)BS!P2YH3V]>_HD-XTI!H @Z6! !#%T7]!%.YG3?8ZY*
M ?+)!OWV%S-KF1T/0_%>UPISRJ+A/Y[HH+_2&I)U9$-"2MD]316MTB.J*)YS
MS#^($D@&Y'[;"21Z2=R<+@F2S%DLJCX[=4%XLIL/$Q"A4,Q+?:WWJ;QZ*?T1
M=:NH\-FLR[ 4UQMU(R+Q\(T)PV6/>[ADBTS;'$OQ+$HX]E3+2;A. 3U_.9\;
M6 M&>7!$DW-4SDNNDHN]N]8Z??%!J=;/'WCM2A2AY?&7B>W\,V"-;YXD0+VM
MU]O3'1O#T^#^P.%^U3EER62!"&OY?"!7RM1:&(N)C38&-B2X"^TGE)+W*DZ,
MY6IHM&U?=KW'BI3B 0I1,\EU E1!F3<F\[7DC&QXF=P ,"7!F4RS2 "@8@(
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M4E2MR4%RC!2'MW+I%'YKJ"JJ*A9:<7R"1 6=KQ:\"#L2/RG&X8.'E\"650I
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MO.=LUB?.</"@]!U ^ACD/"AX8H_[77@>/0\(N'Q(^?\ )LS[R9[G"_M/B?\
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M?S6)_P#L[00V7X7O#:Y"E>'O@NIP;!?#'0X/N <C!Z3,=-Y&%_:G%/[5F_\
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M7)KJ6GK&4O/(0\TL(>=2 XL3$5Q*- ZW_1('2[%.[_#YQ>B*AEUOSFU-.-@
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M)*SS.#\04CE^&%)/-\-H/:V$]_\ N^O>#[^7Q:,P73DJ3+06@$K1YIE !@S
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MVD$+[[_1_+!^\^^6".'Q?\6/_(/_ )F#]Y]\L$*__%C_ ,@_^CP?O/OE@C*
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ME.9:P1^E X]#(J34-8YE63U%=_E+XQ!EO,JEK+LTJ:-@GE"W$9>YRH"H0""
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M4N<5*F*MAMS, R4I0D\H1!8#I;ITV">IA7=W-P7LZZLW\HUFSK3G@_TKK?\
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MGV14FI>%>>:7JZO2F;42N U54+X4N/U==IRC6O254WJ;6+52W]E;\EU]O/\
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F"%@@A8((6""%@@A8((6""%@@A8((6""%@@A8((6""%@@A8((_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g729258g83b31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g83b31.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[21*4&AO=&]S:&]P(#,N,  X0DE-! 0
M     %D< 5H  QLE1QP"   "   < E  "')R,C8W.#DT' (% #A-:6-R;W-O
M9G0@5V]R9" M(%!L:6%N=" M($9O<FT@4RTQ("T@4')I;G1E<B!697)S:6]N
M+F1O8P X0DE-!"4      !"T5G/JZND_!/4!<A#"^EZ&.$))300Z      #E
M    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
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M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #P     $  @/      0 ".$))300F       .             #^    X
M0DE-! T       0   !X.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         ".$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      ,U    !@             !"0   ?D
M         0                         !              'Y   !"0
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !"0
M  !29VAT;&]N9P   ?D    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    &
M.$))300,     !G"     0   *    !4   !X   G8   !FF !@  ?_8_^(,
M6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )
M  8 ,0  86-S<$U31E0     245#('-21T(               $  /;6  $
M    TRU(4" @
M               18W!R=    5     S9&5S8P   80   !L=W1P=    ?
M   48FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@
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M14,V,3DV-BTR+C$
M                     %A96B        #S40 !     1;,6%E:(
M              !865H@        ;Z(  #CU   #D%A96B        !BF0
MMX4  !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@
M    9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M     &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I
M;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#
M;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M      !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M      !,"58 4    %<?YVUE87,          0
M  */     G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 >
M ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L
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M76G_ (P_K S*ZBSI%#P:<([KP"#NO</:S3_N/4__ +<M_P""6%C=)ZYEP<;
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M]2J=@];JK$ZO;Z>+F[=6[FOV,_,_T?\ VKL6C_BK!'U(P0>0Z\?^#6I*:O\
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M )M']N?:OL?KU_T+9ZN_W;/Z1^BV?O+J&QM$<1HOE9))3__9.$))300A
M  !5     0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
M$P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X
M0DE-!"(      49-30 J    "  ( 1(  P    $  0   1H !0    $   !N
M 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(  @   !0
M  "< 3L  @    D   "PAVD !     $   "\    Z  :/L   "<0 !H^P
M)Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$Y.C U.C X(#$S
M.C P.C T ')R,C8W.#DT       #H $  P    '__P  H ( !     $   'Y
MH , !     $   $)          8! P #     0 &   !&@ %     0   38!
M&P %     0   3X!*  #     0 "   " 0 $     0   48" @ $     0
M            2     $   !(     3A"24T#_0      "           _^$!
M2$U- "H    (  @!$@ #     0     !&@ %     0   &X!&P %     0
M '8!*  #     0 "   !,0 "    '@   'X!,@ "    %    )P!.P "
M"0   +"':0 $     0   +P   #H   #P     $   /      4%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3DZ,#4Z,#@@,3,Z,# Z,#0 <G(R
M-C<X.30       .@ 0 #     ?__  "@ @ $     0   ?F@ P $     0
M 0D         !@$#  ,    !  8   $:  4    !   !-@$;  4    !   !
M/@$H  ,    !  (   (!  0    !   !1@("  0    !              /
M     0   \     !_^% %&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M(S$X=WBV%QHD,C11<Y'P-CI!5UEQ=':7L;*U&!DS0E188=5B@866F,'6_\0
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MHE[SCU.H<3*'$3F,(^/+ENQ?M6;MJ1TMFW-)8GD<=E\LKR]Y\^PV3H>P&@/
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MAJ4:\MF>1W[,<32XZ_%SM<6-'ESB&@$D!0[V-S8[7;)*SR1"I7J>M,7-&92
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M+V<7$E?(3T[=,&/W/+5M=ZGVB3PJ7,42=@J@N8G5O'IF\8JAYO& @4%Q]P
MN *9,[Z:.I]?9T,!$>0=R&.+CL-+ ?BF(V&GB#HD-^#[NPIH_P#P\=&-<3+D
M^IYVEO#@_)Q-;KN"4CX*C3HR#F6D\3)]H07_ !+MBF<../E)<HOVE)-/R"(F
M,5Y<IJ9MG<HH83JJF933YU%^14_0ZA@8@)U"D4-U.4#!KN4^DOK'*1OADRGH
MX'Z!BQM:MC_A TUHEK1,L!K1X:.]X!(^96W8;Z(.@<+(R>/"^OL1ESA-E[5K
M)[<X[<\P6I7U>3CY+NQLD ^X!&SB222"::**::**1"II))$*FFFF0 *1-,A
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M--5:[+/<A=M&<"(O+]+P1)@P*IMD<G>W7<=9F,X#;KK<]?3768N]%!G+M4
MMDSF5]+TI@@S7;Q4%DU_A+W*Q[9U$VM V \J3:D%CXQ5E$,LV!HVRXZ?#@<7
MZOJ[.N?XFRT]46?C:UH^MC*I*(M1A2'>D53K):Y#RXF.M(I2THLMI>OSPK=A
MSN;M+DE.3VU#+""BT(VC&LEV1Y2)C,Z,AS_4$1:==-NQ7UQA=# UO45NKQY
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MUJ$6CVF;E?\ .6=YYS2'YGD\G6R=-#6[T N^LU]91,(F$7G8^E]_?/\ M/\
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MW'@V/5<X *BAG'54"D+U$H &:_D.N.C,3_OO4&+B<S7P16!:D&AQ'V5432>
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H($JQ)4D$T;JS[YV#%HP&;E%"IMB$,JH\.9=14") F1;_ &$3"+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g729258g86p37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g86p37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1>T4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %YB^8$ X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!=5MD         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              2@   +D
M  $                          0             "Y    2@
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   2@     4F=H
M=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $H     %)G:'1L;VYG   "Y     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      --     $   "@    0    >   '@    -&  8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 0 "@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MS-SF;VEN]NCA(@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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ME)BBU=8I9&:$HZ372%AU=H*&AY>TM;;"XO_$ !T! 0 " P$! 0$
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M,O'D7M4XL1H+E%2OJEK*ZTFW$CX4&:I5SL #2TNOA]?$  'XB+-()NRV$XB
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M3]HG2OHYTIJME[)K8H:.*GI9&1OIJ>4M=+'B<<<C'..(YVOEII8#^D/^C?\
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MM]'C^S$__<;8_P"1:?T1].O^$L_Q=/\ YU'WA2_O0>[YD)^/6^CQ]V8GX_\
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M=J5Q_0IU6=6FZ149A:T,&$79EI6M0T@K8HR+4.K&1TZH[9+'EV$<JJHHP9R
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M;]G5GKW ^%[J+,Q"IR4O*R*BZB1W\B]>G2*4IBIG<N5%C$*(B B4HFX 1[B
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MM,S1Z'AE+78P7M/M87^NW%>SO6%BIP;5]3U9"&&[!>(!I +6D &UP#:]K@9
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M0SZP1V9)\W>0/]0MS_<K/_\ N[0[0H+95M)[ZB'_ #^&=N>J>A5=\X'][/\
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MC6#EH;A=)V^,1J@<@*+'(0HG*1::/0UWV\V@N3V$TVD)N!2:0"@3ORP;2T/
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M0@ 4A"%   I2E "E*       <:]6UK6-:QC6L8QH:QC0&M:UH :UK18!K0
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M:W4A>:5#I3S6(HTQ5WT6A7G**@24?(J3BCI%Y%NV2Z+(C@ATU#98L39=XX,
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MW1@F2 5+[(R$H[KKUV=J"GK7L-BT2]=,!D@\$!+HF5CSYWR\^\K;;HH6OR^
M(^D'K/ "/^,SMO8 $1_5PIG'8._QUL4W]9_RGC;EYNGGSY^2D@)3>8 81^(E
M'S]W'(<!R(^7U![_ #W[CF.\)WZ7T*JS$!!$>0'\V/<W("/8/</<.-8WG,9@
M]F?B/.76B[NJ(H";5 ,,3N$$ ,;_ !Y&Y3N!1'SL\4/N =9]GD 37('KC7L*
MD_(?!2DZ3?UA_P#@&_P:Z%QS'>%"ZIE2 8P"J0! 1 0%0H" @/D("8! 0\A
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M%&S@I# "R)SIG Q3"&N3LN@H>CD-;'L"CIMBLVC'%!M!NRH(J$5L,( AAJ1
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ML4YVUY\[<K>\6[Q=>FI%)-NDD@B0$T44R)))EYZ2)IE A"!R(CP4I0 .1$>
M\]%"X7_.%O[4I_<&T1:]_1E?Y5M7_=CSS_?2L^B+SS[)./FIOO/_ .<ON<\O
M/OFBV!^#OW^]K:BS9;3,C0<K@^[ZY<1!S)X:=NIRY^3KF%>VY\><=U;OSQG;
M;K^_FVD#_'Q][G43^P?AE;+(9Y?I?ADI&O;YY_3YKT3[SY')4/MHW32>&[:A
M1,J-<2OE:'<7AFY&M8LA8UZ$=-*"Z(LW$&2H^-TJHF(H8A2"4W5R' V[M>#8
M&QMJ;;JHIYZ;9=%/72PTD9FJ964\;I',AC NY[K6:!>VIR"ZNPMD3[?VSLS8
MM++!!4;5K:>AAFJG[NGBDJ9&Q-DF?P8TN!=;,@6%S8+RVY9F]X+6N8C>7C>C
MDG+3B0ROCUG#(W.O52+953(9W7APEJ@AK\4DJNG'RGC+I@_%4"H@B/ * H =
M_P"P[[1^@O2OH]6=)=L='=H2T]<)Z"BI:N*.6:FK*4M,N!P+(W,F$L>ZJH[B
M-S9&6)9GN?:;T%V[T'Z1'HV_:E!/44T=-6OJJ,.W4U-4M?@:]CP7Q2-=&\/@
MD(<6ECP<+@I_[&,\;L*]OXQEM]S/N)N&8:CD#'N4[5 N;*RA43R[:ELXM9V:
M2:P[%HC%OHUW+MT6?0(D<H\"/48#B7VM?5="?^AE'24E!4Q]*14E\TYQ$"/>
MO+\<Q<(Y8#$6,C8UF+&+NL<SXV-FT/O"61\L9H3& R(#UP\X;&UKM(.(N-[$
M6R &4Y?3";LL_P"T_#V'YC;A8*?7\@9&S$RHA%+E4EKBRD&2U<FY4T<RCDI&
M-%!\NNP1,FZ,N8")IJ%\,W5VXO1;8-+TCVD=FU&UH]D.-/-/#/- 9XI7P-WC
MX76>S=NW0>]I)LXL+=2%GK*EU+#O6P/J+/:TL8X!P#C;%GJ ; VT!ODM(,EG
M7TGLCNSI-CD]PNWECE%3;O;H]O,-\%S/LN&KCZUUU25ASL4[> NI<DB+<[>7
M37*FD1LJ4&YA5*<.))"R*ID9#*VHBCF>(9GQEC9XF2EK'F,XBT3!H<6$DAIL
M3<76RUQ+;EN'0ENN%Q;<B]\[7]]LAP6T+T3&<=P62)'?%C//V29#)DWA.R8Y
MA8ZP.EE?550M%3>3SU6+9+"!X]DKRV,1JLHJNF8#D.J<"EY]!TKVOLG:E10_
M=&R:;94--00QU8@CW;JBO< :A]RXWB8X8(<P2"2<RM6C@GA9*)ZA]2Y\SW1N
M<  R&PP,  &8%RXYW-^%EOH14(DS155.1,A&R1CG4,4A"@"91$QCF$"E />(
MB ![]>5T&0T&GR6VHK8"W2L\Y72]4].IK5M2F=?2\<2S=Z65%.4<1H^ @F@B
M9/\ 0XK]CJ@!3=//;JU\;^S?[6OZ0-N[>V+]PS;*^Y(G2FIDJ=\VHM6.I T,
MW$6 FQ??$X6RXW7V#[1?LI_Z [$Z/;9^_P"FVL-O%H%-#3.@?2XJ..K]=QFD
MQ6Q[LC"TW%^8$L]?95\?6!<P8VRU>9&-=8XSG)XE9M:Q;X9\P8U&%LA)&<G6
M)&M>LQEI51-1!>HNBF?MX]/EM)J&!!T=-,.1(K':X5W!HS24BYW333J-);Z%
M.GA?F]K22*E=K4 $7;*B+HJXK@WO<L'MYU* 47<,J(LV2:J/T]$]WGE[OGU*
M1B(C\KGP=0\>PF0]/N ?7''?\U[_ /8_?]VHX^X?/S_-%<VI1-$31$T1-$31
M$T1-$31$T1-$31%&+>)D'(V,-O\ <+ABUNK\IF3^I,'DTA N+4XI51FK;"P]
MWR"WJS4Q7%D<4.I/IBU(PJ0\OE(HJ1P,GUE$BUKWC*>[IS5=NMXP=N(MV5V$
M["9Q*^;!MY9U)#*4EBRI7"\4L91E,J$E( ;I(,(6E'?Q_JS*;;E/)0J:#AZB
MF4GGSY[E@ZF[H-]67+?C?&V(KQDF^L)#*UD);LFO\4T7$;9U5XFDU2;E8^&/
M:PEVR$;7+!)S#%Q"S#",MBPI)1C9TX715<C8M(:QV)IQ7R#@7"V7K-!);<YM
MOJ!<99K9DIC%!3U#I('MJ-[ABCGC?/%NI-V14Q-)?!CL71;P-,L=GLNW-3%R
M5D_)MH](ALNHELP1;Z+5*7<MQZ%9RS,V*L2$#DP4L'RK47,/"Q2QYB*]92ZW
MY2R29 (D44Q^F8H:JM:PMK[O>/Y\;6X+;CHB@Y-  ^D3K@" "'XBZW>8<_Z.
M%+U+1<C*_5[E()&A(["1\%,(2)^XH??*7O\ >X^/U_AYUE#>8;[A]>KJ&?C.
M-_YG?Q'ZKDB*1@Y.BD8>1#D4R&^'D(@/_5JKB6GU26Y<#;GR4$DZDGM)*_7J
M[?\ TA'_ (HG_-U7&_\ ,[O/U4+6MM:<+HL=Q9$5E4B#O+W*\E3.<A1$+3&A
MSP40 1XX#ZN ^K75V>T%LQ(!_$:,P"<PX\1?@/'K4\&]C<^/LM^"E!ZZ\_LM
MS_QZO_/UOX6_D;_"WMY>=-$N>95O*Q,6JJJJK',U%5%#'45.W2,<ZAQ$QCG.
M8HF,<QAY,81$PF'GD=;#9I6@!LC@ #8!S@ !E:P( L!86L+#/@JD ZCK\]Y6
M#-R\3&([=LZJI1[--5/$N0#)J)MTRF(8*Q)<"4P%Y*8/=P/;W:UZV>5U+,TO
M>6E@!:YSC>YY$D$6ZN*EH .@T/P*P)1D$1H])'P4N1IU6$?N9>XC!,.1'MYB
M/<?KU[&A<?0Z7UC_ %$?5HT6R6NX DW .9X=:QWG))(C+#PE23*(;IMJ7!@(
M4HA_C@<?!V$ ]_\ U:Y_2 D[+GS.L>5S^\;]/<+J\8 )L ,B<AG_ "S-^I;^
MM?.%E7F+K%K"(R/ND9F.) #==FHX=Q#GQ)AF(\>[[1[]]?8>B--O=B4[R-7S
M"QZI"+\R./O6I4289+9^RTY?W0-=/#X97UA:P^V_2#[*B@)C%0-N -R/(E#J
MPC;0 .?+G@!'SYX^K7)Z=4^YI:%ULG5+VY#+*)QSU^*O3O#\=KY #,@GVAD;
M=>BWZ7++6.\?V2@5"WVB/A;+E&>4K5"AG JF>V.91:+/UVC%-),_YPT04665
M5%-),H!U' 3% ?FBV//<L#;Z<9L<H[;,@12\G8XN6@(Y6XU,U56:!-/;;66Z
M\E QK-F_27922[Y\DFW09K-US&6.FJ@F9=)/12-1VK7YZ+.N2&%KY8<5/*]?
M4)6]8GJ%YNK2R5")I<?C&R55-E$-:T5&!BV%>N*UJ8V)634O$6Y4D)-S$*HS
M,<T7(/@D)OG^O>>.O=;W[LI<!&*D@ !$18N@   1$1% X   '<1$>W'OU9GM
M-_O#XA0M>@QDT'44(^4 G6;Z(-773R81 ?H@3IY,'8> [@( /NUZH/CL/Q&V
M+=,8M8YDZ]_#+JRU[9Z9]F?+YV\%TQK;OU\TN,$Y]J'8!%GDO9RWKQHPJXNB
MQQG/A>,+(KDQG -A-X(+&,IT=8\Z8XKN...[L.+UF^MA)+<1OGA));?F>:9V
M SLW$6C@,0&(@<+@#%;4 7RLNV:+FC](&CY0P$XZ0,U=& GN#I 2"!0[>8<!
MJ=ZPF^\;<<W@]QOEGGERMPR8;96]UN)YBW$+D8R;,(B+"4$1Z1$1:NA$> $"
MCR).1X 1 /@ B&HQQ_O&ZW]L&]]=2=1D>8RYI;JX99<!GEU#/J&?%?@T5,#P
M4T=)#QQP M'(\=N [>&/N[!]6AD8;W=&0.3P386R[P.7 (!GRO\ /L[?%<>Q
MY;G]*Y#D _L)S[__ #?[VF\8+>O':^F)HMSXD7T\E+'D4"'EAX_*N0[]P_(3
MG_H^WW]-Y&<\;/>X7!S'YK#*^FNMTL;VL;\N*X]D2O/'LR0Y\OT$Y_Z/4!\?
M![ +YW<+:<,^//JXHGLB5_6R0[^7Y"<_]%JPDCS]=FOYF]G/J[K);Q\_HN?8
M\L/]3)#SX_0;D._ ]OSO^?X-1CC!_K&:W]L<1QSS'$<D7!H>6X'\JY'\R(_H
M)S\/[7J=Y'IC9_$VWQ4V/(]Q56F8N6]H*F)&R/'@M2B8C-R(#PT1 P<E3'GW
M@(?$! =8HGQB,#&S]JXQ 7NXGB1?@A!OH;@ ]EA:ZII8R:(('+'RA3 7I*8K
M1V!@*'N 03Y OEV[!Y:R[QFH>VYL#9X!MK8D.!X  7UMP"K8'@#;/33K\?%<
M#&31A 1CI01#G@1:.A$.?I" #T"/<1$1X\QY$?/D8WD8RQ-%P1[318#*QL<A
MJ!;KXJ;=7\UP$7, ' 1TF !R''J;H #G@1#CP^.X@ C]8?$--XS(%[+Y$6<+
M7-S<9\\]-2-2EM<N.>7&UL^NV78N?9<R;Z(QTF///T1:.O>/4(<"GQW'N/Q'
MOYZG&RQ]=@!R)Q-MQRUMERTUZTZ^//P^&2X]CRP_U+D/_0W ?'_P?U:&2/\
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M=8%2078;$$@\Q[K\1JLT$#IW%C+7 )S-A;QY=?N4G/DIOX_9WVX>[_0&LO\
M^(7O_P"S4;YWYG]_Z\.'BMK[LGYL_B_1=M"F[^E2"8,][<"AU< 'S#V;MQQU
M#VR& =^=3O3^=W>>O++Z]O7ADHY(W!IL20"+$>_,]5^%LP+KZC2-_G/ZOVW
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M9> 23Z9#&-AW#6X8KN<6ASO:>!C.*^(%U@76=F0#J+F'2/=()7.+I&M:QKB
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M[N==F[(<3>X,?J$&X+<BL7/=KF#5:RXK,71(R"2!A?FT+(LUY1X_K;[)<(I
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M9:L.9[U5PR673=*DD?6#*B0Y5"AU<]78AV:S:=!/MFG=5[*BK(SM"E8 3/2
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M"Z(V!_UJMX7/]>?I=>6VJ_#6/ O?!'_X<NOBI!^BW>^M>DNVQEZ@'IA,Y#P
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MXD7 7I&T5%\E_P X6_M2G]P;1%KX]&5_E6U?/]6+//G_ +J5G\OJT1>>79*
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MW?CR[B/.MDGU3UW&>GPX:9@&XMJI_3P4\/0,?]RUVV_['(W]\RVZT5)U]P^
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M37CI6QP)F<A)*NG,-<F:S9)1%PZ%2*?L&TB@*JB92ZN:9KJD5.,@NK(:N1H
M D9'&T.IP3<MQ2,$T;\S&X6.(%UZB=PIC3X01Z-- UY.;))793@<2V,NC<S+
M&'',6"S;/8@4L5IJTU(W>SN(FHL+XK%1SERFO+I6V\HEC26DDT5%)-)6JP9W
M\=6FP,#BQ6D%W8K*& "Z24XD+MY(_.FDI8BTAKV;Z3'43%UCBDF8UD((#<#&
MVL2XJ&2EC0T,:?QHYGXAB8_<@[F,MX,9(XR$$D.<6C0"T7)[8.RD:,6A-<FR
M#V';Y'D;Y')V:&274CQ?51E5VP$>5U>!>N)F(.T4F4W:RHQTT^=+)3L>[;#T
M:P&A_J1O"!"ZH='9@)8)I62,#1<MQ1B/=V>#&X$NPAS0%D])(,SBP.=-N"XN
M<;DPL>UP<0+VD<_%=I#V:-<1>]QI;-'"3=FV<WB-L!*B>Q.L:+R\%)QLA7IF
MW6*.L\S8Y>1K<W&N74S'2#%3Y/*PYHM% CDY'J:Z8= Y#28@ 7@N;'Z/ XML
M8J<32S\""^<[XQN=?=EF(%EW&STDD6+"&N<))0'DB5XIV4Y!O>T1:P/PYO#P
M+.]4*4^*<>L<48[JV/(Y^[E6M:9.41DW_P"BY%Y(23Z8DGJP=:G0+F1D72I$
MQ44%-,Q"&4.8HG-M-:V-D;&7:R**.%H(%\,3 P$V%KFQ)L,(O86 "P/>Z222
M1V;Y9'2.M?VG6RSS-@&MOJ;7.9).0=6U'/X'XY=ZJFHX&UKY#0CC87&HR\D(
MFIT/Q\Z_H+!$T!&77;Q'*_5H/JBX-Y#]@_P:9#J 'T\]R+&6;,;3M[NF*9N&
MFJ_#)8WN\7=9$LM".Y20F46T"[BO8T<]:OV81:2Z,JY7765(Y*9RW9F\(2%4
M =:&/\2GF-L,6_:6VM(_?-DC<&OT:UK7EP!!]>YXV5R\B&>(>U.V,8KW:S=R
M13 X<KN+H@TD:--KW%U@^Q[89BTYSK.<)B[PRLU67,:NR00K;UN9-A"HV)FU
MKOA%ES1;^*FFLZG\H'LO'O9ANNS4&O.XQ%XLEJL5,Z.<U)D:^1P<'@LLV1QI
M_1W,()(;%BM*W"-\+;LO+"5:67>1;D,+6!KFAV,[QH=4"?$'  &1H;NP#^%9
MQ?AQ@$68YV;STG5*K$2.1(!&?JMCS'),9>)J\LR8,XS,LP6:D%HEF2?(ZC[3
M4GB2)ZO*E='8_<P!\P4#MK%%0B**DC;*\&GHV43I TXW,BFCF;)$+VCEQ,+'
MX\3'-<;:"^66J,TM1(Z($3U;*S=EUVA[('P;MYL2^(M(.6%P(.?K&V1+EMJD
M[1DN,O#?(1F42@WKBDS$/(,9&7EY>JX_M6/8YZG,@^;I-$'+*RA+2*0LEEEY
M)D8I5"HN.$YGH]_)5O$F 5+:T!F G=OK-G1;-<;W <R)L3)6M N7%S2;82L<
M<V[93-+"YU,^G(<7>VRGKI*X-L00USWRR1N<;^K@(&(&]CXLV4,L96ZFV8F1
MW\XPQ_*1[ZG5M>";M&%<9K5Y^TND?%K)NU#IEN5NDW%K<+G)U,6[=A"$*LBU
M(N.:*G$4V]Q7.&:&.XL64SV2&&F!OFV&6:>0._:$C66&[:HDE,D0CM8%T4DF
M>4D\;HPZ<@ >M)#%'';1A:]P)QD*<NMG0:^\_-8DTT_4\.?GWV1-3Y\^>M$T
M1-1J>K7+CEEU'CX(FFO9S]YOW<._@BSOA;\[L?UGBO[F0#^+7+VEK#V/^+5D
MCX^[YJ6YB@<IB&#DIBB4P?$# ("'WP'7$610;Q3Z.S;3A/*BN8<;QN0*_;W$
ME(R;I%/*%W<5MX,E*3\VK'O*PXEU(5S#-I:SSLA'Q*K0S%@[D5UVJ*:ANK1%
M.;1%\E_SA;^U*?W!M$6OCT97?:VKVX_HQ9Y_OI6?OHB\\NR3]2F^!_Y2^YSL
M \?Z-%L^H0^]^#6U#[/_ #$W]P'DB^5]%'$]@^:OC= /]#NKCQP'S[;=>/B(
M?/92/<'U\_;I*/PR#S'=ROE?+CS4BU\]"1?SV!;M?2Q"'XW=Z00.?+;7:!$.
M [<P<A[^.1YX]XB <=N.^M52..5\C\#V+4[C/]33' ?_ $!I@A]OR<C/(/>/
M8?/MW]WOW&>R.1: 3R& 7SO89V[NZHT]Y^)7=V[\#Z6S9QQ[L [I^?M\&B?X
M?XM8I]6]A\^>" 9GMR[+#Z*;?IE_S_83_OMT_P"]5?=8X_;;VH=#V%1,^(_5
M[@["(@/U<![P\OL]XZW#\^/#/AX6'AP4J^/1%B!<Z^E5,/8 OV#A\@-Q_0L/
M[A[#]@@//P'6I+;&???O/RL@N+<QQZU;^\CC\=#MH^[\1EC;ZO\ 1'G/P?']
M[4P^T?[O;^TWLOV^]0>'4?/T5M2HA[*E.._Y62 =NW/+-;S#W<=_+MWYY#RU
MLF^9TRYZX;GAS[;ZY<4(%K?'/X\?.:G?Z!C_ +EKMM_V.1O[YEMUHJSN'4!\
M//O6J;"_^37>-W\M\>XX0$?/GV]&<>[^+]_6Q![.G[3P=+6RU&?RSR.J'7W#
MX#SS[5AGTC8\[-<Q#_X.F!][Y>5KC@/<'U<CJ\N3'"YT'O\ 6%],[Z:6-SQ4
M#VF_WNLY^;_3EZ7MQ#IXRV?9W>1ZJJ,@UV?6EQ'JM^0<IODL>3!VAT1('B"L
M#@B0I%*(\GZ0 HB(!K!#++!+'-"\QS0N$L<C2 8WQG$V0$@AN C%B.0L3H"A
M )L1<$V++7)Q&V$#B3[-K7)("\9[S%TC1]NV-ZO0Y7>X_F[O#8;R3:XB@6N=
M<8_&>))UJ8M#EXP3E(]FVLT8FR>/(U(69EF+YNP.1<JB1#%B/I9_TUIV;8&U
MZC;C&25% RKE>9"R2BJ7PU,%R;_AS,<6BUB,+VG"5O;1V%6]'*L[-KZ#[NJ!
M!3U>X+ PB&M@9402@ 6M)%(TG.X(+7>LT@33VJW#)"7I&-D'L;*NZAE5+9=[
MI'6^M[CKE,OW5Z*SH5I41BV4=*NI$JHP@(,Y<@INSJ*)"41!(B?2/L(]APOZ
M(3[9&VX(:QE=@CV))6X9)Z!I$<LK:8/L9M\=XQN$XHQCM>UN+Z2\5K*;T=SH
MS"YSJEL8+&RYEK"^V5Q?$<K.(%S=>T+7C%N)HB:(FB)HB:(FB)HB:(FB+4)N
MB]&U<<\;I'VY"'R'78Y C'"L8QHTU&KJ1\@WQV3)Y)9_*2C-D>:92C-W>HN9
MJWL:2;1[IQ#NHZQLGC)V42E/GZ>_4><K2PAZ,O(.T^0VQW+!UBH%KO>/*O.5
M[-SC)CVQL(JT.)RCXOI"4A1$:M%)IQR4$QH;[U%K*,RKR /VRLJ]<.DU5=$)
MO>^6FG5H.H6UY@6US6('?H35HW$E1AZQD&L/<N'ML@]R).7%C*/*0YK;^(RG
M#Q*M2A8ENQ=-;10E\F.[-4I.6]:=&G&YB/)(C<K4Z!+]]K7OU6/N/+L6>=SD
M:[VU;H-FN<\CY3R[>,605LS3'2,*6FDM$!CP\WAA]"P8Q[>E55>S%3DG_#!%
M>:?/DONB@*+"KTF$@X_4#XK.H^E5V:A)%AAM]]"8,S-(DB1P]D\)(\<FL1NI
M($9#5O6#,DW"B;<[D""B5=1-(3 <P )+<,N\?&]E&20W^[=%]Z4'E--WDT:0
MVVP6:@+S'S+Y4\-*U/,K52Q-8PR85,3];B)9/'29R@).ELJ4XD'H!0EO-P>?
M(^?C(H?2G;-PE"P8W*\A.'8*2Q(4</Y1"6/$I.$V:LH6/^2GK)HY)XLBT4>
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M,+38LA0BE5QW56=A6D,.Y0;M(I6&KC!O*'>.U:L5!%%FHW6\=<YRID*F8YC
M7OHHL>KGJ-+=NOR6/]P>^+ 6XFLXCQ[B5[D"RV:>W+;6)N+1^:?(["/<Q$+G
M;']@DY,TP^K:$8WCVD(S=2:KYRZ2:%:(G5%8"\") +7[K$YBXMVG/7NT6Y+1
M%X MX=6R!#[Q]V?B8PRD^;RN?[Y,QSZ'QW:Y>.>1S]T@9JZ;/F,6LV737(3Q
M"&34,42"4P"(&#7Z7^S?IKT7V#T3H=G[4VM3TU8V6JE?"0][F-DF<Y@>6,<
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MWT>X\ ;[OP41X[<^?D'?3TT6_JW9<<>OAGK?]%.#K\.[S\5Q\V7;GV\GP(B
M#[-6XY ._ ^L??[_ 'M3Z:!?\,_Q#Z9G,7^&J8.OP[N*!C,!Y'V^G^UJW <^
M7DO^'GR#XCIZ:+_U9.?YP<^KU?=EKUIN^OP_5/FS_P#'R?ES^EJWE_Z1[_K^
M]IZ</W9_B'7U7[?DF[Z_!/FT#]?T_P!K5O/W_P!,?O\ O[?'3TT?NS_&./\
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MEAW5JB[E(HJ5PAS+^VV\G"MP%?H!5)IXR)B])N0*>%NP^>]2>%BP !$6;,
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M#1]WE91M49E5C&XV39K7UZN5H?I0J:4@4S,\V<.08E<$.F97@.@XB!1LT N
M)#02 7.OA:";7.$.=8:FP)MH"<E:&-LLT43I8X&R2,C=/-O-S"U[@TRR[J.6
M7=Q@E[]U%))A:<$;W6:=0_H=&D6K.[CGK:OW:DNZZZH>/$*=E66D5,G-H*!A
MU9R.EIZ"7I-*8,VJ[BS/H<)1JE,JR4Q"3!#RSELV:++B "0"' $BXO8@'47
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M4C 5XN!R7RMPU4AB$(F0B:9"IIIE*0A"% I"$* %*0A2@!2E*4  I0
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M=_(+N'Z1$Y%5NP:,T&;%) I)OPY?"WZCEGK=3I(0$R$( F$"%*0!,(F,(%
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M(FB)HB:(FB*ES<'#66)D(&PQ4?-PDJV49R<3*M$'\=(-%> 4;/&;DBB#A$_
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0HB:(FB)HB:(FB)HB:(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g729258g89q84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g89q84.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[12L4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %)"^4F0X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!F@           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              2,   /8
M  $                          0             #V    2,
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   2,     4F=H
M=&QO;F<   /8    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $C     %)G:'1L;VYG   #V     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      *+     $   "@    +P   >   %@@   *$  8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ +P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M     /_A0 )H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME
M="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^
M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L]
M(D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P
M-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H
M='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*
M(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y04V-R:7!T-2YD;&P@5F5R<VEO
M;B U+C(N,CPO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF
M>41A=&4^,C R,"TP,RTQ,U0Q.#HR,CHU-"LP-3HS,#PO>&UP.DUO9&EF>41A
M=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(P+3 S+3$S5#$V.C,R
M.C4R*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-971A
M9&%T841A=&4^,C R,"TP,RTQ,U0Q.#HR,CHU-"LP-3HS,#PO>&UP.DUE=&%D
M871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D
M9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP
M9&8Z4')O9'5C97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H5VEN9&]W
M<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^
M"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC
M<F]S;V9T(%=O<F0@+2!0;&EA;G1?0VQE86Y?=F5R<VEO;CPO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @
M(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @
M(" @(" @(" @(" @/')D9CIL:3YR<C,U.3 Y,SPO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @
M(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V
M96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \
M>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C1$-$5$-#5&,C@V-45!,3$X-3 S
M.3%!,$%!,T8W1#1"/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP
M34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C0Y-$5$-#5&,C@V-45!,3$X-3 S.3%!
M,$%!,T8W1#1"/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ
M3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-#DT140T-48R.#8U14$Q,3@U
M,#,Y,4$P04$S1C=$-$(\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @
M(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)
M1#YX;7 N:6ED.C0Y-$5$-#5&,C@V-45!,3$X-3 S.3%!,$%!,T8W1#1"/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#(P+3 S+3$S5#$X.C(R.C(Y*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T
M;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E
M9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-$,T140T
M-48R.#8U14$Q,3@U,#,Y,4$P04$S1C=$-$(\+W-T179T.FEN<W1A;F-E240^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,#,M,3-4,3@Z
M,C(Z-30K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O
M=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I
M;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E
M+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A
M<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\
M+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)
M1#YX;7 N:6ED.C1$-$5$-#5&,C@V-45!,3$X-3 S.3%!,$%!,T8W1#1"/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#(P+3 S+3$S5#$X.C(R.C4T*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T
M;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E
M9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP
M34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C1#-$5$-#5&,C@V
M-45!,3$X-3 S.3%!,$%!,T8W1#1"/"]S=%)E9CII;G-T86YC94E$/@H@(" @
M(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.C0Y-$5$-#5&,C@V
M-45!,3$X-3 S.3%!,$%!,T8W1#1"/"]S=%)E9CID;V-U;65N=$E$/@H@(" @
M(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-#DT
M140T-48R.#8U14$Q,3@U,#,Y,4$P04$S1C=$-$(\+W-T4F5F.F]R:6=I;F%L
M1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @
M(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP
M:&]T;W-H;W Z0V]L;W)-;V1E/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M
M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K
M970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_\  $0@ FP(- P$1  (1 0,1 ?_$ !X   $$ P$!
M 0             !!08' @0( PD*_\0 9!   00! @,#!P8'"0H+!@0' 0(#
M! 4& !$'$B$($S$)%!5!4531(F%QD9*A%A<9@9.QTR,D,E64P=+A\!@E-#5$
M15*$EM0S0DA88G)T@Z*S\29D<X*&LC96M,,**#ACH\+$_\0 ' $! 0$! 0$!
M 0$           $" P0%!@<(_\0 2A$  0(# P@'!08#" $$ P$  0 1 @,A
M,4%1!!(389&AT? %!E)Q@;'!!R)3HN$4%A<RDI,50O$C,T-58G*"TC4D)6/"
M9'3BH__:  P# 0 "$0,1 #\ 9^U?Y4/R@V$]I_M 8;B7:BS^CQ?&.*^7T>/U
M,-R"(E345UD\U!@Q4F,5=RTRD(W6I2CRC=0.O]7] ^S3JKEO1.093/Z-,<Z?
MDN3S(YABB<Q1R88XKP"Y)/>5^&RSIK*),^.7#-C@$,<P!C=G,!9=?MQ;G_\
M*U>4E_YW'$;[<#_<]?7_  IZI?Y9\QXE<AT_E##^VF> #>"/RM/E)3_RN.(W
MZ2O'ZX>J/91U1OZ-;_E$?5/X_E-TV9N'H4OY6CRDVV_]UOQ&V]O>5_\ N>A]
ME'5('_QKZ\X\5D=8,H=M+&_/^D>:/RM/E)?'^ZXXB_I*_P#5YGOI^%'5%O\
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MQ'4.4'Y3U>3L>O4>:;;C?U#H->^9[).IT.;FY"_N EHC$,XL[&TWVZZ7K/\
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M<?.'( ^_S/4_"KJB+>C*?[R/5#T]E/Q9FX>00/*T^4EW_P#ZN>(^_P#\2O\
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MI6^_ARC(>MTR+H>')X.DHHLHRJ#[5  9>ADF5FQ03#0F$F*CFA!8V%--DK1
MB$$ &%@Y))Q)(LMKB"RPX#<5>QWF^&\-,A[3+6$\/[JKR6JO<\C8E!KW\(XI
M5N3VI?DU%KC_ '*K/&,AQ^2IF2\]&=1$%<VML!040?H]*]%]<\EG97*R811R
M(Y$<.2Y[F;)G"#W<V(UCA)>$9T1.=$^L=I<>1Q#.BA9_>-E8?=N-AM_ENJN(
MNV3=XQ;\?>&N/T%1PCK(.+9BVAK-^&U^;.#E&'R<J:LJ2RREU+;<6NF5%3W;
M##330*66E)=W<!W^UU7R?K/%U?Z4R;+X9QGY3DY$N3- AT4<,LP1"$D5)C]X
M^\:NUP'BBF9,)\(AAA $0;.-KX%V[NX6$L>Q?*59I@/'7B+GLOAQGW!V'28;
MCF*9Y%XMTURI.4YJ_CN)-U;G#-#*4%VX>E67*E$5Q C!"#WH(YAK\]U<Z+Z3
MR'HO(X9^29=!/TDV7'($.:(!%.F'21"%R :%P#<P%5Z)LW)S'& (34>]4NX;
M\NH4JUF"B-UV@.R%Q%XA=B#+<JK,=HZ;-T87&[5&+1*6)$H<1D827ZZ'.E^:
ML)=*,A=,2TMDM'8I0KF0KJ-=I_1_6?)LEZ2@E0Y7,F2ID<?1$V9.$<<<F8T9
M@BH =&3%+@! !<8)G9%&99(A8@:4."Q!:@!9B [TON5TP>)O VGSWM0P+F+V
M<Z>9C?!;(:WA!EE+8Q\B1GMR_F$6TQ"W4V_&\S@9+ I5O,,,--I4S&:[N0"1
MRGY<_HSK+.G=$SA#TG%(G3O[>4[&3"940,$8[.E C+$C"CK0F9*!-A:$@9N;
M6K9X; :\6I:R>N)'%K@.U&\HQC'"KB3PGQF;QC[.G!E_#UUI@Q*3(\MK&:E>
M?PJPB&IIJT>4S*3*AM(0AU_92!S '4Z/Z(Z=$_JM'E.29<8LDZ6RR*:8HB\J
M5%I!*CC J82\+$U8UL<7*I^2P#+#[GO2I0P?-() )#B@-6:E:6?G+;!0VE)V
M! Y3L.4$IZ$CU$$C<>K8]-?WK)964"5"#%F,![LRL3$6DD%ZWTJ]*NOS<V;)
MF1/"S&K $;+V;%9[CVCZQKT9DX?XDO<=V95<_P"S')/G19 D ]=A].W\^NL)
MCA!SHX27)<0M1A_I \D,<@6@Q&XB@[BQ;Q1S$^"B?SZHBB-D0W<[."N?D]X;
MN,1\BE^5_I?^(?'5SCVAL/\ U4TF3]F+?_V2;GVGZSH\6(VPJY^38'Y^*"2!
MN5?^+^O4,9'\PY[P II,GNA)[R0-\2.8^/,=O;OIGEGS@WASZ;GN?D]PK@\0
MWNQ2<W_2^_\ KT$9)81#Y5,^1?"P_P!Q.X%TO,=P.;J?5OIGEV,0?P]$SY%T
M)(QSB#L)?BC=0]9^O?\ 4=7.B[0.P;B 51'DQN([\[BR7=1]?_BV_6=,Z+M
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MC$=\K=D.D I&X5_%.M/57*\NRZ;EO0\O+\BRV3+A$N>)H,G*99 .CCE1 B.
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MF6X,0 )MA8LS:@GY)*,PQ&$#,:$@N8R8H2 &LI>6%#5Z'/LH]JS@Y QWL?\
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M00&)K;22;:@ VZTBZ)R"(M%$8C_JCKWW FVU[-2AX\BGY*8!0%?Q' 4!S?\
MM;:[N#<$A>S?7<C?8]"1ZM>G\2NO$.<!'DPSOS-D\ >KU-":AZN$_@^0?E$4
M6HB.)QK!NH'IYT2?D5/)4$_X!Q*VV_\ S=;> V]C6VP^8[:'VE=>A091*#"D
M(D06![,X&@<WL*L@ZO9#F_WD9>I FQ5)KAMK5)^12\E+[AQ(Z>'_ +76O[/I
MKE^)'7D$--R>G_X\L-W  !0]7LB=\^9=_BQ767@;DOY%+R4P\(/$?\V7V_U?
M\#K0]I77H,TZ13_\>#BM'J]D?Q8CJTD:0>12\E-MRBNXD<H)4$C+K7;F/B=@
MT-B3U)'7?5@]I'7AP!,R?W7(?)X*'$-WEWOWAU?R-R=),<AGTL9)U/[Q\%Z?
MD6?)4E(3YAQ'Y =P!EEH0D^LA!:&VX/78=1KO.]JO7V1 ()L>3Q0,X_])+.:
M'+L0Q!MLM[RD?0V2 G.$UZ D5<6,7#V8UQU_0SL/]A?LE=F.CXAP>SO'R5-?
MF5Y33\I-[=S[%Q4^GKY46M\U+Z4]PT(TR1SI0-EJ()\$@?@^F^M/2_3\Z7E'
M2,4,R9+$<,L"',$,,9A) A<@5A%F"]V39')R6#,D@PPEB00'<!JN&!-26I5:
M>9C_ -LLDV4>MQ.Z>&Y[T['8[^KV]/9X$'&2B(2OSQ$D0FAO:EXHS6%PS%UU
M,J$VF+]7'9XJ._V_MMKLTSXD7ZCP4T4O'Y@C1IOQ(OU?1-%*Q^9&C3?B1?J^
MB:*5C\R-&F_$B_5]$T4K'YD:--^)%^KZ)HI6/S(T:;\2+]7T312L?F1HTWXD
M7ZOHFBE8_,C1IOQ(OU?1-%*Q^9&C3?B1?J^B:*5C\R-&F_$B_5]$T4K'YD:-
M-^)%^KZ)HI6/S(T:;\2+]7T312L?F1HTWXD7ZOHFBE8_,C1IOQ(OU?1-%*Q^
M9&C3?B1?J^B:*5C\R-&F_$B_5]$T4K'YD:--^)%^KZ)HI6/S(\?F^K^?I]>H
M89I']Y%M^@\TT4O'YES1Q/SCB- XZ\)^%>&9#1XU4YUAV=7UM86U,S:R&;'&
M&4O5RVEO*2&(;G-R2]]P$<RNG+OKB1$"7FD%ZL2XH*-_6S!42I=:XO5[Z"@.
MWU56\*^VC%S*CCIM\!NYN0T5C=TF=6^.B-^"U$Y429+#%\\]+=0X*:X0PE4>
M2V%-(6\A"5;@@2M3I2=]E#K#,+#7N":"#$CQ/ [UY7O:SF75CB#F#U$NLQY4
M7B;9YG-D-PK"Q9B<-*Q-O,B5;;J@TX+./NTF1_" 6"CJGK030F;$SUJQ+6BT
M&]^_N5$J'$CQ-M+*'^E"ZDU-VR\7OG&:ZNX<9M-RIQ-=/E8=6KA3;*'C-@B*
M[&R-QX.MLN1TLRD.R([:N];0A:E@<NA#M_;&S%V+C$^0U5M5T<+NYIK+8[T^
M-]KGARZ[&;=@6\-<G,_P%E)GEN/Z$N3SJC"_"AM5Q;+NPBN?7NS(*T .@D[=
MH1$0&F1A^_\ H?/8RSHI9+B)L "0STJ]3;R65Y,WF6+XCSL<>QWN<'8QIJTC
M925I4MR]<?0/1"6P2%->;E2RO;8$#Y1W&^LV,?XL?]:/3#FCJ:&7VQ98"1YO
M;9P4Y &Y4-MB=]@=QUZ]1[?'IZM]"([ID3XO_75<IH90+YQ/_*FQ@EU&F_$B
M_5]%=%*Q^9&C3?B1?J^B:*5C\R-&F_$B_5]$T4K'YD:--^)%^KZ)HI6/S(T:
M;\2+]7T312L?F1HTWXD7ZOHFBE8_,C1IOQ(OU?1-%*Q^9&C3?B1?J^B:*5C\
MR-&F_$B_5]$T4K'YD:--^)%^KZ)HI6/S(T:;\2+]7T312L?F1HTWXD7ZOHFB
ME8_,C1IOQ(OU?1-%*Q^9&C3?B1?J^B:*5C\R-&F_$B_5]$T4K'YD:--^)%^K
MZ)HI6/S(T:;\2+]7T312L?F4QQI/]YLT/4[T['0'?;]]M^KKM]7S:Y3#'"8'
M,4PN2Q+@$6$>JAERA;$!WQ *&[=/#?Y+?3I[#[?B/S^KI,FQQ0 "5,<VEJ [
M "RAER3_ #?_ .G A* /$;=?9T\-^N_A\=40S# "88Y=;VOLUC&SS5$J3=%7
M_>]*:SS95&C3?B1?J^BNBE8_,L' HLOA#G<N!A]33W(%AEU+*U-N*0K=*D!8
M3S@CJG<:S$9L <'/-6SBXLP( Y\%-#+)H2[-2+T[E\L7>V=Q?B\-;>HF0<9C
M<<\6XITM/D+ZJL''5\+KV^:AU.21H:E<JI5E#?3%9=;5W:)B5[IYMAK)G36_
MNY5C664U=U0=38"Z"#$FSOUW-JLN5UJ[4LJDS2LCWDCSG#$2,KH[:$Y6QHEP
M]DU5+B1:N'"E-K2T8KCDI #KA3S))*U @;TS)L1]Z&"&&UX0Q<4HUQ#X5N2*
M3 SYQ!O+FM*CDO@ZO+L_\0,JXDXOE5ME\>-$LJ3/;['&8L1"$!BLA%I4..^I
MI1:>EI0Z"Z\GY*]NG4$ZH$41']I$, "6<7WB_O%-2:*4WYG(I^9GUZKF[U>G
MAX>SV_.#Z_'K_5TUMIC?WD3B]SB+]EVJU30RG?./=G4P1J--^)%^KZ*Z*5C\
MR#ML=]_#U'^WS^S?PWU(L^$.8HHC5A:]E XYUW6&5*S@2:?[N'.]YA2;#$,Q
M(&WRJE/4=.LA0/@>O3;U]3O\VO/%'$8H'EQVDBP$N'<?7R"[Z.207B/=4O:W
MJ%#P .FQ\#U'MV^O;X#PV UTACF9PAS)D+NQPQ:SOVW47.*7)((?70E\-6U_
M1&NK3/B1?J^BYZ*5C\R/IU0)@_Q(CXG@$T4H_P Q%:M%SN0$)2"4; 'K\D@+
M/Y]O4/7[/#70 U!F1M;:2YYX4*V)$B*F=4XFF-C+D#C=QMXA<(>(1LU0H%IP
M.KL6B_AO/CP%/Y'@MK=O/L4N8N);)7.Q>'*80S;,!)4VEX._P0HCRQP1:2'-
MF1FM02<'(>EHK;:::D63R  !$":@M:U;'M=W\,#7=P3M/T=LQBE7;HDWUA9Y
M'281<Y?3LM1Z-O+LEJI%[216:]*DR#!G5#/?F6VDMM.#D5_"Z]1#&W]Y%;2I
MLNMP:^N%%S$B6*9Q[C$_A9Y+K-22A2DD[D$@]=QO\Q]@\-4B9=,BV_0JZ*6+
M2?$I-1IOQ(OU?1-%*Q^9&A$VZ9%M^@\TT4K'YD@]9( )/J\=OG/]O5K<N;,A
M?[5#%,@ ( H2;"+]Q.NQ=(8HHK1065[J=_=ZKK?LT\JJ?*N@Z6\,> ]T7X?-
MKXF6S94R:!*E12Q""^<![SFVF#$<E:7/V7U%N[E>1K;JK!Y*[B<65"*\H+;+
MIV4VH(V( ZC;?<;[';KKZ,J;##!#"8A^6!JAJ0@&I%A-#OL68@U!6M?YK'Q-
MAQ<)@]!7(\:6SW]?[UD;;_-\G;ZM:T\OLC;"GN]GY3Z!)Z#N#X4UD3[!'D$_
M4$[Z:>7V1MA1H<!^GZ)?05R/\S6?\GD;_5R[Z?:);MFC<VUF5:&UAL]&='H*
MYVW]"VFWM\VD[?\ VZ:>7V1MA4]WL_*>"3T'<?Q-9_R:3_1TT\OLC;"GN]GY
M3P2^@KG^);,?3&DC]:=-/+[(VPI[N'RG@E-#=#_,MI_)I!_4G33R^R-L*$0B
MX?I?R"Q]!W'\36?\FD?T=-/+[(VPI[O9^4\$>@[C^)[(_1'D$_4!OI]HE]D;
MN"-#@/T_1'H.X_B:S_DTC^CIIY?9&V%/=[/RG@E]!7.V_H6TV]OFTG;_ .W3
M3R^R-L*>[V?E/!'H*Y_B6T_DLG^CIIY?9&V%/=[/RG@D]!W'\36?\FD_T=-/
M+[(VPI[O9^4\$OH*Y_B:SZ_^[R/Z/_IIIY?9&Y5H<!L^E/%'H*Y_B:S_ )/(
M]?YM#E$L?RC<?((PP&P(]!7'\36?\GD?3_HZ:>7V1\J,,!L"/05R #Z&L]CX
M?O:1_1TT\OLC<C# ; D-%<]?[RV?AUWBR/ ^W=!V!]OC[-43Y> &MQLHF:,!
MLX>6U5[EO!'',XMJB^RO";"SNZ*'.K:J>/2$.7"K;,;3HC3D539,:6!M(202
MXD\IZ'7(SH31A6V_"]G\7I?@L$1 E@!A9YFOAZ)HF=G'A[/F)G.\+VV)"<=7
MB;K,"+-KH,K'74J3Z,GU\0MQ9[*4K4MI]]*Y#;BN<+!',)I86L#'TU,X6@"P
M)=[Z^@+)HK.RYPPJ$)BUG"YYAIF':0FFR;-P,Q[J((-PA(<4HD3H20Q*))YF
MP!U(WT$V&P0PU;"MFK:#KH A$1B#.U'J:UL#+:;[,?#>-8UMI&X92(EI4RV[
M"MGQE6<26V]'B)A-MNO,K2MZO\V0A @/*<CNE"2M!/76H9T.$+=P\F'=J%EB
MK,,>\IV<[/F"N+EK?X:!Y=B\S-GB1#DK,]Z.I2H[L\K!$IN.ZHJC-N;ED[%!
M  &N@RH 58M986J_>3=W5=UF&%G) <]W=<K/327G(VWZ'L"EM"4H28C_ "I2
M@!*>4<NPY4C8;#^#XDC0Y2*5!\'+L+:UWM8ZK ?R@]P'J1R%EZ#N?736?CU_
M>L@$GU[[('7VZIGRV%^JE%6A[([F=MCI/0=QX^AK/;V^;2/Z.LZ>7;FAN^%&
M& V >:/0=Q_$UG_)I \?_E^?33R^R/E3-& V!+Z!N>O]Y;/IU/[VD';Z?DZG
MVB7V?+@F:,!L"#17(.WH6SW_ .S2?Z.KIY?9'RJ-"+OE?R"3T%<CQI;,?ZM)
M_HZ:>7V1MA3W>S\IX)?05R?"EM#_ *M)_HZ:>7V1MA3W>S\IX(]!7/\ $UE_
M)W_AJ?:)79W?15A@-@0:*Y'^9;/^32=OKY=73R^R/E4]W#Y3P2>@[C^)K/\
MDTC^CIIY?9&V%/=[/RG@E]!7.V_H6TV]OFTG;_[=-/+[(VPI[O9^4\$GH.X_
MB:S_ )-)_HZ:>7V1MA3W>S\IX)?05S_$UF/IC2 ?J*=]/M$OLC=P1H<!^GZ)
M/05S_$MG_)I/]'33R^R-L*>[V?E/!'H.X_B:S_DTC^CIIY?9&V%/=[/RG@E-
M%<CQI;0?3&D_T=-/+[(VPI[O9^4\$GH*Y/A2V9_U:3_1TT\OLC;"GN]GY3P1
MZ#N/XFL_Y-)_HZ:>7V1MA3W>S\IX*7XU36J*C,DJJ[!"G:=H-I4RZE;BDR6U
M<C>Z?E*V!W3U/AN-<YD^$D9I9K\&!L&#&T!G?O4C@@B!.8'8-0UK@]HJ;%#4
M4]V -J:S)V1T5#?"T[)VY5;)(\">IZ[D_FZPY4\/O1XC\Q&ZMXW!UST8(?,A
M)+U,,-A%V]CW7467H6Z4>M-8^'AYL^2""?\ H=/_ $VZ[Z#*14&(F' DU-F
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MZ+VV/L/U'6=)!V@B0CU$'K_;V?V.@CAB>$1 EN>_P1.T-.U/;@;G=43;I_\
MW#H+0]X?QH"-PI:Z0E\ZC-3?#5,R =MMO$_/OZO5M]_YM:) !)+,'/=W6HO3
M8^P_4=9TD':"(V/L/U'320=H(@@]>A)VZ#P.YWV\?K_-H9D':!YYM1<<\>>S
MQ;\8LQM<DI74XCF>,XK4S>$/%.,X@V&-9C7R)/G--8QT?NTO&;F)(7%MH3B%
MLOM+Y@CG0DA[L3  %[Q1ACWX<$4,PG@)Q\J,GP^3?9C';C468XGD2[.EGR(]
M7&Q6MQZ5 RS 45">5EQBZO7F[B/S-%I+8^44K2$ZQH?]<6WGG%&K4[Z6ZOKW
M,5WTO92EJ2DI2I2E >P$]!O\PV'YM!*8@Y\19D2;'V'ZCK>D@!(SA39M\T1L
M?8?J.FD@[018D[>K?KMM]>M N :5'.^B*X.&AWKK([;?OY(V^AA!^OJ=]>2:
M7C.JFQ%0=_Q!Q.%>7$61%N5OQK"2TZ6 V6RM*R%<NYWVWW*?I\?'7N&21Q"&
M,@ "&$U<.X=_&FL%K;$%36G/>FD<2\.]RO1^9K^8ZT<EBN#Z_>XA$GXR\/\
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M.O,%4T!+2B'02$ '4,V+>;3M#76V5 P2'\U3;KQQYM4?I.UME-)Q&FM<0K.
MSA<=[-$FIKA$E.I5#-6G%VT3V-EE*7[ )EKYN4(*E*W2-;$XX1/9G /5[0:
MV^)V+N^OGD#D!6GQJX]YA3=G1KBKB==+P_(CQ"Q/&%5\PP)LF3#MLCB4TIR
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M-8UXO?$^'-8[^#]^?"DLA_J3Y^/ZAK<4^5$ ###MLVEMBYF$FR$"N/U;8D]
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M.ON19D-R6Y2*6^ZS/[L3$N*(^6J0EIM+CJP75!I'RP1N)II>HD5JP#ULUV#
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MD>K1G%7-;Z&E]&\&1)Z2G^]O?:/3[OSZ,->T\41Z2G^]O?;T8:]IXHCTE/\
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MK>A2>C[#J/,9?4<I_<%C<;^!.VKI8,?+BCG ;3P2^C[$=/,9>WB!W"B-]MO
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M?XZ<*FICE4SG-#,N!62;:/5QIC:Y4R+'K';=(CD)[HN/P&E264E7,XT"M*2
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M7]DA0HX[O#"MX32*^XA1IL+)G*.'Z);S24U'4DLEVI<D0XS25(>:4[WI7S)
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MO%.!W$SA5C&4S*C)>(_X72K/B/&BMINF;3+I#TA<P<ORE,P.]2Q&C]YR)9;
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M%P/!+S$L(OL<<O*!<R>Y9*IA3X\S4X_1QYC2D1HR*IM9+Z$ \TQQ2^:0I2E
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M=)Y!NG?E]@!&Q '@ ?F'CUT18F.T=]T#K[.A VVV!]7K/TG1$J&6T'=*=N@
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(C1$:(C1%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g729258g90l67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g90l67.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1IF4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &DJ^9S X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8/XU         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              10   )*
M  $                          0             "2@   10
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   10     4F=H
M=&QO;F<   )*    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $4     %)G:'1L;VYG   "2@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 2P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MHZO1S+IOR/K<X^F<6OZ?\Y66L$ XUC3N?=:YK'?KE%GZ+U/\(Q:O4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*KEZ(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HBXBRJA3])#<<]/GT^0_6-W
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MDQ& U;**E\=8S5Z@F)450("BA0$J0<%-%7'&H):QX9G@ZJ$X  34#CGJ;^\
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M1-$31$T1-$31$T1-$31$T1-$31$T1-$6TO\ V(_F' <\AP(AP(#R #V$0XY
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M%%7>0J3!PR\%@1SXG+SSSBHQN6T/'H3G0/D0U00N\WN;.]V>2<58YV^H;5\
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MX[]^WRX'MQ\>...>_GWT1:?"3Y$>D!$W(&YY'D!YY >1[E[B %\@#@
MBVUVC9RF=%P@FLBH0Z:B2I0.D<BA3$.4R9N2#U%,8HB(<B!A#GN.B$/0JF:6
M#L/M\7O\*,\;4Z.Q))Q,G!/\=1<&RBJDXAYI9PXF(T\-')-6A6DHLZ<JR"1$
MRE=G<+"OU^*?D^?GG!1J-Y3C=>[@*]"5:#AJU78QI#P%=BF$%!1#%/P6,5#Q
M3-&/CHUB@ ]*#-DR;H-6Z!.")HI)D*  4."J\+/8/P_:+S#Y,LF-:;.W^OH1
M[:$MLM!,7\W&)1+I\^B?5'CE)0Z2L4]E))Y%KARO'.I!ZX9J(*NESG(JH F4
MH   / %$O<3#V$>1YY$>1$?B/(_;HB^B0H\B(#[P<#[QO+S^?;\G&B+;]71Z
M^OPP$_/5U"(B/5W][N/UN_'/GQVYX  T1=?*P,).LU(Z;B8Z9CU@*"S"69MY
M%DL!1ZB>,T>)K(*]!NY/$3-T#W+QHBYR#1JV02:MFZ+=L@F5)!N@D1%%%(A0
M(1-)),"D(F0@ 4A"E I2@!2@ !QHBWN@O// \B A]8W' CSQQSP <_9HBT>"
ME\4RC]X=7'?G@.>> ^0!P >0!QHB^%;(%^JD0//X<]Q-U&'@>>YC>^8WF8_O
M&$3=]$7T$$0'J!,@"'/ @'<.H  P!\@-P F . $P <0$W?1%\%NB(B84RB(B
M!AYY$.HI@,4_ B(>(40 2J<=9>DH 8 *  1:A23$>1* CV[]_(#=90\_(IA$
M2AY% Q@*  8P"1?!12'@1( B!0)\>Y YX*;O[Q0Y'W3<AW\M$7T$4P$1Z ]X
M1$>>1\_/@!$0 #>9@#@##R)@$1$1(@(I@/4!0 W;N B B!1$0 1 >1* B/NC
MR7X<<:(MS1$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1?#% P
M<&#D.2CQ]I3 8OE\A !X\A\AY#1%H!%,/(OQ$1]XP\B(B(]7(^]R(CSU<]N
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M+W*MIEJ,Q(3<S,%8)3YHL\Z>%:2+URTASSQX=@I+ Q21];.AU !$U%B'$O=
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M@CMA)QSQI9%FSQHY2_%+(*IG*)#I"8GF'(F W 7Z'V*$N 1K#[A7!2>0_?\
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M^R\>N7KZ*0V'(>R:*IHBI/C^N2T&\OKB8(0#3]UF9B.5(N145HIPH46/B=
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MMGP%!LX.Q5EG$8?QW'-:];A(-IA6[2JQ:*,98A2_%>VF:9"H28) "97A%BD
M   U%D':M_/.%E7W1508WV_VN[>/WU>)/\Q9M47Z1>Q4-NL/N%.0GD/W_P!
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M10_U0#(C*AX447]K;5J>-RN=1 BAR9RRJ0@F(4QDR%M3\@$*)@$0*4O8"AP
M (@' =M<#8,F48]H;TN7$V.Q @WH821#OTAA<%@ &8-RJO<_&TZ:/]']V9'
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M^<*B_M7$?9^60Y[?AUROV_\ Y5(:X&P/YMI__?S_ /S*]U\;6^'?_P #A/\
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M36M+<NR+.U2#G<;Y.JA[=/,ZO%24[7RM(WVQ(H.E6;=PY(\6%,3E:KF*84S
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M9Z+SME*4(.6#I+[K!V'8 ^")PY_+_P!&OABV^4:L\,50<_V6S@8HAC)5369
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M5G<+76)AVZK0CQ\JM'G(W*^=-V*:JA"*"<Y/'<I\\%#MR/?N [LW&Q2X@\!
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MG5YQ-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$6VJ(@F<0#D0*/ >7(_
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M,V#'50F)-\?Q7LA(P3!RZ<J@' JJN%D3F4Y+P4!,(B !Y\=M9C$3)8W1-BA
M:F\6%:>N2V8<1.AA AB,(J'H^K/KU.3**&['"F(H/'$$\A<<5",<*Y/QFT.X
M80$:DLJU=6^,2<-CG(@4? 73,9-8O(E.F8Q3 ("(#T-GXJ;,FS!\\D"1-/U&
MF\(7##^[3-='9^)Q$4<0,Z)MUPY)9G]F'&H:])');?L("@B(8HH1@XYX/6HS
MJ(IV$..6XB("81$QNX=PX'MSK4&+Q&]$8<1,!S(BB'*@]K^JU)N,Q<,V(01Q
M1#>+L133.A)M0-P51:=1JA1D7#6JUF&K+1TMZTY:PS!LR0<.C$*0SE0&Q"%5
M.8A"% Q@$0*0I>>   ^4R=,FD?,F13(A0;T1)Z U 6O,Q.(Q 'S8HB(:@$NS
MZY?@ZKW"'U!_](?Y@'6"^2WM$5@3TW^&O1]Y-9X/F-Y68K%BN]UA2_)8/0K+
M)6R2-G>S*5+^EL:%)4:.XVQI%+%54BA9'P$&8._>6*1VH8K\OU9O92SG6AX"
M^H< N3^BBIZ+;#LE7=S%4F:QM*P..*XU"76A]R4W5JSA[/$:NY@)=)(8G'U:
MGYQG)I2B)RLI!PHVBEA:/55E$NLADPI#:ZU^VO1LRR@+M8U:G"KGPY58A91Q
M!$Z8]/(";D0X$I1$ ]T3 )OB(B)TPX*/O< (@ ",62QD=]FT_-4CDO+^Y=UC
M7T=5N0IYWMDCS7D9Z.N4S 5DGKK$MQ(C.MH60F&22!T^'C)4BQBI(&\PU7&C
M\]>A%/:W%8$5NP>K-S%&J3U<#BROK[7(JEV/;SCVZQM2IL67--!JM_N3:K0Q
M8J!G92V5.*.]7.P.4RYVXLA1:((N#'.DT;I("82DY&'CP]J>BR%F%!6EK$C+
MJO<MMO6"V4$M6&F*:(A7W:[9=:%)6X_V8HY9@8S5;U/P3(D52 QQ()2IB'B&
MY^L/-<]-,NR,-->KW?7JH^;U8]C$TS;9&Q;)M&Q[#=)B!JQ8LT4V[5HV1;65
M-)!L@B4B2"*90Z2))@!"!V#MH+](O8H;=8?<*>Q/(?O_ * U%5!/(6Y#+Y-P
MMNP/B7%=:N+VG4VKW"4E+'<%JXF9O92KE;-FY$F#P3'36;' 3  =7'P^/=P^
MR\$=FPX_$XF;+BFS(X(8((!$!N1&%R36T+TLY)X<^;BYT.(BDRY(C$(A.\2
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MK/.R%LH&X+&"6WR'VUV/;N6?B ]M;HE\%U[/,:U1>MS1RF/6="?.K1+S!B=
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M]N=V-;6=WLA3Y'<7B&M9/=T0DTE45YU-=16!^D9H4)DS,45DS$,]+ Q)E>D
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ML[PMVK5VZO1?#X)W*@'3^K#NA@[_ /B\Q: B/S[U8O/8>.W_ &_/^+V02_\
MAT4)-X89T6Z-*,6<"[]C>108I@3&YU N1_\ +*@H[<<J?[<JM=:ENQW(1-XR
M%)9-F1Q5M^=C8)2'@H9T5FM*9=31CRM8"/C8[PVATA,94Z"SKAVF(< (#KI;
M6G82;L/9,6'D'#@8C&#=?>!)F@4)#N^0,(U)+*R#B1'$)CF &'ZC=V)<6MU[
MT5PHH 9(#&#I$0X,4W)@$1\P*(]Q*(]73U<#T\=0%$1*'DR0*$N"8N3$V+Z
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MC!?,#8XJ3!NX@</V>ZKN%A24;P5G,@HS*0@""RPS=C8(&3,("0"H&*< X#H
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M1?1"!#%*C#B$&$WAS(>IIHSK=Q\K!.\DEV!<F@>K.2_&^5:%XKFI #JY4X
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M P"!SE$1 P]8G$3'$>0'W2<Z[ (H(J16YC71\N/4KQT?S=\N!$&)>@8MT#$
M,U&LUA#G*Q,F7'/<#CJK91G,>Q1L=3MH=>PF,0\.]>LIV B6Y5?:S!^D1,$9
M194PI)D.)RDY.)>LIN/CIF)BQ<J7)C,J$ EP 06N"#8GF]@'HO(XX[0Q&W!L
MV1M&+"0'9W\41# (CO"9!+%"#3_,J7)I>JT2>W/,,FP>P[W=%?%VD@W5:KM3
MP5*X51<$\(Z9Q^C9N 4(<Q!$!+QU"(#WYUC.V=C9T441QD4N$PM0!HLMTN>K
MVR8-61[$VK')G82/XAG1B<"&,B6\(.AW'J"07!%2N/!;9\KUN)C82(W-WQE$
MQ+)G'1[-*'I8)M&3%N1N@BB<U:$QTP2*0AQ$3"!@^8ZLC#8F4#"=HF*$"@ A
M[AK:&PKW2?A[:F&ERI4&WIX@EC= ,N7#8, 2(81:IH!5^7)QNUR71,\MZ/:,
MJ3N1(63HTC/>!--(9L9H_:RK-LF+<T5%L#'*9%<P& YSD^1.>!#+"&>,7,AF
M8@SH?E.( &((C'U<011^?--G2]H8+:_\)BMHS,9+CP\4T01@0[L6^ \+,2&+
M%^8"FV@42F,41'ZH#W^8CR;L/?L(\=^==A>O6Z ?C#!\.D!X_+SHH P]2=2M
M? ?(/S:,-%5]X /( #1$T1-$31$T1-$732SMJR26=OG;=@T;)D,LZ=K)-VZ9
M3G$O6=900 ABF "D*<R951/T_C.! ":K%3S%@+<%'7#>M#J^A]'=#.YBRK8I
M_&NX^V94PRA-MH*3@X2*BO42S4@O8X>-J;I@H_K2,>O#***K BH6/,W*\/:9
M=[:97\L*K&MJNS.(8C7VL^7-V5[KT?>0\VV+"4%C_.N ;Q@FSX=K='HR?T^R
M10\B6*^IQM>19K6IXM2'KY*+,\78B86DDN95P*_"*JHI^(:>>>BH_7-[]&TY
M!7 VP "7 "(^\;N/Q$1Y'@!$3 '(CP"GOE\A[ &BJA!OM_M=V\?OJ\2?YBS:
MHOTB]BH;=8?<*<A/(?O_ * U%5UKS@RAB";@!#C@"B(B)B<AP< 'CCI >"\K
M$ /$+V'7RC,(B@AC+B,MNL*][A0B(VY?:^5QEU#JWQGO:WN9S2UR)41W:M*]
MC&]DD&(4L,(U64<1==?G,"<-])3R[.2=*))<(C)JB@\4%/JZ1YZA]=L7;>R=
MEXC#XF?L6+&3) ))_C8Y4,<3$;VZ)<8 W3_+4%G)&>CB,)-G @S (2:AG+@@
MV)%LS=V7M\'8*W*XQEZVVNFZ1MD+'M>C/9 T=+#M4JZKILBS,QB_ZY6$G(2C
M0S$W@JJ.?$54?> )50*J)B!J[5VOL?:$R=-PFQX\!/G3(XP8L7,GB F)S3<A
MA((#@.!""PLPSDX:;*A@@,;RX0W\MW#MO.Y:*HI5LKJ;!3@*8 / F$ ,)^DW
M B/!A'I-[Q>H?V(\B4/=$.0'7G2"27A!!SH[=?T6X U$(!BG Q2<E^8>0\=N
MX\=A#Y_#[AUE" (0(8=T!V%LWL^O)0@$F(ER6)T#!N5N:* (@!_[[GGI#GN
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M'#%)@$,4P3 0(15B+L]B<PSZNNU-^/?B6."9)F[3BBDQPF&(&3 00QHP8W)
MLSD79I/,&R3=%)L@F1NV0;D(F@0.0223(F4B*9@Z4_#(02%( =Q "]^PAKKR
MH),N$0RX0&H&-&9@*<6_-5XZ='-FQF:9F]O$DQ_+W#$23]3DO7ZBVN86\L)
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M$31$T1-$31$T1-$31$T1<"4;M7D<]:/FJ+UDZ;+-G;-RB5PV=MER"DNV<H'
MR:S==(YDETE"BFHD<Y% $@FT16H+5Z';:B]G9&;QM8MQNW5I+OSOYJH[<=Q6
M3,3T.6<+J"*RRU)KT\WK441V!EQ>##1L2=QRIU.@%0QAK^[^9=6?BHP=^#6!
M/<UUNXJI>[8MFVW?:8REFV%:*6%F;6)75NN\[,S=TR+='"1S&!>V7RU24S:9
ME$BISJMVKZ3<1[=02F:E3,"90GGG?-7(6H+Y_CL%+'1$T10;V?\ ]TK?9^^V
M4_T?<"Z*F_2'V"F\X 12-QQVX'D2]8A]I0X'WOD/PY$=%%2S)F. R7!)P9KK
M?J-X;Q)X,GCRR*UJ7/X)  &JT@DDJ*K$P\"9(""7J[&$ [A]9,XR)@F"7+FL
M"-V:-Z&N;:Z<RL(X!'#NDD5=P5%YOL7KK*QO;:USON71LLNR:QDI-_A9<!)O
M(]@8RC)HZ=$CSG63;&.840 I0#JX.;CRZ<6V3%*^3%A\'#"&+0RF+M8/$U?Z
MBSZ$K5&$ B?>F/8G>%12]'ID'4O<?4\*+7HVN#8[7:S,DU0]N7*9&=GW76H)
M^'TB;PSN.GG\7RER7OSQY:Y4R/YD1CW887RA  ]/=;D(W0 Y+9DN>Y]E[W6"
MJ:(FB)HB:(M!RE-T@8.0 P<=OCP(?]NL8BS?\P"77'6+TDY3*!C" B4PAU%Z
MN!XY  X#S 2B !R(!\=9=0/OR6!)#B$.W,L]1FY';FH;94CMT\Y*V2(I!,0!
M2GZ1F4<>=^FH60&SID"+LST6!@8$7(LHJ+<Q2J#X94"F* &Y#G8R5BXS$))@
M(=@2<@"1:C\[EV7F]I_XW-WX,#_""&(L\[YN^(#":C<#"($BX(9F"Z?$M;W5
MU%&F5N>2PT:EP#:,A)!6,/<S6)6+CD4VJ3ABHX!.-&0.FB8YB.$>CQCFX5$0
MX'&3#M&7##"?EFC1$WW>+T!<L*:Y%39\K;$OY4&*_@S+AW8=Z SOF%F=G @)
MNPW16C9B;K,#AU=?8P@ F#W^/^;P"GPXY_L?N<\_'6_!\S_>"'(@C7VUMW7J
M 0P_NST\'WO9<_7T1-$31$T1-$31$T1-$31$T1-$31%%C=#N@J.V6&JC^P5>
MYWJ=O,\O7ZC3*$VAG%DFG3"+<S4LNB:PSM:AT6$5%M%G;Y5S-,S=($31!PLJ
M1$Q///-5&_<1EJGYEP?M&RG47BGT8N^X_#D]#>TTT6#\C-9&T$41>- <+E1<
M,W!%FCDI5#$*LB8"F,3I.>B_0^Q6,5830Y4SOP5R8DG&@ \R#$.__G:'V?\
MXFHLEK]IQO[8L?X6W_2:(GM.-_;!C\O_ *6AY_+^R:(GM.-_;%C_  MO^DT1
M/:<;^V+'^%M_TFB)[3C?VQ8_PMO^DT1/:<;^V+'^%M_TFB)[3C?VP8_PMO\
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M2KTJ&]=709&=O960>R$F[<2,M+S,Q*.'DM/3DJ]<JN7\I(NUW3ERNJJH?DW
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M4E3QSB4<F?O(""77*+AM68MRH=M",5%5?5F";=,IBD*5-.*CS1\V]ZZJ: B
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MFS[;!*WC8)!7>9P5EK,M8R>$#DN->LI-K#2UWKM88(I.B05=EW*0+ Y=I*N
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MJ]7>C6;\CV>WJSX^]*WLA6:[C,2Q8,[#*VW'F2*>*Q7T:PNM)F'$',2]-G
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M0A"\$ IGT'N:MEWKQ97&ZKLHVTTO<#:=T59Q/68?-5RC&\7/7-LQ3!THFAU
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M2IKJ&Q<TX4;WJ? ,_3[)?1WX_P R8SPSDNN9^S))[-C9&;[B,;[4YULR8TJ
MR)!6MQ+,E64BNDYLSC'K*X-'EJK%<7E5&8F7:NU05!0>;1LW]/9_7CDC$D$D
M4#,/7[@\.-L@P6B8&16,@F*K<ABI*'3(HHEU%*03IB)!-RJ'XL>@R?20  0$
M.^HLO//,UV#<HE1(42]''4'0 ]0%]X>"@/ >Z =BAQV#@._'.B+>T1<8Q0-Q
M[HCW.0>DH<"4>1$IB'[#]_E\0\]$4>*-MBPSC3,62\XT6DMZWD/+C:(:Y E(
MM15JQL"D*98[.0<Q"9B1X2JP*>&_?IH@Y?$30!PL?P2 !.//[>#JI'$#@I0#
MC@"@ <>78..W/?C[]$3K)SQUEY\^.H.>.>.>.?GV^_1%9Q]*!N8PW"U-+#D!
MN#I%!W:UBQU'*>'Z5)6!=@XG+/6),)",J4\NVXC8Q"[QXR$$W3G'C(CM5\W$
MA3E* @\\\^ZCWK:_WRRS:M-:*'6)<?LMYF0YO=ML)W02>S7=#:(]A7-V>#++
M6HVRM%[5&MA9O).QXWFEFYRS2*A3A%6QJ19B_;BFY(HJ8PJ:*OYYW5XO9OM%
MJ^T#%KJBQ-@G+S:[7:9J_P"3\BV(2FL&0,@V9R,A-V*5%(A44O&7-X;)J@4J
M+5JD1N' %#1!3SST4R0\@^X/L_D^&B+[HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+8<E,9$X%,8ANP@8H"(@)3 /(
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MV$J!!DWPM6B9G"#5R_,X=MVAW*A405 @#P' EDI-Z(FB)HB:(O@B  (B(
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M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(MEP4#)& 2B;R'@.0'L(#SV
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5(FB)HB:(FB)HB:(FB)HB:(FB+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g729258g91e38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g91e38.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1F>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &8*^93 X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8.6B         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              +P   %H
M  $                          0             !:    +P
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   +P     4F=H
M=&QO;F<   %H    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   "\     %)G:'1L;VYG   !:     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !SA"24T$
M#      /'0    $   "@    5    >   )V    / 0 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 5 "@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M9=6=2,<7759+7;A5CAU.0WVN&ZRBYS++*?=^;^C2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@ N@%E P$1  (1 0,1 ?_$ !\  0  !@,! 0
M       ! @8'" D$!0H#"__$ %T0  $# P($ @8&! 8)$ L!  $" P0%!A$
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MOAV1Q/1-!N =12L,@7J; A?4>C)L? _V9,;M_@:&?U_3?7YZ?LSB/_P.J_\
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M]*V5E+B"-=GV5[0MX$]SBTN+B#G,#H?Y^&5YYV[[)5>TNF92I.:R!!YI&=[
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MUGJ<-I)D%I:08OOX?65L#8GQ*R*14.-+9(DU.FVSQ5V2QD&;2A#VYWABPTG
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MUPTZ=19NWUTWTVS%J%!DU LU&Y4/NKCU%AZ48DB6M4EI 90 2YX02LN<C9:
M R]'2XW3XII><:MU$$<U3F?R $Y<Z.4 CJ;K2]J.$]A/^Q&K%.AP-G$0'BG[
MA^G=4Y6@@0WGYS?NV$+,+<SBM5N+3S&9I=4FU69$]2=K%3FS+BKTI+@Y&XL=
M:TATH7V$=E#Q<65<J#D:]XI.BC0>+N:UO-!DX%[&3<;VM,"5^=G&139Q"HUI
M91IMJO:'TB (#W1+A:8 L<',F5MQ]$#L3N'M3M1N)>NXE!G6O-W8N^+7:'1*
MHRN%4V+>IM.3!C39L)QM$FGOU%7V[464VR\B-R\S86H:K>XN!Y1!F]R,W-\>
MG7I"QQ$6/,-CL>_?*W"I.1]\?BE1Q^( _7[NVK094O\ $1X0/U16UW V@VQW
M6I;M%W'L:W+RICPY/5Z[2H\S /7,=YU"Y$4C/13*V"">XU?IUM12/P/+3UG/
MIM;$;XB4^OK'YK&%_A/OG;P>L\,._P!>VV$5@8C;<WUC=K:M2<DF-'I%TK=N
M>VH2@0DL6G=-"3RI 2WV)S*>LH//+KM,RJ3]YU(EM2V_P"#$XC??!D&>AM O
M^<CYKX-[^<3NU@+6_7#5,O2C,J^TW"X:*HF\X:6QA(E57;.[9-"N^G$_>+%M
MS[R<&?9:4$XU9%"E6/P5&M.0*I#8@V'-@9WD^DIX;V[][1-YW^INEMYQ@<.6
MYM0-"M_=:W:9=06&OJ/>OKVV]]MR,?[D59=]Q;<N*1TSE35/6#@X)SG5MV@K
ML_LV/?$P:8+Q<&QY/SB( )0>LV.\7C;)\/G)"RE2XVI(4%H((R"%)(/R()!_
M G5&,J$\1O\ 31WY?O)^]^CW[_#OHD'IW^7539'O'?'<=_=\_AHBX%1JU+I$
M&54JK4H%-I\*.[*F3Y\R/#AQ(S()>D2),AQMEAEH EQUQ:4(Q[2AJ0TNL 73
M: "2;8$=R+7E6]Y]P.*NHO[?<+=0G6QM>F4[3MP.)I^*1#?B));FV[L?'EMA
M-SW%+0%LO7NY%7;-"C\TN(_5)ZDLIO-ITM)!J@/,<P8"#<X+BV>LD ]T3<3]
M?4?C=9>[4[2V=LQ9M-L.PZ,JFT.$XY(E/N.+E5*KU27AZHUZM5![FEU6L5*6
M%OSI\AP/NJ4I06I(;:&/6>=22YTM).(($;1-X&T$>2CZ_%7>" /B=4A@WO\
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M#!/Q&,DWD3;K,8SX-OYX_P!1'AY@GORX H)&/B?(#YYQT'?YCXZEQ(+0 8D
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M@FH^C1:7/(<0PP&@EIATR1$ @P/B6^X=K2X-95J-$@R"X VG8G:!,&#FY7L
MI\J++;C38TAJ1&D,^L,R676Y##S#R5.,O-20>5<<M86RMOFRV\@E10L$^$N=
MR5'4J@--["06/!:Z02'"#!EI$$9&ZWF1(,MR"#(OZCIO;"[@$'."#@X."#@]
M\''8X(./CH"#@@^"*.I1-$5/S:'2YSOBS:/!F/%1 ?EQ69"PDDXY5*;DK( Z
M<JU-H'0<H&B+X_5:W%#!MVB8QCK28P5CMDA#'+DCJ<=,Z(N,Y:EL*;4%4"BJ
MR2"%4V"<]_)3!QC]7;(U8JTQ5(YV->!/WO*=^MLCS5^E7K4/[&J^A:>:F2PG
MO,1WF=]UQ/J5:)"DIMB@%0ZG^YD//S5B/D9Z]<8SU&H&DH-;)T]+_*T [R;$
M [W'IMD_MCB,AM/B&I)'*)=6J3,7_>_+RPHLV1:*"2W;M$YC[9 IT17*1UQR
M^ 2,>61\M!IJ 'PTV";P V)\8N/5*G%>(U&\E;557,B""YYD;D@F_7'B5]Q:
MUNY"D6_1$*0K*3]$P@X4I',@MJ#">1Q*_NY.<ZOM8&X '4#:%KR]E2]0!T&T
MQ8R)-YD$=;STRN]2XPRVTE*$H2DAL)& G/;&#D9YL#&<9. ,]-45'%K>87O?
MJ9^O&8[T@#X?P&W=@1>W5?=#J$J)YDE.<$)4"!DX [X)YO9QTZ].^JQ/[P(,
M#-B9$S$!3:.8.!$D'%LYN>B@I0;6DGID^R.A^/D?(=_=TSJE[B!(N)V$_P H
MZ^2ID2&G)P-SG;?O G\U*B0RGG42,I_F=,YQDC'4] <D8SYG&-2?A:ZI&!<F
M>F#L#;'=D;28:>0'O@1;O-YWL3N3UOSE)#B<'SZCX'Y>??J/_P"ZJ16EW!V2
MVIW4@&G;B;;V=>L;',EFY;=IM8!7D?:E<Q@K#O3 ^VR!Y#OJJGJ=31^XYX$@
MPUQ@Q@D?=ZV\.Y3,?S_+<>4+&T\!NV]OMNC:"_\ ?38I;CG,S%VSW<O&#;S)
MZG$>RZS4:]9#:3@##ENI'4#(/45'4<P(<&D[R(O/2WR\TD&/GO-]Y_4CPNOL
M[P_\5]'7X=J\:]TU" A/AQV-P]G=H;BEAD#L].M^UK1E25Y[.2'VE?''74\[
M-V0;&Q@2-\3ZSE ?+?&XQGZ[E.K9SC6F-^!,XP*!36^G\HM[A_LUF?R]1GQ*
MY4+AB!7O_DN<X.,=YYJ(_P#+/^;?T/\ ))W@>&WX_A$;+XQ^"&V[JJ$6J\0>
MZ&ZG$@[%D-3F:!N57(L';N/4&3@RV-LK)IMMV+(())AN56BS9D0 #QG2-#J0
MS^S#6SN()@>'?/=? 43]0%F/2Z%3J+3X],H]+BT^!";;C0X<!AF)$C1F,)89
M8C-MLLA#:21R! :5C*G5$:M$EQDGYD_BBJ74(FB)HB:(M;_I2<?Q3JGGM]>K
M*SY?WQ-\_?J1D6FXMUOCS4X#C!-L"Y-Q8"\DX%C=>9>XZ?%K-X;5T.H-"13*
MWNIMW1ZG#65AJ;3*E>5%ASH<@(&'6Y41UQE;:B>=*RG!!QJ*!875^>F]ES I
M"TD$2#!;8Q\4 ;Q *LU&MJ,:XBK2Y2'?UK"R' V!Y@V-K9Z]!O\ ^(;CQC<-
MV[#VRM/H5AV[2;;M>VI\&H7$U.,:6S4*<A]N+";I;K(BF$CE92W(#;:V@.24
MXLAH^B=E.QN@XWH75M17UK'<_*/=>[+1!D9.UY.+'(QY#V^]I'%^S'$Z6ETG
M#Z6II&F'%[VO@2+EQ9   DFUAS&2K/CTL;9) J^S!(ZD"+7\@=>^*B<=CUQY
M'W:ZP^S3A(M]NUP)P"[3CNZG?N/@<+@?^^[C>^@X4 =YK?E!/D9Z743Z6 *!
M2*ILSE0*0/5[@3U(P.HG93W[CJ.XU6?9EPG#];KVL-G.#]/(;^\1%%I) N((
M,[C*'VV\;Y26Z#A1(!+01J@"0+ DO@ FQ)L-U0VY/IBU6!9%RWHQ&VINJ3;M
M(J-4BV]1XUPMS:I)AMJ4U :??FD(4M21SO(;<$9HE]QOD0K&!Q'V><#T.GJ5
M--Q+65N5CG0^I0,\C"Z"!+KP)'Q$;23?;\(]K?&^)\1TVGK\/X93;4J4FEU(
M5^8,?4:UQDNY1 )+2XD MDJ^.^G S6N-B?MCQ*6)>-I;42-P]E+!EW)09UJ5
M"O/R)]3CR:XQ.74J;6**PZN)3K@AT)P.4IQR4W3&W7)!0&Q"\@U(.GJ5:+(<
MP5N7F?8AK7$<PM$D P/ 9$+Z TE3[53I:BJ',>Z@U_*WFB7LY@' G$[DGX1;
M=9,\,7"%?6QO"C<7#@_N5)I-=J]=OUVF[F6+":AU:GP;LD-RH]1HK-7]>%,J
M,2,[)@)+XDS(\C$R/+CJ:#S=H'!L=[&WKW+*$_.W=TP1F)\UF)M=ME9VT%BV
M_MS8-#:H-JVO %-I5/;7SK<5S%^5/F2GB\]4*E4YBW*C4*M->D3ZE/??EU!:
MI[S[JY<Z3)S@#PV$IZF/PGY96L'B"XT.(C9/<G=VB.1MHEV+:E5VMI%(NF?9
MESQA;$#<F+>%5C5>\:DK<VB4:>W2Q9CMML--5.U:;4[BN6C*>K-,AL26W(0D
M>&?0?7T5VFQ''CNQN+2]R[_K^WTBH;:VQ1:7&M.JV=MK4HC<^ZI=J4FY7YUQ
M2W-R+HFTBC,B4\)31MIZ# BJC2&+LG\P2H@,XOX7^HWW'3$W\]'GQ-7GQ3[,
M3K_OR'0(U<@7A(I3<BUXWAV[(I<JCT2L0VXLINL5V'*J$-VIRH%0\"H/.,+C
M(;EHB3S(CMD6P'(SC(S[O/\ +1$T16UWG_\ 8_NM_P V]\?]F:GJ]I_[Q0_X
MU+_K:J*GW'>"_,*E_P"^%2_^8U'_ *T]K[JX#_<M%_\ 3Z7_ /"%Q&J_MG?[
MQ_!R^ ^ZK_[?VZVM#^S?_ON_ZRJ'89X?D%+JM4*9..89_7\M5,^\//\  IE%
MMH="D.("T+!2XE:BA); Y5\RDCF'3FSR]<' ^]K&U.C;K6O:X-((Y?BP03<=
MX ( [^BM^^-.JPW^'QW!DV'GW$ KT3>B*]+C)V=GVUPQ\3UR/2MIYTAJW]L-
MT:Q(2IW;685MQ8MJWE*7(4?J(ZEQM$*NJ==5:C_JD6I/F@(2[2/G#VD^S_[(
M:W%-(VFT, ?48"&FISU&,^& (=+I!, M!F)!'5\.UYK%E&;NYHZ_"TGOW:2(
MB_F%[$J=(9EQ428[Z)#+^'&G6G0^TI"TI*2TZ!RN-*20IM:2I*T*"PHA6O#B
M"TD$1%L1BV%NCG;I81/>N=J%":(I2I(Z%20?<2!_IT1?%4EA+;BU.H2AOF"R
MI24A/+GF)).   22>P!)QC5+WMIM+G$!HR20 /$FP'>J@QQ<UH:>9T<H@R9Q
M R9D8F9LM<V\GI)>&?:&N5&V9=8K5\UBDS%1:U&L&FIJ\>ENATM+;EU27*@4
M=UV,O+<N)#J$F4ROF2N.E22G7':_MWP+0U3ISJW%['N:\4Z1=RN:2TRX3(D&
M#8'J%[3V4]@7;OMKHVZS2:1FBH>[:ZF[B3GZ=M1I (<P%@EO?<X$=+X[ \6F
MQW$M#FHVNNYJHU:E,LO5>UIT9ZF7%28SB@VE^539I0MR,MP^&)L'QF4N#E2X
MH@:V7"NTG#., -T^H8^H?_+YFFH9W+&DN$F]A8KC.VGLZ[3=@M5]CX_PYU,.
MEM/4T@XZ=_+(YF5.46B" 3<&1?%QKWW^V0VMDQZ=N3O#MM84Z2D&-!NZ^:#0
MYKJ>P4B-5JE"D.(]RTH/,.H/7774.%\1U;.;2Z+5UF3RA]*A4>TD9'.&P3W
MSXK@W5:=$CWM6FV8@/>QKB/ F3/6%7MMW3;5YTJ-7K2N*B711)J Y$K%OU6#
M5Z9);.,+8G4]^1%<2<_S'58.0<$'6+J=/7TK_=ZFG5TU5N65F.I.O_A>&F\3
MT53*E-TE@#V]621UL6SMU2NJF&CUE<+G;GIIDP4]U"/M1+]6>\!0/W"0^4%.
M0"2!YD:IIAK_ '0<>67@'F-Q< NOL1-]NL1%NJXM9J:C0993+FVR0TD-'?.(
M.3@E:X^!G??<7=7<3>"WKYK\JI0K5A4!%,@R&$),5U^5/CSI2UMI"E*DOLJ:
M""?8*!T!!&NT[7\&T_#=)PVM0IAGVI@,\L<_PB8( ![R,;]%YUV%[0:SC&MX
MOI]0ZH\:-Y YI(9\;@0=FS$]8B86S9QQ"E-CG;!02@#G222KHI/<>T/,$9 [
MZXD,/NW9D 3Y[;] .\3U7I-N=A%S)@8F.[K?%[K71MQN]N5<O'7?^V;U9=F[
M9VU8]R59=-"6EMQ*M)K5MPZ&AU:"5D,B'<*(2"0II:W_ !NBD8ZGB7#J%'LY
MHZX:T:C4.,NCXH+3(M>9-X)QBQ7!<%XSK-?VOXOI'>\.CTE/D;+7>[#PX"9/
MPQ )-YS>,[*1V'R&N7&!NN_4G1 PE*C\!S$?AG./PZ9[ZI<Z-B? '\@44/"'
MZ2_S'[M3 Z#T11\/_'<_I?\ EJ.;_"[T10\-.<97GXYY?SQ@_+/PU3[IO5W^
M;Y?5^]3/AZ!"EW!]L?@D9_#IJB#T/H5"G23CKG(]X\M7&3$$$1BWU]'N13:K
M1-$31$T1:WO2E?\ !-J?_P!=V3_UF9J6R' B)D1.)FT]W52-XS%HSD+S2U(*
M5N/LO[T[R[5$ $#EQ?=!/,H@IY<=,Y4G_*3K&:RJ]U7WU0TRXPWW9B2<<I/P
M]+DQF;3-3M.UVG=[PU2>:8()P9DD"UQG$""-UN.XYM_Z?8&_ZK1K>V]IU.FM
MV9;TZ-=,W:XWW4I4N5'6MV#)<9@5!Q C(80EI!4%I;4I2>P.O9^PNGT3^'.;
MJN(\0T[R\PREJQ2D P)#"*A!$$D R<7B/G3VH\1XOI.+TAH>':/54!2#:CJ]
M!E6&N YA+FODD" .^]I!PMJG$;M_59462+4MN&F&AH)8I_#[5(S+Z$U"!./C
M,KMU:EH_D#<5I!4 (<ZI-K(4ZT=>AT=!HG!S*/$=74L6NYM7JW/@@@P2T.F#
M(<"((:018CR9_&->]W.>!:'X'">72TFL!Z.Y:8;,Y!GF$BX)"[Q7%'8*<I5M
M_923@DI<X<JH<#'7F0:+S%('52>F1T\]6W\&T,.!UW$@ T\W)KM:7@1<AKZK
MFEV8#@039P(LJSQ[B<$-X!PQI@P7</T@:#%G%QT]FBQ+I  O.ZHG<3C"MBAV
M+=]>M_:"Q[QK%/MVK2:?;4GASE18==E-QGUIA5)4NB*C-0EE(;E,O(YWHI=)
M'+DZP.(<'X4WAE>I1XEQ*JX,>',J:SF$EA@/IR)G!L7'JYP 6PX)Q;C6HX[H
MZ53AG"Z5,U*(=4HZ+2SRNJ,!A[:0-KB!$W$"25N'K6Z>UUUT7A)K.Y>XV[FV
M5WQ]G[(WED[:;+U.ZK7M&OP-P+$EV\JF733:(R[49-(MZJ2ZI]!4]-9ITBD.
MTV$^MYUE"61\]:BF?M&J8QO.QE:J"YXPUKW2Z]P2T<W7&8,?8VB;ST:3G M=
M]FI. 8?AD,#G?=!$ @R( #8$@0KZ[)PMF>(>V9U_6#=&]]1MR/=-<MQ$V;OC
MOA3$39]O.Q&Z@ZW$C[A1VVVVZ@XME"%H*74-NI*" M(QL>5K'ZD'TOTLK^PW
MWO\ +%I$V^759!4C:&SZ%/B5>&BZ)M2IR@N')N"^[^N,%22%)+S=PW!5><)4
M.GBA8/F"GH;3Q+F&)@B^8N/T^KA3];VO/S.5C'='$].M^_+HM"=LS<]ST:/<
MC]OO5>W:1(J ATVFT&F5LRKB1(9J:9<@>MRA2X42-X,B))B+C*0Y))7<\8\O
M0=,VVGQ43W'>UK[]X\!(]!:AGN,-RXK9A-T?ANOAZFUV+6(55IU?I=2I4A$>
M'3:XXW&31X]OM.5"%75T9FCTTRY],,M5298FQ0MKPWB=3T!%M_#<7D1*JJP.
M)Z##N&UMJK-V O/;^@0YEF6]3S6[>B6W1&:-/JXM=R+1(<,MNI-NO1I(+!:?
M;<CQFGBX(\MEU43]6M\]]E*V!#).<$$\JNH(.".J2<>7N\M2B^FB*VF]! V>
MW6)( &V]\9). /\ 4S4^Y.KVG_O%#_C4O^MJHJ?<=X+\PN7_ +X5$>9J$]0'
MO2J4\$J'O2H_=/8^6ONCL^]E30Z-U-S7M&@I-)8X. =[H#E):2)FT9E<1JK5
MC-I<8G_F7P!'*KK[OVZV]$@,>"8)>Z ;$_&=C=4.(AM]OT4O]?R[ZK%\7\+_
M (*W(F)$])$^B=LD]AW\@.A."?+H"?D"?+4![1)#F_#,W%NL]/-2",@CUWS\
MLJ)4$I47"$I!4%<[:'&QA20OQ$.(=26QS#Q?LW%H;4I:4%82#/OVT:534._L
MJ;2XN)AL"T\V-Q-XD09"I]T*A;@DD8 )-L^ $^1M&5Z%O1%>B0F[\5"VN)WB
M?M>5%V:ISC-=VRVPK;;C$K=F9'+;],N*[8[ZW7'=M62I<JDPGD(?O26XB1)9
M1:3?A7+\R^TKMU]L?J>&Z-S:H<.1[F.#VM#7!]BTEG.2T "\3)V:>HX;HO=!
ME9S2"/NR(,D<MK X,F8B/(^R&F1&8$1N%&81&BQ4ML16&FTLL-1VV6DM-1V$
M8;CL-) ::CM(;:92CPT-H"<:\1DN )R0)M%^_?UOU6Z78:(H @G ()'< C(_
M#1%P'4J)*@.H63G!QW.1DXQ\,]\:MGGY[8BPVON?KULJ26EH,B0;@D3;>!FT
MFW<K7;NT>Z*SME?U+LJ7ZE<]1M>LQJ%*+2'?5ZO*A.HC.$N%/5+RD%.">I('
M4$#%XC3?6T=6E3GF<-A<[8/0^-B5O.S^HT]'CW#-1K@U^CHZB@:S";.ILJ O
MFQ$<L FP^$3T/BN<M!ZCO3HU^SYM'N&WJS4H%SVS,0U#J$.I1ZE&@S6''*@]
M&E.REH>>JGC*A2$RX++KK"W6_M3\O<9[/\1I\;JBHZK[E[G.)+' 0^I@GE(,
M F1C:P7ZV=ENW'#M1POASN"NT8T='AK6DTO=/87,:TD.>UQ:2XB 7&Y(G==S
M86X5R</>]HO3:2LQ)E2L';J^J]4ZH93;]-GTU5!F(=::9B.<CL=3;\!;+ 0M
M+<\*6YX3C#P'J7L>X52UG;+3\,J/#FO+&O >"8)CFZP1 ,B8D'$#Q3^DMQK3
M\5[$.UNHX729K6<QHU7T2Q\,P9=N"''F;(Z2(*L4Y2:WNR8]XW5==4K-Y7K4
MI52K]9K+CDZ2^Y](*8D27''GEOOE*04,,LS5> 2AIJ,F*$N#])=)I=)P2B=*
MR@QU+3L#FEM+_!,#X#&+DD @B\B_Y9NI5M;2?J'UFAX)(:'7;)( ^\(C8"XZ
M+,'T87$)N-P_\8=D[10:K.=VYW<N 6O<=H+E/3H8J4^EKFTBYX3#3SZ8DZ,V
MREIXH#2'FW%1Y*$>"3KB/:)P71<3[/U>-,I4J-?3R6N<&L+@#$08GFW&28WL
MJN#5ZQU/V?WGP3>]C$]#>]@?E<KV<DI4D(5RJ"D>V% 9QCN0>PQY=@!TU\U-
M>&NY.8>\: 6G!.<"9ZX&!&Y77.:7$3]QPY78B!F>D_1PM(E<DU/@JXRI]SS(
M$Q&U6Z+4GQ);"%OLN0)TPR\,,I!09=MU.1("J>27'H$PRH:5C&O6J9/:WLY2
MT]G:WAP'(P#F?81 8 7@$#83,3B#XGJ:[.P7:>K5<UWV#BU67O/PL',9YN8P
MR6DB>XF#%ALIO[B;VHM+;YZ]HMXT"I0GZ0]4*8B!48LA4EE*'$H6 T^LQ8J9
M#3C$F4ZE*&76W$.J0IM21PFFX'K7:K[-5H56<I(>'L>TP)-P6@BWQ#H+@V7?
M<7[6\*T7#OM5&M3K5Z[)TU*BX/J%S@2WX6?%$P"2(!!$3$8W\ NW]>>:W%XC
M+UA2H5R;X5Q#E"B36GFY,.Q:2Y*-(F/,OH2N*]6YLRH5(H4$!4!V R,N1U$9
MG:/B#*GV;AU(@,T;0" ;.>X $1N6@9!R2(LL+L/PZKI="[B>L#OMG%'FI5+V
MEKVMYI;S<P$$]#G,W,;-1@ #(SC]7O\ EKF%WBCD'L<Z*)!P0?--%*:(FB)H
MB:(FB)HB:(FB+6YZ4P'^*57%X)2Q>UFO/* )#33<F2AQQ9'1*$*6A*EJPE*E
MI!(*ADI@D. R1 \21"\UM2@2:C,H%:HTF**K;=PT2YZ.MU:C%54Z!4X=5IZ)
M!9<:5X2I41OQ$MN-N\G,4.)5A0B0X2WXH@_#>2.F<XWW\!12;6I$,KU(:#;G
M):.IC$S!B#>;6NO1!:''#9%U6O;E6O396Y%5\4YEJHI@NV74Z:EYM(2^*?+J
M5?IDU49UT>,VEZ-&PVLMK9?(+RJQQ+6:8$4C68#(/*7 F1!L(N1)O)B^P6-6
MX7PW6U ZOIZ-=P(#"ZFQ]Q$-#C)@F(%ID3T5KM[_ $BVUVUD>W54WA\J507<
M$NHM!5<DV;3V([< 1'?9%&EW,X2I,D!"7FHP)3U<2G)1SO:GMEQ+LYHZ>J:S
M6N-3ED<]1NWH29-[7@67I_LP]B.C]H_$=3H*6FT6D;08ZH7U--3<V6RXM-A)
M) (%W9 DP!1R/2,RG8='F-\(M/1&K4:F2:6[]<;:2Q*:JJO!A*C.KI* IY^2
M6O%;#@\)L\Y6D KUS=/VI<7=I]-7-#7--=],-<:E3E <0)OD?O&8 $V@KU9W
M]$GA+*=<NXIP)K]/6?1=3=I&->'#+2,R18-@DF(.0>@I/I4K%7N?:>W%S<,P
MCR;OJPI")%+K=L51Z*A=#G5UF8EJ32H$-]E^-"3ZL]](*8?3*;/BE#B5:S>#
M^T;B7$.)?L]];4'F>V8JU8)>8$D.W,$ R3(@X7/]M_Z,VE['<!;V@I:G@VJ;
MR/M0TK"]H:#(#^4N8\$\L&.5P@@&2K \=>X+%^7K_"4N1#MVI0;#AV7:] I-
M48FU*G4:/*J\^H3*S,A%AAB9,>K<M@Q(KLF$S3XK+4<**AGM31U/O'5#4#F5
M :C[S:[G3)^\XG)@F28L)\(Y/<-Y6B"TFER[AN">6 0(/@!80!;8IZ&=+R>"
M2@/+0M*)VY6Y4N.M>4B0PNYEQU2D..8+R%OQI#(6@J2MV.^V"5MK J5L;^-O
M" MKK@YD*&"<I(PG )^6<#/XZ*5U@C!LO%MKPEOK+TAUED(=D/>&RT9#JD,D
MN/!MI$<!2LF/A.0EOH1?9IA24DE 0I>.9"$D(3R\QY4X(P!G*<  JYB""O1%
MQT1$*DLN.L)<+2PME2XY!9*4*3GG<)Y2T3AGE)(0I2$$IRLD7<:(FB*DK_MU
MV[[%O.TV)"8;USVM7[?9EJ2XM,9VL4J53VY"T,N-.K0RN0EQ:$.)4I*2 >NJ
MV5#2>RJ&\QIO:\-B9Y2#$09QT\(-U#AS @VE>365_8W6];\R6\UQ,[:,MR)<
ME]#2MOKK64M.N*4T7'!5 E3Z HA7)E*NJNO?7M/"?:_5X;HVZ8Z%SVLIAH+6
MMF1T'." 9-@ 8%[W6GU'#!6<;Q.,D3WV@_EY+CJ_L;;>T _[*'; ]/.P;H'7
MIW_NL,>?D3GW:SO^^LN#@[AU4!Q$DLID"\XJ5 UUXL?%4,X.UHCF'0C(OX#%
M_)4O>O\ 8[>\UEV;=EX2>)3;.=&M*VJ[<TB"W8MS-N36:'2Y-3=B-NO51QIM
MR2B*IA"U(*4+<2HC*<ZJTGMD<[4TJ;=$X&I5ITY]UIVN;SO#"265>9L FX!Z
MP91W!J(:3:P_ &-OSZ"5YWRG[P<2TEQ*5-K6I(*4J:0T"T6Y#K[7@)#@<6E3
M#CH;(0A!=4C/O.DU='5:5M>J?=4WTA4<]W*V70'EO,8N1M)-[@+G]12;3JFF
MT\P)@\I!@@S:^]Y[^ISZ&O1&^B+D;ZR+=XH.)Z@2H^SK$B+5MMMLJPP4.;IR
M8RD.0;GNJ%(\=U.W3*E*D4RF2VFWKR>6J1(;C6NED7!X5[2O:4"#P7@;G,+9
MIUJK#S-$3));S $@6!(()$C =ON'<.!#*CQM,$$3 B+YZ>L&)7L2IS+441H4
M:.B/"B-I:B,M(4RRTAMMQI*6FFTAI*$I;4E+9R&FU-J\19>0AKY_=4<]P?4<
M75*CB7$DEQ,$R=[QDFYME;Z V&B(V N!:<X_#!MLN[T12%QL<V5H'+GFRH#E
MP HYZ],)4DG/D0?/1/\ 3SZ+K9U8I=)8<EU*HQ(<5L+4M^4^RPRVE!]LJ==6
ME.$=C[7L^X:I+FM$EP ZDA7*-&M7>*=&E4JO<>5K*;2]SB3  #9-S;K*LM&X
MF-@I]UTRQX6\6W\^[J[,=IU(MF)=-&D5:H364*==BQ(+<Q4A]]MM"G%M--J6
ME"5*Y0.NK+-51J$M8\.,Q#2'',;%;>MV<XW0T[M77X;J]/IZ8EU2M0J4VV&2
M7-%HDWC;HI]T.(79/9252(&ZFY=IV%,N!$Y=&BW+6XM*=JC4%:$RG(+<U]A3
M[<<NL^,64K2V76P<!2<U.K4VDBH0R/XR(MXXS>0.]1PK@7%^/.<WA>CJZMU,
M0X4J9D1T+6W\9[^DXKUZ1Z/[BQK=3I;9V'W>W%C6W/JK:$MVS7KL^CH("/6%
MOL!54=I\9YU 6EQU;;:E-).$<I.BUVBX;JVUJ_NZ52JUCB  "YP;,D09,'?J
M9G"[30ZCMYV&K:.B^OQ3A>DU&H93Y7&KR0^I3+PP/EH$$"(A>8.PIVWME[V;
ML0+VJ- H-KRML]_K7I\&L/1:?39=1>A52-0Z;#3S\R9?BML-1HZ"5$E*6DD@
M <;['.>G[26N:[D_VKD8TF)Y:IEH!)!(;$C:=E];_P!(O1:O7^R+L_J-'3JU
M:YHTJFKJTV$\[7TFN+G1:)/,9N.:V5B[LMM/OSQ&5][;G9FV:Q>]5M&DIN0T
M2FU>G0!3J=+FM,O26FJA58'CN>NAMTO<WCQU)0L)\+F.OTKXEQSA79W04]9Q
M*I2Y]233!>6@O<T3!<X18&(W[S9?EQ0T>L=6J:>E5+P'2]H<3[LN,\K@)@WB
M\6%K%;?^ #ABVLX9=]G=XN,_?';2S-U]OU2$VYM'4;\H]1N"W:Q4XX2JY+RG
MQ9[D<ST1G5)I<!+LU30==>E/I):CH^?NWOM,T?&J(X-PSW5+35'2]P(:#$_"
M&X@P#.(B)V]0[/\ LV[15],WB6DX=K-32<;5:3N>F"1)^)H(&<$S-B%Z5MLM
M[=J-Z:=4:GM1N!;-]PZ1)$&IR[8K,2JM0IBDA0C2G(3SH9=*"%I;<*%E/M<H
M!UY"P4JM=E85&N+ &EK78@7L)\>GBJN)\+U_".;3ZW35:%5VU1CFF3>)(%S.
MT['!$ZS^.SB%V:ORC4JR;#W*LRY[SMFXJQ]8+9IM0IM2JM*?IL!;3ZIL )<<
MC.,22XAX/!M:)&$J',D:]8]E#A5XQK''XZ+6!K@-@TFV1![]K^ \/]NG"M=0
M[+<.USM/7I.?5<:-5]-S6O) !Y7%L'UB.E@M8]!K%/F6SPS)FR(S]/3>]N-5
MQ+RVUQTTY.]M5,QB:T4%"F&V,EUAQ(0MO+"T\IZ]SQ:FVG2[2ZEE%@>6-^RN
M@@L=]GB6D7;> 2T@R+77DO!F5M;Q;L1IJE6I79SD:FF 7"K%8D-(@FI+3@AT
M"++?\CCEX.6&4M-<0VTS<>)E"4HNRE(893&RPH*2B2EAM#/*4-L(Z)*",#"L
M_-;M50KN]X^K#VF'<SN4DR8D$\Q,]9.Q7W%I.Q7:6MIA6H<&U;M(&33>T0QS
M8'W#B(@$BU^I &1$/=G;BH;?'=2%>UN2=N&Z"[<2[T9JD)RVDT1A@RWJNJH)
M>,44]F*#(=EET,MM#Q%+Y03K,VG;K_I9:6IP[74M4-%4TM=FI<0!1=3<*AFX
MAI:#<;QY+K+*W]V8W&4I%B;HV/=KB GF10KFHU24.?[OL1)2U>UUY>^?CJU[
M^C,>\9/3F!ZC8GI\QNLG5\ XUH:8JZKANKH4SBI5T]5C#X.<UH])5W$OLJ&4
MNMJ!"B"%I.0A7*H]#V2KH3Y'IJX"'"6D$=09'R6H/PYM&9M%X_'/13\Z, \R
M<$X!R,$GK^S4H#.%-HB:(FB)HB:(FB*!['SZ'I[]$5O-Q-N[5W2LZX;!OBBM
M5VU;D@.TVL4Z6%>%(C.GQ MI:!XK4N.ZEM^-+:(6PZA)R"-#<$=1">!C\?+P
M6G>K^AEMKZ4EJM7?F[*%;[TAQR%1ZQ:<2Y)<)MPDHCKJC=QTEJ4TPCV&7EP(
M:P@<BT/.DN&WSMI0&S,^%[1M_+&%2UCW$\[N?)O'A>]QMC>\S?CH]#8LHY4<
M3E93@\J%IV^;Y0,<P2E*;WP%8.0<#'0CIJMS@\$ND<UIQ!B!F>Z#/AT531!/
M*,?PB(/4VV,="#OA4[7?0EM5M<5U_B9K3BH?CED';F.LI,L-(>R7[T<2,I83
MS8'4="#Y\[Q_@%+CVG;0KU'\C+@DX@0"V2!-OQ,8)]3]F_M2XG[.=16K:'34
M]4^L"UP>Z_*YH!!@& <1%IR%WL/T0UZP&(L>+QAWBU&B-1(L)H6)3GQ$C1'"
M[#;C%RYLH;1X128J!X:P4MYP>O/GL/0%&G09J7GW0EDF>4,$@B]@UPF!WW%E
MZ7J_Z27%:W.[]B:.FZM4-0O.?>@S\0Y1)D@S]XB)"H69Z#ENKW!2KHK'$Y<4
MFJTFH)J;$H[=4[F4^W!D4OE 9NE*T1Q$D.-(;2KJV$I&?9Q?X+V.H\+U9UAK
M O#FO!!D<S3(O(&1-[QT,1SG:SVX\7[6<'/!M5IJ=.DYCV2R0)>T@D@B)$R=
M@>@E7"A^AAH<N6VU<_$)=%4I+S@34X5-LJG4ZI2F?$Y%-Q*O*N&I1X16A*VD
MO?0LI<=0YSXI;Y#V],U 2"Z6Q:)@DEUYM/>-IZRO!3+B][@0>=Q;:T'/A,@[
MCOPMP.U.V-J[.6):^VE@45NWK/L^GM4JB4J*D):9BH=$A^1(<*4"3.G2GY4V
MH2BALS94E^2XD2RI NJ/H_7UA70T1-$31$T1-$31%!0!20<X(\N_X:@F.I\,
MHODEM(4" O(]^,?CTU'-_A=Z(O@I"CS>P3U..G?K\LX^0U2XNP&R)&Q.X^H4
M@3W>.-\_)6JWU;6K9+>%(2<JVNOX#F1S))-JU8 *21[:"3A;8"BXG* E14 <
MO2.92U>FJN  97I.<3]WE;4:X\QP+3<JEUVD1-C: ?TGU7D_]$SZ(.I;S5*B
M\2'%!;CD3:.)435-O]KZS%+,C<AYF2]ZM<%U4QY!2W8R%I+L"G26GW;GY@[)
M:;H9;-2]@[5^TEU7AM'A?"' $L:Q]>@^0P "3S--R8Y<D#F+BM8SAM-U4UG@
M&'3!B3:2;CJ1WVLO8'"A(IS4:GPX:8M/B,LQH4>*SX,>*PPREEME##24MM-(
M2URMMX4VT@(*'/M TWXQ4>7/-1Q>^H]TN<9,EQDDF#WDGJ8C$[, - #1 VC;
MSV$6]!X=LVDA2/9(QG)P0!D*P.H^77/N'SI @]23F,>)Z6[KJ5R=5(L1^+GB
M5H'#18*+CF,)JMSW'4VK=LRWQ,,0U6MNL./^-*>"'3%I5$BH74*M*2RZEN&O
M 9D2WH\=[!U^H^STIF"<7CSGN,2-Y[EU?8_LU7[2\49I:0<*;"#6(87""1 (
MM',.:_\ A\"/,[Q#<6]W;A3'S?\ <]1O*<X2L6RVZ[3['I&%%3<6%;,9QF%+
M3'!##4JO&IRRVVE:)3!5R:Y;5<6>ZF\,<#!B 9N"01&(QXSDX/V3V7[(=C>
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M6?'CE)".5;7*"3H^V?:CCVEX[Q/AU#5UJ=!E:HSE8Z!REH#FX@R"3 BQZ7'
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MXEG5)^#==A7O:\UM2PN/6[<J]-7D*(409<)D+2"#A220>XSY[&EJJ#P/B;<
MW!(GIL;XR"GV<_XKQ&!X9,^@)(@WLJ8M.=<U9G-Q:30J]4I+JTH:C0*5.FR'
M%$@!+;,>.XZM1)'1"%8\\==14U-%LD.%MA.+WPK)I/DP"8D6N/$P8LMI_#CP
M2<6>\3D$TG;ZJV'0'RGQKLW BR+?C1(RCE4B'3)C:*U4%@>TEF/%9C.#J9:
M>88-3B=)EIOM9T6S<B/H]%/NJG\)'C ^L+TD<*7!W8_"]:4RET>2[<EY7 ]'
MG7C>=1:#=2J\MI'*EIA*.<PZ;$0I::;$"O#;:<5DJ=67!SFKUE2M))-^XQOL
M-X)SY+;Z=@I@;=T#,B<' WV[B("RT^C8HSRK43@'"5!>4K( (&,E))ZJ ('4
MD]#C4^[<Z[MS:P,_/;&W<L]VI%I($=09M;8 CZPI_HV.,@K^ZI*3E*,!2@"D
M$XP"H$$9/4$'SU5[EU\V,&VY\_K*@ZDC)CQ/_P#90--CCH5X/08*4 G.,<H(
MRK.1U3D=<:>Z/?\ Y?YI]H/?]?\ ,K.;YTI"K"K02 1ZA40"4XQ_)ACRZ>X^
M_P#/5S3TRVH# O\ /&-QFUB)\E4VO_5YM8Y,YL>MHZ7F;RJ6]'$4M\'VTJ%=
M FFST*Z%0!-5F],@$'.??TUZ!IA%(>)S?H!\A]87,UC+_  'NN?]?-9TZOJT
MFB)HBD*T$'VAYCKT.<>XX.B+B@\@21GFYB0CSZCO@]<Y\CCH/<1J!)%QUZ'K
MTM$9\[=8>Z+@2/PZSG.US^2Z2N7%2:##5+JTQN,@<R4A14775X)#;#21SO.'
M& &TJP<<V!DC%U&MH:60XR=F\LDQG;OVB9%PKVGTE;5N+6"\]0 ,#,]_CF 9
M5H9&X]W5)"F[4M!Q3*P? G5I]2$J R/&+#'(L)62.GK15UP1K1ZGM!6+@VAI
M77,7:=X@@1TVS$"QQO:' =-2,ZS5L$7Y09L,@D S&UQZ&!9>\>'VO[OSX5;W
M*JRY;]**UTJ'$;#$"GH6<N-LQ$!3?B.X3XLE[Q7UH;0/$!!UI]90XCKW>_<7
MM;%Z6 &"[K21@&=\SW;[0<8X?PD^ZT]-KN4S[R023L+B9&QBQZVBB+FV_B6!
M$6GQFH28S7V;J5!MQUIL%0'+TYRH#  QU(&M#68&/#-^8 @DS!($=#\Q!*[S
M1\<&OTKG-(D,)COCPD$6\5J=N[B^VCD+N%Z\+@FTB=3YDR$Q1&H+R9?V#RX_
MC.E3?AMAT)YTI6M*R#S =<Z[;@_"]/J:!+^4EH)Y2))<!U.0<1;,;+SGCW:3
MB&BK^[H.?!,%P=8 DB9-X&]HMDK$RN<1EBU<S)=F7+/9DM%;R&YD4O)>\/*T
MH(PH+2LI"2DGJ%<N.NMM5T>B%(Z=S&-^$C[L$%PCFM($$S(. M7H.T7%O?BN
MRM4J%K@\M#B06M(<!MD V-I*R V?HVW/$YMU0KYOW;JVZ_)BRJW1F9=5I$2<
MRXBF5-R+)G4Y4ACE;CU%<-#N$K6T!S$I(!!YBGQOBG9PU*?#Z[VTW/ J-8\
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3B:(FB)HB:(FB)HB:(FB)HB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g729258g95c69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g95c69.jpg
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M43>9X9XO68XIBO\ K$SX7/89,!@,!@,!@,!@?4<22I).3J"2E"=0482>0<6
MTDXDT&RS23BC-" 848 0@&%C"( P"V$6MZWO6!$2L_'YP]3:JP5E7<H4+"3K
M5C3Q"K""QUI&$Z:4PB0F#.?X.X(QMYJ,$)>S1^L=H>D(3QMQ& D2ML.V01LL
MO-Q=9UO6=>OJR*N>*^3:C;HLU5ISW5D+10JP1VQ%@L<4;TJAFLH<570;4W3+
MMEC7#D9,*<EL12.:A2<>BC1VF-((AM*)3%B9F=9GIXNZ]+S75^8WA_D ZU':
M\#.;J?';SY(5<M=+$W"6;4J4R=RC2^'.S]ITTGT>0ZOD9<UK1(%J;9)[^G-
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MK58Z- @2$ UH!*5&E)*3IR@:T$LHL  ZUH.L(MHP& P& P& P& P& P& P&
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MWZ5?DC_!V9@6KX# 8# 8# 8# @WY*OF,=&?F6C_6=@P)R8# 8# 8# 8# 8#
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M5\;OTJ_)'^#LS M7P& P& P& P&!!OR5?,8Z,_,M'^L[!@3DP& P& P& P&
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MYM+4]I!H'EL;W= ,8#!HG-$F7I!C*%Z18QIE91I(AEBUH0!;!O8!?QAWK?\
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M&L5G7)SA>E&(5A:TXXDHIC<+=@$-12!64(@0UB-E/7*D)(R3U91)1Y(QAOS
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M!@,!@,!@57^.7[_7E^^DP,^PIQ!@6H8'Q&+8 #$$ C1!"(02P;!H9F]:WO0
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MK+)<U6VNWI%SK-;7ILY'I3HJ%<M5@3;$_:Y0\1T^S:/JD"*'HFI>]:D-^W3
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M_P#H^'OWTL!\I%?_ .1[\E_]'P]^^E@/E(K_ /R/?DO_ */A[]]+ ?*17_\
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M&Y,W*D9B9_&XH5I3FROK:T/36O;R!,4W;A# 8# 8# 8# 8# 8# 8# 8# 8#
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+ 8# 8# 8# 8'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g729258g96g32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g96g32.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1AZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &%Z^8C@X0DE-! 0      $8< 5H  QLE1QP"   "9V4< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0IL=ZR*\1R,4>=;E#J3 6"#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8.8E         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              18   )C
M  $                          0             "8P   18
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   18     4F=H
M=&QO;F<   )C    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $6     %)G:'1L;VYG   "8P    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !CA"24T$
M#      -^@    $   "@    20   >   (C@   -W@ 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 20"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:  P# 0 "$0,1 #\ ]525#J'56X5S*C4;-['6$M<T0&EH_/C]
MY5*OK+58V3C6,<?HM? )'[S4+"X8Y$6!HDR\KZPUY=C<7!9D8[7 5N=8VN6N
M;5[MVZQ^ZFW[1ZGZ'^9_F]]BK7Y?UQ--5E.#0RSW^K27A_#:/1]_J4M]UCLO
M=_4J_2*P?K R2!0XP/WF\_NI?\X:@1OJ+ 1()>T:CZ3?[*7$.Z?;EV1'.^M9
MV@=,J;N )(O:[:27^TSLW[6^GO\ _ _4_P %!^;];#;->!46;*R^MSPTM>65
MV6AEVYS+F>IZ]#O;_HK%:P>OX^;8VMC"TO)#9([&!I_+;[VH1^L<.</LQ]I(
M^F.QC]U+B"O;G9%:A%]O^N&[7IE.UKCQ<T;FDN]/\]VUS6;/5_UK1.D]3Z[F
M9%7VS ^QX[F.<\N)W22WTV>[;M=7]%_^F]3U/\$FM^LMC( PW$Z2USPTB?)S
M$_\ SE: 2['+8YEX_P#(I<0[IP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5V9W@I*6UO%89&>&HJ.V)T145F.3E:;&_\0 ' $!  $% 0$
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M7E]W+HLFW,]JOT1[26YMG<5[[G5=I&[EG-;@6A;]&V_W N2]%V64@FYZ_9U
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MSS_%,FM[=I9/,,;AVLXXTMQIU*:Q&*D.LJXO-J0%\DK;40E:,!23V(&,"O\
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M([5O_9M@Q=Y-8\\(X7$$DWD1 !K6IIRZ\*=W[+3=-JUISZ:>HDLP)B77H:V
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M:2$0*,_*^B!)I]/DQ9TQ++L-GE&896XE<%LLR%LON/K?,Y27%P6V%@&X<-X
M) DU%1)F#-#;R[5[%[+[YV?=>PXOYR]KL6( =Q'@(B&APXA\(I )!I$U6V.Q
M6T[&WEL1G5SY$NK50>]U*9+8C*E&3(<\0LO24-H?DM,QFZ?%0'E!*5Q"L)]W
M/N[>-C8KFB&S$1&L#EK4:@ZQ3SCVEWYM&\M[N+L<C9GN=PM/%'VC  '^&E9M
M"F)T(E(0I#1*FEF._&<6D)X!0;*@&P/$62I/):&P@$E6$CTM8>(XQQ0!4BN4
MFM#6DUY5D%:23@.)9]G(ZB^=B;Q:#'2F%&4TGW=E*6HR)#B\+;!;"$Y5EM:
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MH*GMA9\Q?EJ2WEJ9J<)"1+\",PIY)=>4^&$>]AE+I>\)AB2PPX2V PZLK="
MVX483\-X,-$GD1;G41/AKFN:?N7&82 QQ-3PRT$^,<CG3D5(2?&=\-N2[GQ&
M6VRVD%+:F5EGQ)#F>[[?+T<40%=L$\D@BTM^T(FG3G2^?RG+48F#B,)XF$1:
M1TT-<@8I,WJF]4;J$:,XU17F'I25K5^&>5X 6V MQ92TV3PR2!VP<''9)Q;X
MVZ^!63LY -"9BG8>>0T.@NL3@VU#E5LRZRY3I,R2I$MAQ<0K*#&/(MQPOP$J
M<" $\W0YGR8)XIS5QOB.@O?GRH3<3:Y6R?MN(P$@'Z3G-B?$Z*8F Z\@-B,E
MP(4A+2E%+;K>,*\9*6RKS#!Y@@@#..VKGP@238$#+6MLCG\P2M3M&U8SXII!
M,$R#IZ&<W5Q;=1XGC+!1P3R2T&UD.J"<+!*4J"0I>.*B0DI/97PU4&-Q<+XJ
M4-M('T5[#AS2_%D/ )X8K($@ B0.M!.H39NX7Z'*;J4(O1YL"0F4RM#+WB,I
M2GQ ILI1Q4HK 0L9XJ9*DIRK U;V3&Q=DVAO X\+7M+JQ #A)C,1,1G<+'?L
MAV]KV8N'1P(:26W<T@"]*GQZE=*-N;QB7U:E,N&,MIQUZ,VU-:04H4U-9'%T
MJ03R!405A![E.% $=SZUNO:3M&&'@\33'Q=AH0X2-+<BO%?:/=V)N_>!P\/#
M((<,P!]K/XB.8D@&5G8RH%1[X&3\>P_K&/S=M;'C:Z6@RZ#2#SY+4XK6XC8)
MA[03$&X%:Q!FH%>D*\6FH?JEH?V52(H]CV 6<GT^&1JUC@^X)RX")YP#Y+!X
M3H<_#R6XK8(2 1@]OT#6E;^]_,?DH5>JD5IK7[3;_C*C?TO"T1/EN>$EQ>,X
MP ,9[EUP#RY!5W/U4GDKT2"2!HBM52K]/H\*14:M.I]+@Q@A3TVHRFX<2.%J
M",OR9"FFFTE9_!K<4T'.Z4@X*M$3Z%-3-:8?:4P\Q)8:DLR(SZ7X[K+S8<:6
MRZWR0^TX@A;;Z"&G$*26RL=R1.GCY#VSD@=R0GN?51&/+\^XT1:C[DU&J0>J
M#I_9IU#76(\VW]PXM1EIELQ$4:(:>RM50*'4+7,0A>$^"P4*4DC!SDZ(MJ4O
M*00K!!2@9"@M>>1^)!/%0 "O,,A'8D:*0"3 2YE'/HW@D<3R)R#\0$Y/8]B?
M3\O;5DNQ0_AX);($@&3,S::SW9J# D%PD9$]XMXS'RI5)4I*DI"%J&,)!4DD
M@CT*AA1^/$8SC')/J+@=\1;#@1F00.^W=*2TV,G2GR)]%0[LE(=--OX*:2$_
MKQ[L$$*!*O\ CG4\*'$J">6"2TKSMCCR42K":E $3S)/JGKFIH4^H8 0 5'
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M*HQ'8:A+D.KCY:<YN(::+ZG2VM(5&*'"6$,2@T'%@(=_#%*3I'M]WB/;DQQ
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M\4%(2J'-)!$5@B* Y6L<I_"E'O<5OV1(.8(BIS^*)UD]JR*W$O%3,Q57J$@
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M%WC=NV7W9?(B'&3/;),YF\3-.J],W)C8>V[*[9=J<,3;,/#'NBX%[G"(X@X
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M!?,TBW;F$Y4 L9[EM*G"IQ4DJ_!<@5_7"EJ3R"TLY4L@9#!94%*->$XD@#F
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MVM(MEC3,B\\JW/G4=T&%G8^S,;LV$YMSAX9-<W,!,BLFMJ^(4I./H2XH@$%
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M0>7@O"PW@+A_B/A3Y>'-+:*5::U^TV_XRHW]+PM$3QT H<R,CL2,E/HZX?K
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M_8I>L2)+IMK6C3ZAA<R%;%%AR'DQ! 2Y*BTN*S)6(:(D!N&EUUM2Q#3$C!D
M)1#CH; !2LS>5P1R^1'8 J)S\ D>I^0/;MWT1:B[G5213^J#I_C(HD^K(JE
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MM!C!;Q-)B8)Y2.($T,:]_P N,II+;S="0RR])H\EQQVFUEQWPS'>?:+H9?\
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MUYY7H2%Y@ YL FO77FD%NPH[Y0\^TPM*D)C./KX%YTK RR5G/-:U%M*,DDX
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MXG[3_P OFHQOMGH%WJ]BS_@W>W_/[:_Z-+UX3^5:NT;)_F/\,.%Z)[)6Q/\
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MO'+8&Q.;TQ:=T5[=,EF:O9^R5-!I6X3!"5\D?\%*\O;[%=S\L]M:\^SQ(_K
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M#8C:?_;7U^%J*7>WS'/X_P!'NF9(]]32( &75+GV?TCB4'<%I22"!RI[V.X
M\R0H)41C(/8@]]7#[.G_ +0/_*8[*])E4/\ ;QKS+M@<1H,6,NFO*U+),^SV
M*E)4N_F5D)4%*-+7S7R2$C*^61QQD#TR3\#C50]GW?\ :&]C2/JJQ[?M_P#M
MY_\ 5'A2W<K2KV<BUO\ BKW%;4VE3CC;9I:R0MP)"E*/(9^J/3Y#0^SY)D8[
M0?Y3;O\ .54/R@  C]'FO_>\HT\<TNCV=2T\ =Q0>&5'%.<&58&"<D]DJRK!
M!'?'IZOZ/NRV@6H>$D\SV^>JI_I^(C\P=3_O1Y1Y0L:N'V9\^K1EMP=UA3)#
M[D9<IU%*<>1)3&=4MM"TN+*DE.1YVU(YXX+06R4FD^SSS;:6SD> B)Z?CS6R
MV'\IS-CONGW@K0XT TL8BDUY6"D7:;H)F;9W';U??W$:KCM!JL&H!2Z.(STI
MF+X!5$44**64!;3CC1:*1S=47$*';61LNY#L[VO.,'\+FN^R026D'I<>40M;
MOGV]PMZX&/A-W6W .,U[>+WL\/$" 8%R)FM><$ST@ Q^;\P _JUT"\VUY_0#
MY+W1%::U^TV_XRHW]+PM$3U9PESOCT!^T%UP%(^U7ICX^FB+67J-J%-CT2@&
M2BM.IAUA4HJMUQ3==C(DT&L4UE^)SIE38D(D/2VH,YEV.5H@.RGVU-NMM*TY
M?*GT[$F.GK+YY*8]OHI:LJRXKL1J&EFTZ S[HRZMUN*ABD0D!E#KB&W%AE8+
M*%J;;6X@%U24'R@GKZ++$TVGPW9$N/$CLR)2TF3(9CLH>=] "\ZVVEUT) [>
M(M1&!W  P1:J;DUF12^I[I_9CT.I5-FIT'<* Z_"92XQ26ET]EQ4VH\G4\8J
M0 #A*R"H$)^&B+:QM:@1A 0",E(  !.3GRX21CL $@@]SWT3P]67S'^UJ2/[
MJ,'_ ,R+<'Y%,*S^DXU[]^2H?]$;:?\ ^Q'B5YM[9$_G&&.31X.^@7,!/P_Y
M*?Z]>O8W_ YX9\H7'8MF#( @=(:?FJM6U95*O3_UD_Z0UA;P_JF-S:!WF%?V
M;]OA<WM\#/F%]DG1I^Y/Z;__ $&;7C\GZCZ,?ZSKY$WX3^EMY\]NVH]OOS]5
M[AL7]4P?Y,/_ $!;-#ZZ?\F?TIUJQ]MO^6?-JR4IJXBT7]I#^X^W8^R#2_Z:
M@:Z?V.K[1[L&N./):C?7]1Q_Y!X$GS 7R2)]5?83^<]_T#7U>QH#,4@9G5>.
MX( 9M/\ *?!T>2$>A^_^H:KOB80Z#P'U1M?=]6^ E5*]#]Q_1J<9@&+ F@Y9
M$1DHQ:XD:\*[T^Q9_P ';V?Y];?_ $>5_MUX-^5@1M.R ?WCO_C7HGLF(]Y_
ME@=Q/U7=C7CR[9(ND@HQV[G\V/\ ;HB;R!@.=SV05#)/K]OV'XC5'NVNQ<,F
M?M10QHJ7GAPW1%J<HGZYROC*ZL"1U,;[D'_QI7>/AC'TM(/Z=?6'L5 W!L9(
M#I8*.J!06M"\9WLT?I#:":R[.L5-M+K7SD3Z]_\ ?[,:ZWB&3&#HW[UKQ _=
M:>H!7J3ZC [XSZ_,#Y_:=.(P1 $Z"%(>00P!K0^CH$&EO,K9OHQ.>JS8-/P5
MN?:R3\\&J,Y_W.=<5^4%Q;[-;1&;'S?4C70K;[@,[TP&6 >RU#5S1ZC1?9#'
M'%)2/1*&@/\ ^V-?+ $$]!\Q\E[ * #3,U/:G.JD2+HSV/H$%0^_('Z#J")$
M&>Q2VXZK@_[9]( V4QGS?J@)^\H:]->T_DC=PG>P :?V%Q)^RX+A/;-Q:-F#
M:!X<'9TXFB!ZE<(D)'$?'))[]_L_)Z?#7MQ)>:_##6CX:33->>.)!@& *"*<
M\NL=(56!\A_(-.'_ !.[U3)U/>50O    &?ZO_GJEXAF(VI!9!FMR;=R$<0)
M)-"TBO//ER7UW] 0_P"Y&V7_ .:S)_\ SW!_O]NOE+VR'#[0;Q R>([&KV?<
M7]E[-_+\@MSF/17WC]&N7;8<Z]ZW)H2-"4OJ5"-$1HB-$1HB-$1HB-$1HB-$
M6IO]VALJCK#5T.29=Q0M\U[6)W@I\6;0W8]LUFT!+3"E.4>OK>\&=/@/+;3-
MAMLA;"EA))P3HI@P#D;*U[(]=_3AO[-WM19%Y(A4+8;=*7LY=]YW>(EIV?4[
MX@16I,^!:M=K$V/&KL>,7?=U26."5OMN-H25(4 2#H5ANZ?M"MH-HNLC9?H\
MNN*_%J^]>T%R;PT7<U^MT6#85(HMO5I^BF%5)LQ]H!ZH/1G'8DQ$@1"E3+>5
M+=3HD'3LSY]TCU*DF^^K*V+*ZB>GCI[9M"Z+H?ZBJ'>E?MW<:WS39=AT.'9M
M)55UIJ=13*4[*758Z0(2Z>V\RGWB$M;A1*24DBA.F6=Q]5C?63UR[2='?3-O
MIU+5=^+N92]@8% FWG9%B7)095U,N7#>="LF)#D,^]2$TF2BI5UMUQ-2:9);
MB2D)3XB" 2#Y^ GR4^VIO3MU<]O[;UERZK?M^=NI:]MW7:%LU^O4BFW)4X5T
MP8TVFL0J1*EM39\A2I*8G&$P\%RT+9;Y+24Z*(]=%*VB(T1&B(T1&B(T1&B(
MT1:7=?\ UH6MT!],-[=3%WVA7+\IEHS*%2V+4MV7"@5.KU*XJDU3(#+<ZH Q
M(K2'7"Z^Z\" V@I3YE).BD">P2>@7,J7[>JV;%M3JG8WWZ3MW-F=Z^EW9^U-
M\*GL_7+BM.KOWQ8%YW%;EO4:KV[=-'=DT>.E*[KHDU]F:0\8\A:4H0X@I!(H
M#/K+O@CJ-(*GCKP]L7MKT)=+73?U.W5L_?5^T_J/F4-JAV;;-5H\6KV_!GVE
M^K2JS:C-G)]TEJI5)2II,:(D.2Y)!:\B% DB_(QY_13GMC[2C:+>;JEV*Z<M
MLJ14+IH^_P!T92^M"T-UH=3IYM]-G-WQ3K)C6M*I*>52:N R9CLF=S6A%/<8
M73Y+3<QIY"21?E]1;O37KNZV]]^D)Q%8V\Z(MS>I';:C;<U[<;<7="TKYL2U
M+:V]@6XJJ2JO"K3-T3XU0<<IM!I+UPS)<5EV,B ^TA!4^VZ@1,3H!,]\H!.8
MF8@S]%JU=?MP]K;#]FGM#[0J[MEK[IM1WWEUJ#M9T\M5:C/[@7,JBUZYXDRJ
MM31B$S;L.U+4J5[U"MK8]SAT?W5EYQM^=$\24CRGUV5Z+$KS]NY:42S^E>5M
MATWWMN+N3U-]/]4ZDX]AR;VL^S(EF;=VV'G:^B;=5QOQ*/6:X(]/JWN%/IS@
M<6Y&8+R0B0G43YD=T_12&SZG*?+[I5-3]O/85U6=TZ5'ISZ9-W=^-Q-_-E;N
MZ@Y6V%+J%#MJL[<[76'6JI0KEK%Q3ZWX,.>ZJH4*LLT9NF\DU1$-,B/S;>0D
MR@:3H.M(]6\EC%?_ .R#MM+JHUE5#I<Z;]SNHJH3=@U]2NZM(IE:MZTW]H-L
M8-<GV[5S7EUUQI-1KD.JTJHQD0X 5XB66)' MRFP"!LR+$?AYQ\ILNOFV_5M
MMMNGTF6QUBVC3[MJ^VMU;;-;E4RCTF@2ZO>4BGJ:<#](A4" ER54*NS-9?@(
MCQ4J]X<:\5O\&H8*E:B=(/M<-B^IS:+?'>V^+>KO3/8VQV\2MGZ_,W?FPXSZ
MJF\Q'=I\RHLTYMXT)4M<A##D*>?$B/$(D.((5@I@S%^E>G?*Z$6AOIL_?][7
M'MQ9.XEL73?%H4.@W+<]N4.HHJ$ZAT2YV@_0)]1,<+CQT51A27HS2GO>"TI+
MBV4)4DDD$>/A=2OHH1HB-$1HB-$5IK7[3;_C*C?TO"T1.WDA;;J"0"K '+T*
MBZX$@Y^9('P/R(]=$4"[E[47'>EV6M=5OWP_;#UL >[1!3DU*,ZZ:C!G.25-
MF0TR3+C0ETV2F2V\/=WUI0$%1)**]+?>/O4W4UJ0RS$;ER$RIC<5A$R4VVAA
M$F4VPE$AY+"20RAQTEQ+:#Q2%)'P!)2KB^2$=L=U)&3D  G!)Q\OY/GHBU'W
M*K"Z7U/[ M)I-3J3=1M[<*&X] 98<9I(,!ITSJD%O-K1%2@<5*:2\L9&$DC1
M%M4R6UX4 H%7%02<X2%?(_)0\W<DY[8201HB^8[VM"B>J,@X[65;GYFB!^;7
MOWY*?[(VW_Q \RO-O;,1M&%SX?\ 03\US"3\/^2G^O7KV-_U?_+*X[%LWM_T
ML56K:LJAPX3D?OD?Z:=8.\:;'B_\OBX!9&R"=HP^3@>Y?9+T:?N3NF\__8=M
MB/Y+/HF-?(N^_P"U-Y'_ /N;1XXQ)7M^QTV3 YX;#W-CR6S0^NG_ "9_2G6K
M'VV_Y9\VK)2FKB+1;VD7;H]W9/\ ]0I?]-4_73>QU/:/=ATQODM/ONFP;0=,
M/ZKY)4>A/Q)_W_3KZR%&8OJX!7D&$/U>T_R^;B?P0CT/W_U#4C]KA=6^352V
M^'U'D54KT/W']&KFT?MCT/F%&+^U'_*N]/L6?\';V?Y];?\ T>3KP3\K/]9V
M3_,=_P#&%Z+[)VQ/Y!YKNQKQU=JD'O5O[S^E.B)&3Z._Y(_HT;^UPOYOHJ,3
M[#NB^,CJP_=+[\?9NI=_]*/G^O7U;[%?[O;$?\)'< O'=[_U_'YGYD+7O75K
M6*I/K_)_I)T4?OLZGY+9KHP[]5NP)_\ M0M3^E&=<5^4/_=K'_D?_J*W'L__
M &M@?SX?^MB^R1C\;_DL_P"J3KY;S/0>;E["G&I1(N>I_P F?]).B"A!T7"'
MVT/8[)CY?J@_T&M>S?DE^UO;_P#!Y.7!^VMMC_YO];5PA1]4?E_2=>WLN>C?
M)>>O^T>SR"JU6J50KOG[$@C[RH#]!U:Q3#7<PT=Y*J%&GF8[A*^N[H#_ '(V
MRW_-9K_7NZ^5?;4#^D>\AE[P>+0O9]Q@#=>RQGA@]L!;G,>BOO'Z-<JVPZ#R
M6WNE]2B-$1HB-$1HB-$1HB-$1HB-$7S<>W>MC>#8/<+I,]I5TZ;?75N%N1L%
M-OK:N\K>LN@U2OU:IV3N%;56%O.2*?08\BJOP:3=RT3Y#H:<CLEN,'0$J"5%
M4"*S'<9(TTR%[3(*X9;Z=(N]^P^VGL[D[MPZ[2=E-Q=KMW=TM_:K4=H[YW5M
MFW^I+>:N5*JN2-P;)M:7$JBZS!H57ATFW*O."!29;$8M(]Y:0E)534Q$"E_+
M09D013G*D"D=",_>7>7V=NVVY=,WNW_VKM7H3ZFUIOVY]NMQ=MWC4:7N!N'5
M=O;=K42H.RJC2%4U$FCLT.BUBJ"74HC5-E)BE#C0#UZ]54",[=9N&C*,I[N2
MM'3_ +>=:,VU_9%-VO:6]<7<JU>DWVF=NTF?<% O:%^I6[5T3?&C;/Q[CF5&
M+';HLIQ\VDQ:SE:=C%Y*J0Y%+C)8*BF1D9!.=OW37N-^><JU0;%V4N'V-G5=
M8.V'3=U2QNO>-TNV10>J"O7'MSN2NG7A?%-ZH-D*_=%,6_-1):NV\E3);UP4
M7Z/IS\^F6/ J#KK[4 *4Z]>O7S45Y5!ZSPD:3704FEPHRWTV7WVJG43OW9G4
MG<.Y&V%P77:/2N.EN_X'3IN?N_=%(M&S+ MRM42WMC+CM*H4J/M[<]LS0U%W
M IF$/U.4Y.%4=;:AN+<B-8.??-^44YU3I_#J +1VF2;QK-5^A;:5.K%'M6V:
M1<-7-P5^EV_1J=7*\6BP:W6(--C1JG5RR2HLFI36GYI:*B6R]PR<9U*H60:(
MC1$:(C1$:(C1$:(N//MV>G[>#J;]G-NAM)L79-9W!W$K-U[>3:9;- =A,U63
M$IURQW9\B*Y4)4*,E4-A7CJ*Y""E*2H9XZ*08GF"%HOU4>QG9V_]GSUS5+:A
M[>+JDZU.HG9G;NS571N?<D2X+^DT2U+OL2K_ *@;==E/P:53Z;3XU&ER74!U
MM<Q%-BLK=<]UCI))F+#P'*8[EK1NKMGUB=<]B^RVVEO3V=N\6V-H])?51L%"
MW?=W)K-BUFB7GMA'M[Z)O^X?HRFU0.Q[;IE,H;C-9B23*D2&:[%C1VWE>, 4
MS<@_O2.R?J/G16'I ]DIUO['^THWUVQ@W3N9M1TGV1TJ[U[5])'539U0H$FM
M;?VSNGOM8^\5M61069[DA;==HU0E7O%G1I-(]R:C_2I:D!+D$*>O7DG%R%01
MXB]9H!32PLM_/:)=*777+Z"-M?9[;2[D[S]5EV]46_%+LC?[JCW =MF)4MK.
MGN77HEPW<[<+T!RE+1 ,6- H\!BF0IDB?0F+GI\H8EL-O$!&=*12<[ZY2.L<
MU'/M/O9)]5NX(H=Y]'&YNWL7;/8+H*OSIAVQZ:[MV^-T5A9KMI5RVKL?V]JK
M]4I]%HU\[B68W;=F0;EFL^_TN5">E*F!N8HH*)OST[]:1E34+D#N-[/?K<.R
M7L^+.ZP^F'=+?'9G:GI=ORS:):G38BB6/O!M7NQ>CLV#:MO;C5AJJ+F56G46
M&JDRG'VITFB39)FB9'CM)<#L??\ /GF:^J30BA$Q6>0$1,U@D95$J?MJ.G'V
MFG1I=/2?U.;G=+]X=0=S2NA+<'HYK=B;=2;:8NG:VHRKLN1S:UF]D(DQZ?,9
M%%K,!BIU6FNN(XQUF0XVZA;RY\O'U93(-+3,\K<ZVKF37DH?N+V4^ZFQ?3WL
M'MPGI,ZJKQZPKWV)N>U[BW#V&W/H]J[2LR[SN6M5V+M7NLI4AJ2]1;03-8E5
M.0%+1*5+FQXKSQ9;Y%/%G\.8-Q2EL^5IFHI,?6;T?;27ST,^SIV7VFEVS4]U
M]PMB-E(<*;:%H/0V*K=5QQ_>JO,MZA2*@XU!]Y3+GNT^-(DN-L/&.'5% 6 "
MH,$G0F_*5\XG3]9?6/3.F#VHFRM[^S,WUK<[JYW*OC<G;^#<\JQVZ#&7>WNM
M,HT"LJCW(9C<VA2":Q(GP5)\ 1$%MM?-0!(%:QUSOI/K-="/8(=)74?T2/\
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MV'=%\975< >IC?G/_E3N_P#I1[7U;[%?[N[#T=\EXUOHD;?BQF3X.*U]6D
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M4J6^ZR@$]OP@].)U;Q,088!<0!.>GKNYJ[@X.)CNX,)I<[0=OT\E@J-\=K'
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M& \<ZVU[(S\%+=U;>ZV 3-*:TI<Z]$VB;X[8SFU/1+UMN0PAQ;2W&:BVX M
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M_P#@<MS[/?VO@?YC/_D*^QZ/^Q)^Y/\ JT:^5VW/K]YR]D2^JD2+GJ?\F?\
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M X>(D$&:T@WM%ZC.#"<&$*AK)RH#7+I7-)JCD%*GPH9"1Q/%>0G*E.)P"$G
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M\4HYK:9S%*Z]T64L]FMNS!:!$$M)!Z'A!)\+JH])?5Z<#^Y:WA[@Y'N]EDX
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M#(T[N6]HMUXV\AA##-<,.BAS((L,B/-<JATE=7Q';I;W@0,G 5&LP9&3@_\
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M,78Y>0TIY*=+T^(=X\13UT4B*_"-((B\4-NT Z3HLT9: PH@!. E/(\AA/;
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M-?.>W[@JA7DJDH;4<G"BDG'J0,@Y^P@YR?4=A\AH.+,@Z1^ 4_-5H0EL$)&
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MJ!,CR6E.QE1Y#,QM@E:W4-\&V8[Y 605JX\C;Q<,":D2=18SI^,=5.W;#C[
M1QP0X5!S$"W"><'0S6%?7HR$27.2"$MI4V5)"DN*"T*4.8"4+R ""E24E) !
M3VXZMG"(<(S@Y=HY4,TGE$+#P7EV()BO6\5,5T@6B1DNH?2*@_K3^8<>-?K
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MW#I45-Q4_N@YE8/=^W%%O9-->FORX]3I<A-1B2Z5.E,24\$E"?"D-OH<:\,
M>'P4DMJP6N&-9K7N:9!FQ,WY@URI<DC.ZSL+>+-UGB."_:#-"T384@BG9Y*
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M/F*@%9)PKMW1_BCN>_;L1)-3'3KTSU)KSLI@BM:9_>*=R85)YV,T9,.,)$I
M:#C:E!I*F5J0"X%!:_0*S^Q@C!P/AJL,! YP:1]"?&%($@9S:EC6@MUO -]1
M<8SX*'"\4)$CPW3R4XKBAM14M+:B."@01A2DHSC/''86P8>= 3V"10$BO.LY
M<U<>'#AX !07$FO,&U@<X$\EY%?\-QR.'/";[ )XIX+*DA#A!3@ J_\ Z9 [
M'';60P@Q!N*R(K>HC2+@@3("8LX>&7$5BLB1/TL1>9HKNME"&P$E 0OF$,-.
M.$)"SEP\'%*9YC" M922KPFN_P"";*;KF@L (K04/GG&O4P"(*Q\%[R>( $N
MD@FMSEV=W),6UQV5L(0K#8>?99:\0O<UH=*R%,-E*@RAPK=9+:4-(YJ#A=2
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M(OIGW5KWKS?VH@;R %P(Z01RSGR6A^YBG#N%=X6VE*A<$YL(1V)3S!"^^3D
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MH(O81!DY23VUEPY$;EAQ10IMLK')3"0@E'#GQ/ )'KZ ?#MC5HVUG/I09R1
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MO6L.\'5D8QD.EM ()^LD923@'(R3DD'[]6FMD DUKIF3R[:V*N.)DB9HT9Y
M:GMZB+)VXE2E,(2,@$!/%(QX:25*[GN1DYQGZQ('H!JN*9Q0<J9:5%U4UT-F
M:]I,Y9WI-([+JLI+7ACN5)Y%:L84,DD' ( 5Q(&0"3@8.JA(  F1<R37*8I,
MZBX"MNDDN, &8B(R[1WB-)"\<4X0E3:T%GD4K05*X\,\L*"%!06%?#L!\M0:
M=/P)!,"8\%'H(#2#YD$+=PK 4E:5*5CS)47#Z@$<%9&1V /IJ8FMR;5N<[G(
M4MI>YN.=# # @"=2+@WY:3EHK5*<=9*GFD^"D)7S+:$AQ24)45$K<;+'% ')
M(\8N**1Q:^!O 5:,C'73/MU\"J]GPSBS() L;4RUO7*)R(3:VK N:[;'=W'8
MOB?1Z35YTA5"I\>D4RI(>ICQ6Q'E51R>T9<9N3X1>0U$;B)0VM"5NM*4,;@[
ML/N&8U(>P/:1>")K (FF5S%%BG>6"S:/<15A+#/^$P:#(QI&05KMVM5@S)EN
M75"IT6N4Q"GH\B#XXA5VG.!89J<"(XZ](CI4\TN.]%<E/.,RTN15K2E"'GM6
M6\&)!H!E3LRC7*DS2(6XQ?<XFS\1@M+9 ;_"ZTF#]Q$Q$+-&I+LI+R(X/X!Q
M#<A9!;82RM#I;4QXP65+<*$A2.2N()'J!JIQ.5)H.XW-._42:2M9AO8PP)^&
M !:U!$$#E%1-0$G3J4W"8EJ9:6TMZ<Y(=+@6X\X'G5+0A;BVG%%ML*PTRE7@
M,I 0RVA 2!:-8K-OKGZTR60][3$6-:S23,3<7J>E5?G?*V' 2Z\E:LH3D.!2
M3P4E2ECS*7W63COV./31I@7-1<3:O,"]KCMHL8UDW,U.4?*,M<X7APVM#;H#
MG-"/#6I"7.'AE"O-R"D\B4C("1\<#!TD4!URBW=/CV*ZQULZ1X 6&5ZZTT7B
ME+RA,<AM9#8*2G@%M)4O"^*4AL%".8("0',(Y!0SRH.,)+=*1:H( ZS&<WH*
MA/=@5(F23>14SEI]16$YYK4ALJ4HAI:BI3:>"5AP'B64)XAI*0#AM 2@8;2$
M]L:D&8YBEAUK::Y]LJ?>8=00:4()$$FEP)YCF:!4(? #B4\@M)5D'B5YQQ20
ME&%84 .7+/<^H&J7 E[:9"*'(>=)"@PU[26D P:#(CX8/32#\NH'2:VI.TZ2
MXKFKZ<J_8@  \F5=_@2/R$??VUU6[1^I/7\.EJZWA>5^TS_^DH'SYD?*NFE2
MN?VY*B=P[U\(.AT5R=S+G9*>2L8;^_';UQD9]<:UF*/USH_B,UB.DTGGSBJ[
MK=9C9<(DP#AX<6_A;3/(WTZ2L-(*^(<&?P1*TY2" /4COG)QD=R/3&>^L0Q)
MH;ZC*9RCI\UN'$M L12.&YIT(Y'GFED"*6@? =;65!"PEM*&G"%!(<6I:22H
M =R% <BH^AP+ZQW@U-9J:V'D1KGX2J),M$=+ <]W8 );<4H'S.?!+#REI:6#
M\CGX@$#MIKR]9K+V?9QB_OB:DF^8F<].XQSMT6K4>=-E4^)-ARY-/*??8B5L
M.26FW6VY678X>=0@-H=0L\''SQ!R <:IX.9.MC\LHGE%*JK:]EQ<,0":P1!K
M2]HN,J9UUO*4MN%2>25*6V4D<R%AS"_P:4A(0$E3@'(@CR(^.2IPM$7F:6&<
M\P#0TC.5K\+W@@FW:*QUZ$FM9 (-"W<;Y!"4%96@X"O&*>/H,K\11!^HX,Y'
MH,^F=6B9Y".@B^=HR'S5;6.;,$1$D1;I M6Y\[^MJ#26TH \9PI4M+H\164C
MR_@T$- 9.#Y,]P,C0GQ@5N;4Z2,JQ='!SB;\H(ZS\4]M+T$ !,Y$=U+I*TMO
M.--!*DH0WP:<'+S)/ #(YKPHY4>7=7880*YTRD5I$F*#+U6\QT""8FUB?GE4
MW[[MXR&%(1Y5G".*@MM+I*0/+W92UQ.?4@#(^'<C6,0<AE)O:*',#6V?8KH?
MQR3$C3URZY&PEXAEQG*%!*E AQ2D<QV(X@$9*<<?7&1GY#L+&0$ZZ4MSSUIG
M>J ^/B*5&EQ2F=\_.!2"I+84H*604J_"K/P "B4A/;TQ@?'MH3-)I $B*2*Y
M5@FG;%3*F0+\SR\!-2>W*+I2-#0W_?"6TH5Y"[YBMWN>_-  *SW/= "1ZGMJ
M0PMI4MS)(M36T0K3L8.H8KH+G*H-*C,E7)?@K;!*64$**D^&E8=5Q!.5964I
MSCMZ8SC5POPZ_:Y&E:9V.@^>:L'#Q#\((I4BE*Y99WKTH%@^XE78I%J5N=*D
M^X);AI;4\7O"9/%04EOFA*G%N+!XE# +I)P@!6$ZKV>#%14BES/<"!0TIEG;
M>;BP'8FU<3Q(P\P+16:GE%(SE:<6]=EVV3<$*R+D@RJ%6D06)T:*](#TN8S5
M5O2Z,U.;CR'H;LIRGN-/<@IMXI0U'DAJ2D-/YKL-PR$B#4$4BU8N: &U@<AZ
M#C;!L^V; =IXF.=A!P;);D*FTDAPI!%:$$T'1_9)4U=^V Y,4R)+UPTTOI8#
M[37X60EQL ..+5XO%*@\C(1GT2 <&-D_;]2!E%_5;YFH@^+^TA&'LNV-%SAX
MH! B3P/J8RKGRRD+M,T<H&/G^@ :ZIMAT'DO'&_O?S'Y?)*:E5*TUK]IM_QE
M1OZ7A:(KDCZROR_ZQS1$IHB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$
M5*T)6,*&1]Y!'PR""""/@000>X(.B)(Q6"4DM]T$*2>2^R@.(6?-W< [!Q65
MC)PH$G1%46&B,<!@G) R >W'O@C((]0<@GN03WT1>EIL]BG([#!4HC 3QXX)
MQPQZHQQ)[D$]]$7@9;&  <#.!S6?4DDG*NY).<G)R <]A@B]\)'?*<DXR225
M=@ /,3D=@,@'O\<Y.2+P,-#\7/<DDJ42?K>51))4@<CQ;5E">W%(P,$50;0!
MQX^7''!)(*<YXD$]P#G .0 2D ))!(J/=V>7+AWY%9/)?=15RY'S8)R ,G\0
M!OZ@"015!IL#BE(2/0!)*<#Y#B1Q&.P Q@$@=B<D5!C,$DEL$DY))4?EV[DX
M3V^H/+Z]NYT1>^ UD'"L@E6?$<SR(P5$\LE6 !R.5  8(P-$1[LP>.6D'AGB
M5#D4Y!2K!.3YTJ4%_OP2%\@=$2B$(0,(2$CY#[/3^0=ONT15:(C1$:(C1$:(
MC1$:(M7^KPI.R5PA7$_\*6X,  G KU-(!SZ$'OZ]@3\]:_>0:<"MP9Y=O6*<
MZ&E5O_9G^U,.D4=\J_)<@$9+B%\E(2%I*F<X2H\00HE60<>GJ/M]._'DEW'%
M0)@1IRSRR'->KEH+)F 7B3-Y(K8=D<B+27O@E&%J<(4LKX%6"K'JD>4<>P].
MWI]HR:&<4"8[)O)F_KHJL1C0XFL -T_A$FD==4X24I4VASBZL*R@>&DEM)2,
META(/AGOW]02>V/6^PB@/7Q/+H::955B2+4'2<[]<IY#1*M**I2@4D*.4E/8
M))/<$#"<#C\OA^70\7'RI$BD7/<?&*Z1BO' UK1+HK6.S6W84.*890I1 "0O
MU:4%#MC(4<_6R?4C[O357!//BTFM9FY\-2I&&]F'QO:8B0:1H!SL<KJD+3*4
ME25*1PXK*E'LXEL=T]ROU[>BN_KGX:I@AT4^'6!>PH)GKG7.MKC#F@F:BT0>
M=\I5NJB):HSBVD,>,6SX3SJ0 @>;DA[ _8L*\@3V/8*^V0]P(F!$P3(%#7LK
M:DVF5L]A>SAB0($ 37YBQKER60[:W*[^M?;5JK+'@6^S,IDU;(2P\Y,I]0E4
MYSB$*<(0$MER,H--\&W1X:$(2!K?,VY_YOAX?$V/=AIO,:"O#2PTZBO-;=NQ
M[]MQ<;##P#BN=((B"29M8P($TJ;+ =R'V?>:#[O,%+N<UAM5$>:BN3\MH(54
MX#Z&0V?HF7%82BH2<($5R/!"$"2A+XU>)\;B3$UJ,]"?& *&,EN=@8]H#,4G
MA  K,PT"]Z09/8:+(J,NKN^^KJ#49@,J(8:1R2),1#1S*#2E*2VZ7'"6VB5<
M48[]B=6W.-6\X\>M9Z#HLC$P<)CW%H=!<8J"*F10 4%HDA9$VS@\G5)07$H<
M=*7!Y5$<N !;(!!)!&3C'<Z@@$<-9S@YBAI6P%#;E<+&><A8$B(KG!(M%K&0
M#G!E:.E2W7%+PIM3KCF',I6HA1".';B24D8( Y'T &J:93ST^[/K3LMNF) !
ML:URO%*B!S%J();"U)*'F^"RO*E-X2VHJ('ID^4CC@X[=P1C5+I%IBM3E$F2
M:]T="%>PR"V/^) D"TTG6AL*2.<RJ4ME1!P0HD*Y!:@2$+24@C) &2CD!VPI
M9[ :H#6DD&MI$4O,9^,&])M622(-A20 *V,R:F:6R&=5ZY,1'C.2)+J6V(92
M\%C"@H9R$+1V+I(!RVWA0!(SZ'5[AB@DT$\J6SH/55' W3QZ\NFLE8)$=JM:
MN1-89*8-'CL/%+:F^$FL+4KRK2CWEM4-IGECS-OK6!Z)U6&M/"3,@ 4Z9T--
M9I3DL[&]W^K  $-%8Y">7K*%V"Z3U\]J2/0(KE6R<\LY+.2%8\WKZD GUQDZ
MZ/=T>Z(&L\A'//*J\>]IVG])'6N6ACKF:^"T$W0*?UQ+N2CCYJW.6<E15EM7
M;C@8/;N?@,X SWUK<4'C>[1Q!O6IK%1RO.J[S=&&[:-GPF,:Z1AL$&WPL$UB
M!-\YY* [EOR/2%MQH%.G7#4'W"U[K2#&68R4#BMZ5,D*:C1&4.K2E1>5C 4<
MCX6@R:U&8RDU.E3$C7Q73;)NW%XN'&L9@213+E:V:P\;L-OW?0[1BQ6*S-J*
M9 GBDU%R>+<4VD.\:T\(J82'"OR8B2)#O+'!@C&:@&P"9'.;UR$92/O@K,QM
MTC#^V:33A,$=D$<HH182K978EZ;CU)J*U"53:%&2I+"Y2%PW"I) ,IWWQ390
M0%,\4)A^*?%5C]B4-"&',BLFMA4&+'YUM*R-D.Q[-/&QKJ#+KJ:VK(J:4LI%
MV]V^HMA0UK=4JH51TK?FU!;;3;\KDMI)0&F$,QQ&$9H-Y0RE91V).3JGP.=9
M[J?BM3O3:R]X;A<,=).?"#\[\E(\J6%J>PX&&FT8Y)<6A/AE7B\4K40K'@Y7
MS&.WPU9XG#T=+G4P9[!.JUW"[@#H$D&ELJ$@5&?6)B)6/OUJ)'8<FN*<5";+
M:%S'$I3"SXLV+()F\'6UEN0X<K2@1_! <,C (-3<-Q9Q%IGPS@'/QU,JG%PW
M-?PL?2(,F?$16 #R-:&UQ\=.5)/+([E:5I\7CVR4*0GN/0DCX9QWQK%P\3B=
MPNM7*#XDUR [S*J>"QI)$FMJB1K:HF\V%1=>E2PE9="3R4IO )RYCL7#@#L?
MAZ$8[ZR"69<LQF-.>L7-]<?$<X/X8@4-NW,Z&"*Q.JK4A@?A.2U%'S4#GB?M
M'<'N.W\FJ>%D9@P0!([YBI@36M.BR'.+& C4R#,";<XBM^W(^(<D*!PXDY(2
MA 4HNJ5W'$C/U!VQVQZY[ZQ"QHS,<R/H%)=!,'7(1J:SUCPNG*6RA&5D'@<8
M /(%1P0KOD_(=_R8U(:!-3EIK.DY*DNJ0!<9UL<CW330W2X\RL)46\I!PD#D
M,'(PHY*?N&!ZC'QU6 ) F_9V9W[;]BQ]9TD5]5Z\QF"';85P<PI(<6DAOQ>&
M,XR2O"0>Z<=@1GT^S5):W2\U@#E-M>NG-5!Y;:O6?K;U11?N!8Z[ZI2*0:FB
M*P7'W'$J2I4=:U8)4"49:6D EI2$J4E024+01RU+1[LR+@YUMW<UO]U;PP=F
M+GO XC0S:#2G.\4I%C*Q#;K9DVS<DZZ;EN"HW5<#Z5(3)J;KDI^$VX6TH3'F
M/YDNL)C,LL1V7''&H;: F,VR"K.0'TGB)@$]8I4:<L]:DK/VO?G%@G!P'<.&
M<A?2#!@]@$ULML-I_$3N;9BBDJ1^J&FIRZO/I)4A!2,?62%8!&"3@9^.J]D,
MXP.9<WI$U[O'K?A-[_KMAVMSS).'C9?]VZO;RH(!79!  &!Z=OS@'76B@ T7
MD I/7S *KT4IA4X[DJ(III3:' ]%>0ITJ2@+C2F9"<E*'#ZM#'D()P#V).B)
MFE=:!60U322L@ R9*1PP2#R]T5C*B5$8]3@=O17UKZ[^2D1G/*#]Q7CKU<"#
MABF Y RF:\5=_@GG!2D*/H"K(!^!]-$IS';/R"MCM:G170Q,D4**^\$&*S(J
MBF7'@HAO\&AZ$T9!#KB4.!DGBLMI&2K!*$_,JM X4U3<)3YE>]R4$)/8N\#
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M^[/;5'V=,X)%"!2,[YVZD$**$C(9QEKEW7I1!#066^3:E*\QY@X'?/8Y'?\
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MKVSC[NY[_''PU>+F&^M+UMRSB+&@7-TI4]UO%,R0LJ"4J2583QY$E1'8K&,
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MJP5*WHI\*'$::AQ(S,6+%90Q&BL-(8CQVFDI;;;9::"&FD(1A+:&T\4H">.
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MSF$=CGOZC&KA<6GXHK'KN%:#N 5T8+B1!SM21T\32D2>M:@N0%@<"<%05S"
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MWNG"!%#4K-5]+F\*4^&U;D7PFU,ELIJ,<K=P4N.>,".P4X7$JXGDI!00H!(
MH_,-HBF&)BLD7ISRZ5S"UH]IMUYXKN@PS2\?(7IXIHGI8WI2A"?H*.21Q5FH
MQR,-#\$3V^LHDA7;&021C U;.[MI/_#%_P"(9FIOV^"N#VEW1GCOC/\ 5NFF
M7E\CI6GI7WF2%H^@8R@L')54F"00%< /LSQR/@.P['3]';3 EDP"/M#, 4^7
M;-;TGVDW."2,=]9/[-UYMW5/=8I1KI:WF;X)-"8(2 %GZ1CI20%%2>(0E"E
M$D'D0<%.20G!N-V#: !.'_[@>PF:UDYY5,*EWM-NO]W%?VX9OZZ_5"9TN[WA
MEXQZ!'D.IPMEM=69;"W A0*2OCD(5E(]/WWY*_S+:*?!XCU)[JJYA>TFY6N#
MG8SQ-XPG<NO3.,I6\/2YMY=^W6V"*!>L9N/6UUJHU!UE$E,I#;<M32DA+H&%
M)&%)&>X2D=L^NSV7#?A,(>(/\(K7E]W;9<3O_;=FV[;CC;,XNPHB2TM-]#\U
MJ1N)TM[G57<.Z+DHU#@R(]8JDA],M,QAEY^&OD6$. CD/#4K*DGU[_?K2;?N
MK'Q7EV"P.!D_;B]8Y?4<UU.Q>TVPMV9F%C8CL,M8QI(829:V,JQX]%CJ>EO>
M0!(7;<(*;P$%NHL\3C'UCC..V<8[9['6+A[JVX,@X8FD#C;--9^Z0%F8/M%N
M9F('_G#P*S.&XF36@)R\[1=,'>EW>IF0VEJU6'?52I JT?PT@)6E#920''#@
MI))5CX^O;5X;JVH'[(@Q^\W7L-N4S/57L3VGW,)#<?$=_P#B<.E:>'X7>-TO
M;Q("E/6]$4M2 GM462!Y 4@>(%]DN*)4?4<>(RDXU=&[-HB"WJ)$>?*#]RH_
MI3NH6QGT-/U;C\ZGGX)^>F+=P^(E-!BH!X*;6:A'44A!0M*5IX>&HA32!Q"0
M"4I/S.L@[%CP(985^+/M^N5IA6<3VEW63#<=_";QAN;X7BMIZ:)1'3%NVVT!
M]"QU+4L!PFHQN!#(4F*Z4>$%*6.2/>$\L.H04C /<-AQYJ.E?P[_ +R:3[2;
ML: 68SRX6!PW14UO2-.?9#>5TN[LR& W^IZ$"&_&2!4&0D2&DR5MMEO /G+B
M6@H** 4M$I[*T?L6.[_AS07(GMK?F/O62/:K=(_XCC_^-V<SG\JUZ)-GIAW?
M:(85;L5;87W<^DFL*&,=Q]8GEY^6>./($^BM6W;!M#HA@SFH%U4?:K=!!G%?
M44'NW:F+CG7P.2H/2[O!S"VZ'&:4VEQ++B*BRA;;2P\UQ"DCFIP-K0D!2N)0
M#D9.-1^C]IK0#M$&W;ZU5#?:C=$R<1\F"8PW7[P!6O4!*,]+6[*5AQ^BM+)*
MB<5)GZ[:0E*BG'HM"R$\5 >*%J4"A00'Z-QX^R!6:&NM>9@37MTO#VKW+'[1
M]C'ZITCE>(/F:YIZUTS;ML^5% C#!;*%BI,>4H(424\0%([*20H*6M2LA2
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MI[S6IN'N:;CJ=MU]^/2*7<[$.KU27+L--/A%ZE0GX<""A^I0WY4BEL,<]S0
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<HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>g729258g99f54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g99f54.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2@(4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )^R^$"(#A"24T$!       1AP!6@ #&R5'' (   +8,!P"4  (<G(S-3
MDP.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !!(?8!XNOC*GEKW7?&L  @Z.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'(L+1         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !(L
M+1  $  @$BPM$  0 ".$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             "7@  !5D
M   0                         !              59   "7@
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "7@    !29V
MAT;&]N9P  !5D    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   EX     4F=H=&QO;F<   59     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    '.$))30
M0,     !V(     0   *    !'   !X   A2   !UL !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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MZAKQ:OB[  L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ R '$ P$1  (1 0,1 ?_$ !\
M  $$ @,! 0             %!@<(! D! PH""__$ ' 0  $$ @$" P,$!@X2
M"@X+  0" P4& 0<( !$2$R$)%!46&#%!"A<B45AA&B,V-U97<7B!EYBXU-<9
M)"<R-3A5=G>1E)66H;6WU=8E-$*$A['!T>'P)C-#1$=38W)T@I.SM/$H.4A4
M8F1F@Z>VT__$ !T! 0 " P$! 0$            ! @,$!08'" G_Q !A$0 "
M 0($ P,&!P@*#P8& @,! @,$$0 %$B$3,4$&46$'%")Q@? 5(S*1H;'1%C-2
M4U23P=,7)#1"5724E>'Q)34V0V)R=I*6LK.TMM+51'-U@Z*U"$56@H748V1E
MH\/_V@ , P$  A$#$0 _ +K>T8]J]SVT-S7W[J+5.\6:MKVD6>(C:S YUAJ"
M<S&ADU&NR;[696QT&6FC,N''%D9</DBG$^=Y3:T,-MM(_4_8#R9]C,]['Y-F
MV9Y5)45U7%4M/*N89C")&CKJJ!"(X:M(E^+C1;(BW(N0223Y?,,SK*>KGBBD
M58T*:08T/RHT8[E23=F/CT Q2UCVVGM/RGV11>16"2276QQAV-+:'>?(?>6E
MMEIEIO5ZG'777%)0TVVE2G%JPE'=7;&?8'R/>3P L<FD"J"S$YKFP"@;FY-:
M+6',GE:Y&^-'X:K[7XR #<DQ1V ]JBUAS)Y=1OL][][6OVO.KC0H_8&Y)&JE
MR+9ZPFY32>A$()7$RA<',C-O-:S=8]^@YR//A9R-4YB0A)@(J+E1@SQWAT:5
M!Y,/)=F:.]!EXJECX9?A9OFQ*I-&)H'(-:"8YXF66&4#A31L)(G=+,<TF9YK
M%;BG1<LH#0QCTDTET-UVD36G$0V9-2Z@+B^$?[7WVLL91J[LD_?3 E,MUALM
M7K<L]JGCFEV7F:>) &V1H6)^UYF:R%&,V>$;<F'(YN'?,*=CQ3GSP9 82Z>2
MOR9R5T^6IE4KUE+34]741+F.=$10U4D\=.S2^=\(/*U-/IAUF72FLH$*LT?"
MN9\+C<1>'Q#%JX40O($61E52NIM*,A<J"$UH&(+J"T,>VZ]IQG.,8Y'LYSGM
MC&,::T+WRK/;T3_,OSWSWSZ8QCU^G&<]^MK]AWR??P+)S_A7-MAOS_;PMRY]
M^UL8_AK,/QJ_FH]N>Y&G8;=_S8D&]^UC]L!K'$6J_P"WI6J)F5R#$<J7T?H9
MA+QT1@+,U$.Y3K)?N<]!XDXSX[ &>[S4)\2C_BH >3A?-T:+R9>2S,C**"@6
MJ,(1I1#G&:L521I$BE'[=L\$K0SK%.A:&5H9EB=S$X7(^:9I&JL[:5;8$PQ@
M7T1RZ2=-@W"FBD*DAN')&X!5U):\G[9CVK,()!2$UO.2B +1%+G*R=)Z'TD
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M1V) CD)'.R,;64D->K>U3]LA=+%/U&M;0L4G:*J<S$V2 QH71HDM"394^-5
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M?2O-(L>Q^7Z NY"F2:_HW4MLAP+%5ME[ILM?E6LD1DY <M>04Q#R+"7%LJ>
MDX[;! 1;27FG&LN#ON(PXVM&5>)"L8L<_K@;&DR0';8]F\@!W%QL<MZC<>&*
M^;QGDT_\JJ?UV%CYM=$_1?R!_=1<COXTNH^Z"M_)<C_T;R#_ *;AYO'^%/\
MRJI_78/FUT3]%_(']U%R._C2Z?=!6_DN1_Z-Y!_TW#S>/\*?^55/Z[!\VNB?
MHOY _NHN1W\:73[H*W\ER/\ T<R#_IN'F\?X4_\ *JG];@^;71/T7\@?W47(
M[^-+I]T%;^2Y'_HWD'_3</-X_P *?^55/Z[!\VNB?HOY _NHN1W\:73[H*W\
MER/_ $;R#_IN'F\?X4_\JJ?UV#YM=$_1?R!_=1<COXTNGW05OY+D?^CF0?\
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M9.S673T^5P*(8YLQE2HK:YDV:MF1(HH:;CD:TI8D(A4A6D=@3B6/M$\?>_\
M2[Z"_4^T]0>W^0N_^/K+]T6??PUFOJ^$:S]=?Z<<+AQ?B8?S:_9@^T3Q]_!W
MT%^T]0?]!=/NBS[^&LU_G&L_7X<.+\3#^;7[,'VB>/OX.^@OVGJ#_H+I]T6?
M?PUFW\XUGZ[#AQ?B8?S:_9C)"T'QZ?,%8<X[Z#\#Q#+:^VGJ#A64K<2E7;/P
M+TSVSZ9[>F>@[0Y\2!\-9MS_ (1K/UV)$<1('!AW(_O:_9B0OFO<9_P=]%_M
M24#_ %?ZR_#^>_PUFW\XUGZ[&3@0?B8OS:?9@^:]QH_!WT7^U)0/]7^GP_GO
M\-9M_.-9^NPX$'XF+\VGV8/FO<9_P=]%_M24#_5_I\/Y[_#6;?SC6?KL.!!^
M)B_-I_RX/FO<9_P=]%_M24#_ %?Z?#^>_P -9M_.-9^NPX$'XF+\VGV8/FO<
M:/P=]%_M24#_ %?Z?#^>_P -9M_.-9^NPX$'XF+\VGV8/FO<9_P=]%_M24#_
M %?Z?#^>_P -9M_.-9^NPX$'XF+\VGV8/FO<9_P=]%_M24#_ %?Z?#^>_P -
M9M_.-9^NPX$'XF+\VGV8/FO<9_P=]%_M24#_ %?Z?#^>_P -9M_.-9^NPX$'
MXF+\VGV89-QUSKW7-GX[A:]H=,H@<EOYPJ1$IM7@ZN*>2UH?=[+1)H\(""T4
M^TUG+3;SZ''$-Y\"583Z=;U'6UM;39\];5U56R9(JHU542U#(ISO)B54RNY4
M$[D @$[XQR(J/3!$50:@W"J%'WB?>P WY8F:HWTVTVW9-7)U_>ZH-KZ9AHD&
MU6B, "K&Q&I>"&FG9:@F"R9I4I%1#I&8:5(.#C5L2S+HS33WEN*;Y-31)3TF
M7U2UM'4-7)4.]+3R2-54!@G:%4KD:-$C><+QH!&\H:$AB5)MC,')EDCT. BQ
M,)"!PY.(I8JAO<M'8+("!I8@"XWQ6O9?./7^M-W1FD3Z?<)21,V+J75LC:1B
MJ?%UV&M>WZK?+_#8=;L-FB9F3BH*AZXL=ALA\)%R*QW'(N*C!90Y<LF%YRR*
MSZ2=(XE5%K8BP:CH$S&8D"[!#!*BH]M)E)1RET,F<QL%U7!/"IY@@N24J:UZ
M"/>P75QHW)6]] #"]R!#W)KGXYK"?A5:=7KK8E%B-*V_?&SK5[Z1/AP%*J-Q
MXM*,)P3 6$!V-C?M.\A7=IN2D;$WV>(B6JL] T:?8E\MO2I)J5IV4K>KRFCY
MV.O-*ZHHKW.P,,E.4"V(>60*[PK&[$4^)$J[DTN:U2CIIRRDAJ;6YGB\:Y-P
M42)M*R/(H6>MM<G8QBOZY&T9.5JZVS9_(2NZ1@3O=SIBLM)K9\C;=\R8Y(+H
M8\TYK[4-$V@<T[&2+\>F[0P%<*(4>I^/ZJ7&J DVB=9*J20 M^TZ:)IY'4#<
MK4E8J2GE *<6K@D&M#9BI<5 (.N(+"J7"GSJ>18(E);8F!G:HGB!#\&GF0E&
M%U96A/:$Z<WJ>6SF.E=8Q2M7Z?VY 3NQY^@QPMCJN\*Y=KK2A1@8FVR\M%V,
M6ET25L=H@YT&->A!'P\H>/8(:*7<,#$\K$((V".&/)O,(<RDLPNK+#2U$3R.
MI*WXNDLL3/B&C82)&H,C.&(T@[ 5CT" @@,#+4Q2)&+;^@#9G"B/.,//@G;-
MY1";5QKR@UN^U3Y3Z3D6BR8XFYDXY%;/T<[6@2S;!-B6$]EN#UB\AYT6E2LG
M/W0P>#JLG#B*D0HB)=+2+HG$.62O%^^5LPHZRKT$6Y1K0U.E@S,RPS-+' $C
M,R50K7C(>(SYE") 05*Y?44L'$!'23SN)B" JET6-YKOPUHKG^J/K]M>>T_9
M)*<K\?MEJ.D0IBL!TJ8N-!IV[MCU^FK),G7;< ]8*3HZR$R$ZNJOPL7)OQP3
M9!6358#PSS\'+#F) "BCAG"L3IDG.59=FD\2% [*L468*0SJ-2Q.!>32KYHZ
M?B5_F0)WJY( P"W$2YC6Y?&Y#,HUM)1@%0;!ID)(02,CFM'/:LTV7ML'/Z@V
MRR]1&J!$6RRCQ 'VMH;8.PXW54O$4<K91IP51:?8C-PU4\N37(X0@82>6D-7
MN0/Q38GM"\Z;MP9>$+V4R,'C1Q&I-V9"Y.D7N(I"#8+KUX5,T<#@K\="9CI+
M,(EM,1Q/1NH/!YD;<6+8W?1@27/%J/JR;F?I+:%=C8J7K<-8(.='I:+238+'
MQA)Y*KH\?'/7R,7!V>O0QM<@YPVS,CPR)]V0AF%J90]/1MF1E=([$M)+%"BB
MP+/+5QT5P6( 19I "6TE@KD"P!:%NP8@?)B::]P5TJ&>VU[LR(Q%O1%U)8W(
M$L5OEA79>:@X6?I%LH*Y.'V:4=)W ZI U^.L6IK/>JU;Z4/9AK"76I:Q@-ZZ
MLUH='$F$MM4QIBSJ7F-%L+D!A,BZ*F07*4M/YP[[(I597AF56D* <"50DTCZ
M8D,L!+Z9D)R<)BT* $O//P$4 LP9HXY821&'-YT?5$@O(W#E 75&PQ$K7/N.
ML51V/-4/3%\FY_5]"V3=[;#S4U1:V!"-4V.F2:NV_(F69PR:!OY<3EJ,/J<3
M/XB0G$G3+(F"HAF5K/+P:6LJ;"U'3R32!M2V='S*(Q,H5I%;7E54#>/4H,6I
M5)E$-XH3)44M.3<U<Z1Q\,JQ*,E!(9069(["/,J8CT[,>)I8JJ-(ZW.:$#7;
M0?5;Y59>%E7[5!U.%''=@, -6"2I?&JSFU<JP$V;X?*R@(W($BT+D1AXD%%)
MU_>Y-P7(U5<E9C/4:*>:2%G!9!+(OR5+0TY85<FEF%EI%42SDL!PW!35HD(P
MPJ\T$4RJ=+K$#I#-::?B>;1BRWO5&,Q0C3]] 5V4R1J8_#]HG7#B9*2:U->$
MTVL4#;]NMD@V5!R=C:E-;*T85 PM5K\*=),6\2]Q&^*F3$S<=*H ;))9\M9<
M3YTNWC=^'HU@@RM!%&H#ZVGGS&7+5B9&16C(GCU$L-01P&19 \:W2/7<AELJ
MSRNQ(T+3P425S3!KD,#"S#2M_30Z2RE6,@3O,!^#3KF:D=9VRNQ=VUQM>QO4
MBZ1R*=LU%PI.X-(ZFK$"!'662B1\CVDK:$C)Q@3@;UCL86*WFOQ;DJ=B".EF
M":[[V6F90I!;XY*J216 )]*-:?<+<+9W8B,%UA4+(6^21(R$M<+8: K Z>3L
MZ@$C>X4 N0ICV,]HG$2%9.N8VC=MV*&FKA0:_JR%H4.B[WV[1MTXP4[E 4?(
MU*#40Y79&"J]F>AWH]9QX9<JW'I3*L"/29L2+!9S3GTG$DRDH"4$,/FP,Y9M
M  <U<.E#9K-Z5B&"SPGT<0Z5&B(69@&,\KU"< #>Y3S:4L_R?0:Q(*EG>!S:
M=L6Q:YKZMZ6N*79?=I>JWY>RV"E109->C)7DQ5IB^P+$9/3ISS$=;.,UD'^3
MUA%KDR7"SD/("M+.43%#0DBM/!#<!I8HIWWU&**IH*RNI6NMT?C)0U (1VX:
MQW8AG1&AXV2!I[&VXC!&G6Z5-#3SJP/IH8_A"G^4HU.^D>BDC+A;&Y%;NI&\
M+1K 4/5)T,4[J:,HDB;"W(0J.E-M_;E- =N)8UE-'D\1,=I.7BXB'A8R)+OU
MXMU0JH<A5\$O2:JK(2=!!UM45,*E%+ "FR_X2),=PS,\0:$*KC2_QINH,>,I
MA7A\;4 BQQNRLP4EI*J&BL'(TJ.+.LERIM&K+NUF&?J[E59+OL!J(/#:<I$)
MJ2(N5KF8/3>W5'NVPFY[4I$U$MJ<?/Q478>6UNIE%1F(J=L4B\\?[@>0**T8
M[=&#JT@(,96G>(C?6M134=0C@CY09:H'2%#(EFDTV8#$Z%=*_OM4P<-8%>$\
MJ%;7V(,9](DASL@O;"]&<I#A;Y/,V^/C(S6PE;Y%V*.-%B9CY3)9X\6*FQ$N
MUE/Q,S,H5*14W-6$H JO5-Z*2U"Q$:[9RW)A^,QF81PS22*=44594%49&U0T
M5;-1RE-RKV98+L9(P'F5461"TL600,\RQ(=GFH(%=QI42U]!'6QJ]_24@&:U
MD8&.,EVC<+'(W1.=T([8JQ5CM+;1C9:7L8L)8TN2VJ3Q:1'RDCQK!A;#+&1.
MQ3F)<"0:Y5:R,<"JZIJ7#9%M7F .?#8I4[E+!9)(G.AH9Z6DE-B56JK9Y:>F
M@&FY8R2Q@&0#@HKW>161U&)5+QB5/21J>:KC((!>F@B>:64@D:2L<<IX3'BL
M5&A6$D;,NZ&Y@1NWLKJA]=,BMCQ5.G;I8AAAVD5]B C8NC2$38(]!,N]*/0E
ME,O+E=@W7LH4=8:'L0)+K2*ZMYW$9AYF:D<X\OI*F< :UBJ*FA@K5@-B+&2*
M4SQ*6'Q(T/()00<KPZ*@1&^EZN>&'>S/!#55%*TVXL1')!P9" 2)71E3AM<*
M_'KE@)O7X,"UK^VP)4U0I2WP4]*9J@D!<G:D34HFZLPL?&7&S3L U&35WKHP
MC5G:&44@LS(I9S$;DXS:E3AO4J!O!45,"J6!,@IZRMHBX<   RT,GRUC8H\3
M!-W6/ .<8)'II&S, ;)Q(*:H&VY/H52CT=5F21;[*7J[3_:&7H:,I<]L?5[)
M(,GH@[?-^C*.B%"D:15,HC9]@P(NS;-<'MS$)4#"')4"'#Q9)F5:"5#08Z#3
M (BL2F0TR@AC.ZPEU!"B9XL@9"$)+B/B9TJDC6WH6 NJ\>6L%E:Q4QL^E2P)
M*1OFH8%K*@?3EVJY(078DV-TL-+<V(.'D,"DZDV/D)-KV/#D2J)#76&!ZGK#
M;]>T9/["2"Y=T2QL.3L"QCLQ5?C@"[H3#!&GO5T8XF!B)O%&QE,*JI#3"@"A
MBHTR9HQCR^-B"1>HD212RZEA"AI2NI1BS(5UDLMD%0W4:DHT26L87  X$4D;
M6?296;3%KTL0W-><UY:W':LA)/44X/<MKZVU3?8VCPDW4"<P0EZ^WA(S<H?=
M9VUP$+(QT/ :@46U#!Q8]A]XDATH:D67I9540.LZ4; V-7E\.8&P;3%%(E&7
MO<!G >OIE4*H<JS,4]$A9FC:$U%Q<05]10+NNJ26)JC0H -E9HZ2I9CJ:/4H
M4. 5+N:]<L9RCV^]096JK%*QE,V^SK*(Q4TBV^R[&ROBQ,<BGVH&NBR,7(0L
MNP0 S C,K&L:Y;&6AP(Y1<@M^(K')K%0=))@J! 56[&S#+_CF-K!$&8))+:^
MB&-WN6!3$O'I,8U"TE**D$V&_%JHS$HOZ3L:5DCU%+RL!\@AFSX/FE09FQQM
M?779\!,V-53*_,$&U]<39HVS:SG=ENV*L%M2N6[!4H5N!*J$E8XQ1 K-R\<0
M\TQAM+[MY&$:3.P-HFE%MKLD=-4U2R@7VCGCI9?-W)TRZ6*$B.0I"Q%V101=
MRBBX< ,U33TI0W4$21R5,7%C($D6H!T!>/6LZ Y:UKD3/R,74==;6B((&O"3
M3-]LE1)CZ+(2"@JP7*5D&R86Y&EST8Y:6!L"AD%)-S#V IE: 0@R9&X&I9&Y
M".>> :K R-3U551S,BWU:4GI) 20!I:,BY+*F(FQC&Q,D,$QTG4(Q44T%7$K
MD;!FAJ(VM>X.H6L 6>&F_P \7EA_9_KG[UGC5UW,W_M?V7_\"J/^)NT6,,/W
MRJ_[]?\ =J?#KLG]&C?][?\ PC'7G'^4?9]0Q+_*/L^H80^JXK@Z88.F&#IA
M@Z88.F&#IA@Z88.F&#IABAFSMN;!W5:CM':&$S&1#N9B'V#M25!0^"($(0N(
MG(RMB$-/,/MIPZE#TR6WAF1;(P) >-]7O[/+KI*^2HCI\KJXXQ'P7JZZC?BS
MTDK,S+3)(R+3P5*+&6E='J)Z=K*(!*K&/['V9[-]GNS65#M9V]IWFEF0R]GN
MS50W &9+PT>&NJHHI#6STTCN%AIVCI*5PC2U-682L,GQ/6/5_"ZL!:SU;59"
MV;<N0@3\=%,"G24Y;I3+CD:/.662;0ZXL=E[WM;$8(K"!DJRVAF.%,4?G)-P
MLOIPE*JSUM1)*L=.C+59I65!1ZBHKJP-(M3,@):6IKJN6*#4>$LZ66--?+:/
M.O*7FTF=]J,P&6=E<IMYU72L,OR7**)6CC@R;)TX;TM/*Z"*"GIJ6"HJ"J<>
M2&HD5B\DZ T$54G'=F[/0');CLQ,M,3"A'\$QE<=G#23%@"NMH:8DI8<<C(I
MDNEE @JG3H^ML Q#[V3\U*D[1QSU[&HKVAAA>><I(\%/ &6GHZ;2BI301*=4
MD4&TM0SR22S6C9>+VR[6P5SMD'9A?@SL=12'S2AIEE@&83E4$^8Y@99)*FKD
MED2U-YXY>*E2 -##-Q5%K>MK'S[!TPP=,,'3#&=&?T2 _P#3!O\ WR.I7F/6
M/KQ*\QZQ]>)BZSXSX.F&#IA@Z88.F&#IA@Z88.F&()W'^;#C7]/Y^Y'^8O=W
M?O\ B[=^NUE/[D[0_P#@J_\ O>38P3?+I_\ OS_L)[XG;KBXSXCVPZDU3;K
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M#(H)%"(.,?&::=*?4N"JL+%5(U![$ C6-(#V(MJ 1+-S&E;'T1:0S"UF86!
ML2+!KZ@-]@US<<C<WYXR:W3:A30QXZH56MU6/$C(Z$$!K<'&088L-#J-7$1
MXT6**RS&1:Y&07' -H2("H\U0S362G\N7))N222;$DF]R%5 3ZD15'<JJO(
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MNI=6%C&VA[D !@)B5O>Q913SEPI)00R%K!3A<C>6NDY:6B(@"<GRB[!B):A
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M.*@95]=! M[AIC!L3AX^2I6JZ?N&5&%C7BVR$1I55O$0'$RJW,NE6$&?")C
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MQ-$[%EU2:ZBGJGD<BWQC5%+3REE"C7$+"SR!_J%XS\8:_#R<!%NC,0<E%6^
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MBU,MVFM4\R')I>:EM"9K[M.%A2-H.!PE:=CIUE<97LA;GV1#*A$97'M0MB2
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MQW\)Z>:U/Y//^9D_Y<-:?A+_ )P^W!\K*M^B6O\ ]^8[^$]/-:G\GG_,R?\
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M^0P\[G']\]?HIMS_ ,'!\Y#>G?M]LRR8SGZLO#?P;OC\7_']>7W.9):_F$9
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M>/\ ?18].OCX/.I^?$Y?X*';:_[W8BWCUOSQSGDAO/T_FEV3';TSGSAL^O\
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M<;4\K&<Y[O!T5%(BUISG.,>7D'P9PE.%85W7E?CZ[RA=H:PGAFAH%/)**C4
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MST7G9UW0.Z,FT6R3!$9PF,&(Q@F-J%9B1HZJ42"?4M^%J,-$B'/G2^9.4/\
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MF#IA@Z88Q#I ",'47)'!QXJ,XPLDXED0=&<_1A3Q"VVTYSVSVQE6._;TZ87
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M(62#9'A(R26/<:CKLK7CCE=E-ED62&2B1Z>2-RC0S 5T,A281E48%@ P.*@
MB^H6O&0V[(T<AG598W0,LD9:GD4-'K#%3I)MNKTSE9K.T4[0=KEAK?37>1=>
MK<U18J:IUDDQ!9&T1:).-J=DO%7C)W7%?L[^5*CPH^4MXN)J12@6"=DED"^?
M.Q**I#M)3I4H%N-<;TWG9":PFMTA#.R#T@%)*@6)EE*F0$$"*9X7//2R3BGN
MP4L54R%0&.QN=_1:SHU+<*GO*FEW-S7)%96Q>=G4B2KUUC*J7/"3.M-B6C7,
MXZ<N!D;%#K2?*5@PX;(LN:K(13"25H)\YI&2.IG54:.HE2X86261=!CD>)DN
M"!Z#QD74E#:Z,RV)J\:JY5@K6"-?3L5EB252 0" R2*;, PY, ;@5VYF:DU3
M&Z[I%VCM9:^ N<'RBX4KA;<%3*X)9XA<IS'T1#2:HR>8C6Y4#,C#R,A%'9%+
M:R7''&!$>8,2\TOVG9#-<TDS"LHI,RKY*.;LUVQ$U(]94-32B/LEG<T8E@:0
MQ2".6..5 Z'3(B.MF52-"LBB$:.(XPZU-'I<(H9;UD -F N+@D&QW!(Y8OQU
MX;&_@Z88.F&#IA@Z88.F&*T[BVM::-91(J$5&X%?B!3%X,#40[DAXPUA64K2
M^WC"/ PC[G*?IQGPYSG.<8LH!YW]GU^K])'+K1F(-AW8B9/(K8BUI0A$(M2E
M(0EM$4ZM:UYSV\*$X+RI67,YQX$XQWSW\.,]_7,Z1<]+7WN.G7U<MNFXOMO3
M6W@?9]EL2'&;8NXL<5/7&4JE<@PA233SY5MN+CHH(1'G%R$K)$F>0**"/W?,
M5G.&@FO"\>^*WW3U4VOMN.\_1M;YS]&+@MS)[A;:XN1S^SZL:L]X^W?X^ZGG
M_@%7)EMP> Q]IR<H=?:165"LJ6E!0<U/2<<W,,$Y]WPR;!L240^HT5 <L4]E
MUAJ,6 )/M &_CZMKCQ^;GBR'&CVDG&GDR1"P%.LE,CK+*9S:XFD6FL+KDP)8
M9 B1]]?PLX9FO'6E)BY,B0<KDW*E+2Z^>\5D8YM\K+Q9B2>+*28A"3K:YA "
MB+Y5S$%50$^2%4#2 HM%[7N+;ZK\[D&X)ZWN 0>^V][8MTS+0]>2H*!J%7K;
M0<NB58%"H<2*RS(I:4*Q.C)%=!0T9D1]]E!OE9+0,^ZVV0MI>,.9)*RKF.J:
MJJ928S%>2>5R8B=1CN[$F,L 2GR21>U]\0%4:@JJI)4M90+D$,";#TB+7!.]
MP"+;8[9*WTVO035LLX6N:_!4YJ2.!M%EAX&MQ5/)><045(QQ\@]D2,4Z^LIX
MUUHT13Q+HZW<J>*;0Y45=4!*!4U $RJDP$T@$R(H5$D]+XQ46RJK7"J-(  M
MB=*MS"FS%N0-F)NQW'RF-R2 ";WY[XHQ8?:>\1H(N4PBXT"UR,B8')39&OM:
MV?9*90F(]YD8Z3-E:#7+*!*DQ?PCW]AYLV1-B\)!+P@?#PJU1YS4 1J*B;3$
MKK$O%?3&LJE9%07 0.K,KA0 X9@P(.%KW)47=0K$BQ918!2=[KL %)VM8#;%
MBM#<MM1;EBCY;2%VU1(.2,P;\6@XAH6NV]V?:==&DUV*FR3$-:HN8#?'\D]%
MHB(^2QC(SSC:ABAGG:R32RZ!++)*(T$<8D=GX<8O9$#$A5!N0JV47Y7OB/WQ
M.G2S;L;#4QYW)M=COS-R;\N=I;F-B;7 RMP1VOOLH<RWE!$;Y6?,SCNEK!;9
MJPW%X[_=XRMC*<=_N<Y[=Z;>(^D7^;8?/W<S@2PZC>_/8_H!^;Z,,(K?^S07
M\L&C0XKF$]\)=BW$^+';./$VKWOP.ISG'IEI2\9[9PG*OIQ;2#RN1W_/<6 V
MZ=#SN!8'%2S==N[;[??GX60I_D%MHR&E@Z_)5F"FRHN08A)LNNKF1(N66PXB
M/D#8G,J%\3$#*6P\7'(-!<,&2XPV8&ZXDAL5Y^OOY#?GZQW>)-K8:SX8L+Q9
MG]RVC0>NISD&S6&-Q&@2Z;O\BVO)J9!H=DF08\^OLY.D76HR3A!HR1&;)*R8
MA!7A-'#+P^&/3<<^>,MP=QRQ8#IA@Z88.F&#IA@Z88.F&#IA@Z88.F&#IA@Z
M88.F&#IA@Z88.F&&I;[G!4B+Q)33SJED.X$BHH%G)DU.R*TY4U&0L:WG#YQC
MB4J=<PCPL!BMOGR#XD>*46S5F"BY/@!U)[@.I^KF;#?$,P47/S#F3W =_P#6
M=L5BN,T3/LL3FU'T@P2R6D5_6,2I^28+-7W<"9F&@TNO7FR.^6M\:.:$3$ 9
MPA0$1(/A9L;VLS%A=]ATC&^]C;5U+=P&PV-KB^,+&^[[#HEB=[$^EWGU7'4=
M2.]F%M5O0AR???IM<4E.6:Q"E9;LIC7;.$YG[&*ZKX3A;:DI5&UE:)(932?'
M;B6G'04+,WRO1'X(._M8 6VZ#<?A$;8KN? 7Y [\^I]MMM^XX?D-!0U>"1'0
M<8#$@H4IS P S0S:W7,]W7W<-I3E\AY7=;Y#V7'WW,Y<><6O.59L  +  #PQ
M/+EC6MSAYGS_ !VO<-1R=;?*^BS5/@9DY^/3+LVF0F)^QV6#"77;$)@V$ISM
M)DH&"F5%S\%-NSIDT#'P[8!8GG$^FR6B[+UJ)2YKVIR_),XJZB5*&GKYX(8?
M-Z>.&1YYQ,4U+4<2:& F:!>+3N@,KMH7#49=VYFI:S-NSW8C.^TV195'%\*5
MF4TE1521U52\B14T"0)(\DL8$,M0L4%3)%!.DTBPQ 2-0*6VERMY:;)V!=..
M=;M6DXZU05'I.T0:-/.3DY,R517.D5>8M<X!%UY-/M:8:T/QI:Q3*?*R%7%K
ML797I2(KM?S'2G:7L3V:J94RW*LR\HV80L\:U*P1Y=V8BE5K7AJ*CSGS[TU*
MF<134C1CBPL0RN?1T_DF[99Y1TT_;;MCV:\C.75"+/\ !M95OG?;IX&17<3Y
M-0/3/EK")@123STV8I.>!/ CAXQM8UX/OG0/'35M6D(J1V'?(PR7#L2BVK+L
M2>?!/EI0^*:(.C#FAPU"?$0AS)$V;*C86%CG!HP><*2*-UP:G,JO.*B;,JZ@
MH,KJ:IR[T&6+IHZ900D:1BYN_"56F93I>9I'4*I"C1KLJ[/9)4G*NS.;YQGN
M344<45/FV?*D>95TG#5ZJ:1$5"D)J6E6CC9%ECI1#'*6D1I&52=[;]1'S!*-
M!S[+H %E5XDP<M*>Z24110<1B/AS$D#)V8*:VO\ &(J.55&SR2:.&!.DMQ?Q
M)LQO#I&WI#?Z[]W3;O//&E8;7-MO'P-^74$VVMMSP]HG:.T3GIX,JH.B+!85
MB/DB-<["#&4V&-93%3K<<^\X9/(GH^)@#QZA&/B3=8.MD?53I.>GX^=1$BHZ
M$?./#^GYO' @=/;OL+\AT^L\B=L3K3I*7F:C5IB?C50\]*UR#DIN(6.^(J+E
MSHP4J2CE"E+<*&R$:Z\-D<EQ9#/E^6^I3J5YS4\S;OQ!M?;E[]]O?KUPX^F(
MP=,,,*0H$;DM^8K)1%-GGW5$/G0:6T1\F2K.%+<GX!>/A,PX\I*$OGN,,3J6
M4Y:"F0N_CQ4J+W'HGO'CSN.1OU//Q&(M8W&Q[QUY\^_GZ_'"WKK)GRW&9M54
M&;L(L3(M15OAQ,F0YH:\C9-926MM1U>?(\#;K\5(*2R^XEM(LC,N-+>9M'\O
M==['T@-N=_$K?KWFP!.,B&YW6QL=QRWML.[EUMW"]L62ZV,9<'3#%<N8G]*/
MRF_6Y;O_ ,V=GZ]!V2_NJ[,_Y09-_P"XTV->K_<E5_%YO]FV)>U]^8&D?UH5
MK_(H77*K_P!W5O\ &ZG_ &SXRQ_>X_\ $7_5&&1<]#T*\7838,DNU1-DQ 1M
M1GWJK<;%5P[Q38:9D+#"U&]1\+(""V:!B)N8FS(X<UOW@4>Q6N%05\G[?:HF
M9T&B1^*'&M)D1)8F),<BQF4H&7N'&E#J"$F5]$ZRHJ*N=970Q%&TM"\CQ.NS
MQM((P[*XW!/!B96OJC>-7B*/=BQJIQ%U'2\PA4"N[-SM74&BL6F3NTY/66O@
M0NN+=JBJP\?)3K\CXHFGTV\V<:OAG,F83+2IECE5RD^8;(DY2S,9&+'7-Q3-
M)^_DDG-(996)N.(_F-*"0  (ME!>0O4-8*H"B- BI$!:.-$:9T1%Z*K5$MA<
MFS*M]"1JK5A>">A84K3)_N]QEI'0L;68?7$C-VLP\V+BZ7,G3E2"?>RRU[PS
M!ER1C6/"EE<T(H-BRJF_@\(N-A?1(90%984@5A\H1QT\]+&+F]]$%3+&+W&Z
MN09%#@6+$EO2U22RF_5YI(I9#M;Y<D,;D>!461F4SOJ34L%INOR];KTU:YL*
M;N-PO9C]NF&YHY-AOEAD+9:GAR4!A>2+*6:7EIK(>&U,BE21+0>!PDCBL  J
M*@  4N0>I+NTC$GK=V9O L0-K 0S%F+D[D(O@!&BQH /!%5?4HOO<F&^;'YR
ME=_70<&OW[7'SKU78W^W,_\ DWVT_P"#L^QIUOWA?XS1?[[3XMMUY7&W@Z88
M.F&#IA@Z88.F&*0<DL.+O$8A"5*RJO I2EM.5..+7(R3:4(QC.<K4KQ=DH2C
M*L]\^'&<]\9R+\D^T?0.MQ[=^G3&)^8]7Z3B(;-9Z%H+6]CV_M&09"AZT(VI
M0^'$JD9>5-:=^#4^KA><R[+6FQ/-O"Q\< ZD\Y_^4AG1T9<DD5)N?#YK[D_I
M[M^?6PE5L+GGT/.PV^OJ>[J,>/KG]S\Y <J+9+5"WG+U]J1DB/?"U55I$DN&
MK88T@SF.D;L^ Y&"W6UH8R@I2I%Q4!%?$F6X2&JM@;/:8QDGI]5]KCZ?#F>E
MC;&90-R1SO[;#EUM8==K>-\4VG-:S T3=)MY.<UO4SM222Y,F2N'BIN^,Q?P
MZEQXZ6<".2;K<7-2SF1WZY(-P-8L+QJ'#V(J-8$;@FU@?7SV[N_W[I!Z=6OX
M<B3?8W//U<AT.$<=VT3]]&*K43&W"PSUB8,KU5I487&"SIIK@)HL1#U:HDU:
MR1@;33J!@HR#9BUL%!J!B_NFGE8G?WZ\O$>.Q]>&P&^P&QON1:]P"01W';?G
MCUB<!M=\S-5UQI_>&YY3%>EJZ"J*U$1(2%DF:M*$,1SWF%6XF12_ _"VV2XA
M%2CS;-!^2^DI1 ,BRM7610VQ/,6 Z^.P)Z>RVYYC&NY%R%[SO?F-^@YW[\/'
MGEQY9Y-Z&L $A*V%RVZ_3*[,IF(TM19,U9JW6)I(U;F "O-Q*1-C'.)B5(:6
M.8.6Z.2T3@=E\*0EA< #IN  +<CN.5]S:^P-]@;8A#I.^]]CO;:]_'E_7MMC
MRI4L5S_8CS]ADLQ)Y0I+TP\9) !5YMZ:;#1++,9=F6L(B"C'BR\K<A)$8ENT
M(6O+842?)8AMS/M-_:2?Z!ZL9SO?T=^[;<\K ;6\;WWMXX<+ZGX;8EVT%)Z^
MF8>W?+!FN27>1D3+-!S<)-H;/%#R9*F,"29T@SW>M$,MC+XOD$OM3\#(SS-E
MG?D!SZ^WD-[W/>.6WCB2+ ,3XVL+;@\]NG=O;PVM:S7?M'>9>C]FP M&OUKM
M-4%AH^()U_L0:<N=!^$5]DB*9AHJ)ECQRXRK QD;&R;DY4I"$F)$!U+TI.RZ
M",/N/?Z\186/*_=W\O#V6^>UM_29Q YO:BYPU623%1+]&V'6V1R+EK*=.'*D
MXQI3K83EJJQC6&5S=,D)/*AXV<9%9?%4^-'3\>&Z8 J3;CE[^_JV._.UJE=K
M&UCO?U[^PBX_3SN9VF8E^&.>%=^Z2K&71GNV<)<9RE;?B3GQJ3A?JMMUM7@R
MC.,^'S,>%2<@-P2-B>O,; >_6U_$7PD6-OF]6-@.G<93K2IXSG.<^XOYSWSW
M^F0,SVQV].V._9./JQC&/JZHW,^OW]G=X8RI\D>WZSB2^HQ;!TPP=,,'3#!T
MPP=,,'3#!TPP=,,'3#!TPP=,,'3#!TPPR[S=XNBQ+9QC3Q\C($8CJ_ !*:S*
M6"7<:<=:CP$.K0VG"&6G2SS'E($C8X<H\QQL<=>>JNX07._0 <R?;W<R>0%R
M<59@HN=^X#F3[\^X8K!)2,H),L3$\ABW[6L0Y T' B/+'AJ[$I<:R2,&MX<E
M4-5HU]0KE@LI,>5*2)J@TDB&&OP5<8UB6)NUF<[ #DHY[7OL-B38F]MMU&,1
M)O<[L1L.X;6MW=]^?+;<8=M<IV(TURQ3QF+!<"F5LOS#K2VAHP5Y27'8FM@O
M/$YAXI2TH40E#[ADHZTT1*%$J9&;&D+:Y)NQZGH.X#H/K/,G%;=_/WY>_P"B
MSVZMB<'3#$!;1XS:BW+<*Q==@09TQ)U=D05H)J9D@(::%C#C):$$L<<$^RB7
M$@YF0,EXX5U:&/?WO&:V8RVTRWQ<Q[/Y7FM72UM= TTM( J+Q9$BE5':2)*B
M)&"S)#*[2QJX*B0ZF#  #Z#V5\J';/L5DN;9%V<S*.@H\X=Y9I?,Z::MI)IH
MH::JGRVKEC>6AGK*6GAI:B6$B1H$"1M&2S%6M/'[5%G^&EM586H66! 9C:Q>
MM>*S1+U6 14YP''Q%GK> )#,$PYX''JE)JDJ=+8:0-.UZ5!RX(YV(T2)%CC1
M8XT 5(T551%46550 *H %@   -N6/#5-54UM1-5UE1-5U51(\U145,KSSSRR
M$L\LLLK-))(Y)+.S%B223?"%4+G=:/<HO5&X)(2?=LWO^-4;5%CV(9J^KB07
MY21IERB T-P\'M6,A!#)U&()(E=OT#%V"QUR$K'P";K$1<VM<>T=WB/#U\O;
MC ;'<"W>.?M]QM[<6$ZC$8.F&#IA@Z88.F&#IAARU3^BO^]GO^-'5TY^S[,7
M3F?5^D8DOK+C+@Z88KES$_I1^4WZW+=_^;.S]>@[)?W5=F?\H,F_]QIL:]7^
MY*K^+S?[-L2]K[\P-(_K0K7^10NN57_NZM_C=3_MGQEC^]Q_XB_ZHQ5#;\K=
M0>1D8B<9WH[K]O6]&(TJ'J&+V*14IG>"KY=<;%!W1+Z\A9B+AJZBJCZB"@G]
MQJ UHB*G=B2(^"YR+R9!\UWE3SEH4,LZ10/3Q2:5AD935&6/6]HQQ;0I4&1E
MF2/A-0E9#,PVE6%A3I*_"C:6H6IF12\L<96E$+B-?C&:.]0\*Q@QR2!EJP4$
M(->(#9G)N_M:]D[[#;: JL7,OFW26@-,[MU3."RLYQ6W<1?*431H-I_8-DIE
M"VCFAC4.Y5T,]V?L$O$1M5GK/;ZZ-/$YV"CCV9F0)4Q4\A#J9XQ49,U/420K
M:2"60O7QLGQ4B4T3MH1=<LE$&RAM*R$0O*@:-A#)>N$T44[?%2HL:4[!O3C>
M1U(9M:Q)BZLW)RRKC?'FFE4C:LO'3.R;F#=K!<]9;=E4F:LF]X[*@JU*XL-C
MJ$G=:F=3]<B5&>C@-\2=)M"*T]$/SDKL^</DD!PA9FC$GH**/XXKIUK,E)6%
M9(]"<-S)/34YT -,JU4<4L+5#220U*B[F,J0TQ,8;6JA.)2ZHWXC\0 )+.@:
MXC9X9)8Y5A6..2X'#>QV:?U//-V\O<$E,0NY]\Q8DQNZAW:@769IZMPW60US
M)?#;M3:,\;#D:\.J^8@J#@AX$0+#<.(R$[&$1H<)J,498 &\JVOZ6E9I!$7!
M);4T/#;4V[7W](,!,FGBMI-U*PML/1#&"/B@6 4 3"39=AM;T2I/1S8_.4KO
MZZ#@U^_:X^=>L[&_VYG_ ,F^VG_!V?8T:W[PO\9HO]]I\6VZ\KC;P=,,'3#!
MTPP=,,'3#%4-PK0G9,4GW-!+JZX+X'UD>5[DVT=(K==PC#3F5*6E7@2YA2,H
MQXD8SC#N<]2.3;D<O&YWMZOJ\+XH39AM<D;;\N?O?YNN/*A[7WF#FU[@-T#&
MS4HG7FEW&FK= C28X8EEVG+1?Q'+I(;L3(ID(:L0SP]:?%4V@OXJ5.C-.9 (
M?;D8QD )Y#[.O/Q^KYCC3\8W$Q5LJ][!K\3;*:E4'(6FN;(L[@L3L@6%C(8N
MVANAU@_$\]6YVQM328M4 LJ<@V6Q29$""?BU#,P;FQ'U[$>R_L^<\K8L#86/
M,#F!8@D];^P$W'<.N)GY7WVJ/RVTH:ID05EKW(_=U5Y,QE[>8L\3/4J)=C-D
MO0NNIR#=#8C%35:SN GY1RM>,GHY8PL<( RW+-.Q\>/U_5[+?..5[XJNWC86
MZ&Y'L.YM_3C8/[$#25>O5NVQM*8K$4[-ZZ%IT!4)LP5;I4#(64:X)L1T=X_
MED@VN-1P3KSC69%2S37VE!#R!31$K8;G?U\^1&_,<COXW[SB)"3Z.XN3?J+
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M>=Y+8\%4')60)(<PRTQ%P6927-\;V<]F6,LCKR2K./#E&4Y7GLVG'3W]7?\
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M@(CFCC!$7$JZ^&0JH=H[LXWY.T>3YADM;E>;>3R7+\W-#-!EN?=FLZ8PM6+
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M)(%D81.X&D.\8(1FT@"Y!-@.X6PM24S3+4-!$TZ)PUF**95346TK(06"AB6
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H(8<C(<D"++)<ER,R9@1$HED%!B8\422;G$@6%L2#U&)P=,,'3#'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
